PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wilson, CW; Nguyen, CT; Chen, MH; Yang, JH; Gacayan, R; Huang, J; Chen, JN; Chuang, PT				Wilson, Christopher W.; Nguyen, Catherine T.; Chen, Miao-Hsueh; Yang, Jehn-Hsiahn; Gacayan, Rhodora; Huang, Jie; Chen, Jau-Nian; Chuang, Pao-Tien			Fused has evolved divergent roles in vertebrate Hedgehog signalling and motile ciliogenesis	NATURE			English	Article							KINESIN-RELATED PROTEIN; TRANSDUCTION; DROSOPHILA; HOMOLOG; MECHANISM; DEFECTS; COSTAL2; PRODUCT; COMPLEX; GROWTH	Hedgehog (Hh) signalling is essential for several aspects of embryogenesis(1,2). In Drosophila, Hh transduction is mediated by a cytoplasmic signalling complex(3-5) that includes the putative serine-threonine kinase Fused (Fu) and the kinesin Costal 2 (Cos2, also known as Cos), yet Fu does not have a conserved role in Hh signalling in mammals(6,7). Mouse Fu (also known as Stk36) mutants are viable and seem to respond normally to Hh signalling. Here we show that mouse Fu is essential for construction of the central pair apparatus of motile, 912 cilia and offers a new model of human primary ciliary dyskinesia. We found that mouse Fu physically interacts with Kif27, a mammalian Cos2 orthologue(8), and linked Fu to known structural components of the central pair apparatus, providing evidence for the first regulatory component involved in central pair construction. We also demonstrated that zebrafish Fu is required both for Hh signalling and cilia biogenesis in Kupffer's vesicle. Mouse Fu rescued both Hh-dependent and-independent defects in zebrafish. Our results delineate a new pathway for central pair apparatus assembly, identify common regulators of Hh signalling and motile ciliogenesis, and provide insights into the evolution of the Hh cascade.	[Wilson, Christopher W.; Chen, Miao-Hsueh; Yang, Jehn-Hsiahn; Gacayan, Rhodora; Chuang, Pao-Tien] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Nguyen, Catherine T.; Huang, Jie; Chen, Jau-Nian] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California San Francisco; University of California System; University of California Los Angeles	Chuang, PT (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	pao-tien.chuang@ucsf.edu	Chen, Jau-Nian/AAM-7808-2020	Chen, Jau-Nian/0000-0001-8807-3607; Chen, Miao-Hsueh/0000-0002-9715-3067; YANG, JEHN-HSIAHN/0000-0001-8648-0882	National Institutes of Health; American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091915] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank H. Bourne, C. C. Hui, Z. Zhang, J. Strauss III and W. Hwang for constructs, antibodies and sharing of unpublished results; R. Harland and T. Mikawa for X. tropicalis and chicken tissue; K. Thorn and S. Dandekar for assistance with microscopy and ciliary beat frequency analysis; M.-L. Cheong and Y. Nozawa for technical assistance; and D. Casso, S. Coughlin, T. Kornberg, W. Marshall, T. Mikawa, K. Wemmer and members of the Chen and Chuang laboratories for discussion and critical reading of the manuscript. Some data for this study were acquired at the Nikon Imaging Center at UCSF/QB3. This work was supported by grants from the National Institutes of Health to J.-N. C. and P.-T. C., and a Career Investigator Award from the American Lung Association to P.-T. C.	Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Chen JN, 1996, DEVELOPMENT, V122, P3809; Chen MH, 2005, MOL CELL BIOL, V25, P7042, DOI 10.1128/MCB.25.16.7042-7053.2005; Chen WB, 2001, DEVELOPMENT, V128, P2385; Chilvers MA, 2003, J ALLERGY CLIN IMMUN, V112, P518, DOI 10.1067/mai.2003.1701; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; Davis EE, 2006, DEV CELL, V11, P9, DOI 10.1016/j.devcel.2006.06.009; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; FRISCH D, 1968, ANAT REC, V162, P221, DOI 10.1002/ar.1091620209; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Katoh Y, 2004, INT J ONCOL, V25, P1875; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; McKean PG, 2003, CURR BIOL, V13, P598, DOI 10.1016/S0960-9822(03)00174-X; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Merchant M, 2005, MOL CELL BIOL, V25, P7054, DOI 10.1128/MCB.25.16.7054-7068.2005; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Nagy A., 2003, MANIPULATING MOUSE E; Neilson LI, 1999, GENOMICS, V60, P272, DOI 10.1006/geno.1999.5914; Oh SA, 2005, CURR BIOL, V15, P2107, DOI 10.1016/j.cub.2005.10.044; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Sambrook J., 2001, MOL CLONING LAB MANU; Sapiro R, 2000, BIOL REPROD, V62, P511, DOI 10.1095/biolreprod62.3.511; Shu XD, 2007, DEVELOPMENT, V134, P1921, DOI 10.1242/dev.02851; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Smith EF, 1997, MOL BIOL CELL, V8, P455, DOI 10.1091/mbc.8.3.455; Tay SY, 2005, DEVELOPMENT, V132, P625, DOI 10.1242/dev.01606; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Yang XZ, 2008, B MATH BIOL, V70, P1192, DOI 10.1007/s11538-008-9296-3; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zhang ZB, 2002, MOL CELL BIOL, V22, P7993, DOI 10.1128/MCB.22.22.7993-8004.2002	37	107	114	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					98	U105		10.1038/nature07883	http://dx.doi.org/10.1038/nature07883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19305393	Green Accepted			2022-12-28	WOS:000265801300037
J	Coumailleau, F; Furthauer, M; Knoblich, JA; Gonzalez-Gaitan, M				Coumailleau, F.; Fuerthauer, M.; Knoblich, J. A.; Gonzalez-Gaitan, M.			Directional Delta and Notch trafficking in Sara endosomes during asymmetric cell division	NATURE			English	Article							RECEPTOR ACTIVATION; DROSOPHILA EMBRYOS; DOMAIN PROTEIN; FYVE DOMAIN; ENDOCYTOSIS; LOCALIZATION; SUPPRESSOR; PRESENILIN; SANPODO; FATE	Endocytosis has a crucial role during Notch signalling after the asymmetric division of fly sensory organ precursors (SOPs): directional signalling is mediated by differential endocytosis of the ligand Delta and the Notch effector Sanpodo in one of the SOP daughters, pIIb(1-3). Here we show a new mechanism of directional signalling on the basis of the trafficking of Delta and Notch molecules already internalized in the SOP and subsequently targeted to the other daughter cell, pIIa. Internalized Delta and Notch traffic to an endosome marked by the protein Sara(4,5). During SOP mitosis, Sara endosomes containing Notch and Delta move to the central spindle and then to pIIa. Subsequently, in pIIa (but not in pIIb) Notch appears cleaved in Sara endosomes in a gamma-secretase-and Delta internalization-dependent manner, indicating that the release of the intracellular Notch tail to activate Notch target genes has occurred. We thus uncover a new mechanism to bias signalling even before asymmetric endocytosis of Sanpodo and Delta takes place in the daughter cells: already during SOP mitosis, asymmetric targeting of Delta and Notch-containing Sara endosomes will increase Notch signalling in pIIa and decrease it in pIIb.	[Coumailleau, F.; Fuerthauer, M.; Gonzalez-Gaitan, M.] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; [Coumailleau, F.; Fuerthauer, M.; Gonzalez-Gaitan, M.] Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; [Knoblich, J. A.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	University of Geneva; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Furthauer, M (corresponding author), Univ Geneva, Dept Biochem, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	Maximilian.Fuerthauer@unige.ch; Marcos.Gonzalez@unige.ch	FÃrthauer, Maximilian/AAY-4516-2020; Knoblich, Juergen A/C-2974-2015	FÃrthauer, Maximilian/0000-0001-6344-6585; Knoblich, Juergen A/0000-0002-6751-3404; Gonzalez-Gaitan, Marcos/0000-0002-6295-7321; COUMAILLEAU, Franck/0000-0002-1392-5665	EMBO; Human Frontier Science Program (HFSP); Fondation pour la recherche medicale (FRM); Max Planck Society; Volkswagen; FP6 Strep (ONCASYM); Swiss National Science Foundation (SNF); SystemsX (LipidX); HFSP	EMBO(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Fondation pour la recherche medicale (FRM)(Fondation pour la Recherche Medicale); Max Planck Society(Max Planck SocietyFoundation CELLEX); Volkswagen(Volkswagen); FP6 Strep (ONCASYM)(European Commission); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); SystemsX (LipidX); HFSP(Human Frontier Science Program)	We thank S. Bray, P. Bryant, D. Glover, C. Gonzalez, E. Lai, C. Micchelli, M. Muskavitch, M. O'Connor, J. Posakony, F. Schweisguth, J. Skeath and A. Wodarz for providing reagents, and the M. G.-G. laboratory members, A. Martinez-Arias and F. Schweisguth for critically reading the manuscript. We thank S. Sigrist and W. Fouquet for providing us the opportunity to perform stimulated emission depletion (STED) microscopy. We thank A. Schwabedissen, D. Backash, C. Alliod and A. Beguin for technical assistance. M. F. thanks M. P. Euzenot for support. M. F. has benefited from EMBO and Human Frontier Science Program (HFSP) long-term postdoctoral fellowships and F. C. from a Fondation pour la recherche medicale (FRM) postdoctoral fellowship. This work was supported by the Max Planck Society, Volkswagen, an FP6 Strep (ONCASYM), the Swiss National Science Foundation (SNF), SystemsX (LipidX) and HFSP.	Andrews R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000493; Bardin AJ, 2006, DEV CELL, V10, P245, DOI 10.1016/j.devcel.2005.12.017; Beckmann J, 2007, BLOOD, V109, P5494, DOI 10.1182/blood-2006-11-055921; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bokel C, 2006, SCIENCE, V314, P1135, DOI 10.1126/science.1132524; Cournailleau F, 2008, CURR OPIN CELL BIOL, V20, P462, DOI 10.1016/j.ceb.2008.03.007; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Emery G, 2006, CURR OPIN CELL BIOL, V18, P407, DOI 10.1016/j.ceb.2006.06.009; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Gallagher CM, 2006, DEV CELL, V11, P641, DOI 10.1016/j.devcel.2006.09.014; Gho M, 1999, DEVELOPMENT, V126, P3573; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; Langevin J, 2005, CURR BIOL, V15, P955, DOI 10.1016/j.cub.2005.04.054; Le Borgne R, 2003, DEV CELL, V5, P139, DOI 10.1016/S1534-5807(03)00187-4; Minestrini G, 2003, MOL BIOL CELL, V14, P4028, DOI 10.1091/mbc.E03-04-0214; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096	28	137	138	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1051	1055		10.1038/nature07854	http://dx.doi.org/10.1038/nature07854			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19295516				2022-12-28	WOS:000265412900048
J	Strahlman, E; Rockhold, F; Freeman, A				Strahlman, Ellen; Rockhold, Frank; Freeman, Andrew			Public disclosure of clinical research	LANCET			English	Editorial Material							TRIALS		[Strahlman, Ellen; Rockhold, Frank] GlaxoSmithKline Inc, Res & Dev, King Of Prussia, PA 19406 USA; [Freeman, Andrew] GlaxoSmithKline Inc, Res & Dev, Uxbridge, Middx, England	GlaxoSmithKline; GlaxoSmithKline	Rockhold, F (corresponding author), GlaxoSmithKline Inc, Res & Dev, King Of Prussia, PA 19406 USA.	Frank.W.Rockhold@gsk.com	Rockhold, Frank W./C-7078-2019	Rockhold, Frank W./0000-0003-3732-4765; Freeman, Andrew/0000-0002-9061-4668				De Angelis C, 2005, LANCET, V365, P1827, DOI 10.1016/S0140-6736(05)66588-9; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; GlaxoSmithKline, CLIN STUD REG; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Zarin DA, 2008, SCIENCE, V319, P1340, DOI 10.1126/science.1153632	6	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2009	373	9672					1319	1320		10.1016/S0140-6736(09)60613-9	http://dx.doi.org/10.1016/S0140-6736(09)60613-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	434UR	19321201				2022-12-28	WOS:000265300100008
J	Engler, AJ; Humbert, PO; Wehrle-Haller, B; Weaver, VM				Engler, Adam J.; Humbert, Patrick O.; Wehrle-Haller, Bernhard; Weaver, Valerie M.			Multiscale Modeling of Form and Function	SCIENCE			English	Review							PLANAR CELL POLARITY; SPATIAL-DISTRIBUTION; TISSUE ARCHITECTURE; ADHESION MOLECULE; INTEGRIN ALPHA; EVOLUTION; EXPRESSION; MATRIX; PROTEINS; COLLAGEN	Topobiology posits that morphogenesis is driven by differential adhesive interactions among heterogeneous cell populations. This paradigm has been revised to include force-dependent molecular switches, cell and tissue tension, and reciprocal interactions with the microenvironment. It is now appreciated that tissue development is executed through conserved decision-making modules that operate on multiple length scales from the molecular and subcellular level through to the cell and tissue level and that these regulatory mechanisms specify cell and tissue fate by modifying the context of cellular signaling and gene expression. Here, we discuss the origin of these decision-making modules and illustrate how emergent properties of adhesion-directed multicellular structures sculpt the tissue, promote its functionality, and maintain its homeostasis through spatial segregation and organization of anchored proteins and secreted factors and through emergent properties of tissues, including tension fields and energy optimization.	[Weaver, Valerie M.] Univ Calif San Francisco, Ctr Bioengn & Tissue Regenerat, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Dept Anat, Dept Bioengn & Therapeut Sci, Ctr Regenerat Med, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; [Engler, Adam J.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Humbert, Patrick O.] Peter MacCallum Canc Ctr, Cell Cycle & Canc Genet Lab, Div Res, Melbourne, Vic, Australia; [Wehrle-Haller, Bernhard] Ctr Med Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Diego; Peter Maccallum Cancer Center; University of Geneva	Weaver, VM (corresponding author), Univ Calif San Francisco, Ctr Bioengn & Tissue Regenerat, San Francisco, CA 94143 USA.	Valerie.weaver@ucsfmedctr.org	Engler, Adam/AAF-4016-2019; Humbert, Patrick O/L-4264-2016	Engler, Adam/0000-0003-1642-5380; Humbert, Patrick O/0000-0002-1366-6691; Weaver, Valerie marie/0000-0003-4786-6752	NIH [R01-CA078731]; Department of Defense Era of Hope Breast Cancer Research [W81XWH-05-1-330]; Department of Energy [A107165]; California Institute for Regenerative Medicine [RS1-00449]; American Heart Association [0865150F]; Australian NHMRC; CCV; Prostate Cancer Foundation of Australia; AICR UK; NHMRC Career Development Award; Swiss National Science Foundation; Nevus Outreach; NATIONAL CANCER INSTITUTE [R01CA078731] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Era of Hope Breast Cancer Research(United States Department of Defense); Department of Energy(United States Department of Energy (DOE)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); American Heart Association(American Heart Association); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); CCV(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Prostate Cancer Foundation of Australia; AICR UK; NHMRC Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Nevus Outreach; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We apologize to the many authors whose work is not cited due to space limitations. This work was supported by grants NIH R01-CA078731, Department of Defense Era of Hope Breast Cancer Research Grant W81XWH-05-1-330, Department of Energy A107165, and California Institute for Regenerative Medicine RS1-00449 to V.M.W.; American Heart Association 0865150F to A.J.E.; the Australian NHMRC, CCV, Prostate Cancer Foundation of Australia; the AICR UK and NHMRC Career Development Award to P.O.H.; and the Swiss National Science Foundation and Nevus Outreach to B.W.-H.	Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Bowers-Morrow VM, 2004, BIOL REV, V79, P611, DOI 10.1017/S1464793103006389; Brouzes E, 2004, CURR OPIN GENET DEV, V14, P367, DOI 10.1016/j.gde.2004.06.005; Brower DL, 1997, P NATL ACAD SCI USA, V94, P9182, DOI 10.1073/pnas.94.17.9182; Brown NH, 2000, MATRIX BIOL, V19, P191, DOI 10.1016/S0945-053X(00)00064-0; Bukahrova T, 2005, J CELL SCI, V118, P4295, DOI 10.1242/jcs.02557; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Chen H, 2005, J CELL BIOL, V169, P459, DOI 10.1083/jcb.200410100; Cluzel C, 2005, J CELL BIOL, V171, P383, DOI 10.1083/jcb.200503017; Cornillon S, 2008, EUKARYOT CELL, V7, P1600, DOI 10.1128/EC.00155-08; Cornillon S, 2006, EMBO REP, V7, P617, DOI 10.1038/sj.embor.7400701; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Darribere T, 2000, MECH DEVELOP, V92, P239, DOI 10.1016/S0925-4773(00)00245-8; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Desprat N, 2008, DEV CELL, V15, P470, DOI 10.1016/j.devcel.2008.07.009; Edelman G. M., 1988, TOPOBIOLOGY INTRO MO; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Exposito JY, 2008, J BIOL CHEM, V283, P28226, DOI 10.1074/jbc.M804573200; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Grimson MJ, 2000, NATURE, V408, P727, DOI 10.1038/35047099; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Heinemeier KM, 2007, J PHYSIOL-LONDON, V582, P1303, DOI 10.1113/jphysiol.2007.127639; Heino J, 2009, INT J BIOCHEM CELL B, V41, P341, DOI 10.1016/j.biocel.2008.08.021; Hughes AL, 2001, J MOL EVOL, V52, P63, DOI 10.1007/s002390010134; Ingber DE, 1998, SCI AM, V278, P48, DOI 10.1038/scientificamerican0198-48; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Johnson CP, 2004, P NATL ACAD SCI USA, V101, P6963, DOI 10.1073/pnas.0307567100; Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x; King N, 2004, DEV CELL, V7, P313, DOI 10.1016/j.devcel.2004.08.010; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Knack BA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-136; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; Li F, 2008, MICROBIOL-SGM, V154, P1193, DOI 10.1099/mic.0.2007/013789-0; Li S, 2002, J CELL BIOL, V157, P1279, DOI 10.1083/jcb.200203073; Li SH, 2005, J CELL SCI, V118, P2913, DOI 10.1242/jcs.02422; Macara IG, 2008, CELL, V135, P801, DOI 10.1016/j.cell.2008.11.006; Magie CR, 2008, BIOL BULL-US, V214, P218, DOI 10.2307/25470665; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; *NIH, R01CA078731 NIH; Pancer Z, 1997, MOL BIOL EVOL, V14, P391, DOI 10.1093/oxfordjournals.molbev.a025775; PAULSSON M, 1992, CRIT REV BIOCHEM MOL, V27, P93; Rogulja D, 2008, DEV CELL, V15, P309, DOI 10.1016/j.devcel.2008.06.003; Rozario T, 2009, DEV BIOL, V327, P386, DOI 10.1016/j.ydbio.2008.12.025; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Shvartsman SY, 2002, DEVELOPMENT, V129, P2577; Siu CH, 2004, SEMIN CELL DEV BIOL, V15, P633, DOI 10.1016/j.semcdb.2004.09.004; Small AR, 2008, J THEOR BIOL, V252, P593, DOI 10.1016/j.jtbi.2008.02.009; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Strutt H, 2003, CURR BIOL, V13, P1451, DOI 10.1016/S0960-9822(03)00545-1; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; Tucker RP, 2009, INT J BIOCHEM CELL B, V41, P424, DOI 10.1016/j.biocel.2008.08.003; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Weber U, 2008, DEV BIOL, V316, P110, DOI 10.1016/j.ydbio.2008.01.016; Whittaker CA, 2006, DEV BIOL, V300, P252, DOI 10.1016/j.ydbio.2006.07.044; Williams CM, 2008, CANCER RES, V68, P3185, DOI 10.1158/0008-5472.CAN-07-2673; Zamir EA, 2003, ANN BIOMED ENG, V31, P1327, DOI 10.1114/1.1623487; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	79	132	133	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					208	212		10.1126/science.1170107	http://dx.doi.org/10.1126/science.1170107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359578	Green Accepted			2022-12-28	WOS:000265024400034
J	Steinbrook, R				Steinbrook, Robert			The NIH Stimulus -- The Recovery Act and Biomedical Research.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						Heinig SJ, 2007, NEW ENGL J MED, V357, P1042, DOI 10.1056/NEJMsb071774; Loscalzo J, 2006, NEW ENGL J MED, V354, P1665, DOI 10.1056/NEJMp068050; *NIH, 2009, RFAOD090003 NIH; Steinbrook R, 2009, NEW ENGL J MED, V360, P1057, DOI 10.1056/NEJMp0900665	4	15	15	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 9	2009	360	15					1479	1481		10.1056/NEJMp0901819	http://dx.doi.org/10.1056/NEJMp0901819			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430GL	19357402	Bronze			2022-12-28	WOS:000264976800002
J	Rothman, DJ; McDonald, WJ; Berkowitz, CD; Chimonas, SC; DeAngelis, CD; Hale, RW; Nissen, SE; Osborn, JE; Scully, JH; Thomson, GE; Wofsy, D				Rothman, David J.; McDonald, Walter J.; Berkowitz, Carol D.; Chimonas, Susan C.; DeAngelis, Catherine D.; Hale, Ralph W.; Nissen, Steven E.; Osborn, June E.; Scully, James H., Jr.; Thomson, Gerald E.; Wofsy, David			Professional Medical Associations and Their Relationships With Industry A Proposal for Controlling Conflict of Interest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHARMACEUTICAL-INDUSTRY; PHYSICIANS; GIFTS; PERSPECTIVE; GUIDELINES; EDUCATION; CENTERS; SUPPORT; ETHICS	Professional medical associations (PMAs) play an essential role in defining and advancing health care standards. Their conferences, continuing medical education courses, practice guidelines, definitions of ethical norms, and public advocacy positions carry great weight with physicians and the public. Because many PMAs receive extensive funding from pharmaceutical and device companies, it is crucial that their guidelines manage both real and perceived conflict of interests. Any threat to the integrity of PMAs must be thoroughly and effectively resolved. Current PMA policies, however, are not uniform and often lack stringency. To address this situation, the authors first identified and analyzed conflicts of interest that may affect the activities, leadership, and members of PMAs. The authors then went on to formulate guidelines, both short-term and long-term, to prevent the appearance or reality of undue industry influence. The recommendations are rigorous and would require many PMAs to transform their mode of operation and perhaps, to forgo valuable activities. To maintain integrity, sacrifice may be required. Nevertheless, these changes are in the best interest of the PMAs, the profession, their members, and the larger society.	[Rothman, David J.; Thomson, Gerald E.] Columbia Univ, Coll Phys & Surg, Inst Med Profess, New York, NY USA; [McDonald, Walter J.] Council Med Specialty Soc, Chicago, IL USA; [Berkowitz, Carol D.] Amer Acad Pediat, Elk Grove Village, IL USA; [Chimonas, Susan C.] Columbia Univ, Coll Phys & Surg, Ctr Med Profess, New York, NY USA; [DeAngelis, Catherine D.] JAMA, Chicago, IL USA; [Hale, Ralph W.] Amer Coll Obstetricians & Gynecologists, Washington, DC 20024 USA; [Nissen, Steven E.] Amer Coll Cardiol, Washington, DC USA; [Osborn, June E.] Jr Fdn, New York, NY USA; [Scully, James H., Jr.] Amer Psychiat Assoc, Arlington, VA USA; [Thomson, Gerald E.] Amer Coll Physicians, Philadelphia, PA USA; [Wofsy, David] Univ Calif San Francisco, San Francisco, CA 94143 USA	Columbia University; American Academy of Pediatrics; Columbia University; American College of Cardiology; American College of Physicians; University of California System; University of California San Francisco	Rothman, DJ (corresponding author), Columbia Coll Phys & Surg, Ctr Med Profess, 630 W 168th St, New York, NY 10032 USA.	djr5@columbia.edu		Chimonas, Susan/0000-0002-7742-5950	Pew Charitable Trusts	Pew Charitable Trusts	This work was funded by the Pew Charitable Trusts.	*ADV MED TECHN ASS, COD ETH INT HLTH CAR; *AM AC DERM, AAD SEAL REC PARTN; *AM AC DERM, AC DERM BOARD DIR M; *AM COLL CARD, CME CE CERT ED SAT S; *ASS AM MED COLL, SCI BAS INFL REC S; Association of American Medical Colleges, IND FUND MED ED REP; Bernat JL, 1998, NEUROLOGY, V50, P327, DOI 10.1212/WNL.50.2.327; Blumenthal D, 2004, NEW ENGL J MED, V351, P1885, DOI 10.1056/NEJMhpr042734; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; Brody H, 2003, AM J BIOETHICS, V3, P58, DOI 10.1162/15265160360706633; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; CAREY B, 2008, NY TIMES, pA13; Chimonas S, 2005, HEALTH AFFAIR, V24, P949, DOI 10.1377/hlthaff.24.4.949; Chimonas S, 2007, J GEN INTERN MED, V22, P184, DOI 10.1007/s11606-006-0041-z; Coyle SL, 2002, ANN INTERN MED, V136, P396, DOI 10.7326/0003-4819-136-5-200203050-00014; Dana J, 2003, JAMA-J AM MED ASSOC, V290, P252, DOI 10.1001/jama.290.2.252; DeMaria AN, 2007, J AM COLL CARDIOL, V49, P1220, DOI 10.1016/j.jacc.2007.02.026; Ehringhaus SH, 2008, JAMA-J AM MED ASSOC, V299, P665, DOI 10.1001/jama.299.6.665; Finucane TE, 2004, AM J MED, V117, P842, DOI 10.1016/j.amjmed.2004.05.029; Fletcher S, 2008, CONTINUING ED HLTH P; Foster RS, 2003, J AM COLL SURGEONS, V196, P505, DOI 10.1016/S1072-7515(03)00110-8; Kassirer JP, 2007, PERSPECT BIOL MED, V50, P7, DOI 10.1353/pbm.2007.0006; Katz D, 2003, AM J BIOETHICS, V3, P39, DOI 10.1162/15265160360706552; Morin K, 2003, AM J BIOETHICS, V3, P54, DOI 10.1162/15265160360706606; Pellegrino ED, 1999, JAMA-J AM MED ASSOC, V282, P984, DOI 10.1001/jama.282.10.984; *PHARM RES MAN AM, COD INT HLTH CAR PRO; Podolsky SH, 2008, JAMA-J AM MED ASSOC, V300, P831, DOI 10.1001/jama.300.7.831; Relman AS, 2007, JAMA-J AM MED ASSOC, V298, P2668, DOI 10.1001/jama.298.22.2668; Ross JS, 2008, JAMA-J AM MED ASSOC, V299, P1800, DOI 10.1001/jama.299.15.1800; Rothman DJ, 2008, JAMA-J AM MED ASSOC, V299, P695, DOI 10.1001/jama.299.6.695; Sniderman AD, 2009, JAMA-J AM MED ASSOC, V301, P429, DOI 10.1001/jama.2009.15; Steinbrook R, 2008, JAMA-J AM MED ASSOC, V299, P1060, DOI 10.1001/jama.299.9.1060; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; Wofsy D, 2005, ARTHRITIS RHEUM, V52, P395, DOI 10.1002/art.20865; C T MAGAZINE	35	229	233	1	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 1	2009	301	13					1367	1372		10.1001/jama.2009.407	http://dx.doi.org/10.1001/jama.2009.407			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426LM	19336712				2022-12-28	WOS:000264709800026
J	Veatch, RM				Veatch, Robert M.			The art of medicine The sources of professional ethics: why professions fail	LANCET			English	Editorial Material												veatchr@georgetown.edu						British Medical Association, 2004, MED ETH TOD BMAS HDB; Orr RD, 1997, J CLIN ETHIC, V8, P377; Veatch Robert M., 1973, P C SPONS I SOC ETH	3	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					1000	1001		10.1016/S0140-6736(09)60596-1	http://dx.doi.org/10.1016/S0140-6736(09)60596-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422AA	19330942				2022-12-28	WOS:000264398200015
J	Gates, BD				Gates, Byron D.			Flexible Electronics	SCIENCE			English	Editorial Material							INK; AG		Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Gates, BD (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	bgates@sfu.ca	Genoe, Jan/B-5392-2008; Gates, Byron D/F-6473-2016	Genoe, Jan/0000-0002-4019-5979; Gates, Byron D/0000-0001-9108-3208				Ahn BY, 2009, SCIENCE, V323, P1590, DOI 10.1126/science.1168375; Comiskey B, 1998, NATURE, V394, P253, DOI 10.1038/28349; Forrest SR, 2004, NATURE, V428, P911, DOI 10.1038/nature02498; Gamerith S, 2007, ADV FUNCT MATER, V17, P3111, DOI 10.1002/adfm.200600762; Kim D, 2008, ADV MATER, V20, P3084, DOI 10.1002/adma.200702750; Menard E, 2007, CHEM REV, V107, P1117, DOI 10.1021/cr050139y; Noguchi Y, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2959728; Perelaer J, 2006, ADV MATER, V18, P2101, DOI 10.1002/adma.200502422; Sirringhaus H, 2000, SCIENCE, V290, P2123, DOI 10.1126/science.290.5499.2123; Smay JE, 2002, LANGMUIR, V18, P5429, DOI 10.1021/la0257135; Yun JW, 2008, JPN J APPL PHYS, V47, P5070, DOI 10.1143/JJAP.47.5070	11	204	212	17	208	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 20	2009	323	5921					1566	1567		10.1126/science.1171230	http://dx.doi.org/10.1126/science.1171230			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299605				2022-12-28	WOS:000264342300023
J	Jess, DB; Mathioudakis, M; Erdelyi, R; Crockett, PJ; Keenan, FP; Christian, DJ				Jess, David B.; Mathioudakis, Mihalis; Erdelyi, Robert; Crockett, Philip J.; Keenan, Francis P.; Christian, Damian J.			Alfven Waves in the Lower Solar Atmosphere	SCIENCE			English	Article							CORONAL LOOPS; BRIGHT POINTS; H-ALPHA; CHROMOSPHERE; MODES; WIND; FLUX; KINK; SUN	The flow of energy through the solar atmosphere and the heating of the Sun's outer regions are still not understood. Here, we report the detection of oscillatory phenomena associated with a large bright-point group that is 430,000 square kilometers in area and located near the solar disk center. Wavelet analysis reveals full-width half-maximum oscillations with periodicities ranging from 126 to 700 seconds originating above the bright point and significance levels exceeding 99%. These oscillations, 2.6 kilometers per second in amplitude, are coupled with chromospheric line-of-sight Doppler velocities with an average blue shift of 23 kilometers per second. A lack of cospatial intensity oscillations and transversal displacements rules out the presence of magneto-acoustic wave modes. The oscillations are a signature of Alfven waves produced by a torsional twist of +/- 22 degrees. A phase shift of 180 degrees across the diameter of the bright point suggests that these torsional Alfven oscillations are induced globally throughout the entire brightening. The energy flux associated with this wave mode is sufficient to heat the solar corona.	[Jess, David B.; Mathioudakis, Mihalis; Crockett, Philip J.; Keenan, Francis P.] Queens Univ Belfast, Astrophys Res Ctr, Sch Math & Phys, Belfast BT7 1NN, Antrim, North Ireland; [Jess, David B.] NASA, Goddard Space Flight Ctr, Solar Phys Lab, Greenbelt, MD 20771 USA; [Erdelyi, Robert] Univ Sheffield, Solar Phys & Space Plasma Res Ctr, Sheffield S3 7RH, S Yorkshire, England; [Christian, Damian J.] Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA	Queens University Belfast; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Sheffield; California State University System; California State University Northridge	Jess, DB (corresponding author), Queens Univ Belfast, Astrophys Res Ctr, Sch Math & Phys, Belfast BT7 1NN, Antrim, North Ireland.	d.jess@qub.ac.uk	erdelyi, robertus/AAQ-3262-2020	erdelyi, robertus/0000-0003-3439-4127; Jess, David/0000-0002-9155-8039; Christian, Damian/0000-0003-1746-3020	Northern Ireland Department for Employment and Learning [Studentship]; NSF, Hungary [K67746]; Atomic Weapons Establishment Aldermaston [William Penney Fellowship]; Science and Technology Facilities Council; STFC [ST/H008799/1, ST/F002327/1, ST/F002270/1, PP/E000711/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/E000711/1, ST/F002270/1, ST/F002327/1, ST/H008799/1] Funding Source: researchfish	Northern Ireland Department for Employment and Learning; NSF, Hungary; Atomic Weapons Establishment Aldermaston; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	D.B.J. is supported by a Northern Ireland Department for Employment and Learning studentship and thanks NASA Goddard Space Flight Center for a Co-operative Award in Science and Technology studentship. R.E. thanks M. Keray for encouragement and is grateful to NSF, Hungary (Orszagos Tudomanyos Kutatasi Alapprogram, ref. no. K67746), for financial support. F.P.K. is grateful to the Atomic Weapons Establishment Aldermaston for the award of a William Penney Fellowship. The SST is operated on the island of La Palma by the Institute for Solar Physics of the Royal Swedish Academy of Sciences in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias. These observations have been funded by the Optical Infrared Coordination network, an international collaboration supported by the Research Infrastructures Programme of the European Commission's Sixth Framework Programme. This work is supported by the Science and Technology Facilities Council, and we thank L. H. M. Rouppe van der Voort for help with MOMFBD image processing.	Brown DS, 2001, SOL PHYS, V201, P305, DOI 10.1023/A:1017907406350; Cally PS, 2008, SOL PHYS, V251, P251, DOI 10.1007/s11207-007-9086-3; Copil P, 2008, ASTRON ASTROPHYS, V478, P921, DOI 10.1051/0004-6361:20078481; De Pontieu B, 2007, SCIENCE, V318, P1574, DOI 10.1126/science.1151747; Erdelyi R, 2007, SCIENCE, V318, P1572, DOI 10.1126/science.1153006; Fossum A, 2005, NATURE, V435, P919, DOI 10.1038/nature03695; Goossens M, 2008, ASTRON ASTROPHYS, V484, P851, DOI 10.1051/0004-6361:200809728; Kalkofen W, 1997, ASTROPHYS J, V486, pL145, DOI 10.1086/310842; Kukhianidze V, 2006, ASTRON ASTROPHYS, V449, pL35, DOI 10.1051/0004-6361:200600018; Leenaarts J, 2006, ASTRON ASTROPHYS, V449, P1209, DOI 10.1051/0004-6361:20054482; Nakariakov V. M., 2005, LRSP, V2, P41, DOI DOI 10.12942/LRSP-2005-3; Nakariakov VM, 2003, ASTRON ASTROPHYS, V412, pL7, DOI 10.1051/0004-6361:20031660; Nuno BSA, 2008, ASTRON ASTROPHYS, V486, P577, DOI 10.1051/0004-6361:20079231; Ofman L, 2002, ASTROPHYS J, V568, pL135, DOI 10.1086/340329; Perez-Suarez D, 2008, ASTRON ASTROPHYS, V492, P575, DOI 10.1051/0004-6361:200809507; Ruderman MS, 1997, ASTRON ASTROPHYS, V320, P305; Scharmer GB, 2003, P SOC PHOTO-OPT INS, V4853, P370, DOI 10.1117/12.460387; Solanki SK, 1999, ASTRON ASTROPHYS, V347, pL27; Tirry WJ, 1996, ASTROPHYS J, V471, P501, DOI 10.1086/177986; TITLE AM, 1981, OPT ENG, V20, P815, DOI 10.1117/12.7972820; Tomczyk S, 2007, SCIENCE, V317, P1192, DOI 10.1126/science.1143304; Van Doorsselaere T, 2008, ASTROPHYS J LETT, V676, pL73, DOI 10.1086/587029; Van Noort M, 2005, SOL PHYS, V228, P191, DOI 10.1007/s11207-005-5782-z; Verdini A, 2007, ASTROPHYS J, V662, P669, DOI 10.1086/510710; VERNAZZA JE, 1981, ASTROPHYS J SUPPL S, V45, P635, DOI 10.1086/190731; Vranjes J, 2008, ASTRON ASTROPHYS, V478, P553, DOI 10.1051/0004-6361:20078274; Zaqarashvili TV, 2003, ASTRON ASTROPHYS, V399, pL15, DOI 10.1051/0004-6361:20030084	27	329	332	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1582	1585		10.1126/science.1168680	http://dx.doi.org/10.1126/science.1168680			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299614	Green Published, Green Submitted			2022-12-28	WOS:000264342300032
J	Lin, YY; Lu, JY; Zhang, JM; Walter, W; Dang, WW; Wan, J; Tao, SC; Qian, J; Zhao, YM; Boeke, JD; Berger, SL; Zhu, H				Lin, Yu-yi; Lu, Jin-ying; Zhang, Junmei; Walter, Wendy; Dang, Weiwei; Wan, Jun; Tao, Sheng-Ce; Qian, Jiang; Zhao, Yingming; Boeke, Jef D.; Berger, Shelley L.; Zhu, Heng			Protein Acetylation Microarray Reveals that NuA4 Controls Key Metabolic Target Regulating Gluconeogenesis	CELL			English	Article							SISTER-CHROMATID COHESION; LIFE-SPAN EXTENSION; PHOSPHOENOLPYRUVATE CARBOXYKINASE GTP; SACCHAROMYCES-CEREVISIAE; HISTONE ACETYLTRANSFERASE; CALORIE RESTRICTION; MOUSE-LIVER; HEPATIC GLUCONEOGENESIS; FUNCTIONAL DISSECTION; LYSINE ACETYLATION	Histone acetyltransferases (HATs) and histone deacetylases (HDACs) conduct many critical functions through nonhistone substrates in metazoans, but only chromatin-associated nonhistone substrates are known in Saccharomyces cerevisiae. Using yeast proteome microarrays, we identified and validated many nonchromatin substrates of the essential nucleosome acetyltransferase of H4 (NuA4) complex. Among these, acetylation sites (Lys19 and 514) of phosphoenolpyruvate carboxykinase (Pck1p) were determined by tandem mass spectrometry. Acetylation at Lys514 was crucial for enzymatic activity and the ability of yeast cells to grow on nonfermentable carbon sources. Furthermore, Sir2p deacetylated Pck1p both in vitro and in vivo. Loss of Pck1p activity blocked the extension of yeast chronological life span caused by water starvation. In human hepatocellular carcinoma (HepG2) cells, human Pck1 acetylation and glucose production were dependent on TIP60, the human homolog of ESA1. Our findings demonstrate a regulatory function for the NuA4 complex in glucose metabolism and life span by acetylating a critical metabolic enzyme.	[Lin, Yu-yi; Lu, Jin-ying; Tao, Sheng-Ce; Boeke, Jef D.; Zhu, Heng] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Lu, Jin-ying; Tao, Sheng-Ce; Zhu, Heng] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; [Lu, Jin-ying; Tao, Sheng-Ce; Zhu, Heng] Johns Hopkins Univ, Sch Med, Dept Mol Sci, Baltimore, MD 21205 USA; [Wan, Jun; Qian, Jiang] Johns Hopkins Univ, Sch Med, Wilmer Eye Ctr, Baltimore, MD 21205 USA; [Lu, Jin-ying] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan; [Zhang, Junmei; Zhao, Yingming] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Walter, Wendy; Dang, Weiwei; Berger, Shelley L.] Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Taiwan University; National Taiwan University Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; The Wistar Institute	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA.	jboeke@jhmi.edu; berger@wistar.org; heng.zhu@jhmi.edu	Wan, Jun/AAN-1337-2020; Wan, Jun/H-7132-2013; Wan, Jun/A-2177-2014; Tao, Sheng-ce/A-5833-2012	Wan, Jun/0000-0001-9286-6562; Wan, Jun/0000-0001-9286-6562; Wan, Jun/0000-0001-9286-6562; Tao, Sheng-ce/0000-0002-9210-1823; Boeke, Jef/0000-0001-5322-4946; Dang, Weiwei/0000-0002-6931-4636; Berger, Shelley/0000-0001-5398-4400	National Institutes of Health [U54 RR 020839, R01CA126832, R01EY017589]; Keck Foundation; NATIONAL CANCER INSTITUTE [R01CA126832] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank E. M. Cooper, L. Dai, A. Norris, and K. A. O'Donnell for gifts of reagents; J. Liu, J. T. Stivers, H. Takahashi, S. Taverna, J. Zhang, and members of the Zhu and Boeke labs for valuable discussions throughout the course of the work. This work was supported in part by National Institutes of Health Roadmap Grant U54 RR 020839, "Technology Center for Networks and Pathways'' (to J.D.B., S.L.B., and H.Z.); the Keck Foundation (H.Z.); and National Institutes of Health Grants R01CA126832 (to Y.Z.) and R01EY017589 (to J. Q.).	Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Ashrafi K, 2000, GENE DEV, V14, P1872; Auger A, 2008, MOL CELL BIOL, V28, P2257, DOI 10.1128/MCB.01755-07; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; BALY DL, 1985, J NUTR, V115, P872, DOI 10.1093/jn/115.7.872; Beale EG, 2004, TRENDS ENDOCRIN MET, V15, P129, DOI 10.1016/j.tem.2004.02.006; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Boudreault AA, 2003, GENE DEV, V17, P1415, DOI 10.1101/gad.1056603; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Choi JK, 2008, MOL CELL BIOL, V28, P6967, DOI 10.1128/MCB.00570-08; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Delbaere LTJ, 2004, BBA-PROTEINS PROTEOM, V1697, P271, DOI 10.1016/j.bbapap.2003.11.030; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio Paola, 2007, Methods Mol Biol, V371, P89; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4; Hagopian K, 2008, BIOSCIENCE REP, V28, P107, DOI 10.1042/BSR20080015; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Haurie V, 2001, J BIOL CHEM, V276, P76, DOI 10.1074/jbc.M008752200; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lardy H, 1972, ENZYMES, P117; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li Y, 2007, CELL DEATH DIFFER, V14, P2058, DOI 10.1038/sj.cdd.4402219; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Lu JY, 2008, MOL CELL PROTEOMICS, V7, P35, DOI 10.1074/mcp.M700353-MCP200; Matte A, 1997, J BIOL CHEM, V272, P8105, DOI 10.1074/jbc.272.13.8105; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mitchell L, 2008, MOL CELL BIOL, V28, P2244, DOI 10.1128/MCB.01653-07; Neugebauer RC, 2008, CURR PHARM DESIGN, V14, P562; Permutt MA, 2000, TRENDS ENDOCRIN MET, V11, P383, DOI 10.1016/S1043-2760(00)00329-5; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Raab RM, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-40; Ravanal MC, 2003, J PROTEIN CHEM, V22, P311, DOI 10.1023/A:1025306105105; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; ROGNSTAD R, 1979, J BIOL CHEM, V254, P1875; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Smith ER, 1998, P NATL ACAD SCI USA, V95, P3561, DOI 10.1073/pnas.95.7.3561; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tao SC, 2007, COMB CHEM HIGH T SCR, V10, P706, DOI 10.2174/138620707782507386; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; van Voorst F, 2006, YEAST, V23, P351, DOI 10.1002/yea.1359; VanDemark AP, 2007, MOL CELL, V27, P817, DOI 10.1016/j.molcel.2007.08.018; vandenBerg MA, 1996, J BIOL CHEM, V271, P28953, DOI 10.1074/jbc.271.46.28953; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yin ZK, 2000, MOL MICROBIOL, V35, P553, DOI 10.1046/j.1365-2958.2000.01723.x; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; Zhang HY, 2004, MOL CELL BIOL, V24, P9424, DOI 10.1128/MCB.24.21.9424-9436.2004; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	74	240	252	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1073	1084		10.1016/j.cell.2009.01.033	http://dx.doi.org/10.1016/j.cell.2009.01.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303850	Green Accepted, Bronze			2022-12-28	WOS:000264403900013
J	Tosatti, E				Tosatti, Erio			Fullerides in a Squeeze	SCIENCE			English	Editorial Material							SUPERCONDUCTIVITY		[Tosatti, Erio] Scuola Int Super Studi Avanzati, Trieste, Italy; [Tosatti, Erio] CNR, INFM, Democritos Natl Simulat Ctr, Trieste, Italy; [Tosatti, Erio] Int Ctr Theoret Phys, Trieste, Italy	International School for Advanced Studies (SISSA); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Abdus Salam International Centre for Theoretical Physics (ICTP)	Tosatti, E (corresponding author), Scuola Int Super Studi Avanzati, Trieste, Italy.	tosatti@sissa.it						ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; Batlogg B, 2000, PHYS WORLD, V13, P33; Capone M, 2002, SCIENCE, V296, P2364, DOI 10.1126/science.1071122; CAPONE M, REV MOD PHY IN PRESS; Fabrizio M, 1997, PHYS REV B, V55, P13465, DOI 10.1103/PhysRevB.55.13465; Ganin AY, 2008, NAT MATER, V7, P367, DOI 10.1038/nmat2179; Gunnarsson O., 2004, ALKALI DOPED FULLERI; GUNNARSSON O, 1997, REV MOD PHYS, V69; Gweon GH, 2004, NATURE, V430, P187, DOI 10.1038/nature02731; Kanoda K, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.051007; Klupp G, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.085415; Prassides K, 1999, J AM CHEM SOC, V121, P11227, DOI 10.1021/ja992931k; Ramirez A. P., 1994, Superconductivity Review, V1, P1; Takabayashi Y, 2009, SCIENCE, V323, P1585, DOI 10.1126/science.1169163; ZHOU O, 1995, PHYS REV B, V52, P483, DOI 10.1103/PhysRevB.52.483	15	8	8	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 20	2009	323	5921					1570	1571		10.1126/science.1171840	http://dx.doi.org/10.1126/science.1171840			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299608				2022-12-28	WOS:000264342300026
J	Naish, T; Powell, R; Levy, R; Wilson, G; Scherer, R; Talarico, F; Krissek, L; Niessen, F; Pompilio, M; Wilson, T; Carter, L; DeConto, R; Huybers, P; McKay, R; Pollard, D; Ross, J; Winter, D; Barrett, P; Browne, G; Cody, R; Cowan, E; Crampton, J; Dunbar, G; Dunbar, N; Florindo, F; Gebhardt, C; Graham, I; Hannah, M; Hansaraj, D; Harwood, D; Helling, D; Henrys, S; Hinnov, L; Kuhn, G; Kyle, P; Laufer, A; Maffioli, P; Magens, D; Mandernack, K; McIntosh, W; Millan, C; Morin, R; Ohneiser, C; Paulsen, T; Persico, D; Raine, I; Reed, J; Riesselman, C; Sagnotti, L; Schmitt, D; Sjunneskog, C; Strong, P; Taviani, M; Vogel, S; Wilch, T; Williams, T				Naish, T.; Powell, R.; Levy, R.; Wilson, G.; Scherer, R.; Talarico, F.; Krissek, L.; Niessen, F.; Pompilio, M.; Wilson, T.; Carter, L.; DeConto, R.; Huybers, P.; McKay, R.; Pollard, D.; Ross, J.; Winter, D.; Barrett, P.; Browne, G.; Cody, R.; Cowan, E.; Crampton, J.; Dunbar, G.; Dunbar, N.; Florindo, F.; Gebhardt, C.; Graham, I.; Hannah, M.; Hansaraj, D.; Harwood, D.; Helling, D.; Henrys, S.; Hinnov, L.; Kuhn, G.; Kyle, P.; Laeufer, A.; Maffioli, P.; Magens, D.; Mandernack, K.; McIntosh, W.; Millan, C.; Morin, R.; Ohneiser, C.; Paulsen, T.; Persico, D.; Raine, I.; Reed, J.; Riesselman, C.; Sagnotti, L.; Schmitt, D.; Sjunneskog, C.; Strong, P.; Taviani, M.; Vogel, S.; Wilch, T.; Williams, T.			Obliquity-paced Pliocene West Antarctic ice sheet oscillations	NATURE			English	Article							ATLANTIC DEEP-WATER; EUSTATIC SEA-LEVEL; CLIMATE VARIABILITY; ROSS SEA; OCEAN; FLUCTUATIONS; GREENHOUSE; DELTA-O-18; AMPLITUDE; HISTORY	Thirty years after oxygen isotope records from microfossils deposited in ocean sediments confirmed the hypothesis that variations in the Earth's orbital geometry control the ice ages(1), fundamental questions remain over the response of the Antarctic ice sheets to orbital cycles(2). Furthermore, an understanding of the behaviour of the marine-based West Antarctic ice sheet (WAIS) during the 'warmer-than-present' early-Pliocene epoch (similar to 5-3 Myr ago) is needed to better constrain the possible range of ice-sheet behaviour in the context of future global warming(3). Here we present a marine glacial record from the upper 600 m of the AND-1B sediment core recovered from beneath the northwest part of the Ross ice shelf by the ANDRILL programme and demonstrate well-dated, similar to 40-kyr cyclic variations in ice-sheet extent linked to cycles in insolation influenced by changes in the Earth's axial tilt (obliquity) during the Pliocene. Our data provide direct evidence for orbitally induced oscillations in the WAIS, which periodically collapsed, resulting in a switch from grounded ice, or ice shelves, to open waters in the Ross embayment when planetary temperatures were up to similar to 3 degrees C warmer than today(4) and atmospheric CO2 concentration was as high as similar to 400 p. p. m. v. (refs 5, 6). The evidence is consistent with a new ice-sheet/ice-shelf model(7) that simulates fluctuations in Antarctic ice volume of up to +7 m in equivalent sea level associated with the loss of the WAIS and up to +3 m in equivalent sea level from the East Antarctic ice sheet, in response to ocean-induced melting paced by obliquity. During interglacial times, diatomaceous sediments indicate high surface-water productivity, minimal summer sea ice and air temperatures above freezing, suggesting an additional influence of surface melt(8) under conditions of elevated CO2.	[Naish, T.; Carter, L.; McKay, R.; Barrett, P.; Cody, R.; Dunbar, G.; Hannah, M.; Hansaraj, D.] Victoria Univ Wellington, Antarctic Res Ctr, Wellington 6012, New Zealand; [Naish, T.; Browne, G.; Cody, R.; Crampton, J.; Graham, I.; Hansaraj, D.; Henrys, S.; Raine, I.; Strong, P.] GNS Sci, Lower Hutt 5040, New Zealand; [Powell, R.; Scherer, R.; Vogel, S.] No Illinois Univ, Dept Geog & Environm Geosci, De Kalb, IL 60115 USA; [Levy, R.; Winter, D.; Reed, J.] Univ Nebraska, Dept Geosci, ANDRILL Sci Management Off, Lincoln, NE 68588 USA; [Wilson, G.; Ohneiser, C.] Univ Otago, Dept Geol, Dunedin 9001, Otago, New Zealand; [Talarico, F.] Univ Siena, Dipartimento Sci Terra, I-53100 Siena, Italy; [Krissek, L.; Wilson, T.; Millan, C.] Ohio State Univ, Dept Geol Sci, Columbus, OH 43210 USA; [Niessen, F.; Gebhardt, C.; Helling, D.; Kuhn, G.; Magens, D.] Alfred Wegener Inst Polar & Marine Res, Inst Geosci, D-27515 Bremerhaven, Germany; [Pompilio, M.] Ist Nazl Geofis & Vulcanol, I-56126 Pisa, Italy; [DeConto, R.] Univ Massachusetts, Dept Geosci, Morrell Sci Ctr 233, Amherst, MA 01003 USA; [Huybers, P.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Pollard, D.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Ross, J.; Dunbar, N.; Kyle, P.; McIntosh, W.] New Mexico Inst Min & Technol, Socorro, NM 87801 USA; [Cowan, E.] Appalachian State Univ, Dept Geol, Boone, NC 28608 USA; [Florindo, F.; Sagnotti, L.] Ist Nazl Geofis & Vulcanol, I-00143 Rome, Italy; [Hinnov, L.] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; [Laeufer, A.] Fed Inst Geosci & Nat Resources, BGR, D-30655 Hannover, Germany; [Maffioli, P.] Univ Milano Bicocca, Dipartimento Sci Geol & Geotecnol, I-20126 Milan, Italy; [Mandernack, K.] Colorado Sch Mines, Dept Chem & Geochem, Golden, CO 80401 USA; [Morin, R.] US Geol Survey, Denver, CO 80225 USA; [Paulsen, T.] Univ Wisconsin, Dept Geol, Oshkosh, WI 54901 USA; [Persico, D.] Univ Parma, Dipartimento Sci Terra, I-43100 Parma, Italy; [Reed, J.] Iowa State Univ, CHRONOS, Dept Geol & Atmospher Sci, Ames, IA 50011 USA; [Riesselman, C.] Stanford Univ, Sch Earth Sci, Dept Geol & Environm Sci, Stanford, CA 94305 USA; [Schmitt, D.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2G7, Canada; [Sjunneskog, C.] Louisiana State Univ, Dept Geol & Geophys, Baton Rouge, LA 70803 USA; [Taviani, M.] ISMAR Bologna, CNR, I-40129 Bologna, Italy; [Wilch, T.] Albion Coll, Dept Geol, Albion, MI 49224 USA; [Williams, T.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Victoria University Wellington; GNS Science - New Zealand; Northern Illinois University; University of Nebraska System; University of Nebraska Lincoln; University of Otago; University of Siena; University System of Ohio; Ohio State University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Istituto Nazionale Geofisica e Vulcanologia (INGV); University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; New Mexico Institute of Mining Technology; University of North Carolina; Appalachian State University; Istituto Nazionale Geofisica e Vulcanologia (INGV); Johns Hopkins University; University of Milano-Bicocca; Colorado School of Mines; United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Parma; Iowa State University; Stanford University; University of Alberta; Louisiana State University System; Louisiana State University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Albion College; Columbia University	Naish, T (corresponding author), Victoria Univ Wellington, Antarctic Res Ctr, POB 600, Wellington 6012, New Zealand.	tim.naish@vuw.ac.nz	Ohneiser, Christian/B-5797-2018; Schmitt, Douglas R/A-4091-2010; Läufer, Andreas/ABC-1465-2020; Hannah, Michael/H-1083-2015; Riesselman, Christina/H-5037-2012; McKay, Robert/N-2449-2015; Levy, Richard/E-2477-2011; Florindo, Fabio/F-4119-2010; Henrys, Stuart/ABD-7378-2020; Hinnov, Linda/D-9486-2013; Taviani, Marco/AAF-2168-2020; Wilson, Gary/B-3803-2010; Sagnotti, Leonardo/AFM-3916-2022; Pompilio, Massimo/M-5380-2019; Florindo, Fabio/M-1459-2019; Florindo, Fabio/AAU-2548-2021; Vogel, Stefan/I-1963-2014; Raine, James I/D-5124-2009; Crampton, James/G-1381-2012; Pompilio, Massimo/C-5892-2008; Gebhardt, Catalina/C-4817-2009; CNR, Ismar/P-1247-2014; talarico, franco/G-9472-2012	Schmitt, Douglas R/0000-0001-6920-0658; Läufer, Andreas/0000-0003-2219-0450; Hannah, Michael/0000-0002-2275-0086; McKay, Robert/0000-0002-5602-6985; Florindo, Fabio/0000-0002-6058-9748; Henrys, Stuart/0000-0002-7164-5274; Taviani, Marco/0000-0003-0414-4274; Sagnotti, Leonardo/0000-0003-3944-201X; Florindo, Fabio/0000-0002-6058-9748; Raine, James I/0000-0001-5294-2102; Crampton, James/0000-0003-3270-9981; Pompilio, Massimo/0000-0002-0742-0679; Vogel, Stefan/0000-0002-4350-7130; Hinnov, Linda/0000-0001-8027-4834; Gebhardt, Catalina/0000-0002-3227-0676; Persico, Davide/0000-0001-5194-9724; CNR, Ismar/0000-0001-5351-1486; talarico, franco/0000-0002-7254-4301; Ohneiser, Christian/0000-0002-2781-2522; Dunbar, Nelia/0000-0002-5181-937X; Kuhn, Gerhard/0000-0001-6069-7485; Naish, Tim/0000-0002-1185-9932; Huybers, Peter/0000-0002-3734-8145; Wilson, Gary/0000-0003-0025-3641; Levy, Richard/0000-0002-8783-0167; Niessen, Frank/0000-0001-6453-0594; Riesselman, Christina/0000-0002-2436-4306	US National Science Foundation; New Zealand Foundation for Research Science and Technology; Royal Society of New Zealand Marsden Fund; Italian Antarctic Research Programme; German Research Foundation; Alfred Wegener Institute for Polar and Marine Research	US National Science Foundation(National Science Foundation (NSF)); New Zealand Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology); Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Italian Antarctic Research Programme; German Research Foundation(German Research Foundation (DFG)); Alfred Wegener Institute for Polar and Marine Research	The ANDRILL project is a multinational collaboration between the Antarctic programmes of Germany, Italy, New Zealand and the United States. Antarctica New Zealand is the project operator and developed the drilling system in collaboration with A. Pyne. Antarctica New Zealand supported the drilling team at Scott Base; Raytheon Polar Services Corporation supported the science team at McMurdo Station and the Crary Science and Engineering Laboratory. The ANDRILL Science Management Office at the University of Nebraska- Lincoln provided science planning and operational support. The scientific studies are jointly supported by the US National Science Foundation, the New Zealand Foundation for Research Science and Technology and the Royal Society of New Zealand Marsden Fund, the Italian Antarctic Research Programme, the German Research Foundation and the Alfred Wegener Institute for Polar and Marine Research.	Chappell J, 1996, EARTH PLANET SC LETT, V141, P227, DOI 10.1016/0012-821X(96)00062-3; CODY R, 2001, GLOB PLANET CH UNPUB; Cody RD, 2008, PALAEOGEOGR PALAEOCL, V260, P92, DOI 10.1016/j.palaeo.2007.08.020; Cowan EA, 1999, SEDIMENTOLOGY, V46, P1109, DOI 10.1046/j.1365-3091.1999.00267.x; Crundwell M, 2008, PALAEOGEOGR PALAEOCL, V260, P202, DOI 10.1016/j.palaeo.2007.08.023; Ding ZL, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000725; Domack EW, 1999, GEOL SOC AM BULL, V111, P1517, DOI 10.1130/0016-7606(1999)111<1517:LPHROT>2.3.CO;2; Dowdeswell JA, 1998, QUATERNARY SCI REV, V17, P243, DOI 10.1016/S0277-3791(97)00071-1; DOWSETT HJ, 1990, GEOLOGY, V18, P435, DOI 10.1130/0091-7613(1990)018<0435:HESLDT>2.3.CO;2; Dunbar GB, 2008, PALAEOGEOGR PALAEOCL, V260, P50, DOI 10.1016/j.palaeo.2007.08.018; DWYER GS, 1995, SCIENCE, V270, P1347, DOI 10.1126/science.270.5240.1347; Hall IR, 2001, NATURE, V412, P809, DOI 10.1038/35090552; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Hill DJ, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P517; Huybers P, 2006, SCIENCE, V313, P508, DOI 10.1126/science.1125249; Huybers P, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001463; Kennett JP, 1993, GEOGR ANN A, V75A, P202; Kim SJ, 2000, PALEOCEANOGRAPHY, V15, P451, DOI 10.1029/1999PA000459; Lewis AR, 2008, P NATL ACAD SCI USA, V105, P10676, DOI 10.1073/pnas.0802501105; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Lisiecki LE, 2008, NATURE, V456, P85, DOI 10.1038/nature07425; Mckay RM, 2008, PALAEOGEOGR PALAEOCL, V260, P245, DOI 10.1016/j.palaeo.2007.08.015; MERCER JH, 1978, NATURE, V271, P321, DOI 10.1038/271321a0; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Naish T, 2009, DEV EARTH ENV SCI, V8, P465, DOI 10.1016/S1571-9197(08)00011-6; Naish TR, 2009, PHILOS T R SOC A, V367, P169, DOI 10.1098/rsta.2008.0223; NAISH TR, 2008, ANTARCTICA KEYSTONE, P71, DOI DOI 10.3133/OF2007-1047; NAISH TR, 2007, GEOLOGY, V25, P1139; NAISH TR, 2007, TERRA ANTARTICA, V14; O Cofaigh C, 2001, QUATERNARY SCI REV, V20, P1411, DOI 10.1016/S0277-3791(00)00177-3; POWELL R, 2001, TERRA ANTARTICA, V0008; Powell R., 2002, MODERN GLACIAL ENV, P361, DOI [10.1016/B978-075064226-2/50015-5, DOI 10.1016/B978-075064226-2/50015-5]; POWELL RD, 2003, SPEC PUBL GEOL SOC L, V203, P215; Raymo ME, 2006, SCIENCE, V313, P492, DOI 10.1126/science.1123296; Raymo ME, 2008, NATURE, V451, P284, DOI 10.1038/nature06589; Raymo ME, 1996, MAR MICROPALEONTOL, V27, P313, DOI 10.1016/0377-8398(95)00048-8; Scherer RP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032254; SHACKLETON NJ, 1984, NATURE, V307, P620, DOI 10.1038/307620a0; Solomon S., 2007, PHYS SCI BASIS WORKI; TIEDEMANN R, 1994, PALEOCEANOGRAPHY, V9, P619, DOI 10.1029/94PA00208; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; VANDERBURGH J, 1993, SCIENCE, V260, P1788, DOI 10.1126/science.260.5115.1788; Young M. A., 1984, MILANKOVITCH CLIMATE, V126, P707	43	432	441	6	196	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					322	U84		10.1038/nature07867	http://dx.doi.org/10.1038/nature07867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19295607	Green Published			2022-12-28	WOS:000264285600038
J	Kearney, MK; Weininger, RB; Vachon, MLS; Harrison, RL; Mount, BM				Kearney, Michael K.; Weininger, Radhule B.; Vachon, Mary L. S.; Harrison, Richard L.; Mount, Balfour M.			Self-care of Physicians Caring for Patients at the End of Life "Being Connected ... A Key to My Survival"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WRITTEN EMOTIONAL EXPRESSION; STRESS REDUCTION; MENTAL-HEALTH; OF-LIFE; SURGICAL ONCOLOGISTS; HOSPITAL CONSULTANTS; PERSONAL WELLNESS; CONTROLLED-TRIAL; PALLIATIVE CARE; IMMUNE FUNCTION	Physicians providing end-of-life care are subject to a variety of stresses that may lead to burnout and compassion fatigue at both individual and team levels. Through the story of an oncologist, we discuss the prodromal symptoms and signs leading to burnout and compassion fatigue and present the evidence for prevention. We define and discuss factors that contribute to burnout and compassion fatigue and consider factors that may mitigate burnout. We explore the practice of empathy and discuss an approach for physicians to maximize wellness through self-awareness in the setting of caring for patients with end-stage illness. Finally, we discuss some practical applications of self-care in the workplace.	[Kearney, Michael K.] Santa Barbara Cottage Hosp, Palliat Care Serv, Santa Barbara, CA 93102 USA; [Kearney, Michael K.] Visiting Nurse & Hosp Care Santa Barbara, Santa Barbara, CA USA; [Weininger, Radhule B.] La Casa de Maria Retreat & Conf Ctr, Santa Barbara, CA USA; [Vachon, Mary L. S.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Vachon, Mary L. S.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Harrison, Richard L.] Univ British Columbia, Counseling Psychol Program, Vancouver, BC V5Z 1M9, Canada; [Mount, Balfour M.] McGill Univ, Dept Med, Montreal, PQ, Canada	Santa Barbara Cottage Hospital; University of Toronto; University of Toronto; University of British Columbia; McGill University	Kearney, MK (corresponding author), Santa Barbara Cottage Hosp, Palliat Care Serv, POB 689,Pueblo Bath St, Santa Barbara, CA 93102 USA.	mkearney@sbch.org						Allegra CJ, 2005, J ONCOL PRACT, V1, P140, DOI 10.1200/jop.2005.1.4.140; Armstrong J, 2004, J CLIN ONCOL, V22, P4425, DOI 10.1200/JCO.2004.07.138; Arnold D, 2005, J HUMANIST PSYCHOL, V45, P239, DOI 10.1177/0022167805274729; Asai M, 2007, PSYCHO-ONCOLOGY, V16, P421, DOI 10.1002/pon.1066; Balch CM, 2007, ANN SURG ONCOL, V14, P3029, DOI 10.1245/s10434-007-9588-0; BARNARD D, 2000, CROSSING OVER NARRAT; Beddoe AE, 2004, J NURS EDUC, V43, P305; Boston PH, 2006, J PAIN SYMPTOM MANAG, V32, P13, DOI 10.1016/j.jpainsymman.2006.01.009; Brady DW, 2002, ANN INTERN MED, V137, P220, DOI 10.7326/0003-4819-137-3-200208060-00025; Bressi C, 2008, BRIT J CANCER, V98, P1046, DOI 10.1038/sj.bjc.6604270; Calhoun L., 1999, FACILITATING POSTTRA; Calhoun LG, 1998, LEA SER PER CLIN PSY, P215; Cepeda MS, 2008, J PAIN SYMPTOM MANAG, V35, P623, DOI 10.1016/j.jpainsymman.2007.08.011; Charon R, 2001, JAMA-J AM MED ASSOC, V286, P1897, DOI 10.1001/jama.286.15.1897; CHARON R, 2008, NARRATIVE MED HONORI, P156; Cohen-Katz Joanne, 2004, Holist Nurs Pract, V18, P302; Coster JS, 1997, PROF PSYCHOL-RES PR, V28, P5, DOI 10.1037/0735-7028.28.1.5; Dahlin Marie E, 2007, BMC Med Educ, V7, P6, DOI 10.1186/1472-6920-7-6; Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3; Desalvo Louise, 1999, WRITING WAY HEALING; Elit L, 2004, GYNECOL ONCOL, V94, P134, DOI 10.1016/j.ygyno.2004.04.014; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; *EUR COMM, 2004, PROM DEV INT PALL CA; Fallowfield L, 2003, BRIT J CANCER, V89, P1445, DOI 10.1038/sj.bjc.6601309; Fallowfield L, 2002, LANCET, V359, P650, DOI 10.1016/S0140-6736(02)07810-8; Figley C.R., 2002, TREATING COMPASSION; Figley C.R., 1995, COMPASSION FATIGUE C, DOI 10.1192/bjp.bp.114.150078; Fillion L, 2009, PSYCHO-ONCOLOGY, V18, P1300, DOI 10.1002/pon.1513; Frisina PG, 2004, J NERV MENT DIS, V192, P629, DOI 10.1097/01.nmd.0000138317.30764.63; GARFIELD C, 1995, SOMETIMES MY HEART G; Gentry J., 2002, TREATING COMPASSION; Graham J, 1996, PALLIATIVE MED, V10, P185, DOI 10.1177/026921639601000302; Graham J, 2002, EUR J CANCER CARE, V11, P188, DOI 10.1046/j.1365-2354.2002.00338.x; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; Grunfeld E, 2000, CAN MED ASSOC J, V163, P166; Halbesleben JRB, 2008, HEALTH CARE MANAGE R, V33, P29, DOI 10.1097/01.HMR.0000304493.87898.72; Harris AHS, 2006, J CONSULT CLIN PSYCH, V74, P243, DOI 10.1037/0022-006X.74.2.243; HARRISON RL, PSYCHOTHERA IN PRESS; Haward R, 2003, BRIT J CANCER, V89, P15, DOI 10.1038/sj.bjc.6601073; Hojat M, 2002, AM J PSYCHIAT, V159, P1563, DOI 10.1176/appi.ajp.159.9.1563; HUGGARD PK, 2008, MANAGING COMPASSION; Jackson VA, 2008, J PALLIAT MED, V11, P893, DOI 10.1089/jpm.2007.2480; Johnson T.A., 2006, PROFESSIONALS WEEP E, P3; Kabat-Zinn J, 2003, CLIN PSYCHOL-SCI PR, V10, P144, DOI 10.1093/clipsy/bpg016; Kash KM, 2000, ONCOLOGY-NY, V14, P1621; Kearney M, 2009, PLACE HEALING WORKIN; Keeton K, 2007, OBSTET GYNECOL, V109, P949, DOI 10.1097/01.AOG.0000258299.45979.37; Kjeldmand D, 2004, PATIENT EDUC COUNS, V55, P230, DOI 10.1016/j.pec.2003.09.009; KOBASA SC, 1982, J PERS SOC PSYCHOL, V42, P168, DOI 10.1037/0022-3514.42.1.168; KOBASA SC, 1979, J PERS SOC PSYCHOL, V37, P1, DOI 10.1037/0022-3514.37.1.1; Kornfield Jack, 2008, WISE HEART GUIDE UNI; Kuerer HM, 2007, ANN SURG ONCOL, V14, P3043, DOI 10.1245/s10434-007-9579-1; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Le Blanc PM, 2007, J APPL PSYCHOL, V92, P213, DOI 10.1037/0021-9010.92.1.213; Leiter MP, 2005, NEW HORIZ MANAG, P544; Linley PA, 2005, PSYCHOTHER PSYCHOSOM, V74, P185, DOI 10.1159/000084004; Mackereth Peter A, 2005, Eur J Oncol Nurs, V9, P147, DOI 10.1016/j.ejon.2004.04.006; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C, 2003, CURR DIR PSYCHOL SCI, V12, P189, DOI 10.1111/1467-8721.01258; Maslach C, 2008, J APPL PSYCHOL, V93, P498, DOI 10.1037/0021-9010.93.3.498; Meier DE, 2001, JAMA-J AM MED ASSOC, V286, P3007, DOI 10.1001/jama.286.23.3007; Morgan Nancy P, 2008, Oncologist, V13, P196, DOI 10.1634/theoncologist.2007-0147; Mount BM, 2007, J PAIN SYMPTOM MANAG, V33, P372, DOI 10.1016/j.jpainsymman.2006.09.014; Muscatello MRA, 2006, PSYCHOL REP, V99, P641, DOI 10.2466/PR0.99.2.641-650; Neff KD, 2007, J RES PERS, V41, P139, DOI 10.1016/j.jrp.2006.03.004; Novack DH, 1997, JAMA-J AM MED ASSOC, V278, P502, DOI 10.1001/jama.278.6.502; Novack DH, 1999, ACAD MED, V74, P516, DOI 10.1097/00001888-199905000-00017; O'Cleirigh C, 2008, BRIT J HEALTH PSYCH, V13, P81, DOI 10.1348/135910707X250884; Pearlman L. A., 1999, SECONDARY TRAUMATIC, P51; Pennebaker J.W., 1997, OPENING HEALING POWE; Perry Beth, 2008, Can Oncol Nurs J, V18, P87; Petrie KJ, 2004, PSYCHOSOM MED, V66, P272, DOI 10.1097/01.psy.0000116782.49850.d3; Pierce B, 2007, J PALLIAT CARE, V23, P32, DOI 10.1177/082585970702300105; QUILL TE, 1990, ARCH INTERN MED, V150, P1857, DOI 10.1001/archinte.150.9.1857; Rabinowitz S, 1996, AAOHN J, V44, P28; RAMIREZ AJ, 1995, BRIT J CANCER, V71, P1263, DOI 10.1038/bjc.1995.244; Ramirez AJ, 1996, LANCET, V347, P724, DOI 10.1016/S0140-6736(96)90077-X; Robinson Katya, 2004, J Palliat Med, V7, P637, DOI 10.1089/jpm.2004.7.637; ROHAN EA, 2005, EXLPORATION VICARIOU; Saakvitne, 1995, TRAUMA THERAPIST COU, P31; Salston M, 2003, J TRAUMA STRESS, V16, P167, DOI 10.1023/A:1022899207206; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, V3rd, P22; Shanafelt T, 2006, J CLIN ONCOL, V24, P4020, DOI 10.1200/JCO.2006.05.8248; Shanafelt TD, 2005, J GEN INTERN MED, V20, P559, DOI 10.1007/s11606-005-0102-8; Shanafelt TD, 2005, ONCOLOGY-BASEL, V68, P23, DOI 10.1159/000084519; SHAPIRO S, 2008, MINDFULNESS THERAPEU; Shapiro S. L., 2005, INT J STRESS MANAGE, V12, P164, DOI [10.1037/1072-5245.12.2.164, DOI 10.1037/1072-5245.12.2.164]; Shapiro SL, 2007, TRAIN EDUC PROF PSYC, V1, P105, DOI 10.1037/1931-3918.1.2.105; Shapiro SL, 1998, J BEHAV MED, V21, P581, DOI 10.1023/A:1018700829825; SHAPIRO SL, CASS SEM JUN 27 2008; Siegal Dan, 2017, DR DAN SIEGALS HAND; Smyth JM, 1999, JAMA-J AM MED ASSOC, V281, P1304, DOI 10.1001/jama.281.14.1304; SPANN C, 2004, POET HEALER CONT POE; Spickard A, 2002, JAMA-J AM MED ASSOC, V288, P1447, DOI 10.1001/jama.288.12.1447; Stamm B.H., 2002, PSYCHOSOCIAL STRESS, P107; Stanton AL, 2002, J CLIN ONCOL, V20, P4160, DOI 10.1200/JCO.2002.08.521; Taylor C, 2005, LANCET, V366, P742, DOI 10.1016/S0140-6736(05)67178-4; TEDESCHI RG, 1995, TRAUMA TRANSFORMATIO, P43; Travado L, 2005, PSYCHO-ONCOLOGY, V14, P661, DOI 10.1002/pon.890; Vachon M., 2007, PRINCIPLES PRACTICE, V3rd, P667; VACHON MLS, 1995, PALLIATIVE MED, V9, P91, DOI 10.1177/026921639500900202; Vachon MLS, 2009, HDB PSYCHIAT PALLIAT; Vachon MLS., 1987, OCCUPATIONAL STRESS; VACHON MLS, 2008, PALLIATIVE MED, P75; VACHON MLS, PSYCHOONCOL IN PRESS; Valent P., 2002, TREATING COMPASSION, P17; Wallace BA, 2006, AM PSYCHOL, V61, P690, DOI 10.1037/0003-066X.61.7.690; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071; Whippen DA, 2004, J CLIN ONCOL, V22, p532S; WHIPPEN DA, 1991, J CLIN ONCOL, V9, P1916, DOI 10.1200/JCO.1991.9.10.1916; Wright B, 2004, PALLIATIVE MED, V18, P3, DOI 10.1191/0269216304pm866ed	111	257	262	0	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 18	2009	301	11					1155	1164		10.1001/jama.2009.352	http://dx.doi.org/10.1001/jama.2009.352			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	419UC	19293416				2022-12-28	WOS:000264244200021
J	Kline, JA				Kline, Jeffry A.			Simplification of the revised Geneva score did not decrease accuracy for diagnosis of pulmonary embolism	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Carolinas Med Ctr, Charlotte, NC 28203 USA	Carolinas Medical Center	Kline, JA (corresponding author), Carolinas Med Ctr, Charlotte, NC 28203 USA.							KLINE JA, 2008, J THROMB HAEMOST, V772, P80; Klok FA, 2008, ARCH INTERN MED, V168, P2131, DOI 10.1001/archinte.168.19.2131; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416	3	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6							JC3-15	10.7326/0003-4819-150-6-200903170-02015	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-02015			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423AJ	19306497				2022-12-28	WOS:000264468500037
J	Smirnov, DA; Morley, M; Shin, E; Spielman, RS; Cheung, VG				Smirnov, Denis A.; Morley, Michael; Shin, Eunice; Spielman, Richard S.; Cheung, Vivian G.			Genetic analysis of radiation-induced changes in human gene expression	NATURE			English	Article							GENOME-WIDE ASSOCIATION; CELLS; LINKAGE; DISSECTION; APOPTOSIS; TRAITS; GROWTH	Humans are exposed to radiation through the environment and in medical settings. To deal with radiation-induced damage, cells mount complex responses that rely on changes in gene expression. These gene expression responses differ greatly between individuals(1) and contribute to individual differences in response to radiation(2). Here we identify regulators that influence expression levels of radiation-responsive genes. We treated radiation-induced changes in gene expression as quantitative phenotypes(3,4), and conducted genetic linkage and association studies to map their regulators. For more than 1,200 of these phenotypes there was significant evidence of linkage to specific chromosomal regions. Nearly all of the regulators act in trans to influence the expression of their target genes; there are very few cis-acting regulators. Some of the transacting regulators are transcription factors, but others are genes that were not known to have a regulatory function in radiation response. These results have implications for our basic and clinical understanding of how human cells respond to radiation.	[Smirnov, Denis A.; Cheung, Vivian G.] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Morley, Michael; Shin, Eunice; Cheung, Vivian G.] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Spielman, Richard S.; Cheung, Vivian G.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Cheung, Vivian G.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	Cheung, VG (corresponding author), Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.	vcheung@mail.med.upenn.edu	Cheung, Vivian G./AAT-3115-2020	Morley, Michael/0000-0002-0958-7376	National Center for Research Resources; National Institutes of Health; University of Pennsylvania Center for Excellence in Environmental Toxicology; W. W. Smith Endowed Chair; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081930] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Center for Excellence in Environmental Toxicology; W. W. Smith Endowed Chair; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. George and W. Ewens for advice and discussion, A. Bruzel, S. Solomon, T. Weber and K. Halasa for technical help, and C. McGarry for manuscript preparation. Some analyses for this paper were performed by using the program package S. A. G. E., which is supported by a grant from the National Center for Research Resources. This work is supported by grants from the National Institutes of Health (to V. G. C. and R. S. S.), by seed grants from the University of Pennsylvania Center for Excellence in Environmental Toxicology (to V. G. C.), by the W. W. Smith Endowed Chair (to V. G. C.) and the Howard Hughes Medical Institute (to V. G. C.).	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amundson SA, 2008, CANCER RES, V68, P415, DOI 10.1158/0008-5472.CAN-07-2120; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Burdick JT, 2006, NAT GENET, V38, P1002, DOI 10.1038/ng1863; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Correa CR, 2004, AM J HUM GENET, V75, P885, DOI 10.1086/425221; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Myers Jason W, 2006, J RNAi Gene Silencing, V2, P181; Pan DN, 2006, CANCER LETT, V235, P26, DOI 10.1016/j.canlet.2005.03.045; Pant PVK, 2006, GENOME RES, V16, P331, DOI 10.1101/gr.4559106; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000294; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Sato N, 2000, EXP CELL RES, V255, P321, DOI 10.1006/excr.1999.4797; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; SELVAKUMARAN M, 1994, MOL CELL BIOL, V14, P2352, DOI 10.1128/MCB.14.4.2352; Shete S, 2003, HUM HERED, V55, P79, DOI 10.1159/000072312; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529	30	155	158	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					587	U120		10.1038/nature07940	http://dx.doi.org/10.1038/nature07940			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19349959	Green Accepted			2022-12-28	WOS:000266370500043
J	Lee, YJ; Yi, H; Kim, WJ; Kang, K; Yun, DS; Strano, MS; Ceder, G; Belcher, AM				Lee, Yun Jung; Yi, Hyunjung; Kim, Woo-Jae; Kang, Kisuk; Yun, Dong Soo; Strano, Michael S.; Ceder, Gerbrand; Belcher, Angela M.			Fabricating Genetically Engineered High-Power Lithium-Ion Batteries Using Multiple Virus Genes	SCIENCE			English	Article							CARBON NANOTUBE; ELECTRODE PERFORMANCE; HIGH-CAPACITY; PEPTIDES; CATHODE; FEPO4	Development of materials that deliver more energy at high rates is important for high-power applications, including portable electronic devices and hybrid electric vehicles. For lithium-ion (Li+) batteries, reducing material dimensions can boost Li+ ion and electron transfer in nanostructured electrodes. By manipulating two genes, we equipped viruses with peptide groups having affinity for single-walled carbon nanotubes (SWNTs) on one end and peptides capable of nucleating amorphous iron phosphate (a-FePO4) fused to the viral major coat protein. The virus clone with the greatest affinity toward SWNTs enabled power performance of a-FePO4 comparable to that of crystalline lithium iron phosphate (c-LiFePO4) and showed excellent capacity retention upon cycling at 1C. This environmentally benign low-temperature biological scaffold could facilitate fabrication of electrodes from materials previously excluded because of extremely low electronic conductivity.	[Lee, Yun Jung; Yi, Hyunjung; Yun, Dong Soo; Ceder, Gerbrand; Belcher, Angela M.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Kim, Woo-Jae; Strano, Michael S.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Kang, Kisuk] Korea Adv Inst Sci & Technol, Dept Mat Sci & Engn, Taejon 305701, South Korea; [Kang, Kisuk] Korea Adv Inst Sci & Technol, Inst Ecoenergy, Taejon 305701, South Korea; [Belcher, Angela M.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Massachusetts Institute of Technology (MIT)	Belcher, AM (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	belcher@mit.edu	Yi, Hyunjung/C-8672-2012; Ceder, Gerbrand/Y-2544-2019; Kang, Kisuk/B-5776-2011; Kim, Woo-Jae/F-8036-2013	Yi, Hyunjung/0000-0001-8812-497X; Kang, Kisuk/0000-0002-8696-1886; Kim, Woo-Jae/0000-0001-8761-6809	Army Research Office Institute of the Institute of Collaborative Biotechnologies (ICB); U.S. NSF through the Materials Research Science and Engineering Centers program; Korean Government [KRF-2005-214-D00260]; Korea Science and Engineering Foundation of the Ministry of Education, Science and Technology [R01-2008-000-10913-0]; Energy Resource Technology Development program by the Ministry of Knowledge Economy [2008-E-EL11-P-08-3-010]; Office of Naval Research; EPSRC [EP/C01197X/2, EP/C01197X/1] Funding Source: UKRI	Army Research Office Institute of the Institute of Collaborative Biotechnologies (ICB); U.S. NSF through the Materials Research Science and Engineering Centers program(National Science Foundation (NSF)); Korean Government(Korean Government); Korea Science and Engineering Foundation of the Ministry of Education, Science and Technology; Energy Resource Technology Development program by the Ministry of Knowledge Economy; Office of Naval Research(Office of Naval Research); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Army Research Office Institute of the Institute of Collaborative Biotechnologies (ICB) and U.S. NSF through the Materials Research Science and Engineering Centers program. H.Y. is grateful for Korean Government Overseas Scholarship. W.-J.K. is grateful for support from the Korea Research Foundation Grant funded by the Korean Government (MOEHRD) (KRF-2005-214-D00260). K.K is grateful for funding support from Korea Science and Engineering Foundation of the Ministry of Education, Science and Technology (No. R01-2008-000-10913-0) and Energy Resource Technology Development program by the Ministry of Knowledge Economy (No. 2008-E-EL11-P-08-3-010). M.S.S. is grateful for funding from the NSF and the Office of Naval Research Young Investigator Grant.	Ahn S, 1998, ELECTROCHEM SOLID ST, V1, P111; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Bruce PG, 2008, ANGEW CHEM INT EDIT, V47, P2930, DOI 10.1002/anie.200702505; Chung SY, 2002, NAT MATER, V1, P123, DOI 10.1038/nmat732; Croce F, 2002, ELECTROCHEM SOLID ST, V5, pA47, DOI 10.1149/1.1449302; Delacourt C, 2006, ELECTROCHEM SOLID ST, V9, pA352, DOI 10.1149/1.2201987; Hu YS, 2007, ADV MATER, V19, P1963, DOI 10.1002/adma.200700697; Huang Y, 2005, NANO LETT, V5, P1429, DOI 10.1021/nl050795d; Kang KS, 2006, SCIENCE, V311, P977, DOI 10.1126/science.1122152; Kavan L, 2007, CHEM MATER, V19, P4716, DOI 10.1021/cm071107p; Khalil AS, 2007, P NATL ACAD SCI USA, V104, P4892, DOI 10.1073/pnas.0605727104; Kim DH, 2006, ELECTROCHEM SOLID ST, V9, pA439, DOI 10.1149/1.2218308; Moore VC, 2003, NANO LETT, V3, P1379, DOI 10.1021/nl034524j; Nam KT, 2008, P NATL ACAD SCI USA, V105, P17227, DOI 10.1073/pnas.0711620105; Nam KT, 2008, ACS NANO, V2, P1480, DOI 10.1021/nn800018n; Nam KT, 2004, NANO LETT, V4, P23, DOI 10.1021/nl0347536; Prosini PP, 2002, J ELECTROCHEM SOC, V149, pA297, DOI 10.1149/1.1435359; Sakamoto JS, 2002, J ELECTROCHEM SOC, V149, pA26, DOI 10.1149/1.1425791; Shi ZC, 2008, ELECTROCHIM ACTA, V53, P2665, DOI 10.1016/j.electacta.2007.06.079; Tarascon JM, 2004, DALTON T, P2988, DOI 10.1039/b408442j; Wang Q, 2007, J AM CHEM SOC, V129, P3163, DOI 10.1021/ja066260j; Wang SQ, 2003, NAT MATER, V2, P196, DOI 10.1038/nmat833; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911	24	622	650	13	673	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1051	1055		10.1126/science.1171541	http://dx.doi.org/10.1126/science.1171541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19342549				2022-12-28	WOS:000266246700036
J	Tran, C; Ouk, S; Clegg, NJ; Chen, Y; Watson, PA; Arora, V; Wongvipat, J; Smith-Jones, PM; Yoo, D; Kwon, A; Wasielewska, T; Welsbie, D; Chen, CD; Higano, CS; Beer, TM; Hung, DT; Scher, HI; Jung, ME; Sawyers, CL				Tran, Chris; Ouk, Samedy; Clegg, Nicola J.; Chen, Yu; Watson, Philip A.; Arora, Vivek; Wongvipat, John; Smith-Jones, Peter M.; Yoo, Dongwon; Kwon, Andrew; Wasielewska, Teresa; Welsbie, Derek; Chen, Charlie Degui; Higano, Celestia S.; Beer, Tomasz M.; Hung, David T.; Scher, Howard I.; Jung, Michael E.; Sawyers, Charles L.			Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer	SCIENCE			English	Article							ANDROGEN-RECEPTOR; NONSTEROIDAL ANTIANDROGENS; STRUCTURAL BASIS; BICALUTAMIDE; AFFINITY; ANTAGONISM; RESISTANCE; LIGAND; MODEL	Metastatic prostate cancer is treated with drugs that antagonize androgen action, but most patients progress to a more aggressive form of the disease called castration-resistant prostate cancer, driven by elevated expression of the androgen receptor. Here we characterize the diarylthiohydantoins RD162 and MDV3100, two compounds optimized from a screen for nonsteroidal antiandrogens that retain activity in the setting of increased androgen receptor expression. Both compounds bind to the androgen receptor with greater relative affinity than the clinically used antiandrogen bicalutamide, reduce the efficiency of its nuclear translocation, and impair both DNA binding to androgen response elements and recruitment of coactivators. RD162 and MDV3100 are orally available and induce tumor regression in mouse models of castration-resistant human prostate cancer. Of the first 30 patients treated with MDV3100 in a Phase I/II clinical trial, 13 of 30 (43%) showed sustained declines (by >50%) in serum concentrations of prostate-specific antigen, a biomarker of prostate cancer. These compounds thus appear to be promising candidates for treatment of advanced prostate cancer.	[Ouk, Samedy; Yoo, Dongwon; Jung, Michael E.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Tran, Chris; Clegg, Nicola J.; Chen, Yu; Watson, Philip A.; Arora, Vivek; Wongvipat, John; Kwon, Andrew; Wasielewska, Teresa; Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Smith-Jones, Peter M.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA; [Chen, Yu; Scher, Howard I.] Mem Sloan Kettering Canc Ctr, Genitourinary Oncol Serv, Div Solid Tumor Oncol, New York, NY 10065 USA; [Chen, Yu; Scher, Howard I.] Mem Sloan Kettering Canc Ctr, Sidney Kimmel Ctr Prostate & Urol Canc, New York, NY 10065 USA; [Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Welsbie, Derek; Chen, Charlie Degui] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Higano, Celestia S.] Univ Washington, Div Oncol, Dept Med, Fred Hutchinson Canc Ctr, Seattle, WA 98109 USA; [Higano, Celestia S.] Univ Washington, Div Oncol, Dept Urol, Fred Hutchinson Canc Ctr, Seattle, WA 98109 USA; [Beer, Tomasz M.] Oregon Hlth & Sci Univ, OHSU Knight Canc Inst, Portland, OR 97239 USA; [Hung, David T.] Medivation Inc, San Francisco, CA 94105 USA	University of California System; University of California Los Angeles; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Oregon Health & Science University	Jung, ME (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	jung@chem.ucla.edu; sawyersc@mskcc.org	Sawyers, Charles/G-5327-2016; Yoo, Dongwon/GVT-7588-2022	Yoo, Dongwon/0000-0002-4547-6948	Prostate Cancer Foundation; National Cancer Institute; U.S. Department of Defense Prostate Cancer Research Program Clinical Consortium Award [PC051382]; Charles H. Revson Foundation; American Society of Clinical Oncology Young Investigator Award; American Association for Cancer Research Bristol Myers Squibb Fellowship; NATIONAL CANCER INSTITUTE [P50CA092629] Funding Source: NIH RePORTER	Prostate Cancer Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Defense Prostate Cancer Research Program Clinical Consortium Award(United States Department of Defense); Charles H. Revson Foundation; American Society of Clinical Oncology Young Investigator Award; American Association for Cancer Research Bristol Myers Squibb Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Balk and M. Diamond for plasmids; E. De Stanchina, N. Wu, Q. Weige, and C. Wa for assistance with pharmacokinetic and serum protein binding studies; O. Ouerfelli, A. Dilhas, H. Zhao, and G. Yang for chemistry support; the Memorial Sloan-Kettering Cancer Center (MSKCC) molecular cytology core for immunohistochemistry; S. Cai, E. Burnazi, and the MSKCC Radiochemistry Core for 18F-FDHT production; the MSKCC Small-Animal Imaging Core Facility; D. Liang for technical support; and D. Danila for helpful discussions. Funded in part by the Prostate Cancer Foundation, the National Cancer Institute, and U.S. Department of Defense PC051382 Prostate Cancer Research Program Clinical Consortium Award. N.J.C. is supported by the Charles H. Revson Foundation. Y.C. is supported by an American Society of Clinical Oncology Young Investigator Award and American Association for Cancer Research Bristol Myers Squibb Fellowship. C.L.S. is a Doris Duke Distinguished Clinical Scientist. C.T., S.O., J.W., D.Y., D.W., C.C., M.E.J., and C.L.S. are co-inventors on patent applications covering RD162, MDV3100, and related compounds. C.L.S. and M.J. have been paid consultants for and have stock options in Medivation, Inc. D.T.H. is an employee of Medivation, Inc.	Baek SH, 2006, P NATL ACAD SCI USA, V103, P3100, DOI 10.1073/pnas.0510842103; Bohl CE, 2005, P NATL ACAD SCI USA, V102, P6201, DOI 10.1073/pnas.0500381102; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; COCKSHOTT ID, 1990, EUR UROL, V18, P10; Ellwood-Yen K, 2006, CANCER RES, V66, P10513, DOI 10.1158/0008-5472.CAN-06-1397; Hodgson MC, 2005, J BIOL CHEM, V280, P6511, DOI 10.1074/jbc.M408972200; Kelly WK, 1997, UROL CLIN N AM, V24, P421, DOI 10.1016/S0094-0143(05)70389-X; Kolvenbag GJCM, 1998, PROSTATE CANCER P D, V1, P307, DOI 10.1038/sj.pcan.4500262; Larson SM, 2004, J NUCL MED, V45, P366; Liu WN, 2008, NEOPLASIA, V10, P897, DOI 10.1593/neo.08428; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Ozers MS, 2007, BIOCHEMISTRY-US, V46, P683, DOI 10.1021/bi061321b; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; TEUTSCH G, 1994, J STEROID BIOCHEM, V48, P111, DOI 10.1016/0960-0760(94)90257-7; Van Dort ME, 2000, J MED CHEM, V43, P3344, DOI 10.1021/jm000163y; Yoshida T, 2005, CANCER RES, V65, P9611, DOI 10.1158/0008-5472.CAN-05-0817	18	1623	1720	9	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					787	790		10.1126/science.1168175	http://dx.doi.org/10.1126/science.1168175			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19359544	Green Accepted			2022-12-28	WOS:000265832400047
J	Iglehart, JK				Iglehart, John K.			The Struggle for Reform - Challenges and Hopes for Comprehensive Health Care Legislation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		BAUCUS M, 2009, CALL ACTION HLTH REF; CALMES J, 2009, NY TIMES        0319, pA1; Congressional Budget Office, 2008, BUDG OPT, V1; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Medicare Payment Advisory Commission, 2009, MED PAYM POL REP C	5	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1693	1695		10.1056/NEJMp0902651	http://dx.doi.org/10.1056/NEJMp0902651			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	435XY	19339715				2022-12-28	WOS:000265377800001
J	Cooper, PJ; Tomlinson, M; Swartz, L; Landman, M; Molteno, C; Stein, A; McPherson, K; Murray, L				Cooper, Peter J.; Tomlinson, Mark; Swartz, Leslie; Landman, Mireille; Molteno, Chris; Stein, Alan; McPherson, Klim; Murray, Lynne			Improving quality of mother-infant relationship and infant attachment in socioeconomically deprived community in South Africa: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							MATERNAL SENSITIVITY; PERIURBAN SETTLEMENT; POSTNATAL DEPRESSION; SECURITY; INTERVENTIONS; METAANALYSIS; IMPACT	Objective To assess the efficacy of an intervention designed to improve the mother-infant relationship and security of infant attachment in a South African peri-urban settlement with marked adverse socioeconomic circumstances. Design Randomised controlled trial. Setting Khayelitsha, a peri-urban settlement in South Africa. Participants 449 pregnant women. Interventions The intervention was delivered from late pregnancy and for six months postpartum. Women were visited in their homes by previously untrained lay community workers who provided support and guidance in parenting. The purpose of the intervention was to promote sensitive and responsive parenting and secure infant attachment to the mother. Women in the control group received no therapeutic input from the research team. Main outcome measures Primary outcomes: quality of mother-infant interactions at six and 12 months postpartum; infant attachment security at 18 months. Secondary outcome: maternal depression at six and 12 months. Results The intervention was associated with significant benefit to the mother-infant relationship. At both six and 12 months, compared with control mothers, mothers in the intervention group were significantly more sensitive (6 months: mean difference=0.77 (SD 0.37), t=2.10, P<0.05, d=0.24; 12 months: mean difference=0.42 (0.18), t=-2.04, P<0.05, d=0.26) and less intrusive (6 months: mean difference=0.68 (0.36), t=2.28, P<0.05, d=0.26; 12 months: mean difference=-1.76 (0.86), t=2.28, P<0.05, d=0.24) in their interactions with their infants. The intervention was also associated with a higher rate of secure infant attachments at 18 months (116/156 (74%) v 102/162 (63%); Wald=4.74, odds ratio=1.70, P<0.05). Although the prevalence of maternal depressive disorder was not significantly reduced, the intervention had a benefit in terms of maternal depressed mood at six months (z=2.05, P=0.04) on the Edinburgh postnatal depression scale). Conclusions The intervention, delivered by local lay women, had a significant positive impact on the quality of the mother-infant relationship and on security of infant attachment, factors known to predict favourable child development. If these effects persist, and if they are replicated, this intervention holds considerable promise for use in the developing world. Trial registration Current Controlled Trials ISRCTN25664149.	[Cooper, Peter J.; Murray, Lynne] Univ Reading, Sch Psychol, Reading RG6 6AL, Berks, England; [Tomlinson, Mark] Univ Cape Town, MRC, Hlth Syst Res Unit, ZA-7505 Tygerberg, South Africa; [Tomlinson, Mark; Swartz, Leslie] Univ Stellenbosch, Dept Psychol, ZA-7602 Matieland, South Africa; [Landman, Mireille] Parent Ctr, Matieland, South Africa; [Molteno, Chris] Groote Schuur Hosp, Dept Psychiat & Mental Hlth, ZA-7925 Cape Town, South Africa; [Stein, Alan] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England	University of Reading; University of Cape Town; Stellenbosch University; University of Cape Town; University of Oxford	Cooper, PJ (corresponding author), Univ Reading, Sch Psychol, Reading RG6 6AL, Berks, England.	p.j.cooper@rdg.ac.uk	Swartz, Leslie/A-5168-2008	Swartz, Leslie/0000-0003-1741-5897; Stein, Alan/0000-0001-8207-2822	Wellcome Trust [B574100]; Vlotman Trust	Wellcome Trust(Wellcome TrustEuropean Commission); Vlotman Trust	This study was supported by a grant (B574100) from the Wellcome Trust. MT was supported by a fellowship from the Vlotman Trust.	Ainsworth M., 1978, PATTERNS ATTACHMENT; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3; Atkinson L, 2000, CLIN PSYCHOL REV, V20, P1019, DOI 10.1016/S0272-7358(99)00023-9; Bakermans-Kranenburg MJ, 2003, PSYCHOL BULL, V129, P195, DOI 10.1037/0033-2909.129.2.195; Barbarin O.A., 2001, MANDELAS CHILDREN GR; Belsky J, 2002, DEV PSYCHOPATHOL, V14, P293, DOI 10.1017/S0954579402002067; Brazelton T. B., 1995, NEONATAL BEHAV ASSES; Brislin R.W., 1986, FIELD METHODS CROSS, P137; Campbell SB, 2004, DEV PSYCHOPATHOL, V16, P231, DOI 10.1017/S0954579404044499; Cooper PJ, 2002, BRIT J PSYCHIAT, V180, P76, DOI 10.1192/bjp.180.1.76; Cooper PJ, 1999, BRIT J PSYCHIAT, V175, P554, DOI 10.1192/bjp.175.6.554; DeWolff MS, 1997, CHILD DEV, V68, P571, DOI 10.2307/1132107; Farran D.C., 1986, PARENT CAREGIVER INV; FIRST MB, 1996, STRUCTURED CLIN INTE, V1; Granic I, 2006, PSYCHOL REV, V113, P101, DOI 10.1037/0033-295X.113.1.101; Greenberg M., 1999, HDB ATTACHMENT; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hamilton CE, 2000, CHILD DEV, V71, P690, DOI 10.1111/1467-8624.00177; MAIN M, 2005, ATTACHMENT INFANCY A; MAIN M, 1990, ATTACHMENT PRESCHOOL, P35; Martins C, 2000, J CHILD PSYCHOL PSYC, V41, P737, DOI 10.1111/1469-7610.00661; Murray L, 1996, J CHILD PSYCHOL PSYC, V37, P927, DOI 10.1111/j.1469-7610.1996.tb01490.x; Murray L, 1996, CHILD DEV, V67, P2512, DOI 10.2307/1131637; MURRAY L, HDB INFANT IN PRESS; MURRAY L, 2002, SOCIAL BABY; Nylen KJ, 2006, INFANT MENT HEALTH J, V27, P327, DOI 10.1002/imhj.20095; Patel V, 2002, AM J PSYCHIAT, V159, P43, DOI 10.1176/appi.ajp.159.1.43; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Ranson KE, 2008, EARLY CHILD DEV CARE, V178, P129, DOI 10.1080/03004430600685282; Schneider BH, 2001, DEV PSYCHOL, V37, P86, DOI 10.1037//0012-1649.37.1.86; Solomon J., 1999, HDB ATTACHMENT THEOR, P287; Sroufe L. A., 2005, ATTACHMENT INFANCY A; STEIN A, 1994, J CHILD PSYCHOL PSYC, V35, P733, DOI 10.1111/j.1469-7610.1994.tb01218.x; TETI DM, 1990, INTERDISCIPLINARY AS, P191; Thalheimer W., 2002, CALCULATE EFFECT SIZ; Tomlinson M, 2005, CHILD DEV, V76, P1044, DOI 10.1111/j.1467-8624.2005.00896.x; VAN IJZENDOORN MH, 1995, J CHILD PSYCHOL PSYC, V36, P225; Waters E, 2000, CHILD DEV, V71, P684, DOI 10.1111/1467-8624.00176; WHO, 1995, IMPR PSYCH DEV CHILD; WOLKE D, 1990, J PEDIATR PSYCHOL, V15, P237, DOI 10.1093/jpepsy/15.2.237	41	170	172	1	40	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 14	2009	338								b974	10.1136/bmj.b974	http://dx.doi.org/10.1136/bmj.b974			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	434TI	19366752	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-28	WOS:000265296600021
J	Furlong, KP; Lay, T; Ammon, CJ				Furlong, Kevin P.; Lay, Thorne; Ammon, Charles J.			A Great Earthquake Rupture Across a Rapidly Evolving Three-Plate Boundary	SCIENCE			English	Article							SOLOMON-ISLANDS; ARC	On 1 April 2007 a great, tsunamigenic earthquake (moment magnitude 8.1) ruptured the Solomon Islands subduction zone at the triple junction where the Australia and Solomon Sea-Woodlark Basin plates simultaneously underthrust the Pacific plate with different slip directions. The associated abrupt change in slip direction during the great earthquake drove convergent anelastic deformation of the upper Pacific plate, which generated localized uplift in the forearc above the subducting Simbo fault, potentially amplifying local tsunami amplitude. Elastic deformation during the seismic cycle appears to be primarily accommodated by the overriding Pacific forearc. This earthquake demonstrates the seismogenic potential of extremely young subducting oceanic lithosphere, the ability of ruptures to traverse substantial geologic boundaries, and the consequences of complex coseismic slip for uplift and tsunamigenesis.	[Furlong, Kevin P.; Ammon, Charles J.] Penn State Univ, Dept Geosci, State Coll, PA 16802 USA; [Lay, Thorne] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of California System; University of California Santa Cruz	Furlong, KP (corresponding author), Penn State Univ, Dept Geosci, State Coll, PA 16802 USA.	kevin@geodyn.psu.edu	Lay, Thorne/ABE-6272-2021		NSF [EAR0635570]	NSF(National Science Foundation (NSF))	The Incorporated Research Institutions for Seismology data management center provided the broadband seismic data. We thank C. Biryol and S. L. Beck for sharing a preprint manuscript and H. Kanamori for discussions about surface wave STFs and slip inversions. This work was supported in part by NSF under grant EAR0635570 (T.L.). We thank three anonymous reviewers for comments on the manuscript.	Ammon CJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026303; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Fisher M. A., 2007, SCI TSUNAMI HAZARDS, V26, P3; Fritz HM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031654; LAY T, 1980, PHYS EARTH PLANET IN, V21, P283, DOI 10.1016/0031-9201(80)90134-X; Mann P, 1998, TECTONOPHYSICS, V295, P259, DOI 10.1016/S0040-1951(98)00129-2; McAdoo B.G., 2008, EOS, V89, P169, DOI DOI 10.1029/2008EO180001; Taylor FW, 2008, NAT GEOSCI, V1, P253, DOI 10.1038/ngeo159; Tregoning P, 1998, GEOPHYS RES LETT, V25, P3627, DOI 10.1029/98GL52761; Tregoning P, 1998, J GEOPHYS RES-SOL EA, V103, P12181, DOI 10.1029/97JB03676	10	45	45	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					226	229		10.1126/science.1167476	http://dx.doi.org/10.1126/science.1167476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359581				2022-12-28	WOS:000265024400039
J	Kudla, G; Murray, AW; Tollervey, D; Plotkin, JB				Kudla, Grzegorz; Murray, Andrew W.; Tollervey, David; Plotkin, Joshua B.			Coding-Sequence Determinants of Gene Expression in Escherichia coli	SCIENCE			English	Article							SYNONYMOUS CODON USAGE; RNA SECONDARY STRUCTURE; MESSENGER-RNA; TRANSLATION INITIATION; PROTEIN EXPRESSION; BIAS; DOWNSTREAM; MUTATIONS; STABILITY; SELECTION	Synonymous mutations do not alter the encoded protein, but they can influence gene expression. To investigate how, we engineered a synthetic library of 154 genes that varied randomly at synonymous sites, but all encoded the same green fluorescent protein (GFP). When expressed in Escherichia coli, GFP protein levels varied 250-fold across the library. GFP messenger RNA (mRNA) levels, mRNA degradation patterns, and bacterial growth rates also varied, but codon bias did not correlate with gene expression. Rather, the stability of mRNA folding near the ribosomal binding site explained more than half the variation in protein levels. In our analysis, mRNA folding and associated rates of translation initiation play a predominant role in shaping expression levels of individual genes, whereas codon bias influences global translation efficiency and cellular fitness.	[Kudla, Grzegorz; Plotkin, Joshua B.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Kudla, Grzegorz; Plotkin, Joshua B.] Univ Penn, Program Appl Math & Computat Sci, Philadelphia, PA 19104 USA; [Murray, Andrew W.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Tollervey, David] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Tollervey, David] Univ Edinburgh, Ctr Syst Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Pennsylvania; University of Pennsylvania; Harvard University; University of Edinburgh; University of Edinburgh	Plotkin, JB (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	jplotkin@sas.upenn.edu	Tollervey, David/AAR-6662-2020; Plotkin, Joshua B/E-6947-2013	Tollervey, David/0000-0003-2894-2772; Kudla, Grzegorz/0000-0002-7924-2744	Burroughs Wellcome Fund; James S. McDonnell Foundation; Penn Genome Frontiers Institute; Defense Advanced Research Projects Agency [HR0011-05-1-0057]; Foundation for Polish Science; European Molecular Biology Organization; Wellcome Trust/BBSRC [BB/DO19621/1]; BBSRC [BB/D019621/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D019621/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); James S. McDonnell Foundation; Penn Genome Frontiers Institute; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Wellcome Trust/BBSRC(Wellcome TrustUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Helwak, J. Lucks, P. Sharp, L. Hurst, and members of the Plotkin and Tollervey laboratories for conceptual input; and A. Heath (Sigma), A. Aitken, J. Skerker, T. Shimizu, I. Iost, and J. Han for reagents, protocols, and equipment. Support provided by the Burroughs Wellcome Fund, James S. McDonnell Foundation, Penn Genome Frontiers Institute, and Defense Advanced Research Projects Agency "FunBio Program" HR0011-05-1-0057 (J.B.P.); Foundation for Polish Science and European Molecular Biology Organization (G.K.); Wellcome Trust/BBSRC grant BB/DO19621/1 (D.T.).	AKASHI H, 1994, GENETICS, V136, P927; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Boycheva S, 2003, BIOINFORMATICS, V19, P987, DOI 10.1093/bioinformatics/btg082; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; de Valdivia EIG, 2004, NUCLEIC ACIDS RES, V32, P5198, DOI 10.1093/nar/gkh857; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; EYREWALKER A, 1993, NUCLEIC ACIDS RES, V21, P4599, DOI 10.1093/nar/21.19.4599; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Griswold KE, 2003, PROTEIN EXPRES PURIF, V27, P134, DOI 10.1016/S1046-5928(02)00578-8; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; HALL MN, 1982, NATURE, V295, P616, DOI 10.1038/295616a0; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; IOST I, 1995, EMBO J, V14, P3252, DOI 10.1002/j.1460-2075.1995.tb07328.x; JACQUES N, 1990, MOL MICROBIOL, V4, P1063, DOI 10.1111/j.1365-2958.1990.tb00679.x; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Lithwick G, 2003, GENOME RES, V13, P2665, DOI 10.1101/gr.1485203; MUDD EA, 1990, MOL MICROBIOL, V4, P2127, DOI 10.1111/j.1365-2958.1990.tb00574.x; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Parmley JL, 2007, BIOESSAYS, V29, P515, DOI 10.1002/bies.20592; Qing GL, 2003, J MOL MICROB BIOTECH, V6, P133, DOI 10.1159/000077244; ROSENBERG AH, 1993, J BACTERIOL, V175, P716, DOI 10.1128/JB.175.3.716-722.1993; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	28	970	1002	10	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					255	258		10.1126/science.1170160	http://dx.doi.org/10.1126/science.1170160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359587	Green Accepted			2022-12-28	WOS:000265024400047
J	Polynkin, P; Kolesik, M; Moloney, JV; Siviloglou, GA; Christodoulides, DN				Polynkin, Pavel; Kolesik, Miroslav; Moloney, Jerome V.; Siviloglou, Georgios A.; Christodoulides, Demetrios N.			Curved Plasma Channel Generation Using Ultraintense Airy Beams	SCIENCE			English	Article							LASER-PULSES; FEMTOSECOND; FILAMENTATION	Plasma channel generation (or filamentation) using ultraintense laser pulses in dielectric media has a wide spectrum of applications, ranging from remote sensing to terahertz generation to lightning control. So far, laser filamentation has been triggered with the use of ultrafast pulses with axially symmetric spatial beam profiles, thereby generating straight filaments. We report the experimental observation of curved plasma channels generated in air using femtosecond Airy beams. In this unusual propagation regime, the tightly confined main intensity feature of the axially nonsymmetric laser beam propagates along a bent trajectory, leaving a curved plasma channel behind. Secondary channels bifurcate from the primary bent channel at several locations along the beam path. The broadband radiation emanating from different longitudinal sections of the curved filament propagates along angularly resolved trajectories.	[Polynkin, Pavel; Kolesik, Miroslav; Moloney, Jerome V.] Univ Arizona, Coll Opt Sci, Tucson, AZ 85721 USA; [Moloney, Jerome V.] Univ Arizona, Dept Math, Tucson, AZ 85721 USA; [Siviloglou, Georgios A.; Christodoulides, Demetrios N.] Univ Cent Florida, Ctr Res & Educ Opt & Lasers, Coll Opt & Photon, Orlando, FL 32816 USA	University of Arizona; University of Arizona; State University System of Florida; University of Central Florida	Polynkin, P (corresponding author), Univ Arizona, Coll Opt Sci, Tucson, AZ 85721 USA.	ppolynkin@optics.arizona.edu	Siviloglou, Georgios A/H-8564-2018	Siviloglou, Georgios/0000-0002-6864-1272	U.S. Air Force Office of Scientific Research [FA9550-07-1-0010, FA9550-07-1-0256]; Lockheed Martin Corporation	U.S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Lockheed Martin Corporation	This work was supported by the U.S. Air Force Office of Scientific Research through grants FA9550-07-1-0010 and FA9550-07-1-0256. The contribution of G.A.S. and D.N.C. was partially supported by Lockheed Martin Corporation. We thank T.-M. O. Crust for stimulating discussions and D. Hansen and T. Milster for fabricating cubic phase masks used in the experiments.	Akturk S, 2009, OPT COMMUN, V282, P129, DOI 10.1016/j.optcom.2008.09.048; Baumgartl J, 2008, NAT PHOTONICS, V2, P675, DOI 10.1038/nphoton.2008.201; Besieris IM, 2007, OPT LETT, V32, P2447, DOI 10.1364/OL.32.002447; BRAUN A, 1995, OPT LETT, V20, P73, DOI 10.1364/OL.20.000073; Broky J, 2008, OPT EXPRESS, V16, P12880, DOI 10.1364/OE.16.012880; Chateauneuf M, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2889501; Couairon A, 2007, PHYS REP, V441, P47, DOI 10.1016/j.physrep.2006.12.005; D'Amico C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.235002; Faccio D, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.193901; Hauri CP, 2004, APPL PHYS B-LASERS O, V79, P673, DOI 10.1007/s00340-004-1650-z; Kasparian J, 2008, OPT EXPRESS, V16, P5757, DOI 10.1364/OE.16.005757; Kolesik M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.283902; Luo Q, 2006, APPL PHYS B-LASERS O, V82, P105, DOI 10.1007/s00340-005-2008-x; Mlejnek M, 1998, OPT LETT, V23, P382, DOI 10.1364/OL.23.000382; Polynkin P, 2008, OPT EXPRESS, V16, P15733, DOI 10.1364/OE.16.015733; Proulx A, 2000, OPT COMMUN, V174, P305, DOI 10.1016/S0030-4018(99)00691-4; Saari P, 2008, OPT EXPRESS, V16, P10303, DOI 10.1364/OE.16.010303; Siviloglou GA, 2008, OPT LETT, V33, P207, DOI 10.1364/OL.33.000207; Siviloglou GA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.213901; Siviloglou GA, 2007, OPT LETT, V32, P979, DOI 10.1364/OL.32.000979; Tzortzakis S, 2000, OPT LETT, V25, P1270, DOI 10.1364/OL.25.001270; *USAF OFF SCI RES, FA95500710010 US AIR	23	696	733	4	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					229	232		10.1126/science.1169544	http://dx.doi.org/10.1126/science.1169544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359582				2022-12-28	WOS:000265024400040
J	Rieder, HL				Rieder, Hans L.			Fourth-generation fluoroquinolones in tuberculosis	LANCET			English	Editorial Material							RESISTANT TUBERCULOSIS		Int Union TB & Lung Dis, CH-3038 Kirchlindach, Switzerland		Rieder, HL (corresponding author), Int Union TB & Lung Dis, CH-3038 Kirchlindach, Switzerland.	TBRieder@tbrieder.org						[Anonymous], 2008, GUID PROGR MAN DRUG; [Anonymous], 1912, MONATSH CHEM, DOI DOI 10.1007/BF01517946; BROUET G, 1977, REV FR MAL RESPIR, V5, P5; COMROE JH, 1978, AM REV RESPIR DIS, V117, P773; Conde MB, 2009, LANCET, V373, P1183, DOI 10.1016/S0140-6736(09)60333-0; CROFTON J, 1958, AM REV TUBERC PULM, V77, P869; Dobler CC, 2009, EUR RESPIR J, V33, P160, DOI 10.1183/09031936.00104108; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; LEHMANN J, 1964, AM REV RESPIR DIS, V90, P953; LESHER GY, 1962, J MED PHARMACEUT CH, V5, P1063, DOI 10.1021/jm01240a021; MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062; Nathanson E, 2004, INT J TUBERC LUNG D, V8, P1382; SENSI P, 1959, Farmaco Sci, V14, P146; World Health Organization, 2006, GUID PROGR MAN DRUG	14	20	20	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 4	2009	373	9670					1148	1149		10.1016/S0140-6736(09)60559-6	http://dx.doi.org/10.1016/S0140-6736(09)60559-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429SO	19345815				2022-12-28	WOS:000264940600005
J	Kohl, SW; Weiner, L; Schwartsburd, L; Konstantinovski, L; Shimon, LJW; Ben-David, Y; Iron, MA; Milstein, D				Kohl, Stephan W.; Weiner, Lev; Schwartsburd, Leonid; Konstantinovski, Leonid; Shimon, Linda J. W.; Ben-David, Yehoshoa; Iron, Mark A.; Milstein, David			Consecutive Thermal H-2 and Light-Induced O-2 Evolution from Water Promoted by a Metal Complex	SCIENCE			English	Article							O-O BOND; RUTHENIUM DIIMINE COMPLEXES; ARTIFICIAL PHOTOSYNTHESIS; SOLAR-ENERGY; OXIDATION; MECHANISM; CATALYSTS; ACTIVATION; REACTIVITY; CONVERSION	Discovery of an efficient artificial catalyst for the sunlight-driven splitting of water into dioxygen and dihydrogen is a major goal of renewable energy research. We describe a solution-phase reaction scheme that leads to the stoichiometric liberation of dihydrogen and dioxygen in consecutive thermal-and light-driven steps mediated by mononuclear, well-defined ruthenium complexes. The initial reaction of water at 25 degrees C with a dearomatized ruthenium (II) [Ru(II)] pincer complex yields a monomeric aromatic Ru(II) hydrido-hydroxo complex that, on further reaction with water at 100 degrees C, releases H-2 and forms a cis dihydroxo complex. Irradiation of this complex in the 320-to-420-nanometer range liberates oxygen and regenerates the starting hydrido-hydroxo Ru(II) complex, probably by elimination of hydrogen peroxide, which rapidly disproportionates. Isotopic labeling experiments with (H2O)-O-17 and (H2O)-O-18 show unequivocally that the process of oxygen-oxygen bond formation is intramolecular, establishing a previously elusive fundamental step toward dioxygen-generating homogeneous catalysis.	[Kohl, Stephan W.; Schwartsburd, Leonid; Ben-David, Yehoshoa; Milstein, David] Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel; [Weiner, Lev; Konstantinovski, Leonid; Shimon, Linda J. W.; Iron, Mark A.] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Milstein, D (corresponding author), Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel.	david.milstein@weizmann.ac.il	Milstein, David/E-9092-2012; Iron, Mark A./K-1758-2012; Lev, Weiner/GZK-4484-2022	Milstein, David/0000-0002-2320-0262; Iron, Mark A./0000-0001-9774-2358; Shimon, Linda/0000-0002-7861-9247	Israel Science Foundation; American Chemical Society; Deutsch-Israelische Partnerschaft; Helen and Martin Kimmel Center for Molecular Design; Humboldt Foundation, Feodor Lynen Postdoctoral Fellowship	Israel Science Foundation(Israel Science Foundation); American Chemical Society(American Chemical Society); Deutsch-Israelische Partnerschaft; Helen and Martin Kimmel Center for Molecular Design; Humboldt Foundation, Feodor Lynen Postdoctoral Fellowship(Alexander von Humboldt Foundation)	This project was supported by the Israel Science Foundation, the Petroleum Research Fund administered by the American Chemical Society, the programme for Deutsch-Israelische Partnerschaft, and the Helen and Martin Kimmel Center for Molecular Design. S.W.K. thanks the Humboldt Foundation for a Feodor Lynen Postdoctoral Fellowship. D.M. holds the Israel Matz Professorial Chair of Organic Chemistry. We thank M. Feller for fruitful discussions, A. Tishbee and R. Kramer for performing mass spectroscopy, A. Khenkin and H. Weissman for carrying out GC-MS and GC measurements, and E. Shirman for photon flux measurements. Structural parameters for 2.nH2O are available free of charge from the Cambridge Crystallographic Data Centre under identification number CCDC-681749.	Alstrum-Acevedo JH, 2005, INORG CHEM, V44, P6802, DOI 10.1021/ic050904r; Balzani V, 2008, CHEMSUSCHEM, V1, P26, DOI 10.1002/cssc.200700087; Ben-Ari E, 2006, J AM CHEM SOC, V128, P15390, DOI 10.1021/ja066411i; Betley TA, 2008, INORG CHEM, V47, P1849, DOI 10.1021/ic701972n; Binstead RA, 2000, J AM CHEM SOC, V122, P8464, DOI 10.1021/ja993235n; BLUM O, 1995, J AM CHEM SOC, V117, P4582, DOI 10.1021/ja00121a016; Chakraborty S, 2005, INORG CHEM, V44, P6865, DOI 10.1021/ic0505605; Deng ZP, 2008, INORG CHEM, V47, P1835, DOI 10.1021/ic7010875; Geletii YV, 2008, ANGEW CHEM INT EDIT, V47, P3896, DOI 10.1002/anie.200705652; Grela MA, 1996, J PHYS CHEM-US, V100, P16940, DOI 10.1021/jp953562r; Gunanathan C, 2007, SCIENCE, V317, P790, DOI 10.1126/science.1145295; Hurst JK, 2008, INORG CHEM, V47, P1753, DOI 10.1021/ic700724h; Hurst JK, 2005, COORDIN CHEM REV, V249, P313, DOI 10.1016/j.ccr.2004.06.017; Kaplan AW, 1998, ORGANOMETALLICS, V17, P5072, DOI 10.1021/om980295d; Kato S, 2004, J BIOL CHEM, V279, P52376, DOI 10.1074/jbc.M403532200; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Limburg J, 1999, SCIENCE, V283, P1524, DOI 10.1126/science.283.5407.1524; McDaniel ND, 2008, J AM CHEM SOC, V130, P210, DOI 10.1021/ja074478f; MILSTEIN D, 1986, J AM CHEM SOC, V108, P6387, DOI 10.1021/ja00280a045; Muckerman JT, 2008, INORG CHEM, V47, P1787, DOI 10.1021/ic701892v; Nakabayashi Y, 2007, CHEM-EUR J, V13, P3980, DOI 10.1002/chem.200601271; Romero I, 2008, INORG CHEM, V47, P1824, DOI 10.1021/ic700911y; Ruttinger W, 1997, CHEM REV, V97, P1, DOI 10.1021/cr950201z; SIEGBAHN PEM, 1993, J PHYS CHEM-US, V97, P2564, DOI 10.1021/j100113a017; von Sonntag J, 2004, CHEM-EUR J, V10, P440, DOI 10.1002/chem.200305136; Yagi M, 2001, CHEM REV, V101, P21, DOI 10.1021/cr980108l; Yang X, 2006, J AM CHEM SOC, V128, P7476, DOI 10.1021/ja053710j; Zhang J, 2005, J AM CHEM SOC, V127, P10840, DOI 10.1021/ja052862b	28	408	410	7	318	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 3	2009	324	5923					74	77		10.1126/science.1168600	http://dx.doi.org/10.1126/science.1168600			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342584				2022-12-28	WOS:000264802100034
J	Clohessy, JG; Pandolfi, PP				Clohessy, John G.; Pandolfi, Pier Paolo			beta-tting on p63 as a Metastatic Suppressor	CELL			English	Editorial Material							TGF-BETA; MUTANT	Although much is known about the genes that promote metastasis, few suppressors of metastasis have been found. Adorno et al. (2009) now identify p63 as a potent suppressor of metastasis and uncover an intricate mechanism for the inactivation of metastasis in cancer cells in response to transforming growth factor beta.	[Clohessy, John G.; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Canc Ctr, Canc Gene Program, Boston, MA 02215 USA; [Clohessy, John G.; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol & Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Canc Ctr, Canc Gene Program, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu		Clohessy, John/0000-0001-5186-9775				Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Don ASA, 2006, EXP CELL RES, V312, P4181, DOI 10.0116/j.yexcr.2006.09.023; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Rossner MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002762; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045	8	7	7	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					28	31		10.1016/j.cell.2009.03.028	http://dx.doi.org/10.1016/j.cell.2009.03.028			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345184	Bronze			2022-12-28	WOS:000264813300011
J	Brook, RH				Brook, Robert H.			Quality, Transparency, and the US Government	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brook, Robert H.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Brook, Robert H.] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA; [Brook, Robert H.] Robert Wood Johnson UCLA Clin Scholars Program, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Brook, RH (corresponding author), RAND Corp, 1776 Main St,POB 2138, Santa Monica, CA 90407 USA.	robert_brook@rand.org	Young, Alexander/A-1523-2009	Young, Alexander/0000-0002-9367-9213				CARLISLE D, ACCESS PUBLIC RECORD; *CTR MED MED SERV, RFPCMSMIDS20080001; *OB AM, HEALTHC ISS; *OFF STAT HLTH PLA, STAT CAL PUBL M	4	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 1	2009	301	13					1377	1378		10.1001/jama.2009.427	http://dx.doi.org/10.1001/jama.2009.427			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426LM	19336715				2022-12-28	WOS:000264709800029
J	Koppel, R; Kreda, D				Koppel, Ross; Kreda, David			Health Care Information Technology Vendors' "Hold Harmless" Clause Implications for Patients and Clinicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNINTENDED CONSEQUENCES; SYSTEMS		[Koppel, Ross] Univ Penn, Dept Sociol, Philadelphia, PA 19104 USA; [Koppel, Ross] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Kreda, David] Social Res Corp, Wyncote, PA USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Koppel, R (corresponding author), Univ Penn, Dept Sociol, 113 McNeil Bldg, Philadelphia, PA 19104 USA.	rkoppel@sas.upenn.edu	Tao, Youyou/D-2367-2014	Koppel, Ross/0000-0002-8235-9900				Agency for Healthcare Research and Quality, 2008, AG HEALTHC RES QUAL; Ash JS, 2007, ST HEAL T, V129, P198; Carayon P, 2006, QUAL SAF HEALTH CARE, V15, pI50, DOI 10.1136/qshc.2005.015842; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Han YY, 2005, PEDIATRICS, V116, P1506, DOI 10.1542/peds.2005-1287; Harrison MI, 2007, J AM MED INFORM ASSN, V14, P542, DOI 10.1197/jamia.M2384; HOFFMAN S, 2008, HARV J LAW TECHNOL, V22, P1; Karsh BT, 2006, APPL ERGON, V37, P283, DOI 10.1016/j.apergo.2005.07.003; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Koppel R, 2008, J AM MED INFORM ASSN, V15, P408, DOI 10.1197/jamia.M2616; *SCIENCEDAILY, PROF CALL REG EL HLT; SILVERSTEIN S, SOCIOTECHNOLOGIC ISS; Van der Sijs H, 2006, J AM MED INFORM ASSN, V13, P138, DOI 10.1197/jamia.M1809; 2005, INSIDE HEALTHCARE CO, V15	14	62	63	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 25	2009	301	12					1276	1278		10.1001/jama.2009.398	http://dx.doi.org/10.1001/jama.2009.398			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	423JO	19318655				2022-12-28	WOS:000264492800028
J	MacGregor, GA; de Wardener, HE				MacGregor, Graham A.; de Wardener, Hugh E.			The French salt industry in court	LANCET			English	Editorial Material							RISK		[MacGregor, Graham A.] Univ London, St Georges Hosp, Blood Pressure Unit, Div Cardiac & Vasc Med, London SW17 0RE, England; [de Wardener, Hugh E.] Univ London Imperial Coll Sci Technol & Med, London, England	St Georges University London; University of London; Imperial College London	MacGregor, GA (corresponding author), Univ London, St Georges Hosp, Blood Pressure Unit, Div Cardiac & Vasc Med, London SW17 0RE, England.	g.macgregor@sgul.ac.uk						ALDERMAN MH, 1995, HYPERTENSION, V25, P1144, DOI 10.1161/01.HYP.25.6.1144; de Wardener HE, 1999, J HUM HYPERTENS, V13, P1, DOI 10.1038/sj.jhh.1000759; *FDN SCI CIT, 2008, NOT LIB ACT BROUGHT; *FRENCH FOOD SAF A, 2002, REP SALT EV REC; *NAT AC MED, 2004, REP SALT INT BLOOD P; 2008, LIBERATION FR   0313; 2006, SALT SKIP NEWS, V140, P4	7	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					990	992		10.1016/S0140-6736(09)60589-4	http://dx.doi.org/10.1016/S0140-6736(09)60589-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	422AA	19304002				2022-12-28	WOS:000264398200010
J	Slade, D; Lindner, AB; Paul, G; Radman, M				Slade, Dea; Lindner, Ariel B.; Paul, Gregory; Radman, Miroslav			Recombination and Replication in DNA Repair of Heavily Irradiated Deinococcus radiodurans	CELL			English	Article							BREAK-INDUCED REPLICATION; DOUBLE-STRAND BREAKS; ESCHERICHIA-COLI; TARGETED MUTAGENESIS; MICROCOCCUS; POLYMERASE; RADIATION; PROTEIN; DAMAGE; RADIORESISTANCE	Deinococcus radiodurans' extreme resistance to ionizing radiation, desiccation, and DNA-damaging chemicals involves a robust DNA repair that reassembles its shattered genome. The repair process requires diploidy and commences with an extensive exonucleolytic erosion of DNA fragments. Liberated single-stranded overhangs prime strand elongation on overlapping fragments and the elongated complementary strands reestablish chromosomal contiguity by annealing. We explored the interdependence of the DNA recombination and replication processes in the reconstitution of the D. radiodurans genome disintegrated by ionizing radiation. The priming of extensive DNA repair synthesis involves RecA and RadA proteins. DNA polymerase III is essential for the initiation of repair synthesis, whereas efficient elongation requires DNA polymerases I and III. Inactivation of both polymerases leads to degradation of DNA fragments and rapid cell death. The present in vivo characterization of key recombination and replication processes dissects the mechanism of DNA repair in heavily irradiated D. radiodurans.	[Slade, Dea; Lindner, Ariel B.; Paul, Gregory; Radman, Miroslav] Univ Paris 05, Fac Med, INSERM, U571, F-75015 Paris, France; [Radman, Miroslav] Mediterranean Inst Life Sci, Split 21000, Croatia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Radman, M (corresponding author), Univ Paris 05, Fac Med, INSERM, U571, 156 Rue Vaugirard, F-75015 Paris, France.	miroslav.radman@inserm.fr	Lindner, Ariel/K-9247-2019; Lindner, Ariel B/I-8503-2016; Radman, Miroslav/HDM-5955-2022	Lindner, Ariel/0000-0001-5015-6511; Lindner, Ariel B/0000-0001-5015-6511; Radman, Miroslav/0000-0002-7034-4365; Slade, Dea/0000-0002-0052-5910; Radman, Miroslav/0000-0003-0216-3148	Institut National de la Sante et de la Recherche Medicale (INSERM); Boehringer Ingelheim Fonds	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	D. S. wishes to thank Dragana Ahel and Rupert Thorough for revision and editing of the manuscript. We thank Marina Elez and Dennis R. Harris for comments pertaining to the manuscript. We acknowledge generous gifts: Mary E. Lidstrom for pRAD1, John R. Battista for the polA mutant, and Suzanne Sommer for the recA mutant. We also thank Sophie Viel at Institut Curie in Paris for using <SUP>137</SUP>Cs gamma-ray source, Kathleen Smith of Eucodis for lending the PFGE equipment, and Gely Chantal of INSERM unit 876 for using the scintillation counter. This work was funded by Institut National de la Sante et de la Recherche Medicale (INSERM). D. S. is a Boehringer Ingelheim Fonds Ph. D. fellow. D. S. carried out all the experiments. D. S. and M. R. designed the experiments. D. S., A. B. L., and M. R. interpreted the results. G. P. computed an algorithm for quantitative analysis of PFGE gels. D. S. and M. R. wrote the manuscript.	ANDERSON AW, 1956, FOOD TECHNOL-CHICAGO, V10, P575; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; BIANCHI ME, 1983, CELL, V35, P511, DOI 10.1016/0092-8674(83)90185-X; Blasius M, 2006, MOL MICROBIOL, V60, P165, DOI 10.1111/j.1365-2958.2006.05077.x; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; DRIEDGER A A, 1970, Radiation Research, V44, P835, DOI 10.2307/3573160; FORMOSA T, 1986, CELL, V47, P793, DOI 10.1016/0092-8674(86)90522-2; Gladyshev E, 2008, P NATL ACAD SCI USA, V105, P5139, DOI 10.1073/pnas.0800966105; GUTMAN PD, 1993, J BACTERIOL, V175, P3581, DOI 10.1128/jb.175.11.3581-3590.1993; HANSEN MT, 1978, J BACTERIOL, V134, P71, DOI 10.1128/JB.134.1.71-75.1978; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; HARSOJO KS, 1981, J BIOCH, V90, P877; Holmes AM, 1999, CELL, V96, P415, DOI 10.1016/S0092-8674(00)80554-1; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Jolivet E, 2006, MOL MICROBIOL, V59, P338, DOI 10.1111/j.1365-2958.2005.04946.x; Kim JI, 2002, P NATL ACAD SCI USA, V99, P7917, DOI 10.1073/pnas.122218499; Kornberg A., 1992, DNA REPLICATION; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kraus E, 2001, P NATL ACAD SCI USA, V98, P8255, DOI 10.1073/pnas.151008198; Lecointe F, 2004, MOL MICROBIOL, V53, P1721, DOI 10.1111/j.1365-2958.2004.04233.x; LETT JT, 1970, J MOL BIOL, V48, P395, DOI 10.1016/0022-2836(70)90053-7; Levin-Zaidman S, 2003, SCIENCE, V299, P254, DOI 10.1126/science.1077865; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; MINTON KW, 1995, BIOESSAYS, V17, P457, DOI 10.1002/bies.950170514; MOSELEY BEB, 1975, J BACTERIOL, V121, P422, DOI 10.1128/JB.121.2.422-428.1975; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; SINHA NK, 1972, J BACTERIOL, V112, P1321, DOI 10.1128/JB.112.3.1321-1334.1972; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Tian B, 2007, BBA-GEN SUBJECTS, V1770, P902, DOI 10.1016/j.bbagen.2007.01.016; Vandewiele D, 2002, MUTAT RES-FUND MOL M, V499, P85, DOI 10.1016/S0027-5107(01)00268-8; VUKOVICNAGY B, 1974, INT J RADIAT BIOL, V25, P329, DOI 10.1080/09553007414550401; Wang X, 2004, MOL CELL BIOL, V24, P6891, DOI 10.1128/MCB.24.16.6891-6899.2004; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Xu WL, 2001, MOL MICROBIOL, V39, P286, DOI 10.1046/j.1365-2958.2001.02267.x; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; Zhou Q, 2006, CHINESE SCI BULL, V51, P2993, DOI 10.1007/s11434-006-2209-7	42	177	191	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1044	1055		10.1016/j.cell.2009.01.018	http://dx.doi.org/10.1016/j.cell.2009.01.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303848	Bronze			2022-12-28	WOS:000264403900011
J	Zoncu, R; Perera, RM; Balkin, DM; Pirruccello, M; Toomre, D; De Camilli, P				Zoncu, Roberto; Perera, Rushika M.; Balkin, Daniel M.; Pirruccello, Michelle; Toomre, Derek; De Camilli, Pietro			A Phosphoinositide Switch Controls the Maturation and Signaling Properties of APPL Endosomes	CELL			English	Article							CLATHRIN-COATED PITS; ENDOCYTIC PATHWAY; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; INDEPENDENT ENDOCYTOSIS; MEDIATED ENDOCYTOSIS; BAR-PH; RECEPTOR; PROTEIN; MEMBRANE; RAB5	The recent identification of several novel endocytic compartments has challenged our current understanding of the topological and functional organization of the endocytic pathway. Using quantitative single vesicle imaging and acute manipulation of phosphoinositides we show that APPL endosomes, which participate in growth factor receptor trafficking and signaling, represent an early endocytic intermediate common to a subset of clathrin derived endocytic vesicles and macropinosomes. Most APPL endosomes are precursors of classical PI3P positive endosomes, and PI3P plays a critical role in promoting this conversion. Depletion of PI3P causes a striking reversion of Rab5 positive endosomes to the APPL stage, and results in enhanced growth factor signaling. These findings reveal a surprising plasticity of the early endocytic pathway. Importantly, PI3P functions as a switch to dynamically regulate maturation and signaling of APPL endosomes.	[Zoncu, Roberto; Perera, Rushika M.; Balkin, Daniel M.; Pirruccello, Michelle; Toomre, Derek; De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Zoncu, Roberto; Balkin, Daniel M.; Pirruccello, Michelle; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Zoncu, Roberto; Balkin, Daniel M.; Pirruccello, Michelle; De Camilli, Pietro] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Toomre, D (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	derek.toomre@yale.edu; pietro.decamilli@yale.edu		Pirruccello-Straub, Michelle/0000-0002-7996-857X	NIH [CA46128, DK45735, NS36251, DA018343]; New Innovator award [1DP20D002980-01]; MSTP TG [5T32GM07205]; Mathers Charitable Foundation; Keck Foundation; Kavli Foundation; Yale Cancer Center; NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036251, R37NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002980] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Innovator award; MSTP TG; Mathers Charitable Foundation; Keck Foundation(W.M. Keck Foundation); Kavli Foundation; Yale Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank P. P. Di Fiore and S. Ferguson for critical reading of the manuscript; Ariad Pharmaceuticals for generously providing us with the rapalogue AP021967; J, Keen, B. Larijani, N. Fili, S. Corvera, and S. Grinstein for valuable reagents; A. Karpikov for help with the TIRF calibration; D. Sabatini and J. Settleman for support. This work was supported by grants from the NIH (CA46128, DK45735, NS36251, and DA018343 to P. D. C., New Innovator award 1DP20D002980-01 to D. T., and MSTP TG 5T32GM07205 to D. M. B.), the G. Harold and Leila Y. Mathers Charitable Foundation, the Keck Foundation and the Kavli Foundation to P. D. C., and the Yale Cancer Center ASC-IRG grant to D. T.	Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; De Matteis MA, 2005, BBA-MOL CELL RES, V1744, P396, DOI 10.1016/j.bbamcr.2005.04.013; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Fili N, 2006, P NATL ACAD SCI USA, V103, P15473, DOI 10.1073/pnas.0607040103; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Haglund Kaisa, 2007, Critical Reviews in Oncogenesis, V13, P39; Hayakawa A, 2006, P NATL ACAD SCI USA, V103, P11928, DOI 10.1073/pnas.0508832103; Hu LYA, 2003, J BIOL CHEM, V278, P26295, DOI 10.1074/jbc.M212352200; Ivetac I, 2005, MOL BIOL CELL, V16, P2218, DOI 10.1091/mbc.e04-09-0799; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lee JA, 2008, AUTOPHAGY, V4, P230, DOI 10.4161/auto.5384; Li J, 2007, STRUCTURE, V15, P525, DOI 10.1016/j.str.2007.03.011; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Lowe M, 2005, TRAFFIC, V6, P711, DOI 10.1111/j.1600-0854.2005.00311.x; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Merithew E, 2003, J BIOL CHEM, V278, P8494, DOI 10.1074/jbc.M211514200; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Perera RM, 2006, P NATL ACAD SCI USA, V103, P19332, DOI 10.1073/pnas.0609795104; Porat-Shliom N, 2008, MOL BIOL CELL, V19, P765, DOI 10.1091/mbc.E07-08-0841; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Tosoni D, 2005, CELL, V123, P875, DOI 10.1016/j.cell.2005.10.021; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Varsano T, 2006, MOL CELL BIOL, V26, P8942, DOI 10.1128/MCB.00305-06; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Wu JL, 2006, DEVELOPMENT, V133, P3651, DOI 10.1242/dev.02547; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	51	255	262	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1110	1121		10.1016/j.cell.2009.01.032	http://dx.doi.org/10.1016/j.cell.2009.01.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303853	Green Accepted, Bronze			2022-12-28	WOS:000264403900016
J	Caplan, AL; Patrizio, P				Caplan, Arthur L.; Patrizio, Pasquale			The beginning of the end of the embryo wars	LANCET			English	Editorial Material									[Caplan, Arthur L.] Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA; [Patrizio, Pasquale] Yale Univ, Fertil Ctr, New Haven, CT USA	University of Pennsylvania; Pennsylvania Medicine; Yale University	Caplan, AL (corresponding author), Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA.	caplan@mail.med.upenn.edu	Patrizio, Pasquale/AGO-0674-2022					Caplan AL, 2007, SOCIETY, V44, P26, DOI 10.1007/BF02919513; George R.P., 2008, EMBRYO DEFENSE HUMAN; Gottweis H, 2009, HEALTH TECHNOL SOC, P1, DOI 10.1057/9780230594364; Guenin LM, 2008, MORALITY OF EMBRYO USE, P1; Kovalevsky G, 2005, FERTIL STERIL, V84, P325, DOI 10.1016/j.fertnstert.2005.04.020; Ord T, 2008, AM J BIOETHICS, V8, P12, DOI 10.1080/15265160802248146; Quinn B., 2009, GUARDIAN	7	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2009	373	9669					1074	1075		10.1016/S0140-6736(09)60638-3	http://dx.doi.org/10.1016/S0140-6736(09)60638-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	427IS	19338071	Bronze			2022-12-28	WOS:000264773600015
J	Wang, P; Gonzalez, MC; Hidalgo, CA; Barabasi, AL				Wang, Pu; Gonzalez, Marta C.; Hidalgo, Cesar A.; Barabasi, Albert-Laszlo			Understanding the Spreading Patterns of Mobile Phone Viruses	SCIENCE			English	Article							COMMUNICATION-NETWORKS; EPIDEMIC; DYNAMICS; DISEASE	We modeled the mobility of mobile phone users in order to study the fundamental spreading patterns that characterize a mobile virus outbreak. We find that although Bluetooth viruses can reach all susceptible handsets with time, they spread slowly because of human mobility, offering ample opportunities to deploy antiviral software. In contrast, viruses using multimedia messaging services could infect all users in hours, but currently a phase transition on the underlying call graph limits them to only a small fraction of the susceptible users. These results explain the lack of a major mobile virus breakout so far and predict that once a mobile operating system's market share reaches the phase transition point, viruses will pose a serious threat to mobile communications.	[Wang, Pu; Gonzalez, Marta C.; Hidalgo, Cesar A.; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys, Ctr Complex Network Res, Boston, MA 02115 USA; [Wang, Pu; Gonzalez, Marta C.; Hidalgo, Cesar A.; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Biol, Ctr Complex Network Res, Boston, MA 02115 USA; [Wang, Pu; Gonzalez, Marta C.; Hidalgo, Cesar A.; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Comp Sci, Ctr Complex Network Res, Boston, MA 02115 USA; [Wang, Pu; Hidalgo, Cesar A.] Univ Notre Dame, Ctr Complex Network Res, Notre Dame, IN 46556 USA; [Wang, Pu; Hidalgo, Cesar A.] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Hidalgo, Cesar A.] Harvard Univ, John F Kennedy Sch Govt, Ctr Int Dev, Cambridge, MA 02139 USA; [Barabasi, Albert-Laszlo] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA	Northeastern University; Northeastern University; Northeastern University; University of Notre Dame; University of Notre Dame; Harvard University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Barabasi, AL (corresponding author), Northeastern Univ, Dept Phys, Ctr Complex Network Res, Boston, MA 02115 USA.	barabasi@gmail.com	Barabasi, Albert-Laszlo/S-6474-2017; Hidalgo, Cesar A./B-5155-2009; Gonzalez, Marta C./E-9456-2011	Hidalgo, Cesar A./0000-0002-6977-9492; Gonzalez, Marta C./0000-0002-8482-0318; /0000-0002-6031-5982; Barabasi, Albert/0000-0002-4028-3522	James S. McDonnell Foundation; NSF [CNS-0540348]; Information Technology Research [DMR-0426737, IIS-0513650]; Defense Threat Reduction Agency Award [HDTRA1-08-1-0027]; U.S. Office of Naval Research Award [N00014-07-C]	James S. McDonnell Foundation; NSF(National Science Foundation (NSF)); Information Technology Research; Defense Threat Reduction Agency Award(United States Department of DefenseDefense Threat Reduction Agency); U.S. Office of Naval Research Award	The human mobility data that were used as a basis for the simulations relied on an anonymized billing data set that was previously recorded by a mobile provider as required by law and for billing purposes and not for the purpose of this project. We thank D. Brockmann, M. Hypponen, J. Park, Z. Qu, C. Song, A. Vazquez, A. Vespignani, and G. Xiao for discussions and comments on the manuscript. We also thank M. Hypponen for providing us the valuable mobile phone virus records data. This work was supported by the James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems; NSF within the Dynamic Data Driven Applications Systems (CNS-0540348), Information Technology Research (DMR-0426737), and IIS-0513650 programs; the Defense Threat Reduction Agency Award HDTRA1-08-1-0027; and the U.S. Office of Naval Research Award N00014-07-C.	ANDERSEN RM, 1992, INFECT DIS HUMANS DY; Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; Balthrop J, 2004, SCIENCE, V304, P527, DOI 10.1126/science.1095845; BOSE A, 2006, SEC WORKSH, P1; Caldarelli G., 2007, SCALE FREE NETWORKS; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Chen YP, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046107; CHENG J, 2007, P 5 ACM INT C MOB SY; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Dorogovtsev SN, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.025101; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hidalgo CA, 2008, PHYSICA A, V387, P3017, DOI 10.1016/j.physa.2008.01.073; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Hypponen M, 2006, SCI AM, V295, P70, DOI 10.1038/scientificamerican1106-70; Kleinberg J, 2007, NATURE, V449, P287, DOI 10.1038/449287a; Lambiotte R, 2008, PHYSICA A, V387, P5317, DOI 10.1016/j.physa.2008.05.014; Mickens J. W., 2005, P 4 ACM WORKSH WIR S, P77, DOI DOI 10.1145/1080793.1080806; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Shevchenko A., 2005, OVERVIEW MOBILE DEVI; Su J., 2006, P 4 ACM WORKSH REC M, P9; Yan G., 2007, P 2 ACM S INF COMP C; Zucker D.F., 2005, P XTECH 2005 MAY, P25	28	322	339	5	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1071	1076		10.1126/science.1167053	http://dx.doi.org/10.1126/science.1167053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19342553	Green Submitted			2022-12-28	WOS:000266246700042
J	Kirch, DG; Vernon, DJ				Kirch, Darrell G.; Vernon, David J.			The Ethical Foundation of American Medicine In Search of Social Justice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH		[Kirch, Darrell G.; Vernon, David J.] Assoc Amer Med Coll, Washington, DC 20037 USA	Association of American Medical Colleges	Kirch, DG (corresponding author), Assoc Amer Med Coll, 2450 N St NW, Washington, DC 20037 USA.	dgkirch@aamc.org						ADLER N, 2008, REACHING HLTH LIFE F; Beauchamp TL, 2008, PRINCIPLES BIOMEDICA, V6th; Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P2789, DOI 10.1001/jama.299.23.2789; Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P947, DOI 10.1001/jama.299.8.947; GILLON R, 1985, BRIT MED J, V291, P201, DOI 10.1136/bmj.291.6489.201; Hartzband P, 2009, NEW ENGL J MED, V360, P101, DOI 10.1056/NEJMp0806369; Jolly P., DIVERSITY US MED STU; Jost TS, 2008, JAMA-J AM MED ASSOC, V299, P2561, DOI 10.1001/jama.299.21.2561; Kluge Eike-Henner W, 2007, MedGenMed, V9, P57; Lee TH, 2008, NEW ENGL J MED, V359, P333, DOI 10.1056/NEJMp0804261; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mathews SC, 2008, JAMA-J AM MED ASSOC, V300, P2913, DOI 10.1001/jama.2008.846; Pellegrino E D, 1994, J Contemp Health Law Policy, V10, P47; Steinbrook R, 2008, NEW ENGL J MED, V359, P2629, DOI 10.1056/NEJMp0808520; Weiss Gail Garfinkel, 2008, Med Econ, V85, P42; WEISS GG, 2008, MED ECON, V85, P46	16	14	14	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 8	2009	301	14					1482	1484		10.1001/jama.2009.456	http://dx.doi.org/10.1001/jama.2009.456			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429MN	19351948				2022-12-28	WOS:000264924900031
J	Choi, CM; Vilain, S; Langen, M; Van Kelst, S; De Geest, N; Yan, J; Verstreken, P; Hassan, BA				Choi, Ching Man; Vilain, Sven; Langen, Marion; Van Kelst, Sofie; De Geest, Natalie; Yan, Jiekun; Verstreken, Patrik; Hassan, Bassem A.			Conditional Mutagenesis in Drosophila	SCIENCE			English	Article							GENE		[Choi, Ching Man; Vilain, Sven; Langen, Marion; Van Kelst, Sofie; De Geest, Natalie; Yan, Jiekun; Verstreken, Patrik; Hassan, Bassem A.] VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Choi, Ching Man; Vilain, Sven; Langen, Marion; Van Kelst, Sofie; De Geest, Natalie; Yan, Jiekun; Verstreken, Patrik; Hassan, Bassem A.] Katholieke Univ Leuven, Sch Med, Ctr Human Genet, B-3000 Louvain, Belgium; [Choi, Ching Man; Vilain, Sven; Verstreken, Patrik; Hassan, Bassem A.] Katholieke Univ Leuven, Grp Biomed, Doctoral Program Mol & Dev Genet, B-3000 Louvain, Belgium; [Langen, Marion; Verstreken, Patrik; Hassan, Bassem A.] Katholieke Univ Leuven, Grp Biomed, Doctoral Program Mol & Cognit Neurosci, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven	Hassan, BA (corresponding author), VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium.	Bassem.Hassan@med.kuleuven.be	Vilain, Sven/AHA-7944-2022; Hassan, Bassem A/D-5221-2012; Verstreken, Patrik/AAC-7591-2022	Hassan, Bassem A/0000-0001-9533-4908; Verstreken, Patrik/0000-0002-5073-5393; Langen, Marion/0000-0001-6109-6593	VIB; Impuls; CREA; GOA; K. U. Leuven [G.0542.08N, G.0543.08N]; FWO [G.0542.08N, G.0543.08N]; Marie Curie [MEXT-CT-2006-042267]; Flemish government	VIB; Impuls; CREA; GOA; K. U. Leuven(KU Leuven); FWO(FWO); Marie Curie(European Commission); Flemish government(European Commission)	We thank A. Jarman, H. Bellen, M. Calos, J. Bischof, K. Basler, J. Bateman, T. Wu, A. Roebroeck, as well as the Developmental Studies Hybridoma Bank (DSHB) and the Bloomington Stock Center, for sharing flies and reagents. We thank X. Quan, S. Aerts, J. Kasprowicz, and S. Kuenen for useful discussion and technical assistance. This work was supported by VIB (B.A.H., P.V.), and Impuls, CREA, and GOA (Geconcerteerd Onderzoeks Acties) grants from K. U. Leuven and FWO (Fonds Wetenschaplijke Onderzoek) grants G.0542.08N and G.0543.08N to B.A.H. as well as Research fund K. U. Leuven, and a Marie Curie Excellence grant (MEXT-CT-2006-042267) to P.V. S.V. was partially supported by a K.U. Leuven Methusalem grant from the Flemish government. pSTAR GenBank accession number is FJ710212.	Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Rooke JE, 2000, METH MOL B, V137, P15; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426	6	41	41	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					54	54		10.1126/science.1168275	http://dx.doi.org/10.1126/science.1168275			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342580				2022-12-28	WOS:000264802100028
J	Omabegho, T; Sha, R; Seeman, NC				Omabegho, Tosan; Sha, Ruojie; Seeman, Nadrian C.			A Bipedal DNA Brownian Motor with Coordinated Legs	SCIENCE			English	Article							DOUBLE-CROSSOVER MOLECULES; SINGLE-STRANDED-DNA; FLEXIBILITY; TRANSPORT; KINETICS	A substantial challenge in engineering molecular motors is designing mechanisms to coordinate the motion between multiple domains of the motor so as to bias random thermal motion. For bipedal motors, this challenge takes the form of coordinating the movement of the biped's legs so that they can move in a synchronized fashion. To address this problem, we have constructed an autonomous DNA bipedal walker that coordinates the action of its two legs by cyclically catalyzing the hybridization of metastable DNA fuel strands. This process leads to a chemically ratcheted walk along a directionally polar DNA track. By covalently cross-linking aliquots of the walker to its track in successive walking states, we demonstrate that this Brownian motor can complete a full walking cycle on a track whose length could be extended for longer walks. We believe that this study helps to uncover principles behind the design of unidirectional devices that can function without intervention. This device should be able to fulfill roles that entail the performance of useful mechanical work on the nanometer scale.	[Sha, Ruojie; Seeman, Nadrian C.] NYU, Dept Chem, New York, NY 10003 USA; [Omabegho, Tosan] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	New York University; Harvard University	Seeman, NC (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.	ned.seeman@nyu.edu			National Institute of General Medical Sciences; NSF; Army Research Office; Office of Naval Research; New York Nano-Bio-Molecular Information Technology Incubator program of the Department of Energy; W. M. Keck Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029554] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); Army Research Office; Office of Naval Research(Office of Naval Research); New York Nano-Bio-Molecular Information Technology Incubator program of the Department of Energy; W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Mao, H. Yan, and N. Jonoska for critical reading of the manuscript. This research has been supported by grants to N.C.S. from the National Institute of General Medical Sciences, NSF, the Army Research Office, the Office of Naval Research, the New York Nano-Bio-Molecular Information Technology Incubator program of the Department of Energy, and the W. M. Keck Foundation.	Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Bois JS, 2005, NUCLEIC ACIDS RES, V33, P4090, DOI 10.1093/nar/gki721; FISCHER SG, 1979, CELL, V16, P191, DOI 10.1016/0092-8674(79)90200-9; FU TJ, 1994, J MOL BIOL, V236, P91, DOI 10.1006/jmbi.1994.1121; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; GIA O, 1992, BIOCHEMISTRY-US, V31, P11818, DOI 10.1021/bi00162a021; Green SJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.238101; Kay ER, 2007, ANGEW CHEM INT EDIT, V46, P72, DOI 10.1002/anie.200504313; Mai J, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011102; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Mills JB, 1999, J MOL BIOL, V285, P245, DOI 10.1006/jmbi.1998.2287; Pei R, 2006, J AM CHEM SOC, V128, P12693, DOI 10.1021/ja058394n; Sa-Ardyen P, 2003, BIOPHYS J, V84, P3829, DOI 10.1016/S0006-3495(03)75110-8; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Shapiro E, 2006, SCI AM, V294, P44, DOI 10.1038/scientificamerican0506-44; Sherman WB, 2004, NANO LETT, V4, P1203, DOI 10.1021/nl049527q; Shin JS, 2004, J AM CHEM SOC, V126, P10834, DOI 10.1021/ja047543j; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Tian Y, 2005, ANGEW CHEM INT EDIT, V44, P4355, DOI 10.1002/anie.200500703; Turberfield AJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.118102; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	24	453	467	3	241	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					67	71		10.1126/science.1170336	http://dx.doi.org/10.1126/science.1170336			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342582	Green Accepted			2022-12-28	WOS:000264802100032
J	Alberti, S; Halfmann, R; King, O; Kapila, A; Lindquist, S				Alberti, Simon; Halfmann, Randal; King, Oliver; Kapila, Atul; Lindquist, Susan			A Systematic Survey Identifies Prions and Illuminates Sequence Features of Prionogenic Proteins	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST PRIONS; HET-S; ENVIRONMENTAL-STRESS; GENETIC-VARIATION; AMYLOID FIBRILS; SUP35 PROTEIN; PSI+ PRION; RICH PRION; IN-VITRO	Prions are proteins that convert between structurally and functionally distinct states, one or more of which is transmissible. In yeast, this ability allows them to act as non-Mendelian elements of phenotypic inheritance. To further our understanding of prion biology, we conducted a bioinformatic proteome-wide survey for prionogenic proteins in S. cerevisiae, followed by experimental investigations of 100 prion candidates. We found an unexpected amino acid bias in aggregation-prone candidates and discovered that 19 of these could also form prions. At least one of these prion proteins, Mot3, produces a bona fide prion in its natural context that increases population-level phenotypic heterogeneity. The self-perpetuating states of these proteins present a vast source of heritable phenotypic variation that increases the adaptability of yeast populations to diverse environments.	[Alberti, Simon; Halfmann, Randal; King, Oliver; Kapila, Atul; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Halfmann, Randal; Kapila, Atul; Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02139 USA; [King, Oliver] Boston Biomed Res Inst, Watertown, MA 02472 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Boston Biomedical Research Institute	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	Alberti, Simon/ABB-8277-2021; Alberti, Simon/B-2822-2017	Alberti, Simon/0000-0003-4017-6505; Halfmann, Randal/0000-0002-6592-1471	G. Harold and Leila Y. Mathers Foundation; NIH [GM025874]; HHMI; Deutsche Forschungsgemeinschaft (DFG); NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025874, R01GM025874] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the G. Harold and Leila Y. Mathers Foundation, NIH grant GM025874, and HHMI. S.A. was supported by a fellowship of the Deutsche Forschungsgemeinschaft (DFG). R.H. was supported by a fellowship of the NSF. We are grateful to Ndubuisi Azubuine and Tsering Nanchung for constant supply of plates and media. We thank Sherwin Chan and Gerald Fink for contributing the URA3-HIS5 plasmid. We thank Jijun Dong for assisting with TEM, and members of the Lindquist lab for critical reading of the manuscript.	Abramova N, 2001, J BACTERIOL, V183, P2881, DOI 10.1128/JB.183.9.2881-2887.2001; AIGLE M, 1975, MOL GEN GENET, V136, P327, DOI 10.1007/BF00341717; Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Alexandrov IM, 2008, J BIOL CHEM, V283, P15185, DOI 10.1074/jbc.M802071200; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Baskakov IV, 2007, BBA-MOL BASIS DIS, V1772, P692, DOI 10.1016/j.bbadis.2006.07.007; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chernoff YO, 2007, FEBS LETT, V581, P3695, DOI 10.1016/j.febslet.2007.04.075; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Diaz-Avalos R, 2005, P NATL ACAD SCI USA, V102, P10165, DOI 10.1073/pnas.0504599102; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Grishin AV, 1998, GENETICS, V149, P879; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Harrison PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r40; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hongay C, 2002, EMBO J, V21, P4114, DOI 10.1093/emboj/cdf415; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; King OD, 2007, THEOR POPUL BIOL, V72, P560, DOI 10.1016/j.tpb.2007.08.006; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LeVine H, 1997, ARCH BIOCHEM BIOPHYS, V342, P306, DOI 10.1006/abbi.1997.0137; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; LIEBMAN SW, 1979, J BACTERIOL, V139, P1068, DOI 10.1128/JB.139.3.1068-1071.1979; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; LUND PM, 1981, GENET RES, V37, P173, DOI 10.1017/S0016672300020140; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Mrsa V, 1999, J BACTERIOL, V181, P3076, DOI 10.1128/JB.181.10.3076-3086.1999; Mukhopadhyay S, 2007, P NATL ACAD SCI USA, V104, P2649, DOI 10.1073/pnas.0611503104; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Namy O, 2008, NAT CELL BIOL, V10, P1069, DOI 10.1038/ncb1766; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Perrett S, 2008, CURR OPIN STRUC BIOL, V18, P52, DOI 10.1016/j.sbi.2007.12.005; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; RAM AFJ, 1994, YEAST, V10, P1019, DOI 10.1002/yea.320100804; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2005, NAT CELL BIOL, V7, P1039, DOI 10.1038/ncb1105-1039; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Sabate R, 2007, J MOL BIOL, V370, P768, DOI 10.1016/j.jmb.2007.05.014; Salnikova AB, 2005, J BIOL CHEM, V280, P8808, DOI 10.1074/jbc.M410150200; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Saupe SJ, 2000, CURR OPIN MICROBIOL, V3, P608, DOI 10.1016/S1369-5274(00)00148-X; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shkundina IS, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1519, DOI 10.1134/S0006297907130081; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Taneja V, 2007, MOL CELL, V27, P67, DOI 10.1016/j.molcel.2007.05.027; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247; Tuite M, 2008, BIOCHEM SOC T, V36, P1083, DOI 10.1042/BST0361083; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Vitrenko YA, 2007, J BIOL CHEM, V282, P1779, DOI 10.1074/jbc.M609269200; Wang XL, 2006, PROTEINS, V63, P297, DOI 10.1002/prot.20761; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Zenthon JF, 2006, EUKARYOT CELL, V5, P217, DOI 10.1128/EC.5.2.217-225.2006	77	701	715	2	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					146	158		10.1016/j.cell.2009.02.044	http://dx.doi.org/10.1016/j.cell.2009.02.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345193	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000264813300021
J	Francis, NJ; Follmer, NE; Simon, MD; Aghia, G; Butler, JD				Francis, Nicole J.; Follmer, Nicole E.; Simon, Matthew D.; Aghia, George; Butler, Jeffrey D.			Polycomb Proteins Remain Bound to Chromatin and DNA during DNA Replication In Vitro	CELL			English	Article							GENOME-WIDE ANALYSIS; SIMIAN VIRUS-40 DNA; EARLY MOUSE EMBRYOS; HISTONE H3; TRANSCRIBING POLYMERASE; DROSOPHILA-MELANOGASTER; POLYTENE CHROMOSOMES; H2A UBIQUITYLATION; REPRESSIVE COMPLEX; CELLS	The transcriptional status of a gene can be maintained through multiple rounds of cell division during development. This epigenetic effect is believed to reflect heritable changes in chromatin folding and histone modifications or variants at target genes, but little is known about how these chromatin features are inherited through cell division. A particular challenge for maintaining transcription states is DNA replication, which disrupts or dilutes chromatin-associated proteins and histone modifications. PRC1-class Polycomb group protein complexes are essential for development and are thought to heritably silence transcription by altering chromatin folding and histone modifications. It is not known whether these complexes and their effects are maintained during DNA replication or subsequently re-established. We find that when PRC1-class Polycomb complex-bound chromatin or DNA is replicated in vitro, Polycomb complexes remain bound to replicated templates. Retention of Polycomb proteins through DNA replication may contribute to maintenance of transcriptional silencing through cell division.	[Francis, Nicole J.; Follmer, Nicole E.; Aghia, George; Butler, Jeffrey D.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Simon, Matthew D.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Simon, Matthew D.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Francis, NJ (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	francis@mcb.harvard.edu	Simon, Matthew/ABF-9127-2020	Simon, Matthew/0000-0001-7423-5265	National Institutes of Health [GM078456-01]; Searle Scholar award; March of Dimes Basil O'Connor Scholar award; Helen Hay Whitney fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar award; March of Dimes Basil O'Connor Scholar award(March of Dimes); Helen Hay Whitney fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Kingston, T. Maniatis, W. M. Michael, N. Kleckner, A. Murray, A. Mazo, L. Kobrossy, B. Lengsfeld, and S. Lo for advice and support throughout the project and J. Muller, R. Jones, B. Stillman, and W. M. Michael for reagents. This work was supported by the National Institutes of Health (GM078456-01), a Searle Scholar award and a March of Dimes Basil O'Connor Scholar award to N.J.F., and a Helen Hay Whitney fellowship to M.D.S.	Abmayr S. M., 2006, CURRENT PROTOCOLS MO, P1211; Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Annunziato AT, 2005, J BIOL CHEM, V280, P12065, DOI 10.1074/jbc.R400039200; Azuara V, 2006, NAT PROTOC, V1, P2171, DOI 10.1038/nprot.2006.353; Benson LJ, 2006, J BIOL CHEM, V281, P9287, DOI 10.1074/jbc.M512956200; Beuchle D, 2001, DEVELOPMENT, V128, P993; BONNEANDREA C, 1990, NATURE, V343, P719, DOI 10.1038/343719a0; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Carruthers LM, 1999, METHOD ENZYMOL, V304, P19; CLARK DJ, 1992, CELL, V71, P11, DOI 10.1016/0092-8674(92)90262-B; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; JACKMAN J, 2003, METHODS SYNCHRONIZIN; Kind J, 2008, CELL, V133, P813, DOI 10.1016/j.cell.2008.04.036; King IFG, 2005, MOL CELL BIOL, V25, P6578, DOI 10.1128/MCB.25.15.6578-6591.2005; King IFG, 2002, MOL CELL BIOL, V22, P7919, DOI 10.1128/MCB.22.22.7919-7928.2002; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Kohn KW, 2008, MOL BIOL CELL, V19, P1, DOI 10.1091/mbc.E07-06-0528; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; LANFORD RE, 1988, VIROLOGY, V167, P72, DOI 10.1016/0042-6822(88)90055-4; Lavigne M, 2004, MOL CELL, V13, P415, DOI 10.1016/S1097-2765(04)00006-1; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; LI JJ, 1984, P NATL ACAD SCI-BIOL, V81, P6973, DOI 10.1073/pnas.81.22.6973; Logie C, 1997, EMBO J, V16, P6772, DOI 10.1093/emboj/16.22.6772; Marchetti M, 2003, DEVELOPMENT, V130, P3683, DOI 10.1242/dev.00587; Mihaly J, 1998, MOL CELL, V1, P1065, DOI 10.1016/S1097-2765(00)80107-0; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Mohd-Sarip A, 2005, GENE DEV, V19, P1755, DOI 10.1101/gad.347005; Mohd-Sarip A, 2006, MOL CELL, V24, P91, DOI 10.1016/j.molcel.2006.08.007; Moshkin YM, 2001, P NATL ACAD SCI USA, V98, P570, DOI 10.1073/pnas.021353598; Ng RK, 2008, CELL CYCLE, V7, P1173, DOI 10.4161/cc.7.9.5791; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Poux S, 2001, DEVELOPMENT, V128, P75; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Rastegar M, 2004, MOL CELL BIOL, V24, P8090, DOI 10.1128/MCB.24.18.8090-8103.2004; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Ringrose L, 2007, CURR OPIN CELL BIOL, V19, P290, DOI 10.1016/j.ceb.2007.04.010; SANCHEZ JA, 1992, J CELL SCI, V103, P907; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Schnitzler G R, 2001, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2105s50; Schwartz YB, 2005, MOL CELL BIOL, V25, P432, DOI 10.1128/MCB.25.1.432-439.2005; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Simon JA, 2002, CURR OPIN GENET DEV, V12, P210, DOI 10.1016/S0959-437X(02)00288-5; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; STUDITSKY VM, 1994, CELL, V76, P371, DOI 10.1016/0092-8674(94)90343-3; Terranova R, 2008, DEV CELL, V15, P668, DOI 10.1016/j.devcel.2008.08.015; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009	71	133	134	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 2	2009	137	1					110	122		10.1016/j.cell.2009.02.017	http://dx.doi.org/10.1016/j.cell.2009.02.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19303136	Green Accepted, Bronze			2022-12-28	WOS:000264813300018
J	Werner, RM; McNutt, R				Werner, Rachel M.; McNutt, Robert			A New Strategy to Improve Quality Rewarding Actions Rather Than Measures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERFORMANCE-MEASURES; MORTALITY; CARE		[Werner, Rachel M.] Univ Penn, Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA; [Werner, Rachel M.] Univ Penn, Sch Med, Ctr Hlth Equ Res & Promot, Philadelphia, PA 19104 USA; [McNutt, Robert] Rush Univ, Med Ctr, Dept Med, Chicago, IL 60612 USA	University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center; Rush University	Werner, RM (corresponding author), Univ Penn, Sch Med, Div Gen Internal Med, 423 Guardian Dr,1230 Blockley Hall, Philadelphia, PA 19104 USA.	rwerner@mail.med.upenn.edu		Werner, Rachel/0000-0003-3435-4221				*AG HEALTHC RES QU, NAT HEALTHC QUAL REP; Bradley EH, 2006, JAMA-J AM MED ASSOC, V296, P72, DOI 10.1001/jama.296.1.72; *CTR MED MED, PREM HOSP QUAL INC D; Fonarow GC, 2007, JAMA-J AM MED ASSOC, V297, P61, DOI 10.1001/jama.297.1.61; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; HOERL RW, 1998, QUALITY PROGR    JUN, P35; Liker J. K., 2004, TOYOTA WAY 14 MANAGE; McNutt RA, 2004, JAMA-J AM MED ASSOC, V292, P2516, DOI 10.1001/jama.292.20.2516; Rosenthal MB, 2006, NEW ENGL J MED, V355, P1895, DOI 10.1056/NEJMsa063682; Shannon RP, 2006, JT COMM J QUAL PATIE, V32, P479, DOI 10.1016/S1553-7250(06)32063-6; Werner RM, 2008, HEALTH SERV RES, V43, P1464, DOI 10.1111/j.1475-6773.2007.00817.x; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Werner RM, 2009, HEALTH SERV RES, V44, P379, DOI 10.1111/j.1475-6773.2008.00915.x	13	28	28	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 1	2009	301	13					1375	1377		10.1001/jama.2009.423	http://dx.doi.org/10.1001/jama.2009.423			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426LM	19336714				2022-12-28	WOS:000264709800028
J	Chambers, K				Chambers, K.			Geoff Foster: paediatrician remaining hopeful in Zimbabwe Profile	LANCET			English	Biographical-Item									The Lancet, London NW1 7BY, England		Chambers, K (corresponding author), The Lancet, London NW1 7BY, England.							FOSTER GE, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					999	999		10.1016/S0140-6736(09)60595-X	http://dx.doi.org/10.1016/S0140-6736(09)60595-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422AA	19304004				2022-12-28	WOS:000264398200014
J	Weiner, LM; Dhodapkar, MV; Ferrone, S				Weiner, Louis M.; Dhodapkar, Madhov V.; Ferrone, Soldano			Monoclonal antibodies for cancer immunotherapy	LANCET			English	Review							NON-HODGKINS-LYMPHOMA; DENDRITIC CELL MATURATION; METASTATIC BREAST-CANCER; MHC CLASS-I; HUMAN ANTIIDIOTYPIC ANTIBODIES; MEDIATED ANTIGEN PRESENTATION; FC-GAMMA RECEPTORS; COATED TUMOR-CELLS; CROSS-PRESENTATION; IMMUNE-RESPONSE	Monoclonal antibodies are effective treatments for many malignant diseases. However, the ability of antibodies to initiate tumour-antigen-specific immune responses has received less attention than have other mechanisms of antibody action. We describe the rationale and evidence for the development of antibodies that can stimulate host tumour-antigen-specific immune responses. Such responses can be induced through the induction of antibody-dependent cellular cytotoxicity, promotion of antibody-targeted cross-presentation of tumour antigens, or by triggering of the idiotypic network. Future treatment modifications or combinations might be able to prolong, amplify, and shape these immune responses to increase the clinical benefits of antibody therapy for human cancer.	[Weiner, Louis M.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20016 USA; [Dhodapkar, Madhov V.] Yale Univ, Sect Hematol, New Haven, CT USA; [Dhodapkar, Madhov V.] Rockefeller Univ, Lab Tumor Immunol & Immunotherapy, New York, NY 10021 USA; [Ferrone, Soldano] Univ Pittsburgh, Inst Canc, Dept Surg, Pittsburgh, PA USA; [Ferrone, Soldano] Univ Pittsburgh, Inst Canc, Dept Pathol, Pittsburgh, PA USA; [Ferrone, Soldano] Univ Pittsburgh, Inst Canc, Dept Immunol, Pittsburgh, PA USA	Georgetown University; Yale University; Rockefeller University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Weiner, LM (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, 3970 Reservoir Rd NW,Suite E501, Washington, DC 20016 USA.	weinerl@georgetown.edu			Damon Runyon Cancer Research Fund; Dana Foundation [CA106802, CA109465];  [CA51008];  [CAS0633];  [CA121033];  [CA105500]; NATIONAL CANCER INSTITUTE [R01CA109465, P30CA051008, R01CA106802, R01CA121033, R01CA105500, R01CA050633] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Fund; Dana Foundation; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	LMW is supported by grants CA51008, CAS0633, CA121033. MVD is supported by the Damon Runyon Cancer Research Fund, the Dana Foundation and grants CA106802 and CA109465. SF is sponsored by grant CA105500.	Akiyama K, 2003, J IMMUNOL, V170, P1641, DOI 10.4049/jimmunol.170.4.1641; Amigorena S, 1999, SEMIN IMMUNOL, V11, P385, DOI 10.1006/smim.1999.0196; Amigorena S, 2002, J EXP MED, V195, pF1, DOI 10.1084/jem.20011925; AUSTIN EB, 1989, IMMUNOLOGY, V67, P525; Baneijee D, 2008, J IMMUNOTHER, V31, P113, DOI 10.1097/CJI.0b013e31815a5892; Bave U, 2003, J IMMUNOL, V171, P3296, DOI 10.4049/jimmunol.171.6.3296; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Boruchov AM, 2005, J CLIN INVEST, V115, P2914, DOI 10.1172/JCI24772; Bradt BM, 2003, CLIN CANCER RES, V9, p4007S; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Chamuleau MED, 2004, CANCER RES, V64, P5546, DOI 10.1158/0008-5472.CAN-04-1350; Chang CC, 2005, J BIOL CHEM, V280, P10164, DOI 10.1074/jbc.M409161200; Chatterjee SK, 1998, CANCER RES, V58, P1217; CHEUNG NKV, 1994, CANCER RES, V54, P2228; Cheung NKV, 2000, CLIN CANCER RES, V6, P2653; Clark JI, 1997, CANCER IMMUNOL IMMUN, V44, P265, DOI 10.1007/s002620050382; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Coiffier B, 2002, SEMIN ONCOL, V29, P18, DOI 10.1053/sonc.2002.32749; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Davis TA, 2000, J CLIN ONCOL, V18, P3135, DOI 10.1200/JCO.2000.18.17.3135; Davis TA, 1999, CLIN CANCER RES, V5, P611; de Bono JS, 2004, ANN ONCOL, V15, P1825, DOI 10.1093/annonc/mdh472; den Haan JMM, 2002, J EXP MED, V196, P817, DOI 10.1084/jem.20020295; Dhodapkar KM, 2007, J EXP MED, V204, P1359, DOI 10.1084/jem.20062545; Dhodapkar KM, 2005, P NATL ACAD SCI USA, V102, P6243, DOI 10.1073/pnas.0502547102; Dhodapkar KM, 2005, P NATL ACAD SCI USA, V102, P2910, DOI 10.1073/pnas.0500014102; Dhodapkar KM, 2002, J EXP MED, V195, P125, DOI 10.1084/jem.20011097; Dhodapkar MV, 2008, CELL DEATH DIFFER, V15, P39, DOI 10.1038/sj.cdd.4402247; Durrant LG, 2001, INT J CANCER, V92, P414, DOI 10.1002/ijc.1194; FAGERBERG J, 1993, CANCER IMMUNOL IMMUN, V37, P264, DOI 10.1007/BF01518521; FAGERBERG J, 1995, CANCER RES, V55, P1824; FAGERBERG J, 1995, P NATL ACAD SCI USA, V92, P4773, DOI 10.1073/pnas.92.11.4773; Fischer N, 2007, PATHOBIOLOGY, V74, P3, DOI 10.1159/000101046; FOON KA, 1995, J CLIN INVEST, V96, P334, DOI 10.1172/JCI118039; Foon KA, 1998, CLIN CANCER RES, V4, P1117; Franki SN, 2008, BLOOD, V111, P1504, DOI 10.1182/blood-2007-03-080507; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Groh V, 2005, P NATL ACAD SCI USA, V102, P6461, DOI 10.1073/pnas.0501953102; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Heijnen I A, 1997, Int Rev Immunol, V16, P29, DOI 10.3109/08830189709045702; Herlyn Dorothee, 2003, Cancer Chemother Biol Response Modif, V21, P287; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Jinushi M, 2006, P NATL ACAD SCI USA, V103, P9190, DOI 10.1073/pnas.0603503103; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; Kaminski MS, 2000, BLOOD, V96, P1259, DOI 10.1182/blood.V96.4.1259.h8001259_1259_1266; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kawano K, 2005, CANCER RES, V65, P6002; KOPROWSKI H, 1984, P NATL ACAD SCI-BIOL, V81, P216, DOI 10.1073/pnas.81.1.216; Kreitman RJ, 2001, NEW ENGL J MED, V345, P241, DOI 10.1056/NEJM200107263450402; Leonard JP, 2002, SEMIN ONCOL, V29, P81, DOI 10.1053/sonc.2002.30149; LOSMAN MJ, 1991, P NATL ACAD SCI USA, V88, P3421, DOI 10.1073/pnas.88.8.3421; Lundin J, 2002, BLOOD, V100, P768, DOI 10.1182/blood-2002-01-0159; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; MILLER RA, 1982, NEW ENGL J MED, V306, P517, DOI 10.1056/NEJM198203043060906; MITTELMAN A, 1992, P NATL ACAD SCI USA, V89, P466, DOI 10.1073/pnas.89.2.466; Murray JL, 2004, CANCER RES, V64, P5481, DOI 10.1158/0008-5472.CAN-04-0517; Nagata Y, 2002, P NATL ACAD SCI USA, V99, P10629, DOI 10.1073/pnas.112331099; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; OEGEN JG, 2002, NAT IMMUNOL, V3, P611; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Rafiq K, 2002, J CLIN INVEST, V110, P71, DOI 10.1172/JCI200215640; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; ROBINS RA, 1991, CANCER RES, V51, P5425; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; SALEH MN, 1993, J IMMUNOL, V151, P3390; Schultes BC, 1998, CANCER IMMUNOL IMMUN, V46, P201, DOI 10.1007/s002620050479; Schuurhuis DH, 2002, J IMMUNOL, V168, P2240, DOI 10.4049/jimmunol.168.5.2240; Sedlik C, 2003, J IMMUNOL, V170, P846, DOI 10.4049/jimmunol.170.2.846; Selenko N, 2002, J CLIN IMMUNOL, V22, P124, DOI 10.1023/A:1015463811683; Shahied LS, 2004, J BIOL CHEM, V279, P53907, DOI 10.1074/jbc.M407888200; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Sievers EL, 1999, BLOOD, V93, P3678, DOI 10.1182/blood.V93.11.3678; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Spendlove I, 2000, EUR J IMMUNOL, V30, P2944, DOI 10.1002/1521-4141(200010)30:10<2944::AID-IMMU2944>3.0.CO;2-U; STEINITZ M, 1988, J IMMUNOL, V141, P3516; STEPLEWSKI Z, 1983, SCIENCE, V221, P865, DOI 10.1126/science.6879183; Sulica A, 2001, Int Rev Immunol, V20, P371, DOI 10.3109/08830180109054414; Taylor C, 2007, CLIN CANCER RES, V13, P5133, DOI 10.1158/1078-0432.CCR-07-0507; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Wagner U, 2001, CLIN CANCER RES, V7, P1154; Weiner LM, 2008, CLIN CANCER RES, V14, P502, DOI 10.1158/1078-0432.CCR-07-1509; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; WENG WK, 2005, ASCO ANN M ED BOOK C, P200; WETTENDORFF M, 1989, P NATL ACAD SCI USA, V86, P3787, DOI 10.1073/pnas.86.10.3787; Witzig TE, 2002, J CLIN ONCOL, V20, P2453, DOI 10.1200/JCO.2002.11.076; Yao TJ, 1999, CLIN CANCER RES, V5, P77	93	204	218	2	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					1033	1040		10.1016/S0140-6736(09)60251-8	http://dx.doi.org/10.1016/S0140-6736(09)60251-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422AA	19304016	Green Accepted			2022-12-28	WOS:000264398200031
J	Weijers, D; Friml, J				Weijers, Dolf; Friml, Jiri			SnapShot: Auxin Signaling and Transport	CELL			English	Editorial Material							PLANT DEVELOPMENT; RECEPTORS; TIR1		[Weijers, Dolf] Wageningen Univ, NL-6703 HA Wageningen, Netherlands; VIB, B-9052 Ghent, Belgium; [Friml, Jiri] Univ Ghent, B-9052 Ghent, Belgium	Wageningen University & Research; Flanders Institute for Biotechnology (VIB); Ghent University	Weijers, D (corresponding author), Wageningen Univ, NL-6703 HA Wageningen, Netherlands.		Friml, Jiri/D-9511-2012; Weijers, Dolf/ABI-1332-2020; Weijers, Dolf/A-2076-2010	Friml, Jiri/0000-0002-8302-7596; Weijers, Dolf/0000-0003-4378-141X; Weijers, Dolf/0000-0003-4378-141X				Badescu GO, 2006, TRENDS PLANT SCI, V11, P217, DOI 10.1016/j.tplants.2006.03.001; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kleine-Vehn J, 2008, ANNU REV CELL DEV BI, V24, P447, DOI 10.1146/annurev.cellbio.24.110707.175254; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Vieten A, 2007, TRENDS PLANT SCI, V12, P160, DOI 10.1016/j.tplants.2007.03.006	8	33	37	2	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 20	2009	136	6					1172	U200	1172.e1	10.1016/j.cell.2009.03.009	http://dx.doi.org/10.1016/j.cell.2009.03.009			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303857	Green Published, Bronze			2022-12-28	WOS:000264403900021
J	Wong, RHF; Chang, I; Hudak, CSS; Hyun, S; Kwan, HY; Sul, HS				Wong, Roger H. F.; Chang, Inhwan; Hudak, Carolyn S. S.; Hyun, Suzanne; Kwan, Hiu-Yee; Sul, Hei Sook			A Role of DNA-PK for the Metabolic Gene Regulation in Response to Insulin	CELL			English	Article							FATTY-ACID SYNTHASE; MITOCHONDRIAL GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; DEPENDENT PROTEIN-KINASE; UPSTREAM STIMULATORY FACTORS; HORMONAL-REGULATION; IN-VIVO; NUTRITIONAL REGULATION; TRANSGENIC MICE; E-BOX; PROMOTER	Fatty acid synthase (FAS) is a central enzyme in lipogenesis and transcriptionally activated in response to feeding and insulin signaling. The transcription factor USF is required for the activation of FAS transcription, and we show here that USF phosphorylation by DNA-PK, which is dephosphorylated by PP1 in response to feeding, triggers a switch-like mechanism. Under fasting conditions, USF-1 is deacetylated by HDAC9, causing promoter inactivation. In contrast, feeding induces the recruitment of DNA-PK to USF-1 and its phosphorylation, which then allows recruitment of P/CAF, resulting in USF-1 acetylation and FAS promoter activation. DNA break/repair components associated with USF induce transient DNA breaks during FAS activation. In DNA-PK-deficient SCID mice, feeding-induced USF-1 phosphorylation/acetylation, DNA breaks, and FAS activation leading to lipogenesis are impaired, resulting in decreased triglyceride levels. Our study demonstrates that a kinase central to the DNA damage response mediates metabolic gene activation.	[Wong, Roger H. F.; Chang, Inhwan; Hudak, Carolyn S. S.; Hyun, Suzanne; Kwan, Hiu-Yee; Sul, Hei Sook] Univ Calif Berkeley, Dept Nutrit Sci & Toxicol, Berkeley, CA 94720 USA; [Wong, Roger H. F.; Sul, Hei Sook] Univ Calif Berkeley, Comparat Biochem Program, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Sul, HS (corresponding author), Univ Calif Berkeley, Dept Nutrit Sci & Toxicol, Berkeley, CA 94720 USA.	hsul@nature.berkeley.edu	Han, Zaiqi/AAI-2233-2019; Wong, Hoi Fung Roger/F-2044-2013	KWAN, Hiu Yee/0000-0002-6088-7323	NIH [DK81098, DK75682]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081098, T32DK061918, R01DK075682] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant DK81098 and DK75682 to H. S. S. We are grateful to Drs. Tony Kouzarides, Kathy Meek, Arthur Zelent, Angus Lamond, Moshe Oren, and Jerry Shay for various HAT, DNA-PK, HDAC9, PP1, -0.7 p53-Luc and Kus constructs, respectively. We thank YongEun Lee, Shelley Ling, Nicole Cho, Eunice Kim, Philip Lee, JiHyun (Amy) Cho, Aabid Farukhi, Sue Lee, and Helen Wong for excellent technical assistance; Jenny Huang, Aditi Ananth, Melanie Ma, Fanny Yan, and Nayoung Bae for assistance; and Drs. Mary Ann Williams, Jen-Chywan (Wally) Wang, and Maryam Ahmadian for critical reading of the manuscript. We also thank Dr. Donald Scott for nuclear run-on protocol, and we thank Dr. Daniel P. Cashman for critical discussions of the data and review of the manuscript.	Allen PB, 1998, J BIOL CHEM, V273, P4089, DOI 10.1074/jbc.273.7.4089; Brady MJ, 2001, RECENT PROG HORM RES, V56, P157, DOI 10.1210/rp.56.1.157; Casado M, 1999, J BIOL CHEM, V274, P2009, DOI 10.1074/jbc.274.4.2009; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; Danska JS, 1996, MOL CELL BIOL, V16, P5507; Dircks LK, 1997, BBA-LIPID LIPID MET, V1348, P17, DOI 10.1016/S0005-2760(97)00106-9; Douglas P, 2001, J BIOL CHEM, V276, P18992, DOI 10.1074/jbc.M011703200; Douglas P, 2007, MOL CELL BIOL, V27, P1581, DOI 10.1128/MCB.01962-06; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Griffin MJ, 2007, J BIOL CHEM, V282, P5453, DOI 10.1074/jbc.M610566200; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hashimoto M, 2003, J RADIAT RES, V44, P151, DOI 10.1269/jrr.44.151; JERKINS AA, 1995, J BIOL CHEM, V270, P1416, DOI 10.1074/jbc.270.38.22135; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Latasa MJ, 2000, P NATL ACAD SCI USA, V97, P10619, DOI 10.1073/pnas.180306597; Latasa MJ, 2003, MOL CELL BIOL, V23, P5896, DOI 10.1128/MCB.23.16.5896-5907.2003; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Mejat A, 2005, NAT NEUROSCI, V8, P313, DOI 10.1038/nn1408; Moon YS, 2000, J BIOL CHEM, V275, P10121, DOI 10.1074/jbc.275.14.10121; MOUSTAID N, 1991, J BIOL CHEM, V266, P18550; MOUSTAID N, 1993, BIOCHEM J, V292, P767, DOI 10.1042/bj2920767; MOUSTAID N, 1994, J BIOL CHEM, V269, P5629; Pajukanta P, 2004, NAT GENET, V36, P371, DOI 10.1038/ng1320; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; PAULAUSKIS JD, 1988, J BIOL CHEM, V263, P7049; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SHIN DH, 1991, J BIOL CHEM, V266, P23834; Soncini M, 1995, J BIOL CHEM, V270, P30339, DOI 10.1074/jbc.270.51.30339; Su HS, 2000, J NUTR, V130, p315S, DOI 10.1093/jn/130.2.315S; Sul HS, 1998, ANNU REV NUTR, V18, P331, DOI 10.1146/annurev.nutr.18.1.331; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; WANG D, 1995, J BIOL CHEM, V270, P28716, DOI 10.1074/jbc.270.48.28716; Wang D, 1997, J BIOL CHEM, V272, P26367, DOI 10.1074/jbc.272.42.26367; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; YET SF, 1995, BIOCHEMISTRY-US, V34, P7303, DOI 10.1021/bi00022a003; YET SF, 1993, BIOCHEMISTRY-US, V32, P9486, DOI 10.1021/bi00087a029	42	179	186	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1056	1072		10.1016/j.cell.2008.12.040	http://dx.doi.org/10.1016/j.cell.2008.12.040			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303849	Bronze, Green Accepted			2022-12-28	WOS:000264403900012
J	DeMatteo, RP; Ballman, KV; Antonescu, CR; Maki, RG; Pisters, PWT; Demetri, GD; Blackstein, ME; Blanke, CD; von Mehren, M; Brennan, MF; Patel, S; McCarter, MD; Polikoff, JA; Tan, BR; Owzar, K				DeMatteo, Ronald P.; Ballman, Karla V.; Antonescu, Cristina R.; Maki, Robert G.; Pisters, Peter W. T.; Demetri, George D.; Blackstein, Martin E.; Blanke, Charles D.; von Mehren, Margaret; Brennan, Murray F.; Patel, Shreyaskumar; McCarter, Martin D.; Polikoff, Jonathan A.; Tan, Benjamin R.; Owzar, Kouros		ACOSOG Intergrp Adjuvant GIST Stud	Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							TYROSINE KINASE; PROGNOSTIC-FACTORS; DOSE IMATINIB; PHASE-III; MUTATIONS; KIT; RESISTANCE; INHIBITOR; PROGRESSION; MANAGEMENT	Background Gastrointestinal stromal tumour is the most common sarcoma of the intestinal tract. Imatinib mesylate is a small molecule that inhibits activation of the KIT and platelet-derived growth factor receptor a proteins, and is effective in first-fine treatment of metastatic gastrointestinal stromal tumour. We postulated that adjuvant treatment with imatinib would improve recurrence-free survival compared with placebo after, resection of localised, primary gastrointestinal stromal tumour. Methods We undertook a randomised phase III, double-blind, placebo-controlled, multicentre trial. Eligible patients had complete gross resection of a primary gastrointestinal stromal tumour-at least 3 cm in size and positive for the KIT protein by immunohistochemistry. Patients were randomly assigned, by A stratified biased coin design, to imatinib 400 mg (n=359) or to placebo (n=354) daily for 1 year after surgical resection. Patients and investigators were blinded to the treatment group. Patients assigned to placebo were eligible to crossover to imatinib treatment in the event of tumour recurrence. The primary endpoint was recurrence-free survival, and analysis was by intention to treat. Accrual was stopped early because the trial results crossed the interim analysis efficacy boundary for recurrence-free survival. This study is registered with ClinicalTrials.gov, number NCT00041197. Findings All randomised patients were included in the analysis. At median follow-up of 19.7 months (minimum-maximum 0-56-4), 30 (8%) patients in the imatinib group and 70 (20%) in the placebo group had had tumour recurrence or had died. Imatinib significantly improved recurrence-free survival compared with placebo (98% [95% CI 96-100] vs 83% [78-88] at 1 year; hazard ratio [HR] 0.35 [0.22-0.53]; one-sided p<0.0001). Adjuvant imatinib was well tolerated, with the most common serious events being dermatitis (11 [3%] vs 0), abdominal pain (12 [3%] vs six [1%]), and diarrhoea (ten [2%] vs five [1%]) in the imatinib group and hyperglycaemia (two [<1%] vs seven [2%]) in the placebo group. Interpretation Adjuvant imatinib therapy is safe and seems to improve recurrence-free survival compared with placebo after the resection of primary gastrointestinal stromal tumour. Funding US National Institutes of Health and Novartis Pharmaceuticals.	[DeMatteo, Ronald P.; Antonescu, Cristina R.; Maki, Robert G.; Brennan, Murray F.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Ballman, Karla V.] Mayo Clin, Rochester, MN USA; [Pisters, Peter W. T.; Patel, Shreyaskumar] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Demetri, George D.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Blackstein, Martin E.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Blanke, Charles D.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Blanke, Charles D.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [von Mehren, Margaret] Fox Chase Canc Ctr, Philadelphia, PA USA; [McCarter, Martin D.] Univ Colorado, Denver Sch Med, Aurora, CO USA; [Polikoff, Jonathan A.] Kaiser Permanente So Calif, San Diego, CA USA; [Tan, Benjamin R.] Washington Univ, Sch Med, St Louis, MO USA; [Owzar, Kouros] Duke Univ, Durham, NC USA	Memorial Sloan Kettering Cancer Center; Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of British Columbia; British Columbia Cancer Agency; Fox Chase Cancer Center; University of Colorado System; University of Colorado Anschutz Medical Campus; Kaiser Permanente; Washington University (WUSTL); Duke University	DeMatteo, RP (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	dematter@mskcc.org	Maki, Robert G./AAI-2793-2020; Maki, Robert G/J-9145-2019	Maki, Robert G/0000-0002-9853-2528; Brennan, Murray/0000-0003-2358-4371; Ballman, Karla/0000-0002-4492-0357	American College of Surgeons Oncology Group (ACOSOG) and the National Cancer Institute (NCI) [ACOSOG Z9001]; Novartis and NCI under CRADA [1111.1]; Public Health Service Grants [U10 CA076001]; National Cancer Institute [CA94503, CA102613]; National Institutes of Health; Novartis; NATIONAL CANCER INSTITUTE [U10CA076001, R01CA102613, R21CA094503] Funding Source: NIH RePORTER	American College of Surgeons Oncology Group (ACOSOG) and the National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Novartis and NCI under CRADA; Public Health Service Grants(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The ACOSOG Z9001 trial was undertaken through a collaboration between the American College of Surgeons Oncology Group (ACOSOG) and the National Cancer Institute (NCI) and through a contract between Novartis and NCI under CRADA 1111.1. This work was supported by Public Health Service Grants U10 CA076001 (ACOSOG) and CA94503 and CA102613 (RPD) from the National Cancer Institute, National Institutes of Health, and by Novartis, who provided imatinib and the placebo. The views expressed are those of the authors and do not necessarily represent the official views of the National Cancer Institute. We are indebted to members of CTEP who made this trial possible. The trial was endorsed by the Southwest Oncology Group (SWC)G), Cancer and Leukemia Group B (CALGB), Eastern Cooperative Oncology Group (ECOG), and the National Cancer Institute of Canada (NCI-C), all of which participated through the Cancer Trials Support Unit (CTSU). We thank Samuel A Wells Jr and Vijaya Chadararn who were instrumental in the development and early conduct of this trial, and Sue Budinger who coordinated the study; Chris Corless for providing assistance with pathological review; and Linda McCall for doing the analyses and creating the tables and graphs.	Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; BLACKSTEIN ME, 2005, P AN M AM SOC CLIN, V23, P9010; Blanke CD, 2008, J CLIN ONCOL, V26, P620, DOI 10.1200/JCO.2007.13.4403; Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; Blay JY, 2007, J CLIN ONCOL, V25, P1107, DOI 10.1200/JCO.2006.09.0183; *CANC THER EV PROG, 2003, COMM TERM ADV EV VER; Chen LL, 2004, CANCER RES, V64, P5913, DOI 10.1158/0008-5472.CAN-04-0085; Debiec-Rychter M, 2005, GASTROENTEROLOGY, V128, P270, DOI 10.1053/j.gastro.2004.11.020; Debiec-Rychter M, 2006, EUR J CANCER, V42, P1093, DOI 10.1016/j.ejca.2006.01.030; DeMatteo RP, 2000, ANN SURG, V231, P51, DOI 10.1097/00000658-200001000-00008; DeMatteo RP, 2002, HUM PATHOL, V33, P466, DOI 10.1053/hupa.2002.124122; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Freidlin B, 1999, CONTROL CLIN TRIALS, V20, P395, DOI 10.1016/S0197-2456(99)00017-3; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; JANEWAY KA, 2006, P AN M AM SOC CLIN, V24, P9159; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Lux ML, 2000, AM J PATHOL, V156, P791, DOI 10.1016/S0002-9440(10)64946-2; NG EH, 1992, ANN SURG, V215, P68, DOI 10.1097/00000658-199201000-00010; Nilsson B, 2005, CANCER-AM CANCER SOC, V103, P821, DOI 10.1002/cncr.20862; Prakash S, 2005, J PEDIAT HEMATOL ONC, V27, P179, DOI 10.1097/01.mph.0000157790.81329.47; Tryggvason G, 2005, INT J CANCER, V117, P289, DOI 10.1002/ijc.21167; VANGLABBECKE MM, 2007, P AN M AM SOC CLIN, V25, P10004; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0; Verweij J, 2007, EUR J CANCER, V43, P974, DOI 10.1016/j.ejca.2007.01.018; Zalcberg JR, 2005, EUR J CANCER, V41, P1751, DOI 10.1016/j.ejca.2005.04.034	30	913	1008	0	59	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2009	373	9669					1097	1104		10.1016/S0140-6736(09)60500-6	http://dx.doi.org/10.1016/S0140-6736(09)60500-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427IS	19303137	Green Accepted			2022-12-28	WOS:000264773600030
J	Gros, J; Feistel, K; Viebahn, C; Blum, M; Tabin, CJ				Gros, Jerome; Feistel, Kerstin; Viebahn, Christoph; Blum, Martin; Tabin, Clifford J.			Cell Movements at Hensen's Node Establish Left/Right Asymmetric Gene Expression in the Chick	SCIENCE			English	Article							EMBRYO; CILIA	In vertebrates, the readily apparent left/right (L/R) anatomical asymmetries of the internal organs can be traced to molecular events initiated at or near the time of gastrulation. However, the earliest steps of this process do not seem to be universally conserved. In particular, how this axis is first defined in chicks has remained problematic. Here we show that asymmetric cell rearrangements take place within chick embryos, creating a leftward movement of cells around the node. It is the relative displacement of cells expressing sonic hedgehog (Shh) and fibroblast growth factor 8 (Fgf8) that is responsible for establishing their asymmetric expression patterns. The creation of asymmetric expression domains as a passive effect of cell movements represents an alternative strategy for breaking L/R symmetry in gene activity.	[Gros, Jerome; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Feistel, Kerstin; Blum, Martin] Univ Hohenheim, Inst Zool, D-70953 Stuttgart, Germany; [Viebahn, Christoph] Univ Gottingen, Dept Anat & Embryol, D-37079 Gottingen, Germany	Harvard University; Harvard Medical School; University Hohenheim; University of Gottingen	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu		Feistel, Kerstin/0000-0003-3397-8972; Gros, Jerome/0000-0002-2264-2851	Human Frontier Science Program fellowship; Ph.D. fellowship from the Boehringer Ingelheim Fonds; Deutsche Forschungsgemeinschaft (DFG) [VI 151-8-1]; NIH [R01-HD045499]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD045499] Funding Source: NIH RePORTER	Human Frontier Science Program fellowship(Human Frontier Science Program); Ph.D. fellowship from the Boehringer Ingelheim Fonds(Boehringer Ingelheim); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank M. Levin for helpful suggestions for addressing the role of ion channels, R. ORahilly for providing information regarding human embryos, D. Rath and P. Schwarts for provision of pig embros and assistance with electron microscopy; and C. Cui, C. Little, and B. Rongish for discussing data before publication. This work was supported by a Human Frontier Science Program fellowship to J.G., a Ph.D. fellowship from the Boehringer Ingelheim Fonds to K.F., a grant from the Deutsche Forschungsgemeinschaft (DFG) to M.B., a grant from the DFG (VI 151-8-1) to C.V., and grant R01-HD045499 from NIH to C.J.T.	Cui C, 2009, ANAT REC, V292, P557, DOI 10.1002/ar.20872; Dathe V, 2002, ANAT EMBRYOL, V205, P343, DOI 10.1007/s00429-002-0269-2; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; HERTWIG O, 1910, LEHRBUCH ENGWICKLUNG; Kirby ML, 2003, DEV BIOL, V253, P175, DOI 10.1016/S0012-1606(02)00024-6; Kolliker A, 1879, ENTWICKLUNGSGESCHICH; Lee JD, 2008, DEV DYNAM, V237, P3464, DOI 10.1002/dvdy.21598; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; O'Rahilly R. R, 2006, EMBRYONIC HUMAN BRAI; Raya A, 2006, NAT REV GENET, V7, P283, DOI 10.1038/nrg1830; Wei L, 2001, DEVELOPMENT, V128, P2953; Yin YL, 2009, DEVELOPMENT, V136, P655, DOI 10.1242/dev.028464	15	126	128	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					941	944		10.1126/science.1172478	http://dx.doi.org/10.1126/science.1172478			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19359542	Green Accepted			2022-12-28	WOS:000266048800040
J	Zebker, HA; Stiles, B; Hensley, S; Lorenz, R; Kirk, RL; Lunine, J				Zebker, Howard A.; Stiles, Bryan; Hensley, Scott; Lorenz, Ralph; Kirk, Randolph L.; Lunine, Jonathan			Size and Shape of Saturn's Moon Titan	SCIENCE			English	Article							RADAR; ORIGIN; PLANETS; LAKES	Cassini observations show that Saturn's moon Titan is slightly oblate. A fourth-order spherical harmonic expansion yields north polar, south polar, and mean equatorial radii of 2574.32 +/- 0.05 kilometers (km), 2574.36 +/- 0.03 km, and 2574.91 +/- 0.11 km, respectively; its mean radius is 2574.73 +/- 0.09 km. Titan's shape approximates a hydrostatic, synchronously rotating triaxial ellipsoid but is best fit by such a body orbiting closer to Saturn than Titan presently does. Titan's lack of high relief implies that most-but not all-of the surface features observed with the Cassini imaging subsystem and synthetic aperture radar are uncorrelated with topography and elevation. Titan's depressed polar radii suggest that a constant geopotential hydrocarbon table could explain the confinement of the hydrocarbon lakes to high latitudes.	[Zebker, Howard A.] Stanford Univ, Dept Geophys, Stanford, CA 94305 USA; [Zebker, Howard A.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Stiles, Bryan; Hensley, Scott] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Lorenz, Ralph] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Kirk, Randolph L.] US Geol Survey, Flagstaff, AZ 86001 USA; [Lunine, Jonathan] Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; [Lunine, Jonathan] Univ Arizona, Dept Phys, Tucson, AZ 85721 USA	Stanford University; Stanford University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; United States Department of the Interior; United States Geological Survey; University of Arizona; University of Arizona	Zebker, HA (corresponding author), Stanford Univ, Dept Geophys, Stanford, CA 94305 USA.	zebker@stanford.edu	Lorenz, Ralph D/B-8759-2016	Lorenz, Ralph D/0000-0001-8528-4644; zebker, howard/0000-0001-9931-5237; Lunine, Jonathan/0000-0003-2279-4131	Cassini Project; NASA	Cassini Project; NASA(National Aeronautics & Space Administration (NASA))	We thank the Cassini Radar Team for detailed planning of these observations. This work was supported by the Cassini Project and by NASA as part of the Cassini Data Analysis Program. We also thank the reviewers for many constructive comments on our error analysis and data interpretation. The Cassini Project is a joint endeavor of NASA, the European Space Agency, and the Italian Space Agency. Cassini is managed by JPL, California Institute of Technology, under a contract with NASA.	ALBERS S, MAP TITAN DERIVED IM; ANTREASIAN PG, 2008, AM I AER ASTR AAS AS; Barnes JW, 2008, ICARUS, V195, P400, DOI 10.1016/j.icarus.2007.12.006; Castillo-Rogez JC, 2007, ICARUS, V190, P179, DOI 10.1016/j.icarus.2007.02.018; DERMOTT SF, 1979, ICARUS, V37, P310, DOI 10.1016/0019-1035(79)90137-4; DERMOTT SF, 1988, ICARUS, V73, P25, DOI 10.1016/0019-1035(88)90084-X; ELACHI C, 1991, P IEEE, V79, P867, DOI 10.1109/5.90164; Elachi C, 2005, SCIENCE, V308, P970, DOI 10.1126/science.1109919; Fortes AD, 2007, ICARUS, V188, P139, DOI 10.1016/j.icarus.2006.11.002; Mitri G, 2007, ICARUS, V186, P385, DOI 10.1016/j.icarus.2006.09.004; MOORE RK, 1981, IEEE T AERO ELEC SYS, V17, P410, DOI 10.1109/TAES.1981.309069; OJAKANGAS GW, 1989, ICARUS, V81, P220, DOI 10.1016/0019-1035(89)90052-3; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; Rhodes D. R., 1959, INTRO MONOPULSE; Stiles BW, 2009, ICARUS, V202, P584, DOI 10.1016/j.icarus.2009.03.032; Stofan ER, 2007, NATURE, V445, P61, DOI 10.1038/nature05438; Tobie G, 2006, NATURE, V440, P61, DOI 10.1038/nature04497; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539; Zebker HA, 2009, ICARUS, V200, P240, DOI 10.1016/j.icarus.2008.10.023	19	80	80	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	2009	324	5929					921	923		10.1126/science.1168905	http://dx.doi.org/10.1126/science.1168905			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19342551				2022-12-28	WOS:000266048800033
J	Dong, XH; Biswas, A; Suel, KE; Jackson, LK; Martinez, R; Gu, HM; Chook, YM				Dong, Xiuhua; Biswas, Anindita; Sueel, Katherine E.; Jackson, Laurie K.; Martinez, Rita; Gu, Hongmei; Chook, Yuh Min			Structural basis for leucine-rich nuclear export signal recognition by CRM1	NATURE			English	Article							PROTEIN EXPORT; NUCLEOCYTOPLASMIC TRANSPORT; SEQUENCE REQUIREMENTS; IMPORTIN-BETA; T-ANTIGEN; LOCALIZATION; PREDICTION; PATHWAY; COMPLEX; SYSTEM	CRM1 (also known as XPO1 and exportin 1) mediates nuclear export of hundreds of proteins through the recognition of the leucine-rich nuclear export signal (LR-NES). Here we present the 2.9 angstrom structure of CRM1 bound to snurportin 1 (SNUPN). Snurportin 1 binds CRM1 in a bipartite manner by means of an amino-terminal LR-NES and its nucleotide-binding domain. The LR-NES is a combined alpha-helical-extended structure that occupies a hydrophobic groove between two CRM1 outer helices. The LR-NES interface explains the consensus hydrophobic pattern, preference for intervening electronegative residues and inhibition by leptomycin B. The second nuclear export signal epitope is a basic surface on the snurportin 1 nucleotide-binding domain, which binds an acidic patch on CRM1 adjacent to the LR-NES site. Multipartite recognition of individually weak nuclear export signal epitopes may be common to CRM1 substrates, enhancing CRM1 binding beyond the generally low affinity LR-NES. Similar energetic construction is also used in multipartite nuclear localization signals to provide broad substrate specificity and rapid evolution in nuclear transport.	[Dong, Xiuhua; Biswas, Anindita; Sueel, Katherine E.; Jackson, Laurie K.; Martinez, Rita; Gu, Hongmei; Chook, Yuh Min] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Chook, YM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk, Dallas, TX 75390 USA.	yuhmin.chook@utsouthwestern.edu	Chook, Yuh Min/AAA-9549-2019		National Institute of Health (NIH) [R01GM069909, R01GM069909-03S1, 5-T32-GM008297]; Welch Foundation [I-1532]; UT Southwestern Endowed Scholars Program; US Department of Energy; Office of Energy Research [W-31-109-ENG-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008297, R01GM069909] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); UT Southwestern Endowed Scholars Program; US Department of Energy(United States Department of Energy (DOE)); Office of Energy Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Sheng, C. Kong, D. Tomchick and C. Dann for assistance during data collection and structure determination, S. Padrick for advice on fluorescence binding assays, G. Suel and T. Cagatay for help with microscopy, K. Weis for yeast strains and constructs, X. Zhang, L. Rice and M. Rosen for discussion. This work is funded by National Institute of Health (NIH) grants R01GM069909, R01GM069909-03S1, 5-T32-GM008297, Welch Foundation grant I-1532 and the UT Southwestern Endowed Scholars Program. Use of the Argonne National Laboratory Stuctural Biology Center beamlines at the Advanced Photon Source, was supported by the US Department of Energy, Office of Energy Research, under contract no. W-31-109-ENG-38.	Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; DINGWALL C, 1982, CELL, V30, P449, DOI 10.1016/0092-8674(82)90242-2; DONG X, NATURE STRU IN PRESS, DOI DOI 10.1038/NSMB.1585; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelsma D, 2004, EMBO J, V23, P3643, DOI 10.1038/sj.emboj.7600370; Englmeier L, 2001, EMBO REP, V2, P926, DOI 10.1093/embo-reports/kve200; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kosugi S, 2008, TRAFFIC, V9, P2053, DOI 10.1111/j.1600-0854.2008.00825.x; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LANFORD RE, 1984, CELL, V37, P801, DOI 10.1016/0092-8674(84)90415-X; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Mancias JD, 2005, TRAFFIC, V6, P278, DOI 10.1111/j.1600-0854.2005.00279.x; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100; Mitrousis G, 2008, J BIOL CHEM, V283, P7877, DOI 10.1074/jbc.M709093200; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; NISHI K, 1994, J BIOL CHEM, V269, P6320; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Petosa C, 2004, MOL CELL, V16, P761, DOI 10.1016/j.molcel.2004.11.018; Richards SA, 1997, SCIENCE, V276, P1842, DOI 10.1126/science.276.5320.1842; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SIKORSKI RS, 1989, GENETICS, V122, P19; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Strasser A, 2005, EMBO J, V24, P2235, DOI 10.1038/sj.emboj.7600701; Suel KE, 2006, METHODS, V39, P342, DOI 10.1016/j.ymeth.2006.06.015; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Swanton E, 2006, CELL, V127, P877, DOI 10.1016/j.cell.2006.11.018; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thomas F, 2003, J CELL SCI, V116, P2409, DOI 10.1242/jcs.00464; Tran EJ, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.015; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	50	238	243	3	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1136	U71		10.1038/nature07975	http://dx.doi.org/10.1038/nature07975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19339969	Green Accepted			2022-12-28	WOS:000265754600040
J	Singh, R; Kaushik, S; Wang, YJ; Xiang, YQ; Novak, I; Komatsu, M; Tanaka, K; Cuervo, AM; Czaja, MJ				Singh, Rajat; Kaushik, Susmita; Wang, Yongjun; Xiang, Youqing; Novak, Inna; Komatsu, Masaaki; Tanaka, Keiji; Cuervo, Ana Maria; Czaja, Mark J.			Autophagy regulates lipid metabolism	NATURE			English	Article							LOW-DENSITY-LIPOPROTEIN; PHOSPHATIDYLINOSITOL 3-KINASE; TRIACYLGLYCEROL; LIPOLYSIS; DISEASE; STRESS; CYP2E1; ROLES; LIVER	The intracellular storage and utilization of lipids are critical to maintain cellular energy homeostasis. During nutrient deprivation, cellular lipids stored as triglycerides in lipid droplets are hydrolysed into fatty acids for energy. A second cellular response to starvation is the induction of autophagy, which delivers intracellular proteins and organelles sequestered in double-membrane vesicles (autophagosomes) to lysosomes for degradation and use as an energy source. Lipolysis and autophagy share similarities in regulation and function but are not known to be interrelated. Here we show a previously unknown function for autophagy in regulating intracellular lipid stores (macrolipophagy). Lipid droplets and autophagic components associated during nutrient deprivation, and inhibition of autophagy in cultured hepatocytes and mouse liver increased triglyceride storage in lipid droplets. This study identifies a critical function for autophagy in lipid metabolism that could have important implications for human diseases with lipid over-accumulation such as those that comprise the metabolic syndrome.	[Singh, Rajat; Kaushik, Susmita; Wang, Yongjun; Xiang, Youqing; Cuervo, Ana Maria; Czaja, Mark J.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Singh, Rajat; Kaushik, Susmita; Wang, Yongjun; Xiang, Youqing; Novak, Inna; Cuervo, Ana Maria; Czaja, Mark J.] Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA; [Kaushik, Susmita; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Kaushik, Susmita; Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Studies, Bronx, NY 10461 USA; [Novak, Inna] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA; [Komatsu, Masaaki; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Tokyo Metropolitan Institute of Medical Science	Czaja, MJ (corresponding author), Albert Einstein Coll Med, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	amcuervo@aecom.yu.edu; czaja@aecom.yu.edu	Komatsu, Masaaki/B-8321-2011; Kaushik, Susmita/GVS-3186-2022; Novak, Inna/ABF-9575-2020	Komatsu, Masaaki/0000-0001-7672-7722; Kaushik, Susmita/0000-0002-6096-5387; Cuervo, Ana Maria/0000-0002-0771-700X	National Institute of Diabetes and Digestive and Kidney Diseases; National Institute on Aging; American Liver Foundation Postdoctoral Research Fellowship Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061498, K01DK087776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031782, R01AG021904] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Liver Foundation Postdoctoral Research Fellowship Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. Silver for his discussions, N. Mizushima for providing the Atg5<SUP>-/-</SUP> mouse embryonic fibroblasts, R. Stockert for the protein disulphide isomerase antibody and the personnel at the Analytical Imaging Facility for their technical assistance. This work was supported by National Institutes of Health grants from the National Institute of Diabetes and Digestive and Kidney Diseases and National Institute on Aging, a Glenn Award and an American Liver Foundation Postdoctoral Research Fellowship Award (R.S.).	Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brasaemle DL, 2006, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB0315S29; CUERVO AM, 1995, EUR J BIOCHEM, V227, P792, DOI 10.1111/j.1432-1033.1995.tb20203.x; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; DUNN WA, 1990, J CELL BIOL, V110, P1935, DOI 10.1083/jcb.110.6.1935; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; Kaushik S, 2006, EMBO J, V25, P3921, DOI 10.1038/sj.emboj.7601283; Kellner-Weibel G, 2001, J LIPID RES, V42, P768; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; MARZELLA L, 1982, J CELL BIOL, V93, P144, DOI 10.1083/jcb.93.1.144; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Owen O E, 1979, Adv Exp Med Biol, V111, P169; Piva R, 2006, BLOOD, V107, P689, DOI 10.1182/blood-2005-05-2125; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Sahai A, 2006, AM J PHYSIOL-GASTR L, V291, pG55, DOI 10.1152/ajpgi.00360.2005; Schattenberg JRM, 2005, J BIOL CHEM, V280, P9887, DOI 10.1074/jbc.M410310200; Wang YJ, 2004, J BIOL CHEM, V279, P31089, DOI 10.1074/jbc.M404170200; Wang YJ, 2008, J BIOL CHEM, V283, P4766, DOI 10.1074/jbc.M706666200; WIGGINS D, 1992, BIOCHEM J, V284, P457, DOI 10.1042/bj2840457; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c	35	2530	2646	24	536	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1131	U64		10.1038/nature07976	http://dx.doi.org/10.1038/nature07976			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19339967	Green Submitted, Green Accepted			2022-12-28	WOS:000265754600039
J	Maund, JR; Smartt, SJ				Maund, Justyn R.; Smartt, Stephen J.			The Disappearance of the Progenitors of Supernovae 1993J and 2003gd	SCIENCE			English	Article							PLATEAU SUPERNOVA; IMAGE SUBTRACTION; CORE-COLLAPSE; STAR; SUPERGIANT; M74	Using images from the Hubble Space Telescope and the Gemini Telescope, we confirmed the disappearance of the progenitors of two type II supernovae (SNe) and evaluated the presence of other stars associated with them. We found that the progenitor of SN 2003gd, an M-supergiant star, is no longer observed at the SN location and determined its intrinsic brightness using image subtraction techniques. The progenitor of SN 1993J, a K-supergiant star, is also no longer present, but its B-supergiant binary companion is still observed. The disappearance of the progenitors confirms that these two supernovae were produced by red supergiants.	[Maund, Justyn R.] Univ Copenhagen, Dark Cosmol Ctr, Niels Bohr Inst, DK-2100 Copenhagen O, Denmark; [Maund, Justyn R.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Smartt, Stephen J.] Queens Univ Belfast, Astrophys Res Ctr, Sch Math & Phys, Belfast BT7 1NN, Antrim, North Ireland	University of Copenhagen; Niels Bohr Institute; University of California System; University of California Santa Cruz; Queens University Belfast	Maund, JR (corresponding author), Univ Copenhagen, Dark Cosmol Ctr, Niels Bohr Inst, Juliane Maries Vej 30, DK-2100 Copenhagen O, Denmark.	justyn@dark-cosmology.dk		Maund, Justyn/0000-0003-0733-7215	Science and Technology Facilities Council [PP/D508212/1, ST/G000921/1, PP/C506805/1] Funding Source: researchfish; STFC [PP/C506805/1, PP/D508212/1, ST/G000921/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Alard C, 1998, ASTROPHYS J, V503, P325, DOI 10.1086/305984; Alard C, 2000, ASTRON ASTROPHYS SUP, V144, P363, DOI 10.1051/aas:2000214; ALDERING G, 1994, ASTRON J, V107, P662, DOI 10.1086/116886; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; Eldridge JJ, 2004, MON NOT R ASTRON SOC, V353, P87, DOI 10.1111/j.1365-2966.2004.08041.x; ELIAS JH, 1985, ASTROPHYS J SUPPL S, V57, P91, DOI 10.1086/190997; Gal-Yam A, 2009, NATURE, V458, P865, DOI 10.1038/nature07934; GILMOZZI R, 1987, NATURE, V328, P318, DOI 10.1038/328318a0; HENDEN A, 2002, GRB CIRCULAR NETWORK, V1242, P1; Hendry MA, 2005, MON NOT R ASTRON SOC, V359, P906, DOI 10.1111/j.1365-2966.2005.08928.x; Hook IM, 2004, PUBL ASTRON SOC PAC, V116, P425, DOI 10.1086/383624; Maund JR, 2004, NATURE, V427, P129, DOI 10.1038/nature02161; MAUND JR, 2005, THESIS I ASTRONOMY C; McNaught R. H., 2003, IAU CIRC, P2; PASTORELLO A, 2009, ASTROPH09012075; PODSIADLOWSKI P, 1993, NATURE, V364, P509, DOI 10.1038/364509a0; Smartt SJ, 2004, SCIENCE, V303, P499, DOI 10.1126/science.1092967; SMARTT SJ, 2008, ASTROPH08090403; Sugerman BEK, 2006, SCIENCE, V313, P196, DOI 10.1126/science.1128131; Van Dyk SD, 2003, PUBL ASTRON SOC PAC, V115, P1289, DOI 10.1086/378308; Van Dyk SD, 2002, PUBL ASTRON SOC PAC, V114, P1322, DOI 10.1086/344382; WILLIAMS KA, 2008, ASTROPH08111577; WOOSLEY SE, 1994, ASTROPHYS J, V429, P300, DOI 10.1086/174319	25	82	82	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 24	2009	324	5926					486	488		10.1126/science.1170198	http://dx.doi.org/10.1126/science.1170198			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19299586	Green Submitted			2022-12-28	WOS:000265411200039
J	Gradinaru, V; Mogri, M; Thompson, KR; Henderson, JM; Deisseroth, K				Gradinaru, Viviana; Mogri, Murtaza; Thompson, Kimberly R.; Henderson, Jaimie M.; Deisseroth, Karl			Optical Deconstruction of Parkinsonian Neural Circuitry	SCIENCE			English	Article							DEEP-BRAIN-STIMULATION; MOTOR CORTEX STIMULATION; SUBTHALAMIC NUCLEUS STIMULATION; TREATMENT-RESISTANT DEPRESSION; TRANSCRANIAL MAGNETIC STIMULATION; BASAL GANGLIA; MOVEMENT-DISORDERS; IN-VIVO; TRANSGENIC MICE; DISEASE	Deep brain stimulation (DBS) is a therapeutic option for intractable neurological and psychiatric disorders, including Parkinson's disease and major depression. Because of the heterogeneity of brain tissues where electrodes are placed, it has been challenging to elucidate the relevant target cell types or underlying mechanisms of DBS. We used optogenetics and solid-state optics to systematically drive or inhibit an array of distinct circuit elements in freely moving parkinsonian rodents and found that therapeutic effects within the subthalamic nucleus can be accounted for by direct selective stimulation of afferent axons projecting to this region. In addition to providing insight into DBS mechanisms, these results demonstrate an optical approach for dissection of disease circuitry and define the technological toolbox needed for systematic deconstruction of disease circuits by selectively controlling individual components.	[Gradinaru, Viviana; Mogri, Murtaza; Thompson, Kimberly R.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Gradinaru, Viviana] Stanford Univ, Program Neurosci, Stanford, CA 94305 USA; [Henderson, Jaimie M.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu		Henderson, Jaimie/0000-0002-3276-2267	Kinetics Foundation; William M. Keck Foundation; Snyder Foundation; Albert Yu and Mary Bechmann Foundation; Wallace Coulter Foundation; California Institute for Regenerative Medicine; McKnight Foundation; Esther A. and Joseph Klingenstein Fund; NSF; National Institute of Mental Health; National Institute on Drug Abuse; NIH Pioneer Award; SGF; SIGF; Bio-X; NARSAD; John Blume Foundation; Davis Phinney Foundation	Kinetics Foundation; William M. Keck Foundation(W.M. Keck Foundation); Snyder Foundation; Albert Yu and Mary Bechmann Foundation; Wallace Coulter Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); McKnight Foundation; Esther A. and Joseph Klingenstein Fund; NSF(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIH Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SGF; SIGF; Bio-X; NARSAD(NARSAD); John Blume Foundation; Davis Phinney Foundation	K.D. is supported by the Kinetics Foundation, the William M. Keck Foundation, the Snyder Foundation, the Albert Yu and Mary Bechmann Foundation, and the Wallace Coulter Foundation, as well as by California Institute for Regenerative Medicine, the McKnight Foundation, the Esther A. and Joseph Klingenstein Fund, NSF, National Institute of Mental Health, National Institute on Drug Abuse, and the NIH Pioneer Award. V.G. is supported by SGF and SIGF (Stanford Graduate Fellowships). M.M is supported by Bio-X and SGF Fellowships. K.R.T. is supported by NARSAD. J.M.H is supported by the Coulter Foundation, the John Blume Foundation and the Davis Phinney Foundation. We especially thank A. M. Aravanis for mentoring and advice on animal surgery and in vivo recordings, F. Zhang and H. C. Tsai for assistance with Cre-dependent opsin targeting, L. Meltzer for useful discussion, advice and help on immunohistochemistry, G. Feng and G. Augustine for collaboration on generation of the Thy-1 mice (available at the Jackson Laboratory), and V. Sohal for help with power spectra analysis. We also thank the entire Deisseroth lab for useful discussions. The materials and methods described herein are freely distributed and supported by the authors (www.stanford.edu/group/dlab).	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Arle JE, 2008, J NEUROSURG, V109, P133, DOI 10.3171/JNS/2008/109/7/0133; Bekar L, 2008, NAT MED, V14, P75, DOI 10.1038/nm1693; BENABID AL, 1994, STEREOT FUNCT NEUROS, V62, P76, DOI 10.1159/000098600; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bronte-Stewart H, 2009, EXP NEUROL, V215, P20, DOI 10.1016/j.expneurol.2008.09.008; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; Canavero S, 2002, J NEUROSURG, V97, P1208, DOI 10.3171/jns.2002.97.5.1208; Canavero S, 2000, MOVEMENT DISORD, V15, P169, DOI 10.1002/1531-8257(200001)15:1<169::AID-MDS1030>3.0.CO;2-W; Cilia R, 2007, MOVEMENT DISORD, V22, P111, DOI 10.1002/mds.21207; Degos B, 2008, EUR J NEUROSCI, V27, P2599, DOI 10.1111/j.1460-9568.2008.06229.x; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dostrovsky JO, 2002, MOVEMENT DISORD, V17, pS63, DOI 10.1002/mds.10143; Drouot' X, 2004, NEURON, V44, P769, DOI 10.1016/j.neuron.2004.11.023; Fregni F, 2005, J NEUROL NEUROSUR PS, V76, P1614, DOI 10.1136/jnnp.2005.069849; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Gross RE, 2008, CLIN NEUROPHYSIOL, V119, P1947, DOI 10.1016/j.clinph.2008.06.003; Hamani C, 2004, BRAIN, V127, P4, DOI 10.1093/brain/awh029; Khedr EM, 2006, MOVEMENT DISORD, V21, P2201, DOI 10.1002/mds.21089; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; Lefaucheur JP, 2004, CLIN NEUROPHYSIOL, V115, P2530, DOI 10.1016/j.clinph.2004.05.025; Levy R, 2001, BRAIN, V124, P2105, DOI 10.1093/brain/124.10.2105; Li S, 2007, J NEUROPHYSIOL, V98, P3525, DOI 10.1152/jn.00808.2007; LIMOUSIN P, 1995, LANCET, V345, P91, DOI 10.1016/S0140-6736(95)90062-4; Liu Y, 2008, NEUROSCI BIOBEHAV R, V32, P343, DOI 10.1016/j.neubiorev.2006.10.007; Lozano AM, 2008, BIOL PSYCHIAT, V64, P461, DOI 10.1016/j.biopsych.2008.05.034; Matsuya T, 2007, J PHARMACOL SCI, V103, P329, DOI 10.1254/jphs.SCZ070058; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; McIntyre CC, 2002, J NEUROPHYSIOL, V88, P1592, DOI 10.1152/jn.2002.88.4.1592; McNeely HE, 2008, J NERV MENT DIS, V196, P405, DOI 10.1097/NMD.0b013e3181710927; Metz GA, 2005, EUR J NEUROSCI, V22, P735, DOI 10.1111/j.1460-9568.2005.04238.x; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Pagni C A, 2003, J Neurosurg Sci, V47, P189; Payoux P, 2004, ARCH NEUROL-CHICAGO, V61, P1307, DOI 10.1001/archneur.61.8.1307; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Rezai AR, 2008, NEUROSURGERY, V62, P809, DOI [10.1227/01.NEU.0000297003.12598.89, 10.1227/01.neu.0000316285.52865.53]; RIDDING MC, 1995, ANN NEUROL, V37, P181, DOI 10.1002/ana.410370208; RIVKEES SA, 1995, BRAIN RES, V677, P193, DOI 10.1016/0006-8993(95)00062-U; Shen KZ, 2003, NEUROSCIENCE, V116, P99, DOI 10.1016/S0306-4522(02)00656-5; SMITH Y, 1988, BRAIN RES, V453, P353, DOI 10.1016/0006-8993(88)90177-1; Strafella AP, 2007, MOVEMENT DISORD, V22, P2113, DOI 10.1002/mds.21691; Tabar V, 2008, NAT MED, V14, P379, DOI 10.1038/nm1732; Vitek JL, 2002, MOVEMENT DISORD, V17, pS69, DOI 10.1002/mds.10144; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wang L., UNPUB; Wingeier B, 2006, EXP NEUROL, V197, P244, DOI 10.1016/j.expneurol.2005.09.016; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	58	1084	1140	7	397	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					354	359		10.1126/science.1167093	http://dx.doi.org/10.1126/science.1167093			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19299587	Green Accepted			2022-12-28	WOS:000265221600033
J	Hanania, NA; Sockrider, M; Giraldo, L; Valdez, R; Flores, E; Reibman, J; DiMango, E; Rogers, L; Cammarata, C; Carapetyan, K; Sormillon, J; Simpson, E; Williams, L; Sundy, J; Dudek, G; Newton, R; Dugdale, A; Teague, WG; Fitzpatrick, A; Khatri, S; Patel, R; Peabody, J; Hunter, E; Whitlock, D; Smith, L; Moy, J; Naureckas, E; Olopade, CS; Hixon, J; Brees, A; Rivera, G; Sietsema, S; Zagaja, V; Busk, M; Williams, C; Puntenney, P; Busk, N; Leone, F; Hayes-Hampton, M; Summer, WR; Meyaski, G; Wenzel, S; Katial, R; Lopez, L; Lima, J; Blake, K; Santos, A; Vega, K; Lambiase, L; Langford, T; Schaeffer, D; Lang, J; Mcrae, M; Karpel, J; Cohen, R; Ramdeo, R; Irvin, CG; Dixon, AE; Kaminsky, DA; Colletti, R; Burns, SM; Bourassa, LM; Lang, SE; Griffes, LV; Pratt, R; Nakos, KB; Girard, KJ; Mastronarde, J; Mccoy, K; Parsons, J; Drake, J; Compton, R; Raterman, L; Cosmar, D; Gerald, LB; Bailey, WC; Erwin, S; Kelley, A; Laken, D; Wanner, A; Lockey, R; Mendes, E; McCullough, S; Fimbel, B; Grandstaff, M; Blumenthal, MN; Brottman, G; Hagen, J; Decker, A; Lascewski, D; Kelleher, S; Bachman, K; Quintard, C; Sherry, C; Salzman, G; Pyszczynski, D; Haney, P; Castro, M; Bacharier, L; Sumino, K; Scheipeter, ME; Tarsi, J; Wasserman, S; Ramsdell, J; Vitin, J; Tucker, T; Anthonisen, N; Wise, R; Holbrook, J; Brown, E; Amend-Libercci, D; Barry, K; Daniel, M; Lears, A; Leatherman, G; Levine, C; Masih, R; Modak, S; Nowakowski, D; Prusakowski, N; Shade, D; Shiflett, C; Sugar, E; Richter, J; Anthonisen, N; Lancet, E; Santos, A; Taggart, V; Edelman, N; Wise, R; Holbrook, J; Hanania, N; Williams, L; Teague, G; Smith, L; Busk, M; Leone, F; Karpel, J; Summer, W; Blumenthal, M; Lima, J; Katial, R; Irvin, C; Reibman, J; Dozor, A; Mastronarde, J; Castro, M; Gerald, L; Salzman, G; Wanner, A; Wasserman, S; Lazarus, S; Calhoun, W; Kahrilas, P; McWilliams, B; Rogatko, A; Sorkness, C; Lancet, E; Vento, R; Edelman, N; Rappaport, S; Pezza, G; Taggart, V; Weinmann, G; Snider, G; Anthonisen, N; Castro, M; Fish, J; Ingbar, D; Jenkinson, S; Mannino, D; Perlstadt, H; Rosenwasser, L; Samet, J; Schraufnagel, D; Smith, J; Smith, L; Standiford, T; Wanner, A; Weaver, T				Hanania, N. A.; Sockrider, M.; Giraldo, L.; Valdez, R.; Flores, E.; Reibman, J.; DiMango, E.; Rogers, L.; Cammarata, C.; Carapetyan, K.; Sormillon, J.; Simpson, E.; Williams, L.; Sundy, J.; Dudek, G.; Newton, R.; Dugdale, A.; Teague, W. G.; Fitzpatrick, A.; Khatri, S.; Patel, R.; Peabody, J.; Hunter, E.; Whitlock, D.; Smith, L.; Moy, J.; Naureckas, E.; Olopade, C. S.; Hixon, J.; Brees, A.; Rivera, G.; Sietsema, S.; Zagaja, V.; Busk, M.; Williams, C.; Puntenney, P.; Busk, N.; Leone, F.; Hayes-Hampton, M.; Summer, W. R.; Meyaski, G.; Wenzel, S.; Katial, R.; Lopez, L.; Lima, J.; Blake, K.; Santos, A.; Vega, K.; Lambiase, L.; Langford, T.; Schaeffer, D.; Lang, J.; McRae, M.; Karpel, J.; Cohen, R.; Ramdeo, R.; Irvin, C. G.; Dixon, A. E.; Kaminsky, D. A.; Colletti, R.; Burns, S. M.; Bourassa, L. M.; Lang, S. E.; Griffes, L. V.; Pratt, R.; Nakos, K. B.; Girard, K. J.; Mastronarde, J.; McCoy, K.; Parsons, J.; Drake, J.; Compton, R.; Raterman, L.; Cosmar, D.; Gerald, L. B.; Bailey, W. C.; Erwin, S.; Kelley, A.; Laken, D.; Wanner, A.; Lockey, R.; Mendes, E.; McCullough, S.; Fimbel, B.; Grandstaff, M.; Blumenthal, M. N.; Brottman, G.; Hagen, J.; Decker, A.; Lascewski, D.; Kelleher, S.; Bachman, K.; Quintard, C.; Sherry, C.; Salzman, G.; Pyszczynski, D.; Haney, P.; Castro, M.; Bacharier, L.; Sumino, K.; Scheipeter, M. E.; Tarsi, J.; Wasserman, S.; Ramsdell, J.; Vitin, J.; Tucker, T.; Anthonisen, N.; Wise, R.; Holbrook, J.; Brown, E.; Amend-Libercci, D.; Barry, K.; Daniel, M.; Lears, A.; Leatherman, G.; Levine, C.; Masih, R.; Modak, S.; Nowakowski, D.; Prusakowski, N.; Shade, D.; Shiflett, C.; Sugar, E.; Richter, J.; Anthonisen, N.; Lancet, E.; Santos, A.; Taggart, V.; Edelman, N.; Wise, R.; Holbrook, J.; Hanania, N.; Williams, L.; Teague, G.; Smith, L.; Busk, M.; Leone, F.; Karpel, J.; Summer, W.; Blumenthal, M.; Lima, J.; Katial, R.; Irvin, C.; Reibman, J.; Dozor, A.; Mastronarde, J.; Castro, M.; Gerald, L.; Salzman, G.; Wanner, A.; Wasserman, S.; Lazarus, S.; Calhoun, W.; Kahrilas, P.; McWilliams, B.; Rogatko, A.; Sorkness, C.; Lancet, E.; Vento, R.; Edelman, N.; Rappaport, S.; Pezza, G.; Taggart, V.; Weinmann, G.; Snider, G.; Anthonisen, N.; Castro, M.; Fish, J.; Ingbar, D.; Jenkinson, S.; Mannino, D.; Perlstadt, H.; Rosenwasser, L.; Samet, J.; Schraufnagel, D.; Smith, J.; Smith, L.; Standiford, T.; Wanner, A.; Weaver, T.		Amer Lung Assoc Asthma Clinical Re	Efficacy of Esomeprazole for Treatment of Poorly Controlled Asthma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; QUALITY-OF-LIFE; ESOPHAGEAL ACID PERFUSION; PREVALENCE; SYMPTOMS; METHACHOLINE; VALIDATION; GUIDELINES; DIFFICULT; DIAGNOSIS	Background: Gastroesophageal reflux is common among patients with asthma but often causes mild or no symptoms. It is not known whether treatment of gastroesophageal reflux with proton-pump inhibitors in patients who have poorly controlled asthma without symptoms of gastroesophageal reflux can substantially improve asthma control. Methods: In a parallel-group, double-blind trial, we randomly assigned 412 participants with inadequately controlled asthma, despite treatment with inhaled corticosteroids, and with minimal or no symptoms of gastroesophageal reflux to receive either 40 mg of esomeprazole twice a day or matching placebo. Participants were followed for 24 weeks with the use of daily asthma diaries, spirometry performed once every 4 weeks, and questionnaires that asked about asthma symptoms. We used ambulatory pH monitoring to ascertain the presence or absence of gastroesophageal reflux in the participants. The primary outcome was the rate of episodes of poor asthma control, as assessed on the basis of entries in asthma diaries. Results: Episodes of poor asthma control occurred with similar frequency in the placebo and esomeprazole groups (2.3 and 2.5 events per person-year, respectively; P=0.66). There was no treatment effect with respect to individual components of the episodes of poor asthma control or with respect to secondary outcomes, including pulmonary function, airway reactivity, asthma control, symptom scores, nocturnal awakening, or quality of life. The presence of gastroesophageal reflux, which was documented by pH monitoring in 40% of participants with minimal or no symptoms, did not identify a subgroup of patients that benefited from treatment with proton-pump inhibitors. There were fewer serious adverse events among patients receiving esomeprazole than among those receiving placebo (11 vs. 17). Conclusions: Despite a high prevalence of asymptomatic gastroesophageal reflux among patients with poorly controlled asthma, treatment with proton-pump inhibitors does not improve asthma control. Asymptomatic gastroesophageal reflux is not a likely cause of poorly controlled asthma. (ClinicalTrials.gov number, NCT00069823.) N Engl J Med 2009;360:1487-99.	[Sockrider, M.; Giraldo, L.; Valdez, R.; Flores, E.; Hanania, N.] Baylor Coll Med, Houston, TX 77030 USA; [Reibman, J.; DiMango, E.; Rogers, L.; Cammarata, C.; Carapetyan, K.; Sormillon, J.; Simpson, E.] Columbia Univ, New York Univ Consortium, New York, NY USA; [Williams, L.; Sundy, J.; Dudek, G.; Newton, R.; Dugdale, A.] Duke Univ, Med Ctr, Durham, NC USA; [Teague, W. G.; Fitzpatrick, A.; Khatri, S.; Patel, R.; Peabody, J.; Hunter, E.; Whitlock, D.] Emory Univ, Sch Med, Atlanta, GA USA; [Smith, L.; Moy, J.; Naureckas, E.; Olopade, C. S.; Hixon, J.; Brees, A.; Rivera, G.; Sietsema, S.; Zagaja, V.] Illinois Consortium, Chicago, IL USA; [Busk, M.; Williams, C.; Puntenney, P.; Busk, N.] Indiana Univ, Asthma Clin Res Ctr, Indianapolis, IN 46204 USA; [Leone, F.; Hayes-Hampton, M.] Univ Penn, Philadelphia, PA 19104 USA; [Summer, W. R.; Meyaski, G.] Louisiana State Univ, Hlth Sci Ctr, Ernest N Morial Asthma Allergy & Resp Dis Ctr, New Orleans, LA USA; [Wenzel, S.; Katial, R.; Lopez, L.] Natl Jewish Med & Res Ctr, Denver, CO USA; [Lima, J.; Blake, K.; Santos, A.; Vega, K.; Lambiase, L.; Langford, T.; Schaeffer, D.; Lang, J.; McRae, M.] Univ Florida Consortium, Nemours Childrens Clin, Jacksonville, FL USA; [Karpel, J.; Cohen, R.; Ramdeo, R.] N Shore Long Isl Jewish Hlth Syst, New Hyde Pk, NY USA; [Irvin, C. G.; Dixon, A. E.; Kaminsky, D. A.; Colletti, R.; Burns, S. M.; Bourassa, L. M.; Lang, S. E.; Griffes, L. V.; Pratt, R.; Nakos, K. B.; Girard, K. J.] No New England Consortium, Colchester, VT USA; [Mastronarde, J.; McCoy, K.; Parsons, J.; Drake, J.; Compton, R.; Raterman, L.; Cosmar, D.] Nationwide Childrens Hosp, Ohio State Univ Med Ctr, Columbus, OH USA; [Gerald, L. B.; Bailey, W. C.; Erwin, S.; Kelley, A.; Laken, D.] Univ Alabama Birmingham, Birmingham, AL USA; [Lockey, R.; McCullough, S.] Univ S Florida, Tampa, FL USA; [Wanner, A.; Mendes, E.] Univ Miami, Miami, FL USA; [Brottman, G.; Hagen, J.; Decker, A.; Lascewski, D.; Kelleher, S.; Bachman, K.; Quintard, C.; Sherry, C.; Blumenthal, M.] Univ Minnesota, Minneapolis, MN USA; [Salzman, G.; Pyszczynski, D.; Haney, P.] Univ Missouri, Sch Med, Kansas City, MO USA; [Castro, M.; Bacharier, L.; Sumino, K.; Scheipeter, M. E.; Tarsi, J.] Washington Univ, St Louis Asthma Clin Res Ctr, St Louis, MO 63130 USA; [Wasserman, S.; Ramsdell, J.; Vitin, J.; Tucker, T.] Univ Calif San Diego, San Diego, CA 92103 USA; [Anthonisen, N.] Resp Hosp, Winnipeg, MB, Canada; [Wise, R.; Holbrook, J.; Brown, E.; Amend-Libercci, D.; Barry, K.; Daniel, M.; Lears, A.; Leatherman, G.; Levine, C.; Masih, R.; Modak, S.; Nowakowski, D.; Prusakowski, N.; Shade, D.; Shiflett, C.; Sugar, E.] Johns Hopkins Univ, Ctr Clin Trials, Data Coordinating Ctr, Baltimore, MD USA; [Richter, J.] Temple Univ, Sch Med, Esophageal PH Probe Qual Control Ctr, Philadelphia, PA 19122 USA; [Lancet, E.; Edelman, N.; Vento, R.; Rappaport, S.; Pezza, G.] Amer Lung Assoc, Project Off, New York, NY 10019 USA; [Taggart, V.; Weinmann, G.] NHLBI, Project Off, Bethesda, MD 20892 USA	Baylor College of Medicine; Columbia University; Duke University; Emory University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Pennsylvania; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; National Jewish Health; State University System of Florida; University of Florida; Northwell Health; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University of Alabama System; University of Alabama Birmingham; State University System of Florida; University of South Florida; University of Miami; University of Minnesota System; University of Minnesota Twin Cities; University of Missouri System; University of Missouri Kansas City; Washington University (WUSTL); University of California System; University of California San Diego; University of Manitoba; Children's Hospital Research Institute of Manitoba; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hanania, NA (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.		Hanania, Nicola A/C-5875-2016; Parsons, Jonathan/E-3824-2011; Sumino, Kaharu/AAA-2028-2021	Hanania, Nicola A/0000-0003-3087-9530; Schraufnagel, Dean/0000-0003-0063-7223; Sumino, Kaharu/0000-0002-6214-2966; Calhoun, William/0000-0001-7075-712X; Fitzpatrick, Anne/0000-0002-2933-5926; Mannino, David/0000-0003-3646-7828; Bacharier, Leonard/0000-0003-0432-2704; Wise, Robert/0000-0002-8353-2349	National Heart, Lung, and Blood Institute [5U01HL072968]; American Lung Association; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072968] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Lung Association; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Heart, Lung, and Blood Institute (5U01HL072968) and the American Lung Association. The study drug and placebo were supplied by AstraZeneca.	BOUSQUET J, 1994, AM J RESP CRIT CARE, V149, P371, DOI 10.1164/ajrccm.149.2.8306032; Canning BJ, 2003, AM J MED, V115, p45S, DOI 10.1016/S0002-9343(03)00192-X; Choy D, 1997, Respirology, V2, P163, DOI 10.1111/j.1440-1843.1997.tb00073.x; Coughlan JL, 2001, THORAX, V56, P198, DOI 10.1136/thorax.56.3.198; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Cuttitta G, 2000, AM J RESP CRIT CARE, V161, P177, DOI 10.1164/ajrccm.161.1.9808014; Dal Negro RW, 2007, RESP MED, V101, P1814, DOI 10.1016/j.rmed.2007.02.009; Damiano A, 2002, DIGEST DIS SCI, V47, P1530, DOI 10.1023/A:1015815102175; DeVault KR, 2005, AM J GASTROENTEROL, V100, P190, DOI 10.1111/j.1572-0241.2005.41217.x; Donnellan C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003245.pub2; EKSTROM T, 1989, CHEST, V96, P995, DOI 10.1378/chest.96.5.995; Field SK, 1996, CHEST, V109, P316, DOI 10.1378/chest.109.2.316; FISH JE, 1999, DIFFICULT ASTHMA, P77; Gibson PG, 2003, COCHRANE DATABASE SY, pCD001496, DOI DOI 10.1002/14651858.CD001496; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Harding SM, 1996, AM J MED, V100, P395, DOI 10.1016/S0002-9343(97)89514-9; Harding SM, 1997, CHEST, V111, P1389, DOI 10.1378/chest.111.5.1389; Harding SM, 2000, AM J RESP CRIT CARE, V162, P34, DOI 10.1164/ajrccm.162.1.9907072; HARDING SM, 1995, CHEST, V108, P1220, DOI 10.1378/chest.108.5.1220; Harding SM, 1999, CHEST, V115, P654, DOI 10.1378/chest.115.3.654; HERVE P, 1986, AM REV RESPIR DIS, V134, P986, DOI 10.1164/arrd.1986.134.5.986; Irvin CG, 2007, AM J RESP CRIT CARE, V175, P235, DOI 10.1164/rccm.200603-416OC; IRWIN RS, 1993, CHEST, V103, P1662, DOI 10.1378/chest.103.6.1662; JACK CIA, 1995, THORAX, V50, P201, DOI 10.1136/thx.50.2.201; Juniper EF, 2006, RESP MED, V100, P616, DOI 10.1016/j.rmed.2005.08.012; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; Keene ON, 2007, PHARM STAT, V6, P89, DOI 10.1002/pst.250; Kiljander TO, 2004, CHEST, V126, P1490, DOI 10.1378/chest.126.5.1490; Kiljander TO, 2006, AM J RESP CRIT CARE, V173, P1091, DOI 10.1164/rccm.200507-1167OC; Lacy BE, 2008, DIGEST DIS SCI, V53, P2627, DOI 10.1007/s10620-007-0188-4; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Littner MR, 2005, CHEST, V128, P1128, DOI 10.1378/chest.128.3.1128; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; *NAT ASTHM ED PREV, 2007, EXPT PAN REP 3 EPR3; Ours TM, 2003, AM J GASTROENTEROL, V98, P545, DOI 10.1016/S0002-9270(02)06026-4; Revicki DA, 1998, CHEST, V114, P998, DOI 10.1378/chest.114.4.998; RICHTER JE, 1992, DIGEST DIS SCI, V37, P849, DOI 10.1007/BF01300382; Richter JE, 1999, CHEST, V116, P1150, DOI 10.1378/chest.116.5.1150; SIMPSON WG, 1995, ARCH INTERN MED, V155, P798, DOI 10.1001/archinte.155.8.798; SONTAG SJ, 1990, GASTROENTEROLOGY, V99, P613, DOI 10.1016/0016-5085(90)90945-W; TUCHMAN DN, 1984, GASTROENTEROLOGY, V87, P872; Vincent D, 1997, EUR RESPIR J, V10, P2255, DOI 10.1183/09031936.97.10102255; Wu DN, 2000, CHEST, V118, P1553, DOI 10.1378/chest.118.6.1553; Zerbib F, 2002, AM J RESP CRIT CARE, V166, P1206, DOI 10.1164/rccm.200110-033OC	44	255	259	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 9	2009	360	15					1487	1499						13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430GL	19357404	Green Accepted			2022-12-28	WOS:000264976800005
J	Eisenberg, R				Eisenberg, Richard			Rethinking Water Splitting	SCIENCE			English	Editorial Material							HYDROGEN-PRODUCTION; MECHANISMS; CONVERSION; OXIDATION		Univ Rochester, Dept Chem, Rochester, NY 14627 USA	University of Rochester	Eisenberg, R (corresponding author), Univ Rochester, Dept Chem, Rochester, NY 14627 USA.	eisenberg@chem.rochester.edu		Eisenberg, Richard/0000-0003-1762-535X				Alstrum-Acevedo JH, 2005, INORG CHEM, V44, P6802, DOI 10.1021/ic050904r; ARCHER MD, 2008, SERIES PHOTOCONVERSI, V3, P1; Du PW, 2008, J AM CHEM SOC, V130, P12576, DOI 10.1021/ja804650g; Eisenberg R, 2008, INORG CHEM, V47, P1697, DOI 10.1021/ic800155g; *EN INF ADM, 2008, INT ENG OUTL 2008; Esswein AJ, 2007, CHEM REV, V107, P4022, DOI 10.1021/cr050193e; Fihri A, 2008, ANGEW CHEM INT EDIT, V47, P564, DOI 10.1002/anie.200702953; Gloaguen F, 2009, CHEM SOC REV, V38, P100, DOI 10.1039/b801796b; Gratzel M, 2005, INORG CHEM, V44, P6841, DOI 10.1021/ic0508371; Jacobsen GM, 2008, ENERG ENVIRON SCI, V1, P167, DOI 10.1039/b805309j; Kohl SW, 2009, SCIENCE, V324, P74, DOI 10.1126/science.1168600; Liu F, 2008, INORG CHEM, V47, P1727, DOI 10.1021/ic701249s; Pecoraro VL, 2008, INORG CHEM, V47, P1765, DOI 10.1021/ic7017488; Schulz WG, 2007, CHEM ENG NEWS, V85, P12, DOI 10.1021/cen-v085n051.p012; WOHLGEMUTH J, 2007, KIRKOTHMER ENCY CHEM, V23, P32; Zhang J, 2005, J AM CHEM SOC, V127, P10840, DOI 10.1021/ja052862b	16	117	120	4	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 3	2009	324	5923					44	45		10.1126/science.1172247	http://dx.doi.org/10.1126/science.1172247			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342575				2022-12-28	WOS:000264802100023
J	Goddard, J; deShazo, R				Goddard, Jerome; deShazo, Richard			Bed Bugs (Cimex lectularius) and Clinical Consequences of Their Bites	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HEPATITIS-B-VIRUS; PERMETHRIN-IMPREGNATED BEDNETS; SURFACE-ANTIGEN; BULLOUS ERUPTION; BEDBUGS; HEMIPTERUS; TRANSMISSION; HYPERSENSITIVITY; PURIFICATION; INFESTATIONS	Context Bed bug (Cimex lectularius) infestations are rapidly increasing worldwide. Health consequences include nuisance biting and cutaneous and systemic reactions. The potential for bed bugs to serve as disease vectors and optimal methods for bed bug pest control and eradication are unclear. Objectives To present current knowledge of the health and medical effects of bed bugs and to explore key issues in pest control and eradication efforts. Data Sources A search of MEDLINE and EMBASE databases (1960-October 2008) for articles using the keywords bed bugs, Cimex lectularius, humans, parasitology, pathogenicity, and drug effects. For pest control, PubMed and Toxline searches (1960-October 2008) were performed using the keywords bed bugs, Cimex, control, prevention, and eradication. Manual searches of older journals, textbooks, pest control trade journals, and newspapers (1892-October 2008) were also performed. Study Selection Original accounts or investigations of bed bugs, clinical responses with sufficient detail of cause and effect between the bed bug bite and clinical response, and convincing evidence of substantiated presence of bed bug exposure. For pest control, documentation that an eradication measure quantitatively decreased bed bugs. Data Extraction A trained medical reference librarian assisted with the literature search. Two authors with expertise in the diagnosis, treatment, and eradication of bed bugs reviewed the clinical articles. One author evaluated the pest control articles. Data Synthesis Fifty-three articles met inclusion criteria and were summarized. Only 2 clinical trials concerning bed bugs were identified and tested the ability of pest control interventions to eradicate bed bugs. Although transmission of more than 40 human diseases has been attributed to bed bugs, there is little evidence that they are vectors of communicable disease. A variety of clinical reactions to bed bugs have been reported, including cutaneous and rarely systemic reactions. A wide range of empirical treatments, including antibiotics, antihistamines, topical and oral corticosteroids, and epinephrine, have been used for bite reactions with varying results. No evidence-based interventions to eradicate bed bugs or prevent bites were identified. Conclusions Treatment options for cutaneous and systemic reactions from bed bug bites have not been evaluated in clinical trials and there is no evidence that outcomes differ significantly from those receiving no treatment. Evidence for disease transmission by bed bugs is lacking. Pest control and eradication is challenging due to insecticide resistance, lack of effective products, and health concerns about spraying mattresses with pesticides.	[Goddard, Jerome] Mississippi State Univ, Dept Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Goddard, Jerome; deShazo, Richard] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS USA	Mississippi State University; University of Mississippi; University of Mississippi Medical Center	Goddard, J (corresponding author), Mississippi State Univ, Dept Entomol & Plant Pathol, Box 9775, Mississippi State, MS 39762 USA.	jgoddard@entomology.msstate.edu		Goddard, Jerome/0000-0002-2617-7141				Abdel-Naser M, 2006, PARASITOL RES, V98, P550, DOI 10.1007/s00436-005-0076-9; Abou Gamra E M, 1991, J Egypt Soc Parasitol, V21, P735; Alexander JOD, 1984, ARTHROPODS HUMAN SKI; ALLINGTON HV, 1954, JAMA-J AM MED ASSOC, V155, P240, DOI 10.1001/jama.1954.03690210018005; Bartley J. D., 1974, Military Medicine, V139, P884; BAUERDUBAU K, 2004, BETTWANZEN ARZT 0930; Bircher AJ, 2005, DERMATOLOGY, V210, P119, DOI 10.1159/000082567; Blow JA, 2001, J MED ENTOMOL, V38, P694, DOI 10.1603/0022-2585-38.5.694; Brasch Jochen, 2006, J Dtsch Dermatol Ges, V4, P1077, DOI 10.1111/j.1610-0387.2006.0606129.x; BROTMAN B, 1973, LANCET, V1, P1305; Brown, 1944, ANN ALLERGY, V2, P235; BURTON GJ, 1963, PUBLIC HEALTH REP, V78, P513, DOI 10.2307/4591852; Campbell CAR, 1925, BATS MOSQUITOES DOLL; Cestari TF, 2005, CLIN DERMATOL, V23, P545, DOI 10.1016/j.clindermatol.2005.01.013; Chandler A.C., 1936, INTRO HUMAN PARASITO; Churchill TP, 1930, J AMER MED ASSOC, V95, P1975, DOI 10.1001/jama.1930.27210260001007b; COLBY FM, 1900, INT YB; COOPER DL, 1948, JAMA-J AM MED ASSOC, V138, P1206; COOPER R, 2004, MALLIS HDB PEST CONT, P494; CRISSEY JT, 1981, INT J DERMATOL, V20, P411, DOI 10.1111/j.1365-4362.1981.tb02004.x; Cuenca BS., 1935, J ALLERGY, V6, P397; Curtis C. F., 2003, Journal of Vector Borne Diseases, V40, P1; DESHAZO RD, 1984, J ALLERGY CLIN IMMUN, V74, P841, DOI 10.1016/0091-6749(84)90188-X; DOANE RW, 2010, INSECTS DIS; Doggett S, 2004, ENVIRON HEALTH-GLOB, V4, P30; EDWARDS JF, 1892, ANN HYG, V7, P675; ELMASRY SA, 1990, J EGYPT PUBLIC HLTH, V55, P230; Elston DM, 2000, CUTIS, V65, P262; FANTHAM HB, 1916, ANIMAL PARASITES MAN; Fletcher CL, 2002, CLIN EXP DERMATOL, V27, P74, DOI 10.1046/j.0307-6938.2001.00967.x; Gbakima A A, 2002, West Afr J Med, V21, P268; Goddard J, 2003, INFECT MED, V20, P473; Goddard J, 2008, SOUTH MED J, V101, P854, DOI 10.1097/SMJ.0b013e31817be9db; HAMBURGER F, 1937, ACTA PAEDIATR, V22, P420; Harlan Harold J., 2006, American Entomologist, V52, P99; HECT O, 1930, ZOOL ANZ, V87, P94; Honig P J, 1986, Pediatr Dermatol, V3, P189, DOI 10.1111/j.1525-1470.1986.tb00512.x; HU XY, 1984, CHINESE MED J-PEKING, V97, P928; Hwang SW, 2005, EMERG INFECT DIS, V11, P533, DOI 10.3201/eid1104.041126; Jorg Miguel Eduardo, 1992, Revista da Sociedade Brasileira de Medicina Tropical, V25, P277, DOI 10.1590/S0037-86821992000400012; JUPP PG, 1979, S AFR MED J, V56, P54; JUPP PG, 1991, S AFR MED J, V79, P320; JUPP PG, 1987, AIDS, V1, P171; JUPP PG, 1978, S AFR MED J, V53, P598; KEMPER H., 1929, Zeitschrift fur Desinfektion, V21, P61; Kemper H, 1936, Z KLEINTIERK PELZTIE, V12, P1; KING F, 1989, PARASITOL TODAY, V5, P100, DOI 10.1016/0169-4758(89)90045-8; KINNEAR J, 1948, LANCET, V252, P55, DOI 10.1016/S0140-6736(48)90447-4; Leverkus M, 2006, J INVEST DERMATOL, V126, P91, DOI 10.1038/sj.jid.5700012; Liebold K, 2003, J EUR ACAD DERMATOL, V17, P461, DOI 10.1046/j.1468-3083.2003.00778.x; LINDSAY SW, 1989, MED VET ENTOMOL, V3, P377, DOI 10.1111/j.1365-2915.1989.tb00244.x; Masetti M, 2007, PARASITOL INT, V56, P81, DOI 10.1016/j.parint.2006.12.002; MAY M, 2007, SAN FRANCISCO C 0408, pA1; MAY M, 2007, SAN FRANCISCO C 0408, pA8; MAYANS MV, 1994, LANCET, V343, P761, DOI 10.1016/S0140-6736(94)91838-4; McKIEL J. A., 1961, Pcdiat. Clin. N. Amer, V8, P795; Meek Frank, 2008, Behav Healthc, V28, P28; Mouchtouri VA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-100; Mumcuoglu KY, 2008, ISR MED ASSOC J, V10, P388; NELSON G S, 1963, Trans R Soc Trop Med Hyg, V57, P149, DOI 10.1016/0035-9203(63)90032-4; NEWBERRY K, 1991, MED VET ENTOMOL, V5, P503, DOI 10.1111/j.1365-2915.1991.tb00579.x; OGSTON CW, 1979, J INFECT DIS, V140, P411, DOI 10.1093/infdis/140.3.411; OGSTON CW, 1980, T ROY SOC TROP MED H, V74, P823, DOI 10.1016/0035-9203(80)90216-3; Oswalt ML, 2007, IMMUNOL ALLERGY CLIN, V27, P177, DOI 10.1016/j.iac.2007.03.004; PARSONS D J, 1955, Ohio State Med J, V51, P669; Patton W.S., 1913, TXB MED ENTOMOLOGY; PATTON WS, 1929, INSECTS TICKS VENO 1; PINTO L, 2008, BED BUG HDB COMPLETE; Potter Michael F., 2006, American Entomologist, V52, P102; Quarles W., 2007, IPM Practitioner, V29, P1; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; ROOK A, 1961, PEDIATR CLIN N AM, V8, P817; ROTHBERG AD, 1994, LANCET, V344, P125, DOI 10.1016/S0140-6736(94)91308-0; Ryan Nathan, 2004, N S W Public Health Bull, V15, P215; RYCKMAN R E, 1985, Bulletin of the Society of Vector Ecologists, V10, P122; Ryckman R.E., 1979, CALIFORNIA VECTOR VIEWS, V26, P25; RYCKMAN R E, 1981, Bulletin of the Society of Vector Ecologists, V6, P93; Ryckman R.E., 1979, CALIFORNIA VECTOR VIEWS, V26, P1; SANSOM JE, 1992, ARCH DERMATOL, V128, P272, DOI 10.1001/archderm.128.2.272; Scarupa MD, 2006, J ALLERGY CLIN IMMUN, V117, P1508, DOI 10.1016/j.jaci.2006.03.034; Sharma SK, 2006, J MED ENTOMOL, V43, P884, DOI 10.1603/0022-2585(2006)43[884:WRABOO]2.0.CO;2; Silverman AL, 2001, AM J GASTROENTEROL, V96, P2194, DOI 10.1111/j.1572-0241.2001.03955.x; STERNBERG LOUIS, 1929, MED JOUR & REC, V129, P622; Stucki A, 2008, NEW ENGL J MED, V359, P1047, DOI 10.1056/NEJMicm060268; TAYLOR P, 1980, CENT AFR J MED, V26, P198; Temu EA, 1999, MED VET ENTOMOL, V13, P457, DOI 10.1046/j.1365-2915.1999.00194.x; Ter Poorten MC, 2005, PEDIATR DERMATOL, V22, P183, DOI 10.1111/j.1525-1470.2005.22301.x; Tharakaram S, 1999, CLIN EXP DERMATOL, V24, P241, DOI 10.1046/j.1365-2230.1999.00467.x; Usinger R. L., 1966, MONOGRAPH CIMICIDAE, VVII; Valenzuela JG, 1998, J EXP BIOL, V201, P2659; Valenzuela JG, 1996, EXP PARASITOL, V83, P184, DOI 10.1006/expr.1996.0065; Valenzuela JG, 1998, J BIOL CHEM, V273, P30583, DOI 10.1074/jbc.273.46.30583; WEBB PA, 1989, J INFECT DIS, V160, P970, DOI 10.1093/infdis/160.6.970; WILLS W, 1977, LANCET, V2, P217	95	222	232	4	75	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 1	2009	301	13					1358	1366		10.1001/jama.2009.405	http://dx.doi.org/10.1001/jama.2009.405			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426LM	19336711	Bronze			2022-12-28	WOS:000264709800025
J	Gelbart, WM; Knobler, CM				Gelbart, William M.; Knobler, Charles M.			Pressurized Viruses	SCIENCE			English	Editorial Material							EJECTION FORCES; DNA EJECTION; MOTOR		[Gelbart, William M.; Knobler, Charles M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Gelbart, WM (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	gelbart@chem.ucla.edu						EARNSHAW WC, 1977, NATURE, V268, P598, DOI 10.1038/268598a0; Evilevitch A, 2003, P NATL ACAD SCI USA, V100, P9292, DOI 10.1073/pnas.1233721100; Fuller DN, 2007, J MOL BIOL, V373, P1113, DOI 10.1016/j.jmb.2007.09.011; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P16868, DOI 10.1073/pnas.0704008104; Gaussier H, 2006, J MOL BIOL, V357, P1154, DOI 10.1016/j.jmb.2006.01.013; Grayson P, 2006, VIROLOGY, V348, P430, DOI 10.1016/j.virol.2006.01.003; Grayson P, 2007, CURR OPIN MICROBIOL, V10, P401, DOI 10.1016/j.mib.2007.04.004; Kindt J, 2001, P NATL ACAD SCI USA, V98, P13671, DOI 10.1073/pnas.241486298; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Mangenot S, 2005, CURR BIOL, V15, P430, DOI 10.1016/j.cub.2004.12.080; Michel JP, 2006, P NATL ACAD SCI USA, V103, P6184, DOI 10.1073/pnas.0601744103; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; RAU DC, 1992, BIOPHYS J, V61, P246, DOI 10.1016/S0006-3495(92)81831-3; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Tzlil S, 2003, BIOPHYS J, V84, P1616, DOI 10.1016/S0006-3495(03)74971-6	15	76	76	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1682	1683		10.1126/science.1170645	http://dx.doi.org/10.1126/science.1170645			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325104				2022-12-28	WOS:000264559800026
J	Hirsch, C; Gauss, R; Horn, SC; Neuber, O; Sommer, T				Hirsch, Christian; Gauss, Robert; Horn, Sabine C.; Neuber, Oliver; Sommer, Thomas			The ubiquitylation machinery of the endoplasmic reticulum	NATURE			English	Review							ER-ASSOCIATED DEGRADATION; UNFOLDED PROTEIN RESPONSE; ANCHORED UBIQUITIN LIGASE; MANNOSIDASE-LIKE PROTEIN; N-LINKED GLYCANS; QUALITY-CONTROL; MEMBRANE-PROTEIN; SACCHAROMYCES-CEREVISIAE; MISFOLDED GLYCOPROTEINS; ALPHA-MANNOSIDASE	As proteins travel through the endoplasmic reticulum (ER), a quality-control system retains newly synthesized polypeptides and supports their maturation. Only properly folded proteins are released to their designated destinations. Proteins that cannot mature are left to accumulate, impairing the function of the ER. To maintain homeostasis, the protein-quality-control system singles out aberrant polypeptides and delivers them to the cytosol, where they are destroyed by the proteasome. The importance of this pathway is evident from the growing list of pathologies associated with quality-control defects in the ER.	[Hirsch, Christian; Gauss, Robert; Horn, Sabine C.; Neuber, Oliver; Sommer, Thomas] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Sommer, T (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	tsommer@mdc-berlin.de			German Research Foundation (DFG); Boehringer Ingelheim Fonds; Helmholtz PhD fellowship	German Research Foundation (DFG)(German Research Foundation (DFG)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Helmholtz PhD fellowship	We thank all members of the Sommer laboratory for critical reading of the manuscript. We apologize to those authors whose work could not be cited because of space limitations. Work in T. S.'s laboratory is supported by the German Research Foundation (DFG) and the RUBICON Network of Excellence. R. G. was a fellow of the Boehringer Ingelheim Fonds. S. C. H. is the recipient of a Helmholtz PhD fellowship.	Avezov E, 2008, MOL BIOL CELL, V19, P216, DOI 10.1091/mbc.E07-05-0505; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; CAMIRAND A, 1991, J BIOL CHEM, V266, P15120; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Cattaneo M, 2008, J CELL PHYSIOL, V215, P794, DOI 10.1002/jcp.21364; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Daniels R, 2003, MOL CELL, V11, P79, DOI 10.1016/S1097-2765(02)00821-3; de Virgilio M, 1998, J BIOL CHEM, V273, P9734, DOI 10.1074/jbc.273.16.9734; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; DEVERAUX Q, 1995, J BIOL CHEM, V270, P23726, DOI 10.1074/jbc.270.40.23726; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; Hammarstrom P, 2003, BIOCHEMISTRY-US, V42, P6656, DOI 10.1021/bi027319b; Hampton RY, 2002, ANNU REV CELL DEV BI, V18, P345, DOI 10.1146/annurev.cellbio.18.032002.131219; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Jakob CA, 2001, EMBO REP, V2, P423; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; JELINEKKELLY S, 1988, J BIOL CHEM, V263, P14757; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liang J, 2006, J CELL SCI, V119, P4011, DOI 10.1242/jcs.03163; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Moremen KW, 2006, CURR OPIN STRUC BIOL, V16, P592, DOI 10.1016/j.sbi.2006.08.005; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Nadav E, 2003, BIOCHEM BIOPH RES CO, V303, P91, DOI 10.1016/S0006-291X(03)00279-1; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Olivari S, 2007, FEBS LETT, V581, P3658, DOI 10.1016/j.febslet.2007.04.070; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Sekijima Y, 2003, LAB INVEST, V83, P409, DOI 10.1097/01.LAB.0000059937.11023.1F; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Shamu CE, 2001, MOL BIOL CELL, V12, P2546, DOI 10.1091/mbc.12.8.2546; Shen YX, 2006, BIOCHEM BIOPH RES CO, V349, P1285, DOI 10.1016/j.bbrc.2006.08.173; Solda T, 2007, MOL CELL, V27, P238, DOI 10.1016/j.molcel.2007.05.032; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Suzuki T, 2001, J BIOL CHEM, V276, P21601, DOI 10.1074/jbc.M100826200; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tremblay LO, 1999, GLYCOBIOLOGY, V9, P1073, DOI 10.1093/glycob/9.10.1073; Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	99	278	283	3	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					453	460		10.1038/nature07962	http://dx.doi.org/10.1038/nature07962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19325625				2022-12-28	WOS:000264532400034
J	Tobian, AAR; Serwadda, D; Quinn, TC; Kigozi, G; Gravitt, PE; Laeyendecker, O; Charvat, B; Ssempijja, V; Riedesel, M; Oliver, AE; Nowak, RG; Moulton, LH; Chen, MZ; Reynolds, SJ; Wawer, MJ; Gray, RH				Tobian, Aaron A. R.; Serwadda, David; Quinn, Thomas C.; Kigozi, Godfrey; Gravitt, Patti E.; Laeyendecker, Oliver; Charvat, Blake; Ssempijja, Victor; Riedesel, Melissa; Oliver, Amy E.; Nowak, Rebecca G.; Moulton, Lawrence H.; Chen, Michael Z.; Reynolds, Steven J.; Wawer, Maria J.; Gray, Ronald H.			Male Circumcision for the Prevention of HSV-2 and HPV Infections and Syphilis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SIMPLEX-VIRUS TYPE-2; SEXUALLY-TRANSMITTED INFECTIONS; HUMAN-PAPILLOMAVIRUS INFECTION; HIV-INFECTION; GENITAL HERPES; CERVICAL-CANCER; MEN; RAKAI; PREVALENCE; RISK	Background Male circumcision significantly reduced the incidence of human immunodeficiency virus (HIV) infection among men in three clinical trials. We assessed the efficacy of male circumcision for the prevention of herpes simplex virus type 2 (HSV-2) and human papillomavirus (HPV) infections and syphilis in HIV-negative adolescent boys and men. Methods We enrolled 5534 HIV-negative, uncircumcised male subjects between the ages of 15 and 49 years in two trials of male circumcision for the prevention of HIV and other sexually transmitted infections. Of these subjects, 3393 (61.3%) were HSV-2-seronegative at enrollment. Of the seronegative subjects, 1684 had been randomly assigned to undergo immediate circumcision (intervention group) and 1709 to undergo circumcision after 24 months (control group). At baseline and at 6, 12, and 24 months, we tested subjects for HSV-2 and HIV infection and syphilis, along with performing physical examinations and conducting interviews. In addition, we evaluated a subgroup of subjects for HPV infection at baseline and at 24 months. Results At 24 months, the cumulative probability of HSV-2 seroconversion was 7.8% in the intervention group and 10.3% in the control group (adjusted hazard ratio in the intervention group, 0.72; 95% confidence interval [CI], 0.56 to 0.92; P = 0.008). The prevalence of high-risk HPV genotypes was 18.0% in the intervention group and 27.9% in the control group (adjusted risk ratio, 0.65; 95% CI, 0.46 to 0.90; P = 0.009). However, no significant difference between the two study groups was observed in the incidence of syphilis (adjusted hazard ratio, 1.10; 95% CI, 0.75 to 1.65; P = 0.44). Conclusions In addition to decreasing the incidence of HIV infection, male circumcision significantly reduced the incidence of HSV-2 infection and the prevalence of HPV infection, findings that underscore the potential public health benefits of the procedure. (ClinicalTrials.gov numbers, NCT00425984 and NCT00124878.)	[Tobian, Aaron A. R.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Quinn, Thomas C.; Laeyendecker, Oliver; Oliver, Amy E.; Reynolds, Steven J.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Gravitt, Patti E.; Nowak, Rebecca G.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol & Mol Microbiol & Immunol, Baltimore, MD USA; [Charvat, Blake; Chen, Michael Z.; Wawer, Maria J.; Gray, Ronald H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Moulton, Lawrence H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth & Biostat, Baltimore, MD USA; [Serwadda, David] Makerere Univ, Inst Publ Hlth, Kampala, Uganda; [Kigozi, Godfrey; Ssempijja, Victor] Rakai Hlth Sci Program, Entebbe, Uganda; [Quinn, Thomas C.; Laeyendecker, Oliver; Riedesel, Melissa; Reynolds, Steven J.] NIAID, Div Intramural Res, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Makerere University; Rakai Health Sciences Program; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Quinn, TC (corresponding author), Rangos Bldg,Rm 530,855 N Wolfe St, Baltimore, MD 21205 USA.	tquinn@jhmi.edu	Hug, Balthasar L./G-1568-2010; Laeyendecker, Oliver B/B-9331-2009	Reynolds, Steven/0000-0002-5403-2759; Laeyendecker, Oliver/0000-0002-6429-4760; Moulton, Lawrence/0000-0001-7041-7387	National Institutes of Health [U01-AI-51171]; Bill and Melinda Gates Foundation [22006.02]; Fogarty International Center [5D43TW001508, D43TW00015]; Intramural Research Program of the National Institute of Allergy and Infectious Diseases; FOGARTY INTERNATIONAL CENTER [D43TW001508, T22TW000015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000358, ZIAAI000361, U01AI051171, ZIAAI001040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Intramural Research Program of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the National Institutes of Health (U01-AI-51171), the Bill and Melinda Gates Foundation (22006.02), and the Fogarty International Center (5D43TW001508 and D43TW00015) and by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2001, AIDS, V15, pS31, DOI 10.1097/00002030-200108004-00004; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; Auvert B, 2006, PLOS MED, V3, P705, DOI 10.1371/journal.pmed.0030226; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Baldwin SB, 2003, J INFECT DIS, V187, P1064, DOI 10.1086/368220; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; BWAYO J, 1994, ARCH INTERN MED, V154, P1391, DOI 10.1001/archinte.154.12.1391; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; COOK LS, 1994, AM J PUBLIC HEALTH, V84, P197, DOI 10.2105/AJPH.84.2.197; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; COREY L, 1983, ANN INTERN MED, V98, P958, DOI 10.7326/0003-4819-98-6-958; Corey L, 2000, JAMA-J AM MED ASSOC, V283, P791, DOI 10.1001/jama.283.6.791; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; Fenton KA, 2008, LANCET INFECT DIS, V8, P244, DOI 10.1016/S1473-3099(08)70065-3; Gamiel JL, 2008, CLIN VACCINE IMMUNOL, V15, P888, DOI 10.1128/CVI.00453-07; Gravitt PE, 1998, J CLIN MICROBIOL, V36, P3020, DOI 10.1128/JCM.36.10.3020-3027.1998; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Gray R, 2004, AIDS, V18, P2428; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.069; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Lavreys L, 1999, J INFECT DIS, V180, P330, DOI 10.1086/314884; McCoombe SG, 2006, AIDS, V20, P1491, DOI 10.1097/01.aids.0000237364.11123.98; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Reynolds SJ, 2004, LANCET, V363, P1039, DOI 10.1016/S0140-6736(04)15840-6; Serwadda D, 2003, J INFECT DIS, V188, P1492, DOI 10.1086/379333; Shin HR, 2004, J INFECT DIS, V190, P468, DOI 10.1086/421279; SOBNGWITAMBEKOU J, 2009, J INFEST DI IN PRESS, V199; Szabo R, 2000, BRIT MED J, V320, P1592, DOI 10.1136/bmj.320.7249.1592; Urassa M, 1997, AIDS, V11, P73, DOI 10.1097/00002030-199701000-00011; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; WAWER M, 2008, P 15 C RETR OPP INF; Weaver BA, 2004, J INFECT DIS, V189, P677, DOI 10.1086/381395; Weiss HA, 2001, AIDS, V15, pS97, DOI 10.1097/00002030-200108004-00011; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9; Xu F, 2007, SEX TRANSM DIS, V34, P479, DOI 10.1097/01.olq.0000253335.41841.04	41	345	370	1	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2009	360	13					1298	1309		10.1056/NEJMoa0802556	http://dx.doi.org/10.1056/NEJMoa0802556			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423VP	19321868	Green Accepted			2022-12-28	WOS:000264524100005
J	Vance, D; Teagle, DAH; Foster, GL				Vance, Derek; Teagle, Damon A. H.; Foster, Gavin L.			Variable Quaternary chemical weathering fluxes and imbalances in marine geochemical budgets	NATURE			English	Article							ISOTOPE SYSTEMATICS; EARLY HOLOCENE; SEA-LEVEL; SOIL AGE; STRONTIUM; RATES; EROSION; OCEAN; PLEISTOCENE; EVOLUTION	Rivers are the dominant source of many elements and isotopes to the ocean. But this input from the continents is not balanced by the loss of the elements and isotopes through hydrothermal and sedimentary exchange with the oceanic crust, or by temporal changes in the marine inventory for elements that are demonstrably not in steady state(1-4). To resolve the problem of the observed imbalance in marine geochemical budgets, attention has been focused on uncertainties in the hydrothermal and sedimentary fluxes(1-4). In recent Earth history, temporally dynamic chemical weathering fluxes from the continents are an inevitable consequence of periodic glaciations(5-9). Chemical weathering rates on modern Earth are likely to remain far from equilibrium owing to the physical production of finely ground material at glacial terminations(10-13) that acts as a fertile substrate for chemical weathering. Here we explore the implications of temporal changes in the riverine chemical weathering flux for oceanic geochemical budgets. We contend that the riverine flux obtained from observations of modern rivers is broadly accurate, but not representative of time-scales appropriate for elements with oceanic residence longer than Quaternary glacial-interglacial cycles. We suggest that the pulse of rapid chemical weathering initiated at the last deglaciation has not yet decayed away and that weathering rates remain about two to three times the average for an entire late Quaternary glacial cycle. Taking into account the effect of the suggested non-steady-state process on the silicate weathering flux helps to reconcile the modelled marine strontium isotope budget with available data. Overall, we conclude that consideration of the temporal variability in riverine fluxes largely ameliorates long-standing problems with chemical and isotopic mass balances in the ocean.	[Vance, Derek; Foster, Gavin L.] Univ Bristol, Dept Earth Sci, Bristol Isotope Grp, Bristol BS8 1RJ, Avon, England; [Teagle, Damon A. H.] Univ Southampton, Natl Oceanog Ctr, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England	University of Bristol; NERC National Oceanography Centre; University of Southampton	Vance, D (corresponding author), Univ Bristol, Dept Earth Sci, Bristol Isotope Grp, Wills Mem Bldg, Bristol BS8 1RJ, Avon, England.	d.vance@bristol.ac.uk	Foster, Gavin/W-5968-2019; Foster, Gavin/CAF-4654-2022	Foster, Gavin/0000-0003-3688-9668	Blaustein Visiting Research Professorship at Stanford; Natural Environment Research Council [NER/T/S/2003/00048, NE/E001971/1] Funding Source: researchfish; NERC [NE/E001971/1] Funding Source: UKRI	Blaustein Visiting Research Professorship at Stanford; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank H. Palike, M. Palmer, C. Hawkesworth, T. Elliott, D. Schmidt, M. Gutjahr and M. Andersen for reading and improving an earlier version of this paper, and J. Phillips for help with a statistics problem. This work was done while D. V. held a Blaustein Visiting Research Professorship at Stanford.	Anderson SP, 2007, ANNU REV EARTH PL SC, V35, P375, DOI 10.1146/annurev.earth.35.031306.140033; BELL M, 1985, QUATERNARY RES, V23, P154, DOI 10.1016/0033-5894(85)90026-2; Blum JD, 1997, GEOCHIM COSMOCHIM AC, V61, P3193, DOI 10.1016/S0016-7037(97)00148-8; Clark PU, 2006, QUATERNARY SCI REV, V25, P3150, DOI 10.1016/j.quascirev.2006.07.008; Davis AC, 2003, EARTH PLANET SC LETT, V211, P173, DOI 10.1016/S0012-821X(03)00191-2; Dosseto A, 2008, EARTH PLANET SC LETT, V265, P1, DOI 10.1016/j.epsl.2007.10.023; Elderfield H, 1996, ANNU REV EARTH PL SC, V24, P191, DOI 10.1146/annurev.earth.24.1.191; Foster GL, 2006, NATURE, V444, P918, DOI 10.1038/nature05365; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Galy A, 1999, GEOCHIM COSMOCHIM AC, V63, P1905, DOI 10.1016/S0016-7037(99)00081-2; Goodbred SL, 2000, GEOLOGY, V28, P1083, DOI 10.1130/0091-7613(2000)28<1083:EGSDDS>2.0.CO;2; Harlavan Y, 1998, GEOCHIM COSMOCHIM AC, V62, P33, DOI 10.1016/S0016-7037(97)00328-1; HENDERSON GM, 1994, EARTH PLANET SC LETT, V128, P643, DOI 10.1016/0012-821X(94)90176-7; Hinderer M, 2001, GEODIN ACTA, V14, P231, DOI 10.1016/S0985-3111(01)01070-1; HODELL DA, 1989, EARTH PLANET SC LETT, V92, P165, DOI 10.1016/0012-821X(89)90044-7; Holland HD, 2005, AM J SCI, V305, P220, DOI 10.2475/ajs.305.3.220; Millot R, 2002, EARTH PLANET SC LETT, V196, P83, DOI 10.1016/S0012-821X(01)00599-4; Nielsen SG, 2006, EARTH PLANET SC LETT, V251, P120, DOI 10.1016/j.epsl.2006.09.002; Oxburgh R, 2007, EARTH PLANET SC LETT, V263, P246, DOI 10.1016/j.epsl.2007.08.033; PALMER MR, 1989, EARTH PLANET SC LETT, V92, P11, DOI 10.1016/0012-821X(89)90017-4; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Peucker-Ehrenbrink B, 1998, GEOCHIM COSMOCHIM AC, V62, P3193, DOI 10.1016/S0016-7037(98)00227-0; Porder S, 2007, EARTH PLANET SC LETT, V258, P414, DOI 10.1016/j.epsl.2007.03.047; Stoll HM, 1998, GEOCHIM COSMOCHIM AC, V62, P1107, DOI 10.1016/S0016-7037(98)00042-8; TAYLOR A, 1995, GEOLOGY, V23, P979, DOI 10.1130/0091-7613(1995)023<0979:RBSAAS>2.3.CO;2; Teagle DAH, 2003, EARTH PLANET SC LETT, V210, P81, DOI 10.1016/S0012-821X(03)00126-2; THOMAS MF, 1995, QUATERNARY SCI REV, V14, P193, DOI 10.1016/0277-3791(95)00004-9; Tipper ET, 2006, EARTH PLANET SC LETT, V250, P241, DOI 10.1016/j.epsl.2006.07.037; West AJ, 2005, EARTH PLANET SC LETT, V235, P211, DOI 10.1016/j.epsl.2005.03.020; White AF, 2003, CHEM GEOL, V202, P479, DOI 10.1016/j.chemgeo.2003.03.001	30	173	176	2	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					493	496		10.1038/nature07828	http://dx.doi.org/10.1038/nature07828			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19325631				2022-12-28	WOS:000264532400041
J	Rahighi, S; Ikeda, F; Kawasaki, M; Akutsu, M; Suzuki, N; Kato, R; Kensche, T; Uejima, T; Bloor, S; Komander, D; Randow, F; Wakatsuki, S; Dikic, I				Rahighi, Simin; Ikeda, Fumiyo; Kawasaki, Masato; Akutsu, Masato; Suzuki, Nobuhiro; Kato, Ryuichi; Kensche, Tobias; Uejima, Tamami; Bloor, Stuart; Komander, David; Randow, Felix; Wakatsuki, Soichi; Dikic, Ivan			Specific Recognition of Linear Ubiquitin Chains by NEMO Is Important for NF-kappa B Activation	CELL			English	Article							ANHIDROTIC ECTODERMAL DYSPLASIA; POLYUBIQUITIN CHAINS; CONJUGATING ENZYME; BINDING DOMAINS; IKK-GAMMA; COMPLEX; IMMUNODEFICIENCY; TURNOVER; REQUIRES; REVEALS	Activation of nuclear factor-kappa B (NF-kappa B), a key mediator of inducible transcription in immunity, requires binding of NF-kappa B essential modulator (NEMO) to ubiquitinated substrates. Here, we report that the UBAN (ubiquitin binding in ABIN and NEMO) motif of NEMO selectively binds linear (head-to-tail) ubiquitin chains. Crystal structures of the UBAN motif revealed a parallel coiled-coil dimer that formed a heterotetrameric complex with two linear diubiquitin molecules. The UBAN dimer contacted all four ubiquitin moieties, and the integrity of each binding site was required for efficient NF-kappa B activation. Binding occurred via a surface on the proximal ubiquitin moiety and the canonical Ile44 surface on the distal one, thereby providing specificity for linear chain recognition. Residues of NEMO involved in binding linear ubiquitin chains are required for NF-kappa B activation by TNF-alpha and other agonists, providing an explanation for the detrimental effect of NEMO mutations in patients suffering from X-linked ectodermal dysplasia and immunodeficiency.	[Rahighi, Simin; Kawasaki, Masato; Akutsu, Masato; Suzuki, Nobuhiro; Kato, Ryuichi; Uejima, Tamami; Wakatsuki, Soichi] High Energy Accelerator Res Org KEK, Struct Biol Res Ctr, Photon Factory, Inst Mat Struct Sci, Tsukuba, Ibaraki 3050801, Japan; [Rahighi, Simin; Kawasaki, Masato; Akutsu, Masato; Kato, Ryuichi; Wakatsuki, Soichi] Grad Univ Adv Studies, Kanagawa 2400193, Japan; [Ikeda, Fumiyo; Kensche, Tobias; Dikic, Ivan] Univ Frankfurt, Inst Biochem & Cluster Excellence Frankfurt 2, Sch Med, D-60590 Frankfurt, Main, Germany; [Ikeda, Fumiyo; Dikic, Ivan] Mediterranean Inst Life Sci, Tumor Biol Program, Split 21000, Croatia; [Akutsu, Masato; Bloor, Stuart; Komander, David; Randow, Felix] MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Cambridge CB2 0QH, England; [Dikic, Ivan] Univ Split, Dept Immunol, Sch Med, Split 21000, Croatia	High Energy Accelerator Research Organization (KEK); Graduate University for Advanced Studies - Japan; Goethe University Frankfurt; MRC Laboratory Molecular Biology; University of Split	Wakatsuki, S (corresponding author), High Energy Accelerator Res Org KEK, Struct Biol Res Ctr, Photon Factory, Inst Mat Struct Sci, Tsukuba, Ibaraki 3050801, Japan.	soichi.wakatsuki@kek.jp; ivan.dikic@biochem2.de	Ikeda, Fumiyo/AAD-3770-2020; Dikic, Ivan/O-4650-2015; Suzuki, Nobuhiro/M-7238-2015; Uejima, Tamami/C-4128-2017; akutsu, masato/L-4095-2016	Ikeda, Fumiyo/0000-0003-0407-2768; Dikic, Ivan/0000-0001-8156-9511; Suzuki, Nobuhiro/0000-0001-8420-5852; akutsu, masato/0000-0002-9839-3345; Wakatsuki, Soichi/0000-0001-5896-7968; Kato, Ryuichi/0000-0003-2087-2896	Deutsche Forschungsgemeinschaft [EXC115]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Medical Research Council [MC_U105170648, MC_U105192732] Funding Source: researchfish; MRC [MC_U105192732, MC_U105170648] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to Marc Schmidt-Supprian for the NEMO-KOMEFs used in this study. We are thankful to Kazuhiro Iwai for sharing results prior to publication of the manuscripts. We thank Caroline Grabbe, Daniela Hoeller, and the members of our labs for discussions, constructive comments, and critical reading of the manuscript. I. F. is a postdoctoral fellow of the Japan Society for the Promotion of Science. This work was supported by grants from Deutsche Forschungsgemeinschaft, the Cluster of Excellence "Macromolecular Complexes'' of the Goethe University Frankfurt (EXC115) to I. D., and partly by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) to M. K. and Target Protein Research Program of the MEXT to S. W.	Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Blankenship JW, 2009, BIOCHEM J, V417, P149, DOI 10.1042/BJ20081885; Bloor S, 2008, P NATL ACAD SCI USA, V105, P1279, DOI 10.1073/pnas.0706552105; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Cordier F, 2008, J MOL BIOL, V377, P1419, DOI 10.1016/j.jmb.2008.01.048; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Filipe-Santos O, 2006, J EXP MED, V203, P1745, DOI 10.1084/jem.20060085; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Oshima S, 2009, NATURE, V457, P906, DOI 10.1038/nature07575; Puel A, 2004, CURR OPIN IMMUNOL, V16, P34, DOI 10.1016/j.coi.2003.11.013; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	35	545	565	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1098	1109		10.1016/j.cell.2009.03.007	http://dx.doi.org/10.1016/j.cell.2009.03.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303852	Bronze			2022-12-28	WOS:000264403900015
J	Geisler, JH; Theodor, JM				Geisler, Jonathan H.; Theodor, Jessica M.			Hippopotamus and whale phylogeny	NATURE			English	Letter							ARTIODACTYLS; TREE		[Geisler, Jonathan H.] Georgia So Univ, Dept Geol & Geog, Statesboro, GA 30460 USA; [Geisler, Jonathan H.] Georgia So Univ, Georgia So Museum, Statesboro, GA 30460 USA; [Theodor, Jessica M.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University System of Georgia; Georgia Southern University; University System of Georgia; Georgia Southern University; University of Calgary	Geisler, JH (corresponding author), Georgia So Univ, Dept Geol & Geog, Statesboro, GA 30460 USA.	geislerj@georgiasouthern.edu		Geisler, Jonathan/0000-0002-4880-1152; Theodor, Jessica/0000-0002-5159-7041				ELTRINGHAM SK, 1999, HIPPOS; Gatesy J, 1996, MOL BIOL EVOL, V13, P954, DOI 10.1093/oxfordjournals.molbev.a025663; Gatesy J, 2002, SYST BIOL, V51, P652, DOI 10.1080/10635150290102311; Geisler Jonathan H., 2005, Journal of Mammalian Evolution, V12, P145, DOI 10.1007/s10914-005-4963-8; Geisler Jonathan H., 2007, P19; Goloboff P., 2000, TREE ANAL USING NEW; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Nummela S, 2007, ANAT REC, V290, P716, DOI 10.1002/ar.20528; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Thewissen JGM, 2007, NATURE, V450, P1190, DOI 10.1038/nature06343; WALL WP, 1983, J PALEONTOL, V57, P197	11	53	55	0	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 19	2009	458	7236					E1	E4		10.1038/nature07776	http://dx.doi.org/10.1038/nature07776			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19295550				2022-12-28	WOS:000264285600031
J	Yun, MH; Hiom, K				Yun, Maximina H.; Hiom, Kevin			CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle	NATURE			English	Article							HOMOLOGOUS RECOMBINATION; END RESECTION; MAMMALIAN-CELLS; DAMAGE; BRCA1; CTIP; DOMAINS; PROTEIN; GENE; LINE	The repair of DNA double-strand breaks (DSBs) is tightly regulated during the cell cycle. In G1 phase, the absence of a sister chromatid means that repair of DSBs occurs through non-homologous end-joining or microhomology-mediated end-joining (MMEJ)(1). These pathways often involve loss of DNA sequences at the break site and are therefore error-prone. In late S and G2 phases, even though DNA end-joining pathways remain functional(2), there is an increase in repair of DSBs by homologous recombination, which is mostly error-free(3,4). Consequently, the relative contribution of these different pathways to DSB repair in the cell cycle has a large influence on the maintenance of genetic integrity. It has remained unknown how DSBs are directed for repair by different, potentially competing, repair pathways. Here we identify a role for CtIP (also known as RBBP8) in this process in the avian B-cell line DT40. We establish that CtIP is required not only for repair of DSBs by homologous recombination in S/G2 phase but also for MMEJ in G1. The function of CtIP in homologous recombination, but not MMEJ, is dependent on the phosphorylation of serine residue 327 and recruitment of BRCA1. Cells expressing CtIP protein that cannot be phosphorylated at serine 327 are specifically defective in homologous recombination and have a decreased level of single-stranded DNA after DNA damage, whereas MMEJ remains unaffected. Our data support a model in which phosphorylation of serine 327 of CtIP as cells enter S phase and the recruitment of BRCA1 functions as a molecular switch to shift the balance of DSB repair from error-prone DNA end-joining to error-free homologous recombination.	[Yun, Maximina H.; Hiom, Kevin] MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Hiom, K (corresponding author), MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Hills Rd, Cambridge CB2 0QH, England.	hiom@mrc-lmb.cam.ac.uk		Yun, Maximina/0000-0001-9019-2453	Medical Research Council [MC_U105184300, U.1051.03.005(78826)] Funding Source: Medline; MRC [MC_U105184300] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Chen PL, 2005, MOL CELL BIOL, V25, P3535, DOI 10.1128/MCB.25.9.3535-3542.2005; Endicott JA, 1999, CURR OPIN STRUC BIOL, V9, P738, DOI 10.1016/S0959-440X(99)00038-X; Greenberger JS, 2006, EXP HEMATOL, V34, P46; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Ma JL, 2003, MOL CELL BIOL, V23, P8820, DOI 10.1128/MCB.23.23.8820-8828.2003; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schlegel BP, 2006, CANCER RES, V66, P5181, DOI 10.1158/0008-5472.CAN-05-3209; Simpson LJ, 2003, EMBO J, V22, P1654, DOI 10.1093/emboj/cdg161; Sonoda E, 2001, PHILOS T ROY SOC B, V356, P111, DOI 10.1098/rstb.2000.0755; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tauchi H, 2002, ONCOGENE, V21, P8967, DOI 10.1038/sj.onc.1206136; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004	21	378	386	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					460	U184		10.1038/nature07955	http://dx.doi.org/10.1038/nature07955			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19357644	Green Accepted			2022-12-28	WOS:000266243700053
J	Kelly, JX; Smilkstein, MJ; Brun, R; Wittlin, S; Cooper, RA; Lane, KD; Janowsky, A; Johnson, RA; Dodean, RA; Winter, R; Hinrichs, DJ; Riscoe, MK				Kelly, Jane X.; Smilkstein, Martin J.; Brun, Reto; Wittlin, Sergio; Cooper, Roland A.; Lane, Kristin D.; Janowsky, Aaron; Johnson, Robert A.; Dodean, Rozalia A.; Winter, Rolf; Hinrichs, David J.; Riscoe, Michael K.			Discovery of dual function acridones as a new antimalarial chemotype	NATURE			English	Article							CHLOROQUINE RESISTANCE TRANSPORTER; TRANSMEMBRANE PROTEIN PFCRT; PLASMODIUM-FALCIPARUM; DIGESTIVE VACUOLE; BETA-HEMATIN; IN-VITRO; DRUG; MALARIA; MUTATIONS; MECHANISM	Preventing and delaying the emergence of drug resistance is an essential goal of antimalarial drug development. Monotherapy and highly mutable drug targets have each facilitated resistance, and both are undesirable in effective long-term strategies against multi-drug-resistant malaria. Haem remains an immutable and vulnerable target, because it is not parasite-encoded and its detoxification during haemoglobin degradation, critical to parasite survival, can be subverted by drug-haem interaction as in the case of quinolines and many other drugs(1-5). Here we describe a new antimalarial chemotype that combines the haem-targeting character of acridones, together with a chemosensitizing component that counteracts resistance to quinoline antimalarial drugs. Beyond the essential intrinsic characteristics common to deserving candidate antimalarials ( high potency in vitro against pan-sensitive and multi-drug-resistant Plasmodium falciparum, efficacy and safety in vivo after oral administration, inexpensive synthesis and favourable physicochemical properties), our initial lead, T3.5 (3-chloro-6-(2-diethylamino-ethoxy)-10-(2-diethylamino-ethyl)acridone), demonstrates unique synergistic properties. In addition to 'verapamil-like' chemosensitization to chloroquine and amodiaquine against quinoline-resistant parasites, T3.5 also results in an apparently mechanistically distinct synergism with quinine and with piperaquine. This synergy, evident in both quinoline-sensitive and quinoline-resistant parasites, has been demonstrated both in vitro and in vivo. In summary, this innovative acridone design merges intrinsic potency and resistance-counteracting functions in one molecule, and represents a new strategy to expand, enhance and sustain effective antimalarial drug combinations.	[Kelly, Jane X.; Smilkstein, Martin J.; Janowsky, Aaron; Johnson, Robert A.; Dodean, Rozalia A.; Winter, Rolf; Hinrichs, David J.; Riscoe, Michael K.] Portland VA Med Ctr, Portland, OR 97239 USA; [Kelly, Jane X.; Smilkstein, Martin J.; Dodean, Rozalia A.; Winter, Rolf; Riscoe, Michael K.] Portland State Univ, Dept Chem, Portland, OR 97201 USA; [Smilkstein, Martin J.; Janowsky, Aaron; Johnson, Robert A.; Hinrichs, David J.; Riscoe, Michael K.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Brun, Reto; Wittlin, Sergio] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Cooper, Roland A.; Lane, Kristin D.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Portland State University; Oregon Health & Science University; University of Basel; Swiss Tropical & Public Health Institute; Old Dominion University	Kelly, JX (corresponding author), Portland VA Med Ctr, Portland, OR 97239 USA.	kellyja@ohsu.edu; riscoem@ohsu.edu	Lane, Kristin D./AAS-3596-2020	Lane, Kristin D./0000-0002-4352-0562; Dodean, Rozalia/0000-0001-5002-4607	Merit Review Program of the Department of Veterans Affairs	Merit Review Program of the Department of Veterans Affairs(US Department of Veterans Affairs)	We thank D. Kyle for the gift of P. falciparum parasite Tm90-C2B, and the Malaria Research and Reference Resource Center for supplying P. falciparum parasites D6, Dd2 and 7G8. We thank A. P. Waters and C. J. Janse for the donation of GFP- labelled P. berghei strain ANKA. We thank L. Jones- Brando and R. Yolken for the cytotoxicity (HFF) data. We are grateful to A. Cornea for the confocal imaging. We thank K. Liebman, C. Hudson, S. Burgess and D. Peyton for compound characterization. We acknowledge financial support from the Merit Review Program of the Department of Veterans Affairs. United States patent applications have been filed by the US Department of Veterans Affairs to protect the intellectual property described in this report.	Bhattacharjee AK, 2002, J CHEM INF COMP SCI, V42, P1212, DOI 10.1021/ci0200265; Bhattacharjee AK, 2001, ANTIMICROB AGENTS CH, V45, P2655, DOI 10.1128/AAC.45.9.2655-2657.2001; Biot Christophe, 2006, Infectious Disorders - Drug Targets, V6, P173, DOI 10.2174/187152606784112155; Biot C, 2005, MOL PHARMACEUT, V2, P185, DOI 10.1021/mp0500061; Burgess SJ, 2006, J MED CHEM, V49, P5623, DOI 10.1021/jm060399n; Cooper RA, 2005, ACTA TROP, V94, P170, DOI 10.1016/j.actatropica.2005.04.004; Cooper RA, 2002, MOL PHARMACOL, V61, P35, DOI 10.1124/mol.61.1.35; Cooper RA, 2007, MOL MICROBIOL, V63, P270, DOI 10.1111/j.1365-2958.2006.05511.x; Egan TJ, 2008, MOL BIOCHEM PARASIT, V157, P127, DOI 10.1016/j.molbiopara.2007.11.005; Egan TJ, 2007, CURR OPIN INFECT DIS, V20, P598, DOI 10.1097/QCO.0b013e3282f1673a; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FITCH CD, 1969, P NATL ACAD SCI USA, V64, P1181, DOI 10.1073/pnas.64.4.1181; Fivelman QL, 2004, ANTIMICROB AGENTS CH, V48, P4097, DOI 10.1128/AAC.48.11.4097-4102.2004; Foley M, 1997, INT J PARASITOL, V27, P231, DOI 10.1016/S0020-7519(96)00152-X; Kelly JX, 2007, ANTIMICROB AGENTS CH, V51, P4133, DOI 10.1128/AAC.00669-07; KROGSTAD DJ, 1987, SCIENCE, V238, P1283, DOI 10.1126/science.3317830; Krugliak M, 2002, MOL BIOCHEM PARASIT, V119, P249, DOI 10.1016/S0166-6851(01)00427-3; Kumar S, 2007, LIFE SCI, V80, P813, DOI 10.1016/j.lfs.2006.11.008; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; OLLIARO PL, 1995, PARASITOL TODAY, V11, P294, DOI 10.1016/0169-4758(95)80042-5; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; van Schalkwyk DA, 2006, DRUG RESIST UPDATE, V9, P211, DOI 10.1016/j.drup.2006.09.002; Waller KL, 2003, J BIOL CHEM, V278, P33593, DOI 10.1074/jbc.M302215200; Wellems TE, 2002, SCIENCE, V298, P124, DOI 10.1126/science.1078167; *WHO, 2006, WHOHTMMAL20061108; YAYON A, 1984, EMBO J, V3, P2695, DOI 10.1002/j.1460-2075.1984.tb02195.x	28	146	150	0	39	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					270	273		10.1038/nature07937	http://dx.doi.org/10.1038/nature07937			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	445FR	19357645	Green Accepted			2022-12-28	WOS:000266036100045
J	Sato, T; Vries, RG; Snippert, HJ; van de Wetering, M; Barker, N; Stange, DE; van Es, JH; Abo, A; Kujala, P; Peters, PJ; Clevers, H				Sato, Toshiro; Vries, Robert G.; Snippert, Hugo J.; van de Wetering, Marc; Barker, Nick; Stange, Daniel E.; van Es, Johan H.; Abo, Arie; Kujala, Pekka; Peters, Peter J.; Clevers, Hans			Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche	NATURE			English	Article							SMALL-INTESTINE; EPITHELIAL-CELLS; EXPRESSION; DIFFERENTIATION; PROLIFERATION; INHIBITION; CULTURES; GROWTH; COLON; MICE	The intestinal epithelium is the most rapidly self-renewing tissue in adult mammals. We have recently demonstrated the presence of about six cycling Lgr(5+) stem cells at the bottoms of small-intestinal crypts(1). Here we describe the establishment of long-term culture conditions under which single crypts undergo multiple crypt fission events, while simultanously generating villus-like epithelial domains in which all differentiated cell types are present. Single sorted Lgr(5+) stem cells can also initiate these crypt-villus organoids. Tracing experiments indicate that the Lgr(5+) stem-cell hierarchy is maintained in organoids. We conclude that intestinal crypt-villus units are self-organizing structures, which can be built from a single stem cell in the absence of a non-epithelial cellular niche.	[Sato, Toshiro; Vries, Robert G.; Snippert, Hugo J.; van de Wetering, Marc; Barker, Nick; Stange, Daniel E.; van Es, Johan H.; Clevers, Hans] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Sato, Toshiro; Vries, Robert G.; Snippert, Hugo J.; van de Wetering, Marc; Barker, Nick; Stange, Daniel E.; van Es, Johan H.; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Abo, Arie] Nuvelo Inc, San Carlos, CA 94070 USA; [Kujala, Pekka; Peters, Peter J.] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Netherlands Cancer Institute	Clevers, H (corresponding author), Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@niob.knaw.nl	Barker, Nick/AAS-2774-2020; Stange, Daniel E/O-1837-2015; Barker, Nick/AAE-9833-2021; Barker, Nick/A-5535-2011; van+Es, Johan/ABD-5411-2021; Sato, Toshiro/J-3522-2014	Stange, Daniel E/0000-0003-4246-2230; Barker, Nick/0000-0003-3566-4475; Sato, Toshiro/0000-0001-8353-8137				Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; Dignass AU, 2001, EUR J GASTROEN HEPAT, V13, P763, DOI 10.1097/00042737-200107000-00002; EVANS GS, 1992, J CELL SCI, V101, P219; FUKAMACHI H, 1992, J CELL SCI, V103, P511; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Hofmann C, 2007, GASTROENTEROLOGY, V132, P587, DOI 10.1053/j.gastro.2006.11.017; Kedinger M, 1998, ANN NY ACAD SCI, V859, P1, DOI 10.1111/j.1749-6632.1998.tb11107.x; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC183, DOI 10.1152/ajpcell.1999.277.2.C183; Sasaki T, 2002, EXP CELL RES, V275, P185, DOI 10.1006/excr.2002.5499; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STCLAIR WH, 1985, CELL TISSUE KINET, V18, P255; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6; Yen TH, 2006, STEM CELL REV, V2, P203, DOI 10.1007/s12015-006-0048-1	30	3827	4001	55	591	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					262	U147		10.1038/nature07935	http://dx.doi.org/10.1038/nature07935			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19329995				2022-12-28	WOS:000266036100043
J	Kallander, K; Nsungwa-Sabiiti, J				Kallander, Karin; Nsungwa-Sabiiti, Jesca			Home-based management of malaria in the era of urbanisation	LANCET			English	Editorial Material							SUB-SAHARAN AFRICA; COMBINATION TREATMENT		[Kallander, Karin; Nsungwa-Sabiiti, Jesca] Karolinska Inst, Div Global Hlth, S-17177 Stockholm, Sweden; [Kallander, Karin; Nsungwa-Sabiiti, Jesca] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Nsungwa-Sabiiti, Jesca] Minist Hlth, Child Hlth Div, Kampala, Uganda	Karolinska Institutet; Makerere University	Kallander, K (corresponding author), Karolinska Inst, Div Global Hlth, S-17177 Stockholm, Sweden.	Karin.kallander@ki.se		Kallander, Karin/0000-0002-5778-5780				[Anonymous], 2008, WORLD MAL REP 2008; [Anonymous], 2004, SCAL HOM BAS MAN MAL; D'Alessandro U, 2005, TROP MED INT HEALTH, V10, P1, DOI 10.1111/j.1365-3156.2004.01375.x; Donnelly MJ, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-12; Hopkins H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-134; Keiser J, 2004, AM J TROP MED HYG, V71, P118, DOI 10.4269/ajtmh.2004.71.118; KNUDSEN AB, 1992, B WORLD HEALTH ORGAN, V70, P1; *MED MAL VENT, 2008, UND ANT MARK UG 2007; Pagnoni F, 2005, TROP MED INT HEALTH, V10, P621; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Staedke SG, 2009, LANCET, V373, P1623, DOI 10.1016/S0140-6736(09)60328-7; WHO, 2000, AB DECL ROLL BACK MA	12	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 9	2009	373	9675					1582	1584		10.1016/S0140-6736(09)60359-7	http://dx.doi.org/10.1016/S0140-6736(09)60359-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	445QJ	19362362				2022-12-28	WOS:000266066300006
J	Mummery-Widmer, JL; Yamazaki, M; Stoeger, T; Novatchkova, M; Bhalerao, S; Chen, D; Dietzl, G; Dickson, BJ; Knoblich, JA				Mummery-Widmer, Jennifer L.; Yamazaki, Masakazu; Stoeger, Thomas; Novatchkova, Maria; Bhalerao, Sheetal; Chen, Doris; Dietzl, Georg; Dickson, Barry J.; Knoblich, Juergen A.			Genome-wide analysis of Notch signalling in Drosophila by transgenic RNAi	NATURE			English	Article							CELL-FATE; PROTEIN TRAFFICKING; BOUNDARY FORMATION; GENE; HAIRLESS; LOCALIZATION; NUMB; INTEGRATION; SUPPRESSOR; ENDOCYTOSIS	Genome-wide RNA interference (RNAi) screens have identified near-complete sets of genes involved in cellular processes. However, this methodology has not yet been used to study complex developmental processes in a tissue-specific manner. Here we report the use of a library of Drosophila strains expressing inducible hairpin RNAi constructs to study the Notch signalling pathway during external sensory organ development. We assigned putative loss-of-function phenotypes to 21.2% of the protein-coding Drosophila genes. Using secondary assays, we identified 6 new genes involved in asymmetric cell division and 23 novel genes regulating the Notch signalling pathway. By integrating our phenotypic results with protein interaction data, we constructed a genome-wide, functionally validated interaction network governing Notch signalling and asymmetric cell division. We used clustering algorithms to identify nuclear import pathways and the COP9 signallosome as Notch regulators. Our results show that complex developmental processes can be analysed on a genome-wide level and provide a unique resource for functional annotation of the Drosophila genome.	[Mummery-Widmer, Jennifer L.; Yamazaki, Masakazu; Stoeger, Thomas; Novatchkova, Maria; Bhalerao, Sheetal; Knoblich, Juergen A.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Novatchkova, Maria; Bhalerao, Sheetal; Dietzl, Georg; Dickson, Barry J.] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Chen, Doris] MFPL, Dept Biochem, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Knoblich, JA (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015; Dickson, Barry/AAE-7632-2019	Knoblich, Juergen A/0000-0002-6751-3404; Dickson, Barry/0000-0003-0715-892X; Chen, Doris/0000-0001-8835-0280; Stoeger, Thomas/0000-0002-5540-4278	Austrian Science Fund FWF [P 16629] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; BANG AG, 1991, DEVELOPMENT, V111, P89; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; BRAND AH, 1993, DEVELOPMENT, V118, P401; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Calleja M, 2000, DEVELOPMENT, V127, P3971; Cavodeassi F, 2002, DEVELOPMENT, V129, P3815; Crowner D, 2003, CURR BIOL, V13, P967, DOI 10.1016/S0960-9822(03)00325-7; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dove SK, 2002, CURR BIOL, V12, P885, DOI 10.1016/S0960-9822(02)00891-6; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Gallagher CM, 2006, DEV CELL, V11, P641, DOI 10.1016/j.devcel.2006.09.014; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gho M, 1996, DEVELOPMENT, V122, P1673; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; Meshorer E, 2008, J CELL BIOL, V181, P9, DOI 10.1083/jcb.200802155; Milan M, 2005, DEV DYNAM, V233, P804, DOI 10.1002/dvdy.20384; Milan M, 2001, CELL, V106, P785, DOI 10.1016/S0092-8674(01)00489-5; Mistry H, 2004, MECH DEVELOP, V121, P1495, DOI 10.1016/j.mod.2004.07.007; Nagel AC, 2000, MECH DEVELOP, V94, P3, DOI 10.1016/S0925-4773(00)00319-1; O'Connor-Giles KM, 2003, DEV CELL, V5, P231, DOI 10.1016/S1534-5807(03)00226-0; Pi HW, 2004, P NATL ACAD SCI USA, V101, P8378, DOI 10.1073/pnas.0306010101; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Rozen S, 2000, Methods Mol Biol, V132, P365; Rusten TE, 2006, MOL BIOL CELL, V17, P3989, DOI 10.1091/mbc.E06-03-0239; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; SCHWEISGUTH F, 1994, DEVELOPMENT, V120, P1433; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; Tekotte H, 2002, DEV BIOL, V244, P396, DOI 10.1006/dbio.2002.0612; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104	54	234	245	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					987	U59		10.1038/nature07936	http://dx.doi.org/10.1038/nature07936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19363474	Green Accepted			2022-12-28	WOS:000265412900033
J	Kumar, S; Kanthan, A; Abraham, RD				Kumar, Saurabh; Kanthan, Ajita; Abraham, Robert D.			Where are my testes?	LANCET			English	Editorial Material									[Kumar, Saurabh; Kanthan, Ajita; Abraham, Robert D.] Westmead Hosp, Div Med, Dept Cardiol, Sydney, NSW 2125, Australia	University of Sydney	Kumar, S (corresponding author), Westmead Hosp, Div Med, Dept Cardiol, Hawkesbury Rd, Sydney, NSW 2125, Australia.	drsaurabhkumar@hotmail.com		Kumar, Saurabh/0000-0002-5643-5076				Barber TD, 2006, UROLOGY, V67, P8469, DOI 10.1016/j.urology.2005.10.036; Lapecorella M, 2003, BLOOD COAGUL FIBRIN, V14, P95, DOI 10.1097/00001721-200301000-00017; McKay Damian, 2006, BMC Urol, V6, P17; NOURI A, 1993, ANN PEDIATR-PARIS, V40, P628; Paduch DA, 2008, CURR OPIN UROL, V18, P621, DOI 10.1097/MOU.0b013e32831367c7	5	0	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2009	373	9671					1310	1310		10.1016/S0140-6736(09)60508-0	http://dx.doi.org/10.1016/S0140-6736(09)60508-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432PN	19362678				2022-12-28	WOS:000265146300034
J	Xie, XW; Li, Y; Liu, ZQ; Haruta, M; Shen, WJ				Xie, Xiaowei; Li, Yong; Liu, Zhi-Quan; Haruta, Masatake; Shen, Wenjie			Low-temperature oxidation of CO catalysed by Co3O4 nanorods	NATURE			English	Article							CARBON-MONOXIDE; OXIDE CATALYSTS; SURFACE; POWDERS; OXYGEN; WATER	Low-temperature oxidation of CO, perhaps the most extensively studied reaction in the history of heterogeneous catalysis, is becoming increasingly important in the context of cleaning air and lowering automotive emissions(1,2). Hopcalite catalysts (mixtures of manganese and copper oxides) were originally developed for purifying air in submarines, but they are not especially active at ambient temperatures and are also deactivated by the presence of moisture(3,4). Noble metal catalysts, on the other hand, are water tolerant but usually require temperatures above 100 degrees C for efficient operation(5,6). Gold exhibits high activity at low temperatures and superior stability under moisture, but only when deposited in nanoparticulate form on base transition-metal oxides(7-9). The development of active and stable catalysts without noble metals for low-temperature CO oxidation under an ambient atmosphere remains a significant challenge. Here we report that tricobalt tetraoxide nanorods not only catalyse CO oxidation at temperatures as low as -77 degrees C but also remain stable in a moist stream of normal feed gas. High-resolution transmission electron microscopy demonstrates that the Co3O4 nanorods predominantly expose their {110} planes, favouring the presence of active Co3+ species at the surface. Kinetic analyses reveal that the turnover frequency associated with individual Co3+ sites on the nanorods is similar to that of the conventional nanoparticles of this material, indicating that the significantly higher reaction rate that we have obtained with a nanorod morphology is probably due to the surface richness of active Co3+ sites. These results show the importance of morphology control in the preparation of base transition-metal oxides as highly efficient oxidation catalysts.	[Xie, Xiaowei; Li, Yong; Shen, Wenjie] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Catalysis, Dalian 116023, Peoples R China; [Liu, Zhi-Quan] Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China; [Haruta, Masatake] Tokyo Metropolitan Univ, Grad Sch Urban Environm Sci, Dept Appl Chem, Tokyo 1920397, Japan; [Haruta, Masatake] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; State Key Laboratory of Catalysis, CAS; Chinese Academy of Sciences; Institute of Metal Research, CAS; Tokyo Metropolitan University; Japan Science & Technology Agency (JST)	Shen, WJ (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Catalysis, Dalian 116023, Peoples R China.	shen98@dicp.ac.cn	haruta, masatake/J-6561-2012; Liu, Zhi-Quan/G-4635-2017	Liu, Zhi-Quan/0000-0001-7097-8977; Xie, Xiaowei/0000-0001-6134-5748	National Natural Science Foundation of China; National Basic Research Program of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	We thank C. Li, L. Lin and X. Bao of the Dalian Institute of Chemical Physics, Chinese Academy of Sciences, for their encouragement and discussions. We also acknowledge financial supports for this research work from the National Natural Science Foundation of China and the National Basic Research Program of China.	BEAUFILS JP, 1982, J APPL CRYSTALLOGR, V15, P301, DOI 10.1107/S0021889882012023; Broqvist P, 2002, J CATAL, V210, P198, DOI 10.1006/jcat.2002.3678; CUNNINGHAM DAH, 1994, CATAL LETT, V25, P257, DOI 10.1007/BF00816305; Date M, 2004, ANGEW CHEM INT EDIT, V43, P2129, DOI 10.1002/anie.200453796; Fortunato G, 2001, J MATER CHEM, V11, P905, DOI 10.1039/b007306g; Grillo F, 2004, APPL CATAL B-ENVIRON, V48, P267, DOI 10.1016/j.apcatb.2003.11.003; HARUTA M, 1993, J CATAL, V144, P175, DOI 10.1006/jcat.1993.1322; HARUTA M, 1987, CHEM LETT, P405, DOI 10.1246/cl.1987.405; Heck RM, 2001, APPL CATAL A-GEN, V221, P443, DOI 10.1016/S0926-860X(01)00818-3; Jansson J, 2002, J CATAL, V211, P387, DOI 10.1006/jcat.2002.3738; Jansson J, 2000, J CATAL, V194, P55, DOI 10.1006/jcat.2000.2924; Merrill DR, 1921, J AM CHEM SOC, V43, P1982, DOI 10.1021/ja01442a002; Oh SH, 2007, J CATAL, V245, P35, DOI 10.1016/j.jcat.2006.09.016; Omata K, 1996, APPL CATAL A-GEN, V146, P255, DOI 10.1016/S0926-860X(96)00151-2; PERTI D, 1985, AICHE J, V31, P1420, DOI 10.1002/aic.690310903; Petitto SC, 2008, J MOL CATAL A-CHEM, V281, P49, DOI 10.1016/j.molcata.2007.08.023; Saalfrank JW, 2004, ANGEW CHEM INT EDIT, V43, P2028, DOI 10.1002/anie.200351935; Sharma S, 2008, APPL CATAL A-GEN, V337, P130, DOI 10.1016/j.apcata.2007.10.028; Shelef M, 2000, CATAL TODAY, V62, P35, DOI 10.1016/S0920-5861(00)00407-7; Szegedi A, 2005, CHEM COMMUN, P1441, DOI 10.1039/b416852f; Thormahlen P, 1999, J CATAL, V188, P300, DOI 10.1006/jcat.1999.2665; Trimm DL, 2001, CATAL REV, V43, P31, DOI 10.1081/CR-100104386; Twigg MV, 2007, APPL CATAL B-ENVIRON, V70, P2, DOI 10.1016/j.apcatb.2006.02.029; YAO YY, 1974, J CATAL, V33, P108, DOI 10.1016/0021-9517(74)90250-4; YOON CH, 1988, J CATAL, V113, P267, DOI 10.1016/0021-9517(88)90256-4; ZIOLKOWSKI J, 1991, J MOL CATAL, V67, P199	26	2068	2157	90	2841	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 9	2009	458	7239					746	749		10.1038/nature07877	http://dx.doi.org/10.1038/nature07877			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19360084				2022-12-28	WOS:000265193600037
J	Campbell, BH				Campbell, Bruce H.			The Code	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												bcampbel@mcw.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 8	2009	301	14					1415	1416		10.1001/jama.2009.459	http://dx.doi.org/10.1001/jama.2009.459			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429MN	19351928				2022-12-28	WOS:000264924900001
J	Jack, A				Jack, Andrew			Look after the pennies	BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	Andrew.Jack@ft.com		Jack, Andrew/0000-0001-9679-2898				BUVINIK M, 2009, GLOB FINAN CRIS ASSE; *COMM SOC DET HLTH, 2008, FINAL REP CLOS GAP; *G20 LEADERS, 2009, GLOB PLAN RECOV REF; Jack A., 2009, FINANCIAL TIMES; *UNAIDS LEAD TRANS, 2009, UNAIDS PREPAR FUTURE; *WHO, 2009, FINAN CRIS GLOB HLTH	6	1	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2009	338								b1380	10.1136/bmj.b1380	http://dx.doi.org/10.1136/bmj.b1380			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431ZH	19359308				2022-12-28	WOS:000265102800026
J	Steinberg, MB; Greenhaus, S; Schmelzer, AC; Bover, MT; Foulds, J; Hoover, DR; Carson, JL				Steinberg, Michael B.; Greenhaus, Shelley; Schmelzer, Amy C.; Bover, Michelle T.; Foulds, Jonathan; Hoover, Donald R.; Carson, Jeffrey L.			Triple-Combination Pharmacotherapy for Medically Ill Smokers A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							NICOTINE REPLACEMENT THERAPY; SMOKING-CESSATION; TOBACCO DEPENDENCE; DOUBLE-BLIND; NASAL SPRAY; PATCH; BUPROPION; GUM; INHALER	Background: Smokers with medical illnesses are at particular risk for complications caused by tobacco. Clinical trial data on the effectiveness of triple-combination pharmacotherapy for tobacco dependence treatment in these high-risk smokers are not available. Objective: To evaluate extended duration of a triple-medication combination versus standard-duration therapy with the nicotine patch alone and 6-month abstinence rates in smokers with medical illnesses. Design: Randomized clinical trial from 2005 to 2007. Setting: Single primary care setting. Patients: 127 smokers 18 years or older with predefined medical illnesses were recruited from the local community. Intervention: Participants were allocated by blocked randomization to receive either the nicotine patch alone for a standard 10-week, tapering course (n = 64) or the combination of nicotine patch, nicotine oral inhaler, and bupropion ad libitum (n = 63). Nonstudy staff, who used computer-generated tables, assigned participants by telephone. No study staff had access to the randomization tables before randomization, thus maintaining concealment. Participants and study personnel were not blinded to treatment assignment. Measurements: The primary outcome was 7-day, exhaled carbon monoxide-confirmed point abstinence at 26 weeks after target quit date. Secondary outcomes were the time to first relapse, duration of medication use, and adverse effects of medications. Analyses were conducted on an intention-to-treat basis with participants who were lost to follow-up (patch alone [n = 13] and combination therapy [n = 18]) classified as still smoking. Results: Both treatment groups had similar baseline characteristics. Abstinence rates at 26 weeks were 35% (22 of 63 patients) for the combination group versus 19% (12 of 64 patients) for the patch-alone group (relapse benefit, 16% [95% Cl, 1% to 31%]; P = 0.040). The adjusted odds ratio for abstinence in the combination group was 2.57 (Cl, 1.05 to 6.32; P = 0.041). The median time to relapse was significantly longer in the combination group than in the patch-alone group (65 days vs. 23 days; P = 0.005). Some side effects occurred more frequently in the combination group (for example, insomnia [25% vs. 9%] and anxiety [22% vs. 3%]), but the proportion of participants who discontinued study medications because of adverse events was similar in both groups (6%). Limitations: Approximately 25% of participants were lost to follow-up (proportions were similar between treatment groups). Treatment personnel and participants were unblinded. Conclusion: Flexibly dosed triple-combination pharmacotherapy for up to 6 months was more effective than standard-duration nicotine patch therapy for outpatient smokers with medical illnesses.	[Steinberg, Michael B.] Univ Med & Dent New Jersey, Div Gen Internal Med, Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA; Rutgers State Univ, Sch Publ Hlth, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Steinberg, MB (corresponding author), Univ Med & Dent New Jersey, Div Gen Internal Med, Robert Wood Johnson Med Sch, 125 Paterson St,Suite 2304, New Brunswick, NJ 08903 USA.	michael.steinberg@umdnj.edu	Bover Manderski, Michelle/C-2225-2019; Foulds, Jonathan/AAM-6750-2021	Bover Manderski, Michelle/0000-0003-0000-221X; Foulds, Jonathan/0000-0003-2296-0726	Cancer Institute of New Jersey; Robert Wood Johnson Foundation	Cancer Institute of New Jersey; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	Primary Funding Source: Cancer Institute of New Jersey and Robert Wood Johnson Foundation.	Blondal T, 1999, BRIT MED J, V318, P285, DOI 10.1136/bmj.318.7179.285; Bohadana A, 2000, ARCH INTERN MED, V160, P3128, DOI 10.1001/archinte.160.20.3128; Centers for Disease Control and Prevention (CDC), 2006, MMWR MORB MORTAL WKL, V55, P1194; Cox LS, 2003, CANCER-AM CANCER SOC, V98, P632, DOI 10.1002/cncr.11538; Croghan GA, 2003, NICOTINE TOB RES, V5, P181, DOI 10.1080/1462220031000073252; Croghan IT, 2007, MAYO CLIN PROC, V82, P186, DOI 10.4065/82.2.186; Evins AE, 2007, J CLIN PSYCHOPHARM, V27, P380, DOI 10.1097/01.jcp.0b013e3180ca86fa; FAGERSTROM KO, 1993, PSYCHOPHARMACOLOGY, V111, P271, DOI 10.1007/BF02244941; Fiore MC, 2008, TREATING TOBACCO USE; Foulds J, 2008, ADDICTION, V103, P1379, DOI 10.1111/j.1360-0443.2008.02313.x; Hurt RD, 2002, ADDICT BEHAV, V27, P493, DOI 10.1016/S0306-4603(01)00188-5; JARVIS MJ, 1987, AM J PUBLIC HEALTH, V77, P1435, DOI 10.2105/AJPH.77.11.1435; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; KORNITZER M, 1995, PREV MED, V24, P41, DOI 10.1006/pmed.1995.1006; Kozlowski LT, 2007, ADDICT BEHAV, V32, P2140, DOI 10.1016/j.addbeh.2007.01.030; Murray RP, 1996, CHEST, V109, P438, DOI 10.1378/chest.109.2.438; Puska P., 1995, TOB CONTROL, V4, P231, DOI [DOI 10.1136/TC.4.3.231, 10.1136/tc.4.3.231]; Rock V. J., 2007, Morbidity and Mortality Weekly Report, V56, P1157; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Steinberg MB, 2006, AM J PREV MED, V30, P405, DOI 10.1016/j.amepre.2005.12.008; Steinberg MB, 2006, PREV MED, V42, P114, DOI 10.1016/j.ypmed.2005.11.013; Steinberg MB, 2008, ANN INTERN MED, V148, P554, DOI 10.7326/0003-4819-148-7-200804010-00012; Sweeney CT, 2001, CNS DRUGS, V15, P453, DOI 10.2165/00023210-200115060-00004; Thorndike AN, 2007, AM J PUBLIC HEALTH, V97, P1878, DOI 10.2105/AJPH.2006.092577; US Food and Drug Administration, DRUGS FDA; van Berkel TFM, 1999, EUR HEART J, V20, P1773, DOI 10.1053/euhj.1999.1658	26	61	61	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2009	150	7					447	+		10.7326/0003-4819-150-7-200904070-00004	http://dx.doi.org/10.7326/0003-4819-150-7-200904070-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	432EZ	19349630				2022-12-28	WOS:000265117600002
J	Conde, MB; Efron, A; Laredo, C; De Souza, GRM; Graca, NP; Cezar, MC; Ram, M; Chaudhary, MA; Bishai, WR; Kritski, AL; Chaisson, RE				Conde, Marcus B.; Efron, Anne; Laredo, Carla; Muzy De Souza, Gilvan R.; Graca, Nadja P.; Cezar, Michelle C.; Ram, Malathi; Chaudhary, Mohammad A.; Bishai, William R.; Kritski, Afranio L.; Chaisson, Richard E.			Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial	LANCET			English	Article							EARLY BACTERICIDAL ACTIVITY; PULMONARY TUBERCULOSIS; GATIFLOXACIN; REGIMENS; CULTURE	Background New treatments are needed to shorten the time required to cure tuberculosis and to treat drug-resistant strains. The fluoroquinolone moxifloxacin is a promising new agent that might have additive activity to existing antituberculosis agents. We assessed the activity and safety of moxifloxacin in the initial stage of tuberculosis treatment. Methods We undertook a phase 11, double-blind, randomised controlled trial of a regimen that included moxifloxacin in adults with sputum smear-positive tuberculosis at one hospital in Rio de Janeiro, Brazil. 170 participants received isoniazid, rifampicin, and pyrazinamide at standard doses and were assigned by permuted block randomisation to receive either moxifloxacin (400 mg) with an ethambutol placebo (n=85) or ethambutol (15-20 mg/kg) plus moxifloxacin placebo (n=85) 5 days per week for 8 weeks. The primary endpoint was the proportion of patients whose sputum culture had converted to negative by week 8. Analysis was by modified intention to treat (ITT); patients whose baseline cultures were negative, contaminated, or contained drug-resistant Mycobacterium tuberculosis were excluded from the analysis. Additionally, all missing 8-week results were deemed treatment failures. This study is registered with ClinicalTrials.gov, number NCT00082173. Findings 74 patients assigned to the moxifloxacin group and 72 in the ethambutol group were included in the modified ITT population. 125 patients had 8-week data (moxifloxacin n=64, ethambutol n=61); the main reason for absence of data was culture contamination. At 8 weeks, culture conversion to negative had occurred in 59 (80%) of 74 patients in the moxifloxacin group compared with 45 (63%) of 72 in the ethambutol group (difference 17.2%, 95% Cl 2.8-31.7; p=0.03). There were 16 adverse events (eight in each group) in 12 patients. Only one event was judged related to study drug (grade 3 cutaneous reaction in the ethambutol group). Interpretation Moxifloxacin improved culture conversion in the initial phase of tuberculosis treatment. Trials to assess whether moxifloxacin can be used to shorten the duration of tuberculosis treatment are justified.	[Efron, Anne; Bishai, William R.; Chaisson, Richard E.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21231 USA; [Ram, Malathi; Chaudhary, Mohammad A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Conde, Marcus B.; Laredo, Carla; Muzy De Souza, Gilvan R.; Graca, Nadja P.; Cezar, Michelle C.; Kritski, Afranio L.] Univ Fed Rio de Janeiro, Inst Doencas Torax, Hosp Clementino Fraga Filho, Rio De Janeiro, Brazil	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidade Federal do Rio de Janeiro	Chaisson, RE (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, 1550 Orleans St,1M-08, Baltimore, MD 21231 USA.	rchaiss@jhmi.edu	Kritski, Afranio/I-6760-2016; Conte, Marcus B/A-2501-2013	Conte, Marcus B/0000-0002-7249-4455; kritski, afranio/0000-0002-5900-6007	Office of Orphan Product Development, US Food and Drug Administration [R01FD002135]; Fogarty International Center of the US National Institutes of Health [TW006885]; NIH [01607]; FOGARTY INTERNATIONAL CENTER [U2RTW006885] Funding Source: NIH RePORTER; FOOD AND DRUG ADMINISTRATION [R01FD002135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI001637] Funding Source: NIH RePORTER	Office of Orphan Product Development, US Food and Drug Administration; Fogarty International Center of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by the Office of Orphan Product Development, US Food and Drug Administration (grant number R01FD002135). Additional support for training was provided by the Fogarty International Center of the US National Institutes of Health (grant TW006885 and NIH grant 01607). Moxifloxacin and matching placebo were supplied by Bayer Healthcare, which had no role in the design, conduct, or analysis of the study. A career development grant helped to support REC's participation. We thank the members of our data safety and monitoring board, Reynaldo Dietze (Chair), Leda Jamal, and Ronir Raggio Luiz. We also thank Jacques Grosset, Eric Nuermberger, Andrew Vernon, Fernanda Mello, Susan Dorman, and Richard O'Brien for encouragement and advice; Anna Grazia Marsico and Gisele Betzler de Oliveira Vieira for managing laboratory specimens; and Bonnie S King for assistance with data management. Finally, we thank all the patients who volunteered to participate in this trial.	[Anonymous], 1972, LANCET, V1, P1079; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Burman WJ, 2006, AM J RESP CRIT CARE, V174, P331, DOI 10.1164/rccm.200603-360OC; Chang KC, 2004, AM J RESP CRIT CARE, V170, P1124, DOI 10.1164/rccm.200407-905OC; DORMAN S, 2007, 47 INT C ANT AG CHEM; DYE C, 2002, B WORLD HEALTH ORGAN, V80, P37; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; Gillespie SH, 1999, J ANTIMICROB CHEMOTH, V44, P393, DOI 10.1093/jac/44.3.393; Gillespie SH, 2005, J ANTIMICROB CHEMOTH, V56, P1169, DOI 10.1093/jac/dki376; Gosling RD, 2003, AM J RESP CRIT CARE, V168, P1342, DOI 10.1164/rccm.200305-682OC; *HONG KONG CHEST S, 1978, AM REV RESPIR DIS, V118, P219; Ji BH, 1998, ANTIMICROB AGENTS CH, V42, P2066, DOI 10.1128/AAC.42.8.2066; Jindani A, 2004, LANCET, V364, P1244, DOI 10.1016/S0140-6736(04)17141-9; Johnson JL, 2006, INT J TUBERC LUNG D, V10, P605; Kent PT, 1985, GUIDE LEVEL 3 LAB; KUBICA GP, 1963, AM REV RESPIR DIS, V87, P775; Lounis N, 2001, ANTIMICROB AGENTS CH, V45, P3482, DOI 10.1128/AAC.45.12.3482-3486.2001; MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062; Miyazaki E, 1999, ANTIMICROB AGENTS CH, V43, P85, DOI 10.1128/AAC.43.1.85; Nuermberger EL, 2004, AM J RESP CRIT CARE, V170, P1131, DOI 10.1164/rccm.200407-885OC; Nuermberger EL, 2004, AM J RESP CRIT CARE, V169, P421, DOI 10.1164/rccm.200310-1380OC; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Pletz MWR, 2004, ANTIMICROB AGENTS CH, V48, P780, DOI 10.1128/AAC.48.3.780-782.2004; Rustomjee R, 2008, INT J TUBERC LUNG D, V12, P128; WHO, 2008, GLOBAL TUBERCULOSIS; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614	26	237	249	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2009	373	9670					1183	1189		10.1016/S0140-6736(09)60333-0	http://dx.doi.org/10.1016/S0140-6736(09)60333-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429SO	19345831	Green Accepted			2022-12-28	WOS:000264940600032
J	Jung, HW; Tschaplinski, TJ; Wang, L; Glazebrook, J; Greenberg, JT				Jung, Ho Won; Tschaplinski, Timothy J.; Wang, Lin; Glazebrook, Jane; Greenberg, Jean T.			Priming in Systemic Plant Immunity	SCIENCE			English	Article							ACQUIRED-RESISTANCE; ARABIDOPSIS-THALIANA; SALICYLIC-ACID; SIGNAL; ACCUMULATION; PATHOGEN; TOBACCO	Plants possess inducible systemic defense responses when locally infected by pathogens. Bacterial infection results in the increased accumulation of the mobile metabolite azelaic acid, a nine-carbon dicarboxylic acid, in the vascular sap of Arabidopsis that confers local and systemic resistance against the pathogen Pseudomonas syringae. Azelaic acid primes plants to accumulate salicylic acid (SA), a known defense signal, upon infection. Mutation of the AZELAIC ACID INDUCED 1 (AZI1) gene, which is induced by azelaic acid, results in the specific loss of systemic immunity triggered by pathogen or azelaic acid and of the priming of SA induction in plants. Furthermore, the predicted secreted protein AZI1 is also important for generating vascular sap that confers disease resistance. Thus, azelaic acid and AZI1 are components of plant systemic immunity involved in priming defenses.	[Jung, Ho Won; Greenberg, Jean T.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Tschaplinski, Timothy J.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Wang, Lin; Glazebrook, Jane] Univ Minnesota, Dept Plant Biol, Microbial & Plant Genom Inst, St Paul, MN 55108 USA	University of Chicago; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Minnesota System; University of Minnesota Twin Cities	Greenberg, JT (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 1103 E 57th St EBC410, Chicago, IL 60637 USA.	jgreenbe@midway.uchicago.edu	Wang, Lin/D-4021-2009; Tschaplinski, Timothy/D-6382-2018	Tschaplinski, Timothy/0000-0002-9540-6622; Greenberg, Jean/0000-0002-7213-7618; Glazebrook, Jane/0000-0001-5167-736X	NSF [IOB-0450207, IOB-0419648]; Korea Research Foundation fellowship; Office of Biological and Environmental Research of the U.S. Department of Energy; U.S. Department of Energy [DE-AC05-00OR22725]	NSF(National Science Foundation (NSF)); Korea Research Foundation fellowship(National Research Foundation of Korea); Office of Biological and Environmental Research of the U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This work was funded by NSF grants to J.T.G. (IOB-0450207) and J.G. (IOB-0419648) and by a fellowship from Korea Research Foundation to H.W.J., and T.J.T. was supported by the Office of Biological and Environmental Research of the U.S. Department of Energy. Oak Ridge National Laboratory is managed by UT-Battelle for the U.S. Department of Energy under contract DE-AC05-00OR22725. We thank J. Bergelson and L. Mets for the use of their high-performance liquid chromatographys, F. Katagiri and J. Malamy for useful discussions, R. Cameron for sharing her detailed exudate collection protocol, and N. Engle for analysis of exudates. A patent application related to this work has been filed by the University of Chicago and UT-Battelle on behalf of inventors J.T.G., H.W.J., and T.J.T. on the use of azelaic acid to confer protection in crop plants against infection.	Cameron RK, 1999, PHYSIOL MOL PLANT P, V55, P121, DOI 10.1006/pmpp.1999.0214; Chassot C, 2007, PLANT J, V49, P972, DOI 10.1111/j.1365-313X.2006.03017.x; Chaturvedi R, 2008, PLANT J, V54, P106, DOI 10.1111/j.1365-313X.2007.03400.x; DEAN RA, 1986, PHYTOPATHOLOGY, V76, P966, DOI 10.1094/Phyto-76-966; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; Nandi A, 2004, PLANT CELL, V16, P465, DOI 10.1105/tpc.016907; Park SW, 2007, SCIENCE, V318, P113, DOI 10.1126/science.1147113; Pieterse CMJ, 1998, PLANT CELL, V10, P1571, DOI 10.1105/tpc.10.9.1571; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Sato M, 2007, PLANT J, V49, P565, DOI 10.1111/j.1365-313X.2006.02972.x; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; Vlot AC, 2008, PLANT J, V56, P445, DOI 10.1111/j.1365-313X.2008.03618.x	13	564	592	6	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					89	91		10.1126/science.1170025	http://dx.doi.org/10.1126/science.1170025			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342588				2022-12-28	WOS:000264802100038
J	Jeong, H; Then, F; Melia, TJ; Mazzulli, JR; Cui, L; Savas, JN; Voisine, C; Paganetti, P; Tanese, N; Hart, AC; Yamamoto, A; Krainc, D				Jeong, Hyunkyung; Then, Florian; Melia, Thomas J., Jr.; Mazzulli, Joseph R.; Cui, Libin; Savas, Jeffrey N.; Voisine, Cindy; Paganetti, Paolo; Tanese, Naoko; Hart, Anne C.; Yamamoto, Ai; Krainc, Dimitri			Acetylation Targets Mutant Huntingtin to Autophagosomes for Degradation	CELL			English	Article							INCLUSION-BODY FORMATION; CAENORHABDITIS-ELEGANS; POLYGLUTAMINE EXPANSIONS; IN-VITRO; DISEASE; PROTEIN; DYSFUNCTION; MODEL; AGGREGATION; NEURODEGENERATION	Huntington's disease (HD) is an incurable neurodegenerative disease caused by neuronal accumulation of the mutant protein huntingtin. Improving clearance of the mutant protein is expected to prevent cellular dysfunction and neurodegeneration in HD. We report here that such clearance can be achieved by posttranslational modification of the mutant Huntingtin (Htt) by acetylation at lysine residue 444 (K444). Increased acetylation at K444 facilitates trafficking of mutant Htt into autophagosomes, significantly improves clearance of the mutant protein by macroautophagy, and reverses the toxic effects of mutant huntingtin in primary striatal and cortical neurons and in a transgenic C. elegans model of HD. In contrast, mutant Htt that is rendered resistant to acetylation dramatically accumulates and leads to neurodegeneration in cultured neurons and in mouse brain. These studies identify acetylation as a mechanism for removing accumulated protein in HD, and more broadly for actively targeting proteins for degradation by autophagy.	[Jeong, Hyunkyung; Then, Florian; Mazzulli, Joseph R.; Cui, Libin; Krainc, Dimitri] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat,Dept Neurol, Charlestown, MA 02129 USA; [Voisine, Cindy; Hart, Anne C.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat,Ctr Canc Res, Charlestown, MA 02129 USA; [Melia, Thomas J., Jr.] Yale Univ, Dept Cell Biol, New Haven, CT 06519 USA; [Savas, Jeffrey N.; Tanese, Naoko] New York Univ, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Savas, Jeffrey N.] New York Univ, Sch Med, NYU & NIH Grad Partnership Program Struct Biol, New York, NY 10016 USA; [Paganetti, Paolo] Novartis Pharma AG, NIBR Basel, Neurosci Dis, CH-4002 Basel, Switzerland; [Yamamoto, Ai] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Yale University; New York University; National Institutes of Health (NIH) - USA; New York University; Novartis; Columbia University	Krainc, D (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat,Dept Neurol, Charlestown, MA 02129 USA.	krainc@helix.mgh.harvard.edu	Yamamoto, Ai/D-1100-2011; Paganetti, Paolo/AAF-8039-2020; Voisine, Cindy/AAG-9045-2019	Paganetti, Paolo/0000-0003-1896-6324; Tanese, Naoko/0000-0002-1946-3211; Voisine, Cindy/0000-0001-7165-9636	DFG;  [R01NS050352];  [R01 NS051303];  [R01 NS050199]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050352, R01NS063973, R01NS051303, R01NS050199] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); ; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Drs. K. Kegel, M. DiFiglia, C. D. Allis, A. Basu, H. Park, and A.B. Young and members of the Krainc laboratory for helpful suggestions and comments on the manuscript. We also thank Drs. D. Sarracino, B. Krastins, J. Kowalak, S. Markey, and A. Makusky for help with mass spectrometry; B. Hyman, W. Stoothoff, and C. Lill for help with live-cell imaging; E. Regulier for help with lentiviral transductions; A. Weiss and A. Roscic for help with HN10 cells; H. Ischiropoulos for use of HPLC system; N. Mizushima for Atg5-deficient cells; A. Kazantsev for CBP and CBP Delta Q constructs; Y. Yoshimori for GFP-LC3; G.A. Fitzgerald for p300 and P/CAF; P.W. Faber for osm::Htt564-150Q; and the New York Structural Biology Center for the EM facilities. This work was supported by R01NS050352 and R01 NS051303 (to D.K.) and R01 NS050199 (to A.Y.). F.T. is a fellow of the DFG. Author contributions: H.J. and F.T. contributed equally to this work.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bates EA, 2006, J NEUROSCI, V26, P2830, DOI 10.1523/JNEUROSCI.3344-05.2006; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Faber PW, 1999, P NATL ACAD SCI USA, V96, P179, DOI 10.1073/pnas.96.1.179; Graham RK, 2006, NEUROBIOL DIS, V21, P444, DOI 10.1016/j.nbd.2005.08.007; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hart AC, 1999, J NEUROSCI, V19, P1952; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; LAWRENCE BP, 1993, J CELL SCI, V105, P473; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lunkes A, 1998, HUM MOL GENET, V7, P1355, DOI 10.1093/hmg/7.9.1355; MARZELLA L, 1982, J CELL BIOL, V93, P144, DOI 10.1083/jcb.93.1.144; Mazzulli JR, 2006, J NEUROSCI, V26, P10068, DOI 10.1523/JNEUROSCI.0896-06.2006; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Regulier E, 2003, HUM MOL GENET, V12, P2827, DOI 10.1093/hmg/ddg305; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Stromhaug PE, 1998, BIOCHEM J, V335, P217, DOI 10.1042/bj3350217; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Voisine Cindy, 2004, V277, P141; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Weiss A, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-11; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030	48	296	306	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					60	72		10.1016/j.cell.2009.03.018	http://dx.doi.org/10.1016/j.cell.2009.03.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345187	Bronze, Green Accepted			2022-12-28	WOS:000264813300014
J	Fabian, TC				Fabian, Timothy C.			Whole-body CT in multiple trauma	LANCET			English	Editorial Material									Univ Tennessee, Hlth Sci Ctr, Dept Surg, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Fabian, TC (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Surg, Memphis, TN 38163 USA.	tfabian@utmem.edu						Brenner DJ, 2004, RADIOLOGY, V232, P735, DOI 10.1148/radiol.2323031095; FABIAN TC, 1986, J TRAUMA, V26, P602, DOI 10.1097/00005373-198607000-00003; Hayward R, 2003, BRIT MED J, V326, P1273, DOI 10.1136/bmj.326.7401.1273; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; SHAFTAN GW, 1989, B AM COLL SURG, V74, P21; Snyder GE, 2008, ANN EMERG MED, V52, P101, DOI 10.1016/j.annemergmed.2007.03.023	7	10	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2009	373	9673					1408	1409		10.1016/S0140-6736(09)60354-8	http://dx.doi.org/10.1016/S0140-6736(09)60354-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437QL	19321200				2022-12-28	WOS:000265501900008
J	Macdonald, S; Dixit, A; Wyatt, MG				Macdonald, S.; Dixit, A.; Wyatt, M. G.			Picture quiz "Brain attack"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRANSIENT ISCHEMIC ATTACK; CAROTID STENOSIS; SYMPTOMATIC PATIENTS; ENDARTERECTOMY; STROKE; TRIAL; RISK		[Macdonald, S.; Dixit, A.; Wyatt, M. G.] Newcastle Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne NE7 7TN, Tyne & Wear, England	Newcastle Upon Tyne Hospitals NHS Foundation Trust	Wyatt, MG (corresponding author), Newcastle Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne NE7 7TN, Tyne & Wear, England.	mike.wyatt@nuth.nhs.uk		Wyatt, Michael G/0000-0002-9144-4437				[Anonymous], 1994, STROKE, V25, P2523; Corriveau MM, 2004, J VASC SURG, V39, P735, DOI 10.1016/j.jvs.2003.12.017; DEANE C, 2007, SOC VASC TECHN GREAT; Halliday A, 2004, LANCET, V363, P1491; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; *NAT I HLTH CLIN E, 2007, 233 IPG NAT I HLTH C; National Institutes of Health and Clinical Excellence, 2008, NIC CLIN GUID; OATES CP, 2008, EUR J VASC ENDO 1127; Schulz UG, 2004, STROKE, V35, P2459, DOI 10.1161/01.STR.0000143455.55877.b9; Sen S, 2000, CEREBROVASC DIS, V10, P102, DOI 10.1159/000016038; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Vidjak V, 2007, COLLEGIUM ANTROPOL, V31, P775; Wardlaw JM, 2006, HEALTH TECHNOL ASSES, V10, P1; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P	14	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2009	338								a3109	10.1136/bmj.a3109	http://dx.doi.org/10.1136/bmj.a3109			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429AM	19359302				2022-12-28	WOS:000264893200001
J	Teerlink, JR; Metra, M; Felker, GM; Ponikowski, P; Voors, AA; Weatherley, BD; Marmor, A; Katz, A; Grzybowski, J; Unemori, E; Teichman, SL; Cotter, G				Teerlink, John R.; Metra, Marco; Felker, G. Michael; Ponikowski, Piotr; Voors, Adriaan A.; Weatherley, Beth Davison; Marmor, Alon; Katz, Amos; Grzybowski, Jacek; Unemori, Elaine; Teichman, Sam L.; Cotter, Gad			Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study	LANCET			English	Article							RENAL VASODILATION; PREGNANCY HORMONE; CLINICAL-TRIALS; PEPTIDE; HYPERFILTRATION; HEMODYNAMICS; ANTAGONIST; ENDOTHELIN; TEZOSENTAN; OUTCOMES	Background Most patients admitted for acute heart failure have normal or increase blood pressure. Relaxin is a natural human peptide that affects multiple vascular control pathways, suggesting potential mechanisms of benefit for such patients. We assessed the dose response of relaxin's effect on symptom relief, other clinical outcomes, and safety. Methods In a placebo-controlled, parallel-group, dose-ranging study, 234 patients with acute heart failure, dyspnoea, congestion on chest radiograph, and increased brain natriuretic peptide (BNP) or N-terminal prohormone of BNP, mild-to-moderate renal insufficiency, and systolic blood pressure greater than 125 mm Hg were recruited from 54 sites in eight countries and enrolled within 16 h of presentation. Patients were randomly assigned, in a double-blind manner via a telephone-based interactive voice response system, to standard care plus 48-h intravenous infusion Of placebo (n=62) or relaxin 10 mu g/kg (n=40), 30 mu g/kg (n=43), 100 mu g/kg (n=39), or 250 mu g/kg (n=50) per day. Several clinical endpoints were explored to assess whether intravenous relaxin should be pursued in larger studies of acute heart failure, to identify an optimum dose, and to help to assess endpoint selection and power calculations. Analysis was by modified intention to treat. This study is registered with ClinicalTrials.gov, number NCT00520806. Findings In the modified intention-to-treat population, 61 patients were assessed in the placebo group, 40 in the relaxin 10 mu g/kg per day group, 42 in the relaxin 30 mu g/kg per day group, 37 in the relaxin 100 mu g/kg per day group, and 49 in the relaxin 250 mu g/kg per day group. Dyspnoea improved with relaxin 30 mu g/kg compared with placebo, as assessed by Likert scale (17 of 42 patients [40%] moderately or markedly improved at 6 h, 12 h, and 24 h vs 14 of 61 [23%]; p=0.044) and visual analogue scale through day 14 (8214 mmxh [SD 87121 vs 4622 mmxh [90031; p=0.053). Length of stay was 10.2 days (SD 6.1) for relaxin-treated patients versus 12.0 days (7.3) for those given placebo, and days alive out of hospital were 47.9 (10.1) versus 44.2 (14.2). Cardiovascular death or readmission due to heart or renal failure at day 60 was reduced with relaxin (2.6% [95% Cl 0.4-16.8] vs 17.2% [9.6-29.6]; p=0.053). The number of serious adverse events was similar between groups. Interpretation When given to patients with acute heart failure and normal-to-increased blood pressure, relaxin was associated with favourable relief of dyspnoea and other clinical outcomes, with acceptable safety.	[Teerlink, John R.] Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Metra, Marco] Univ Brescia, Dept Expt & Appl Sci, Sect Cardiovasc Dis, Brescia, Italy; [Felker, G. Michael] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Ponikowski, Piotr] Med Univ, Mil Hosp, Dept Cardiol, Dept Hlth Sci, Wroclaw, Poland; [Voors, Adriaan A.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9713 AV Groningen, Netherlands; [Weatherley, Beth Davison; Cotter, Gad] Momentum Res, Durham, NC USA; [Marmor, Alon] Ziv Med Ctr, Inst Heart, Safed, Israel; [Katz, Amos] Barzilai Govt Hosp, Dept Cardiol, Ashqelon, Israel; [Grzybowski, Jacek] Inst Cardiol, Dept Gen Cardiol, Warsaw, Poland; [Unemori, Elaine; Teichman, Sam L.] Corthera, San Mateo, CA USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of Brescia; Duke University; Wroclaw Medical University; University of Groningen; Ziv Medical Center; Ben Gurion University; Barzilai Medical Center; Institute of Cardiology - Poland	Teerlink, JR (corresponding author), Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, Cardiol 111C,4150 Clemet St, San Francisco, CA 94121 USA.	john.teerlink@ucsf.edu	Felker, Michael/AAX-2288-2021; Katz, Amos/E-6261-2011; Voors, Adriaan/ABE-6784-2020; Teerlink, John R/D-2986-2012; Metra, marco/E-7101-2010; Ponikowski, Piotr/O-6454-2015	Ponikowski, Piotr/0000-0002-3391-7064; Katz, Amos/0000-0003-0422-934X; Cotter, Gad/0000-0002-9613-3339; Felker, Gary/0000-0002-5931-1239; Metra, Marco/0000-0001-6691-8568	Corthera (USA)	Corthera (USA)	The Pre-RELAX-AHF study is supported by Corthera (USA).	ADHERE Scientific Advisory Committee, 2006, AC DEC HEART FAIL NA; Colucci WS, 2000, NEW ENGL J MED, V343, P246, DOI 10.1056/NEJM200007273430403; Conrad KP, 2005, ANN NY ACAD SCI, V1041, P147, DOI 10.1196/annals.1282.022; Conrad KP, 2004, ENDOCRINOLOGY, V145, P3289, DOI 10.1210/en.2003-1612; Cotter G, 2004, EUR J HEART FAIL, V6, P601, DOI 10.1016/j.ejheart.2004.05.004; Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541; Danielson LA, 2003, J APPL PHYSIOL, V95, P1509, DOI 10.1152/japplphysiol.00545.2003; Danielson LA, 2000, AM J PHYSIOL-REG I, V279, pR1298, DOI 10.1152/ajpregu.2000.279.4.R1298; Debrah DO, 2005, HYPERTENSION, V46, P745, DOI 10.1161/01.HYP.0000184230.52059.33; Debrah DO, 2005, J APPL PHYSIOL, V98, P1013, DOI 10.1152/japplphysiol.01083.2004; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Dschietzig T, 2003, CIRC RES, V92, P32, DOI 10.1161/01.RES.0000051884.27117.7E; DSCHIETZIG T, 2009, J CARD FAIL, DOI DOI 10.1016/J.CARDFAIL.2009.1001.1008; Fisher C, 2002, CIRCULATION, V106, P292, DOI 10.1161/01.CIR.0000025630.05387.45; Follath F, 2002, LANCET, V360, P196, DOI 10.1016/S0140-6736(02)09455-2; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Gheorghiade M, 2009, J AM COLL CARDIOL, V53, P557, DOI 10.1016/j.jacc.2008.10.041; Halls ML, 2006, MOL PHARMACOL, V70, P214, DOI 10.1124/mol.105.021691; Heart Failure Society Of America, 2006, J Card Fail, V12, pe86; Jeyabalan A, 2007, ADV EXP MED BIOL, V612, P65; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; McMurray JJV, 2007, JAMA-J AM MED ASSOC, V298, P2009, DOI 10.1001/jama.298.17.2009; Metra M, 2009, HEART FAIL REV, V14, P299, DOI 10.1007/s10741-008-9127-5; Nieminen MS, 2006, EUR HEART J, V27, P2725, DOI 10.1093/eurheartj/ehl193; Pang PS, 2008, EUR HEART J, V29, P816, DOI 10.1093/eurheartj/ehn048; Smith MC, 2006, J AM SOC NEPHROL, V17, P3192, DOI 10.1681/ASN.2005090950; Svendsen AM, 2008, MOL CELL ENDOCRINOL, V296, P10, DOI 10.1016/j.mce.2008.07.014; Teerlink JR, 2005, AM J CARDIOL, V96, p59G, DOI 10.1016/j.amjcard.2005.07.022; Teichman SL, 2009, HEART FAIL REV, V14, P321, DOI 10.1007/s10741-008-9129-3	29	305	330	2	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2009	373	9673					1429	1439		10.1016/S0140-6736(09)60622-X	http://dx.doi.org/10.1016/S0140-6736(09)60622-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437QL	19329178				2022-12-28	WOS:000265501900031
J	Aller, SG; Yu, J; Ward, A; Weng, Y; Chittaboina, S; Zhuo, RP; Harrell, PM; Trinh, YT; Zhang, QH; Urbatsch, IL; Chang, G				Aller, Stephen G.; Yu, Jodie; Ward, Andrew; Weng, Yue; Chittaboina, Srinivas; Zhuo, Rupeng; Harrell, Patina M.; Trinh, Yenphuong T.; Zhang, Qinghai; Urbatsch, Ina L.; Chang, Geoffrey			Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding	SCIENCE			English	Article							ABC TRANSPORTER; MULTIDRUG-RESISTANCE; CASSETTE TRANSPORTER; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; PURIFICATION; CONFORMATION; RECOGNITION; MECHANISMS; MICROSCOPY	P-glycoprotein (P-gp) detoxifies cells by exporting hundreds of chemically unrelated toxins but has been implicated in multidrug resistance (MDR) in the treatment of cancers. Substrate promiscuity is a hallmark of P-gp activity, thus a structural description of poly-specific drug-binding is important for the rational design of anticancer drugs and MDR inhibitors. The x-ray structure of apo P-gp at 3.8 angstroms reveals an internal cavity of similar to 6000 angstroms cubed with a 30 angstrom separation of the two nucleotide-binding domains. Two additional P-gp structures with cyclic peptide inhibitors demonstrate distinct drug-binding sites in the internal cavity capable of stereoselectivity that is based on hydrophobic and aromatic interactions. Apo and drug-bound P-gp structures have portals open to the cytoplasm and the inner leaflet of the lipid bilayer for drug entry. The inward-facing conformation represents an initial stage of the transport cycle that is competent for drug binding.	[Aller, Stephen G.; Yu, Jodie; Weng, Yue; Chittaboina, Srinivas; Zhang, Qinghai; Chang, Geoffrey] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Ward, Andrew] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Zhuo, Rupeng; Harrell, Patina M.; Trinh, Yenphuong T.; Urbatsch, Ina L.] Texas Tech Univ, Hlth Sci Ctr, Lubbock, TX 79430 USA; [Weng, Yue] Wuhan Univ, Coll Chem & Mol Sci, Wuhan 430072, Peoples R China	Scripps Research Institute; Scripps Research Institute; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Wuhan University	Chang, G (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,CB105, La Jolla, CA 92037 USA.	gchang@scripps.edu	Ward, Andrew B/F-9203-2014; Ward, Andrew/ABD-7728-2021	Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; Aller, Stephen/0000-0003-0379-5534; Weng, Yue/0000-0001-9126-3321	Army [W81XWH-05-1-0316]; NIH [GM61905, GM078914, GM073197]; Beckman Foundation; Skaggs Chemical Biology Foundation; Jasper L. and Jack Denton Wilson Foundation; Southwest Cancer and Treatment Center; Norton B. Gilula Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, R01GM061905, F32GM078914] Funding Source: NIH RePORTER	Army; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; Skaggs Chemical Biology Foundation; Jasper L. and Jack Denton Wilson Foundation; Southwest Cancer and Treatment Center; Norton B. Gilula Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. C. Rees, I. Wilson, R. H. Spencer, M. B. Stowell, A. Senior, A. Frost, V. M. Unger, C. D. Stout, and P. Wright. Y. Weng was supported by a scholarship from P. R. China. We thank Stanford Synchrotron Radiation Lightsource, Advanced Light Source, and Advanced Photon Source. This work was supported by grants from the Army (W81XWH-05-1-0316), NIH (GM61905, GM078914, and GM073197), the Beckman Foundation, the Skaggs Chemical Biology Foundation, Jasper L. and Jack Denton Wilson Foundation, the Southwest Cancer and Treatment Center, and the Norton B. Gilula Fellowship. Coordinates and structure factors deposited to the Protein DataBank (PDB accession codes 3G5U, 3G60, and 3G61).	*AM CANC SOC HOM, 2007, GLOB CANC FACTS FIG; Bosch I, 1997, BIOCHEMISTRY-US, V36, P5685, DOI 10.1021/bi962728r; Callaghan R, 1997, BBA-BIOMEMBRANES, V1328, P109, DOI 10.1016/S0005-2736(97)00079-5; Chami M, 2002, J MOL BIOL, V315, P1075, DOI 10.1006/jmbi.2001.5309; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dong JH, 2005, SCIENCE, V308, P1023, DOI 10.1126/science.1106592; Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Hofacker M, 2007, J BIOL CHEM, V282, P3951, DOI 10.1074/jbc.M609899200; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Lam FC, 2001, J NEUROCHEM, V76, P1121, DOI 10.1046/j.1471-4159.2001.00113.x; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Loo TW, 1997, J BIOL CHEM, V272, P31945, DOI 10.1074/jbc.272.51.31945; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; RAVIV Y, 1990, J BIOL CHEM, V265, P3975; Rosenberg MF, 2003, J BIOL CHEM, V278, P8294, DOI 10.1074/jbc.M211758200; Schumacher MA, 2002, MOL MICROBIOL, V45, P885, DOI 10.1046/j.1365-2958.2002.03039.x; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tombline G, 2005, BIOCHEMISTRY-US, V44, P12879, DOI 10.1021/bi0509797; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6	32	1507	1567	7	453	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1718	1722		10.1126/science.1168750	http://dx.doi.org/10.1126/science.1168750			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325113	Green Accepted			2022-12-28	WOS:000264559800037
J	Hochstrasser, M				Hochstrasser, Mark			Origin and function of ubiquitin-like proteins	NATURE			English	Review							ESCHERICHIA-COLI; MOLYBDOPTERIN SYNTHASE; MOLECULAR EVOLUTION; BIOSYNTHESIS; CONJUGATION; SULFUR; SYSTEM; ISG15; YEAST; ACTIVATION	Eukaryotic proteins can be modified through attachment to various small molecules and proteins. One such modification is conjugation to ubiquitin and ubiquitin-like proteins (UBLs), which controls an enormous range of physiological processes. Bound UBLs mainly regulate the interactions of proteins with other macromolecules, for example binding to the proteasome or recruitment to chromatin. The various UBL systems use related enzymes to attach specific UBLs to proteins (or other molecules), and most of these attachments are transient. There is increasing evidence suggesting that such UBL-protein modification evolved from prokaryotic sulphurtransferase systems or related enzymes. Moreover, proteins similar to UBL-conjugating enzymes and UBL-deconjugating enzymes seem to have already been widespread at the time of the last common ancestor of eukaryotes, suggesting that UBL-protein conjugation did not first evolve in eukaryotes.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Hochstrasser, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave,POB 208114, New Haven, CT 06520 USA.	mark.hochstrasser@yale.edu		Hochstrasser, Mark/0000-0002-1131-5484	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053756, R01GM046904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I thank V. J. Rubenstein, A. Kusmierczyk and J. Bloom for comments on the manuscript. Work in my laboratory is funded by grants from the National Institutes of Health.	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Appleyard MVCL, 1998, J BIOL CHEM, V273, P14869, DOI 10.1074/jbc.273.24.14869; Archer CT, 2008, J BIOL CHEM, V283, P21789, DOI 10.1074/jbc.M803075200; Begley TP, 2006, NAT PROD REP, V23, P15, DOI 10.1039/b207131m; Burns KE, 2005, J AM CHEM SOC, V127, P11602, DOI 10.1021/ja053476x; Burroughs AM, 2008, J STRUCT BIOL, V162, P205, DOI 10.1016/j.jsb.2007.12.006; Burroughs AM, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-4; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Cavalier-Smith T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-19; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Dassa B, 2004, TRENDS GENET, V20, P538, DOI 10.1016/j.tig.2004.08.010; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Duda DM, 2005, J MOL BIOL, V349, P774, DOI 10.1016/j.jmb.2005.04.011; Durfee LA, 2008, J BIOL CHEM, V283, P23895, DOI 10.1074/jbc.M804069200; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Godert AM, 2007, J BACTERIOL, V189, P2941, DOI 10.1128/JB.01200-06; Goehring AS, 2003, EUKARYOT CELL, V2, P930, DOI 10.1128/EC.2.5.930-936.2003; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; HAAS AL, 1987, J BIOL CHEM, V262, P11315; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; HOCHSTRASSER M, 2006, PROTEIN DEGRADATION, P249; Huang B, 2008, RNA, V14, P2183, DOI 10.1261/rna.1184108; Huang DT, 2004, ONCOGENE, V23, P1958, DOI 10.1038/sj.onc.1207393; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Iyer LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r60; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-45; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim I, 2004, MOL BIOL CELL, V15, P3357, DOI 10.1091/mbc.E03-11-0835; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Malakhova OA, 2008, J BIOL CHEM, V283, P8783, DOI 10.1074/jbc.C800030200; MCGRATH JP, 1991, EMBO J, V10, P227, DOI 10.1002/j.1460-2075.1991.tb07940.x; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nakai Y, 2008, J BIOL CHEM, V283, P27469, DOI 10.1074/jbc.M804043200; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Okumura A, 2008, P NATL ACAD SCI USA, V105, P3974, DOI 10.1073/pnas.0710629105; Palacios S, 2005, MOL BIOL CELL, V16, P2822, DOI 10.1091/mbc.E04-11-1005; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rajagopalan KV, 1997, BIOCHEM SOC T, V25, P757, DOI 10.1042/bst0250757; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Roush RF, 2008, J AM CHEM SOC, V130, P3603, DOI 10.1021/ja7101949; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Schmitz J, 2008, BIOCHEMISTRY-US, V47, P6479, DOI 10.1021/bi800477u; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; SHARP PM, 1987, TRENDS ECOL EVOL, V2, P328, DOI 10.1016/0169-5347(87)90108-X; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Steinacher R, 2005, CURR BIOL, V15, P616, DOI 10.1016/j.cub.2005.02.054; Taylor SV, 1998, J BIOL CHEM, V273, P16555, DOI 10.1074/jbc.273.26.16555; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Ulrich HD, 2004, CELL CYCLE, V3, P15; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Volker C, 2002, CURR TOP MICROBIOL, V268, P1; Wang CY, 2001, NAT STRUCT BIOL, V8, P47; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Xu P, 2006, BBA-PROTEINS PROTEOM, V1764, P1940, DOI 10.1016/j.bbapap.2006.09.004; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101	75	571	589	4	113	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					422	429		10.1038/nature07958	http://dx.doi.org/10.1038/nature07958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19325621	Green Accepted			2022-12-28	WOS:000264532400030
J	O'Rourke, MF				O'Rourke, Michael F.			Should doctors recommend automated external defibrillators for use at home after myocardial infarction? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							HOSPITAL CARDIAC-ARREST		[O'Rourke, Michael F.] Univ New S Wales, Darlinghurst, NSW 2010, Australia; [O'Rourke, Michael F.] St Vincents Clin, Darlinghurst, NSW 2010, Australia	University of New South Wales Sydney	O'Rourke, MF (corresponding author), Univ New S Wales, 438 Victoria St, Darlinghurst, NSW 2010, Australia.	m.orourke@unsw.edu.au		Hutchinson, Mathew/0000-0002-8286-0113				Bardy GH, 2008, NEW ENGL J MED, V358, P1793, DOI 10.1056/NEJMoa0801651; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; EISENBERG MS, 1989, AM J CARDIOL, V63, P443, DOI 10.1016/0002-9149(89)90316-0; HAYES DL, 2008, BRAUNWALDS HEART DIS, P831; Norris RM, 2005, HEART, V91, P1537, DOI 10.1136/hrt.2004.057018; O'Rourke MF, 2005, HEART, V91, P1505, DOI 10.1136/hrt.2005.061572; Weaver WD, 2002, NEW ENGL J MED, V347, P1223, DOI 10.1056/NEJMp020108; Whitfield R, 2005, RESUSCITATION, V64, P269, DOI 10.1016/j.resuscitation.2005.01.003	8	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 23	2009	338								b874	10.1136/bmj.b874	http://dx.doi.org/10.1136/bmj.b874			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LO	19307277				2022-12-28	WOS:000264639400018
J	Dowrick, C; Leydon, GM; McBride, A; Howe, A; Burgess, H; Clarke, P; Maisey, S; Kendrick, T				Dowrick, Christopher; Leydon, Geraldine M.; McBride, Anita; Howe, Amanda; Burgess, Hana; Clarke, Pamela; Maisey, Sue; Kendrick, Tony			Patients' and doctors' views on depression severity questionnaires incentivised in UK quality and outcomes framework: qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; PERFORMANCE	Objective To gain understanding of general practitioners' and patients' opinions of the routine introduction of standardised measures of severity of depression through the UK general practice quality and outcomes framework. Design Semistructured qualitative interview study, with purposive sampling and constant comparative analysis. Participants 34 general practitioners and 24 patients. Setting 38 general practices in three sites in England: Southampton, Liverpool, and Norfolk. Results Patients generally favoured the measures of severity for depression, whereas general practitioners were generally cautious about the validity and utility of such measures and sceptical about the motives behind their introduction. Both general practitioners and patients considered that assessments of severity should be seen as one aspect of holistic care. General practitioners considered their practical wisdom and clinical judgment ("phronesis") to be more important than objective assessments and were concerned that the assessments reduced the human element of the consultation. Patients were more positive about the questionnaires, seeing them as an efficient and structured supplement to medical judgment and as evidence that general practitioners were taking their problems seriously through a full assessment. General practitioners and patients were aware of the potential for manipulation of indicators: for economic reasons for doctors and for patients to avoid stigma or achieve desired outcomes. Conclusions Despite general practitioners' caution about measures of severity for depression, these may benefit primary care consultations by increasing patients' confidence that general practitioners are correct in their diagnosis and are making systematic efforts to assess and manage their mental health problems. Further education of primary care staff may optimise the use and interpretation of depression questionnaires.	[Dowrick, Christopher; Clarke, Pamela] Univ Liverpool, Sch Populat Community & Behav Sci, Liverpool L69 3GB, Merseyside, England; [Burgess, Hana; Kendrick, Tony] Univ Southampton, Primary Med Care Grp, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England; [Howe, Amanda; Maisey, Sue] Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England	University of Liverpool; University of Southampton; University of East Anglia	Dowrick, C (corresponding author), Univ Liverpool, Sch Populat Community & Behav Sci, Liverpool L69 3GB, Merseyside, England.	cfd@liverpool.ac.uk	Leydon, Geraldine M/C-4968-2011; Kendrick, Tony/H-8558-2014	Kendrick, Tony/0000-0003-1618-9381; Leydon, Geraldine Marie/0000-0001-5986-3300	Lilly; Lundbeck; Servier; Wyeth pharmaceuticals; Southampton City Primary Care Trust and the Mental Health Research Network, East Anglia, West, and North West hubs	Lilly(Eli Lilly); Lundbeck(Lundbeck Corporation); Servier(Servier); Wyeth pharmaceuticals(Wyeth); Southampton City Primary Care Trust and the Mental Health Research Network, East Anglia, West, and North West hubs	Funding: This study was funded by an unrestricted educational grant from Lilly, Lundbeck, Servier, and Wyeth pharmaceuticals. It also received funding from Southampton City Primary Care Trust and the Mental Health Research Network, East Anglia, West, and North West hubs. None of the above bodies had any role in study design; the collection, analysis, and interpretation of data; the writing of the paper; or the decision to submit this paper for publication. The study was sponsored by the University of Liverpool.	*BRIT MED ASS, 2006, NHS EMPL REV GMS CON; Bushnell J, 2006, FAM PRACT, V23, P53, DOI 10.1093/fampra/cmi097; Davies H T, 1997, J Eval Clin Pract, V3, P187, DOI 10.1046/j.1365-2753.1997.00003.x; Doran T, 2008, NEW ENGL J MED, V359, P274, DOI 10.1056/NEJMsa0800310; Glasgow RE, 2005, MED CARE, V43, P436, DOI 10.1097/01.mlr.0000160375.47920.8c; Hilton S, 2008, BRIT J GEN PRACT, V58, P353, DOI 10.3399/bjgp08X280128; Kendrick T, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b750; Lorenz K, 2005, INT J QUAL HEALTH C, V17, P409, DOI 10.1093/intqhc/mzi054; Maisey S, 2008, J HEALTH SERV RES PO, V13, P133, DOI 10.1258/jhsrp.2008.007118; May C, 1996, SOCIOL REV, V44, P187, DOI 10.1111/j.1467-954X.1996.tb00421.x; National Institute for Clinical Excellence, 2004, DEPR MAN DEPR PRIM S; Nutley S, 1998, J Health Serv Res Policy, V3, P50; Steel N, 2007, BRIT J GEN PRACT, V57, P449; Strauss A., 1998, BASICS QUALITATIVE R; Wood Fiona, 2002, Health Expect, V5, P282, DOI 10.1046/j.1369-6513.2002.00186.x	15	110	111	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2009	338								b663	10.1136/bmj.b663	http://dx.doi.org/10.1136/bmj.b663			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	422NW	19299474	hybrid			2022-12-28	WOS:000264436000001
J	Hippisley-Cox, J; Coupland, C; Robson, J; Sheikh, A; Brindle, P				Hippisley-Cox, Julia; Coupland, Carol; Robson, John; Sheikh, Aziz; Brindle, Peter			Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE RISK; MISSING DATA; MULTIPLE IMPUTATION; GENERAL-PRACTICE; BLOOD-PRESSURE; LIFE-STYLE; PREVENTION; MELLITUS; PREVALENCE; GLUCOSE	Objective To develop and validate a new diabetes risk algorithm (the QDScore) for estimating 10 year risk of acquiring diagnosed type 2 diabetes over a 10 year time period in an ethnically and socioeconomically diverse population. Design Prospective open cohort study using routinely collected data from 355 general practices in England and Wales to develop the score and from 176 separate practices to validate the score. Participants 2 540 753 patients aged 25-79 in the derivation cohort, who contributed 16 436 135 person years of observation and of whom 78 081 had an incident diagnosis of type 2 diabetes; 1 232 832 patients (7 643 037 person years) in the validation cohort, with 37 535 incident cases of type 2 diabetes. Outcome measures A Cox proportional hazards model was used to estimate effects of risk factors in the derivation cohort and to derive a risk equation in men and women. The predictive variables examined and included in the final model were self assigned ethnicity, age, sex, body mass index, smoking status, family history of diabetes, Townsend deprivation score, treated hypertension, cardiovascular disease, and current use of corticosteroids; the outcome of interest was incident diabetes recorded in general practice records. Measures of calibration and discrimination were calculated in the validation cohort. Results A fourfold to fivefold variation in risk of type 2 diabetes existed between different ethnic groups. Compared with the white reference group, the adjusted hazard ratio was 4.07 (95% confidence interval 3.24 to 5.11) for Bangladeshi women, 4.53 (3.67 to 5.59) for Bangladeshi men, 2.15 (1.84 to 2.52) for Pakistani women, and 2.54 (2.20 to 2.93) for Pakistani men. Pakistani and Bangladeshi men had significantly higher hazard ratios than Indian men. Black African men and Chinese women had an increased risk compared with the corresponding white reference group. In the validation dataset, the model explained 51.53% (95% confidence interval 50.90 to 52.16) of the variation in women and 48.16% (47.52 to 48.80) of that in men. The risk score showed good discrimination, with a D statistic of 2.11 (95% confidence interval 2.08 to 2.14) inwomenand 1.97 (1.95 to 2.00) in men. The model was well calibrated. Conclusions The QDScore is the first risk prediction algorithm to estimate the 10 year risk of diabetes on the basis of a prospective cohort study and including both social deprivation and ethnicity. The algorithm does not need laboratory tests and can be used in clinical settings and also by the public through a simple web calculator (www.qdscore.org).	[Hippisley-Cox, Julia; Coupland, Carol] Div Primary Care, Nottingham NG2 7RD, England; [Robson, John] Barts & London Queen Marys Sch Med & Dent, Ctr Hlth Sci, London E1 2AT, England; [Sheikh, Aziz] Univ Edinburgh, GP Sect, Ctr Populat Hlth Sci, Edinburgh EH8 9DX, Midlothian, Scotland; [Brindle, Peter] Bristol Primary Care Trust, Avon Primary Care Res Collaborat, Bristol BS2 8EE, Avon, England	University of London; Queen Mary University London; University of Edinburgh	Hippisley-Cox, J (corresponding author), Div Primary Care, Tower Bldg,Univ Pk, Nottingham NG2 7RD, England.	Julia.hippisley-cox@nottingham.ac.uk	Greiver, Michelle/N-8764-2015; Robson, John/H-3904-2014; Hippisley-Cox, Julia/AAY-2788-2020; Sheikh, Aziz/D-2818-2009	Greiver, Michelle/0000-0001-8957-0285; Robson, John/0000-0001-6889-0415; Hippisley-Cox, Julia/0000-0002-2479-7283; Sheikh, Aziz/0000-0001-7022-3056; Coupland, Carol/0000-0002-2327-3306				Bagust A, 2002, DIABETIC MED, V19, P1, DOI 10.1046/j.1464-5491.19.s4.2.x; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; *BRIT HEART FDN, 2003, HLTH SURV ENGL PREV; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Clark TG, 2003, J CLIN EPIDEMIOL, V56, P28, DOI 10.1016/S0895-4356(02)00539-5; Conen D, 2007, EUR HEART J, V28, P2937, DOI 10.1093/eurheartj/ehm400; Department of Health, 2004, HLTH SURV ENGL 2004; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Gail MH, 2005, BIOSTATISTICS, V6, P227, DOI 10.1093/biostatistics/kxi005; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Gillies CL, 2008, BMJ-BRIT MED J, V336, P1180, DOI 10.1136/bmj.39545.585289.25; Ginde AA, 2008, J GEN INTERN MED, V23, P1346, DOI 10.1007/s11606-008-0661-6; Glumer C, 2004, DIABETES CARE, V27, P727, DOI 10.2337/diacare.27.3.727; Graf E, 1999, STAT MED, V18, P2529; Gray A, 2002, BRIT MED J, V325, P860, DOI 10.1136/bmj.325.7369.860; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; HARRIS MI, 1993, DIABETES CARE, V16, P642, DOI 10.2337/diacare.16.4.642; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley-Cox J, 2004, LANCET, V364, P423, DOI 10.1016/S0140-6736(04)16765-2; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Hoerger TJ, 2004, ANN INTERN MED, V140, P689, DOI 10.7326/0003-4819-140-9-200405040-00008; Holt TA, 2008, BRIT J GEN PRACT, V58, P192, DOI 10.3399/bjgp08X277302; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hux JE, 2000, DIABETES, V49, pA388; *INF CTR, 2004, HLTH SURV ENGL HLTH, P435; Kanaya AM, 2005, DIABETES CARE, V28, P404, DOI 10.2337/diacare.28.2.404; KANNEL WB, 1979, CIRCULATION, V59, P8, DOI 10.1161/01.CIR.59.1.8; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; McNeely MJ, 2003, DIABETES CARE, V26, P758, DOI 10.2337/diacare.26.3.758; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Rahman M, 2008, FAM PRACT, V25, P191, DOI 10.1093/fampra/cmn024; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; RIMM EB, 1993, AM J PUBLIC HEALTH, V83, P211, DOI 10.2105/AJPH.83.2.211; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; SIMMONS D, 1989, BRIT MED J, V298, P18, DOI 10.1136/bmj.298.6665.18; Simmons RK, 2007, DIABETIC MED, V24, P830, DOI 10.1111/j.1464-5491.2007.02173.x; Smith JP, 2007, P NATL ACAD SCI USA, V104, P13225, DOI 10.1073/pnas.0611234104; Spijkerman A, 2007, DIABETES CARE, V27, P116; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; Steyerberg EW, 2007, J CLIN EPIDEMIOL, V60, P979, DOI 10.1016/j.jclinepi.2007.03.003; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; WAUGH N, 2007, HLTH TECHNOL ASSESS, V11; Weakliem DL, 1999, SOCIOL METHOD RES, V27, P359, DOI 10.1177/0049124199027003002; Weber MB, 2008, LANCET, V371, P473, DOI 10.1016/S0140-6736(08)60233-0; Wild S, 2008, DIABETIC MED, V25, P194, DOI 10.1111/j.1464-5491.2008.02382.x; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068	61	167	169	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2009	338								b880	10.1136/bmj.b880	http://dx.doi.org/10.1136/bmj.b880			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422NU	19297312	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000264435800005
J	Richards, T				Richards, Tessa			Feature European Working Time Directive Running out of time	BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com						Iglehart JK, 2008, NEW ENGL J MED, V359, P2633, DOI 10.1056/NEJMp0808736; POUNDER R, 2009, BMJ; *ROY COLL PHYS, EUR WORK TIM DIR; *ROY COLL SURG ENG, EUR WORK TIM DIR DEB	4	12	12	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 14	2009	338								b1507	10.1136/bmj.b1507	http://dx.doi.org/10.1136/bmj.b1507			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434TI	19366749				2022-12-28	WOS:000265296600015
J	Soucy, TA; Smith, PG; Milhollen, MA; Berger, AJ; Gavin, JM; Adhikari, S; Brownell, JE; Burke, KE; Cardin, DP; Critchley, S; Cullis, CA; Doucette, A; Garnsey, JJ; Gaulin, JL; Gershman, RE; Lublinsky, AR; McDonald, A; Mizutani, H; Narayanan, U; Olhava, EJ; Peluso, S; Rezaei, M; Sintchak, MD; Talreja, T; Thomas, MP; Traore, T; Vyskocil, S; Weatherhead, GS; Yu, J; Zhang, J; Dick, LR; Claiborne, CF; Rolfe, M; Bolen, JB; Langston, SP				Soucy, Teresa A.; Smith, Peter G.; Milhollen, Michael A.; Berger, Allison J.; Gavin, James M.; Adhikari, Sharmila; Brownell, James E.; Burke, Kristine E.; Cardin, David P.; Critchley, Stephen; Cullis, Courtney A.; Doucette, Amanda; Garnsey, James J.; Gaulin, Jeffrey L.; Gershman, Rachel E.; Lublinsky, Anna R.; McDonald, Alice; Mizutani, Hirotake; Narayanan, Usha; Olhava, Edward J.; Peluso, Stephane; Rezaei, Mansoureh; Sintchak, Michael D.; Talreja, Tina; Thomas, Michael P.; Traore, Tary; Vyskocil, Stepan; Weatherhead, Gabriel S.; Yu, Jie; Zhang, Julie; Dick, Lawrence R.; Claiborne, Christopher F.; Rolfe, Mark; Bolen, Joseph B.; Langston, Steven P.			An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer	NATURE			English	Article							NEDD8 CONJUGATION PATHWAY; KAPPA-B-ALPHA; UBIQUITIN LIGASE; DNA-DAMAGE; G(2)/M CHECKPOINT; ACTIVATING ENZYME; CELL-CYCLE; DEGRADATION; CDT1; COMPLEX	The clinical development of an inhibitor of cellular proteasome function suggests that compounds targeting other components of the ubiquitin-proteasome system might prove useful for the treatment of human malignancies. NEDD8-activating enzyme (NAE) is an essential component of the NEDD8 conjugation pathway that controls the activity of the cullin-RING subtype of ubiquitin ligases, thereby regulating the turnover of a subset of proteins upstream of the proteasome. Substrates of cullin-RING ligases have important roles in cellular processes associated with cancer cell growth and survival pathways. Here we describe MLN4924, a potent and selective inhibitor of NAE. MLN4924 disrupts cullin-RING ligase-mediated protein turnover leading to apoptotic death in human tumour cells by a new mechanism of action, the deregulation of S-phase DNA synthesis. MLN4924 suppressed the growth of human tumour xenografts in mice at compound exposures that were well tolerated. Our data suggest that NAE inhibitors may hold promise for the treatment of cancer.	[Soucy, Teresa A.; Smith, Peter G.; Milhollen, Michael A.; Berger, Allison J.; Gavin, James M.; Adhikari, Sharmila; Brownell, James E.; Burke, Kristine E.; Cardin, David P.; Critchley, Stephen; Cullis, Courtney A.; Doucette, Amanda; Garnsey, James J.; Gaulin, Jeffrey L.; Gershman, Rachel E.; Lublinsky, Anna R.; McDonald, Alice; Mizutani, Hirotake; Narayanan, Usha; Olhava, Edward J.; Peluso, Stephane; Rezaei, Mansoureh; Sintchak, Michael D.; Talreja, Tina; Thomas, Michael P.; Traore, Tary; Vyskocil, Stepan; Weatherhead, Gabriel S.; Yu, Jie; Zhang, Julie; Dick, Lawrence R.; Claiborne, Christopher F.; Rolfe, Mark; Bolen, Joseph B.; Langston, Steven P.] Millennium Pharmaceut Inc, Cambridge, MA 02139 USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Soucy, TA (corresponding author), Millennium Pharmaceut Inc, 40 Landsdowne St, Cambridge, MA 02139 USA.	teresa.soucy@mpi.com	Zhang, Julie/GQH-2525-2022; Dick, Lawrence/ABA-8831-2021	Dick, Larry/0000-0002-6880-0405				Archambault V, 2005, MOL CELL BIOL, V25, P6707, DOI 10.1128/MCB.25.15.6707-6721.2005; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; BLOCH A, 1971, BIOCHEMISTRY-US, V10, P4394, DOI 10.1021/bi00800a007; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen YZ, 2000, J BIOL CHEM, V275, P8929, DOI 10.1074/jbc.275.12.8929; Chiba T, 2004, CURR PROTEIN PEPT SC, V5, P177, DOI 10.2174/1389203043379783; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; HAAS AL, 1982, J BIOL CHEM, V257, P329; HANDELI S, 1992, CELL, V71, P599, DOI 10.1016/0092-8674(92)90594-3; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kane RC, 2003, ONCOLOGIST, V8, P508, DOI 10.1634/theoncologist.8-6-508; Kane RC, 2007, CLIN CANCER RES, V13, P5291, DOI 10.1158/1078-0432.CCR-07-0871; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim Y, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-18; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kondo T, 2004, J BIOL CHEM, V279, P27315, DOI 10.1074/jbc.M314023200; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Lin JJ, 2007, J BIOL CHEM, V282, P30357, DOI 10.1074/jbc.M705178200; Lovejoy CA, 2006, MOL CELL BIOL, V26, P7977, DOI 10.1128/MCB.00819-06; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Saxena S, 2003, CELL CYCLE, V2, P283, DOI 10.4161/cc.2.4.443; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wilkinson KD, 2005, P NATL ACAD SCI USA, V102, P15280, DOI 10.1073/pnas.0504842102; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	46	1327	1382	9	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 9	2009	458	7239					732	U67		10.1038/nature07884	http://dx.doi.org/10.1038/nature07884			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	433GZ	19360080				2022-12-28	WOS:000265193600033
J	Enoch, S; Roshan, A; Shah, M				Enoch, Stuart; Roshan, Amit; Shah, Mamta			Emergency and early management of burns and scalds	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PEDIATRIC BURNS; RESUSCITATION; GUIDELINES; MORTALITY; DEATH; CARE; ABC		[Shah, Mamta] Cent Manchester & Manchester Childrens Hosp NHS T, Manchester, Lancs, England; [Enoch, Stuart] Univ Hosp Manchester, Manchester M23 9LT, Lancs, England; [Roshan, Amit] Addenbrookes Hosp, Cambridge Univ Hosp, Cambridge CB2 8QE, England	Royal Manchester Children's Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Shah, M (corresponding author), Booth Hall Childrens Hosp, Reg Paediat Burns Unit, Manchester M9 7AA, Lancs, England.	mamta.shah@cmmc.nhs.uk	Roshan, Amit/AAV-5512-2020	Roshan, Amit/0000-0002-2034-2759				Allison K, 2004, EMERG MED J, V21, P112, DOI 10.1136/emj.2003.008789; Alsbjorn B, 2007, BURNS, V33, P155, DOI 10.1016/j.burns.2006.07.025; Barrow RE, 2000, RESUSCITATION, V45, P91, DOI 10.1016/S0300-9572(00)00175-1; Bloemsma GC, 2008, BURNS, V34, P1103, DOI 10.1016/j.burns.2008.02.010; *BRIT BURN ASS, 2008, EM MAN SEV BURSN COU; Cubison TCS, 2006, BURNS, V32, P992, DOI 10.1016/j.burns.2006.02.007; Hettiaratchy S, 2004, BMJ-BRIT MED J, V329, P101, DOI 10.1136/bmj.329.7457.101; Hudspith J, 2004, BRIT MED J, V328, P1487, DOI 10.1136/bmj.328.7454.1487; La Hei ER, 2006, BURNS, V32, P550, DOI 10.1016/j.burns.2005.11.014; McGill DJ, 2007, BURNS, V33, P833, DOI 10.1016/j.burns.2006.10.404; *NAT BURN CAR REV, 2001, STAND STRAT BURN CAR, P68; Peck MD, 2008, BURNS, V34, P303, DOI 10.1016/j.burns.2007.08.014; Pereira C, 2004, BURNS, V30, P761, DOI 10.1016/j.burns.2004.05.012; Perel P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub3; Pham TN, 2008, J BURN CARE RES, V29, P257, DOI 10.1097/BCR.0b013e31815f3876; Renkielska A, 2006, BURNS, V32, P867, DOI 10.1016/j.burns.2006.01.024; Ryan CM, 1998, NEW ENGL J MED, V338, P362, DOI 10.1056/NEJM199802053380604; Sawada Y, 1997, BURNS, V23, P55, DOI 10.1016/S0305-4179(96)00080-0; Wachtel TL, 2000, BURNS, V26, P156, DOI 10.1016/S0305-4179(99)00047-9; Wharton SM, 2001, BURNS, V27, P183, DOI 10.1016/S0305-4179(00)00097-8; Whitaker IS, 2008, ANN PLAS SURG, V60, P333, DOI 10.1097/SAP.0b013e31806bf446; *WHO, FACTS INJ BURNS; Wilkinson E, 1998, BURNS, V24, P139, DOI 10.1016/S0305-4179(98)80001-6; Yuan J, 2007, J BURN CARE RES, V28, P514, DOI 10.1097/BCR.0B013E318053DB13	24	31	34	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2009	338								b1037	10.1136/bmj.b1037	http://dx.doi.org/10.1136/bmj.b1037			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431ZI	19357185				2022-12-28	WOS:000265102900001
J	Hlatky, MA; Boothroyd, DB; Bravata, DM; Boersma, E; Booth, J; Brooks, MM; Carrie, D; Clayton, TC; Danchin, N; Flather, M; Hamm, CW; Hueb, WA; Kahler, J; Kelsey, SF; King, SB; Kosinski, AS; Lopes, N; McDonald, KM; Rodriguez, A; Serruys, P; Sigwart, U; Stables, RH; Owens, DK; Pocock, SJ				Hlatky, Mark A.; Boothroyd, Derek B.; Bravata, Dena M.; Boersma, Eric; Booth, Jean; Brooks, Maria M.; Carrie, Didier; Clayton, Tim C.; Danchin, Nicolas; Flather, Marcus; Hamm, Christian W.; Hueb, Whady A.; Kaehler, Jan; Kelsey, Sheryl F.; King, Spencer B.; Kosinski, Andrzej S.; Lopes, Neuza; McDonald, Kathryn M.; Rodriguez, Alfredo; Serruys, Patrick; Sigwart, Ulrich; Stables, Rodney H.; Owens, Douglas K.; Pocock, Stuart J.			Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials	LANCET			English	Article							LONG-TERM SURVIVAL; 5-YEAR FOLLOW-UP; DIABETES-MELLITUS; ANGIOPLASTY; REVASCULARIZATION; METAANALYSIS; OUTCOMES; GRAFT; MORTALITY; THERAPY	Background Coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI) are alternative treatments for multivessel coronary disease. Although the procedures have been compared in several randomised trials, their long-term effects on mortality in key clinical subgroups are uncertain. We undertook a collaborative analysis of data from randomised trials to assess whether the effects of the procedures on mortality are modified by patient characteristics. Methods We pooled individual patient data from ten randomised trials to compare the effectiveness of CABG with PCI according to patients' baseline Clinical Characteristics. We used stratified, random effects Cox proportional hazards models to test the effect on all-cause mortality of randomised treatment assignment and its interaction with clinical characteristics. All analyses were by intention to treat. Findings Ten participating trials provided data on 7812 patients. PCI was done with balloon angioplasty in six trials and with bare-metal stents in four trials. Over a median follow-up of 5.9 years (IQR 5.0-10.0), 575 (15%) of 3889 patients assigned to CABG died compared with 628 (16%) of 3923 patients assigned to PCI (hazard ratio [HR] 0.91, 95% CI 0.82-1.02; p=0.12). In patients with diabetes (CABG, n=615; PCI, n=618), mortality was substantially lower in the CABG group than in the PCI group (HR 0.70, 0.56-0.87); however, mortality was similar between groups in patients without diabetes (HR 0.98, 0.86-1.12; p=0.014 for interaction). Patient age modified the effect of treatment on mortality, with hazard ratios of 1.25 (0.94-1.66) in patients younger than 55 years, 0.90 (0.75-1.09) in patients aged 55-64 years, and 0.82 (0.70-0.97) in patients 65 years and older (p=0.002 for interaction). Treatment effect was not modified by the number of diseased vessels or other baseline characteristics. Interpretation Long-term mortality is similar after CABG and PCI in most patient subgroups with multivessel coronary artery disease, so choice of treatment should depend on patient preferences for other outcomes. CABG might be a better option for patients with diabetes and patients aged 65 years or older because we found mortality to be lower in these subgroups.	[Hlatky, Mark A.; Boothroyd, Derek B.; Bravata, Dena M.; McDonald, Kathryn M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Boersma, Eric; Serruys, Patrick] Erasmus Univ, Dept Cardiol, Rotterdam, Netherlands; [Booth, Jean; Flather, Marcus] Royal Brampton & Harefield NHS Trust, London, England; [Brooks, Maria M.; Kelsey, Sheryl F.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Carrie, Didier] Hop Rangueil, Toulouse, France; [Clayton, Tim C.; Pocock, Stuart J.] London Sch Hyg & Trop Med, London WC1, England; [Danchin, Nicolas] Univ Paris 05, AP HP, Paris, France; [Hamm, Christian W.] Max Planck Inst Physiol & Clin Res, Kerckhoff Klin, D-6350 Bad Nauheim, Germany; [Hueb, Whady A.] Inst Coracao, Sao Paulo, Brazil; [King, Spencer B.] St Josephs Heart & Vasc Inst, Atlanta, GA USA; [Kosinski, Andrzej S.] Duke Univ, Sch Med, Durham, NC USA; [Rodriguez, Alfredo] Sanat Otamendi, Buenos Aires, DF, Argentina; [Sigwart, Ulrich] Univ Geneva, Dept Cardiol, Geneva, Switzerland; [Stables, Rodney H.] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England; [Owens, Douglas K.] VA Palo Alto Healthcare Syst, Palo Alto, CA USA	Stanford University; Erasmus University Rotterdam; Erasmus MC; Royal Brompton & Harefield NHS Foundation Trust; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; CHU de Toulouse; University of London; London School of Hygiene & Tropical Medicine; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Kerckhoff Clinic; Max Planck Society; Universidade de Sao Paulo; Duke University; University of Geneva; Liverpool Heart & Chest Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Hlatky, MA (corresponding author), Stanford Univ, Sch Med, HRP Redwood Bldg,Room 150, Stanford, CA 94305 USA.	hlatky@stanford.edu	Danchin, Nicolas/AAN-8291-2020; Carrie, Didier/M-5781-2014; Hamm, Christian W./I-3155-2017; Hueb, Whady/A-7919-2013	Hamm, Christian W./0000-0001-6763-4161; Hueb, Whady/0000-0002-3166-6054; CARRIE, didier/0000-0003-2479-8144; Stables, Rodney Hilton/0000-0002-9244-7015; Brooks, Maria/0000-0002-2030-7873; Hlatky, Mark/0000-0003-4686-9441; Clayton, Tim/0000-0002-1266-3288; Boothroyd, Derek Brian/0000-0001-5387-6995	Agency for Healthcare Research and Quality, Rockville, MD, USA [290-02-0017]	Agency for Healthcare Research and Quality, Rockville, MD, USA(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This manuscript is derived from work supported under a contract with the Agency for Healthcare Research and Quality, Rockville, MD, USA (#290-02-0017); some of the contributing trials were initially conducted with industrial support. We thank Artyom Sedrakyan for his support of this project. Our late colleagues, Katherine Detre of the BARI trial<SUP>2</SUP> and Anthony Rickards of the CABRI trial,' were important contributors to the investigation of CABG and PCI. Disclaimer: This article has not yet been approved by the funding agency. The authors of this article are responsible for its contents. No statement in this article should be construed as an official position of the Agency for Healthcare Research and Quality or the US Department of Health and Human Services.	Alderman EL, 1996, NEW ENGL J MED, V335, P217; [Anonymous], 1995, Lancet, V346, P1179; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Barsness GW, 1997, CIRCULATION, V96, P2551, DOI 10.1161/01.CIR.96.8.2551; Booth J, 2008, CIRCULATION, V118, P381, DOI 10.1161/CIRCULATIONAHA.107.739144; Bravata DM, 2007, ANN INTERN MED, V147, P703, DOI 10.7326/0003-4819-147-10-200711200-00185; Brener SJ, 2004, CIRCULATION, V109, P2290, DOI 10.1161/01.CIR.0000126826.58526.14; Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048; Brophy JM, 2003, ANN INTERN MED, V138, P777, DOI 10.7326/0003-4819-138-10-200305200-00005; Carrie D, 1997, CIRCULATION, V96, P1; Farkouh ME, 2008, AM HEART J, V155, P215, DOI 10.1016/j.ahj.2007.10.012; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316; Henderson RA, 1998, LANCET, V352, P1419, DOI 10.1016/S0140-6736(98)03358-3; Hoffman SN, 2003, J AM COLL CARDIOL, V41, P1293, DOI 10.1016/S0735-1097(03)00157-8; Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475; Kaehler J, 2005, EUR HEART J, V26, P2148, DOI 10.1093/eurheartj/ehi385; Kapur A, 2005, AM HEART J, V149, P13, DOI 10.1016/j.ahj.2004.07.001; King SB, 2000, J AM COLL CARDIOL, V35, P1116, DOI 10.1016/S0735-1097(00)00546-5; Kurbaan AS, 2001, AM J CARDIOL, V87, P947, DOI 10.1016/S0002-9149(01)01426-6; Malenka DJ, 2005, CIRCULATION, V112, pI371, DOI 10.1161/CIRCULATIONAHA.104.526392; MARK DB, 1994, CIRCULATION, V89, P2015, DOI 10.1161/01.CIR.89.5.2015; Morrison DA, 2001, J AM COLL CARDIOL, V38, P143, DOI 10.1016/S0735-1097(01)01366-3; Niles NW, 2001, J AM COLL CARDIOL, V37, P1008, DOI 10.1016/S0735-1097(00)01205-5; Ong ATL, 2006, AM HEART J, V151, P1194, DOI 10.1016/j.ahj.2005.07.017; POCOCK SJ, 1995, LANCET, V346, P1184, DOI 10.1016/S0140-6736(95)92897-9; Rodriguez A, 1996, J AM COLL CARDIOL, V27, P1178, DOI 10.1016/0735-1097(95)00592-7; Rodriguez AE, 2005, J AM COLL CARDIOL, V46, P582, DOI 10.1016/j.jacc.2004.12.081; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Serruys PW, 2005, J AM COLL CARDIOL, V46, P575, DOI 10.1016/j.jacc.2004.12.082; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Smith PK, 2006, ANN THORAC SURG, V82, P1420, DOI 10.1016/j.athoracsur.2006.04.044; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; Therneau TM, 2003, J COMPUT GRAPH STAT, V12, P156, DOI 10.1198/1061860031365; Thompson SG, 2005, LANCET, V365, P341, DOI 10.1016/S0140-6736(05)17790-3	37	543	566	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2009	373	9670					1190	1197		10.1016/S0140-6736(09)60552-3	http://dx.doi.org/10.1016/S0140-6736(09)60552-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429SO	19303634				2022-12-28	WOS:000264940600033
J	Fellstrom, BC; Jardine, AG; Schmieder, RE; Holdaas, H; Bannister, K; Beutler, J; Chae, DW; Chevaile, A; Cobbe, SM; Gronhagen-Riska, C; De Lima, JJ; Lins, R; Mayer, G; McMahon, AW; Parving, HH; Remuzzi, G; Samuelsson, O; Sonkodi, S; Suleymanlar, G; Tsakiris, D; Tesar, V; Todorov, V; Wiecek, A; Wuthrich, RP; Gottlow, M; Johnsson, E; Zannad, F				Fellstroem, Bengt C.; Jardine, Alan G.; Schmieder, Roland E.; Holdaas, Hallvard; Bannister, Kym; Beutler, Jaap; Chae, Dong-Wan; Chevaile, Alejandro; Cobbe, Stuart M.; Groenhagen-Riska, Carola; De Lima, Jose J.; Lins, Robert; Mayer, Gert; McMahon, Alan W.; Parving, Hans-Henrik; Remuzzi, Giuseppe; Samuelsson, Ola; Sonkodi, Sandor; Sueleymanlar, Gultekin; Tsakiris, Dimitrios; Tesar, Vladimir; Todorov, Vasil; Wiecek, Andrzej; Wuethrich, Rudolf P.; Gottlow, Mattis; Johnsson, Eva; Zannad, Faiez		AURORA Study Grp	Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RENAL-TRANSPLANT RECIPIENTS; TYPE-2 DIABETES-MELLITUS; CARDIAC OUTCOMES; DIALYSIS PATIENTS; DISEASE; ATORVASTATIN; CHOLESTEROL; CORONARY; INFLAMMATION; RISK	Background Statins reduce the incidence of cardiovascular events in patients at high cardiovascular risk. However, a benefit of statins in such patients who are undergoing hemodialysis has not been proved. Methods We conducted an international, multicenter, randomized, double-blind, prospective trial involving 2776 patients, 50 to 80 years of age, who were undergoing maintenance hemodialysis. We randomly assigned patients to receive rosuvastatin, 10 mg daily, or placebo. The combined primary end point was death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke. Secondary end points included death from all causes and individual cardiac and vascular events. Results After 3 months, the mean reduction in low-density lipoprotein (LDL) cholesterol levels was 43% in patients receiving rosuvastatin, from a mean baseline level of 100 mg per deciliter (2.6 mmol per liter). During a median follow-up period of 3.8 years, 396 patients in the rosuvastatin group and 408 patients in the placebo group reached the primary end point (9.2 and 9.5 events per 100 patient-years, respectively; hazard ratio for the combined end point in the rosuvastatin group vs. the placebo group, 0.96; 95% confidence interval [CI], 0.84 to 1.11; P = 0.59). Rosuvastatin had no effect on individual components of the primary end point. There was also no significant effect on all-cause mortality (13.5 vs. 14.0 events per 100 patient-years; hazard ratio, 0.96; 95% CI, 0.86 to 1.07; P = 0.51). Conclusions In patients undergoing hemodialysis, the initiation of treatment with rosuvastatin lowered the LDL cholesterol level but had no significant effect on the composite primary end point of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke. (ClinicalTrials.gov number, NCT00240331.)	[Fellstroem, Bengt C.] Univ Uppsala Hosp, Renal Unit, Dept Med Sci, SE-75185 Uppsala, Sweden; [Samuelsson, Ola] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Gottlow, Mattis; Johnsson, Eva] AstraZeneca, Molndal, Sweden; [Jardine, Alan G.; Cobbe, Stuart M.] British Heart Fdn, Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Schmieder, Roland E.] Univ Hosp, Erlangen, Germany; [Holdaas, Hallvard] Univ Oslo, Rikshosp, N-0027 Oslo, Norway; [Bannister, Kym] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Beutler, Jaap] Jeroen Bosch Hosp, Shertogenbosch, Netherlands; [Chae, Dong-Wan] Seoul Natl Univ, Bundang Hosp, Kyonggi Do, South Korea; [Chevaile, Alejandro] Hosp Cent Dr Ignacio Morones Prieto, San Luis Potosi, Mexico; [Groenhagen-Riska, Carola] Helsinki Univ Hosp, Helsinki, Finland; [De Lima, Jose J.] Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor, Sao Paulo, Brazil; [Lins, Robert] ZNA Stuivenberg, Antwerp, Belgium; [Mayer, Gert] Med Univ Innsbruck, Innsbruck, Austria; [McMahon, Alan W.] Univ Alberta Hosp, Edmonton, AB T6G 2B7, Canada; [Parving, Hans-Henrik] Rigshosp, DK-2100 Copenhagen, Denmark; [Parving, Hans-Henrik] Aarhus Univ, Aarhus, Denmark; [Remuzzi, Giuseppe] Osped Riuniti Bergamo, Azienda Osped, I-24100 Bergamo, Italy; [Sonkodi, Sandor] Szeged Sci Univ, Szeged, Hungary; [Sueleymanlar, Gultekin] Akdeniz Univ, TR-07058 Antalya, Turkey; [Tsakiris, Dimitrios] Gen Hosp Veria, Veria, Greece; [Tesar, Vladimir] Charles Univ Prague, Prague, Czech Republic; [Todorov, Vasil] Univ Hosp, Pleven, Bulgaria; [Wiecek, Andrzej] Med Univ Silesia, Katowice, Poland; [Wuethrich, Rudolf P.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Zannad, Faiez] Ctr Hosp Univ, Ctr Invest Clin, Nancy, France; [Zannad, Faiez] Nancy Univ, Nancy, France	Uppsala University; Uppsala University Hospital; Sahlgrenska University Hospital; AstraZeneca; University of Glasgow; University of Erlangen Nuremberg; University of Oslo; National Hospital Norway; Royal Adelaide Hospital; Jeroen Bosch Ziekenhuis; Seoul National University (SNU); Hospital Central Dr. Ignacio Morones Prieto; University of Helsinki; Helsinki University Central Hospital; Universidade de Sao Paulo; ZNA Stuivenberg; Medical University of Innsbruck; University of Alberta; Rigshospitalet; University of Copenhagen; Aarhus University; Ospedali Riuniti di Bergamo; Szeged University; Akdeniz University; Charles University Prague; Medical University Pleven; Medical University Silesia; University of Zurich; University Zurich Hospital; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine	Fellstrom, BC (corresponding author), Univ Uppsala Hosp, Renal Unit, Dept Med Sci, SE-75185 Uppsala, Sweden.	bengt.fellstrom@medsci.uu.se	Švára, František/R-4544-2017; Suleymanlar, Gultekin/C-2106-2016; Zoccali, Carmine/B-9445-2009; Jardine, Alan/L-5770-2019; Healy, Helen/G-2686-2010; Gowdak, Luis Henrique Wolff/M-7153-2017; Zannad, Faiez/K-4649-2019; Tesar, Vladimir/O-2312-2017; Gowdak, Luis Henrique Wolff/C-4844-2012; Švára, František/S-8133-2019; Johnson, David/F-2897-2011; Remuzzi, Giuseppe/V-9766-2017	Švára, František/0000-0002-9189-7524; Suleymanlar, Gultekin/0000-0001-7935-6402; Healy, Helen/0000-0003-4342-5300; Gowdak, Luis Henrique Wolff/0000-0002-6785-7506; Tesar, Vladimir/0000-0001-6982-0689; Gowdak, Luis Henrique Wolff/0000-0002-6785-7506; Johnson, David/0000-0001-5491-3460; Mount, Peter/0000-0001-7637-3661; Mayer, Gert/0000-0002-5039-543X; Remuzzi, Giuseppe/0000-0002-6194-3446; Debska-Slizien, Maria Alicja/0000-0001-8210-8063; Maxwell, Alexander P./0000-0002-6110-7253; Van der Niepen, Patricia/0000-0002-6401-1580; Bos, Willem Jan W/0000-0002-5062-2567; van Buren, Marjolijn/0000-0002-1822-6863; Jardine, Alan/0000-0001-5815-9370; Dehais, frederic/0000-0003-0854-7919	Novartis; Roche; Merck-Schering-Plough; Wyeth; Amgen; AstraZeneca; Genzyme; Vifor	Novartis(Novartis); Roche(Roche Holding); Merck-Schering-Plough(Merck & CompanySchering Plough Corporation); Wyeth(Wyeth); Amgen(Amgen); AstraZeneca(AstraZeneca); Genzyme(Sanofi-AventisGenzyme Corporation); Vifor	Dr. Fellstrom reports receiving consulting fees from AstraZeneca, Novartis, Roche, and Wyeth, lecture fees from Astellas, Novartis, and Roche, and grant support from Novartis, Roche, Merck-Schering-Plough, and Wyeth and serving as national coordinator for the Study of Heart and Renal Protection (SHARP) study at Oxford University's Clinical Trial Service Unit; Dr. Jardine, receiving consulting fees from Novartis, AstraZeneca, and Wyeth and lecture fees from Novartis and Astellas; Dr. Schmie-der, receiving consulting and lecture fees from AstraZeneca, Novartis, Merck Sharp & Dohme, and Pfizer; Dr. Holdaas, receiving consulting fees from Novartis, AstraZeneca, and Schering-Plough and lecture fees from Novartis and AstraZeneca, and serving as national coordinator for the SHARP study; Dr. Bannister, receiving consulting fees from Baxter, Amgen, and Genzyme, lecture fees from Servier and Boehringer Ingelheim, and grant support from Amgen; Dr. Beutler, receiving lecture fees from Pfizer; Dr. Chevaile, receiving consulting fees from AstraZeneca; Dr. Cobbe, receiving consulting fees and grant support from AstraZeneca; Dr. Gronhagen-Riska, receiving grant support from AstraZeneca and serving as national coordinator for the SHARP study; Dr. De Lima, receiving consulting fees from AstraZeneca; Dr. Lins, receiving consulting fees from AstraZeneca and Novartis and lecture fees from Servier and Sanofi-Aventis; Dr. Mayer, receiving consulting fees from AstraZeneca and Genzyme, lecture fees from Genzyme and Amgen, and grant support from Amgen; Dr. McMahon, receiving consulting fees from AstraZeneca and Schering-Plough and lecture fees from AstraZeneca; Dr. Parving, receiving consulting and lecture fees from AstraZeneca, Merck, and Novartis and having equity ownership and stock options in Novo Nordisk; Dr. Remuzzi, serving on the Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients with Progressive Renal Disease (PLANET) and AURORA advisory committees for AstraZeneca; Dr. Samuelsson, receiving lecture fees from AstraZeneca; Dr. Sonkodi, receiving lecture fees from AstraZeneca, Richter Gedeon Nyrt, and Egis Nyrt; Dr. Tesar, receiving lecture fees from Amgen and Novartis; Dr. Wiecek, receiving consulting fees from AstraZeneca; Dr. Wuthrich, receiving consulting fees from Amgen, Genzyme, Novartis, and Vifor, lecture fees from Amgen, Vifor, and Wyeth, and grant support from Amgen, Genzyme, Novartis, Vifor, and Wyeth; Mr. Gottlow, being an employee of and owning stock or having other ownership interest in AstraZeneca; Dr. Johnsson, being an employee of and owning stock or having other ownership interest in AstraZeneca; and Dr. Zannad, receiving consulting fees from Servier, Novartis, ResMed, Daiichi Sankyo, Pfizer, AstraZeneca, and Merck and lecture fees from Pfizer, Daiichi Sankyo, Servier, and Medtronic. All authors except for employees of AstraZeneca received honoraria for serving on the steering committee of the AURORA study. No other potential conflict of interest relevant to this article was reported.; We thank all the participating patients, study nurses, investigators, and members of the AURORA data and safety monitoring board and clinical end-point committee for making the trial possible; Dr. A. H. Zwinderman (Amsterdam) for independent data analysis; and Karin Sabel (AstraZeneca, Molndal, Sweden), study team leader. AstraZeneca provided and funded editorial support for an earlier version of the article.	Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Baigent C, 2008, LANCET, V371, P2084; Baigent C, 2000, LANCET, V356, P147, DOI 10.1016/S0140-6736(00)02456-9; Baigent C, 2003, KIDNEY INT, V63, pS207, DOI 10.1046/j.1523-1755.63.s84.4.x; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Baigent C, 2007, SEMIN DIALYSIS, V20, P498, DOI 10.1111/j.1525-139X.2007.00340.x; Dale KM, 2006, JAMA-J AM MED ASSOC, V295, P74, DOI 10.1001/jama.295.1.74; Fellstrom B, 2005, CURR CONTR TRIALS C, V6, DOI 10.1186/1468-6708-6-9; Fellstrom B, 2007, KIDNEY BLOOD PRESS R, V30, P314, DOI 10.1159/000106803; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Ford I, 2007, NEW ENGL J MED, V357, P1477, DOI 10.1056/NEJMoa065994; Forrester JS, 2007, AM J CARDIOL, V99, P732, DOI 10.1016/j.amjcard.2006.09.125; Geluk CA, 2005, EUR HEART J, V26, P1314, DOI 10.1093/eurheartj/ehi253; Guerin AP, 2008, CURR HYPERTENS REP, V10, P107, DOI 10.1007/s11906-008-0021-2; Herzog CA, 2008, SEMIN DIALYSIS, V21, P300, DOI 10.1111/j.1525-139X.2008.00455.x; Holdaas H, 2005, AM J TRANSPLANT, V5, P2929, DOI 10.1111/j.1600-6143.2005.01105.x; Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0; Kidney Disease Outcomes Quality Initiative (K/DOQI) Group, 2003, AM J KIDNEY DIS S, V41, pI; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Krane V, 2008, KIDNEY INT, V74, P1461, DOI 10.1038/ki.2008.484; Liu YM, 2004, JAMA-J AM MED ASSOC, V291, P451, DOI 10.1001/jama.291.4.451; Mason NA, 2005, AM J KIDNEY DIS, V45, P119, DOI 10.1053/j.ajkd.2004.09.025; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; *ROY COLL PHYS, 2006, CHRON KIDN DIS AD UK; Sarnak MJ, 2003, AM J KIDNEY DIS, V41, pS11, DOI 10.1016/S0272-6386(03)00372-X; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Shepherd J, 2008, J AM COLL CARDIOL, V51, P1448, DOI 10.1016/j.jacc.2007.11.072; Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Thavendiranathan P, 2006, ARCH INTERN MED, V166, P2307, DOI 10.1001/archinte.166.21.2307; Tonelli M, 2004, CIRCULATION, V110, P1557, DOI 10.1161/01.CIR.0000143892.84582.60; Tonelli M, 2006, BMJ-BRIT MED J, V332, P1426, DOI 10.1136/bmj.38814.566019.2F; Vaziri ND, 2006, AM J PHYSIOL-RENAL, V290, pF262, DOI 10.1152/ajprenal.00099.2005; Wanner C, 2005, NEW ENGL J MED, V353, P1640; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545	35	1406	1451	4	129	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2009	360	14					1395	1407		10.1056/NEJMoa0810177	http://dx.doi.org/10.1056/NEJMoa0810177			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427AL	19332456	Green Published			2022-12-28	WOS:000264751800005
J	Tess, AV; Smetana, GW				Tess, Anjala V.; Smetana, Gerald W.			Medical Evaluation of Patients Undergoing Electroconvulsive Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CARDIOVASCULAR COMPLICATIONS; BRAIN-TUMOR; HIGH-RISK; ECT; ESMOLOL; ASYSTOLE; SAFETY; GLYCOPYRROLATE; PRETREATMENT; LABETALOL	AFTER A PERIOD OF DECLINING USE, ELECTROCONVULSIVE THERAPY (ECT) is now used more widely as a treatment for major depression and other psychiatric disorders(1). Many patients undergoing ECT are elderly and have multiple coexisting medical conditions. Consultants are often asked to provide a medical evaluation before ECT, although many may feel uncomfortable in this role. There is little summary guidance from the literature on the medical assessment of these patients. The technique and efficacy of ECT have been reviewed in the Journal(1). In this article, we present an approach for medical consultants, with special attention to patients with coexisting medical conditions and to the management of complications that may occur after the procedure.	[Tess, Anjala V.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Tess, AV (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, 333 Brookline Ave, Boston, MA 02115 USA.	atess@bidmc.harvard.edu						ALEXOPOULOS GS, 1984, J AM GERIATR SOC, V32, P651, DOI 10.1111/j.1532-5415.1984.tb02253.x; American Psychiatric Association, 2001, PRACT EL THER REC TR; Burd J, 1998, AM J GERIAT PSYCHIAT, V6, P203; Carney S, 2003, LANCET, V361, P799; CASTELLI I, 1995, ANESTH ANALG, V80, P557, DOI 10.1097/00000539-199503000-00022; CATTAN RA, 1990, J AM GERIATR SOC, V38, P753, DOI 10.1111/j.1532-5415.1990.tb01465.x; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dannon PN, 1998, J ECT, V14, P245; de Carle AJ, 2000, J ECT, V16, P252, DOI 10.1097/00124509-200009000-00005; DEC GW, 1985, JAMA-J AM MED ASSOC, V253, P2525, DOI 10.1001/jama.253.17.2525; DECINA P, 1984, AM J PSYCHIAT, V141, P298; DEVANAND DP, 1988, J CLIN PSYCHOPHARM, V8, P153, DOI 10.1097/00004714-198804000-00027; Devanand DP, 1995, CONVULSIVE THER, V11, P232; Dolenc TJ, 2004, PACE, V27, P1257, DOI 10.1111/j.1540-8159.2004.00617.x; Fleisher LA, 2007, J AM COLL CARDIOL, V50, P1707, DOI 10.1016/j.jacc.2007.09.001; GERRING JP, 1982, J CLIN PSYCHIAT, V43, P140; GREENAN J, 1983, J ROY SOC MED, V76, P369; HOWIE MB, 1992, ANESTH ANALG, V75, P805; HOWIE MB, 1990, ANESTH ANALG, V71, P384; KRAMER BA, 1985, AM J PSYCHIAT, V142, P1190; Leung M, 2003, J CLIN PSYCHIAT, V64, P551, DOI 10.4088/JCP.v64n0509; Lisanby SH, 2007, NEW ENGL J MED, V357, P1939, DOI 10.1056/NEJMct075234; Locala JA, 2005, J ECT, V21, P12, DOI 10.1097/01.yct.0000154881.12464.57; MALTBIE AA, 1980, J NERV MENT DIS, V168, P400, DOI 10.1097/00005053-198007000-00002; Markowitz JS, 2001, J ECT, V17, P280, DOI 10.1097/00124509-200112000-00008; Martin M, 1992, J Geriatr Psychiatry Neurol, V5, P149; Mayur PM, 1998, BRIT J ANAESTH, V81, P466, DOI 10.1093/bja/81.3.466; McCall WV, 1996, J CLIN PSYCHIAT, V57, P199; McCully RB, 2003, AM J CARDIOL, V91, P1147, DOI 10.1016/S0002-9149(03)00172-3; Mehta V, 2004, MAYO CLIN PROC, V79, P1396, DOI 10.4065/79.11.1396; MILLER LJ, 1994, HOSP COMMUNITY PSYCH, V45, P444; Mueller PS, 2006, NETH J MED, V64, P417; Mueller PS, 2007, MAYO CLIN PROC, V82, P1360, DOI 10.4065/82.11.1360; Najjar F, 1998, J ECT, V14, P266; Patkar AA, 2000, J ECT, V16, P189, DOI 10.1097/00124509-200006000-00011; Patra KK, 2004, J ECT, V20, P186, DOI 10.1097/00124509-200409000-00011; Petrides G, 1996, CONVULSIVE THER, V12, P91; Rasmussen KG, 2007, J NEUROPSYCH CLIN N, V19, P191, DOI 10.1176/appi.neuropsych.19.2.191; Rasmussen P, 2007, J ECT, V23, P147, DOI 10.1097/YCT.0b013e318033ffd8; RICE EH, 1994, AM J PSYCHIAT, V151, P1637; Rose D, 2003, BRIT MED J, V326, P1363, DOI 10.1136/bmj.326.7403.1363; Rumi Demetrio Ortega, 2002, Arq Bras Cardiol, V79, P149; Sackeim HA, 2007, NEUROPSYCHOPHARMACOL, V32, P244, DOI 10.1038/sj.npp.1301180; Selim M, 2007, NEW ENGL J MED, V356, P706, DOI 10.1056/NEJMra062668; Shiwach RS, 2001, PSYCHIATR SERV, V52, P1095, DOI 10.1176/appi.ps.52.8.1095; Takada JY, 2005, BRAZ J MED BIOL RES, V38, P1349, DOI 10.1590/S0100-879X2005000900009; Tecoult E, 2001, EUR J ANAESTH, V18, P511, DOI 10.1046/j.1365-2346.2001.00885.x; van den Broek WW, 1999, BRIT J ANAESTH, V83, P271, DOI 10.1093/bja/83.2.271; WEINER SJ, 1994, HEADACHE, V34, P155, DOI 10.1111/j.1526-4610.1994.hed3403155.x; WEINGER MB, 1991, ANESTH ANALG, V73, P556; Wijeysundera DN, 2003, AM J MED, V114, P742, DOI 10.1016/S0002-9343(03)00165-7; ZIELINSKI RJ, 1993, AM J PSYCHIAT, V150, P904	52	81	86	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2009	360	14					1437	1444		10.1056/NEJMra0707755	http://dx.doi.org/10.1056/NEJMra0707755			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427AL	19339723				2022-12-28	WOS:000264751800009
J	Colwell, RR				Colwell, Rita R.			Professional Science Master's Programs Merit Wider Support	SCIENCE			English	Editorial Material									[Colwell, Rita R.] Univ Maryland, College Pk, MD 20742 USA; [Colwell, Rita R.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Colwell, Rita R.] Natl Sci Fdn, Arlington, VA 22230 USA	University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Science Foundation (NSF)	Colwell, RR (corresponding author), Univ Maryland, College Pk, MD 20742 USA.	rcolwell@umiacs.umd.edu						Colwell R, 2008, BIOSCIENCE, V58, P3, DOI 10.1641/B580101; National Research Council, 2008, SCI PROF MAST ED COM, DOI 10.17226/12064	2	6	6	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 27	2009	323	5922					1676	1677		10.1126/science.1171209	http://dx.doi.org/10.1126/science.1171209			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325100				2022-12-28	WOS:000264559800022
J	Jia, XT; Hofmann, M; Meunier, V; Sumpter, BG; Campos-Delgado, J; Romo-Herrera, JM; Son, HB; Hsieh, YP; Reina, A; Kong, J; Terrones, M; Dresselhaus, MS				Jia, Xiaoting; Hofmann, Mario; Meunier, Vincent; Sumpter, Bobby G.; Campos-Delgado, Jessica; Romo-Herrera, Jose Manuel; Son, Hyungbin; Hsieh, Ya-Ping; Reina, Alfonso; Kong, Jing; Terrones, Mauricio; Dresselhaus, Mildred S.			Controlled Formation of Sharp Zigzag and Armchair Edges in Graphitic Nanoribbons	SCIENCE			English	Article							THIN CARBON-FILMS; GRAPHENE NANORIBBONS	Graphene nanoribbons can exhibit either quasi-metallic or semiconducting behavior, depending on the atomic structure of their edges. Thus, it is important to control the morphology and crystallinity of these edges for practical purposes. We demonstrated an efficient edge-reconstruction process, at the atomic scale, for graphitic nanoribbons by Joule heating. During Joule heating and electron beam irradiation, carbon atoms are vaporized, and subsequently sharp edges and step-edge arrays are stabilized, mostly with either zigzag- or armchair-edge configurations. Model calculations show that the dominant annealing mechanisms involve point defect annealing and edge reconstruction.	[Hofmann, Mario; Son, Hyungbin; Hsieh, Ya-Ping; Kong, Jing; Dresselhaus, Mildred S.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Jia, Xiaoting; Reina, Alfonso] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Meunier, Vincent; Sumpter, Bobby G.] Oak Ridge Natl Lab, Div Math & Comp Sci, Oak Ridge, TN 37831 USA; [Meunier, Vincent; Sumpter, Bobby G.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; [Campos-Delgado, Jessica; Romo-Herrera, Jose Manuel; Terrones, Mauricio] Inst Potosino Invest Cient & Tecnol, Lab Nanosci & Nanotechnol Res LINAN, San Luis Potosi 78213, Mexico; [Campos-Delgado, Jessica; Romo-Herrera, Jose Manuel; Terrones, Mauricio] Inst Potosino Invest Cient & Tecnol, Adv Mat Dept, San Luis Potosi 78213, Mexico; [Dresselhaus, Mildred S.] MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; Instituto Potosino Investigacion Cientifica y Tecnologica; Instituto Potosino Investigacion Cientifica y Tecnologica; Massachusetts Institute of Technology (MIT)	Dresselhaus, MS (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	millie@mgm.mit.edu	Hofmann, Mario/ABH-6784-2020; Hsieh, Ya-Ping/N-4228-2017; Hofmann, Mario/A-8548-2008; Son, Hyungbin/AAH-8511-2021; Meunier, Vincent/F-9391-2010; Terrones, Mauricio/B-3829-2014; Jia, Xiaoting/E-2669-2015; Sumpter, Bobby G/C-9459-2013	Hofmann, Mario/0000-0003-1946-2478; Hsieh, Ya-Ping/0000-0002-6065-751X; Meunier, Vincent/0000-0002-7013-179X; Terrones, Mauricio/0000-0003-0010-2851; Jia, Xiaoting/0000-0003-4890-6103; Sumpter, Bobby G/0000-0001-6341-0355; CAMPOS-DELGADO, JESSICA/0000-0003-1273-5795	NSF [CTS-05-06830]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) Mexico [56787, 45772, 41464, 2004-01-013]; UT-Battelle; Division of Materials Science and Engineering, U.S. Department of Energy; Division of Scientific User Facilities, U.S. Department of Energy	NSF(National Science Foundation (NSF)); Consejo Nacional de Ciencia y Tecnologia (CONACYT) Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UT-Battelle; Division of Materials Science and Engineering, U.S. Department of Energy(United States Department of Energy (DOE)); Division of Scientific User Facilities, U.S. Department of Energy(United States Department of Energy (DOE))	We thank Z. Ren, S. Chen, B. I. Yakobson, S. Gradecak, G. Dresselhaus, and G. Chen for valuable and fruitful discussions, and E. Gracia-Espino for providing the Pt-coated ribbons that we used in some experiments. This work was supported by NSF grant Nanoscale Interdisciplinary Research Teams CTS-05-06830. We also thank Consejo Nacional de Ciencia y Tecnologia (CONACYT) Mexico for grants 56787 (Laboratory for Nanoscience and Nanotechnology Research LINAN), 45772 (M.T.), 41464 Interamerican Collaboration (M.T.), 2004-01-013/SALUD-CONACYT (M.T.), and Ph.D. scholarships (J.C.-D. and J.M.R.H.). A portion of the present research was supported in part by the Laboratory Directed Research and Development Program of ORNL, managed by UT-Battelle, by the Division of Materials Science and Engineering, U.S. Department of Energy, and by the Center for Nanophase Materials Sciences, sponsored by the Division of Scientific User Facilities, U.S. Department of Energy (V.M. and B.G.S.). A patent that is related to the production of these graphic nanoribbons has been submitted by some of the authors and holds the U.S. patent application number 12/042,544.	Areshkin DA, 2007, NANO LETT, V7, P204, DOI 10.1021/nl062132h; Banhart F, 1999, REP PROG PHYS, V62, P1181, DOI 10.1088/0034-4885/62/8/201; Campos-Delgado J, 2008, NANO LETT, V8, P2773, DOI 10.1021/nl801316d; Cancado LG, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.247401; Cancado LG, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.047403; Cervantes-Sodi F, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.165427; Enoki T, 2007, INT REV PHYS CHEM, V26, P609, DOI 10.1080/01442350701611991; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; GOMA J, 1980, THIN SOLID FILMS, V65, P221, DOI 10.1016/0040-6090(80)90256-4; Han MY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206805; Jin C, 2008, NANO LETT, V8, P1127, DOI 10.1021/nl0732676; Kelly B.T., 1981, PHYS GRAPHITE; Latil S, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.201402; Li TC, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.085408; Li XL, 2008, SCIENCE, V319, P1229, DOI 10.1126/science.1150878; Meyer JC, 2007, NATURE, V446, P60, DOI 10.1038/nature05545; Nakada K, 1996, PHYS REV B, V54, P17954, DOI 10.1103/PhysRevB.54.17954; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; ROUZAUD JN, 1983, THIN SOLID FILMS, V105, P75, DOI 10.1016/0040-6090(83)90333-4; Shemella P, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2761531; Son YW, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.216803; Son YW, 2006, NATURE, V444, P347, DOI 10.1038/nature05180; Tapaszto L, 2008, NAT NANOTECHNOL, V3, P397, DOI 10.1038/nnano.2008.149; Vandescuren M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195401; Wakabayashi K, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.125428; Wang XR, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.206803; Yang L, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.186801; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	29	583	589	4	325	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1701	1705		10.1126/science.1166862	http://dx.doi.org/10.1126/science.1166862			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325109				2022-12-28	WOS:000264559800032
J	Jenniskens, P; Shaddad, MH; Numan, D; Elsir, S; Kudoda, AM; Zolensky, ME; Le, L; Robinson, GA; Friedrich, JM; Rumble, D; Steele, A; Chesley, SR; Fitzsimmons, A; Duddy, S; Hsieh, HH; Ramsay, G; Brown, PG; Edwards, WN; Tagliaferri, E; Boslough, MB; Spalding, RE; Dantowitz, R; Kozubal, M; Pravec, P; Borovicka, J; Charvat, Z; Vaubaillon, J; Kuiper, J; Albers, J; Bishop, JL; Mancinelli, RL; Sandford, SA; Milam, SN; Nuevo, M; Worden, SP				Jenniskens, P.; Shaddad, M. H.; Numan, D.; Elsir, S.; Kudoda, A. M.; Zolensky, M. E.; Le, L.; Robinson, G. A.; Friedrich, J. M.; Rumble, D.; Steele, A.; Chesley, S. R.; Fitzsimmons, A.; Duddy, S.; Hsieh, H. H.; Ramsay, G.; Brown, P. G.; Edwards, W. N.; Tagliaferri, E.; Boslough, M. B.; Spalding, R. E.; Dantowitz, R.; Kozubal, M.; Pravec, P.; Borovicka, J.; Charvat, Z.; Vaubaillon, J.; Kuiper, J.; Albers, J.; Bishop, J. L.; Mancinelli, R. L.; Sandford, S. A.; Milam, S. N.; Nuevo, M.; Worden, S. P.			The impact and recovery of asteroid 2008 TC3	NATURE			English	Article								In the absence of a firm link between individual meteorites and their asteroidal parent bodies, asteroids are typically characterized only by their light reflection properties, and grouped accordingly into classes(1-3). On 6 October 2008, a small asteroid was discovered with a flat reflectance spectrum in the 554-995nm wavelength range, and designated 2008 TC3 (refs 4-6). It subsequently hit the Earth. Because it exploded at 37km altitude, no macroscopic fragments were expected to survive. Here we report that a dedicated search along the approach trajectory recovered 47 meteorites, fragments of a single body named Almahata Sitta, with a total mass of 3.95 kg. Analysis of one of these meteorites shows it to be an achondrite, a polymict ureilite, anomalous in its class: ultra-fine-grained and porous, with large carbonaceous grains. The combined asteroid and meteorite reflectance spectra identify the asteroid as F class(3), now firmly linked to dark carbon-rich anomalous ureilites, a material so fragile it was not previously represented in meteorite collections.	[Jenniskens, P.; Albers, J.; Bishop, J. L.; Mancinelli, R. L.] Carl Sagan Ctr, SETI Inst, Mountain View, CA 94043 USA; [Shaddad, M. H.; Numan, D.; Kudoda, A. M.] Univ Khartoum, Dept Phys, Khartoum 11115, Sudan; [Elsir, S.] Juba Univ, Dept Phys, Juba, Sudan; [Zolensky, M. E.; Le, L.; Robinson, G. A.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Le, L.; Robinson, G. A.] Jacobs Technol Engn Sci Contact Grp, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Friedrich, J. M.] Fordham Univ, Dept Chem, Bronx, NY 10458 USA; [Friedrich, J. M.] Amer Museum Nat Hist, Dept Earth & Planetary Sci, New York, NY 10024 USA; [Rumble, D.; Steele, A.] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Chesley, S. R.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Fitzsimmons, A.; Duddy, S.; Hsieh, H. H.] Queens Univ Belfast, Sch Math & Phys, Belfast BT7 1NN, Antrim, North Ireland; [Ramsay, G.] Armagh Observ, Armagh BT61 9DG, North Ireland; [Brown, P. G.; Edwards, W. N.] Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada; [Tagliaferri, E.] ET Space Syst, Camarillo, CA 93012 USA; [Boslough, M. B.; Spalding, R. E.] Sandia Natl Labs, Albuquerque, NM 87185 USA; [Dantowitz, R.; Kozubal, M.] Dexter Sch, Clay Ctr Observ, Brookline, MA 02445 USA; [Dantowitz, R.; Kozubal, M.] Southfield Sch, Clay Ctr Observ, Brookline, MA 02445 USA; [Pravec, P.; Borovicka, J.] Acad Sci Czech Republ, Astron Inst, Ondrejov 25165, Czech Republic; [Charvat, Z.] Czech Hydrometeorol Inst, Prague 14306 4, Czech Republic; [Vaubaillon, J.] Inst Mecan Celeste & Calcul Ephemerides, F-75014 Paris, France; [Kuiper, J.] Dutch Meteor Soc, NL-3732 XD De Bilt, Netherlands; [Sandford, S. A.; Milam, S. N.; Nuevo, M.; Worden, S. P.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	University of Khartoum; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Fordham University; American Museum of Natural History (AMNH); Carnegie Institution for Science; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Queens University Belfast; Western University (University of Western Ontario); United States Department of Energy (DOE); Sandia National Laboratories; Czech Academy of Sciences; Astronomical Institute of the Czech Academy of Sciences; Czech Hydrometeorological Institute; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Jenniskens, P (corresponding author), Carl Sagan Ctr, SETI Inst, 515 N Whisman Rd, Mountain View, CA 94043 USA.	Petrus.M.Jenniskens@nasa.gov	Rumble, Douglas/AAU-3930-2020; Borovicka, Jiri/F-4257-2014; Brown, Peter/C-8763-2018; Pravec, Petr/G-9037-2014; Pravec, Petr/AAE-2695-2019; Mancinelli, Rocco/L-8971-2016; Steele, Andrew/A-3573-2013; Milam, Stefanie/D-1092-2012	Rumble, Douglas/0000-0002-7440-9189; Borovicka, Jiri/0000-0002-5569-8982; Pravec, Petr/0000-0001-8434-9776; Steele, Andrew/0000-0001-9643-2841; Milam, Stefanie/0000-0001-7694-4129; Bishop, Janice/0000-0002-6681-9954; Zolensky, Michael/0000-0002-3181-1303; Brown, Peter/0000-0001-6130-7039	NASA Planetary Astronomy program; NASA's Cosmochemistry program [NNX07AI48G]; STFC [ST/F011016/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F011016/1] Funding Source: researchfish	NASA Planetary Astronomy program(National Aeronautics & Space Administration (NASA)); NASA's Cosmochemistry program(National Aeronautics & Space Administration (NASA)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the University of Khartoum for support of the field campaigns, and students and staff of the Physics Department of the Faculty of Sciences for their efforts to recover the meteorites. P. J. is supported by the NASA Planetary Astronomy program. D. R. acknowledges the support of NASA's Cosmochemistry program (grant NNX07AI48G). A. Alunni, J. Travis-Garcia and L. Hofland of NASA Ames Research Center, and J. Herrin of NASA Johnson Space Flight Center, provided laboratory assistance. The work conducted at JPL/Caltech was under contract with NASA. The William Hershel Telescope is operated on the island of La Palma by the Isaac Newton Group in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias.	BELL JF, 1989, ICARUS, V78, P426, DOI 10.1016/0019-1035(89)90189-9; BOROVICKA J, 2008, 8994 IAU; Britt DT, 2003, METEORIT PLANET SCI, V38, P1161, DOI 10.1111/j.1945-5100.2003.tb00305.x; Brown P, 2002, NATURE, V420, P294, DOI 10.1038/nature01238; Brown P, 2008, US GOVT RELEASE BOLI; Brown PG, 2002, METEORIT PLANET SCI, V37, P661, DOI 10.1111/j.1945-5100.2002.tb00846.x; Ceplecha Z, 1998, SPACE SCI REV, V84, P327, DOI 10.1023/A:1005069928850; CHESLEY S, 2008, NASA JPL NEAR EARTH; ELHASSAN M, 2008, TRAIL 2008 TC3; GAFFEY MJ, 1993, ICARUS, V106, P573, DOI 10.1006/icar.1993.1194; GOODRICH CA, 1992, METEORITICS, V27, P327, DOI 10.1111/j.1945-5100.1992.tb00215.x; Goodrich CA, 2007, GEOCHIM COSMOCHIM AC, V71, P2876, DOI 10.1016/j.gca.2007.03.023; Grady M.M., 2006, METEORITES EARLY SOL, P3; HIROI T, 2001, LUNAR PLANET SCI C, V32; Matthews M. S., 1989, ASTEROIDS, VII; McCoy TJ, 1996, GEOCHIM COSMOCHIM AC, V60, P2681, DOI 10.1016/0016-7037(96)00109-3; McGaha J.E., 2008, 2008TC50 MIN PLAN CT, P1; Mittlefehldt D. W., 1998, REV MINERAL, V36, P1; Pravec P, 2007, ICARUS, V190, P250, DOI 10.1016/j.icarus.2007.02.023; Pravec P, 2005, ICARUS, V173, P108, DOI 10.1016/j.icarus.2004.07.021; SANDFORD SA, 1993, METEORITICS, V28, P579, DOI 10.1111/j.1945-5100.1993.tb00281.x; SWINBANK R, 1994, MON WEATHER REV, V122, P686, DOI 10.1175/1520-0493(1994)122<0686:ASTDAS>2.0.CO;2; Tholen D.J., 1984, THESIS U ARIZONA TUC; Vernazza P, 2008, NATURE, V454, P858, DOI 10.1038/nature07154; Yeomans D., 2008, NASA JPL NEAR EARTH; ZELLNER B, 1985, ICARUS, V61, P355, DOI 10.1016/0019-1035(85)90133-2; Zolensky M, 2008, AM MINERAL, V93, P1295, DOI 10.2138/am.2008.2614	27	276	278	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					485	488		10.1038/nature07920	http://dx.doi.org/10.1038/nature07920			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19325630				2022-12-28	WOS:000264532400039
J	Bostrom, J; Yu, SF; Kan, D; Appleton, BA; Lee, CV; Billeci, K; Man, W; Peale, F; Ross, S; Wiesmann, C; Fuh, G				Bostrom, Jenny; Yu, Shang-Fan; Kan, David; Appleton, Brent A.; Lee, Chingwei V.; Billeci, Karen; Man, Wenyan; Peale, Franklin; Ross, Sarajane; Wiesmann, Christian; Fuh, Germaine			Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site	SCIENCE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SOMATIC HYPERMUTATION; BREAST-CANCER; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; RECEPTOR; COMPLEX; XENOGRAFTS; DIVERSITY	The interface between antibody and antigen is often depicted as a lock and key, suggesting that an antibody surface can accommodate only one antigen. Here, we describe an antibody with an antigen binding site that binds two distinct proteins with high affinity. We isolated a variant of Herceptin, a therapeutic monoclonal antibody that binds the human epidermal growth factor receptor 2 (HER2), on the basis of its ability to simultaneously interact with vascular endothelial growth factor (VEGF). Crystallographic and mutagenesis studies revealed that distinct amino acids of this antibody, called bH1, engage HER2 and VEGF energetically, but there is extensive overlap between the antibody surface areas contacting the two antigens. An affinity-improved version of bH1 inhibits both HER2-and VEGF-mediated cell proliferation in vitro and tumor progression in mouse models. Such "two-in-one" antibodies challenge the monoclonal antibody paradigm of one binding site, one antigen. They could also provide new opportunities for antibody-based therapy.	[Bostrom, Jenny; Appleton, Brent A.; Lee, Chingwei V.; Man, Wenyan; Wiesmann, Christian; Fuh, Germaine] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Yu, Shang-Fan; Kan, David; Ross, Sarajane] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Billeci, Karen] Genentech Inc, Dept Assay & Automat Technol, San Francisco, CA 94080 USA; [Peale, Franklin] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Fuh, G (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way, San Francisco, CA 94080 USA.	gml@gene.com		Appleton, Brent/0000-0003-1136-5649; Wiesmann, Christian/0000-0002-4092-9880	Chalmers University of Technology, Sweden; Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]	Chalmers University of Technology, Sweden; Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE))	We thank the Protein Engineering structure group, L. Haber, and D. McMahon for technical consultation and C. Eigenbrot for helpful advice. We also thank members of the DNA synthesis, DNA sequencing, in vivo cell culture, and protein chemistry groups at Genentech. We are grateful for the support of R. Neutze and Chalmers University of Technology, Sweden. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract no. DE-AC02-05CH11231. The atomic coordinates of the bH1/HER2 and bH1/VEGF were deposited in the Protein Data Bank with accession numbers 3BDY and 3BE1, respectively. G.F. and J.B. are inventors of the patent application "Multispecific Antibodies" (Pub. App. No. 20080069820), which relates to this work. All authors are or were under the employment of Genentech and declare competing financial interests.	Baselga J, 1998, CANCER RES, V58, P2825; Bernard-Marty C, 2006, DRUGS, V66, P1577, DOI 10.2165/00003495-200666120-00004; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Clark LA, 2006, J IMMUNOL, V177, P333, DOI 10.4049/jimmunol.177.1.333; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; DallAcqua W, 1996, BIOCHEMISTRY-US, V35, P9667, DOI 10.1021/bi960819i; FIELDS BA, 1995, NATURE, V374, P739, DOI 10.1038/374739a0; Foote J, 2003, SCIENCE, V299, P1327, DOI 10.1126/science.1082717; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Jimenez R, 2003, P NATL ACAD SCI USA, V100, P92, DOI 10.1073/pnas.262411399; KELLEY RF, 1993, BIOCHEMISTRY-US, V32, P6828, DOI 10.1021/bi00078a005; Kufer P, 2004, TRENDS BIOTECHNOL, V22, P238, DOI 10.1016/j.tibtech.2004.03.006; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; Mylvaganam SE, 1998, J MOL BIOL, V281, P301, DOI 10.1006/jmbi.1998.1942; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; Neuberger MS, 2008, IMMUNOL CELL BIOL, V86, P124, DOI 10.1038/sj.icb.7100160; NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; Pegram MD, 2002, SEMIN ONCOL, V29, P29, DOI 10.1053/sonc.2002.34053; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Senn BM, 2003, EUR J IMMUNOL, V33, P950, DOI 10.1002/eji.200323340; Sethi DK, 2006, IMMUNITY, V24, P429, DOI 10.1016/j.immuni.2006.02.010; Tomlinson IM, 1996, J MOL BIOL, V256, P813, DOI 10.1006/jmbi.1996.0127; WELLS JA, 1993, RECENT PROG HORM RES, V48, P253; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0	27	266	381	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1610	1614		10.1126/science.1165480	http://dx.doi.org/10.1126/science.1165480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299620				2022-12-28	WOS:000264342300040
J	Carreira, A; Hilario, J; Amitani, I; Baskin, RJ; Shivji, MKK; Venkitaraman, AR; Kowalczykowski, SC				Carreira, Aura; Hilario, Jovencio; Amitani, Ichiro; Baskin, Ronald J.; Shivji, Mahmud K. K.; Venkitaraman, Ashok R.; Kowalczykowski, Stephen C.			The BRC Repeats of BRCA2 Modulate the DNA-Binding Selectivity of RAD51	CELL			English	Article							HOMOLOGY-DIRECTED REPAIR; REPLICATION PROTEIN-A; FILAMENT FORMATION; STRAND EXCHANGE; RECOMBINATION; PROMOTES; COMPLEX; CANCER; STABILIZATION; MEDIATOR	The breast cancer susceptibility protein, BRCA2, is essential for recombinational DNA repair. BRCA2 delivers RAD51 to double-stranded DNA (dsDNA) breaks through interaction with eight conserved, similar to 35 amino acid motifs, the BRC repeats. Here we show that the solitary BRC4 promotes assembly of RAD51 onto single-stranded DNA (ssDNA), but not dsDNA, to stimulate DNA strand exchange. BRC4 acts by blocking ATP hydrolysis and thereby maintaining the active ATP-bound form of the RAD51-ssDNA filament. Single-molecule visualization shows that BRC4 does not disassemble RAD51-dsDNA filaments but rather blocks nucleation of RAD51 onto dsDNA. Furthermore, this behavior is manifested by a domain of BRCA2 comprising all eight BRC repeats. These results establish that the BRC repeats modulate RAD51-DNA interaction in two opposing but functionally reinforcing ways: targeting active RAD51 to ssDNA and prohibiting RAD51 nucleation onto dsDNA. Thus, BRCA2 recruits RAD51 to DNA breaks and, we propose, the BRC repeats regulate DNA-binding selectivity.	[Carreira, Aura; Hilario, Jovencio; Amitani, Ichiro; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Carreira, Aura; Hilario, Jovencio; Amitani, Ichiro; Baskin, Ronald J.; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Shivji, Mahmud K. K.; Venkitaraman, Ashok R.] Hutchison MRC Res Ctr, MRC, Canc Cell Unit, Cambridge CB2 0XZ, England	University of California System; University of California Davis; University of California System; University of California Davis	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu		Carreira, Aura/0000-0001-5489-4343	NIH [GM-62653, GM-64745]; Ministerio de Educacion y Ciencia (Spain); Susan G. Komen postdoctoral fellowship [PDF0707927]; U. K. Medical Research Council; MRC [G9900064, G0700651, G0600332, MC_U105359877] Funding Source: UKRI; Medical Research Council [G0700651, G9900064, G0600332, MC_U105359877] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062653, R01GM064745, R37GM062653] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Susan G. Komen postdoctoral fellowship(Susan G. Komen Breast Cancer Foundation); U. K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr. Ryan Jensen for providing us with the full-length BRCA2 construct and to all the members of the Kowalczykowski lab (Jason Bell, Petr Cejka, Anthony Forget, Ryan Jensen, Taeho Kim, Edgar Valencia-Morales, Amitabh Nimonkar, Jody Plank, Katsumi Morimatsu, Behzad Rad, Jason Wong, Rebecca Wright, and Liang Yang) for insightful comments on the manuscript. This work was supported by NIH grants (GM-62653 and GM-64745) to S. C. K., a postdoctoral fellowship from Ministerio de Educacion y Ciencia (Spain) to A. C., a Susan G. Komen postdoctoral fellowship (PDF0707927) to J. H., and funds from the U. K. Medical Research Council to M. K. K. S. and A. R. V. We thank Owen Davies and Luca Pellegrini for BRCA2BRC1-8 purification.	Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Chen CF, 1999, J BIOL CHEM, V274, P32931, DOI 10.1074/jbc.274.46.32931; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Galkin VE, 2005, P NATL ACAD SCI USA, V102, P8537, DOI 10.1073/pnas.0407266102; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Hilario J, 2009, P NATL ACAD SCI USA, V106, P361, DOI 10.1073/pnas.0811965106; Kim HK, 2002, GENES CELLS, V7, P1125, DOI 10.1046/j.1365-2443.2002.00588.x; Kowalczykowski SC, 2005, NATURE, V433, P591, DOI 10.1038/433591a; Mazin AV, 2000, EMBO J, V19, P1148, DOI 10.1093/emboj/19.5.1148; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Nomme J, 2008, GENES CELLS, V13, P471, DOI 10.1111/j.1365-2443.2008.01180.x; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Petalcorin MIR, 2007, P NATL ACAD SCI USA, V104, P8299, DOI [10.1073/pnas.0702805104, 10.1073/pnas.0702808104]; Saeki H, 2006, P NATL ACAD SCI USA, V103, P8768, DOI 10.1073/pnas.0600298103; San Filippo J, 2006, J BIOL CHEM, V281, P11649, DOI 10.1074/jbc.M601249200; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Shivji MKK, 2006, NUCLEIC ACIDS RES, V34, P4000, DOI 10.1093/nar/gkl505; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234	34	169	178	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1032	1043		10.1016/j.cell.2009.02.019	http://dx.doi.org/10.1016/j.cell.2009.02.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303847	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000264403900010
J	Volkow, ND; Fowler, JS; Logan, J; Alexoff, D; Zhu, W; Telang, F; Wang, GJ; Jayne, M; Hooker, JM; Wong, C; Hubbard, B; Carter, P; Warner, D; King, P; Shea, C; Xu, YW; Muench, L; Apelskog-Torres, K				Volkow, Nora D.; Fowler, Joanna S.; Logan, Jean; Alexoff, David; Zhu, Wei; Telang, Frank; Wang, Gene-Jack; Jayne, Millard; Hooker, Jacob M.; Wong, Christopher; Hubbard, Barbara; Carter, Pauline; Warner, Donald; King, Payton; Shea, Colleen; Xu, Youwen; Muench, Lisa; Apelskog-Torres, Karen			Effects of Modafinil on Dopamine and Dopamine Transporters in the Male Human Brain Clinical Implications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INDUCED WAKEFULNESS; DOUBLE-BLIND; ORAL METHYLPHENIDATE; C-11 RACLOPRIDE; BLOOD-FLOW; BINDING; DRUG; PET; AMPHETAMINE; INCREASES	Context Modafinil, a wake-promoting drug used to treat narcolepsy, is increasingly being used as a cognitive enhancer. Although initially launched as distinct from stimulants that increase extracellular dopamine by targeting dopamine transporters, recent preclinical studies suggest otherwise. Objective To measure the acute effects of modafinil at doses used therapeutically (200 mg and 400 mg given orally) on extracellular dopamine and on dopamine transporters in the male human brain. Design, Setting, and Participants Positron emission tomography with [C-11] raclopride (D-2/D-3 radioligand sensitive to changes in endogenous dopamine) and [C-11] cocaine (dopamine transporter radioligand) was used to measure the effects of modafinil on extracellular dopamine and on dopamine transporters in 10 healthy male participants. The study took place over an 8-month period (2007-2008) at Brookhaven National Laboratory. Main Outcome Measures Primary outcomes were changes in dopamine D-2/D-3 receptor and dopamine transporter availability (measured by changes in binding potential) after modafinil when compared with after placebo. Results Modafinil decreased mean (SD) [C-11] raclopride binding potential in caudate (6.1% [6.5%]; 95% confidence interval [CI], 1.5% to 10.8%; P = .02), putamen (6.7% [4.9%]; 95% CI, 3.2% to 10.3%; P = .002), and nucleus accumbens (19.4% [20%]; 95% CI, 5% to 35%; P = .02), reflecting increases in extracellular dopamine. Modafinil also decreased [C-11] cocaine binding potential in caudate (53.8% [13.8%]; 95% CI, 43.9% to 63.6%; P < .001), putamen (47.2% [11.4%]; 95% CI, 39.1% to 55.4%; P < .001), and nucleus accumbens (39.3% [10%]; 95% CI, 30% to 49%; P = .001), reflecting occupancy of dopamine transporters. Conclusions In this pilot study, modafinil blocked dopamine transporters and increased dopamine in the human brain ( including the nucleus accumbens). Because drugs that increase dopamine in the nucleus accumbens have the potential for abuse, and considering the increasing use of modafinil, these results highlight the need for heightened awareness for potential abuse of and dependence on modafinil in vulnerable populations.	[Volkow, Nora D.] Natl Inst Drug Abuse, Bethesda, MD 20892 USA; [Volkow, Nora D.; Telang, Frank; Jayne, Millard; Muench, Lisa] NIAAA, Bethesda, MD USA; [Fowler, Joanna S.; Logan, Jean; Alexoff, David; Wang, Gene-Jack; Hooker, Jacob M.; Wong, Christopher; Hubbard, Barbara; Carter, Pauline; Warner, Donald; King, Payton; Shea, Colleen; Xu, Youwen; Apelskog-Torres, Karen] Brookhaven Natl Lab, Upton, NY 11973 USA; [Fowler, Joanna S.; Wang, Gene-Jack] Mt Sinai Sch Med, New York, NY USA; [Fowler, Joanna S.] SUNY Stony Brook, Dept Chem, Stony Brook, NY USA; [Zhu, Wei] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); United States Department of Energy (DOE); Brookhaven National Laboratory; Icahn School of Medicine at Mount Sinai; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Volkow, ND (corresponding author), Natl Inst Drug Abuse, 6001 Execut Blvd,Room 5274,MSC 9581, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov	Hooker, Jacob M/P-5716-2018	Hooker, Jacob M/0000-0002-9394-7708; Logan, Jean/0000-0002-6993-9994	Brookhaven National Laboratory [DE-AC02-98CH10886]; Office of Biological and Environmental Research; National Institutes of Health [K05DA020001]; National Institute on Alcohol Abuse; Alcoholism Intramural research program [F32EB997320]; National Institute of Biomedical Imaging and Bioengineering; General Research Clinical Centers [MO1RR10710]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA020001] Funding Source: NIH RePORTER	Brookhaven National Laboratory(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Alcoholism Intramural research program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); General Research Clinical Centers; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was carried out at Brookhaven National Laboratory under contract DE-AC02-98CH10886 with the US Department of Energy with infrastructure support from its Office of Biological and Environmental Research. Support was also provided by grant K05DA020001 (J.S.F.) from the National Institutes of Health, the National Institute on Alcohol Abuse and Alcoholism Intramural research program, grant F32EB997320 (J.M.H.) from the National Institute of Biomedical Imaging and Bioengineering, and grant MO1RR10710 from the General Research Clinical Centers. A Goldhaber distinguished fellowship provided support for Dr Hooker.	ALEXOFF DL, 1995, NUCL MED BIOL, V22, P893, DOI 10.1016/0969-8051(95)00042-V; [Anonymous], 2007, NATURE, V450, P320, DOI 10.1038/450320a; Biederman J, 2006, J CLIN PSYCHIAT, V67, P727, DOI 10.4088/JCP.v67n0506; CRONE C, 1963, ACTA PHYSIOL SCAND, V58, P292, DOI 10.1111/j.1748-1716.1963.tb02652.x; Dackis CA, 2005, NEUROPSYCHOPHARMACOL, V30, P205, DOI 10.1038/sj.npp.1300600; EHRIN E, 1987, J LABELLED COMPD RAD, V24, P931, DOI 10.1002/jlcr.2580240808; Ferraro L, 1997, BIOL PSYCHIAT, V42, P1181, DOI 10.1016/S0006-3223(97)00353-3; FOWLER JS, 1989, SYNAPSE, V4, P371, DOI 10.1002/syn.890040412; Gjedde A, 2005, INT REV NEUROBIOL, V63, P1, DOI 10.1016/S0074-7742(05)63001-2; Gold LH, 1996, PSYCHOPHARMACOLOGY, V126, P286, DOI 10.1007/BF02247379; Greenhill LL, 2006, PEDIATR ANN, V35, P552, DOI 10.3928/0090-4481-20060801-07; Hart CL, 2008, NEUROPSYCHOPHARMACOL, V33, P761, DOI 10.1038/sj.npp.1301472; Hilaire ZD, 2001, NEUROREPORT, V12, P3533, DOI 10.1097/00001756-200111160-00032; Jasinski DR, 2000, CLIN NEUROPHARMACOL, V23, P149, DOI 10.1097/00002826-200005000-00004; Joo EP, 2008, J SLEEP RES, V17, P82, DOI 10.1111/j.1365-2869.2008.00624.x; Kruszewski SP, 2006, AM J PSYCHIAT, V163, P549, DOI 10.1176/appi.ajp.163.3.549; Kruszewski SP, 2007, J CLIN PSYCHIAT, V68, P970, DOI 10.4088/JCP.v68n0624b; Lin JS, 1996, P NATL ACAD SCI USA, V93, P14128, DOI 10.1073/pnas.93.24.14128; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; LOGAN J, 1994, J CEREBR BLOOD F MET, V14, P995, DOI 10.1038/jcbfm.1994.132; MACNAIR DM, 1971, EDITS MANUAL PROFILE; Madras BK, 2006, J PHARMACOL EXP THER, V319, P561, DOI 10.1124/jpet.106.106583; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; Minzenberg MJ, 2008, SCIENCE, V322, P1700, DOI 10.1126/science.1164908; Murillo-Rodriguez E, 2007, BEHAV BRAIN RES, V176, P353, DOI 10.1016/j.bbr.2006.10.016; Myrick Hugh, 2004, Ann Clin Psychiatry, V16, P101, DOI 10.1080/10401230490453743; Qu WM, 2008, J NEUROSCI, V28, P8462, DOI 10.1523/JNEUROSCI.1819-08.2008; SAS Institute Inc, SAS STAT 9 2 US GUID; Scammell TE, 2000, J NEUROSCI, V20, P8620, DOI 10.1523/JNEUROSCI.20-22-08620.2000; Stoops WW, 2005, PSYCHOPHARMACOLOGY, V182, P186, DOI 10.1007/s00213-005-0044-1; Volkow N, 2005, NAT NEUROSCI, V8, P1429, DOI 10.1038/nn1105-1429; VOLKOW ND, 1994, SYNAPSE, V16, P255, DOI 10.1002/syn.890160402; Volkow ND, 2002, SYNAPSE, V44, P175, DOI 10.1002/syn.10075; Volkow ND, 2002, SYNAPSE, V43, P181, DOI 10.1002/syn.10038; Volkow ND, 1998, AM J PSYCHIAT, V155, P1325, DOI 10.1176/ajp.155.10.1325; Wang GJ, 1997, EUR ADDICT RES, V3, P49, DOI 10.1159/000259147; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; 2006, 2006 PHYS DESK REFER, P1002	38	372	377	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 18	2009	301	11					1148	1154		10.1001/jama.2009.351	http://dx.doi.org/10.1001/jama.2009.351			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419UC	19293415	Green Published, Green Accepted			2022-12-28	WOS:000264244200020
J	Gal-Yam, A; Leonard, DC				Gal-Yam, A.; Leonard, D. C.			A massive hypergiant star as the progenitor of the supernova SN 2005gl	NATURE			English	Article							RED SUPERGIANT PROGENITOR; LUMINOUS BLUE VARIABLES	Our understanding of the evolution of massive stars before their final explosions as supernovae is incomplete, from both an observational and a theoretical standpoint. A key missing piece in the supernova puzzle is the difficulty of identifying and studying progenitor stars. In only a single case-that of supernova SN 1987A in the Large Magellanic Cloud-has a star been detected at the supernova location before the explosion, and been subsequently shown to have vanished after the supernova event(1). The progenitor of SN 1987A was a blue supergiant, which required a rethink of stellar evolution models(2). The progenitor of supernova SN 2005gl was proposed to be an extremely luminous object(3), but the association was not robustly established (it was not even clear that the putative progenitor was a single luminous star). Here we report that the previously proposed(3) object was indeed the progenitor star of SN 2005gl. This very massive star was likely a luminous blue variable that standard stellar evolution predicts should not have exploded in that state.	[Gal-Yam, A.] Weizmann Inst Sci, Fac Phys, Benoziyo Ctr Astrophys, IL-76100 Rehovot, Israel; [Leonard, D. C.] San Diego State Univ, Dept Astron, San Diego, CA 92182 USA	Weizmann Institute of Science; California State University System; San Diego State University	Gal-Yam, A (corresponding author), Weizmann Inst Sci, Fac Phys, Benoziyo Ctr Astrophys, IL-76100 Rehovot, Israel.	avishay.gal-yam@weizmann.ac.il		Gal-Yam, Avishay/0000-0002-3653-5598	Israeli Science Foundation; EU; Benoziyo Center for Astrophysics; Peter and Patricia Gruber; Weizmann Institute	Israeli Science Foundation(Israel Science Foundation); EU(European Commission); Benoziyo Center for Astrophysics; Peter and Patricia Gruber; Weizmann Institute	We acknowledge advice from E. Nakar, R. Sari, E. Baron, S. Smartt, M. Modjaz and P. Mazzali, and E. Ofek also for his help with Fig. 1. This work is based on observations with the NASA/ESA Hubble Space Telescope, obtained at the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., for NASA. A. G.-Y. acknowledges support by the Israeli Science Foundation, an EU Seventh Framework Programme Marie Curie IRG fellowship, the Benoziyo Center for Astrophysics, a research grant from the Peter and Patricia Gruber Awards, and the William Z. and Eda Bess Novick New Scientists Fund at the Weizmann Institute.	ALDERING G, 1994, ASTRON J, V107, P662, DOI 10.1086/116886; ARNETT WD, 1989, ANNU REV ASTRON ASTR, V27, P629, DOI 10.1146/annurev.aa.27.090189.003213; Dessart L, 2009, MON NOT R ASTRON SOC, V394, P21, DOI 10.1111/j.1365-2966.2008.14042.x; Filippenko AV, 1997, ANNU REV ASTRON ASTR, V35, P309, DOI 10.1146/annurev.astro.35.1.309; Gal-Yam A, 2007, ASTROPHYS J, V656, P372, DOI 10.1086/510523; GILMOZZI R, 1987, NATURE, V328, P318, DOI 10.1038/328318a0; Hendry MA, 2006, MON NOT R ASTRON SOC, V369, P1303, DOI 10.1111/j.1365-2966.2006.10374.x; HUMPHREYS RM, 1994, PUBL ASTRON SOC PAC, V106, P1025, DOI 10.1086/133478; Kotak R, 2006, ASTRON ASTROPHYS, V460, pL5, DOI 10.1051/0004-6361:20065800; LANGER N, 1994, ASTRON ASTROPHYS, V290, P819; Leonard DC, 2008, PUBL ASTRON SOC PAC, V120, P1259, DOI 10.1086/595797; Li WD, 2006, ASTROPHYS J, V641, P1060, DOI 10.1086/499916; MAEDER A, 1994, ANNU REV ASTRON ASTR, V32, P227; Mazzali PA, 2008, SCIENCE, V321, P1185, DOI 10.1126/science.1158088; Nadyozhin DK, 2003, MON NOT R ASTRON SOC, V346, P97, DOI 10.1046/j.1365-2966.2003.07070.x; Pastorello A, 2007, NATURE, V447, P829, DOI 10.1038/nature05825; PUCKETT T, 2005, IAU CIRC, V8615; Roelofs G, 2008, MON NOT R ASTRON SOC, V391, P290, DOI 10.1111/j.1365-2966.2008.13887.x; Salamanca I, 1998, MON NOT R ASTRON SOC, V300, pL17, DOI 10.1046/j.1365-8711.1998.02093.x; SCHLEGEL EM, 1990, MON NOT R ASTRON SOC, V244, P269; Smartt SJ, 2004, SCIENCE, V303, P499, DOI 10.1126/science.1092967; SMARTT SJ, 2008, DEATH MASSIVE STARS, V1; Smith N, 2008, ASTROPHYS J, V686, P467, DOI 10.1086/591021; Smith N, 2007, ASTROPHYS J, V666, P1116, DOI 10.1086/519949; Smith N, 2006, ASTROPHYS J, V645, pL45, DOI 10.1086/506523; Trundle C, 2008, ASTRON ASTROPHYS, V483, pL47, DOI 10.1051/0004-6361:200809755; VanDyk S.D., 2007, HIGHLIGHTS ASTRON, V14, P205, DOI [10.1017/S1743921307010174, DOI 10.1017/S1743921307010174]; Woosley SE, 2007, NATURE, V450, P390, DOI 10.1038/nature06333	28	248	249	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					865	867		10.1038/nature07934	http://dx.doi.org/10.1038/nature07934			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19305392				2022-12-28	WOS:000265182500037
J	Cohen, SP; Strassels, SA; Foster, L; Marvel, J; Williams, K; Crooks, M; Gross, A; Kurihara, C; Nguyen, C; Williams, N				Cohen, Steven P.; Strassels, Scott A.; Foster, Leslie; Marvel, John; Williams, Kayode; Crooks, Matthew; Gross, Andrew; Kurihara, Connie; Nguyen, Cuong; Williams, Necia			Comparison of fluoroscopically guided and blind corticosteroid injections for greater trochanteric pain syndrome: multicentre randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-BACK-PAIN; EPIDURAL STEROID INJECTIONS; HIP PAIN; LUMBOSACRAL RADICULOPATHY; BURSITIS; PROGNOSIS; GUIDANCE	Objective To determine whether fluoroscopic guidance improves outcomes of injections for greater trochanteric pain syndrome. Design Multicentre double blind randomised controlled study. Setting Three academic and military treatment facilities in the United States and Germany. Participants 65 patients with a clinical diagnosis of greater trochanteric pain syndrome. Interventions Injections of corticosteroid and local anaesthetic into the trochanteric bursa, using fluoroscopy (n=32) or landmarks ( that is, "blind" injections; n=33) for guidance. Main outcome measures Primary outcome measures: 010 numerical rating scale pain scores at rest and with activity at one month ( positive categorical outcome predefined as >= 50% pain reduction either at rest or with activity, coupled with positive global perceived effect). Secondary outcome measures included Oswestry disability scores, SF-36 scores, reduction in drug use, and patients' satisfaction. Results No differences in outcomes occurred favouring either the fluoroscopy or blind treatment groups. One month after injection the average pain scores were 2.7 at rest and 5.0 with activity in the fluoroscopy group compared with 2.2 and 4.0 in the blind injection group. Three months after the injection, 15 (47%) patients in the blind group and 13 (41%) in the fluoroscopy group continued to have a positive outcome. Conclusion Although using fluoroscopic guidance dramatically increases treatment costs for greater trochanteric pain syndrome, it does not necessarily improve outcomes. Trial registration Clinical trials NCT00480675	[Cohen, Steven P.; Marvel, John; Williams, Kayode; Crooks, Matthew] Johns Hopkins Sch Med, Dept Anesthesiol, Baltimore, MD USA; [Cohen, Steven P.] Johns Hopkins Sch Med, Dept Crit Care Med, Baltimore, MD USA; [Cohen, Steven P.; Kurihara, Connie] Walter Reed Army Med Ctr, Washington, DC 20307 USA; [Strassels, Scott A.] Univ Texas Austin, Div Pharm Practice, Austin, TX 78712 USA; [Nguyen, Cuong] Landstuhl Reg Med Ctr, Dept Surg, Phys Med & Rehabil Serv, Landstuhl, Germany; [Williams, Necia] Walter Reed Army Med Ctr, Integrated Anesthesia Serv, Bethesda, MD USA; [Williams, Necia] Natl Naval Med Ctr, Bethesda, MD USA; [Foster, Leslie] Walter Reed Army Med Ctr, Dept Orthoped Surg, Washington, DC USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; University of Texas System; University of Texas Austin; Landstuhl Regional Medical Center; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Cohen, SP (corresponding author), 550 N Broadway,Suite 301, Baltimore, MD 21029 USA.	scohen40@jhmi.edu			John P Murtha Neuroscience and Pain Institute, Johnstown, PA; US Army; Army Regional Anesthesia and Pain Medicine Initiative, Washington, DC	John P Murtha Neuroscience and Pain Institute, Johnstown, PA; US Army(United States Department of DefenseUnited States Army); Army Regional Anesthesia and Pain Medicine Initiative, Washington, DC	This study was funded in part by a congressional grant from the John P Murtha Neuroscience and Pain Institute, Johnstown, PA; the US Army; and the Army Regional Anesthesia and Pain Medicine Initiative, Washington, DC. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.	ANDERSON T P, 1958, Arch Phys Med Rehabil, V39, P617; BENZON HT, 1986, PAIN, V24, P277, DOI 10.1016/0304-3959(86)90115-6; Bird PA, 2001, ARTHRITIS RHEUM, V44, P2138, DOI 10.1002/1529-0131(200109)44:9<2138::AID-ART367>3.0.CO;2-M; Cohen SP, 2005, BRIT J ANAESTH, V94, P100, DOI 10.1093/bja/aei012; Cohen SP, 2007, ANESTHESIOLOGY, V107, P99, DOI 10.1097/01.anes.0000267518.20363.0d; Cohen SP, 2007, CLIN J PAIN, V23, P45, DOI 10.1097/01.ajp.0000210941.04182.ea; COLLEE G, 1990, BRIT J RHEUMATOL, V29, P354; Fairbank J C, 1980, Physiotherapy, V66, P271; Fishman SM, 1998, REGION ANESTH PAIN M, V23, P554, DOI 10.1016/S1098-7339(98)90080-3; Fredman B, 1999, ANESTH ANALG, V88, P367, DOI 10.1097/00000539-199902000-00027; GORDON E J, 1961, Clin Orthop, V20, P193; Kingzett-Taylor A, 1999, AM J ROENTGENOL, V173, P1123, DOI 10.2214/ajr.173.4.10511191; KROUT R M, 1959, Arch Phys Med Rehabil, V40, P8; Lievense A, 2005, BRIT J GEN PRACT, V55, P199; Manchikanti Laxmaiah, 2007, Pain Physician, V10, P261; Manchikanti Laxmaiah, 2004, Pain Physician, V7, P465; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; Perez RSGM, 2003, PAIN, V102, P297, DOI 10.1016/S0304-3959(02)00414-1; RAMAN D, 1982, ANN RHEUM DIS, V41, P602, DOI 10.1136/ard.41.6.602; RASMUSSEN KJE, 1985, SCAND J RHEUMATOL, V14, P417, DOI 10.3109/03009748509102047; RENFREW DL, 1991, AM J NEURORADIOL, V12, P1003; Rosenberg JM, 2000, CLIN J PAIN, V16, P18, DOI 10.1097/00002508-200003000-00004; Segal NA, 2007, ARCH PHYS MED REHAB, V88, P988, DOI 10.1016/j.apmr.2007.04.014; Shbeeb MI, 1996, J RHEUMATOL, V23, P2104; Stojanovic MP, 2002, SPINE, V27, P509, DOI 10.1097/00007632-200203010-00011; Strine TW, 2005, AM J PUBLIC HEALTH, V95, P2042, DOI 10.2105/AJPH.2005.066225; SWEZEY RL, 1976, ARCH PHYS MED REHAB, V57, P387; Tortolani P Justin, 2002, Spine J, V2, P251, DOI 10.1016/S1529-9430(02)00198-5; Walker P, 2007, CLIN ORTHOP RELAT R, P144, DOI 10.1097/BLO.0b013e31802f9f9a; Weinstein JN, 2007, SPINE, V32, pS58, DOI 10.1097/BRS.0b013e318053d4fc; WHITE AH, 1980, SPINE, V5, P78, DOI 10.1097/00007632-198001000-00014; World Health Organization, 2000, WORLD HLTH REP 2000	33	57	59	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2009	338								b1088	10.1136/bmj.b1088	http://dx.doi.org/10.1136/bmj.b1088			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434TI	19366755	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000265296600001
J	Nicholson, M; Hoye, R				Nicholson, Matthew; Hoye, Russell			Reducing Adolescents' Exposure to Alcohol Advertising and Promotion During Televised Sports	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							YOUTH		[Hoye, Russell] La Trobe Univ, Sch Management, Bundoora, Vic 3086, Australia; [Nicholson, Matthew] Univ Ballarat, Sch Human Movement & Sport Sci, Ballarat, Vic 3353, Australia	La Trobe University; Federation University Australia	Hoye, R (corresponding author), La Trobe Univ, Sch Management, Bundoora, Vic 3086, Australia.	r.hoye@latrobe.edu.au	Hoye, Russell/AAW-5890-2020	Hoye, Russell/0000-0001-9000-1848; Nicholson, Matthew/0000-0002-7229-6037				*ALC OTH DRUGS COU, 2005, SUBM NAT ALC STRAT 2; *AM MED ASS OFF AL, 2002, PARTN FOE ALC IND YO; Anderson P, 2009, ALCOHOL ALCOHOLISM, V44, P229, DOI 10.1093/alcalc/agn115; *CTR ALC MARK YOUT, 2008, YOUTH EXP ALC ADV TE; Federal Trade Commission, 2008, SELF REG ALC IND; Fortin RB, 2005, EFFECTIVENESS REGULA; Hastings G, 2005, J PUBLIC HEALTH POL, V26, P296, DOI 10.1057/palgrave.jphp.3200039; Jernigan DH, 2005, J PUBLIC HEALTH POL, V26, P287, DOI 10.1057/palgrave.jphp.3200042; *NAT AC SCI NAT AC, 2003, RED UND DRINK COLL R; Ringel JS, 2006, J ADOLESCENT HEALTH, V39, P473, DOI 10.1016/j.jadohealth.2006.02.006; *SEN STAND COMM CO, 2008, ALC TOLL RED BILL 20, P75; Shifrin DL, 2006, PEDIATRICS, V118, P2563, DOI 10.1542/peds.2006-2698; Statistical Research Inc., 2001, AAF ESPN CHILDR SPOR; *WHO DEP MENT HLTH, 2004, GLOB STAT REP ALC PO; Winter MV, 2008, J STUD ALCOHOL DRUGS, V69, P676, DOI 10.15288/jsad.2008.69.676	15	6	6	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 8	2009	301	14					1479	1482		10.1001/jama.2009.469	http://dx.doi.org/10.1001/jama.2009.469			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429MN	19351947				2022-12-28	WOS:000264924900030
J	Stanley, MA; Wilson, NL; Novy, DM; Rhoades, HM; Wagener, PD; Greisinger, AJ; Cully, JA; Kunik, ME				Stanley, Melinda A.; Wilson, Nancy L.; Novy, Diane M.; Rhoades, Howard M.; Wagener, Paula D.; Greisinger, Anthony J.; Cully, Jeffrey A.; Kunik, Mark E.			Cognitive Behavior Therapy for Generalized Anxiety Disorder Among Older Adults in Primary Care A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FORM HEALTH SURVEY; PSYCHOMETRIC PROPERTIES; LATER LIFE; DEPRESSION; QUALITY; SF-36; COOCCURRENCE; VALIDATION; UTILITY; IMPACT	Context Cognitive behavior therapy (CBT) can be effective for late-life generalized anxiety disorder (GAD), but only pilot studies have been conducted in primary care, where older adults most often seek treatment. Objective To examine effects of CBT relative to enhanced usual care (EUC) in older adults with GAD in primary care. Design, Setting, and Participants Randomized clinical trial recruiting 134 older adults (mean age, 66.9 years) from March 2004 to August 2006 in 2 primary care settings. Treatment was provided for 3 months; assessments were conducted at baseline, posttreatment (3 months), and over 12 months of follow-up, with assessments at 6, 9, 12, and 15 months. Intervention Cognitive behavior therapy (n=70) conducted in the primary care clinics. Treatment included education and awareness, motivational interviewing, relaxation training, cognitive therapy, exposure, problem-solving skills training, and behavioral sleep management. Patients assigned to receive EUC (n=64) received biweekly telephone calls to ensure patient safety and provide minimal support. Main Outcome Measures Primary outcomes included worry severity (Penn State Worry Questionnaire) and GAD severity (GAD Severity Scale). Secondary outcomes included anxiety ratings (Hamilton Anxiety Rating Scale, Beck Anxiety Inventory), coexistent depressive symptoms (Beck Depression Inventory II), and physical/mental health quality of life (12-Item Short Form Health Survey). Results Cognitive behavior therapy compared with EUC significantly improved worry severity (45.6 [95% confidence interval {CI}, 43.4-47.8] vs 54.4 [95% CI, 51.4-57.3], respectively; P < .001), depressive symptoms (10.2 [95% CI, 8.5-11.9] vs 12.8 [95% CI, 10.5-15.1], P=.02), and general mental health (49.6 [95% CI, 47.4-51.8] vs 45.3 [95% CI, 42.6-47.9], P=.008). There was no difference in GAD severity in patients receiving CBT vs those receiving EUC (8.6 [95% CI, 7.7-9.5] vs 9.9 [95% CI, 8.7-11.1], P=.19). In intention-to-treat analyses, response rates defined according to worry severity were higher following CBT compared with EUC at 3 months (40.0% [28/70] vs 21.9% [14/64], P=.02). Conclusions Compared with EUC, CBT resulted in greater improvement in worry severity, depressive symptoms, and general mental health for older patients with GAD in primary care. However, a measure of GAD severity did not indicate greater improvement with CBT. Trial Registration clinicaltrials.gov Identifier: NCT00308724	[Stanley, Melinda A.; Wilson, Nancy L.; Wagener, Paula D.; Cully, Jeffrey A.; Kunik, Mark E.] Houston Ctr Qual Care & Utilizat Studies, Houston, TX USA; [Stanley, Melinda A.; Wilson, Nancy L.; Cully, Jeffrey A.; Kunik, Mark E.] Baylor Coll Med, Houston, TX 77030 USA; [Novy, Diane M.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Rhoades, Howard M.] Univ Texas Houston, Hlth Sci Ctr, Houston, TX USA; [Greisinger, Anthony J.] Kelsey Res Fdn, Houston, TX USA; [Cully, Jeffrey A.; Kunik, Mark E.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Cully, Jeffrey A.; Kunik, Mark E.] VA S Cent Mental Illness Res Educ & Clin Ctr, Houston, TX USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Stanley, MA (corresponding author), Houston Ctr Qual Care & Utilizat Studies MEDVAMC, Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, 2002 Holcombe Blvd, Houston, TX 77030 USA.	mstanley@bcm.tmc.edu			National Institute of Mental Health (NIMH) [R01-MH53932]; Houston VA Health Services Research and Development Center of Excellence [HFP90-020]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH053932] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Houston VA Health Services Research and Development Center of Excellence; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding/Support: This research was supported by a grant from the National Institute of Mental Health (NIMH) (R01-MH53932) to Dr Stanley and by the Houston VA Health Services Research and Development Center of Excellence (Houston Center for Quality of Care and Utilization Studies [HFP90-020]).	Allain H, 2005, DRUG AGING, V22, P749, DOI 10.2165/00002512-200522090-00004; Arean P, 2008, GERONTOLOGIST, V48, P311, DOI 10.1093/geront/48.3.311; Beck A.T., 1996, BDI 2 BECK DEPRESSIO, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Beekman ATF, 1998, INT J GERIATR PSYCH, V13, P717, DOI 10.1002/(SICI)1099-1166(1998100)13:10<717::AID-GPS857>3.0.CO;2-M; Beekman ATF, 2000, AM J PSYCHIAT, V157, P89, DOI 10.1176/ajp.157.1.89; BORKOVEC TD, 1972, J BEHAV THER EXP PSY, V3, P257, DOI 10.1016/0005-7916(72)90045-6; Brenes GA, 2005, J AM GERIATR SOC, V53, P34, DOI 10.1111/j.1532-5415.2005.53007.x; Brenes GA, 2007, AM J GERIAT PSYCHIAT, V15, P262, DOI 10.1097/JGP.0b013e31802e21f0; First M. B., 1997, STRUCTURED CLIN INTE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Gum AM, 2006, GERONTOLOGIST, V46, P14, DOI 10.1093/geront/46.1.14; Hendriks GJ, 2008, ACTA PSYCHIAT SCAND, V117, P403, DOI 10.1111/j.1600-0447.2008.01190.x; Hopko DR, 2003, PSYCHOL ASSESSMENT, V15, P173, DOI 10.1037/1040-3590.15.2.173; Jenkinson C, 1997, J PUBLIC HEALTH MED, V19, P179, DOI 10.1093/oxfordjournals.pubmed.a024606; Mantella RC, 2007, AM J GERIAT PSYCHIAT, V15, P673, DOI 10.1097/JGP.0b013e31803111f2; McHorney CA, 1996, GERONTOLOGIST, V36, P571, DOI 10.1093/geront/36.5.571; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Mohlman J, 2005, BEHAV RES THER, V43, P447, DOI 10.1016/j.brat.2004.03.007; Mohlman J, 2003, AM J GERIAT PSYCHIAT, V11, P24; Pinquart M, 2007, AM J GERIAT PSYCHIAT, V15, P639, DOI 10.1097/JGP.0b013e31806841c8; Rollman BL, 2005, ARCH GEN PSYCHIAT, V62, P1332, DOI 10.1001/archpsyc.62.12.1332; Rollman BL, 2008, J GEN INTERN MED, V23, P447, DOI 10.1007/s11606-007-0449-0; Roy-Byrne PP, 2005, ARCH GEN PSYCHIAT, V62, P290, DOI 10.1001/archpsyc.62.3.290; Schoevers RA, 2005, AM J GERIAT PSYCHIAT, V13, P31, DOI 10.1176/appi.ajgp.13.1.31; Segal DL, 2008, BEHAV MODIF, V32, P3, DOI 10.1177/0145445507303833; Senior AC, 2007, PSYCHOL AGING, V22, P392, DOI 10.1037/0882-7974.22.2.392; Shear K, 2006, DEPRESS ANXIETY, V23, P77, DOI 10.1002/da.20149; Shear MK, 2001, DEPRESS ANXIETY, V13, P166, DOI 10.1002/da.1033.abs; Skopp NA, 2006, AM J GERIAT PSYCHIAT, V14, P292, DOI 10.1097/01.JGP.0000192505.56434.7e; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Stanley MA, 2004, BEHAV MODIF, V28, P73, DOI 10.1177/0145445503259259; Stanley MA, 2003, J CONSULT CLIN PSYCH, V71, P309, DOI 10.1037/0022-006X.71.2.309; Stanley MA, 2003, AM J GERIAT PSYCHIAT, V11, P92, DOI 10.1176/appi.ajgp.11.1.92; Stanley MA, 2001, J CLIN GEROPSYCHOLOG, V7, P105, DOI DOI 10.1023/A:1009533621832; Tolin DF, 2005, AM J GERIAT PSYCHIAT, V13, P150; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weiss Brandon J, 2009, Depress Anxiety, V26, pE10, DOI 10.1002/da.20520; Wells K, 2004, ARCH GEN PSYCHIAT, V61, P378, DOI 10.1001/archpsyc.61.4.378; Wells KB, 1999, SOC PSYCH PSYCH EPID, V34, P20, DOI 10.1007/s001270050107; Wetherell JL, 2005, PSYCHIAT CLIN N AM, V28, P871, DOI 10.1016/j.psc.2005.09.006; Wetherell JL, 2004, J PSYCHIAT RES, V38, P305, DOI 10.1016/j.jpsychires.2003.09.003; Wetherell JL, 2003, J CONSULT CLIN PSYCH, V71, P31, DOI 10.1037/0022-006X.71.1.31; WETHERELL JL, AM J GERIAT IN PRESS	44	178	180	2	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 8	2009	301	14					1460	1467		10.1001/jama.2009.458	http://dx.doi.org/10.1001/jama.2009.458			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429MN	19351943	Green Accepted			2022-12-28	WOS:000264924900026
J	Doherty, S				Doherty, Steven			Change Page Prescribe systemic corticosteroids in acute asthma	BRITISH MEDICAL JOURNAL			English	Editorial Material							EVIDENCE-BASED IMPLEMENTATION; EMERGENCY-DEPARTMENT; GUIDELINES		[Doherty, Steven] Univ Newcastle, Rural Clin Sch, Callaghan, NSW 2308, Australia; [Doherty, Steven] NEMSC, Tamworth, NSW 2348, Australia	University of Newcastle	Doherty, S (corresponding author), Univ Newcastle, Rural Clin Sch, Callaghan, NSW 2308, Australia.	Steven.doherty@hnehealth.nsw.gov.au						BOWLER SD, 1992, THORAX, V47, P584, DOI 10.1136/thx.47.8.584; Doherty S, 2007, J PAEDIATR CHILD H, V43, P611, DOI 10.1111/j.1440-1754.2007.01151.x; Doherty SR, 2007, EMERG MED AUSTRALAS, V19, P31, DOI 10.1111/j.1742-6723.2006.00910.x; Edmonds ML, 2002, CHEST, V121, P1798, DOI 10.1378/chest.121.6.1798; Ferlie EB, 2001, MILBANK Q, V79, P281, DOI 10.1111/1468-0009.00206; Gibson P, 1996, AUST PRESCR, V19, P44; *GLOB IN ASTHM, 2008, GLOB STRAT ASTHM MAN; Kelly AM, 2003, INTERN MED J, V33, P406, DOI 10.1046/j.1445-5994.2003.00469.x; *NAT I CLIN STUD, 2007, QUAL RES IMPL BEST P; Rowe BH, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000195.pub2; Rowe BH, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002178; Smith M., 2003, COCHRANE DB SYST REV, V2003, DOI DOI 10.1002/14651858.CD002886	12	1	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 3	2009	338								b1234	10.1136/bmj.b1234	http://dx.doi.org/10.1136/bmj.b1234			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429AP	19346286				2022-12-28	WOS:000264893500003
J	Pagano, D; Freemantle, N; Bridgewater, B; Howell, N; Ray, D; Jackson, M; Fabri, BM; Au, J; Keenan, D; Kirkup, B; Keogh, BE				Pagano, D.; Freemantle, N.; Bridgewater, B.; Howell, N.; Ray, D.; Jackson, M.; Fabri, B. M.; Au, J.; Keenan, D.; Kirkup, B.; Keogh, B. E.		QuORU UHB Birmingham; N W Quality Improvement Programme	Social deprivation and prognostic benefits of cardiac surgery: observational study of 44 902 patients from five hospitals over 10 years	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS-INDEX; SOCIOECONOMIC INEQUALITIES; CARDIOVASCULAR RISK; HEART-DISEASE; OBESITY; MORTALITY; HEALTH; OUTCOMES; TRIALS; WEIGHT	Objective To assess the effects of social deprivation on survival after cardiac surgery and to examine the influence of potentially modifiable risk factors. Design Analysis of prospectively collected data. Prognostic models used to examine the additional effect of social deprivation on the end points. Setting Birmingham and north west England. Participants 44 902 adults undergoing cardiac surgery, 1997-2007. Main outcome measures Social deprivation with census based 2001 Carstairs scores. All cause mortality in hospital and at mid-term follow-up. Results In hospital mortality for all cardiac procedures was 3.25% and mid-term follow-up ( median 1887 days; range 1180-2725 days) mortality was 12.4%. Multivariable analysis identified social deprivation as an independent predictor of mid-term mortality ( hazard ratio 1.024, 95% confidence interval 1.015 to 1.033; P<0.001). Smoking (P<0.001), body mass index (BMI, P<0.001), and diabetes (P<0.001) were associated with social deprivation. Smoking at time of surgery (1.294, 1.191 to 1.407, P<0.001) and diabetes (1.305, 1.217 to 1.399, P<0.001) were independent predictors of mid-term mortality. The relation between BMI and mid-term mortality was non-linear and risks were higher in the extremes of BMI (P<0.001). Adjustment for smoking, BMI, and diabetes reduced but did not eliminate the effects of social deprivation on mid-term mortality (1.017, 1.007 to 1.026, P<0.001). Conclusions Smoking, extremes of BMI, and diabetes, which are potentially modifiable risk factors associated with social deprivation, are responsible for a significant reduction in survival after surgery, but even after adjustment for these variables social deprivation remains a significant independent predictor of increased risk of mortality.	[Pagano, D.; Howell, N.; Ray, D.] Queen Elizabeth Hosp, Univ Hosp Birmingham Fdn Trust, Cardiothorac Surg Unit, Birmingham B15 2TH, W Midlands, England; [Freemantle, N.] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England; [Bridgewater, B.] Univ S Manchester Hosp, Dept Cardiothorac Surg, Manchester M23 9LT, Lancs, England; [Jackson, M.] Liverpool Heart & Chest Hosp NHS Trust, Dept Clin Qual, Liverpool L14 3PE, Merseyside, England; [Fabri, B. M.] Liverpool Heart & Chest Hosp NHS Trust, Dept Cardiothorac Surg, Liverpool L14 3PE, Merseyside, England; [Au, J.] Blackpool Victoria Hosp, Dept Cardiothorac Surg, Blackpool FY3 8NR, England; [Keenan, D.] Manchester Royal Infirm, Dept Cardiothorac Surg, Manchester M13 9WL, Lancs, England; [Kirkup, B.] Dept Hlth, London SW1A 2NS, England; [Keogh, B. E.] Univ Coll Hosp, London W1G 8PH, England	University of Birmingham; University of Birmingham; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Liverpool Heart & Chest Hospital; Liverpool Heart & Chest Hospital; University of Manchester; University of London; University College London	Pagano, D (corresponding author), Queen Elizabeth Hosp, Univ Hosp Birmingham Fdn Trust, Cardiothorac Surg Unit, Birmingham B15 2TH, W Midlands, England.	domenico.pagano@uhb.nhs.uk		Freemantle, Nick/0000-0001-5807-5740				Acheson D., 1998, INDEPENDENT INQUIRY; Alderman EL, 2000, J AM COLL CARDIOL, V35, P1122; Black Report, 1980, IN HLTH REP RES WORK; Bonow RO, 1998, CIRCULATION, V98, P1949, DOI 10.1161/01.CIR.98.18.1949; Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122; Delahanty LM, 2008, J AM DIET ASSOC, V108, pS66, DOI 10.1016/j.jada.2008.01.026; Ellaway A, 2005, BMJ-BRIT MED J, V331, P611, DOI 10.1136/bmj.38575.664549.F7; Galinanes M, 2004, CARDIOVASC RES, V61, P512, DOI 10.1016/j.cardiores.2003.11.028; Government Office for Science, 2007, FOR TACKL OB FUT CHO; Gruberg L, 2002, J AM COLL CARDIOL, V39, P578, DOI 10.1016/S0735-1097(01)01802-2; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Keogh B, 2004, 5 NATL ADULT CARDIAC; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; MARMOT MG, 1978, J EPIDEMIOL COMMUN H, V32, P244, DOI 10.1136/jech.32.4.244; Morgan Oliver, 2006, Health Stat Q, P28; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Pagano D, 2008, J THORAC CARDIOV SUR, V135, P495, DOI 10.1016/j.jtcvs.2007.11.045; PEKKANEN J, 1995, BRIT MED J, V311, P589, DOI 10.1136/bmj.311.7005.589; Romao I, 2008, J AM DIET ASSOC, V108, pS24, DOI 10.1016/j.jada.2008.01.022; SIMOPOULOS AP, 1984, ANN INTERN MED, V100, P285, DOI 10.7326/0003-4819-100-2-285; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; *TEAM RDC, 2004, LANG ENV STAT COMP; Toumpoulis IK, 2005, ANN THORAC SURG, V79, P1902, DOI 10.1016/j.athoracsur.2004.12.025; Tunstall-Pedoe H, 2006, HEART, V92, P307, DOI 10.1136/hrt.2005.077289; Wagner BD, 2007, ANN THORAC SURG, V84, P10, DOI 10.1016/j.athoracsur.2007.03.017; WANNAMETHEE G, 1989, BRIT MED J, V299, P1497, DOI 10.1136/bmj.299.6714.1497; *WHO, 1998, OB PREV MAN WORLD EP; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1	30	34	35	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2009	338								b902	10.1136/bmj.b902	http://dx.doi.org/10.1136/bmj.b902			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429AO	19342410	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000264893400008
J	Reilly, BM; Hart, PD; Mascarell, S; Chatrath, H				Reilly, Brendan M.; Hart, Peter D.; Mascarell, Susana; Chatrath, Hemant			A Question Well Put	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TUMOR-INDUCED OSTEOMALACIA; ONCOGENIC OSTEOMALACIA; PHOSPHATE HOMEOSTASIS; HYPOPHOSPHATEMIA; TRANSPORT; PROTEINS; FGF-23	A 51-year-old woman with a history of hypertension and depression reported progressively worsening pain in the left thigh over a period of several months, which had made her unable to walk for the past week. She also described generalized weakness and pains in her lower back, arms, and chest. She reported no weight loss, anorexia, trauma, or fever. She did not drink alcohol or smoke cigarettes. She reported having undergone hip surgery 6 months earlier to repair a "stress fracture" of her painful left leg. Physical examination was unremarkable except for severe pain with any movement of the patient's left thigh and tenderness to palpation of both upper arms, several ribs bilaterally, and her lower spine. Muscle strength and range of motion of the joints were otherwise normal.	[Reilly, Brendan M.] Weill Cornell Med Ctr, Dept Med, New York, NY 10065 USA; [Hart, Peter D.; Mascarell, Susana; Chatrath, Hemant] Cook Cty Stroger Hosp, Dept Med, Chicago, IL USA; [Hart, Peter D.; Mascarell, Susana] Rush Med Coll, Chicago, IL 60612 USA	Cornell University; John H Stroger Junior Hospital Cook County; Rush University	Reilly, BM (corresponding author), Weill Cornell Med Ctr, Dept Med, 525 E 68th St,Rm M-522,Box 130, New York, NY 10065 USA.	brr2013@med.cornell.edu	Chatrath, Hemant/D-9599-2012					CAI Q, 1994, NEW ENGL J MED, V330, P1645, DOI 10.1056/NEJM199406093302304; de Beur SMJ, 2005, JAMA-J AM MED ASSOC, V294, P1260; de Beur SMJ, 2002, J CLIN ENDOCR METAB, V87, P2467, DOI 10.1210/jc.87.6.2467; Dewey J., 1910, WE THINK; Hsu C, 2008, NEW ENGL J MED, V359, P640, DOI 10.1056/NEJMe0804660; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Kumar R, 2000, BONE, V27, P333, DOI 10.1016/S8756-3282(00)00334-3; Levi M, 2008, NEW ENGL J MED, V359, P1171, DOI 10.1056/NEJMe0805943; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; MCCANCE RA, 1947, Q J MED, V16, P33; Schiavi SC, 2002, CURR OPIN NEPHROL HY, V11, P423, DOI 10.1097/00041552-200207000-00009; Schon D.A, 2017, REFLECTIVE PRACTITIO; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Shimada T, 2002, ENDOCRINOLOGY, V143, P3179, DOI 10.1210/en.143.8.3179; Sommer S, 2007, J STEROID BIOCHEM, V103, P497, DOI 10.1016/j.jsbmb.2006.11.010	15	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2009	360	14					1446	1451		10.1056/NEJMcps0806165	http://dx.doi.org/10.1056/NEJMcps0806165			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427AL	19339725				2022-12-28	WOS:000264751800012
J	Yamanaka, S				Yamanaka, Shinya			A Fresh Look at iPS Cells	CELL			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; GENERATION; MOUSE; DIFFERENTIATION; EXPRESSION; INDUCTION; THERAPY; NEURONS; ALS	The potential of induced pluripotent stem (iPS) cells is enormous, but many obstacles remain before their medical and pharmaceutical applications can be fully realized.	Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	Kyoto University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Yamanaka, S (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan.	yamanaka@frontier.kyoto-u.ac.jp						Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Ellis J, 2009, CELL STEM CELL, V4, P198, DOI 10.1016/j.stem.2009.02.010; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; KAJI K, 2009, NATURE, DOI DOI 10.1038/NA-TURE07864; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Li JY, 2008, TRENDS NEUROSCI, V31, P146, DOI 10.1016/j.tins.2007.12.001; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yamanaka S, 2000, EMBO J, V19, P5533, DOI 10.1093/emboj/19.20.5533; Yang DL, 2008, STEM CELLS, V26, P55, DOI 10.1634/stemcells.2007-0494; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	41	517	566	9	186	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					13	17		10.1016/j.cell.2009.03.034	http://dx.doi.org/10.1016/j.cell.2009.03.034			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345179	Bronze			2022-12-28	WOS:000264813300006
J	Andriole, GL; Grubb, RL; Buys, SS; Chia, D; Church, TR; Fouad, MN; Gelmann, EP; Kvale, PA; Reding, DJ; Weissfeld, JL; Yokochi, LA; Crawford, ED; O'Brien, B; Clapp, JD; Rathmell, JM; Riley, TL; Hayes, RB; Kramer, BS; Izmirlian, G; Miller, AB; Pinsky, PF; Prorok, PC; Gohagan, JK; Berg, CD				Andriole, Gerald L.; Grubb, Robert L., III; Buys, Saundra S.; Chia, David; Church, Timothy R.; Fouad, Mona N.; Gelmann, Edward P.; Kvale, Paul A.; Reding, Douglas J.; Weissfeld, Joel L.; Yokochi, Lance A.; Crawford, E. David; O'Brien, Barbara; Clapp, Jonathan D.; Rathmell, Joshua M.; Riley, Thomas L.; Hayes, Richard B.; Kramer, Barnett S.; Izmirlian, Grant; Miller, Anthony B.; Pinsky, Paul F.; Prorok, Philip C.; Gohagan, John K.; Berg, Christine D.		PLCO Project Team	Mortality Results from a Randomized Prostate-Cancer Screening Trial	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; RADICAL PROSTATECTOMY; ANDROGEN DEPRIVATION; RADIATION-THERAPY; RISK-FACTORS; OUTCOMES; COMPLICATIONS; BIOPSIES; LUNG	Background The effect of screening with prostate-specific-antigen (PSA) testing and digital rectal examination on the rate of death from prostate cancer is unknown. This is the first report from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial on prostate-cancer mortality. Methods From 1993 through 2001, we randomly assigned 76,693 men at 10 U. S. study centers to receive either annual screening (38,343 subjects) or usual care as the control (38,350 subjects). Men in the screening group were offered annual PSA testing for 6 years and digital rectal examination for 4 years. The subjects and health care providers received the results and decided on the type of follow-up evaluation. Usual care sometimes included screening, as some organizations have recommended. The numbers of all cancers and deaths and causes of death were ascertained. Results In the screening group, rates of compliance were 85% for PSA testing and 86% for digital rectal examination. Rates of screening in the control group increased from 40% in the first year to 52% in the sixth year for PSA testing and ranged from 41 to 46% for digital rectal examination. After 7 years of follow-up, the incidence of prostate cancer per 10,000 person-years was 116 (2820 cancers) in the screening group and 95 (2322 cancers) in the control group (rate ratio, 1.22; 95% confidence interval [CI], 1.16 to 1.29). The incidence of death per 10,000 person-years was 2.0 (50 deaths) in the screening group and 1.7 (44 deaths) in the control group (rate ratio, 1.13; 95% CI, 0.75 to 1.70). The data at 10 years were 67% complete and consistent with these overall findings. Conclusions After 7 to 10 years of follow-up, the rate of death from prostate cancer was very low and did not differ significantly between the two study groups. (ClinicalTrials.gov number, NCT00002540.)	[Berg, Christine D.] NCI, Canc Prevent Div, NIH, Bethesda, MD 20892 USA; [Andriole, Gerald L.; Grubb, Robert L., III] Washington Univ, Sch Med, St Louis, MO USA; [Buys, Saundra S.] Huntsman Canc Inst, Salt Lake City, UT USA; [Chia, David] Univ Calif Los Angeles, Immunogenet Ctr, Los Angeles, CA USA; [Church, Timothy R.] Univ Minnesota, Minneapolis, MN USA; [Fouad, Mona N.] Univ Alabama Birmingham, Med Sch Birmingham, Birmingham, AL USA; [Gelmann, Edward P.] Georgetown Univ, Lombardi Canc Ctr, Washington, DC USA; [Kvale, Paul A.] Henry Ford Hlth Syst, Detroit, MI USA; [Reding, Douglas J.] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI 54449 USA; [Weissfeld, Joel L.] Univ Pittsburgh, Med Ctr Canc Pavil, Pittsburgh, PA USA; [Yokochi, Lance A.] Pacific Hlth Res Inst, Honolulu, HI USA; [Crawford, E. David] Univ Colorado, Anschutz Canc Pavil, Denver, CO 80202 USA; [O'Brien, Barbara] WESTAT Corp, Rockville, MD 20850 USA; [Clapp, Jonathan D.; Rathmell, Joshua M.; Riley, Thomas L.] Informat Management Serv Inc, Rockville, MD USA; [Kramer, Barnett S.] NIH, Off Dis Prevent, Bethesda, MD 20892 USA; [Miller, Anthony B.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL); Huntsman Cancer Institute; University of California System; University of California Los Angeles; University of Minnesota System; University of Minnesota Twin Cities; University of Alabama System; University of Alabama Birmingham; Georgetown University; Henry Ford Health System; Henry Ford Hospital; Marshfield Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pacific Health Research & Education Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Westat; Information Management Services, Inc.; National Institutes of Health (NIH) - USA; University of Toronto	Berg, CD (corresponding author), NCI, Canc Prevent Div, NIH, 6130 Execut Blvd,Rm 3112, Bethesda, MD 20892 USA.	bergc@mail.nih.gov	Schliep, Karen C/A-2803-2012; Church, Timothy/AAH-7017-2020	Church, Timothy/0000-0003-3292-5035; Clapp, Jonathan/0000-0002-8058-5808; Bresalier, Robert/0000-0002-9740-281X	National Cancer Institute; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN025514, N01CN025524, N01CN025515, N01CN025476] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [N01CA025518, N01CA075022, N01CA025511, N01CA025522, N01CA025513, N01CA025524, N01CA025514, N01CA025512, N01CA025516, N01CA025515] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by contracts from the National Cancer Institute.	Ahlbom A, 1993, BIOSTATISTICS EPIDEM; Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Alibhai, 2007, JNCI-J NATL CANCER I, V99, P1648, DOI 10.1093/jnci/djm222; Alibhai SMH, 2005, JNCI-J NATL CANCER I, V97, P1525, DOI 10.1093/jnci/dji313; American Cancer Society, AM CANC SOC GUID EAR; American Urological Association, 2000, ONCOLOGY WILLISTON P, V14, P277; American Urological Association, 2000, ONCOLOGY WILLISTON P, V14, P280; Andriole GL, 2005, JNCI-J NATL CANCER I, V97, P433, DOI 10.1093/jnci/dji065; *AUA, 2000, ONCOLOGY WILLISTON P, V14, P267; Aus G, 1996, BRIT J UROL, V77, P851, DOI 10.1046/j.1464-410X.1996.01014.x; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Etzioni R, 2008, LANCET ONCOL, V9, P407, DOI 10.1016/S1470-2045(08)70112-8; FLEMING ID, 2000, CONTROL CLIN TRIA S4, V21, pS400; Fowler FJ, 2002, CANCER-AM CANCER SOC, V95, P287, DOI 10.1002/cncr.10656; Gohagan JK, 2000, CONTROL CLIN TRIALS, V21, p251S, DOI 10.1016/S0197-2456(00)00097-0; Grubb RL, 2008, BJU INT, V102, P1524, DOI 10.1111/j.1464-410X.2008.08214.x; Hamilton AS, 2001, J CLIN ONCOL, V19, P2517, DOI 10.1200/JCO.2001.19.9.2517; Hayes RB, 2000, CONTROL CLIN TRIALS, V21, p349S, DOI 10.1016/S0197-2456(00)00101-X; KAWACHI MII, 2007, NAT COMPREHENSIVE CA; Labrie F, 2004, PROSTATE, V59, P311, DOI 10.1002/pros.20017; LIM AJ, 1995, J UROLOGY, V154, P1420, DOI 10.1016/S0022-5347(01)66881-2; Lin K, 2008, ANN INTERN MED, V149, P192, DOI 10.7326/0003-4819-149-3-200808050-00009; MARTIN RM, C18281A8145 CAN RES; Pinsky PF, 2005, J UROLOGY, V173, P746, DOI 10.1097/01.ju.0000152697.25708.71; Potosky AL, 2004, J NATL CANCER I, V96, P1358, DOI 10.1093/jnci/djh259; POTOSKY AL, 1995, JAMA-J AM MED ASSOC, V273, P548, DOI 10.1001/jama.273.7.548; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Rietbergen JBW, 1997, UROLOGY, V49, P875, DOI 10.1016/S0090-4295(97)00100-3; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Tsai HK, 2007, J NATL CANCER I, V99, P1516, DOI 10.1093/jnci/djm168; US Preventive Serv Task Force, 2008, ANN INTERN MED, V149, P185, DOI 10.7326/0003-4819-149-3-200808050-00008; Yao SL, 1999, J NATL CANCER I, V91, P1950, DOI 10.1093/jnci/91.22.1950	33	2083	2165	2	151	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2009	360	13					1310	1319		10.1056/NEJMoa0810696	http://dx.doi.org/10.1056/NEJMoa0810696			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423VP	19297565	Green Accepted			2022-12-28	WOS:000264524100006
J	Enriquez-Sarano, M; Akins, CW; Vahanian, A				Enriquez-Sarano, Maurice; Akins, Cary W.; Vahanian, Alec			Mitral regurgitation	LANCET			English	Review							CONGESTIVE-HEART-FAILURE; LEFT-VENTRICULAR DYSFUNCTION; QUANTITATIVE DOPPLER ASSESSMENT; NATRIURETIC PEPTIDE LEVELS; LONG-TERM SURVIVAL; VALVE REPAIR; ORIFICE AREA; MYOCARDIAL-INFARCTION; SURGICAL-CORRECTION; NATURAL-HISTORY	Mitral regurgitation affects more than 2 million people in the USA. The main causes are classified as degenerative (with valve prolapse) and ischaemic (ie, due to consequences of coronary disease) in developed countries, or rheumatic (in developing countries). This disorder generally progresses insidiously, because the heart compensates for increasing regurgitant volume by left-atrial enlargement, causes left-ventricular overload and dysfunction, and yields poor outcome when it becomes severe. Doppler-echocardiographic methods can be used to quantify the severity of mitral regurgitation. Yearly mortality rates with medical treatment in patients aged 50 years or older are about 3% for moderate organic regurgitation and about 6% for severe organic regurgitation. Surgery is the only treatment proven to improve symptoms and prevent heart failure. Valve repair improves outcome compared with valve replacement and reduces mortality of patient with severe organic mitral regurgitation by about 70%. The best short-term and long-term results are obtained in asymptomatic patients operated on in advanced repair centres with low operative mortality (<1%) and high repair rates (>= 80-90%). These results emphasise the importance of early detection and assessment of mitral regurgitation.	[Enriquez-Sarano, Maurice] Mayo Clin, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA; [Akins, Cary W.] Harvard Univ, Sch Med, Div Cardiac Surg, Boston, MA USA; [Vahanian, Alec] Univ Paris, Hop Bichat, Dept Cardiol, F-75252 Paris, France	Mayo Clinic; Harvard University; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Enriquez-Sarano, M (corresponding author), Mayo Clin, Div Cardiovasc Dis & Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	Sarano.maurice@mayo.edu						Acar C, 2004, J HEART VALVE DIS, V13, P741; AKINS CW, 1994, ANN THORAC SURG, V58, P668, DOI 10.1016/0003-4975(94)90725-0; Alfieri O, 2001, J THORAC CARDIOV SUR, V122, P674, DOI 10.1067/mtc.2001.117277; American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Amigoni M, 2007, EUR HEART J, V28, P326, DOI 10.1093/eurheartj/ehl464; ANWAR A, 1991, AM J MED SCI, V302, P89, DOI 10.1097/00000441-199108000-00004; Avierinos JF, 2003, STROKE, V34, P1339, DOI 10.1161/01.STR.0000072274.12041.FF; Avierinos JF, 2002, CIRCULATION, V106, P1355, DOI 10.1161/01.CIR.0000028933.34260.09; BARLOW JB, 1963, AM HEART J, V66, P443, DOI 10.1016/0002-8703(63)90375-2; Bax JJ, 2004, CIRCULATION, V110, pII103, DOI 10.1161/01.CIR-0000138196.06772.4e; BLOOMFIELD P, 1991, NEW ENGL J MED, V324, P573, DOI 10.1056/NEJM199102283240901; Borger MA, 2006, ANN THORAC SURG, V81, P1153, DOI 10.1016/j.athoracsur.2005.08.080; Breithardt OA, 2003, J AM COLL CARDIOL, V41, P765, DOI 10.1016/S0735-1097(02)02937-6; Bridgewater B, 2006, HEART, V92, P939, DOI 10.1136/hrt.2005.076109; Bursi F, 2006, AM J MED, V119, P103, DOI 10.1016/j.amjmed.2005.08.025; Bursi F, 2005, CIRCULATION, V111, P295, DOI 10.1161/01.CIR.0000151097.30779.04; Byrne MJ, 2004, CIRCULATION, V110, P3088, DOI 10.1161/01.CIR.0000146904.13677.E4; Capomolla S, 2000, AM HEART J, V139, P596, DOI 10.1016/S0002-8703(00)90036-X; CARPENTIER A, 1971, J THORAC CARDIOV SUR, V61, P1; CARPENTIER A, 1983, J THORAC CARDIOV SUR, V86, P323; COHN LH, 1988, ANN THORAC SURG, V45, P284, DOI 10.1016/S0003-4975(10)62463-0; Comin-Colet J, 2002, TRANSPLANT P, V34, P177, DOI 10.1016/S0041-1345(01)02717-8; Cosgrove DM, 1998, ANN THORAC SURG, V65, P1535, DOI 10.1016/S0003-4975(98)00300-2; COSGROVE DM, 1986, CIRCULATION, V74, P82; CRAWFORD MH, 1990, CIRCULATION, V81, P1173, DOI 10.1161/01.CIR.81.4.1173; DAVID TE, 1993, ANN THORAC SURG, V56, P7, DOI 10.1016/0003-4975(93)90396-Y; David TE, 2003, J THORAC CARDIOV SUR, V125, P1143, DOI 10.1067/mtc.2003.406; DELOCHE A, 1990, J THORAC CARDIOV SUR, V99, P990; Detaint D, 2005, CIRCULATION, V111, P2391, DOI 10.1161/01.CIR.0000164269.80908.9D; Detaint D, 2006, CIRCULATION, V114, P265, DOI 10.1161/CIRCULATIONAHA.106.619239; DiGregorio V, 2004, ANN THORAC SURG, V78, P807, DOI 10.1016/j.athoracsur.2004.03.041; Disse S, 1999, AM J HUM GENET, V65, P1242, DOI 10.1086/302624; Dujardin KS, 1997, CIRCULATION, V96, P3409; Dujardin KS, 2001, AM J CARDIOL, V87, P570, DOI 10.1016/S0002-9149(00)01433-8; DURAN CG, 1980, J THORAC CARDIOV SUR, V79, P326; Ellis SG, 2002, AM J CARDIOL, V89, P315, DOI 10.1016/S0002-9149(01)02231-7; Ennezat PV, 2006, HEART, V92, P1091, DOI 10.1136/hrt.2005.071654; Enriquez-Sarano M, 2005, NEW ENGL J MED, V352, P875, DOI 10.1056/NEJMoa041451; Enriquez-Sarano M, 1999, J AM COLL CARDIOL, V34, P1137, DOI 10.1016/S0735-1097(99)00313-7; Enriquez-Sarano R, 1999, J AM COLL CARDIOL, V34, P1129, DOI 10.1016/S0735-1097(99)00314-9; ENRIQUEZSARANO M, 1995, CIRCULATION, V91, P1022, DOI 10.1161/01.CIR.91.4.1022; EnriquezSarano M, 1997, J AM COLL CARDIOL, V29, P153, DOI 10.1016/S0735-1097(96)00436-6; ENRIQUEZSARANO M, 1995, J AM COLL CARDIOL, V25, P703, DOI 10.1016/0735-1097(94)00434-R; ENRIQUEZSARANO M, 1995, CIRCULATION, V92, P2496, DOI 10.1161/01.CIR.92.9.2496; ENRIQUEZSARANO M, 1994, J AM COLL CARDIOL, V24, P1536, DOI 10.1016/0735-1097(94)90151-1; ENRIQUEZSARANO M, 1993, J AM COLL CARDIOL, V21, P1211, DOI 10.1016/0735-1097(93)90248-Y; ENRIQUEZSARANO M, 1993, CIRCULATION, V87, P841, DOI 10.1161/01.CIR.87.3.841; ENRIQUEZSARANO M, 1994, CIRCULATION, V90, P830, DOI 10.1161/01.CIR.90.2.830; ENRIQUEZSARANO M, 1994, J AM COLL CARDIOL, V23, P443, DOI 10.1016/0735-1097(94)90432-4; ENRIQUEZSARANO M, 1995, CIRCULATION, V92, P2951, DOI 10.1161/01.CIR.92.10.2951; Essop MR, 2005, CIRCULATION, V112, P3584, DOI 10.1161/CIRCULATIONAHA.105.539775; Feldman T, 2005, J AM COLL CARDIOL, V46, P2134, DOI 10.1016/j.jacc.2005.07.065; Flameng W, 2003, CIRCULATION, V107, P1609, DOI 10.1161/01.CIR.0000058703.26715.9D; Fornes P, 1999, CARDIOVASC PATHOL, V8, P81, DOI 10.1016/S1054-8807(98)00021-0; FREEMAN WK, 1992, J AM COLL CARDIOL, V20, P599, DOI 10.1016/0735-1097(92)90014-E; Gammie JS, 2007, CIRCULATION, V115, P881, DOI 10.1161/CIRCULATIONAHA.106.634436; Gelfand EV, 2006, J CARDIOVASC MAGN R, V8, P503, DOI 10.1080/10976640600604856; Gillinov AM, 1998, J THORAC CARDIOV SUR, V116, P734, DOI 10.1016/S0022-5223(98)00450-4; Gillinov AM, 2001, J THORAC CARDIOV SUR, V122, P1125, DOI 10.1067/mtc.2001.116557; Gorman JH, 2006, SEMIN THORAC CARDIOV, V18, P135, DOI 10.1053/j.semtcvs.2006.07.003; Grande-Allen KJ, 2003, J AM COLL CARDIOL, V42, P271, DOI 10.1016/S0735-1097(03)00626-0; Grigioni F, 1999, J AM COLL CARDIOL, V34, P2078, DOI 10.1016/S0735-1097(99)00474-X; Grigioni F, 2005, J AM COLL CARDIOL, V45, P260, DOI 10.1016/j.jacc.2004.10.030; Grigioni F, 2002, J AM COLL CARDIOL, V40, P84, DOI 10.1016/S0735-1097(02)01922-8; Grigioni F, 2001, CIRCULATION, V103, P1759, DOI 10.1161/01.CIR.103.13.1759; GROSE R, 1984, CIRCULATION, V69, P214, DOI 10.1161/01.CIR.69.2.214; Grossi EA, 2001, J CARDIAC SURG, V16, P328, DOI 10.1111/j.1540-8191.2001.tb00530.x; Grossman PM, 2004, AM J PHYSIOL-HEART C, V287, pH878, DOI 10.1152/ajpheart.00007.2003; Hammermeister K, 2000, J AM COLL CARDIOL, V36, P1152, DOI 10.1016/S0735-1097(00)00834-2; HOCHREITER C, 1986, CIRCULATION, V73, P900, DOI 10.1161/01.CIR.73.5.900; HORSTKOTTE D, 1983, Z KARDIOL, V72, P494; Host U, 1997, AM J CARDIOL, V80, P655, DOI 10.1016/S0002-9149(97)00445-1; Hung J, 2004, CIRCULATION, V110, pII85, DOI 10.1161/01.CIR.0000138192.65015.45; Hung J, 2002, CIRCULATION, V106, P2594, DOI 10.1161/01.CIR.0000038363.83133.6D; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Kamblock J, 2005, J HEART VALVE DIS, V14, P440; KEREN G, 1986, AM HEART J, V112, P517, DOI 10.1016/0002-8703(86)90516-8; KEREN G, 1989, AM HEART J, V118, P748, DOI 10.1016/0002-8703(89)90588-7; KISHON Y, 1992, MAYO CLIN PROC, V67, P1023, DOI 10.1016/S0025-6196(12)61116-1; Klein A L, 1990, J Am Soc Echocardiogr, V3, P54; KLIGFIELD P, 1987, AM J CARDIOL, V60, P397, DOI 10.1016/0002-9149(87)90261-X; Kumanohoso T, 2003, J THORAC CARDIOV SUR, V125, P135, DOI 10.1067/mtc.2003.78; Lam BK, 2005, ANN THORAC SURG, V79, P462, DOI 10.1016/j.athoracsur.2004.07.040; Lamas GA, 1997, CIRCULATION, V96, P827; Lancellotti P, 2003, CIRCULATION, V108, P1713, DOI 10.1161/01.CIR.0000087599.49332.05; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lebrun F, 2001, J AM COLL CARDIOL, V38, P1685, DOI 10.1016/S0735-1097(01)01605-9; Lee EM, 1996, CIRCULATION, V94, P2117, DOI 10.1161/01.CIR.94.9.2117; Leung DY, 1996, J AM COLL CARDIOL, V28, P1198, DOI 10.1016/S0735-1097(96)00281-1; Levine AB, 1998, AM J CARDIOL, V82, P1299, DOI 10.1016/S0002-9149(98)00623-7; Levine HJ, 1996, J AM COLL CARDIOL, V28, P1083, DOI 10.1016/S0735-1097(96)00288-4; LEVINE RA, 1987, CIRCULATION, V75, P756, DOI 10.1161/01.CIR.75.4.756; Ling LH, 1996, NEW ENGL J MED, V335, P1417, DOI 10.1056/NEJM199611073351902; Ling LH, 1997, CIRCULATION, V96, P1819, DOI 10.1161/01.CIR.96.6.1819; Lund MB, 1996, HEART, V75, P591, DOI 10.1136/hrt.75.6.591; Mallidi HR, 2004, J THORAC CARDIOV SUR, V127, P636, DOI 10.1016/j.jtcvs.2003.09.010; Matsumura T, 2003, J AM COLL CARDIOL, V42, P458, DOI 10.1016/S0735-1097(03)00649-1; Matsunaga A, 2004, J HEART VALVE DIS, V13, P390; McGee EC, 2004, J THORAC CARDIOV SUR, V128, P916, DOI 10.1016/j.jtcvs.2004.07.037; Mehta RH, 2000, AM J CARDIOL, V86, P1193, DOI 10.1016/S0002-9149(00)01201-7; Messas E, 2001, CIRCULATION, V104, P1958, DOI 10.1161/hc4201.097135; Messika-Zeitoun D, 2006, J AM COLL CARDIOL, V47, P2521, DOI 10.1016/j.jacc.2006.02.043; Mitts WR, 2004, AM HEART J, V148, P144, DOI 10.1016/j.ahj.2004.01.021; Mohr FW, 1999, EUR J CARDIO-THORAC, V15, P233, DOI 10.1016/S1010-7940(99)00033-0; MOHTY D, 2001, CIRCULATION S1, V104, P11; Monin JL, 2005, J AM COLL CARDIOL, V46, P302, DOI 10.1016/j.jacc.2005.03.064; Nagatsu M, 2000, CIRCULATION, V101, P653, DOI 10.1161/01.CIR.101.6.653; Ngaage DL, 2004, J CARDIOVASC SURG, V45, P477; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; OLSON LJ, 1987, MAYO CLIN PROC, V62, P22, DOI 10.1016/S0025-6196(12)61522-5; Pierard LA, 2004, NEW ENGL J MED, V351, P1627, DOI 10.1056/NEJMoa040532; ROLDAN CA, 1992, J AM COLL CARDIOL, V20, P1127, DOI 10.1016/0735-1097(92)90368-W; ROSEN SE, 1994, AM J CARDIOL, V74, P374, DOI 10.1016/0002-9149(94)90406-5; Rosenhek R, 2006, CIRCULATION, V113, P2238, DOI 10.1161/CIRCULATIONAHA.105.599175; Rossi A, 2000, J AM COLL CARDIOL, V35, P1256, DOI 10.1016/S0735-1097(00)00515-5; SCHON HR, 1994, J HYPERTENS, V12, pS95; SCHWAMMENTHAL E, 1994, CIRCULATION, V90, P307, DOI 10.1161/01.CIR.90.1.307; Shuhaiber J, 2007, EUR J CARDIO-THORAC, V31, P267, DOI 10.1016/j.ejcts.2006.11.014; Smedira NG, 1996, J THORAC CARDIOV SUR, V112, P287, DOI 10.1016/S0022-5223(96)70251-9; STARLING MR, 1993, J AM COLL CARDIOL, V22, P239, DOI 10.1016/0735-1097(93)90840-W; STEVENSON LW, 1990, J AM COLL CARDIOL, V15, P174, DOI 10.1016/0735-1097(90)90196-V; Suri RM, 2006, J THORAC CARDIOV SUR, V132, P1390, DOI 10.1016/j.jtcvs.2006.07.018; Sutton TM, 2003, J AM COLL CARDIOL, V41, P2280, DOI 10.1016/S0735-1097(03)00486-8; TCHENG JE, 1992, ANN INTERN MED, V117, P18, DOI 10.7326/0003-4819-117-1-18; Tischler MD, 1998, AM J CARDIOL, V82, P242, DOI 10.1016/S0002-9149(98)00325-7; Tribouilloy CM, 1999, CIRCULATION, V99, P400, DOI 10.1161/01.CIR.99.3.400; Tribouilloy CM, 1998, CIRCULATION, V98, pII108; Trochu JN, 2000, J AM COLL CARDIOL, V35, P1890, DOI 10.1016/S0735-1097(00)00617-3; Vahanian A, 2004, CIRCULATION, V109, P1572, DOI 10.1161/01.CIR.0000124794.16806.E3; Vahanian A, 2007, EUR HEART J, V28, P230, DOI 10.1093/eurheartj/ehl428; VANDERVOORT PM, 1993, CIRCULATION, V88, P1150, DOI 10.1161/01.CIR.88.3.1150; Waagstein F, 2003, EUR J HEART FAIL, V5, P679, DOI 10.1016/S1388-9842(03)00105-3; Watanabe N, 2005, J AM COLL CARDIOL, V45, P763, DOI 10.1016/j.jacc.2004.11.048; Webb JG, 2006, CIRCULATION, V113, P851, DOI 10.1161/CIRCULATIONAHA.105.591602; Westenberg JJM, 2005, CIRCULATION, V112, pI437, DOI 10.1161/CIRCULATIONAHA.104.525501; WISENBAUGH T, 1994, CIRCULATION, V89, P191, DOI 10.1161/01.CIR.89.1.191; WISENBAUGH T, 1984, J AM COLL CARDIOL, V3, P916, DOI 10.1016/S0735-1097(84)80349-6; Wong DR, 2005, ANN THORAC SURG, V80, P570, DOI 10.1016/j.athoracsur.2005.03.034; Wu AH, 2005, J AM COLL CARDIOL, V45, P381, DOI 10.1016/j.jacc.2004.09.073; YELLIN EL, 1979, CIRC RES, V45, P677, DOI 10.1161/01.RES.45.5.677; Yiu SF, 2000, CIRCULATION, V102, P1400, DOI 10.1161/01.CIR.102.12.1400; YORAN C, 1979, CIRCULATION, V60, P170, DOI 10.1161/01.CIR.60.1.170; Yun KL, 1999, CIRCULATION, V100, P90; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	144	523	541	0	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2009	373	9672					1382	1394		10.1016/S0140-6736(09)60692-9	http://dx.doi.org/10.1016/S0140-6736(09)60692-9			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434UR	19356795				2022-12-28	WOS:000265300100036
J	Akopyants, NS; Kimblin, N; Secundino, N; Patrick, R; Peters, N; Lawyer, P; Dobson, DE; Beverley, SM; Sacks, DL				Akopyants, Natalia S.; Kimblin, Nicola; Secundino, Nagila; Patrick, Rachel; Peters, Nathan; Lawyer, Phillip; Dobson, Deborah E.; Beverley, Stephen M.; Sacks, David L.			Demonstration of Genetic Exchange During Cyclical Development of Leishmania in the Sand Fly Vector	SCIENCE			English	Article							TRYPANOSOMA-BRUCEI; GENOMIC ORGANIZATION; DONOVANI COMPLEX; MAJOR FRIEDLIN; RECOMBINATION; TRANSMISSION; EXPRESSION; VIRULENCE; MARKER; CROSS	Genetic exchange has not been shown to be a mechanism underlying the extensive diversity of Leishmania parasites. We report here evidence that the invertebrate stages of Leishmania are capable of having a sexual cycle consistent with a meiotic process like that described for African trypanosomes. Hybrid progeny were generated that bore full genomic complements from both parents, but kinetoplast DNA maxicircles from one parent. Mating occurred only in the sand fly vector, and hybrids were transmitted to the mammalian host by sand fly bite. Genetic exchange likely contributes to phenotypic diversity in natural populations, and analysis of hybrid progeny will be useful for positional cloning of the genes controlling traits such as virulence, tissue tropism, and drug resistance.	[Kimblin, Nicola; Secundino, Nagila; Patrick, Rachel; Peters, Nathan; Lawyer, Phillip; Sacks, David L.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Akopyants, Natalia S.; Dobson, Deborah E.; Beverley, Stephen M.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Washington University (WUSTL)	Sacks, DL (corresponding author), NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	dsacks@nih.gov	Secundino, Nagila/AAM-4553-2020; Peters, Nathan/AAW-8289-2020	Peters, Nathan/0000-0002-2548-9581; Beverley, Stephen/0000-0001-5319-0811	Intramural Research Program of the NIH; National Institute of Allergy and Infectious Diseases (NIAID) [A1029646, A1020941]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029646, ZIAAI000256] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases (NIAID), and in part by NIAID grant support (S.M.B., D.E.D., and N.S.A. A1029646 and A1020941). We thank K. Owens for inventorying and shipping parasite strains; K. Beacht for mouse infection studies; and M. Grigg, L. Miller, and A. Sher for critical review of the manuscript. Maxicircle sequences have been submitted to GenBank and had been assigned accession numbers FJ349262 to FJ349263 (12S rRNA) and FJ349264 to FJ349265 (Divergent region).	Capul AA, 2007, INFECT IMMUN, V75, P4629, DOI 10.1128/IAI.00735-07; Capul AA, 2007, J BIOL CHEM, V282, P14006, DOI 10.1074/jbc.M610869200; CRUZ AK, 1993, P NATL ACAD SCI USA, V90, P1599, DOI 10.1073/pnas.90.4.1599; Dobson DE, 2006, MOL BIOCHEM PARASIT, V146, P231, DOI 10.1016/j.molbiopara.2005.12.012; Dobson DE, 2003, J BIOL CHEM, V278, P28840, DOI 10.1074/jbc.M302728200; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; GIBSON W, 1992, MOL BIOCHEM PARASIT, V51, P189, DOI 10.1016/0166-6851(92)90069-V; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Heitman J, 2006, CURR BIOL, V16, pR711, DOI 10.1016/j.cub.2006.07.064; Hope M, 1999, MOL BIOCHEM PARASIT, V104, P1, DOI 10.1016/S0166-6851(99)00103-6; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; JENNI L, 1986, NATURE, V322, P173, DOI 10.1038/322173a0; JOSHI PB, 1995, GENE, V156, P145, DOI 10.1016/0378-1119(95)00042-5; KELLY JM, 1991, MOL BIOCHEM PARASIT, V46, P253, DOI 10.1016/0166-6851(91)90049-C; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; Martinez-Calvillo S, 2001, MOL BIOCHEM PARASIT, V116, P147, DOI 10.1016/S0166-6851(01)00310-3; Mauricio IL, 1999, PARASITOLOGY, V119, P237, DOI 10.1017/S0031182099004710; MOODY ME, 1993, GENETICS, V134, P649; Nolder D, 2007, AM J TROP MED HYG, V76, P573, DOI 10.4269/ajtmh.2007.76.573; Ravel C, 1998, PARASITOL TODAY, V14, P301, DOI 10.1016/S0169-4758(98)01275-7; Ravel C, 2006, INT J PARASITOL, V36, P1383, DOI 10.1016/j.ijpara.2006.06.019; Rose MD, 1996, ANNU REV CELL DEV BI, V12, P663, DOI 10.1146/annurev.cellbio.12.1.663; Schwenkenbecher JM, 2006, INT J PARASITOL, V36, P237, DOI 10.1016/j.ijpara.2005.09.010; Thiel T, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh006; Tibayrenc M., 1993, Archives de l'Institut Pasteur de Tunis, V70, P375; TURNER CMR, 1995, EXP PARASITOL, V80, P234, DOI 10.1006/expr.1995.1029	26	224	226	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					265	268		10.1126/science.1169464	http://dx.doi.org/10.1126/science.1169464			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359589	Green Accepted			2022-12-28	WOS:000265024400050
J	Turnipseed, M; Crowder, LB; Sagarin, RD; Roady, SE				Turnipseed, Mary; Crowder, Larry B.; Sagarin, Raphael D.; Roady, Stephen E.			Legal Bedrock for Rebuilding America's Ocean Ecosystems	SCIENCE			English	Editorial Material									[Turnipseed, Mary; Roady, Stephen E.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Crowder, Larry B.] Duke Univ, Nicholas Sch Environm, Ctr Marine Conservat, Beaufort, NC 28516 USA; [Sagarin, Raphael D.] Duke Univ, Nicholas Inst Environm Policy Solut, Durham, NC 27708 USA; [Roady, Stephen E.] Duke Univ, Sch Law, Durham, NC 27708 USA; [Roady, Stephen E.] Earthjustice, Washington, DC 20036 USA	Duke University; Duke University; Duke University; Duke University	Turnipseed, M (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	mary.turnipseed@duke.edu						[Anonymous], 1983, FED REGISTER, V48; Archer J. H., 1994, PUBLIC TRUST DOCTRIN; Crowder LB, 2006, SCIENCE, V313, P617, DOI 10.1126/science.1129706; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; McLeod K.L., 2005, SCI CONSENSUS STATEM; PARENTEAU PA, 2008, OCEAN COASTAL LAW PO, pCH19; *PEW OC COMM, 2003, AM LIV OC CHART COUR; Rosenberg AA, 2006, FRONT ECOL ENVIRON, V4, P303, DOI 10.1890/1540-9295(2006)4[303:RUFPAP]2.0.CO;2; Ruhl J. B., 2006, SE ENV LAW J, V15, P223; SHACKEROFF JS, ECOSYSTEM B IN PRESS; Turnipseed M, 2009, ECOL LAW QUART, V36, P1; *US COMM OC POL, 2004, OC BLUEPR 21 CENT FI; 2007, GLOBAL MARITIME BOUN; [No title captured]	14	30	32	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					183	184		10.1126/science.1170889	http://dx.doi.org/10.1126/science.1170889			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	430WX	19359567	Green Submitted			2022-12-28	WOS:000265024400023
J	West, SD; McBeath, HA; Stradling, JR				West, Sophie D.; McBeath, Helen A.; Stradling, John R.			Easily Missed? Obstructive sleep apnoea in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSITIVE AIRWAY PRESSURE; PREVALENCE; RISK; MEN		[West, Sophie D.; Stradling, John R.] Churchill Hosp, Oxford Ctr Resp Med, Sleep Unit, Oxford OX3 7LJ, England; [McBeath, Helen A.] St Clements Surg, Oxford OX4 1JS, England	University of Oxford	West, SD (corresponding author), Churchill Hosp, Oxford Ctr Resp Med, Sleep Unit, Oxford OX3 7LJ, England.	sophie@west66.freeserve.co.uk		Stradling, John/0000-0003-4971-5018				[Anonymous], 2008, BBC NEWS; Cross MD, 2008, THORAX, V63, P578, DOI 10.1136/thx.2007.081877; Dancey DR, 2003, CHEST, V123, P1544, DOI 10.1378/chest.123.5.1544; DAVIES RJO, 1992, THORAX, V47, P101, DOI 10.1136/thx.47.2.101; Giles TL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001106.pub2; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kohler M, 2008, EUR RESPIR J, V32, P1488, DOI 10.1183/09031936.00026608; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; *NIH CLIN EXC, 2008, COST TEMPL CONT POS; Pepperell JCT, 2002, LANCET, V359, P204, DOI 10.1016/S0140-6736(02)07445-7; STRADLING JR, 1991, THORAX, V46, P85, DOI 10.1136/thx.46.2.85; Sundaram S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001004.pub2; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Wang HQ, 2007, J AM COLL CARDIOL, V49, P1625, DOI 10.1016/j.jacc.2006.12.046; West SD, 2006, THORAX, V61, P945, DOI 10.1136/thx.2005.057745; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	17	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2009	338								b1165	10.1136/bmj.b1165	http://dx.doi.org/10.1136/bmj.b1165			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431ZH	19351671				2022-12-28	WOS:000265102800001
J	Hulme, PE; Pysek, P; Nentwig, W; Vila, M				Hulme, Philip E.; Pysek, Petr; Nentwig, Wolfgang; Vila, Montserrat			Will Threat of Biological Invasions Unite the European Union?	SCIENCE			English	Editorial Material							PATHWAYS		[Hulme, Philip E.] Lincoln Univ, Bioprotect Res Ctr, Canterbury, New Zealand; [Pysek, Petr] Acad Sci Czech Republ, Inst Bot, CZ-25243 Pruhonice, Czech Republic; [Pysek, Petr] Charles Univ Prague, Dept Ecol, CZ-12801 Vinicna 7, Czech Republic; [Nentwig, Wolfgang] Univ Bern, Inst Ecol & Evolut, CH-3012 Bern, Switzerland; [Vila, Montserrat] CSIC, EBD, E-41092 Seville, Spain	Lincoln University - New Zealand; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague; University of Bern; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Hulme, PE (corresponding author), Lincoln Univ, Bioprotect Res Ctr, POB 84, Canterbury, New Zealand.	philip.hulme@lincoln.ac.nz	Hulme, Philip/F-7454-2011; Vila, Montserrat/D-9339-2013; Nentwig, Wolfgang/A-6624-2011; Pysek, Petr/B-1957-2012	Hulme, Philip/0000-0001-5712-0474; Vila, Montserrat/0000-0003-3171-8261; 				Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; *CZ PRES EU GOV CZ, WORK PROGR PRIOR CZ; DAISIE, 2009, HDB AL SPEC EUR; *EC, 2008, 789 COM EC; EEA (EEA European Enviroment Agency), 2007, HALT LOSS BIOD 2010; *EUR COMM, 2007, SINGL MARK GOODS; Flash Eurobarometer 219, 2007, ATT EUR ISS BIOD; Genovesi P, 2005, BIOL INVASIONS, V7, P127, DOI 10.1007/s10530-004-9642-9; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2006, J APPL ECOL, V43, P835, DOI 10.1111/j.1365-2664.2006.01227.x; Hulme Philip E., 2007, V25, P56; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; McGeoch MA, 2006, CONSERV BIOL, V20, P1635, DOI 10.1111/j.1523-1739.2006.00579.x; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; 2007, EFSAJ, V468, P1; 2007, EFSAJ, V539, P1	17	247	257	3	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					40	41		10.1126/science.1171111	http://dx.doi.org/10.1126/science.1171111			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427TN	19342572	Green Submitted			2022-12-28	WOS:000264802100020
J	Long, S; Neale, G; Vincent, C				Long, Susannah; Neale, Graham; Vincent, Charles			The Competent Novice Practising safely in the foundation years	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL GUIDELINES; ADVERSE EVENTS; SEVERE SEPSIS; MANAGEMENT; ERROR; EMERGENCY; PEOPLE		[Long, Susannah; Vincent, Charles] St Marys Hosp, Imperial Coll, Clin Safety Res Unit, London W2 1NY, England	Imperial College London	Long, S (corresponding author), St Marys Hosp, Imperial Coll, Clin Safety Res Unit, Praed St, London W2 1NY, England.	s.long@imperial.ac.uk	Vincent, Charles A/D-1134-2010	Vincent, Charles A/0000-0003-0270-0222				Bates DW, 2000, BRIT MED J, V320, P788, DOI 10.1136/bmj.320.7237.788; Cave J, 2008, BRIT MED J, V336, P326, DOI 10.1136/bmj.39455.639340.AD; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Espinosa JA, 2000, BRIT MED J, V320, P737, DOI 10.1136/bmj.320.7237.737; Gao F, 2005, CRIT CARE, V9, pR764, DOI 10.1186/cc3909; General Medical Council, 2006, GOOD MED PRACT; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; Morey JC, 2002, HEALTH SERV RES, V37, P1553, DOI 10.1111/1475-6773.01104; Murphy MF, 2004, CURR OPIN HEMATOL, V11, P334, DOI 10.1097/01.moh.0000142801.38087.e5; *NAT PAT SAF AG, 2008, ACT REG 5 ACT IMPR P; *NHS LIG AUTH, 2002, 0202 NHS LIT AUTH; Potter J, 2006, CLIN MED, V6, P303, DOI 10.7861/clinmedicine.6-3-303; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768; *ROY COLL PHYS, 2007, GEN REC KEEP STAND; VINCENT C, 1994, LANCET, V343, P1609, DOI 10.1016/S0140-6736(94)93062-7; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; Vincent C., 2006, PATIENT SAFETY; Wolff AM, 2001, MED J AUSTRALIA, V174, P621, DOI 10.5694/j.1326-5377.2001.tb143469.x; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527	21	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2009	338								b1046	10.1136/bmj.b1046	http://dx.doi.org/10.1136/bmj.b1046			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429AP	19346284				2022-12-28	WOS:000264893500001
J	Warren, WS; Jenista, E; Branca, RT; Chen, X				Warren, Warren S.; Jenista, Elizabeth; Branca, Rosa Tamara; Chen, Xin			Increasing Hyperpolarized Spin Lifetimes Through True Singlet Eigenstates	SCIENCE			English	Article							MAGNETIC-RESONANCE SPECTRA; POLARIZATION; NMR	The sensitivity limitations for magnetic resonance imaging of organic molecules have recently been addressed by hyperpolarization methods, which prepare excess nuclear spin polarization. This approach can increase sensitivity by orders of magnitude, but the enhanced signal relaxes away in tens of seconds, even in favorable cases. Here we show theoretically that singlet states between strongly coupled spins in molecules can be used to store and retrieve population in very-long-lived disconnected eigenstates, as long as the coupling between the spins substantially exceeds both the couplings to other spins and the resonance frequency difference between them. Experimentally, 2,3-carbon-13-labeled diacetyl has a disconnected eigenstate that can store population for minutes and is read out by hydration to make the two spins inequivalent.	[Warren, Warren S.] Duke Univ, Dept Chem, Durham, NC 27708 USA; Duke Univ, Ctr Mol & Biomol Imaging, Durham, NC 27708 USA	Duke University; Duke University	Warren, WS (corresponding author), Duke Univ, Dept Chem, Durham, NC 27708 USA.	warren.warren@duke.edu		Branca, Rosa Tamara/0000-0002-6871-1824	NIH [EB02122]; North Carolina Biotechnology Center; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002122] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina Biotechnology Center; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the NIH under grant EB02122 and by the North Carolina Biotechnology Center. We thank D. Bhattacharyya for his help in determining optimal conditions to hyperpolarize diacetyl; M. Jenista for help with calculations; T. Ribiero for his assistance in running NMR spectra; L. Bouchard for discussions of singlet character in strongly coupled systems; and S. Craig, E. Toone, D. Coltart, and M. S. Warren for particularly useful discussions on the chemistry of these compounds. A provisional patent has been submitted on this work by W.S.W. and Duke University.	ABRAGAM A, 1978, REP PROG PHYS, V41, P395, DOI 10.1088/0034-4885/41/3/002; ABRAHAM RJ, 1961, CAN J CHEM, V39, P216, DOI 10.1139/v61-025; Ahuja P, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2778429; ANET FA, 1961, CAN J CHEM, V39, P2262, DOI 10.1139/v61-300; BECKER ED, 2000, HIGH RESOLUTION NMR, P171; Bell R., 1966, ADV PHYS ORG CHEM, V4, P1, DOI DOI 10.1016/S0065-3160(08)60351-2; BOWERS CR, 1987, J AM CHEM SOC, V109, P5541, DOI 10.1021/ja00252a049; Carravetta M, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1893983; Carravetta M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.153003; Day IJ, 2007, MAGN RESON CHEM, V45, P1018, DOI 10.1002/mrc.2090; DELCAMPO G, 1992, ANALYST, V117, P1343, DOI 10.1039/an9921701343; Gabellieri C, 2008, J AM CHEM SOC, V130, P4598, DOI 10.1021/ja8001293; Golman K, 2003, P NATL ACAD SCI USA, V100, P10435, DOI 10.1073/pnas.1733836100; Golman K, 2001, MAGNET RESON MED, V46, P1, DOI 10.1002/mrm.1152; Golman K, 2006, CANCER RES, V66, P10855, DOI 10.1158/0008-5472.CAN-06-2564; Hall DA, 1997, SCIENCE, V276, P930, DOI 10.1126/science.276.5314.930; HOECKER W. H., 1942, Journal of Dairy Science, V25, P175, DOI 10.3168/jds.S0022-0302(42)95279-2; Jakobsen JA, 2005, EUR RADIOL, V15, P941, DOI 10.1007/s00330-004-2601-0; Kiselyov AS, 2006, CHEM BIOL DRUG DES, V68, P308, DOI 10.1111/j.1747-0285.2006.00456.x; Kurhanewicz J, 2008, J NUCL MED, V49, P341, DOI 10.2967/jnumed.107.045112; MacFall JR, 1996, RADIOLOGY, V200, P553, DOI 10.1148/radiology.200.2.8685356; McCarney ER, 2007, P NATL ACAD SCI USA, V104, P1754, DOI 10.1073/pnas.0610540104; Merritt ME, 2007, P NATL ACAD SCI USA, V104, P19773, DOI 10.1073/pnas.0706235104; MUSHER JI, 1962, TETRAHEDRON, V18, P791, DOI 10.1016/S0040-4020(01)92729-2; Natterer J, 1997, PROG NUCL MAG RES SP, V31, P293, DOI 10.1016/S0079-6565(97)00007-1; POPLE JA, 1957, CAN J CHEM, V35, P1060, DOI 10.1139/v57-143; SAUPE A, 1965, Z NATURFORSCH PT A, VA 20, P572; van Rooy FGBGJ, 2007, AM J RESP CRIT CARE, V176, P498, DOI 10.1164/rccm.200611-1620OC	28	169	171	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1711	1714		10.1126/science.1167693	http://dx.doi.org/10.1126/science.1167693			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325112	Green Accepted, Green Submitted			2022-12-28	WOS:000264559800035
J	Watson, M; McPherson, A; Murray, SA				Watson, Max; McPherson, Alan; Murray, Scott A.			Should hospices be exempt from following national cardiopulmonary resuscitation guidelines? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Watson, Max] No Ireland Hosp, Belfast BT15 3LH, Antrim, North Ireland; [Watson, Max] Univ Ulster, Coleraine, Ireland; [Murray, Scott A.] Univ Edinburgh, Primary Palliat Care Res Grp, Div Community Hlth Sci, Gen Practice Sect, Edinburgh EH8 9YL, Midlothian, Scotland	Ulster University; University of Edinburgh	Watson, M (corresponding author), No Ireland Hosp, Belfast BT15 3LH, Antrim, North Ireland.	max.watson@nihospicec.org						[Anonymous], NAT SURV PAT ACT DAT; *ROYAL COLL NURS B, 2007, DEC REL CARD RES JOI; Twycross R, 2003, INTRO PALLIATIVE CAR	3	4	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 26	2009	338								b965	10.1136/bmj.b965	http://dx.doi.org/10.1136/bmj.b965			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LR	19325181				2022-12-28	WOS:000264639700005
J	Gilbert, DT; Killingsworth, MA; Eyre, RN; Wilson, TD				Gilbert, Daniel T.; Killingsworth, Matthew A.; Eyre, Rebecca N.; Wilson, Timothy D.			The Surprising Power of Neighborly Advice	SCIENCE			English	Article							HEALTH STATE VALUATION; QUALITY-OF-LIFE; DURABILITY BIAS; HEDONIC ADAPTATION; DISABILITY PARADOX; DECISION-MAKING; PEOPLE; PREDICTIONS; EMOTIONS; FUTURE	Two experiments revealed that (i) people can more accurately predict their affective reactions to a future event when they know how a neighbor in their social network reacted to the event than when they know about the event itself and (ii) people do not believe this. Undergraduates made more accurate predictions about their affective reactions to a 5-minute speed date (n = 25) and to a peer evaluation (n = 88) when they knew only how another undergraduate had reacted to these events than when they had information about the events themselves. Both participants and independent judges mistakenly believed that predictions based on information about the event would be more accurate than predictions based on information about how another person had reacted to it.	[Gilbert, Daniel T.; Killingsworth, Matthew A.; Eyre, Rebecca N.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Wilson, Timothy D.] Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA	Harvard University; University of Virginia	Gilbert, DT (corresponding author), Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA.	gilbert@wjh.harvard.edu	Killingsworth, Murray/O-3736-2019	Killingsworth, Murray/0000-0002-6125-1183	NSF [BCS-0722132]	NSF(National Science Foundation (NSF))	We acknowledge the support of research grant BCS-0722132 from NSF to D.T.G. and T.D.W.	Albrecht GL, 1999, SOC SCI MED, V48, P977, DOI 10.1016/S0277-9536(98)00411-0; Ayton P, 2007, THINK REASONING, V13, P62, DOI 10.1080/13546780600872726; Baron J, 2003, MED DECIS MAKING, V23, P422, DOI 10.1177/0272989X03257277; Blumenthal JA, 2005, INDIANA LAW J, V80, P155; BOYD NF, 1990, MED DECIS MAKING, V10, P58, DOI 10.1177/0272989X9001000109; Bronsteen J, 2008, COLUMBIA LAW REV, V108, P1516; Carlsmith KM, 2008, J PERS SOC PSYCHOL, V95, P1316, DOI 10.1037/a0012165; Damschroder LJ, 2005, SOC SCI MED, V61, P267, DOI 10.1016/j.socscimed.2004.11.060; DELAROCHEFOUCAU.F, 2007, COLLECTED MAXIMS OTH, P354; Ditto PH, 2005, HEALTH PSYCHOL, V24, pS63, DOI 10.1037/0278-6133.24.4.S63; Dunn EW, 2007, PERS SOC PSYCHOL B, V33, P85, DOI 10.1177/0146167206294201; Dunn EW, 2003, PERS SOC PSYCHOL B, V29, P1421, DOI 10.1177/0146167203256867; Epley N, 2000, J PERS SOC PSYCHOL, V79, P861, DOI 10.1037//0022-3514.79.6.861; Gilbert DT, 2007, SCIENCE, V317, P1351, DOI 10.1126/science.1144161; Gilbert DT, 1998, J PERS SOC PSYCHOL, V75, P617, DOI 10.1037/0022-3514.75.3.617; Gilbert DT, 2004, PSYCHOL SCI, V15, P14, DOI 10.1111/j.0963-7214.2004.01501003.x; Gilbert DT, 2002, J PERS SOC PSYCHOL, V82, P503, DOI 10.1037//0022-3514.82.4.503; GRIFFIN DW, 1990, J PERS SOC PSYCHOL, V59, P1128, DOI 10.1037/0022-3514.59.6.1128; Kassam KS, 2008, J EXP SOC PSYCHOL, V44, P1533, DOI 10.1016/j.jesp.2008.07.008; Kawakami K, 2009, SCIENCE, V323, P276, DOI 10.1126/science.1164951; Kermer DA, 2006, PSYCHOL SCI, V17, P649, DOI 10.1111/j.1467-9280.2006.01760.x; Lee K, 2009, J PERS SOC PSYCHOL, V96, P460, DOI 10.1037/a0014059; Liberman N, 2008, SCIENCE, V322, P1201, DOI 10.1126/science.1161958; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Menzel P, 2002, SOC SCI MED, V55, P2149, DOI 10.1016/S0277-9536(01)00358-6; Rhodes R, 2008, CAMB Q HEALTHC ETHIC, V17, P54, DOI 10.1017/S0963180108080067; Riis J, 2005, J EXP PSYCHOL GEN, V134, P3, DOI 10.1037/0096-3445.134.1.3; SACKETT DL, 1978, J CHRON DIS, V31, P697, DOI 10.1016/0021-9681(78)90072-3; Shalowitz DI, 2007, PLOS MED, V4, P423, DOI 10.1371/journal.pmed.0040035; Ubel PA, 2005, HEALTH PSYCHOL, V24, pS57, DOI 10.1037/0278-6133.24.4.S57; Ubel PA, 2005, J EXP PSYCHOL-APPL, V11, P111, DOI 10.1037/1076-898X.11.2.111; Ubel PA, 2003, QUAL LIFE RES, V12, P599, DOI 10.1023/A:1025119931010; Ubel PA, 2001, MED DECIS MAKING, V21, P190, DOI 10.1177/02729890122062488; van Hemert DA, 2007, COGNITION EMOTION, V21, P913, DOI 10.1080/02699930701339293; Wilson TD, 2005, J PERS SOC PSYCHOL, V88, P5, DOI 10.1037/0022-3514.88.1.5; Wilson TD, 2000, J PERS SOC PSYCHOL, V78, P821, DOI 10.1037/0022-3514.78.5.821; Wilson TD, 2004, PERS SOC PSYCHOL B, V30, P340, DOI 10.1177/0146167203256974; Wilson TD, 2001, PERS SOC PSYCHOL B, V27, P1648, DOI 10.1177/01461672012712008; Wood SL, 2007, J CONSUM PSYCHOL, V17, P188, DOI 10.1016/S1057-7408(07)70028-1	39	56	62	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 20	2009	323	5921					1617	1619		10.1126/science.1166632	http://dx.doi.org/10.1126/science.1166632			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	421EN	19299622	Green Published			2022-12-28	WOS:000264342300042
J	Mohammed, MA; Deeks, JJ; Girling, A; Rudge, G; Carmalt, M; Stevens, AJ; Lilford, RJ				Mohammed, Mohammed A.; Deeks, Jonathan J.; Girling, Alan; Rudge, Gavin; Carmalt, Martin; Stevens, Andrew J.; Lilford, Richard J.			Evidence of methodological bias in hospital standardised mortality ratios: retrospective database study of English hospitals	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK; PERFORMANCE; ADJUSTMENT; QUALITY; CARE	Objective To assess the validity of case mix adjustment methods used to derive standardised mortality ratios for hospitals, by examining the consistency of relations between risk factors and mortality across hospitals. Design Retrospective analysis of routinely collected hospital data comparing observed deaths with deaths predicted by the Dr Foster Unit case mix method. Setting Four acute National Health Service hospitals in the West Midlands (England) with case mix adjusted standardised mortality ratios ranging from 88 to 140. Participants 96 948 (April 2005 to March 2006), 126 695 (April 2006 to March 2007), and 62 639 (April to October 2007) admissions to the four hospitals. Main outcome measures Presence of large interaction effects between case mix variable and hospital in a logistic regression model indicating non-constant risk relations, and plausible mechanisms that could give rise to these effects. Results Large significant (P <= 0.0001) interaction effects were seen with several case mix adjustment variables. For two of these variables-the Charlson (comorbidity) index and emergency admission-interaction effects could be explained credibly by differences in clinical coding and admission practices across hospitals. Conclusions The Dr Foster Unit hospital standardised mortality ratio is derived from an internationally adopted/adapted method, which uses at least two variables (the Charlson comorbidity index and emergency admission) that are unsafe for case mix adjustment because their inclusion may actually increase the very bias that case mix adjustment is intended to reduce. Claims that variations in hospital standardised mortality ratios from Dr Foster Unit reflect differences in quality of care are less than credible.	[Mohammed, Mohammed A.; Deeks, Jonathan J.; Rudge, Gavin; Stevens, Andrew J.; Lilford, Richard J.] Univ Birmingham, Unit Publ Hlth Epidemiol & Biostat, Birmingham B15 2TT, W Midlands, England; [Carmalt, Martin] Royal Orthopaed Hosp, Birmingham B31 2AP, W Midlands, England	University of Birmingham; Royal Orthopaedic Hospital	Mohammed, MA (corresponding author), Univ Birmingham, Unit Publ Hlth Epidemiol & Biostat, Birmingham B15 2TT, W Midlands, England.	M.A.Mohammed@Bham.ac.uk	Deeks, Jon/AAV-5745-2020; Girling, Alan J/A-7843-2012	Deeks, Jon/0000-0002-8850-1971; Girling, Alan/0000-0003-2022-045X; Stevens, Andrew/0000-0003-2079-3397	EPSRC MATCH consortium; EPSRC [EP/F063822/1] Funding Source: UKRI; MRC [G0800808] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F063822/1] Funding Source: researchfish; Medical Research Council [G0800808] Funding Source: researchfish	EPSRC MATCH consortium(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: The study was part of a study commissioned by the NHS West Midlands Strategic Health Authority. AG is supported by the EPSRC MATCH consortium.	*CAN TEL, 2007, EXP HOP REP HELPS CU; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Deeks J J, 2003, Health Technol Assess, V7, piii; Dixon J, 1998, J PUBLIC HEALTH MED, V20, P63, DOI 10.1093/oxfordjournals.pubmed.a024721; *FOST INT, WHAT IS FOST INT; *FOST INT, HOSP GUID; *GUARD, 2008, HOSP SURG DEATH RAT; *HEALTHC COMM, 2006, AC HOSP PORTF REV MA; Heijink R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-73; *I HEALTHC IMPR, 2005, RED HOSP MORT RAT 2; Iezzoni LI, 1997, JAMA-J AM MED ASSOC, V278, P1600, DOI 10.1001/jama.278.19.1600; Institute for Healthcare Improvement, 2003, MOV YOUR DOT MEAS EV; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; JARMAN B, 2006, NEWSWEEK INT    1030; KOSTER M, 2008, LAKAR TIDNINGEN, V19, P1391; Lilford R, 2004, LANCET, V363, P1147, DOI 10.1016/S0140-6736(04)15901-1; Lilford RJ, 2007, BMJ-BRIT MED J, V335, P648, DOI 10.1136/bmj.39317.641296.AD; Locker TE, 2005, BRIT MED J, V330, P1188, DOI 10.1136/bmj.38440.588449.AE; Marshall MN, 2000, QUAL HEALTH CARE, V9, P53, DOI 10.1136/qhc.9.1.53; Moran J L, 2003, Crit Care Resusc, V5, P292; Nicholl J, 2007, J EPIDEMIOL COMMUN H, V61, P1010, DOI 10.1136/jech.2007.061747; Pitches DW, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-91; SMITH R, 2008, DAILY TELEGRAPH 0326; The Canadian Institute for Health Information, 2007, HSMR NEW APPR MEAS H; van Doorn C, 2001, J CLIN EPIDEMIOL, V54, P694, DOI 10.1016/S0895-4356(00)00367-X	25	121	122	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2009	338								b780	10.1136/bmj.b780	http://dx.doi.org/10.1136/bmj.b780			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422NV	19297447	Green Published, hybrid			2022-12-28	WOS:000264435900002
J	Bursey, F				Bursey, Ford			Review: Combinations of clinical findings had moderate sensitivity and specificity for diagnosing the irritable bowel syndrome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Mem Univ Newfoundland, St John, NF, Canada	Memorial University Newfoundland	Bursey, F (corresponding author), Mem Univ Newfoundland, St John, NF, Canada.		Bursey, Ford/AAK-8568-2020					Ford AC, 2008, JAMA-J AM MED ASSOC, V300, P1793, DOI 10.1001/jama.300.15.1793; OWENS DM, 1995, ANN INTERN MED, V122, P107, DOI 10.7326/0003-4819-122-2-199501150-00005; Paterson WG, 1999, CAN MED ASSOC J, V161, P154	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6							JC3-13	10.7326/0003-4819-150-6-200903170-02013	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423AJ	19306495				2022-12-28	WOS:000264468500035
J	Buttery, JP; Graham, SM				Buttery, Jim P.; Graham, Stephen M.			Immunisation timing: the protective layer in vaccine coverage	LANCET			English	Editorial Material							CHILDHOOD IMMUNIZATION; RISK-FACTORS; INDONESIA; IMPACT; AGE		[Buttery, Jim P.; Graham, Stephen M.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Buttery, Jim P.; Graham, Stephen M.] Univ Melbourne, Royal Childrens Hosp, Ctr Int Child Heath, Dept Paediat, Parkville, Vic 3052, Australia; [Buttery, Jim P.] Monash Univ, Dept Paediat, Clayton, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Monash University	Buttery, JP (corresponding author), Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	jim.buttery@mcri.edu.au		Graham, Stephen/0000-0003-3525-2294				BATES AS, 1994, JAMA-J AM MED ASSOC, V272, P1105, DOI 10.1001/jama.272.14.1105; Bisgard KM, 2005, PEDIATRICS, V116, pE285, DOI 10.1542/peds.2004-2759; Clark A, 2009, LANCET, V373, P1543, DOI 10.1016/S0140-6736(09)60317-2; Cunliffe NA, 1998, B WORLD HEALTH ORGAN, V76, P525; Daly AD, 2003, SAMJ S AFR MED J, V93, P606; Jani JV, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-161; Lim SS, 2008, LANCET, V372, P2031, DOI 10.1016/S0140-6736(08)61869-3; Murakami H, 2008, B WORLD HEALTH ORGAN, V86, P948, DOI 10.2471/BLT.07.048579; RUFF TA, 1995, J INFECT DIS, V171, P290, DOI 10.1093/infdis/171.2.290; Semba Richard D., 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P120; Simonsen L, 2005, J INFECT DIS, V192, pS36, DOI 10.1086/431512; Szilagyi P G, 1996, J Public Health Manag Pract, V2, P18	12	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 2	2009	373	9674					1499	1500		10.1016/S0140-6736(09)60340-8	http://dx.doi.org/10.1016/S0140-6736(09)60340-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440OT	19303632				2022-12-28	WOS:000265710300004
J	Clark, A; Sanderson, C				Clark, Andrew; Sanderson, Colin			Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data	LANCET			English	Article							INFLUENZAE TYPE-B; PERTUSSIS-VACCINE; UNITED-STATES; IMMUNIZATION; TIMELINESS; AGE; DELAY; INTUSSUSCEPTION; CONJUGATE; COVERAGE	Background Vaccinations are often delayed until well after the recommended ages, leaving many children exposed for longer than they should be. We estimated vaccination coverage at different ages, and delays in administration, in 45 low-income and middle-income countries. Methods We used data for 217706 children from Demographic and Health Surveys between 1996 and 2005 (median 2002), which provided data for vaccination of children on the basis of events recorded on vaccination cards and interviews with mothers, with imputation of missing values and survival analysis. We devised an index combining coverage and delay. Findings For vaccinated children, the median of the median delays in the 45 countries was 2.3 weeks (IQR 1.4-4.6) for bacille Calmette-Guerin (BCG); 2.4 weeks (1.2-3.3) for diphtheria, tetanus, and pertussis (DTP1); 2.7 weeks (1.7-3.1) for measles-containing vaccine (MCV1); and 6.2 weeks (3.5-8.5) for DTP3. However, in the 12 countries with the longest delays for each vaccination, at least 25% of the children vaccinated were more than 10 weeks late for BCG, 8 weeks for DTP1, 11 weeks for MCV1, and 19 weeks for DTP3. Variation within countries was substantial: the median of the IQRs in the 45 countries for delay in DTP3 was 10.9 weeks, 7.9 weeks for MCV1, 5.4 weeks for BCG, and 5.3 weeks for DTP1. The median of the national coverage rates for DTP1 increased from 57% in children aged 12 weeks to 88% at 12 months, and for DTP3 from 65% at 12 months to 76% at 3 years. Interpretation The timeliness of children's vaccination varies widely between and particularly within countries, and published yearly estimates of national coverage do not capture these variations. Delayed vaccination could have important implications for the effect of new and established vaccines on the burden of disease.	[Sanderson, Colin] Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, Dept Publ Hlth & Policy, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Sanderson, C (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Serv Res Unit, Dept Publ Hlth & Policy, Keppel St, London WC1E 7HT, England.	colin.sanderson@lshtm.ac.uk	Sanderson, Colin F/O-9877-2014	Sanderson, Colin/0000-0002-4838-6112	WHO's Initiative for Vaccine Research; Strategic Advisory Group of Experts (SAGE)	WHO's Initiative for Vaccine Research; Strategic Advisory Group of Experts (SAGE)	We acknowledge funding from WHO's Initiative for Vaccine Research, and feedback from the Strategic Advisory Group of Experts (SAGE). We thank Lara Wolfson, Tracey Goodman, and Robert Steinglass for commenting on an earlier draft. We acknowledge special permission to analyse and publish data from four of the 45 DHS surveys analysed (Eritrea 2002; Cambodia 2000; Mauritania 2000/01; and Yemen 1997).	ABBOTTS B, 1993, AM J DIS CHILD, V147, P965, DOI 10.1001/archpedi.1993.02160330055018; Akmatov MK, 2008, VACCINE, V26, P3805, DOI 10.1016/j.vaccine.2008.05.031; BARAFF LJ, 1984, PEDIATRICS, V73, P37; Barzilay EJ, 2006, VACCINE, V24, P904, DOI 10.1016/j.vaccine.2005.08.092; Belloni C, 2003, PEDIATRICS, V111, P1042, DOI 10.1542/peds.111.5.1042; Crowcroft NS, 2003, LANCET INFECT DIS, V3, P413, DOI 10.1016/S1473-3099(03)00669-8; Dannetun E, 2004, VACCINE, V22, P4228, DOI 10.1016/j.vaccine.2004.04.018; Daskalaki I, 2008, PEDIATRICS, V122, pE33, DOI 10.1542/peds.2007-2464; Dayan GH, 2006, AM J EPIDEMIOL, V163, P561, DOI 10.1093/aje/kwj074; Dombkowski KJ, 2002, AM J PREV MED, V23, P36, DOI 10.1016/S0749-3797(02)00442-7; FUNKHOUSER AW, 1987, JAMA-J AM MED ASSOC, V257, P1341, DOI 10.1001/jama.257.10.1341; *GLOB ADV COMM VAC, 2006, WEEKL EP REC; Haber P, 2008, PEDIATRICS, V121, P1206, DOI 10.1542/peds.2007-3793; HALSEY N, 1985, B WORLD HEALTH ORGAN, V63, P1151; Heininger U, 2006, EUR J PEDIATR, V165, P124, DOI 10.1007/s00431-005-0014-y; Hull BP, 2006, VACCINE, V24, P4403, DOI 10.1016/j.vaccine.2006.02.049; HUTCHINS S, 1993, MISSED OPPORTUNITIES; Kalies H, 2006, PEDIATR INFECT DIS J, V25, P507, DOI 10.1097/01.inf.0000222413.47344.23; Kroger Andrew T., 2006, Morbidity and Mortality Weekly Report, V55, P1; Laubereau B, 2002, EPIDEMIOL INFECT, V128, P185, DOI 10.1017/S0950268801006550; Luman ET, 2005, AM J PUBLIC HEALTH, V95, P1367, DOI 10.2105/AJPH.2004.046284; Luman ET, 2005, JAMA-J AM MED ASSOC, V293, P1204, DOI 10.1001/jama.293.10.1204; Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7; Ndiritu M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-132; ORENSTEIN WA, 1983, RECENT ADV IMMUNIZAT, V451; Rothman KJ, 2006, J INFECT DIS, V193, P898, DOI 10.1086/500217; vonKries R, 1997, EUR J PEDIATR, V156, P282, DOI 10.1007/s004310050601; *WHO, 2007, WEEKL EP REC ROT POS; *WHO, 2008, WHO UNICEF EST COV; *WHO UNICEF, 1980, WHO UNICEF EST NAT I; World Health Organization/UNICEF, 2005, GIVS GLOB IMM VIS ST	31	242	243	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2009	373	9674					1543	1549		10.1016/S0140-6736(09)60317-2	http://dx.doi.org/10.1016/S0140-6736(09)60317-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440OT	19303633				2022-12-28	WOS:000265710300033
J	Nishikimi, A; Fukuhara, H; Su, WJ; Hongu, T; Takasuga, S; Mihara, H; Cao, QH; Sanematsu, F; Kanai, M; Hasegawa, H; Tanaka, Y; Shibasaki, M; Kanaho, Y; Sasaki, T; Frohman, MA; Fukui, Y				Nishikimi, Akihiko; Fukuhara, Hideo; Su, Wenjuan; Hongu, Tsunaki; Takasuga, Shunsuke; Mihara, Hisashi; Cao, Qinhong; Sanematsu, Fumiyuki; Kanai, Motomu; Hasegawa, Hiroshi; Tanaka, Yoshihiko; Shibasaki, Masakatsu; Kanaho, Yasunori; Sasaki, Takehiko; Frohman, Michael A.; Fukui, Yoshinori			Sequential Regulation of DOCK2 Dynamics by Two Phospholipids During Neutrophil Chemotaxis	SCIENCE			English	Article							PHOSPHATIDIC-ACID; CELL-MIGRATION; DOWNSTREAM ACTIVATION; RAC ACTIVATION; MOTILITY; POLARITY; PROTEINS; COMPLEX; ROLES; ARF6	During chemotaxis, activation of the small guanosine triphosphatase Rac is spatially regulated to organize the extension of membrane protrusions in the direction of migration. In neutrophils, Rac activation is primarily mediated by DOCK2, an atypical guanine nucleotide exchange factor. Upon stimulation, we found that DOCK2 rapidly translocated to the plasma membrane in a phosphatidylinositol 3,4,5-trisphosphate-dependent manner. However, subsequent accumulation of DOCK2 at the leading edge required phospholipase D-mediated synthesis of phosphatidic acid, which stabilized DOCK2 there by means of interaction with a polybasic amino acid cluster, resulting in increased local actin polymerization. When this interaction was blocked, neutrophils failed to form leading edges properly and exhibited defects in chemotaxis. Thus, intracellular DOCK2 dynamics are sequentially regulated by distinct phospholipids to localize Rac activation during neutrophil chemotaxis.	[Nishikimi, Akihiko; Fukuhara, Hideo; Cao, Qinhong; Sanematsu, Fumiyuki; Tanaka, Yoshihiko; Fukui, Yoshinori] Kyushu Univ, Med Inst Bioregulat, Dept Neurosci & Immunol, Div Immunogenet, Fukuoka 8128582, Japan; [Nishikimi, Akihiko; Tanaka, Yoshihiko; Fukui, Yoshinori] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1020075, Japan; [Su, Wenjuan; Frohman, Michael A.] SUNY Stony Brook, Dept Pharmacol, Ctr Dev Genet, Stony Brook, NY 11794 USA; [Hongu, Tsunaki; Hasegawa, Hiroshi; Kanaho, Yasunori] Univ Tsukuba, Inst Basic Med Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Takasuga, Shunsuke; Sasaki, Takehiko] Akita Univ, Sch Med, Dept Pathol & Immunol, Div Microbiol, Akita 0108543, Japan; [Mihara, Hisashi; Kanai, Motomu; Shibasaki, Masakatsu] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan	Kyushu University; Japan Science & Technology Agency (JST); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tsukuba; Akita University; University of Tokyo	Fukui, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Neurosci & Immunol, Div Immunogenet, Fukuoka 8128582, Japan.	fukui@bioreg.kyushu-u.ac.jp	Kanai, Motomu/J-6807-2016; Nishikimi, Akihiko/I-4692-2018	Kanai, Motomu/0000-0003-1977-7648; Nishikimi, Akihiko/0000-0001-9497-7557; Sasaki, Takehiko/0000-0003-1837-3748; TANAKA, Yoshihiko/0000-0002-6458-5082; Fukui, Yoshinori/0000-0003-2335-8745	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Toray Science Foundation; CREST program of Japan Science and Technology Agency; Global Center of Excellence program of the Japan Society for the Promotion of Science; NIH [R01GM71520]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071520, R01GM084251] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Toray Science Foundation(Toray Industries, Inc.); CREST program of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Global Center of Excellence program of the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants for Targeted Proteins Research Project, Genome Network Project, Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Toray Science Foundation; CREST program of Japan Science and Technology Agency; the Global Center of Excellence program of the Japan Society for the Promotion of Science; and NIH award R01GM71520.	ALA A, 2009, MOL PHARM, V75, P437; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gardiner EM, 2002, CURR BIOL, V12, P2029, DOI 10.1016/S0960-9822(02)01334-9; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.200602142; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; McDermott M, 2004, BIOCHEM CELL BIOL, V82, P225, DOI 10.1139/o03-079; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zouwail S, 2005, BIOCHEM J, V389, P207, DOI 10.1042/BJ20050085	24	204	211	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					384	387		10.1126/science.1170179	http://dx.doi.org/10.1126/science.1170179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19325080	Green Accepted			2022-12-28	WOS:000265221600041
J	Moszynski, P				Moszynski, Peter			Feature Medicine and Conflict Humanitarianism on trial in Sudan	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												globewisecom@hotmail.com							0	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2009	338								b1395	10.1136/bmj.b1395	http://dx.doi.org/10.1136/bmj.b1395			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434TI	19366740				2022-12-28	WOS:000265296600005
J	Tokuriki, N; Tawfik, DS				Tokuriki, Nobuhiko; Tawfik, Dan S.			Protein Dynamism and Evolvability	SCIENCE			English	Review							LATENT EVOLUTIONARY POTENTIALS; CONFORMATIONAL DIVERSITY; MOLECULAR EVOLUTION; SEQUENCE SPACE; ENZYME; STABILITY; PROMISCUITY; FLEXIBILITY; PLASTICITY; EMERGENCE	The traditional view that proteins possess absolute functional specificity and a single, fixed structure conflicts with their marked ability to adapt and evolve new functions and structures. We consider an alternative, "avant-garde view" in which proteins are conformationally dynamic and exhibit functional promiscuity. We surmise that these properties are the foundation stones of protein evolvability; they facilitate the divergence of new functions within existing folds and the evolution of entirely new folds. Packing modes of proteins also affect their evolvability, and poorly packed, disordered, and conformationally diverse proteins may exhibit high evolvability. This dynamic view of protein structure, function, and evolvability is extrapolated to describe hypothetical scenarios for the evolution of the early proteins and future research directions in the area of protein dynamism and evolution.	[Tokuriki, Nobuhiko; Tawfik, Dan S.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Tawfik, DS (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tawfik@weizmann.ac.il	TOKURIKI, NOBUHIKO/A-2968-2010		Israel Science Foundation; European Union MiFEM network	Israel Science Foundation(Israel Science Foundation); European Union MiFEM network	We gratefully acknowledge financial support from the Israel Science Foundation and the European Union MiFEM network. We thank M. Fuxreiter, L. James, and R. Milo for their insightful comments.	Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Amitai G, 2007, HFSP J, V1, P67, DOI [10.2976/1.2739115/10.2976/1, 10.2976/1.2739115]; Anantharaman V, 2003, CURR OPIN CHEM BIOL, V7, P12, DOI 10.1016/S1367-5931(02)00018-2; Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Andreeva A, 2006, CURR OPIN STRUC BIOL, V16, P399, DOI 10.1016/j.sbi.2006.04.003; Bershtein S, 2008, MOL BIOL EVOL, V25, P2311, DOI 10.1093/molbev/msn174; Bornberg-Bauer E, 1999, P NATL ACAD SCI USA, V96, P10689, DOI 10.1073/pnas.96.19.10689; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Brown DW, 2009, BIOCHEMISTRY-US, V48, P1847, DOI 10.1021/bi900078q; Chen Y, 2005, J MOL BIOL, V348, P349, DOI 10.1016/j.jmb.2005.02.010; Corazza A, 2006, PROTEINS, V62, P64, DOI 10.1002/prot.20703; Curtis EA, 2005, NAT STRUCT MOL BIOL, V12, P994, DOI 10.1038/nsmb1003; Daggett V, 2003, TRENDS BIOCHEM SCI, V28, P18, DOI 10.1016/S0968-0004(02)00012-9; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; DEVISSER JA, 1959, EVOL INT J ORG EVOL, V57, P2003; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Earl DJ, 2004, P NATL ACAD SCI USA, V101, P11531, DOI 10.1073/pnas.0404656101; Ferrada E, 2008, P ROY SOC B-BIOL SCI, V275, P1595, DOI 10.1098/rspb.2007.1617; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Meier S, 2007, BIOESSAYS, V29, P1095, DOI 10.1002/bies.20661; Meier S, 2007, CURR BIOL, V17, P173, DOI 10.1016/j.cub.2006.10.063; Milo R, 2007, P NATL ACAD SCI USA, V104, P16998, DOI 10.1073/pnas.0707673104; Muralidhara BK, 2008, J MOL BIOL, V377, P232, DOI 10.1016/j.jmb.2007.12.068; Schultes EA, 2000, SCIENCE, V289, P448, DOI 10.1126/science.289.5478.448; Skopalik J, 2008, J PHYS CHEM B, V112, P8165, DOI 10.1021/jp800311c; Thorpe IF, 2007, P NATL ACAD SCI USA, V104, P8821, DOI 10.1073/pnas.0610064104; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Trifonov EN, 2003, CURR OPIN STRUC BIOL, V13, P110, DOI 10.1016/S0959-440X(03)00005-8; Tuinstra RL, 2008, P NATL ACAD SCI USA, V105, P5057, DOI 10.1073/pnas.0709518105; Vamvaca K, 2008, J MOL BIOL, V382, P971, DOI 10.1016/j.jmb.2008.07.049; Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wei YN, 2004, PROTEIN ENG DES SEL, V17, P67, DOI 10.1093/protein/gzh007; Wroe R, 2007, HFSP J, V1, P79, DOI [10.2976/1.2739116, 10.2976/1.2739116/10.2976/1]; Yadid I, 2007, J MOL BIOL, V365, P10, DOI 10.1016/j.jmb.2006.09.055; Yomo T, 1999, NAT STRUCT BIOL, V6, P743, DOI 10.1038/11512	47	622	631	4	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					203	207		10.1126/science.1169375	http://dx.doi.org/10.1126/science.1169375			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359577				2022-12-28	WOS:000265024400033
J	Ridker, PM; Danielson, E; Fonseca, FAH; Genest, J; Gotto, AM; Kastelein, JJP; Koenig, W; Libby, P; Lorenzatti, AJ; MacFadyen, JG; Nordestgaard, BG; Shepherd, J; Willerson, JT; Glynn, RJ				Ridker, Paul M.; Danielson, Eleanor; Fonseca, Francisco A. H.; Genest, Jacques; Gotto, Antonio M., Jr.; Kastelein, John J. P.; Koenig, Wolfgang; Libby, Peter; Lorenzatti, Alberto J.; MacFadyen, Jean G.; Nordestgaard, Borge G.; Shepherd, James; Willerson, James T.; Glynn, Robert J.		JUPITER Trial Study Grp	Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial	LANCET			English	Article							ACUTE CORONARY SYNDROMES; STATIN THERAPY; ARTERY-DISEASE; PRAVASTATIN; PREVENTION; GUIDELINES; OUTCOMES; RISK	Background Statins lower high-sensitivity C-reactive protein (hsCRP) and cholesterol concentrations, and hypothesis generating analyses suggest that clinical outcomes improve in patients given statins who achieve hsCRP concentrations less than 2 mg/L in addition to LDL cholesterol less than 1.8 mmol/L (<70 mg/dL). However, the benefit of lowering both LDL cholesterol and hsCRP after the start of statin therapy is controversial. We prospectively tested this hypothesis. Methods In an analysis of 15 548 initially healthy men and women participating in the JUPITER trial (87% of full cohort), we prospectively assessed the effects of rosuvastatin 20 mg versus placebo on rates of non-fatal myocardial infarction, non-fatal stroke, admission for unstable angina, arterial revascularisation, or cardiovascular death (prespecified endpoints) during a maximum follow-up of 5 years (median 1.9 years), according to on-treatment concentrations of LDL cholesterol (>= 1.8 mmol/L or <1.8 mmol/L) and hsCRP (2:2 mg/L or <2 mg/L). We included all events occurring after randomisation. This trial is registered with ClinicalTrials.gov, number NCT00239681. Findings Compared with placebo, participants allocated to rosuvastatin who achieved LDL cholesterol less than 1.8 mmol/L bad a 55% reduction in vascular events (event rate 1.11 vs 0.51 per 100 person-years; hazard ratio [HR] 0.45, 95% CI 0.34-0.60, p<0.0001), and those achieving hsCRP less than 2 mg/L a 62% reduction (event rate 0.42 per 100 person-years; HR 0.38, 95% Cl 0.26-0.56, p<0.0001). Although LDL cholesterol and hsCRP reductions were only weakly correlated in individual patients (r values <0.15), we recorded a 65% reduction in vascular events in participants allocated to rosuvastatin who achieved both LDL cholesterol less than 1.8 mmol/L and hsCRP less than 2 mg/L (event rate 0.38 per 100 person-years; adjusted HR 0.35, 95% CI 0.23-0.54), versus a 33% reduction in those who achieved one or neither target (event rate 0.74 per 100 person-years; HR 0.67, 95% CI 0.52-0.87) (p across treatment groups <0.0001). In participants who achieved LDL cholesterol less than 1.8 mmol/L and hsCRP less than 1 mg/L, we noted a 79% reduction (event rate 0.24 per 100 person-years; HR 0.21, 95% Cl 0.09-0.52). Achieved hsCRP concentrations were predictive of event rates irrespective of the lipid endpoint used, including the apolipoprotein B to apolipoprotein AI ratio. Interpretation For people choosing to start pharmacological prophylaxis, reduction in both LDL cholesterol and hsCRP are indicators of successful treatment with rosuvastatin.	[Ridker, Paul M.; Danielson, Eleanor; MacFadyen, Jean G.; Glynn, Robert J.] Harvard Univ, Ctr Cardiovasc Dis Prevent, Sch Med, Brigham & Womens Hosp, Boston, MA 02215 USA; [Ridker, Paul M.; Libby, Peter] Harvard Univ, Div Cardiovasc Med, Sch Med, Brigham & Womens Hosp, Boston, MA 02215 USA; [Fonseca, Francisco A. H.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Genest, Jacques] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Gotto, Antonio M., Jr.] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA; [Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Ulm, Germany; [Lorenzatti, Alberto J.] Hosp Cordoba, Cordoba, Argentina; [Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Herlev, Denmark; [Shepherd, James] Univ Glasgow, Glasgow, Lanark, Scotland; [Willerson, James T.] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Universidade Federal de Sao Paulo (UNIFESP); McGill University; Cornell University; University of Amsterdam; Academic Medical Center Amsterdam; Ulm University; University of Copenhagen; Herlev & Gentofte Hospital; University of Glasgow; Saint Lukes Episcopal Hospital; Texas Heart Institute	Ridker, PM (corresponding author), Harvard Univ, Ctr Cardiovasc Dis Prevent, Sch Med, Brigham & Womens Hosp, Boston, MA 02215 USA.	pridker@partners.org	Fonseca, Francisco Antonio Helfenstein/A-6480-2010; Complexos, INCT Fluidos/H-9172-2013; Libby, Peter/AAY-6404-2021; Kastelein, John/AAF-7950-2020; Nordestgaard, Borge Gronne/ABF-1310-2020	Fonseca, Francisco Antonio Helfenstein/0000-0002-9911-4598; Libby, Peter/0000-0002-1502-502X; da Silva Franco, Roberto Jorge/0000-0001-9787-4393; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Koenig, Wolfgang/0000-0002-2064-9603	National Heart Lung and Blood Institute; National Cancer Institute; Donald W Reynolds Foundation; Leducq Foundation; AstraZeneca; Novartis; Merck; Abbott; Roche; Sanofi-Aventis; Pfizer; Schering-Plough; Merck Schering Plough; ISIS; Genzyme; Dade-Behring; GlaxoSmithKline; Takeda; Bristol Myers Squibb	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W Reynolds Foundation; Leducq Foundation(Leducq Foundation); AstraZeneca(AstraZeneca); Novartis(Novartis); Merck(Merck & Company); Abbott(Abbott Laboratories); Roche(Roche Holding); Sanofi-Aventis(Sanofi-Aventis); Pfizer(Pfizer); Schering-Plough(Merck & CompanySchering Plough Corporation); Merck Schering Plough(Merck & CompanySchering Plough Corporation); ISIS; Genzyme(Sanofi-AventisGenzyme Corporation); Dade-Behring; GlaxoSmithKline(GlaxoSmithKline); Takeda(Takeda Pharmaceutical Company Ltd); Bristol Myers Squibb(Bristol-Myers Squibb)	During the period of this study, PMR reports having received investigator-initiated research grant support from the National Heart Lung and Blood Institute, the National Cancer Institute, the Donald W Reynolds Foundation, the Leducq Foundation, AstraZeneca, Novartis, Merck, Abbott, Roche, and Sanofi-Aventis; consulting fees and/or lecture fees from AstraZeneca, Novartis, Merck-Schering Plough, Sanofi-Aventis, ISIS, and Vascular Biogenics; and is listed as a co-inventor on patents held by the Brigham and Women's Hospital that relate to the use of inflammatory biomarkers in cardiovascular disease. These patents have been licensed to several entities, including AstraZeneca. FAHF reports having received research grants, lecture fees, and consulting fees from AstraZeneca, Pfizer, Schering-Plough, Sanofi-Aventis, and Merck. JG reports having received lecture fees from AstraZeneca, Schering Plough, Pfizer, Novartis, and Sanofi-Aventis; and consulting fees from AstraZeneca, Merck, Srhering-Plough, Pfizer, Novartis, and Sanofi-Aventis. AMG reports having received consulting fees from Dupont, Novartis, Aegerion, Arisaph, KOWA, Merck, Merck Schering Plough, Pfizer, and Reliant. JJPK reports receiving research grant support from AstraZeneca, Pfizer, Roche, Novartis, Merck, Merck Schering Plough, ISIS, Genzyme, and Sanofi-Aventis; lecture fees from AstraZeneca, GlaxoSmithKline, Pfizer, Novartis, and Boehringer-Ingelhiem; and consulting fees from AstraZeneca, Abbott, Pfizer, ISIS, Genzyme, Roche, Novartis, Merck, Merck Schering Plough, and Sanofi-Aventis. WK reports receiving research grant support from Dade-Behring and GlaxoSmithKline; lecture fees from AstraZeneca, Pfizer, Novartis, GlaxoSmith Kline, and Boehringer-Ingelheim; and consulting fees from GlaxoSmithKline and Roche. PL reports consulting fees from and serves on the Scientific Advisory boards of VIA Pharmaceutical, Interleukin Genetics, Bind Biosciences, Carolus Therapeutics, and Kowa Research Institute. AJL reports receiving research grant support, lecture fees, and consulting fees from AstraZeneca, Takeda, and Novartis. BGN reports receiving lecture fees from AstraZeneca, Sanofi-Aventis, Pfizer, Boehinger Ingelheim, and Merck; and consulting fees from AstraZeneca, Abbott, and BG Medicine. JS reports receiving lecture fees from AstraZeneca, Pfizer, and Merck; and consulting fees from AstraZeneca, Merck, Pfizer, Nicox, and Oxford Biosciences. RJG reports receiving research grant support from AstraZeneca and Bristol Myers Squibb. JTW, ED, and JGMF declare that they have no conflict of interest.	Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Arnaud C, 2005, TRENDS CARDIOVAS MED, V15, P202, DOI 10.1016/j.tcm.2005.07.002; Arnaud C, 2005, ARTERIOSCL THROM VAS, V25, P1231, DOI 10.1161/01.ATV.0000163840.63685.0c; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Davignon J, 2004, CIRCULATION, V109, P39, DOI 10.1161/01.CIR.0000131517.20177.5a; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Jialal I, 2001, CIRCULATION, V103, P1933; Kastelein JJP, 2008, CIRCULATION, V117, P3002, DOI 10.1161/CIRCULATIONAHA.107.713438; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Morrow DA, 2006, CIRCULATION, V114, P281, DOI 10.1161/CIRCULATIONAHA.106.628909; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2001, CIRCULATION, V103, P1191; Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Sabatine MS, 2007, CIRCULATION, V115, P1528, DOI 10.1161/CIRCULATIONAHA.106.649939; van der Steeg WA, 2007, ANN INTERN MED, V146, P640, DOI 10.7326/0003-4819-146-9-200705010-00007	22	767	805	0	48	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 4	2009	373	9670					1175	1182		10.1016/S0140-6736(09)60447-5	http://dx.doi.org/10.1016/S0140-6736(09)60447-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429SO	19329177				2022-12-28	WOS:000264940600031
J	King, RD; Rowland, J; Oliver, SG; Young, M; Aubrey, W; Byrne, E; Liakata, M; Markham, M; Pir, P; Soldatova, LN; Sparkes, A; Whelan, KE; Clare, A				King, Ross D.; Rowland, Jem; Oliver, Stephen G.; Young, Michael; Aubrey, Wayne; Byrne, Emma; Liakata, Maria; Markham, Magdalena; Pir, Pinar; Soldatova, Larisa N.; Sparkes, Andrew; Whelan, Kenneth E.; Clare, Amanda			The Automation of Science	SCIENCE			English	Article							ONTOLOGY; GROWTH	The basis of science is the hypothetico-deductive method and the recording of experiments in sufficient detail to enable reproducibility. We report the development of Robot Scientist "Adam," which advances the automation of both. Adam has autonomously generated functional genomics hypotheses about the yeast Saccharomyces cerevisiae and experimentally tested these hypotheses by using laboratory automation. We have confirmed Adam's conclusions through manual experiments. To describe Adam's research, we have developed an ontology and logical language. The resulting formalization involves over 10,000 different research units in a nested treelike structure, 10 levels deep, that relates the 6.6 million biomass measurements to their logical description. This formalization describes how a machine contributed to scientific knowledge.	[King, Ross D.; Rowland, Jem; Aubrey, Wayne; Byrne, Emma; Liakata, Maria; Markham, Magdalena; Soldatova, Larisa N.; Sparkes, Andrew; Whelan, Kenneth E.; Clare, Amanda] Aberystwyth Univ, Dept Comp Sci, Aberystwyth SY23 3DB, Dyfed, Wales; [Oliver, Stephen G.; Pir, Pinar] Univ Cambridge, Dept Biochem, Cambridge Syst Biol Ctr, Cambridge CB2 1GA, England; [Young, Michael] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3DD, Dyfed, Wales	Aberystwyth University; University of Cambridge; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	King, RD (corresponding author), Aberystwyth Univ, Dept Comp Sci, Aberystwyth SY23 3DB, Dyfed, Wales.	rdk@aber.ac.uk	Pir, Pinar/AAA-5103-2022; Oliver, Stephen/AAQ-5992-2021; Aubrey, Wayne/AAE-7321-2021; Soldatova, Larisa/AAE-4656-2020	Oliver, Stephen/0000-0003-3410-6439; Pir, Pinar/0000-0002-0078-4904; Soldatova, Larisa/0000-0001-6489-3029; Clare, Amanda/0000-0001-8315-3659; King, Ross/0000-0001-7208-4387; Liakata, Maria/0000-0001-5765-0416	Biotechnology and Biological Sciences Research Council; SRIF 2 award; fellowships from the Royal Commission; Engineering and Physical Sciences Research Council; Royal Academy of Engineering; RC-UK Fellowship; BBSRC [BB/F008228/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F008228/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); SRIF 2 award; fellowships from the Royal Commission; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Academy of Engineering(Royal Academy of Engineering - UK); RC-UK Fellowship(UK Research & Innovation (UKRI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by grants from the Biotechnology and Biological Sciences Research Council to R.D.K., S.G.O., and M.Y.; by a SRIF 2 award to R.D.K.; by fellowships from the Royal Commission for the Great Exhibition of 1851, the Engineering and Physical Sciences Research Council, and the Royal Academy of Engineering to A.C.; and by a RC-UK Fellowship to L.N.S. We thank D. Struttman for help with yeast and M. Benway for help with Adam.	[Anonymous], 2006, NATURE, V440, P383, DOI 10.1038/440383a; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berners-Lee T, 2001, SCI AM, V284, P34, DOI 10.1038/scientificamerican0501-34; BUCHANAN BG, 1969, MACH INTELL, V5, P209; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; HEY T, 2003, GRID COMPUTING MAKIN, V36, P809; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Horrocks I., 2003, J WEB SEMANT, V1, P7, DOI DOI 10.1016/J.WEBSEM.2003.07.001; King RD, 2004, NATURE, V427, P247, DOI 10.1038/nature02236; KING RD, 2008, ROBOT SCI PROJECT; Langley P., 1987, SCI DISCOVERY COMPUT; Soldatova LN, 2006, BIOINFORMATICS, V22, pE464, DOI 10.1093/bioinformatics/btl207; Soldatova LN, 2006, J R SOC INTERFACE, V3, P795, DOI 10.1098/rsif.2006.0134; TOULMIN S, 2003, ENCY BRITANNICA DELU; Turing A.M., 1950, MIND, P433, DOI DOI 10.1093/MIND/LIX.236.433; Ullman J., 1988, PRINCIPLES DATABASE, V1; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; Whelan KE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-97; YOUNG M, 1973, J EXP BOT, V24, P1172, DOI 10.1093/jxb/24.6.1172; Zabriskie TM, 2000, NAT PROD REP, V17, P85, DOI 10.1039/a801345d; ZYTKOW JM, 1990, PROCEEDINGS : EIGHTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 AND 2, P889	21	303	311	3	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					85	89		10.1126/science.1165620	http://dx.doi.org/10.1126/science.1165620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342587	Green Published			2022-12-28	WOS:000264802100037
J	Collins, CA; Stott, JP; Hilton, M; Kay, ST; Stanford, SA; Davidson, M; Hosmer, M; Hoyle, B; Liddle, A; Lloyd-Davies, E; Mann, RG; Mehrtens, N; Miller, CJ; Nichol, RC; Romer, AK; Sahlen, M; Viana, PTP; West, MJ				Collins, Chris A.; Stott, John P.; Hilton, Matt; Kay, Scott T.; Stanford, S. Adam; Davidson, Michael; Hosmer, Mark; Hoyle, Ben; Liddle, Andrew; Lloyd-Davies, Ed; Mann, Robert G.; Mehrtens, Nicola; Miller, Christopher J.; Nichol, Robert C.; Romer, A. Kathy; Sahlen, Martin; Viana, Pedro T. P.; West, Michael J.			Early assembly of the most massive galaxies	NATURE			English	Article							BRIGHTEST CLUSTER GALAXIES; LUMINOUS RED GALAXIES; EVOLUTION; XMM; DISCOVERY; STELLAR; Z=1.26	The current consensus is that galaxies begin as small density fluctuations in the early Universe and grow by in situ star formation and hierarchical merging(1). Stars begin to form relatively quickly in sub-galactic-sized building blocks called haloes which are subsequently assembled into galaxies. However, exactly when this assembly takes place is a matter of some debate(2,3). Here we report that the stellar masses of brightest cluster galaxies, which are the most luminous objects emitting stellar light, some 9 billion years ago are not significantly different from their stellar masses today. Brightest cluster galaxies are almost fully assembled 425 billion years after the Big Bang, having grown to more than 90 per cent of their final stellar mass by this time. Our data conflict with the most recent galaxy formation models(4,5) based on the largest simulations of dark-matter halo development(1). These models predict protracted formation of brightest cluster galaxies over a Hubble time, with only 22 per cent of the stellar mass assembled at the epoch probed by our sample. Our findings suggest a new picture in which brightest cluster galaxies experience an early period of rapid growth rather than prolonged hierarchical assembly.	[Collins, Chris A.; Stott, John P.; Hilton, Matt] Liverpool John Moores Univ, Astrophys Res Inst, Birkenhead CH41 1LD, Merseyside, England; [Hilton, Matt] Univ KwaZulu Natal, Sch Math Sci, Astrophys & Cosmol Res Unit, ZA-4000 Durban, South Africa; [Hilton, Matt] S African Astron Observ, ZA-7935 Cape Town, South Africa; [Kay, Scott T.] Univ Manchester, Sch Phys & Astron, Jodrell Bank, Ctr Astrophys, Manchester M13 9PL, Lancs, England; [Stanford, S. Adam] Univ Calif Davis, Dept Phys, Davis, CA 95616 USA; [Stanford, S. Adam] Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94551 USA; [Davidson, Michael; Mann, Robert G.] Univ Edinburgh, Royal Observ, Inst Astron, SUPA, Edinburgh EH9 3HJ, Midlothian, Scotland; [Hosmer, Mark; Liddle, Andrew; Lloyd-Davies, Ed; Mehrtens, Nicola; Romer, A. Kathy; Sahlen, Martin] Univ Sussex, Ctr Astron, Brighton BN1 9QH, E Sussex, England; [Hoyle, Ben; Nichol, Robert C.] Univ Portsmouth, ICG, Portsmouth PO1 2EG, Hants, England; [Miller, Christopher J.] Natl Opt Astron Observ, Cerro Tololo Inter Amer Observ, Tucson, AZ 85719 USA; [Viana, Pedro T. P.] Univ Porto, Fac Ciencias, Dept Matemat Aplicada, P-4169007 Oporto, Portugal; [Viana, Pedro T. P.] Univ Porto, Ctr Astrofis, P-4150762 Oporto, Portugal; [West, Michael J.] European So Observ, Santiago 19001, Chile	Liverpool John Moores University; University of Kwazulu Natal; National Research Foundation - South Africa; South African Astronomical Observatory; University of Manchester; Jodrell Bank Centre for Astrophysics; University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Edinburgh; University of Sussex; University of Portsmouth; National Optical Astronomy Observatory; Universidade do Porto; Universidade do Porto; European Southern Observatory	Collins, CA (corresponding author), Liverpool John Moores Univ, Astrophys Res Inst, 12 Quays House, Birkenhead CH41 1LD, Merseyside, England.	cac@astro.livjm.ac.uk	Sahlen, Martin/C-6308-2008; Stott, John/AAC-6491-2019; Hilton, Matthew James/N-5860-2013; Sahlén, Martin/N-7951-2019	Stott, John/0000-0002-1679-9983; Hilton, Matthew James/0000-0002-8490-8117; Sahlén, Martin/0000-0003-0973-4804; hoyle, ben/0000-0002-2571-1357; Kay, Scott/0000-0002-2277-9049; Viana, Pedro/0000-0003-1572-8531; Liddle, Andrew/0000-0002-8164-4830	NASA; Liverpool John Moores University; STFC; South African National Research Foundation; Research in Astronomy, Inc.; Science and Technology Facilities Council [ST/H001581/1, PP/E001149/1, ST/F006977/1, ST/F002858/1] Funding Source: researchfish; STFC [ST/F002858/1, ST/H001581/1, PP/E001149/1, ST/F006977/1] Funding Source: UKRI	NASA(National Aeronautics & Space Administration (NASA)); Liverpool John Moores University; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); South African National Research Foundation(National Research Foundation - South Africa); Research in Astronomy, Inc.; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work is based in part on data collected at the Subaru Telescope, which is operated by the National Astronomical Observatory of Japan and the XMM- Newton, an ESA science mission funded by contributions from ESA member states and from NASA. We acknowledge financial support from Liverpool John Moores University and the STFC. M. H. acknowledges support from the South African National Research Foundation. IRAF is distributed by the National Optical Astronomy Observatories, which are operated by the Association of Universities for Research in Astronomy, Inc., under cooperative agreement with the National Science Foundation. We thank G. De Lucia for making simulation results available to us in tabular form, I. Tanaka for developing the MCSRED package used to reduce the MOIRCS data, M. Salaris for discussions on stellar population synthesis models and B. Maughan for discussions on cluster masses.	Almeida C, 2008, MON NOT R ASTRON SOC, V386, P2145, DOI 10.1111/j.1365-2966.2008.13179.x; Bower RG, 2006, MON NOT R ASTRON SOC, V370, P645, DOI 10.1111/j.1365-2966.2006.10519.x; Bremer MN, 2006, MON NOT R ASTRON SOC, V371, P1427, DOI 10.1111/j.1365-2966.2006.10767.x; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Burke DJ, 2000, ASTROPHYS J, V532, pL105, DOI 10.1086/312579; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Collins CA, 1998, MON NOT R ASTRON SOC, V297, P128, DOI 10.1046/j.1365-8711.1998.01482.x; De Lucia G, 2007, MON NOT R ASTRON SOC, V375, P2, DOI 10.1111/j.1365-2966.2006.11287.x; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; Demarco R, 2007, ASTROPHYS J, V663, P164, DOI 10.1086/518117; EGGEN OJ, 1962, ASTROPHYS J, V136, P748, DOI 10.1086/147433; Hilton M, 2007, ASTROPHYS J, V670, P1000, DOI 10.1086/522827; Kampakoglou M, 2008, MON NOT R ASTRON SOC, V384, P1414, DOI 10.1111/j.1365-2966.2007.12747.x; LARSON RB, 1974, MON NOT R ASTRON SOC, V166, P585, DOI 10.1093/mnras/166.3.585; LAUER TR, 1994, ASTROPHYS J, V425, P418, DOI 10.1086/173997; Lin YT, 2004, ASTROPHYS J, V617, P879, DOI 10.1086/425412; Mullis CR, 2005, ASTROPHYS J, V623, pL85, DOI 10.1086/429801; Romer AK, 2001, ASTROPHYS J, V547, P594, DOI 10.1086/318382; Rosati P, 1999, ASTRON J, V118, P76, DOI 10.1086/300934; SAHLEN M, 2008, XMM CLUSTER SURVEY F; SANDAGE A, 1973, ASTROPHYS J, V183, P743, DOI 10.1086/152263; Springel V, 2005, NATURE, V435, P629, DOI 10.1038/nature03597; Stanford SA, 2006, ASTROPHYS J, V646, pL13, DOI 10.1086/506449; Stott JP, 2008, MON NOT R ASTRON SOC, V384, P1502, DOI 10.1111/j.1365-2966.2007.12807.x; Vale A, 2008, MON NOT R ASTRON SOC, V383, P355, DOI 10.1111/j.1365-2966.2007.12544.x; van Dokkum PG, 2008, ASTROPHYS J LETT, V677, pL5, DOI 10.1086/587874; Wake DA, 2006, MON NOT R ASTRON SOC, V372, P537, DOI 10.1111/j.1365-2966.2006.10831.x; Whiley IM, 2008, MON NOT R ASTRON SOC, V387, P1253, DOI 10.1111/j.1365-2966.2008.13324.x; Yamada T, 2002, ASTROPHYS J, V577, pL89, DOI 10.1086/344400	30	131	132	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					603	606		10.1038/nature07865	http://dx.doi.org/10.1038/nature07865			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19340075	Green Submitted			2022-12-28	WOS:000264796200034
J	Heath, I; Rubinstein, A; Stange, KC; van Driel, ML				Heath, Iona; Rubinstein, Adolfo; Stange, Kurt C.; van Driel, Mieke L.			Quality in primary health care: a multidimensional approach to complexity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Heath, Iona] Caversham Grp Practice, London NW5 2UP, England; [Rubinstein, Adolfo] Univ Buenos Aires, Fac Med, Hosp Italiano, Div Family & Community Med, Buenos Aires, DF, Argentina; [Stange, Kurt C.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Rubinstein, Adolfo] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina; [van Driel, Mieke L.] Bond Univ, Fac Hlth Sci & Med, Gold Coast, Qld 4229, Australia; [van Driel, Mieke L.] Univ Ghent, Dept Gen Practice & Primary Hlth Care, B-9000 Ghent, Belgium	Hospital Italiano de Buenos Aires; University of Buenos Aires; Case Western Reserve University; Bond University; Ghent University	Heath, I (corresponding author), Caversham Grp Practice, London NW5 2UP, England.	iona.heath@dsl.pipex.com	van Driel, Mieke/D-1167-2011	van Driel, Mieke/0000-0003-1711-9553				[Anonymous], QUAL OUTC FRAM; CAMPBELL SM, ANN FAM MED, V6, P228; Checkland K, 2008, SOCIOL HEALTH ILL, V30, P788, DOI 10.1111/j.1467-9566.2008.01081.x; De Maeseneer JM, 2003, LANCET, V362, P1314, DOI 10.1016/S0140-6736(03)14576-X; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Fortin M, 2006, ANN FAM MED, V4, P104, DOI 10.1370/afm.516; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fortin M, 2007, BMJ-BRIT MED J, V334, P1016, DOI 10.1136/bmj.39201.463819.2C; Geynan JP, 2007, ANN FAM MED, V5, P257, DOI 10.1370/afm.649; Gimpel N.E., 2006, QUAL PRIMARY CARE, V14, P211; Howie J. G., 1997, 75 ROYAL COLL GEN PR; ILLNESS C, 1995, MED CARE, pJS60; Meads G., 2006, PRIMARY CARE 21 CENT; OUCHI WG, 1980, ADMIN SCI QUART, V25, P129, DOI 10.2307/2392231; Roland M, 2007, BRIT J GEN PRACT, V57, P525; Stange KC, 1998, J FAM PRACTICE, V46, P363; Starfield Barbara, 2003, Ann Fam Med, V1, P8, DOI 10.1370/afm.1; *U OXF, PAT REP OUTC MEAS	18	64	65	4	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2009	338								b1242	10.1136/bmj.b1242	http://dx.doi.org/10.1136/bmj.b1242			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429AO	19342404				2022-12-28	WOS:000264893400003
J	Burlingham, WJ				Burlingham, William J.			A Lesson in Tolerance - Maternal Instruction to Fetal Cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ANTIGENS		Univ Wisconsin, Dept Surg, Div Transplantat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Burlingham, WJ (corresponding author), Univ Wisconsin, Dept Surg, Div Transplantat, Madison, WI 53706 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066219] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI066219, R01 AI066219-04] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Burlingham WJ, 1998, NEW ENGL J MED, V339, P1657, DOI 10.1056/NEJM199812033392302; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Molitor-Dart ML, 2007, J IMMUNOL, V179, P6749, DOI 10.4049/jimmunol.179.10.6749; Streilein JW, 2003, NAT REV IMMUNOL, V3, P879, DOI 10.1038/nri1224; van Rood JJ, 2002, BLOOD, V99, P1572, DOI 10.1182/blood.V99.5.1572	5	35	36	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2009	360	13					1355	1357		10.1056/NEJMcibr0810752	http://dx.doi.org/10.1056/NEJMcibr0810752			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423VP	19321873	Green Accepted			2022-12-28	WOS:000264524100015
J	Aliev, AE; Oh, JY; Kozlov, ME; Kuznetsov, AA; Fang, SL; Fonseca, AF; Ovalle, R; Lima, MD; Haque, MH; Gartstein, YN; Zhang, M; Zakhidov, AA; Baughman, RH				Aliev, Ali E.; Oh, Jiyoung; Kozlov, Mikhail E.; Kuznetsov, Alexander A.; Fang, Shaoli; Fonseca, Alexandre F.; Ovalle, Raquel; Lima, Marcio D.; Haque, Mohammad H.; Gartstein, Yuri N.; Zhang, Mei; Zakhidov, Anvar A.; Baughman, Ray H.			Giant-Stroke, Superelastic Carbon Nanotube Aerogel Muscles	SCIENCE			English	Article							ACTUATORS; ELASTOMERS; NANOCOMPOSITES; SHEETS; MEMORY	Improved electrically powered artificial muscles are needed for generating force, moving objects, and accomplishing work. Carbon nanotube aerogel sheets are the sole component of new artificial muscles that provide giant elongations and elongation rates of 220% and (3.7 x 10(4))% per second, respectively, at operating temperatures from 80 to 1900 kelvin. These solid-state-fabricated sheets are enthalpic rubbers having gaslike density and specific strength in one direction higher than those of steel plate. Actuation decreases nanotube aerogel density and can be permanently frozen for such device applications as transparent electrodes. Poisson's ratios reach 15, a factor of 30 higher than for conventional rubbers. These giant Poisson's ratios explain the observed opposite sign of width and length actuation and result in rare properties: negative linear compressibility and stretch densification.	[Aliev, Ali E.; Oh, Jiyoung; Kozlov, Mikhail E.; Kuznetsov, Alexander A.; Fang, Shaoli; Fonseca, Alexandre F.; Ovalle, Raquel; Lima, Marcio D.; Haque, Mohammad H.; Gartstein, Yuri N.; Zhang, Mei; Zakhidov, Anvar A.; Baughman, Ray H.] Univ Texas Dallas, Alan G MacDiarmid NanoTech Inst, Richardson, TX 75083 USA	University of Texas System; University of Texas Dallas	Baughman, RH (corresponding author), Univ Texas Dallas, Alan G MacDiarmid NanoTech Inst, Richardson, TX 75083 USA.	ray.baughman@utdallas.edu	Fonseca, Alexandre/H-3105-2011; Lima, Marcio/G-4634-2012; Baughman, Ray/A-8628-2018; Fonseca, Alexandre F./K-5477-2019; Aliev, Ali/R-3034-2019	Fonseca, Alexandre/0000-0001-8413-9744; Baughman, Ray/0000-0001-5845-5137; Zakhidov, Anvar/0000-0003-3983-2229; Aliev, Ali/0000-0003-0034-9707	Air Force Office of Scientific Research [FA9550-05-C-0088]; NSF [DMI-0609115]; Office of Naval Research [N00014-08-1-0654]; Robert A. Welch Foundation [AT-0029]; Honda Corporation; Lintec Corporation; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Robert A. Welch Foundation(The Welch Foundation); Honda Corporation; Lintec Corporation; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We thank T. Mirfakhrai, J. D. W. Madden, and V. M. Agranovich for their contributions. Supported by Air Force Office of Scientific Research grant FA9550-05-C-0088, NSF grant DMI-0609115, Office of Naval Research MURI grant N00014-08-1-0654, Robert A. Welch Foundation Grant AT-0029, Honda Corporation, Lintec Corporation, and the Brazilian agency CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). A provisional patent for nanofiber actuators and strain amplifiers has been filed by the authors (Patent Office Provisional Filing No. 61089275).	Ahir SV, 2005, NAT MATER, V4, P491, DOI 10.1038/nmat1391; Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; Baughman RH, 1998, SCIENCE, V279, P1522, DOI 10.1126/science.279.5356.1522; Baughman RH, 2003, NATURE, V425, P667, DOI 10.1038/425667a; Courty S, 2003, EUROPHYS LETT, V64, P654, DOI 10.1209/epl/i2003-00277-9; Deshpande VV, 2006, NANO LETT, V6, P1092, DOI 10.1021/nl052513f; Evans KE, 2000, ADV MATER, V12, P617, DOI 10.1002/(SICI)1521-4095(200005)12:9<617::AID-ADMA617>3.0.CO;2-3; Gupta S, 2004, J APPL PHYS, V95, P2038, DOI 10.1063/1.1641518; Kim P, 1999, SCIENCE, V286, P2148, DOI 10.1126/science.286.5447.2148; Koerner H, 2004, NAT MATER, V3, P115, DOI 10.1038/nmat1059; Madden JDW, 2004, IEEE J OCEANIC ENG, V29, P706, DOI 10.1109/JOE.2004.833135; Miaudet P, 2007, SCIENCE, V318, P1294, DOI 10.1126/science.1145593; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; Rueckes T, 2000, SCIENCE, V289, P94, DOI 10.1126/science.289.5476.94; Sapmaz S, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.235414; Spinks GM, 2002, ADV MATER, V14, P1728, DOI 10.1002/1521-4095(20021203)14:23<1728::AID-ADMA1728>3.0.CO;2-8; Vohrer U, 2004, CARBON, V42, P1159, DOI 10.1016/j.carbon.2003.12.044; Yakobson BI, 2006, J NANOPART RES, V8, P105, DOI 10.1007/s11051-005-8335-3; Zhang M, 2005, SCIENCE, V309, P1215, DOI 10.1126/science.1115311	19	423	441	32	666	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1575	1578		10.1126/science.1168312	http://dx.doi.org/10.1126/science.1168312			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299612				2022-12-28	WOS:000264342300030
J	Fuentes, R; Petersson, P; Siesser, WB; Caron, MG; Nicolelis, MAL				Fuentes, Romulo; Petersson, Per; Siesser, William B.; Caron, Marc G.; Nicolelis, Miguel A. L.			Spinal Cord Stimulation Restores Locomotion in Animal Models of Parkinson's Disease	SCIENCE			English	Article							TRIGEMINAL NERVE-STIMULATION; DEEP BRAIN-STIMULATION; L-DOPA; SUBTHALAMIC NUCLEUS; MOTOR; RAT; MOVEMENT; NEURONS; CORTEX	Dopamine replacement therapy is useful for treating motor symptoms in the early phase of Parkinson's disease, but it is less effective in the long term. Electrical deep-brain stimulation is a valuable complement to pharmacological treatment but involves a highly invasive surgical procedure. We found that epidural electrical stimulation of the dorsal columns in the spinal cord restores locomotion in both acute pharmacologically induced dopamine-depleted mice and in chronic 6-hydroxydopamine-lesioned rats. The functional recovery was paralleled by a disruption of aberrant low-frequency synchronous corticostriatal oscillations, leading to the emergence of neuronal activity patterns that resemble the state normally preceding spontaneous initiation of locomotion. We propose that dorsal column stimulation might become an efficient and less invasive alternative for treatment of Parkinson's disease in the future.	[Fuentes, Romulo; Petersson, Per; Caron, Marc G.; Nicolelis, Miguel A. L.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Petersson, Per] Lund Univ, Dept Expt Med Sci, Neuronano Res Ctr, BMC F10, S-22184 Lund, Sweden; [Siesser, William B.; Caron, Marc G.] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; [Nicolelis, Miguel A. L.] Duke Univ, Ctr Neuroengn, Durham, NC 27710 USA; [Nicolelis, Miguel A. L.] Duke Univ, Dept Biomed Engn, Durham, NC 27710 USA; [Nicolelis, Miguel A. L.] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27710 USA; [Nicolelis, Miguel A. L.] ELS IINN, BR-59066060 Natal, RN, Brazil; [Nicolelis, Miguel A. L.] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland	Duke University; Lund University; Duke University; Duke University; Duke University; Duke University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Fuentes, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	fuentes@neuro.duke.edu	Petersson, Per/P-1878-2019; Fuentes, Romulo/AFR-1296-2022; Fuentes, Romulo/N-4258-2019; Petersson, Per/A-5740-2010	Petersson, Per/0000-0001-6697-0171; Fuentes, Romulo/0000-0002-6282-7287; Fuentes, Romulo/0000-0002-6282-7287; Petersson, Per/0000-0001-6697-0171	National Institute of Neurological Disorders and Stroke (NINDS) [R33NS049534]; International Neuroscience Network Foundation; Ruth K. Broad Postdoctoral Award; NRC; Knut and Alice Wallenberg Foundation;  [R01NS019576];  [R01MH073853]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R33NS049534, R21NS049534, R01NS019576] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); International Neuroscience Network Foundation; Ruth K. Broad Postdoctoral Award; NRC(National Research Centre (NRC)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. M. Chan, G. Lehew, and J. Meloy for outstanding technical assistance; R. Gainetdinov, S.-C. Lin, H. Zhang, and K. Dzirasa for valuable comments; and S. Halkiotis for proofreading the manuscript. This work was supported by the National Institute of Neurological Disorders and Stroke (NINDS) R33NS049534 and the International Neuroscience Network Foundation to M.A.L.N., R01NS019576 and R01MH073853 to M.G.C., Ruth K. Broad Postdoctoral Award to R.F., and NRC and Knut and Alice Wallenberg Foundation to P.P. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NINDS or the National Institutes of Health. M.A.L.N. dedicates this paper to Lily Safra for her continuing support and to the memory of his grandfather, Angelo Nicolelis, who suffered from Parkinson's disease. M.A.L.N. acknowledges a visiting professorship, Chaire Blaise Pascal, from the Region Ile de France at the Ecole Superieure de Physique et de Chimie Industrielles, Paris.	Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Brooks DJ, 2006, BIOL PSYCHIAT, V59, P908, DOI 10.1016/j.biopsych.2005.12.017; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; BRUDZYNSKI SM, 1993, CAN J PHYSIOL PHARM, V71, P394, DOI 10.1139/y93-060; CARLSSON A, 1972, ACTA NEUROL SCAND, V48, P11; Cenci MA, 2002, NAT REV NEUROSCI, V3, P574, DOI 10.1038/nrn877; Costa RM, 2006, NEURON, V52, P359, DOI 10.1016/j.neuron.2006.07.030; DeGiorgio CM, 2006, EPILEPSIA, V47, P1213, DOI 10.1111/j.1528-1167.2006.00594.x; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Drouot' X, 2004, NEURON, V44, P769, DOI 10.1016/j.neuron.2004.11.023; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; Fanselow EE, 2000, J NEUROSCI, V20, P8160; GLICKSTEIN M, 1991, TRENDS NEUROSCI, V14, P480, DOI 10.1016/0166-2236(91)90055-Y; Grillner S, 2008, BRAIN RES REV, V57, P2, DOI 10.1016/j.brainresrev.2007.06.027; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Hornykiewicz O, 2002, AMINO ACIDS, V23, P65, DOI 10.1007/s00726-001-0111-9; LLOYD KG, 1975, J PHARMACOL EXP THER, V195, P453; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Plaha P, 2006, BRAIN, V129, P1732, DOI 10.1093/brain/awl127; SAKAI K, 1994, BRAIN RES, V633, P144, DOI 10.1016/0006-8993(94)91533-4; Schlesinger I, 2007, MOVEMENT DISORD, V22, P2394, DOI 10.1002/mds.21739; SHAW KM, 1980, Q J MED, V49, P283; Smith Y, 2004, TRENDS NEUROSCI, V27, P520, DOI 10.1016/j.tins.2004.07.004; Sotnikova TD, 2005, PLOS BIOL, V3, P1488, DOI 10.1371/journal.pbio.0030271; WALL PD, 1970, BRAIN, V93, P505, DOI 10.1093/brain/93.3.505; Wilson CJ, 2005, NEURON, V45, P575, DOI 10.1016/j.neuron.2004.12.053; Winkler C, 2002, NEUROBIOL DIS, V10, P165, DOI 10.1006/nbdi.2002.0499	28	189	223	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1578	1582		10.1126/science.1164901	http://dx.doi.org/10.1126/science.1164901			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299613	Green Accepted			2022-12-28	WOS:000264342300031
J	Lagier-Tourenne, C; Cleveland, DW				Lagier-Tourenne, Clotilde; Cleveland, Don W.			Rethinking ALS: The FUS about TDP-43	CELL			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; BINDING PROTEIN TLS; TARDBP MUTATIONS; DISEASE; GENE	Mutations in TDP-43, a DNA/RNA-binding protein, cause an inherited form of the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Two recent studies (Kwiatkowski et al., 2009; Vance et al., 2009) now report that mutations in FUS/TLS, another DNA/RNA-binding protein, also trigger premature degeneration of motor neurons. TDP-43 and FUS/TLS have striking structural and functional similarities, implicating alterations in RNA processing as a key event in ALS pathogenesis.	[Lagier-Tourenne, Clotilde; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Lagier-Tourenne, Clotilde; Cleveland, Don W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021; lagier-Tourenne, Clotilde/ABE-6303-2020	lagier-Tourenne, Clotilde/0000-0002-3058-8322; Cleveland, Don/0000-0002-1934-3682	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS069144, R37NS027036] Funding Source: NIH RePORTER; NINDS NIH HHS [R37 NS027036, RC1 NS069144, RC1 NS069144-01, R37 NS027036-23] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Banks GT, 2008, MAMM GENOME, V19, P299, DOI 10.1007/s00335-008-9117-x; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Corrado L, 2009, HUM MUTAT, V30, P688, DOI 10.1002/humu.20950; Daoud H, 2009, J MED GENET, V46, P112, DOI 10.1136/jmg.2008.062463; Doi H, 2008, J BIOL CHEM, V283, P6489, DOI 10.1074/jbc.M705306200; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Janknecht R, 2005, GENE, V363, P1, DOI 10.1016/j.gene.2005.08.007; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047	20	445	462	0	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1001	1004		10.1016/j.cell.2009.03.006	http://dx.doi.org/10.1016/j.cell.2009.03.006			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303844	Green Accepted, Bronze			2022-12-28	WOS:000264403900007
J	Mao, YW; Ge, XC; Frank, CL; Madison, JM; Koehler, AN; Doud, MK; Tassa, C; Berry, EM; Soda, T; Singh, KK; Biechele, T; Petryshen, TL; Moon, RT; Haggarty, SJ; Tsai, LH				Mao, Yingwei; Ge, Xuecai; Frank, Christopher L.; Madison, Jon M.; Koehler, Angela N.; Doud, Mary Kathryn; Tassa, Carlos; Berry, Erin M.; Soda, Takahiro; Singh, Karun K.; Biechele, Travis; Petryshen, Tracey L.; Moon, Randall T.; Haggarty, Stephen J.; Tsai, Li-Huei			Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3 beta/beta-Catenin Signaling	CELL			English	Article							GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; HIPPOCAMPAL NEUROGENESIS; DISC1; BRAIN; MICE; LITHIUM; CELLS; DISRUPTED-IN-SCHIZOPHRENIA-1; EXPRESSION	The Disrupted in Schizophrenia 1 (DISC1) gene is disrupted by a balanced chromosomal translocation (1; 11) (q42; q14.3) in a Scottish family with a high incidence of major depression, schizophrenia, and bipolar disorder. Subsequent studies provided indications that DISC1 plays a role in brain development. Here, we demonstrate that suppression of DISC1 expression reduces neural progenitor proliferation, leading to premature cell cycle exit and differentiation. Several lines of evidence suggest that DISC1 mediates this function by regulating GSK3 beta. First, DISC1 inhibits GSK3 beta activity through direct physical interaction, which reduces beta-catenin phosphorylation and stabilizes beta-catenin. Importantly, expression of stabilized beta-catenin overrides the impairment of progenitor proliferation caused by DISC1 loss of function. Furthermore, GSK3 inhibitors normalize progenitor proliferation and behavioral defects caused by DISC1 loss of function. Together, these results implicate DISC1 inGSK3 beta/beta-catenin signaling pathways and provide a framework for understanding how alterations in this pathway may contribute to the etiology of psychiatric disorders.	[Mao, Yingwei; Ge, Xuecai; Frank, Christopher L.; Soda, Takahiro; Singh, Karun K.; Biechele, Travis; Moon, Randall T.; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Mao, Yingwei; Ge, Xuecai; Frank, Christopher L.; Soda, Takahiro; Singh, Karun K.; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Mao, Yingwei] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Soda, Takahiro] Harvard Univ, Sch Med, Phd Program, Boston, MA 02115 USA; [Soda, Takahiro] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Koehler, Angela N.; Doud, Mary Kathryn; Tassa, Carlos; Berry, Erin M.; Petryshen, Tracey L.; Haggarty, Stephen J.] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Ctr Human Genet Res, Boston, MA 02114 USA; [Koehler, Angela N.; Doud, Mary Kathryn; Tassa, Carlos; Berry, Erin M.; Petryshen, Tracey L.; Haggarty, Stephen J.] Massachusetts Gen Hosp, Mol Neurogenet Unit, Ctr Human Genet Res, Boston, MA 02114 USA; [Madison, Jon M.; Berry, Erin M.; Petryshen, Tracey L.; Haggarty, Stephen J.; Tsai, Li-Huei] Broad Inst Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA; [Madison, Jon M.; Berry, Erin M.; Petryshen, Tracey L.; Haggarty, Stephen J.; Tsai, Li-Huei] MIT, Cambridge, MA 02139 USA; [Biechele, Travis; Moon, Randall T.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Biechele, Travis; Moon, Randall T.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Tsai, LH (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Soda, Takahiro/AHC-3347-2022; Moon, Randall/M-5605-2019; Moon, Randall T/B-1743-2014; Petryshen, Tracey/X-5850-2019; Haggarty, Stephen J/M-9495-2016	Soda, Takahiro/0000-0001-6268-2965; Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408; Petryshen, Tracey/0000-0002-7972-4612; Haggarty, Stephen J/0000-0002-7872-168X; Mao, Yingwei/0000-0001-7339-1565	National Alliance for Research on Schizophrenia and Depression Young Investigator Award; Natural Sciences and Engineering Research Council Postdoctoral Award; National Institutes of Health [NS37007]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037007] Funding Source: NIH RePORTER	National Alliance for Research on Schizophrenia and Depression Young Investigator Award(NARSAD); Natural Sciences and Engineering Research Council Postdoctoral Award(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Sawa for providing the human DISC1 cDNA construct, C. Lois for the FUGW construct, X. He for FLAG-Dvl2, HA-GSK3 beta, FLAG-WT-beta-catenin, and SA-beta-catenin constructs, Y. Ma and M. Greenberg for Ngn2 antibodies, and F. Gage for the AHP cells. We acknowledge E. Scolnick, B. A. Samuels, Z. Xie, D. Meletis, M. Carlen, C. Bragg, J. Buchman, P. Thanawala, and M. Dobbin for technical support, helpful discussion, and critical reading of the manuscript. L.-H. T. is an investigator of the Howard Hughes Medical Institute and the director of the neurobiology program at the Stanley Center for Psychiatric Research. Y. M. is a recipient of the National Alliance for Research on Schizophrenia and Depression Young Investigator Award. K. K. S. is a recipient of a Natural Sciences and Engineering Research Council Postdoctoral Award and a Human Frontiers Science Program Research Fellowship. T. S. is a recipient of the Singleton Fellowship. This work was partially supported by a National Institutes of Health grant (NS37007) to L.-H. T.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adachi K, 2007, STEM CELLS, V25, P2827, DOI 10.1634/stemcells.2007-0177; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Flagstad P, 2004, NEUROPSYCHOPHARMACOL, V29, P2052, DOI 10.1038/sj.npp.1300516; Gould TD, 2008, BEHAV BRAIN RES, V189, P117, DOI 10.1016/j.bbr.2007.12.028; Gould TD, 2007, NEUROPSYCHOPHARMACOL, V32, P2173, DOI 10.1038/sj.npp.1301338; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Harwood AJ, 2005, MOL PSYCHIATR, V10, P117, DOI 10.1038/sj.mp.4001618; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kvajo M, 2008, P NATL ACAD SCI USA, V105, P7076, DOI 10.1073/pnas.0802615105; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Li W, 2007, P NATL ACAD SCI USA, V104, P18280, DOI 10.1073/pnas.0706900104; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Ma L, 2002, GENOMICS, V80, P662, DOI 10.1006/geno.2002.7012; Ma YC, 2008, NEURON, V58, P65, DOI 10.1016/j.neuron.2008.01.037; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Newton SS, 2007, CNS DRUGS, V21, P715, DOI 10.2165/00023210-200721090-00002; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Plotkin B, 2003, J PHARMACOL EXP THER, V305, P974, DOI 10.1124/jpet.102.047381; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schuller U, 2007, BRAIN RES, V1140, P161, DOI 10.1016/j.brainres.2006.05.105; Selenica ML, 2007, BRIT J PHARMACOL, V152, P959, DOI 10.1038/sj.bjp.0707471; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4	46	601	635	0	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1017	1031		10.1016/j.cell.2008.12.044	http://dx.doi.org/10.1016/j.cell.2008.12.044			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303846	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000264403900009
J	Woolf, SH				Woolf, Steven H.			Social Policy as Health Policy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISPARITIES; MORTALITY; IMPACT		Virginia Commonwealth Univ, Ctr Human Needs, Richmond, VA 23298 USA	Virginia Commonwealth University	Woolf, SH (corresponding author), Virginia Commonwealth Univ, Ctr Human Needs, 1200 Broad St,POB 980251, Richmond, VA 23298 USA.	swoolf@vcu.edu						Braveman P, 2008, OVERCOMING OBSTACLES; Cole BL, 2007, ANNU REV PUBL HEALTH, V28, P393, DOI 10.1146/annurev.publhealth.28.083006.131942; *COMM FUND COMM HI, 2008, WHY NOT BEST RES NAT; Garces E, 2002, AM ECON REV, V92, P999, DOI 10.1257/00028280260344560; Goldman N, 2001, ANN NY ACAD SCI, V954, P118; Hartman M, 2009, HEALTH AFFAIR, V28, P246, DOI 10.1377/hlthaff.28.1.246; Kawachi I, 2005, HEALTH AFFAIR, V24, P343, DOI 10.1377/hlthaff.24.2.343; Miech RA, 2009, AM J PREV MED, V36, P126, DOI 10.1016/j.amepre.2008.09.041; National Center for Health Statistics, 2007, HLTH US 2007 CHARTB; *RW JOHNS FDN COMM, ED HLTH CALC; SMOLENSKY E, 1988, VULNERABLE, P29; Turrell G, 2007, J EPIDEMIOL COMMUN H, V61, P723, DOI 10.1136/jech.2006.050609; Woolf SH, 2004, AM J PUBLIC HEALTH, V94, P2078, DOI 10.2105/AJPH.94.12.2078; WOOLF SH, 2009, PRINCIPLES PUBLIC HL	14	32	33	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 18	2009	301	11					1166	1169		10.1001/jama.2009.320	http://dx.doi.org/10.1001/jama.2009.320			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	419UC	19293418				2022-12-28	WOS:000264244200023
J	Connolly, SJ; Yusuf, S; Camm, J; Chrolavicius, S; Commerford, P; Flather, M; Hart, RG; Hohnloser, SH; Joyner, C; Pfeffer, M; Gaudin, C; Blumenthal, M; Marchese, C; Pogue, J; Hart, R; Hohnloser, S; Anand, I; Arthur, H; Avezum, A; Budaj, A; Ceremuzynski, L; De Caterina, R; Diaz, R; Dorian, P; Flaker, G; Fox, KAA; Franzosi, MG; Goldhaber, S; Golitsyn, S; Granger, C; Halon, D; Hermosillo, A; Hunt, D; Jansky, P; Karatzas, N; Keltai, M; Kozan, O; Lanas, F; Lau, P; Le Heuzey, JY; Lewis, BS; Morais, J; Morillo, C; Paolasso, E; Peters, RJ; Pfisterer, M; Piegas, L; Pipilis, A; Sitkei, E; Swedberg, K; Talajic, M; Valentin, V; Van Mieghem, W; Varigos, J; Ameriso, S; Atra, M; Avezum, A; Berwanger, O; Bonilla, C; Bornstein, N; Budaj, A; Chamiec, T; Chan, YK; Cottin, Y; Csiba, L; Cybulski, J; Czepiel, A; De Raedt, H; Diaz, R; Dvorakova, H; Eikelboom, J; Ergene, O; Fodor, G; Galli, M; Gardinale, E; Golitsyn, S; Granger, C; Gross, B; Goodfield, P; Halon, D; Happola, O; Healey, J; Himbert, D; Hunt, D; Jacobsson, F; Jansky, P; Kalvach, P; Karatzas, N; Keltai, M; Kies, B; Laine, M; Lam, A; Le Heuzey, JY; Lewis, BS; Lewis, S; Leys, D; Maggioni, AP; Massaro, A; Mayosi, BM; Norrving, B; Okay, T; Olah, L; Osende, JO; Oto, A; Peeters, A; Penicka, M; Perakis, A; Piegas, L; Pipilis, A; Pizzolato, G; Rafti, F; Renkin, J; Siva, A; Steg, PG; Stockins, B; Strozynska, E; Swedberg, K; Turazza, F; Vanderhoven, L; Vizel, S; Widimsky, P; Zaborski, J; Albers, G; Hankey, G; Norrving, B; Shuaib, A; Silva, J; Wyse, DG; Cairns, JA; Gent, M; Hirsh, J; Marler, J; Pritchett, E; Wittes, J; Beresh, H; Floyd, L; Gasic, Z; Holadyk-Gris, I; Lawrence, M; Moro, I; Perry, S; Roberts, J; Rodrigues, T; Robinson, L; Stevens, C; Worthy, L; Yuan, F; Guerrero, RAA; Allall, O; Amuchastegui, LM; Boskis, M; Labarta, MHB; Castellanos, CR; Chiale, P; Cuneo, CA; Czcczuo, A; Gabito, AJ; Garrido, M; Guzman, LA; Hasban, EG; Hershson, AR; Hominal, MA; Krauss, JG; Luciardi, HL; Marzetti, EM; Montana, OR; Rabinovich, RF; Ramos, HR; Sanchez, AS; Schygiel, PO; Sumay, GM; Vogel, DR; Zaidman, CJ; Aroney, GM; Ashby, DT; Barlow, MA; Cooke, P; Cross, DB; Fitzpatrick, MA; Garrahy, P; Karrasch, J; Nelson, GI; Rees, D; Roger, SD; Rogers, J; Singh, BB; Stickland, JF; Waites, JH; Walsh, WF; Eichinger, J; Huber, K; Leisch, F; Boland, J; Conraads, VM; Cools, FJC; De Roy, L; El Allaf, D; Mairesse, GH; Vankelecom, B; Abrantes, J; Armaganijan, D; Atie, J; Blacher, C; Bodanese, LC; Braga, JCF; Braile, MV; Chaves, H; Coelho, OR; Cunha, CLP; De Lima, GG; de Paola, AAV; Esteves, JP; Francischetti, A; Francischetti, AE; Lorga-Filho, AM; Maia, LN; Marcussi, DM; Marin-Neto, JA; Meneghelo, ZM; Rocha, RM; Nogueira, PR; Oigman, W; Paiva, M; Precoma, DB; Rabelo, W; Rabelo, A; Rassi, S; Rassi, A; Reis, G; Rossi, PR; Neto, JMR; Saraiva, JK; Sobral-Filho, DC; Zimmermann, SL; Ashton, TA; Bhargava, R; Carroll, S; Chehayeb, R; Connors, SP; Constance, C; Costi, P; Coutu, B; Crystal, E; Douketis, JD; Fortin, C; Fox, BA; Gupta, MK; Krahn, AD; Kuritzky, R; Kwok, K; Leader, R; Ma, P; Mangat, I; Maranda, CR; Matangi, MF; Moddel, G; Mukherjee, A; Nawaz, S; Palaic, M; Pandey, AS; Rebane, TM; Ruel, M; Sapp, JL; Senaratne, MP; St-Hilaire, R; Talbot, P; To, TB; Vakani, M; Weigel, MA; Wulffhart, Z; Yao, L; Zaniol, D; Conejeros, CR; Corbalan, R; Dussaillant, GR; Escobar, E; Hassi, ME; Parra, CA; Stockins, BA; Varleta, PE; Berka, L; Dedek, V; Florian, J; Hejhal, O; Herold, M; Klimsa, Z; Kotik, I; Simon, J; Smetana, K; Spinar, J; Spinarova, L; Tousek, F; Husted, S; Nielsen, T; Pehrson, S; Tuxen, C; Harjola, VP; Huikuri, HV; Kettunen, RVJ; Melin, JH; Peuhkurinen, K; Carlioz, R; Coisne, D; Decoulx, E; Defaye, P; Demarcq, JM; Gacem, K; Galley, DL; Lardoux, HM; Mabo, P; Mansour, M; Olive, TG; Poulard, JE; Pruvot, CF; Rey, JL; Bauer, WR; Baumann, G; Berghofer, G; Boehm, G; Borggrefe, MM; Brucker, G; Darius, H; Duray, GZ; Felix, SB; Fink, P; Fritz, H; Haberl, R; Hoffmann, S; Horacek, T; Kalusche, DW; Kasper, W; Katus, HA; Klepzig, HH; Loos, U; Merher, R; Munzel, T; Neuzner, J; Ochs, HR; Pieske, B; Pollock, BW; Schmidt, A; Schumacher, M; Seidl, K; Speier, U; Spitzer, SG; Stenzel, G; Volkmann, H; Wunderlich, J; Zacharzowsky, U; Antonakoudis, H; Georgakopoulos, N; Goudevenos, JA; Iliopoulos, TA; Kallikazaros, I; Pyrgakis, VN; Skoufas, P; Chan, WK; Chan, HW; Fung, JWH; Li, SK; Wong, KS; Forster, T; Karpati, P; Keltai, K; Kovacs, A; Kurta, G; Laszlo, Z; Rapi, J; Regos, L; Rostas, L; Szakal, I; Tomcsanyi, J; Toth, C; Bloch, L; Khader, N; Klainman, E; Koukoui, D; Lotan, C; Marmor, A; Omary, MZ; Reisin, LH; Vered, Z; Zeltser, D; Zimlichman, R; Bianconi, L; Bicego, D; Cosmi, D; Filigheddu, F; Garini, A; Lunati, M; Moretti, L; Mos, L; Pontiroli, AE; Renda, G; Ricci, S; Rossi, P; Santonastaso, M; Scioli, GA; Stramba-Badiale, M; Terrosu, P; Omar, R; Ong, TK; Ahmad, WAW; Alvarado, R; Calvo, C; Cordero-Cabra, JA; Hernandez, I; Jerjes-Sanchez, C; Lara, S; Rosas, EL; Molina, L; Morales, E; Petersen-Aranguren, F; Bovio, EMP; Pozas, G; Torres, FJR; Holwerda, K; Lok, DJA; Nierop, R; Pieterse, MGC; van der Heijden, R; van Kempen, L; Oie, BK; Omland, TM; Otterstad, J; von Brandis, C; Bronisz, M; Chizynski, K; Czerski, T; Dluzniewski, M; Gessek, J; Gieroba, A; Gniot, JR; Gorny, J; Halaczuiewicz, H; Janik, K; Janion, M; Jerzykowska, O; Kawka-Urbanek, T; Kincel, K; Kocon, S; Kopaczewski, J; Krasowski, W; Makuch, M; Malinowski, S; Miastkowski, Z; Mickiewicz-Pawlowska, M; Miekus, P; Obrebska-Tabaczka, E; Ogorek, M; Piasecka-Krysiak, E; Piepiorka, AW; Piotrowski, W; Pluta, W; Puzio, E; Rekosz, J; Sinkiewicz, W; Stopinski, M; Szelemej, R; Tendera, M; Trusz-Gluza, M; Wilkoszynski, M; Zalska, B; Antunes, E; Carrageta, MO; de Sousa, J; Martins, L; Mendonca, MI; Silvestre, I; Akatova, EV; Aleksandrov, V; Antuch, EA; Arutyunov, G; Bart, B; Belousov, YB; Chernichka, II; Dovgalevsky, P; Gratsiansky, N; Ivleva, AY; Kislyak, OA; Mareyev, VY; Maykov, EB; Milyagin, V; Novikova, TN; Panchenko, EP; Reshetko, O; Semernin, E; Sidorenko, BA; Sinopalnikov, A; Skvortsova, V; Solomatin, A; Sukhinina, TS; Suslina, ZA; Titkov, Y; Tsyrline, V; Chan, B; Foo, D; Omar, AR; Teo, WS; Brown, BG; Ebrahim, IO; Gibson, GJ; Klug, E; Marx, JD; Mntla, PS; Okreglicki, A; Pretorius, M; Roos, JS; Snyders, F; Van, LJ; Cano, L; Garcia-Puig, J; Hernandez-Madrid, A; Mostaza, JM; Orriach, MD; Sabate, X; Vinolas, X; Blomstrom, P; Jacobsson, F; Johansson, L; Klintberg, L; Lycksell, M; Nilsson, O; Rasmanis, G; Nilehn, KES; Ulvenstam, G; Baumgartner, RW; Francois, M; Gallino, A; Moccetti, T; Tettenborn, BE; Chou, HT; Kuo, JY; Lai, WT; Lin, JL; Lin, LJ; Ueng, KC; Yeih, DF; Bakar, M; Ilerigelen, B; Kumral, E; Nisanci, Y; Savas, ZI; Adgey, Y; Brack, MJ; Cleland, J; Davey, PP; Davies, J; Glen, SK; Jennings, K; Levy, T; Lip, GYH; Moriarty, AJ; Pearson, C; Purvis, JA; Pye, MP; Savelieva, I; Senior, R; Trouton, TG; Ahmed, IS; Amin, M; Anderson, JL; Bauernfeind, RA; Belew, K; Bilazarian, SD; Black, RA; Burton, ME; Cebe, JE; Chandrashekhar, YS; Chen, C; Das, D; Denny, DM; Desai, V; Fahmy, RN; Fishbein, GJ; Gelernt, MD; Gerber, J; Goldberg, MC; Grena, PG; Honan, MB; Hunter, JJ; Jacobson, J; Jarmukli, NF; Klancke, K; Kobayashi, JF; Lewis, SJ; Little, T; Mallis, I; Marani, AM; Marshall, JJ; Meltzer, P; Menapace, FJ; O'Neill, PG; Pearce, DJ; Quick, A; Ravipudi, S; Rivera, E; Sackett, M; Salerno, DM; Schussheim, A; Sheikh, K; Shettigar, UR; Treasure, CB; Vidaillet, H; Vijay, N; Wagner, D; Walker, JL; Winters, SL; Young, DR; Zoble, RG				Connolly, S. J.; Yusuf, S.; Camm, J.; Chrolavicius, S.; Commerford, P.; Flather, M.; Hart, R. G.; Hohnloser, S. H.; Joyner, C.; Pfeffer, M.; Gaudin, C.; Blumenthal, M.; Marchese, C.; Pogue, J.; Hart, R.; Hohnloser, S.; Anand, I.; Arthur, H.; Avezum, A.; Budaj, A.; Ceremuzynski, L.; De Caterina, R.; Diaz, R.; Dorian, P.; Flaker, G.; Fox, K. A. A.; Franzosi, M. G.; Goldhaber, S.; Golitsyn, S.; Granger, C.; Halon, D.; Hermosillo, A.; Hunt, D.; Jansky, P.; Karatzas, N.; Keltai, M.; Kozan, O.; Lanas, F.; Lau, P.; Le Heuzey, J. Y.; Lewis, B. S.; Morais, J.; Morillo, C.; Paolasso, E.; Peters, R. J.; Pfisterer, M.; Piegas, L.; Pipilis, A.; Sitkei, E.; Swedberg, K.; Talajic, M.; Valentin, V.; Van Mieghem, W.; Varigos, J.; Ameriso, S.; Atra, M.; Avezum, A.; Berwanger, O.; Bonilla, C.; Bornstein, N.; Budaj, A.; Chamiec, T.; Chan, Y. K.; Cottin, Y.; Csiba, L.; Cybulski, J.; Czepiel, A.; De Raedt, H.; Diaz, R.; Dvorakova, H.; Eikelboom, J.; Ergene, O.; Fodor, G.; Galli, M.; Gardinale, E.; Golitsyn, S.; Granger, C.; Gross, B.; Goodfield, P.; Halon, D.; Happola, O.; Healey, J.; Himbert, D.; Hunt, D.; Jacobsson, F.; Jansky, P.; Kalvach, P.; Karatzas, N.; Keltai, M.; Kies, B.; Laine, M.; Lam, A.; Le Heuzey, J. Y.; Lewis, B. S.; Lewis, S.; Leys, D.; Maggioni, A. P.; Massaro, A.; Mayosi, B. M.; Norrving, B.; Okay, T.; Olah, L.; Osende, J. O.; Oto, A.; Peeters, A.; Penicka, M.; Perakis, A.; Piegas, L.; Pipilis, A.; Pizzolato, G.; Rafti, F.; Renkin, J.; Siva, A.; Steg, P. G.; Stockins, B.; Strozynska, E.; Swedberg, K.; Turazza, F.; Vanderhoven, L.; Vizel, S.; Widimsky, P.; Zaborski, J.; Albers, G.; Hankey, G.; Norrving, B.; Shuaib, A.; Silva, J.; Wyse, D. G.; Cairns, J. A.; Gent, M.; Hirsh, J.; Marler, J.; Pritchett, E.; Wittes, J.; Beresh, H.; Floyd, L.; Gasic, Z.; Holadyk-Gris, I.; Lawrence, M.; Moro, I.; Perry, S.; Roberts, J.; Rodrigues, T.; Robinson, L.; Stevens, C.; Worthy, L.; Yuan, F.; Guerrero, R. A. Ahuad; Allall, O.; Amuchastegui, L. M.; Boskis, M.; Labarta, M. H. Bustamante; Castellanos, C. R.; Chiale, P.; Cuneo, C. A.; Czcczuo, A.; Gabito, A. J.; Garrido, M.; Guzman, L. A.; Hasban, E. G.; Hershson, A. R.; Hominal, M. A.; Krauss, J. G.; Luciardi, H. L.; Marzetti, E. M.; Montana, O. R.; Rabinovich, R. F.; Ramos, H. R.; Sanchez, A. S.; Schygiel, P. O.; Sumay, G. M.; Vogel, D. R.; Zaidman, C. J.; Aroney, G. M.; Ashby, D. T.; Barlow, M. A.; Cooke, P.; Cross, D. B.; Fitzpatrick, M. A.; Garrahy, P.; Karrasch, J.; Nelson, G. I.; Rees, D.; Roger, S. D.; Rogers, J.; Singh, B. B.; Stickland, J. F.; Waites, J. H.; Walsh, W. F.; Eichinger, J.; Huber, K.; Leisch, F.; Boland, J.; Conraads, V. M.; Cools, F. J. C.; De Roy, L.; El Allaf, D.; Mairesse, G. H.; Vankelecom, B.; Abrantes, J.; Armaganijan, D.; Atie, J.; Blacher, C.; Bodanese, L. C.; Braga, J. C. F.; Braile, M. V.; Chaves, H.; Coelho, O. R.; Cunha, C. L. P.; De Lima, G. G.; de Paola, A. A. V.; Esteves, J. P.; Francischetti, A.; Francischetti, A. E.; Lorga-Filho, A. M.; Maia, L. N.; Marcussi, D. M.; Marin-Neto, J. A.; Meneghelo, Z. M.; Rocha, R. Mourilhe; Nogueira, P. R.; Oigman, W.; Paiva, M.; Precoma, D. B.; Rabelo, W.; Rabelo, A., Jr.; Rassi, S.; Rassi, A., Jr.; Reis, G.; Rossi, P. R.; Neto, J. M. Rossi; Saraiva, J. K.; Sobral-Filho, D. C.; Zimmermann, S. L.; Ashton, T. A.; Bhargava, R.; Carroll, S.; Chehayeb, R.; Connors, S. P.; Constance, C.; Costi, P.; Coutu, B.; Crystal, E.; Douketis, J. D.; Fortin, C.; Fox, B. A.; Gupta, M. K.; Krahn, A. D.; Kuritzky, R.; Kwok, K.; Leader, R.; Ma, P.; Mangat, I.; Maranda, C. R.; Matangi, M. F.; Moddel, G.; Mukherjee, A.; Nawaz, S.; Palaic, M.; Pandey, A. S.; Rebane, T. M.; Ruel, M.; Sapp, J. L.; Senaratne, M. P.; St-Hilaire, R.; Talbot, P.; To, T. B.; Vakani, M.; Weigel, M. A.; Wulffhart, Z.; Yao, L.; Zaniol, D.; Conejeros, C. R.; Corbalan, R.; Dussaillant, G. R.; Escobar, E.; Hassi, M. E.; Parra, C. A.; Stockins, B. A.; Varleta, P. E.; Berka, L.; Dedek, V.; Florian, J.; Hejhal, O.; Herold, M.; Klimsa, Z.; Kotik, I.; Simon, J.; Smetana, K.; Spinar, J.; Spinarova, L.; Tousek, F.; Husted, S.; Nielsen, T.; Pehrson, S.; Tuxen, C.; Harjola, V. P.; Huikuri, H. V.; Kettunen, R. V. J.; Melin, J. H.; Peuhkurinen, K.; Carlioz, R.; Coisne, D.; Decoulx, E.; Defaye, P.; Demarcq, J. M.; Gacem, K.; Galley, D. L.; Lardoux, H. M.; Mabo, P.; Mansour, M.; Olive, T. G.; Poulard, J. E.; Pruvot, C. F.; Rey, J. L.; Bauer, W. R.; Baumann, G.; Berghoefer, G.; Boehm, G.; Borggrefe, M. M.; Bruecker, G.; Darius, H.; Duray, G. Z.; Felix, S. B.; Fink, P.; Fritz, H.; Haberl, R.; Hoffmann, S.; Horacek, T.; Kalusche, D. W.; Kasper, W.; Katus, H. A.; Klepzig, H. H.; Loos, U.; Merher, R.; Munzel, T.; Neuzner, J.; Ochs, H. R.; Pieske, B.; Pollock, B. W.; Schmidt, A.; Schumacher, M.; Seidl, K.; Speier, U.; Spitzer, S. G.; Stenzel, G.; Volkmann, H.; Wunderlich, J.; Zacharzowsky, U.; Antonakoudis, H.; Georgakopoulos, N.; Goudevenos, J. A.; Iliopoulos, T. A.; Kallikazaros, I.; Pyrgakis, V. N.; Skoufas, P.; Chan, W. K.; Chan, H. W.; Fung, J. W. H.; Li, S. K.; Wong, K. S.; Forster, T.; Karpati, P.; Keltai, K.; Kovacs, A.; Kurta, G.; Laszlo, Z.; Rapi, J.; Regos, L.; Rostas, L.; Szakal, I.; Tomcsanyi, J.; Toth, C.; Bloch, L.; Khader, N.; Klainman, E.; Koukoui, D.; Lotan, C.; Marmor, A.; Omary, M. Z.; Reisin, L. H.; Vered, Z.; Zeltser, D.; Zimlichman, R.; Bianconi, L.; Bicego, D.; Cosmi, D.; Filigheddu, F.; Garini, A.; Lunati, M.; Moretti, L.; Mos, L.; Pontiroli, A. E.; Renda, G.; Ricci, S.; Rossi, P.; Santonastaso, M.; Scioli, G. A.; Stramba-Badiale, M.; Terrosu, P.; Omar, R.; Ong, T. K.; Ahmad, W. A. Wan; Alvarado, R.; Calvo, C.; Cordero-Cabra, J. A.; Hernandez, I.; Jerjes-Sanchez, C.; Lara, S.; Lopez Rosas, E.; Molina, L.; Morales, E.; Petersen-Aranguren, F.; Picos Bovio, E. M.; Pozas, G.; Robles Torres, F. J.; Holwerda, K.; Lok, D. J. A.; Nierop, R.; Pieterse, M. G. C.; van der Heijden, R.; van Kempen, L.; Oie, B. K.; Omland, T. M.; Otterstad, J.; von Brandis, C.; Bronisz, M.; Chizynski, K.; Czerski, T.; Dluzniewski, M.; Gessek, J.; Gieroba, A.; Gniot, J. R.; Gorny, J.; Halaczuiewicz, H.; Janik, K.; Janion, M.; Jerzykowska, O.; Kawka-Urbanek, T.; Kincel, K.; Kocon, S.; Kopaczewski, J.; Krasowski, W.; Makuch, M.; Malinowski, S.; Miastkowski, Z.; Mickiewicz-Pawlowska, M.; Miekus, P.; Obrebska-Tabaczka, E.; Ogorek, M.; Piasecka-Krysiak, E.; Piepiorka, A. W.; Piotrowski, W.; Pluta, W.; Puzio, E.; Rekosz, J.; Sinkiewicz, W.; Stopinski, M.; Szelemej, R.; Tendera, M.; Trusz-Gluza, M.; Wilkoszynski, M.; Zalska, B.; Antunes, E.; Carrageta, M. O.; de Sousa, J.; Martins, L.; Mendonca, M. I.; Silvestre, I.; Akatova, E. V.; Aleksandrov, V.; Antuch, E. A.; Arutyunov, G.; Bart, B.; Belousov, Y. B.; Chernichka, I. I.; Dovgalevsky, P.; Gratsiansky, N.; Ivleva, A. Y.; Kislyak, O. A.; Mareyev, V. Y.; Maykov, E. B.; Milyagin, V.; Novikova, T. N.; Panchenko, E. P.; Reshetko, O.; Semernin, E.; Sidorenko, B. A.; Sinopalnikov, A.; Skvortsova, V.; Solomatin, A.; Sukhinina, T. S.; Suslina, Z. A.; Titkov, Y.; Tsyrline, V.; Chan, B.; Foo, D.; Omar, A. R.; Teo, W. S.; Brown, B. G.; Ebrahim, I. O.; Gibson, G. J.; Klug, E.; Marx, J. D.; Mntla, P. S.; Okreglicki, A.; Pretorius, M.; Roos, J. S.; Snyders, F.; Van, L. J.; Cano, L.; Garcia-Puig, J.; Hernandez-Madrid, A.; Mostaza, J. M.; Orriach, M. D.; Sabate, X.; Vinolas, X.; Blomstrom, P.; Jacobsson, F.; Johansson, L.; Klintberg, L.; Lycksell, M.; Nilsson, O.; Rasmanis, G.; Nilehn, K. E. Saldeen; Ulvenstam, G.; Baumgartner, R. W.; Francois, M.; Gallino, A.; Moccetti, T.; Tettenborn, B. E.; Chou, H. -T.; Kuo, J. -Y.; Lai, W. -T.; Lin, J. L.; Lin, L. -J.; Ueng, K. C.; Yeih, D. -F.; Bakar, M.; Ilerigelen, B.; Kumral, E.; Nisanci, Y.; Savas, Z. I.; Adgey, Y.; Brack, M. J.; Cleland, J.; Davey, P. P.; Davies, J.; Glen, S. K.; Jennings, K.; Levy, T.; Lip, G. Y. H.; Moriarty, A. J.; Pearson, C.; Purvis, J. A.; Pye, M. P.; Savelieva, I.; Senior, R.; Trouton, T. G.; Ahmed, I. S.; Amin, M.; Anderson, J. L.; Bauernfeind, R. A.; Belew, K.; Bilazarian, S. D.; Black, R. A.; Burton, M. E.; Cebe, J. E.; Chandrashekhar, Y. S.; Chen, C.; Das, D.; Denny, D. M.; Desai, V.; Fahmy, R. N.; Fishbein, G. J.; Gelernt, M. D.; Gerber, J.; Goldberg, M. C.; Grena, P. G.; Honan, M. B.; Hunter, J. J.; Jacobson, J.; Jarmukli, N. F.; Klancke, K.; Kobayashi, J. F.; Lewis, S. J.; Little, T.; Mallis, I.; Marani, A. M.; Marshall, J. J.; Meltzer, P.; Menapace, F. J.; O'Neill, P. G.; Pearce, D. J.; Quick, A.; Ravipudi, S.; Rivera, E.; Sackett, M.; Salerno, D. M.; Schussheim, A.; Sheikh, K.; Shettigar, U. R.; Treasure, C. B.; Vidaillet, H.; Vijay, N.; Wagner, D.; Walker, J. L.; Winters, S. L.; Young, D. R.; Zoble, R. G.			Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE CORONARY SYNDROMES; ANTITHROMBOTIC THERAPY; ORAL ANTICOAGULATION; PLATELET ACTIVATION; CONTROLLED-TRIAL; VASCULAR EVENTS; WARFARIN; THROMBOGENESIS; STROKE; RISK	BACKGROUND Vitamin K antagonists reduce the risk of stroke in patients with atrial fibrillation but are considered unsuitable in many patients, who usually receive aspirin instead. We investigated the hypothesis that the addition of clopidogrel to aspirin would reduce the risk of vascular events in patients with atrial fibrillation. METHODS A total of 7554 patients with atrial fibrillation who had an increased risk of stroke and for whom vitamin K-antagonist therapy was unsuitable were randomly assigned to receive clopidogrel (75 mg) or placebo, once daily, in addition to aspirin. The primary outcome was the composite of stroke, myocardial infarction, non-central nervous system systemic embolism, or death from vascular causes. RESULTS At a median of 3.6 years of follow-up, major vascular events had occurred in 832 patients receiving clopidogrel (6.8% per year) and in 924 patients receiving placebo (7.6% per year) (relative risk with clopidogrel, 0.89; 95% confidence interval [CI], 0.81 to 0.98; P = 0.01). The difference was primarily due to a reduction in the rate of stroke with clopidogrel. Stroke occurred in 296 patients receiving clopidogrel (2.4% per year) and 408 patients receiving placebo (3.3% per year) (relative risk, 0.72; 95% CI, 0.62 to 0.83; P<0.001). Myocardial infarction occurred in 90 patients receiving clopidogrel (0.7% per year) and in 115 receiving placebo (0.9% per year) (relative risk, 0.78; 95% CI, 0.59 to 1.03; P = 0.08). Major bleeding occurred in 251 patients receiving clopidogrel (2.0% per year) and in 162 patients receiving placebo (1.3% per year) (relative risk, 1.57; 95% CI, 1.29 to 1.92; P<0.001). CONCLUSIONS In patients with atrial fibrillation for whom vitamin K-antagonist therapy was unsuitable, the addition of clopidogrel to aspirin reduced the risk of major vascular events, especially stroke, and increased the risk of major hemorrhage. (ClinicalTrials.gov number, NCT00249873.)	[Connolly, S. J.; Yusuf, S.; Chrolavicius, S.; Pogue, J.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [Hart, R. G.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Hohnloser, S. H.] Goethe Univ Hosp, Frankfurt, Germany; [Pfeffer, M.] Brigham & Womens Hosp, Boston, MA 02115 USA	McMaster University; Population Health Research Institute; University of Texas System; University of Texas Health San Antonio; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Harvard University; Brigham & Women's Hospital	Connolly, SJ (corresponding author), McMaster Univ, Populat Hlth Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	stuart.connolly@phri.ca	Torres, Filipa/G-9742-2016; COTTIN, YVES/ABA-4622-2020; Акатова, Evgenia/ABF-6562-2021; Widimsky, Petr/P-8088-2016; Hankey, Graeme J/H-4968-2014; Suslina, Zinaida Aleksandrovna/C-7453-2012; Avezum, Alvaro/AAP-7687-2020; Hermosillo, Antonio G/E-5752-2014; Lanas, Fernando/AAE-8842-2022; Chen, Christopher/E-7023-2013; Iats, Inct/K-2300-2013; Stramba-Badiale, Marco/AAA-6183-2020; Turazza, Fabio/AAB-8736-2020; Avezum, Alvaro AA/K-6137-2016; Chaves, Humberto/ABE-7033-2021; Tendera, Michal/AAA-1875-2022; LEYS, Didier/G-2955-2016; van Kempen, Léon/AAX-5866-2021; De Caterina, Raffaele/K-3857-2016; Schmidt, André/G-1569-2011; Chizynski, Krzysztof/S-9510-2016; Cairns, John/AAI-8744-2021; Rocha, Ricardo Mourilhe/ABC-5053-2020; Arutyunov, Gregory/M-7368-2019; Golitsyn, Sergey/ABH-2143-2020; Precoma, Dalton B/D-5674-2013; Rassi, Anis/AAJ-3368-2020; Keltai, Katalin/V-4350-2019; Reshetko, Olga/I-7011-2013; Kovrazhkina, Elena/AAR-2425-2021; Chizynski, Krzysztof/U-1123-2019; Marchese, Cristiana/HCI-3501-2022; Fox, keith A A/I-3742-2013; STEG, Philippe Gabriel/Z-1567-2019; Kislyak, Oxana Andreevna/K-8235-2018; Panchenko, Elizaveta/AAN-1884-2020; pontiroli, antonio e/AAI-5575-2020; Douketis, James/AAO-5659-2021; Defaye, Pascal/S-6110-2019; Kuo, Jen-Yuan/AAX-5448-2021; Eikelboom, John/AAG-6117-2019; Peeters, Anna/M-8284-2019; Siva, Aksel/A-5132-2016; van Kempen, Leon/ABG-6815-2020; Marwick, Thomas/AAK-3869-2021; Duray, Gabor/ABD-1455-2020; ameriso, sebastian/AAV-2296-2020; Harjola, Veli-Pekka/G-9229-2015; Maia, Lilia Nigro/AAV-6938-2021; Marin-Neto, Jose Antonio/F-6099-2012; Swedberg, Karl/B-2475-2008; Sinkiewicz, Wladyslaw/G-5169-2014	Widimsky, Petr/0000-0001-5686-7752; Hankey, Graeme J/0000-0002-6044-7328; Chen, Christopher/0000-0002-1047-9225; Turazza, Fabio/0000-0002-2348-5309; Avezum, Alvaro AA/0000-0002-3073-6890; LEYS, Didier/0000-0003-4408-4392; van Kempen, Léon/0000-0003-0646-0705; De Caterina, Raffaele/0000-0003-1637-574X; Schmidt, André/0000-0002-1090-8165; Chizynski, Krzysztof/0000-0001-8723-7403; Rocha, Ricardo Mourilhe/0000-0003-2501-302X; Arutyunov, Gregory/0000-0002-6645-2515; Golitsyn, Sergey/0000-0001-9913-9974; Keltai, Katalin/0000-0002-8294-9062; Reshetko, Olga/0000-0003-3107-7636; Kislyak, Oxana Andreevna/0000-0002-2028-8748; Eikelboom, John/0000-0003-4126-1285; Peeters, Anna/0000-0003-4340-9132; Siva, Aksel/0000-0002-8340-6641; Marwick, Thomas/0000-0001-9065-0899; Lanas, Fernando/0000-0003-3595-9759; Albers, Gregory/0000-0003-0263-4632; Yusuf, Salim/0000-0003-4776-5601; Fox, Keith/0000-0002-0140-2752; Talajic, Mario/0000-0001-8469-4748	Sanofi-Aventis; Bristol-Myers Squibb	Sanofi-Aventis(Sanofi-Aventis); Bristol-Myers Squibb(Bristol-Myers Squibb)	Supported by grants from Sanofi-Aventis and Bristol-Myers Squibb.	Atalar E, 2003, PLATELETS, V14, P407, DOI 10.1080/09537100310001638814; Birman-Deych E, 2006, STROKE, V37, P1070, DOI 10.1161/01.STR.0000208294.46968.a4; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly S, 2006, AM HEART J, V151, P1187, DOI 10.1016/j.ahj.2005.06.026; Connolly SJ, 2007, CIRCULATION, V116, P449, DOI 10.1161/CIRCULATIONAHA.107.695163; FUSTER V, 2007, J AM COLL CARDIOL, V50, P562; Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Heeringa J, 2006, J THROMB HAEMOST, V4, P1944, DOI 10.1111/j.1538-7836.2006.02115.x; HELGASON CM, 1993, STROKE, V24, P1458, DOI 10.1161/01.STR.24.10.1458; Hylek EM, 2006, STROKE, V37, P1075, DOI 10.1161/01.STR.0000209239.71702.ce; Kamath S, 2002, BLOOD COAGUL FIBRIN, V13, P627, DOI 10.1097/00001721-200210000-00008; Li-Saw-Hee FL, 2000, STROKE, V31, P828, DOI 10.1161/01.STR.31.4.828; LIP GYH, 1995, BRIT HEART J, V73, P527; Mitusch R, 1996, THROMB HAEMOSTASIS, V75, P219; Muller I, 2002, PATHOPHYSIOL HAEMO T, V32, P16, DOI 10.1159/000057284; Singer DE, 2008, CHEST, V133, p546S, DOI 10.1378/chest.08-0678; van Walraven C, 2002, JAMA-J AM MED ASSOC, V288, P2441, DOI 10.1001/jama.288.19.2441; Waldo AL, 2005, J AM COLL CARDIOL, V46, P1729, DOI 10.1016/j.jacc.2005.06.077; Watson T, 2009, LANCET, V373, P155, DOI 10.1016/S0140-6736(09)60040-4; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; YAMAUCHI K, 1986, JPN HEART J, V27, P481; Yusuf S, 2001, NEW ENGL J MED, V345, P494	26	853	901	1	92	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2009	360	20					2066	2078		10.1056/NEJMoa0901301	http://dx.doi.org/10.1056/NEJMoa0901301			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444WN	19336502				2022-12-28	WOS:000266011200005
J	Vinson, VJ				Vinson, Valda J.			Proteins in Motion INTRODUCTION	SCIENCE			English	Editorial Material													Vinson, Valda/GVR-8232-2022						0	21	34	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					197	197		10.1126/science.324.5924.197	http://dx.doi.org/10.1126/science.324.5924.197			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359575				2022-12-28	WOS:000265024400031
J	Zhao, SM; Lin, Y; Xu, W; Jiang, WQ; Zha, ZY; Wang, P; Yu, W; Li, ZQ; Gong, LL; Peng, YJ; Ding, JP; Lei, QY; Guan, KL; Xiong, Y				Zhao, Shimin; Lin, Yan; Xu, Wei; Jiang, Wenqing; Zha, Zhengyu; Wang, Pu; Yu, Wei; Li, Zhiqiang; Gong, Lingling; Peng, Yingjie; Ding, Jianping; Lei, Qunying; Guan, Kun-Liang; Xiong, Yue			Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1 alpha	SCIENCE			English	Article							DEPENDENT ISOCITRATE DEHYDROGENASE; MECHANISM; TUMORS	Heterozygous mutations in the gene encoding isocitrate dehydrogenase-1 (IDH1) occur in certain human brain tumors, but their mechanistic role in tumor development is unknown. We have shown that tumor-derived IDH1 mutations impair the enzyme's affinity for its substrate and dominantly inhibit wild-type IDH1 activity through the formation of catalytically inactive heterodimers. Forced expression of mutant IDH1 in cultured cells reduces formation of the enzyme product, alpha-ketoglutarate (alpha-KG), and increases the levels of hypoxia-inducible factor subunit HIF-1 alpha, a transcription factor that facilitates tumor growth when oxygen is low and whose stability is regulated by alpha-KG. The rise in HIF-1 alpha levels was reversible by an alpha-KG derivative. HIF-1 alpha levels were higher in human gliomas harboring an IDH1 mutation than in tumors without a mutation. Thus, IDH1 appears to function as a tumor suppressor that, when mutationally inactivated, contributes to tumorigenesis in part through induction of the HIF-1 pathway.	[Zhao, Shimin; Lin, Yan; Xu, Wei; Jiang, Wenqing; Zha, Zhengyu; Wang, Pu; Yu, Wei; Lei, Qunying; Guan, Kun-Liang; Xiong, Yue] Fudan Univ, Inst Biomed Sci, Mol & Cell Biol Lab, Shanghai 200032, Peoples R China; [Zhao, Shimin; Xu, Wei; Jiang, Wenqing; Wang, Pu; Yu, Wei; Xiong, Yue] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Lei, Qunying; Guan, Kun-Liang] Fudan Univ, Sch Med, Dept Biol Chem, Shanghai 200032, Peoples R China; [Li, Zhiqiang] Wuhan Univ, Dept Neurosurg, Zhongnan Hosp, Wuhan 430071, Peoples R China; [Gong, Lingling] Wuhan Univ, Dept Pathol, Zhongnan Hosp, Wuhan 430071, Peoples R China; [Peng, Yingjie; Ding, Jianping] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Xiong, Yue] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Fudan University; Fudan University; Fudan University; Wuhan University; Wuhan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California San Diego; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill	Guan, KL (corresponding author), Fudan Univ, Inst Biomed Sci, Mol & Cell Biol Lab, 130 Dong An Rd, Shanghai 200032, Peoples R China.	kuguan@ucsd.edu; yxiong@email.unc.edu	Peng, Yingjie/B-1280-2013; Guan, Kun-Liang/ADK-7088-2022; YU, WEI/C-3822-2012; YU, WEI/G-6710-2013; Lei, Qun-Ying/J-1390-2017	Lei, Qun-Ying/0000-0002-8547-8518; ding, jian ping/0000-0001-7029-7346; YU, WEI/0000-0001-9898-4607; Zhiqiang, LI/0000-0002-4148-780X	Chinese Ministry of Education; State Key Development Programs of China [2009CB918401, 2006CB806700]; National 863 Program of China [2006AA02A308]; China NSF [30600112, 30871255]; Shanghai Key Basic Research Projects [06JC14086, 07PJ14011, 08JC1400900]; NIH; NATIONAL CANCER INSTITUTE [R01CA068377] Funding Source: NIH RePORTER	Chinese Ministry of Education(Ministry of Education, China); State Key Development Programs of China; National 863 Program of China(National High Technology Research and Development Program of China); China NSF(National Natural Science Foundation of China (NSFC)); Shanghai Key Basic Research Projects; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Fudan Molecular and Cell Biology Laboratory for valuable input; Y. Liu, X. Liu, and H. Zhu for assistance with histology; Z. Bao, L. Yang, Q. Shi, and G. Zhao for clinical samples; and S. Jackson for reading the manuscript. This work is supported by the 985 program from the Chinese Ministry of Education, State Key Development Programs of China (2009CB918401, 2006CB806700), National 863 Program of China (2006AA02A308), China NSF grants (30600112 and 30871255) and Shanghai Key Basic Research Projects (06JC14086, 07PJ14011, and 08JC1400900), and NIH grants (to K.-L.G. and Y.X.). Y. Xiong, K.-L. Guan, and S. Zhao are applying for a patent related to the work on permeable alpha-ketogluterate.	ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; INGEBRETSEN OC, 1976, BIOCHIM BIOPHYS ACTA, V452, P302, DOI 10.1016/0005-2744(76)90180-7; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Semenza GL, 2007, DRUG DISCOV TODAY, V12, P853, DOI 10.1016/j.drudis.2007.08.006; Soundar S, 2000, J BIOL CHEM, V275, P5606, DOI 10.1074/jbc.275.8.5606; WINKLER BS, 1986, EXP EYE RES, V43, P829, DOI 10.1016/S0014-4835(86)80013-6; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	12	870	966	4	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					261	265		10.1126/science.1170944	http://dx.doi.org/10.1126/science.1170944			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359588	Green Accepted			2022-12-28	WOS:000265024400049
J	Cantor, JD				Cantor, Julie D.			Conscientious Objection Gone Awry -- Restoring Selfless Professionalism in Medicine.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif Los Angeles, Sch Law, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Cantor, JD (corresponding author), Univ Calif Los Angeles, Sch Law, Los Angeles, CA 90024 USA.							LIPTAK A, 2005, NY TIMES        0904; PEAR R, 2008, NY TIMES        0626, pA14	2	54	55	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 9	2009	360	15					1484	1485		10.1056/NEJMp0902019	http://dx.doi.org/10.1056/NEJMp0902019			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	430GL	19321857				2022-12-28	WOS:000264976800004
J	Tarduno, J; Bunge, HP; Sleep, N; Hansen, U				Tarduno, John; Bunge, Hans-Peter; Sleep, Norm; Hansen, Ulrich			The Bent Hawaiian-Emperor Hotspot Track: Inheriting the Mantle Wind	SCIENCE			English	Review							PLUME-RIDGE INTERACTION; TRUE POLAR WANDER; PACIFIC PLATE; CIRCULATION MODELS; DATA ASSIMILATION; MOTION; FLOW; CONVECTION; VISCOSITY; APPARENT	Bends in volcanic hotspot lineaments, best represented by the large elbow in the Hawaiian-Emperor chain, were thought to directly record changes in plate motion. Several lines of geophysical inquiry now suggest that a change in the locus of upwelling in the mantle induced by mantle dynamics causes bends in hotspot tracks. Inverse modeling suggests that although deep flow near the core-mantle boundary may have played a role in the Hawaiian-Emperor bend, capture of a plume by a ridge, followed by changes in sub-Pacific mantle flow, can better explain the observations. Thus, hotspot tracks can reveal patterns of past mantle circulation.	[Tarduno, John] Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA; [Tarduno, John] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA; [Bunge, Hans-Peter] Univ Munich, Dept Earth & Environm Sci, D-80333 Munich, Germany; [Sleep, Norm] Stanford Univ, Dept Geophys, Stanford, CA 94305 USA; [Hansen, Ulrich] Univ Munster, Inst Geophys, D-48149 Munster, Germany	University of Rochester; University of Rochester; University of Munich; Stanford University; University of Munster	Tarduno, J (corresponding author), Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA.	john@earth.rochester.edu	bunge, hans-peter/AAA-1860-2021	Tarduno, John/0000-0002-0490-0124	NSF	NSF(National Science Foundation (NSF))	We thank R. Cottrell and P. Doubrovine for discussions. This work was supported by the NSF.	Anderson DL, 2000, GEOPHYS RES LETT, V27, P3623, DOI 10.1029/2000GL011533; Besse J, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000050; Bunge HP, 2005, PHYS EARTH PLANET IN, V153, P3, DOI 10.1016/j.pepi.2005.03.017; Bunge HP, 1997, J GEOPHYS RES-SOL EA, V102, P11991, DOI 10.1029/96JB03806; Bunge HP, 2003, GEOPHYS J INT, V152, P280, DOI 10.1046/j.1365-246X.2003.01823.x; Bunge HP, 2002, PHILOS T R SOC A, V360, P2545, DOI 10.1098/rsta.2002.1080; CANDE SC, 1995, SCIENCE, V270, P947, DOI 10.1126/science.270.5238.947; Cottrell RD, 2003, TECTONOPHYSICS, V362, P321, DOI 10.1016/S0040-1951(02)00643-1; Courtillot V, 2003, EARTH PLANET SC LETT, V205, P295, DOI 10.1016/S0012-821X(02)01048-8; DiVenere V, 1999, EARTH PLANET SC LETT, V170, P105, DOI 10.1016/S0012-821X(99)00096-5; Doubrovine PV, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005584; Doubrovine PV, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005585; DUPRE B, 1983, NATURE, V303, P142, DOI 10.1038/303142a0; HAGER BH, 1984, J GEOPHYS RES, V89, P6003, DOI 10.1029/JB089iB07p06003; HAGER BH, 1979, J GEOPHYS RES, V84, P1031, DOI 10.1029/JB084iB03p01031; HANSEN U, 1993, PHYS EARTH PLANET IN, V77, P205, DOI 10.1016/0031-9201(93)90099-U; Keller RA, 2000, NATURE, V405, P673, DOI 10.1038/35015057; Kerr RC, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000749; KOPPELMAN A, 2004, U ST THOMAS LJ, V2, P5; Lenardic A, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003639; Lowman JP, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000583; Mitrovica JX, 1996, J GEOPHYS RES-SOL EA, V101, P555, DOI 10.1029/95JB03208; MOLNAR P, 1973, NATURE, V246, P288, DOI 10.1038/246288a0; Montelli R, 2004, SCIENCE, V303, P338, DOI 10.1126/science.1092485; Morgan W.J., 1981, SEA VOLUME 7 OCEANIC, V7, P443; Morgan W.J., 1972, GEOL SOC AM MEM, V132, P7, DOI [DOI 10.1130/MEM132-P7, 10.1130/MEM132-p7]; Muller RD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001743; Norton IO, 2007, GEOL SOC AM SPEC PAP, V430, P451, DOI 10.1130/2007.2430(22); NORTON IO, 1995, TECTONICS, V14, P1080, DOI 10.1029/95TC01256; Piazzoni AS, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001697; Reigber C, 2005, J GEODYN, V39, P1, DOI 10.1016/j.jog.2004.07.001; Ribe NM, 1996, J GEOPHYS RES-SOL EA, V101, P16195, DOI 10.1029/96JB01187; RICHARDS MA, 1988, J GEOPHYS RES-SOLID, V93, P7690, DOI 10.1029/JB093iB07p07690; RICHARDS MA, 1992, NATURE, V355, P437, DOI 10.1038/355437a0; RICHARDS MA, 1991, NATO ADV SCI I C-MAT, V334, P571; RICHARDS MA, 1989, NATURE, V342, P900, DOI 10.1038/342900a0; Richards MA, 1999, GEOPHYS RES LETT, V26, P1777, DOI 10.1029/1999GL900331; Sharp WD, 2006, SCIENCE, V313, P1281, DOI 10.1126/science.1128489; Simmons NA, 2006, EARTH PLANET SC LETT, V246, P109, DOI 10.1016/j.epsl.2006.04.003; Sleep NH, 2003, CR GEOSCI, V335, P9, DOI 10.1016/S1631-0713(03)00008-7; Sleep NH, 1996, J GEOPHYS RES-SOL EA, V101, P28065, DOI 10.1029/96JB02463; Sleep NH, 2007, GEOL SOC AM SPEC PAP, V430, P29, DOI 10.1130/2007.2430(02); Sleep NH, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001680; Steinberger B, 1998, GEOPHYS J INT, V132, P412, DOI 10.1046/j.1365-246x.1998.00447.x; Steinberger B, 2004, NATURE, V430, P167, DOI 10.1038/nature02660; Tarduno JA, 2003, SCIENCE, V301, P1064, DOI 10.1126/science.1086442; TARDUNO JA, 1995, SCIENCE, V269, P956, DOI 10.1126/science.269.5226.956; Tarduno JA, 2001, EARTH PLANET SC LETT, V184, P549, DOI 10.1016/S0012-821X(00)00348-4; Tarduno JA, 1997, EARTH PLANET SC LETT, V153, P171, DOI 10.1016/S0012-821X(97)00169-6; TARDUNO JA, 1995, NATURE, V378, P477, DOI 10.1038/378477a0; Tarduno JA, 2007, CHEM GEOL, V241, P234, DOI 10.1016/j.chemgeo.2007.01.021; Torsvik TH, 2002, EARTH PLANET SC LETT, V202, P185, DOI 10.1016/S0012-821X(02)00807-5	52	105	117	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					50	53		10.1126/science.1161256	http://dx.doi.org/10.1126/science.1161256			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342579				2022-12-28	WOS:000264802100027
J	Koulouri, O; Conway, GS				Koulouri, Olympia; Conway, Gerard S.			Management of hirsutism	BMJ-BRITISH MEDICAL JOURNAL			English	Review							POLYCYSTIC-OVARY-SYNDROME; RANDOMIZED CONTROLLED-TRIALS; HAIR-GROWTH; FACIAL HAIR; WOMEN; METAANALYSES; FINASTERIDE		[Conway, Gerard S.] Univ Coll London Hosp, Dept Endocrinol, London NW1 2PQ, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	Conway, GS (corresponding author), Univ Coll London Hosp, Dept Endocrinol, London NW1 2PQ, England.	g.conway@ucl.ac.uk						Andrade RJ, 1999, LANCET, V353, P983, DOI 10.1016/S0140-6736(99)00564-4; Batukan C, 2007, GYNECOL ENDOCRINOL, V23, P38, DOI 10.1080/09637480601137066; Clayton WJ, 2005, BRIT J DERMATOL, V152, P986, DOI 10.1111/j.1365-2133.2005.06426.x; Coffey S, 2006, GYNECOL ENDOCRINOL, V22, P80, DOI 10.1080/09513590600604541; Cosma M, 2008, J CLIN ENDOCR METAB, V93, P1135, DOI 10.1210/jc.2007-2429; DARNEY PD, 1995, AM J MED, V98, P104; DeUgarte CM, 2006, J CLIN ENDOCR METAB, V91, P1345, DOI 10.1210/jc.2004-2301; FARQUHAR C, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; FERRIMAN D, 1961, J CLIN ENDOCR METAB, V21, P1440, DOI 10.1210/jcem-21-11-1440; Haedersdal M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004684; KAPLAN B, 1995, ANN PHARMACOTHER, V29, P736, DOI 10.1177/106002809502907-817; Koulouri O, 2008, CLIN ENDOCRINOL, V68, P800, DOI 10.1111/j.1365-2265.2007.03105.x; Lakryc EM, 2003, GYNECOL ENDOCRINOL, V17, P57, DOI 10.1080/713603187; Lipton MG, 2006, J PSYCHOSOM RES, V61, P161, DOI 10.1016/j.jpsychores.2006.01.016; Martin KA, 2008, J CLIN ENDOCR METAB, V93, P1105, DOI 10.1210/jc.2007-2437; Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864; Sundstrom J, 2006, BMJ-BRIT MED J, V332, P878, DOI 10.1136/bmj.38766.624097.1F; Swiglo BA, 2008, J CLIN ENDOCR METAB, V93, P1153, DOI 10.1210/jc.2007-2430; Tartagni M, 2000, FERTIL STERIL, V73, P718, DOI 10.1016/S0015-0282(99)00633-0; Van der Spuy Z M, 2003, Cochrane Database Syst Rev, pCD001125, DOI 10.1002/14651858.CD001125; Wolf JE, 2007, INT J DERMATOL, V46, P94, DOI 10.1111/j.1365-4632.2006.03079.x	21	10	12	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2009	338								b847	10.1136/bmj.b847	http://dx.doi.org/10.1136/bmj.b847			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LS	19329515				2022-12-28	WOS:000264639800013
J	Matsuura, K; Vargo, EL; Kawatsu, K; Labadie, PE; Nakano, H; Yashiro, T; Tsuji, K				Matsuura, Kenji; Vargo, Edward L.; Kawatsu, Kazutaka; Labadie, Paul E.; Nakano, Hiroko; Yashiro, Toshihisa; Tsuji, Kazuki			Queen Succession Through Asexual Reproduction in Termites	SCIENCE			English	Article							CLONAL REPRODUCTION; COLONY FOUNDATION; RHINOTERMITIDAE; PARTHENOGENESIS; ISOPTERA; ANT		[Matsuura, Kenji; Nakano, Hiroko; Yashiro, Toshihisa] Okayama Univ, Grad Sch Environm Sci, Lab Insect Ecol, Okayama 7008530, Japan; [Vargo, Edward L.; Labadie, Paul E.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Vargo, Edward L.; Labadie, Paul E.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Kawatsu, Kazutaka] Kyoto Univ, Grad Sch Agr, Lab Insect Ecol, Kyoto 6068502, Japan; [Tsuji, Kazuki] Univ Ryukyus, Fac Agr, Okinawa 9000213, Japan	Okayama University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Kyoto University; University of the Ryukyus	Matsuura, K (corresponding author), Okayama Univ, Grad Sch Environm Sci, Lab Insect Ecol, Okayama 7008530, Japan.	kenjijpn@cc.okayama-u.ac.jp	Yashiro, Toshihisa/J-3120-2015; Vargo, Edward/D-1097-2010; Tsuji, Kazuki/D-6607-2014; Kawtasu, Kazutaka/B-1066-2010; Matsuura, Kenji/H-8364-2019	Yashiro, Toshihisa/0000-0002-9582-4605; Vargo, Edward/0000-0002-8712-1248; Tsuji, Kazuki/0000-0002-2027-8582; Kawtasu, Kazutaka/0000-0003-4447-4761; Matsuura, Kenji/0000-0002-9099-6694	Japan Society for the Promotion of Science; Program for Promotion of Basic Research Activities for Innovative Biosciences	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Basic Research Activities for Innovative Biosciences	We are grateful to K. Shimizu, E. Hasegawa, S. Dobata, and N. E. Pierce for discussion and to W. Booth, D. R. Tarpy, K. Ross, L. Keller, and C. Schal for comments on the manuscript. Funded by the Japan Society for the Promotion of Science (K.M., K.T.) and the Program for Promotion of Basic Research Activities for Innovative Biosciences (K.M.).	Fournier D, 2005, NATURE, V435, P1230, DOI 10.1038/nature03705; Matsuura K, 2004, INSECT SOC, V51, P325, DOI 10.1007/s00040-004-0746-0; Matsuura K, 2001, POPUL ECOL, V43, P119, DOI 10.1007/PL00012022; Ohkawara K, 2006, BIOL LETTERS, V2, P359, DOI 10.1098/rsbl.2006.0491; Pearcy M, 2004, SCIENCE, V306, P1780, DOI 10.1126/science.1105453; Shellman-Reeve JS, 1999, P ROY SOC B-BIOL SCI, V266, P137, DOI 10.1098/rspb.1999.0613; Thorne BL, 1999, ETHOL ECOL EVOL, V11, P149, DOI 10.1080/08927014.1999.9522833	7	108	115	3	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 27	2009	323	5922					1687	1687		10.1126/science.1169702	http://dx.doi.org/10.1126/science.1169702			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325106				2022-12-28	WOS:000264559800028
J	Neilsen, J; Lee, JC				Neilsen, Joseph; Lee, Julia C.			Accretion disk winds as the jet suppression mechanism in the microquasar GRS 1915+105	NATURE			English	Article							X-RAY BINARIES; BLACK-HOLE; INFRARED FLARES; SPECTRAL STATES; RADIO-EMISSION; GRS-1915+105; VARIABILITY; RADIATION; GALAXY; SPECTROSCOPY	Stellar-mass black holes with relativistic jets, also known as microquasars, mimic the behaviour of quasars and active galactic nuclei(1). Because timescales around stellar-mass black holes are orders of magnitude smaller than those around more distant supermassive black holes, microquasars are ideal nearby 'laboratories' for studying the evolution of accretion disks and jet formation in black-hole systems(2). Whereas studies of black holes have revealed a complex array of accretion activity, the mechanisms that trigger and suppress jet formation remain a mystery. Here we report the presence of a broad emission line in the faint, hard states and narrow absorption lines in the bright, soft states of the microquasar GRS 1915+105. ('Hard' and 'soft' denote the character of the emitted X-rays.) Because the hard states exhibit prominent radio jets(3), we argue that the broad emission line arises when the jet illuminates the inner accretion disk. The jet is weak or absent during the soft states(4), and we show that the absorption lines originate when the powerful radiation field around the black hole drives a hot wind off the accretion disk(5-7). Our analysis shows that this wind carries enough mass away from the disk to halt the flow of matter into the radio jet.	[Neilsen, Joseph; Lee, Julia C.] Harvard Univ, Dept Astron, Cambridge, MA 02138 USA	Harvard University	Neilsen, J (corresponding author), Harvard Univ, Dept Astron, 60 Garden St,MS-10, Cambridge, MA 02138 USA.	jneilsen@cfa.harvard.edu	; Lee, Julia/G-2381-2015	Neilsen, Joseph/0000-0002-8247-786X; Lee, Julia/0000-0002-7336-3588	Harvard University Graduate School of Arts and Sciences; Faculty of Arts and Sciences	Harvard University Graduate School of Arts and Sciences; Faculty of Arts and Sciences(Ondokuz Mayis University)	We acknowledge support from the Harvard University Graduate School of Arts and Sciences (J.N.) and the Faculty of Arts and Sciences (J.C.L.). We thank G. Pooley for providing the radio data used in this paper and we acknowledge conversations with R. Remillard, who provided the Rossi X-ray Timing Explorer spectra, and M. Begelman.	BEGELMAN MC, 1983, ASTROPHYS J, V271, P70, DOI 10.1086/161178; Belloni T, 2000, ASTRON ASTROPHYS, V355, P271; Canizares CR, 2005, PUBL ASTRON SOC PAC, V117, P1144, DOI 10.1086/432898; Dhawan V, 2000, ASTROPHYS J, V543, P373, DOI 10.1086/317088; Eikenberry SS, 1998, ASTROPHYS J, V494, pL61, DOI 10.1086/311158; Eikenberry SS, 1998, ASTROPHYS J, V506, pL31, DOI 10.1086/311630; Esin AA, 1997, ASTROPHYS J, V489, P865, DOI 10.1086/304829; Fender R, 2004, ANNU REV ASTRON ASTR, V42, P317, DOI 10.1146/annurev.astro.42.053102.134031; Fender R, 1999, ASTROPHYS J, V519, pL165, DOI 10.1086/312128; Fender RP, 1997, MON NOT R ASTRON SOC, V290, pL65, DOI 10.1093/mnras/290.4.L65; Greiner J, 2001, NATURE, V414, P522, DOI 10.1038/35107019; Hannikainen DC, 2005, ASTRON ASTROPHYS, V435, P995, DOI 10.1051/0004-6361:20042250; Houck JC, 2000, ASTR SOC P, V216, P591; Janiuk A, 2000, ASTROPHYS J, V542, pL33, DOI 10.1086/312911; Kallman T, 2001, ASTROPHYS J SUPPL S, V133, P221, DOI 10.1086/319184; Klein-Wolt M, 2002, MON NOT R ASTRON SOC, V331, P745, DOI 10.1046/j.1365-8711.2002.05223.x; Kotani T, 2000, ASTROPHYS J, V539, P413, DOI 10.1086/309200; Lee JC, 2002, ASTROPHYS J, V567, P1102, DOI 10.1086/338588; Markoff S, 2005, ASTROPHYS J, V635, P1203, DOI 10.1086/497628; McClintock JE, 2006, ASTROPHYS J, V652, P518, DOI 10.1086/508457; Mirabel IF, 1999, ANNU REV ASTRON ASTR, V37, P409, DOI 10.1146/annurev.astro.37.1.409; MIRABEL IF, 1994, NATURE, V371, P46, DOI 10.1038/371046a0; Mirabel IF, 1998, ASTRON ASTROPHYS, V330, pL9; Muno MP, 1999, ASTROPHYS J, V527, P321, DOI 10.1086/308063; Pooley GG, 1997, MON NOT R ASTRON SOC, V292, P925, DOI 10.1093/mnras/292.4.925; Proga D, 2000, ASTROPHYS J, V538, P684, DOI 10.1086/309154; Proga D, 2000, ASTROPHYS J, V543, P686, DOI 10.1086/317154; Proga D, 2002, ASTROPHYS J, V565, P455, DOI 10.1086/324534	28	213	215	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 26	2009	458	7237					481	484		10.1038/nature07680	http://dx.doi.org/10.1038/nature07680			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19325629				2022-12-28	WOS:000264532400038
J	Schroeder, FH; Hugosson, J; Roobol, MJ; Tammela, TLJ; Ciatto, S; Nelen, V; Kwiatkowski, M; Lujan, M; Lilja, H; Zappa, M; Denis, LJ; Recker, F; Berenguer, A; Maattanen, L; Bangma, CH; Aus, G; Villers, A; Rebillard, X; van der Kwast, T; Blijenberg, BG; Moss, SM; de Koning, HJ; Auvinen, A				Schroeder, Fritz H.; Hugosson, Jonas; Roobol, Monique J.; Tammela, Teuvo L. J.; Ciatto, Stefano; Nelen, Vera; Kwiatkowski, Maciej; Lujan, Marcos; Lilja, Hans; Zappa, Marco; Denis, Louis J.; Recker, Franz; Berenguer, Antonio; Maattanen, Liisa; Bangma, Chris H.; Aus, Gunnar; Villers, Arnauld; Rebillard, Xavier; van der Kwast, Theodorus; Blijenberg, Bert G.; Moss, Sue M.; de Koning, Harry J.; Auvinen, Anssi		ERSPC Investigators	Screening and Prostate-Cancer Mortality in a Randomized European Study	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; ANTIGEN; ERSPC; VALIDATION; PREDICTION; DIAGNOSIS; INTERVAL; BIOPSY; IMPACT; NG/ML	Background The European Randomized Study of Screening for Prostate Cancer was initiated in the early 1990s to evaluate the effect of screening with prostate-specific-antigen (PSA) testing on death rates from prostate cancer. Methods We identified 182,000 men between the ages of 50 and 74 years through registries in seven European countries for inclusion in our study. The men were randomly assigned to a group that was offered PSA screening at an average of once every 4 years or to a control group that did not receive such screening. The predefined core age group for this study included 162,243 men between the ages of 55 and 69 years. The primary outcome was the rate of death from prostate cancer. Mortality follow-up was identical for the two study groups and ended on December 31, 2006. Results In the screening group, 82% of men accepted at least one offer of screening. During a median follow-up of 9 years, the cumulative incidence of prostate cancer was 8.2% in the screening group and 4.8% in the control group. The rate ratio for death from prostate cancer in the screening group, as compared with the control group, was 0.80 (95% confidence interval [CI], 0.65 to 0.98; adjusted P = 0.04). The absolute risk difference was 0.71 death per 1000 men. This means that 1410 men would need to be screened and 48 additional cases of prostate cancer would need to be treated to prevent one death from prostate cancer. The analysis of men who were actually screened during the first round (excluding subjects with noncompliance) provided a rate ratio for death from prostate cancer of 0.73 (95% CI, 0.56 to 0.90). Conclusions PSA-based screening reduced the rate of death from prostate cancer by 20% but was associated with a high risk of overdiagnosis. (Current Controlled Trials number, ISRCTN49127736.)	[Schroeder, Fritz H.; Roobol, Monique J.; Bangma, Chris H.] Erasmus MC, Dept Urol, NL-3000 CA Rotterdam, Netherlands; [van der Kwast, Theodorus] Erasmus MC, Dept Pathol, NL-3000 CA Rotterdam, Netherlands; [Blijenberg, Bert G.] Erasmus MC, Dept Clin Chem, NL-3000 CA Rotterdam, Netherlands; [de Koning, Harry J.] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Hugosson, Jonas; Aus, Gunnar] Sahlgrens Univ Hosp, Dept Urol, Gothenburg, Sweden; [Tammela, Teuvo L. J.] Tampere Univ Hosp, Dept Urol, Tampere, Finland; [Auvinen, Anssi] Univ Tampere, Tampere Sch Publ Hlth, FIN-33101 Tampere, Finland; [Ciatto, Stefano] Inst Canc Prevent, Dept Diagnost Med Imaging, Florence, Italy; [Zappa, Marco] Inst Canc Prevent, Epidemiol Unit, Florence, Italy; [Nelen, Vera] Prov Inst Hyg, Antwerp, Belgium; [Kwiatkowski, Maciej; Recker, Franz] Kantonsspital Aarau, Dept Urol, Aarau, Switzerland; [Lujan, Marcos; Berenguer, Antonio] Hosp Univ Getafe, Dept Urol, Madrid, Spain; Lund Univ, Malmo Univ Hosp, Dept Lab Med, Malmo, Sweden; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Denis, Louis J.] Oncol Ctr Antwerp, Antwerp, Belgium; [Maattanen, Liisa] Finnish Canc Registry, FIN-00170 Helsinki, Finland; [Villers, Arnauld] Ctr Hosp Reg Univ, Dept Urol, Lille, France; [Rebillard, Xavier] Clin Beau Soleil, Dept Urol, Montpellier, France; [Moss, Sue M.] Canc Screening Evaluat Unit, Surrey, England	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Sahlgrenska University Hospital; Tampere University; Tampere University Hospital; Tampere University; Kantonsspital Aarau AG (KSA); Hospital Universitario de Getafe; Lund University; Skane University Hospital; Memorial Sloan Kettering Cancer Center; Finnish Cancer Registry; Universite de Lille - ISITE; CHU Lille; Beau Soleil Clinic; Universite de Montpellier	Schroeder, FH (corresponding author), Erasmus MC, Dept Urol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	secr.schroder@erasmusmc.nl	PAEZ, ALVARO/G-5458-2012; Rubeca, Tiziana/J-5280-2018; Arnauld, VILLERS A/K-6629-2016; zappa, marco/AAB-3294-2019; Lilja, Hans/S-9703-2019; Auvinen, Anssi/AAL-2111-2020; Auvinen, Anssi/AAD-9311-2020; NEELS, Hugo M/B-4721-2017; de+Koning, Harry/AAF-9062-2019	Rubeca, Tiziana/0000-0002-1870-4722; Arnauld, VILLERS A/0000-0002-6298-7758; zappa, marco/0000-0002-6606-9786; Lilja, Hans/0000-0001-5871-7846; Auvinen, Anssi/0000-0003-1125-4818; NEELS, Hugo M/0000-0002-9034-168X; de+Koning, Harry/0000-0003-4682-3646; Rietbergen, John/0000-0002-3840-0873; Stranne, Johan/0000-0002-4295-6524; Visakorpi, Tapio/0000-0002-5004-0364; Holmberg, Erik/0000-0001-5107-4550	European Union; Beckman Coulter; MRC [G0501019] Funding Source: UKRI; Medical Research Council [G0501019] Funding Source: researchfish	European Union(European Commission); Beckman Coulter; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from Europe Against Cancer and the fifth and sixth framework program of the European Union, by grants from agencies or health authorities in the participating countries, and by unconditional grants from Beckman Coulter. The studies in each national center were funded by numerous local grants (see Supplementary Appendix 2).	AALEN O, 1978, ANN STAT, V6, P701, DOI 10.1214/aos/1176344247; Ali K, 2007, INT J CANCER, V120, P170, DOI 10.1002/ijc.22161; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Aus G, 2005, ARCH INTERN MED, V165, P1857, DOI 10.1001/archinte.165.16.1857; CATALONA WJ, 1991, NEW ENGL J MED, V325, P1324; de Koning HJ, 2002, INT J CANCER, V98, P268, DOI 10.1002/ijc.10188; De Koning HJ, 2003, BJU INT, V92, P71, DOI 10.1111/j.1465-5101.2003.04402.x; De Koning HJ, 2003, BJU INT, V92, P112, DOI 10.1111/j.1464-410X.2003.4410x.x; DENIS LJ, 1995, CANCER, V75, P1187, DOI 10.1002/1097-0142(19950301)75:5<1187::AID-CNCR2820750521>3.0.CO;2-G; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Essink-Bot ML, 2003, BJU INT, V92, P101, DOI 10.1111/j.1464-410X.2003.04409.x; Essink-Bot ML, 1998, J NATL CANCER I, V90, P925, DOI 10.1093/jnci/90.12.925; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; Hakama M., 2008, INT ENCY PUBLIC HLTH, P464; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; International Agency for Research on Cancer, 2002, IARC HDB CANC PREV, V7; Korfage IJ, 2007, BJU INT, V99, P801, DOI 10.1111/j.1464-410X.2006.06707.x; Korfage IJ, 2006, EUR J CANCER, V42, P165, DOI 10.1016/j.ejca.2005.10.011; Korfage IJ, 2003, QUAL LIFE RES, V12, P459, DOI 10.1023/A:1023402706666; Laffin RJ, 2001, CLIN CHEM, V47, P129; Madalinska JB, 2001, PROSTATE, V46, P87; Madalinska JB, 2001, J CLIN ONCOL, V19, P1619, DOI 10.1200/JCO.2001.19.6.1619; Makinen T, 2002, UROLOGY, V60, P846; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Raaijmakers R, 2002, UROLOGY, V60, P826, DOI 10.1016/S0090-4295(02)01958-1; Roemeling S, 2007, CANCER-AM CANCER SOC, V110, P2218, DOI 10.1002/cncr.23029; Roobol MJ, 2006, PROSTATE, V66, P604, DOI 10.1002/pros.20352; Roobol MJ, 2005, UROLOGY, V65, P343, DOI 10.1016/j.urology.2004.09.046; Roobol MJ, 2007, JNCI-J NATL CANCER I, V99, P1296, DOI 10.1093/jnci/djm101; Schroder FH, 2003, BJU INT, V92, P1, DOI 10.1111/j.1464-410X.2003.04389.x; Schroder FH, 1998, JNCI-J NATL CANCER I, V90, P1817, DOI 10.1093/jnci/90.23.1817; Schroder FH, 2001, UROLOGY, V57, P83, DOI 10.1016/S0090-4295(00)00863-3; Smith PH, 2003, BJU INT, V92, P55, DOI 10.1111/j.1465-5101.2003.04398.x; STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501; STAMEY TA, 1995, UROLOGY, V45, P2, DOI 10.1016/S0090-4295(95)96168-2; STENMAN UH, 1994, LANCET, V344, P1594, DOI 10.1016/S0140-6736(94)90405-7; Steyerberg EW, 2007, J UROLOGY, V177, P107, DOI 10.1016/j.juro.2006.08.068; WOLTERS T, INT J CANC IN PRESS	38	2869	2997	3	305	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2009	360	13					1320	1328		10.1056/NEJMoa0810084	http://dx.doi.org/10.1056/NEJMoa0810084			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423VP	19297566	Green Submitted			2022-12-28	WOS:000264524100007
J	O'Sullivan, G; Liu, B; Hart, D; Seed, P; Shennan, A				O'Sullivan, Geraldine; Liu, Bing; Hart, Darren; Seed, Paul; Shennan, Andrew			Effect of food intake during labour on obstetric outcome: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARBOHYDRATE SOLUTION INTAKE; ORAL INTAKE; DOUBLE-BLIND; POLICIES	Objective To investigate the effect of feeding during labour on obstetric and neonatal outcomes. Design Prospective randomised controlled trial. Setting Birth centre in London teaching hospital. Participants 2426 nulliparous, non-diabetic women at term, with a singleton cephalic presenting fetus and in labour with a cervical dilatation of less than 6 cm. Intervention Consumption of a light diet or water during labour. Main outcome measures The primary outcome measure was spontaneous vaginal delivery rate. Other outcomes measured included duration of labour, need for augmentation of labour, instrumental and caesarean delivery rates, incidence of vomiting, and neonatal outcome. Results The spontaneous vaginal delivery rate was the same in both groups (44%; relative risk 0.99, 95% confidence interval 0.90 to 1.08). No clinically important differences were found in the duration of labour (geometric mean: eating, 597 min v water, 612 min; ratio of geometric means 0.98, 95% confidence interval 0.93 to 1.03), the caesarean delivery rate (30% v 30%; relative risk 0.99, 0.87 to 1.12), or the incidence of vomiting (35% v 34%; relative risk 1.05, 0.9 to 1.2). Neonatal outcomes were also similar. Conclusions Consumption of a light diet during labour did not influence obstetric or neonatal outcomes in participants, nor did it increase the incidence of vomiting. Women who are allowed to eat in labour have similar lengths of labour and operative delivery rates to those allowed water only. Trial registration Current Controlled Trials ISRCTN33298015.	[Liu, Bing; Seed, Paul; Shennan, Andrew] Kings Coll London, Maternal & Fetal Res Unit, London SE1 7EH, England; [O'Sullivan, Geraldine] St Thomas Hosp, Dept Anaesthesia, Guys & St Thomas NHS Fdn Trust, London SE1 7EH, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Shennan, A (corresponding author), Kings Coll London, Maternal & Fetal Res Unit, London SE1 7EH, England.	andrew.shennan@kcl.ac.uk	Seed, Paul T/C-4435-2008	Seed, Paul T/0000-0001-7904-7933; Shennan, Andrew/0000-0001-5273-3132	Obstetric Anaesthetists' Association; Special Trustees of the St Thomas' Hospital; Tommy's-The Baby Charity	Obstetric Anaesthetists' Association; Special Trustees of the St Thomas' Hospital; Tommy's-The Baby Charity	Funding: This study was supported by a grant from the Obstetric Anaesthetists' Association and the Special Trustees of the St Thomas' Hospital. AS is supported by Tommy's-The Baby Charity.	Albers L, 1999, J NURSE-MIDWIFERY, V44, P135; [Anonymous], 2007, ANESTHESIOLOGY, V106, P843; *DEP HLTH, 2004, WHY MOTH DIE 2000 20; *DEP HLTH SOC SERV, 2001, 5 DEP HLTH SOC SERV; *DEP HLTH WELSH OF, 1998, REP CONF ENQ MAT DEA; Department of Health Welsh Office Scottish Home and Health Department and Department of Health and Social Services Northern Ireland, 1996, REP CONF ENQ MAT DEA; Department of Health Welsh Office Scottish Home and Health Department Department of Health and Social Services Northern Ireland, 1994, REP CONF ENQ MAT DEA; FRYE A, 1994, MIDWIFERY TODAY, V31, P25; Hawkins JL, 1998, J CLIN ANESTH, V10, P449, DOI 10.1016/S0952-8180(98)00054-3; Jones E, 1996, BMJ-BRIT MED J, V313, P36, DOI 10.1136/bmj.313.7048.36; Kluger MT, 1999, ANAESTHESIA, V54, P19, DOI 10.1046/j.1365-2044.1999.00642.x; Kollef MH, 1999, NEW ENGL J MED, V340, P627, DOI 10.1056/NEJM199902253400807; Kubli M, 2002, ANESTH ANALG, V94, P404, DOI 10.1097/00000539-200202000-00033; Lewis G, 2007, 7 CEMACH; Lewis P, 1998, Pract Midwife, V1, P4; MENDELSON CL, 1946, AM J OBSTET GYNECOL, V52, P191; MICHAEL S, 1991, ANAESTHESIA, V46, P1071, DOI 10.1111/j.1365-2044.1991.tb09928.x; NIMMO WS, 1975, LANCET, V1, P890; O'Sullivan G, 2007, INT ANESTHESIOL CLIN, V45, P133, DOI 10.1097/AIA.0b013e31802b8dea; O'Sullivan Geraldine, 2003, Anesthesiol Clin North Am, V21, P87; Parsons M, 2004, MIDWIFERY, V20, P72, DOI 10.1016/S0266-6138(03)00055-X; Parsons M, 2007, MIDWIFERY, V23, P131, DOI 10.1016/j.midw.2006.03.007; Porter JS, 1997, ANAESTHESIA, V52, P1151, DOI 10.1111/j.1365-2044.1997.238-az0373.x; Scheepers HCJ, 2004, BJOG-INT J OBSTET GY, V111, P1382, DOI 10.1111/j.1471-0528.2004.00277.x; Scheepers HCJ, 2002, BJOG-INT J OBSTET GY, V109, P178, DOI 10.1016/S1470-0328(02)01062-5; Scheepers HCJ, 1998, EUR J OBSTET GYN R B, V78, P37; Scrutton MJL, 1999, ANAESTHESIA, V54, P329, DOI 10.1046/j.1365-2044.1999.00750.x; SIMKIN P, 1986, BIRTH-ISS PERINAT C, V13, P234, DOI 10.1111/j.1523-536X.1986.tb01054.x; Sleutel M, 1999, J Obstet Gynecol Neonatal Nurs, V28, P507, DOI 10.1111/j.1552-6909.1999.tb02024.x; Tranmer JE, 2005, JOGNN-J OBST GYN NEO, V34, P319, DOI 10.1177/0884217505276155; Watanabe T, 2001, J PERINAT MED, V29, P528, DOI 10.1515/JPM.2001.073; YIANNOUZIS C, 1994, MIDWIFERY RES DATABA, P196; Zimmermann DL, 1996, ANESTH ANALG, V82, P612, DOI 10.1097/00000539-199603000-00032	33	47	49	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2009	338								b784	10.1136/bmj.b784	http://dx.doi.org/10.1136/bmj.b784			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LP	19318702	Green Published, hybrid			2022-12-28	WOS:000264639500012
J	Guise, A; Woodward, D; Lee, PT; De Vogli, R; Tillman, T; Mccoy, D				Guise, Andy; Woodward, David; Lee, Patrick T.; De Vogli, Roberto; Tillman, Taavi; McCoy, David			Engaging the health community in global economic reform	LANCET			English	Editorial Material									[McCoy, David] UCL, Ctr Int Hlth & Dev, London WC1N 1EH, England; [Guise, Andy] London Sch Hyg & Trop Med, London WC1, England; [Lee, Patrick T.] Massachusetts Gen Hosp, Boston, MA 02114 USA	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Massachusetts General Hospital	Mccoy, D (corresponding author), UCL, Ctr Int Hlth & Dev, London WC1N 1EH, England.	d.mccoy@ucl.ac.uk	Tillmann, Taavi/R-6026-2016	Tillmann, Taavi/0000-0002-8428-3719; Guise, Andy/0000-0002-0981-4663				*B WOODS PROJ, WHAT AR MAIN CRIT WO; CHAN M, 2008, GLOBALISATION HLTH; Epstein G., 2005, CAPITAL FLIGHT CAPIT; Globalization Knowledge Network, 2007, HLTH EQ GLOB RIGHTS; KWA E, 2003, SCENES WTO REAL WORL; MacDonald R, 2009, LANCET, V373, P273, DOI 10.1016/S0140-6736(08)61773-0; MCCOY D, 2008, GLOBAL HLTH WATCH 2; *TAX JUST NETW, 2009, END OFFSH SECR SYST; WHO Commission on Social Determinants of Health World Health Organization, 2008, CLOS GAP GEN HLTH EQ; 2009, LETS PUT FINANCE ITS; 2009, LONDON SUMMIT 2009	11	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					987	989		10.1016/S0140-6736(09)60588-2	http://dx.doi.org/10.1016/S0140-6736(09)60588-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	422AA	19304001				2022-12-28	WOS:000264398200008
J	Maleczka, RE				Maleczka, Robert E., Jr.			Copper Puts Arenes in a Hard Position	SCIENCE			English	Editorial Material									Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	Michigan State University	Maleczka, RE (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.	maleczka@chemistry.msu.edu						[Anonymous], 2005, CHEM ENG NEWS; Astruc D., 2002, MODERN ARENE CHEM, P1; CAREY JS, 2003, ORG BIOL CHEM, V4, P2337; Constable DJC, 2007, GREEN CHEM, V9, P411, DOI 10.1039/b703488c; Desai LV, 2008, J AM CHEM SOC, V130, P13285, DOI 10.1021/ja8045519; Evindar G, 2006, J ORG CHEM, V71, P1802, DOI 10.1021/jo051927q; Hoger S, 2001, J AM CHEM SOC, V123, P5651, DOI 10.1021/ja003990x; Holleman AF, 1924, CHEM REV, V1, P187, DOI 10.1021/cr60002a002; Huffman LM, 2008, J AM CHEM SOC, V130, P9196, DOI 10.1021/ja802123p; Maleczka RE, 2003, J AM CHEM SOC, V125, P7792, DOI 10.1021/ja0349857; Norberg AM, 2008, CURR OPIN DRUG DISC, V11, P853; Phipps RJ, 2009, SCIENCE, V323, P1593, DOI 10.1126/science.1169975; Roberts R. M., 1984, FRIEDELCRAFTS ALKYLA; SNIECKUS V, 1990, CHEM REV, V90, P879, DOI 10.1021/cr00104a001; Wilhelm T, 2005, ORG LETT, V7, P4053, DOI 10.1021/ol051628n	15	8	8	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1572	1573		10.1126/science.1172298	http://dx.doi.org/10.1126/science.1172298			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299610				2022-12-28	WOS:000264342300028
J	Carelle-Calmels, N; Saugier-Veber, P; Girard-Lemaire, F; Rudolf, G; Doray, B; Guerin, E; Kuhn, P; Arrive, M; Gilch, C; Schmitt, E; Fehrenbach, S; Schnebelen, A; Frebourg, T; Flori, E				Carelle-Calmels, Nadege; Saugier-Veber, Pascale; Girard-Lemaire, Francoise; Rudolf, Gabrielle; Doray, Berenice; Guerin, Eric; Kuhn, Pierre; Arrive, Mathilde; Gilch, Catherine; Schmitt, Evelyne; Fehrenbach, Severine; Schnebelen, Albert; Frebourg, Thierry; Flori, Elisabeth			Genetic Compensation in a Human Genomic Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGENITAL HEART-DISEASE; LOW-COPY REPEATS; 22Q11.2 DELETION; MICRODUPLICATION; REARRANGEMENTS; VARIABILITY; FEATURES; TRAITS	Cytogenetic studies of the parents of a girl with the DiGeorge (or velocardiofacial) syndrome, who carried a deletion at 22q11.2, revealed an unexpected rearrangement of both 22q11.2 regions in the unaffected father. He carried a 22q11.2 deletion on one copy of chromosome 22 and a reciprocal 22q11.2 duplication on the other copy of chromosome 22. Genetic compensation, which is consistent with the normal phenotype of the father, was shown through quantitative-expression analyses of genes located within the genetic region associated with the DiGeorge syndrome. This finding has implications for genetic counseling and represents a case of genetic compensation in a human genomic disorder.	[Carelle-Calmels, Nadege; Girard-Lemaire, Francoise; Arrive, Mathilde; Gilch, Catherine; Schmitt, Evelyne; Flori, Elisabeth] Strasbourg Univ Hosp, Dept Cytogenet, Strasbourg, France; [Rudolf, Gabrielle] Strasbourg Univ Hosp, Dept Neurol, Strasbourg, France; [Doray, Berenice] Strasbourg Univ Hosp, Dept Med Genet, Strasbourg, France; [Guerin, Eric] Strasbourg Univ Hosp, Dept Biochem & Mol Biol, Strasbourg, France; [Kuhn, Pierre] Strasbourg Univ Hosp, Dept Pediat, Strasbourg, France; [Saugier-Veber, Pascale; Fehrenbach, Severine; Frebourg, Thierry] Rouen Univ Hosp, Dept Genet, Rouen, France; [Saugier-Veber, Pascale; Fehrenbach, Severine; Frebourg, Thierry] Univ Rouen, Rouen, France; [Schnebelen, Albert] Saverne Hosp, Dept Pediat, Saverne, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Rouen; Universite de Rouen Normandie	Flori, E (corresponding author), Hop Hautepierre, Cytogenet Serv, Ave Moliere, F-67098 Strasbourg, France.	elisabeth.flori@chru-strasbourg.fr	Frebourg, Thierry/AAK-8390-2020	Saugier-Veber, Pascale/0000-0002-8045-6432; CALMELS, Nadege/0000-0001-8516-8184; Rudolf, Gabrielle/0000-0002-2050-3911; GUERIN, ERIC/0000-0003-1388-2834; Frebourg, Thierry/0000-0003-0399-4007				Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Digilio MC, 2003, CLIN GENET, V63, P308, DOI 10.1034/j.1399-0004.2003.00049.x; Digilio MC, 1997, AM J MED GENET, V73, P95; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Ensenauer RE, 2003, AM J HUM GENET, V73, P1027, DOI 10.1086/378818; Jacquet H, 2002, HUM MOL GENET, V11, P2243, DOI 10.1093/hmg/11.19.2243; LeanaCox J, 1996, AM J MED GENET, V65, P309, DOI 10.1002/(SICI)1096-8628(19961111)65:4<309::AID-AJMG12>3.0.CO;2-Y; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; McDonald-McGinn DM, 2001, GENET MED, V3, P23, DOI 10.1097/00125817-200101000-00006; Ou Z, 2008, GENET MED, V10, P267, DOI 10.1097/GIM.0b013e31816b64c2; Portnoi MF, 2005, AM J MED GENET A, V137A, P47, DOI 10.1002/ajmg.a.30847; Saitta SC, 2004, HUM MOL GENET, V13, P417, DOI 10.1093/hmg/ddh041; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Shouman N, 2003, INT J ORAL MAX SURG, V32, P198, DOI 10.1054/ijom.2002.0336; Thompson PW, 1998, J MED GENET, V35, P789, DOI 10.1136/jmg.35.9.789; WILSON DI, 1992, LANCET, V340, P573, DOI 10.1016/0140-6736(92)92107-Q; Yobb TM, 2005, AM J HUM GENET, V76, P865, DOI 10.1086/429841	20	38	41	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2009	360	12					1211	1216		10.1056/NEJMoa0806544	http://dx.doi.org/10.1056/NEJMoa0806544			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420IU	19297573				2022-12-28	WOS:000264283400007
J	Scott, RM; Smith, ER				Scott, R. Michael; Smith, Edward R.			MEDICAL PROGRESS Moyamoya Disease and Moyamoya Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SICKLE-CELL-DISEASE; TRANSFORMING GROWTH FACTOR-BETA(1); CENTRAL-NERVOUS-SYSTEM; SURGICAL REVASCULARIZATION; CEREBROSPINAL-FLUID; PEDIATRIC MOYAMOYA; MR-ANGIOGRAPHY; CONVENTIONAL ANGIOGRAPHY; EPIDEMIOLOGIC FEATURES; CLINICAL-FEATURES		[Smith, Edward R.] Childrens Hosp, Dept Neurosurg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Smith, ER (corresponding author), Childrens Hosp, Dept Neurosurg, 300 Longwood Ave, Boston, MA 02115 USA.	edward.smith@childrens.harvard.edu		Smith, Edward/0000-0002-6317-8450				Baba T, 2008, J NEUROL NEUROSUR PS, V79, P900, DOI 10.1136/jnnp.2007.130666; Bowen MD, 2005, J CHILD NEUROL, V20, P194, DOI 10.1177/08830738050200030501; Caldarelli M, 2001, J Neurosurg Sci, V45, P83; Choi JU, 1997, CLIN NEUROL NEUROSUR, V99, pS11, DOI 10.1016/S0303-8467(97)00033-4; Dauser RC, 1997, J NEUROSURG, V86, P719, DOI 10.3171/jns.1997.86.4.0719; Dobson SR, 2002, BLOOD, V99, P3144, DOI 10.1182/blood.V99.9.3144; EZURA M, 1992, NEUROSURGERY, V31, P1105, DOI 10.1227/00006123-199212000-00018; Fujiwara H, 2005, EUR J RADIOL, V55, P224, DOI 10.1016/j.ejrad.2004.11.009; Fujiwara J, 1996, CHILD NERV SYST, V12, P69, DOI 10.1007/BF00819498; Fukui M, 2000, NEUROPATHOLOGY, V20, pS61, DOI 10.1046/j.1440-1789.2000.00300.x; Fukui M, 1997, CLIN NEUROL NEUROSUR, V99, pS238; Fung LWE, 2005, CHILD NERV SYST, V21, P358, DOI 10.1007/s00381-004-1118-9; Gebreyohanns M, 2004, CNS SPECTRUMS, V9, P445; Hallemeier CL, 2006, STROKE, V37, P1490, DOI 10.1161/01.STR.0000221787.70503.ca; Han DH, 1997, CLIN NEUROL NEUROSUR, V99, pS151; Han DH, 2000, ACTA NEUROCHIR, V142, P1263, DOI 10.1007/s007010070024; Han H, 2003, J KOREAN MED SCI, V18, P876, DOI 10.3346/jkms.2003.18.6.876; Hankinson TC, 2008, J NEUROSURG-PEDIATR, V1, P211, DOI 10.3171/PED/2008/1/3/211; Hojo M, 1998, J NEUROSURG, V89, P623, DOI 10.3171/jns.1998.89.4.0623; Houkin K, 1996, STROKE, V27, P1342, DOI 10.1161/01.STR.27.8.1342; Houkin K, 2001, NEUROSURG CLIN N AM, V12, P575, DOI 10.1016/S1042-3680(18)30044-5; Ikeda H, 1999, AM J HUM GENET, V64, P533, DOI 10.1086/302243; Ikezaki K, 1997, STROKE, V28, P2513, DOI 10.1161/01.STR.28.12.2513; Ikezaki K, 2000, J CHILD NEUROL, V15, P350, DOI 10.1177/088307380001500512; Imaizumi T, 1998, PEDIATR NEUROL, V18, P321, DOI 10.1016/S0887-8994(97)00209-9; Inoue TK, 2000, J CHILD NEUROL, V15, P179, DOI 10.1177/088307380001500307; Irikura K, 1996, ACTA NEUROCHIR, V138, P1282, DOI 10.1007/BF01411056; Isono M, 2002, J CLIN NEUROSCI, V9, P644, DOI 10.1054/jocn.2002.1103; Iwama T, 1996, NEUROSURGERY, V38, P1120, DOI 10.1097/00006123-199606000-00011; Iwama T, 1997, CLIN NEUROL NEUROSUR, V99, pS187, DOI 10.1016/S0303-8467(97)00081-4; Jea A, 2005, PEDIATRICS, V116, pE694, DOI 10.1542/peds.2005-0568; Kang HS, 2006, NEUROSURGERY, V58, P1074, DOI 10.1227/01.NEU.0000215854.66011.4F; KATZ DA, 1995, RADIOLOGY, V195, P445, DOI 10.1148/radiology.195.2.7724764; Kawaguchi S, 1996, ACTA NEUROCHIR, V138, P1287, DOI 10.1007/BF01411057; Kawaguchi S, 2000, J NEUROSURG, V93, P397, DOI 10.3171/jns.2000.93.3.0397; Kelly ME, 2006, CEREBROVASC DIS, V22, P109, DOI 10.1159/000093238; Kirkham Fenella J., 2004, Curr Treat Options Neurol, V6, P357, DOI 10.1007/s11940-996-0028-4; KODAMA N, 1979, ARCH NEUROL-CHICAGO, V36, P16, DOI 10.1001/archneur.1979.00500370046008; KONO S, 1990, STROKE, V21, P1044, DOI 10.1161/01.STR.21.7.1044; Kuroda S, 2005, STROKE, V36, P2148, DOI 10.1161/01.STR.0000182256.32489.99; Kuroda S, 2001, NEUROSURGERY, V49, P463, DOI 10.1097/00006123-200108000-00039; KUROKAWA T, 1985, NEUROPEDIATRICS, V16, P29, DOI 10.1055/s-2008-1052540; Lim M, 2006, CURR NEUROVASC RES, V3, P237, DOI 10.2174/156720206778018730; Lubman DI, 2003, J INT NEUROPSYCH SOC, V9, P806, DOI 10.1017/S1355617703950132; Malek AM, 1997, PEDIATR NEUROSURG, V27, P182, DOI 10.1159/000121249; Massaro M, 1998, ARCH OPHTHALMOL-CHIC, V116, P253; Matsushima T, 1998, Neurosurg Focus, V5, pe4; Matsushima T, 1998, NEUROL MED-CHIR, V38, P297, DOI 10.2176/nmc.38.suppl_297; Mineharu Y, 2008, NEUROLOGY, V70, P2357, DOI 10.1212/01.wnl.0000291012.49986.f9; NAGARAJA D, 1994, ACTA NEUROL SCAND, V90, P251; Nanba R, 2005, CHILD NERV SYST, V21, P62, DOI 10.1007/s00381-004-1005-4; Nanba R, 2004, STROKE, V35, P2837, DOI 10.1161/01.STR.0000148237.13659.e6; Nomura S, 2001, CHILD NERV SYST, V17, P270, DOI 10.1007/s003810000407; OHAEGBULAM C, 2001, PEDIAT NEUROSURGERY, P1077; OKA K, 1981, VIRCHOWS ARCH A, V392, P247, DOI 10.1007/BF02155663; Parmar R C, 2000, Indian Pediatr, V37, P1005; Pegelow C H, 2001, Paediatr Drugs, V3, P421, DOI 10.2165/00128072-200103060-00003; Riebel T, 2003, EUR RADIOL, V13, P563, DOI 10.1007/s00330-002-1481-4; Roach E S, 2000, Semin Pediatr Neurol, V7, P244; Rosser TL, 2005, NEUROLOGY, V64, P553, DOI 10.1212/01.WNL.0000150544.00016.69; Sakurai K, 2004, J HUM GENET, V49, P278, DOI 10.1007/s10038-004-0143-6; Scott R M, 2000, Clin Neurosurg, V47, P378; Scott RM, 2004, J NEUROSURG, V100, P142, DOI 10.3171/ped.2004.100.2.0142; Sencer S, 2000, EUR RADIOL, V10, P569, DOI 10.1007/s003300050962; Seol HJ, 2005, J NEUROSURG, V103, P439, DOI 10.3171/ped.2005.103.5.0439; Smith ER, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/2/E17; Smith ER, 2005, SKULL BASE-INTERD AP, V15, P15, DOI 10.1055/s-2005-868160; Soriano SG, 2002, NEUROSURGERY, V50, P544, DOI 10.1097/00006123-200203000-00022; SUZUKI J, 1983, STROKE, V14, P104, DOI 10.1161/01.STR.14.1.104; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012; TAGAWA T, 1987, STROKE, V18, P906, DOI 10.1161/01.STR.18.5.906; Takagi Y, 2006, NEUROSURGERY, V58, P740, DOI 10.1227/01.NEU.0000192167.54627.3A; Takagi Y, 2007, NEUROL MED-CHIR, V47, P1, DOI 10.2176/nmc.47.1; Takagi Y, 2007, NEUROSURGERY, V60, P338, DOI 10.1227/01.NEU.0000249275.87310.FF; Takanashi J I, 1998, Eur J Paediatr Neurol, V2, P83, DOI 10.1016/S1090-3798(98)80046-9; Takeuchi K., 1957, BRAIN NERVE, V9, P37; TANGHETTI B, 1983, J NEUROSURG, V59, P1092, DOI 10.3171/jns.1983.59.6.1092; Uchino K, 2005, NEUROLOGY, V65, P956, DOI 10.1212/01.wnl.0000176066.33797.82; Ueno M, 2000, J NEUROSURG, V92, P907; Ullrich NJ, 2007, NEUROLOGY, V68, P932, DOI 10.1212/01.wnl.0000257095.33125.48; Veeravagu A, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/2/E16; Wakai K, 1997, CLIN NEUROL NEUROSUR, V99, pS1, DOI 10.1016/S0303-8467(97)00031-0; YAMADA I, 1995, RADIOLOGY, V196, P211, DOI 10.1148/radiology.196.1.7784569; YAMADA I, 1992, RADIOLOGY, V184, P773, DOI 10.1148/radiology.184.3.1509066; YAMASHITA M, 1983, J NEUROSURG, V58, P120, DOI 10.3171/jns.1983.58.1.0120; Yilmaz EY, 2001, ARCH NEUROL-CHICAGO, V58, P1274, DOI 10.1001/archneur.58.8.1274; Yonekawa Y, 1997, CLIN NEUROL NEUROSUR, V99, pS58, DOI 10.1016/S0303-8467(97)00042-5; Yoshimoto T, 1996, STROKE, V27, P2160, DOI 10.1161/01.STR.27.12.2160	88	965	1024	3	93	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2009	360	12					1226	1237		10.1056/NEJMra0804622	http://dx.doi.org/10.1056/NEJMra0804622			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420IU	19297575				2022-12-28	WOS:000264283400009
J	Airan, RD; Thompson, KR; Fenno, LE; Bernstein, H; Deisseroth, K				Airan, Raag D.; Thompson, Kimberly R.; Fenno, Lief E.; Bernstein, Hannah; Deisseroth, Karl			Temporally precise in vivo control of intracellular signalling	NATURE			English	Article							ACTIVATION; NUCLEUS; PHOTOSTIMULATION; ADDICTION; RECEPTORS; REVEALS	In the study of complex mammalian behaviours, technological limitations have prevented spatiotemporally precise control over intracellular signalling processes. Here we report the development of a versatile family of genetically encoded optical tools ('optoXRs') that leverage common structure -function relationships(1) among G-protein-coupled receptors (GPCRs) to recruit and control, with high spatiotemporal precision, receptor-initiated biochemical signalling pathways. In particular, we have developed and characterized two optoXRs that selectively recruit distinct, targeted signalling pathways in response to light. The two optoXRs exerted opposing effects on spike firing in nucleus accumbens in vivo, and precisely timed optoXR photostimulation in nucleus accumbens by itself sufficed to drive conditioned place preference in freely moving mice. The optoXR approach allows testing of hypotheses regarding the causal impact of biochemical signalling in behaving mammals, in a targetable and temporally precise manner.	[Airan, Raag D.; Thompson, Kimberly R.; Fenno, Lief E.; Bernstein, Hannah; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Fenno, Lief/AAF-9638-2019; Fenno, Lief/AAK-2924-2020	Airan, Raag/0000-0001-5259-5606; Bernstein, Hannah/0000-0002-6512-1378	NIH/NIMH National Research Service Award; Stanford Medical Scientist Training Program; NARSAD Young Investigator Award; CIRM; McKnight; Coulter; Klingenstein; Keck; NSF; NIDA; NIH Pioneer Award; Albert Yu and Mary Bechmann Foundation; Kinetics Foundation	NIH/NIMH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Stanford Medical Scientist Training Program; NARSAD Young Investigator Award(NARSAD); CIRM(California Institute for Regenerative Medicine); McKnight; Coulter; Klingenstein(Klingenstein Philanthropies); Keck; NSF(National Science Foundation (NSF)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Yu and Mary Bechmann Foundation; Kinetics Foundation	We thank B. Kobilka, B. Knutson, M. P. Bokoch, T. Sudhof, R. Malenka and the Deisseroth Laboratory for comments and discussion. We appreciate the gifts of pCNGA2-C460W/E583M from J. W. Karpen, pcDNA3.1-beta<INF>2</INF>AR from B. Kobilka and pDT-alpha<INF>1</INF>AR from C. Hague. We thank T. Jardetzky for use of a Biotek Synergy4 plate reader. R. D. A. is supported by a NIH/NIMH National Research Service Award and the Stanford Medical Scientist Training Program. K. R. T. is supported by a NARSAD Young Investigator Award. K. D. is supported by CIRM, McKnight, Coulter, Klingenstein, Keck, NSF, NIMH, NIDA, the NIH Pioneer Award, the Albert Yu and Mary Bechmann Foundation and the Kinetics Foundation.	Airan RD, 2007, CURR OPIN NEUROBIOL, V17, P587, DOI 10.1016/j.conb.2007.11.003; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Carelli RM, 2004, CURR OPIN NEUROBIOL, V14, P763, DOI 10.1016/j.conb.2004.10.001; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Furuta T, 1999, P NATL ACAD SCI USA, V96, P1193, DOI 10.1073/pnas.96.4.1193; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Karnik SS, 2003, TRENDS ENDOCRIN MET, V14, P431, DOI 10.1016/j.tem.2003.09.007; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P359, DOI 10.1016/j.tips.2007.06.010; Kim JM, 2005, BIOCHEMISTRY-US, V44, P2284, DOI 10.1021/bi048328i; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Oliveira L, 1999, PROTEIN ENG, V12, P1087, DOI 10.1093/protein/12.12.1087; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pettit DL, 1997, NEURON, V19, P465, DOI 10.1016/S0896-6273(00)80361-X; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Potts JT, 2005, NEUROSCIENCE, V132, P1123, DOI 10.1016/j.neuroscience.2004.12.018; Rich TC, 2001, J GEN PHYSIOL, V118, P63, DOI 10.1085/jgp.118.1.63; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; WHITE FJ, 1986, J NEUROSCI, V6, P274; WILSON CJ, 2003, SYNAPTIC ORG BRAIN, P361; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	30	483	537	2	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1025	1029		10.1038/nature07926	http://dx.doi.org/10.1038/nature07926			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19295515				2022-12-28	WOS:000265412900042
J	Bird, SM; Merrall, ELC				Bird, Sheila M.; Merrall, Elizabeth L. C.			Serial offending: evaluation of drugs courts	LANCET			English	Editorial Material							JUSTICE		[Bird, Sheila M.; Merrall, Elizabeth L. C.] MRC, Biostat Unit, Cambridge CB2 0SR, England	MRC Biostatistics Unit	Bird, SM (corresponding author), MRC, Biostat Unit, Cambridge CB2 0SR, England.	sheila.bird@mrc-bsu.cam.ac.uk			MRC [MC_U105260794] Funding Source: UKRI; Medical Research Council [MC_U105260794] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bird SM, 2004, LANCET, V364, P1457, DOI 10.1016/S0140-6736(04)17230-9; Deschenes EP, 1995, JUSTICE SYST J, V18, P55, DOI 10.1080/23277556.1995.10871222; Farrington DP, 2006, CRIME JUSTICE, V34, P55, DOI 10.1086/500057; *HOM OFF SCI ADV C, 2008, 21 CENT DRUGS STAT S; King R, 2005, AM J EPIDEMIOL, V162, P694, DOI 10.1093/aje/kwi263; McIvor G., 2006, OPERATION EFFECTIVEN; *MIN JUST, 2008, DED DRUG COURT PIL P; Ministry of Justice, 2008, TIM INT CRIM P MAG C; Perera R, 2007, BRIT MED J, V334, P127, DOI 10.1136/bmj.39045.396817.68; Shapland J, 2008, DOES RESTORATIVE JUS; *UN OFF DRUGS CRIM, DRUG TREATM COURTS W; Wilson D.B., 2006, J EXPT CRIMINOLOGY, V2, P459, DOI DOI 10.1007/s11292-006-9019-4	12	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 11	2009	373	9671					1231	1233		10.1016/S0140-6736(09)60707-8	http://dx.doi.org/10.1016/S0140-6736(09)60707-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	432PN	19362660				2022-12-28	WOS:000265146300008
J	Cravedi, P; Ruggenenti, P; Remuzzi, G				Cravedi, Paolo; Ruggenenti, Piero; Remuzzi, Giuseppe			Sirolimus to replace calcineurin inhibitors? Too early yet	LANCET			English	Editorial Material							RENAL-TRANSPLANTATION; EFFICACY; CYCLOSPORINE; THERAPY		[Cravedi, Paolo; Ruggenenti, Piero; Remuzzi, Giuseppe] Azienda Osped, Osped Riuniti Bergamo, Nephrol Unit, Mario Negri Inst Pharmacol Res, I-24125 Bergamo, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Ospedali Riuniti di Bergamo	Remuzzi, G (corresponding author), Azienda Osped, Osped Riuniti Bergamo, Nephrol Unit, Mario Negri Inst Pharmacol Res, I-24125 Bergamo, Italy.	gremuzzi@marionegri.it	Cravedi, Paolo/AAA-1390-2019; Remuzzi, Giuseppe/V-9766-2017	Cravedi, Paolo/0000-0001-7837-0923; Remuzzi, Giuseppe/0000-0002-6194-3446				Barozzi P, 2008, TRANSPLANTATION, V86, P738, DOI 10.1097/TP.0b013e318184112c; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Buhaescu I, 2006, THER DRUG MONIT, V28, P577, DOI 10.1097/01.ftd.0000245377.93401.39; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Groth CG, 1999, TRANSPLANTATION, V67, P1036, DOI 10.1097/00007890-199904150-00017; Kahan BD, 2000, LANCET, V356, P194, DOI 10.1016/S0140-6736(00)02480-6; Morelon E, 2001, NEPHROL DIAL TRANSPL, V16, P18, DOI 10.1093/ndt/16.1.18; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Ruggenenti P, 2007, TRANSPLANTATION, V84, P956, DOI 10.1097/01.tp.0000284808.28353.2c; Tomlanovich SJ, 2007, CLIN J AM SOC NEPHRO, V2, P198, DOI 10.2215/CJN.00340107	10	17	19	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2009	373	9671					1235	1236		10.1016/S0140-6736(09)60709-1	http://dx.doi.org/10.1016/S0140-6736(09)60709-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432PN	19362662				2022-12-28	WOS:000265146300010
J	Kim, J; Ashenhurst, JA; Movassaghi, M				Kim, Justin; Ashenhurst, James A.; Movassaghi, Mohammad			Total Synthesis of (+)-11,11 '-Dideoxyverticillin A	SCIENCE			English	Article							CONCISE TOTAL-SYNTHESIS; PERMANGANATE; OXIDATION; ACID; EPIDITHIODIOXOPIPERAZINES; BIOSYNTHESIS; CONSTRUCTION; VERTICILLIN; DERIVATIVES; EXPRESSION	The fungal metabolite (+)-11,11'-dideoxyverticillin A, a cytotoxic alkaloid isolated from a marine Penicillium sp., belongs to a fascinating family of densely functionalized, stereochemically complex, and intricate dimeric epidithiodiketopiperazine natural products. Although the dimeric epidithiodiketopiperazines have been known for nearly 4 decades, none has succumbed to total synthesis. We report a concise enantioselective total synthesis of (+)-11,11'- dideoxyverticillin A via a strategy inspired by our biosynthetic hypothesis for this alkaloid. Highly stereo- and chemoselective advanced-stage tetrahydroxylation and tetrathiolation reactions, as well as a mild strategy for the introduction of the epidithiodiketopiperazine core in the final step, were developed to address this highly sensitive substructure. Our rapid functionalization of the advanced molecular framework aims to mimic plausible biosynthetic steps and offers an effective strategy for the chemical synthesis of other members of this family of alkaloids.	[Kim, Justin; Ashenhurst, James A.; Movassaghi, Mohammad] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Movassaghi, M (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	movassag@mit.edu			Amgen; AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Merck; Lilly; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089732] Funding Source: NIH RePORTER	Amgen(Amgen); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Lilly(Eli Lilly); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.M. is an Alfred P. Sloan Research Fellow and a Beckman Young Investigator. J.K. and J.A.A. acknowledge predoctoral (National Defense Science and Engineering Graduate) and postdoctoral [Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)] fellowships, respectively. We thank P. Muller for assistance with x-ray structures of (+)-1 and (+)-14. We acknowledge generous support from Amgen, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck, and Lilly. Structural parameters for (+)-1 and (+)-14 are freely available from the Cambridge Crystallographic Data Centre under CCDC-719219 and CCDC-719218, respectively.	Chen H, 2002, CHEM BIOL, V9, P103, DOI 10.1016/S1074-5521(02)00090-X; Chen Y, 2005, FEBS LETT, V579, P3683, DOI 10.1016/j.febslet.2005.05.053; Chen Y, 2005, BIOCHEM BIOPH RES CO, V329, P1334, DOI 10.1016/j.bbrc.2005.02.115; CUTHBERTSON E, 1975, TETRAHEDRON LETT, V16, P1345; FIROUZABADI H, 1982, TETRAHEDRON LETT, V23, P1847, DOI 10.1016/S0040-4039(00)86758-1; Fox EM, 2008, MYCOL RES, V112, P162, DOI 10.1016/j.mycres.2007.08.017; FUKUYAMA T, 1981, TETRAHEDRON, V37, P2045, DOI 10.1016/S0040-4020(01)97960-8; Gardiner DM, 2005, MICROBIOL-SGM, V151, P1021, DOI 10.1099/mic.0.27847-0; Gardiner DM, 2005, FEMS MICROBIOL LETT, V248, P241, DOI 10.1016/j.femsle.2005.05.046; GARDNER KA, 1995, SCIENCE, V269, P1849, DOI 10.1126/science.7569922; HAUSER D, 1970, HELV CHIM ACTA, V53, P1061, DOI 10.1002/hlca.19700530521; HERSCHEID JDM, 1980, J ORG CHEM, V45, P1880, DOI 10.1021/jo01298a023; KATAGIRI K, 1970, J ANTIBIOT, V23, P420, DOI 10.7164/antibiotics.23.420; KIRBY GW, 1980, BIOSYNTH MYCOTOX, P301; KISHI Y, 1973, J AM CHEM SOC, V95, P6490, DOI 10.1021/ja00800a077; Movassaghi M, 2008, ANGEW CHEM INT EDIT, V47, P1485, DOI 10.1002/anie.200704960; Movassaghi M, 2007, ANGEW CHEM INT EDIT, V46, P3725, DOI 10.1002/anie.200700705; Overman LE, 2007, ORG LETT, V9, P5267, DOI 10.1021/ol702518t; Rauk A, 1999, BIOCHEMISTRY-US, V38, P9089, DOI 10.1021/bi990249x; Ruble JC, 1998, J AM CHEM SOC, V120, P11532, DOI 10.1021/ja982890c; SALA T, 1978, J CHEM SOC CHEM COMM, P253, DOI 10.1039/c39780000253; Schoendorf A, 2001, P NATL ACAD SCI USA, V98, P1501, DOI 10.1073/pnas.98.4.1501; SEEBACH D, 1983, J AM CHEM SOC, V105, P5390, DOI 10.1021/ja00354a034; Son BW, 1999, NAT PROD LETT, V13, P213, DOI 10.1080/10575639908048788; Strassner T, 2000, J AM CHEM SOC, V122, P7821, DOI 10.1021/ja000981f; WILLIAMS RM, 1980, J ORG CHEM, V45, P2625, DOI 10.1021/jo01301a017; WOODWARD RB, 1958, J AM CHEM SOC, V80, P209, DOI 10.1021/ja01534a053; Wu ZC, 2000, ANGEW CHEM INT EDIT, V39, P3866, DOI 10.1002/1521-3773(20001103)39:21<3866::AID-ANIE3866>3.0.CO;2-E; Zhang YX, 2005, ANTI-CANCER DRUG, V16, P515, DOI 10.1097/00001813-200506000-00007	29	250	256	4	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					238	241		10.1126/science.1170777	http://dx.doi.org/10.1126/science.1170777			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	430WX	19359584	Green Accepted, Green Submitted			2022-12-28	WOS:000265024400043
J	Sherman, W				Sherman, William			Building a Better Nano-Biped	SCIENCE			English	Editorial Material							DNA; TRANSPORT; WALKING; DEVICE		Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Sherman, W (corresponding author), Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA.	wsherman@bnl.gov	Sherman, William/B-4700-2008					Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; GREEN S, 2008, PHYS REV LETT, V101, P238; Hess H, 2005, NANO LETT, V5, P629, DOI 10.1021/nl0478427; Kumara MT, 2008, NANO LETT, V8, P1971, DOI 10.1021/nl800907y; Liao SP, 2004, SCIENCE, V306, P2072, DOI 10.1126/science.1104299; Omabegho T, 2009, SCIENCE, V324, P67, DOI 10.1126/science.1170336; Pei R, 2006, J AM CHEM SOC, V128, P12693, DOI 10.1021/ja058394n; Sahu S, 2008, NANO LETT, V8, P3870, DOI 10.1021/nl802294d; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Sherman WB, 2004, NANO LETT, V4, P1203, DOI 10.1021/nl049527q; Shin JS, 2004, J AM CHEM SOC, V126, P10834, DOI 10.1021/ja047543j; Tian Y, 2005, ANGEW CHEM INT EDIT, V44, P4355, DOI 10.1002/anie.200500703; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	14	5	5	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 3	2009	324	5923					46	47		10.1126/science.1172136	http://dx.doi.org/10.1126/science.1172136			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342576				2022-12-28	WOS:000264802100024
J	Cantone, I; Marucci, L; Iorio, F; Ricci, MA; Belcastro, V; Bansal, M; Santini, S; di Bernardo, M; di Bernardo, D; Cosma, MP				Cantone, Irene; Marucci, Lucia; Iorio, Francesco; Ricci, Maria Aurelia; Belcastro, Vincenzo; Bansal, Mukesh; Santini, Stefania; di Bernardo, Mario; di Bernardo, Diego; Cosma, Maria Pia			A Yeast Synthetic Network for In Vivo Assessment of Reverse-Engineering and Modeling Approaches	CELL			English	Article							ASH1 MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; REGULATORY NETWORKS; CELL-CYCLE; EXPRESSION PROFILES; ORDERED RECRUITMENT; ESCHERICHIA-COLI; GENE NETWORKS; BUDDING YEAST	Systems biology approaches are extensively used to model and reverse engineer gene regulatory networks from experimental data. Conversely, synthetic biology allows "de novo'' construction of a regulatory network to seed new functions in the cell. At present, the usefulness and predictive ability of modeling and reverse engineering cannot be assessed and compared rigorously. We built in the yeast Saccharomyces cerevisiae a synthetic network, IRMA, for in vivo "benchmarking'' of reverse-engineering and modeling approaches. The network is composed of five genes regulating each other through a variety of regulatory interactions; it is negligibly affected by endogenous genes, and it is responsive to small molecules. We measured time series and steady-state expression data after multiple perturbations. These data were used to assess state-of-the-art modeling and reverse-engineering techniques. A semiquantitative model was able to capture and predict the behavior of the network. Reverse engineering based on differential equations and Bayesian networks correctly inferred regulatory interactions from the experimental data.	[Cantone, Irene; Marucci, Lucia; Iorio, Francesco; Ricci, Maria Aurelia; Belcastro, Vincenzo; Bansal, Mukesh; di Bernardo, Diego; Cosma, Maria Pia] TIGEM, I-80131 Naples, Italy; [Marucci, Lucia; Santini, Stefania; di Bernardo, Mario; di Bernardo, Diego] Univ Naples Federico 2, Dept Syst & Comp Engn, I-80125 Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II	di Bernardo, D (corresponding author), TIGEM, I-80131 Naples, Italy.	dibernardo@tigem.it; cosma@tigem.it	di Bernardo, Mario/AAL-9311-2021; di Bernardo, Mario/I-2805-2012; di Bernardo, Diego/I-9440-2012; Marucci, Lucia/P-1582-2016; Cantone, Irene/AAB-1071-2020; Iorio, Francesco/H-3282-2019; Cosma, Maria Pia/E-8731-2015; di Bernardo, Diego/AAF-5881-2021; Iorio, Francesco/H-3284-2019	di Bernardo, Mario/0000-0002-2171-4745; di Bernardo, Diego/0000-0002-1911-7407; Marucci, Lucia/0000-0002-7553-6358; Cantone, Irene/0000-0002-8156-7126; Cosma, Maria Pia/0000-0003-4207-5097; di Bernardo, Diego/0000-0002-1911-7407; Iorio, Francesco/0000-0001-7063-8913; Belcastro, Vincenzo/0000-0003-3749-0018	EC; "Fondazione Telethon" Institutional; SEMM (European School of Molecular Medicine); Italian MIUR-FIRB ITALBIONET	EC(European CommissionEuropean Commission Joint Research Centre); "Fondazione Telethon" Institutional(Fondazione Telethon); SEMM (European School of Molecular Medicine); Italian MIUR-FIRB ITALBIONET(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by EC Framework 6 (COBIOS) and by a "Fondazione Telethon" Institutional grant to TIGEM; I.C. and M.B. were supported by SEMM (European School of Molecular Medicine). F.I. is part of the University of Salerno Ph.D. program. M.A.R. is part of University of Naples "Federico II" undergraduate program. V.B. is part of the Open University Ph.D. program and supported by Italian MIUR-FIRB ITALBIONET to D.d.B. We thank Graciana Diez-Roux, Andrea Ballabio, and Joerg Stelling for helping with the manuscript; Kim Nasmyth for providing the K2072 yeast strain; Mark Johnston for providing the YM4271 strain; and Susan Lindquist for providing Gateway vectors.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; ALON U, 2006, DESIGN PRINCIPLES BI, V10; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bhoite LT, 2001, GENE DEV, V15, P2457, DOI 10.1101/gad.921601; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; Cosma MP, 2004, EMBO REP, V5, P953, DOI 10.1038/sj.embor.7400251; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Della Gatta G, 2008, GENOME RES, V18, P939, DOI 10.1101/gr.073601.107; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Ferreiro JA, 2004, NUCLEIC ACIDS RES, V32, P1617, DOI 10.1093/nar/gkh324; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gonsalvez GB, 2003, RNA, V9, P1383, DOI 10.1261/rna.5120803; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hayete B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100118; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; Jona G, 2000, BBA-GENE STRUCT EXPR, V1491, P37, DOI 10.1016/S0167-4781(00)00016-6; Kaern M, 2003, ANNU REV BIOMED ENG, V5, P179, DOI 10.1146/annurev.bioeng.5.040202.121553; Khosla C, 2003, NAT REV DRUG DISCOV, V2, P1019, DOI 10.1038/nrd1256; KURAS L, 1995, FEBS LETT, V367, P15, DOI 10.1016/0014-5793(95)00528-H; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Liu Jingdong, 1993, Methods (Orlando), V5, P125, DOI 10.1006/meth.1993.1017; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; MELLOR J, 1990, EMBO J, V9, P4017, DOI 10.1002/j.1460-2075.1990.tb07623.x; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Nalley K, 2006, NATURE, V442, P1054, DOI 10.1038/nature05067; NASMYTH K, 1990, CELL, V62, P631, DOI 10.1016/0092-8674(90)90110-Z; NASMYTH K, 1987, CELL, V48, P579, DOI 10.1016/0092-8674(87)90236-4; OCONNELL KF, 1995, MOL CELL BIOL, V15, P1879; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Szallasi Z, 2006, SYST MOD CELL BIOL, DOI 10.7551/mitpress/9780262195485.001.0001.; Traven A, 2006, EMBO REP, V7, P496, DOI 10.1038/sj.embor.7400679; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Voth WP, 2007, EMBO J, V26, P4324, DOI 10.1038/sj.emboj.7601859; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448	44	278	286	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					172	181		10.1016/j.cell.2009.01.055	http://dx.doi.org/10.1016/j.cell.2009.01.055			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19327819	Bronze			2022-12-28	WOS:000264813300023
J	Sun, YX; Kucej, M; Fan, HY; Yu, H; Sun, QY; Zou, H				Sun, Yuxiao; Kucej, Martin; Fan, Heng-Yu; Yu, Hong; Sun, Qing-Yuan; Zou, Hui			Separase Is Recruited to Mitotic Chromosomes to Dissolve Sister Chromatid Cohesion in a DNA-Dependent Manner	CELL			English	Article							CELL-CYCLE; CLEAVAGE; ANAPHASE; SECURIN; PHOSPHORYLATION; COMPLEX; PROTEIN; ARMS; CTCF; LOCALIZATION	Sister chromatid separation is triggered by the separase-catalyzed cleavage of cohesin. This process is temporally controlled by cell-cycle-dependent factors, but its biochemical mechanism and spatial regulation remain poorly understood. We report that cohesin cleavage by human separase requires DNA in a sequence-nonspecific manner. Separase binds to DNA in vitro, but its proteolytic activity, measured by its autocleavage, is not stimulated by DNA. Instead, biochemical characterizations suggest that DNA mediates cohesin cleavage by bridging the interaction between separase and cohesin. In human cells, a fraction of separase localizes to the mitotic chromosome. The importance of the chromosomal DNA in cohesin cleavage is further demonstrated by the observation that the cleavage of the chromosome-associated cohesins is sensitive to nuclease treatment. Our observations explain why chromosome-associated cohesins are specifically cleaved by separase and the soluble cohesins are left intact in anaphase.	[Sun, Yuxiao; Kucej, Martin; Zou, Hui] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Yu, Hong] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Fan, Heng-Yu] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Baylor College of Medicine; Chinese Academy of Sciences; Institute of Zoology, CAS	Zou, H (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	hui.zou@utsouthwestern.edu		Kucej, Martin/0000-0001-9129-4216	Damon Runyon Cancer Foundation (DRS) [35-03]; American Cancer Society [RSG-04-171-01-CCG]; Welch Foundation [I-1594]; NIH [R01GM081466-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081466] Funding Source: NIH RePORTER	Damon Runyon Cancer Foundation (DRS); American Cancer Society(American Cancer Society); Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Lydia Chiu and Julie Covino for technical support, Hongtao Yu for helpful discussions, and Eric Olson for critical reading and comments of the manuscript. We also thank Hongtao Yu, David Pellman, and Stephen Taylor for generously providing the myc<INF>6</INF>-SCC1, separase-V5, and myc-separase stable cell lines, respectively. H.Z. is the Kenneth G. and Elaine A. Langone Scholar supported by the Damon Runyon Cancer Foundation (DRS-#35-03). This work is also supported by a Research Scholar Grant from the American Cancer Society (RSG-04-171-01-CCG), a research grant from the Welch Foundation (I-1594), and a NIH R01 grant (R01GM081466-02) to H.Z.	Akhmedov AT, 1999, J BIOL CHEM, V274, P38216, DOI 10.1074/jbc.274.53.38216; Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Bembenek JN, 2007, DEVELOPMENT, V134, P3837, DOI 10.1242/dev.011361; Chestukhin A, 2003, P NATL ACAD SCI USA, V100, P4574, DOI 10.1073/pnas.0730733100; Fan HY, 2006, CELL CYCLE, V5, P198, DOI 10.4161/cc.5.2.2321; Fousteri MI, 2000, EMBO J, V19, P1691, DOI 10.1093/emboj/19.7.1691; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Hirano M, 2006, MOL CELL, V21, P175, DOI 10.1016/j.molcel.2005.11.026; Hornig NCD, 2004, EMBO J, V23, P3144, DOI 10.1038/sj.emboj.7600303; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Huang XX, 2005, MOL BIOL CELL, V16, P4725, DOI 10.1091/mbc.E05-03-0190; Ivanov D, 2005, CELL, V122, P849, DOI 10.1016/j.cell.2005.07.018; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Mei JJ, 2001, CURR BIOL, V11, P1197, DOI 10.1016/S0960-9822(01)00325-6; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Nakajima M, 2007, J CELL SCI, V120, P4188, DOI 10.1242/jcs.011528; Nasmyth K, 2005, PHILOS T R SOC B, V360, P483, DOI 10.1098/rstb.2004.1604; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pfleghaar K, 2005, PLOS BIOL, V3, P2127, DOI 10.1371/journal.pbio.0030416; Rollins RA, 1999, GENETICS, V152, P577; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Sun YX, 2006, CELL CYCLE, V5, P2537, DOI 10.4161/cc.5.21.3407; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Waizenegger IC, 2002, CURR BIOL, V12, P1368, DOI 10.1016/S0960-9822(02)01073-4; Wang ZY, 2001, MOL ENDOCRINOL, V15, P1870, DOI 10.1210/me.15.11.1870; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zou H, 2002, FEBS LETT, V528, P246, DOI 10.1016/S0014-5793(02)03238-6; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	38	44	45	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					123	132		10.1016/j.cell.2009.01.040	http://dx.doi.org/10.1016/j.cell.2009.01.040			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345191	Green Accepted, Bronze			2022-12-28	WOS:000264813300019
J	DeAngelis, CD				DeAngelis, Catherine D.			The Roman Article: Read It Again-in the Same Journal	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DUPLICATE PUBLICATION					cathy.deangelis@jama-archives.org						DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1745, DOI 10.1001/jama.292.14.1745; FLANAGIN A, 2007, AMA MANUAL STYLE GUI, P148; MARTIN J, IMPACT DUPLICATE PUB; ROMAN G, 1985, JAMA-J AM MED ASSOC, V253, P2104, DOI 10.1001/jama.1985.03350380120034; Tramer MR, 1997, BMJ-BRIT MED J, V315, P635, DOI 10.1136/bmj.315.7109.635; von Elm E, 2004, JAMA-J AM MED ASSOC, V291, P974, DOI 10.1001/jama.291.8.974	6	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 1	2009	301	13					1382	1383		10.1001/jama.2009.401	http://dx.doi.org/10.1001/jama.2009.401			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426LM	19336717	Bronze			2022-12-28	WOS:000264709800031
J	Toor, R				Toor, Rachel			Me and My Fibroid	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												racheltoor@earthlink.net							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 25	2009	301	12					1208	1209		10.1001/jama.301.12.1208	http://dx.doi.org/10.1001/jama.301.12.1208			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423JO	19318642				2022-12-28	WOS:000264492800001
J	Kizhatil, K; Baker, SA; Arshavsky, VY; Bennett, V				Kizhatil, Krishnakumar; Baker, Sheila A.; Arshavsky, Vadim Y.; Bennett, Vann			Ankyrin-G Promotes Cyclic Nucleotide-Gated Channel Transport to Rod Photoreceptor Sensory Cilia	SCIENCE			English	Article							BRONCHIAL EPITHELIAL-CELLS; MEMBRANE-PROTEINS; LATERAL MEMBRANE; INITIAL SEGMENTS; SPECTRIN; REQUIRES; SUBUNIT; AXON; BETA(2)-SPECTRIN; CARDIOMYOCYTES	Cyclic nucleotide-gated (CNG) channels localize exclusively to the plasma membrane of photosensitive outer segments of rod photoreceptors where they generate the electrical response to light. Here, we report the finding that targeting of CNG channels to the rod outer segment required their interaction with ankyrin-G. Ankyrin-G localized exclusively to rod outer segments, coimmunoprecipitated with the CNG channel, and bound to the C-terminal domain of the channel beta 1 subunit. Ankyrin-G depletion in neonatal mouse retinas markedly reduced CNG channel expression. Transgenic expression of CNG channel beta-subunit mutants in Xenopus rods showed that ankyrin-G binding was necessary and sufficient for targeting of the beta 1 subunit to outer segments. Thus, ankyrin-G is required for transport of CNG channels to the plasma membrane of rod outer segments.	[Kizhatil, Krishnakumar; Bennett, Vann] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Baker, Sheila A.; Arshavsky, Vadim Y.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA	Duke University; Duke University	Bennett, V (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	benne012@mc.duke.edu	Kizhatil, Krish/AAR-5868-2021	Kizhatil, Krishnakumar/0000-0003-3755-6101; Baker, Sheila/0000-0002-0259-0652	NIH [EY12859]; Howard Hughes Medical Institute (HHMI); NATIONAL EYE INSTITUTE [P30EY005722, R01EY012859] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Hoffman for constructing the plasmids used in the study. V.Y.A. was funded by NIH grant EY12859. V.B. is an investigator of Howard Hughes Medical Institute (HHMI) and was funded by HHMI.	Ayalon G, 2008, CELL, V135, P1189, DOI 10.1016/j.cell.2008.10.018; Baker SA, 2008, J CELL BIOL, V183, P485, DOI 10.1083/jcb.200806009; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Huttl S, 2005, J NEUROSCI, V25, P130, DOI 10.1523/JNEUROSCI.3764-04.2005; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Jenkins PM, 2006, CURR BIOL, V16, P1211, DOI 10.1016/j.cub.2006.04.034; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Kizhatil K, 2009, EXP EYE RES, V88, P55, DOI 10.1016/j.exer.2008.09.022; Kondo H, 2004, INVEST OPHTH VIS SCI, V45, P4433, DOI 10.1167/iovs.04-0544; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; MADREPERLA SA, 1989, J CELL BIOL, V109, P1483, DOI 10.1083/jcb.109.4.1483; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matulef K, 2003, ANNU REV CELL DEV BI, V19, P23, DOI 10.1146/annurev.cellbio.19.110701.154854; Michalakis S, 2006, J BIOL CHEM, V281, P35156, DOI 10.1074/jbc.M606409200; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mohler PJ, 2004, J BIOL CHEM, V279, P40185, DOI 10.1074/jbc.M406018200; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Nguyen-Legros J, 2000, INT REV CYTOL, V196, P245; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Poetsch A, 2001, J BIOL CHEM, V276, P48009, DOI 10.1074/jbc.M108941200; Wiesner B, 1998, J CELL BIOL, V142, P473, DOI 10.1083/jcb.142.2.473; WOHLFART P, 1992, J BIOL CHEM, V267, P644; Zhang X, 1998, J BIOL CHEM, V273, P30785, DOI 10.1074/jbc.273.46.30785; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	29	58	62	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1614	1617		10.1126/science.1169789	http://dx.doi.org/10.1126/science.1169789			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299621	Green Accepted			2022-12-28	WOS:000264342300041
J	Barnaby, W				Barnaby, Wendy			Do nations go to war over water?	NATURE			English	Editorial Material							COOPERATION; CONFLICT					w.barnaby@btinternet.com						ALLAN JA, 2005, GOVT OPPOSITION, V40, P615; BARNABY W, 2002, PLAGUE MAKERS SECRET; *INT PAN CLIM CHAN, 2008, CLIM CHANG WAT; *UN WORLD WAT DEV, 2009, 3 UN WORLD WAT DEV; Yoffe S, 2003, J AM WATER RESOUR AS, V39, P1109, DOI 10.1111/j.1752-1688.2003.tb03696.x; Zeitoun M, 2007, WATER INT, V32, P105, DOI 10.1080/02508060708691968; [No title captured]	7	84	84	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 19	2009	458	7236					282	283		10.1038/458282a	http://dx.doi.org/10.1038/458282a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	420JH	19295588	Bronze			2022-12-28	WOS:000264285600017
J	Bibbins-Domingo, K; Pletcher, MJ; Lin, F; Vittinghoff, E; Gardin, JM; Arynchyn, A; Lewis, CE; Williams, OD; Hulley, SB				Bibbins-Domingo, Kirsten; Pletcher, Mark J.; Lin, Feng; Vittinghoff, Eric; Gardin, Julius M.; Arynchyn, Alexander; Lewis, Cora E.; Williams, O. Dale; Hulley, Stephen B.			Racial Differences in Incident Heart Failure among Young Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR MASS; DENSITY-LIPOPROTEIN CHOLESTEROL; HIGH BLOOD-PRESSURE; ATHEROSCLEROSIS RISK; LIFETIME RISK; RENAL-DISEASE; WORKING GROUP; HYPERTENSION; BLACK; HYPERTROPHY	Background The antecedents and epidemiology of heart failure in young adults are poorly understood. Methods We prospectively assessed the incidence of heart failure over a 20-year period among 5115 blacks and whites of both sexes who were 18 to 30 years of age at baseline. Using Cox models, we examined predictors of hospitalization or death from heart failure. Results Over the course of 20 years, heart failure developed in 27 participants (mean [+/- SD] age at onset, 39 +/- 6 years), all but 1 of whom were black. The cumulative incidence of heart failure before the age of 50 years was 1.1% (95% confidence interval [CI], 0.6 to 1.7) in black women, 0.9% (95% CI, 0.5 to 1.4) in black men, 0.08% (95% CI, 0.0 to 0.5) in white women, and 0% (95% CI, 0 to 0.4) in white men (P = 0.001 for the comparison of black participants and white participants). Among blacks, independent predictors at 18 to 30 years of age of heart failure occurring 15 years, on average, later included higher diastolic blood pressure (hazard ratio per 10.0 mm Hg, 2.1; 95% CI, 1.4 to 3.1), higher body-mass index (the weight in kilograms divided by the square of the height in meters) (hazard ratio per 5.7 units, 1.4; 95% CI, 1.0 to 1.9), lower high-density lipoprotein cholesterol (hazard ratio per 13.3 mg per deciliter [0.34 mmol per liter], 0.6; 95% CI, 0.4 to 1.0), and kidney disease (hazard ratio, 19.8; 95% CI, 4.5 to 87.2). Three quarters of those in whom heart failure subsequently developed had hypertension by the time they were 40 years of age. Depressed systolic function, as assessed on a study echocardiogram when the participants were 23 to 35 years of age, was independently associated with the development of heart failure 10 years, on average, later (hazard ratio for abnormal systolic function, 36.9; 95% CI, 6.9 to 198.3; hazard ratio for borderline systolic function, 3.5; 95% CI, 1.2 to 10.2). Myocardial infarction, drug use, and alcohol use were not associated with the risk of heart failure. Conclusions Incident heart failure before 50 years of age is substantially more common among blacks than among whites. Hypertension, obesity, and systolic dysfunction that are present before a person is 35 years of age are important antecedents that may be targets for the prevention of heart failure. (ClinicalTrials.govnumber, NCT00005130.)	[Bibbins-Domingo, Kirsten; Pletcher, Mark J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Bibbins-Domingo, Kirsten; Pletcher, Mark J.; Lin, Feng; Vittinghoff, Eric; Hulley, Stephen B.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Div Gen Med, San Francisco, CA 94143 USA; [Bibbins-Domingo, Kirsten] Univ Calif San Francisco, UCSF Ctr Vulnerable Populat, San Francisco Gen Hosp, San Francisco, CA 94143 USA; [Gardin, Julius M.] Hackensack Univ, Med Ctr, Dept Med, Hackensack, NJ USA; [Arynchyn, Alexander; Lewis, Cora E.; Williams, O. Dale] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Hackensack University Medical Center; University of Alabama System; University of Alabama Birmingham	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.				National Heart, Lung, and Blood Institute [N01-HC-95095, N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-45134, N01-HC-05187, N01-HC-45205, N01-HC-45204]; Robert Wood Johnson Amos Faculty Development Program; National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK078124]; University of California, San Francisco; Hellman Family Faculty Award; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC045134, N01HC005187, N01HC095095, N01HC048048, N01HC048050, N01HC048049, N01HC048047] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048050, R01HL048048, R01HL081257, R29HL048048, R01HL048049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078124] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert Wood Johnson Amos Faculty Development Program; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of California, San Francisco(University of California System); Hellman Family Faculty Award; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Heart, Lung, and Blood Institute (a diversity supplement to CARDIA contract N01-HC-95095), the Robert Wood Johnson Amos Faculty Development Program, and the National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK078124), and a University of California, San Francisco, Hellman Family Faculty Award (all to Dr. Bibbins-Domingo). The CARDIA study is supported by contracts from the National Heart, Lung, and Blood Institute (N01-HC-95095, N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-45134, N01-HC-05187, N01-HC-45205, and N01-HC-45204).	Bahrarni H, 2008, ARCH INTERN MED, V168, P2138, DOI 10.1001/archinte.168.19.2138; Bakris GL, 2003, ARCH INTERN MED, V163, P1555, DOI 10.1001/archinte.163.13.1555; Bibbins-Domingo K, 2006, ARCH INTERN MED, V166, P1396, DOI 10.1001/archinte.166.13.1396; Bleumink GS, 2004, EUR HEART J, V25, P1614, DOI 10.1016/j.ehj.2004.06.038; Cohn JN, 2002, J CARD FAIL, V8, P56, DOI 10.1054/jcaf.2002.32950; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Douglas JG, 2003, ARCH INTERN MED, V163, P525, DOI 10.1001/archinte.163.5.525; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; GARDIN JM, 1995, CIRCULATION, V92, P380, DOI 10.1161/01.CIR.92.3.380; Goldberg LR, 2006, CIRCULATION, V113, P2851, DOI 10.1161/CIRCULATIONAHA.105.600437; Gu QP, 2006, CIRCULATION, V113, P213, DOI 10.1161/CIRCULATIONAHA.105.542290; Haider AW, 2003, ANN INTERN MED, V138, P10, DOI 10.7326/0003-4819-138-1-200301070-00006; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Horio T, 2003, AM J HYPERTENS, V16, P938, DOI 10.1016/S0895-7061(03)01015-X; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; KALOGEROPOULOS A, ARCH INTERN IN PRESS; Kannel W B, 2000, Heart Fail Rev, V5, P167; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; KONSTAM MA, 1993, CIRCULATION, V88, P2277, DOI 10.1161/01.CIR.88.5.2277; LAUER MS, 1991, JAMA-J AM MED ASSOC, V266, P231, DOI 10.1001/jama.266.2.231; LAUER MS, 1991, J AM COLL CARDIOL, V18, P1287, DOI 10.1016/0735-1097(91)90549-O; Lee DS, 2007, HYPERTENSION, V50, P869, DOI 10.1161/HYPERTENSIONAHA.107.095380; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lewis CE, 2000, AM J EPIDEMIOL, V151, P1172, DOI 10.1093/oxfordjournals.aje.a010167; Liu K, 1996, CIRCULATION, V93, P60, DOI 10.1161/01.CIR.93.1.60; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; *NAT I ALC AB ALC, WHAT IS SAF LEV DRIN; Nunez E, 2005, HYPERTENSION, V45, P58, DOI 10.1161/01.HYP.0000149951.70491.4c; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Ostchega Y, 2008, AM J HYPERTENS, V21, P159, DOI 10.1038/ajh.2007.32; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Sarnak MJ, 2005, ANN INTERN MED, V142, P497, DOI 10.7326/0003-4819-142-7-200504050-00008; Schocken DD, 2008, CIRCULATION, V117, P2544, DOI 10.1161/CIRCULATIONAHA.107.188965; Stehman-Breen CO, 2003, J AM SOC NEPHROL, V14, P2352, DOI 10.1097/01.ASN.0000083392.11042.14; Struthers AD, 2002, LANCET, V359, P1430, DOI 10.1016/S0140-6736(02)08358-7; Victor RG, 2008, ARCH INTERN MED, V168, P1285, DOI 10.1001/archinte.168.12.1285; Wang TJ, 2003, ANN INTERN MED, V138, P907, DOI 10.7326/0003-4819-138-11-200306030-00012; Wright JT, 2005, JAMA-J AM MED ASSOC, V293, P1595, DOI 10.1001/jama.293.13.1595; Yancy CW, 2005, AM J CARDIOL, V96, p3I, DOI 10.1016/j.amjcard.2005.07.028; 2005, MMWR MORB MORTAL WKL, V54, P7	46	379	380	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2009	360	12					1179	1190		10.1056/NEJMoa0807265	http://dx.doi.org/10.1056/NEJMoa0807265			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420IU	19297571	Green Accepted, Bronze			2022-12-28	WOS:000264283400004
J	Lee, SJR; Escobedo-Lozoya, Y; Szatmari, EM; Yasuda, R				Lee, Seok-Jin R.; Escobedo-Lozoya, Yasmin; Szatmari, Erzsebet M.; Yasuda, Ryohei			Activation of CaMKII in single dendritic spines during long-term potentiation	NATURE			English	Article							PROTEIN-KINASE-II; YELLOW FLUORESCENT PROTEIN; RESONANCE ENERGY-TRANSFER; CA2+ CHANNELS; SYNAPTIC PLASTICITY; LTP; INDUCTION; NEURONS; RAS; PHOSPHORYLATION	Calcium/calmodulin-dependent kinase II (CaMKII) plays a central part in long-term potentiation (LTP), which underlies some forms of learning and memory. Here we monitored the spatiotemporal dynamics of CaMKII activation in individual dendritic spines during LTP using two-photon fluorescence lifetime imaging microscopy, in combination with two-photon glutamate uncaging. Induction of LTP and associated spine enlargement in single spines triggered transient (similar to 1 min) CaMKII activation restricted to the stimulated spines. CaMKII in spines was specifically activated by NMDA receptors and L-type voltage-sensitive calcium channels, presumably by nanodomain Ca2+ near the channels, in response to glutamate uncaging and depolarization, respectively. The high degree of compartmentalization and channel specificity of CaMKII signalling allow stimuli-specific spatiotemporal patterns of CaMKII signalling and may be important for synapse-specificity of synaptic plasticity.	[Lee, Seok-Jin R.; Escobedo-Lozoya, Yasmin; Szatmari, Erzsebet M.; Yasuda, Ryohei] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Yasuda, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	yasuda@neuro.duke.edu	Yasuda, Ryohei/E-7726-2011	Yasuda, Ryohei/0000-0001-6263-9297	Burroughs Wellcome Fund; Dana Foundation; Alfred P. Sloan Foundation; Autism Speaks; National Alliance of Autism Research; Whitehall Foundation; Alzheimer's Association; National Institute of Mental Health [R01MH08004]; National Science Foundation [0642000]; Duke University Undergraduate Research Support Grants; Howard Hughes Neuroscience Forum Fellowship; Ruth K. Broad Biomedical Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080047] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Dana Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Autism Speaks; National Alliance of Autism Research; Whitehall Foundation; Alzheimer's Association(Alzheimer's Association); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); Duke University Undergraduate Research Support Grants; Howard Hughes Neuroscience Forum Fellowship; Ruth K. Broad Biomedical Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank H. Murakoshi for purified mEGFP and technical advice, Y. Hayashi for complementary DNAs and shRNA, A. Wang for cultured slices, T. Zimmerman and D. Kloetzer for laboratory management, and M. Ehlers, C. Harvey, J. Lisman, M. Patterson, S. Raghavachari, K. Svoboda, R. Weinberg and H. Zhong for comments on the manuscript. This study was funded by Burroughs Wellcome Fund, Dana Foundation, Alfred P. Sloan Foundation, Autism Speaks, National Alliance of Autism Research, Whitehall Foundation, Alzheimer's Association, National Institute of Mental Health (R01MH08004), National Science Foundation (0642000), Duke University Undergraduate Research Support Grants (S.- J. R. L.), Howard Hughes Neuroscience Forum Fellowship (S.- J. R. L.), and Ruth K. Broad Biomedical Research Foundation (E.M.S.).	Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Chen HX, 2001, J NEUROPHYSIOL, V85, P1368, DOI 10.1152/jn.2001.85.4.1368; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Conti R, 2002, HIPPOCAMPUS, V12, P667, DOI 10.1002/hipo.10096; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; FUKUNAGA K, 1995, J BIOL CHEM, V270, P6119, DOI 10.1074/jbc.270.11.6119; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; Kwok S, 2008, BIOCHEM BIOPH RES CO, V369, P519, DOI 10.1016/j.bbrc.2008.02.070; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MCALLISTER AK, 2000, SCI STKE, pPL1; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Ohno M, 2002, CURR BIOL, V12, P654, DOI 10.1016/S0960-9822(02)00767-4; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Remy S, 2007, P NATL ACAD SCI USA, V104, P17192, DOI 10.1073/pnas.0707919104; Rosenberg OS, 2006, FEBS J, V273, P682, DOI 10.1111/j.1742-4658.2005.05088.x; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; YASUDA R, 2004, SCI STKE, pPL5; Yasuda R, 2006, CURR OPIN NEUROBIOL, V16, P551, DOI 10.1016/j.conb.2006.08.012; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	45	458	464	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					299	U58		10.1038/nature07842	http://dx.doi.org/10.1038/nature07842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19295602	Green Accepted			2022-12-28	WOS:000264285600033
J	Piot, P; Kazatchkine, M; Dybul, M; Lob-Levyt, J				Piot, Peter; Kazatchkine, Michel; Dybul, Mark; Lob-Levyt, Julian			AIDS: lessons learnt and myths dispelled	LANCET			English	Editorial Material							HIV PREVENTION; IMMUNITY; VACCINE; STEP		[Kazatchkine, Michel] Global Fund Fight AIDS TB & Malaria, CH-1214 Geneva, Switzerland; [Piot, Peter] Bill & Melinda Gates Fdn, Seattle, WA USA; [Piot, Peter] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth, London, England; [Lob-Levyt, Julian] GAVI Alliance, Geneva, Switzerland; [Dybul, Mark] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC USA	Bill & Melinda Gates Foundation; Imperial College London; Georgetown University	Kazatchkine, M (corresponding author), Global Fund Fight AIDS TB & Malaria, Chemin Blandonnet 8, CH-1214 Geneva, Switzerland.	michel.kazatchkine@theglobalfund.org						Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bertozzi SM, 2008, LANCET, V372, P831, DOI 10.1016/S0140-6736(08)60889-2; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Commision on AIDS in Asia, 2008, RED AIDS AS CRAFT EF; Gouws E, 2006, SEX TRANSM INFECT, V82, pIII51, DOI 10.1136/sti.2006.020164; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Merson MH, 2008, LANCET, V372, P475, DOI 10.1016/S0140-6736(08)60884-3; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Piot P, 2007, AM J PUBLIC HEALTH, V97, P1934, DOI 10.2105/AJPH.2007.121418; PRICE JE, 2007, HIV IMPL M KIG RWAND; STONEBURNER R, 2006, 16 INT AIDS C TOR; The Global Fund, 2007, PARTN IMP RES REP; UNAIDS, 2009, WHAT COUNTR NEED INV; *UNAIDS WHO, 2007, AIDS EP UPD 2007; WHO UNAIDS UNICEF, 2008, UN ACC SCAL PRIOR HI; World Health Organization, 2008, GLOB BURD DIS 2004 U	17	55	56	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2009	374	9685					260	263		10.1016/S0140-6736(09)60321-4	http://dx.doi.org/10.1016/S0140-6736(09)60321-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	474DP	19303630				2022-12-28	WOS:000268263000035
J	Monfils, MH; Cowansage, KK; Klann, E; LeDoux, JE				Monfils, Marie-H.; Cowansage, Kiriana K.; Klann, Eric; LeDoux, Joseph E.			Extinction-Reconsolidation Boundaries: Key to Persistent Attenuation of Fear Memories	SCIENCE			English	Article							CONDITIONED FEAR; RECEPTOR TRAFFICKING; CONTEXTUAL CONTROL; EXPOSURE; CONSOLIDATION; MECHANISMS; PROTEIN; RETURN; REDUCTION; RESPONSES	Dysregulation of the fear system is at the core of many psychiatric disorders. Much progress has been made in uncovering the neural basis of fear learning through studies in which associative emotional memories are formed by pairing an initially neutral stimulus (conditioned stimulus, CS; e. g., a tone) to an unconditioned stimulus (US; e. g., a shock). Despite recent advances, the question of how to persistently weaken aversive CS-US associations, or dampen traumatic memories in pathological cases, remains a major dilemma. Two paradigms (blockade of reconsolidation and extinction) have been used in the laboratory to reduce acquired fear. Unfortunately, their clinical efficacy is limited: Reconsolidation blockade typically requires potentially toxic drugs, and extinction is not permanent. Here, we describe a behavioral design in which a fear memory in rats is destabilized and reinterpreted as safe by presenting an isolated retrieval trial before an extinction session. This procedure permanently attenuates the fear memory without the use of drugs.	[Monfils, Marie-H.; Cowansage, Kiriana K.; Klann, Eric; LeDoux, Joseph E.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Monfils, Marie-H.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [LeDoux, Joseph E.] NYU, Dept Psychol, New York, NY 10003 USA; [LeDoux, Joseph E.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; [LeDoux, Joseph E.] NYU, Emot Brain Inst, New York, NY 10003 USA	New York University; University of Texas System; University of Texas Austin; New York University; Nathan Kline Institute for Psychiatric Research; New York University	Monfils, MH (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	monfils@mail.utexas.edu	Monfils, Marie/F-1282-2013	Monfils, Marie-H./0000-0001-8971-6651; Cowansage, Kiriana/0000-0002-1681-686X	NIH [R37 MH038774, P50 MH058911, R01 MH046516, K05 MH067048, NS034007, NS047384, F31MH083472]; postdoctoral fellowships from the Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038774, R01MH091147, F31MH083472, R01MH046516, P50MH058911, K05MH067048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047384, R01NS034007, R29NS034007, R37NS034007] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); postdoctoral fellowships from the Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH grants R37 MH038774, P50 MH058911, R01 MH046516, and K05 MH067048 (J.E.L.); NIH grants NS034007 and NS047384 (E.K.); postdoctoral fellowships from the Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research, and Alberta Heritage Foundation for Medical Research (M.-H.M.); and NIH doctoral fellowship F31MH083472 (K.K.C.). We thank K. Nader, M. Davis, C. Cain, J. Johansen, D. Schiller, and G. Quirk and members of his lab for helpful comments.	Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; BLACKSTONE C, 1994, J NEUROSCI, V14, P7585; BOUTON ME, 1979, J EXP PSYCHOL ANIM B, V5, P368, DOI 10.1037/0097-7403.5.4.368; BOUTON ME, 1979, LEARN MOTIV, V10, P445, DOI 10.1016/0023-9690(79)90057-2; Cain CK, 2003, J EXP PSYCHOL ANIM B, V29, P323, DOI 10.1037/0097-7403.29.4.323; Debiec J, 2004, NEUROSCIENCE, V129, P267, DOI 10.1016/j.neuroscience.2004.08.018; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; Effting M, 2007, BEHAV RES THER, V45, P2002, DOI 10.1016/j.brat.2007.02.011; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; HELLSTROM K, 1995, BEHAV RES THER, V33, P959, DOI 10.1016/0005-7967(95)00028-V; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Hupbach A, 2007, LEARN MEMORY, V14, P47, DOI 10.1101/lm.365707; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Lee JLC, 2006, J NEUROSCI, V26, P10051, DOI 10.1523/JNEUROSCI.2466-06.2006; Li SH, 2008, J EXP PSYCHOL-ANIM B, V34, P336, DOI 10.1037/0097-7403.34.3.336; Mamiya N, 2009, J NEUROSCI, V29, P402, DOI 10.1523/JNEUROSCI.4639-08.2009; Maren S, 2006, P NATL ACAD SCI USA, V103, P18020, DOI 10.1073/pnas.0608398103; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Myers KM, 2006, LEARN MEMORY, V13, P216, DOI 10.1101/lm.119806; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Pavlov I.P., 1927, CONDITIONED REFLEXES; Powers MB, 2004, J CONSULT CLIN PSYCH, V72, P448, DOI 10.1037/0022-006X.72.3.448; RESCORLA RA, 1975, J EXP PSYCHOL-ANIM B, V104, P88, DOI 10.1037/0097-7403.1.1.88; RICHARDSON R, 1982, AM J PSYCHOL, V95, P67, DOI 10.2307/1422660; ROBBINS SJ, 1990, J EXP PSYCHOL ANIM B, V16, P235, DOI 10.1037/0097-7403.16.3.235; Rowe MK, 1998, BEHAV RES THER, V36, P701, DOI 10.1016/S0005-7967(97)10016-X; Rowe MK, 1998, BEHAV RES THER, V36, P719, DOI 10.1016/S0005-7967(97)10017-1; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sangha S, 2003, J NEUROSCI, V23, P8034; Schiller D, 2008, LEARN MEMORY, V15, P394, DOI 10.1101/lm.909208; SQUIRE LR, 1981, ANNU REV PHARMACOL, V21, P323, DOI 10.1146/annurev.pa.21.040181.001543; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Tronson NC, 2006, NAT NEUROSCI, V9, P167, DOI 10.1038/nn1628; Westbrook FR, 2002, J EXP PSYCHOL-ANIM B, V28, P97, DOI 10.1037//0097-7403.28.1.97; Wolpe J., 1966, PRACTICE BEHAV THERA	36	642	680	0	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					951	955		10.1126/science.1167975	http://dx.doi.org/10.1126/science.1167975			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	445KD	19342552	Green Accepted			2022-12-28	WOS:000266048800043
J	Klin, A; Lin, DJ; Gorrindo, P; Ramsay, G; Jones, W				Klin, Ami; Lin, David J.; Gorrindo, Phillip; Ramsay, Gordon; Jones, Warren			Two-year-olds with autism orient to non-social contingencies rather than biological motion	NATURE			English	Article							PERCEPTION; FACE; AREA; RECOGNITION; FIXATION; DEFICITS; INFANTS	Typically developing human infants preferentially attend to biological motion within the first days of life(1). This ability is highly conserved across species(2,3) and is believed to be critical for filial attachment and for detection of predators(4). The neural underpinnings of biological motion perception are overlapping with brain regions involved in perception of basic social signals such as facial expression and gaze direction(5), and preferential attention to biological motion is seen as a precursor to the capacity for attributing intentions to others(6). However, in a serendipitous observation(7), we recently found that an infant with autism failed to recognize point-light displays of biological motion, but was instead highly sensitive to the presence of a non-social, physical contingency that occurred within the stimuli by chance. This observation raised the possibility that perception of biological motion may be altered in children with autism from a very early age, with cascading consequences for both social development and the lifelong impairments in social interaction that are a hallmark of autism spectrum disorders(8). Here we show that two-year-olds with autism fail to orient towards point-light displays of biological motion, and their viewing behaviour when watching these point-light displays can be explained instead as a response to non-social, physical contingencies-physical contingencies that are disregarded by control children. This observation has far-reaching implications for understanding the altered neurodevelopmental trajectory of brain specialization in autism(9).	[Klin, Ami; Lin, David J.; Gorrindo, Phillip; Ramsay, Gordon; Jones, Warren] Yale Univ, Sch Med, Yale Child Study Ctr, New Haven, CT 06519 USA; [Ramsay, Gordon] Haskins Labs Inc, New Haven, CT 06511 USA; [Jones, Warren] Yale Univ, Sch Med, Interdepartmental Neurosci Program, New Haven, CT 06520 USA	Yale University; Yale University; Haskins Laboratories; Yale University	Klin, A (corresponding author), Yale Univ, Sch Med, Yale Child Study Ctr, New Haven, CT 06519 USA.	ami.klin@yale.edu; warren.jones@yale.edu		Gorrindo, Phillip/0000-0002-0296-8790	National Institutes of Mental Health [U54-MH66494]; Autism Speaks; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH066494] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Autism Speaks; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant from the National Institutes of Mental Health (U54-MH66494), by Autism Speaks (piloting of methods), and by the Simons Foundation ( current methodological developments). We wish to thank the families of the children included in this study for their time and participation. We would also like to thank F. Shic for conceptual discussions and thoughts on methods. We would like to thank L. Dickholtz, A. Kord, L. Else and M. Campisi for their assistance in creating the biological motion stimuli. We also wish to thank K. Carr, A. Blank, A. Bhatt, S. Shultz and K. Knoch for their help in this research project, and our colleagues K. Chawarska, R. Paul and F. Volkmar for conceptual discussions and for their contributions to the clinical characterization of the samples.	Bidet-Caulet A, 2005, NEUROIMAGE, V28, P132, DOI 10.1016/j.neuroimage.2005.06.018; BLAKE R, 1993, PSYCHOL SCI, V4, P54, DOI 10.1111/j.1467-9280.1993.tb00557.x; Blake R, 2003, PSYCHOL SCI, V14, P151, DOI 10.1111/1467-9280.01434; BREDIN H, 2006, IET INT C VIS INF EN, P255; Chawarska K., 2008, AUTISM SPECTRUM DISO; CHEN PY, 2002, CORRELATION PARAMETR, P20; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Driver J, 2000, CURR BIOL, V10, pR731, DOI 10.1016/S0960-9822(00)00740-5; FOX R, 1982, SCIENCE, V218, P486, DOI 10.1126/science.7123249; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Hershey J, 2000, ADV NEUR IN, V12, P813; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Johnson MH, 2006, CURR BIOL, V16, pR376, DOI 10.1016/j.cub.2006.04.008; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Jokisch D, 2005, EUR J NEUROSCI, V21, P3439, DOI 10.1111/j.1460-9568.2005.04145.x; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; Jordan H, 2002, PSYCHOL SCI, V13, P162, DOI 10.1111/1467-9280.00429; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Klin A, 2003, PHILOS T R SOC B, V358, P345, DOI 10.1098/rstb.2002.1202; Klin A, 2008, DEVELOPMENTAL SCI, V11, P40, DOI 10.1111/j.1467-7687.2007.00608.x; LEIGH RJ, 1999, NEUROLOGY EYE MOVEME, P94; Neri P, 1998, NATURE, V395, P894, DOI 10.1038/27661; Omori E, 1996, INT J COMPARAT PSYCH, V9, P92; Oram MW, 1996, J NEUROPHYSIOL, V76, P109, DOI 10.1152/jn.1996.76.1.109; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; Pelphrey KA, 2005, CEREB CORTEX, V15, P1866, DOI 10.1093/cercor/bhi064; Rabiner L. R., 1978, DIGITAL PROCESSING S; Regolin L, 2000, ANIM COGN, V3, P53, DOI 10.1007/s100710050050; Reid VM, 2006, NEUROSCI LETT, V395, P211, DOI 10.1016/j.neulet.2005.10.080; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; Tchorz J, 2002, SPEECH COMMUN, V38, P1, DOI 10.1016/S0167-6393(01)00040-1; Thompson JC, 2005, J NEUROSCI, V25, P9059, DOI 10.1523/JNEUROSCI.2129-05.2005; Vallortigara G, 2005, PLOS BIOL, V3, P1312, DOI 10.1371/journal.pbio.0030208; Volkmar FR, 2004, J CHILD PSYCHOL PSYC, V45, P135, DOI 10.1046/j.0021-9630.2003.00317.x; VONCOLLANI E, 2001, BINOMIAL DISTRIBUTIO, P182	36	521	539	5	155	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					257	U142		10.1038/nature07868	http://dx.doi.org/10.1038/nature07868			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	445FR	19329996	Green Accepted			2022-12-28	WOS:000266036100042
J	Brownell, KD; Frieden, TR				Brownell, Kelly D.; Frieden, Thomas R.			Ounces of Prevention - The Public Policy Case for Taxes on Sugared Beverages	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							METAANALYSIS; CONSUMPTION		[Brownell, Kelly D.] Yale Univ, Rudd Ctr Food Policy & Obes, New Haven, CT 06520 USA	Yale University	Brownell, KD (corresponding author), Yale Univ, Rudd Ctr Food Policy & Obes, New Haven, CT 06520 USA.			Frieden, Thomas/0000-0002-4759-2256				Forshee RA, 2008, AM J CLIN NUTR, V87, P1662, DOI 10.1093/ajcn/87.6.1662; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005; Nielson SJ, 2005, AM J PREV MED, V28, P413, DOI 10.1016/j.amepre.2005.03.007; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; 2008, BEVERAGE DIGEST 1121, P3	6	303	309	0	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 30	2009	360	18					1805	1808		10.1056/NEJMp0902392	http://dx.doi.org/10.1056/NEJMp0902392			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	438MU	19357400	Bronze			2022-12-28	WOS:000265560300001
J	Reid, DM; Devogelaer, JP; Saag, K; Roux, C; Lau, CS; Reginster, JY; Papanastasiou, P; Ferreira, A; Hartl, F; Fashola, T; Mesenbrink, P; Sambrook, PN				Reid, David M.; Devogelaer, Jean-Pierre; Saag, Kenneth; Roux, Christian; Lau, Chak-Sing; Reginster, Jean-Yves; Papanastasiou, Philemon; Ferreira, Alberto; Hartl, Florian; Fashola, Taiwo; Mesenbrink, Peter; Sambrook, Philip N.		HORIZON Investigators	Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial	LANCET			English	Article							CORTICOSTEROID-INDUCED OSTEOPOROSIS; ORAL CORTICOSTEROIDS; VERTEBRAL FRACTURE; BISPHOSPHONATE THERAPY; BONE-DENSITY; ALENDRONATE; WOMEN; EPIDEMIOLOGY; PERSISTENCE; SAFETY	Background Persistent use of glucocorticoid drugs is associated with bone loss and increased fracture risk. Concurrent oral bisphosphonates increase bone mineral density and reduce frequency of vertebral fractures, but are associated with poor compliance and adherence. We aimed to assess whether one intravenous infusion of zoledronic acid was non-inferior to daily oral risedronate for prevention and treatment of glucocorticoid-induced osteoporosis. Methods This 1-year randomised, double-blind, double-dummy, non-inferiority study of 54 centres in 12 European countries, Australia, Hong Kong, Israel, and the USA, tested the effectiveness of 5 mg intravenous infusion of zoledronic acid versus 5 mg oral risedronate for prevention and treatment of glucocorticoid-induced osteoporosis. 833 patients were randomised 1:1 to receive zoledronic acid (n=416) or risedronate (n=417). Patients were stratified by sex, and allocated to prevention or treatment subgroups dependent on duration of glucocorticoid use immediately preceding the study. The treatment subgroup consisted of those treated for more than 3 months (272 patients on zoledronic acid and 273 on risedronate), and the prevention subgroup of those treated for less than 3 months (144 patients on each drug). 62 patients did not complete the study because of adverse events, withdrawal of consent, loss to follow-up, death, misrandomisation, or protocol deviation. The primary endpoint was percentage change from baseline in lumbar spine bone mineral density. Drug efficacy was assessed on a modified intention-to-treat basis and safety was assessed on an intention-to-treat basis. This trial is registered with ClinicalTrials.gov, number NCT00100620. Findings Zoledronic acid was non-inferior and superior to risedronate for increase of lumbar spine bone mineral density in both the treatment (least-squares mean 4.06% [SE 0.28] vs 2.71% [SE 0.28], mean difference 1.36% [95% CI 0.67-2.05], p=0.0001) and prevention (2.60% [0.45] vs 0.64% [0.46], 1.96% [1.04-2.88], p<0.0001) subgroups at 12 months. Adverse events were more frequent in patients given zoledronic acid than in those on risedronate, largely as a result of transient symptoms during the first 3 days after infusion. Serious adverse events were worsening rheumatoid arthritis for the treatment subgroup and pyrexia for the prevention subgroup. Interpretation A single 5 mg intravenous infusion of zoledronic acid is non-inferior, possibly more effective, and more acceptable to patients than is 5 mg of oral risedronate daily for prevention and treatment of bone loss that is associated with glucocorticoid. use.	[Reid, David M.] Univ Aberdeen, Sch Med, Aberdeen AB25 2ZD, Scotland; [Devogelaer, Jean-Pierre] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Saag, Kenneth] Univ Alabama Birmingham, Birmingham, AL USA; [Roux, Christian] Paris Descartes Univ, Paris, France; [Lau, Chak-Sing] Univ Dundee, Dundee, Scotland; [Reginster, Jean-Yves] Univ Liege, Liege, Belgium; [Papanastasiou, Philemon; Ferreira, Alberto; Fashola, Taiwo] Novartis Pharma AG, Basel, Switzerland; [Hartl, Florian] F Hoffman LaRoche AG, Basel, Switzerland; [Mesenbrink, Peter] Novartis Pharmaceut, E Hanover, NJ USA; [Sambrook, Philip N.] Univ Sydney, Sydney, NSW 2006, Australia	University of Aberdeen; Universite Catholique Louvain; University of Alabama System; University of Alabama Birmingham; UDICE-French Research Universities; Universite Paris Cite; University of Dundee; University of Liege; Novartis; Roche Holding; Novartis; University of Sydney	Reid, DM (corresponding author), Univ Aberdeen, Sch Med, Aberdeen AB25 2ZD, Scotland.	d.m.reid@abdn.ac.uk	Blanco, Francisco J./C-3192-2014	Blanco, Francisco J./0000-0001-9821-7635; Lau, Wallace Chak Sing/0000-0001-6698-8355; Lippuner, Kurt/0000-0002-7195-3779	Roche; Novartis; TMRI Scotland; Schering-Plough; Abbott; Amgen; Servier; Merck; Sharpe Dohme; Procter Gamble; Fonds National de Recherche Scientifique Medicale Belge; Aventis; Eli Lilly Co; TAP; GlaxoSmithKline; Bristol Myers Squibb; Merck, Sharpe Dohme; Rottapharm; Teva; Lilly; Australian National Health and Medical Research Council; Medical Research Council [U1475000001] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish	Roche(Roche Holding); Novartis(Novartis); TMRI Scotland; Schering-Plough(Merck & CompanySchering Plough Corporation); Abbott(Abbott Laboratories); Amgen(Amgen); Servier(Servier); Merck(Merck & Company); Sharpe Dohme; Procter Gamble(Procter & Gamble); Fonds National de Recherche Scientifique Medicale Belge(Fonds de la Recherche Scientifique - FNRS); Aventis(Sanofi-Aventis); Eli Lilly Co(Eli Lilly); TAP; GlaxoSmithKline(GlaxoSmithKline); Bristol Myers Squibb(Bristol-Myers Squibb); Merck, Sharpe Dohme(Merck & Company); Rottapharm; Teva(Teva Pharmaceutical Industries); Lilly(Eli Lilly); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	DMR has received consulting, advisory board, lecture fees, and any combination of the three from Pfizer, Novartis, Roche, Amgen, GlaxoSmithKline, and AstraZeneca; has received grant support from Roche, Novartis, and TMRI Scotland; and has equity ownership or stock options in AstraZeneca and GlaxoSmithKline. J-PD has received consulting or advisory board fees from Novartis; lecture fees from Merck, Sharpe & Dohme, Procter & Gamble, Servier, and Roche; and grant support from Schering-Plough, Abbott, Amgen, Novartis, Servier, Merck, Sharpe & Dohme, Procter & Gamble, and Fonds National de Recherche Scientifique Medicale Belge. KS has received consulting or advisory board fees from Eli Lilly & Co, Merck, Novartis, Amgen, Roche, Procter & Gamble, and Aventis; lecture fees from Merck and Novartis; and grant support from Aventis, Eli Lilly & Co, Novartis, Amgen, Roche, TAP, and GlaxoSmithKline. CR has received consulting, advisory board, or lecture fees from Merck, Sharpe & Dohme, Servier, Novartis, Roche, Alliance, Amgen, and Nycomed. C-SL has received consulting or advisory board fees from Novartis, Merck, Sharpe & Dohme, Aventis, and Centocor; and lecture fees from Aspreva, Merck, and Sharpe & Dohme. J-YR has received consulting, advisory board, or lecture fees, or a combination of the three from Servier, Novartis, Negma, Lilly, Wyeth, Amgen, GlaxoSmithKline, Roche, Merckle, Nycomed, NPS, Theramex, UCB, Merck, Sharpe & Dohme, Rottapharm, IBSA, Genevrier, Teijin, Teva, Ebewee Pharma, Zodiac, Analis, Theramex, Nycomed, and Novo Nordisk; and grant support from Bristol Myers Squibb, Merck, Sharpe & Dohme, Rottapharm, Teva, Lilly, Novartis, Roche, GlaxoSmithKline, Amgen, and Servier. PP, AF, TF, and PM are employees of Novartis and own stock in Novartis. FH was an employee of Novartis during the study. PS received consulting or advisory board fees from Merck, Sanofi-Aventis, Servier, and Novartis; lecture fees from Roche; and grant support from the Australian National Health and Medical Research Council.	Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Briesacher BA, 2007, BONE, V41, P882, DOI 10.1016/j.bone.2007.07.009; Buckley L, 2001, ARTHRITIS RHEUM, V44, P1496; Canalis E, 2007, OSTEOPOROSIS INT, V18, P1319, DOI 10.1007/s00198-007-0394-0; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cohen S, 1999, ARTHRITIS RHEUM, V42, P2309, DOI 10.1002/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K; Cramer JA, 2007, OSTEOPOROSIS INT, V18, P1023, DOI 10.1007/s00198-006-0322-8; Cramer JA, 2006, CLIN THER, V28, P1686, DOI 10.1016/j.clinthera.2006.10.013; de Nijs RNJ, 2006, NEW ENGL J MED, V355, P675, DOI 10.1056/NEJMoa053569; Devogelaer JP, 2006, OSTEOPOROSIS INT, V17, P8, DOI 10.1007/s00198-005-2032-z; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Hamilton B, 2003, OSTEOPOROSIS INT, V14, P259, DOI 10.1007/s00198-002-1370-3; Hollis BW, 2004, J CLIN ENDOCR METAB, V89, P3149, DOI 10.1210/jc.2004-0682; Kanis JA, 2007, HEALTH TECHNOL ASSES, V11, P1; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; MELTON LJ, 1993, OSTEOPOROSIS INT, V3, P113, DOI 10.1007/BF01623271; *NORTHR GRUMM, 2003, MED DICT REG ACT MED; Reid DM, 2000, J BONE MINER RES, V15, P1006, DOI 10.1359/jbmr.2000.15.6.1006; Saag KG, 2007, NEW ENGL J MED, V357, P2028, DOI 10.1056/NEJMoa071408; Saag KG, 1998, NEW ENGL J MED, V339, P292, DOI 10.1056/NEJM199807303390502; Sambrook PN, 2003, J BONE MINER RES, V18, P919, DOI 10.1359/jbmr.2003.18.5.919; Seeman E, 2007, OSTEOPOROSIS INT, V18, P711, DOI 10.1007/s00198-006-0294-8; Siris ES, 2006, MAYO CLIN PROC, V81, P1013, DOI 10.4065/81.8.1013; Strampel W, 2007, DRUG SAFETY, V30, P755, DOI 10.2165/00002018-200730090-00003; van Staa TP, 2006, CALCIFIED TISSUE INT, V79, P129, DOI 10.1007/s00223-006-0019-1; van Staa TP, 2000, RHEUMATOLOGY, V39, P1383, DOI 10.1093/rheumatology/39.12.1383; Van Staa TP, 2003, ARTHRITIS RHEUM, V48, P3224, DOI 10.1002/art.11283; van Staa TP, 2002, OSTEOPOROSIS INT, V13, P777, DOI 10.1007/s001980200108; Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993; Wallach S, 2000, CALCIFIED TISSUE INT, V67, P277, DOI 10.1007/s002230001146; Walsh LJ, 1996, BRIT MED J, V313, P344, DOI 10.1136/bmj.313.7053.344; *WHO, ESS MED WHO MOD LIST; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	33	316	346	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2009	373	9671					1253	1263		10.1016/S0140-6736(09)60250-6	http://dx.doi.org/10.1016/S0140-6736(09)60250-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432PN	19362675				2022-12-28	WOS:000265146300028
J	Lee, GM; Craik, CS				Lee, Gregory M.; Craik, Charles S.			Trapping Moving Targets with Small Molecules	SCIENCE			English	Editorial Material							PROTEIN-PROTEIN INTERACTIONS; HIGH-AFFINITY LIGANDS; NMR-SPECTROSCOPY; ALLOSTERIC REGULATION; BINDING MODES; IN-VITRO; DYNAMICS; ANTAGONISTS; INHIBITORS; MECHANISM	Structure-based drug design traditionally uses static protein models as inspirations for focusing on "active" site targets. Allosteric regulation of biological macromolecules, however, is affected by both conformational and dynamic properties of the protein or protein complex and can potentially lead to more avenues for therapeutic development. We discuss the advantages of searching for molecules that conformationally trap a macromolecule in its inactive state. Although multiple methodologies exist to probe protein dynamics and ligand binding, our current discussion highlights the use of nuclear magnetic resonance spectroscopy in the drug discovery and design process.	[Lee, Gregory M.; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Craik, CS (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 600 16th St,Box 2280, San Francisco, CA 94158 USA.	craik@cgl.ucsf.edu			NIH [1R01A1067423]; HIV Accessory and Regulatory Complex Center [P50 GM082250]; UCSF-Gladstone Institute for Virology & Immunology/Center for AIDS Research Clinical Science Pilot Award [P30-AI027763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067423, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HIV Accessory and Regulatory Complex Center; UCSF-Gladstone Institute for Virology & Immunology/Center for AIDS Research Clinical Science Pilot Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by grants from the NIH (grant 1R01A1067423) and the HIV Accessory and Regulatory Complex Center (grant P50 GM082250). G.M.L. is a recipient of the 2007 2008 UCSF-Gladstone Institute for Virology & Immunology Center for AIDS Research Clinical Science Pilot Award (grant P30-AI027763). We also thank K. Dill, J. Gross, D. Hostetter, and T. Shahian for discussion and proofreading of this manuscript.	Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Babe LM, 1997, CELL, V91, P427, DOI 10.1016/S0092-8674(00)80426-2; Best JL, 2004, P NATL ACAD SCI USA, V101, P17622, DOI 10.1073/pnas.0406374101; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Caskey CT, 2007, ANNU REV MED, V58, P1, DOI 10.1146/annurev.med.58.042705.124037; D'Silva L, 2005, J AM CHEM SOC, V127, P13220, DOI 10.1021/ja052143x; De Francesco R, 2007, ADV DRUG DELIVER REV, V59, P1242, DOI 10.1016/j.addr.2007.04.016; DILL K, 1R01A1067423 NIH; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Golovanov AP, 2007, J AM CHEM SOC, V129, P6528, DOI 10.1021/ja070505q; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hornak V, 2007, DRUG DISCOV TODAY, V12, P132, DOI 10.1016/j.drudis.2006.12.011; Hu CQ, 2008, CURR MED CHEM, V15, P1720, DOI 10.2174/092986708784872375; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Martinez-Cajas JL, 2008, DRUGS, V68, P43, DOI 10.2165/00003495-200868010-00004; Martins S, 2008, CURR MED CHEM, V15, P1083, DOI 10.2174/092986708784221467; Masterson LR, 2008, J AM CHEM SOC, V130, P7818, DOI 10.1021/ja802701w; MOBLEY DL, STRUCTURE IN PRESS; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nomura AM, 2005, NAT STRUCT MOL BIOL, V12, P1019, DOI 10.1038/nsmb1006; O'Hare T, 2005, CANCER RES, V65, P4500, DOI 10.1158/0008-5472.CAN-05-0259; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Schanda P, 2008, J MOL BIOL, V380, P726, DOI 10.1016/j.jmb.2008.05.040; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Showalter SA, 2008, J AM CHEM SOC, V130, P6472, DOI 10.1021/ja800201j; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Sprangers R, 2007, NAT METHODS, V4, P697, DOI 10.1038/NMETH1080; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Tsai CJ, 1999, P NATL ACAD SCI USA, V96, P9970, DOI 10.1073/pnas.96.18.9970; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Verkhivker GM, 2002, CURR OPIN STRUC BIOL, V12, P197, DOI 10.1016/S0959-440X(02)00310-X; Volkman HM, 2005, J AM CHEM SOC, V127, P4649, DOI 10.1021/ja042761y; WEBER G, 1972, BIOCHEMISTRY-US, V11, P864, DOI 10.1021/bi00755a028; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526	41	131	135	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					213	215		10.1126/science.1169378	http://dx.doi.org/10.1126/science.1169378			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359579	Green Accepted			2022-12-28	WOS:000265024400035
J	Delamothe, T				Delamothe, Tony			On the Contrary What to cut	BRITISH MEDICAL JOURNAL			English	Editorial Material												tdelamothe@bmj.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2009	338								b1457	10.1136/bmj.b1457	http://dx.doi.org/10.1136/bmj.b1457			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	431ZH	19351681				2022-12-28	WOS:000265102800023
J	Altman, DG; Bland, JM				Altman, Douglas G.; Bland, J. Martin			Practice Statistics Notes Parametric v non-parametric methods for data analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Altman, Douglas G.] Univ Oxford, Wolfson Coll Annexe, Ctr Stat Med, Oxford OX2 6UD, England; [Bland, J. Martin] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of Oxford; University of York - UK	Altman, DG (corresponding author), Univ Oxford, Wolfson Coll Annexe, Ctr Stat Med, Oxford OX2 6UD, England.	doug.altman@csm.ox.ac.uk						Altman DG, 1999, BMJ-BRIT MED J, V318, P1667, DOI 10.1136/bmj.318.7199.1667; Bland JM, 1996, BRIT MED J, V312, P770; CAMPBELL MJ, 2000, STAT CONFIDENCE, P36	3	40	40	2	37	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2009	338								a3167	10.1136/bmj.a3167	http://dx.doi.org/10.1136/bmj.a3167			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429AO	19342403				2022-12-28	WOS:000264893400001
J	Cook-Deegan, R; Chandrasekharan, S; Angrist, M				Cook-Deegan, Robert; Chandrasekharan, Subhashini; Angrist, Misha			The dangers of diagnostic monopolies	NATURE			English	Editorial Material									[Cook-Deegan, Robert; Chandrasekharan, Subhashini; Angrist, Misha] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Duke University	Cook-Deegan, R (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA.	gelp@duke.edu		Cook-Deegan, Robert/0000-0002-8251-4237	NHGRI NIH HHS [P50 HG003391, P50 HG003391-050001] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		*ASS U TECHN MAN, 2007, PUBL INT 9 POINTS CO; Cho MK, 2003, J MOL DIAGN, V5, P3, DOI 10.1016/S1525-1578(10)60444-8; Henry MR, 2003, J LAW MED ETHICS, V31, P442, DOI 10.1111/j.1748-720X.2003.tb00107.x; Jensen K, 2005, SCIENCE, V310, P239, DOI 10.1126/science.1120014; *SECR ADV COMM GEN, 2009, PUBL CONS DRAF REP G; Walsh T, 2006, JAMA-J AM MED ASSOC, V295, P1379, DOI 10.1001/jama.295.12.1379; 2005, REAPING BENEFITS GEN	7	27	29	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					405	406		10.1038/458405a	http://dx.doi.org/10.1038/458405a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	423YJ	19325608	Green Accepted			2022-12-28	WOS:000264532400018
J	Kluger, N; Dereure, O				Kluger, Nicolas; Dereure, Olivier			Penile Papules	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kluger, Nicolas; Dereure, Olivier] CHU Montpellier, F-34295 Montpellier, France	Universite de Montpellier; CHU de Montpellier	Kluger, N (corresponding author), CHU Montpellier, F-34295 Montpellier, France.	nicolaskluger@yahoo.fr	Kluger, Nicolas/L-4220-2019	Kluger, Nicolas/0000-0002-5225-8316					0	0	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2009	360	13					1336	1336		10.1056/NEJMicm067654	http://dx.doi.org/10.1056/NEJMicm067654			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423VP	19321870				2022-12-28	WOS:000264524100009
J	Park, CM; Goo, JM				Park, Chang Min; Goo, Jin Mo			"Popcorn" Calcifications in a Pulmonary Chondroid Hamartoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Park, Chang Min; Goo, Jin Mo] Seoul Natl Univ Hosp, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital	Park, CM (corresponding author), Seoul Natl Univ Hosp, Seoul 110744, South Korea.	cmpark@radiol.snu.ac.kr	Goo, Jin Mo/AFT-4543-2022; Goo, Jin Mo/J-2732-2012						0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2009	360	12					E17	E17		10.1056/NEJMicm0708685	http://dx.doi.org/10.1056/NEJMicm0708685			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420IU	19297567				2022-12-28	WOS:000264283400011
J	Pollard, D; DeConto, RM				Pollard, David; DeConto, Robert M.			Modelling West Antarctic ice sheet growth and collapse through the past five million years	NATURE			English	Article							CLIMATE; SHELF; EVOLUTION; PARAMETERIZATION; RETREAT; FLOW	The West Antarctic ice sheet (WAIS), with ice volume equivalent to similar to 5 m of sea level(1), has long been considered capable of past and future catastrophic collapse(2-4). Today, the ice sheet is fringed by vulnerable floating ice shelves that buttress the fast flow of inland ice streams. Grounding lines are several hundred metres below sea level and the bed deepens upstream, raising the prospect of runaway retreat(3,5). Projections of future WAIS behaviour have been hampered by limited understanding of past variations and their underlying forcing mechanisms(6,7). Its variation since the Last Glacial Maximum is best known, with grounding lines advancing to the continental-shelf edges around similar to 15 kyr ago before retreating to near-modern locations by similar to 3 kyr ago(8). Prior collapses during the warmth of the early Pliocene epoch(9) and some Pleistocene interglacials have been suggested indirectly from records of sea level and deep-sea-core isotopes, and by the discovery of open-ocean diatoms in subglacial sediments(10). Until now(11), however, little direct evidence of such behaviour has been available. Here we use a combined ice sheet/ice shelf model(12) capable of high-resolution nesting with a new treatment of grounding-line dynamics and ice-shelf buttressing 5 to simulate Antarctic ice sheet variations over the past five million years. Modelled WAIS variations range from full glacial extents with grounding lines near the continental shelf break, intermediate states similar to modern, and brief but dramatic retreats, leaving only small, isolated ice caps on West Antarctic islands. Transitions between glacial, intermediate and collapsed states are relatively rapid, taking one to several thousand years. Our simulation is in good agreement with a new sediment record (ANDRILL AND-1B) recovered from the western Ross Sea(11), indicating a long-term trend from more frequently collapsed to more glaciated states, dominant 40-kyr cyclicity in the Pliocene, and major retreats at marine isotope stage 31 (similar to 1.07 Myr ago) and other super-interglacials.	[Pollard, David] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [DeConto, Robert M.] Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Massachusetts System; University of Massachusetts Amherst	Pollard, D (corresponding author), Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA.	pollard@essc.psu.edu			US National Science Foundation [ATM-0513402/0513421, ANT-034248, ANT-0424589]	US National Science Foundation(National Science Foundation (NSF))	We thank T. Naish and R. Powell for discussions on this work, and P. Barrett for comments on the manuscript. This work was funded by the US National Science Foundation under awards ATM-0513402/0513421, ANT-034248 and ANT-0424589.	Anderson J.B., 1999, ANTARCTIC MARINE GEO; Beckmann A, 2003, OCEAN MODEL, V5, P157, DOI 10.1016/S1463-5003(02)00019-7; Conway H, 1999, SCIENCE, V286, P280, DOI 10.1126/science.286.5438.280; Dinniman MS, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004036; Hearty PJ, 2007, QUATERNARY SCI REV, V26, P2090, DOI 10.1016/j.quascirev.2007.06.019; Hill DJ, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P517; Holland PR, 2008, J CLIMATE, V21, P2558, DOI 10.1175/2007JCLI1909.1; Hulbe C, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000603; Huybers P, 2008, NAT GEOSCI, V1, P787, DOI 10.1038/ngeo311; Huybrechts P, 2002, QUATERNARY SCI REV, V21, P203, DOI 10.1016/S0277-3791(01)00082-8; Huybrechts P., 1998, 3 EISMINT WORKSH MOD; Huybrechts P., 1993, GEOGR ANN A, V75, P221, DOI [10.2307/521202, DOI 10.1080/04353676.1993.11880395, DOI 10.2307/521202]; Kawamura K, 2007, NATURE, V448, P912, DOI 10.1038/nature06015; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Lisiecki LE, 2008, NATURE, V456, P85, DOI 10.1038/nature07425; Lythe MB, 2001, J GEOPHYS RES-SOL EA, V106, P11335, DOI 10.1029/2000JB900449; MACAYEAL DR, 1986, J GLACIOL, V32, P72, DOI 10.3189/S0022143000006900; Marshall SJ, 1999, CLIM DYNAM, V15, P533, DOI 10.1007/s003820050298; Mckay RM, 2008, PALAEOGEOGR PALAEOCL, V260, P245, DOI 10.1016/j.palaeo.2007.08.015; MERCER JH, 1978, NATURE, V271, P321, DOI 10.1038/271321a0; O'Brien PE, 2007, PALAEOGEOGR PALAEOCL, V245, P390, DOI 10.1016/j.palaeo.2006.09.002; Oppenheimer M, 2004, CLIMATIC CHANGE, V64, P1, DOI 10.1023/B:CLIM.0000024792.06802.31; Pattyn F, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000394; Philippon G, 2006, EARTH PLANET SC LETT, V248, P750, DOI 10.1016/j.epsl.2006.06.017; Pollard D, 2005, GLOBAL PLANET CHANGE, V45, P9, DOI 10.1016/j.gloplacha.2004.09.011; Pollard D, 2007, SPEC PUBL INT ASS SE, V39, P37; Ravelo AC, 2004, NATURE, V429, P263, DOI 10.1038/nature02567; RAYNAUD D, 2003, EARTHS CLIMATE ORBIT, V11, P27; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Ritz C, 2001, J GEOPHYS RES-ATMOS, V106, P31943, DOI 10.1029/2001JD900232; Scherer RP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032254; SCHERER RP, 1991, GLOBAL PLANET CHANGE, V90, P395, DOI 10.1016/0921-8181(91)90005-H; Schoof C, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000664; Shepherd A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021106; Weertman J., 1974, J GLACIOL, V13, P3, DOI [DOI 10.3189/S0022143000023327, 10.3189/S0022143000023327]	36	662	674	3	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					329	U89		10.1038/nature07809	http://dx.doi.org/10.1038/nature07809			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19295608				2022-12-28	WOS:000264285600039
J	Whittington, AG; Hofmeister, AM; Nabelek, PI				Whittington, Alan G.; Hofmeister, Anne M.; Nabelek, Peter I.			Temperature-dependent thermal diffusivity of the Earth's crust and implications for magmatism	NATURE			English	Article							HEAT; LEUKOGRANITES; CONDUCTIVITY; CONSTRAINTS; ANATEXIS; ORIGIN; MODEL	The thermal evolution of planetary crust and lithosphere is largely governed by the rate of heat transfer by conduction(1-3). The governing physical properties are thermal diffusivity (kappa) and conductivity (k=kappa rho C-P), where rho denotes density and C-P denotes specific heat capacity at constant pressure. Although for crustal rocks both kappa and k decrease above ambient temperature(4,5), most thermal models of the Earth's lithosphere assume constant values for kappa (similar to 1 mm(2) s(-1)) and/or k (similar to 3 to 5 W m(-1) K-1)(6,7) owing to the large experimental uncertainties associated with conventional contact methods at high temperatures. Recent advances in laser-flash analysis(8,9) permit accurate (+/- 2 per cent) measurements on minerals and rocks to geologically relevant temperatures(10). Here we provide data from laser-flash analysis for three different crustal rock types, showing that kappa strongly decreases from 1.5-2.5 mm(2) s(-1) at ambient conditions, approaching 0.5 mm(2) s(-1) at mid-crustal temperatures. The latter value is approximately half that commonly assumed, and hot middle to lower crust is therefore a much more effective thermal insulator than previously thought. Above the quartz alpha-beta phase transition, crustal kappa is nearly independent of temperature, and similar to that of mantle materials(11). Calculated values of k indicate that its negative dependence on temperature is smaller than that of kappa, owing to the increase of C-P with increasing temperature, but k also diminishes by 50 per cent from the surface to the quartz alpha-beta transition. We present models of lithospheric thermal evolution during continental collision and demonstrate that the temperature dependence of kappa and C-P leads to positive feedback between strain heating in shear zones and more efficient thermal insulation, removing the requirement for unusually high radiogenic heat production to achieve crustal melting temperatures. Positive feedback between heating, increased thermal insulation and partial melting is predicted to occur in many tectonic settings, and in both the crust and the mantle, facilitating crustal reworking and planetary differentiation(12).	[Whittington, Alan G.; Nabelek, Peter I.] Univ Missouri, Dept Geol Sci, Columbia, MO 65211 USA; [Hofmeister, Anne M.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA	University of Missouri System; University of Missouri Columbia; Washington University (WUSTL)	Whittington, AG (corresponding author), Univ Missouri, Dept Geol Sci, Columbia, MO 65211 USA.	whittingtona@missouri.edu	Hofmeister, Anne/ABH-6054-2020; Whittington, Alan/AAU-2361-2021	Whittington, Alan/0000-0003-2477-3043	US National Science Foundation	US National Science Foundation(National Science Foundation (NSF))	We thank M. Liu for providing the original version of the program OROGEN. This work was supported by the US National Science Foundation.	Annen C, 2006, J PETROL, V47, P505, DOI 10.1093/petrology/egi084; Branlund JM, 2008, AM MINERAL, V93, P1620, DOI 10.2138/am.2008.2821; Chapman D. S., 1992, CONTINENTAL LOWER CR, V23, P179; Degiovanni A., 1994, THERMAL CONDUCTIVITY, P623; ENGLAND P, 1993, GEOL SOC SP, V74, P401, DOI 10.1144/GSL.SP.1993.074.01.27; Harrison TM, 1998, J GEOPHYS RES-SOL EA, V103, P27017, DOI 10.1029/98JB02468; Hartz EH, 2008, GEOLOGY, V36, P331, DOI 10.1130/G24424A.1; Hofmann R., 1997, High Temperatures - High Pressures, V29, P703, DOI 10.1068/htrt115; Hofmeister AM, 2006, PHYS CHEM MINER, V33, P45, DOI 10.1007/s00269-005-0056-8; Hofmeister AM., 2007, MINERAL PHYS, P543; Hofmeister AM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026036; Hofmeister AM, 2008, EUR J MINERAL, V20, P537, DOI 10.1127/0935-1221/2008/0020-1814; Huerta AD, 1999, J METAMORPH GEOL, V17, P349; Jamieson RA, 1998, GEOL SOC SPEC PUBL, V138, P23, DOI 10.1144/GSL.SP.1996.138.01.03; LIU M, 1993, TECTONICS, V12, P776, DOI 10.1029/93TC00131; Michaut C, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004464; Mottaghy D, 2008, INT J EARTH SCI, V97, P435, DOI 10.1007/s00531-007-0238-3; Nabelek PI, 2004, T ROY SOC EDIN-EARTH, V95, P73, DOI 10.1017/S0263593300000936; Nabelek PI, 1999, GEOLOGY, V27, P523, DOI 10.1130/0091-7613(1999)027<0523:LITBHO>2.3.CO;2; PatinoDouce AE, 1998, J PETROL, V39, P689, DOI 10.1093/petroj/39.4.689; Pertermann M, 2008, CONTRIB MINERAL PETR, V155, P689, DOI 10.1007/s00410-007-0265-x; Pertermann M, 2006, AM MINERAL, V91, P1747, DOI 10.2138/am.2006.2105; Petitjean S, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001053; Robie R. A., 1979, USGS BULL, V1452, DOI DOI 10.3133/B2131; Schumacher S, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002429.2006; STEIN CA, 1992, NATURE, V359, P123, DOI 10.1038/359123a0; THOMSON W, 1999, SCIENCE, V9, P665; Turcotte DL, 2001, GEODYNAMICS, P132; Vosteen HD, 2003, PHYS CHEM EARTH, V28, P499, DOI 10.1016/S1474-7065(03)00069-X; Whittington AG, 2002, MINERAL MAG, V66, P53, DOI 10.1180/0026461026610015	30	321	328	5	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					319	321		10.1038/nature07818	http://dx.doi.org/10.1038/nature07818			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19295606				2022-12-28	WOS:000264285600037
J	Booth, GL				Booth, Gillian L.			Intensive and standard glucose control did not differ for major CV events or death in poorly controlled type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Toronto, St Michaels Hosp, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Booth, GL (corresponding author), Univ Toronto, St Michaels Hosp, Toronto, ON M5B 1W8, Canada.							[Anonymous], 2009, DIABETES CARE, V32, pS6, DOI 10.2337/dc09-S006; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987	6	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6							JC3-8	10.7326/0003-4819-150-6-200903170-02008	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423AJ	19306490				2022-12-28	WOS:000264468500031
J	Li, LJ; Gattass, RR; Gershgoren, E; Hwang, H; Fourkas, JT				Li, Linjie; Gattass, Rafael R.; Gershgoren, Erez; Hwang, Hana; Fourkas, John T.			Achieving lambda/20 Resolution by One-Color Initiation and Deactivation of Polymerization	SCIENCE			English	Article							2-PHOTON; LITHOGRAPHY; MICROSCOPY; NANOSCOPY	In conventional photolithography, diffraction limits the resolution to about one-quarter of the wavelength of the light used. We introduce an approach to photolithography in which multiphoton absorption of pulsed 800-nanometer (nm) light is used to initiate cross-linking in a polymer photoresist and one-photon absorption of continuous-wave 800-nm light is used simultaneously to deactivate the photopolymerization. By employing spatial phase-shaping of the deactivation beam, we demonstrate the fabrication of features with scalable resolution along the beam axis, down to a 40-nm minimum feature size. We anticipate application of this technique for the fabrication of diverse two- and three-dimensional structures with a feature size that is a small fraction of the wavelength of the light employed.	[Li, Linjie; Gattass, Rafael R.; Gershgoren, Erez; Fourkas, John T.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Hwang, Hana] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Fourkas, John T.] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Fourkas, John T.] Univ Maryland, Maryland NanoCtr, College Pk, MD 20742 USA; [Fourkas, John T.] Univ Maryland, Ctr Nanophys & Adv Mat, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Fourkas, JT (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.	fourkas@umd.edu	Hwang, Hana/B-3999-2011; li, linjie/C-7845-2009; Fourkas, John T/B-3500-2009	Fourkas, John T/0000-0002-4522-9584	UMD-NSF-MRSEC [DMR 05-20471]	UMD-NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We appreciate the support of the Maryland NanoCenter and its Nanoscale Imaging, Spectroscopy, and Properties Laboratory (NISPLab). NISPLab is supported in part by NSF as a Materials Research Science and Engineering Center (MRSEC) Shared Experimental Facility. This work was supported in part by the UMD-NSF-MRSEC under grant DMR 05-20471. We are grateful to E. Williams for the use of her AFM and to J. Goldhar, Y. Leng, and V. Yun for fabricating the phase mask used in this work. The University of Maryland has filed a provision patent based on the work presented in this paper.	BEIJERSBERGEN MW, 1994, OPT COMMUN, V112, P321, DOI 10.1016/0030-4018(94)90638-6; Colley CS, 2002, J AM CHEM SOC, V124, P14952, DOI 10.1021/ja026099m; Farrer RA, 2005, NANO LETT, V5, P1139, DOI 10.1021/nl050687r; Harke B, 2008, NANO LETT, V8, P1309, DOI 10.1021/nl073164n; Haske W, 2007, OPT EXPRESS, V15, P3426, DOI 10.1364/OE.15.003426; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Hirschfelder J. O., 1954, MOL THEORY GASES LIQ; Ito H, 2005, ADV POLYM SCI, V172, P37, DOI 10.1007/b97574; Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; LaFratta CN, 2007, ANGEW CHEM INT EDIT, V46, P6238, DOI 10.1002/anie.200603995; Rumi M, 2008, ADV POLYM SCI, V213, P1, DOI 10.1007/12_2008_133; Sun HB, 2003, APPL PHYS LETT, V83, P819, DOI 10.1063/1.1598293; Sun HB, 2002, APPL PHYS LETT, V80, P3673, DOI 10.1063/1.1478128; Tan DF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2535504; Thompson SE, 2006, MATER TODAY, V9, P20, DOI 10.1016/S1369-7021(06)71539-5; Xing JF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2717532; Yang D, 2005, MRS BULL, V30, P976, DOI 10.1557/mrs2005.251	19	384	406	12	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					910	913		10.1126/science.1168996	http://dx.doi.org/10.1126/science.1168996			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19359543				2022-12-28	WOS:000266048800030
J	Evan, AT; Vimont, DJ; Heidinger, AK; Kossin, JP; Bennartz, R				Evan, Amato T.; Vimont, Daniel J.; Heidinger, Andrew K.; Kossin, James P.; Bennartz, Ralf			The Role of Aerosols in the Evolution of Tropical North Atlantic Ocean Temperature Anomalies	SCIENCE			English	Article							SEA-SURFACE TEMPERATURE; SAHARAN DUST; VARIABILITY; TRANSPORT; PRODUCT; IMPACT; SST	Observations and models show that northern tropical Atlantic surface temperatures are sensitive to regional changes in stratospheric volcanic and tropospheric mineral aerosols. However, it is unknown whether the temporal variability of these aerosols is a key factor in the evolution of ocean temperature anomalies. We used a simple physical model, incorporating 26 years of satellite data, to estimate the temperature response of the ocean mixed layer to changes in aerosol loadings. Our results suggest that the mixed layer's response to regional variability in aerosols accounts for 69% of the recent upward trend, and 67% of the detrended and 5-year low pass-filtered variance, in northern tropical Atlantic Ocean temperatures.	[Evan, Amato T.] Univ Wisconsin, Cooperat Inst Meteorol Satellite Studies, Madison, WI 53706 USA; [Evan, Amato T.; Vimont, Daniel J.; Bennartz, Ralf] Univ Wisconsin, Dept Atmospher & Ocean Sci, Madison, WI 53706 USA; [Heidinger, Andrew K.] NOAA, NESDIS, Ctr Satellite Applicat & Res STAR, Madison, WI 53706 USA; [Kossin, James P.] NOAA, NESDIS, Natl Climat Data Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; National Oceanic Atmospheric Admin (NOAA) - USA; National Center Atmospheric Research (NCAR) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Evan, AT (corresponding author), Univ Wisconsin, Cooperat Inst Meteorol Satellite Studies, Madison, WI 53706 USA.	atevan@wisc.edu	Heidinger, Andrew/F-5591-2010; Evan, Amato/GZL-2684-2022; Kossin, James/C-2022-2016; Kossin, James/D-3929-2011; Bennartz, Ralf/F-3760-2010	Heidinger, Andrew/0000-0001-7631-109X; Evan, Amato/0000-0003-2812-3750; Kossin, James/0000-0003-0461-9794; Bennartz, Ralf/0000-0001-7133-9659	NOAA/NESDIS/STAR; Risk Prediction Initiative	NOAA/NESDIS/STAR(National Oceanic Atmospheric Admin (NOAA) - USA); Risk Prediction Initiative	We thank three anonymous reviewers for their constructive comments. Supported by grants from NOAA/NESDIS/STAR and Risk Prediction Initiative. The views, opinions, and findings contained in this report are those of the authors and should not be construed as an official NOAA or U.S. government position, policy, or decision.	Barnett TP, 2005, SCIENCE, V309, P284, DOI 10.1126/science.1112418; Chang P, 2000, J CLIMATE, V13, P2195, DOI 10.1175/1520-0442(2000)013<2195:TEOLSS>2.0.CO;2; Delworth TL, 2000, CLIM DYNAM, V16, P661, DOI 10.1007/s003820000075; Deser C, 2003, J CLIMATE, V16, P57, DOI 10.1175/1520-0442(2003)016<0057:UTPOSS>2.0.CO;2; Dunion JP, 2008, J CLIMATE, V21, P5242, DOI 10.1175/2008JCLI1868.1; Engelstaedter S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029971; Engelstaedter S, 2006, EARTH-SCI REV, V79, P73, DOI 10.1016/j.earscirev.2006.06.004; Evan AT, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001774; Evan AT, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006336; Foltz GR, 2008, J CLIMATE, V21, P5048, DOI 10.1175/2008JCLI2232.1; Foltz GR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027394; Foltz GR, 2006, J CLIMATE, V19, P6122, DOI 10.1175/JCLI3961.1; Foltz GR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035042; Goldenberg SB, 2001, SCIENCE, V293, P474, DOI 10.1126/science.1060040; Goudie AS, 2001, EARTH-SCI REV, V56, P179, DOI 10.1016/S0012-8252(01)00067-8; Holland GJ, 2007, PHILOS T R SOC A, V365, P2695, DOI 10.1098/rsta.2007.2083; Husar RB, 1997, J GEOPHYS RES-ATMOS, V102, P16889, DOI 10.1029/96JD04009; Kaufman YJ, 2005, P NATL ACAD SCI USA, V102, P11207, DOI 10.1073/pnas.0505191102; Mahowald NM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017880; Moulin C, 1997, NATURE, V387, P691, DOI 10.1038/42679; Prospero JM, 2003, SCIENCE, V302, P1024, DOI 10.1126/science.1089915; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Santer BD, 2006, P NATL ACAD SCI USA, V103, P13905, DOI 10.1073/pnas.0602861103; SATO M, 1993, J GEOPHYS RES-ATMOS, V98, P22987, DOI 10.1029/93JD02553; Stowe LL, 1997, J GEOPHYS RES-ATMOS, V102, P16923, DOI 10.1029/96JD02132; Trenberth KE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026894; Vecchi GA, 2007, NATURE, V450, P1066, DOI 10.1038/nature06423; Wong S, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032297; Yoshioka M, 2007, J CLIMATE, V20, P1445, DOI 10.1175/JCLI4056.1	29	135	139	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					778	781		10.1126/science.1167404	http://dx.doi.org/10.1126/science.1167404			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19325076				2022-12-28	WOS:000265832400044
J	Macosko, EZ; Pokala, N; Feinberg, EH; Chalasani, SH; Butcher, RA; Clardy, J; Bargmann, CI				Macosko, Evan Z.; Pokala, Navin; Feinberg, Evan H.; Chalasani, Sreekanth H.; Butcher, Rebecca A.; Clardy, Jon; Bargmann, Cornelia I.			A hub-and-spoke circuit drives pheromone attraction and social behaviour in C-elegans	NATURE			English	Article							CAENORHABDITIS-ELEGANS; NATURAL VARIATION; CHEMOSENSORY NEURONS; CHEMICAL REPELLENTS; NEUROPEPTIDE-Y; GENE; CHEMOTAXIS; INHIBITION; MODULATION; EXPRESSION	Innate social behaviours emerge from neuronal circuits that interpret sensory information on the basis of an individual's own genotype, sex and experience. The regulated aggregation behaviour of the nematode Caenorhabditis elegans, a simple animal with only 302 neurons, is an attractive system to analyse these circuits. Wild social strains of C. elegans aggregate in the presence of specific sensory cues, but solitary strains do not(1-4). Here we identify the RMG inter/motor neuron as the hub of a regulated circuit that controls aggregation and related behaviours. RMG is the central site of action of the neuropeptide receptor gene npr-1, which distinguishes solitary strains (high npr-1 activity) from wild social strains (low npr-1 activity); high RMG activity is essential for all aspects of social behaviour. Anatomical gap junctions connect RMG to several classes of sensory neurons known to promote aggregation, and to ASK sensory neurons, which are implicated in male attraction to hermaphrodite pheromones(5). We find that ASK neurons respond directly to pheromones, and that high RMG activity enhances ASK responses in social strains, causing hermaphrodite attraction to pheromones at concentrations that repel solitary hermaphrodites. The coordination of social behaviours by RMG suggests an anatomical hub-and-spoke model for sensory integration in aggregation, and points to functions for related circuit motifs in the C. elegans wiring diagram.	[Macosko, Evan Z.; Pokala, Navin; Feinberg, Evan H.; Chalasani, Sreekanth H.; Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, New York, NY 10065 USA; [Butcher, Rebecca A.; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Rockefeller University; Harvard University; Harvard Medical School	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, 1230 York Ave, New York, NY 10065 USA.	cori@rockefeller.edu	Macosko, Evan/X-4664-2019; Pokala, Navin/AAH-5719-2019	Pokala, Navin/0000-0003-2323-6190; Bargmann, Cornelia/0000-0002-8484-0618	Howard Hughes Medical Institute; Harold and Leila Y Mathers Charitable Foundation; Jensam Foundation; National Institute of Health [GM07739, CA24487, GM077943]; NATIONAL CANCER INSTITUTE [R01CA024487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, F32GM077943] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Harold and Leila Y Mathers Charitable Foundation; Jensam Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Looger for GCaMP2.2b, M. Nonet for cleavage-resistant synaptobrevin, and J. Ragains for synthesizing ascarosides. This work was funded by the Howard Hughes Medical Institute, the Harold and Leila Y Mathers Charitable Foundation, the Jensam Foundation, and National Institute of Health grants GM07739 (E.Z.M. and E. H. F.), CA24487 ( J. C.) and GM077943 ( R. A. B.). C. I. B. is an Investigator of the Howard Hughes Medical Institute.	BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1990, COLD SPRING HARB SYM, V55, P529; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; BRENNER S, 1974, GENETICS, V77, P71; Butcher RA, 2008, P NATL ACAD SCI USA, V105, P14288, DOI 10.1073/pnas.0806676105; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; Davies AG, 2004, NEURON, V42, P731, DOI 10.1016/j.neuron.2004.05.004; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hammock EAD, 2006, PHILOS T R SOC B, V361, P2187, DOI 10.1098/rstb.2006.1939; HART AC, 2006, WORMBOOK BEHAV; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Hodgkin J, 1997, GENETICS, V146, P149; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Okochi Y, 2005, EMBO J, V24, P2127, DOI 10.1038/sj.emboj.7600697; PLUMMER MR, 1991, J NEUROSCI, V11, P2339; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Suzuki H, 2008, NATURE, V454, P114, DOI 10.1038/nature06927; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; TOTH PT, 1993, NATURE, V364, P635, DOI 10.1038/364635a0; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; White JQ, 2007, CURR BIOL, V17, P1847, DOI 10.1016/j.cub.2007.09.011; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	40	309	313	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1171	U110		10.1038/nature07886	http://dx.doi.org/10.1038/nature07886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19349961	Green Accepted, Green Submitted			2022-12-28	WOS:000265754600048
J	Robson, WLM				Robson, W. Lane M.			Evaluation and Management of Enuresis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MONOSYMPTOMATIC NOCTURNAL ENURESIS; ORAL DESMOPRESSIN; BLADDER CAPACITY; INTRANASAL DESMOPRESSIN; CHILDREN; CONSTIPATION; SECONDARY; ADOLESCENTS; POLYURIA; SAFETY	The parents of an 8-year-old boy bring him to the pediatrician's office for evaluation of nightly bed-wetting. On half the nights, his urine soaks through a pair of absorbent disposable underpants into the sheets. He often does not void during school hours, and when he returns home after school, he usually rushes to the bathroom. He arrives home thirsty after school, and the majority of his daily fluid intake is in the 5 hours from 3: 30 p. m. to bedtime. His physical examination is normal, apart from hard stool palpated in the left lower quadrant. In the office he voids 170 ml of urine and has urgency at this volume (average functional capacity for his age, 300 ml). How should this boy be evaluated and treated?	Childrens Clin, Calgary, AB T3B 0M3, Canada		Robson, WLM (corresponding author), Childrens Clin, Suite 111,4411 16th Ave NW, Calgary, AB T3B 0M3, Canada.	wlmrobson@gmail.com						Bael AM, 2006, J UROLOGY, V176, P1596, DOI 10.1016/j.juro.2006.06.037; BONDE HV, 1994, SCAND J UROL NEPHROL, V28, P349, DOI 10.3109/00365599409180511; Butler RJ, 2008, SCAND J UROL NEPHROL, V42, P257, DOI 10.1080/00365590701748054; Butler RJ, 2007, SCAND J UROL NEPHROL, V41, P407, DOI 10.1080/00365590701571506; Byrd RS, 1996, PEDIATRICS, V98, P414; De Guchtenaere A, 2009, J UROLOGY, V181, P302, DOI 10.1016/j.juro.2008.09.040; Dehoorne JL, 2006, J UROLOGY, V176, P749, DOI 10.1016/S0022-5347(06)00297-7; Dehoorne JL, 2006, J UROLOGY, V176, P754, DOI 10.1016/S0022-5347(06)00299-0; Glazener C. M. A., 2005, COCHRANE DB SYST REV, V2; Glazener CM, 2003, COCHRANE DB SYST REV, V3; Glazener CM, 2002, COCHRANE DB SYST REV; Hagglof B, 1997, SCAND J UROL NEPHROL, V31, P79; HELLSTROM AL, 1987, J UROLOGY, V138, P847, DOI 10.1016/S0022-5347(17)43395-7; Joensson IM, 2008, J UROLOGY, V179, P1997, DOI 10.1016/j.juro.2008.01.055; KOFF SA, 1983, UROLOGY, V21, P248, DOI 10.1016/0090-4295(83)90079-1; Loening-Baucke V, 2006, PEDIATRICS, V118, P528, DOI 10.1542/peds.2006-0220; LoeningBaucke V, 1997, PEDIATRICS, V100, P228, DOI 10.1542/peds.100.2.228; Longstaffe S, 2000, PEDIATRICS, V105, P935; Lottmann H, 2007, INT J CLIN PRACT, V61, P1454, DOI 10.1111/j.1742-1241.2007.01493.x; McGrath KH, 2008, J PAEDIATR CHILD H, V44, P19, DOI 10.1111/j.1440-1754.2007.01207.x; Neveus T, 2006, SCAND J UROL NEPHROL, V40, P31, DOI 10.1080/00365590500407803; Neveus T, 2003, ACTA PAEDIATR, V92, P1118, DOI 10.1080/08035250310005837; Neveus T, 2000, SCAND J UROL NEPHROL, V34, P1; Neveus T, 2001, J UROLOGY, V166, P2459, DOI 10.1016/S0022-5347(05)65616-9; NEVEUS T, EVALUATION TREATMENT; Neveus T, 2008, PEDIATR NEPHROL, V23, P1201, DOI 10.1007/s00467-008-0859-1; Neveus T, 2008, PEDIATR NEPHROL, V23, P263, DOI 10.1007/s00467-007-0662-4; Neveus T, 2006, J UROLOGY, V176, P314, DOI 10.1016/S0022-5347(06)00305-3; NORGAARD JP, 1985, J UROLOGY, V134, P1029, DOI 10.1016/S0022-5347(17)47581-1; Nurko S, 2008, J PEDIATR, V153, P254, DOI 10.1016/j.jpeds.2008.01.039; Raes A, 2007, J UROLOGY, V178, P1048, DOI 10.1016/j.juro.2007.05.060; Robson WLM, 2007, J UROLOGY, V178, P24, DOI 10.1016/j.juro.2007.03.015; Robson WLM, 2000, CLIN PEDIATR, V39, P379, DOI 10.1177/000992280003900701; Robson WLM, 2005, PEDIATRICS, V115, P956, DOI 10.1542/peds.2004-1402; Robson WLM, 1996, EUR J PEDIATR, V155, P959, DOI 10.1007/BF02282887; Rushton HG, 1996, J UROLOGY, V156, P651, DOI 10.1016/S0022-5347(01)65775-6; Schulman SL, 2001, J UROLOGY, V166, P2427, DOI 10.1016/S0022-5347(05)65608-X; Skoog SJ, 1997, J UROLOGY, V158, P1035, DOI 10.1016/S0022-5347(01)64383-0; STENBERG A, 1994, PEDIATRICS, V94, P841; Van Hoeck KJ, 2007, J UROLOGY, V178, P2132, DOI 10.1016/j.juro.2007.07.051; Vande Walle JGJ, 2006, BJU INT, V97, P603, DOI 10.1111/j.1464-410X.2006.05999.x; Walle JV, 2007, J UROLOGY, V178, P2630, DOI 10.1016/j.juro.2007.08.029; Yeung CK, 1999, J UROLOGY, V162, P1049, DOI 10.1016/S0022-5347(01)68062-5	43	46	55	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2009	360	14					1429	1436		10.1056/NEJMcp0808009	http://dx.doi.org/10.1056/NEJMcp0808009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427AL	19339722				2022-12-28	WOS:000264751800008
J	Carlsson, F; Brown, EJ				Carlsson, Fredric; Brown, Eric J.			The Art of Making an Exit	SCIENCE			English	Editorial Material							ACTIN-BASED MOTILITY; MYCOBACTERIUM-MARINUM; SECRETION; TUBERCULOSIS; CYTOLYSIS; PATHOGENS; VIRULENCE; MOVEMENT		[Carlsson, Fredric; Brown, Eric J.] Genentech Inc, Microbial Pathogenesis, San Francisco, CA 94080 USA	Roche Holding; Genentech	Carlsson, F (corresponding author), Genentech Inc, Microbial Pathogenesis, 1 DNA Way, San Francisco, CA 94080 USA.	carlsson.fredric@gene.com; brown.eric@gene.com		Carlsson, Fredric/0000-0003-0875-4395				Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Stamm LA, 2004, MICROBES INFECT, V6, P1418, DOI 10.1016/j.micinf.2004.10.003; Stamm LM, 2005, P NATL ACAD SCI USA, V102, P14837, DOI 10.1073/pnas.0504663102; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367	15	4	4	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 27	2009	323	5922					1678	1679		10.1126/science.1172254	http://dx.doi.org/10.1126/science.1172254			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325101				2022-12-28	WOS:000264559800023
J	Bergink, S; Jentsch, S				Bergink, Steven; Jentsch, Stefan			Principles of ubiquitin and SUMO modifications in DNA repair	NATURE			English	Review							BINDING PROTEINS; DAMAGE; COMPLEX; PCNA; LIGASE; UBIQUITYLATION; RECOMBINATION; PROTEOLYSIS; BRCA1; GLYCOSYLASE	With the discovery in the late 1980s that the DNA-repair gene RAD6 encodes a ubiquitin-conjugating enzyme, it became clear that protein modification by ubiquitin conjugation has a much broader significance than had previously been assumed. Now, two decades later, ubiquitin and its cousin SUMO are implicated in a range of human diseases, including breast cancer and Fanconi anaemia, giving fresh momentum to studies focused on the relationships between ubiquitin, SUMO and DNA-repair pathways.	[Bergink, Steven; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	Jentsch@biochem.mpg.de	Bergink, Steven/AAE-3020-2019	Bergink, Steven/0000-0002-1142-869X	Max Planck Society; Centre for Integrated Protein Science Munich; Deutsche Krebshilfe; RUBICON Network of Excellence	Max Planck Society(Max Planck SocietyFoundation CELLEX); Centre for Integrated Protein Science Munich; Deutsche Krebshilfe(Deutsche Krebshilfe); RUBICON Network of Excellence	We thank A. Buchberger, S. Muller and members of the Department of Molecular Cell Biology at the Max Planck Institute for Biochemistry for discussions. S. J. is supported by the Max Planck Society, the Centre for Integrated Protein Science Munich, the Deutsche Krebshilfe and the RUBICON Network of Excellence.	Arakawa H, 2006, PLOS BIOL, V4, P1947, DOI 10.1371/journal.pbio.0040366; Araki M, 2001, J BIOL CHEM, V276, P18665, DOI 10.1074/jbc.M100855200; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Bergink S, 2006, GENE DEV, V20, P1343, DOI 10.1101/gad.373706; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; Frampton J, 2006, MOL BIOL CELL, V17, P2976, DOI 10.1091/mbc.e05-11-1008; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Fu Y, 2008, CELL, V133, P601, DOI 10.1016/j.cell.2008.02.050; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gillette TG, 2006, EMBO J, V25, P2529, DOI 10.1038/sj.emboj.7601120; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kawabe Y, 2000, J BIOL CHEM, V275, P20963, DOI 10.1074/jbc.C000273200; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Leach CA, 2005, J CELL BIOL, V171, P947, DOI 10.1083/jcb.200508100; Lindahl T, 1997, CURR OPIN GENET DEV, V7, P158, DOI 10.1016/S0959-437X(97)80124-4; Lommel L, 2002, CURR GENET, V42, P9, DOI 10.1007/s00294-002-0332-9; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mao Y, 2000, J BIOL CHEM, V275, P26066, DOI 10.1074/jbc.M001831200; MASUTANI C, 1994, EMBO J, V13, P1831, DOI 10.1002/j.1460-2075.1994.tb06452.x; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Postow L, 2008, J CELL BIOL, V182, P467, DOI 10.1083/jcb.200802146; Russell SJ, 1999, MOL CELL, V3, P687, DOI 10.1016/S1097-2765(01)80001-0; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Smith DM, 2006, J STRUCT BIOL, V156, P72, DOI 10.1016/j.jsb.2006.04.012; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Somesh BP, 2007, CELL, V129, P57, DOI 10.1016/j.cell.2007.01.046; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Trickey M, 2008, MOL CELL BIOL, V28, P3905, DOI 10.1128/MCB.02116-07; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wang QE, 2005, NUCLEIC ACIDS RES, V33, P4023, DOI 10.1093/nar/gki684; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a; Yurchenko V, 2006, MOL CELL BIOL, V26, P1786, DOI 10.1128/MCB.26.5.1786-1794.2006; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	75	428	442	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					461	467		10.1038/nature07963	http://dx.doi.org/10.1038/nature07963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19325626				2022-12-28	WOS:000264532400035
J	Finfer, S; Blair, D; Bellomo, R; McArthur, C; Mitchell, I; Myburgh, J; Norton, R; Potter, J; Chittock, D; Dhingra, V; Foster, D; Cook, D; Dodek, P; Hebert, P; Henderson, W; Heyland, D; McDonald, E; Ronco, J; Schweitzer, L; Peto, R; Sandercock, P; Sprung, C; Young, JD; Su, S; Heritier, S; Li, Q; Bompoint, S; Billot, L; Crampton, L; Darcy, F; Jayne, K; Kumarasinghe, V; Little, L; McEvoy, S; MacMahon, S; Pandey, S; Ryan, S; Shukla, R; Vijayan, B; Atherton, S; Bell, J; Hadfield, L; Hourigan, C; McArthur, C; Newby, L; Simmonds, C; Buhr, H; Eccleston, M; McGuinness, S; Parke, R; Bellomo, R; Bates, S; Goldsmith, D; Mercer, I; O'Sullivan, K; Gazzard, R; Hill, D; Tauschke, C; Ghelani, D; Nand, K; Reece, G; Sara, T; Elliott, S; Ernest, D; Hamilton, A; Ashley, R; Bailey, A; Crowfoot, E; Gissane, J; Mitchell, I; Ranse, J; Whiting, J; Douglas, K; Milliss, D; Tan, J; Wong, H; Blythe, D; Palermo, A; Hardie, M; Harrigan, P; McFadyen, B; Micallef, S; Parr, M; Boase, A; Tai, J; Williams, A; Cole, L; Seppelt, I; Weisbrodt, L; Whereat, S; Flanagan, A; Liang, J; Bass, F; Campbell, M; Hammond, N; Nicholson, L; Shehabi, Y; Foote, J; Peake, S; Williams, P; Deans, R; Fourie, C; Lassig-Smith, M; Lipman, J; Stuart, J; Bell, A; Field, T; McAllister, R; Marsden, K; Turner, A; Ankers, S; Bird, S; Finfer, S; Lee, R; O'Connor, A; Potter, J; Ramakrishnan, N; Raper, R; Dhiacou, V; Girling, K; Jovanovska, A; Myburgh, J; Groves, N; Holmes, J; Santamaria, J; Smith, R; Baker, S; Roberts, B; Andrews, L; Dinsdale, R; Fenton, R; Mackle, D; Mortimer, S; French, C; Little, L; Raunow, H; Gales, M; Hill, F; Rachakonda, S; Rogan, D; Allsop, C; Higgins, L; Robinson, B; Champagne, K; Doig, C; Knox, L; Taylor, P; Wilson, C; Drover, J; Hammond, S; Mann, E; Myers, M; Robinson, A; Harvey, J; Skrobik, Y; Baumgartner, A; Meade, L; Vlahakis, N; Ethier, C; Kramer-Kile, M; Mehta, S; Gaudert, C; Kanji, S; McArdle, T; Watpool, I; Clarke, F; Cook, D; McDonald, E; Tkaczyk, A; Marshall, J; Morrissey, J; Porretta, K; Smith, O; Wen, V; Ashley, BJ; Dodek, P; Mans, S; Bojilov, B; Code, K; Fowler, R; Marinoff, N; Chu, L; Granton, J; McGrath-Chong, M; Steinberg, M; Ferguson, N; Go, S; Matte, A; Rosenberg, J; Stevenson, J; Jacka, M; Sonnema, L; Autio, R; Chittock, D; Davies, D; Ganz, P; Gardner, M; Logie, S; Smith, L; Atkins, L; Auld, F; Stewart, M; Wood, G				Finfer, S.; Blair, D.; Bellomo, R.; McArthur, C.; Mitchell, I.; Myburgh, J.; Norton, R.; Potter, J.; Chittock, D.; Dhingra, V.; Foster, D.; Cook, D.; Dodek, P.; Hebert, P.; Henderson, W.; Heyland, D.; McDonald, E.; Ronco, J.; Schweitzer, L.; Peto, R.; Sandercock, P.; Sprung, C.; Young, J. D.; Su, S.; Heritier, S.; Li, Q.; Bompoint, S.; Billot, L.; Crampton, L.; Darcy, F.; Jayne, K.; Kumarasinghe, V.; Little, L.; McEvoy, S.; MacMahon, S.; Pandey, S.; Ryan, S.; Shukla, R.; Vijayan, B.; Atherton, S.; Bell, J.; Hadfield, L.; Hourigan, C.; McArthur, C.; Newby, L.; Simmonds, C.; Buhr, H.; Eccleston, M.; McGuinness, S.; Parke, R.; Bellomo, R.; Bates, S.; Goldsmith, D.; Mercer, I.; O'Sullivan, K.; Gazzard, R.; Hill, D.; Tauschke, C.; Ghelani, D.; Nand, K.; Reece, G.; Sara, T.; Elliott, S.; Ernest, D.; Hamilton, A.; Ashley, R.; Bailey, A.; Crowfoot, E.; Gissane, J.; Mitchell, I.; Ranse, J.; Whiting, J.; Douglas, K.; Milliss, D.; Tan, J.; Wong, H.; Blythe, D.; Palermo, A.; Hardie, M.; Harrigan, P.; McFadyen, B.; Micallef, S.; Parr, M.; Boase, A.; Tai, J.; Williams, A.; Cole, L.; Seppelt, I.; Weisbrodt, L.; Whereat, S.; Flanagan, A.; Liang, J.; Bass, F.; Campbell, M.; Hammond, N.; Nicholson, L.; Shehabi, Y.; Foote, J.; Peake, S.; Williams, P.; Deans, R.; Fourie, C.; Lassig-Smith, M.; Lipman, J.; Stuart, J.; Bell, A.; Field, T.; McAllister, R.; Marsden, K.; Turner, A.; Ankers, S.; Bird, S.; Finfer, S.; Lee, R.; O'Connor, A.; Potter, J.; Ramakrishnan, N.; Raper, R.; Dhiacou, V.; Girling, K.; Jovanovska, A.; Myburgh, J.; Groves, N.; Holmes, J.; Santamaria, J.; Smith, R.; Baker, S.; Roberts, B.; Andrews, L.; Dinsdale, R.; Fenton, R.; Mackle, D.; Mortimer, S.; French, C.; Little, L.; Raunow, H.; Gales, M.; Hill, F.; Rachakonda, S.; Rogan, D.; Allsop, C.; Higgins, L.; Robinson, B.; Champagne, K.; Doig, C.; Knox, L.; Taylor, P.; Wilson, C.; Drover, J.; Hammond, S.; Mann, E.; Myers, M.; Robinson, A.; Harvey, J.; Skrobik, Y.; Baumgartner, A.; Meade, L.; Vlahakis, N.; Ethier, C.; Kramer-Kile, M.; Mehta, S.; Gaudert, C.; Kanji, S.; McArdle, T.; Watpool, I.; Clarke, F.; Cook, D.; McDonald, E.; Tkaczyk, A.; Marshall, J.; Morrissey, J.; Porretta, K.; Smith, O.; Wen, V.; Ashley, B. J.; Dodek, P.; Mans, S.; Bojilov, B.; Code, K.; Fowler, R.; Marinoff, N.; Chu, L.; Granton, J.; McGrath-Chong, M.; Steinberg, M.; Ferguson, N.; Go, S.; Matte, A.; Rosenberg, J.; Stevenson, J.; Jacka, M.; Sonnema, L.; Autio, R.; Chittock, D.; Davies, D.; Ganz, P.; Gardner, M.; Logie, S.; Smith, L.; Atkins, L.; Auld, F.; Stewart, M.; Wood, G.		NICE-SUGAR Study Investigators; NICE Australia-New Zealand; SUGAR North Amer Management Comm; Inde-pendent Data Safety; Study Stat Ctr; Study Coordinating Ctr; Australia-New Zealand Site	Intensive versus Conventional Glucose Control in Critically Ill Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TIGHT GLYCEMIC CONTROL; INSULIN THERAPY; MYOCARDIAL-INFARCTION; STRESS HYPERGLYCEMIA; DIABETIC-PATIENTS; BLOOD-GLUCOSE; CARE UNITS; MORTALITY; MANAGEMENT	Background The optimal target range for blood glucose in critically ill patients remains unclear. Methods Within 24 hours after admission to an intensive care unit (ICU), adults who were expected to require treatment in the ICU on 3 or more consecutive days were randomly assigned to undergo either intensive glucose control, with a target blood glucose range of 81 to 108 mg per deciliter (4.5 to 6.0 mmol per liter), or conventional glucose control, with a target of 180 mg or less per deciliter (10.0 mmol or less per liter). We defined the primary end point as death from any cause within 90 days after randomization. Results Of the 6104 patients who underwent randomization, 3054 were assigned to undergo intensive control and 3050 to undergo conventional control; data with regard to the primary outcome at day 90 were available for 3010 and 3012 patients, respectively. The two groups had similar characteristics at baseline. A total of 829 patients (27.5%) in the intensive-control group and 751 (24.9%) in the conventional-control group died (odds ratio for intensive control, 1.14; 95% confidence interval, 1.02 to 1.28; P = 0.02). The treatment effect did not differ significantly between operative (surgical) patients and nonoperative (medical) patients (odds ratio for death in the intensive-control group, 1.31 and 1.07, respectively; P = 0.10). Severe hypoglycemia (blood glucose level, = 40 mg per deciliter [2.2 mmol per liter]) was reported in 206 of 3016 patients (6.8%) in the intensive-control group and 15 of 3014 (0.5%) in the conventional-control group (P<0.001). There was no significant difference between the two treatment groups in the median number of days in the ICU (P = 0.84) or hospital (P = 0.86) or the median number of days of mechanical ventilation (P = 0.56) or renal-replacement therapy (P = 0.39). Conclusions In this large, international, randomized trial, we found that intensive glucose control increased mortality among adults in the ICU: a blood glucose target of 180 mg or less per deciliter resulted in lower mortality than did a target of 81 to 108 mg per deciliter. (ClinicalTrials.gov number, NCT00220987.)	[Su, S.; Heritier, S.; Li, Q.; Bompoint, S.; Billot, L.; Crampton, L.; Darcy, F.; Jayne, K.; Kumarasinghe, V.; Little, L.; McEvoy, S.; MacMahon, S.; Pandey, S.; Ryan, S.; Shukla, R.; Vijayan, B.; Study Stat Ctr; Study Coordinating Ctr] Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia; [McArthur, C.; Atherton, S.; Bell, J.; Hadfield, L.; Hourigan, C.; Newby, L.; Simmonds, C.; Australia-New Zealand Site] Auckland City Hosp, Dept Crit Care Med, Auckland, New Zealand; [Buhr, H.; Eccleston, M.; McGuinness, S.; Parke, R.] Auckland City Hosp, Cardiovasc Intens Care Unit, Auckland, New Zealand; [Bellomo, R.; Bates, S.; Goldsmith, D.; Mercer, I.; O'Sullivan, K.] Austin Hosp, Melbourne, Vic 3084, Australia; [Gazzard, R.; Hill, D.; Tauschke, C.] Ballarat Base Hosp, Ballarat, Vic, Australia; [Ghelani, D.; Nand, K.; Reece, G.; Sara, T.] Blacktown Hosp, Blacktown, NSW, Australia; [Elliott, S.; Ernest, D.; Hamilton, A.] Box Hill Hosp, Box Hill, Vic, Australia; [Mitchell, I.; Ashley, R.; Bailey, A.; Crowfoot, E.; Gissane, J.; Ranse, J.; Whiting, J.] Canberra Hosp, Canberra, ACT, Australia; [Douglas, K.; Milliss, D.; Tan, J.; Wong, H.] Concord Repatriat Gen Hosp, Concord, NSW, Australia; [Blythe, D.; Palermo, A.] Fremantle Hosp, Fremantle, WA, Australia; [Hardie, M.; Harrigan, P.; McFadyen, B.] John Hunter Hosp, Newcastle, NSW, Australia; [Micallef, S.; Parr, M.] Liverpool Hosp, Liverpool, NSW, Australia; [Boase, A.; Tai, J.; Williams, A.] Middlemore Hosp, Auckland 6, New Zealand; [Cole, L.; Seppelt, I.; Weisbrodt, L.; Whereat, S.] Nepean Hosp, Nepean, NSW, Australia; [Flanagan, A.; Liang, J.] N Shore Hosp, Auckland, New Zealand; [Bass, F.; Campbell, M.; Hammond, N.; Nicholson, L.; Shehabi, Y.] Prince Wales Hosp, Sydney, NSW, Australia; [Foote, J.; Peake, S.; Williams, P.] Queen Elizabeth Hosp, Adelaide, SA, Australia; [Douglas, K.; Deans, R.; Fourie, C.; Lipman, J.; Stuart, J.] Royal Brisbane Hosp, Brisbane, Qld 4029, Australia; [Bell, A.; Field, T.; McAllister, R.; Marsden, K.; Turner, A.] Royal Hobart Hosp, Hobart, Tas, Australia; [Finfer, S.; Potter, J.; Ankers, S.; Bird, S.; Lee, R.; O'Connor, A.; Ramakrishnan, N.; Raper, R.] Royal N Shore Hosp, Sydney, NSW, Australia; [Myburgh, J.; Dhiacou, V.; Girling, K.; Jovanovska, A.] St George Hosp, Sydney, NSW, Australia; [Groves, N.; Holmes, J.; Santamaria, J.; Smith, R.] St Vincents Hosp, Melbourne, Vic, Australia; [Baker, S.; Roberts, B.] Sir Charles Gairdner Hosp, Perth, WA, Australia; [Andrews, L.; Dinsdale, R.; Fenton, R.; Mackle, D.; Mortimer, S.] Wellington Hosp, Wellington, New Zealand; [Little, L.; French, C.; Raunow, H.] Western Hosp, Melbourne, Vic, Australia; [Gales, M.; Hill, F.; Rachakonda, S.; Rogan, D.] Wollongong Hosp, Wollongong, NSW, Australia; [Allsop, C.] NSW Inst Trauma & Injury Management, Sydney, NSW, Australia; [Higgins, L.] Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia; [Robinson, B.] Univ Sydney, Fac Med, Kolling Inst, Sydney, NSW 2006, Australia; [Robinson, B.] Royal N Shore Hosp, Dept Endocrinol, Sydney, NSW, Australia; [Champagne, K.; Doig, C.; Knox, L.; Taylor, P.; Wilson, C.] Calgary Hlth Reg, Calgary, AB, Canada; [Drover, J.; Hammond, S.; Mann, E.; Myers, M.; Robinson, A.] Kingston Gen Hosp, Kingston, ON K7L 2V7, Canada; [Harvey, J.; Skrobik, Y.] Maisonneuve Rosemont Hosp, Montreal, PQ, Canada; [Baumgartner, A.; Meade, L.; Vlahakis, N.] Mayo Clin, Rochester, MN USA; [Ethier, C.; Kramer-Kile, M.; Mehta, S.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Gaudert, C.; Kanji, S.; McArdle, T.; Watpool, I.] Ottawa Gen Hosp, Ottawa, ON K1H 8L6, Canada; [Cook, D.; McDonald, E.; Clarke, F.; Tkaczyk, A.] St Josephs Healthcare, Hamilton, ON, Canada; [Marshall, J.; Morrissey, J.; Porretta, K.; Smith, O.; Wen, V.] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Dodek, P.; Ashley, B. J.; Mans, S.] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; [Bojilov, B.; Code, K.; Fowler, R.; Marinoff, N.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Chu, L.; Granton, J.; McGrath-Chong, M.; Steinberg, M.] Toronto Gen Hosp, Toronto, ON, Canada; [Ferguson, N.; Go, S.; Matte, A.; Rosenberg, J.; Stevenson, J.] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada; [Jacka, M.; Sonnema, L.] Univ Alberta Hosp, Edmonton, AB T6G 2B7, Canada; [Chittock, D.; Autio, R.; Davies, D.; Ganz, P.; Gardner, M.; Logie, S.; Smith, L.] Vancouver Gen Hosp, Vancouver, BC, Canada; [Atkins, L.; Auld, F.; Stewart, M.; Wood, G.] Vancouver Isl Hlth Author, Victoria, BC, Canada	University of Sydney; Auckland City Hospital; Auckland City Hospital; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Blacktown & Mount Druitt Hospital; Box Hill Hospital; Australian National University; Canberra Hospital; Concord Repatriation General Hospital; University of Western Australia; John Hunter Hospital; Liverpool Hospital; Nepean Hospital; Royal Brisbane & Women's Hospital; Royal Hobart Hospital; Royal North Shore Hospital; University of Sydney; St George Hospital; St Vincent's Hospital Melbourne; University of Western Australia; Western Hospital; Wollongong Hospital; University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; University of Sydney; University of Calgary; Queens University - Canada; Universite de Montreal; Mayo Clinic; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; St. Paul's Hospital; University of Saskatchewan; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Alberta; University of British Columbia; Vancouver Island Health Authority			Mehta, Sangeeta/C-4623-2015; Santamaria, John/M-9581-2019; Morrissey, James H/H-4933-2011; Ferguson, Niall/D-7619-2019; French, Craig/ABF-5087-2020; Billot, Laurent/Y-1241-2019; Morrissey, James H./GLR-5645-2022; Ernest, David/I-1699-2013; Parke, Rachael/AAX-4004-2021; schuetz, philipp/C-8475-2013; FRENCH, CRAIG/HGA-5299-2022; Skrobik, Yoanna/K-8165-2014; Williams, Patricia/AAH-6571-2019	Morrissey, James H/0000-0002-1570-1569; Ferguson, Niall/0000-0002-6213-5264; French, Craig/0000-0003-1363-9711; Billot, Laurent/0000-0002-4975-9793; Parke, Rachael/0000-0003-4209-0334; schuetz, philipp/0000-0001-6400-4949; Skrobik, Yoanna/0000-0002-5315-6020; Micallef, Sharon/0000-0002-8496-2324; SHEHABI, Yahya/0000-0003-4707-7462; Hammond, Naomi/0000-0002-6559-7747; Bellomo, Rinaldo/0000-0002-1650-8939; Mitchell, Imogen/0000-0001-6013-4922; Myburgh, John/0000-0003-4088-7016; Finfer, Simon/0000-0002-2785-5864; Bompoint, Severine/0000-0001-5226-4321	Australian National Health and Medical Research Council; Health Research Council of New Zealand; Canadian Institutes for Health Research	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Health Research Council of New Zealand(Health Research Council of New Zealand); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	Supported by grants from the Australian National Health and Medical Research Council, the Health Research Council of New Zealand, and the Canadian Institutes for Health Research.	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Angus DC, 2005, AM J RESP CRIT CARE, V172, P1358, DOI 10.1164/rccm.2508009; Aragon D, 2006, AM J CRIT CARE, V15, P370, DOI 10.4037/ajcc2006.15.4.370; Bellomo R, 2005, MAYO CLIN PROC, V80, P1546, DOI 10.4065/80.12.1546; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Chase JG, 2007, CRIT CARE, V11, DOI 10.1186/cc6099; *CRIT CAR NUTR, 2007, US ENT NUTR VS PAR N; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Dunbar JC, 1996, ACTA DIABETOL, V33, P263; Finfer S, 2009, CRIT CARE RESUSC, V11, P46; Gale SC, 2007, AM SURGEON, V73, P454; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Herlein JA, 2006, ENDOCRINOLOGY, V147, P2781, DOI 10.1210/en.2005-1247; Inzucchi SE, 2006, NEW ENGL J MED, V355, P1903, DOI 10.1056/NEJMcp060094; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Krumholz HM, 2008, NEW ENGL J MED, V358, P2537, DOI 10.1056/NEJMp0803740; Langley J, 2007, DIABETES-METAB RES, V23, P184, DOI 10.1002/dmrr.696; Mackenzie I, 2005, INTENS CARE MED, V31, P1136, DOI 10.1007/s00134-005-2677-2; Malmberg K, 2005, EUR HEART J, V26, P650, DOI 10.1093/eurheartj/ehi199; MALMBERG K, 1995, J AM COLL CARDIOL, V26, P57, DOI 10.1016/0735-1097(95)00126-K; Mitchell I, 2006, INTENS CARE MED, V32, P867, DOI 10.1007/s00134-006-0135-4; *NICE SUGAR STUD I, AM J RESP CRIT CARE; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Rodbard Helena W, 2007, Endocr Pract, V13 Suppl 1, P1; Shulman R, 2007, CRIT CARE, V11, DOI 10.1186/cc5964; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Su S, 2007, COMPUT STAT DATA AN, V51, P3983, DOI 10.1016/j.csda.2006.06.008; Su S, 2007, J STAT SOFTW, V21, P1; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Van den Berghe G, 2006, DIABETES, V55, P3151, DOI 10.2337/db06-0855; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016	37	3056	3201	4	167	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2009	360	13					1283	1297		10.1056/NEJMoa0810625	http://dx.doi.org/10.1056/NEJMoa0810625			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423VP	19318384	Green Published			2022-12-28	WOS:000264524100004
J	Pryke, SR; Griffith, SC				Pryke, Sarah R.; Griffith, Simon C.			Genetic Incompatibility Drives Sex Allocation and Maternal Investment in a Polymorphic Finch	SCIENCE			English	Article							MALE ATTRACTIVENESS; NATURAL-SELECTION; COLOR MORPHS; RATIO; BIRDS; EGGS; CHOICE	Genetic compatibility may drive individual mate choice decisions because of predictable fitness effects associated with breeding with incompatible partners. In Gouldian finches (Erythrura gouldiae), females paired with genetically incompatible males of alternative color morphs overproduce sons, presumably to reduce investment in inviable daughters. We also observed a reduced overall investment in clutch size, egg size, and care to offspring resulting from incompatible matings. Within-female experimental pairings demonstrate that female birds have the ability to adaptively adjust the sex of their eggs and allocate resources on the basis of partner quality. Female Gouldian finches thus make cumulative strategic allocation decisions to minimize the costs of poor-quality pairings when faced with a genetically incompatible partner.	[Pryke, Sarah R.; Griffith, Simon C.] Macquarie Univ, Dept Brain Behav & Evolut, Sydney, NSW 2109, Australia	Macquarie University	Pryke, SR (corresponding author), Macquarie Univ, Dept Brain Behav & Evolut, Sydney, NSW 2109, Australia.	sarah.pryke@mq.edu.au	Griffith, Simon/A-1996-2010; Pryke, Sarah/G-7484-2011; Griffith, Simon/AAH-3706-2021	Griffith, Simon/0000-0001-7612-4999; Griffith, Simon/0000-0001-7612-4999	Australian Research Council; L'Oreal [Women in Science Fellowship]; Save The Gouldian Fund;  [New South Global Postdoctoral Fellowship]	Australian Research Council(Australian Research Council); L'Oreal(L'Oreal Group); Save The Gouldian Fund; 	We thank A. Badyaev, R. Montgomerie, T. Price, A. Russell, and B. Sinervo for comments; D. Briscoe, R. Brooks, R. Bonduriansky, T. Burke, and M. Olsson for discussion; and R. Merrill, J. Brazill-Boast, and L. A. Rollins for technical help. Funded by the Australian Research Council (grants awarded to S.R.P. and S.C.G.), a New South Global Postdoctoral Fellowship (to S.R.P.), a L'Oreal For Women in Science Fellowship (to S.R.P.), and the Save The Gouldian Fund. The Animal Care and Ethics Committee of the University of New South Wales and Macquarie University approved this research.	BIRKHEAD TR, 1993, BIOL J LINN SOC, V50, P295, DOI 10.1111/j.1095-8312.1993.tb00933.x; BURLEY N, 1986, EVOLUTION, V40, P1191, DOI 10.1111/j.1558-5646.1986.tb05744.x; CHARNOV E L, 1982; Cordero PJ, 2000, BEHAV ECOL SOCIOBIOL, V48, P353, DOI 10.1007/s002650000252; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; DELOPE F, 1993, EVOLUTION, V47, P1152, DOI 10.1111/j.1558-5646.1993.tb02142.x; Ewen JG, 2004, P ROY SOC B-BIOL SCI, V271, P1277, DOI 10.1098/rspb.2004.2735; Fawcett TW, 2007, BEHAV ECOL, V18, P71, DOI 10.1093/beheco/arl052; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Griffith SC, 1999, NATURE, V400, P358, DOI 10.1038/22536; Komdeur J, 2002, PHILOS T R SOC B, V357, P373, DOI 10.1098/rstb.2001.0927; PETRIE M, 1993, P ROY SOC B-BIOL SCI, V251, P127, DOI 10.1098/rspb.1993.0018; Pryke SR, 2007, J EVOLUTION BIOL, V20, P1512, DOI 10.1111/j.1420-9101.2007.01332.x; Pryke SR, 2009, EVOLUTION, V63, P793, DOI 10.1111/j.1558-5646.2008.00584.x; RICE WR, 1992, SCIENCE, V256, P1436, DOI 10.1126/science.1604317; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; SOUTHERN HN, 1945, J GENET, V47, P51, DOI 10.1007/BF02989037; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000; West SA, 2002, SCIENCE, V295, P1685, DOI 10.1126/science.1069043; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; WILLIAMS TD, 1994, BIOL REV, V69, P35, DOI 10.1111/j.1469-185X.1994.tb01485.x	23	77	80	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1605	1607		10.1126/science.1168928	http://dx.doi.org/10.1126/science.1168928			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299618	Green Submitted			2022-12-28	WOS:000264342300038
J	Scott, TF; Kowalski, BA; Sullivan, AC; Bowman, CN; McLeod, RR				Scott, Timothy F.; Kowalski, Benjamin A.; Sullivan, Amy C.; Bowman, Christopher N.; McLeod, Robert R.			Two-Color Single-Photon Photoinitiation and Photoinhibition for Subdiffraction Photolithography	SCIENCE			English	Article							2-PHOTON RADICAL-PHOTOINITIATOR; POLYMERIZATION; SYSTEM; PHOTOPOLYMERIZATION; BENZOSPIROPYRANS; MICROFABRICATION; LITHOGRAPHY; WAVELENGTH; RESOLUTION	Controlling and reducing the developed region initiated by photoexposure is one of the fundamental goals of optical lithography. Here, we demonstrate a two-color irradiation scheme whereby initiating species are generated by single-photon absorption at one wavelength while inhibiting species are generated by single-photon absorption at a second, independent wavelength. Co-irradiation at the second wavelength thus reduces the polymerization rate, delaying gelation of the material and facilitating enhanced spatial control over the polymerization. Appropriate overlapping of the two beams produces structures with both feature sizes and monomer conversions otherwise unobtainable with use of single- or two-photon absorption photopolymerization. Additionally, the generated inhibiting species rapidly recombine when irradiation with the second wavelength ceases, allowing for fast sequential exposures not limited by memory effects in the material and thus enabling fabrication of complex two- or three-dimensional structures.	[Kowalski, Benjamin A.; Sullivan, Amy C.; McLeod, Robert R.] Univ Colorado, Dept Elect & Comp Engn, Boulder, CO 80309 USA; [Scott, Timothy F.; Bowman, Christopher N.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	McLeod, RR (corresponding author), Univ Colorado, Dept Elect & Comp Engn, Boulder, CO 80309 USA.	robert.mcleod@colorado.edu	Bowman, Christopher N/B-1490-2008; McLeod, Robert R/R-2569-2019; Scott, Timothy/AAV-5819-2021	Bowman, Christopher N/0000-0001-8458-7723; Scott, Timothy/0000-0002-5893-3140; MCLEOD, ROBERT/0000-0001-6354-0168	NSF [IIP-0750506, IIP-0822695, ECS-0636650]; NIH [DE10959]; University of Colorado; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010959, R29DE010959] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Supported by NSF programs IIP-0750506, IIP-0822695, and ECS-0636650, NIH grant DE10959, and the University of Colorado Innovative Seed Grant Program. A preliminary patent based on this technology has been filed by T.F.S., A.C.S., C.N.B., and R.R.M.	Arlt J, 2000, OPT LETT, V25, P191, DOI 10.1364/OL.25.000191; Cumpston BH, 1999, NATURE, V398, P51, DOI 10.1038/17989; Donnert G, 2006, P NATL ACAD SCI USA, V103, P11440, DOI 10.1073/pnas.0604965103; Flory PJ., 1953, PRINCIPLES POLYM CHE, V672; Haske W, 2007, OPT EXPRESS, V15, P3426, DOI 10.1364/OE.15.003426; ICHIMURA K, 1988, J POLYM SCI POL LETT, V26, P185, DOI 10.1002/pol.1988.140260403; Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130; LEE SK, 1991, CHEM MATER, V3, P852, DOI 10.1021/cm00017a021; LEE SK, 1991, CHEM MATER, V3, P858, DOI 10.1021/cm00017a022; LOUGNOT DJ, 1988, J APPL PHYS, V63, P4841, DOI 10.1063/1.340477; Lovell LG, 2001, POLYMER, V42, P421, DOI 10.1016/S0032-3861(00)00386-4; SOH SK, 1982, J POLYM SCI POL CHEM, V20, P1299, DOI 10.1002/pol.1982.170200513; Strandwitz NC, 2008, J AM CHEM SOC, V130, P8280, DOI 10.1021/ja711295k; Sullivan AC, 2007, APPL OPTICS, V46, P295, DOI 10.1364/AO.46.000295; Sun HB, 2000, OPT LETT, V25, P1110, DOI 10.1364/OL.25.001110; Sun HB, 2004, ADV POLYM SCI, V170, P169, DOI 10.1007/b94405; Tanaka T, 2002, APPL PHYS LETT, V80, P312, DOI 10.1063/1.1432450	17	318	338	11	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					913	917		10.1126/science.1167610	http://dx.doi.org/10.1126/science.1167610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19359546				2022-12-28	WOS:000266048800031
J	Matsushita, K; Takeuchi, O; Standley, DM; Kumagai, Y; Kawagoe, T; Miyake, T; Satoh, T; Kato, H; Tsujimura, T; Nakamura, H; Akira, S				Matsushita, Kazufumi; Takeuchi, Osamu; Standley, Daron M.; Kumagai, Yutaro; Kawagoe, Tatsukata; Miyake, Tohru; Satoh, Takashi; Kato, Hiroki; Tsujimura, Tohru; Nakamura, Haruki; Akira, Shizuo			Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay	NATURE			English	Article							AUTOIMMUNITY; RECOGNITION; ACTIVATION; CLEAVAGE; INNATE	Toll-like receptors (TLRs) recognize microbial components, and evoke inflammation and immune responses(1-3). TLR stimulation activates complex gene expression networks that regulate the magnitude and duration of the immune reaction. Here we identify the TLR-inducible gene Zc3h12a as an immune response modifier that has an essential role in preventing immune disorders. Zc3h12a-deficient mice suffered from severe anaemia, and most died within 12 weeks. Zc3h12a(-/-) mice also showed augmented serum immunoglobulin levels and autoantibody production, together with a greatly increased number of plasma cells, as well as infiltration of plasma cells to the lung. Most Zc3h12a(-/-) splenic T cells showed effector/memory characteristics and produced interferon-gamma in response to T-cell receptor stimulation. Macrophages from Zc3h12a (-/-) mice showed highly increased production of interleukin (IL)-6 and IL-12p40 (also known as IL12b), but not TNF, in response to TLR ligands. Although the activation of TLR signalling pathways was normal, Il6 messenger RNA decay was severely impaired in Zc3h12a (-/-) macrophages. Overexpression of Zc3h12a accelerated Il6 mRNA degradation via its 3'-untranslated region (UTR), and destabilized RNAs with 3'-UTRs for genes including Il6, Il12p40 and the calcitonin receptor gene Calcr. Zc3h12a contains a putative amino-terminal nuclease domain, and the expressed protein had RNase activity, consistent with a role in the decay of Il6 mRNA. Together, these results indicate that Zc3h12a is an essential RNase that prevents immune disorders by directly controlling the stability of a set of inflammatory genes.	[Matsushita, Kazufumi; Takeuchi, Osamu; Kumagai, Yutaro; Kawagoe, Tatsukata; Miyake, Tohru; Satoh, Takashi; Kato, Hiroki; Akira, Shizuo] Osaka Univ, Host Def Lab, Suita, Osaka 5650871, Japan; [Standley, Daron M.] Osaka Univ, Lab Syst Immunol, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Matsushita, Kazufumi; Takeuchi, Osamu; Kumagai, Yutaro; Kawagoe, Tatsukata; Miyake, Tohru; Satoh, Takashi; Kato, Hiroki; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Tsujimura, Tohru] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan; [Nakamura, Haruki] Osaka Univ, Inst Prot Res, Res Ctr Struct & Funct Prote, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Hyogo College of Medicine; Osaka University	Akira, S (corresponding author), Osaka Univ, Host Def Lab, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Takeuchi, Osamu/AAG-9359-2019; Takeuchi, Osamu/D-6007-2011; Akira, Shizuo/C-3134-2009; Standley, Daron/D-2343-2009; Kumagai, Yutaro/L-7732-2018	Takeuchi, Osamu/0000-0002-1260-6232; Kumagai, Yutaro/0000-0002-5039-3979; Miyake, Toru/0000-0003-0947-0116	Japanese Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare in Japan; Global Center of Excellence Program of Japan; NIH [P01 AI070167]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Global Center of Excellence Program of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all colleagues in our laboratory, E. Kamada for secretarial assistance, and Y. Fujiwara, M. Kumagai and R. Abe for technical assistance. We thank S. Sato for discussions and W. Zhao and K. Kirkwood for plasmids. This work was supported by the Special Coordination Funds of the Japanese Ministry of Education, Culture, Sports, Science and Technology, grants from the Ministry of Health, Labour and Welfare in Japan, the Global Center of Excellence Program of Japan, and the NIH (P01 AI070167).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Barabino SML, 1997, GENE DEV, V11, P1703, DOI 10.1101/gad.11.13.1703; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Datta S, 2008, J IMMUNOL, V180, P2545, DOI 10.4049/jimmunol.180.4.2545; Feng M, 2004, NAT STRUCT MOL BIOL, V11, P450, DOI 10.1038/nsmb754; Fukuyama H, 2005, NAT IMMUNOL, V6, P99, DOI 10.1038/ni1151; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kinoshita K, 2004, BIOINFORMATICS, V20, P1329, DOI 10.1093/bioinformatics/bth073; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Miyoshi Keita, 2008, V442, P29, DOI 10.1007/978-1-59745-191-8_3; Paschoud S, 2006, MOL CELL BIOL, V26, P8228, DOI 10.1128/MCB.01155-06; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Zhao W, 2008, J BIOL CHEM, V283, P1778, DOI 10.1074/jbc.M707573200; Zhou LM, 2006, CIRC RES, V98, P1177, DOI 10.1161/01.RES.0000220106.64661.71	22	452	469	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1185	U124		10.1038/nature07924	http://dx.doi.org/10.1038/nature07924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19322177				2022-12-28	WOS:000265754600050
J	Cannon, CP				Cannon, Christopher P.			Can the polypill save the world from heart disease?	LANCET			English	Editorial Material							CONTROLLED-TRIAL; CHOLESTEROL		[Cannon, Christopher P.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Cannon, Christopher P.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Cannon, CP (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	cpcannon@partners.org	Cannon, Christopher P/AAY-7644-2020; Maseeh, Arun/AAO-7868-2021	Cannon, Christopher P/0000-0003-4596-2791; Maseeh, Arun/0000-0002-5435-941X				Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; *IND POL STUD TIPS, 2009, LANCET; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Lee JK, 2006, JAMA-J AM MED ASSOC, V296, P2563, DOI 10.1001/jama.296.21.joc60162	4	25	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 18	2009	373	9672					1313	1314		10.1016/S0140-6736(09)60652-8	http://dx.doi.org/10.1016/S0140-6736(09)60652-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434UR	19339044				2022-12-28	WOS:000265300100004
J	Miles, MA; Yeo, M; Mauricio, IL				Miles, Michael A.; Yeo, Matthew; Mauricio, Isabel L.			Leishmania Exploit Sex	SCIENCE			English	Editorial Material							HYBRIDS; TRANSMISSION; TRYPANOSOMES; EXCHANGE		[Miles, Michael A.; Yeo, Matthew; Mauricio, Isabel L.] Univ London London Sch Hyg & Trop Med, Pathogen Mol Biol Unit, Dept Infect & Trop Dis, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Miles, MA (corresponding author), Univ London London Sch Hyg & Trop Med, Pathogen Mol Biol Unit, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	michael.miles@lshtm.ac.uk	Mauricio, Isabel/H-5272-2011	Mauricio, Isabel/0000-0002-7748-4643	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Akopyants NS, 2009, SCIENCE, V324, P265, DOI 10.1126/science.1169464; Boyle JP, 2006, P NATL ACAD SCI USA, V103, P10514, DOI 10.1073/pnas.0510319103; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; Gibson W, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-4; Heitman J, 2006, CURR BIOL, V16, pR711, DOI 10.1016/j.cub.2006.07.064; JENNI L, 1986, NATURE, V322, P173, DOI 10.1038/322173a0; LEWIS MD, INCOCT2005015407 WEL; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Nolder D, 2007, AM J TROP MED HYG, V76, P573, DOI 10.4269/ajtmh.2007.76.573; Poxleitner MK, 2008, SCIENCE, V319, P1530, DOI 10.1126/science.1153752; Schwenkenbecher JM, 2006, INT J PARASITOL, V36, P237, DOI 10.1016/j.ijpara.2005.09.010; TIBAYRENC M, 1991, PARASITOL TODAY, V7, P228, DOI 10.1016/0169-4758(91)90234-F; Volf P, 2007, INT J PARASITOL, V37, P589, DOI 10.1016/j.ijpara.2007.02.002; Yeo M, 2005, INT J PARASITOL, V35, P225, DOI 10.1016/j.ijpara.2004.10.024	15	16	18	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					187	+		10.1126/science.1172789	http://dx.doi.org/10.1126/science.1172789			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359570				2022-12-28	WOS:000265024400026
J	Worden, AZ; Lee, JH; Mock, T; Rouze, P; Simmons, MP; Aerts, AL; Allen, AE; Cuvelier, ML; Derelle, E; Everett, MV; Foulon, E; Grimwood, J; Gundlach, H; Henrissat, B; Napoli, C; McDonald, SM; Parker, MS; Rombauts, S; Salamov, A; Von Dassow, P; Badger, JH; Coutinho, PM; Demir, E; Dubchak, I; Gentemann, C; Eikrem, W; Gready, JE; John, U; Lanier, W; Lindquist, EA; Lucas, S; Mayer, KFX; Moreau, H; Not, F; Otillar, R; Panaud, O; Pangilinan, J; Paulsen, I; Piegu, B; Poliakov, A; Robbens, S; Schmutz, J; Toulza, E; Wyss, T; Zelensky, A; Zhou, K; Armbrust, EV; Bhattacharya, D; Goodenough, UW; Van de Peer, Y; Grigoriev, IV				Worden, Alexandra Z.; Lee, Jae-Hyeok; Mock, Thomas; Rouze, Pierre; Simmons, Melinda P.; Aerts, Andrea L.; Allen, Andrew E.; Cuvelier, Marie L.; Derelle, Evelyne; Everett, Meredith V.; Foulon, Elodie; Grimwood, Jane; Gundlach, Heidrun; Henrissat, Bernard; Napoli, Carolyn; McDonald, Sarah M.; Parker, Micaela S.; Rombauts, Stephane; Salamov, Aasf; Von Dassow, Peter; Badger, Jonathan H.; Coutinho, Pedro M.; Demir, Elif; Dubchak, Inna; Gentemann, Chelle; Eikrem, Wenche; Gready, Jill E.; John, Uwe; Lanier, William; Lindquist, Erika A.; Lucas, Susan; Mayer, Klaus F. X.; Moreau, Herve; Not, Fabrice; Otillar, Robert; Panaud, Olivier; Pangilinan, Jasmyn; Paulsen, Ian; Piegu, Benoit; Poliakov, Aaron; Robbens, Steven; Schmutz, Jeremy; Toulza, Eve; Wyss, Tania; Zelensky, Alexander; Zhou, Kemin; Armbrust, E. Virginia; Bhattacharya, Debashish; Goodenough, Ursula W.; Van de Peer, Yves; Grigoriev, Igor V.			Green Evolution and Dynamic Adaptations Revealed by Genomes of the Marine Picoeukaryotes Micromonas	SCIENCE			English	Article							GENE-EXPRESSION; LAND PLANTS; ALGAE; CHLAMYDOMONAS; ENDOSYMBIOSIS; RIBOSWITCHES; PERSPECTIVE; METABOLISM; PROVIDES; ORIGIN	Picoeukaryotes are a taxonomically diverse group of organisms less than 2 micrometers in diameter. Photosynthetic marine picoeukaryotes in the genus Micromonas thrive in ecosystems ranging from tropical to polar and could serve as sentinel organisms for biogeochemical fluxes of modern oceans during climate change. These broadly distributed primary producers belong to an anciently diverged sister clade to land plants. Although Micromonas isolates have high 18S ribosomal RNA gene identity, we found that genomes from two isolates shared only 90% of their predicted genes. Their independent evolutionary paths were emphasized by distinct riboswitch arrangements as well as the discovery of intronic repeat elements in one isolate, and in metagenomic data, but not in other genomes. Divergence appears to have been facilitated by selection and acquisition processes that actively shape the repertoire of genes that are mutually exclusive between the two isolates differently than the core genes. Analyses of the Micromonas genomes offer valuable insights into ecological differentiation and the dynamic nature of early plant evolution.	[Worden, Alexandra Z.; Simmons, Melinda P.; Cuvelier, Marie L.; McDonald, Sarah M.; Demir, Elif] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Lee, Jae-Hyeok; Goodenough, Ursula W.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Mock, Thomas; Parker, Micaela S.; Armbrust, E. Virginia] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Rouze, Pierre; Rombauts, Stephane; Robbens, Steven; Van de Peer, Yves] Univ Ghent, Dept Plant Syst Biol, Flanders Inst Biotechnol VIB, B-9052 Ghent, Belgium; [Rouze, Pierre; Rombauts, Stephane; Robbens, Steven; Van de Peer, Yves] Univ Ghent, Dept Mol Genet, B-9052 Ghent, Belgium; [Aerts, Andrea L.; Grimwood, Jane; Salamov, Aasf; Dubchak, Inna; Lindquist, Erika A.; Lucas, Susan; Otillar, Robert; Pangilinan, Jasmyn; Poliakov, Aaron; Schmutz, Jeremy; Zhou, Kemin; Grigoriev, Igor V.] US DOE, JGI, Walnut Creek, CA 94598 USA; [Allen, Andrew E.; Badger, Jonathan H.] J Craig Venter Inst, San Diego, CA 92121 USA; [Cuvelier, Marie L.; Everett, Meredith V.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Derelle, Evelyne] Univ Paris 06, CNRS, Observ Oceanol, F-66651 Banyuls Sur Mer, France; [Foulon, Elodie; Von Dassow, Peter; Not, Fabrice] Univ Paris 06, CNRS, Stn Biol Roscoff, Roscoff, France; [Grimwood, Jane; Mayer, Klaus F. X.; Schmutz, Jeremy] Stanford Univ, Sch Med, Stanford Human Genome Ctr, Palo Alto, CA 94304 USA; [Gundlach, Heidrun; Coutinho, Pedro M.] German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, D-85764 Neuherberg, Germany; [Henrissat, Bernard] Univ Aix Marseille 1, F-13288 Marseille, France; [Henrissat, Bernard] Univ Aix Marseille 2, F-13288 Marseille, France; [Napoli, Carolyn] Univ Arizona, Inst Biol, Tucson, AZ 85719 USA; [Gentemann, Chelle] Remote Sensing Syst, Santa Rosa, CA 95401 USA; [Eikrem, Wenche] Univ Oslo, N-0316 Oslo, Norway; [Gready, Jill E.] Australian Natl Univ, Coll Med Biol & Environm, Div Mol Biosci, Canberra, ACT 2601, Australia; [John, Uwe] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Lanier, William; Bhattacharya, Debashish] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Panaud, Olivier; Piegu, Benoit] Univ Perpignan, Lab Genome & Dev Plantes, F-66860 Perpignan, France; [Paulsen, Ian] Macquarie Univ, Dept Chem & Biomol Sci, N Ryde, NSW 2109, Australia; [Toulza, Eve] Univ Montpellier 2, F-34095 Montpellier 05, France; [Wyss, Tania] Univ Miami, Dept Biol, Miami, FL 33149 USA; [Zelensky, Alexander] Erasmus MC, Dept Genet, NL-3015 CE Rotterdam, Netherlands	Monterey Bay Aquarium Research Institute; Washington University (WUSTL); University of Washington; University of Washington Seattle; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; United States Department of Energy (DOE); Joint Genome Institute - JGI; J. Craig Venter Institute; University of Miami; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Stanford University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Arizona; University of Oslo; Australian National University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Iowa; Universite Perpignan Via Domitia; Macquarie University; Universite de Montpellier; University of Miami; Erasmus University Rotterdam; Erasmus MC	Worden, AZ (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.	azworden@mbari.org	Van de Peer, Yves/D-4388-2009; Mayer, Klaus FX/M-7941-2015; Zelensky, Alex/S-3162-2019; Paulsen, Ian T/K-3832-2012; Worden, Alexandra Z./AAD-6567-2019; Henrissat, Bernard/J-2475-2012; von Dassow, Peter/A-5399-2012; john, uwe/S-3009-2016; Schmutz, Jeremy/N-3173-2013; Rombauts, Stephane/P-2420-2019; Van de Peer, Yves/AAE-7666-2019; Rombauts, Stephane M/D-7640-2014; Toulza, Eve/A-9919-2012; Allen, Andrew E/C-4896-2012; Zelensky, Alex/G-1201-2012; Zelensky, Alexander/Y-7734-2018; Grimwood, Jane/ABD-5737-2021; Mock, Thomas/A-3127-2008	Van de Peer, Yves/0000-0003-4327-3730; Mayer, Klaus FX/0000-0001-6484-1077; Zelensky, Alex/0000-0002-2664-271X; Paulsen, Ian T/0000-0001-9015-9418; Henrissat, Bernard/0000-0002-3434-8588; john, uwe/0000-0002-1297-4086; Schmutz, Jeremy/0000-0001-8062-9172; Rombauts, Stephane/0000-0002-3985-4981; Van de Peer, Yves/0000-0003-4327-3730; Rombauts, Stephane M/0000-0002-3985-4981; Toulza, Eve/0000-0003-2049-2279; Allen, Andrew E/0000-0001-5911-6081; Zelensky, Alex/0000-0002-2664-271X; Zelensky, Alexander/0000-0003-3387-7346; Mock, Thomas/0000-0001-9604-0362; Derelle, Evelyne/0000-0002-1499-4240; von Dassow, Peter/0000-0002-1858-1953; Worden, Alexandra/0000-0002-9888-9324; Parker, Micaela/0000-0003-1007-4612; Gundlach, Heidrun/0000-0002-6757-0943; Grigoriev, Igor/0000-0002-3136-8903; Gentemann, Chelle/0000-0002-2250-3106	DOE Biological and Environmental Research Program [DE-AC02-05CH11231, DE-AC52-07NA27344, DE-AC02-06NA25396, DEFC02-99ER62873]; NSF Molecular and Cellular Biosciences (MCB) [0326829, 0429359]; Gordon and Betty Moore Foundation; Lucille and David Packard Foundation	DOE Biological and Environmental Research Program; NSF Molecular and Cellular Biosciences (MCB); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Lucille and David Packard Foundation	We thank the Culture Collection for Marine Phytoplankton and Roscoff Culture Collection for providing isolates, in particular F. LeGall, A. Houdan, and D. Vaulot. We also thank R. Gausling, C. Perle, Q. Ren, D. Root, L. Stal, J. Van Wye, T. Weissman, R.M. Welsh, and U. Wollenzien. F. Partensky, N. Simon, P. Deschamps, and S. Ball facilitated chloroplast and starch (29) annotations; C. Rancurel and B. Cantarel assisted with carbohydrate-active enzymes (with CNRS funding). We are grateful to S. Giovannoni for thoughtful criticism of the manuscript and overall enthusiasm. Genome sequencing was performed under the DOE Biological and Environmental Research Program contracts DE-AC02-05CH11231, DE-AC52-07NA27344, DE-AC02-06NA25396, and DEFC02-99ER62873. U.W.G. and J.-H.L. were funded by NSF Molecular and Cellular Biosciences (MCB) grant 0326829. Funding carrying the project from inception to completion was provided by a Young Investigator in Marine Microbiology award to A.Z.W. from the Gordon and Betty Moore Foundation with additional funds from NSF MCB grant 0429359 and the Lucille and David Packard Foundation. A.Z.W. coordinated the project and annotation; A.Z.W. and U.W.G. wrote the manuscript with input and sections from J.-H.L., T.M., P.R., and M.P.S. (joint second authors are listed in alphabetical order), and Y.V.P. and D.B. performed intellectually based editing to which S. Rombauts and M.S.P. contributed; I.V.G. coordinated the sequencing and analysis at JGI. A.L.A., A.E.A., M.L.C., E. Derelle, M.V.E., E.F., J.G., H.G., B.H., C.N., S.M.M., M.S.P., S. Rombauts, A.S., and P.V.D. also made substantial contributions (listed in alphabetical order). J.H.B. and A.E.A. constructed the phylogenomic analysis tool. A.Z.W., E.V.A., K.F.X.M., U.W.G., and Y.V.P. supervised analyses; A.Z.W. conceived the study with input from D.B., H.M., and E.V.A. All others contributed as members of the Micromonas genome consortium or JGI sequencing and are listed in alphabetical order. RCC299 and CCMP1545 assemblies and annotations are available at www.jgi.doe.gov/MicromonasRCC299 and www.jgi.doe.gov/MicromonasCCMP1545, respectively. Genome assemblies together with predicted gene models and annotations were deposited at DNA Data Bank of Japan/European Molecular Biology Laboratory/GenBank under the project accession numbers ACCO00000000 and ACCP00000000 for RCC299 and CCMP1545, respectively.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Cavalier-Smith T, 2000, TRENDS PLANT SCI, V5, P174, DOI 10.1016/S1360-1385(00)01598-3; Cheah MT, 2007, NATURE, V447, P497, DOI 10.1038/nature05769; Croft MT, 2007, P NATL ACAD SCI USA, V104, P20770, DOI 10.1073/pnas.0705786105; DellaPenna D, 2008, SCIENCE, V320, P479, DOI 10.1126/science.1153715; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Deschamps P, 2008, GENETICS, V178, P2373, DOI 10.1534/genetics.108.087205; Floyd SK, 2007, INT J PLANT SCI, V168, P1, DOI 10.1086/509079; Gaut BS, 2008, SCIENCE, V320, P484, DOI 10.1126/science.1153586; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Goodenough U, 2007, SEMIN CELL DEV BIOL, V18, P350, DOI 10.1016/j.semcdb.2007.02.006; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; KNIGHTJONES EW, 1951, NATURE, V167, P445, DOI 10.1038/167445a0; Lane CE, 2008, TRENDS ECOL EVOL, V23, P268, DOI 10.1016/j.tree.2008.02.004; Lee JH, 2007, PLANT PHYSIOL, V144, P1813, DOI 10.1104/pp.107.100891; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Lynch M, 2007, ORIGINS GENOME ARCHI; McFadden GI, 1999, CURR OPIN PLANT BIOL, V2, P513, DOI 10.1016/S1369-5266(99)00025-4; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wachter A, 2007, PLANT CELL, V19, P3437, DOI 10.1105/tpc.107.053645; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Worden A Z, 2008, MICROECOL OCEANS, V2, P159, DOI [10.1002/9780470281840.ch6, DOI 10.1002/9780470281840.CH6]; Worden AZ, 2006, AQUAT MICROB ECOL, V43, P165, DOI 10.3354/ame043165	28	472	776	6	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					268	272		10.1126/science.1167222	http://dx.doi.org/10.1126/science.1167222			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359590	Green Submitted			2022-12-28	WOS:000265024400051
J	Blumenthal, D				Blumenthal, David			Stimulating the Adoption of Health Information Technology.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Blumenthal, David] Massachusetts Gen Hosp Partners Healthcare Syst, Inst Hlth Policy, Boston, MA 02114 USA; [Blumenthal, David] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Partners Healthcare System; Harvard University; Harvard Medical School	Blumenthal, D (corresponding author), Massachusetts Gen Hosp Partners Healthcare Syst, Inst Hlth Policy, Boston, MA 02114 USA.		Tao, Youyou/D-2367-2014						0	461	466	0	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 9	2009	360	15					1477	1479		10.1056/NEJMp0901592	http://dx.doi.org/10.1056/NEJMp0901592			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	430GL	19321856				2022-12-28	WOS:000264976800001
J	Jugdutt, BI				Jugdutt, Bodh I.			Limiting Fibrosis after Myocardial Infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FRIZZLED-RELATED PROTEIN-2		[Jugdutt, Bodh I.] Univ Alberta, Div Cardiol, Dept Med, Edmonton, AB, Canada; [Jugdutt, Bodh I.] Univ Alberta, Fac Med, Cardiovasc Res Grp, Edmonton, AB, Canada	University of Alberta; University of Alberta	Jugdutt, BI (corresponding author), Univ Alberta, Div Cardiol, Dept Med, Edmonton, AB, Canada.							Blankesteijn WM, 2001, ACTA PHYSIOL SCAND, V173, P75, DOI 10.1046/j.1365-201X.2001.00887.x; Frangogiannis NG, 2006, CURR MED CHEM, V13, P1877, DOI 10.2174/092986706777585086; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104	5	21	24	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 9	2009	360	15					1567	1569		10.1056/NEJMcibr0810801	http://dx.doi.org/10.1056/NEJMcibr0810801			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430GL	19357414				2022-12-28	WOS:000264976800017
J	Mello, MM; Studdert, DM; Brennan, TA				Mello, Michelle M.; Studdert, David M.; Brennan, Troyen A.			Shifting Terrain in the Regulation of Off-Label Promotion of Pharmaceuticals.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FDA; PHYSICIANS; DOCUMENTS; TRIAL		[Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Studdert, David M.] Univ Melbourne, Sch Law, Melbourne, Vic, Australia; [Studdert, David M.] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic, Australia; [Brennan, Troyen A.] CVS Caremark, Woonsocket, RI USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Melbourne; University of Melbourne	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.		Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537; Mello, Michelle/0000-0003-2877-4270	Greenwall Faculty Scholars Program; Australian Research Council	Greenwall Faculty Scholars Program; Australian Research Council(Australian Research Council)	Supported by a grant from the Greenwall Faculty Scholars Program (to Dr. Mello), and a Federation Fellowship from the Australian Research Council (to Dr. Studdert).	Abrams Thomas, 2005, ETHICS PHARM IND, P153; Angell M, 2008, JAMA-J AM MED ASSOC, V300, P1069, DOI 10.1001/jama.300.9.1069; [Anonymous], 1998, FED REG, V63, P64556; BERENSON A, 2006, NY TIMES        0722; Cuzzolin L, 2006, EXPERT OPIN DRUG SAF, V5, P703, DOI 10.1517/14740338.5.5.703; Danzis Scott D., 2005, ETHICS PHARM IND, P184; *DEP JUST, 2006, BIOPH FIRM INT PAY U; *DEP JUST, 2008, OTS PAY MOR 4 MILL R; *DEP JUST, 2005, SER PAY 704 MILL ILL; *DEP JUST, 2007, TOP EX GUIL MISBR OX; *DEP JUST, 2009, JAZZ PHARM INC AGR P; *DEP JUST, 2006, SCH PAY 435 MILL IMP; *DEP JUST, 2007, BRISTOLMYERS SQUIBB; *DEP JUST, 2004, WARNERLAMBERT PAY 43; *DEP JUST CELL THE, 2009, PAY US 10 5 MILL RES; Department of Justice, 2009, E LILL CO AGR PAY 1; Fleisher L.D., 2004, TELEMEDICINE E HLTH; Food and Drug Administration, 1994, FED REGISTER, V59, P59820; *GOV ACC OFF, 2008, PUBL GOV ACC OFF; Greenland P, 2008, JAMA-J AM MED ASSOC, V299, P953, DOI 10.1001/jama.299.8.953; Helm Katherine A., 2007, FORDHAM INTELLECTUAL, V18, P117, DOI DOI 10.1007/S00228-005-0981-Y; Hill KP, 2008, ANN INTERN MED, V149, P251, DOI 10.7326/0003-4819-149-4-200808190-00006; Kesselheim AS, 2008, ANN INTERN MED, V149, P342, DOI 10.7326/0003-4819-149-5-200809020-00009; Kesselheim AS, 2008, NEW ENGL J MED, V359, P536; Kesselheim AS, 2008, NEW ENGL J MED, V358, P1727, DOI 10.1056/NEJMsb0708920; Loucks MK, 2006, FOOD DRUG LAW J, V61, P577; Lurie P, 2005, J PUBLIC HEALTH POL, V26, P389, DOI 10.1057/palgrave.jphp.3200049; MARKUS CM, 2008, HLTH LAWYERS WE 0404; MUNDY A, 2008, WALL STREET J   0418, pA14; *OFF COMM OFF POL, 2009, GUID IND GOOD REPR P; ORSINIMEINHARD K, 2007, SEATTLE TIMES   0418, pD1; Psaty BM, 2008, JAMA-J AM MED ASSOC, V299, P1949, DOI 10.1001/jama.299.16.1949; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Ross JS, 2008, JAMA-J AM MED ASSOC, V299, P1800, DOI 10.1001/jama.299.15.1800; SAUL S, 2008, NY TIMES        0419, pB3; Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107; US Food and Drug Administration, 2009, FED REGISTER, V74, P1694; 1992, FED REG, V57, P56412; 2007, FDA WEEK, V13; 1996, FED REG, V61, P52800	40	47	51	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 9	2009	360	15					1557	1566		10.1056/NEJMhle0807695	http://dx.doi.org/10.1056/NEJMhle0807695			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430GL	19357413				2022-12-28	WOS:000264976800016
J	Phan, A; Shufelt, C; Merz, CNB				Phan, Anita; Shufelt, Chrisandra; Merz, C. Noel Bairey			Persistent Chest Pain and No Obstructive Coronary Artery Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIAC SYNDROME-X; CONVERTING ENZYME-INHIBITION; REFRACTORY ANGINA-PECTORIS; SYNDROME EVALUATION WISE; SPINAL-CORD STIMULATION; ENDOTHELIAL DYSFUNCTION; BLOOD-FLOW; FOLLOW-UP; VASODILATOR RESERVE; UNSTABLE ANGINA	Patients with persistent chest pain and no obstructive coronary artery disease are often labeled as having noncardiac pain and not offered further cardiologic testing or treatment. Diagnostic uncertainty for persistent chest pain is associated with adverse quality of life, morbidity, and health care costs. Two underdiagnosed cardiac causes for persistent chest pain include microvascular coronary disease and abnormal cardiac nociception. Microvascular coronary disease is associated with an increased risk of adverse cardiovascular events such as myocardial infarction, congestive heart failure, and sudden cardiac death, and treatment directed at improving endothelial function can improve outcomes. Abnormal cardiac nociception is also a cause for persistent chest pain caused by heightened coronary pain perception. Coronary reactivity testing allows for direct measurement of blood flow characteristics in response to vasoactive agents for the diagnoses of microvascular coronary disease and can be a useful tool to differentiate causes of chest pain. Coronary reactivity testing is an invasive method for assessing coronary vascular function, with current evidence suggesting that its associated risk is relatively low compared with the adverse prognosis associated with microvascular coronary dysfunction. Accurate diagnosis in patients with persistent chest pain and normal coronary arteries can be challenging and deserves adequate investigation in light of the associated morbidity, mortality, and health care costs.	[Phan, Anita; Shufelt, Chrisandra; Merz, C. Noel Bairey] Cedars Sinai Med Ctr, Dept Med, Cedars Sinai Heart Inst, Div Cardiol, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Merz, CNB (corresponding author), 444 S San Vicente Blvd,Ste 600, Los Angeles, CA 90272 USA.	merz@cshs.org		Shufelt, Chrisandra/0000-0001-6886-9210	National Heart, Lung, and Blood Institute [N01-HV-68161, N01-HV-68162, N01-HV-68163, N01-HV-68164]; National Center for Research Resources [MO1-RR00425]; Gustavus and Louis Pfeiffer Research Foundation, Denville, New Jersey; Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh; Edythe L. Broad Women's Heart Research Endowment, Cedars-Sinai Medical Center; Barbra Streisand Women's Heart Disease Research and Education Program, Cedars-Sinai Medical Center, Los Angeles, California; DIVISION OF HEART AND VASCULAR DISEASES [N01HV068162, N01HV068161, N01HV068164, N01HV068163] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Gustavus and Louis Pfeiffer Research Foundation, Denville, New Jersey; Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh; Edythe L. Broad Women's Heart Research Endowment, Cedars-Sinai Medical Center; Barbra Streisand Women's Heart Disease Research and Education Program, Cedars-Sinai Medical Center, Los Angeles, California; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding/Support: This work was supported by contracts from the National Heart, Lung, and Blood Institute (N01-HV-68161, N01-HV-68162, N01-HV-68163, N01-HV-68164), General Clinical Research Center grant MO1-RR00425 from the National Center for Research Resources, and grants from the Gustavus and Louis Pfeiffer Research Foundation, Denville, New Jersey; the Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh; the Women's Guild of Cedars-Sinai Medical Center; the Edythe L. Broad Women's Heart Research Endowment, Cedars-Sinai Medical Center; and the Barbra Streisand Women's Heart Disease Research and Education Program, Cedars-Sinai Medical Center, Los Angeles, California.	Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Alegria JR, 2005, EUR HEART J, V26, P1159, DOI 10.1093/eurheartj/ehi203; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Bugiardini R, 2005, JAMA-J AM MED ASSOC, V293, P477, DOI 10.1001/jama.293.4.477; BUGIARDINI R, 1989, AM J CARDIOL, V63, P286, DOI 10.1016/0002-9149(89)90332-9; Caliskan M, 2007, CLIN CARDIOL, V30, P475, DOI 10.1002/clc.20140; CANNON RO, 1990, J AM COLL CARDIOL, V16, P1359, DOI 10.1016/0735-1097(90)90377-2; CANNON RO, 1994, NEW ENGL J MED, V330, P1411, DOI 10.1056/NEJM199405193302003; CANNON RO, 1985, AM J CARDIOL, V56, P242, DOI 10.1016/0002-9149(85)90842-2; CHAUHAN A, 1994, J AM COLL CARDIOL, V23, P364, DOI 10.1016/0735-1097(94)90421-9; CHAUHAN A, 1994, CIRCULATION, V89, P694, DOI 10.1161/01.CIR.89.2.694; Chen JW, 2002, AM J CARDIOL, V90, P974, DOI 10.1016/S0002-9149(02)02664-4; COOKE RA, 1994, BRIT HEART J, V72, P231; DIVER DJ, 1994, AM J CARDIOL, V74, P531, DOI 10.1016/0002-9149(94)90739-0; GULATI MCD, ARCH INTERN IN PRESS; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Hasdai D, 1998, MAYO CLIN PROC, V73, P1133, DOI 10.4065/73.12.1133; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Houghton JL, 2000, CHEST, V118, P756, DOI 10.1378/chest.118.3.756; ISNER JM, 1981, AM HEART J, V102, P645, DOI 10.1016/0002-8703(81)90088-0; KASKI JC, 1994, J AM COLL CARDIOL, V23, P652, DOI 10.1016/0735-1097(94)90750-1; KATON W, 1988, AM J MED, V84, P1, DOI 10.1016/0002-9343(88)90001-0; Kayikcioglu M, 2003, EUR HEART J, V24, P1999, DOI 10.1016/S0195-668X(03)00478-0; Kelley BM, 1997, PHARMACOL BIOCHEM BE, V57, P707, DOI 10.1016/S0091-3057(96)00342-5; LAGERQVIST B, 1992, BRIT HEART J, V68, P282; LANTINGA LJ, 1988, AM J CARDIOL, V62, P209, DOI 10.1016/0002-9149(88)90213-5; Lanza GA, 1999, AM J CARDIOL, V84, P854, DOI 10.1016/S0002-9149(99)00450-6; Merz CNB, 2007, CURR CARDIOVASC RISK, V1, P167; MERZ CNB, 2006, J AM COLL CARDIOL, V47, pS21, DOI [DOI 10.1016/J.JACC.2004.12.084, 10.1016/j.jacc.2004.12.084]; Modena MG, 2002, J AM COLL CARDIOL, V40, P505, DOI 10.1016/S0735-1097(02)01976-9; Murray S, 1999, HEART, V82, P89, DOI 10.1136/hrt.82.1.89; Murray S, 2000, HEART, V83, P217, DOI 10.1136/heart.83.2.217; Pepine CJ, 2008, J AM COLL CARDIOL, V52, P528, DOI 10.1016/j.jacc.2008.03.065; PHIBBS B, 1988, AM J CARDIOL, V62, P472, DOI 10.1016/0002-9149(88)90982-4; POTTS SG, 1995, PSYCHOL MED, V25, P339, DOI 10.1017/S0033291700036242; Qian JY, 2000, AM HEART J, V140, P502, DOI 10.1067/mhj.2000.109221; Quyyumi AA, 2006, J AM COLL CARDIOL, V47, p66S, DOI 10.1016/j.jacc.2004.11.075; Reis SE, 2001, AM HEART J, V141, P735, DOI 10.1067/mhj.2001.114198; Rosen SD, 2002, HEART, V87, P513, DOI 10.1136/heart.87.6.513; ROSEN SD, 1994, CIRCULATION, V90, P50, DOI 10.1161/01.CIR.90.1.50; SHAPIRO LM, 1988, BRIT MED J, V296, P170, DOI 10.1136/bmj.296.6616.170-a; Shaw LJ, 2006, CIRCULATION, V114, P894, DOI 10.1161/CIRCULATIONAHA.105.609990; Simaitis Audrius, 2003, Medicina (Kaunas), V39, P21; TenVaarwerk IAM, 1999, HEART, V82, P82, DOI 10.1136/hrt.82.1.82; Tio RA, 2002, J INVEST MED, V50, P133, DOI 10.2310/6650.2002.31305; Tsujita K, 2008, AM J CARDIOL, V102, P1608, DOI 10.1016/j.amjcard.2008.07.054; Valeriani M, 2005, EUR HEART J, V26, P975, DOI 10.1093/eurheartj/ehi229; von Mering GO, 2004, CIRCULATION, V109, P722, DOI 10.1161/01.CIR.0000115525.92645.16; Wu EB, 2000, QJM-INT J MED, V93, P543, DOI 10.1093/qjmed/93.8.543; Yang EH, 2004, MAYO CLIN PROC, V79, P1284, DOI 10.4065/79.10.1284; ZEIHER AM, 1991, CIRCULATION, V84, P1984, DOI 10.1161/01.CIR.84.5.1984	51	49	55	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 8	2009	301	14					1468	1474		10.1001/jama.2009.425	http://dx.doi.org/10.1001/jama.2009.425			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429MN	19351944				2022-12-28	WOS:000264924900027
J	Waltz, D; Buchanan, BG				Waltz, David; Buchanan, Bruce G.			Automating Science	SCIENCE			English	Editorial Material									[Waltz, David] Columbia Univ, Ctr Computat Learning Syst, New York, NY 10115 USA; [Buchanan, Bruce G.] Univ Pittsburgh, Dept Comp Sci, Pittsburgh, PA 15260 USA	Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Waltz, D (corresponding author), Columbia Univ, Ctr Computat Learning Syst, New York, NY 10115 USA.	waltz@ccls.columbia.edu; buchanan@cs.pitt.edu			NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NCI NIH HHS [5 U54 CA 121852-03] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON C, 2008, WIRED            JUN; Duda R., 1979, Expert Systems in the Micro-Electronic Age. Proceedings of the 1979 AISB Summer School, P153; King RD, 2009, SCIENCE, V324, P85, DOI 10.1126/science.1165620; LANGLEY P, 1981, COGNITIVE SCI, V5, P31, DOI 10.1016/S0364-0213(81)80025-0; Lindsay R.K., 1980, APPL ARTIF INTELL, V1st ed.; Muggleton SH, 2006, NATURE, V440, P409, DOI 10.1038/440409a; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Srinivasan A, 1996, ARTIF INTELL, V85, P277, DOI 10.1016/0004-3702(95)00122-0; ZYTKOW JM, 1990, PROCEEDINGS : EIGHTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 AND 2, P889; MACH READ PAP 2007 A	10	38	38	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 3	2009	324	5923					43	44		10.1126/science.1172781	http://dx.doi.org/10.1126/science.1172781			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427TN	19342574				2022-12-28	WOS:000264802100022
J	Zinner, E				Zinner, Elmer			The Women's & Children's HMO	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												ezinner@stny.rr.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 1	2009	301	13					1320	1320		10.1001/jama.2009.421	http://dx.doi.org/10.1001/jama.2009.421			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426LM	19336698				2022-12-28	WOS:000264709800001
J	Hagedorn, M; Rohde, KH; Russell, DG; Soldati, T				Hagedorn, Monica; Rohde, Kyle H.; Russell, David G.; Soldati, Thierry			Infection by Tubercular Mycobacteria Is Spread by Nonlytic Ejection from Their Amoeba Hosts	SCIENCE			English	Article							MARINUM; MACROPHAGES; VISUALIZATION; SECRETION; GRANULOMA; VIRULENCE	To generate efficient vaccines and cures for Mycobacterium tuberculosis, we need a far better understanding of its modes of infection, persistence, and spreading. Host cell entry and the establishment of a replication niche are well understood, but little is known about how tubercular mycobacteria exit host cells and disseminate the infection. Using the social amoeba Dictyostelium as a genetically tractable host for pathogenic mycobacteria, we discovered that M. tuberculosis and M. marinum, but not M. avium, are ejected from the cell through an actin-based structure, the ejectosome. This conserved nonlytic spreading mechanism requires a cytoskeleton regulator from the host and an intact mycobacterial ESX-1 secretion system. This insight offers new directions for research into the spreading of tubercular mycobacteria infections in mammalian cells.	[Hagedorn, Monica; Soldati, Thierry] Univ Geneva, Fac Sci, Dept Biochim, CH-1211 Geneva 4, Switzerland; [Rohde, Kyle H.; Russell, David G.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA	University of Geneva; Cornell University	Soldati, T (corresponding author), Univ Geneva, Fac Sci, Dept Biochim, Sci 2,30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	thierry.soldati@unige.ch	Russell, David G/N-5280-2019; Russell, David G/D-4533-2009; SOLDATI, Thierry/U-6494-2019; SOLDATI, Thierry/A-2902-2009	Russell, David G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X; SOLDATI, Thierry/0000-0002-2056-7931; SOLDATI, Thierry/0000-0002-2056-7931	Swiss National Science Foundation; Swiss 3R Foundation; U.S. NIH [AI 067027, HL 055936]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067027] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss 3R Foundation; U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We gratefully acknowledge L. Ramakrishnan and C. Cosma for providing strains of M. marinum, various GFP expression vectors, and advice; G. Griffiths for GFP-expressing M. avium; B. C. VanderVen for providing GFP-expressing M. tuberculosis; F. Rivero and M. Maniak for providing Dictyostelium mutant strains; C. Bauer of the National Center of Competence in Research imaging platform for his help with microscopy; P. Walther and E. Schmid for their expert help with the SEM; and D. Soldati for critical reading of the manuscript. The work was supported by the Swiss National Science Foundation in the form of a grant to T.S. and an individual short-term fellowship to M.H. The T.S. group participates in the NEMO (nonmammalian experimental models for the study of bacterial infections) network supported by the Swiss 3R Foundation. D.G.R. and K.H.R. are supported by grants AI 067027 and HL 055936 from the U.S. NIH.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Boyer L, 2006, J CELL BIOL, V173, P809, DOI 10.1083/jcb.200509009; Byrd TF, 1998, INFECT IMMUN, V66, P5132, DOI 10.1128/IAI.66.11.5132-5139.1998; Carlsson F, 2006, J CELL PHYSIOL, V209, P288, DOI 10.1002/jcp.20721; Castro-Garza J, 2002, FEMS MICROBIOL LETT, V212, P145, DOI 10.1111/j.1574-6968.2002.tb11258.x; Chen GK, 2007, SCIENCE, V317, P678, DOI 10.1126/science.1143991; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Lee E, 2002, TRAFFIC, V3, P186, DOI 10.1034/j.1600-0854.2002.030304.x; Mandato CA, 2001, J CELL BIOL, V154, P785, DOI 10.1083/jcb.200103105; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Somesh BP, 2006, TRAFFIC, V7, P1194, DOI 10.1111/j.1600-0854.2006.00455.x; Stamm LA, 2004, MICROBES INFECT, V6, P1418, DOI 10.1016/j.micinf.2004.10.003; Stamm LM, 2005, P NATL ACAD SCI USA, V102, P14837, DOI 10.1073/pnas.0504663102; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Tan T, 2006, CELL MICROBIOL, V8, P1417, DOI 10.1111/j.1462-5822.2006.00721.x; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; ZIGMOND SH, 1993, CELL MOTIL CYTOSKEL, V25, P309, DOI 10.1002/cm.970250402	27	157	159	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1729	1733		10.1126/science.1169381	http://dx.doi.org/10.1126/science.1169381			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325115	Green Published, Green Accepted			2022-12-28	WOS:000264559800040
J	Chakraborty, P; Gioia, G; Kieffer, SW				Chakraborty, Pinaki; Gioia, Gustavo; Kieffer, Susan W.			Volcanic mesocyclones	NATURE			English	Article							ERUPTION	A strong volcanic plume consists of a vertical column of hot gases and dust topped with a horizontal 'umbrella'(1). The column rises, buoyed by entrained and heated ambient air, reaches the neutral-buoyancy level, then spreads radially to form the umbrella. In classical models of strong volcanic plumes, the plume is assumed to remain always axisymmetric and non-rotating. Here we show that the updraught of the rising column induces a hydrodynamic effect not addressed to date-a 'volcanic mesocyclone'. This volcanic mesocyclone sets the entire plume rotating about its axis, as confirmed by an unprecedented analysis of satellite images from the 1991 eruption of Mount Pinatubo(2-4). Destabilized by the rotation, the umbrella loses axial symmetry and becomes lobate in plan view, in accord with satellite records of recent eruptions on Mounts Pinatubo, Manam, Reventador, Okmok, Chaiten and Ruang. The volcanic mesocyclone spawns waterspouts(5,6) or dust devils(6-8), as seen in numerous eruptions, and groups the electric charges about the plume to form the 'lightning sheath' that was so prominent in the recent eruption of Mount Chaiten. The concept of a volcanic mesocyclone provides a unified explanation for a disparate set of poorly understood phenomena in strong volcanic plumes(5-10).	[Chakraborty, Pinaki; Kieffer, Susan W.] Univ Illinois, Dept Geol, Urbana, IL 61801 USA; [Gioia, Gustavo] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Chakraborty, P (corresponding author), Univ Illinois, Dept Geol, Urbana, IL 61801 USA.	chakrabo@illinois.edu			Walgreen Chair funds; NSF\EAR [06-09712]; NSF\DMR [06-04435]	Walgreen Chair funds; NSF\EAR(National Science Foundation (NSF)); NSF\DMR(National Science Foundation (NSF))	We acknowledge discussions with A. Tupper, D. MacGorman, S. Nesbitt and M. Fromm. We thank the members of the 'volcanic clouds' discussion list for help with satellite images. P. C. and S. W. K. acknowledge support through the latter's Walgreen Chair funds and NSF\EAR grant 06-09712 (S. Esperanza, programme director). G. G. acknowledges support through NSF\DMR grant 06-04435 (W. Fuller-Mora, programme director).	ANDERSON R, 1965, SCIENCE, V148, P1179, DOI 10.1126/science.148.3674.1179; Baines PG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024597; BRUNING E, 2008, THESIS U OKLAHOMA; Chakraborty P, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024915; DAVIESJONES RP, 2001, METEOR MONOGR AM MET, V50, P167, DOI DOI 10.1175/0065-9401-28.50.167; Dubosclard G, 1999, GEOPHYS RES LETT, V26, P3389, DOI 10.1029/1999GL008371; Gioia G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.138001; GRIFFITHS RW, 1986, ANNU REV FLUID MECH, V18, P59, DOI 10.1146/annurev.fl.18.010186.000423; Hoblitt RP, 2000, PHILOS T ROY SOC A, V358, P1639, DOI 10.1098/rsta.2000.0608; Holasek RE, 1996, J GEOPHYS RES-SOL EA, V101, P27635, DOI 10.1029/96JB01179; KLEMP JB, 1987, ANNU REV FLUID MECH, V19, P369, DOI 10.1146/annurev.fluid.19.1.369; Krehbiel PR, 2000, EOS T AGU, V81, P21, DOI DOI 10.1029/00EO00014; Landau L. D., 1988, COURSE THEORETICAL P, V6; LINDEN PF, 1992, ROTATING FLUIDS GEOP, P99; MacGorman DR, 2005, MON WEATHER REV, V133, P2583, DOI 10.1175/MWR2994.1; Mather TA, 2006, SURV GEOPHYS, V27, P387, DOI 10.1007/s10712-006-9007-2; Oswalt JS, 1996, FIRE AND MUD, P625; PAYNE C, 2008, THESIS U OKLAHORNA; Pedlosky J. P., 1979, GEOPHYS FLUID DYNAMI; Self S, 1996, FIRE AND MUD, P1089; Sparks RSJ, 1997, VOLCANIC PLUMES, P574; STOTHERS RB, 1984, SCIENCE, V224, P1191, DOI 10.1126/science.224.4654.1191; Tennekes H., 1972, 1 COURSE TURBULENCE; Thomas RJ, 2007, SCIENCE, V315, P1097, DOI 10.1126/science.1136091; Thorarinsson S., 1964, B AM METEOROL SOC, V45, P440; Tillard S., 1812, PHILOS T ROYAL SOC L, V102, P152; Tupper A, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005499; VALENTINE GA, 1989, J GEOPHYS RES-SOLID, V94, P1867, DOI 10.1029/JB094iB02p01867; Wiens KC, 2005, J ATMOS SCI, V62, P4151, DOI 10.1175/JAS3615.1	30	14	14	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					497	500		10.1038/nature07866	http://dx.doi.org/10.1038/nature07866			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19325632				2022-12-28	WOS:000264532400042
J	Seeliger, MA; Kuriyan, J				Seeliger, Markus A.; Kuriyan, John			A MAPK scaffold Lends a Helping Hand	CELL			English	Editorial Material							PROTEINS; KINASE	The scaffold proteins of signaling pathways are thought to act as passive tethering devices bringing together catalytic components of signaling cascades. Good et al. (2009) now reveal that in the budding yeast the scaffold protein Ste5 acts as an allosteric activator of the mitogen-activated protein kinase Fus3, rendering it competent to be a kinase substrate for signal transmission.	[Seeliger, Markus A.; Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Seeliger, Markus A.; Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Seeliger, Markus A.; Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kuriyan, J (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu	Seeliger, Markus A/D-6409-2013	Seeliger, Markus/0000-0003-0990-1756	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075	6	5	5	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					994	996		10.1016/j.cell.2009.03.002	http://dx.doi.org/10.1016/j.cell.2009.03.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303841	Bronze			2022-12-28	WOS:000264403900004
J	Shimoyama, T; Kato, S; Ishii, S; Watanabe, K				Shimoyama, Takefumi; Kato, Souichiro; Ishii, Shun'ichi; Watanabe, Kazuya			Flagellum Mediates Symbiosis	SCIENCE			English	Article									[Shimoyama, Takefumi; Kato, Souichiro; Ishii, Shun'ichi; Watanabe, Kazuya] Marine Biotechnol Inst, Lab Appl Microbiol, Kamaishi, Iwate 0260001, Japan; [Shimoyama, Takefumi; Watanabe, Kazuya] Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; [Kato, Souichiro; Watanabe, Kazuya] Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Hashimoto Light Energy Convers Project, Bunkyo Ku, Tokyo 1138656, Japan; [Ishii, Shun'ichi] J Craig Venter Inst, San Diego, CA 92121 USA	University of Tokyo; Japan Science & Technology Agency (JST); J. Craig Venter Institute	Watanabe, K (corresponding author), Marine Biotechnol Inst, Lab Appl Microbiol, 3-75-1 Heita, Kamaishi, Iwate 0260001, Japan.	watanabe@light.t.u-tokyo.ac.jp	Kato, Souichiro/M-4151-2018; Albers, Pieter/I-2563-2017	Kato, Souichiro/0000-0002-2527-7730; Ishii, Shun'ichi/0000-0002-0203-8569	New Energy Development Organization of Japan; JST; Japan Society for Promotion of Science	New Energy Development Organization of Japan; JST(Japan Science & Technology Agency (JST)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank K. Nealson for the critical reading of the manuscript, T. Kosaka for microarray setup, and F. Numazaki and M. Sato for technical assistance. This work was supported by the New Energy Development Organization of Japan, JST, and the Japan Society for Promotion of Science.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ishii S, 2005, APPL ENVIRON MICROB, V71, P7838, DOI 10.1128/AEM.71.12.7838-7845.2005; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997	4	88	97	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1574	1574		10.1126/science.1170086	http://dx.doi.org/10.1126/science.1170086			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299611				2022-12-28	WOS:000264342300029
J	Pass, RF; Zhang, CP; Evans, A; Simpson, T; Andrews, W; Huang, ML; Corey, L; Hill, J; Davis, E; Flanigan, C; Cloud, G				Pass, Robert F.; Zhang, Changpin; Evans, Ashley; Simpson, Tina; Andrews, William; Huang, Meei-Li; Corey, Lawrence; Hill, Janie; Davis, Elizabeth; Flanigan, Cynthia; Cloud, Gretchen			Vaccine Prevention of Maternal Cytomegalovirus Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLYCOPROTEIN-B; CLINICAL-TRIALS; RELATIVE IMPORTANCE; WOMEN; IMMUNITY; DISEASE; TRANSMISSION; INFANTS	Background Congenital infection with cytomegalovirus (CMV) is an important cause of hearing, cognitive, and motor impairments in newborns. Methods In this phase 2, placebo-controlled, randomized, double-blind trial, we evaluated a vaccine consisting of recombinant CMV envelope glycoprotein B with MF59 adjuvant, as compared with placebo. Three doses of the CMV vaccine or placebo were given at 0, 1, and 6 months to CMV-seronegative women within 1 year after they had given birth. We tested for CMV infection in the women in quarterly tests during a 42-month period, using an assay for IgG antibodies against CMV proteins other than glycoprotein B. Infection was confirmed by virus culture or immunoblotting. The primary end point was the time until the detection of CMV infection. Results We randomly assigned 234 subjects to receive the CMV vaccine and 230 subjects to receive placebo. A scheduled interim analysis led to a stopping recommendation because of vaccine efficacy. After a minimum of 1 year of follow-up, there were 49 confirmed infections, 18 in the vaccine group and 31 in the placebo group. Kaplan-Meier analysis showed that the vaccine group was more likely to remain uninfected during a 42-month period than the placebo group (P = 0.02). Vaccine efficacy was 50% (95% confidence interval, 7 to 73) on the basis of infection rates per 100 person-years. One congenital infection among infants of the subjects occurred in the vaccine group, and three infections occurred in the placebo group. There were more local reactions (pain, erythema, induration, and warmth) and systemic reactions (chills, arthralgias, and myalgias) in the vaccine group than in the placebo group. Conclusions CMV glycoprotein B vaccine has the potential to decrease incident cases of maternal and congenital CMV infection. (ClinicalTrials.gov number, NCT00125502.)	[Andrews, William] Univ Alabama, Dept Obstet & Gynecol, Birmingham, AL USA; [Flanigan, Cynthia; Cloud, Gretchen] Univ Alabama, Dept Med, Birmingham, AL USA; [Evans, Ashley; Davis, Elizabeth] Univ Alabama, Coll Community Hlth Sci, Dept Pediat, Tuscaloosa, AL USA; [Huang, Meei-Li; Corey, Lawrence] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Corey, Lawrence] Univ Washington, Dept Med, Seattle, WA USA; [Pass, Robert F.; Zhang, Changpin; Simpson, Tina; Hill, Janie] Univ Alabama, Dept Pediat, Birmingham, AL USA; [Huang, Meei-Li; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Tuscaloosa; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham; Fred Hutchinson Cancer Center	Pass, RF (corresponding author), Childrens Hosp, 1600 7th Ave S,CHB 309, Birmingham, AL 35233 USA.	rpass@peds.uab.edu	Corey, Lawrence/AAE-1796-2020	Corey, Lawrence/0000-0002-2179-2436; Pass, Robert/0000-0003-2029-0247	National Institute of Allergy and Infectious Diseases [P01AI043681, U01AI063565]; National Center for Research Resources [M01 RR-00032]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI043681, U01AI063565] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by Sanofi Pasteur and by grants to the University of Alabama at Birmingham (P01AI043681 and U01AI063565) from the National Institute of Allergy and Infectious Diseases and a grant (M01 RR-00032) from the National Center for Research Resources. Study vaccine was provided by Sanofi Pasteur, and MF59 adjuvant was provided by Chiron (now Novartis).	ADLER SP, 1995, J INFECT DIS, V171, P26, DOI 10.1093/infdis/171.1.26; ADLER SP, 1995, J INFECT DIS, V171, P1080; AHLFORS K, 1984, SCAND J INFECT DIS, V16, P129, DOI 10.3109/00365548409087131; Bale JF, 1996, J PEDIATR-US, V128, P347, DOI 10.1016/S0022-3476(96)70279-2; Boeckh M, 2004, J CLIN MICROBIOL, V42, P1142, DOI 10.1128/JCM.42.3.1142-1148.2004; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; CHANDLER SH, 1987, J INFECT DIS, V155, P655, DOI 10.1093/infdis/155.4.655; *CLINICALTRIALS GO, REC CMV GB VACC POST; COX DR, 1972, J R STAT SOC B, V34, P187; Fowler KB, 2004, CLIN INFECT DIS, V38, P1035, DOI 10.1086/382533; Fowler KB, 2003, JAMA-J AM MED ASSOC, V289, P1008, DOI 10.1001/jama.289.8.1008; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; Frey SE, 1999, J INFECT DIS, V180, P1700, DOI 10.1086/315060; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; LEACH CT, 1994, J INFECT DIS, V170, P293, DOI 10.1093/infdis/170.2.293; Mach M, 2006, CYTOMEGALOVIRUSES: MOLECULAR BIOLOGY AND IMMUNOLOGY, P265; MARSHALL GS, 1992, J INFECT DIS, V165, P381, DOI 10.1093/infdis/165.2.381; Mitchell DK, 2002, PEDIATR INFECT DIS J, V21, P133, DOI 10.1097/00006454-200202000-00009; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; PASS RF, 1982, J INFECT DIS, V146, P1, DOI 10.1093/infdis/146.1.1; Pass RF, 1999, J INFECT DIS, V180, P970, DOI 10.1086/315022; PLOTKIN SA, 1984, LANCET, V1, P528; STAGNO S, 1982, NEW ENGL J MED, V306, P945, DOI 10.1056/NEJM198204223061601; STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904; STAGNO S, 1977, NEW ENGL J MED, V296, P1254, DOI 10.1056/NEJM197706022962203; Stratton KR, 2001, VACCINES 21 CENTURY; Zhang CP, 2006, J CLIN VIROL, V35, P338, DOI 10.1016/j.jcv.2005.09.020; Zhang CP, 2004, VACCINE, V23, P507, DOI 10.1016/j.vaccine.2004.06.027	31	511	544	2	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2009	360	12					1191	1199		10.1056/NEJMoa0804749	http://dx.doi.org/10.1056/NEJMoa0804749			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420IU	19297572	Green Accepted			2022-12-28	WOS:000264283400005
J	Peterson, E; Yancy, CW				Peterson, Eric; Yancy, Clyde W.			Eliminating Racial and Ethnic Disparities in Cardiac Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Peterson, Eric] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA; [Peterson, Eric] Duke Clin Res Inst, Durham, NC USA; [Yancy, Clyde W.] Baylor Univ, Med Ctr, Dallas, TX USA	Duke University; Duke University; Baylor University; Baylor University Medical Center	Peterson, E (corresponding author), Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA.		Peterson, Eric David/ABF-5033-2021					American College of Cardiology Foundation, 2002, RAC ETHN DIFF CARD C; Bonow RO, 2005, CIRCULATION, V111, P1205, DOI 10.1161/01.CIR.0000160705.97642.92; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; OBERMAN A, 1984, AM HEART J, V108, P688, DOI 10.1016/0002-8703(84)90656-2; *RW JOHNS FDN QUAL, 2008, EXP SUCC EXC CARD CA	5	45	45	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2009	360	12					1172	1174		10.1056/NEJMp0810121	http://dx.doi.org/10.1056/NEJMp0810121			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	420IU	19297569				2022-12-28	WOS:000264283400002
J	Marmot, MG; Bell, R				Marmot, Michael G.; Bell, Ruth			Action on Health Disparities in the United States Commission on Social Determinants of Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GAP		[Marmot, Michael G.] UCL, Dept Epidemiol, Int Inst Soc & Hlth, London WC1E 6BT, England; UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Marmot, Michael G.] WHO, Commiss Social Determinants Hlth, Geneva, Switzerland	University of London; University College London; University of London; University College London; World Health Organization	Marmot, MG (corresponding author), UCL, Dept Epidemiol, Int Inst Soc & Hlth, 1-19 Torrington Pl, London WC1E 6BT, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G8802774, G19/35, G0100222] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2008, CLOS GAP GEN HLTH EQ; [Anonymous], 2008, WORLD HLTH STAT 2008; Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Commission on Social Determinants of Health, 2008, CSDH FIN REP CLOS GA; Forde I, 2008, LANCET, V372, P1694, DOI 10.1016/S0140-6736(08)61695-5; *HUM DEV REP TEAM, 2008, HUM DEV IND STAT UPD; Marmot MG, 2006, JAMA-J AM MED ASSOC, V295, P1304, DOI 10.1001/jama.295.11.1304; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Murphy M, 2006, AM J PUBLIC HEALTH, V96, P1293, DOI 10.2105/AJPH.2004.056929; Organisation for Economic Co-operation and Development, 2008, GROW UN INC DISTR PO; *RW JOHN FDN, 2008, OV OBST HLTH REP RW; Singh GK, 2006, INT J EPIDEMIOL, V35, P969, DOI 10.1093/ije/dyl083; United Nations Commission on Human Security, 2007, HUM DEV REP 2007 200; *US BUR LAB STAT, 2009, EMPL SIT JAN 2009; Wilensky GR, 2009, HEALTH AFFAIR, V28, pW194, DOI 10.1377/hlthaff.28.2.w194; Woolf SH, 2008, AM J PUBLIC HEALTH, V98, pS26, DOI 10.2105/AJPH.98.Supplement_1.S26	16	103	105	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 18	2009	301	11					1169	1171		10.1001/jama.2009.363	http://dx.doi.org/10.1001/jama.2009.363			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419UC	19293419				2022-12-28	WOS:000264244200024
J	McColl, RJ; Dixon, E				McColl, Ryan J.; Dixon, Elijah			Review: Perioperative beta-blockers provide no clear benefit in patients having noncardiac surgery	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[McColl, Ryan J.; Dixon, Elijah] Univ Calgary, Calgary, AB, Canada	University of Calgary	McColl, RJ (corresponding author), Univ Calgary, Calgary, AB, Canada.							Bangalore S, 2008, LANCET, V372, P1962, DOI 10.1016/S0140-6736(08)61560-3; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6							JC3-4	10.7326/0003-4819-150-6-200903170-02004	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423AJ	19306485				2022-12-28	WOS:000264468500027
J	Sterne, JAC; May, M; Costagliola, D; de Wolf, F; Phillips, AN; Harris, R; Funk, MJ; Geskus, RB; Gill, J; Dabis, F; Miro, JM; Justice, AC; Ledergerber, B; Fatkenheuer, G; Hogg, RS; Monforte, AD; Saag, M; Smith, C; Staszewski, S; Egger, M; Cole, SR				Sterne, Jonathan A. C.; May, Margaret; Costagliola, Dominique; de Wolf, Frank; Phillips, Andrew N.; Harris, Ross; Funk, Michele Joensson; Geskus, Ronald B.; Gill, John; Dabis, Francois; Miro, Jose M.; Justice, Amy C.; Ledergerber, Bruno; Faetkenheuer, Gerd; Hogg, Robert S.; Monforte, Antonella D'Arminio; Saag, Michael; Smith, Colette; Staszewski, Schlomo; Egger, Matthias; Cole, Stephen R.		Start Consortium	Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIROLOGICAL TREATMENT FAILURE; T-LYMPHOCYTE COUNTS; CD4 CELL COUNTS; BASE-LINE; DISEASE PROGRESSION; INFECTED PATIENTS; VIRAL LOAD; RISK; TIME	Background The CD4 cell count at which combination antiretroviral therapy should be started is a central, unresolved issue in the care of HIV-1-infected patients. in the absence of randomised trials, we examined this question in prospective cohort studies. Methods We analysed data from 18 cohort studies of patients with HIV. Antiretroviral-naive patients from 15 of these studies were eligible for inclusion if they had started combination antiretroviral therapy (while AIDS-free, with a CD4 cell count less than 550 cells per mu L, and with no history of injecting drug use) on or after Jan 1, 1998. We used data from patients followed up in seven of the cohorts in the era before the introduction of combination therapy (1989-95) to estimate distributions of lead times (from the first CD4 cell count measurement in an upper range to the upper threshold of a lower range) and unseen AIDS and death events (occurring before the upper threshold of a lower CD4 cell count range is reached) in the absence of treatment. These estimations were used to impute completed datasets in which lead times and unseen AIDS and death events were added to data for treated patients in deferred therapy groups. We compared the effect of deferred initiation of combination therapy with immediate initiation on rates of AIDS and death, and on death alone, in adjacent CD4 cell count ranges of width 100 cells per mu L. Findings Data were obtained for 21247 patients who were followed up during the era before the introduction of combination therapy and 24444 patients who were followed up from the start of treatment. Deferring combination therapy until a CD4 cell count of 251-350 cells per mu L was associated with higher rates of AIDS and death than starting therapy in the range 351-450 Cells per mu L (hazard ratio [HR] 1.28, 95% CI 1.04-1.57). The adverse effect of deferring treatment increased with decreasing CD4 cell count threshold. Deferred initiation of combination therapy was also associated with higher mortality rates, although effects on mortality were less marked than effects on AIDS and death (HR 1.13, 0.80-1.60, for deferred initiation of treatment at CD4 cell count 251-350 cells per mu L compared with initiation at 351-450 cells per mu L). Interpretation Our results suggest that 350 cells per mu L should be the minimum threshold for initiation of antiretroviral therapy, and should help to guide physicians and patients in deciding when to start treatment. Funding UK Medical Research Council.	[Sterne, Jonathan A. C.; May, Margaret; Harris, Ross] Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England; [Costagliola, Dominique] INSERM, U943, Paris, France; [Costagliola, Dominique] Univ Paris 06, UMR S 943, Paris, France; [Costagliola, Dominique] Grp Hosp Pitie Salpetriere, AP HP, Serv Malad Infect & Trop, F-75634 Paris, France; [de Wolf, Frank] HIV Monitoring Fdn, Amsterdam, Netherlands; [Phillips, Andrew N.] UCL, Sch Med, Dept Infect & Populat Hlth, London W1N 8AA, England; [Funk, Michele Joensson] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Geskus, Ronald B.] Univ Amsterdam, Acad Med Ctr, Amsterdam Hlth Serv, NL-1105 AZ Amsterdam, Netherlands; [Geskus, Ronald B.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Gill, John] Univ Calgary, Dept Med, Calgary, AB, Canada; [Dabis, Francois] Univ Victor Segalen, INSERM, U897, Bordeaux, France; [Dabis, Francois] Univ Victor Segalen, ISPED, Bordeaux, France; [Miro, Jose M.] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Hosp Clin & Prov, Infect Dis Serv, Barcelona, Spain; [Justice, Amy C.] Yale Univ, Sch Med, Dept Med, West Haven, CT 06516 USA; [Justice, Amy C.] Yale Univ, Sch Publ Hlth, West Haven, CT 06516 USA; [Justice, Amy C.] VA Connecticut Healthcare Syst, Gen Internal Med Sect, West Haven, CT USA; [Ledergerber, Bruno] Univ Zurich, Div Infect Dis, Zurich, Switzerland; [Ledergerber, Bruno] Univ Zurich, Hosp Epidemiol, Zurich, Switzerland; [Faetkenheuer, Gerd] Univ Cologne, Dept Internal Med, Cologne, Germany; [Hogg, Robert S.] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Hogg, Robert S.] Simon Fraser Univ, Vancouver, BC, Canada; [Monforte, Antonella D'Arminio] San Paolo Univ Hosp, Milan, Italy; [Saag, Michael] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Smith, Colette] UCL, Sch Med, Dept Infect & Populat Hlth, London W1N 8AA, England; [Staszewski, Schlomo] Goethe Univ Frankfurt, Dept Internal Med 2, HIV Treatment & Clin Res Unit, HIVCENTER, Frankfurt, Germany; [Egger, Matthias] Univ Bern, ISPM, CH-3012 Bern, Switzerland; [Cole, Stephen R.] UNC Sch Global Publ Hlth, Chapel Hill, NC USA	University of Bristol; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; UCL Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Calgary; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University of Zurich; University of Zurich; University of Cologne; B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; University of Alabama System; University of Alabama Birmingham; University of London; University College London; UCL Medical School; Goethe University Frankfurt; University of Bern	Sterne, JAC (corresponding author), Univ Bristol, Dept Social Med, Canynge Hall,Whatley Rd, Bristol BS8 2PS, Avon, England.	jonathan.sterne@bristol.ac.uk	Geskus, Ronald B/H-3684-2019; VALLET, Yannick/F-9979-2011; DABIS, FRANCOIS/S-9298-2019; Sterne, Jonathan/Z-3106-2019; Phillips, Andrew N/B-4427-2008; Dodsley, Maria/G-7083-2016; Funk, Michele Jonsson/F-6885-2011; Hogg, Robert S/B-2783-2012; Ledergerber, Bruno/B-5656-2009; Costagliola, Dominique/H-5849-2011; May, Margaret/E-8099-2013; Gill, Michael John/G-7083-2016	Geskus, Ronald B/0000-0002-2740-3155; DABIS, FRANCOIS/0000-0002-1614-8857; Sterne, Jonathan/0000-0001-8496-6053; Phillips, Andrew N/0000-0003-2384-4807; Dodsley, Maria/0000-0001-7587-558X; Funk, Michele Jonsson/0000-0002-3756-7540; Hogg, Robert S/0000-0003-3463-5488; Ledergerber, Bruno/0000-0002-6881-4401; Costagliola, Dominique/0000-0003-0765-0869; May, Margaret/0000-0002-9733-1003; Smith, Colette/0000-0003-2847-3355; Gill, Michael John/0000-0002-8546-8790; Casabona-Barbara, Jordi/0000-0003-4816-5536	UK Medical Research Council [G0700820]; Agence Nationale de Recherche contre le SIDA (ANRS); Institut National de la Sante et de la Recherche Medicale (INSERM); French, Italian, Spanish Swiss Ministries of Health; Swiss HIV Cohort Study; Swiss National Science Foundation [33CSC0-108787]; Stichting HIV Monitoring; European Commission; British Columbia and Alberta Governments; Michael Smith Foundation for Health Research; Canadian Institutes of Health Research; VHA Office of Research and Development; Abbott; Boehringer-Ingelheim; Bristol-Myers Squibb; Gilead; GlaxoSmithYdine; Janssen-Cilag; Pfizer; Roche; Spanish Network for AIDS Research [RIS; ISCIII-RETIC RD06/006]; European Union [BMH4-CT97-2550, QLK2-2000-01431, QLRT-2001-01708, LSHP-CT-2006-018949]; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G0700820, MC_U122886351] Funding Source: researchfish; ESRC [ES/G007543/1] Funding Source: UKRI; MRC [G0700820, MC_U122886351] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Agence Nationale de Recherche contre le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French, Italian, Spanish Swiss Ministries of Health; Swiss HIV Cohort Study; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Stichting HIV Monitoring; European Commission(European CommissionEuropean Commission Joint Research Centre); British Columbia and Alberta Governments; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); VHA Office of Research and Development; Abbott(Abbott Laboratories); Boehringer-Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead(Gilead Sciences); GlaxoSmithYdine; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer(Pfizer); Roche(Roche Holding); Spanish Network for AIDS Research; European Union(European Commission); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to all patients, doctors, nurses, and other people who were involved with the participating cohort studies. We would like to thank participating cohort members, in particular Caroline Sabin and Sarah Walker, who provided thoughtful review and feedback on the content of this manuscript. The ART Cohort Collaboration is supported by the UK Medical Research Council grant G0700820. Sources of funding of individual cohorts include the Agence Nationale de Recherche contre le SIDA (ANRS), the Institut National de la Sante et de la Recherche Medicale (INSERM), the French, Italian, Spanish Swiss Ministries of Health, the Swiss HIV Cohort Study, supported by the Swiss National Science Foundation (grant 33CSC0-108787), the Stichting HIV Monitoring, the European Commission, the British Columbia and Alberta Governments, the Michael Smith Foundation for Health Research, the Canadian Institutes of Health Research, the VHA Office of Research and Development and unrestricted grants from Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithYdine, Janssen-Cilag, Pfizer, and Roche. Supported in part by the Spanish Network for AIDS Research (RIS; ISCIII-RETIC RD06/006). CASCADE has been funded through grants BMH4-CT97-2550, QLK2-2000-01431, QLRT-2001-01708, and LSHP-CT-2006-018949 from the European Union.	Becker SL, 2001, J ACQ IMMUN DEF SYND, V26, P72, DOI 10.1097/00126334-200101010-00011; Binquet C, 2001, AM J EPIDEMIOL, V153, P386, DOI 10.1093/aje/153.4.386; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brodt HR, 1997, AIDS, V11, P1731, DOI 10.1097/00002030-199714000-00010; Burman WJ, 1998, JAMA-J AM MED ASSOC, V280, P93, DOI 10.1001/jama.280.1.93; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; *CDC, 1992, JAMA-J AM MED ASSOC, V267, P2294; Chen RY, 2006, CLIN INFECT DIS, V42, P1003, DOI 10.1086/500453; Chun TW, 1999, P NATL ACAD SCI USA, V96, P10958, DOI 10.1073/pnas.96.20.10958; Clumeck N, 2008, HIV MED, V9, P65, DOI 10.1111/j.1468-1293.2007.00533.x; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; Cole SR, 2004, STAT MED, V23, P3351, DOI 10.1002/sim.1579; Darbyshire JH, 1996, LANCET, V348, P1239, DOI 10.1016/S0140-6736(05)65509-2; Department of Health and Human Services, 2008, GUID US ANT AG HIV 1, P1; DEWOLF F, 1988, J INFECT DIS, V158, P615, DOI 10.1093/infdis/158.3.615; Dorrucci M, 2005, AIDS, V19, P331; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Fatkenheuer G, 1997, AIDS, V11, pF113, DOI 10.1097/00002030-199714000-00001; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Fultz SL, 2006, MED CARE, V44, pS25, DOI 10.1097/01.mlr.0000223670.00890.74; Grabar S, 2000, AIDS, V14, P141, DOI 10.1097/00002030-200001280-00009; Gras L, 2007, JAIDS-J ACQ IMM DEF, V45, P183, DOI 10.1097/QAI.0b013e31804d685b; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; HO DD, 1995, NEW ENGL J MED, V333, P450, DOI 10.1056/NEJM199508173330710; Hogg RS, 1999, CAN MED ASSOC J, V160, P659; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Holmberg SD, 2004, CLIN INFECT DIS, V39, P1699, DOI 10.1086/425743; Jaen A, 2005, MED CLIN-BARCELONA, V124, P525, DOI 10.1157/13073938; Jaen A, 2008, JAIDS-J ACQ IMM DEF, V47, P212, DOI 10.1097/QAI.0b013e31815ee282; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Lampe FC, 2006, ARCH INTERN MED, V166, P521, DOI 10.1001/archinte.166.5.521; Lane HC, 2003, ANN INTERN MED, V138, P680, DOI 10.7326/0003-4819-138-8-200304150-00018; LEDERGERBER B, 1994, SOZ PRAVENTIV MED, V39, P387, DOI 10.1007/BF01299670; Lundgren JD, 1997, J ACQ IMMUN DEF SYND, V16, P153, DOI 10.1097/00042560-199711010-00003; MASUR H, 1993, NEW ENGL J MED, V329, P898, DOI 10.1056/NEJM199309163291228; May M, 2005, J CLIN EPIDEMIOL, V58, P1033, DOI 10.1016/j.jclinepi.2005.02.015; May M, 2004, STAT MED, V23, P2375, DOI 10.1002/sim.1825; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; Mocroft A, 1999, AIDS, V13, P1255, DOI 10.1097/00002030-199907090-00016; Mocroft A, 2002, AIDS, V16, P1663, DOI 10.1097/00002030-200208160-00012; Mocroft A, 1998, AIDS, V12, P2161, DOI 10.1097/00002030-199816000-00011; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Moore RD, 2005, JAIDS-J ACQ IMM DEF, V39, P195; Nolan David, 2005, Sex Health, V2, P153, DOI 10.1071/SH04058; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Phillips AN, 2001, JAMA-J AM MED ASSOC, V286, P2560, DOI 10.1001/jama.286.20.2560; Phillips AN, 2007, BRIT MED J, V334, P76, DOI 10.1136/bmj.39064.406389.94; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Pomerantz RJ, 2001, JAMA-J AM MED ASSOC, V286, P2597, DOI 10.1001/jama.286.20.2597; Porter K, 2003, LANCET, V362, P1267, DOI 10.1016/S0140-6736(03)14570-9; Prins M, 1997, AIDS, V11, P1747, DOI 10.1097/00002030-199714000-00012; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Schechter M, 2004, J INFECT DIS, V190, P1043, DOI 10.1086/422852; SELIGMANN M, 1994, LANCET, V343, P871; Sterling TR, 2003, CLIN INFECT DIS, V36, P812, DOI 10.1086/367934; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Sterne JAC, 2007, JAIDS-J ACQ IMM DEF, V46, P607, DOI 10.1097/QAI.0b013e31815b7dba; Walmsley S, 2002, NEW ENGL J MED, V346, P2039, DOI 10.1056/NEJMoa012354; Wood E, 2005, LANCET INFECT DIS, V5, P407, DOI 10.1016/S1473-3099(05)70162-6; Wood E, 2003, CAN MED ASSOC J, V169, P656	68	555	577	0	50	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2009	373	9672					1352	1363		10.1016/S0140-6736(09)60612-7	http://dx.doi.org/10.1016/S0140-6736(09)60612-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434UR	19361855	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000265300100033
J	Ferguson, MWJ; Duncan, J; Bond, J; Bush, J; Durani, P; So, K; Taylor, L; Chantrey, J; Mason, T; James, G; Laverty, H; Occleston, NL; Sattar, A; Ludlow, A; O'Kane, S				Ferguson, Mark W. J.; Duncan, Jonathan; Bond, Jeremy; Bush, James; Durani, Piyush; So, Karen; Taylor, Lisa; Chantrey, Jonquille; Mason, Tracey; James, Gaynor; Laverty, Hugh; Occleston, Nick L.; Sattar, Abdul; Ludlow, Anna; O'Kane, Sharon			Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies	LANCET			English	Article							GROWTH-FACTOR-BETA; NEUTRALIZING ANTIBODY; MECHANISMS; DISEASE; WOUNDS	Background Research into mechanisms of skin scarring identified transforming growth factor beta 3 (TGF beta 3) as a potential antiscarring therapy. We assessed scar improvement with avotermin (recombinant, active, human TGF beta 3). Methods In three double-blind, placebo-controlled studies, intradermal avotermin (concentrations ranging from 0.25 to 500 ng/100 mu L per linear cm wound margin) was administered to both margins of 1 cm, full-thickness skin incisions, before wounding and 24 h later, in healthy men and women. Treatments (avotermin and placebo or standard wound care) were randomly allocated to wound sites by a computer generated randomisation scheme, and within-participant controls compared avotermin versus placebo or standard wound care alone. Primary endpoints were visual assessment of scar formation at 6 months and 12 months after wounding in two studies, and from week 6 to month 7 after wounding in the third. investigators, participants, and scar assessors were blinded to treatment. Efficacy analyses were intention to treat. These studies are registered with ClinicalTrials.gov, numbers NCT00847925, NCT00847795, and NCT00629811. Results In two studies, avotermin 50 ng/100 mu L per linear cm significantly improved median score on a 100 mm visual analogue scale (VAS) by 5 mm (range -2 to 14; p=0.001) at month 6 and 8 mm (-29 to 18; p=0.0230) at month 12. In the third, avotermin significantly improved total scar scores at all concentrations versus placebo (mean improvement: from 14.84 mm [95 % Cl 5.5-24.2] at 5 ng/100 mu L per linear cm to 64.25 mm [49.4-79.1] at 500 ng/100 mu L per linear cm). Nine [60%] scars treated with avotermin 50 ng/100 mu L per linear cm showed 25% or less abnormal orientation of collagen fibres in the reticular dermis versus five [33%] placebo scars. After only 6 weeks from wounding, avotermin 500 ng/100 mu L per linear cm improved VAS score by 16.12 mm (95% CI 10.61-21.63). Adverse events at wound sites were similar for avotermin and controls. Erythema and oedema were more frequent with avotermin than with placebo, but were transient and deemed to be consistent with normal wound healing. Interpretation Avotermin has potential to provide an accelerated and permanent improvement in scarring.	[Ferguson, Mark W. J.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Duncan, Jonathan; Durani, Piyush; Chantrey, Jonquille] Univ Manchester, Dept Plast & Reconstruct Surg, Fac Med & Human Sci, Manchester, Lancs, England; [Bond, Jeremy; Taylor, Lisa] Ulster Hosp, No Ireland Plast & Maxillofacial Serv, Belfast, Antrim, North Ireland; [Ferguson, Mark W. J.; Duncan, Jonathan; Bond, Jeremy; Bush, James; Durani, Piyush; So, Karen; Taylor, Lisa; Chantrey, Jonquille; Mason, Tracey; James, Gaynor; Laverty, Hugh; Occleston, Nick L.; Sattar, Abdul; Ludlow, Anna; O'Kane, Sharon] Renovo, Manchester M13 9XX, Lancs, England	University of Manchester; University of Manchester	Ferguson, MWJ (corresponding author), Renovo, Manchester Incubator Bldg,48 Grafton St, Manchester M13 9XX, Lancs, England.	mark.ferguson@renovo.com		Durani, Piyush/0000-0002-4388-9570	Renovo	Renovo	This research was funded by Renovo. We thank all the volunteers who participated in the studies; Kathryn Quinn for assistance in the preparation of the manuscript; Andrew Kay, John Hutchison, and David Fairlamb for critically reviewing the report; and Adam Boanas for assistance with histological analyses.	Ashcroft GS, 1997, J INVEST DERMATOL, V108, P430, DOI 10.1111/1523-1747.ep12289705; ASHCROFT GS, 1995, J ANAT, V187, P1; Ashcroft GS, 1998, LAB INVEST, V78, P47; Bayat A, 2004, EXP DERMATOL, V13, P120, DOI 10.1111/j.0906-6705.2004.00165.x; Bayat A, 2003, BRIT MED J, V326, P88, DOI 10.1136/bmj.326.7380.88; Bond JS, 2008, PLAST RECONSTR SURG, V121, P487, DOI 10.1097/01.prs.0000299183.88334.37; Duncan JAL, 2006, PLAST RECONSTR SURG, V118, P909, DOI 10.1097/01.prs.0000232378.88776.b0; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Meier Karen, 2006, Expert Opin Emerg Drugs, V11, P39, DOI 10.1517/14728214.11.1.39; Mustoe TA, 2002, PLAST RECONSTR SURG, V110, P560, DOI 10.1097/00006534-200208000-00031; OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3; SHAH M, 1995, J CELL SCI, V108, P985; SHAH M, 1994, J CELL SCI, V107, P1137; SHAH M, 1992, LANCET, V339, P213, DOI 10.1016/0140-6736(92)90009-R; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; SOMMERLAD BC, 1978, BRIT J PLAST SURG, V31, P34, DOI 10.1016/0007-1226(78)90012-7; WHITBY DJ, 1991, DEV BIOL, V147, P207, DOI 10.1016/S0012-1606(05)80018-1	17	190	208	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2009	373	9671					1264	1274		10.1016/S0140-6736(09)60322-6	http://dx.doi.org/10.1016/S0140-6736(09)60322-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432PN	19362676				2022-12-28	WOS:000265146300029
J	Pollard, PJ; Ratcliffe, PJ				Pollard, Patrick J.; Ratcliffe, Peter J.			Puzzling Patterns of Predisposition	SCIENCE			English	Editorial Material							DEPENDENT ISOCITRATE DEHYDROGENASE; TUMOR SUPPRESSORS; MUTATIONS; IDH1; GLIOMAS; CANCER; RISK		[Pollard, Patrick J.; Ratcliffe, Peter J.] Univ Oxford, Oxford OX3 7BN, England	University of Oxford	Pollard, PJ (corresponding author), Univ Oxford, Henry Wellcome Bldg Mol Physiol, Oxford OX3 7BN, England.	pjr@well.ox.ac.uk	Pollard, Patrick/F-7516-2012	Pollard, Patrick/0000-0002-4459-4993; Ratcliffe, Peter/0000-0002-2853-806X				Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Knauth K, 2006, ONCOGENE, V25, P370, DOI 10.1038/sj.onc.1209062; Li LJ, 2007, MOL CELL BIOL, V27, P5381, DOI 10.1128/MCB.00282-07; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Soundar S, 2000, J BIOL CHEM, V275, P5606, DOI 10.1074/jbc.275.8.5606; Thompson CB, 2009, NEW ENGL J MED, V360, P813, DOI 10.1056/NEJMe0810213; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	14	46	72	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					192	194		10.1126/science.1173362	http://dx.doi.org/10.1126/science.1173362			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359573				2022-12-28	WOS:000265024400029
J	Cypess, AM; Lehman, S; Williams, G; Tal, I; Rodman, D; Goldfine, AB; Kuo, FC; Palmer, EL; Tseng, Y; Doria, A; Kolodny, GM; Kahn, CR				Cypess, Aaron M.; Lehman, Sanaz; Williams, Gethin; Tal, Ilan; Rodman, Dean; Goldfine, Allison B.; Kuo, Frank C.; Palmer, Edwin L.; Tseng, Yu-Hua; Doria, Alessandro; Kolodny, Gerald M.; Kahn, C. Ronald			Identification and Importance of Brown Adipose Tissue in Adult Humans.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; DIET-INDUCED THERMOGENESIS; F-18-FDG PET/CT; FDG-UPTAKE; USA-FAT; OBESITY; TEMPERATURE; PATIENT; MUSCLE; SCANS	Background: Obesity results from an imbalance between energy intake and expenditure. In rodents and newborn humans, brown adipose tissue helps regulate energy expenditure by thermogenesis mediated by the expression of uncoupling protein 1 (UCP1), but brown adipose tissue has been considered to have no physiologic relevance in adult humans. Methods: We analyzed 3640 consecutive (sup 18)F-fluorodeoxyglucose ((sup 18)F-FDG) positron-emission tomographic and computed tomographic (PET-CT) scans performed for various diagnostic reasons in 1972 patients for the presence of substantial depots of putative brown adipose tissue. Such depots were defined as collections of tissue that were more than 4 mm in diameter, had the density of adipose tissue according to CT, and had maximal standardized uptake values of (sup 18)F-FDG of at least 2.0 g per milliliter, indicating high metabolic activity. Clinical indexes were recorded and compared with those of date-matched controls. Immunostaining for UCP1 was performed on biopsy specimens from the neck and supraclavicular regions in patients undergoing surgery. Results: Substantial depots of brown adipose tissue were identified by PET-CT in a region extending from the anterior neck to the thorax. Tissue from this region had UCP1-immunopositive, multilocular adipocytes indicating brown adipose tissue. Positive scans were seen in 76 of 1013 women (7.5%) and 30 of 959 men (3.1%), corresponding to a female:male ratio greater than 2:1 (P<0.001). Women also had a greater mass of brown adipose tissue and higher (sup 18)F-FDG uptake activity. The probability of the detection of brown adipose tissue was inversely correlated with years of age (P<0.001), outdoor temperature at the time of the scan (P=0.02), beta-blocker use (P<0.001), and among older patients, body-mass index (P=0.007). Conclusions: Defined regions of functionally active brown adipose tissue are present in adult humans, are more frequent in women than in men, and may be quantified noninvasively with the use of (sup 18)F-FDG PET-CT. Most important, the amount of brown adipose tissue is inversely correlated with body-mass index, especially in older people, suggesting a potential role of brown adipose tissue in adult human metabolism. N Engl J Med 2009;360:1509-17.	[Kahn, C. Ronald] Joslin Diabet Ctr, Sect Obes & Hormone Act, Div Res, Boston, MA 02215 USA; [Lehman, Sanaz; Williams, Gethin; Tal, Ilan; Rodman, Dean; Kolodny, Gerald M.] Beth Israel Deaconess Med Ctr, Div Nucl Med, Boston, MA 02215 USA; [Kuo, Frank C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Palmer, Edwin L.] Massachusetts Gen Hosp, Div Nucl Med, Boston, MA 02114 USA; [Cypess, Aaron M.; Lehman, Sanaz; Williams, Gethin; Tal, Ilan; Rodman, Dean; Goldfine, Allison B.; Kuo, Frank C.; Palmer, Edwin L.; Tseng, Yu-Hua; Doria, Alessandro; Kolodny, Gerald M.; Kahn, C. Ronald] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kahn, CR (corresponding author), Joslin Diabet Ctr, Sect Obes & Hormone Act, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.	c.ronald.kahn@joslin.harvard.edu	Doria, Alessandro/H-9157-2018; Kahn, Ronald/AAY-2435-2021; Tseng, Yu-Hua/AAE-6471-2021	Doria, Alessandro/0000-0002-3830-4304; Kahn, Ronald/0000-0002-7583-9228; Tseng, Yu-Hua/0000-0003-2053-9559; mcmurry, andy/0000-0001-5604-0704	National Institutes of Health [DK070722, P30 DK46200, DK33201, DK55545, DK046200-16]; Eli Lilly Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025757, UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056690, R01DK055545, R21DK070722, T32DK007260, R01DK033201, P30DK040561, P30DK046200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lilly Foundation(Eli Lilly); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the Clinical Investigator Training Program, Beth Israel Deaconess Medical Center-Harvard/MIT Health Sciences and Technology, in collaboration with Pfizer and Merck; grants from the National Institutes of Health (DK070722 and P30 DK46200 [to Dr. Tseng], DK33201 and DK55545 [to Dr. Kahn], and DK046200-16 [to Dr. Cypess]); and the Eli Lilly Foundation.	Aldhahi Waleed, 2003, Curr Diab Rep, V3, P293, DOI 10.1007/s11892-003-0020-2; Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; ASTRUP A, 1984, CLIN SCI, V66, P179, DOI 10.1042/cs0660179; Baba S, 2007, J NUCL MED, V48, P1715, DOI 10.2967/jnumed.107.041715; Barbaras L, 2007, AM J ROENTGENOL, V188, pW565, DOI 10.2214/AJR.06.1058; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; Cohade C, 2003, J NUCL MED, V44, P1267; Cohade C, 2003, J NUCL MED, V44, P170; Dobert N, 2004, Q J NUCL MED MOL IM, V48, P33; ENGLISH JT, 1973, RADIOLOGY, V107, P279, DOI 10.1148/107.2.279; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fukuchi K, 2004, EXP CLIN ENDOCR DIAB, V112, P601, DOI 10.1055/s-2004-830407; Garcia CA, 2004, MOL IMAGING BIOL, V6, P368, DOI 10.1016/j.mibio.2004.08.003; GARRUTI G, 1992, INT J OBESITY, V16, P383; Gelfand MJ, 2005, PEDIATR RADIOL, V35, P984, DOI 10.1007/s00247-005-1505-8; Gesta S, 2008, CELL, V135, P366, DOI 10.1016/j.cell.2008.09.048; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6; HEATON JM, 1972, J ANAT, V112, P35; HIMMSHAGEN J, 1979, CAN MED ASSOC J, V121, P1361; Hossain P, 2007, NEW ENGL J MED, V356, P973; HUTTUNEN P, 1981, EUR J APPL PHYSIOL O, V46, P339, DOI 10.1007/BF00422121; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lowell BB, 1997, ANNU REV MED, V48, P307; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Parodi K, 2007, INT J RADIAT ONCOL, V68, P920, DOI 10.1016/j.ijrobp.2007.01.063; Parysow O, 2007, CLIN NUCL MED, V32, P351, DOI 10.1097/01.rlu.0000259570.69163.04; Ronti T, 2006, CLIN ENDOCRINOL, V64, P355, DOI 10.1111/j.1365-2265.2006.02474.x; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; ROSS R, 1991, J APPL PHYSIOL, V70, P2164, DOI 10.1152/jappl.1991.70.5.2164; ROTHWELL NJ, 1983, CLIN SCI, V64, P19, DOI 10.1042/cs0640019; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Rousseau C, 2006, EUR J NUCL MED MOL I, V33, P785, DOI 10.1007/s00259-006-0066-x; Sharma AM, 2001, HYPERTENSION, V37, P250, DOI 10.1161/01.HYP.37.2.250; Tatsumi M, 2004, J NUCL MED, V45, P1189; Truong MT, 2004, AM J ROENTGENOL, V183, P1127, DOI 10.2214/ajr.183.4.1831127; Williams G, 2008, AM J ROENTGENOL, V190, P1406, DOI 10.2214/AJR.07.3205; Yang XL, 2003, OBES RES, V11, P1182, DOI 10.1038/oby.2003.163; Yeung HWD, 2003, J NUCL MED, V44, P1789	41	2963	3103	12	367	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 9	2009	360	15					1509	1517		10.1056/NEJMoa0810780	http://dx.doi.org/10.1056/NEJMoa0810780			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430GL	19357406	Green Accepted			2022-12-28	WOS:000264976800007
J	Dupre, ME; Gu, D; Warner, DF; Yi, Z				Dupre, Matthew E.; Gu, Danan; Warner, David F.; Yi, Zeng			Frailty and type of death among older adults in China: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ELDERLY-PEOPLE; SERIOUSLY ILL; OF-LIFE; END; DISABILITY; QUALITY; AGE; PREDICTORS; LONGEVITY; MORTALITY	Objective To examine the association between frailty and type of death among the world's largest oldest-old population in China. Design Prospective cohort study. Setting 2002 and 2005 waves of the Chinese longitudinal healthy longevity survey carried out in 22 provinces throughout China. Participants 13 717 older adults (aged >= 65). Main outcome measures Type of death, categorised as being bedridden for fewer than 30 days with or without suffering and being bedridden for 30 or more days with or without suffering. Results Multinomial analyses showed that higher levels of frailty significantly increased the relative risk ratios of mortality for all types of death. Of those with the highest levels of frailty, men were most likely to experience 30 or more bedridden days with suffering before death (relative risk ratio 8.70, 95% confidence interval 6.31 to 12.00) and women 30 or more bedridden days with no suffering (11.53, 17.84 to 16.96). Regardless of frailty, centenarians and nonagenarians were most likely to experience fewer than 30 bedridden days with no suffering, whereas those aged 65-79 and 80-89 were more likely to experience fewer than 30 bedridden days with suffering. Adjusting for compositional differences had little impact on the link between frailty and type of death for both sexes and age groups. Conclusions The association between frailty and type of death differs by sex and age. Health scholars and clinical practitioners should consider age and sex differences in frailty to develop more effective measures to reduce preventable suffering before death.	[Dupre, Matthew E.] Duke Univ, Med Ctr, Dept Sociol, Durham, NC 27710 USA; [Dupre, Matthew E.; Yi, Zeng] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27710 USA; [Gu, Danan] Portland State Univ, Portland, OR 97207 USA; [Warner, David F.] Case Western Reserve Univ, Dept Sociol, Cleveland, OH 44106 USA; [Yi, Zeng] Peking Univ, China Ctr Econ Res, Beijing 100871, Peoples R China	Duke University; Duke University; Portland State University; Case Western Reserve University; Peking University	Dupre, ME (corresponding author), Duke Univ, Med Ctr, Dept Sociol, Durham, NC 27710 USA.	med11@geri.duke.edu	Dupre, Matthew/ABG-6728-2021; Zeng, Yi/B-1638-2010	Dupre, Matthew/0000-0002-0976-4715; 	National Institute on Aging [R01 AG023627, T32 AG00155]; China Natural Science Foundation; China Social Science Foundation; United Nations Population Funds; Hong Kong Research Grant Council; Portland State University; Carolina Population; National Institute of Child Health and Human Development [NIH 5-T32-HD07168-28]; NIA [R01 AG023627]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050959, T32HD007168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023627, T32AG000155] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China Social Science Foundation; United Nations Population Funds; Hong Kong Research Grant Council(Hong Kong Research Grants Council); Portland State University; Carolina Population; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The data used in this study were from the 2002 and 2005 waves of the Chinese longitudinal healthy longevity survey which was funded by the National Institute on Aging, the China Natural Science Foundation, the China Social Science Foundation, the United Nations Population Funds, and the Hong Kong Research Grant Council. DG's work was partly supported by a National Institute of Aging grant (R01 AG023627, PI: ZY) when he was at Duke University and was partly supported by a provost mini-grant for internationalisation at Portland State University. The work by MED and DFW was partially supported by the Carolina Population Center at the University of North Carolina at Chapel Hill postdoctoral training programme, funded by the National Institute of Child Health and Human Development grant NIH 5-T32-HD07168-28 (MED) and National Institute on Aging grant T32 AG00155 (DFW). ZY's work was supported by NIA grant R01 AG023627.	Abraham A, 2006, J PALLIAT MED, V9, P658, DOI 10.1089/jpm.2006.9.658; Allison PD, 2002, MISSING DATA; Bergman H, 2007, J GERONTOL A-BIOL, V62, P731, DOI 10.1093/gerona/62.7.731; Bookwala J, 2001, DEATH STUD, V25, P127, DOI 10.1080/074811801461919; Bortz WM, 2002, J GERONTOL A-BIOL, V57, pM283, DOI 10.1093/gerona/57.5.M283; Campbell AJ, 1997, AGE AGEING, V26, P315, DOI 10.1093/ageing/26.4.315; Cohen HJ, 2000, J GERONTOL A-BIOL, V55, pM706, DOI 10.1093/gerona/55.12.M706; Cohen LM, 2000, ARCH INTERN MED, V160, P2513, DOI 10.1001/archinte.160.16.2513; Curtis JR, 2000, MANAGING DEATH ICU T; Dupre ME, 2008, AM J PUBLIC HEALTH, V98, P1203, DOI 10.2105/AJPH.2007.113886; Emanuel EJ, 1996, JAMA-J AM MED ASSOC, V275, P1907, DOI 10.1001/jama.275.24.1907; Ferrucci L, 2003, AGING CLIN EXP RES, V15, P310, DOI 10.1007/BF03324515; Field MJ, 1997, APPROACHING DEATH IM; Foley KM, 2001, MANAGING DEATH INTEN, p[103, 127]; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; George Linda K, 2002, Gerontologist, V42 Spec No 3, P86; Gill TM, 1997, J GEN INTERN MED, V12, P757, DOI 10.1046/j.1525-1497.1997.07161.x; Goggins WB, 2005, J GERONTOL A-BIOL, V60, P1046, DOI 10.1093/gerona/60.8.1046; Goodlin SJ, 1999, JAMA-J AM MED ASSOC, V282, P2333, DOI 10.1001/jama.282.24.2333; Gruenewald DA, 2006, ANESTHESIOL CLIN N A, V24, P163, DOI 10.1016/j.atc.2005.12.003; Gu D., 2004, DEMOGR RES, V11, P1, DOI [10.4054/DemRes.2004.11.1, DOI 10.4054/DEMRES.2004.11.1]; Gu D., 2008, HLTH LONGEVITY CHINA, P39, DOI DOI 10.1007/978-1-4020-6752-5_3; Gu DN, 2007, SOC SCI MED, V64, P871, DOI 10.1016/j.socscimed.2006.10.026; Hamel MB, 1999, ANN INTERN MED, V130, P116, DOI 10.7326/0003-4819-130-2-199901190-00005; HAUSER RM, 200603 U WISC CTR DE; Hickman SE, 2001, J PAIN SYMPTOM MANAG, V22, P565, DOI 10.1016/S0885-3924(01)00299-8; Hinton J, 1996, SOC SCI MED, V43, P1229, DOI 10.1016/0277-9536(95)00437-8; Idler EL, 2001, J GERONTOL B-PSYCHOL, V56, pS326, DOI 10.1093/geronb/56.6.S326; Iwashyna TJ, 2002, HEALTH SERV RES, V37, P1531, DOI 10.1111/1475-6773.10562; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Kulminski A, 2007, MECH AGEING DEV, V128, P250, DOI 10.1016/j.mad.2006.12.004; Kulminski AM, 2008, J AM GERIATR SOC, V56, P898, DOI 10.1111/j.1532-5415.2008.01656.x; Markle-Reid M, 2003, J ADV NURS, V44, P58, DOI 10.1046/j.1365-2648.2003.02767.x; Martin FC, 2008, AGE AGEING, V37, P129, DOI 10.1093/ageing/afn011; Martin P, 1996, EXP AGING RES, V22, P121, DOI 10.1080/03610739608254002; Mitnitski A, 2005, J AM GERIATR SOC, V53, P2184, DOI 10.1111/j.1532-5415.2005.00506.x; Mitnitski A B, 2001, ScientificWorldJournal, V1, P323; Mitnitski Arnold B, 2002, BMC Geriatr, V2, P1; Morley JE, 2002, J GERONTOL A-BIOL, V57, pM698, DOI 10.1093/gerona/57.11.M698; Morley JE, 2006, MED CLIN N AM, V90, P837, DOI 10.1016/j.mcna.2006.05.019; Patrick DL, 2003, ANN INTERN MED, V139, P410, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00006; Patrick DL, 2001, J PAIN SYMPTOM MANAG, V22, P717, DOI 10.1016/S0885-3924(01)00333-5; Pinquart M, 2002, OMEGA-J DEATH DYING, V45, P69, DOI 10.2190/5K9J-C320-22LQ-KPH6; PRONOVOST P, 2001, MANAGING DEATH ICU T, P245; Puts MTE, 2005, J AM GERIATR SOC, V53, P40, DOI 10.1111/j.1532-5415.2005.53008.x; ROBINE JM, 2003, DETERMINING HLHT EXP; Rockwood K, 2005, J AM GERIATR SOC, V53, P1069, DOI 10.1111/j.1532-5415.2005.53312.x; ROCKWOOD K, 1994, CAN MED ASSOC J, V150, P489; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P738, DOI 10.1093/gerona/62.7.738; Seale C, 2004, SOC SCI MED, V58, P883, DOI 10.1016/j.socscimed.2003.10.034; Song XW, 2004, J AM GERIATR SOC, V52, P1180, DOI 10.1111/j.1532-5415.2004.52319.x; Steinhauser Karen E, 2002, J Palliat Med, V5, P407, DOI 10.1089/109662102320135298; Stewart AL, 1999, J PAIN SYMPTOM MANAG, V17, P93, DOI 10.1016/S0885-3924(98)00131-6; United Nations, 2007, WORLD POP PROSP 2006; Van Kan GA, 2008, J NUTR HEALTH AGING, V12, P29, DOI 10.1007/BF02982161; Walston J, 2006, J AM GERIATR SOC, V54, P991, DOI 10.1111/j.1532-5415.2006.00745.x; Willcox DC, 2006, AGE, V28, P313, DOI 10.1007/s11357-006-9020-x; WINSHIP C, 1994, SOCIOL METHOD RES, V23, P230, DOI 10.1177/0049124194023002004; Wong P.T.P., 2000, DEATH ATTITUDES OLDE, P23; Yashin AI, 2007, REJUV RES, V10, P75, DOI 10.1089/rej.2006.0500; Yi Z, 2008, RELIABILITY AGE REPO	62	62	66	2	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2009	338								b1175	10.1136/bmj.b1175	http://dx.doi.org/10.1136/bmj.b1175			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	431ZK	19359289	hybrid, Green Published			2022-12-28	WOS:000265103100002
J	Virtanen, KA; Lidell, ME; Orava, J; Heglind, M; Westergren, R; Niemi, T; Taittonen, M; Laine, J; Savisto, NJ; Enerback, S; Nuutila, P				Virtanen, Kirsi A.; Lidell, Martin E.; Orava, Janne; Heglind, Mikael; Westergren, Rickard; Niemi, Tarja; Taittonen, Markku; Laine, Jukka; Savisto, Nina-Johanna; Enerback, Sven; Nuutila, Pirjo			Brief Report: Functional Brown Adipose Tissue in Healthy Adults.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADAPTIVE THERMOGENESIS; THYROID-HORMONE; FAT; PHEOCHROMOCYTOMA; DIFFERENTIATION; TEMPERATURE; REDUCTION; GLUCOSE; HUMANS; MICE	Using positron-emission tomography (PET), we found that cold-induced glucose uptake was increased by a factor of 15 in paracervical and supraclavicular adipose tissue in five healthy subjects. We obtained biopsy specimens of this tissue from the first three consecutive subjects and documented messenger RNA (mRNA) and protein levels of the brown-adipocyte marker, uncoupling protein 1 (UCP1). Together with morphologic assessment, which showed numerous multilocular, intracellular lipid droplets, and with the results of biochemical analysis, these findings document the presence of substantial amounts of metabolically active brown adipose tissue in healthy adult humans.	[Lidell, Martin E.; Heglind, Mikael; Westergren, Rickard; Enerback, Sven] Univ Gothenburg, Dept Med & Clin Genet, Inst Biomed, Sahlgrenska Acad, SE-40530 Gothenburg, Sweden; [Virtanen, Kirsi A.; Orava, Janne; Savisto, Nina-Johanna; Nuutila, Pirjo] Univ Turku, Turku PET Ctr, Turku, Finland; [Niemi, Tarja] Turku Univ Hosp, Dept Surg, FIN-20520 Turku, Finland; [Taittonen, Markku] Turku Univ Hosp, Dept Anesthesiol, FIN-20520 Turku, Finland; [Laine, Jukka] Turku Univ Hosp, Dept Pathol, FIN-20520 Turku, Finland; [Nuutila, Pirjo] Turku Univ Hosp, Dept Med, FIN-20520 Turku, Finland	University of Gothenburg; University of Turku; University of Turku; University of Turku; University of Turku; University of Turku	Enerback, S (corresponding author), Univ Gothenburg, Dept Med & Clin Genet, Inst Biomed, Sahlgrenska Acad, POB 440, SE-40530 Gothenburg, Sweden.	sven.enerback@medgen.gu.se	Nuutila, Pirjo/J-2087-2012	Nuutila, Pirjo/0000-0001-9597-338X; Niemi, Tarja/0000-0001-7436-0496	Swedish Research Council [K2005-32BI-15324-01A]; European Union [QLK3-CT-200202149, LSHM-CT-2003-503041]; Arne and Inga Britt Foundation; Soderberg Foundation; Swedish Foundation for Strategic Research through the Center for Cardiovascular and Metabolic Research; Academy of Finland; University of Turku, Turku University Hospital; Abo Academy; European Commission [LSHMCT-2005-018734]	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union(European Commission); Arne and Inga Britt Foundation; Soderberg Foundation; Swedish Foundation for Strategic Research through the Center for Cardiovascular and Metabolic Research(Swedish Foundation for Strategic Research); Academy of Finland(Academy of Finland); University of Turku, Turku University Hospital; Abo Academy; European Commission(European CommissionEuropean Commission Joint Research Centre)	Supported by grants from the Swedish Research Council (K2005-32BI-15324-01A), the European Union (QLK3-CT-200202149, DIABESITY, and LSHM-CT-2003-503041), the Arne and Inga Britt Foundation, the Soderberg Foundation, the Swedish Foundation for Strategic Research through the Center for Cardiovascular and Metabolic Research, the Academy of Finland, the University of Turku, Turku University Hospital, and Abo Academy and by a contract with the European Commission (LSHMCT-2005-018734).	Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cohade C, 2003, J NUCL MED, V44, P1267; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fukuchi K, 2004, EXP CLIN ENDOCR DIAB, V112, P601, DOI 10.1055/s-2004-830407; Garcia CA, 2006, MOL IMAGING BIOL, V8, P24, DOI 10.1007/s11307-005-0030-3; HAMACHER K, 1986, J NUCL MED, V27, P235; Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; LEAN MEJ, 1989, P NUTR SOC, V48, P243, DOI 10.1079/PNS19890036; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; MA SWY, 1986, CAN J PHYSIOL PHARM, V64, P609, DOI 10.1139/y86-101; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Obregon MJ, 2008, THYROID, V18, P185, DOI 10.1089/thy.2007.0254; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; RICQUIER D, 1982, J CLIN ENDOCR METAB, V54, P803; Soderlund V, 2007, EUR J NUCL MED MOL I, V34, P1018, DOI 10.1007/s00259-006-0318-9; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Yeung HWD, 2003, J NUCL MED, V44, P1789	20	2206	2312	5	155	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 9	2009	360	15					1518	1525		10.1056/NEJMoa0808949	http://dx.doi.org/10.1056/NEJMoa0808949			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430GL	19357407	Bronze			2022-12-28	WOS:000264976800008
J	Ramsey, PG; Miller, ED				Ramsey, Paul G.; Miller, Edward D.			A Single Mission for Academic Medicine Improving Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LOST		[Ramsey, Paul G.] Univ Washington, UW Med, Seattle, WA 98195 USA; [Miller, Edward D.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	University of Washington; University of Washington Seattle; Johns Hopkins University	Ramsey, PG (corresponding author), Univ Washington, UW Med, Box 356350, Seattle, WA 98195 USA.	pramsey@u.washington.edu						Association of American Medical Colleges, 2008, HDB AC MED MED SCH T; Friedenberg RM, 2001, RADIOLOGY, V220, P296, DOI 10.1148/radiology.220.2.r01au42296; KIRCH DG, 2008, 2008 ANN M ASS AM ME; Lewkonia R M, 2001, BMC Med Educ, V1, P4, DOI 10.1186/1472-6920-1-4; Lobas JG, 2006, AM J MED, V119, P617, DOI 10.1016/j.amjmed.2006.04.005; Ludmerer KM, 1999, TIME HEAL; Marks AR, 2004, J CLIN INVEST, V114, P1180, DOI 10.1172/JCI200423408; Pellegrin KL, 1998, ACAD MED, V73, P123, DOI 10.1097/00001888-199802000-00008; PETERSDORF RG, 1995, ACAD MED, V70, pS41, DOI 10.1097/00001888-199507000-00019; PETERSDORF RG, 1995, ACAD MED S, V70, pS48; Turka LA, 2007, J CLIN INVEST, V117, P1734, DOI 10.1172/JCI32797	11	33	35	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 8	2009	301	14					1475	1476		10.1001/jama.2009.472	http://dx.doi.org/10.1001/jama.2009.472			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429MN	19351945				2022-12-28	WOS:000264924900028
J	Grande, LA; Mendez, RD; Krug, RT; Verschuyl, EJ				Grande, Lucinda A.; Mendez, Raul D.; Krug, Richard T.; Verschuyl, Evert-Jan			Attention-grapefruit!	LANCET			English	Editorial Material									[Grande, Lucinda A.] St Peter Family Med, Olympia, WA 98506 USA; [Mendez, Raul D.] Providence St Peter Hosp, Dept Med, Olympia, WA 98506 USA; [Verschuyl, Evert-Jan] Providence St Peter Hosp, Dept Intervent Radiol, Olympia, WA 98506 USA; [Krug, Richard T.] Providence St Peter Hosp, Dept Surg, Olympia, WA 98506 USA		Grande, LA (corresponding author), St Peter Family Med, 525 Lilly Rd NE, Olympia, WA 98506 USA.	lucinda.grande@providence.org						Bailey DG, 1998, BRIT J CLIN PHARMACO, V46, P101, DOI 10.1046/j.1365-2125.1998.00764.x; MAY R., 1957, ANGIOLOGY, V8, P419, DOI 10.1177/000331975700800505; Vandenbroucke JP, 2001, NEW ENGL J MED, V344, P1527, DOI 10.1056/NEJM200105173442007; Virchow R., 1851, ARCH PATHOL ANAT PHY, V3, P427, DOI [10.1007/BF01960918, DOI 10.1007/BF01960918]	4	7	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 4	2009	373	9670					1222	1222		10.1016/S0140-6736(09)60289-0	http://dx.doi.org/10.1016/S0140-6736(09)60289-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429SO	19345832				2022-12-28	WOS:000264940600037
J	Cho, DH; Nakamura, T; Fang, JG; Cieplak, P; Godzik, A; Gu, Z; Lipton, SA				Cho, Dong-Hyung; Nakamura, Tomohiro; Fang, Jianguo; Cieplak, Piotr; Godzik, Adam; Gu, Zezong; Lipton, Stuart A.			S-Nitrosylation of Drp1 Mediates beta-Amyloid-Related Mitochondrial Fission and Neuronal Injury	SCIENCE			English	Article							NITRIC-OXIDE; ALZHEIMERS-DISEASE; DYNAMIN; PROTEIN; NEURODEGENERATION; APOPTOSIS	Mitochondria continuously undergo two opposing processes, fission and fusion. The disruption of this dynamic equilibrium may herald cell injury or death and may contribute to developmental and neurodegenerative disorders. Nitric oxide functions as a signaling molecule, but in excess it mediates neuronal injury, in part via mitochondrial fission or fragmentation. However, the underlying mechanism for nitric oxide-induced pathological fission remains unclear. We found that nitric oxide produced in response to beta-amyloid protein, thought to be a key mediator of Alzheimer's disease, triggered mitochondrial fission, synaptic loss, and neuronal damage, in part via S-nitrosylation of dynamin-related protein 1 (forming SNO-Drp1). Preventing nitrosylation of Drp1 by cysteine mutation abrogated these neurotoxic events. SNO-Drp1 is increased in brains of human Alzheimer's disease patients and may thus contribute to the pathogenesis of neurodegeneration.	[Cho, Dong-Hyung; Nakamura, Tomohiro; Fang, Jianguo; Gu, Zezong; Lipton, Stuart A.] Burnham Inst Med Res, Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA; [Cieplak, Piotr; Godzik, Adam] Burnham Inst Med Res, Bioinformat & Syst Biol Program, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Lipton, SA (corresponding author), Burnham Inst Med Res, Ctr Neurosci Aging & Stem Cell Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	slipton@burnham.org	Fang, Jianguo/K-8058-2016; Godzik, Adam/A-7279-2009; Godzik, Adam/AAW-1467-2020	Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; Lipton, Stuart/0000-0002-3490-1259	Japan Society for the Promotion of Science; NIH [P01 HD29587, R01 EY05477, P01 ES016738, P30 NS057096]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Newmeyer, J. Zaremba, J. Russo, E. Masliah, H. Xu, and Y. Zhang for help or reagents. Supported by the Japan Society for the Promotion of Science (T.N.) and NIH grants P01 HD29587, R01 EY05477, P01 ES016738, and P30 NS057096 (S.A.L.).	Baloyannis SJ, 2006, J ALZHEIMERS DIS, V9, P119; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Bush AI, 2003, P NATL ACAD SCI USA, V100, P11193, DOI 10.1073/pnas.2135061100; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kang-Decker N, 2007, J CELL SCI, V120, P492, DOI 10.1242/jcs.03361; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Li H, 2008, P NATL ACAD SCI USA, V105, P2169, DOI 10.1073/pnas.0711647105; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Low HH, 2006, NATURE, V444, P766, DOI 10.1038/nature05312; Pitts KR, 2004, J BIOL CHEM, V279, P50286, DOI 10.1074/jbc.M405531200; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Wang GF, 2006, P NATL ACAD SCI USA, V103, P1295, DOI 10.1073/pnas.0508354103; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yuan H, 2007, CELL DEATH DIFFER, V14, P462, DOI 10.1038/sj.cdd.4402046; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200	21	795	830	1	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					102	105		10.1126/science.1171091	http://dx.doi.org/10.1126/science.1171091			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342591	Green Accepted			2022-12-28	WOS:000264802100042
J	Maeda, S; Nakagawa, S; Suga, M; Yamashita, E; Oshima, A; Fujiyoshi, Y; Tsukihara, T				Maeda, Shoji; Nakagawa, So; Suga, Michihiro; Yamashita, Eiki; Oshima, Atsunori; Fujiyoshi, Yoshinori; Tsukihara, Tomitake			Structure of the connexin 26 gap junction channel at 3.5 angstrom resolution	NATURE			English	Article							AMINO-ACID-RESIDUES; EXTRACELLULAR LOOP; GATING POLARITY; 3-DIMENSIONAL STRUCTURE; CHARGE SELECTIVITY; DIFFRACTION DATA; PORE; MODEL; IDENTIFICATION; TERMINUS	Gap junctions consist of arrays of intercellular channels between adjacent cells that permit the exchange of ions and small molecules. Here we report the crystal structure of the gap junction channel formed by human connexin 26 (Cx26, also known as GJB2) at 3.5 angstrom resolution, and discuss structural determinants of solute transport through the channel. The density map showed the two membrane-spanning hemichannels and the arrangement of the four transmembrane helices of the six protomers forming each hemichannel. The hemichannels feature a positively charged cytoplasmic entrance, a funnel, a negatively charged transmembrane pathway, and an extracellular cavity. The pore is narrowed at the funnel, which is formed by the six amino-terminal helices lining the wall of the channel, which thus determines the molecular size restriction at the channel entrance. The structure of the Cx26 gap junction channel also has implications for the gating of the channel by the transjunctional voltage.	[Maeda, Shoji; Nakagawa, So; Suga, Michihiro; Yamashita, Eiki; Tsukihara, Tomitake] Osaka Univ, OLABB, Inst Prot Res, Osaka 5650874, Japan; [Oshima, Atsunori; Fujiyoshi, Yoshinori] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; [Tsukihara, Tomitake] Univ Hyogo, Grad Sch Life Sci, Picobiol Inst, Akoh, Hyogo 6781297, Japan	Osaka University; Kyoto University; University of Hyogo	Tsukihara, T (corresponding author), Osaka Univ, OLABB, Inst Prot Res, 6-2-3 Furuedai, Osaka 5650874, Japan.	tsuki@protein.osaka-u.ac.jp	Yamashita, Eiki/V-6758-2019; Oshima, Atsunori/F-8346-2010; Fujiyoshi, Yoshinori/E-5989-2012; Suga, Michi/C-2870-2015	Yamashita, Eiki/0000-0002-4278-0039; Fujiyoshi, Yoshinori/0000-0002-8070-1493; Maeda, Shoji/0000-0002-7762-9793; Oshima, Atsunori/0000-0003-1174-1368	Ministry of Education, Culture, Sports, Science, and Technology of Japan [10687101, 16087206, 18207006, A-041]; Japan Biological Informatics Consortium; Strategic Japan-UK Cooperation Program of the Japan Science and Technology Agency; New Energy and Industrial Technology Development Organization; Grants-in-Aid for Specially Promoted Research	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Biological Informatics Consortium; Strategic Japan-UK Cooperation Program of the Japan Science and Technology Agency; New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Grants-in-Aid for Specially Promoted Research	We thank T. Tomizaki for help in the diffraction data collection on X06SA at the Swiss Light Source. This work was supported by Grants-in-Aid for Scientific Research ( 10687101, 16087206 and 18207006) and the GCOE program (A-041) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan ( to T. T.), the Japan Biological Informatics Consortium ( to T. T.), the Strategic Japan-UK Cooperation Program of the Japan Science and Technology Agency ( to T. T.), and Grants-in-Aid for Specially Promoted Research ( to Y. F.) and the New Energy and Industrial Technology Development Organization ( to Y. F.). We thank T. Walz for critical reading of this manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bellizzi JJ, 1999, STRUCTURE, V7, pR263, DOI 10.1016/S0969-2126(00)80020-9; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; Bukauskas FF, 2001, BIOPHYS J, V81, P137, DOI 10.1016/S0006-3495(01)75687-1; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; DeLano W., 2006, PYMOL MOL GRAPHICS S; Delmar M, 2004, CARDIOVASC RES, V62, P268, DOI 10.1016/j.cardiores.2003.12.030; Dodson E, 1996, ACTA CRYSTALLOGR D, V52, P228, DOI 10.1107/S0907444995010638; EBIHARA L, 1995, BIOPHYS J, V68, P1796, DOI 10.1016/S0006-3495(95)80356-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleishman SJ, 2004, MOL CELL, V15, P879, DOI 10.1016/j.molcel.2004.08.016; Foote CI, 1998, J CELL BIOL, V140, P1187, DOI 10.1083/jcb.140.5.1187; Gong XQ, 2001, CELL COMMUN ADHES, V8, P187, DOI 10.3109/15419060109080721; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; HARRIS AL, 1981, J GEN PHYSIOL, V77, P95, DOI 10.1085/jgp.77.1.95; JAN LY, 1992, ANNU REV PHYSIOL, V54, P535, DOI 10.1146/annurev.physiol.54.1.535; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kelsell DP, 2001, TRENDS CELL BIOL, V11, P2, DOI 10.1016/S0962-8924(00)01866-3; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kronengold J, 2003, J GEN PHYSIOL, V122, P389, DOI 10.1085/jgp.200308861; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levin M, 2007, PROG BIOPHYS MOL BIO, V94, P186, DOI 10.1016/j.pbiomolbio.2007.03.005; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oh S, 2000, J GEN PHYSIOL, V116, P13, DOI 10.1085/jgp.116.1.13; Oh S, 2004, BIOPHYS J, V87, P912, DOI 10.1529/biophysj.103.038448; Oh S, 2008, J PHYSIOL-LONDON, V586, P2445, DOI 10.1113/jphysiol.2008.150805; Oshima A, 2003, J BIOL CHEM, V278, P1807, DOI 10.1074/jbc.M207713200; Oshima A, 2008, CELL COMMUN ADHES, V15, P85, DOI 10.1080/15419060802013588; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peracchia C, 2004, BBA-BIOMEMBRANES, V1662, P61, DOI 10.1016/j.bbamem.2003.10.020; Perkins GA, 1998, J MOL BIOL, V277, P171, DOI 10.1006/jmbi.1997.1580; Purnick PEM, 2000, ARCH BIOCHEM BIOPHYS, V381, P181, DOI 10.1006/abbi.2000.1989; Purnick PEM, 2000, BIOPHYS J, V79, P2403, DOI 10.1016/S0006-3495(00)76485-X; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; SHERIDAN RP, 1982, P NATL ACAD SCI-BIOL, V79, P4545, DOI 10.1073/pnas.79.15.4545; Simon AM, 1998, TRENDS CELL BIOL, V8, P477, DOI 10.1016/S0962-8924(98)01372-5; Skerrett IM, 2002, J CELL BIOL, V159, P349, DOI 10.1083/jcb.200207060; STAUFFER KA, 1991, J CELL BIOL, V115, P141, DOI 10.1083/jcb.115.1.141; SUCHYNA TM, 1993, NATURE, V365, P847, DOI 10.1038/365847a0; Tao L, 2007, MOL PHARMACOL, V71, P570, DOI 10.1124/mol.106.027508; Trexler EB, 2000, BIOPHYS J, V79, P3036, DOI 10.1016/S0006-3495(00)76539-8; Trexler EB, 1996, P NATL ACAD SCI USA, V93, P5836, DOI 10.1073/pnas.93.12.5836; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; UNWIN PNT, 1980, NATURE, V283, P545, DOI 10.1038/283545a0; UNWIN PNT, 1984, NATURE, V307, P609, DOI 10.1038/307609a0; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; Weber PA, 2004, BIOPHYS J, V87, P958, DOI 10.1529/biophysj.103.036350; Zhou XW, 1997, BIOPHYS J, V72, P1946, DOI 10.1016/S0006-3495(97)78840-4	58	520	531	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					597	U61		10.1038/nature07869	http://dx.doi.org/10.1038/nature07869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19340074				2022-12-28	WOS:000264796200033
J	Cohen, D				Cohen, Deborah			Medicine and the Media PSA testing: press coverage in UK and US is an ocean apart	BRITISH MEDICAL JOURNAL			English	Editorial Material												dcohen@bmj.com							0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 27	2009	338								b1287	10.1136/bmj.b1287	http://dx.doi.org/10.1136/bmj.b1287			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	425LS	19329514				2022-12-28	WOS:000264639800004
J	Rowland, D				Rowland, Diane			Health Care and Medicaid - Weathering the Recession	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rowland, Diane] Henry J Kaiser Family Fdn, Washington, DC USA; [Rowland, Diane] Kaiser Commiss Medicaid & Uninsured, Washington, DC USA		Rowland, D (corresponding author), Henry J Kaiser Family Fdn, Washington, DC USA.							Holahan J, 2009, RISING UNEMPLOYMENT; *KAIS COMM MED UN, 2008, UN PRIM; *KAIS COMM MED UN, 2008, TURN MED SCHIP EC RE	3	13	13	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2009	360	13					1273	1276		10.1056/NEJMp0901072	http://dx.doi.org/10.1056/NEJMp0901072			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	423VP	19321865				2022-12-28	WOS:000264524100001
J	Phipps, RJ; Gaunt, MJ				Phipps, Robert J.; Gaunt, Matthew J.			A Meta-Selective Copper-Catalyzed C-H Bond Arylation	SCIENCE			English	Article							FUNCTIONALIZATION; ARENES; ALKENYLATION; METALATION; MECHANISM; EFFICIENT; INDOLES	For over a century, chemical transformations of benzene derivatives have been guided by the high selectivity for electrophilic attack at the ortho/para positions in electron-rich substrates and at the meta position in electron-deficient molecules. We have developed a copper-catalyzed arylation reaction that, in contrast, selectively substitutes phenyl electrophiles at the aromatic carbon-hydrogen sites meta to an amido substituent. This previously elusive class of transformation is applicable to a broad range of aromatic compounds.	[Phipps, Robert J.; Gaunt, Matthew J.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Gaunt, MJ (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	mjg32@cam.ac.uk		Gaunt, Matthew/0000-0002-7214-608X	Biotechnology and Biological Sciences Research Council [Industrial Case Award]; GlaxoSmithKline [Industrial Case Award]; Royal Society [University Research Fellowship];  [Next Generation Fellowship]; Engineering and Physical Sciences Research Council [EP/D074487/1] Funding Source: researchfish; EPSRC [EP/D074487/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline(GlaxoSmithKline); Royal Society(Royal Society of London); ; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We gratefully acknowledge the Biotechnology and Biological Sciences Research Council and GlaxoSmithKline for an Industrial Case Award to R.J.P., the Royal Society for a University Research Fellowship to M.J.G., and Philip and Patricia Brown for a Next Generation Fellowship to M.J.G. We also thank S. Peace (GSK Medicines Research Center, UK) for useful discussion.	Alberico D, 2007, CHEM REV, V107, P174, DOI 10.1021/cr0509760; BARTON DHR, 1987, TETRAHEDRON LETT, V28, P887, DOI 10.1016/S0040-4039(01)81015-7; Beck EM, 2006, J AM CHEM SOC, V128, P2528, DOI 10.1021/ja058141u; Bielawski M, 2007, ADV SYNTH CATAL, V349, P2610, DOI 10.1002/adsc.200700373; Brasche G, 2008, ORG LETT, V10, P2207, DOI 10.1021/ol800619c; Campeau LC, 2008, J AM CHEM SOC, V130, P3266, DOI 10.1021/ja710451s; Chen X, 2006, J AM CHEM SOC, V128, P6790, DOI 10.1021/ja061715q; Cho JY, 2002, SCIENCE, V295, P305, DOI 10.1126/science.1067074; Daugulis O, 2005, ANGEW CHEM INT EDIT, V44, P4046, DOI 10.1002/anie.200500589; Davies DL, 2005, J AM CHEM SOC, V127, P13754, DOI 10.1021/ja052047w; Deprez NR, 2006, J AM CHEM SOC, V128, P4972, DOI 10.1021/ja060809x; Desai LV, 2008, J AM CHEM SOC, V130, P13285, DOI 10.1021/ja8045519; Evindar G, 2006, J ORG CHEM, V71, P1802, DOI 10.1021/jo051927q; Flemming JP, 2008, ORG BIOMOL CHEM, V6, P1215, DOI 10.1039/b716954j; Friedel C., 1877, CR HEBD ACAD SCI, V84, P1392; Garcia-Cuadrado D, 2006, J AM CHEM SOC, V128, P1066, DOI 10.1021/ja056165v; Godula K, 2006, SCIENCE, V312, P67, DOI 10.1126/science.1114731; Grimster NP, 2005, ANGEW CHEM INT EDIT, V44, P3125, DOI 10.1002/anie.200500468; Hassan J, 2002, CHEM REV, V102, P1359, DOI 10.1021/cr000664r; Jia CG, 2001, ACCOUNTS CHEM RES, V34, P633, DOI 10.1021/ar000209h; Lafrance M, 2006, J AM CHEM SOC, V128, P16496, DOI 10.1021/ja067144j; Li BJ, 2008, SYNLETT, P949, DOI 10.1055/s-2008-1042907; Mulvey RE, 2007, ANGEW CHEM INT EDIT, V46, P3802, DOI 10.1002/anie.200604369; MURAI S, 1993, NATURE, V366, P529, DOI 10.1038/366529a0; Murphy JM, 2007, J AM CHEM SOC, V129, P15434, DOI 10.1021/ja076498n; OLAH GA, 1963, FRIEDELCRAFTS RELATE; Phipps RJ, 2008, J AM CHEM SOC, V130, P8172, DOI 10.1021/ja801767s; Rohbogner CJ, 2008, ANGEW CHEM INT EDIT, V47, P1503, DOI 10.1002/anie.200703382; SNIECKUS V, 1990, CHEM REV, V90, P879, DOI 10.1021/cr00104a001; Stuart DR, 2007, J AM CHEM SOC, V129, P12072, DOI 10.1021/ja0745862; Thalji RK, 2004, J AM CHEM SOC, V126, P7192, DOI 10.1021/ja0394986; WANG DH, 2008, J AM CHEM SOC, V130, P14082	32	806	806	8	283	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1593	1597		10.1126/science.1169975	http://dx.doi.org/10.1126/science.1169975			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	421EN	19299616				2022-12-28	WOS:000264342300035
J	Lee, CF; Leigh, DA; Pritchard, RG; Schultz, D; Teat, SJ; Timco, GA; Winpenny, REP				Lee, Chin-Fa; Leigh, David A.; Pritchard, Robin G.; Schultz, David; Teat, Simon J.; Timco, Grigore A.; Winpenny, Richard E. P.			Hybrid organic-inorganic rotaxanes and molecular shuttles	NATURE			English	Article							WHEELS; MACHINES; RINGS	The tetravalency of carbon and its ability to form covalent bonds with itself and other elements enables large organic molecules with complex structures, functions and dynamics to be constructed. The varied electronic configurations and bonding patterns of inorganic elements, on the other hand, can impart diverse electronic, magnetic, catalytic and other useful properties to molecular-level structures. Some hybrid organic-inorganic materials that combine features of both chemistries have been developed, most notably metal-organic frameworks(1), dense and extended organic inorganic frameworks(2) and coordination polymers(3). Metal ions have also been incorporated into molecules that contain interlocked subunits, such as rotaxanes(4-7) and catenanes(6,8), and structures in which many inorganic clusters encircle polymer chains have been described(9). Here we report the synthesis of a series of discrete rotaxane molecules in which inorganic and organic structural units are linked together mechanically at the molecular level. Structural units (dialkyammonium groups) in dumb-bell-shaped organic molecules template the assembly of essentially inorganic 'rings' about 'axles' to form rotaxanes consisting of various numbers of rings and axles. One of the rotaxanes behaves as a 'molecular shuttle'(10): the ring moves between two binding sites on the axle in a large-amplitude motion typical of some synthetic molecular machine systems(11-15). The architecture of the rotaxanes ensures that the electronic, magnetic and paramagnetic characteristics of the inorganic rings-properties that could make them suitable as qubits for quantum computers(16-18)-can influence, and potentially be influenced by, the organic portion of the molecule.	[Lee, Chin-Fa; Leigh, David A.; Schultz, David] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland; [Pritchard, Robin G.; Timco, Grigore A.; Winpenny, Richard E. P.] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England; [Teat, Simon J.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	University of Edinburgh; University of Manchester; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Leigh, DA (corresponding author), Univ Edinburgh, Sch Chem, Kings Bldg,W Mains Rd, Edinburgh EH9 3JJ, Midlothian, Scotland.	david.leigh@ed.ac.uk; richard.winpenny@manchester.ac.uk	Leigh, David/K-5965-2015	Leigh, David/0000-0002-1202-4507	Director, Office of Science; Office of Basic Energy Sciences; the US Department of Energy [DE-AC02-05CH11231]; Swiss National Science Foundation; EPSRC Senior Research Fellow; Royal Society Wolfson Research Merit Award; Engineering and Physical Sciences Research Council [GR/S57396/01, GR/T28652/01, EP/D05138X/1, EP/D029686/1, EP/C545001/1] Funding Source: researchfish; EPSRC [EP/D05138X/1, EP/D029686/1] Funding Source: UKRI	Director, Office of Science(United States Department of Energy (DOE)); Office of Basic Energy Sciences(United States Department of Energy (DOE)); the US Department of Energy(United States Department of Energy (DOE)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EPSRC Senior Research Fellow(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society Wolfson Research Merit Award(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank J. Bella for the exchange spectroscopy NMR experiments, W. Sun for assistance with the preparation of thread 1c and the Engineering and Physical Sciences Research Council (EPSRC) National Mass Spectrometry Service Centre (Swansea, UK) for high-resolution mass spectrometry. This research was funded by the European Commission (through the NoE 'MAGMANet') and EPSRC. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract no. DE-AC02-05CH11231. D. S. is a Swiss National Science Foundation postdoctoral fellow. D. A. L. is an EPSRC Senior Research Fellow and holds a Royal Society Wolfson Research Merit Award.	Affronte M, 2007, CHEM COMMUN, P1789, DOI 10.1039/b615543j; Alam MA, 2008, ANGEW CHEM INT EDIT, V47, P2070, DOI 10.1002/anie.200705308; ANELLI PL, 1991, J AM CHEM SOC, V113, P5131, DOI 10.1021/ja00013a096; ASHTON PR, 1995, ANGEW CHEM INT EDIT, V34, P1869, DOI 10.1002/anie.199518691; Ashton PR, 1996, CHEM-EUR J, V2, P729; Aucagne V, 2006, J AM CHEM SOC, V128, P1784, DOI 10.1021/ja057206q; Batten SR, 1998, ANGEW CHEM INT EDIT, V37, P1460, DOI 10.1002/(SICI)1521-3773(19980619)37:11<1460::AID-ANIE1460>3.0.CO;2-Z; Berna J, 2005, NAT MATER, V4, P704, DOI 10.1038/nmat1455; Bertaina S, 2008, NATURE, V453, P203, DOI 10.1038/nature06962; Cador O, 2004, ANGEW CHEM INT EDIT, V43, P5196, DOI 10.1002/anie.200460211; Cheetham AK, 2007, SCIENCE, V318, P58, DOI 10.1126/science.1147231; FUJITA M, 1994, NATURE, V367, P720, DOI 10.1038/367720a0; Green JE, 2007, NATURE, V445, P414, DOI 10.1038/nature05462; Kay ER, 2007, ANGEW CHEM INT EDIT, V46, P72, DOI 10.1002/anie.200504313; Kim K, 2002, CHEM SOC REV, V31, P96, DOI 10.1039/a900939f; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; KOLCHINSKI AG, 1995, J CHEM SOC CHEM COMM, P1289, DOI 10.1039/c39950001289; Larsen FK, 2003, ANGEW CHEM INT EDIT, V42, P101, DOI 10.1002/anie.200390034; Leuenberger MN, 2001, NATURE, V410, P789, DOI 10.1038/35071024; Liu Y, 2005, J AM CHEM SOC, V127, P9745, DOI 10.1021/ja051088p; Loeb SJ, 2005, CHEM COMMUN, P1511, DOI 10.1039/b416609d; MOCK WL, 1989, J ORG CHEM, V54, P5302, DOI 10.1021/jo00283a024; Nguyen TD, 2005, P NATL ACAD SCI USA, V102, P10029, DOI 10.1073/pnas.0504109102; OGINO H, 1981, J AM CHEM SOC, V103, P1303, DOI 10.1021/ja00395a091; PERRIN CL, 1990, CHEM REV, V90, P935, DOI 10.1021/cr00104a002; Sauvage, 1999, MOL CATENANES ROTAXA; Timco GA, 2005, CHEM COMMUN, P3649, DOI 10.1039/b504912a; Winpenny REP, 2008, ANGEW CHEM INT EDIT, V47, P7992, DOI 10.1002/anie.200802742; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650	29	214	218	3	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					314	318		10.1038/nature07847	http://dx.doi.org/10.1038/nature07847			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	420JH	19295605				2022-12-28	WOS:000264285600036
J	Soares, MO; Iglesias, CP; Bland, JM; Cullum, N; Dumville, JC; Nelson, EA; Torgerson, DJ; Worthy, G				Soares, Marta O.; Iglesias, Cynthia P.; Bland, J. Martin; Cullum, Nicky; Dumville, Jo C.; Nelson, E. Andrea; Torgerson, David J.; Worthy, Gill		VenUS II Team	Cost effectiveness analysis of larval therapy for leg ulcers	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CENSORED-DATA	Objective To assess the cost effectiveness of larval therapy compared with hydrogel in the management of leg ulcers. Design Cost effectiveness and cost utility analyses carried out alongside a pragmatic multicentre, randomised, open trial with equal randomisation. Population Intention to treat population comprising 267 patients with a venous or mixed venous and arterial ulcers with at least 25% coverage of slough or necrotic tissue. Interventions Patients were randomly allocated to debridement with bagged larvae, loose larvae, or hydrogel. Main outcome measure The time horizon was 12 months and costs were estimated from the UK National Health Service perspective. Cost effectiveness outcomes are expressed in terms of incremental costs per ulcer-free day (cost effectiveness analysis) and incremental costs per quality adjusted life years (cost utility analysis). Results The larvae arms were pooled for the main analysis. Treatment with larval therapy cost, on average, 96.70 pound ((sic)109.61; $140.57) more per participant per year (95% confidence interval -491.9 pound to 685.8) pound than treatment with hydrogel. Participants treated with larval therapy healed, on average, 2.42 days before those in the hydrogel arm (95% confidence interval -0.95 to 31. 91 days) and had a slightly better health related quality of life, as the annual difference in QALYs was 0.011 (95% confidence interval -0.067 to 0.071). However, none of these differences was statistically significant. The incremental cost effectiveness ratio for the base case analysis was estimated at 8826 pound per QALY gained and 40 pound per ulcer-free day. Considerable uncertainty surrounds the outcome estimates. Conclusions Debridement of sloughy or necrotic leg ulcers with larval therapy is likely to produce similar health benefits and have similar costs to treatment with hydrogel. Trial registration Current Controlled Trials ISRCTN55114812 and National Research Register N0484123692.	[Bland, J. Martin; Cullum, Nicky; Torgerson, David J.; Worthy, Gill] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Nelson, E. Andrea] Univ Leeds, Sch Healthcare, Leeds LS2 9JT, W Yorkshire, England	University of York - UK; University of Leeds		ms602@york.ac.uk	Cullum, Nicky/AAT-5888-2020; Cullum, Nicky A/F-2438-2011; Nelson, Andrea/K-2733-2012; Dumville, Jo C/O-7867-2014; Torgerson, David/L-4566-2019	Cullum, Nicky/0000-0003-2631-123X; Cullum, Nicky A/0000-0003-2631-123X; Nelson, Andrea/0000-0001-6741-3078; Dumville, Jo C/0000-0002-6546-3685; Torgerson, David/0000-0002-1667-4275; Adderley, Una/0000-0003-1894-3755; McGinnis, Elizabeth/0000-0002-2848-9149; Soares, Marta Ferreira Oliveira/0000-0003-1579-8513	UK National Institute for Health Research Health Technology Assessment Programme [01/41/04]; National Institute for Health Research [01/41/04] Funding Source: researchfish	UK National Institute for Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding: This project was funded by the UK National Institute for Health Research Health Technology Assessment Programme (project No 01/41/04). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Department of Health. Zoobiotic supplied and distributed the loose larvae at no cost and Biomonde supplied the bagged larvae at no cost. These manufacturers had no role in the design of the trial or in the collection, analysis, and interpretation of the data.	BRADLEY M, HLTH TECHNOL ASSES 1, V3, pR3; *BRIT MED ASS, 2006, BRIT NAT FORM, P825; CALLAM MJ, 1985, BRIT MED J, V290, P1855, DOI 10.1136/bmj.290.6485.1855; Cullum N, 2001, Health Technol Assess, V5, P1; Cullum N, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000265; Cullum N, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; Curtis L, 2006, UNIT COSTS HLTH SOCI; DOLAN P, 1995, DISCUSSION PAPER SER, V138; Drummond MF., 2005, METHODS EC EVALUATIO, P55; DUMVILLE J, HLTH TECHNO IN PRESS; Dumville JC, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b773; Efron B., 1994, MONOGRAPHS STAT APPL; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Gardiner JC, 2006, STAT MED, V25, P3648, DOI 10.1002/sim.2484; Iglesias C, 2004, HEALTH TECHNOL ASSES, V8, P1; Iglesias CP, 2005, QUAL LIFE RES, V14, P1705, DOI 10.1007/s11136-005-2751-9; Kind P, 1996, QUALITY LIFE PHARMAC; Lin D Y, 2000, Biostatistics, V1, P35, DOI 10.1093/biostatistics/1.1.35; Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; *NAT I HLTH CLIN E, 2001, NICE TECHN GUID MAN; NELZEN O, 1994, BRIT J SURG, V81, P182, DOI 10.1002/bjs.1800810206; *ROY COLL NURS, 2006, NURS MAN VEN LEG ULC; *SCOTT INT GUID NE, 1998, CAR PAT CHRON LEG UL; Wayman J, 2000, J Tissue Viability, V10, P91; Willan AR, 2005, STAT MED, V24, P131, DOI 10.1002/sim.1794; Willan AR, 2002, STAT METHODS MED RES, V11, P539, DOI 10.1191/0962280202sm308ra; Zhao HW, 1997, BIOMETRIKA, V84, P339, DOI 10.1093/biomet/84.2.339	28	46	46	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2009	338								b825	10.1136/bmj.b825	http://dx.doi.org/10.1136/bmj.b825			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	422NW	19304578	Green Accepted, Green Published, hybrid, Green Submitted			2022-12-28	WOS:000264436000004
J	House, JI; Ayele, B; Porco, TC; Zhou, ZX; Hong, KC; Gebre, T; Ray, KJ; Keenan, JD; Stoller, NE; Whitcher, JP; Gaynor, BD; Emerson, PM; Lietman, TM				House, Jenafir I.; Ayele, Berhan; Porco, Travis C.; Zhou, Zhaoxia; Hong, Kevin C.; Gebre, Teshome; Ray, Kathryn J.; Keenan, Jeremy D.; Stoller, Nicole E.; Whitcher, John P.; Gaynor, Bruce D.; Emerson, Paul M.; Lietman, Thomas M.			Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial	LANCET			English	Article							OCULAR CHLAMYDIA-TRACHOMATIS; AZITHROMYCIN; ELIMINATION; INFECTION; TRANSMISSION; STRATEGIES; COMMUNITY; DISEASE	Background Trachoma-control programmes distribute oral azithromycin to treat the ocular strains of chlamydia that cause the disease and to control infection. Theoretically, elimination of infection is feasible if untreated individuals receive an indirect protective effect from living in repeatedly treated communities, which is similar to herd protection in vaccine programmes. We assessed indirect protection against trachoma with-mass azithromycin distributions. Methods In a cluster randomised trial, 24 subkebeles (government-defined units) in Amhara, Ethiopia, were randomised, with use of a simple random sample, to distribution four times per year of single-dose oral azithromycin to children aged 1-10 years (12 subkebeles, 4764 children), or to delayed treatment until after the study (control; 12 subkebeles, 6014 children). We compared the prevalence of ocular chlamydial infection in untreated individuals 11 years and older between baseline and 12 months in the treated subkebeles, and at 12 months between the treated and control subkebeles. Health-care and laboratory personnel were blinded to-study group. Analysis was intention to treat. The study is registered with clinicaltrials.gov, number NCT00322972. Findings At 12 months, 637 children aged 1-10 years and 561 adults and children aged 11 years and older were analysed in the children-treated group, and 618 and 550, respectively, in the control group. The mean prevalence of infection in children decreased from 48.4% (95% CI 42.9-53.9) to 3.6% (0.8-6.4) after four mass treatments. At 12 months, the mean prevalence of infection in the untreated age group (>= 11 years) was 47% (95% CI 33-57) less than baseline (p=0.002), and 35% (95% CI 1-57) less than that in untreated communities (p=0.04). Interpretation Frequent treatment of children, who are a core group for transmission of trachoma, could eventually eliminate infection from the entire community. Herd protection is offered by repeated mass antibiotic treatments, providing a strategy for elimination of a bacterial disease when an effective vaccine is unavailable. Funding National Institutes of Health.	[Lietman, Thomas M.] Univ Calif San Francisco, Inst Global Hlth, San Francisco, CA 94143 USA; [House, Jenafir I.; Porco, Travis C.; Zhou, Zhaoxia; Hong, Kevin C.; Ray, Kathryn J.; Keenan, Jeremy D.; Stoller, Nicole E.; Whitcher, John P.; Gaynor, Bruce D.; Lietman, Thomas M.] Univ Calif San Francisco, FI Proctor Fdn, San Francisco, CA 94143 USA; [Porco, Travis C.; Keenan, Jeremy D.; Whitcher, John P.; Gaynor, Bruce D.; Lietman, Thomas M.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Porco, Travis C.; Whitcher, John P.; Lietman, Thomas M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Porco, Travis C.] Ctr Infect Dis Preparedness, Berkeley, CA USA; [Ayele, Berhan; Gebre, Teshome; Emerson, Paul M.] Carter Ctr, Addis Ababa, Ethiopia; [Ayele, Berhan; Gebre, Teshome; Emerson, Paul M.] Emory Univ, Carter Ctr, Atlanta, GA 30322 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Emory University	Lietman, TM (corresponding author), Univ Calif San Francisco, Inst Global Hlth, 513 Parnassus Ave,Room S309 Med Sci, San Francisco, CA 94143 USA.	tom.lietman@ucsf.edu	Gebre, Teshome/F-2973-2011; Keenan, Jeremy David/AAO-5882-2020	Gebre, Teshome/0000-0002-9884-0344; Keenan, Jeremy David/0000-0002-7118-1457; Emerson, Paul/0000-0002-6478-8816	The National Institutes of Health [NEI U10 EY016214]; Bernard Osher Foundation; That Man May See; Harper Inglis Trust; Bodri Foundation; South Asia Research Fund; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [U10EY016214] Funding Source: NIH RePORTER	The National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bernard Osher Foundation; That Man May See; Harper Inglis Trust; Bodri Foundation; South Asia Research Fund; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The National Institutes of Health (NEI U10 EY016214) was the main supporter of his trial. We thank the International Trachoma Initiative for their generous donation of azithromycin, the Bernard Osher Foundation, That Man May See, the Harper Inglis Trust, the Bodri Foundation, the South Asia Research Fund, and Research to Prevent Blindness; the data safety and monitoring committee including William Barlow (University of Washington, Washington, DC, USA; Chair), Donald Everett (National Eye Institute, Bethesda, MD, USA), Larry Schwab (International Eye Foundation, Kensington, MD, USA), Arthur Reingold (University of California, Berkeley, CA, USA), and Serge Resnikoff (WHO, Geneva, Switzerland), who were generous with their time and advice and met before, during, and after this 12-month study; and the nurses and health workers who helped collect samples for the study, including Tesfye Belay, Azmaraw Adgo, Melese Temesgen, Gabeyehu Sibhat, Manalosh Berihun, Temesgen Demile, Melkam Berhanu, Mitsalal Aberahraney, Bandni Gedaniu, Tessema Eneyew, and Muluken G-obezie.	ANDERSON R M, 1991; Asiedu K, 2008, B WORLD HEALTH ORGAN, V86, P499, DOI 10.2471/BLT.08.055608; Bailey R, 1999, EPIDEMIOL INFECT, V123, P479, DOI 10.1017/S0950268899003076; Bird M, 2003, J INFECT DIS, V187, P1669, DOI 10.1086/374743; Chidambaram JD, 2006, JAMA-J AM MED ASSOC, V295, P1142, DOI 10.1001/jama.295.10.1142; Diamant J, 2001, Ophthalmic Epidemiol, V8, P109, DOI 10.1076/opep.8.2.109.4156; Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22; Emerson PM, 2000, T ROY SOC TROP MED H, V94, P28, DOI 10.1016/S0035-9203(00)90427-9; Farid M. A., 1980, World Health Forum, V1, P8; FOX JP, 1995, AM J EPIDEMIOL, V141, P187, DOI 10.1093/oxfordjournals.aje.a117420; Gaydos CA, 2002, J CLIN MICROBIOL, V40, P758, DOI 10.1128/JCM.40.3.758-761.2002; Gaynor BD, 2003, EMERG INFECT DIS, V9, P596, DOI 10.3201/eid0905.020577; Gill DA, 2008, CLIN INFECT DIS, V46, P564, DOI 10.1086/526777; Glezen WP, 2006, J CLIN VIROL, V37, P237, DOI 10.1016/j.jcv.2006.08.020; Henderson D A, 1998, Bull World Health Organ, V76 Suppl 2, P17; Hethcote H., 1996, MODELS INFECT HUMAN, V215, P238, DOI 10.1017/CBO9780511662935.030; Holm SO, 2001, B WORLD HEALTH ORGAN, V79, P194; Jacquez J., 1995, EPIDEMIC MODELS THEI, P279; Jha H, 2002, CLIN INFECT DIS, V35, P765, DOI 10.1086/342298; Lakew T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000376; Lietman T, 1999, NAT MED, V5, P572, DOI 10.1038/8451; Melese M, 2004, JAMA-J AM MED ASSOC, V292, P721, DOI 10.1001/jama.292.6.721; Melese M, 2008, JAMA-J AM MED ASSOC, V299, P778, DOI 10.1001/jama.299.7.778; Murray DM, 1998, DESIGN ANAL GROUP RA; Peeling RW, 1998, SEX TRANSM INFECT, V74, P66, DOI 10.1136/sti.74.1.66; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Ray KJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-91; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; Solomon AW, 2004, NEW ENGL J MED, V351, P1962, DOI 10.1056/NEJMoa040979; Solomon AW, 2003, LANCET, V362, P198, DOI 10.1016/S0140-6736(03)13909-8; TAYLOR HR, 1990, SCIENCE, V250, P116, DOI 10.1126/science.2218502; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; Wawer MJ, 1998, AIDS, V12, P1211, DOI 10.1097/00002030-199810000-00014; West SK, 2005, LANCET, V366, P1296, DOI 10.1016/S0140-6736(05)67529-0	34	84	84	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2009	373	9669					1111	1118		10.1016/S0140-6736(09)60323-8	http://dx.doi.org/10.1016/S0140-6736(09)60323-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427IS	19329003				2022-12-28	WOS:000264773600032
J	Smock, RG; Gierasch, LM				Smock, Robert G.; Gierasch, Lila M.			Sending Signals Dynamically	SCIENCE			English	Review							PDZ DOMAIN; PROTEIN ALLOSTERY; BINDING; CALMODULIN; RECEPTOR; LIGAND; TRANSDUCTION; FLEXIBILITY; MECHANISM; PATHWAYS	Proteins mediate transmission of signals along intercellular and intracellular pathways and between the exterior and the interior of a cell. The dynamic properties of signaling proteins are crucial to their functions. We discuss emerging paradigms for the role of protein dynamics in signaling. A central tenet is that proteins fluctuate among many states on evolutionarily selected energy landscapes. Upstream signals remodel this landscape, causing signaling proteins to transmit information to downstream partners. New methods provide insight into the dynamic properties of signaling proteins at the atomic scale. The next stages in the signaling hierarchy-how multiple signals are integrated and how cellular signaling pathways are organized in space and time-present exciting challenges for the future, requiring bold multidisciplinary approaches.	[Smock, Robert G.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Smock, RG (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.	rsmock@student.umass.edu; gierasch@biochem.umass.edu	Gierasch, Lila M/D-1494-2009		NIH [GM027616, OD000945]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027616, T32GM008515] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000945] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by NIH grants GM027616 and OD000945 (L.M.G.).	Ankers JM, 2008, CURR OPIN BIOTECH, V19, P375, DOI 10.1016/j.copbio.2008.07.001; ANSARI A, 1985, P NATL ACAD SCI USA, V82, P5000, DOI 10.1073/pnas.82.15.5000; Besschetnova TY, 2008, P NATL ACAD SCI USA, V105, P12289, DOI 10.1073/pnas.0802868105; Bustamante C, 2008, ANNU REV BIOCHEM, V77, P45, DOI 10.1146/annurev.biochem.012108.120952; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Chi CN, 2008, P NATL ACAD SCI USA, V105, P4679, DOI 10.1073/pnas.0711732105; De Los Rios P, 2005, BIOPHYS J, V89, P14, DOI 10.1529/biophysj.104.055004; Dhulesia A, 2008, J AM CHEM SOC, V130, P8931, DOI 10.1021/ja0752080; Dueber JE, 2004, CURR OPIN STRUC BIOL, V14, P690, DOI 10.1016/j.sbi.2004.10.004; Dunker AK, 2008, NAT CHEM BIOL, V4, P229, DOI 10.1038/nchembio0408-229; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Eliezer D, 2007, NATURE, V447, P920, DOI 10.1038/447920a; Faraldo-Gomez JD, 2007, P NATL ACAD SCI USA, V104, P13643, DOI 10.1073/pnas.0704041104; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Fuentes EJ, 2004, J MOL BIOL, V335, P1105, DOI 10.1016/j.jmb.2003.11.010; Fuxreiter M, 2008, NAT CHEM BIOL, V4, P728, DOI 10.1038/nchembio.127; Galea CA, 2008, J MOL BIOL, V376, P827, DOI 10.1016/j.jmb.2007.12.016; Gianni S, 2006, STRUCTURE, V14, P1801, DOI 10.1016/j.str.2006.10.010; Gsponer J, 2008, STRUCTURE, V16, P736, DOI 10.1016/j.str.2008.02.017; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Jarymowycz VA, 2008, BIOCHEMISTRY-US, V47, P13371, DOI 10.1021/bi801096b; Johnson CK, 2006, BIOCHEMISTRY-US, V45, P14233, DOI 10.1021/bi061058e; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Kong YF, 2009, PROTEINS, V74, P145, DOI 10.1002/prot.22139; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Lenaerts T, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-43; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Linderstrom-Lang K, 1959, ENZYMES, P443; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Marcellino D, 2008, NEUROPHARMACOLOGY, V54, P815, DOI 10.1016/j.neuropharm.2007.12.011; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; *NIH, GM027616 NIH; Ota N, 2005, J MOL BIOL, V351, P345, DOI 10.1016/j.jmb.2005.05.043; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PERUTZ MF, 1966, J MOL BIOL, V21, P199, DOI 10.1016/0022-2836(66)90088-X; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Pollard TD, 2008, BIOCHEM SOC T, V36, P425, DOI 10.1042/BST0360425; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Sarkar P, 2007, MOL CELL, V25, P413, DOI 10.1016/j.molcel.2007.01.004; Sherwood P, 2008, CURR OPIN STRUC BIOL, V18, P630, DOI 10.1016/j.sbi.2008.07.003; Sotomayor M, 2008, BIOPHYS J, V94, P4621, DOI 10.1529/biophysj.107.125591; Stein M, 2007, CURR OPIN STRUC BIOL, V17, P166, DOI 10.1016/j.sbi.2007.03.014; Sue SC, 2008, J MOL BIOL, V380, P917, DOI 10.1016/j.jmb.2008.05.048; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Tripathi S, 2009, P NATL ACAD SCI USA, V106, P2104, DOI 10.1073/pnas.0806872106; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; van den Berk LCJ, 2007, BIOCHEMISTRY-US, V46, P13629, DOI 10.1021/bi700954e; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; WEBER G, 1972, BIOCHEMISTRY-US, V11, P864, DOI 10.1021/bi00755a028; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	56	403	409	2	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					198	203		10.1126/science.1169377	http://dx.doi.org/10.1126/science.1169377			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359576	Green Accepted			2022-12-28	WOS:000265024400032
J	Stratton, MR; Campbell, PJ; Futreal, PA				Stratton, Michael R.; Campbell, Peter J.; Futreal, P. Andrew			The cancer genome	NATURE			English	Review							COLORECTAL CANCERS; HUMAN BREAST; SOMATIC MUTATIONS; LUNG-CANCER; LEUKEMIA; PATHWAYS; GENES; THERAPY; TUMORS; SUSCEPTIBILITY	All cancers arise as a result of changes that have occurred in the DNA sequence of the genomes of cancer cells. Over the past quarter of a century much has been learnt about these mutations and the abnormal genes that operate in human cancers. We are now, however, moving into an era in which it will be possible to obtain the complete DNA sequence of large numbers of cancer genomes. These studies will provide us with a detailed and comprehensive perspective on how individual cancers have developed.	[Stratton, Michael R.; Campbell, Peter J.; Futreal, P. Andrew] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England; [Stratton, Michael R.] Inst Canc Res, Sutton SM2 5NG, Surrey, England; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England	University of Cambridge; Wellcome Trust Sanger Institute; University of London; Institute of Cancer Research - UK; University of Cambridge	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England.	mrs@sanger.ac.uk	Bardelli, Alberto/J-9721-2018		Kay Kendall Leukaemia Fund; Wellcome Trust	Kay Kendall Leukaemia Fund; Wellcome Trust(Wellcome TrustEuropean Commission)	We would like to thank N. Rahman for comments on the manuscript, G. Tang and B. Barrell for contributions to the figures and the Kay Kendall Leukaemia Fund and the Wellcome Trust for support.	Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Beerenwinkel N, 2007, PLOS COMPUT BIOL, V3, P2239, DOI 10.1371/journal.pcbi.0030225; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Bodmer W, 2008, CANCER RES, V68, P3558, DOI 10.1158/0008-5472.CAN-07-6544; Boveri T, 1914, FRAGE ENTSTEHUNG MAL, P1; Cahill DP, 2007, CLIN CANCER RES, V13, P2038, DOI 10.1158/1078-0432.CCR-06-2149; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garcia M, 2007, GLOBAL CANC FACTS FI; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Haferlach Torsten, 2008, Hematology Am Soc Hematol Educ Program, P400, DOI 10.1182/asheducation-2008.1.400; Hanks S, 2005, CELL CYCLE, V4, P225; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kennedy RD, 2006, J CLIN ONCOL, V24, P3799, DOI 10.1200/JCO.2005.05.4171; KRONTIRIS TG, 1981, P NATL ACAD SCI-BIOL, V78, P1181, DOI 10.1073/pnas.78.2.1181; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Loeb LA, 2008, CANCER RES, V68, P6863, DOI 10.1158/0008-5472.CAN-08-2852; Loeb LA, 2008, CANCER RES, V68, P3551, DOI 10.1158/0008-5472.CAN-07-5835; Mariani G, 2009, NAT CLIN PRACT ONCOL, V6, P93, DOI 10.1038/ncponc1298; MILLER DG, 1980, CANCER, V46, P1307, DOI 10.1002/1097-0142(19800915)46:6<1307::AID-CNCR2820460602>3.0.CO;2-6; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; NOWELL PC, 1960, SCIENCE, V132, P1497; Olivier Magali, 2004, IARC Sci Publ, P247; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Schinzel AC, 2008, FRONT BIOSCI-LANDMRK, V13, P71, DOI 10.2741/2661; SHIH C, 1981, NATURE, V290, P261, DOI 10.1038/290261a0; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sleijfer S, 2008, NAT CLIN PRACT ONCOL, V5, P102, DOI 10.1038/ncponc1037; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; Talbot SJ, 2004, EUR J CANCER, V40, P1998, DOI 10.1016/j.ejca.2003.11.039; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Touw IP, 2007, MOL THER, V15, P13, DOI 10.1038/sj.mt.6300040; VANHAFTEN G, NATURE GENE IN PRESS; Volik S, 2003, P NATL ACAD SCI USA, V100, P7696, DOI 10.1073/pnas.1232418100; Von Hansemann D, 1890, VIRCHOWS ARCH PATHOL, V119, P299; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	59	2171	2260	6	417	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					719	724		10.1038/nature07943	http://dx.doi.org/10.1038/nature07943			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19360079	Green Accepted, Bronze			2022-12-28	WOS:000265193600031
J	Walter, LC; Lindquist, K; Nugent, S; Schult, T; Lee, SJ; Casadei, MA; Partin, MR				Walter, Louise C.; Lindquist, Karla; Nugent, Sean; Schult, Tammy; Lee, Sei J.; Casadei, Michele A.; Partin, Melissa R.			Impact of Age and Comorbidity on Colorectal Cancer Screening Among Older Veterans	ANNALS OF INTERNAL MEDICINE			English	Article							FECAL-OCCULT-BLOOD; SERVICES TASK-FORCE; HEALTH-CARE-SYSTEM; PREVENTIVE SERVICES; MEDICARE BENEFICIARIES; ELDERLY-PATIENTS; UNITED-STATES; PROSTATE; AFFAIRS; QUALITY	Background: The Veterans Health Administration, the American Cancer Society, and the American Geriatrics Society recommend colorectal cancer screening for older adults unless they are unlikely to live 5 years or have significant comorbidity that would preclude treatment. Objective: To determine whether colorectal cancer screening is targeted to healthy older patients and is avoided in older patients with severe comorbidity who have life expectancies of 5 years or less. Design: Cohort study. Setting: Veterans Affairs (VA) medical centers in Minneapolis, Minnesota; Durham, North Carolina; Portland, Oregon; and West Los Angeles, California, with linked national VA and Medicare administrative claims. Patients: 27 068 patients 70 years or older who had an outpatient visit at 1 of 4 VA medical centers in 2001 or 2002 and were due for screening. Measurements: The main outcome was receipt of fecal occult blood testing (FOBT), colonoscopy, sigmoidoscopy, or barium enema in 2001 or 2002, on the basis of national VA and Medicare claims. Charlson-Deyo comorbidity scores at the start of 2001 were used to stratify patients into 3 groups ranging from no comorbidity (score of 0) to severe comorbidity (score >= 4), and 5-year mortality was determined for each group. Results: 46% of patients were screened from 2001 through 2002. Only 47% of patients with no comorbidity were screened despite having life expectancies greater than 5 years (5-year mortality, 19%). Although the incidence of screening decreased with age and worsening comorbidity, it was still 41% for patients with severe comorbidity who had life expectancies less than 5 years (5-year mortality, 55%). The number of VA outpatient visits predicted screening independent of comorbidity, such that patients with severe comorbidity and 4 or more visits had screening rates similar to or higher than those of healthier patients with fewer visits. Limitations: Some tests may have been performed for nonscreening reasons. The generalizability of findings to persons who do not use the VA system is uncertain. Conclusion: Advancing age was inversely associated with colorectal cancer screening, whereas comorbidity was a weaker predictor. More attention to comorbidity is needed to better target screening to older patients with substantial life expectancies and avoid screening older patients with limited life expectancies.	San Francisco VA Med Ctr, San Francisco, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Minneapolis Vet Affairs Med Ctr, Minneapolis, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Walter, LC (corresponding author), Vet Affairs Med Ctr 181G, 4150 Clement St, San Francisco, CA 94121 USA.	louise.walter@ucsf.edu		Lindquist, Karla/0000-0002-1971-2273	VA Health Services Research and Development [IIR-04-427]; Robert Wood Johnson Physician Faculty Scholar; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER	VA Health Services Research and Development(US Department of Veterans Affairs); Robert Wood Johnson Physician Faculty Scholar(Robert Wood Johnson Foundation (RWJF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Grant Support: Dr. Walter is supported by VA Health Services Research and Development grant IIR-04-427 and is a Robert Wood Johnson Physician Faculty Scholar. Dr. Lee is a Hartford Geriatrics Health Outcomes Research Scholar.	Ananthakrishnan AN, 2007, ARCH INTERN MED, V167, P258, DOI 10.1001/archinte.167.3.258; BEEBE M, 2002, CURRENT PROCEDURAL T; Boulware LE, 2007, ANN INTERN MED, V146, P289, DOI 10.7326/0003-4819-146-4-200702200-00008; Burack RC, 1998, J GEN INTERN MED, V13, P366, DOI 10.1046/j.1525-1497.1998.00116.x; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen X, 2008, J AM GERIATR SOC, V56, P1511, DOI 10.1111/j.1532-5415.2008.01796.x; Cooper GS, 2008, CANCER, V112, P293, DOI 10.1002/cncr.23176; Cooper Gregory S, 2005, Am J Med, V118, P1413; Cooper GS, 2004, AM J GASTROENTEROL, V99, P1544, DOI 10.1111/j.1572-0241.2004.30902.x; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; El-Serag HB, 2006, ARCH INTERN MED, V166, P2202, DOI 10.1001/archinte.166.20.2202; Etzioni DA, 2006, DIS COLON RECTUM, V49, P1002, DOI 10.1007/s10350-006-0533-2; Fenton JJ, 2007, ARCH INTERN MED, V167, P580, DOI 10.1001/archinte.167.6.580; Fisher DA, 2005, AM J GASTROENTEROL, V100, P2526, DOI 10.1111/j.1572-0241.2005.00322.x; Fisher DA, 2007, CLIN GASTROENTEROL H, V5, P991, DOI 10.1016/j.cgh.2007.04.010; Fisher DA, 2006, CANCER EPIDEM BIOMAR, V15, P1232, DOI 10.1158/1055-9965.EPI-05-0916; Freeman JL, 2002, MED CARE, V40, P36; Gatto NM, 2003, J NATL CANCER I, V95, P230, DOI 10.1093/jnci/95.3.230; Gross CP, 2006, ANN INTERN MED, V145, P646, DOI 10.7326/0003-4819-145-9-200611070-00006; Heflin MT, 2002, J AM GERIATR SOC, V50, P1651, DOI 10.1046/j.1532-5415.2002.50456.x; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Jones RM, 2008, CANCER EPIDEM BIOMAR, V17, P777, DOI 10.1158/1055-9965.EPI-07-0441; Kashner TM, 1998, MED CARE, V36, P1324, DOI 10.1097/00005650-199809000-00005; Klabunde CN, 2007, ANN EPIDEMIOL, V17, P584, DOI 10.1016/j.annepidem.2007.03.011; Ko CW, 2005, GASTROENTEROLOGY, V129, P1163, DOI 10.1053/j.gastro.2005.07.027; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; KUSSMAN MJ, 2007, DIR 2007 004 COL CAN; Ling BS, 2001, J GEN INTERN MED, V16, P822, DOI 10.1046/j.1525-1497.2001.10337.x; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Partin MR, 2008, CANCER EPIDEM BIOMAR, V17, P768, DOI 10.1158/1055-9965.EPI-07-0759; Perlin JB, 2004, AM J MANAG CARE, V10, P828; Pham HH, 2005, JAMA-J AM MED ASSOC, V294, P473, DOI 10.1001/jama.294.4.473; *SEER MED PROGR, 2007, SAS MACR CHARLS COM; Shen YJ, 2003, MED CARE RES REV, V60, P253, DOI 10.1177/1077558703060002007; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; Smith RA, 2007, CA-CANCER J CLIN, V57, P90, DOI 10.3322/canjclin.57.2.90; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Szeto HC, 2002, AM J MANAG CARE, V8, P37; U.S. Census Bureau, 2002, CENS 2000 SUMM FIL 3; *VA INF RES CTR, 2003, RES FIND VA MED DAT; *VA OFF QUAL PERF, 2001, FY2001 VHA PERF MEAS; Walsh JME, 2003, JAMA-J AM MED ASSOC, V289, P1297, DOI 10.1001/jama.289.10.1297; Walter LC, 2005, AM J MED, V118, P1078, DOI 10.1016/j.amjmed.2005.01.063; Walter LC, 2004, JAMA-J AM MED ASSOC, V291, P2466, DOI 10.1001/jama.291.20.2466; Walter LC, 2004, ANN INTERN MED, V140, P681, DOI 10.7326/0003-4819-140-9-200405040-00007; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Walter LC, 2006, JAMA-J AM MED ASSOC, V296, P2336, DOI 10.1001/jama.296.19.2336; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244; 2000, J AM GERIATR SOC, V48, P333	53	130	130	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2009	150	7					465	+		10.7326/0003-4819-150-7-200904070-00006	http://dx.doi.org/10.7326/0003-4819-150-7-200904070-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	432EZ	19349631	Green Accepted			2022-12-28	WOS:000265117600004
J	Schmidt, M; Lipson, H				Schmidt, Michael; Lipson, Hod			Distilling Free-Form Natural Laws from Experimental Data	SCIENCE			English	Article							PRINCIPLES; DISCOVERY; SCIENCE	For centuries, scientists have attempted to identify and document analytical laws that underlie physical phenomena in nature. Despite the prevalence of computing power, the process of finding natural laws and their corresponding equations has resisted automation. A key challenge to finding analytic relations automatically is defining algorithmically what makes a correlation in observed data important and insightful. We propose a principle for the identification of nontriviality. We demonstrated this approach by automatically searching motion-tracking data captured from various physical systems, ranging from simple harmonic oscillators to chaotic double-pendula. Without any prior knowledge about physics, kinematics, or geometry, the algorithm discovered Hamiltonians, Lagrangians, and other laws of geometric and momentum conservation. The discovery rate accelerated as laws found for simpler systems were used to bootstrap explanations for more complex systems, gradually uncovering the "alphabet" used to describe those systems.	[Lipson, Hod] Cornell Univ, Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA	Cornell University	Lipson, H (corresponding author), Cornell Univ, Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.	hod.lipson@cornell.edu	Müller-Tidow, Carsten/O-7207-2018; Giagounidis, Aristoteles/S-7097-2019	Müller-Tidow, Carsten/0000-0002-7166-5232; 	Integrative Graduate Education and Research Traineeship program; U.S. NSF graduate research fellowship; NSF Creative-IT [0757478]; CAREER [0547376]	Integrative Graduate Education and Research Traineeship program(National Science Foundation (NSF)); U.S. NSF graduate research fellowship; NSF Creative-IT; CAREER(National Science Foundation (NSF))	This research was supported in part by Integrative Graduate Education and Research Traineeship program in nonlinear systems, a U.S. NSF graduate research fellowship, and NSF Creative-IT grant 0757478 and CAREER grant 0547376. We thank M. Kurman for editorial consultation and substantive editing of the manuscript.	ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Bongard J, 2007, P NATL ACAD SCI USA, V104, P9943, DOI 10.1073/pnas.0609476104; Clery D, 2005, SCIENCE, V308, P809, DOI 10.1126/science.308.5723.809; CYRIL F, 2007, 2007 IEEE C EV COMP, P23; De Jong E. D., 2003, Genetic Programming and Evolvable Machines, V4, P211, DOI 10.1023/A:1025122906870; Duffy J, 2002, STUD FUZZ SOFT COMP, V100, P61; ELENA B, 2005, 7 INT S SYMB NUM ALG, P321; FORREST S, 1993, SCIENCE, V261, P872, DOI 10.1126/science.8346439; GREGORY P, 2003, EV ART 6 INT C, V2936, P267; Hanc J, 2004, AM J PHYS, V72, P428, DOI 10.1119/1.1591764; Jackel P, 1998, P ROY SOC A-MATH PHY, V454, P3257, DOI 10.1098/rspa.1998.0300; Jones RM, 2005, COMPUT INTELL-US, V21, P480, DOI 10.1111/j.1467-8640.2005.00283.x; King RD, 2004, NATURE, V427, P247, DOI 10.1038/nature02236; Koza JR, 1992, GENETIC PROGRAMMING; LANGLEY P, 1981, COGNITIVE SCI, V5, P31, DOI 10.1016/S0364-0213(81)80025-0; Liang Y, 2008, NONLINEAR DYNAM, V52, P181, DOI 10.1007/s11071-007-9270-x; Marquet PA, 2002, NATURE, V418, P723, DOI 10.1038/418723c; MOR M, 2007, P 21 ASME BIENN C ME, P1; Nee S, 2005, SCIENCE, V309, P1236, DOI 10.1126/science.1114488; Noether E, 1918, MATHEMATISCH PHYSIKA, P235, DOI DOI 10.1080/00411457108231446; SHINBROT T, 1992, AM J PHYS, V60, P491, DOI 10.1119/1.16860; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Szalay A, 2006, NATURE, V440, P413, DOI 10.1038/440413a; Valdes-Perez RE, 1999, COMMUN ACM, V42, P37, DOI 10.1145/319382.319389	24	1187	1212	33	264	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					81	85		10.1126/science.1165893	http://dx.doi.org/10.1126/science.1165893			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342586				2022-12-28	WOS:000264802100036
J	Cotton, CH; Flint, J; Campbell, TG				Cotton, Colleen H.; Flint, Jonathan; Campbell, Thomas G.			Is there an association between NPY and neuroticism?	NATURE			English	Letter							METAANALYSIS		[Cotton, Colleen H.; Flint, Jonathan; Campbell, Thomas G.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Campbell, Thomas G.] Univ Oxford St Cross Coll, Oxford OX1 3LZ, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Cotton, CH (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	thomasgordoncampbell@gmail.com	Campbell, Thomas G/C-2498-2014; Campbell, Thomas/A-6964-2014	Campbell, Thomas G/0000-0002-4508-0089; Campbell, Thomas/0000-0002-4508-0089; Cotton, Colleen/0000-0002-3879-4665; Flint, Jonathan/0000-0002-9427-4429				Abbott A, 2008, NATURE, V454, P154, DOI 10.1038/454154a; Gabriel S., 2004, CURR PROTOC HUM GENE, DOI 10.1002/0471142905.hg0212s42; Munafo MR, 2003, MOL PSYCHIATR, V8, P471, DOI 10.1038/sj.mp.4001326; Munafo MR, 2005, MOL PSYCHIATR, V10, P765, DOI 10.1038/sj.mp.4001664; Willis-Owen SAG, 2005, BIOL PSYCHIAT, V58, P451, DOI 10.1016/j.biopsych.2005.04.050; Zhou ZF, 2008, NATURE, V452, P997, DOI 10.1038/nature06858	6	12	12	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 2	2009	458	7238					E6	E6		10.1038/nature07927	http://dx.doi.org/10.1038/nature07927			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19340021	Bronze			2022-12-28	WOS:000264796200049
J	Cyranoski, D				Cyranoski, David			Retracted paper rattles Korean science	NATURE			English	News Item																			0	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 2	2009	458	7238					561	561		10.1038/458561b	http://dx.doi.org/10.1038/458561b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19340046	Bronze			2022-12-28	WOS:000264796200012
J	Jencks, SF; Williams, MV; Coleman, EA				Jencks, Stephen F.; Williams, Mark V.; Coleman, Eric A.			Rehospitalizations among Patients in the Medicare Fee-for-Service Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Meeting on Reducing Hospital Readmissions	JAN 25, 2008	Washington, DC	Commwlth Fund, Acad Hlth			HEART-FAILURE; HOSPITAL READMISSIONS; RANDOMIZED-TRIAL; CARE	Background Reducing rates of rehospitalization has attracted attention from policymakers as a way to improve quality of care and reduce costs. However, we have limited information on the frequency and patterns of rehospitalization in the United States to aid in planning the necessary changes. Methods We analyzed Medicare claims data from 2003-2004 to describe the patterns of rehospitalization and the relation of rehospitalization to demographic characteristics of the patients and to characteristics of the hospitals. Results Almost one fifth (19.6%) of the 11,855,702 Medicare beneficiaries who had been discharged from a hospital were rehospitalized within 30 days, and 34.0% were rehospitalized within 90 days; 67.1% of patients who had been discharged with medical conditions and 51.5% of those who had been discharged after surgical procedures were rehospitalized or died within the first year after discharge. In the case of 50.2% of the patients who were rehospitalized within 30 days after a medical discharge to the community, there was no bill for a visit to a physician's office between the time of discharge and rehospitalization. Among patients who were rehospitalized within 30 days after a surgical discharge, 70.5% were rehospitalized for a medical condition. We estimate that about 10% of rehospitalizations were likely to have been planned. The average stay of rehospitalized patients was 0.6 day longer than that of patients in the same diagnosis-related group whose most recent hospitalization had been at least 6 months previously. We estimate that the cost to Medicare of unplanned rehospitalizations in 2004 was $17.4 billion. Conclusions Rehospitalizations among Medicare beneficiaries are prevalent and costly.	[Williams, Mark V.] Northwestern Univ, Feinberg Sch Med, Div Hosp Med, Chicago, IL 60611 USA; [Coleman, Eric A.] Univ Colorado, Div Hlth Care Policy & Res, Care Transit Program, Denver, CO 80202 USA	Northwestern University; Feinberg School of Medicine; University of Colorado System; University of Colorado Denver			Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; Williams, Mark V/0000-0001-6107-0457				A Path to Bundled Payment Around a Rehospitalization, 2005, REP C REF DEL SYST, P83; Adeyemo D, 2007, ANN ROY COLL SURG, V89, P363, DOI 10.1308/003588407X183409; ANDERSON GF, 1984, NEW ENGL J MED, V311, P1349, DOI 10.1056/NEJM198411223112105; [Anonymous], 2007, MED MED STAT SUPPL; BARR M, 2006, ADV MED HOME PATIENT; BLUSTEIN J, 1994, AM J PUBLIC HEALTH, V84, P1018, DOI 10.2105/AJPH.84.6.1018; Brumley R, 2007, J AM GERIATR SOC, V55, P993, DOI 10.1111/j.1532-5415.2007.01234.x; Centers for Medicare Medicaid Services, 2008, FED REGISTER, V73, P23673; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Connolly Ceci, 2009, WASHINGTON POST 0130, pA1; Eicheldinger C, 2008, HEALTH CARE FINANC R, V29, P27; Fisher LS, 2000, HEALTH SERV RES, V34, P1351; Friedman B, 2004, MED CARE RES REV, V61, P225, DOI 10.1177/1077558704263799; Gohler A, 2006, J CARD FAIL, V12, P554, DOI 10.1016/j.cardfail.2006.03.003; *IOW FDN MED CAR, 2008, CHRON COND DAT WAR C; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; National Quality Forum, 2007, CAND HOSP CAR ADD PR; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Rollow W, 2006, ANN INTERN MED, V145, P342, DOI 10.7326/0003-4819-145-5-200609050-00134; Ross JS, 2008, ARCH INTERN MED, V168, P1371, DOI 10.1001/archinte.168.13.1371; *SAS I, SAS WIND VERS 8 2	22	3600	3651	3	106	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2009	360	14					1418	1428		10.1056/NEJMsa0803563	http://dx.doi.org/10.1056/NEJMsa0803563			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	427AL	19339721				2022-12-28	WOS:000264751800007
J	Yang, XF; Figueiredo, LM; Espinal, A; Okubo, E; Li, B				Yang, Xiaofeng; Figueiredo, Luisa M.; Espinal, Amin; Okubo, Eiji; Li, Bibo			RAP1 Is Essential for Silencing Telomeric Variant Surface Glycoprotein Genes in Trypanosoma brucei	CELL			English	Article							DNA-BINDING DOMAIN; CELL-CYCLE ARREST; ANTIGENIC VARIATION; AFRICAN TRYPANOSOMES; SACCHAROMYCES-CEREVISIAE; EXPRESSION SITES; FISSION YEAST; HISTONE H3; PROTEIN; KU	Trypanosoma brucei expresses variant surface glycoprotein (VSG) genes in a strictly monoallelic fashion in its mammalian hosts, but it is unclear how this important virulence mechanism is enforced. Telomere position effect, an epigenetic phenomenon, has been proposed to play a critical role in VSG regulation, yet no telomeric protein has been identified whose disruption led to VSG derepression. We now identify tbRAP1 as an intrinsic component of the T. brucei telomere complex and a major regulator for silencing VSG expression sites (ESs). Knockdown of tbRAP1 led to derepression of all VSGs in silent ESs, but not VSGs located elsewhere, and resulted in stronger derepression of genes located within 10 kb from telomeres than genes located further upstream. This graduated silencing pattern suggests that telomere integrity plays a key role in tbRAP1-dependent silencing and VSG regulation.	[Yang, Xiaofeng; Li, Bibo] Cleveland State Univ, Dept Biol Geol & Environm Sci, Ctr Gene Regulat Hlth Dis, Cleveland, OH 44115 USA; [Yang, Xiaofeng] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Obstet & Gynecol, Xian 710061, Shaanxi Prov, Peoples R China; [Figueiredo, Luisa M.; Espinal, Amin; Okubo, Eiji; Li, Bibo] Rockefeller Univ, Mol Parasitol Lab, New York, NY 10065 USA	University System of Ohio; Cleveland State University; Xi'an Jiaotong University; Rockefeller University	Li, B (corresponding author), Cleveland State Univ, Dept Biol Geol & Environm Sci, Ctr Gene Regulat Hlth Dis, Cleveland, OH 44115 USA.	b.li37@csuohio.edu	Figueiredo, Luisa Miranda/C-3908-2018	Figueiredo, Luisa Miranda/0000-0002-5752-6586	National Institute of Health [AI050614, AI21729, AI066095]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050614, R01AI066095, R01AI021729, R37AI021729] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to Piet Borst for the VSG9 antibody and Keith Gull for the RNA Pol I and tubulin antibodies. We greatly appreciate Titia de Lange and George A.M. Cross for insightful discussions, and we thank Margaret J. Irwin, Audrey Lynn, and members of the Li and Cross labs for comments on the manuscript, critical discussions, and technical support. DeltaVision Microscopy was carried out at the RU Bio-Imaging Resource Center with guidance from Alison North and in BGES Department at CSU. FACS analysis was done at the Flow Cytometry Resource Center at RU and the Flow Cytometry Core at CCF. This work was supported by National Institute of Health grants to G.A.M. Cross (AI050614 and AI21729) and to B.L. (AI066095).	Alsford S, 2005, MOL BIOCHEM PARASIT, V144, P142, DOI 10.1016/j.molbiopara.2005.08.009; Alsford S, 2001, MOL BIOCHEM PARASIT, V113, P79, DOI 10.1016/S0166-6851(00)00388-1; Alsford S, 2007, MOL MICROBIOL, V63, P724, DOI 10.1111/j.1365-2958.2006.05553.x; Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Chaves I, 1999, EMBO J, V18, P4846, DOI 10.1093/emboj/18.17.4846; Conway C, 2002, J BIOL CHEM, V277, P21269, DOI 10.1074/jbc.M200550200; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DELANGE T, 1982, NATURE, V299, P451, DOI 10.1038/299451a0; Dreesen O, 2005, NUCLEIC ACIDS RES, V33, P4536, DOI 10.1093/nar/gki769; Dreesen O, 2007, NAT REV MICROBIOL, V5, P70, DOI 10.1038/nrmicro1577; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Evans SK, 1998, CHROMOSOMA, V107, P352, DOI 10.1007/s004120050318; Figueiredo LM, 2008, PLOS BIOL, V6, P1539, DOI 10.1371/journal.pbio.0060161; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gao Q, 2007, STEM CELLS, V25, P3085, DOI 10.1634/stemcells.2007-0478; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Glover L, 2006, EMBO REP, V7, P93, DOI 10.1038/sj.embor.7400575; Glover L, 2007, NUCLEIC ACIDS RES, V35, P872, DOI 10.1093/nar/gkl1100; GOMMERSAMPT J, 1991, NUCLEIC ACIDS RES, V19, P1745, DOI 10.1093/nar/19.8.1745; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Grunstein M, 1997, CURR OPIN CELL BIOL, V9, P383, DOI 10.1016/S0955-0674(97)80011-7; Gunzl A, 2003, EUKARYOT CELL, V2, P542, DOI 10.1128/EC.2.3.542-551.2003; Hanaoka S, 2001, J MOL BIOL, V312, P167, DOI 10.1006/jmbi.2001.4924; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; Hoek M, 2002, MOL BIOCHEM PARASIT, V120, P269, DOI 10.1016/S0166-6851(02)00009-9; Horn D, 2005, CHROMOSOME RES, V13, P525, DOI 10.1007/s10577-005-0991-8; Horn D, 1997, EMBO J, V16, P7422, DOI 10.1093/emboj/16.24.7422; HORN D, 1995, CELL, V83, P555, DOI 10.1016/0092-8674(95)90095-0; Hughes K, 2007, EMBO J, V26, P2400, DOI 10.1038/sj.emboj.7601678; Janzen CJ, 2004, NUCLEIC ACIDS RES, V32, P6575, DOI 10.1093/nar/gkh991; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Konig P, 1997, TRENDS BIOCHEM SCI, V22, P43, DOI 10.1016/S0968-0004(97)01008-6; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Landeira D, 2007, J CELL BIOL, V176, P133, DOI 10.1083/jcb.200607174; Li B, 2005, MOL CELL BIOL, V25, P5011, DOI 10.1128/MCB.25.12.5011-5021.2005; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Li BB, 1996, GENE DEV, V10, P1310, DOI 10.1101/gad.10.11.1310; Lowell JE, 2004, J CELL SCI, V117, P5937, DOI 10.1242/jcs.01515; Marcello L, 2007, GENOME RES, V17, P1344, DOI 10.1101/gr.6421207; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mishra K, 1999, CURR BIOL, V9, P1123, DOI 10.1016/S0960-9822(99)80483-7; Navarro M, 1996, MOL CELL BIOL, V16, P3615; Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Park MJ, 2002, MOL CELLS, V13, P327; Pays E, 2004, CURR OPIN MICROBIOL, V7, P369, DOI 10.1016/j.mib.2004.05.001; Pedram M, 2006, MOL CELL BIOL, V26, P1865, DOI 10.1128/MCB.26.5.1865-1878.2006; Pina B, 2003, MOL GENET GENOMICS, V268, P791, DOI 10.1007/s00438-002-0801-3; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Sheader K, 2005, P NATL ACAD SCI USA, V102, P8716, DOI 10.1073/pnas.0501886102; SHORE D, 1994, TRENDS GENET, V10, P408, DOI 10.1016/0168-9525(94)90058-2; Siegel TN, 2005, MOL CELL BIOL, V25, P9586, DOI 10.1128/MCB.25.21.9586-9594.2005; Teixeira MT, 2005, CHROMOSOME RES, V13, P535, DOI 10.1007/s10577-005-0999-0; VANDERPLOEG LHT, 1984, CELL, V36, P459, DOI 10.1016/0092-8674(84)90239-3; Vanhamme L, 2000, MOL MICROBIOL, V36, P328, DOI 10.1046/j.1365-2958.2000.01844.x; vanLeeuwen F, 1996, NUCLEIC ACIDS RES, V24, P2476, DOI 10.1093/nar/24.13.2476; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zhang XD, 1998, EMBO J, V17, P6404, DOI 10.1093/emboj/17.21.6404	68	125	125	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					99	109		10.1016/j.cell.2009.01.037	http://dx.doi.org/10.1016/j.cell.2009.01.037			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345190	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000264813300017
J	Hernandez, AF; Granger, CB				Hernandez, Adrian F.; Granger, Christopher B.			Advancing care for acute heart failure-no time to relax	LANCET			English	Editorial Material							CLINICAL-OUTCOMES; ASSOCIATION; ANTAGONIST; TEZOSENTAN		[Hernandez, Adrian F.; Granger, Christopher B.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27715 USA	Duke University	Hernandez, AF (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27715 USA.	adrian.hernandez@duke.edu	Hernandez, Adrian F/A-7818-2016; Granger, Christopher B/D-3458-2014	Hernandez, Adrian F/0000-0003-3387-9616; Granger, Christopher B/0000-0002-0045-3291				Cohn JN, 1998, NEW ENGL J MED, V339, P1810, DOI 10.1056/NEJM199812173392503; Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541; Curtis LH, 2008, ARCH INTERN MED, V168, P2481, DOI 10.1001/archinte.168.22.2481; Fonarow GC, 2007, JAMA-J AM MED ASSOC, V297, P61, DOI 10.1001/jama.297.1.61; Gheorghiade M, 2004, JAMA-J AM MED ASSOC, V291, P1963, DOI 10.1001/jama.291.16.1963; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Hernandez AF, 2009, AM HEART J, V157, P271, DOI 10.1016/j.ahj.2008.07.031; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; McMurray JJV, 2007, JAMA-J AM MED ASSOC, V298, P2009, DOI 10.1001/jama.298.17.2009; Poole-Wilson PA, 2002, JAMA-J AM MED ASSOC, V287, P1578, DOI 10.1001/jama.287.12.1578; Teerlink JR, 2009, LANCET, V373, P1429, DOI 10.1016/S0140-6736(09)60622-X; Torre-Amione G, 2003, J AM COLL CARDIOL, V42, P140, DOI 10.1016/S0735-1097(03)00556-4; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531, DOI 10.1001/jama.287.12.1531	13	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2009	373	9673					1401	1402		10.1016/S0140-6736(09)60653-X	http://dx.doi.org/10.1016/S0140-6736(09)60653-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437QL	19329180				2022-12-28	WOS:000265501900004
J	Martin-Moreno, JM; Alonso, P; Claveria, A; Gorgojo, L; Peiro, S				Martin-Moreno, Jose M.; Alonso, Paloma; Claveria, Ana; Gorgojo, Lydia; Peiro, Salvador			Analysis Looking to Europe Spain: a decentralised health system in constant flux	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Martin-Moreno, Jose M.] Univ Valencia, Sch Med, Valencia 46010, Spain; [Martin-Moreno, Jose M.] Univ Valencia, Clin Hosp, Valencia 46010, Spain; [Alonso, Paloma] Globesalud Proyectors & Acc Salud, Madrid, Spain; [Claveria, Ana] Serv Galego Saude, Serv Calidade & Programas, Santiago De Compostela, Spain; [Gorgojo, Lydia] Sanidad Exterior Valencia, Int Travel Vaccinat Ctr, Valencia, Spain; [Peiro, Salvador] Ctr Super Invest Salud Publ, Valencia, Spain; [Peiro, Salvador] Escuela Valenciana Estudios Salud, Valencia, Spain	University of Valencia; University of Valencia	Martin-Moreno, JM (corresponding author), Univ Valencia, Sch Med, Ave Blasco Ibanez 15, Valencia 46010, Spain.	jose.maria.martin@uv.es	Martin-Moreno, Jose M./S-7733-2016; Peiro, Salvador/H-5778-2017; Claveria, Ana/AAD-8178-2021	Martin-Moreno, Jose M./0000-0002-8648-5541; Peiro, Salvador/0000-0002-3902-569X; Claveria, Ana/0000-0001-9552-1260				Askham J, 2008, ARE PATIENTS DECISIO; Borrell F, 2008, GEST CLIN SANIT, V10, P3; COSTAFONT J, 2008, EXPLORING PATHWAYS I; Duran A, 2006, HLTH SYSTEMS TRANSIT, V8, P1; Goodman DC, 2008, NEW ENGL J MED, V358, P1658, DOI 10.1056/NEJMp0800319; *GRUP TRAB AN GAST, 2007, INF GRUP TRAB AN GAS; Herrera E, 2007, J PAIN SYMPTOM MANAG, V33, P591, DOI 10.1016/j.jpainsymman.2007.02.021; *I NAC EST, 2008, EST POBL ACT ESP; Jonsson B, 2007, ANN ONCOL, V18, P1, DOI 10.1093/annonc/mdm095; López-Casasnovas G., 2003, Gac Sanit, V17, P319, DOI 10.1157/13051027; LOPEZCASANOVAS G, 2007, J HLTH EC POLICY LAW, V2, P223; LOPEZVALCARCEL BG, 2005, ESTUDIOS UTILIZACION; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; MARTINMORENO J, 2008, IPAENVIST200722 EUR; Matesanz R., 2007, TRANSPLANT REV-ORLAN, V21, P177, DOI [10.1016/J.TRRE.2007.07.005, DOI 10.1016/J.TRRE.2007.07.005, 10.1016/j.trre.2007.07.005]; *MIN SAN CONS, 2003, REC SIST NAC SAL PRE; *MIN SAN CONS, 2006, SIST INF AT PRIM SIS; *MIN SAN CONS, 2007, INCLASNS DB IND CLAV; Ministerio de Sanidad y Consumo, 2006, ENC NAC SAL; *OECD, 2008, DOES SPAIN COMP; Ostbye T, 2005, ANN FAM MED, V3, P209, DOI 10.1370/afm.310; Preker AS, 2002, B WORLD HEALTH ORGAN, V80, P143; RUBIO JAC, 2003, ATEN PRIM, V32, P288; Saltman RB, 2007, DECENTRALIZATION HLT; Lorenzo IV, 2008, GAC SANIT, V22, P218, DOI 10.1157/13123967; WHO, 2008, HLTH ALL DAT; Zafra Eduardo, 2006, Gac Sanit, V20, P295, DOI 10.1157/13091145	27	42	43	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2009	338								b1170	10.1136/bmj.b1170	http://dx.doi.org/10.1136/bmj.b1170			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429AK	19332452				2022-12-28	WOS:000264893000001
J	Sheps, JA				Sheps, Jonathan A.			Through a Mirror, Differently	SCIENCE			English	Editorial Material							MULTIDRUG ABC TRANSPORTER; P-GLYCOPROTEIN; RESISTANCE; MECHANISM		British Columbia Canc Agcy, BC Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency	Sheps, JA (corresponding author), British Columbia Canc Agcy, BC Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada.	jsheps@bccrc.ca						Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Rauch C, 2007, EUR BIOPHYS J BIOPHY, V36, P121, DOI 10.1007/s00249-006-0113-3; Shapiro AB, 1997, EUR J BIOCHEM, V250, P130, DOI 10.1111/j.1432-1033.1997.00130.x; Shapiro AB, 1997, EUR J BIOCHEM, V250, P122, DOI 10.1111/j.1432-1033.1997.00122.x; van Veen HW, 2001, RES MICROBIOL, V152, P365, DOI 10.1016/S0923-2508(01)01208-6; Zhu BT, 1999, MOL CARCINOGEN, V25, P1, DOI 10.1002/(SICI)1098-2744(199905)25:1<1::AID-MC1>3.0.CO;2-1	10	6	6	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 27	2009	323	5922					1679	1680		10.1126/science.1172428	http://dx.doi.org/10.1126/science.1172428			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325102				2022-12-28	WOS:000264559800024
J	Galhardo, RS; Rosenberg, SM				Galhardo, Rodrigo S.; Rosenberg, Susan M.			Extreme Genome Repair	CELL			English	Editorial Material							DEINOCOCCUS-RADIODURANS; RECOMBINATION; BACTERIOPHAGE-T4	Slade et al. (2009) describe in this issue how the genome of the bacterium Deinococcus radiodurans gets reassembled after being shattered by high-dose radiation. In contrast to the extreme nature of the damage, the steps of repair appear surprisingly ordinary. So, why can't all organisms carry out extreme genome repair?	[Galhardo, Rodrigo S.; Rosenberg, Susan M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dept Mol Virol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dept Microbiol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Rosenberg, SM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	smr@bcm.edu	Galhardo, Rodrigo/L-2238-2016	Galhardo, Rodrigo/0000-0002-5686-9704; Rosenberg, Susan M./0000-0003-1444-473X	NATIONAL CANCER INSTITUTE [R01CA085777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053158] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA085777-05, R01 CA085777-01A1, R01 CA085777-07, R01 CA085777-06A2, R01 CA085777-02, R01 CA085777, R01 CA085777-04, R01CA85777, R01 CA085777-03] Funding Source: Medline; NIGMS NIH HHS [R01 GM053158-12, R01 GM053158-13, R01 GM053158-08, R01 GM053158-09, R01 GM053158-11A1, R01 GM053158, R01GM53158, R01 GM053158-10] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; FORMOSA T, 1986, CELL, V47, P793, DOI 10.1016/0092-8674(86)90522-2; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gladyshev E, 2008, P NATL ACAD SCI USA, V105, P5139, DOI 10.1073/pnas.0800966105; LUDER A, 1982, P NATL ACAD SCI-BIOL, V79, P1101, DOI 10.1073/pnas.79.4.1101; Motamedi MR, 1999, GENE DEV, V13, P2889, DOI 10.1101/gad.13.21.2889; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160	9	3	3	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					998	1000		10.1016/j.cell.2009.03.008	http://dx.doi.org/10.1016/j.cell.2009.03.008			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303843	Green Accepted, Bronze			2022-12-28	WOS:000264403900006
J	Vanneste, S; Friml, J				Vanneste, Steffen; Friml, Jiri			Auxin: A Trigger for Change in Plant Development	CELL			English	Review							YUCCA FLAVIN MONOOXYGENASES; BOX PROTEIN TIR1; TRANSPORT INHIBITORS; TRANSCRIPTIONAL REPRESSION; CELL EXPANSION; PIN PROTEINS; HAIR-CELLS; ARABIDOPSIS; EFFLUX; BINDING	The dynamic, differential distribution of the hormone auxin within plant tissues controls an impressive variety of developmental processes, which tailor plant growth and morphology to environmental conditions. Various environmental and endogenous signals can be integrated into changes in auxin distribution through their effects on local auxin biosynthesis and intercellular auxin transport. Individual cells interpret auxin largely by a nuclear signaling pathway that involves the F box protein TIR1 acting as an auxin receptor. Auxin-dependent TIR1 activity leads to ubiquitination-based degradation of transcriptional repressors and complex transcriptional reprogramming. Thus, auxin appears to be a versatile trigger of preprogrammed developmental changes in plant cells.	[Vanneste, Steffen; Friml, Jiri] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Vanneste, Steffen; Friml, Jiri] Univ Ghent, Dept Plant Biotechnol & Genet, B-9052 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Friml, J (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium.	jiri.friml@psb.vib-ugent.be	Friml, Jiri/D-9511-2012; Vanneste, Steffen/K-8353-2013	Friml, Jiri/0000-0002-8302-7596; Vanneste, Steffen/0000-0002-9948-9672	Odysseus program of the Research Foundation Flanders and EMBO [ATLF 142-2007]	Odysseus program of the Research Foundation Flanders and EMBO(European Molecular Biology Organization (EMBO))	We thank G. Van Isterdael and M. Sauer for art work, B. Peret, J. Kleine-Vehn, and D. Weijers for critical comments, and M. De Cock for help in preparing the manuscript. The authors are supported by the Odysseus program of the Research Foundation Flanders and EMBO (ATLF 142-2007).	Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; Bailly A, 2008, J BIOL CHEM, V283, P21817, DOI 10.1074/jbc.M709655200; Bainbridge K, 2008, GENE DEV, V22, P810, DOI 10.1101/gad.462608; Benjamins R, 2008, ANNU REV PLANT BIOL, V59, P443, DOI 10.1146/annurev.arplant.58.032806.103805; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Braun N, 2008, PLANT CELL, V20, P2746, DOI 10.1105/tpc.108.059048; Chen JG, 2001, GENE DEV, V15, P902, DOI 10.1101/gad.866201; Cheng YF, 2007, PLANT CELL, V19, P2430, DOI 10.1105/tpc.107.053009; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Cho M, 2007, PLANT CELL, V19, P3930, DOI 10.1105/tpc.107.054288; Davies P.J., 2004, PLANT HORMONES BIOSY; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dhonukshe P, 2008, NATURE, V456, P962, DOI 10.1038/nature07409; Dhonukshe P, 2008, P NATL ACAD SCI USA, V105, P4489, DOI 10.1073/pnas.0711414105; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; Dubrovsky JG, 2008, P NATL ACAD SCI USA, V105, P8790, DOI 10.1073/pnas.0712307105; Entchev EV, 2002, TRAFFIC, V3, P98, DOI 10.1034/j.1600-0854.2002.030203.x; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hardtke CS, 2004, DEVELOPMENT, V131, P1089, DOI 10.1242/dev.00925; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; HERTEL R, 1972, PLANTA, V107, P325, DOI 10.1007/BF00386394; Jones AM, 1998, SCIENCE, V282, P1114, DOI 10.1126/science.282.5391.1114; Jones AR, 2009, NAT CELL BIOL, V11, P78, DOI 10.1038/ncb1815; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Kleine-Vehn J, 2008, CURR BIOL, V18, P526, DOI 10.1016/j.cub.2008.03.021; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Leblanc N, 1999, J BIOL CHEM, V274, P28314, DOI 10.1074/jbc.274.40.28314; Lee JS, 2009, PLANT J, V57, P975, DOI 10.1111/j.1365-313X.2008.03741.x; LEYSER HMO, 1993, NATURE, V364, P161, DOI 10.1038/364161a0; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Marchant A, 2002, PLANT CELL, V14, P589, DOI 10.1105/tpc.010354; Mattsson J, 2003, PLANT PHYSIOL, V131, P1327, DOI 10.1104/pp.013623; Merks RMH, 2007, TRENDS PLANT SCI, V12, P384, DOI 10.1016/j.tplants.2007.08.004; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Mockaitis K, 2000, PLANT J, V24, P785, DOI 10.1046/j.1365-313x.2000.00921.x; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Mravec J, 2008, DEVELOPMENT, V135, P3345, DOI 10.1242/dev.021071; Murphy AS, 2002, PLANT PHYSIOL, V128, P935, DOI 10.1104/pp.010519; Muto H, 2007, PLANT PHYSIOL, V144, P187, DOI 10.1104/pp.107.096628; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; PICKETT FB, 1990, PLANT PHYSIOL, V94, P1462, DOI 10.1104/pp.94.3.1462; RAVEN JA, 1975, NEW PHYTOL, V74, P163, DOI 10.1111/j.1469-8137.1975.tb02602.x; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rouse D, 1998, SCIENCE, V279, P1371, DOI 10.1126/science.279.5355.1371; RUBERY PH, 1974, PLANTA, V118, P101, DOI 10.1007/BF00388387; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; SACHS T, 1991, DEVELOPMENT, P83; Sauer M, 2006, GENE DEV, V20, P2902, DOI 10.1101/gad.390806; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; SENN AP, 1988, PLANT PHYSIOL, V88, P131, DOI 10.1104/pp.88.1.131; Shin R, 2007, PLANT CELL, V19, P2440, DOI 10.1105/tpc.107.050963; Shishova M, 2004, J PLANT PHYSIOL, V161, P937, DOI 10.1016/j.jplph.2003.12.005; Sieberer T, 2000, CURR BIOL, V10, P1595, DOI 10.1016/S0960-9822(00)00861-7; Sorefan K, 2009, NATURE, V459, P583, DOI 10.1038/nature07875; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Stone BB, 2008, MOL PLANT, V1, P129, DOI 10.1093/mp/ssm013; Strader LC, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-41; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tanaka H, 2006, CELL MOL LIFE SCI, V63, P2738, DOI 10.1007/s00018-006-6116-5; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Teleman AA, 2001, CELL, V105, P559, DOI 10.1016/S0092-8674(01)00377-4; THEOLOGIS A, 1985, J MOL BIOL, V183, P53, DOI 10.1016/0022-2836(85)90280-3; Thimann KV, 1938, PLANT PHYSIOL, V13, P437, DOI 10.1104/pp.13.3.437; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; Uggla C, 1996, P NATL ACAD SCI USA, V93, P9282, DOI 10.1073/pnas.93.17.9282; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Vieten A, 2007, TRENDS PLANT SCI, V12, P160, DOI 10.1016/j.tplants.2007.03.006; Weijers D, 2005, EMBO J, V24, P1874, DOI 10.1038/sj.emboj.7600659; Whippo CW, 2006, PLANT CELL, V18, P1110, DOI 10.1105/tpc.105.039669; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790; Yang YD, 2006, CURR BIOL, V16, P1123, DOI 10.1016/j.cub.2006.04.029; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306	98	861	924	82	449	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1005	1016		10.1016/j.cell.2009.03.001	http://dx.doi.org/10.1016/j.cell.2009.03.001			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303845	Bronze			2022-12-28	WOS:000264403900008
J	Forcione, DG; Alam, HB; Kalva, SP; Misdraji, J				Forcione, David G.; Alam, Hasan B.; Kalva, Sanjeeva P.; Misdraji, Joseph			A Man with Massive Rectal Bleeding Diverticular disease of the jejunum with hemorrhage	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GASTROINTESTINAL HEMORRHAGE; SURGICAL SIGNIFICANCE; CRITICALLY-ILL; TRANSPORT; DIAGNOSIS; CARE		[Forcione, David G.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Alam, Hasan B.] Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02114 USA; [Kalva, Sanjeeva P.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Misdraji, Joseph] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Forcione, David G.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Kalva, Sanjeeva P.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Misdraji, Joseph] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Forcione, DG (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA.		Misdraji, Joseph/AAD-4588-2019; Misdraji, Joseph/AGX-4779-2022					Akhrass R, 1997, J AM COLL SURGEONS, V184, P383; Alam HB, 2007, SURG CLIN N AM, V87, P55, DOI 10.1016/j.suc.2006.09.015; ALTEMEIER WA, 1963, ARCH SURG-CHICAGO, V86, P732; BASKIN RH, 1952, SURG CLIN N AM, V32, P1185; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Davila RE, 2005, GASTROINTEST ENDOSC, V62, P656, DOI 10.1016/j.gie.2005.07.032; Farrell AJ, 2001, GASTROENTEROL CLIN N, V30, P377, DOI 10.1016/S0889-8553(05)70187-4; GOSTOUT CJ, 1992, J CLIN GASTROENTEROL, V14, P260, DOI 10.1097/00004836-199204000-00014; Holcomb JB, 2007, J TRAUMA, V62, pS36, DOI 10.1097/TA.0b013e3180654134; INDECK M, 1988, J TRAUMA, V28, P1020, DOI 10.1097/00005373-198807000-00018; INSEL J, 1986, CRIT CARE MED, V14, P539, DOI 10.1097/00003246-198606000-00004; Institute of Medicine, 2007, HOSP BAS EM CAR BREA; Institute of Medicine and Committee on Fluid Resuscitation for Combat Casualties, 1999, FLUID RES STAT SCI T; JENSEN DM, 1988, GASTROENTEROLOGY, V95, P1569, DOI 10.1016/S0016-5085(88)80079-9; Jurkovich GJ, 2005, J TRAUMA, V58, P614, DOI 10.1097/01.TA0000159347.03278.E1; KRISHNAMURTHY S, 1983, GASTROENTEROLOGY, V85, P538; KWAN I, 2003, COCHRANE DATABASE SY, V0003, DOI DOI 10.1002/14651858; LEWIS MPN, 1995, GUT, V37, P187, DOI 10.1136/gut.37.2.187; LONGO WE, 1992, DIS COLON RECTUM, V35, P381, DOI 10.1007/BF02048119; Longstreth GF, 1997, AM J GASTROENTEROL, V92, P419; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mapstone J, 2003, J TRAUMA, V55, P571, DOI 10.1097/01.TA.0000062968.69867.6F; Patel VA, 2008, WORLD J GASTROENTERO, V14, P5916, DOI 10.3748/wjg.14.5916; SHACKELFORD RT, 1960, ANN SURG, V151, P930, DOI 10.1097/00000658-196006000-00017; SMITH I, 1990, CRIT CARE MED, V18, P278, DOI 10.1097/00003246-199003000-00006; TAYLOR MT, 1969, AM J SURG, V118, P117, DOI 10.1016/0002-9610(69)90106-8; TSIOTOS GG, 1994, SURGERY, V116, P726; Velmahos GC, 2008, CURR PROB SURG, V45, P446, DOI 10.1067/j.cpsurg.2008.03.002; Warren J, 2004, CRIT CARE MED, V32, P256, DOI 10.1097/01.CCM.0000104917.39204.0A; WILCOX RD, 1990, AM SURGEON, V56, P222; WILCOX RD, 1988, SOUTH MED J, V81, P1386, DOI 10.1097/00007611-198811000-00013; WILCOX RD, 1987, SURG GYNECOL OBSTET, V165, P425; WILLIAMS RA, 1981, SURG GYNECOL OBSTET, V152, P621	33	18	18	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2009	360	12					1239	1248		10.1056/NEJMcpc0810836	http://dx.doi.org/10.1056/NEJMcpc0810836			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420IU	19297577				2022-12-28	WOS:000264283400012
J	Martin, R; O'Neill, D				Martin, Ruth; O'Neill, Desmond			Taxing your memory	LANCET			English	Editorial Material									[Martin, Ruth; O'Neill, Desmond] Adelaide & Meath Hosp, Ctr Ageing Neurosci & Humanities, Dublin 24, Ireland	Trinity College Dublin	Martin, R (corresponding author), Adelaide & Meath Hosp, Ctr Ageing Neurosci & Humanities, Dublin 24, Ireland.	doneill@tcd.ie	O'Neill, Desmond/D-1486-2013	O'Neill, Desmond/0000-0002-5542-9897				Bernabei R, 2008, J GERONTOL A-BIOL, V63, P308, DOI 10.1093/gerona/63.3.308; *CONS INT, 2004, GEN DECL FUT WORLD I; Cullen B, 2007, J NEUROL NEUROSUR PS, V78, P790, DOI 10.1136/jnnp.2006.095414; Ellis G, 2004, BRIT MED BULL, V71, P45, DOI 10.1093/bmb/ldh033; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FOLSTEIN MF, MINIMENTALS STATE EX; Joray S, 2004, AM J GERIAT PSYCHIAT, V12, P639, DOI 10.1176/appi.ajgp.12.6.639; Laennec RTH., 1819, AUSCULTATION MEDIATE; LONGMORE M, 2007, OXFORD HDB CLIN MED, P47; ONEILL D, 1993, POSTGRAD MED J, V69, P599, DOI 10.1136/pgmj.69.814.599; Powsner S, 2005, AM J PSYCHIAT, V162, P627, DOI 10.1176/appi.ajp.162.3.627-a; *PSYCH ASS RES INC, MIN STAT EX 2 MMSE 2; Robinson M., 2007, GLOBAL HLTH GLOBAL A; UN, 2002, 2 WORLD ASSEMBLY AGE; *VHA PHARM BEN MAN, 2007, UPD US MMSE	15	13	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2009	373	9680					2009	2010		10.1016/S0140-6736(09)60349-4	http://dx.doi.org/10.1016/S0140-6736(09)60349-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459DJ	19362360				2022-12-28	WOS:000267080100010
J	Bendavid, E; Bhattacharya, J				Bendavid, Eran; Bhattacharya, Jayanta			The President's Emergency Plan for AIDS Relief in Africa: An Evaluation of Outcomes	ANNALS OF INTERNAL MEDICINE			English	Article							HIV/AIDS	Background: Since 2003, the President's Emergency Plan for AIDS Relief (PEPFAR) has been the most ambitious initiative to address the global HIV epidemic. However, the effect of PEPFAR on HIV-related outcomes is unknown. Objective: To assess the effect of PEPFAR on HIV-related deaths, the number of people living with HIV, and HIV prevalence in sub-Saharan Africa. Design: Comparison of trends before and after the initiation of PEPFAR's activities. Setting: 12 African focus countries and 29 control countries with a generalized HIV epidemic from 1997 to 2007 ( 451 country-year observations). Intervention: A 5-year, $15 billion program for HIV treatment, prevention, and care that started in late 2003. Measurements: HIV-related deaths, the number of people living with HIV, and HIV prevalence. Results: Between 2004 and 2007, the difference in the annual change in the number of HIV-related deaths was 10.5% lower in the focus countries than in the control countries ( P = 0.001). The difference in trends between the groups before 2003 was not significant. The annual growth in the number of people living with HIV was 3.7% slower in the focus countries than in the control countries from 1997 to 2002 ( P = 0.05), but during PEPFAR's activities, the difference was no longer significant. The difference in the change in HIV prevalence did not significantly differ throughout the study period. These estimates were stable after sensitivity analysis. Limitation: The selection of the focus countries was not random, which limits the generalizability of the results. Conclusion: After 4 years of PEPFAR activity, HIV-related deaths decreased in sub-Saharan African focus countries compared with control countries, but trends in adult prevalence did not differ. Assessment of epidemiologic effectiveness should be part of PEPFAR's evaluation programs. Primary Funding Source: Agency for Healthcare Research and Quality.			Bendavid, E (corresponding author), 117 Encina Commons, Stanford, CA 94305 USA.	ebd@stanford.edu			Agency for Healthcare Research and Quality; National Institute on Aging; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI084582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG017253, K02AG024237, R21AG041112] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By a training grant from the Agency for Healthcare Research and Quality ( Dr. Bendavid) and the National Institute on Aging ( Dr. Bhattacharya).	ANDERSON RM, 1988, NATURE, V333, P514, DOI 10.1038/333514a0; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Bristol N, 2008, LANCET, V372, P277, DOI 10.1016/S0140-6736(08)61093-4; COHEN C, 2008, DESIGN CONSIDERATION; Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F; Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1; Duflo Esther, 2005, EVALUATING DEV EFFEC; Easterly W, 2007, J DEV ECON, V84, P755, DOI 10.1016/j.jdeveco.2006.11.002; El-Sadr WM, 2008, NEW ENGL J MED, V359, P553, DOI 10.1056/NEJMp0803762; Ghys PD, 2008, SEX TRANSM INFECT, V84, pI1, DOI 10.1136/sti.2008.032573; Ghys PD, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010199; *GLOB FUND, 2008, PLEDG CONTR; GORGENSALBINO M, 2000, INT BANK RECONSTRUCT; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Joint United Nations Programme on HIV/AIDS (UNAIDS), JOINT UN PROGR HIV A; *OFF US GLOB AIDS, POW PARTN PRES EM PL; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; *PRES EM PLAN AIDS, US 5 YEAR GLOB HIV A; Sachs JD, 2004, BROOKINGS PAP ECO AC, P117; SEPULVEDA J, 2007, PEPFAR IMPLEMENTATIO; Singer J.D., 2003, APPL LONGITUDINAL DA; STOLBERG SG, 2008, NY TIMES        0105; *UN, 2001, DECL COMM HIV AIDS P; *UNAIDS, 2008, REP GLOB AIDS EP EP; UNAIDS, MON DECL COMM HIV AI; UNAIDS, 2007, FIN RES REQ ACH UN A; *US CENS BUR, INT DAT BAS POP PYR; *US DEP STAT, PRES EM PLAN AIDS RE; *US PRES EM PLAN A, MAK DIFF FUND; *WORLD BANK, GOV MATT 2008 WORLDW	30	110	112	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10					688	U5		10.7326/0003-4819-150-10-200905190-00117	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-00117			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19349625	Green Accepted			2022-12-28	WOS:000266285300004
J	Doksani, Y; Bermejo, R; Fiorani, S; Haber, JE; Foiani, M				Doksani, Ylli; Bermejo, Rodrigo; Fiorani, Simona; Haber, James E.; Foiani, Marco			Replicon Dynamics, Dormant Origin Firing, and Terminal Fork Integrity after Double-Strand Break Formation	CELL			English	Article							DNA-DAMAGE RESPONSE; STALLED REPLICATION FORKS; HUMAN-CELLS; CHECKPOINT ACTIVATION; GENOMIC INSTABILITY; CHROMOSOME-III; YEAST; ATR; COMPLEX; ARREST	In response to replication stress, the Mec1/ATR and SUMO pathways control stalled-and damaged-fork stability. We investigated the S phase response at forks encountering a broken template (termed the terminal fork). We show that double-strand break (DSB) formation can locally trigger dormant origin firing. Irreversible fork resolution at the break does not impede progression of the other fork in the same replicon (termed the sister fork). The Mre11-Tel1/ATM response acts at terminal forks, preventing accumulation of cruciform DNA intermediates that tether sister chromatids and can undergo nucleolytic processing. We conclude that sister forks can be uncoupled during replication and that, after DSB-induced fork termination, replication is rescued by dormant origin firing or adjacent replicons. We have uncovered a Tel1/ATM- and Mre11-dependent response controlling terminal fork integrity. Our findings have implications for those genome instability syndromes that accumulate DNA breaks during S phase and for forks encountering eroding telomeres.	[Doksani, Ylli; Bermejo, Rodrigo; Fiorani, Simona; Foiani, Marco] Univ Milan, FIRC Inst Mol Oncol Fdn, IFOM, IEO Campus, I-20139 Milan, Italy; [Doksani, Ylli; Bermejo, Rodrigo; Fiorani, Simona; Foiani, Marco] Univ Milan, DSBB, I-20139 Milan, Italy; [Haber, James E.] Brandeis Univ, Rosenstiel Ctr, Waltham, MA 02254 USA; [Haber, James E.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan; University of Milan; Brandeis University; Brandeis University	Foiani, M (corresponding author), Univ Milan, FIRC Inst Mol Oncol Fdn, IFOM, IEO Campus, Via Adamello 16, I-20139 Milan, Italy.	marco.foiani@ifom-ieo-campus.it	Bermejo, Rodrigo/K-6613-2014; Bermejo, Rodrigo/AAG-7830-2019; Foiani, Marco/M-8234-2014; Bermejo, Rodrigo/S-2445-2019	Bermejo, Rodrigo/0000-0002-2692-7045; Foiani, Marco/0000-0003-4795-834X; Doksani, Ylli/0000-0002-2392-5722; Haber, James/0000-0002-1878-0610	Italian Association for Cancer Research; Telethon-Italy; European Community; Italian Ministry of Health; Regione Lombardia; National Institutes of Health [GM20056, 61766]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076020, R01GM020056, R01GM061766, R37GM020056] Funding Source: NIH RePORTER	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Telethon-Italy(Fondazione Telethon); European Community(European Commission); Italian Ministry of Health(Ministry of Health, Italy); Regione Lombardia(Regione Lombardia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank D. Branzei, F. d'Adda di Fagagna, A. Pellicioli, D. Sherratt, and all members of our laboratories for helpful comments and F. Vanoli for technical suggestions. We are grateful to D. Agostini, E. Nezi, and R. Zonda for artwork. Work in the M. F. laboratory is supported by grants from Italian Association for Cancer Research, Telethon-Italy, European Community, Italian Ministry of Health, and Regione Lombardia. Work in the J.E.H. laboratory is supported by National Institutes of Health grants GM20056 and 61766.	Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bermejo R, 2008, GENE DEV, V22, P2297, DOI 10.1101/gad.1719308; Bianchi A, 2007, CELL, V128, P1051, DOI 10.1016/j.cell.2007.01.041; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Branzei D, 2008, NATURE, V456, P915, DOI 10.1038/nature07587; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BREWER BJ, 1993, SCIENCE, V262, P1728, DOI 10.1126/science.8259517; BREWER BJ, 1992, CELL, V71, P267, DOI 10.1016/0092-8674(92)90355-G; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Ciapponi L, 2004, CURR BIOL, V14, P1360, DOI 10.1016/j.cub.2004.07.019; CONNOLLY B, 1988, MOL CELL BIOL, V8, P2342, DOI 10.1128/MCB.8.6.2342; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; D'Amours D, 2001, GENE DEV, V15, P2238, DOI 10.1101/gad.208701; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Diede SJ, 2001, CURR BIOL, V11, P1336, DOI 10.1016/S0960-9822(01)00400-6; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fiorani S, 2008, CELL CYCLE, V7, P493, DOI 10.4161/cc.7.4.5323; FISHMANLOBELL J, 1992, MOL CELL BIOL, V12, P1292, DOI 10.1128/MCB.12.3.1292; Flott S, 2007, MOL CELL BIOL, V27, P6433, DOI 10.1128/MCB.00135-07; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; Gasser R, 1996, J MOL BIOL, V258, P224, DOI 10.1006/jmbi.1996.0245; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Glover TW, 2005, HUM MOL GENET, V14, pR197, DOI 10.1093/hmg/ddi265; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GREENFEDER SA, 1992, MOL BIOL CELL, V3, P999, DOI 10.1091/mbc.3.9.999; Grenon M, 2006, FEMS YEAST RES, V6, P836, DOI 10.1111/j.1567-1364.2006.00076.x; Haber JE, 2006, DNA REPAIR, V5, P998, DOI 10.1016/j.dnarep.2006.05.025; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kaplun L, 2000, P NATL ACAD SCI USA, V97, P10077, DOI 10.1073/pnas.97.18.10077; Kaye JA, 2004, CURR BIOL, V14, P2096, DOI 10.1016/j.cub.2004.10.051; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; KOSTRIKEN R, 1984, COLD SPRING HARB SYM, V49, P89, DOI 10.1101/SQB.1984.049.01.012; KRYSAN PJ, 1991, MOL CELL BIOL, V11, P1464, DOI 10.1128/MCB.11.3.1464; Lee K, 2008, NATURE, V454, P543, DOI 10.1038/nature07054; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lee SE, 2000, COLD SPRING HARB SYM, V65, P303, DOI 10.1101/sqb.2000.65.303; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lopes M, 2003, MOL CELL, V12, P1499, DOI 10.1016/S1097-2765(03)00473-8; Lucas I, 2001, EMBO J, V20, P6509, DOI 10.1093/emboj/20.22.6509; Makovets S, 2004, MOL CELL BIOL, V24, P4019, DOI 10.1128/MCB.24.9.4019-4031.2004; Marheineke K, 2005, NUCLEIC ACIDS RES, V33, P6931, DOI 10.1093/nar/gki994; Moreau S, 2001, GENETICS, V159, P1423; Morrison AJ, 2007, CELL, V130, P499, DOI 10.1016/j.cell.2007.06.010; Nakada D, 2003, GENE DEV, V17, P1957, DOI 10.1101/gad.1099003; Nakada D, 2004, MOL CELL BIOL, V24, P10016, DOI 10.1128/MCB.24.22.10016-10025.2004; NEWLON CS, 1993, COLD SPRING HARB SYM, V58, P415, DOI 10.1101/SQB.1993.058.01.048; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Poloumienko A, 2001, MOL BIOL CELL, V12, P3317, DOI 10.1091/mbc.12.11.3317; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; RAGHURAMAN MK, 1994, GENE DEV, V8, P554, DOI 10.1101/gad.8.5.554; Rao VA, 2007, MOL CANCER RES, V5, P713, DOI 10.1158/1541-7786.MCR-07-0028; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wang XD, 2008, GENE DEV, V22, P2426, DOI 10.1101/gad.487508; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; ZHU JG, 1992, MOL CELL BIOL, V12, P4733, DOI 10.1128/MCB.12.10.4733; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	93	81	83	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					247	258		10.1016/j.cell.2009.02.016	http://dx.doi.org/10.1016/j.cell.2009.02.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19361851	Green Accepted, Bronze			2022-12-28	WOS:000265456800018
J	Zhu, WX; Lu, L; Hesketh, T				Zhu, Wei Xing; Lu, Li; Hesketh, Therese			China's excess males, sex selective abortion, and one child policy: analysis of data from 2005 national intercensus survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RURAL CHINA; RATIO; MORTALITY; BIRTH	Objectives To elucidate current trends and geographical patterns in the sex ratio at birth and in the population aged under 20 in China and to determine the roles played by sex selective abortion and the one child policy. Design Analysis of household based cross sectional population survey done in November 2005. Setting All of China's 2861 counties. Population 1% of the total population, selected to be broadly representative of the total. Main outcome measure Sex ratio defined as males per 100 females. Results 4 764 512 people under the age of 20 were included. Overall sex ratios were high across all age groups and residency types, but they were highest in the 1-4 years age group, peaking at 126 (95% confidence interval 125 to 126) in rural areas. Six provinces had sex ratios of over 130 in the 1-4 age group. The sex ratio at birth was close to normal for first order births but rose steeply for second order births, especially in rural areas, where it reached 146 (143 to 149). Nine provinces had ratios of over 160 for second order births. The highest sex ratios were seen in provinces that allow rural inhabitants a second child if the first is a girl. Sex selective abortion accounts for almost all the excess males. One particular variant of the one child policy, which allows a second child if the first is a girl, leads to the highest sex ratios. Conclusions In 2005 males under the age of 20 exceeded females by more than 32 million in China, and more than 1.1 million excess births of boys occurred. China will see very high and steadily worsening sex ratios in the reproductive age group over the next two decades. Enforcing the existing ban on sex selective abortion could lead to normalisation of the ratios.	[Hesketh, Therese] UCL, Ctr Int Hlth & Dev, London WC1N 1EH, England; [Lu, Li] Zhejiang Univ, Inst Social & Family Med, Hangzhou 310016, Zhejiang, Peoples R China; [Zhu, Wei Xing] Zhejiang Normal Univ, Coll Law Polit Sci & Publ Adm, Jinhua 310347, Zhejiang, Peoples R China	University of London; University College London; Zhejiang University; Zhejiang Normal University	Hesketh, T (corresponding author), UCL, Ctr Int Hlth & Dev, London WC1N 1EH, England.	t.hesketh@ich.ucl.ac.uk		Hesketh, Therese/0000-0002-7564-9221	Department of Innovation, Universities and Skills; ESRC [ES/F034466/1] Funding Source: UKRI; Economic and Social Research Council [ES/F034466/1] Funding Source: researchfish	Department of Innovation, Universities and Skills; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Funding: This study was funded through a China-UK excellence fellowship for TH from the Department of Innovation, Universities and Skills.	Arnold F., 1987, POPULATION B UN, V23, P44; Attane I, 2002, STUD FAMILY PLANN, V33, P103, DOI 10.1111/j.1728-4465.2002.00103.x; Banister J., 2004, Journal of Population Research, V21, P19; *CHIN POP INF RES, 1949, BAS POP DAT CHIN; *CHIN PROF, FACTS FIG AN; Chu JH, 2001, POPUL DEV REV, V27, P259; COALE AJ, 1991, POPUL DEV REV, V17, P517, DOI 10.2307/1971953; Ding QJ, 2006, BMJ-BRIT MED J, V333, P371, DOI 10.1136/bmj.38775.672662.80; Gu B, 1995, Asia Pac Popul J, V10, P17; Hemminki Elina, 2005, Reprod Health, V2, P5, DOI 10.1186/1742-4755-2-5; Hesketh T, 1997, BRIT MED J, V314, P1685, DOI 10.1136/bmj.314.7095.1685; Hesketh T, 2006, P NATL ACAD SCI USA, V103, P13271, DOI 10.1073/pnas.0602203103; Hudson VM, 2002, INT SECURITY, V26, P5, DOI 10.1162/016228802753696753; JAMES WH, 1987, HUM BIOL, V59, P721; Jha P, 2006, LANCET, V367, P211, DOI 10.1016/S0140-6736(06)67930-0; JOHANSSON S, 1991, POPUL DEV REV, V17, P35, DOI 10.2307/1972351; Klasen S, 2002, POPUL DEV REV, V28, P285, DOI 10.1111/j.1728-4457.2002.00285.x; Li R, 1998, Chin J Popul Sci, V10, P65; Li S, 2007, 4 AS PAC C; Li SZ, 2004, J BIOSOC SCI, V36, P83, DOI 10.1017/S0021932004006121; Lofstedt P, 2004, REPROD HEALTH MATTER, V12, P86, DOI 10.1016/S0968-8080(04)24147-7; Merli MG, 2000, DEMOGRAPHY, V37, P109, DOI 10.2307/2648100; PARK CB, 1995, POPUL DEV REV, V21, P59, DOI 10.2307/2137413; Sen A, 2003, BMJ-BRIT MED J, V327, P1297, DOI 10.1136/bmj.327.7427.1297; Short SE, 1998, STUD FAMILY PLANN, V29, P373, DOI 10.2307/172250; Teitelbaum M S, 1970, J Biosoc Sci Suppl, V2, P61; TULJAPURKAR S, 1995, SCIENCE, V267, P874, DOI 10.1126/science.7846529; Ulizzi L, 2001, HUM BIOL, V73, P121, DOI 10.1353/hub.2001.0014; Winckler EA, 2002, POPUL DEV REV, V28, P379, DOI 10.1111/j.1728-4457.2002.00379.x; Wu ZC, 2003, BRIT MED J, V327, P1319, DOI 10.1136/bmj.327.7427.1319; Wu ZC, 2006, REPROD HEALTH MATTER, V14, P172, DOI 10.1016/S0968-8080(06)27222-7; ZENG Y, 1993, POPUL DEV REV, V19, P283; Zeng Y, 2007, POPUL DEV REV, V33, P215, DOI 10.1111/j.1728-4457.2007.00168.x; ZHANG W, 2007, CHINAS INTERCENSUS S	34	142	142	2	61	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2009	338								b1211	10.1136/bmj.b1211	http://dx.doi.org/10.1136/bmj.b1211			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	431ZK	19359290	hybrid, Green Published			2022-12-28	WOS:000265103100003
J	O'Connor, CM; Whellan, DJ; Lee, KL; Keteyian, SJ; Cooper, LS; Ellis, SJ; Leifer, ES; Kraus, WE; Kitzman, DW; Blumenthal, JA; Rendall, DS; Miller, NH; Fleg, JL; Schulman, KA; McKelvie, RS; Zannad, F; Pina, IL				O'Connor, Christopher M.; Whellan, David J.; Lee, Kerry L.; Keteyian, Steven J.; Cooper, Lawton S.; Ellis, Stephen J.; Leifer, Eric S.; Kraus, William E.; Kitzman, Dalane W.; Blumenthal, James A.; Rendall, David S.; Miller, Nancy Houston; Fleg, Jerome L.; Schulman, Kevin A.; McKelvie, Robert S.; Zannad, Faiez; Pina, Ileana L.		HF-ACTION Investigators	Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure HF-ACTION Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	81st Annual Scientific Session of the American-Heart-Association	NOV 08-12, 2008	New Orleans, LA	Amer Heart Assoc			CARDIAC-RESYNCHRONIZATION; INVESTIGATING OUTCOMES; DIAGNOSIS; MORTALITY; MORBIDITY; DESIGN; LIFE	Context Guidelines recommend that exercise training be considered for medically stable outpatients with heart failure. Previous studies have not had adequate statistical power to measure the effects of exercise training on clinical outcomes. Objective To test the efficacy and safety of exercise training among patients with heart failure. Design, Setting, and Patients Multicenter, randomized controlled trial of 2331 medically stable outpatients with heart failure and reduced ejection fraction. Participants in Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) were randomized from April 2003 through February 2007 at 82 centers within the United States, Canada, and France; median follow-up was 30 months. Interventions Usual care plus aerobic exercise training, consisting of 36 supervised sessions followed by home-based training, or usual care alone. Main Outcome Measures Composite primary end point of all-cause mortality or hospitalization and prespecified secondary end points of all-cause mortality, cardiovascular mortality or cardiovascular hospitalization, and cardiovascular mortality or heart failure hospitalization. Results The median age was 59 years, 28% were women, and 37% had New York Heart Association class III or IV symptoms. Heart failure etiology was ischemic in 51%, and median left ventricular ejection fraction was 25%. Exercise adherence decreased from a median of 95 minutes per week during months 4 through 6 of follow-up to 74 minutes per week during months 10 through 12. A total of 759 patients (65%) in the exercise training group died or were hospitalized compared with 796 patients (68%) in the usual care group (hazard ratio [HR], 0.93 [95% confidence interval {CI}, 0.84-1.02]; P=.13). There were nonsignificant reductions in the exercise training group for mortality (189 patients [16%] in the exercise training group vs 198 patients [17%] in the usual care group; HR, 0.96 [95% CI, 0.79-1.17]; P=.70), cardiovascular mortality or cardiovascular hospitalization (632 [55%] in the exercise training group vs 677 [58%] in the usual care group; HR, 0.92 [95% CI, 0.83-1.03]; P=.14), and cardiovascular mortality or heart failure hospitalization (344 [30%] in the exercise training group vs 393 [34%] in the usual care group; HR, 0.87 [95% CI, 0.75-1.00]; P=.06). In prespecified supplementary analyses adjusting for highly prognostic baseline characteristics, the HRs were 0.89 (95% CI, 0.81-0.99; P=.03) for all-cause mortality or hospitalization, 0.91 (95% CI, 0.82-1.01; P=.09) for cardiovascular mortality or cardiovascular hospitalization, and 0.85 (95% CI, 0.74-0.99; P=.03) for cardiovascular mortality or heart failure hospitalization. Other adverse events were similar between the groups. Conclusions In the protocol-specified primary analysis, exercise training resulted in nonsignificant reductions in the primary end point of all-cause mortality or hospitalization and in key secondary clinical end points. After adjustment for highly prognostic predictors of the primary end point, exercise training was associated with modest significant reductions for both all-cause mortality or hospitalization and cardiovascular mortality or heart failure hospitalization. Trial Registration clinicaltrials.gov Identifier: NCT00047437	[O'Connor, Christopher M.; Whellan, David J.; Lee, Kerry L.; Ellis, Stephen J.; Rendall, David S.; Schulman, Kevin A.] Duke Clin Res Inst, Durham, NC USA; [O'Connor, Christopher M.; Kraus, William E.; Schulman, Kevin A.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Lee, Kerry L.] Duke Univ, Sch Med, Dept Biostat & Bioinformat, Durham, NC 27706 USA; [Blumenthal, James A.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27706 USA; [Whellan, David J.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA; [Keteyian, Steven J.] Henry Ford Hosp, Div Cardiovasc Med, Detroit, MI 48202 USA; [Cooper, Lawton S.; Leifer, Eric S.] NHLBI, Div Prevent & Populat Sci, Bethesda, MD 20892 USA; [Fleg, Jerome L.] NHLBI, Div Cardiovasc Dis, Bethesda, MD 20892 USA; [Kitzman, Dalane W.] Wake Forest Univ, Sch Med, Dept Internal Med, Winston Salem, NC 27109 USA; [Miller, Nancy Houston] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [McKelvie, Robert S.] Hamilton Hlth Sci, Hamilton, ON, Canada; [Zannad, Faiez] Univ Henri Poincare, Ctr Hosp Univ, INSERM, Ctr Invest Clin, Nancy, France; [Pina, Ileana L.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA	Duke University; Duke University; Duke University; Duke University; Jefferson University; Henry Ford Health System; Henry Ford Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Wake Forest University; Stanford University; McMaster University; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Case Western Reserve University	O'Connor, CM (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC USA.	oconn002@mc.duke.edu	Zannad, Faiez/K-4649-2019	Kraus, William E/0000-0003-1930-9684; Zile, Michael/0000-0001-7076-221X; Goldberg, Lee/0000-0002-7906-9638; Hittinger, Luc/0000-0003-1933-5815; Handberg, Eileen/0000-0002-7805-9577; Hershberger, Ray/0000-0001-5683-6526	NHLBI NIH HHS [5U01HL066491, 5U01HL063747, U01 HL066482, 5U01HL064257, U01 HL066494-04, 5U01HL068973, U01 HL068973-06, U01 HL066491, U01 HL064257, U01 HL063747-06S1, U01 HL066501-06, U01 HL066494, U01 HL064257-01A2, 5U01HL064265, 5U01HL066501, U01 HL064250-06, 5U01HL064250, 5U01HL066497, U01 HL066482-04, U01 HL066497, U01 HL066461, U01 HL068973, 5U01HL068980, U01 HL064265-04, U01 HL064264, U01 HL066491-06, U01 HL063747, 5U01HL066494, U01 HL064264-05, U01 HL066501, 5U01HL066482, U01 HL064265, U01 HL068980-05, U01 HL066461-06S1, U01 HL064250, 5U01HL064264, U01 HL066497-04, U01 HL068980, 5U01HL066461] Funding Source: Medline; NIA NIH HHS [R37 AG018915] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 1988, JAMA, V259, P539; Arnold JMO, 2006, CAN J CARDIOL, V22, P23, DOI 10.1016/S0828-282X(06)70237-9; Belardinelli R, 1999, CIRCULATION, V99, P1173, DOI 10.1161/01.CIR.99.9.1173; Bensimhon DR, 2008, AM J CARDIOL, V102, P712, DOI 10.1016/j.amjcard.2008.04.047; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; COATS AJS, 1992, CIRCULATION, V85, P2119, DOI 10.1161/01.CIR.85.6.2119; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; COHN JN, 1983, J AM COLL CARDIOL, V2, P755; COX DR, 1972, J R STAT SOC B, V34, P187; Curtis LH, 2008, ARCH INTERN MED, V168, P418, DOI 10.1001/archinternmed.2007.80; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Flynn KE, 2009, JAMA-J AM MED ASSOC, V301, P1451, DOI 10.1001/jama.2009.457; HAMBRECHT R, 1995, J AM COLL CARDIOL, V25, P1239, DOI 10.1016/0735-1097(94)00568-B; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; McKelvie RS, 2008, HEART FAIL REV, V13, P3, DOI 10.1007/s10741-007-9052-z; Narang R, 1996, EUR HEART J, V17, P120; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Piepoli MF, 2004, BMJ-BRIT MED J, V328, P189, DOI 10.1136/bmj.37938.645220.EE; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; SISCOVICK DS, 1984, NEW ENGL J MED, V311, P874, DOI 10.1056/NEJM198410043111402; Smart N, 2004, AM J MED, V116, P693, DOI 10.1016/j.amjmed.2003.11.033; Whellan DJ, 2007, AM HEART J, V153, P201, DOI 10.1016/j.ahj.2006.11.007	28	1294	1354	1	86	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 8	2009	301	14					1439	1450		10.1001/jama.2009.454	http://dx.doi.org/10.1001/jama.2009.454			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	429MN	19351941	Green Accepted, Bronze			2022-12-28	WOS:000264924900024
J	Ellerbeck, EF; Mahnken, JD; Cupertino, AP; Cox, LS; Greiner, A; Mussulman, LM; Nazir, N; Shireman, TI; Resnicow, K; Ahluwalia, JS				Ellerbeck, Edward F.; Mahnken, Jonathan D.; Cupertino, A. Paula; Cox, Lisa Sanderson; Greiner, Allen; Mussulman, Laura M.; Nazir, Niaman; Shireman, Theresa I.; Resnicow, Kenneth; Ahluwalia, Jasjit S.			Effect of Varying Levels of Disease Management on Smoking Cessation A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							SUSTAINED-RELEASE BUPROPION; RECEPTOR PARTIAL AGONIST; RELAPSED SMOKERS; PRIMARY-CARE; COST-EFFECTIVENESS; COMPETING DEMANDS; NICOTINE PATCHES; PLACEBO; INTERVENTION; VARENICLINE	Background: Cigarette smoking is a chronic, relapsing illness that is inadequately addressed in primary care practice. Objective: To compare cessation rates among smokers who receive pharmacotherapy alone or combined with either moderate-or high-intensity disease management that includes counseling and provider feedback. Design: Randomized clinical trial from June 2004 to December 2007. Setting: 50 rural primary care practices. Participants: 750 persons who smoke more than 10 cigarettes per day. Intervention: Pharmacotherapy alone (n = 250), pharmacotherapy supplemented with up to 2 counseling calls (moderate-intensity disease management) (n = 249), or pharmacotherapy supplemented with up to 6 counseling calls (high-intensity disease management) (n = 251). Interventions were offered every 6 months for 2 years. All participants were offered free pharmacotherapy. Moderate-intensity and high-intensity disease management recipients had postcounseling progress reports faxed to their physicians. Measurements: Self-reported, point-prevalence smoking abstinence at 24 months (primary outcome) and overall (0 to 24 months) analyses of smoking abstinence, utilization of pharmacotherapy, and discussions about smoking with physicians (secondary outcomes). Research assistants who were blinded to treatment assignment conducted outcome assessments. Results: Pharmacotherapy utilization was similar across treatment groups, with 473 of 741 (63.8%), 302 of 739 (40.9%), 175 of 732 (23.9%), and 179 of 726 (24.7%) participants requesting pharmacotherapy during the first, second, third, and fourth 6-month treatment cycles, respectively. Of participants who saw a physician during any given treatment cycle, 37.5% to 59.5% reported that they had discussed smoking cessation with their physician; this did not differ across the treatment groups. Abstinence rates increased throughout the study, and overall (0 to 24 months) analyses demonstrated higher abstinence among the high-intensity disease management group than the moderate-intensity disease management group (odds ratio [OR], 1.43 [95% Cl, 1.00 to 2.03]) and among the combined disease management groups than the pharmacotherapy-alone group (OR, 1.47 [Cl, 1.08 to 2.00]). Self-reported abstinence at 24 months was 68 of 244 (27.9%) and 56 of 238 (23.5%) participants in the high-and moderate-intensity disease management groups, respectively (OR, 1.33 [Cl, 0.88 to 2.02]), and 56 of 244 (23.0%) participants in the pharmacotherapy-alone group (OR, 1.12 [Cl, 0.78 to 1.61] for combined disease management vs. pharmacotherapy alone). Limitation: The effect of pharmacotherapy management cannot be separated from the provision of free pharmacotherapy, and cessation was validated in only 58% of self-reported quitters. Conclusion: Smokers are willing to make repeated pharmacotherapy-assisted quit attempts, leading to progressively greater smoking abstinence. Although point-prevalence abstinence did not differ at 24 months, analyses that incorporated assessments across the full 24 months of treatment suggest that higher-intensity disease management is associated with increased abstinence.	[Ellerbeck, Edward F.] Univ Kansas, Dept Prevent Med & Publ Hlth, Med Ctr, Kansas City, KS 66160 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA	University of Kansas; University of Kansas Medical Center; University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities	Ellerbeck, EF (corresponding author), Univ Kansas, Dept Prevent Med & Publ Hlth, Med Ctr, MSN 1008,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	eellerbe@kumc.edu	Ellerbeck, Edward/I-8438-2014; Shireman, Theresa/J-7854-2015	Ellerbeck, Edward/0000-0002-7774-2729; Shireman, Theresa/0000-0001-6846-8783; Mussulman, Laura/0000-0003-3160-7887	National Cancer Institute [R01-101963]; NATIONAL CANCER INSTITUTE [R01CA101963] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support: From the National Cancer Institute (grant R01-101963). Study medication was provided by GlaxoSmithKline.	*AM CANC SOC, SMOK QUIT HLTH BEN T; *CDC, 1993, MMWR-MORBID MORTAL W, V42, P854; Chen Y, 1995, AM J PUBLIC HEALTH, V85, P1711, DOI 10.2105/AJPH.85.12.1711; Cox LS, 2008, PREV MED, V47, P200, DOI 10.1016/j.ypmed.2008.04.013; Cummings KM, 2006, J PUBLIC HEALTH MAN, V12, P37; CUMMINGS SR, 1988, AM J PUBLIC HEALTH, V78, P574, DOI 10.2105/AJPH.78.5.574; Cupertino AP, 2008, NICOTINE TOB RES, V10, P301, DOI 10.1080/14622200701825817; Curry SJ, 1998, NEW ENGL J MED, V339, P673, DOI 10.1056/NEJM199809033391006; DICLEMENTE CC, 1991, J CONSULT CLIN PSYCH, V59, P295, DOI 10.1037/0022-006X.59.2.295; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Ellerbeck EF, 2001, J FAM PRACTICE, V50, P688; Fiore MC, 2008, TREATING TOBACCO USE; Fu SS, 2006, AM J MANAG CARE, V12, P235; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Glasgow RE, 2001, MILBANK Q, V79, P579, DOI 10.1111/1468-0009.00222; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Gonzales DH, 2001, CLIN PHARMACOL THER, V69, P438, DOI 10.1067/mcp.2001.115750; GOURLAY SG, 1995, BRIT MED J, V311, P363, DOI 10.1136/bmj.311.7001.363; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Holtrop JS, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-18; Jaen CR, 2001, J FAM PRACTICE, V50, P859; Jaen CR, 1997, J FAM PRACTICE, V45, P348; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Joseph AM, 2004, NICOTINE TOB RES, V6, P1075, DOI 10.1080/14622200412331324893; *KDHE, 2005, PRIM CAR HLTH PROF U; Lopez-Quintero C, 2006, AM J PUBLIC HEALTH, V96, P2235, DOI 10.2105/AJPH.2005.071035; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; Miller N, 2005, LANCET, V365, P1849, DOI 10.1016/S0140-6736(05)66615-9; Partin MR, 2006, AM J PREV MED, V31, P293, DOI 10.1016/j.amepre.2006.06.021; ROBINSON MD, 1995, J FAM PRACTICE, V40, P556; Shiffman S, 2004, ADDICTION, V99, P83, DOI 10.1111/j.1360-0443.2004.00576.x; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; Swartz SH, 2005, AM J PREV MED, V29, P288, DOI 10.1016/j.amepre.2005.06.015; Tonnesen P, 1996, EUR RESPIR J, V9, P1619, DOI 10.1183/09031936.96.09081619; TONNESEN P, 1993, ADDICTION, V88, P533, DOI 10.1111/j.1360-0443.1993.tb02060.x; *US DEP HHS, YOU CAN QUIT SMOK CO; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	37	63	64	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2009	150	7					437	+		10.7326/0003-4819-150-7-200904070-00003	http://dx.doi.org/10.7326/0003-4819-150-7-200904070-00003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	432EZ	19349629	Green Accepted			2022-12-28	WOS:000265117600001
J	Trouet, V; Esper, J; Graham, NE; Baker, A; Scourse, JD; Frank, DC				Trouet, Valerie; Esper, Jan; Graham, Nicholas E.; Baker, Andy; Scourse, James D.; Frank, David C.			Persistent Positive North Atlantic Oscillation Mode Dominated the Medieval Climate Anomaly	SCIENCE			English	Article							TROPICAL PACIFIC; RECONSTRUCTION; TEMPERATURE; SIMULATIONS; OCEAN; BACK	The Medieval Climate Anomaly (MCA) was the most recent pre-industrial era warm interval of European climate, yet its driving mechanisms remain uncertain. We present here a 947-year-long multidecadal North Atlantic Oscillation (NAO) reconstruction and find a persistent positive NAO during the MCA. Supplementary reconstructions based on climate model results and proxy data indicate a clear shift to weaker NAO conditions into the Little Ice Age (LIA). Globally distributed proxy data suggest that this NAO shift is one aspect of a global MCA-LIA climate transition that probably was coupled to prevailing La Nina-like conditions amplified by an intensified Atlantic meridional overturning circulation during the MCA.	[Trouet, Valerie; Esper, Jan; Frank, David C.] Swiss Fed Inst Forest Snow & Landscape Res WSL, CH-8903 Birmensdorf, Switzerland; [Esper, Jan] Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Graham, Nicholas E.] Hydrol Res Ctr, San Diego, CA 92130 USA; [Graham, Nicholas E.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Baker, Andy] Univ Birmingham, Sch Geog, Birmingham B15 2TT, W Midlands, England; [Scourse, James D.] Univ Wales Bangor, Sch Ocean Sci, Menai Bridge, Anglesey, Wales	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Bern; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Birmingham; Bangor University	Trouet, V (corresponding author), Swiss Fed Inst Forest Snow & Landscape Res WSL, Zurcherstr 111, CH-8903 Birmensdorf, Switzerland.	trouet@wsl.ch	Baker, Andy/O-5362-2019; Trouet, Valerie/AAE-4888-2021; Frank, David/C-7764-2013; Esper, Jan/O-3127-2018	Baker, Andy/0000-0002-1552-6166; Esper, Jan/0000-0003-3919-014X; Frank, David/0000-0001-5463-5640; Trouet, Valerie/0000-0002-2683-8704	European Commission MILLENNIUM Integrated Project [017008]; National Centre for Competence in Climate Research (NCCR-Climate); National Oceanic and Atmospheric Administration [NA06OA-R4310120]; Royal Society Leverhulme Trust Senior Research Fellowship	European Commission MILLENNIUM Integrated Project; National Centre for Competence in Climate Research (NCCR-Climate)(Swiss National Science Foundation (SNSF)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Royal Society Leverhulme Trust Senior Research Fellowship	J.E., D.C.F., and J.D.S. were supported by the European Commission MILLENNIUM Integrated Project (grant 017008) and J.E. and D.C.F. by the Swiss National Science Foundation through the National Centre for Competence in Climate Research (NCCR-Climate). N.E.G. is grateful for support from National Oceanic and Atmospheric Administration (grant NA06OA-R4310120), and J.D.S. acknowledges a Royal Society Leverhulme Trust Senior Research Fellowship. We thank C. Ammann, E. R. Cook, D. Lund, J. Luterbacher, M.-A. Sicre, J. Smith, D. Stephenson, and three anonymous referees for supplying data and useful suggestions.	Ammann CM, 2007, P NATL ACAD SCI USA, V104, P3713, DOI 10.1073/pnas.0605064103; Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; Cook ER, 2002, J CLIMATE, V15, P1754, DOI 10.1175/1520-0442(2002)015<1754:AWVMRO>2.0.CO;2; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; Emile-Geay J, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001304; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; Esper J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030844; Frank D, 2007, QUATERNARY SCI REV, V26, P3298, DOI 10.1016/j.quascirev.2007.08.002; Glueck MF, 2001, INT J CLIMATOL, V21, P1453, DOI 10.1002/joc.684; Hoerling MP, 2001, SCIENCE, V292, P90, DOI 10.1126/science.1058582; Hurrell J. W., 2003, N ATLANTIC OSCILLATI, V134, P1, DOI [10.1029/134GM01, DOI 10.1029/134GM01]; Hurrell JW, 2004, CLIM DYNAM, V23, P371, DOI 10.1007/s00382-004-0432-y; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Jones PD, 1997, INT J CLIMATOL, V17, P1433, DOI 10.1002/(SICI)1097-0088(19971115)17:13<1433::AID-JOC203>3.0.CO;2-P; Lamb HH, 1965, PALAEOGEOGR PALAEOCL, V1, P13, DOI DOI 10.1016/0031-0182(65)90004-0; Luterbacher J, 1999, GEOPHYS RES LETT, V26, P2745, DOI 10.1029/1999GL900576; Luterbacher J, 2002, CLIM DYNAM, V18, P545, DOI 10.1007/s00382-001-0196-6; Mangini A, 2005, EARTH PLANET SC LETT, V235, P741, DOI 10.1016/j.epsl.2005.05.010; Mann ME, 2005, J CLIMATE, V18, P447, DOI 10.1175/JCLI-3276.1; MITCHELL TD, 2004, 55 U E ANGL TYN CTR; Palmer W.C., 1965, METEOROLOGICAL DROUG; Pauling A, 2006, CLIM DYNAM, V26, P387, DOI 10.1007/s00382-005-0090-8; Proctor CJ, 2000, CLIM DYNAM, V16, P815, DOI 10.1007/s003820000077; Roeckner E, 1999, J CLIMATE, V12, P3004, DOI 10.1175/1520-0442(1999)012<3004:TCCSWA>2.0.CO;2; Stott L, 2004, NATURE, V431, P56, DOI 10.1038/nature02903; Timmermann A, 2007, J CLIMATE, V20, P4899, DOI 10.1175/JCLI4283.1	26	747	772	3	226	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					78	80		10.1126/science.1166349	http://dx.doi.org/10.1126/science.1166349			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342585				2022-12-28	WOS:000264802100035
J	Eichler, HG; Abadie, E; Raine, JM; Salmonson, T				Eichler, Hans-Georg; Abadie, Eric; Raine, June M.; Salmonson, Tomas			Safe Drugs and the Cost of Good Intentions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Eichler, Hans-Georg; Abadie, Eric] EMEA, Comm Med Prod Human Use CHMP, London, England; [Abadie, Eric] Agence Francaise Secur Sanitaire Prod Sante, St Denis, France; [Raine, June M.] Med Healthcare Prod Regulatory Agcy, Vigilance & Risk Management Med, London, England; [Salmonson, Tomas] Lakemedelsverket Med Prod Agcy, Uppsala, Sweden	The Medicines & Healthcare Products Regulatory Agency; Medical Products Agency	Eichler, HG (corresponding author), EMEA, Comm Med Prod Human Use CHMP, London, England.							Calfee J., 2006, REPRESENTATIVE SURVE; FISCHHOFF B, OXFORD TXB IN PRESS; Gazarian M, 2006, MED J AUSTRALIA, V185, P544, DOI 10.5694/j.1326-5377.2006.tb00689.x; Thompson JP, 2008, NEUROLOGY, V71, P357, DOI 10.1212/01.wnl.0000319648.65173.7a; Vandenbroucke JP, 2008, PLOS MED, V5, P339, DOI 10.1371/journal.pmed.0050067	5	50	50	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2009	360	14					1378	1380		10.1056/NEJMp0900092	http://dx.doi.org/10.1056/NEJMp0900092			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427AL	19339718				2022-12-28	WOS:000264751800002
J	Koralek, JD; Weber, CP; Orenstein, J; Bernevig, BA; Zhang, SC; Mack, S; Awschalom, DD				Koralek, J. D.; Weber, C. P.; Orenstein, J.; Bernevig, B. A.; Zhang, Shou-Cheng; Mack, S.; Awschalom, D. D.			Emergence of the persistent spin helix in semiconductor quantum wells	NATURE			English	Article								According to Noether's theorem(1), for every symmetry in nature there is a corresponding conservation law. For example, invariance with respect to spatial translation corresponds to conservation of momentum. In another well-known example, invariance with respect to rotation of the electron's spin, or SU(2) symmetry, leads to conservation of spin polarization. For electrons in a solid, this symmetry is ordinarily broken by spin-orbit coupling, allowing spin angular momentum to flow to orbital angular momentum. However, it has recently been predicted that SU(2) can be achieved in a two-dimensional electron gas, despite the presence of spin-orbit coupling(2). The corresponding conserved quantities include the amplitude and phase of a helical spin density wave termed the 'persistent spin helix'(2). SU(2) is realized, in principle, when the strengths of two dominant spin-orbit interactions, the Rashba(3) (strength parameterized by alpha) and linear Dresselhaus(4) (beta(1)) interactions, are equal. This symmetry is predicted to be robust against all forms of spin-independent scattering, including electron-electron interactions, but is broken by the cubic Dresselhaus term (beta(3)) and spin-dependent scattering. When these terms are negligible, the distance over which spin information can propagate is predicted to diverge as alpha approaches beta(1). Here we report experimental observation of the emergence of the persistent spin helix in GaAs quantum wells by independently tuning alpha and beta(1). Using transient spin-grating spectroscopy(5), we find a spin-lifetime enhancement of two orders of magnitude near the symmetry point. Excellent quantitative agreement with theory across a wide range of sample parameters allows us to obtain an absolute measure of all relevant spin-orbit terms, identifying beta(3) as the main SU(2)violating term in our samples. The tunable suppression of spin relaxation demonstrated in this work is well suited for application to spintronics(6,7).	[Koralek, J. D.; Weber, C. P.; Orenstein, J.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Weber, C. P.] Santa Clara Univ, Dept Phys, Santa Clara, CA 95053 USA; [Orenstein, J.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Bernevig, B. A.] Princeton Univ, Princeton Ctr Theoret Sci, Princeton, NJ 08540 USA; [Zhang, Shou-Cheng] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Mack, S.; Awschalom, D. D.] Univ Calif Santa Barbara, Ctr Spintron & Quantum Computat, Santa Barbara, CA 93106 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Santa Clara University; University of California System; University of California Berkeley; Princeton University; Stanford University; University of California System; University of California Santa Barbara	Koralek, JD (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.	jdkoralek@lbl.gov	Mack, Shawn/F-4008-2011; Orenstein, Joseph W/I-3451-2015; Zhang, Shou-Cheng/B-2794-2010	Mack, Shawn/0000-0001-6696-0483; Koralek, Jake/0000-0001-8289-0497; Orenstein, Joseph/0000-0003-3741-6707	US Department of Energy, Office of Basic Energy Science, Materials Science and Engineering Division; US National Science Foundation and Office of Naval Research	US Department of Energy, Office of Basic Energy Science, Materials Science and Engineering Division(United States Department of Energy (DOE)); US National Science Foundation and Office of Naval Research(National Science Foundation (NSF))	Work performed at Lawrence Berkeley National Laboratory and Stanford University was supported by the US Department of Energy, Office of Basic Energy Science, Materials Science and Engineering Division, and at the University of California, Santa Barbara by the US National Science Foundation and Office of Naval Research. S. M. acknowledges partial support through the National Defense Science and Engineering Graduate Fellowship Program. We thank J. Stephens and J. Krich for discussions, G. Fleming for use of a phase-mask array, and K. Bruns for creating the PSH diagram of Fig. 1c.	Awschalom DD, 2002, NANOSCI TECHNOL, P147; Bernevig BA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.236601; Braun W, 1997, PHYS REV B, V55, P1689, DOI 10.1103/PhysRevB.55.1689; Burkov AA, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.155308; Cameron AR, 1996, PHYS REV LETT, V76, P4793, DOI 10.1103/PhysRevLett.76.4793; Crooker SA, 1995, IEEE J SEL TOP QUANT, V1, P1082, DOI 10.1109/2944.488685; D'Amico I, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.045307; DYAKONOV MI, 1971, SOV PHYS-SOLID STATE, V13, P3023; Fabian J, 2007, ACTA PHYS SLOVACA, V57, P565, DOI 10.2478/v10155-010-0086-8; Froltsov VA, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.045311; Gedik N, 2004, OPT LETT, V29, P2109, DOI 10.1364/OL.29.002109; Krich JJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.226802; Meier F., 1984, OPTICAL ORIENTATION; Noether E, 1918, MATHEMATISCH PHYSIKA, P235, DOI DOI 10.1080/00411457108231446; Ohno M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.045323; Schliemann J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.146801; SCHUBERT EF, 1990, PHYS REV B, V42, P1364, DOI 10.1103/PhysRevB.42.1364; Sherman EY, 2003, APPL PHYS LETT, V82, P209, DOI 10.1063/1.1533839; Silva EADE, 1997, PHYS REV B, V55, P16293, DOI 10.1103/PhysRevB.55.16293; Stanescu TD, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.125307; Weber CP, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.076604; Weber CP, 2005, NATURE, V437, P1330, DOI 10.1038/nature04206; Weng MQ, 2008, J APPL PHYS, V103, DOI 10.1063/1.2899962; Winkler R, 2003, SPRINGER TRACTS MOD, V191, P1, DOI 10.1007/b13586	27	411	413	5	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					610	U73		10.1038/nature07871	http://dx.doi.org/10.1038/nature07871			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19340077	Green Submitted			2022-12-28	WOS:000264796200036
J	Pan, DN; Fujimoto, M; Lopes, A; Wang, YX				Pan, Dongning; Fujimoto, Masaki; Lopes, Andrea; Wang, Yong-Xu			Twist-1 Is a PPAR delta-Inducible, Negative-Feedback Regulator of PGC-1 alpha in Brown Fat Metabolism	CELL			English	Article							ACTIVATED RECEPTOR-DELTA; ADIPOSE-TISSUE; MITOCHONDRIAL BIOGENESIS; ADAPTIVE THERMOGENESIS; GAMMA COACTIVATOR-1; UNCOUPLING PROTEIN; INSULIN-RESISTANCE; GENE-EXPRESSION; ADULT HUMANS; ERR-ALPHA	Brown fat is specialized for energy expenditure, a process that is principally controlled by the transcriptional coactivator PGC-1 alpha. Here, we describe a molecular network important for PGC-1 alpha function and brown fat metabolism. We find that twist-1 is selectively expressed in adipose tissue, interacts with PGC-1 alpha, and is recruited to the promoters of PGC-1 alpha's target genes to suppress mitochondrial metabolism and uncoupling. In vivo, transgenic mice expressing twist-1 in the adipose tissue are prone to high-fat-diet-induced obesity, whereas twist-1 heterozygous knockout mice are obesity resistant. These phenotypes are attributed to their altered mitochondrial metabolism in the brown fat. Interestingly, the nuclear receptor PPAR delta not only mediates the actions of PGC-1 alpha but also regulates twist-1 expression, suggesting a negative-feedback regulatory mechanism. These findings reveal an unexpected physiological role for twist-1 in the maintenance of energy homeostasis and have important implications for understanding metabolic control and metabolic diseases.	[Pan, Dongning; Fujimoto, Masaki; Lopes, Andrea; Wang, Yong-Xu] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Pan, Dongning; Fujimoto, Masaki; Lopes, Andrea; Wang, Yong-Xu] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Wang, YX (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, 364 Plantat St, Worcester, MA 01605 USA.	yongxu.wang@umassmed.edu	Pan, Dongning/P-6523-2019	Pan, Dongning/0000-0001-5463-8155	American Diabetes Association; Smith Family Foundation; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [R56DK076118, R01DK076118]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076118, R56DK076118] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Smith Family Foundation; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. Michael Green, Michael Czech, and Silvia Corvera for insightful comments on this work; Drs. Ron Evans, Marc Montminy, Heonjoong Kang, and Brian Lewis for reagents; Drs. Hong-Ping Guan, Yasuyuki Okawa, and Claude Gazin for help on CHIP assays; Dr. Greg Hendricks and Tracy Levin for electron microscopy; Alison Burkart for help on oxygen consumption, Drs. Matthew Paul and Robert Dallmann for help on the use of iButtons; and Sue Wheeler, Heidi Chandler, and Dr. Denice Godfrey for animal surgery. These studies were funded by grants from the American Diabetes Association, the Smith Family Foundation, and National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (R56DK076118 and R01DK076118).	Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chawla A, 2003, P NATL ACAD SCI USA, V100, P1268, DOI 10.1073/pnas.0337331100; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193; Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Davidson AJ, 2003, J BIOL RHYTHM, V18, P430, DOI 10.1177/0748730403256066; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; GARRUTI G, 1992, INT J OBESITY, V16, P383; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; HUTTUNEN P, 1981, EUR J APPL PHYSIOL O, V46, P339, DOI 10.1007/BF00422121; Kakuma T, 2000, ENDOCRINOLOGY, V141, P4576, DOI 10.1210/en.141.12.4576; Kontani Y, 2005, AGING CELL, V4, P147, DOI 10.1111/j.1474-9726.2005.00157.x; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; LEAN MEJ, 1986, INT J OBESITY, V10, P219; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tiraby C, 2003, TRENDS ENDOCRIN MET, V14, P439, DOI 10.1016/j.tem.2003.10.001; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Villavicencio EH, 2002, GENESIS, V32, P247, DOI 10.1002/gene.10078; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wang XJ, 2005, MOL CELL ENDOCRINOL, V238, P1, DOI 10.1016/j.mce.2005.04.009; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	50	167	174	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					73	86		10.1016/j.cell.2009.01.051	http://dx.doi.org/10.1016/j.cell.2009.01.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345188	Green Accepted, Bronze			2022-12-28	WOS:000264813300015
J	Teis, D; Saksena, S; Emr, SD				Teis, David; Saksena, Suraj; Emr, Scott D.			SnapShot: The ESCRT Machinery	CELL			English	Editorial Material							III COMPLEX		[Teis, David; Saksena, Suraj; Emr, Scott D.] Cornell Univ, Ithaca, NY 14853 USA; [Teis, David] Innsbruck Med Univ, Innsbruck, Austria	Cornell University; Medical University of Innsbruck	Teis, D (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.			Teis, David/0000-0002-8181-0253	HFSP [LT00634/2006-L]; American Heart Association [AHA 0826060D]; Weill Institute for Cell and Molecular Biology	HFSP(Human Frontier Science Program); American Heart Association(American Heart Association); Weill Institute for Cell and Molecular Biology	D.T. is funded by HFSP (LT00634/2006-L). S.S. is supported by a fellowship of the American Heart Association (AHA 0826060D). We are grateful to E.V. MacGurn for assistance with graphics. S.D.E. is supported by funds from the Weill Institute for Cell and Molecular Biology. We also thank Z. Yu and G. Jensen for providing the image of the Vps/Vta1 complex.	Kostelansky MS, 2007, CELL, V129, P485, DOI 10.1016/j.cell.2007.03.016; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Prag G, 2007, DEV CELL, V12, P973, DOI 10.1016/j.devcel.2007.04.013; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yu ZH, 2008, J MOL BIOL, V377, P364, DOI 10.1016/j.jmb.2008.01.009	10	31	31	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 2	2009	137	1							182.e1	10.1016/j.cell.2009.03.027	http://dx.doi.org/10.1016/j.cell.2009.03.027			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345195	Bronze			2022-12-28	WOS:000264813300024
J	Guerrini, I; Jackson, S; Keaney, F				Guerrini, Irene; Jackson, Siobhan; Keaney, Francis			Practice Pregnancy Plus Pregnancy and alcohol misuse	BRITISH MEDICAL JOURNAL			English	Article							BRIEF INTERVENTION; YOUNG-WOMEN; BRAIN; WITHDRAWAL; RISK		[Guerrini, Irene] S London & Maudsley NHS Fdn Trust, Bexley Substance Misuse Serv, London DA8 1RQ, Kent, England; [Jackson, Siobhan] S London & Maudsley NHS Fdn Trust, Queen Elizabeth Hosp Woolwich, Greenwich & Antenatal Clin, Beresford Project, London SE18 6LZ, England; [Keaney, Francis] Maudsley Hosp & Inst Psychiat, S London & Maudsley NHS Fdn Trust, London SE5 8AZ, England	South London & Maudsley NHS Trust; South London & Maudsley NHS Trust; South London & Maudsley NHS Trust; University of London; King's College London	Guerrini, I (corresponding author), S London & Maudsley NHS Fdn Trust, Bexley Substance Misuse Serv, London DA8 1RQ, Kent, England.	irene.guerrini@slam.nhs.uk						Chang G, 2005, OBSTET GYNECOL, V105, P991, DOI 10.1097/01.AOG.0000157109.05453.84; Chang G, 2001, ALCOHOL RES HEALTH, V25, P204; Crome IB, 2007, SEMIN FETAL NEONAT M, V12, P98, DOI 10.1016/j.siny.2006.12.002; Department of Health, 2007, UPD ALC ADV PREGN WO; Gilmore IT, 2008, BRIT MED J, V336, P952, DOI 10.1136/bmj.39520.716863.94; Goransson M, 2003, ADDICTION, V98, P1513, DOI 10.1046/j.1360-0443.2003.00498.x; Guerrini I, 2007, NEUROSCI BIOBEHAV R, V31, P212, DOI 10.1016/j.neubiorev.2006.06.022; HENDERSON J, 2006, BJOG, V114, P243; Maconochie N, 2007, BJOG-INT J OBSTET GY, V114, P170, DOI 10.1111/j.1471-0528.2006.01193.x; Myrick H, 1998, ALCOHOL HEALTH RES W, V22, P38; *NAT I HLTH CLIN E, 2005, PREV RED ALC MIS ED; *NAT TREATM AG SUB, 2006, REV EFF TREATM ALC P; *NAT TREATM AG SUB, 2007, GUID CLIN MAN DRUG M; National Institute for Health and Clincial Excellence, 2008, ANT CAR; NORA AH, 1977, LANCET, V2, P664; O'Connor MJ, 2007, AM J PUBLIC HEALTH, V97, P252, DOI 10.2105/AJPH.2005.077222; Riley EP, 2005, EXP BIOL MED, V230, P357, DOI 10.1177/15353702-0323006-03; *ROYAL COLL OBST G, 2006, RCOG STAT, V5; RUSSELL M, 1988, ALCOHOL CLIN EXP RES, V12, P824, DOI 10.1111/j.1530-0277.1988.tb01354.x; Thomas JD, 1998, ALCOHOL HEALTH RES W, V22, P47; *US DEP HLTH, TIP SER US DEP HLTH, V2; *WHO, 2001, BRIEF INT HAZ HARMF; Young C, 2006, NEUROBIOL DIS, V22, P548, DOI 10.1016/j.nbd.2005.12.015	24	1	1	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 30	2009	338								b845	10.1136/bmj.b845	http://dx.doi.org/10.1136/bmj.b845			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429AK	19332453				2022-12-28	WOS:000264893000012
J	Li, QS; Skinner, PJ; Ha, SJ; Duan, LJ; Mattila, TL; Hage, A; White, C; Barber, DL; O'Mara, L; Southern, PJ; Reilly, CS; Carlis, JV; Miller, CJ; Ahmed, R; Haase, AT				Li, Qingsheng; Skinner, Pamela J.; Ha, Sang-Jun; Duan, Lijie; Mattila, Teresa L.; Hage, Aaron; White, Cara; Barber, Daniel L.; O'Mara, Leigh; Southern, Peter J.; Reilly, Cavan S.; Carlis, John V.; Miller, Christopher J.; Ahmed, Rafi; Haase, Ashley T.			Visualizing Antigen-Specific and Infected Cells in Situ Predicts Outcomes in Early Viral Infection	SCIENCE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; CD8(+) T-CELLS; SIV INFECTION; PERSISTENCE; TRANSMISSION; GLYCOPROTEIN; REPLICATION; RESPONSES; EPITOPES	In the early stages of viral infection, outcomes depend on a race between expansion of infection and the immune response generated to contain it. We combined in situ tetramer staining with in situ hybridization to visualize, map, and quantify relationships between immune effector cells and their targets in tissues. In simian immunodeficiency virus infections in macaques and lymphocytic choriomeningitis virus infections in mice, the magnitude and timing of the establishment of an excess of effector cells versus targets were found to correlate with the extent of control and the infection outcome (i.e., control and clearance versus partial or poor control and persistent infection). This method highlights the importance of the location, timing, and magnitude of the immune response needed for a vaccine to be effective against agents of persistent infection, such as HIV-1.	[Li, Qingsheng; Duan, Lijie; Southern, Peter J.; Haase, Ashley T.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Skinner, Pamela J.; Mattila, Teresa L.; Hage, Aaron; White, Cara] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Ha, Sang-Jun; O'Mara, Leigh; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Barber, Daniel L.] NIAID, Immunobiol Sect, Bethesda, MD 20892 USA; [Reilly, Cavan S.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Carlis, John V.] Univ Minnesota, Inst Technol, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; [Miller, Christopher J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Ctr Comparat Med, Davis, CA 95616 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Davis	Haase, AT (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.	haase001@umn.edu	Barber, Daniel L./V-1190-2019	Skinner, Pamela/0000-0003-3388-1687; Ha, Sang-Jun/0000-0002-1192-6031	NIH [AI48484, AI20048, AI066314]; National Center for Research Resources [RR00169]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI066314, R01AI048484] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Immunology Core Laboratory and Primate Services Unit of the California National Primate Research Center (CNPRC); D. Lu, T. Rourke, R. Dizon, and B. Vang for technical assistance; J. Sedgewick for assistance in setting up the confocal microscope to capture images of silver grains; D. Masopust for helpful discussion; and C. O'Neill and T. Leonard for help in preparing the manuscript and figures. Supported in part by NIH research grants AI48484 (A.T.H.), AI20048 (R.A.), and AI066314 (C.J.M.); National Center for Research Resources grant RR00169 (CNPRC, University of California, Davis); and a gift from the James B. Pendleton Charitable Trust (C.J.M.).	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Davenport MP, 2004, J VIROL, V78, P10096, DOI 10.1128/JVI.78.18.10096-10103.2004; Doherty PC, 1998, SCIENCE, V280, P227, DOI 10.1126/science.280.5361.227; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuroda MJ, 1999, J IMMUNOL, V162, P5127; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; MATLOUBIAN M, 1990, J EXP MED, V172, P1043, DOI 10.1084/jem.172.4.1043; MATLOUBIAN M, 1993, J VIROL, V67, P7340, DOI 10.1128/JVI.67.12.7340-7349.1993; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Mothe BR, 2002, J VIROL, V76, P875, DOI 10.1128/JVI.76.2.875-884.2002; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Reynolds MR, 2005, J VIROL, V79, P9228, DOI 10.1128/JVI.79.14.9228-9235.2005; Skinner PJ, 2000, J IMMUNOL, V165, P613, DOI 10.4049/jimmunol.165.2.613; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003	18	155	169	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1726	1729		10.1126/science.1168676	http://dx.doi.org/10.1126/science.1168676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325114	Green Submitted, Green Accepted			2022-12-28	WOS:000264559800039
J	Goldstein, MA; Goodman, A; del Carmen, MG; Wilbur, DC				Goldstein, Mark A.; Goodman, Annekathryn; del Carmen, Marcela G.; Wilbur, David C.			A Woman with an Abnormal Papanicolaou Smear CIN 3 (severe dysplasia or carcinoma in situ) of the uterine cervix. Endocervical adenocarcinoma in situ	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; SQUAMOUS INTRAEPITHELIAL LESIONS; NATURAL-HISTORY; YOUNG-WOMEN; PARTICLE VACCINE; RISK-FACTORS; NEOPLASIA; CANCER; EFFICACY; TYPE-18		[Goldstein, Mark A.] Massachusetts Gen Hosp, Div Adolescent & Young Adult Med, Boston, MA 02114 USA; [Goodman, Annekathryn; del Carmen, Marcela G.] Massachusetts Gen Hosp, Div Gynecol Oncol, Boston, MA 02114 USA; [Goodman, Annekathryn; del Carmen, Marcela G.] Massachusetts Gen Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02114 USA; [Wilbur, David C.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Goldstein, Mark A.] Harvard Univ, Sch Med, Dept Pediat, Cambridge, MA 02138 USA; [Goodman, Annekathryn; del Carmen, Marcela G.] Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Cambridge, MA 02138 USA; [Wilbur, David C.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Goldstein, MA (corresponding author), Massachusetts Gen Hosp, Div Adolescent & Young Adult Med, Boston, MA 02114 USA.							ACOG Comm Obstet Practice, 2003, OBSTET GYNECOL, V102, P415; Datta SD, 2008, ANN INTERN MED, V148, P493, DOI 10.7326/0003-4819-148-7-200804010-00004; GALL SA, 2007, ANN AM ASS CANC RES; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Huang YK, 2008, BRIT J CANCER, V98, P863, DOI 10.1038/sj.bjc.6604262; Insinga Ralph P, 2007, Infect Agent Cancer, V2, P15, DOI 10.1186/1750-9378-2-15; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Lowy DR, 2006, J CLIN INVEST, V116, P1167, DOI 10.1172/JCI28607; MacLean AB, 2004, GYNECOL ONCOL, V95, P691, DOI 10.1016/j.ygyno.2004.08.006; Melnikow J, 1998, OBSTET GYNECOL, V92, P727, DOI 10.1016/S0029-7844(98)00245-2; Moscicki AB, 2001, JAMA-J AM MED ASSOC, V285, P2995, DOI 10.1001/jama.285.23.2995; Moscicki AB, 2004, J INFECT DIS, V190, P37, DOI 10.1086/421467; Moscicki AB, 2004, LANCET, V364, P1678, DOI 10.1016/S0140-6736(04)17354-6; Moscicki AB, 2007, DIS MARKERS, V23, P229, DOI 10.1155/2007/136906; Moscicki AB, 2006, VACCINE, V24, P42, DOI 10.1016/j.vaccine.2006.06.018; Moscicki AB, 2008, OBSTET GYNECOL, V112, P1335, DOI 10.1097/AOG.0b013e31818c9222; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Paavonen J, 2007, LANCET, V370, P1414; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; *PREV SERV TASK FO, 2008, SCREEN CERV CANC REC; Rodriguez AC, 2007, SEX TRANSM DIS, V34, P494, DOI 10.1097/01.olq.0000251241.03088.a0; Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342; Stanley M, 2007, GYNECOL ONCOL, V107, pS19, DOI 10.1016/j.ygyno.2007.07.068; Stanley M, 2006, VACCINE, V24, P106, DOI 10.1016/j.vaccine.2006.05.110; Villa L, 2007, LANCET, V369, P1861, DOI 10.1016/S0140-6736(07)60852-6; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x; Winer RL, 2008, J INFECT DIS, V197, P279, DOI 10.1086/524875; Winer RL, 2006, NEW ENGL J MED, V354, P2645, DOI 10.1056/NEJMoa053284; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Winer RL, 2005, J INFECT DIS, V191, P731, DOI 10.1086/427557; Winer RL, 2003, AM J EPIDEMIOL, V157, P859; Wright JD, 2005, OBSTET GYNECOL, V106, P115, DOI 10.1097/01.AOG.0000165822.29451.54; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P346, DOI 10.1016/j.ajog.2007.07.047; 2007, GARDASIL PRESCRIBING	38	13	15	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2009	360	13					1337	1344		10.1056/NEJMcpc0810837	http://dx.doi.org/10.1056/NEJMcpc0810837			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423VP	19321871	Green Published			2022-12-28	WOS:000264524100011
J	Kamerow, D				Kamerow, Douglas			Yankee Doodling The papal position on condoms and HIV	BRITISH MEDICAL JOURNAL			English	Editorial Material												dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957					0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 25	2009	338								b1217	10.1136/bmj.b1217	http://dx.doi.org/10.1136/bmj.b1217			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LQ	19321547				2022-12-28	WOS:000264639600004
J	Pronovost, PJ; Colantuoni, E				Pronovost, Peter J.; Colantuoni, Elizabeth			Measuring Preventable Harm Helping Science Keep Pace With Policy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BIOMEDICAL-RESEARCH; PATIENT SAFETY; MORTALITY; QUALITY; RATES		Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Pronovost, Peter J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Colantuoni, Elizabeth] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Pronovost, PJ (corresponding author), 1909 Thames St,2nd Floor, Baltimore, MD 21231 USA.	ppronovo@jhmi.edu						Bradley EH, 2006, JAMA-J AM MED ASSOC, V296, P72, DOI 10.1001/jama.296.1.72; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Haut ER, 2007, J TRAUMA, V63, P1132, DOI 10.1097/TA.0b013e31814856ad; Heijink R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-73; Hofer T P, 2000, Eff Clin Pract, V3, P261; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384; Loscalzo J, 2006, NEW ENGL J MED, V354, P1665, DOI 10.1056/NEJMp068050; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; Pronovost PJ, 2008, JAMA-J AM MED ASSOC, V299, P2197, DOI 10.1001/jama.299.18.2197; Pronovost PJ, 2006, JAMA-J AM MED ASSOC, V296, P696, DOI 10.1001/jama.296.6.696; Resar RK, 2003, QUAL SAF HEALTH CARE, V12, pII39, DOI 10.1136/qhc.12.suppl_2.ii39; Shojania KG, 2002, JAMA-J AM MED ASSOC, V288, P508, DOI 10.1001/jama.288.4.508; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694	14	59	59	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 25	2009	301	12					1273	1275		10.1001/jama.2009.388	http://dx.doi.org/10.1001/jama.2009.388			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423JO	19318654				2022-12-28	WOS:000264492800027
J	Daley, AC; Budd, GE; Caron, JB; Edgecombe, GD; Collins, D				Daley, Allison C.; Budd, Graham E.; Caron, Jean-Bernard; Edgecombe, Gregory D.; Collins, Desmond			The Burgess Shale Anomalocaridid Hurdia and Its Significance for Early Euarthropod Evolution	SCIENCE			English	Article							GREAT-APPENDAGE ARTHROPOD; OPABINIA; FAUNA	As the largest predators of the Cambrian seas, the anomalocaridids had an important impact in structuring the first complex marine animal communities, but many aspects of morphology, diversity, ecology, and affinity remain unclear owing to a paucity of specimens. Here we describe the anomalocaridid Hurdia, based on several hundred specimens from the Burgess Shale in Canada. Hurdia possesses a general body architecture similar to those of Anomalocaris and Laggania, including the presence of exceptionally well-preserved gills, but differs from those anomalocaridids by possessing a prominent anterior carapace structure. These features amplify and clarify the diversity of known anomalocaridid morphology and provide insight into the origins of important arthropod features, such as the head shield and respiratory exites.	[Daley, Allison C.; Budd, Graham E.] Uppsala Univ, Dept Earth Sci, SE-75236 Uppsala, Sweden; [Caron, Jean-Bernard] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Edgecombe, Gregory D.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England	Uppsala University; Royal Ontario Museum; Natural History Museum London	Daley, AC (corresponding author), Uppsala Univ, Dept Earth Sci, Villavagen 16, SE-75236 Uppsala, Sweden.	allison.daley@geo.uu.se	Daley, Allison/A-3117-2015	Daley, Allison/0000-0001-5369-5879; Caron, Jean-Bernard/0000-0002-1670-5502; Edgecombe, Gregory/0000-0002-9591-8011	European Union Marie Curie Research Training Network ZOONET [MRTN-CT-2004-005624]; Swedish Research Council (Vetenskapsradet)	European Union Marie Curie Research Training Network ZOONET(European Commission); Swedish Research Council (Vetenskapsradet)(Swedish Research Council)	We thank J. Bergstrom for discussion. Comments from D. E. G. Briggs, B. S. Lieberman, and anonymous reviewers improved the manuscript. J. Dougherty and F. Collier provided access to specimens at GSC and MCZ, respectively, and D. Erwin and J. Thompson provided access to specimens at NMNH. Permission to collect Burgess Shale specimens was given by Parks Canada to D.C. Funding was provided by European Union Marie Curie Research Training Network ZOONET (grant MRTN-CT-2004-005624) to G.E.B. and A.C.D. and the Swedish Research Council (Vetenskapsradet) to G.E.B. This is ROM Burgess Shale Project number 8.	BERGSTROM J, 1987, LETHAIA, V20, P187, DOI 10.1111/j.1502-3931.1987.tb00777.x; Boxshall GA, 2004, BIOL REV, V79, P253, DOI 10.1017/S1464793103006274; Briggs D.E.G., 1979, Palaeontology (Oxford), V22, P631; Briggs DEG, 2008, J PALEONTOL, V82, P238, DOI 10.1666/06-086.1; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; Budd GE, 1996, LETHAIA, V29, P1, DOI 10.1111/j.1502-3931.1996.tb01831.x; Caron JB, 2008, PALAEOGEOGR PALAEOCL, V258, P222, DOI 10.1016/j.palaeo.2007.05.023; Chen JY, 2004, LETHAIA, V37, P3, DOI 10.1080/00241160410004764; CHLUPAC I, 2002, B CZECH GEOLOGICAL S, V77, P167; Collins D, 1996, J PALEONTOL, V70, P280, DOI 10.1017/S0022336000023362; COLLINS D, 1999, ROTUNDA, V32, P25; COLLINS D, 1992, PALEONTOLOGICAL SOC, V6, P66; CUI Z, 1990, ACTA PALAEONTOL SIN, V29, P328; Dewel R.A., 1998, Systematics Association Special Volume Series, V55, P109; Fletcher TP, 1998, CAN J EARTH SCI, V35, P413, DOI 10.1139/e97-120; HOU XG, 1995, GFF, V117, P163, DOI 10.1080/11035899509546213; Hou XG, 2006, GEOL J, V41, P259, DOI 10.1002/gj.1050; Kuhl G, 2009, SCIENCE, V323, P771, DOI 10.1126/science.1166586; Lieberman BS, 2003, J PALEONTOL, V77, P674, DOI 10.1017/S0022336000044413; Maas A, 2004, PROG NAT SCI-MATER, V14, P158, DOI 10.1080/10020070412331343301; ROLFE W. D. IAN, 1962, BREVIORA MUS COMP ZOOL [HARVARD], V160, P1; Simonetta A.M, 1975, Palaeontographia Italica, V69, P1; Walcott Charles D., 1912, Smithsonian Institution Miscellaneous Collection, V57; Walcott Charles D., 1911, Smithsonian Institution Miscellaneous Collection, V57; Walcott Charles Doolittle, 1911, Smithsonian Institution Miscellaneous Collection, V57; Whiteaves J. F., 1892, CANADIAN RECORD SCI, V5, P205; WHITTINGTON HB, 1985, PHILOS T R SOC B, V309, P569, DOI 10.1098/rstb.1985.0096; Wills MA, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P33; Wolff C, 2008, P ROY SOC B-BIOL SCI, V275, P1023, DOI 10.1098/rspb.2007.1327; Zhang XL, 2007, LETHAIA, V40, P161, DOI 10.1111/j.1502-3931.2007.00013.x	30	138	138	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1597	1600		10.1126/science.1169514	http://dx.doi.org/10.1126/science.1169514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299617				2022-12-28	WOS:000264342300036
J	Xiao, SH; Jan, LY				Xiao, Shaohua; Jan, Lily Yeh			A Gate Keeper for Axonal Transport	CELL			English	Editorial Material							PROTEINS; NEURONS	The axon and dendritic arbor of neurons require different sets of membrane proteins to carry out their functions. In this issue, Song et al. (2009) describe how a cytoplasmic diffusion barrier in the axon initial segment of rat hippocampal neurons ensures that only axonal (and not dendritic) membrane proteins enter the axon.	[Xiao, Shaohua; Jan, Lily Yeh] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	lily.jan@ucsf.edu		Jan, Lily/0000-0003-3938-8498	Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [R01 MH065334] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065334] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Xu MX, 2007, J NEUROSCI, V27, P14158, DOI 10.1523/JNEUROSCI.3675-07.2007	6	5	5	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					996	998		10.1016/j.cell.2009.03.003	http://dx.doi.org/10.1016/j.cell.2009.03.003			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303842	Bronze			2022-12-28	WOS:000264403900005
J	Koder, RL; Anderson, JLR; Solomon, LA; Reddy, KS; Moser, CC; Dutton, PL				Koder, Ronald L.; Anderson, J. L. Ross; Solomon, Lee A.; Reddy, Konda S.; Moser, Christopher C.; Dutton, P. Leslie			Design and engineering of an O-2 transport protein	NATURE			English	Article							CYTOCHROME-C-OXIDASE; HEME-PROTEINS; LIGAND-BINDING; COMPUTATIONAL DESIGN; ELECTRON-TRANSFER; ENZYME CATALYSIS; 4-HELIX BUNDLE; HEMOGLOBIN; MAQUETTE; MECHANISM	The principles of natural protein engineering are obscured by overlapping functions and complexity accumulated through natural selection and evolution. Completely artificial proteins offer a clean slate on which to define and test these protein engineering principles, while recreating and extending natural functions. Here we introduce this method with the design of an oxygen transport protein, akin to human neuroglobin. Beginning with a simple and unnatural helix-forming sequence with just three different amino acids, we assembled a four-helix bundle, positioned histidines to bis-histidine ligate haems, and exploited helical rotation and glutamate burial on haem binding to introduce distal histidine strain and facilitate O-2 binding. For stable oxygen binding without haem oxidation, water is excluded by simple packing of the protein interior and loops that reduce helical-interface mobility. O-2 affinities and exchange timescales match natural globins with distal histidines, with the remarkable exception that O-2 binds tighter than CO.	[Koder, Ronald L.; Anderson, J. L. Ross; Solomon, Lee A.; Reddy, Konda S.; Moser, Christopher C.; Dutton, P. Leslie] Univ Penn, Dept Biochem & Biophys, Johnson Res Fdn, Philadelphia, PA 19104 USA	University of Pennsylvania	Dutton, PL (corresponding author), Univ Penn, Dept Biochem & Biophys, Johnson Res Fdn, Philadelphia, PA 19104 USA.	dutton@mail.med.upenn.edu	Koder, Ronald L/A-6089-2008; Moser, Christopher C/O-6559-2014	Moser, Christopher C/0000-0003-4814-8568; Anderson, Ross/0000-0002-6796-0482; Koder, Ronald/0000-0003-0868-4972; Solomon, Lee/0000-0003-1471-9510	US Department of Energy; US National Institute of Health; US National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041048] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. J. Wand for assistance in NMR measurements, P. R. Rich for FTIR measurements, M. S. Hargrove for neuroglobin reference spectra and discussions, and D. Hilvert for suggestions. This work was supported by grants from US Department of Energy, US National Institute of Health and US National Science Foundation as detailed in Supplementary Information.	ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Borovik AS, 2005, ACCOUNTS CHEM RES, V38, P54, DOI 10.1021/ar030160q; Brannigan JA, 2002, NAT REV MOL CELL BIO, V3, P964, DOI 10.1038/nrm975; Carbone MN, 2007, CURR OPIN STRUC BIOL, V17, P454, DOI 10.1016/j.sbi.2007.08.005; CHANCE B, 1975, P NATL ACAD SCI USA, V72, P1635, DOI 10.1073/pnas.72.4.1635; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Collman JP, 2004, CHEM REV, V104, P561, DOI 10.1021/cr0206059; Darwin C., 1872, ORIGIN SPECIES MEANS, V144, P971; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; ENGELS WR, 1993, TRENDS BIOCHEM SCI, V18, P448, DOI 10.1016/0968-0004(93)90148-G; Frauenfelder H, 2003, P NATL ACAD SCI USA, V100, P8615, DOI 10.1073/pnas.1633688100; Gibney BR, 1999, J AM CHEM SOC, V121, P4952, DOI 10.1021/ja9833117; Gibney BR, 2000, BIOCHEMISTRY-US, V39, P11041, DOI 10.1021/bi000925r; Goldberg DE, 1999, CHEM REV, V99, P3371, DOI 10.1021/cr970152l; Grosset AM, 2001, BIOCHEMISTRY-US, V40, P5474, DOI 10.1021/bi002504f; Hargrove MS, 2000, BIOPHYS J, V79, P2733, DOI 10.1016/S0006-3495(00)76512-X; Hilvert D, 2000, ANNU REV BIOCHEM, V69, P751, DOI 10.1146/annurev.biochem.69.1.751; Huang SS, 2004, P NATL ACAD SCI USA, V101, P5536, DOI 10.1073/pnas.0306676101; Huang SS, 2003, J MOL BIOL, V326, P1219, DOI 10.1016/S0022-2836(02)01441-9; Isogai Y, 1999, BIOCHEMISTRY-US, V38, P7431, DOI 10.1021/bi983006y; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; Koder RL, 2006, J AM CHEM SOC, V128, P14450, DOI 10.1021/ja064883r; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Marshall SA, 2001, J MOL BIOL, V305, P619, DOI 10.1006/jmbi.2000.4319; MATHEWS AJ, 1989, J BIOL CHEM, V264, P16573; MCLENDON G, 1991, STRUCT BOND, V75, P159; Moffet DA, 2001, J AM CHEM SOC, V123, P2109, DOI 10.1021/ja0036007; Moffet DA, 2000, J AM CHEM SOC, V122, P7612, DOI 10.1021/ja001198q; Monien BH, 2007, J MOL BIOL, V371, P739, DOI 10.1016/j.jmb.2007.05.047; MOORE JT, 1993, PROTEIN EXPRES PURIF, V4, P160, DOI 10.1006/prep.1993.1022; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; Pesce A, 2003, STRUCTURE, V11, P1087, DOI 10.1016/S0969-2126(03)00166-7; Peterson ES, 1997, BIOCHEMISTRY-US, V36, P13110, DOI 10.1021/bi971156n; REGAN L, 1988, SCIENCE, V241, P976, DOI 10.1126/science.3043666; ROBERTSON DE, 1994, NATURE, V368, P425, DOI 10.1038/368425a0; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; SHARMA VS, 1976, J BIOL CHEM, V251, P4267; Shifman JM, 1998, BIOCHEMISTRY-US, V37, P16815, DOI 10.1021/bi9816857; Shikama K, 1998, CHEM REV, V98, P1357, DOI 10.1021/cr970042e; SMITH KM, 1986, J ORG CHEM, V51, P666, DOI 10.1021/jo00355a016; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Trent JT, 2001, BIOCHEMISTRY-US, V40, P6155, DOI 10.1021/bi0100790; VALLEE BL, 1968, P NATL ACAD SCI USA, V59, P498, DOI 10.1073/pnas.59.2.498; WANG JH, 1958, J AM CHEM SOC, V80, P3168, DOI 10.1021/ja01545a072; Warshel A, 2003, ANNU REV BIOPH BIOM, V32, P425, DOI 10.1146/annurev.biophys.32.110601.141807; Zhuang JY, 2004, INORG CHEM, V43, P8218, DOI 10.1021/ic048502r	54	184	195	0	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					305	U64		10.1038/nature07841	http://dx.doi.org/10.1038/nature07841			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19295603	Green Accepted			2022-12-28	WOS:000264285600034
J	Yu, JY; Hu, KJ; Smuga-Otto, K; Tian, SL; Stewart, R; Slukvin, II; Thomson, JA				Yu, Junying; Hu, Kejin; Smuga-Otto, Kim; Tian, Shulan; Stewart, Ron; Slukvin, Igor I.; Thomson, James A.			Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences	SCIENCE			English	Article							EPSTEIN-BARR-VIRUS; STABLE REPLICATION; INDUCTION; FIBROBLASTS; GENERATION; PLASMIDS; REPLICON	Reprogramming differentiated human cells to induced pluripotent stem (iPS) cells has applications in basic biology, drug development, and transplantation. Human iPS cell derivation previously required vectors that integrate into the genome, which can create mutations and limit the utility of the cells in both research and clinical applications. We describe the derivation of human iPS cells with the use of nonintegrating episomal vectors. After removal of the episome, iPS cells completely free of vector and transgene sequences are derived that are similar to human embryonic stem (ES) cells in proliferative and developmental potential. These results demonstrate that reprogramming human somatic cells does not require genomic integration or the continued presence of exogenous reprogramming factors and removes one obstacle to the clinical application of human iPS cells.	[Yu, Junying; Smuga-Otto, Kim; Tian, Shulan; Stewart, Ron; Thomson, James A.] Morgridge Inst Res, Madison, WI 53707 USA; [Yu, Junying; Smuga-Otto, Kim; Tian, Shulan; Stewart, Ron; Thomson, James A.] Genome Ctr Wisconsin, Madison, WI 53706 USA; [Yu, Junying; Hu, Kejin; Smuga-Otto, Kim; Slukvin, Igor I.; Thomson, James A.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Slukvin, Igor I.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Thomson, James A.] Univ Wisconsin, Dept Anat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Yu, JY (corresponding author), Morgridge Inst Res, Madison, WI 53707 USA.	jyyu2008@gmail.com; thomson@primate.wisc.edu	wang, baocheng/B-7805-2008; Hu, Kejin/AAQ-8862-2021	wang, baocheng/0000-0002-8236-8014; Hu, Kejin/0000-0003-3111-4054	Charlotte Geyer Foundation; NIH [P51 RR000167, P01 GM081629]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081629] Funding Source: NIH RePORTER	Charlotte Geyer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the Charlotte Geyer Foundation and NIH (grants P51 RR000167 and P01 GM081629). We thank A. Griep, P. Powers, B. Sugden, M. Probasco, A. Elwell, C. Glennon, V. Ruotti, and D. J. Faupel for assistance and advice. The authors declare competing financial interests: J.A.T. is a founder, stock owner, consultant, and board member of Cellular Dynamics International (CDI). He also serves as a scientific adviser to and has financial interests in Tactics II Stem Cell Ventures. I.I.S. is a founder, stock owner, and consultant for CDI. The authors are filing a patent based on the results reported in this paper. Combination 6 and 19 episomal vectors are deposited in Addgene (Cambridge, MA), and vector-free human iPS cell subclones are deposited in the WiCell International Stem Cell (WISC) Bank (Madison, WI). Microarray data are deposited in the Gene Expression Omnibus (GEO) database (accession number GSE15148 [NCBI GEO] ).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Leight ER, 2001, MOL CELL BIOL, V21, P4149, DOI 10.1128/MCB.21.13.4149-4161.2001; Liao J, 2008, CELL RES, V18, P600, DOI 10.1038/cr.2008.51; Nanbo A, 2007, EMBO J, V26, P4252, DOI 10.1038/sj.emboj.7601853; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	22	1612	1883	6	329	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					797	801		10.1126/science.1172482	http://dx.doi.org/10.1126/science.1172482			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19325077	Green Accepted			2022-12-28	WOS:000265832400050
J	Harmon, LJ; Matthews, B; Des Roches, S; Chase, JM; Shurin, JB; Schluter, D				Harmon, Luke J.; Matthews, Blake; Des Roches, Simone; Chase, Jonathan M.; Shurin, Jonathan B.; Schluter, Dolph			Evolutionary diversification in stickleback affects ecosystem functioning	NATURE			English	Article							DISSOLVED ORGANIC-MATTER; RAPID EVOLUTION; SYMPATRIC STICKLEBACKS; BIODIVERSITY; PREY; SPECIATION; PREDATORS; DIVERSITY; SELECTION; DYNAMICS	Explaining the ecological causes of evolutionary diversification is a major focus of biology, but surprisingly little has been said about the effects of evolutionary diversification on ecosystems(1-3). The number of species in an ecosystem and their traits are key predictors of many ecosystem-level processes, such as rates of productivity, biomass sequestration and decomposition(4,5). Here we demonstrate short-term ecosystem-level effects of adaptive radiation in the threespine stickleback (Gasterosteus aculeatus) over the past 10,000 years. These fish have undergone recent parallel diversification in several lakes in coastal British Columbia, resulting in the formation of two specialized species (benthic and limnetic) from a generalist ancestor(6). Using a mesocosm experiment, we demonstrate that this diversification has strong effects on ecosystems, affecting prey community structure, total primary production, and the nature of dissolved organic materials that regulate the spectral properties of light transmission in the system. However, these ecosystem effects do not simply increase in their relative strength with increasing specialization and species richness; instead, they reflect the complex and indirect consequences of ecosystem engineering by sticklebacks. It is well known that ecological factors influence adaptive radiation(7,8). We demonstrate that adaptive radiation, even over short timescales, can have profound effects on ecosystems.	[Harmon, Luke J.; Des Roches, Simone] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA; [Harmon, Luke J.; Matthews, Blake; Shurin, Jonathan B.; Schluter, Dolph] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Harmon, Luke J.; Matthews, Blake; Shurin, Jonathan B.; Schluter, Dolph] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Matthews, Blake] EAWAG, CH-6047 Kastanienbaum, Switzerland; [Chase, Jonathan M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Idaho; University of Idaho; University of British Columbia; University of British Columbia; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Washington University (WUSTL)	Harmon, LJ (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA.	lukeh@uidaho.edu	Harmon, Luke/A-8225-2012; B, A/AHB-5155-2022; Matthews, Blake/B-5608-2009; Des Roches, Simone/A-4814-2011	Matthews, Blake/0000-0001-9089-704X; Des Roches, Simone/0000-0002-5360-8197; Shurin, Jonathan/0000-0001-7870-1972; Harmon, Luke/0000-0002-4985-5750; Schluter, Dolph/0000-0003-1683-7836				Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Bell T, 2003, OECOLOGIA, V134, P578, DOI 10.1007/s00442-002-1135-x; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Erwin DH, 2008, TRENDS ECOL EVOL, V23, P304, DOI 10.1016/j.tree.2008.01.013; Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x; Ghan D, 1998, CAN J FISH AQUAT SCI, V55, P1350, DOI 10.1139/cjfas-55-6-1350; Goudard A, 2008, AM NAT, V171, P91, DOI 10.1086/523945; Grant P. R., 2008, WHY SPECIES MULTIPLY; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; Lennon JT, 2008, ECOL LETT, V11, P1178, DOI 10.1111/j.1461-0248.2008.01225.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; LOSOS JB, 2009, PORTRAIT ADAPTIVE RA; MAZUMDER A, 1990, SCIENCE, V247, P312, DOI 10.1126/science.247.4940.312; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38, DOI 10.4319/lo.2001.46.1.0038; MCPHAIL JD, 1993, CAN J ZOOL, V71, P515, DOI 10.1139/z93-072; Obernosterer I, 2004, LIMNOL OCEANOGR, V49, P117, DOI 10.4319/lo.2004.49.1.0117; Palkovacs EP, 2009, ECOLOGY, V90, P300, DOI 10.1890/08-1673.1; Pienitz R, 2000, NATURE, V404, P484, DOI 10.1038/35006616; Retamal L, 2007, ESTUAR COAST SHELF S, V72, P261, DOI 10.1016/j.ecss.2006.10.022; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Schmitz OJ, 2006, ECOLOGY, V87, P1432, DOI 10.1890/0012-9658(2006)87[1432:PHLEOE]2.0.CO;2; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Snyder WE, 2006, ECOL LETT, V9, P789, DOI 10.1111/j.1461-0248.2006.00922.x; Stibor H, 2004, ECOL LETT, V7, P321, DOI 10.1111/j.1461-0248.2004.00580.x; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; Williamson CE, 1999, LIMNOL OCEANOGR, V44, P795, DOI 10.4319/lo.1999.44.3_part_2.0795; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	30	264	266	4	209	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1167	1170		10.1038/nature07974	http://dx.doi.org/10.1038/nature07974			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19339968				2022-12-28	WOS:000265754600047
J	Basso, C; Corrado, D; Marcus, FI; Nava, A; Thiene, G				Basso, Cristina; Corrado, Domenico; Marcus, Frank I.; Nava, Andrea; Thiene, Gaetano			Arrhythmogenic right ventricular cardiomyopathy	LANCET			English	Review							TASK-FORCE CRITERIA; TERM-FOLLOW-UP; ENDOMYOCARDIAL BIOPSY; MAGNETIC-RESONANCE; SUDDEN-DEATH; PLAKOPHILIN-2 MUTATIONS; QUANTITATIVE ASSESSMENT; ANTIARRHYTHMIC-DRUGS; RISK STRATIFICATION; PLAKOGLOBIN CAUSES	Arrhythmogenic right ventricular cardiomyopathy is a rare inherited heart-muscle disease that is a cause of sudden death in young people and athletes. Causative mutations in genes encoding desmosomal proteins have been identified and the disease is nowadays regarded as a genetically determined myocardial dystrophy. The left ventricle is so frequently involved as to support the adoption of the broad term arrhythmogenic cardiomyopathy. Clinical diagnosis can be achieved by demonstrating function and structure changes of the right ventricle, electrocardiogram depolarisation and repolarisation abnormalities, ventricular arrhythmias, and fibrofatty replacement through endomyocardial biopsy. Although specific, the standardised diagnostic criteria lack sensitivity for early disease and their primary application remains in establishing the diagnosis in probands. However, the main clinical targets are early detection of concealed forms and risk stratification for preventive strategies, which include physical exercise restriction, antiarrhythmic drugs, and implantable cardioverter-defibrillator therapy. Cascade genetic screening of family members of gene-positive probands allows the identification of asymptomatic carriers who would require lifelong follow-up due to the age-related penetrance.	[Thiene, Gaetano] Univ Padua, Sch Med, Dept Med Diagnost Sci & Special Therapies, I-35121 Padua, Italy; [Marcus, Frank I.] Univ Arizona, Tucson, AZ USA	University of Padua; University of Arizona	Thiene, G (corresponding author), Univ Padua, Sch Med, Dept Med Diagnost Sci & Special Therapies, Via A Gabelli 61, I-35121 Padua, Italy.	gaetano.thiene@unipd.it	Nava, Andrea/GPX-9486-2022	basso, cristina/0000-0002-0195-9753; Elliott, Perry/0000-0003-3383-3984; CORRADO, DOMENICO/0000-0003-1487-0392	European Commission, Brussels, Belgium [QLG1-CT-2000-01091]; National Heart, Lung and Blood Institutes, Bethesda, Maryland [UO1-HL65594]; Registry for Cardio-cerebro-vascular Pathology, Veneto Region, Venice; Ministry of Health, MIUR and Telethon, Rome; CARIPARO Foundation, Padova, Italy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL065594] Funding Source: NIH RePORTER	European Commission, Brussels, Belgium(European CommissionEuropean Commission Joint Research Centre); National Heart, Lung and Blood Institutes, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Registry for Cardio-cerebro-vascular Pathology, Veneto Region, Venice; Ministry of Health, MIUR and Telethon, Rome(Ministry of Education, Universities and Research (MIUR)); CARIPARO Foundation, Padova, Italy(Fondazione Cariparo); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by Grant QLG1-CT-2000-01091 5th Framework Programme from the European Commission, Brussels, Belgium; Grant UO1-HL65594 from the National Heart, Lung and Blood Institutes, Bethesda, Maryland; Registry for Cardio-cerebro-vascular Pathology, Veneto Region, Venice; Ministry of Health, MIUR and Telethon, Rome; and CARIPARO Foundation, Padova, Italy.	Angelini A, 1996, AM HEART J, V132, P203, DOI 10.1016/S0002-8703(96)90416-0; Antoniades L, 2006, EUR HEART J, V27, P2208, DOI 10.1093/eurheartj/ehl184; Asimaki A, 2007, AM J HUM GENET, V81, P964, DOI 10.1086/521633; Avella A, 2008, J CARDIOVASC ELECTR, V19, P1127, DOI 10.1111/j.1540-8167.2008.01228.x; Basso C, 2005, CARDIOVASC PATHOL, V14, P37, DOI 10.1016/j.carpath.2004.12.001; Basso C, 2004, EUR HEART J, V25, P531, DOI 10.1016/j.ehj.2003.12.025; Basso C, 2004, CIRCULATION, V109, P1180, DOI 10.1161/01.CIR.0000118494.07530.65; Basso C, 1996, CIRCULATION, V94, P983, DOI 10.1161/01.CIR.94.5.983; Basso C, 2008, EUR HEART J, V29, P2760, DOI 10.1093/eurheartj/ehn415; Basso C, 2006, EUR HEART J, V27, P1847, DOI 10.1093/eurheartj/ehl095; Bauce B, 2005, EUR HEART J, V26, P1666, DOI 10.1093/eurheartj/ehi341; BAUCE B, 2008, BRIT J SPORT MED, DOI DOI 10.1136/BJSM.2007042853; Bauce B, 2008, AM J CARDIOL, V102, P1252, DOI 10.1016/j.amjcard.2008.06.054; Bauce B, 2006, EUR J OBSTET GYN R B, V127, P186, DOI 10.1016/j.ejogrb.2005.10.011; Beffagna G, 2005, CARDIOVASC RES, V65, P366, DOI 10.1016/j.cardiores.2004.10.005; Beffagna G, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-65; Biffi A, 2002, J AM COLL CARDIOL, V40, P446, DOI 10.1016/S0735-1097(02)01977-0; Bluemke DA, 2003, CARDIOLOGY, V99, P153, DOI 10.1159/000070672; Bomma C, 2007, AM J CARDIOL, V100, P99, DOI 10.1016/j.amjcard.2007.02.064; Bowles NE, 2002, J AM COLL CARDIOL, V39, P892, DOI 10.1016/S0735-1097(02)01688-1; Calabrese F, 2006, CARDIOVASC PATHOL, V15, P11, DOI 10.1016/j.carpath.2005.10.004; Chimenti C, 2004, J AM COLL CARDIOL, V43, P2305, DOI 10.1016/j.jacc.2003.12.056; Corrado D, 2006, CIRCULATION, V113, P1634, DOI 10.1161/CIRCULATIONAHA.105.616490; Corrado D, 2005, CIRCULATION, V111, P3042, DOI 10.1161/CIRCULATIONAHA.104.486977; Corrado D, 2003, CIRCULATION, V108, P3084, DOI 10.1161/01.CIR.0000103130.33451.D2; Corrado D, 2003, J AM COLL CARDIOL, V42, P1959, DOI 10.1016/j.jacc.2003.03.002; Corrado D, 2000, HEART, V83, P588, DOI 10.1136/heart.83.5.588; Corrado D, 1997, J AM COLL CARDIOL, V30, P1512, DOI 10.1016/S0735-1097(97)00332-X; Corrado D, 2008, J AM COLL CARDIOL, V51, P731, DOI 10.1016/j.jacc.2007.11.027; Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593; Cox MGPJ, 2008, J CARDIOVASC ELECTR, V19, P775, DOI 10.1111/j.1540-8167.2008.01140.x; d'Amati G, 2000, ARCH PATHOL LAB MED, V124, P287; Dalal D, 2007, J AM COLL CARDIOL, V50, P432, DOI 10.1016/j.jacc.2007.03.049; Dalal D, 2006, J AM COLL CARDIOL, V48, P1416, DOI 10.1016/j.jacc.2006.06.045; DALIENTO L, 1990, AM J CARDIOL, V66, P741, DOI 10.1016/0002-9149(90)91141-R; DALIENTO L, 1995, J AM COLL CARDIOL, V25, P655, DOI 10.1016/0735-1097(94)00433-Q; DALLAVO.S, 1961, AM HEART J, V61, P25, DOI 10.1016/0002-8703(61)90513-0; Ector J, 2007, EUR HEART J, V28, P345, DOI 10.1093/eurheartj/ehl468; Ferreira Alexandre Cesar, 2003, Heart Dis, V5, P393, DOI 10.1097/01.hdx.0000089782.50317.54; Fidler LM, 2009, J CELL MOL MED, V13, P4219, DOI 10.1111/j.1582-4934.2008.00438.x; Fontaine G, 1999, ANNU REV MED, V50, P17, DOI 10.1146/annurev.med.50.1.17; FONTAINE G, 1984, ARCH MAL COEUR VAISS, V77, P872; FONTAINE G, 1995, CURR OPIN CARDIOL, V10, P16, DOI 10.1097/00001573-199501000-00004; Fox PR, 2000, CIRCULATION, V102, P1863; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; GERLIS LM, 1993, BRIT HEART J, V69, P142; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Hamid MS, 2002, J AM COLL CARDIOL, V40, P1445, DOI 10.1016/S0735-1097(02)02307-0; Henriksen E, 1998, CLIN PHYSIOL, V18, P498; Hulot JS, 2004, CIRCULATION, V110, P1879, DOI 10.1161/01.CIR.0000143375.93288.82; Indik JH, 2008, J CARDIOVASC ELECTR, V19, P39, DOI 10.1111/j.1540-8167.2007.00974.x; Kaplan SR, 2004, HEART RHYTHM, V1, P3, DOI 10.1016/j.hrthm.2004.01.001; Kaplan SR, 2004, CARDIOVASC PATHOL, V13, P26, DOI 10.1016/S1054-8807(03)00107-8; Keith D, 1999, HUM MOL GENET, V8, P143, DOI 10.1093/hmg/8.1.143; Kirchhof P, 2006, CIRCULATION, V114, P1799, DOI 10.1161/CIRCULATIONAHA.106.624502; LANCISI GM, 1736, DUAS PARTES DIVISUM; Mallat Z, 1996, NEW ENGL J MED, V335, P1190, DOI 10.1056/NEJM199610173351604; Marcus F, 2003, CIRCULATION, V107, P2975, DOI 10.1161/01.CIR.0000071380.43086.29; MARCUS FI, 1982, CIRCULATION, V65, P384, DOI 10.1161/01.CIR.65.2.384; MARCUS FI, 2007, ARRHYTHMOGENIC RIGHT; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Merner ND, 2008, AM J HUM GENET, V82, P809, DOI 10.1016/j.ajhg.2008.01.010; Nasir K, 2004, CIRCULATION, V110, P1527, DOI 10.1161/01.CIR.0000142293.60725.18; Nava A, 2000, EUR HEART J, V21, P58, DOI 10.1053/euhj.1999.1733; Nava A, 2000, J AM COLL CARDIOL, V36, P2226, DOI 10.1016/S0735-1097(00)00997-9; NAVA A, 1988, J ELECTROCARDIOL, V21, P239, DOI 10.1016/0022-0736(88)90098-2; NAVA A, 1988, J AM COLL CARDIOL, V12, P1222, DOI 10.1016/0735-1097(88)92603-4; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Norman M, 2005, CIRCULATION, V112, P636, DOI 10.1161/CIRCULATIONAHA.104.532234; Ott P, 2003, PACE, V26, P1498, DOI 10.1046/j.1460-9592.2003.t01-1-00217.x; Pelliccia A, 2008, NEW ENGL J MED, V358, P152, DOI 10.1056/NEJMoa060781; Peters S, 2004, INT J CARDIOL, V97, P499, DOI 10.1016/j.ijcard.2003.10.037; Pilichou K, 2006, CIRCULATION, V113, P1171, DOI 10.1161/CIRCULATIONAHA.105.583674; Protonotarios N, 2004, CARDIOVASC PATHOL, V13, P185, DOI 10.1016/j.carpath.2004.03.609; PROTONOTARIOS N, 1986, BRIT HEART J, V56, P321; Rampazzo A, 2002, AM J HUM GENET, V71, P1200, DOI 10.1086/344208; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Saffitz JE, 2005, ANN NY ACAD SCI, V1047, P336, DOI 10.1196/annals.1341.030; Sen-Chowdhry S, 2004, AM J MED, V117, P685, DOI 10.1016/j.amjmed.2004.04.028; Sen-Chowdhry S, 2007, J AM COLL CARDIOL, V50, P1813, DOI 10.1016/j.jacc.2007.08.008; Sen-Chowdhry S, 2007, CIRCULATION, V115, P1710, DOI 10.1161/CIRCULATIONAHA.106.660241; Sen-Chowdhry S, 2006, J AM COLL CARDIOL, V48, P2132, DOI 10.1016/j.jacc.2006.07.045; Syrris P, 2006, CIRCULATION, V113, P356, DOI 10.1161/CIRCULATIONAHA.105.561654; Syrris P, 2006, AM J HUM GENET, V79, P978, DOI 10.1086/509122; Tandri H, 2005, J AM COLL CARDIOL, V45, P98, DOI 10.1016/j.jacc.2004.09.053; Tandri H, 2008, J CARDIOVASC ELECTR, V19, P1212, DOI 10.1111/j.1540-8167.2008.01207.x; Tandri H, 2008, AM HEART J, V155, P147, DOI 10.1016/j.ahj.2007.08.011; Tandri H, 2007, ARRHYTHMOGENIC RV CARDIOMYOPATHY/ DYSPLASIA: RECENT ADVANCES, P135, DOI 10.1007/978-88-470-0490-0_16; Thiene, 1998, Adv Clin Path, V2, P65; THIENE G, 1991, EUR HEART J, V12, P22, DOI 10.1093/eurheartj/12.suppl_D.22; Thiene G, 2004, EUR HEART J, V25, P1772, DOI 10.1016/j.ehj.2004.07.026; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; Thiene G, 2001, CARDIOVASC PATHOL, V10, P109, DOI 10.1016/S1054-8807(01)00067-9; Thiene G, 2007, CARDIOL CLIN, V25, P415, DOI 10.1016/j.ccl.2007.08.009; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; Turrini P, 2001, CIRCULATION, V103, P3075, DOI 10.1161/01.CIR.103.25.3075; UHL HSM, 1952, B JOHNS HOPKINS HOSP, V91, P197; Valente M, 1998, AM J PATHOL, V152, P479; van Tintelen JP, 2006, CIRCULATION, V113, P1650, DOI 10.1161/CIRCULATIONAHA.105.609719; Wichter T, 2005, HERZ, V30, P91, DOI 10.1007/s00059-005-2677-6; Wichter T, 2004, CIRCULATION, V109, P1503, DOI 10.1161/01.CIR.0000121738.88273.43; WICHTER T, 1992, CIRCULATION, V86, P29, DOI 10.1161/01.CIR.86.1.29; Wichter T, 2007, ARRHYTHMOGENIC RV CARDIOMYOPATHY/ DYSPLASIA: RECENT ADVANCES, P147, DOI 10.1007/978-88-470-0490-0_17; Wlodarska EK, 2006, EUROPACE, V8, P596, DOI 10.1093/europace/eul053; Yang Z, 2006, CIRC RES, V99, P646, DOI 10.1161/01.RES.0000241482.19382.c6; Yoerger DM, 2005, J AM COLL CARDIOL, V45, P860, DOI 10.1016/j.jacc.2004.10.070; Yoerger-Sanborn D, 2007, ARRHYTHMOGENIC RV CARDIOMYOPATHY/ DYSPLASIA: RECENT ADVANCES, P129, DOI 10.1007/978-88-470-0490-0_15; Zareba W, 2007, ARRHYTHMOGENIC RV CARDIOMYOPATHY/ DYSPLASIA: RECENT ADVANCES, P121, DOI 10.1007/978-88-470-0490-0_14; [No title captured]	110	533	552	1	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2009	373	9671					1289	1300		10.1016/S0140-6736(09)60256-7	http://dx.doi.org/10.1016/S0140-6736(09)60256-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432PN	19362677				2022-12-28	WOS:000265146300032
J	Wallace, GG; Moulton, SE; Clark, GM				Wallace, G. G.; Moulton, S. E.; Clark, G. M.			Electrode-Cellular Interface	SCIENCE			English	Editorial Material							NEURAL STIMULATION; CONDUCTING POLYMER; POLYPYRROLE; BIOCOMPATIBILITY; OSTEOBLASTS; COMPOSITE; RELEASE; CELLS		[Wallace, G. G.; Moulton, S. E.; Clark, G. M.] Univ Wollongong, Australian Res Council Ctr Excellence Electromat, Intelligent Polymer Res Inst, Wollongong, NSW 2522, Australia	University of Wollongong	Wallace, GG (corresponding author), Univ Wollongong, Australian Res Council Ctr Excellence Electromat, Intelligent Polymer Res Inst, Wollongong, NSW 2522, Australia.	gwallace@uow.edu.au	Wallace, Gordon G/H-1123-2011; Moulton, Simon E/G-1031-2011; Moulton, Simon/AAS-1452-2021	Wallace, Gordon G/0000-0002-0381-7273; Moulton, Simon E/0000-0002-8320-3852; Moulton, Simon/0000-0002-8320-3852				Boockvar JA, 2000, J NEUROSURG, V93, P140, DOI 10.3171/jns.2000.93.1.0140; Campbell TE, 1999, ELECTROANAL, V11, P215, DOI 10.1002/(SICI)1521-4109(199904)11:4<215::AID-ELAN215>3.0.CO;2-#; Chen H, 2008, ADV MATER, V20, P3557, DOI 10.1002/adma.200800757; Clark GM, 2006, PHILOS T R SOC B, V361, P791, DOI 10.1098/rstb.2005.1782; Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518; Czarnecki JS, 2008, TISSUE ENG PT A, V14, P255, DOI 10.1089/tea.2007.0169; Dhillon GS, 2004, J HAND SURG-AM, V29A, P605, DOI 10.1016/j.jhsa.2004.02.006; Gerard M, 2002, BIOSENS BIOELECTRON, V17, P345, DOI 10.1016/S0956-5663(01)00312-8; Hodgson A. J., 1994, SUPRAMOL SCI, V1, P77; Kam NWS, 2009, NANO LETT, V9, P273, DOI 10.1021/nl802859a; LIN Y, 1994, J CONTROL RELEASE, V30, P137, DOI 10.1016/0168-3659(94)90260-7; Newbold C, 2004, J NEURAL ENG, V1, P218, DOI 10.1088/1741-2560/1/4/005; Richardson-Burns SM, 2007, BIOMATERIALS, V28, P1539, DOI 10.1016/j.biomaterials.2006.11.026; Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948; Supronowicz PR, 2002, J BIOMED MATER RES, V59, P499, DOI 10.1002/jbm.10015; Thompson BC, 2006, J CONTROL RELEASE, V116, P285, DOI 10.1016/j.jconrel.2006.09.004; Wang K, 2006, NANO LETT, V6, P2043, DOI 10.1021/nl061241t; Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065; Widge AS, 2007, BIOSENS BIOELECTRON, V22, P1723, DOI 10.1016/j.bios.2006.08.011; Wong YT, 2007, IEEE T NEUR SYS REH, V15, P425, DOI 10.1109/TNSRE.2007.903958	20	85	87	2	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					185	186		10.1126/science.1168346	http://dx.doi.org/10.1126/science.1168346			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359568	Green Submitted			2022-12-28	WOS:000265024400024
J	Campbell, EG				Campbell, Eric G.			The Future of Research Funding in Academic Medicine.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Campbell, Eric G.] Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02114 USA; [Campbell, Eric G.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Campbell, EG (corresponding author), Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02114 USA.							*AC RES DEV, 2008, SCI ENG IND 2008, P1; *ASS MED COLL, MED SCH PROF SYST MS; Ehringhaus SH, 2008, JAMA-J AM MED ASSOC, V299, P665, DOI 10.1001/jama.299.6.665; SPECTOR M, 2008, WALL STREET J   1125	4	29	30	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 9	2009	360	15					1482	1483		10.1056/NEJMp0900132	http://dx.doi.org/10.1056/NEJMp0900132			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430GL	19357403				2022-12-28	WOS:000264976800003
J	Gilestro, GF; Tononi, G; Cirelli, C				Gilestro, Giorgio F.; Tononi, Giulio; Cirelli, Chiara			Widespread Changes in Synaptic Markers as a Function of Sleep and Wakefulness in Drosophila	SCIENCE			English	Article							TUMOR-SUPPRESSOR GENE; DEPENDENT PLASTICITY; PROTEIN; POTENTIATION; WAKING; NEED; DLG	Sleep is universal, strictly regulated, and necessary for cognition. Why this is so remains a mystery, although recent work suggests that sleep, memory, and plasticity are linked. However, little is known about how wakefulness and sleep affect synapses. Using Western blots and confocal microscopy in Drosophila, we found that protein levels of key components of central synapses were high after waking and low after sleep. These changes were related to behavioral state rather than time of day and occurred in all major areas of the Drosophila brain. The decrease of synaptic markers during sleep was progressive, and sleep was necessary for their decline. Thus, sleep may be involved in maintaining synaptic homeostasis altered by waking activities.	[Gilestro, Giorgio F.; Tononi, Giulio; Cirelli, Chiara] Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison	Tononi, G (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA.	gtononi@wisc.edu; ccirelli@wisc.edu	Tononi, Giulio/B-8387-2009; Gilestro, Giorgio/A-8721-2010	Gilestro, Giorgio/0000-0001-7512-8541	National Institute of General Medical Sciences [R01 GM075315]; NIH Director's Pioneer award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075315] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000579] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH Director's Pioneer award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Authors' contributions: G.F.G. performed the experiments; G.F.G., G.T., and C.C. designed the experiments; G.T. and C.C. conceived and coordinated the project. All authors wrote the manuscript and read and approved the final version. We thank D. Paasch, D. Denucci, and M. Uy for technical assistance with fly work; M. Pfister-Genskow for help with Western blot analysis; L. Rodenkirch and the UW Keck Laboratory for Biological Imaging for assistance in confocal microscopy; and D. Bushey for discussion and comments on the manuscript. Supported by National Institute of General Medical Sciences grant R01 GM075315 (C.C.) and an NIH Director's Pioneer award (G.T.).	Albornoz V, 2008, GENE EXPR PATTERNS, V8, P443, DOI 10.1016/j.gep.2008.04.001; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Chen KY, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-1; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fernandez MP, 2008, PLOS BIOL, V6, P518, DOI 10.1371/journal.pbio.0060069; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gorska-Andrzejak J, 2005, PHOTOCH PHOTOBIO SCI, V4, P721, DOI 10.1039/b417023g; Guan Z, 2005, NEURON, V48, P91, DOI 10.1016/j.neuron.2005.08.036; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Kazama H, 2007, NEUROSCIENCE, V145, P1007, DOI 10.1016/j.neuroscience.2006.12.066; Klagges BRE, 1996, J NEUROSCI, V16, P3154; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; Mehnert KI, 2007, DEV NEUROBIOL, V67, P415, DOI 10.1002/dneu.20332; Pyza E, 1999, J NEUROBIOL, V40, P77, DOI 10.1002/(SICI)1097-4695(199907)40:1<77::AID-NEU7>3.0.CO;2-0; Sachse S, 2007, NEURON, V56, P838, DOI 10.1016/j.neuron.2007.10.035; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	28	232	235	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					109	112		10.1126/science.1166673	http://dx.doi.org/10.1126/science.1166673			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342593	Green Accepted			2022-12-28	WOS:000264802100044
J	Herzberg, C; Gazel, E				Herzberg, Claude; Gazel, Esteban			Petrological evidence for secular cooling in mantle plumes	NATURE			English	Article							FLOOD BASALTS; TECTONIC EVOLUTION; THERMAL STRUCTURE; MELT GENERATION; GREENLAND; VOLCANISM; PICRITES	Geological mapping and geochronological studies have shown much lower eruption rates for ocean island basalts (OIBs) in comparison with those of lavas from large igneous provinces (LIPs) such as oceanic plateaux and continental flood provinces(1). However, a quantitative petrological comparison has never been made between mantle source temperature and the extent of melting for OIB and LIP sources. Here we show that the MgO and FeO contents of Galapagos related lavas and their primary magmas have decreased since the Cretaceous period. From petrological modelling(2), we infer that these changes reflect a cooling of the Galapagos mantle plume from a potential temperature of 1,560-1,620 degrees C in the Cretaceous to 1,500 degrees C at present. Iceland also exhibits secular cooling, in agreement with previous studies(3,4). Our work provides quantitative petrological evidence that, in general, mantle plumes for LIPs with Palaeocene-Permian ages were hotter and melted more extensively than plumes of more modern ocean islands. We interpret this to reflect episodic flow from lower-mantle domains that are lithologically and geochemically heterogeneous.	[Herzberg, Claude; Gazel, Esteban] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Herzberg, C (corresponding author), Rutgers State Univ, Dept Earth & Planetary Sci, 610 Taylor Rd, Piscataway, NJ 08854 USA.	herzberg@rci.rutgers.edu	Gazel, Esteban/B-8090-2012					ANDERSON DL, 1982, NATURE, V297, P391, DOI 10.1038/297391a0; Armitage JJ, 2008, EARTH PLANET SC LETT, V269, P248, DOI 10.1016/j.epsl.2008.02.024; Burke K, 2008, EARTH PLANET SC LETT, V265, P49, DOI 10.1016/j.epsl.2007.09.042; Coltice N, 2007, GEOLOGY, V35, P391, DOI 10.1130/G23240A.1; Courtier AM, 2007, EARTH PLANET SC LETT, V264, P308, DOI 10.1016/j.epsl.2007.10.003; Dasgupta R, 2007, J PETROL, V48, P2093, DOI 10.1093/petrology/egm053; DUNCAN RA, 1984, BOULDER COLORADO GEO, V162, P81; Farnetani CG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022360; Forte AM, 2001, NATURE, V410, P1049, DOI 10.1038/35074000; Garnero EJ, 2008, SCIENCE, V320, P626, DOI 10.1126/science.1148028; Herzberg C, 2002, J PETROL, V43, P1857, DOI 10.1093/petrology/43.10.1857; Herzberg C, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001390; Herzberg C, 2004, J PETROL, V45, P2507, DOI 10.1093/petrology/egh039; Herzberg C, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002057; Herzberg C, 2006, NATURE, V444, P605, DOI 10.1038/nature05254; Hirano N, 2006, SCIENCE, V313, P1426, DOI 10.1126/science.1128235; Hoernle K, 2004, GEOLOGY, V32, P697, DOI 10.1130/G20574.1; HOLM PM, 1993, EARTH PLANET SC LETT, V115, P227, DOI 10.1016/0012-821X(93)90224-W; Kerr AC, 1996, LITHOS, V37, P245, DOI 10.1016/0024-4937(95)00039-9; Kerr AC, 2005, GEOLOGY, V33, P269, DOI 10.1130/G21109.1; KUMAGAI I, 2008, GEOPHYS RES LETT, V35, DOI DOI 10.1029/2005GL035079; KUSHIRO I, 1996, GEOPHYS MONOGR SER, V95, P109, DOI DOI 10.1029/GM095P0109; LANGMUIR CH, 1992, GEOPH MONOG SERIES, V71, P183; Lin SC, 2005, NATURE, V436, P250, DOI 10.1038/nature03697; McKenzie D, 2005, EARTH PLANET SC LETT, V233, P337, DOI 10.1016/j.epsl.2005.02.005; MCKENZIE D, 1988, J PETROL, V29, P625, DOI 10.1093/petrology/29.3.625; Putirka KD, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000915; RICHARDS MA, 1989, SCIENCE, V246, P103, DOI 10.1126/science.246.4926.103; Saunders A.D., 1997, GEOPH MONOG SERIES, V100, P45, DOI [10.1029/GM100p0045, 10.1029/GM100P0045]; Slater L, 2001, J PETROL, V42, P321, DOI 10.1093/petrology/42.2.321; Sleep NH, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002090; Sobolev AV, 2005, NATURE, V434, P590, DOI 10.1038/nature03411; STOREY M, 1991, GEOLOGY, V19, P376, DOI 10.1130/0091-7613(1991)019<0376:AOPSOK>2.3.CO;2; Storey M, 2007, CHEM GEOL, V241, P264, DOI 10.1016/j.chemgeo.2007.01.016; Trampert J, 2004, SCIENCE, V306, P853, DOI 10.1126/science.1101996	35	202	208	3	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					619	U83		10.1038/nature07857	http://dx.doi.org/10.1038/nature07857			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19340079				2022-12-28	WOS:000264796200038
J	Chetty, M; Alluri, R; Currie, GP				Chetty, Mahendran; Alluri, Ratna; Currie, Graeme P.			Case report A breathless man with diffuse chest pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PLEURAL EFFUSIONS		[Chetty, Mahendran; Alluri, Ratna; Currie, Graeme P.] Aberdeen Royal Infirm, Chest Clin C, Aberdeen AB25 2ZN, Scotland	University of Aberdeen	Currie, GP (corresponding author), Aberdeen Royal Infirm, Chest Clin C, Aberdeen AB25 2ZN, Scotland.	graeme.currie@nhs.net		Currie, Graeme P/0000-0002-5711-9147				[Anonymous], 2003, THORAX, V58, pii8, DOI DOI 10.1136/THX.58.SUPPL_2.II8; Antony VB, 2001, EUR RESPIR J, V18, P402, DOI 10.1183/09031936.01.00225601; ANTUNES G, 2003, THORAX S2, V58, P29, DOI DOI 10.1136/THORAX.58.SUPPL_2.II29; DIBONITO L, 1992, ACTA CYTOL, V36, P329; LIGHT RW, 1972, ANN INTERN MED, V77, P507, DOI 10.7326/0003-4819-77-4-507; Maskell NA, 2003, LANCET, V361, P1326, DOI 10.1016/S0140-6736(03)13079-6; PANADERO FR, 2003, TXB PLEURAL DIS, P297; 2007, THORAX S2, V62, P926	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2009	338								b1105	10.1136/bmj.b1105	http://dx.doi.org/10.1136/bmj.b1105			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429AM	19359303				2022-12-28	WOS:000264893200002
J	King, G; Gakidou, E; Imai, K; Lakin, J; Moore, RT; Nall, C; Ravishankar, N; Vargas, M; Tellez-Rojo, MM; Avila, JEH; Avila, MH; Llamas, HH				King, Gary; Gakidou, Emmanuela; Imai, Kosuke; Lakin, Jason; Moore, Ryan T.; Nall, Clayton; Ravishankar, Nirmala; Vargas, Manett; Maria Tellez-Rojo, Martha; Hernandez Avila, Juan Eugenio; Hernandez Avila, Mauricio; Hernandez Llamas, Hector			Public policy for the poor? A randomised assessment of the Mexican universal health insurance programme	LANCET			English	Article							DESIGN	Background We assessed aspects of Seguro Popular, a programme aimed to deliver health insurance, regular and preventive medical care, medicines, and health facilities to 50 million uninsured Mexicans. Methods We randomly assigned treatment within 74 matched pairs of health clusters-ie, health facility catchment areas-representing 118 569 households in seven Mexican states, and measured outcomes in a 2005 baseline survey (August, 2005, to September, 2005) and follow-up survey 10 months later (July, 2006, to August, 2006) in 50 pairs (n=32515). The treatment consisted of encouragement to enrol in a health-insurance programme and upgraded medical facilities. Participant states also received funds to improve health facilities and to provide medications for services in treated clusters. We estimated intention to treat and complier average causal effects non-parametrically. Findings Intention-to-treat estimates indicated a 23% reduction from baseline in catastrophic expenditures (1.9% points; 95% CI 0.14-3.66). The effect in poor households was 3.0% points (0.46-5.54) and in experimental compliers was 6.5% points (1.65-11.28), 30% and 59% reductions, respectively. The intention-to-treat effect on health spending in poor households was 426 pesos (39-812), and the complier average causal effect was 915 pesos (147-1684). Contrary to expectations and previous observational research, we found no effects on medication spending, health outcomes, or utilisation. Interpretation Programme resources reached the poor. However, the programme did not show some other effects, possibly due to the short duration of treatment (10 months). Although Seguro Popular seems to be successful at this early stage, further experiments and follow-up studies, with longer assessment periods, are needed to ascertain the long-term effects of the programme.	[King, Gary; Lakin, Jason; Nall, Clayton] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA; [Gakidou, Emmanuela; Ravishankar, Nirmala] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Imai, Kosuke] Princeton Univ, Dept Polit, Princeton, NJ 08544 USA; [Vargas, Manett; Hernandez Avila, Juan Eugenio] Secretaria Salud Mexico, Mexico City, DF, Mexico; [Maria Tellez-Rojo, Martha; Hernandez Avila, Juan Eugenio; Hernandez Avila, Mauricio] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Hernandez Llamas, Hector] Conestadistica, Mexico City, DF, Mexico; [Moore, Ryan T.] Washington Univ, St Louis, MO USA	Harvard University; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Princeton University; Instituto Nacional de Salud Publica; Washington University (WUSTL)	King, G (corresponding author), Harvard Univ, Inst Quantitat Social Sci, 1737 Cambridge St, Cambridge, MA 02138 USA.	king@harvard.edu	Imai, Kosuke/B-7462-2008	Imai, Kosuke/0000-0002-2748-1022; Hernandez-Avila, Juan Eugenio/0000-0001-9638-6718	Mexican Ministry of Health; National Institute of Public Health of Mexico; Harvard University Institute for Quantitative Social Scienc	Mexican Ministry of Health; National Institute of Public Health of Mexico; Harvard University Institute for Quantitative Social Scienc	Funding Mexican Ministry of Health, the National Institute of Public Health of Mexico, and Harvard University Institute for Quantitative Social Science.	Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; *CTR EST FIN PUBL, 2006, CUM DUP GAST SECT SA; Frenk J, 2003, LANCET, V362, P1667, DOI 10.1016/S0140-6736(03)14803-9; Frenk J., 2005, SISTEMA PROTECCION S; Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; Gonzalez-Pier E, 2006, LANCET, V368, P1608, DOI 10.1016/S0140-6736(06)69567-6; GWATKIN DR, 2005, REACHING POOR; HONAKER J, WHAT DO MISSING VALU; Hussey MA, 2007, CONTEMP CLIN TRIALS, V28, P182, DOI 10.1016/j.cct.2006.05.007; IMAI K, 2009, STAT SCI IN PRESS; Imai K, 2008, J R STAT SOC A STAT, V171, P481, DOI 10.1111/j.1467-985X.2007.00527.x; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; KING G, REPLICATION DATA PUB; King G, 2007, J POLICY ANAL MANAG, V26, P479, DOI 10.1002/pam.20279; Kish L, 1965, SURVEY SAMPLING; KNAUL FM, 2005, HEALTH AFFAIR, V24, P1828; *MASS MED SOC, 2008, PHY WORKF STUD FULL; *MEX MIN HLTH, SEG POP BEN; MOORE RT, 2008, POLITICAL ANAL STAT; NIGENDA G, 2003, CALEIDOSCOPIO SALUD, P263; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER	22	186	191	0	40	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2009	373	9673					1447	1454		10.1016/S0140-6736(09)60239-7	http://dx.doi.org/10.1016/S0140-6736(09)60239-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437QL	19359034	Green Submitted			2022-12-28	WOS:000265501900033
J	Royston, P; Moons, KGM; Altman, DG; Vergouwe, Y				Royston, Patrick; Moons, Karel G. M.; Altman, Douglas G.; Vergouwe, Yvonne			Prognosis and prognostic research: Developing a prognostic model	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOGISTIC-REGRESSION; RISK-FACTORS; EPIDEMIOLOGY; PREDICTORS; AREA		[Royston, Patrick] MRC Clin Trials Unit, London NW1 2DA, England; [Moons, Karel G. M.; Vergouwe, Yvonne] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX2 6UD, England	Medical Research Council Clinical Trials Unit; Utrecht University; Utrecht University Medical Center; University of Oxford	Royston, P (corresponding author), MRC Clin Trials Unit, London NW1 2DA, England.	pr@ctu.mrc.ac.uk			UK Medical Research Council [U1228.06.001.00002.01]; Netherlands Organization for Scientific Research [ZON-MW 917.46.360]; Cancer Research UK; Medical Research Council [MC_EX_G0800814] Funding Source: researchfish; MRC [MC_EX_G0800814] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	PR is supported by the UK Medical Research Council (U1228.06.001.00002.01). KGMM and YV are supported by the Netherlands Organization for Scientific Research (ZON-MW 917.46.360). DGA is supported by Cancer Research UK.	Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; BLETTNER M, 1993, STAT MED, V12, P1325, DOI 10.1002/sim.4780121205; Boucher KM, 1998, J CLIN EPIDEMIOL, V51, P1223, DOI 10.1016/S0895-4356(98)00129-2; DeMaris A, 2002, SOCIOL METHOD RES, V31, P27, DOI 10.1177/0049124102031001002; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hernandez AV, 2003, CHEST, V124, P2034, DOI 10.1378/chest.124.5.2034; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Katz MH, 2003, ANN INTERN MED, V138, P644, DOI 10.7326/0003-4819-138-8-200304150-00012; Little R.J.A., 2002, STAT ANAL MISSING DA; MANTEL N, 1970, TECHNOMETRICS, V12, P621, DOI 10.2307/1267207; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Ritchie A, 1999, LANCET, V353, P14; Rosenberg PS, 2003, STAT MED, V22, P3369, DOI 10.1002/sim.1638; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Royston P, 2005, METHOD INFORM MED, V44, P561; Royston P., 2008, MULTIVARIABLE MODEL; Sauerbrei W, 1999, J ROY STAT SOC C-APP, V48, P313, DOI 10.1111/1467-9876.00155; Sauerbrei W, 1999, J R STAT SOC A STAT, V162, P71, DOI 10.1111/1467-985X.00122; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; van den Bosch JE, 2005, ANAESTHESIA, V60, P323, DOI 10.1111/j.1365-2044.2005.04121.x	29	698	709	2	58	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2009	338								b604	10.1136/bmj.b604	http://dx.doi.org/10.1136/bmj.b604			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429AL	19336487				2022-12-28	WOS:000264893100019
J	Chen, M; Briscoe, WH; Armes, SP; Klein, J				Chen, Meng; Briscoe, Wuge H.; Armes, Steven P.; Klein, Jacob			Lubrication at Physiological Pressures by Polyzwitterionic Brushes	SCIENCE			English	Article							BOUNDARY LUBRICATION; FRICTIONAL FORCES; POLYMER; SURFACE; LAYERS; HYDRATION; QUALITY; CHAINS	The very low sliding friction at natural synovial joints, which have friction coefficients of mu < 0.002 at pressures up to 5 megapascals or more, has to date not been attained in any human-made joints or between model surfaces in aqueous environments. We found that surfaces in water bearing polyzwitterionic brushes that were polymerized directly from the surface can have m values as low as 0.0004 at pressures as high as 7.5 megapascals. This extreme lubrication is attributed primarily to the strong hydration of the phosphorylcholine-like monomers that make up the robustly attached brushes, and may have relevance to a wide range of human-made aqueous lubrication situations.	[Chen, Meng; Briscoe, Wuge H.; Klein, Jacob] Univ Oxford, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England; [Armes, Steven P.] Univ Sheffield, Dept Chem, Sheffield S3 7HF, S Yorkshire, England; [Klein, Jacob] Weizmann Inst Sci, IL-76100 Rehovot, Israel	University of Oxford; University of Sheffield; Weizmann Institute of Science	Klein, J (corresponding author), Univ Oxford, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England.	jacob.klein@weizmann.ac.il	Briscoe, Wuge H/H-5435-2018	Briscoe, Wuge H/0000-0001-8025-960X; Chen, Meng/0000-0001-6553-0799; Armes, Steven/0000-0002-8289-6351	Engineering and Physical Sciences Research Council; Petroleum Research Fund [45694-AC7]; Charles McCutchen Foundation; Minerva Foundation at the Weizmann Institute; Engineering and Physical Sciences Research Council [EP/C535421/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Petroleum Research Fund(American Chemical Society); Charles McCutchen Foundation; Minerva Foundation at the Weizmann Institute; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank A. L. Lewis (Biocompatibles Ltd.) for kind donation of the MPC monomer; X. Y. Chen for synthesis of the macroinitiator; I. E. Dunlop, S. Perkin, and W. Feng for help and advice; and P. Pincus for a discussion. S.P.A. is the recipient of a Royal Society Research Merit Award. W.H.B. thanks the Taiho Kogyo Tribology Research Foundation for support. This work was supported by the Engineering and Physical Sciences Research Council, the Petroleum Research Fund (grant 45694-AC7), the Charles McCutchen Foundation, and the Minerva Foundation at the Weizmann Institute.	Briscoe WH, 2006, NATURE, V444, P191, DOI 10.1038/nature05196; CHAN DYC, 1980, J COLLOID INTERF SCI, V77, P283, DOI 10.1016/0021-9797(80)90445-2; Chen M, 2007, CHEMPHYSCHEM, V8, P1303, DOI 10.1002/cphc.200700131; COTTON FA, 1998, ADV INORG CHEM, P1288; Feng W, 2007, BIOINTERPHASES, V2, P34, DOI 10.1116/1.2711705; Forster AM, 2006, J POLYM SCI POL PHYS, V44, P649, DOI 10.1002/polb.20701; Gong JP, 2001, J AM CHEM SOC, V123, P5582, DOI 10.1021/ja003794q; Gourdon D, 2008, LANGMUIR, V24, P1534, DOI 10.1021/la702259c; Hills BA, 2002, J RHEUMATOL, V29, P200; Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.3.CO;2-0; Klein J, 2006, P I MECH ENG J-J ENG, V220, P691, DOI 10.1243/13506501JET143; KLEIN J, 1994, NATURE, V370, P634, DOI 10.1038/370634a0; Kobayashi M, 2007, SOFT MATTER, V3, P740, DOI 10.1039/b615780g; Lee S, 2008, SCIENCE, V319, P575, DOI 10.1126/science.1153273; LIS LJ, 1982, BIOPHYS J, V37, P657; MCCUTCHEN CW, 1966, FED PROC, V25, P1061; Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233; Pabst G, 2000, PHYS REV E, V62, P4000, DOI 10.1103/PhysRevE.62.4000; Park S, 2004, J BIOMECH, V37, P1679, DOI 10.1016/j.jbiomech.2004.02.017; Rappolt M, 2001, COLLOID SURFACE A, V183, P171, DOI 10.1016/S0927-7757(01)00568-4; Raviv U, 2003, NATURE, V425, P163, DOI 10.1038/nature01970; Raviv U, 2002, SCIENCE, V297, P1540, DOI 10.1126/science.1074481; Schorr PA, 2003, MACROMOLECULES, V36, P389, DOI 10.1021/ma011207v; SWANN DA, 1984, ARTHRITIS RHEUM, V27, P552, DOI 10.1002/art.1780270511; Tadmor R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.115503; WITTEN TA, 1990, MACROMOLECULES, V23, P824, DOI 10.1021/ma00205a022; Yaseen M, 2006, LANGMUIR, V22, P5825, DOI 10.1021/la053316z; [No title captured]	28	511	539	22	467	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1698	1701		10.1126/science.1169399	http://dx.doi.org/10.1126/science.1169399			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325108	Green Accepted			2022-12-28	WOS:000264559800031
J	Girit, CO; Meyer, JC; Erni, R; Rossell, MD; Kisielowski, C; Yang, L; Park, CH; Crommie, MF; Cohen, ML; Louie, SG; Zettl, A				Girit, Caglar Oe; Meyer, Jannik C.; Erni, Rolf; Rossell, Marta D.; Kisielowski, C.; Yang, Li; Park, Cheol-Hwan; Crommie, M. F.; Cohen, Marvin L.; Louie, Steven G.; Zettl, A.			Graphene at the Edge: Stability and Dynamics	SCIENCE			English	Article							ATOMIC-STRUCTURE; DIRAC FERMIONS; CARBON; DAMAGE	Although the physics of materials at surfaces and edges has been extensively studied, the movement of individual atoms at an isolated edge has not been directly observed in real time. With a transmission electron aberration-corrected microscope capable of simultaneous atomic spatial resolution and 1-second temporal resolution, we produced movies of the dynamics of carbon atoms at the edge of a hole in a suspended, single atomic layer of graphene. The rearrangement of bonds and beam-induced ejection of carbon atoms are recorded as the hole grows. We investigated the mechanism of edge reconstruction and demonstrated the stability of the "zigzag" edge configuration. This study of an ideal low-dimensional interface, a hole in graphene, exhibits the complex behavior of atoms at a boundary.	[Girit, Caglar Oe; Meyer, Jannik C.; Yang, Li; Park, Cheol-Hwan; Crommie, M. F.; Cohen, Marvin L.; Louie, Steven G.; Zettl, A.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Girit, Caglar Oe; Meyer, Jannik C.; Yang, Li; Park, Cheol-Hwan; Crommie, M. F.; Cohen, Marvin L.; Louie, Steven G.; Zettl, A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Erni, Rolf; Rossell, Marta D.; Kisielowski, C.] Univ Calif Berkeley, Lawrence Berkeley Lab, Natl Ctr Electron Microscopy, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zettl, A (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	azettl@berkeley.edu	Girit, Çağlar/AFT-1507-2022; Meyer, Jannik C/H-8541-2012; Park, Cheol-Hwan/A-1543-2009; Yang, Li/ABE-6270-2020; Zettl, Alex K/O-4925-2016; Erni, Rolf/P-7435-2014; Girit, Çağlar/D-4845-2014; Rossell, Marta D/E-9785-2017	Girit, Çağlar/0000-0001-8953-9261; Meyer, Jannik C/0000-0003-4023-0778; Park, Cheol-Hwan/0000-0003-1584-6896; Yang, Li/0000-0002-8611-6359; Zettl, Alex K/0000-0001-6330-136X; Erni, Rolf/0000-0003-2391-5943; Girit, Çağlar/0000-0001-8953-9261; Rossell, Marta D/0000-0001-8610-8853	Department of Energy [DE-AC02-05CH11231]; Department of Energy, Office of Science, Office of Basic Energy Sciences; Office of Energy Research, Office of Basic Energy Sciences, Materials Sciences, and Engineering Division, of the U.S. Department of Energy [DE-AC02-05CH11231]; National Science Foundation; Office of Science, Office of Basic Energy Science, Division of Material Sciences and Engineering, U.S. Department of Energy	Department of Energy(United States Department of Energy (DOE)); Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Office of Energy Research, Office of Basic Energy Sciences, Materials Sciences, and Engineering Division, of the U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Office of Science, Office of Basic Energy Science, Division of Material Sciences and Engineering, U.S. Department of Energy(United States Department of Energy (DOE))	The National Center for Electron Microscopy is supported by the Department of Energy under contract DE-AC02-05CH11231. The TEAM project is supported by the Department of Energy, Office of Science, Office of Basic Energy Sciences. C.G., J.M., and A.Z. were supported by the Director, Office of Energy Research, Office of Basic Energy Sciences, Materials Sciences, and Engineering Division, of the U.S. Department of Energy under contract DE-AC02-05CH11231, through the sp2-bonded nanostructures program. L.Y., C.-H.P., M.L.C., and S.G.L. were supported by the National Science Foundation and by the Director, Office of Science, Office of Basic Energy Science, Division of Material Sciences and Engineering, U.S. Department of Energy. C.G. thanks P. Vollhardt, V. W. Brar, and Y. Zhang for interesting discussions.	Brar VW, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2771084; Bunch JS, 2007, SCIENCE, V315, P490, DOI 10.1126/science.1136836; Campos-Delgado J, 2008, NANO LETT, V8, P2773, DOI 10.1021/nl801316d; Crespi VH, 1996, PHYS REV B, V54, P5927, DOI 10.1103/PhysRevB.54.5927; Egerton RF, 2006, MICROSC MICROANAL, V12, P65, DOI 10.1017/S1431927606060065; Gass MH, 2008, NAT NANOTECHNOL, V3, P676, DOI 10.1038/nnano.2008.280; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Ishigami M, 2007, NANO LETT, V7, P1643, DOI 10.1021/nl070613a; Kisielowski C, 2008, MICROSC MICROANAL, V14, P469, DOI 10.1017/S1431927608080902; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Martin AV, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.172102; Meyer JC, 2008, NANO LETT, V8, P3582, DOI 10.1021/nl801386m; Meyer JC, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2901147; Meyer JC, 2008, NATURE, V454, P319, DOI 10.1038/nature07094; Meyer JC, 2007, NATURE, V446, P60, DOI 10.1038/nature05545; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Ohta T, 2006, SCIENCE, V313, P951, DOI 10.1126/science.1130681; Rutter GM, 2007, SCIENCE, V317, P219, DOI 10.1126/science.1142882; Smith BW, 2001, J APPL PHYS, V90, P3509, DOI 10.1063/1.1383020; Son YW, 2006, NATURE, V444, P347, DOI 10.1038/nature05180; Tapaszto L, 2008, NAT NANOTECHNOL, V3, P397, DOI 10.1038/nnano.2008.149; Urban KW, 2008, SCIENCE, V321, P506, DOI 10.1126/science.1152800; VOTER AF, 2006, P NATO ADV STUD I RA, P1; YANG L, 2007, NATURE, V99; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zhang YB, 2008, NAT PHYS, V4, P627, DOI 10.1038/nphys1022; Zhou SY, 2006, NAT PHYS, V2, P595, DOI 10.1038/nphys393	29	998	1015	8	638	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1705	1708		10.1126/science.1166999	http://dx.doi.org/10.1126/science.1166999			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325110				2022-12-28	WOS:000264559800033
J	Ming, GL; Song, HJ				Ming, Guo-li; Song, Hongjun			DISC1 Partners with GSK3 beta in Neurogenesis	CELL			English	Editorial Material							SCHIZOPHRENIA; NEURONS	The protein DISC1, encoded by a gene implicated in schizophrenia susceptibility, regulates the development of postmitotic neurons. Mao et al. (2009) now report that DISC1 also regulates the proliferation of embryonic and adult neural progenitor cells through the GSK3 beta/beta-catenin pathway, providing new insights into how susceptibility genes may contribute to the etiology of psychiatric disorders.	[Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Inst Cell Engn, Sch Med, Baltimore, MD 21205 USA; [Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Dept Neurol, Sch Med, Baltimore, MD 21205 USA; [Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Ming, GL (corresponding author), Johns Hopkins Univ, Inst Cell Engn, Sch Med, Baltimore, MD 21205 USA.	gming1@jhmi.edu; shongju1@jhmi.edu	Ming, Guo-li/J-7880-2013	Ming, Guo-li/0000-0002-2517-6075	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048271, P01NS097206] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS097206, R01 NS048271] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beaulieu JM, 2009, ANNU REV PHARMACOL, V49, P327, DOI 10.1146/annurev.pharmtox.011008.145634; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Faulkner RL, 2008, P NATL ACAD SCI USA, V105, P14157, DOI 10.1073/pnas.0806658105; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Marenco S, 2000, DEV PSYCHOPATHOL, V12, P501, DOI 10.1017/S0954579400003138; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	9	46	49	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					990	992		10.1016/j.cell.2009.03.005	http://dx.doi.org/10.1016/j.cell.2009.03.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303839	Green Accepted, Bronze			2022-12-28	WOS:000264403900002
J	Takabayashi, Y; Ganin, AY; Jeglic, P; Arcon, D; Takano, T; Iwasa, Y; Ohishi, Y; Takata, M; Takeshita, N; Prassides, K; Rosseinsky, MJ				Takabayashi, Yasuhiro; Ganin, Alexey Y.; Jeglic, Peter; Arcon, Denis; Takano, Takumi; Iwasa, Yoshihiro; Ohishi, Yasuo; Takata, Masaki; Takeshita, Nao; Prassides, Kosmas; Rosseinsky, Matthew J.			The Disorder-Free Non-BCS Superconductor Cs3C60 Emerges from an Antiferromagnetic Insulator Parent State	SCIENCE			English	Article							FULLERIDES; C-60; (CH3NH2)K3C60; ORDER	The body-centered cubic A15-structured cesium fulleride Cs3C60 is not superconducting at ambient pressure and is free from disorder, unlike the well-studied face-centered cubic A(3)C(60) alkali metal fulleride superconductors. We found that in Cs3C60, where the molecular valences are precisely assigned, the superconducting state at 38 kelvin emerges directly from a localized electron antiferromagnetic insulating state with the application of pressure. This transition maintains the threefold degeneracy of the active orbitals in both competing electronic states; it is thus a purely electronic transition to a superconducting state, with a dependence of the transition temperature on pressure-induced changes of anion packing density that is not explicable by Bardeen-Cooper-Schrieffer (BCS) theory.	[Takabayashi, Yasuhiro; Prassides, Kosmas] Univ Durham, Dept Chem, Durham DH1 3LE, England; [Ganin, Alexey Y.; Rosseinsky, Matthew J.] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England; [Jeglic, Peter; Arcon, Denis] Jozef Stefan Inst, Ljubljana 1000, Slovenia; [Arcon, Denis] Univ Ljubljana, Fac Math & Phys, Ljubljana 1000, Slovenia; [Takano, Takumi; Iwasa, Yoshihiro] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Takata, Masaki] RIKEN, SPring Ctr 8, Mikazuki, Hyogo 6795148, Japan; [Takeshita, Nao] Natl Inst Adv Ind Sci & Technol, Nanoelect Res Inst, Tsukuba, Ibaraki 3058562, Japan	Durham University; University of Liverpool; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; Tohoku University; RIKEN; National Institute of Advanced Industrial Science & Technology (AIST)	Prassides, K (corresponding author), Univ Durham, Dept Chem, South Rd, Durham DH1 3LE, England.	k.prassides@durham.ac.uk; m.j.rosseinsky@liverpool.ac.uk	Iwasa, Yoshihiro/C-1719-2009; Prassides, Kosmas/GVU-9219-2022; Jeglic, Peter/AAB-7347-2022; Prassides, Kosmas/C-9804-2009; nao, Takeshita/A-2948-2013; Takabayashi, Yasuhiro/A-5014-2013; Takata, Masaki/M-1525-2014	Prassides, Kosmas/0000-0003-4524-3084; nao, Takeshita/0000-0001-5081-2777; Takabayashi, Yasuhiro/0000-0002-3493-2194; Jeglic, Peter/0000-0001-8163-9065; Ganin, Alexey/0000-0002-3754-5819	UK Engineering and Physical Sciences Research Council [EP/C511794, GR/S77820]; Engineering and Physical Sciences Research Council [EP/C511794/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the UK Engineering and Physical Sciences Research Council for funding under EP/C511794 and GR/S77820 and for access to the synchrotron x-ray facilities at the European Synchrotron Radiation Facility (where we thank A. N. Fitch for assistance on beamline ID31) and to the muon facilities at ISIS (where we thank S. R. Giblin for assistance on the MuSR instrument). We also thank SPring-8 for access to the synchrotron x-ray facilities	Ashcroft N.W., 1976, SOLID STATE PHYS; Capone M, 2002, SCIENCE, V296, P2364, DOI 10.1126/science.1071122; CAPONE M, 2008, REV MOD PHY IN PRESS; Chibotaru LF, 2007, J MOL STRUCT, V838, P53, DOI 10.1016/j.molstruc.2006.12.064; Comanac A, 2008, NAT PHYS, V4, P287, DOI 10.1038/nphys883; Curely J, 2005, MONATSH CHEM, V136, P987, DOI 10.1007/s00706-005-0305-z; Dahlke P, 2000, J AM CHEM SOC, V122, P12352, DOI 10.1021/ja002861d; Darling GR, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.136404; Ganin AY, 2008, NAT MATER, V7, P367, DOI 10.1038/nmat2179; Ganin AY, 2006, J AM CHEM SOC, V128, P14784, DOI 10.1021/ja066295j; Gunnarsson O, 2005, STRUCT BOND, V114, P71, DOI 10.1007/b101017; Gunnarsson O, 1997, REV MOD PHYS, V69, P575, DOI 10.1103/RevModPhys.69.575; Gunnarsson O, 1996, PHYS REV B, V54, P11026, DOI 10.1103/PhysRevB.54.R11026; Iwasa Y, 2003, J PHYS-CONDENS MAT, V15, pR495, DOI 10.1088/0953-8984/15/13/202; IWASA Y, 1995, PHYS REV B, V51, P3678, DOI 10.1103/PhysRevB.51.3678; Kambe T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.177205; Kawamoto T, 1997, SOLID STATE COMMUN, V101, P231, DOI 10.1016/S0038-1098(96)00584-4; Margadonna S, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.132414; Nam MS, 2007, NATURE, V449, P584, DOI 10.1038/nature06182; PALSTRA TTM, 1995, SOLID STATE COMMUN, V93, P323; Pennington CH, 1996, REV MOD PHYS, V68, P855, DOI 10.1103/RevModPhys.68.855; Prassides K, 1999, J AM CHEM SOC, V121, P11227, DOI 10.1021/ja992931k; Saito S, 2004, SOLID STATE COMMUN, V130, P335, DOI 10.1016/j.ssc.2004.02.011; Sato N, 1998, PHYS REV B, V58, P12433, DOI 10.1103/PhysRevB.58.12433; SCHLICTER CP, 1990, PRINCIPLES MAGNETIC; Takabayashi Y, 2007, CHEM COMMUN, P870, DOI 10.1039/b614596e; TANIGAKI K, 1991, NATURE, V352, P222, DOI 10.1038/352222a0	27	176	176	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 20	2009	323	5921					1585	1590		10.1126/science.1169163	http://dx.doi.org/10.1126/science.1169163			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299615				2022-12-28	WOS:000264342300033
J	Hill, MN; Gorzalka, BB				Hill, Matthew N.; Gorzalka, Boris B.			Impairments in Endocannabinoid Signaling and Depressive Illness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							STRESS-INDUCED ACTIVATION; PITUITARY-ADRENAL AXIS; ANANDAMIDE HYDROLYSIS; HIPPOCAMPUS; MODULATION; BLOCKADE; SYSTEM; BRAIN		[Hill, Matthew N.] Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10021 USA; [Gorzalka, Boris B.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	Rockefeller University; University of British Columbia	Hill, MN (corresponding author), Rockefeller Univ, Neuroendocrinol Lab, 1230 York Ave, New York, NY 10021 USA.	mhill@rockefeller.edu	Hill, Matthew N/J-4610-2013					Aso E, 2008, J NEUROCHEM, V105, P565, DOI 10.1111/j.1471-4159.2007.05149.x; Gobbi G, 2005, P NATL ACAD SCI USA, V102, P18620, DOI 10.1073/pnas.0509591102; Hill MN, 2008, PHARMACOPSYCHIATRY, V41, P48, DOI 10.1055/s-2007-993211; Hill MN, 2007, J NEUROCHEM, V103, P47, DOI 10.1111/j.1471-4159.2007.04688.x; Hill MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2591, DOI 10.1038/sj.npp.1301092; Hill MN, 2005, BEHAV PHARMACOL, V16, P333, DOI 10.1097/00008877-200509000-00006; Hill MN, 2005, NEUROPSYCHOPHARMACOL, V30, P508, DOI 10.1038/sj.npp.1300601; Justinova Z, 2008, BIOL PSYCHIAT, V64, P930, DOI 10.1016/j.biopsych.2008.08.008; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Patel S, 2004, ENDOCRINOLOGY, V145, P5431, DOI 10.1210/en.2004-0638; Pertwee RG, 2008, ADDICT BIOL, V13, P147, DOI 10.1111/j.1369-1600.2008.00108.x; who, DEPR; *ZIM AC REP, PFIZ KILLS DIET DRUG	13	53	53	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 18	2009	301	11					1165	1166		10.1001/jama.2009.369	http://dx.doi.org/10.1001/jama.2009.369			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419UC	19293417				2022-12-28	WOS:000264244200022
J	Taylor, HR				Taylor, Hugh R.			Elimination of blinding trachoma revolves around children	LANCET			English	Editorial Material							COMMUNITY		Univ Melbourne, Melbourne Sch Populat Hlth, Carlton, Vic 3053, Australia	University of Melbourne	Taylor, HR (corresponding author), Univ Melbourne, Melbourne Sch Populat Hlth, Carlton, Vic 3053, Australia.	h.taylor@unimelb.edu.au		Taylor, Hugh/0000-0002-9437-784X				[Anonymous], 2006, CHLAMYDIAL INFECT; Cumberland P, 2008, INT J EPIDEMIOL, V37, P549, DOI 10.1093/ije/dyn045; Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22; GRAYSTON JT, 1963, INVEST OPHTH VISUAL, V2, P460; House JI, 2009, LANCET, V373, P1111, DOI 10.1016/S0140-6736(09)60323-8; JONES BR, 1975, T OPHTHAL SOC UK, V95, P16; Melese M, 2008, JAMA-J AM MED ASSOC, V299, P778, DOI 10.1001/jama.299.7.778; Ngondi J, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000229; Schemann JF, 2007, ACTA TROP, V101, P40, DOI 10.1016/j.actatropica.2006.12.003; Stephens R. S., 2002, CHLAMYDIAL INFECT; Taylor H. R., 2008, TRACHOMA BLINDING SC; TAYLOR HR, 1990, INFECT IMMUN, V58, P3061, DOI 10.1128/IAI.58.9.3061-3063.1990; West ES, 2005, INVEST OPHTH VIS SCI, V46, P83, DOI 10.1167/iovs.04-0327	13	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2009	373	9669					1061	1063		10.1016/S0140-6736(09)60630-9	http://dx.doi.org/10.1016/S0140-6736(09)60630-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	427IS	19328988				2022-12-28	WOS:000264773600008
J	Gross, O; Poeck, H; Bscheider, M; Dostert, C; Hannesschlager, N; Endres, S; Hartmann, G; Tardivel, A; Schweighoffer, E; Tybulewicz, V; Mocsai, A; Tschopp, J; Ruland, J				Gross, Olaf; Poeck, Hendrik; Bscheider, Michael; Dostert, Catherine; Hannesschlaeger, Nicole; Endres, Stefan; Hartmann, Gunther; Tardivel, Aubry; Schweighoffer, Edina; Tybulewicz, Victor; Mocsai, Attila; Tschopp, Juerg; Ruland, Juergen			Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence	NATURE			English	Article							NALP3 INFLAMMASOME; RHEUMATOID-ARTHRITIS; TYROSINE KINASE; ACTIVATION; RECEPTOR; IL-1-BETA; INHIBITOR; DEFICIENT; CRYSTALS; IMMUNITY	Fungal infections represent a serious threat, particularly in immunocompromised patients(1). Interleukin-1 beta (IL-1 beta) is a key pro-inflammatory factor in innate antifungal immunity(2). The mechanism by which the mammalian immune system regulates IL-1 beta production after fungal recognition is unclear. Two signals are generally required for IL-1 beta production: an NF-kappa B-dependent signal that induces the synthesis of pro-IL-1 beta (p35), and a second signal that triggers proteolytic pro-IL-1 beta processing to produce bioactive IL-1 beta (p17) via Caspase-1-containing multiprotein complexes called inflammasomes(3). Here we demonstrate that the tyrosine kinase Syk, operating downstream of several immunoreceptor tyrosine-based activation motif (ITAM)-coupled fungal pattern recognition receptors, controls both pro-IL-1 beta synthesis and inflammasome activation after cell stimulation with Candida albicans. Whereas Syk signalling for pro-IL-1 beta synthesis selectively uses the Card9 pathway, inflammasome activation by the fungus involves reactive oxygen species production and potassium efflux. Genetic deletion or pharmalogical inhibition of Syk selectively abrogated inflammasome activation by C. albicans but not by inflammasome activators such as Salmonella typhimurium or the bacterial toxin nigericin. Nlrp3 (also known as NALP3) was identified as the critical NOD-like receptor family member that transduces the fungal recognition signal to the inflammasome adaptor Asc (Pycard) for Caspase-1 (Casp1) activation and pro-IL-1 beta processing. Consistent with an essential role for Nlrp3 inflammasomes in antifungal immunity, we show that Nlrp3-deficient mice are hypersusceptible to Candida albicans infection. Thus, our results demonstrate the molecular basis for IL-1 beta production after fungal infection and identify a crucial function for the Nlrp3 inflammasome in mammalian host defence in vivo.	[Gross, Olaf; Poeck, Hendrik; Hannesschlaeger, Nicole; Ruland, Juergen] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, D-81675 Munich, Germany; [Gross, Olaf; Dostert, Catherine; Tardivel, Aubry; Tschopp, Juerg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Bscheider, Michael; Endres, Stefan] Univ Munich, Dept Internal Med, Div Clin Pharmacol, D-80539 Munich, Germany; [Hartmann, Gunther] Univ Klinikum Bonn, Inst Clin Chem & Pharmacol, D-53127 Bonn, Germany; [Schweighoffer, Edina; Tybulewicz, Victor] Natl Inst Med Res, London NW7 1AA, England; [Mocsai, Attila] Semmelweis Univ, Sch Med, Budapest, Hungary	Technical University of Munich; University of Lausanne; University of Munich; University of Bonn; MRC National Institute for Medical Research; Semmelweis University	Ruland, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, Ismaninger Str 22, D-81675 Munich, Germany.	jruland@lrz.tum.de	Gross, Olaf/E-4570-2010; Dostert, Catherine/AAJ-5473-2020; Ruland, Jürgen/Q-6680-2018; Mocsai, Attila/B-2792-2008; Hartmann, Gunther/P-7492-2017	Gross, Olaf/0000-0001-8660-3619; Ruland, Jürgen/0000-0002-8381-3597; Hartmann, Gunther/0000-0003-1021-2018; Tybulewicz, Victor/0000-0003-2439-0798; Mocsai, Attila/0000-0002-0512-1157	Marie Curie RTN ApopTrain Fellowship; Swiss National Science Foundation; Deutsche Krebshilfe; Sonderforschungsbereich; Deutsche Forschungsgemeinschaft; MRC [MC_U117527252] Funding Source: UKRI; Medical Research Council [MC_U117527252] Funding Source: researchfish	Marie Curie RTN ApopTrain Fellowship(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Krebshilfe(Deutsche Krebshilfe); Sonderforschungsbereich(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C. Peschel for helpful conversations, K. Schroder for critically reading the manuscript, RIGEL Inc. for providing the Syk inhibitor R406, P. Vandenabeele for the anti-Caspase-1 antibody and V. Dixit for Nlrc4 2/2 mice. O. G. is supported by a Marie Curie RTN ApopTrain Fellowship. This work was supported by Swiss National Science Foundation National Center of Competence in Research molecular oncology and Mugen grants to J. T., an EMBO long-term fellowship to C. D. and a Max-Eder-Program grant from Deutsche Krebshilfe and Sonderforschungsbereich grants from Deutsche Forschungsgemeinschaft to J. R.	Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; Bugarcic A, 2008, GLYCOBIOLOGY, V18, P679, DOI 10.1093/glycob/cwn046; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mencacci A, 2000, INFECT IMMUN, V68, P5126, DOI 10.1128/IAI.68.9.5126-5131.2000; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Pine PR, 2007, CLIN IMMUNOL, V124, P244, DOI 10.1016/j.clim.2007.03.543; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Vasiljeva O, 2008, ONCOGENE, V27, P4191, DOI 10.1038/onc.2008.59; Vonk AG, 2006, J INFECT DIS, V193, P1419, DOI 10.1086/503363; Weinblatt ME, 2008, ARTHRITIS RHEUM-US, V58, P3309, DOI 10.1002/art.23992; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007	29	663	695	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					433	U149		10.1038/nature07965	http://dx.doi.org/10.1038/nature07965			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19339971				2022-12-28	WOS:000266243700047
J	Adams, GB; Alley, IR; Chung, U; Chabner, KT; Jeanson, NT; Lo Celso, C; Marsters, ES; Chen, M; Weinstein, LS; Lin, CP; Kronenberg, HM; Scadden, DT				Adams, Gregor B.; Alley, Ian R.; Chung, Ung-il; Chabner, Karissa T.; Jeanson, Nathaniel T.; Lo Celso, Cristina; Marsters, Emily S.; Chen, Min; Weinstein, Lee S.; Lin, Charles P.; Kronenberg, Henry M.; Scadden, David T.			Haematopoietic stem cells depend on G alpha(s)-mediated signalling to engraft bone marrow	NATURE			English	Article							IN-VIVO; CHOLERA-TOXIN; MICE; DIFFERENTIATION; LYMPHOPOIESIS; MYELOPOIESIS; MIGRATION; SELECTINS; CXCR4	Haematopoietic stem and progenitor cells (HSPCs) change location during development(1) and circulate in mammals throughout life(2), moving into and out of the bloodstream to engage bone marrow niches in sequential steps of homing, engraftment and retention(3-5). Here we show that HSPC engraftment of bone marrow in fetal development is dependent on the guanine-nucleotide-binding protein stimulatory a subunit (G alpha(s)). HSPCs from adult mice deficient in G alpha(s) (G alpha(-/-)(s)) differentiate and undergo chemotaxis, but also do not home to or engraft in the bone marrow in adult mice and demonstrate a marked inability to engage the marrow microvasculature. If deleted after engraftment, G alpha(s) deficiency did not lead to lack of retention in the marrow, rather cytokine-induced mobilization into the blood was impaired. Testing whether activation of G alpha(s) affects HSPCs, pharmacological activators enhanced homing and engraftment in vivo. G alpha(s) governs specific aspects of HSPC localization under physiological conditions in vivo and may be pharmacologically targeted to improve transplantation efficiency.	[Adams, Gregor B.; Alley, Ian R.; Chabner, Karissa T.; Jeanson, Nathaniel T.; Lo Celso, Cristina; Marsters, Emily S.; Scadden, David T.] Harvard Univ, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; [Chung, Ung-il; Kronenberg, Henry M.] Harvard Univ, Sch Med, Endocrine Unit, Boston, MA 02114 USA; [Lin, Charles P.] Harvard Univ, Sch Med, Adv Microscopy Program, Ctr Syst Biol, Boston, MA 02114 USA; [Lin, Charles P.] Harvard Univ, Sch Med, Wellman Ctr Photomed, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Adams, Gregor B.; Lo Celso, Cristina; Scadden, David T.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Scadden, David T.] Harvard Univ, Sch Med, Dept Stem Cell & Regenerat Biol, Boston, MA 02114 USA; [Chen, Min; Weinstein, Lee S.] NIDDKD, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Scadden, DT (corresponding author), Harvard Univ, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA.	dscadden@mgh.harvard.edu	Weinstein, Lee S/I-5575-2015	Weinstein, Lee/0000-0002-1899-5152; Lo Celso, Cristina/0000-0002-1163-4207	Burroughs Wellcome Fund, Doris Duke Charitable Trust; Harvard Stem Cell Institute; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL081030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043313] Funding Source: NIH RePORTER	Burroughs Wellcome Fund, Doris Duke Charitable Trust(Burroughs Wellcome FundDoris Duke Charitable Foundation (DDCF)); Harvard Stem Cell Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Financial support for this work was provided by the Burroughs Wellcome Fund, Doris Duke Charitable Trust (D. T. S.), the Harvard Stem Cell Institute (C. P. L.) and the National Institutes of Health (G. B. A., C. P. L., H. M. K., D. T. S.).	Bastepe M, 2004, P NATL ACAD SCI USA, V101, P14794, DOI 10.1073/pnas.0405091101; Broxmeyer HE, 2007, ANN NY ACAD SCI, V1106, P1, DOI 10.1196/annals.1392.013; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; DEXTER TM, 1985, BLOOD, V65, P1544, DOI 10.1182/blood.V65.6.1544.bloodjournal6561544; Foudi A, 2006, BLOOD, V107, P2243, DOI 10.1182/blood-2005-02-0581; Kawabata T, 1999, P NATL ACAD SCI USA, V96, P5663, DOI 10.1073/pnas.96.10.5663; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; LONG MW, 1988, EXP HEMATOL, V16, P195; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Papayannopoulou T, 2001, BLOOD, V98, P2403, DOI 10.1182/blood.V98.8.2403; PLOEMACHER RE, 1991, BLOOD, V78, P2527; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	21	53	59	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 7	2009	459	7243					103	U111		10.1038/nature07859	http://dx.doi.org/10.1038/nature07859			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19322176	Green Accepted			2022-12-28	WOS:000265801300038
J	Vandenbroucke, JP				Vandenbroucke, Jan P.			The HRT controversy: observational studies and RCTs fall in line	LANCET			English	Editorial Material							POSTMENOPAUSAL HORMONE-THERAPY; INITIATIVE CLINICAL-TRIAL; BREAST-CANCER RISK; CARDIOVASCULAR-DISEASE; RANDOMIZED EXPERIMENTS; AUTHORS RESPONSE; WORLDS		Leiden Univ, Sch Med, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Vandenbroucke, JP (corresponding author), Leiden Univ, Sch Med, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands.	j.p.vandenbroucke@lumc.nl	Vandenbroucke, Jan/AAM-3928-2020	Vandenbroucke, Jan/0000-0001-5668-6716				Hernan MA, 2008, EPIDEMIOLOGY, V19, P766, DOI 10.1097/EDE.0b013e3181875e61; Hernan MA, 2008, EPIDEMIOLOGY, V19, P789, DOI 10.1097/EDE.0b013e318188e85f; Hoover RN, 2008, EPIDEMIOLOGY, V19, P780, DOI 10.1097/EDE.0b013e318188e21d; Prentice RL, 2006, AM J EPIDEMIOL, V163, P589, DOI 10.1093/aje/kwj079; Prentice RL, 2005, AM J EPIDEMIOL, V162, P404, DOI 10.1093/aje/kwi223; Prentice RL, 2008, EPIDEMIOLOGY, V19, P785, DOI 10.1097/EDE.0b013e318188e83b; Prentice RL, 2008, AM J EPIDEMIOL, V167, P1407, DOI 10.1093/aje/kwn090; Prentice RL, 2008, AM J EPIDEMIOL, V167, P1207, DOI 10.1093/aje/kwn044; Reeves GK, 2006, LANCET ONCOL, V7, P910, DOI 10.1016/S1470-2045(06)70911-1; Stampfer MJ, 2008, EPIDEMIOLOGY, V19, P783, DOI 10.1097/EDE.0b013e318188442e; Vandenbroucke JP, 2008, JAMA-J AM MED ASSOC, V300, P2417, DOI 10.1001/jama.2008.723; Vandenbroucke JP, 2004, LANCET, V363, P1728, DOI 10.1016/S0140-6736(04)16261-2; Wilcox A, 2008, EPIDEMIOLOGY, V19, P765, DOI 10.1097/EDE.0b013e318188e872; Willett WC, 2008, EPIDEMIOLOGY, V19, P793, DOI 10.1097/EDE.0b013e318188e84e	14	69	70	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 11	2009	373	9671					1233	1235		10.1016/S0140-6736(09)60708-X	http://dx.doi.org/10.1016/S0140-6736(09)60708-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	432PN	19362661				2022-12-28	WOS:000265146300009
J	Devlin, MJ; Ade, PAR; Aretxaga, I; Bock, JJ; Chapin, EL; Griffin, M; Gundersen, JO; Halpern, M; Hargrave, PC; Hughes, DH; Klein, J; Marsden, G; Martin, PG; Mauskopf, P; Moncelsi, L; Netterfield, CB; Ngo, H; Olmi, L; Pascale, E; Patanchon, G; Rex, M; Scott, D; Semisch, C; Thomas, N; Truch, MDP; Tucker, C; Tucker, GS; Viero, MP; Wiebe, DV				Devlin, Mark J.; Ade, Peter A. R.; Aretxaga, Itziar; Bock, James J.; Chapin, Edward L.; Griffin, Matthew; Gundersen, Joshua O.; Halpern, Mark; Hargrave, Peter C.; Hughes, David H.; Klein, Jeff; Marsden, Gaelen; Martin, Peter G.; Mauskopf, Philip; Moncelsi, Lorenzo; Netterfield, Calvin B.; Ngo, Henry; Olmi, Luca; Pascale, Enzo; Patanchon, Guillaume; Rex, Marie; Scott, Douglas; Semisch, Christopher; Thomas, Nicholas; Truch, Matthew D. P.; Tucker, Carole; Tucker, Gregory S.; Viero, Marco P.; Wiebe, Donald V.			Over half of the far-infrared background light comes from galaxies at z >= 1.2	NATURE			English	Article							DEGREE EXTRAGALACTIC SURVEY; DEEP SUBMILLIMETER SURVEY; FIELD-SOUTH SURVEY; NUMBER COUNTS; SOURCE CATALOGS; STAR-FORMATION; HIGH-REDSHIFT; LOCKMAN HOLE; SPITZER; CHANDRA	Submillimetre surveys during the past decade have discovered a population of luminous, high-redshift, dusty starburst galaxies(1-8). In the redshift range 1 <= z <= 4, these massive submillimetre galaxies go through a phase characterized by optically obscured star formation at rates several hundred times that in the local Universe. Half of the starlight from this highly energetic process is absorbed and thermally re-radiated by clouds of dust at temperatures near 30 K with spectral energy distributions peaking at 100 mu m in the rest frame(9). At 1 <= z <= 4, the peak is redshifted to wavelengths between 200 and 500 mu m. The cumulative effect of these galaxies is to yield extragalactic optical and far-infrared backgrounds with approximately equal energy densities. Since the initial detection of the far-infrared background (FIRB)(10), higher-resolution experiments have sought to decompose this integrated radiation into the contributions from individual galaxies. Here we report the results of an extragalactic survey at 250, 350 and 500 mu m. Combining our results at 500 mu m with those at 24 mu m, we determine that all of the FIRB comes from individual galaxies, with galaxies at z >= 1.2 accounting for 70% of it. As expected, at the longest wavelengths the signal is dominated by ultraluminous galaxies at z > 1.	[Devlin, Mark J.; Klein, Jeff; Rex, Marie; Semisch, Christopher; Truch, Matthew D. P.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Ade, Peter A. R.; Griffin, Matthew; Hargrave, Peter C.; Mauskopf, Philip; Moncelsi, Lorenzo; Pascale, Enzo; Tucker, Carole] Cardiff Univ, Sch Phys & Astron, Cardiff CF24 3AA, S Glam, Wales; [Aretxaga, Itziar; Hughes, David H.] Inst Nacl Astrofis Opt & Electr, Puebla, Mexico; [Bock, James J.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Chapin, Edward L.; Halpern, Mark; Marsden, Gaelen; Ngo, Henry; Scott, Douglas] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Gundersen, Joshua O.; Thomas, Nicholas] Univ Miami, Dept Phys, Coral Gables, FL 33146 USA; [Martin, Peter G.] Univ Toronto, Canadian Inst Theoret Astrophys, Toronto, ON M5S 3H8, Canada; [Martin, Peter G.; Netterfield, Calvin B.; Viero, Marco P.] Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Netterfield, Calvin B.; Wiebe, Donald V.] Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; [Olmi, Luca] Univ Puerto Rico, Dept Phys, Rio Piedras, PR 00931 USA; [Olmi, Luca] INAF Osservatorio Astrofis Arcetri, I-50125 Florence, Italy; [Patanchon, Guillaume] Univ Paris Diderot, Lab APC, F-75205 Paris, France; [Tucker, Gregory S.] Brown Univ, Dept Phys, Providence, RI 02912 USA	University of Pennsylvania; Cardiff University; Instituto Nacional de Astrofisica, Optica y Electronica; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of British Columbia; University of Miami; University of Toronto; University of Toronto; University of Toronto; University of Puerto Rico; University of Puerto Rico Rio Piedras; Istituto Nazionale Astrofisica (INAF); UDICE-French Research Universities; PSL Research University Paris; Universite Paris Cite; Observatoire de Paris; CEA; Centre National de la Recherche Scientifique (CNRS); Brown University	Devlin, MJ (corresponding author), Univ Penn, Dept Phys & Astron, 209 S 33rd St, Philadelphia, PA 19104 USA.	devlin@physics.upenn.edu	hargrave, peter/L-7900-2017; Klein, Jeffrey/E-3295-2013; Moncelsi, Lorenzo/AAU-1009-2020; Pascale, Enzo/A-3665-2012	hargrave, peter/0000-0002-3109-6629; Moncelsi, Lorenzo/0000-0002-4242-3015; Pascale, Enzo/0000-0002-3242-8154; Martin, Peter/0000-0002-5236-3896; Viero, Marco/0000-0003-0545-4872; Tucker, Carole/0000-0002-1851-3918; Aretxaga, Itziar/0000-0002-6590-3994; Ngo, Henry/0000-0001-5172-4859; Mauskopf, Philip/0000-0001-6397-5516; Olmi, Luca/0000-0002-1162-7947; Scott, Douglas/0000-0002-6878-9840; Ade, Peter/0000-0002-5127-0401	NASAUS National Science Foundation Office; Canadian Space Agency; Natural Sciences and Engineering Research Council of Canada; UK Science and Technology Facilities Council; STFC [ST/G002711/1] Funding Source: UKRI	NASAUS National Science Foundation Office(National Science Foundation (NSF)); Canadian Space Agency(Canadian Space Agency); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We acknowledge the support of NASA, the US National Science Foundation Office of Polar Programs, the Canadian Space Agency, the Natural Sciences and Engineering Research Council of Canada and the UK Science and Technology Facilities Council. We are grateful to B. Magnelli for help with the FIDEL 24-mu m data. This research was enabled by the WestGrid computing resources and the SIMBAD and NASA/IPAC databases. We thank the Columbia Scientific Balloon Facility, Ken Borek Air Ltd and the mountaineers of McMurdo Station for their work.	Abergel A, 1996, ASTRON ASTROPHYS, V308, pL5; Barger AJ, 1998, NATURE, V394, P248, DOI 10.1038/28338; Borys C, 2003, MON NOT R ASTRON SOC, V344, P385, DOI 10.1046/j.1365-8711.2003.06818.x; CONDON JJ, 1974, ASTROPHYS J, V188, P279, DOI 10.1086/152714; Coppin K, 2006, MON NOT R ASTRON SOC, V372, P1621, DOI 10.1111/j.1365-2966.2006.10961.x; Coppin K, 2008, MON NOT R ASTRON SOC, V384, P1597, DOI 10.1111/j.1365-2966.2007.12808.x; Dole H, 2006, ASTRON ASTROPHYS, V451, P417, DOI 10.1051/0004-6361:20054446; Dole H, 2004, ASTROPHYS J SUPPL S, V154, P87, DOI 10.1086/422472; Eales S, 2000, ASTRON J, V120, P2244, DOI 10.1086/316823; Eddington AS, 1939, MON NOT R ASTRON SOC, V100, P0353; Fixsen DJ, 1998, ASTROPHYS J, V508, P123, DOI 10.1086/306383; Giavalisco M, 2004, ASTROPHYS J, V600, pL93, DOI 10.1086/379232; Grazian A, 2006, ASTRON ASTROPHYS, V449, P951, DOI 10.1051/0004-6361:20053979; Greve TR, 2004, MON NOT R ASTRON SOC, V354, P779, DOI 10.1111/j.1365-2966.2004.08235.x; Griffin M, 2007, ADV SPACE RES, V40, P612, DOI 10.1016/j.asr.2007.03.032; Hickox RC, 2006, ASTROPHYS J, V645, P95, DOI 10.1086/504070; Hughes DH, 1998, NATURE, V394, P241, DOI 10.1038/28328; Knudsen KK, 2008, MON NOT R ASTRON SOC, V384, P1611, DOI 10.1111/j.1365-2966.2007.12820.x; Lagache G, 2004, ASTROPHYS J SUPPL S, V154, P112, DOI 10.1086/422392; Laurent GT, 2005, ASTROPHYS J, V623, P742, DOI 10.1086/428823; Lehmer BD, 2005, ASTROPHYS J SUPPL S, V161, P21, DOI 10.1086/444590; Lonsdale CJ, 2003, PUBL ASTRON SOC PAC, V115, P897, DOI 10.1086/376850; Luo B, 2008, ASTROPHYS J SUPPL S, V179, P19, DOI 10.1086/591248; Papovich C, 2004, ASTROPHYS J SUPPL S, V154, P70, DOI 10.1086/422880; Pascale E, 2008, ASTROPHYS J, V681, P400, DOI 10.1086/588541; Rowan-Robinson M, 2001, ASTROPHYS J, V549, P745, DOI 10.1086/319450; Smail I, 2002, MON NOT R ASTRON SOC, V331, P495, DOI 10.1046/j.1365-8711.2002.05203.x; SMAIL I, 1997, ASTROPHYS J, V491, pL5	28	146	146	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					737	739		10.1038/nature07918	http://dx.doi.org/10.1038/nature07918			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19360081	Green Submitted			2022-12-28	WOS:000265193600034
J	Despres, JP				Despres, Jean-Pierre			Bringing JUPITER down to earth	LANCET			English	Editorial Material							C-REACTIVE PROTEIN; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; ABDOMINAL OBESITY; RISK-FACTORS; WOMEN; EVENTS; MEN; ATHEROSCLEROSIS		Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Ste Foy, PQ G1V 4G5, Canada		Despres, JP (corresponding author), Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Ste Foy, PQ G1V 4G5, Canada.	Jean-Pierre.Despres@criucpq.ulaval.ca						Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Church TS, 2002, ARTERIOSCL THROM VAS, V22, P1869, DOI 10.1161/01.ATV.0000036611.77940.F8; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Hak AE, 1999, ARTERIOSCL THROM VAS, V19, P1986, DOI 10.1161/01.ATV.19.8.1986; Lemieux I, 2001, ARTERIOSCL THROM VAS, V21, P961, DOI 10.1161/01.ATV.21.6.961; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Sui XM, 2007, AM J EPIDEMIOL, V165, P1413, DOI 10.1093/aje/kwm031; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P2167, DOI 10.1161/01.ATV.17.10.2167	12	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 4	2009	373	9670					1147	1148		10.1016/S0140-6736(09)60448-7	http://dx.doi.org/10.1016/S0140-6736(09)60448-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429SO	19329179				2022-12-28	WOS:000264940600004
J	Donlea, JM; Ramanan, N; Shaw, PJ				Donlea, Jeffrey M.; Ramanan, Narendrakumar; Shaw, Paul J.			Use-Dependent Plasticity in Clock Neurons Regulates Sleep Need in Drosophila	SCIENCE			English	Article							PDF CELLS; GENE; DEPRIVATION; MEMORY; SRF; CONSOLIDATION; MELANOGASTER; MUTANTS; CIRCUIT; AROUSAL	Sleep is important for memory consolidation and is responsive to waking experience. Clock circuitry is uniquely positioned to coordinate interactions between processes underlying memory and sleep need. Flies increase sleep both after exposure to an enriched social environment and after protocols that induce long-term memory. We found that flies mutant for rutabaga, period, and blistered were deficient for experience-dependent increases in sleep. Rescue of each of these genes within the ventral lateral neurons (LN(V)s) restores increased sleep after social enrichment. Social experiences that induce increased sleep were associated with an increase in the number of synaptic terminals in the LNV projections into the medulla. The number of synaptic terminals was reduced during sleep and this decline was prevented by sleep deprivation.	[Donlea, Jeffrey M.; Ramanan, Narendrakumar; Shaw, Paul J.] Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63130 USA	Washington University (WUSTL)	Shaw, PJ (corresponding author), Washington Univ, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63130 USA.	shawp@pcg.wustl.edu	RAMANAN, NARENDRAKUMAR/L-7487-2018		NIH [R01-NS051305-01A1, T32-GM008151]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051305, F31NS063514] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Thimgan, W. Vanderheyden, P. Gray, and P. Taghert for comments. This study was funded by NIH grants R01-NS051305-01A1 and T32-GM008151.	AFFOLTER M, 1994, DEVELOPMENT, V120, P743; Barth M, 1997, LEARN MEMORY, V4, P219, DOI 10.1101/lm.4.2.219; Decker S, 2007, P NATL ACAD SCI USA, V104, P15905, DOI 10.1073/pnas.0702082104; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Fernandez MP, 2008, PLOS BIOL, V6, P518, DOI 10.1371/journal.pbio.0060069; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; FRISTROM D, 1994, DEVELOPMENT, V120, P2661; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; GAUTHIERROUVIERE C, 1993, EXP CELL RES, V209, P208, DOI 10.1006/excr.1993.1303; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; HELFRICHFORSTER C, 1993, J COMP NEUROL, V337, P177, DOI 10.1002/cne.903370202; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Montagne J, 1996, DEVELOPMENT, V122, P2589; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Roch F, 1998, DEVELOPMENT, V125, P1823; Sakai T, 2004, P NATL ACAD SCI USA, V101, P16058, DOI 10.1073/pnas.0401472101; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Zhang YL, 2007, NEURON, V53, P201, DOI 10.1016/j.neuron.2006.12.016	24	173	174	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					105	108		10.1126/science.1166657	http://dx.doi.org/10.1126/science.1166657			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342592	Green Accepted			2022-12-28	WOS:000264802100043
J	Lefevre, M; Proietti, E; Jaouen, F; Dodelet, JP				Lefevre, Michel; Proietti, Eric; Jaouen, Frederic; Dodelet, Jean-Pol			Iron-Based Catalysts with Improved Oxygen Reduction Activity in Polymer Electrolyte Fuel Cells	SCIENCE			English	Article							HEAT-TREATMENT AFFECT; CATHODE CATALYST; NONNOBLE ELECTROCATALYSTS; SPUTTER-DEPOSITION; FE/N/C CATALYSTS; O-2 REDUCTION; CARBON-BLACKS; SITE; ORR; ELECTROREDUCTION	Iron-based catalysts for the oxygen-reduction reaction in polymer electrolyte membrane fuel cells have been poorly competitive with platinum catalysts, in part because they have a comparatively low number of active sites per unit volume. We produced microporous carbon-supported iron-based catalysts with active sites believed to contain iron cations coordinated by pyridinic nitrogen functionalities in the interstices of graphitic sheets within the micropores. We found that the greatest increase in site density was obtained when a mixture of carbon support, phenanthroline, and ferrous acetate was ball-milled and then pyrolyzed twice, first in argon, then in ammonia. The current density of a cathode made with the best iron-based electrocatalyst reported here can equal that of a platinum-based cathode with a loading of 0.4 milligram of platinum per square centimeter at a cell voltage of >= 0.9 volt.	[Lefevre, Michel; Proietti, Eric; Jaouen, Frederic; Dodelet, Jean-Pol] Inst Natl Rech Sci Energie Mat & Telecommun, Varennes, PQ J3X 1S2, Canada	University of Quebec; Institut national de la recherche scientifique (INRS)	Dodelet, JP (corresponding author), Inst Natl Rech Sci Energie Mat & Telecommun, Varennes, PQ J3X 1S2, Canada.	dodelet@emt.inrs.ca	Lefèvre, Michel/B-5729-2009; T, Maiyalagan/C-5716-2011; jaouen, frederic/D-7912-2019	Lefèvre, Michel/0000-0003-3042-6128; T, Maiyalagan/0000-0003-3528-3824; jaouen, frederic/0000-0001-9836-3261	General Motors of Canada; Natural Sciences and Engineering Council of Canada	General Motors of Canada; Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Supported by General Motors of Canada and the Natural Sciences and Engineering Council of Canada. The Cabot Corporation provided the carbon black. U.S. patent application US 61/112,844 related to this work was filed on 10 November 2008.	Bashyam R, 2006, NATURE, V443, P63, DOI 10.1038/nature05118; Charreteur F, 2008, ELECTROCHIM ACTA, V53, P6881, DOI 10.1016/j.electacta.2007.12.051; Charreteur F, 2008, ELECTROCHIM ACTA, V53, P2925, DOI 10.1016/j.electacta.2007.11.002; Dodelet J. P., 2006, N4 MACROCYCLIC METAL, P83; Easton EB, 2006, ELECTROCHEM SOLID ST, V9, pA463, DOI 10.1149/1.2266157; Garsuch A, 2008, J ELECTROCHEM SOC, V155, pB953, DOI 10.1149/1.2949092; Gasteiger HA, 2004, J POWER SOURCES, V127, P162, DOI 10.1016/j.jpowsour.2003.09.013; Gasteiger HA, 2005, APPL CATAL B-ENVIRON, V56, P9, DOI 10.1016/j.apcatb.2004.06.021; GUPTA S, 1989, J APPL ELECTROCHEM, V19, P19, DOI 10.1007/BF01039385; Jaouen F, 2006, J PHYS CHEM B, V110, P5553, DOI 10.1021/jp057135h; Jaouen F, 2006, J ELECTROCHEM SOC, V153, pA689, DOI 10.1149/1.2168418; Jaouen F, 2003, J PHYS CHEM B, V107, P1376, DOI 10.1021/jp021634q; Jaouen F, 2007, ELECTROCHIM ACTA, V52, P5975, DOI 10.1016/j.electacta.2007.03.045; Jaouen F, 2007, J PHYS CHEM C, V111, P5963, DOI 10.1021/jp068273p; Jaouen F, 2007, J PHYS CHEM C, V111, P5971, DOI 10.1021/jp068274h; JASINSKI R, 1964, NATURE, V201, P1212, DOI 10.1038/2011212a0; Koslowski UI, 2008, J PHYS CHEM C, V112, P15356, DOI 10.1021/jp802456e; Lefevre M, 2008, ELECTROCHIM ACTA, V53, P8269, DOI 10.1016/j.electacta.2008.06.050; Maruyama J, 2008, J POWER SOURCES, V182, P489, DOI 10.1016/j.jpowsour.2008.04.040; Maruyama J, 2008, J PHYS CHEM C, V112, P2784, DOI 10.1021/jp709912d; Maruyama J, 2007, CHEM COMMUN, P2879, DOI 10.1039/b703723f; Nallathambi V, 2008, J POWER SOURCES, V183, P34, DOI 10.1016/j.jpowsour.2008.05.020; Schilling T, 2008, ELECTROCHIM ACTA, V53, P5379, DOI 10.1016/j.electacta.2008.02.062; Sirk AHC, 2008, J ELECTROCHEM SOC, V155, pB592, DOI 10.1149/1.2900107; Subramanian NP, 2006, J POWER SOURCES, V157, P56, DOI 10.1016/j.jpowsour.2005.07.031; *US DOE, 2007, TECHN PLAN FUEL CELL; Wood TE, 2008, J POWER SOURCES, V178, P510, DOI 10.1016/j.jpowsour.2007.10.093; Yang RZ, 2007, J ELECTROCHEM SOC, V154, pA275, DOI 10.1149/1.2435670; Yuasa M, 2005, CHEM MATER, V17, P4278, DOI 10.1021/cm050958z; Ziegelbauer JM, 2008, J PHYS CHEM C, V112, P8839, DOI 10.1021/jp8001564	30	2575	2636	62	2494	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					71	74		10.1126/science.1170051	http://dx.doi.org/10.1126/science.1170051			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342583				2022-12-28	WOS:000264802100033
J	Goldston, D				Goldston, David			Mean what you say	NATURE			English	Editorial Material											Goldston, D (corresponding author), Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA.	partyofonecolumn@gmail.com							0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					563	563		10.1038/458563a	http://dx.doi.org/10.1038/458563a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427RK	19340055	Bronze			2022-12-28	WOS:000264796200013
J	Saijo, K; Winner, B; Carson, CT; Collier, JG; Boyer, L; Rosenfeld, MG; Gage, FH; Glass, CK				Saijo, Kaoru; Winner, Beate; Carson, Christian T.; Collier, Jana G.; Boyer, Leah; Rosenfeld, Michael G.; Gage, Fred H.; Glass, Christopher K.			A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced Death	CELL			English	Article							ORPHAN NUCLEAR RECEPTOR; PARKINSONS-DISEASE; GENE-EXPRESSION; ALPHA-SYNUCLEIN; ACTIVATION; NEURODEGENERATION; CELLS; NURR1; HETERODIMERIZATION; PHOSPHORYLATION	Nurr1, an orphan nuclear receptor, plays an essential role in the generation and maintenance of dopaminergic neurons in the brain. Rare mutations in Nurr1 are associated with familial Parkinson's disease, but the underlying basis for this relationship has not been established. Here, we demonstrate that Nurr1 unexpectedly functions to inhibit expression of pro-inflammatory neurotoxic mediators in both microglia and astrocytes. Reduced Nurr1 expression results in exaggerated inflammatory responses in microglia that are further amplified by astrocytes, leading to the production of factors that cause death of tyrosine hydroxylase-expressing neurons. Nurr1 exerts anti-inflammatory effects by docking to NF-kappa B-p65 on target inflammatory gene promoters in a signal-dependent manner. Subsequently, Nurr1 recruits the CoREST corepressor complex, resulting in clearance of NF-kappa B-p65 and transcriptional repression. These studies suggest that Nurr1 protects against loss of dopaminergic neurons in Parkinson's disease in part by limiting the production of neurotoxic mediators by microglia and astrocytes.	[Saijo, Kaoru; Collier, Jana G.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Rosenfeld, Michael G.; Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Rosenfeld, Michael G.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Boyer, Leah] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Winner, Beate; Carson, Christian T.; Boyer, Leah; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute	Saijo, K (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	ksaijo@ucsd.edu; ckg@ucsd.edu	Winner, Beate/K-3730-2012; Glass, Christopher/AAI-3933-2021; Winner, Beate/O-8213-2019	Winner, Beate/0000-0002-6909-0564; Glass, Christopher/0000-0003-4344-3592; Winner, Beate/0000-0002-6909-0564; Boyer, Leah/0000-0002-0546-4344	NIH [CA52599, DK39949, NS34934, DK1877]; Fondation Leducq; CIRM, ISPEN/Biomeasure; Picower Foundation; Alexander von Humboldt Foundation; NATIONAL CANCER INSTITUTE [R01CA052599] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059694, R01HL088129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039949, K11DK001877, R01DK018477, R37DK039949, R01DK091183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); CIRM, ISPEN/Biomeasure(California Institute for Regenerative Medicine); Picower Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are grateful to Christian Schmedt, Amy Sullivan, and Mary Lynn Gage for critical reading of the manuscript. We thank Katerina Akassoglou for BV2 cells; Alexander Mata de Urquiza for the NBRE-luciferase construct; Inder Verma for the lentivirus vector; Amir Gamliel for the Myc-SUMO1, 2, and 3 constructs; Roberto Jappelli and Roland Riek for the lentivirus encoding A30P alpha-Synuclein; Richard Mulligan and Jeng-Shin Lee for pHAGE vector. We thank Chris Benner for statistical analysis; Eunice Meija, Robert Aigner, and Rosa Luna for technical assistance; and Lynn Bautista for help with preparing figures. KS, JGC, and CKG are supported by grants from the NIH (CA52599) and Fondation Leducq. F.H.G., B.W., L.B., and C.C. are supported by grants from CIRM, ISPEN/Biomeasure and the Picower Foundation. B.W. is a Feodor-Lynen fellow of the Alexander von Humboldt Foundation. MGR is supported by grants from NIH (DK39949, NS34934, and DK1877) and is an investigator of Howard Hughes Medical Institute.	Aarnisalo P, 2002, J BIOL CHEM, V277, P35118, DOI 10.1074/jbc.M201707200; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Atkinson TJ, 2008, INT REV IMMUNOL, V27, P255, DOI 10.1080/08830180801959072; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Brown GC, 2007, BIOCHEM SOC T, V35, P1119, DOI 10.1042/BST0351119; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Doi Y, 2008, P NATL ACAD SCI USA, V105, P8381, DOI 10.1073/pnas.0803454105; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Galleguillos D, 2004, J BIOL CHEM, V279, P2005, DOI 10.1074/jbc.M308113200; Gao HM, 2008, J NEUROSCI, V28, P7687, DOI 10.1523/JNEUROSCI.0143-07.2008; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hartmann A, 2003, EXP NEUROL, V184, P561, DOI 10.1016/j.expneurol.2003.08.004; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Maira M, 1999, MOL CELL BIOL, V19, P7549; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meredith GE, 2008, ACTA NEUROPATHOL, V115, P385, DOI 10.1007/s00401-008-0350-x; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nagatsu T, 2005, CURR PHARM DESIGN, V11, P999, DOI 10.2174/1381612053381620; Nordzell M, 2004, BIOCHEM BIOPH RES CO, V313, P205, DOI 10.1016/j.bbrc.2003.11.079; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pei LM, 2006, MOL ENDOCRINOL, V20, P786, DOI 10.1210/me.2005-0331; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Sakurada K, 1999, DEVELOPMENT, V126, P4017; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; THERY C, 1992, J NEUROCHEM, V59, P1183, DOI 10.1111/j.1471-4159.1992.tb08366.x; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Yasuda J, 2004, CANCER SCI, V95, P52, DOI 10.1111/j.1349-7006.2004.tb03170.x; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	52	661	688	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					47	59		10.1016/j.cell.2009.01.038	http://dx.doi.org/10.1016/j.cell.2009.01.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345186	Green Accepted, Bronze			2022-12-28	WOS:000264813300013
J	Kernisan, LP; Lee, SJ; Boscardin, WJ; Landefeld, CS; Dudley, RA				Kernisan, Leslie P.; Lee, Sei J.; Boscardin, W. John; Landefeld, C. Seth; Dudley, R. Adams			Association Between Hospital-Reported Leapfrog Safe Practices Scores and Inpatient Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AORTIC-ANEURYSM REPAIR; QUALITY-OF-CARE; STANDARDS; RISK; SURGERY; VOLUME	Context The Leapfrog Hospital Survey allows hospitals to self-report the steps they have taken toward implementing the Safe Practices for Better Healthcare endorsed by the National Quality Forum. The Leapfrog Group currently ranks hospital performance on the safe practices initiative by quartiles and presents this information to the public on its Web site. It is unknown how well a hospital's resulting Safe Practices Score (SPS) correlates with outcomes such as inpatient mortality. Objective To determine the relationship between hospitals' SPSs and risk-adjusted inpatient mortality rates. Design, Setting, and Participants Observational analysis of discharge data for all urban US hospitals completing the 2006 safe practices initiative and identifiable in the Nationwide Inpatient Sample. Leapfrog provided an SPS for each hospital as well as 3 alternative scores based on shorter versions of the original survey. Hierarchical logistic regression was used to determine the relationship between quartiles of SPS and risk-adjusted inpatient mortality, after adjusting for hospital discharge volume and teaching status. Subgroup analyses were performed using data from patients older than 65 years and patients with 5% or greater expected mortality risk. Main Outcome Measures Inpatient risk-adjusted mortality by quartiles of survey score. Results Of 1075 hospitals completing the 2006 Safe Practices Survey, 155 (14%) were identifiable in the National Inpatient Sample (1 772 064 discharges). Raw observed mortality in the primary sample was 2.09%. Fully adjusted mortality rates by quartile of SPS, from lowest to highest, were 1.97% (95% confidence interval [CI], 1.78%-2.18%), 2.04% (95% CI, 1.84%-2.25%), 1.96% (95% CI, 1.77%-2.16%), and 2.00% (95% CI, 1.80%-2.22%) (P=.99 for linear trend). Results were similar in the subgroup analyses. None of the 3 alternative survey scores was associated with risk-adjusted inpatient mortality, although P values for linear trends were lower (. 80, .20, and .11). Conclusion In this sample of hospitals that completed the 2006 Safe Practices Survey, survey scores were not significantly associated with risk-adjusted inpatient mortality.	[Dudley, R. Adams] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94118 USA; [Kernisan, Leslie P.; Lee, Sei J.; Boscardin, W. John; Landefeld, C. Seth] Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94118 USA; [Boscardin, W. John] Univ Calif San Francisco, Div Biostat, San Francisco, CA 94118 USA; [Kernisan, Leslie P.; Lee, Sei J.; Landefeld, C. Seth] San Francisco VA Med Ctr, Natl VA Qual Scholars Program, San Francisco, CA USA; [Lee, Sei J.; Boscardin, W. John; Landefeld, C. Seth] San Francisco VA Med Ctr, Hlth Serv Res Enhancement Award Program, San Francisco, CA USA; [Landefeld, C. Seth] Stanford Univ, Ctr Adv Study Behav Sci, Palo Alto, CA 94304 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Stanford University	Dudley, RA (corresponding author), Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, 3333 Calif St,Ste 265, San Francisco, CA 94118 USA.	adams.dudley@ucsf.edu			National Institute on Aging, National Institutes of Health [2 T32 AG000212-16]; Robert Wood Johnson Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000212] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding/Support: This study was supported by the UCSF Division of Geriatrics, the UCSF Institute for Health Policy Studies, and the San Francisco VA Medical Center. Dr Kernisan was supported by T32 research fellowship grant 2 T32 AG000212-16 from the National Institute on Aging, National Institutes of Health, followed by a VA Quality Scholars fellowship. Dr Dudley's work was supported by a Robert Wood Johnson Foundation Investigator Award in Health Policy. This study was also supported by the Leapfrog Group, which provided its data at no cost.	*AG HEALTHC RES QU, ALL PAT REF DIAGN RE; Birkmeyer JD, 2004, SURGERY, V135, P569, DOI 10.1016/j.surg.2004.03.004; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Brooke BS, 2008, J VASC SURG, V47, P1155, DOI 10.1016/j.jvs.2008.01.021; Callcut RA, 2006, ANN SURG, V243, P304, DOI 10.1097/01.sla.0000200854.34298.e3; Goshima KR, 2008, ANN VASC SURG, V22, P328, DOI 10.1016/j.avsg.2007.09.013; *HCUP, 2005, INTR HCUP NAT INP SA; Healthcare Cost and Utilization Project (HCUP), 2010, OV NAT INP SAMPL NIS; Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, OV DIS SEV MEAS DISS; Huerta TR, 2008, HEALTH CARE MANAGE R, V33, P341, DOI 10.1097/01.HCM.0000318770.82642.c6; Jha AK, 2008, JT COMM J QUAL PATIE, V34, P318, DOI 10.1016/S1553-7250(08)34040-9; Kilbridge PM, 2006, QUAL SAF HEALTH CARE, V15, P81, DOI 10.1136/qshc.2005.014969; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Krumholz HM, 2002, JAMA-J AM MED ASSOC, V287, P1277, DOI 10.1001/jama.287.10.1277; *LEAPFR GROUP, FACTSH LEAPFR SAF PR; *LEAPFR GROUP, 2007, HEALTHCARE BENCHMARK, V14, P121; Leonardi MJ, 2007, ARCH SURG-CHICAGO, V142, P863, DOI 10.1001/archsurg.142.9.863; Manthous CA, 2004, AM J MED, V116, P188, DOI 10.1016/j.amjmed.2003.08.032; Meurer LN, 2006, ANN FAM MED, V4, P410, DOI 10.1370/afm.553; Olson JR, 2008, HEALTH SERV RES, V43, P1787, DOI 10.1111/j.1475-6773.2008.00888.x; Rodgers M, 2007, ARCH SURG-CHICAGO, V142, P829, DOI 10.1001/archsurg.142.9.829; Romano PS, 2000, HEALTH SERV RES, V34, P1469; Scanlon DP, 2008, MED CARE RES REV, V65, P207, DOI 10.1177/1077558707312499; Shojania KG, 2008, CAN MED ASSOC J, V179, P153, DOI 10.1503/cmaj.080010; The Leapfrog Group, LEAPFR SAF PRACT SCO; Thomas JW, 1999, MED CARE, V37, P83, DOI 10.1097/00005650-199901000-00012; Welke KF, 2005, ANN THORAC SURG, V80, P2114, DOI 10.1016/j.athoracsur.2005.05.017; Young M P, 2000, Eff Clin Pract, V3, P284; 2007, HEALTHCARE BENCHMARK, V14, P1	29	34	34	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 1	2009	301	13					1341	1348		10.1001/jama.2009.422	http://dx.doi.org/10.1001/jama.2009.422			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426LM	19336709	Green Accepted, Bronze			2022-12-28	WOS:000264709800023
J	Makris, NC; Ratilal, P; Jagannathan, S; Gong, Z; Andrews, M; Bertsatos, I; Godo, OR; Nero, RW; Jech, JM				Makris, Nicholas C.; Ratilal, Purnima; Jagannathan, Srinivasan; Gong, Zheng; Andrews, Mark; Bertsatos, Ioannis; Godo, Olav Rune; Nero, Redwood W.; Jech, J. Michael			Critical Population Density Triggers Rapid Formation of Vast Oceanic Fish Shoals	SCIENCE			English	Article							HERRING CLUPEA-HARENGUS; FISHERIES ACOUSTICS; BEHAVIOR; SCHOOLS; DYNAMICS; COMPLEX; GULF	Similarities in the behavior of diverse animal species that form large groups have motivated attempts to establish general principles governing animal group behavior. It has been difficult, however, to make quantitative measurements of the temporal and spatial behavior of extensive animal groups in the wild, such as bird flocks, fish shoals, and locust swarms. By quantifying the formation processes of vast oceanic fish shoals during spawning, we show that (i) a rapid transition from disordered to highly synchronized behavior occurs as population density reaches a critical value; (ii) organized group migration occurs after this transition; and (iii) small sets of leaders significantly influence the actions of much larger groups. Each of these findings confirms general theoretical predictions believed to apply in nature irrespective of animal species.	[Makris, Nicholas C.; Jagannathan, Srinivasan; Bertsatos, Ioannis] MIT, Cambridge, MA 02139 USA; [Ratilal, Purnima; Gong, Zheng; Andrews, Mark] Northeastern Univ, Boston, MA 02115 USA; [Godo, Olav Rune] Inst Marine Res, N-5817 Bergen, Norway; [Nero, Redwood W.] SE Fisheries Sci Ctr, Pascagoula, MS 39568 USA; [Jech, J. Michael] NE Fisheries Sci Ctr, Woods Hole, MA 02543 USA	Massachusetts Institute of Technology (MIT); Northeastern University; Institute of Marine Research - Norway; National Oceanic Atmospheric Admin (NOAA) - USA	Makris, NC (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	makris@mit.edu	Gong, Zheng/K-5808-2012	Godo, Olav Rune/0000-0001-8826-8068	National Oceanographic Partnership Program; Office of Naval Research; Alfred P. Sloan Foundation	National Oceanographic Partnership Program; Office of Naval Research(Office of Naval Research); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This research was supported by the National Oceanographic Partnership Program, the Office of Naval Research, and the Alfred P. Sloan Foundation and is a contribution to the Census of Marine Life. We would like to thank the science parties, officers, and crew of the research vessels Oceanus, Endeavor, Delaware II, and Hugh Sharp	Blaxter J.H.S., 1982, Advances in Marine Biology, V20, P1, DOI 10.1016/S0065-2881(08)60140-6; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Croft DP, 2003, FISH FISH, V4, P138, DOI 10.1046/j.1467-2979.2003.00113.x; Godo OR, 2004, ICES J MAR SCI, V61, P1093, DOI 10.1016/j.icesjms.2004.06.009; Gregoire G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.025702; Hoare DJ, 2000, OIKOS, V89, P546, DOI 10.1034/j.1600-0706.2000.890314.x; Huse I, 1996, ICES J MAR SCI, V53, P863, DOI 10.1006/jmsc.1996.9999; Jech JM, 2006, CAN J FISH AQUAT SCI, V63, P2225, DOI 10.1139/F06-126; Link JS, 2001, J FISH BIOL, V59, P783, DOI 10.1111/j.1095-8649.2001.tb00149.x; Mackinson S, 1999, J FISH BIOL, V55, P972, DOI 10.1111/j.1095-8649.1999.tb00733.x; MacLennan D.N., 1992, SPRINGER SCI BUS MED; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; Makris NC, 2006, SCIENCE, V311, P660, DOI 10.1126/science.1121756; MILINSKI M, 1993, PREDATION RISK FEEDI, P285; Nottestad L, 1996, SARSIA, V80, P277, DOI 10.1080/00364827.1996.10413601; Overholtz WJ, 2007, ICES J MAR SCI, V64, P83, DOI 10.1093/icesjms/fsl009; Overholtz W.J., 2006, J NW ATLANTIC FISHER, V36, P127; Overholtz WJ, 2002, FISH RES, V57, P237, DOI 10.1016/S0165-7836(01)00359-9; PITCHER TJ, 2001, ENCY OCEAN SCI, P978; Pitcher TJ., 1993, Behaviour of teleost fishes, P363, DOI 10.1007/978-94-011-1578-0_12; RAY C, 1999, PETERSON FIELD GUIDE; RAYLEIGH JWS, 1976, THEORY SOUND, V2, P1; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Skaret G, 2003, AQUAT LIVING RESOUR, V16, P299, DOI 10.1016/S0990-7440(03)00006-8; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Toner J, 1998, PHYS REV E, V58, P4828, DOI 10.1103/PhysRevE.58.4828; TORESEN R, 1991, ICES J MAR SCI, V48, P15, DOI 10.1093/icesjms/48.1.15; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Vabo R, 2008, ECOL MODEL, V214, P125, DOI 10.1016/j.ecolmodel.2008.01.026; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Viscido SV, 2005, ECOL MODEL, V183, P347, DOI 10.1016/j.ecolmodel.2004.08.019; ZINKENVICH VN, 1967, ICNAF RES B, V4, P101	33	141	146	4	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 27	2009	323	5922					1734	1737		10.1126/science.1169441	http://dx.doi.org/10.1126/science.1169441			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325116				2022-12-28	WOS:000264559800041
J	Bhoj, VG; Chen, ZJ				Bhoj, Vijay G.; Chen, Zhijian J.			Ubiquitylation in innate and adaptive immunity	NATURE			English	Review							NF-KAPPA-B; E3 UBIQUITIN LIGASE; T-CELL-ACTIVATION; ALPHA-DEPENDENT APOPTOSIS; TUMOR-SUPPRESSOR CYLD; EDITING ENZYME A20; CBL-B; CONJUGATING ENZYME; POLYUBIQUITIN CHAINS; ANTIVIRAL RESPONSES	Protein ubiquitylation has emerged as a key mechanism that regulates immune responses. Much like phosphorylation, ubiquitylation is a reversible covalent modification that regulates the stability, activity and localization of target proteins. As such, ubiquitylation regulates the development of the immune system and many phases of the immune response, including its initiation, propagation and termination. Recent work has shown that several ubiquitin ligases help to prevent the immune system from attacking self tissues. The dysfunction of several ubiquitin ligases has been linked to autoimmune diseases.	[Bhoj, Vijay G.; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251	Howard Hughes Medical Institute; US National Institutes of Health; Welch Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation)	We apologize to the many authors whose publications are not cited directly because of space limitations. We thank J. Cabrera for graphic support. Research in our laboratory is supported by the Howard Hughes Medical Institute and by grants from the US National Institutes of Health and the Welch Foundation.	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Bottomley MJ, 2005, J BIOL CHEM, V280, P11505, DOI 10.1074/jbc.M413959200; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen MZ, 2006, VIRAL IMMUNOL, V19, P349, DOI 10.1089/vim.2006.19.349; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Fukushima T, 2007, P NATL ACAD SCI USA, V104, P6371, DOI 10.1073/pnas.0700548104; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Komander D, 2008, BIOCHEM J, V409, P77, DOI 10.1042/BJ20071399; Krappmann D, 2005, EMBO REP, V6, P321, DOI 10.1038/sj.embor.7400380; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Lineberry NB, 2008, J IMMUNOL, V181, P1622, DOI 10.4049/jimmunol.181.3.1622; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Liu YC, 2007, SEMIN IMMUNOL, V19, P197, DOI 10.1016/j.smim.2007.02.003; Loureiro J, 2006, ADV IMMUNOL, V92, P225, DOI 10.1016/S0065-2776(06)92006-9; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Su L, 2006, J IMMUNOL, V177, P7559, DOI 10.4049/jimmunol.177.11.7559; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Uchida D, 2004, J EXP MED, V199, P167, DOI 10.1084/jem.20031291; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Venuprasad K, 2008, NAT IMMUNOL, V9, P245, DOI 10.1038/ni1564; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704; Wu CJ, 2008, P NATL ACAD SCI USA, V105, P3023, DOI 10.1073/pnas.0712313105; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamamoto M, 2006, J IMMUNOL, V177, P7520, DOI 10.4049/jimmunol.177.11.7520; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yang BL, 2008, NAT IMMUNOL, V9, P1356, DOI 10.1038/ni.1670; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	74	450	485	5	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					430	437		10.1038/nature07959	http://dx.doi.org/10.1038/nature07959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19325622				2022-12-28	WOS:000264532400031
J	Tang, PC; Lee, TH				Tang, Paul C.; Lee, Thomas H.			Your Doctor's Office or the Internet? Two Paths to Personal Health Records	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tang, Paul C.] Palo Alto Med Fdn, Palo Alto, CA USA; [Lee, Thomas H.] Partners HealthCare Syst, Boston, MA USA	Palo Alto Medical Foundation Research Institute; Partners Healthcare System	Tang, PC (corresponding author), Palo Alto Med Fdn, Palo Alto, CA USA.							*NAT COMM VIT HLTH, 2006, PRIV CONF NAT HLTH I; Steinbrook R, 2008, NEW ENGL J MED, V358, P1653, DOI 10.1056/NEJMp0801736; Tang Paul C, 2006, AMIA Annu Symp Proc, P764; Tang PC, 2006, J AM MED INFORM ASSN, V13, P121, DOI 10.1197/jamia.M2025; Tang PC, 2005, HEALTH AFFAIR, V24, P1290, DOI 10.1377/hlthaff.24.5.1290	5	62	62	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2009	360	13					1276	1278		10.1056/NEJMp0810264	http://dx.doi.org/10.1056/NEJMp0810264			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	423VP	19321866				2022-12-28	WOS:000264524100002
J	Reidpath, DD; Allotey, P				Reidpath, Daniel D.; Allotey, Pascale			Opening up public health: a strategy of information and communication technology to support population health	LANCET			English	Editorial Material									[Reidpath, Daniel D.; Allotey, Pascale] Brunel Univ, Ctr Publ Hlth Res, Uxbridge UB8 3PH, Middx, England	Brunel University	Reidpath, DD (corresponding author), Brunel Univ, Ctr Publ Hlth Res, Uxbridge UB8 3PH, Middx, England.	dreidpath@gmail.com		Reidpath, Daniel/0000-0002-8796-0420; Allotey, Pascale/0000-0002-6942-5774				CERRI D, 2007, OPEN STANDARDS OPEN; *HLTH METR NETW, 2007, FRAM STAND COUNTR HL; *KABLEDIRECT, 2007, UK PUBL HEALTHC MARK; Kwankam SY, 2004, B WORLD HEALTH ORGAN, V82, P800; *NETEPI, FREE OP SOURC NETW E; *OP ORG, OP VS PROPR FORM; *OPENOFFICE ORG, 2007, OPENOFFICE ORG 2 3 1; *R DEV COR TEAM, 2008, R VERS 2 6 2 SOFTW; *SAHANA, 2007, SAHANA DIS MAN SYST; *WHO, 2007, INF TECHN SUPP HLTH; *WORLDVISTA, 2008, WORLDVISTA EHR VOE 1	11	7	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					1050	1051		10.1016/S0140-6736(09)60315-9	http://dx.doi.org/10.1016/S0140-6736(09)60315-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	422AA	19304017				2022-12-28	WOS:000264398200033
J	Fuller, DQ; Qin, L; Zheng, YF; Zhao, ZJ; Chen, X; Hosoya, LA; Sun, GP				Fuller, Dorian Q.; Qin, Ling; Zheng, Yunfei; Zhao, Zhijun; Chen, Xugao; Hosoya, Leo Aoi; Sun, Guo-Ping			The Domestication Process and Domestication Rate in Rice: Spikelet Bases from the Lower Yangtze	SCIENCE			English	Article							WILD-RICE; CULTIVATION; PATTERNS; ORIGINS	The process of rice domestication occurred in the Lower Yangtze region of Zhejiang, China, between 6900 and 6600 years ago. Archaeobotanical evidence from the site of Tianluoshan shows that the proportion of nonshattering domesticated rice (Oryza sativa) spikelet bases increased over this period from 27% to 39%. Over the same period, rice remains increased from 8% to 24% of all plant remains, which suggests an increased consumption relative to wild gathered foods. In addition, an assemblage of annual grasses, sedges, and other herbaceous plants indicates the presence of arable weeds, typical of cultivated rice, that also increased over this period.	[Fuller, Dorian Q.] UCL, Inst Archaeol, London WC1H 0PY, England; [Qin, Ling] Peking Univ, Sch Archaeol & Museol, Beijing 100871, Peoples R China; [Zheng, Yunfei; Chen, Xugao; Sun, Guo-Ping] Zhejiang Prov Inst Archaeol & Cultural Rel, Hangzhou 310014, Peoples R China; [Zhao, Zhijun] Chinese Acad Social Sci, Inst Archaeol, Beijing 100710, Peoples R China; [Hosoya, Leo Aoi] Res Inst Humanity & Nat, Kyoto 6038047, Japan	University of London; University College London; Peking University; Chinese Academy of Social Sciences; Research Institute for Humanity & Nature (RIHN)	Fuller, DQ (corresponding author), UCL, Inst Archaeol, Mortimer St, London WC1H 0PY, England.	d.fuller@ucl.ac.uk	Fuller, Dorian/AAF-7400-2019; Fuller, Dorian Q/C-1908-2008	Fuller, Dorian/0000-0002-4859-080X; Fuller, Dorian Q/0000-0002-4859-080X	British Academy; Chinese Education Ministry; Zhejiang Provincial Institute of Archaeology and Cultural Relics; NERC [NE/G005540/1] Funding Source: UKRI; Natural Environment Research Council [NE/G005540/1] Funding Source: researchfish	British Academy; Chinese Education Ministry(Ministry of Education, China); Zhejiang Provincial Institute of Archaeology and Cultural Relics; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Supported by grants from the British Academy, the Chinese Education Ministry, and the Zhejiang Provincial Institute of Archaeology and Cultural Relics. We thank S. Colledge, M. Wollstonecroft, and anonymous reviewers for helping to improve this text.	Allaby RG, 2008, P NATL ACAD SCI USA, V105, P13982, DOI 10.1073/pnas.0803780105; [Anonymous], 2006, ASIAN PERSPECT, V45, P129; [Anonymous], S E ASIAN ARCHAEOLOG; Bellwood Peter, 2005, 1 FARMERS; Crawford GW, 2006, BLACKW STUD GLOB ARC, P77, DOI 10.1002/9780470774670.ch5; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Fuller DQ, 2006, J WORLD PREHIST, V20, P1, DOI 10.1007/s10963-006-9006-8; Fuller DQ, 2007, ANTIQUITY, V81, P316, DOI 10.1017/S0003598X0009520X; FULLER DQ, 2008, HUMAN MIGRATIONS E A, P40; Galinato MI, 1999, UPLAND RICE WEEDS S; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; HARLAN JR, 1973, EVOLUTION, V27, P311, DOI [10.2307/2406971, 10.1111/j.1558-5646.1973.tb00676.x]; HILLMAN GC, 1990, BIOL J LINN SOC, V39, P39, DOI 10.1111/j.1095-8312.1990.tb01611.x; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; LI YH, 1998, ZHONGGUO ZACAO ZHI; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; MOODY K, 1991, WEEDS REPORTED RICE; OKA HI, 1967, EVOLUTION, V21, P249, DOI [10.2307/2406673, 10.1111/j.1558-5646.1967.tb00153.x]; Onishi K, 2007, GENOME, V50, P757, DOI 10.1139/G07-051; Sang T, 2007, J INTEGR PLANT BIOL, V49, P760, DOI 10.1111/j.1744-7909.2007.00510.x; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Tanno K, 2006, SCIENCE, V311, P1886, DOI 10.1126/science.311.5769.1866a; Vaughan DA, 2008, PLANT SCI, V174, P394, DOI 10.1016/j.plantsci.2008.01.016; Weiss E, 2006, SCIENCE, V312, P1608, DOI 10.1126/science.1127235; [Zhejiang sheng wen wu kao gu yan jiu suo Yuyao shi wen wu bao hu guan li suo Hemudu yi zhi bo wu guan (Zhejiang Tianluoshan)], 2007, WEN WU, V2007, p[4, 73]; Zheng YF, 2007, CHINESE SCI BULL, V52, P1654, DOI 10.1007/s11434-007-0258-1; Zong Y, 2007, NATURE, V449, P459, DOI 10.1038/nature06135	27	401	449	6	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1607	1610		10.1126/science.1166605	http://dx.doi.org/10.1126/science.1166605			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	421EN	19299619	Green Submitted			2022-12-28	WOS:000264342300039
J	Srivastava, R				Srivastava, Ranjana			Denial	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2009	360	12					1174	1177		10.1056/NEJMp0809399	http://dx.doi.org/10.1056/NEJMp0809399			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	420IU	19297570				2022-12-28	WOS:000264283400003
J	Gerritsen, KGF; Meulenbelt, J; Spiering, W; Kema, IP; Demir, A; van Driel, VJHM				Gerritsen, Karin G. F.; Meulenbelt, Jan; Spiering, Wilko; Kema, Ido P.; Demir, Ayse; van Driel, Vincent J. H. M.			An unusual cause of ventricular fibrillation	LANCET			English	Editorial Material							HYPERTENSION; LICORICE		[Gerritsen, Karin G. F.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Internal Med, NL-3508 GA Utrecht, Netherlands; [Meulenbelt, Jan] Univ Utrecht, Univ Med Ctr Utrecht, Dept Intens Care, NL-3508 GA Utrecht, Netherlands; [Spiering, Wilko] Univ Utrecht, Univ Med Ctr Utrecht, Dept Vasc Med, NL-3508 GA Utrecht, Netherlands; [van Driel, Vincent J. H. M.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Cardiol, NL-3508 GA Utrecht, Netherlands; [Kema, Ido P.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Demir, Ayse] Meander Med Ctr, Dept Clin Chem, Amersfoort, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; Meander Medisch Centrum	Gerritsen, KGF (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Dept Internal Med, POB 85500, NL-3508 GA Utrecht, Netherlands.	k.g.f.gerritsen@umcutrecht.nl	Thomsen, Henrik Holm/GPS-9009-2022	Thomsen, Henrik Holm/0000-0003-0522-0320; Gerritsen, Karin Gerarda Frederika/0000-0002-1917-6255; Spiering, Wilko/0000-0002-2493-6407				BANNISTER B, 1977, BRIT MED J, V2, P738, DOI 10.1136/bmj.2.6089.738-a; Boganen H, 2007, Ned Tijdschr Geneeskd, V151, P2825; Ploeger B, 2001, TOXICOL APPL PHARM, V170, P46, DOI 10.1006/taap.2000.9078; Quinkler M, 2003, J CLIN ENDOCR METAB, V88, P2384, DOI 10.1210/jc.2003-030138; ROULEAU JL, 1994, J AM COLL CARDIOL, V24, P583, DOI 10.1016/0735-1097(94)90001-9	5	4	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2009	373	9669					1144	1144		10.1016/S0140-6736(09)60514-6	http://dx.doi.org/10.1016/S0140-6736(09)60514-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427IS	19329004				2022-12-28	WOS:000264773600035
J	Whitlock, G; Lewington, S; Sherliker, P; Clarke, R; Emberson, J; Halsey, J; Qizilbash, N; Collins, R; Peto, R; Lewington, S; MacMahon, S; Peto, R; Aromaa, A; Baigent, C; Carstensen, J; Chen, Z; Clarke, R; Collins, R; Duffy, S; Kromhout, D; Neaton, J; Qizilbash, N; Rodgers, A; Tominaga, S; Tornberg, S; Tunstall-Pedoe, H; Whitlock, G; Chambless, L; De Backer, G; De Bacquer, D; Kornitzer, M; Whincup, P; Wannamethee, SG; Morris, R; Wald, N; Morris, J; Law, M; Knuiman, M; Bartholomew, H; Smith, GD; Sweetnam, P; Elwood, P; Yarnell, J; Kronmal, R; Kromhout, D; Sutherland, S; Keil, J; Jensen, G; Schnohr, P; Hames, C; Tyroler, A; Aromaa, A; Knekt, P; Reunanen, A; Tuomilehto, J; Jousilahti, P; VArtiainen, E; Puska, P; Kuznetsova, T; Richart, T; Staessen, J; Thijs, L; Jorgensen, T; Thomsen, T; Sharp, D; Curb, JD; Qizilbash, N; Iso, H; Sato, S; Kitamura, A; Naito, Y; Benetos, A; Guize, L; Goldbourt, U; Tomita, M; Nishimoto, Y; Murayama, T; Criqui, M; Davis, C; Hart, C; Smith, GD; Hole, D; Gillis, C; Jacobs, D; Blackburn, H; Luepker, R; Neaton, J; Eberly, L; Cox, C; Levy, D; D'Agostino, R; Silbershatz, H; Tverdal, A; Selmer, R; Meade, T; Garrow, K; Cooper, J; Speizer, F; Stampfer, M; Menotti, A; Spagnolo, A; Tsuji, I; Imai, Y; Ohkubo, T; Hisamichi, S; Haheim, L; Holme, I; Hjermann, I; Leren, P; Ducimetiere, P; Empana, J; Jamrozik, K; Broadhurst, R; Assmann, G; Schulte, H; Bengtsson, C; Bjorkelund, C; Lissner, L; Sorlie, P; Garcia-Palmieri, M; Barrett-Conner, E; Criqui, M; Langer, R; Hart, C; Smith, GD; Hole, D; Nakachi, K; Imai, K; Fang, X; Li, S; Buzina, R; Nissinen, A; Aravanis, C; Dontas, A; Kafatos, A; Menotti, A; Adachi, H; Toshima, H; Imaizumi, T; Kromhout, D; Nedeljkovic, S; Ostojic, M; Chen, Z; Tunstall-Pedoe, H; Nakayama, T; Yoshiike, N; Yokoyama, T; Date, C; Tanaka, H; Keller, J; Bonaa, K; Arnesen, E; Tunstall-Pedoe, H; Rimm, E; Gaziano, M; Buring, JE; Hennekens, C; Tornberg, S; Carstensen, J; Shipley, M; Leon, D; Marmot, M; Clarke, R; Collins, R; Emberson, J; Halsey, J; Lewington, S; Palmer, A; Parish, S; Peto, R; Sherliker, P; Whitlock, G				Whitlock, Gary; Lewington, Sarah; Sherliker, Paul; Clarke, Robert; Emberson, Jonathan; Halsey, Jim; Qizilbash, Nawab; Collins, Rory; Peto, Richard; Lewington, S.; MacMahon, S.; Peto, R.; Aromaa, A.; Baigent, C.; Carstensen, J.; Chen, Z.; Clarke, R.; Collins, R.; Duffy, S.; Kromhout, D.; Neaton, J.; Qizilbash, N.; Rodgers, A.; Tominaga, S.; Toernberg, S.; Tunstall-Pedoe, H.; Whitlock, G.; Chambless, L.; De Backer, G.; De Bacquer, D.; Kornitzer, M.; Whincup, P.; Wannamethee, S. G.; Morris, R.; Wald, N.; Morris, J.; Law, M.; Knuiman, M.; Bartholomew, H.; Smith, G. Davey; Sweetnam, P.; Elwood, P.; Yarnell, J.; Kronmal, R.; Kromhout, D.; Sutherland, S.; Keil, J.; Jensen, G.; Schnohr, P.; Hames, C.; Tyroler, A.; Aromaa, A.; Knekt, P.; Reunanen, A.; Tuomilehto, J.; Jousilahti, P.; VArtiainen, E.; Puska, P.; Kuznetsova, T.; Richart, T.; Staessen, J.; Thijs, L.; Jorgensen, T.; Thomsen, T.; Sharp, D.; Curb, J. D.; Qizilbash, N.; Iso, H.; Sato, S.; Kitamura, A.; Naito, Y.; Benetos, A.; Guize, L.; Goldbourt, U.; Tomita, M.; Nishimoto, Y.; Murayama, T.; Criqui, M.; Davis, C.; Hart, C.; Smith, G. Davey; Hole, D.; Gillis, C.; Jacobs, D.; Blackburn, H.; Luepker, R.; Neaton, J.; Eberly, L.; Cox, C.; Levy, D.; D'Agostino, R.; Silbershatz, H.; Tverdal, A.; Selmer, R.; Meade, T.; Garrow, K.; Cooper, J.; Speizer, F.; Stampfer, M.; Menotti, A.; Spagnolo, A.; Tsuji, I.; Imai, Y.; Ohkubo, T.; Hisamichi, S.; Haheim, L.; Holme, I.; Hjermann, I.; Leren, P.; Ducimetiere, P.; Empana, J.; Jamrozik, K.; Broadhurst, R.; Assmann, G.; Schulte, H.; Bengtsson, C.; Bjoerkelund, C.; Lissner, L.; Sorlie, P.; Garcia-Palmieri, M.; Barrett-Conner, E.; Criqui, M.; Langer, R.; Hart, C.; Smith, G. Davey; Hole, D.; Nakachi, K.; Imai, K.; Fang, X.; Li, S.; Buzina, R.; Nissinen, A.; Aravanis, C.; Dontas, A.; Kafatos, A.; Menotti, A.; Adachi, H.; Toshima, H.; Imaizumi, T.; Kromhout, D.; Nedeljkovic, S.; Ostojic, M.; CHen, Z.; Tunstall-Pedoe, H.; Nakayama, T.; Yoshiike, N.; Yokoyama, T.; Date, C.; Tanaka, H.; Keller, J.; Bonaa, K.; Arnesen, E.; Tunstall-Pedoe, H.; Rimm, E.; Gaziano, M.; Buring, J. E.; Hennekens, C.; Tornberg, S.; Carstensen, J.; Shipley, M.; Leon, D.; Marmot, M.; Clarke, R.; Collins, R.; Emberson, J.; Halsey, J.; Lewington, S.; Palmer, A.; Parish, S.; Peto, R.; Sherliker, P.; Whitlock, G.		PSC Collaborator ARIC	Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies	LANCET			English	Article							CORONARY-HEART-DISEASE; ABDOMINAL ADIPOSITY; BLOOD-PRESSURE; RISK; OBESITY; OVERWEIGHT; STROKE; CANCER; ASSOCIATION; SMOKING	Background The main associations of body-mass index (BMI) with overall and-cause-specific mortality can best be assessed by long-term prospective follow-up of large numbers of people. The Prospective Studies Collaboration aimed to investigate these associations by sharing data from many studies. Methods Collaborative analyses were undertaken of baseline BMI versus mortality in 57 prospective studies with 894576 participants, mostly in western Europe and North America (61% [n=541452] male, mean recruitment age 46 [SD 11] years, median recruitment year 1,979 [IQR 1975-85], mean BMI 25 [SD 4] kg/m(2)). The analyses were adjusted for age, sex, smoking status, and study. To limit reverse causality, the first 5 years of follow up were excluded, leaving 66 552 deaths of known cause during a mean of 8 (SD 6) further years of follow-up (mean age at death 67 [SD 10] years): 30 416 vascular; 2070 diabetic, renal or hepatic; 22 592 neoplastic; 3770 respiratory; 7704 other. Findings In both sexes, mortality was lowest at about 22.5-25 kg/m(2). Above this range, positive associations were recorded for several specific causes and inverse associations for none, the absolute excess risks for higher BMI and smoking were roughly additive, and each 5 kg/m2 higher BMI was on average associated with about 30% higher overall mortality (hazard ratio per 5 kg/m(2) [HR] 1.29 [95% CI 1.27-1.32]): 40% for vascular mortality (HR 1.41 [1.37-1.45]); 60-120% for diabetic, renal, and hepatic mortality (HRs 2.16 [1.89-2.46], 1.59 [1.27-1.99], and 1.82 [1.59-2.09], respectively); 10% for neoplastic mortality (HR 1.10 [1.06-1.15]); and 20% for respiratory and for all other mortality (HRs 1.20 [1.07-1.34] and 1.20 [1.16-1.25], respectively). Below the range 22.5-25 kg/m(2), BMI was associated inversely with overall mortality, mainly because of strong inverse associations with respiratory disease and lung cancer. These inverse associations were much stronger for smokers than for non-smokers, despite cigarette consumption per smoker varying little with BMI. Interpretation Although other anthropometric measures (eg, waist circumference, waist-to-hip ratio) could well add extra information to BMI, and BMI to them, BMI is in itself a strong predictor of overall mortality both above and below the apparent optimum of about 22.5-25 kg/m(2). The progressive excess mortality above this range is due mainly to vascular disease and is probably largely causal. At 30 35 kg/m(2), median survival is reduced by 2-4 years; at 40-45 kg/m(2), it is reduced by 8-10 years (which is comparable with the effects of smoking). The definite excess mortality below 22.5 kg/m(2) is due mainly to smoking-related diseases, and is not fully explained. Funding UK Medical Research Council, British Heart Foundation, Cancer Research UK, EU BIOMED programme, US National Institute on Aging, and Clinical Trial Service Unit (Oxford, UK).	[Whitlock, Gary] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Jensen, G.; Schnohr, P.] Copenhagen City Heart Study, Copenhagen, Denmark; [Sharp, D.; Curb, J. D.] Honolulu Heart Program, Honolulu, HI USA; [Iso, H.; Sato, S.; Kitamura, A.; Naito, Y.] Ikawa Noichi & Kyowa, Kyowa, Hokkaido, Japan; [Benetos, A.; Guize, L.] Ctr Invest Prevent & Clin IPC, Paris, France; [Levy, D.; D'Agostino, R.; Silbershatz, H.] NHLBI Framingham Heart Study, Framingham, MA USA; [Menotti, A.; Spagnolo, A.] Occupat Grp, Rome, Italy; [Ducimetiere, P.; Empana, J.] Paris Prospect Study, Paris, France; [Bengtsson, C.; Bjoerkelund, C.; Lissner, L.] Prospect Study Women, Gothenburg, Sweden; [Nakachi, K.; Imai, K.] Saitama Cohort Study, Saitama, Japan	University of Oxford; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Whitlock, G (corresponding author), Univ Oxford, Clin Trial Serv Unit, Richard Doll Bldg, Oxford OX3 7LF, England.	psc@ctsu.ox.ac.uk	Morris, Joan/AAT-9211-2020; Wald, Nicholas/AAY-2814-2021; Lennon, Lucy/ABB-9433-2020; Davey Smith, George/A-7407-2013; De Backer, Guy/AAI-4607-2021; NAKAYAMA, Takeo/HCH-0537-2022; Kromhout, Daan/A-8566-2014; De Bacquer, Dirk/HGU-3191-2022; Leon, David A/G-2195-2010; Empana, Jean-Philippe/AAF-6923-2021; Jørgensen, Torben/Z-1335-2018; Marmot, M G/Y-3920-2019; Staessen, Jan A/A-1065-2011; Wald, Nicholas/AAY-8924-2021; Knuiman, Matthew W/I-5549-2013; Kuznetsova, Tatiana/ABI-5662-2020	Morris, Joan/0000-0002-7164-612X; Lennon, Lucy/0000-0002-1738-1351; Davey Smith, George/0000-0002-1407-8314; Leon, David A/0000-0001-9747-1762; Empana, Jean-Philippe/0000-0002-1469-7772; Marmot, M G/0000-0002-2431-6419; Staessen, Jan A/0000-0002-3026-1637; Kuznetsova, Tatiana/0000-0003-4293-4576; Whincup, Peter/0000-0002-5589-4107; Jorgensen, Torben/0000-0001-9453-2830; MacMahon, Stephen/0000-0003-2064-7699; De Bacquer, Dirk/0000-0002-3202-7238; Carstensen, John/0000-0003-2256-8089; Emberson, Jonathan/0000-0001-7792-9422; Morris, Richard/0000-0001-7240-4563; Nakayama, Takeo/0000-0002-7918-6252; Rodgers, Anthony/0000-0003-1282-1896; Jacobs, David/0000-0002-7232-0543; Thijs, Lutgarde/0000-0002-8108-2356; Tverdal, Aage/0000-0002-2909-5678; Eberly, Lynn/0000-0003-4763-330X; s, hema/0000-0002-3440-9475; Lewington, Sarah/0000-0002-4496-4771; Venkatasubramanian, Siddharth/0000-0002-5860-0768	UK Medical Research Council; British Heart Foundation; Cancer Research UK; EU BIOMED; NIA [P01 AG17625-01]; CTSU; Girdlers' Health Research Council of New Zealand Fellowship; Sarah Lewington had a British Heart Foundation Fellowship; NATIONAL INSTITUTE ON AGING [P01AG017625] Funding Source: NIH RePORTER; ESRC [ES/G007438/1] Funding Source: UKRI; MRC [MC_U137686857, G0600705] Funding Source: UKRI; British Heart Foundation [RG/08/013/25942, RG/07/008/23674] Funding Source: researchfish; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Medical Research Council [MC_U137686857, G19/35, G0600705, G8802774, G0100222] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); EU BIOMED; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); CTSU; Girdlers' Health Research Council of New Zealand Fellowship; Sarah Lewington had a British Heart Foundation Fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Prospective Studies Collaboration has been supported by the UK Medical Research Council, British Heart Foundation, Cancer Research UK, EU BIOMED programme, NIA grant P01 AG17625-01, and CTSU overheads. Merck (F Walker) helped support the 1996 meeting of collaborators. Gary Whitlock was supported by a Girdlers' Health Research Council of New Zealand Fellowship, Sarah Lewington had a British Heart Foundation Fellowship to coordinate the project. Sarah Parish supplied unpublished analyses of BMI and cotinine (webappendix).	[Anonymous], 2 WHO GLOB INFOBASE; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Curtis JP, 2005, ARCH INTERN MED, V165, P55, DOI 10.1001/archinte.165.1.55; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Gaemers IC, 2006, CURR OPIN LIPIDOL, V17, P268, DOI 10.1097/01.mol.0000226118.43178.98; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Hu FB, 2008, OBESITY EPIDEMIOLOGY; Janssen I, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2006.00248.x; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Kurth T, 2005, CIRCULATION, V111, P1992, DOI 10.1161/01.CIR.0000161822.83163.B6; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Li TY, 2006, CIRCULATION, V113, P499, DOI 10.1161/CIRCULATIONAHA.105.574087; MANSON JAE, 1990, NEW ENGL J MED, V322, P882, DOI 10.1056/NEJM199003293221303; Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163; MICOZZI MS, 1990, AM J PHYS ANTHROPOL, V81, P375, DOI 10.1002/ajpa.1330810307; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; PETO R, 2006, DEATHS SMOKING; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Rexrode KM, 1998, JAMA-J AM MED ASSOC, V280, P1843, DOI 10.1001/jama.280.21.1843; Rexrode KM, 1997, JAMA-J AM MED ASSOC, V277, P1539, DOI 10.1001/jama.277.19.1539; Smith M, 2008, INT J CANCER, V122, P1604, DOI 10.1002/ijc.23198; Song YM, 2004, STROKE, V35, P831, DOI 10.1161/01.STR.0000119386.22691.1C; Turnbull F, 2003, LANCET, V362, P1527; Wang Y, 2008, KIDNEY INT, V73, P19, DOI 10.1038/sj.ki.5002586; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zhou M, 2008, STROKE, V39, P753, DOI 10.1161/STROKEAHA.107.495374; 2004, HLTH SURVEY ENGLAND	38	2937	3056	6	308	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2009	373	9669					1083	1096		10.1016/S0140-6736(09)60318-4	http://dx.doi.org/10.1016/S0140-6736(09)60318-4			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427IS	19299006	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000264773600029
J	Mukhtasimova, N; Lee, WY; Wang, HL; Sine, SM				Mukhtasimova, Nuriya; Lee, Won Yong; Wang, Hai-Long; Sine, Steven M.			Detection and trapping of intermediate states priming nicotinic receptor channel opening	NATURE			English	Article							SINGLE-CHANNEL; AGONIST BINDING; ACETYLCHOLINE-RECEPTORS; BC3H-1 CELLS; ION CHANNELS; END-PLATE; ACTIVATION; KINETICS; MUTATION; SUBUNIT	In the course of synaptic transmission in the brain and periphery, acetylcholine receptors (AChRs) rapidly transduce a chemical signal into an electrical impulse. The speed of transduction is facilitated by rapid ACh association and dissociation, suggesting a binding site relatively non-selective for small cations. Selective transduction has been thought to originate from the ability of ACh, over that of other organic cations, to trigger the subsequent channel-opening step. However, transitions to and from the open state were shown to be similar for agonists with widely different efficacies(1-3). By studying mutant AChRs, we show here that the ultimate closed-to-open transition is agonist-independent and preceded by two primed closed states; the first primed state elicits brief openings, whereas the second elicits long-lived openings. Long-lived openings and the associated primed state are detected in the absence and presence of an agonist, and exhibit the same kinetic signatures under both conditions. By covalently locking the agonist-binding sites in the bound conformation, we find that each site initiates a priming step. Thus, a change in binding-site conformation primes the AChR for channel opening in a process that enables selective activation by ACh while maximizing the speed and efficiency of the biological response.	[Mukhtasimova, Nuriya; Lee, Won Yong; Wang, Hai-Long; Sine, Steven M.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Receptor Biol Lab, Rochester, MN 55905 USA; [Sine, Steven M.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Sine, SM (corresponding author), Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Receptor Biol Lab, Rochester, MN 55905 USA.	sine@mayo.edu		Lee, Won Yong/0000-0001-7915-1829	National Institutes of Health [NS031744]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031744, R37NS031744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Johnson for computer programming, and C. Free for technical contributions. This work was supported by National Institutes of Health grant NS031744 (S. M. S.).	Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; COLQUHOUN D, 1981, NATURE, V294, P464, DOI 10.1038/294464a0; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; COLQUHOUN D, 1981, PROC R SOC SER B-BIO, V211, P205, DOI 10.1098/rspb.1981.0003; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; Grosman C, 2000, J GEN PHYSIOL, V115, P621, DOI 10.1085/jgp.115.5.621; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; LEE BS, 1991, J BIOL CHEM, V266, P11448; Lee WY, 2008, J GEN PHYSIOL, V132, P265, DOI 10.1085/jgp.200810014; Lee WY, 2004, J GEN PHYSIOL, V124, P555, DOI 10.1085/jgp.200409077; LIU Y, 1991, BIOPHYS J, V60, P424, DOI 10.1016/S0006-3495(91)82068-9; Maconochie DJ, 1998, J PHYSIOL-LONDON, V506, P53, DOI 10.1111/j.1469-7793.1998.053bx.x; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Mukhtasimova N, 2007, J NEUROSCI, V27, P4110, DOI 10.1523/JNEUROSCI.0025-07.2007; Ohno K, 1996, NEURON, V17, P157, DOI 10.1016/S0896-6273(00)80289-5; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; SINE SM, 1986, J PHYSIOL-LONDON, V373, P129, DOI 10.1113/jphysiol.1986.sp016039; SINE SM, 1990, J GEN PHYSIOL, V96, P395, DOI 10.1085/jgp.96.2.395; SINE SM, 1986, J PHYSIOL-LONDON, V370, P357, DOI 10.1113/jphysiol.1986.sp015939; Wang HL, 1997, J GEN PHYSIOL, V109, P757, DOI 10.1085/jgp.109.6.757	25	166	166	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					451	U172		10.1038/nature07923	http://dx.doi.org/10.1038/nature07923			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19339970	Green Accepted			2022-12-28	WOS:000266243700051
J	Kawasaki, T; Matsumura, Y; Tsutsumi, T; Suzuki, K; Ito, M; Soai, K				Kawasaki, Tsuneomi; Matsumura, Yukari; Tsutsumi, Takashi; Suzuki, Kenta; Ito, Masateru; Soai, Kenso			Asymmetric Autocatalysis Triggered by Carbon Isotope (C-13/C-12) Chirality	SCIENCE			English	Article							HIGHLY ENANTIOSELECTIVE SYNTHESIS; ENANTIOMERIC EXCESSES; AMPLIFICATION; CONJUNCTION; QUATERNARY; ALDEHYDES; ADDITIONS; MOLECULE	Many apparently achiral organic molecules on Earth may be chiral because of random substitution of the 1.11% naturally abundant C-13 for C-12 in an enantiotopic moiety within the structure. However, chirality from this source is experimentally difficult to discern because of the very small difference between C-13 and C-12. We have demonstrated that this small difference can be amplified to an easily seen experimental outcome using asymmetric autocatalysis. In the reaction between pyrimidine-5-carbaldehyde and diisopropylzinc, addition of chiral molecules in large enantiomeric excess that are, however, chiral only by virtue of isotope substitution causes a slight enantiomeric excess in the zinc alkoxide of the produced pyrimidyl alkanol. Asymmetric autocatalysis then leads to pyrimidyl alcohol with a large enantiomeric excess. The sense of enantiomeric excess of the product alcohol varies consistently with the sense of the excess enantiomer of the carbon isotopically chiral compound.	[Kawasaki, Tsuneomi; Matsumura, Yukari; Tsutsumi, Takashi; Suzuki, Kenta; Ito, Masateru; Soai, Kenso] Tokyo Univ Sci, Dept Appl Chem, Shinjuku Ku, Tokyo 1628601, Japan	Tokyo University of Science	Soai, K (corresponding author), Tokyo Univ Sci, Dept Appl Chem, Shinjuku Ku, Tokyo 1628601, Japan.	soai@rs.kagu.tus.ac.jp	Kawasaki, Tsuneomi/Q-2490-2016	Kawasaki, Tsuneomi/0000-0002-6332-2096	The Ministry of Education, Culture, Sports, Science and Technology (MEXT)	The Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology (MEXT). The authors are grateful to the reviewers for helpful discussions.	Arigoni D, 1969, TOP STEREOCHEM, V4, P127, DOI DOI 10.1002/9780470147139.CH4; Barabas B, 2008, ORIGINS LIFE EVOL B, V38, P317, DOI 10.1007/s11084-008-9138-1; BARRON LD, 1972, NATURE, V238, P17, DOI 10.1038/238017a0; Blackmond DG, 2001, J AM CHEM SOC, V123, P10103, DOI 10.1021/ja0165133; Cronin JR, 1997, SCIENCE, V275, P951, DOI 10.1126/science.275.5302.951; Evans MA, 2002, J AM CHEM SOC, V124, P9020, DOI 10.1021/ja026703t; Green MM, 1999, ANGEW CHEM INT EDIT, V38, P3139; GREEN MM, 1993, J AM CHEM SOC, V115, P4941, DOI 10.1021/ja00064a086; Haesler J, 2007, NATURE, V446, P526, DOI 10.1038/nature05653; HOREAU A, 1965, J AM CHEM SOC, V87, P4957, DOI 10.1021/ja00949a051; KATSUKI T, 1980, J AM CHEM SOC, V102, P5974, DOI 10.1021/ja00538a077; Kawasaki T, 2006, CHIRALITY, V18, P479, DOI 10.1002/chir.20273; Kawasaki T, 2006, J AM CHEM SOC, V128, P6032, DOI 10.1021/ja061429e; Lavabre D, 2008, TOP CURR CHEM, V284, P67; Mislow K., 1999, TOPICS STEREOCHEMIST, P1, DOI DOI 10.1002/9780470147313.CH1; MITSUNOBU O, 1967, B CHEM SOC JPN, V40, P2380, DOI 10.1246/bcsj.40.2380; Nakanishi K., 2000, CIRCULAR DICHROISM P; Pracejus H, 1966, TETRAHEDRON LETT, V7, P3809; Prieto O, 2003, TETRAHEDRON-ASYMMETR, V14, P1955, DOI 10.1016/S0957-4166(03)00324-0; Sato I, 2003, ANGEW CHEM INT EDIT, V42, P315, DOI 10.1002/anie.200390105; Sato I, 2000, J AM CHEM SOC, V122, P11739, DOI 10.1021/ja002992e; Shibata T, 1998, J AM CHEM SOC, V120, P12157, DOI 10.1021/ja980815w; Shibata T, 1999, ANGEW CHEM INT EDIT, V38, P659, DOI 10.1002/(SICI)1521-3773(19990301)38:5<659::AID-ANIE659>3.0.CO;2-P; SOAI K, 1992, CHEM REV, V92, P833, DOI 10.1021/cr00013a004; Soai K, 1999, J AM CHEM SOC, V121, P11235, DOI 10.1021/ja993128t; Soai K, 2003, TETRAHEDRON-ASYMMETR, V14, P185, DOI 10.1016/S0957-4166(02)00791-7; SOAI K, 1995, NATURE, V378, P767, DOI 10.1038/378767a0; Tsukamoto M, 2002, ADV SYNTH CATAL, V344, P453, DOI 10.1002/1615-4169(200207)344:5<453::AID-ADSC453>3.0.CO;2-U; WEISSBUCH I, 1991, SCIENCE, V253, P637, DOI 10.1126/science.253.5020.637; Zhao G, 2001, TETRAHEDRON-ASYMMETR, V12, P399, DOI 10.1016/S0957-4166(01)00074-X	30	172	172	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 24	2009	324	5926					492	495		10.1126/science.1170322	http://dx.doi.org/10.1126/science.1170322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	436JU	19325079				2022-12-28	WOS:000265411200041
J	Whitehouse, PJ; George, D				Whitehouse, Peter J.; George, Daniel			The art of medicine Banking on stories for healthier cognitive ageing	LANCET			English	Editorial Material									[Whitehouse, Peter J.] Case Western Reserve Univ, Fairhill Ctr, Cleveland, OH 44120 USA; Univ Oxford Hertford Coll, Oxford, England	Case Western Reserve University; University of Oxford	Whitehouse, PJ (corresponding author), Case Western Reserve Univ, Fairhill Ctr, Cleveland, OH 44120 USA.	peter.whitehouse@case.edu						Ballenger JF, 2006, SELF SENILITY ALZHEI; Kleinman A., 1988, ILLNESS NARRATIVES; Stein J, 2008, ENV THREATS HLTH AGI; Whitehouse P, 2008, MYTH ALZHEIMERS WHAT; WHITEHOUSE PJ, 1997, CONCEPTS ALZHEIMER D	5	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 4	2009	373	9670					1166	1167		10.1016/S0140-6736(09)60672-3	http://dx.doi.org/10.1016/S0140-6736(09)60672-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429SO	19350706				2022-12-28	WOS:000264940600014
J	Adorno, M; Cordenonsi, M; Montagner, M; Dupont, S; Wong, C; Hann, B; Solari, A; Bobisse, S; Rondina, MB; Guzzardo, V; Parenti, AR; Rosato, A; Bicciato, S; Balmain, A; Piccolo, S				Adorno, Maddalena; Cordenonsi, Michelangelo; Montagner, Marco; Dupont, Sirio; Wong, Christine; Hann, Byron; Solari, Aldo; Bobisse, Sara; Rondina, Maria Beatrice; Guzzardo, Vincenza; Parenti, Anna R.; Rosato, Antonio; Bicciato, Silvio; Balmain, Allan; Piccolo, Stefano			A Mutant-p53/Smad Complex Opposes p63 to Empower TGF beta-Induced Metastasis	CELL			English	Article							LI-FRAUMENI-SYNDROME; BREAST-CANCER; HISTOLOGIC GRADE; MOUSE MODEL; P53; PROGRESSION; MUTANT; GAIN; MICE; P73	TGF beta ligands act as tumor suppressors in early stage tumors but are paradoxically diverted into potent prometastatic factors in advanced cancers. The molecular nature of this switch remains enigmatic. Here, we show that TGF beta-dependent cell migration, invasion and metastasis are empowered by mutant-p53 and opposed by p63. Mechanistically, TGF beta acts in concert with oncogenic Ras and mutant-p53 to induce the assembly of a mutant-p53/p63 protein complex in which Smads serve as essential platforms. Within this ternary complex, p63 functions are antagonized. Downstream of p63, we identified two candidate metastasis suppressor genes associated with metastasis risk in a large cohort of breast cancer patients. Thus, two common oncogenic lesions, mutant-p53 and Ras, selected in early neoplasms to promote growth and survival, also prefigure a cellular set-up with particular metastasis proclivity by TGF beta-dependent inhibition of p63 function.	[Adorno, Maddalena; Cordenonsi, Michelangelo; Montagner, Marco; Dupont, Sirio; Piccolo, Stefano] Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, I-35100 Padua, Italy; [Wong, Christine; Hann, Byron; Balmain, Allan] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94115 USA; [Solari, Aldo] Univ Padua, Dept Chem Engn Proc, I-35131 Padua, Italy; [Bobisse, Sara; Rondina, Maria Beatrice; Rosato, Antonio] Univ Padua, Dept Oncol & Surg Sci, I-35126 Padua, Italy; [Bobisse, Sara; Rondina, Maria Beatrice; Rosato, Antonio] Univ Padua, Ist Oncol Veneto, I-35126 Padua, Italy; [Guzzardo, Vincenza; Parenti, Anna R.] Univ Padua, Sect Pathol, Dept Med Diagnost Sci & Special Therapies, I-35126 Padua, Italy; [Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Biomed Sci, I-41100 Modena, Italy	University of Padua; University of California System; University of California San Francisco; University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; University of Padua; Universita di Modena e Reggio Emilia	Piccolo, S (corresponding author), Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, Viale Colombo 3, I-35100 Padua, Italy.	piccolo@civ.bio.unipd.it	Montagner, Marco/AAY-3236-2020; Cordenonsi, Michelangelo/K-7692-2016; Dupont, Sirio/AAP-8133-2021; BICCIATO, Silvio/J-4466-2019; Rosato, Antonio/E-8626-2010; Bicciato, Silvio/C-9825-2009	Montagner, Marco/0000-0003-3080-2138; Cordenonsi, Michelangelo/0000-0002-8253-5724; BICCIATO, Silvio/0000-0002-1944-7078; Rosato, Antonio/0000-0002-5263-8386; Bicciato, Silvio/0000-0002-1944-7078; Dupont, Sirio/0000-0002-6869-1966; SOLARI, ALDO/0000-0003-1243-0385; PICCOLO, STEFANO/0000-0002-2037-0004	Swiss National Science Foundation; Cariparo; NCI [U01 CA84244]; Italian Association on Cancer Research (AIRC); Fondazione Cariparo; NATIONAL CANCER INSTITUTE [U01CA084244] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cariparo(Fondazione Cariparo); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Italian Association on Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariparo(Fondazione Cariparo); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is dedicated to the memory of Stefano Ferrari. We thank O. Wessely, G. Bressan, D. Volpin, G. Del Sal, and all members of the Piccolo group for invaluable discussions and comments on the manuscript; G. Del Sal and J. Girardini for transgenic MEFs; L. Morsut for data-mining; A. Colombatti and P. Spessotto for training with transwell and invasion assays; G. Gallina for microarrays; and G. Blandino, L. W. Ellisen, M. Tripodi, and L. Naldini for gifts of reagents. C.W. is a Swiss National Science Foundation fellow. This work is supported by grants from Cariparo (Excellence grant) to S.B., from NCI (U01 CA84244) to A.B. and from the Italian Association on Cancer Research (AIRC) and Fondazione Cariparo (Excellence grant) to S.P.	Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Caulin C, 2007, J CLIN INVEST, V117, P1893, DOI 10.1172/JCI31721; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Sobin, 2009, UICC TNM CLASSIFICAT; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200	22	615	634	1	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 2	2009	137	1					87	98		10.1016/j.cell.2009.01.039	http://dx.doi.org/10.1016/j.cell.2009.01.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345189	Bronze			2022-12-28	WOS:000264813300016
J	Fowler, DM; Kelly, JW				Fowler, Douglas M.; Kelly, Jeffery W.			Aggregating Knowledge about Prions and Amyloid	CELL			English	Editorial Material							PROTEIN	Prions, self-propagating protein structures that can be transmitted between cells and different organisms, usually consist of ordered protein aggregates. Alberti et al. (2009) now present a systematic approach for the discovery of new prions that expands the spectrum of their biological functions.	[Kelly, Jeffery W.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Kelly, Jeffery W.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Fowler, Douglas M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of Washington; University of Washington Seattle	Kelly, JW (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	jkelly@scripps.edu						Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Johan K, 1998, P NATL ACAD SCI USA, V95, P2558, DOI 10.1073/pnas.95.5.2558; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Nemecek J, 2009, P NATL ACAD SCI USA, V106, P1892, DOI 10.1073/pnas.0812470106; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; PRUSINER SB, 1998, LES PRIX NOBEL, P262; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170	9	9	10	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					20	22		10.1016/j.cell.2009.03.030	http://dx.doi.org/10.1016/j.cell.2009.03.030			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345180	Bronze			2022-12-28	WOS:000264813300007
J	Zaz, T; Turki, H				Zaz, Taoufik; Turki, H.			Lupoid Leishmaniasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zaz, Taoufik; Turki, H.] Serv Dermatol, Sfax 3029, Tunisia	Universite de Sfax	Zaz, T (corresponding author), Serv Dermatol, Sfax 3029, Tunisia.	taoufikzaz@gmail.com							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 2	2009	360	14					E20	E20		10.1056/NEJMicm0708175	http://dx.doi.org/10.1056/NEJMicm0708175			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427AL	19339717				2022-12-28	WOS:000264751800011
J	Gogia, S; Sachdev, HS				Gogia, Siddhartha; Sachdev, Harshpal Singh			Neonatal vitamin A supplementation for prevention of mortality and morbidity in infancy: systematic review of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMMUNE-RESPONSES; CHILD-MORTALITY; SURVIVAL; RISK	Objective To evaluate the effect of neonatal vitamin A supplementation on infant mortality, morbidity and early adverse effects. Design Systematic review, meta-analysis, and meta-regression of randomised controlled trials. Data sources Electronic databases and hand search of reviews; abstracts and proceedings of conferences. Review methods Randomised or quasi-randomised or cluster randomised, placebo controlled trials evaluating the effect of prophylactic, neonatal (<1 month) supplementation with synthetic vitamin A on mortality or morbidity within infancy (<1 year), and early adverse effects (<= 7 days). Results The six included trials were from developing countries. There was no convincing evidence of a reduced risk of mortality during infancy (relative risk 0.92, 95% confidence interval 0.75 to 1.12, P=0.393 random effect; I-2=54.1%) or of an increase in early adverse effects including bulging fontanelle (1.16, 0.81 to 1.65, P=0.418; I-2=65.3%). No variable emerged as a significant predictor of mortality, but data for important risk groups (high maternal night blindness prevalence and low birth weights) were restricted. Limited data (from one to four trials) did not indicate a reduced risk of mortality during the neonatal period (0.90, 0.75 to 1.08, P=0.270; I-2=0%), cause specific mortality, common morbidities (diarrhoea and others), and admission to hospital. There was, however, evidence of an increased risk of acute respiratory infection and a reduced risk of clinic visits. Conclusions There is no convincing evidence of a reduced risk of mortality and possibly morbidity or of increased early adverse effects after neonatal supplementation with vitamin A. There is thus no justification for initiating such supplementation as a public health intervention in developing countries for reducing infant mortality and morbidity.	[Gogia, Siddhartha; Sachdev, Harshpal Singh] Sitaram Bhartia Inst Sci & Res, Dept Paediat & Clin Epidemiol, New Delhi 110016, India	Sitaram Bhartia Institute of Science & Research	Sachdev, HS (corresponding author), E-6-12 Vasant Vihar, New Delhi 110057, India.	hpssachdev@gmail.com		Sachdev, Harshpal Singh/0000-0002-4956-9391	Departments of Child and Adolescent Health and Development; Nutrition for Health and Development; World Health Organization, Geneva	Departments of Child and Adolescent Health and Development; Nutrition for Health and Development; World Health Organization, Geneva(World Health Organization)	Funding: This study was funded by Departments of Child and Adolescent Health and Development, and Nutrition for Health and Development, World Health Organization, Geneva. The funding source had no involvement in the study or the decision to publish the manuscript.	Adamson J, 2006, CONTEMP CLIN TRIALS, V27, P305, DOI 10.1016/j.cct.2005.11.003; AWASTHI S, 6 MONTHLY VITAMIN A; Beaton G, 1993, ACC SCN STATE ART SE; Benn CS, 2008, BMJ; Bhutta ZA, 2008, LANCET, V371, P1746, DOI 10.1016/S0140-6736(08)60751-5; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Brookes ST, 2004, J CLIN EPIDEMIOL, V57, P229, DOI 10.1016/j.jclinepi.2003.08.009; Cravioto J., 1990, NFI Bulletin, V11, P5; Darlow BA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000501.pub2; DAULAIRE NMP, 1992, BMJ-BRIT MED J, V304, P207, DOI 10.1136/bmj.304.6821.207; FAWZI WW, 1993, JAMA-J AM MED ASSOC, V269, P898, DOI 10.1001/jama.269.7.898; GLASZIOU PP, 1993, BMJ-BRIT MED J, V306, P366, DOI 10.1136/bmj.306.6874.366; GOGIA S, 2008, LANCET, V371, P417; GOPALAN C, 1992, NFI B, V13, P1; Grotto I, 2003, J PEDIATR-US, V142, P297, DOI 10.1067/mpd.2003.116; HARBORD R, 1998, STATA TECHNICAL B, V42, P16; Harris R, 1999, STATA TECH B, V44, P4; Higgins J., 2008, Cochrane Handbook for Systematic Reviews of Interventions Version, P510; Higgins J. P. T., 2008, COCHRANE HDB SYSTEMA, P488; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kapil Umesh, 2005, Indian J Public Health, V49, P7; Katz J, 2000, AM J CLIN NUTR, V71, P1570; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Martines J, 1998, LANCET, V352, P1257, DOI 10.1016/S0140-6736(98)02487-8; Newton S, 2005, J NUTR, V135, P2669, DOI 10.1093/jn/135.11.2669; Newton S, 2007, J NUTR, V137, P1272, DOI 10.1093/jn/137.5.1272; RAHMATHULLAH L, 1990, NEW ENGL J MED, V323, P929, DOI 10.1056/NEJM199010043231401; ROSS DA, 1993, LANCET, V342, P7, DOI 10.1016/0140-6736(93)91879-Q; Sachdev HPS, 2008, LANCET, V371, P1746, DOI 10.1016/S0140-6736(08)60750-3; Steichen TJ, 1998, STATA TECHNICAL B, V44, P3; Sterne J. A. C., 2008, SYSTEMATIC REV HLTH, V323, P189, DOI [10.1002/9780470693926.ch11, DOI 10.1002/9780470693926.CH11]; Tielsch JM, 2008, BMJ-BRIT MED J, V336, P1385, DOI 10.1136/bmj.39575.486609.80; *UN DEV PROGR, HUM DEV REP 2006; Webb P, 2007, NUTR REV, V65, P233, DOI [10.1301/nr.2007.may.233-245, 10.1111/j.1753-4887.2007.tb00300.x]; WEST KP, 1991, LANCET, V338, P67, DOI 10.1016/0140-6736(91)90070-6; Wieringa FT, 2007, BRIT J NUTR, V98, P1070, DOI 10.1017/S0007114507756945; Wiysonge CS, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003648.pub2	38	52	54	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2009	338								b919	10.1136/bmj.b919	http://dx.doi.org/10.1136/bmj.b919			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LS	19329516	Green Published, hybrid			2022-12-28	WOS:000264639800014
J	Matsumoto-Miyai, K; Sokolowska, E; Zurlinden, A; Gee, CE; Luscher, D; Hettwer, S; Wolfel, J; Ladner, AP; Ster, J; Gerber, U; Rulicke, T; Kunz, B; Sonderegger, P				Matsumoto-Miyai, Kazumasa; Sokolowska, Ewa; Zurlinden, Andreas; Gee, Christine E.; Luescher, Daniel; Hettwer, Stefan; Woelfel, Jens; Ladner, Ana Paula; Ster, Jeanne; Gerber, Urs; Ruelicke, Thomas; Kunz, Beat; Sonderegger, Peter			Coincident Pre- and Postsynaptic Activation Induces Dendritic Filopodia via Neurotrypsin-Dependent Agrin Cleavage	CELL			English	Article							LONG-TERM POTENTIATION; NEOCORTEX IN-VIVO; HIPPOCAMPAL-NEURONS; SPINE FORMATION; NEUROMUSCULAR-JUNCTION; SYNAPTIC-TRANSMISSION; MENTAL-RETARDATION; NERVOUS-SYSTEM; AREA CA1; GROWTH	The synaptic serine protease neurotrypsin is essential for cognitive function, as its deficiency in humans results in severe mental retardation. Recently, we demonstrated the activity-dependent release of neurotrypsin from presynaptic terminals and proteolytical cleavage of agrin at the synapse. Here we show that the activity-dependent formation of dendritic filopodia is abolished in hippocampal neurons from neurotrypsin-deficient mice. Administration of the neurotrypsin-dependent 22 kDa fragment of agrin rescues the filopodial response. Detailed analyses indicated that presynaptic action potential firing is necessary for the release of neurotrypsin, whereas postsynaptic NMDA receptor activation is necessary for the neurotrypsin-dependent cleavage of agrin. This contingency characterizes the neurotrypsinagrin system as a coincidence detector of pre-and postsynaptic activation. As the resulting dendritic filopodia are thought to represent precursors of synapses, the neurotrypsin-dependent cleavage of agrin at the synapse may be instrumental for a Hebbian organization and remodeling of synaptic circuits in the CNS.	[Matsumoto-Miyai, Kazumasa; Sokolowska, Ewa; Zurlinden, Andreas; Luescher, Daniel; Woelfel, Jens; Ladner, Ana Paula; Kunz, Beat; Sonderegger, Peter] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [Gee, Christine E.; Ster, Jeanne; Gerber, Urs] Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland; [Ruelicke, Thomas] Univ Zurich, Inst Lab Anim Sci, CH-8057 Zurich, Switzerland; [Hettwer, Stefan] Neurotune AG, CH-8952 Schlieren, Switzerland	University of Zurich; University of Zurich; University of Zurich	Sonderegger, P (corresponding author), Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland.	peter.sonderegger@bioc.uzh.ch	Gee, Christine E/E-9241-2013	Gee, Christine E/0000-0003-0345-3665; Ster, Jeanne/0000-0002-7277-9135	Swiss National Science Foundation; Olga Mayenfisch Stiftung; Neurotune AG	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Olga Mayenfisch Stiftung; Neurotune AG	We thank P. Caroni for the mouse line L15 expressing membrane-targeted GFP in sparse neurons, G. Miesenbock for the cDNA of superecliptic pHluorin, D. Blaser for mouse husbandry, and B. Gahwiler for critical reading of the manuscript. This work was supported by grants of the Swiss National Science Foundation, the National Center of Competence in Research "Brain Plasticity and Repair'' of the Swiss National Science Foundation, and the Olga Mayenfisch Stiftung. P. S. is a cofounder and minor shareholder (<1%) of Neurotune AG. Part of this work (<10%) was financially supported by Neurotune AG.	Annies M, 2006, MOL CELL NEUROSCI, V31, P515, DOI 10.1016/j.mcn.2005.11.005; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 1998, J NEUROSCI, V18, P8900; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Frischknecht R, 2008, J NEUROSCI, V28, P1568, DOI 10.1523/JNEUROSCI.3398-07.2008; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Gschwend TP, 1997, MOL CELL NEUROSCI, V9, P207, DOI 10.1006/mcne.1997.0616; HANSE E, 1994, J NEUROSCI, V14, P5028; Hebb Donald O., 1949, ORG BEHAV; Hilgenberg LGW, 2006, CELL, V125, P359, DOI 10.1016/j.cell.2006.01.052; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; HUANG YY, 1993, J NEUROSCI, V13, P568; HUBER KM, 1995, J NEUROPHYSIOL, V73, P270, DOI 10.1152/jn.1995.73.1.270; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Jourdain P, 2003, J NEUROSCI, V23, P10645; Khalilov I, 1997, NEURON, V19, P743, DOI 10.1016/S0896-6273(00)80956-3; Knott G, 2008, BRAIN RES REV, V58, P282, DOI 10.1016/j.brainresrev.2008.01.002; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Koulen P, 1999, EUR J NEUROSCI, V11, P4188, DOI 10.1046/j.1460-9568.1999.00848.x; Ksiazek I, 2007, J NEUROSCI, V27, P7183, DOI 10.1523/JNEUROSCI.1609-07.2007; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Li J, 2001, NEUROSCIENCE, V105, P589, DOI 10.1016/S0306-4522(01)00204-4; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McCroskery S, 2006, MOL CELL NEUROSCI, V33, P15, DOI 10.1016/j.mcn.2006.06.004; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Molinari F, 2002, SCIENCE, V298, P1779, DOI 10.1126/science.1076521; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nikonenko I, 2002, HIPPOCAMPUS, V12, P585, DOI 10.1002/hipo.10095; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Reif R, 2007, FASEB J, V21, P3468, DOI 10.1096/fj.07-8800com; Saito Y, 1997, J NEUROSCI, V17, P8792; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Stephan A, 2008, FASEB J, V22, P1861, DOI 10.1096/fj.07-100008; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; VAUGHN JE, 1974, J CELL BIOL, V60, P664, DOI 10.1083/jcb.60.3.664; Wolfer DP, 2001, MOL CELL NEUROSCI, V18, P407, DOI 10.1006/mcne.2001.1029; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	54	83	87	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1161	1171		10.1016/j.cell.2009.02.034	http://dx.doi.org/10.1016/j.cell.2009.02.034			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303856	Bronze, Green Accepted			2022-12-28	WOS:000264403900020
J	Pirrotta, V				Pirrotta, Vincenzo			Polycomb Repression under the Skin	CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; GENES; METHYLATION	Polycomb group proteins control a hierarchy of gene expression during the differentiation of stem cells. In this issue, Ezhkova et al. (2009) show that repression mediated by Polycomb proteins controls the timing of differentiation of precursor cells of the epidermal lineage.	Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Pirrotta, V (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.	pirrotta@dls.rutgers.edu						Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663	8	2	2	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 20	2009	136	6					992	994		10.1016/j.cell.2009.03.004	http://dx.doi.org/10.1016/j.cell.2009.03.004			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303840	Bronze			2022-12-28	WOS:000264403900003
J	Shafazand, S				Shafazand, Shirin			Review: Long-acting beta-agonists do not increase risk for asthma-related hospitalization in patients taking inhaled corticosteroids	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Miami, Miller Sch Med, Miami, FL 33136 USA	University of Miami	Shafazand, S (corresponding author), Univ Miami, Miller Sch Med, Miami, FL 33136 USA.							Jaeschke R, 2008, AM J RESP CRIT CARE, V178, P1009, DOI 10.1164/rccm.200804-494OC; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6							JC3-5	10.7326/0003-4819-150-6-200903170-02005	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423AJ	19306487				2022-12-28	WOS:000264468500028
J	Ramsey, KM; Yoshino, J; Brace, CS; Abrassart, D; Kobayashi, Y; Marcheva, B; Hong, HK; Chong, JL; Buhr, ED; Lee, C; Takahashi, JS; Imai, SI; Bass, J				Ramsey, Kathryn Moynihan; Yoshino, Jun; Brace, Cynthia S.; Abrassart, Dana; Kobayashi, Yumiko; Marcheva, Biliana; Hong, Hee-Kyung; Chong, Jason L.; Buhr, Ethan D.; Lee, Choogon; Takahashi, Joseph S.; Imai, Shin-ichiro; Bass, Joseph			Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD(+) Biosynthesis	SCIENCE			English	Article							NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; GLUCOSE-HOMEOSTASIS; CALORIE RESTRICTION; LIFE-SPAN; SIRT1; TRANSCRIPTION; EXTENSION; COMPONENT; BINDING; CELLS	The circadian clock is encoded by a transcription-translation feedback loop that synchronizes behavior and metabolism with the light-dark cycle. Here we report that both the rate-limiting enzyme in mammalian nicotinamide adenine dinucleotide (NAD(+)) biosynthesis, nicotinamide phosphoribosyltransferase (NAMPT), and levels of NAD(+) display circadian oscillations that are regulated by the core clock machinery in mice. Inhibition of NAMPT promotes oscillation of the clock gene Per2 by releasing CLOCK: BMAL1 from suppression by SIRT1. In turn, the circadian transcription factor CLOCK binds to and up-regulates Nampt, thus completing a feedback loop involving NAMPT/NAD(+) and SIRT1/CLOCK:BMAL1.	[Yoshino, Jun; Brace, Cynthia S.; Imai, Shin-ichiro] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Ramsey, Kathryn Moynihan; Abrassart, Dana; Kobayashi, Yumiko; Marcheva, Biliana; Bass, Joseph] Northwestern Univ, Feinberg Sch Med, Dept Med, Evanston, IL 60208 USA; [Ramsey, Kathryn Moynihan; Abrassart, Dana; Kobayashi, Yumiko; Marcheva, Biliana; Hong, Hee-Kyung; Chong, Jason L.; Buhr, Ethan D.; Takahashi, Joseph S.; Bass, Joseph] Northwestern Univ, Feinberg Sch Med, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Ramsey, Kathryn Moynihan; Kobayashi, Yumiko; Bass, Joseph] NorthShore Univ Hlth Syst Res Inst, Evanston, IL 60201 USA; [Ramsey, Kathryn Moynihan; Kobayashi, Yumiko; Bass, Joseph] Evanston Hosp Corp, Dept Med, Evanston, IL 60201 USA; [Lee, Choogon] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Takahashi, Joseph S.] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA	Washington University (WUSTL); Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; NorthShore University Health System; NorthShore University Health System; State University System of Florida; Florida State University; Howard Hughes Medical Institute; Northwestern University	Imai, SI (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA.	imaishin@wustl.edu; j-bass@northwestern.edu	Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012	Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878; Buhr, Ethan/0000-0002-9250-6644; Marcheva, Biliana/0000-0001-8697-2625; Yoshino, Jun/0000-0001-9833-4356	National Institute of Diabetes and Digestive and Kidney Diseases [T32 DK007169]; National Institute on Aging [AG02150]; Ellison Medical Foundation; Longer Life Foundation; NIH [PO1 AG011412]; Chicago Biomedical Consortium Searle Funds; Juvenile Diabetes Research Foundation; National Institute of Mental Health [P50 MH074924]; Japan Research Foundation for Clinical Pharmacology; Keio University Medical Science Fund; Amylin Pharmaceuticals; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011412, R01AG024150] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); Longer Life Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium Searle Funds; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Japan Research Foundation for Clinical Pharmacology; Keio University Medical Science Fund; Amylin Pharmaceuticals(Bristol-Myers Squibb); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S.-H. Yoo and members of the Bass, Imai, and Takahashi laboratories for discussions. Work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK007169) to K.M.R.; the National Institute on Aging (AG02150), the Ellison Medical Foundation, and the Longer Life Foundation to S.I.; NIH (PO1 AG011412), the Chicago Biomedical Consortium Searle Funds, and the Juvenile Diabetes Research Foundation to J.B.; and a grant from the National Institute of Mental Health (P50 MH074924) to J.S.T. J.Y. is supported by the Japan Research Foundation for Clinical Pharmacology and Keio University Medical Science Fund, J.S.T. is an Investigator in the Howard Hughes Medical Institute and a cofounder of ReSet Therapeutics, and J.S.T. and J.B. are members of its scientific advisory board. J.B. is also an adviser and receives support from Amylin Pharmaceuticals. S.I. holds a patent related to the work reported in this paper, specifically NAMPT and NMN.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Barnea M, 2009, ENDOCRINOLOGY, V150, P161, DOI 10.1210/en.2008-0944; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Hasmann M, 2003, CANCER RES, V63, P7436; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035	25	785	832	10	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	2009	324	5927					651	654		10.1126/science.1171641	http://dx.doi.org/10.1126/science.1171641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19299583	Green Accepted			2022-12-28	WOS:000265608800047
J	Kasparian, J; Wolf, JP				Kasparian, Jerome; Wolf, Jean-Pierre			Laser Beams Take a Curve	SCIENCE			English	Editorial Material							LIGHT FILAMENTS; TRANSPARENT MEDIA; PHYSICS		[Kasparian, Jerome; Wolf, Jean-Pierre] Univ Geneva, GAP Biophoton, CH-1211 Geneva 4, Switzerland	University of Geneva	Kasparian, J (corresponding author), Univ Geneva, GAP Biophoton, 20 Rue Ecole Med, CH-1211 Geneva 4, Switzerland.	jerome.kasparian@unige.ch; jean-pierre.wolf@unige.ch	Kasparian, Jerome/K-4700-2013; Wolf, Jean-Pierre/B-8315-2012	Kasparian, Jerome/0000-0003-2398-3882; Wolf, Jean-Pierre/0000-0003-3729-958X				BERRY MV, 1979, AM J PHYS, V47, P264, DOI 10.1119/1.11855; Besieris IM, 2007, OPT LETT, V32, P2447, DOI 10.1364/OL.32.002447; Broky J, 2008, OPT EXPRESS, V16, P12880, DOI 10.1364/OE.16.012880; Chin SL, 2005, CAN J PHYS, V83, P863, DOI 10.1139/P05-048; Couairon A, 2007, PHYS REP, V441, P47, DOI 10.1016/j.physrep.2006.12.005; Courvoisier F, 2003, APPL PHYS LETT, V83, P213, DOI 10.1063/1.1592615; Faccio D, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.193901; Kasparian J, 2000, APPL PHYS B-LASERS O, V71, P877, DOI 10.1007/s003400000463; Kasparian J, 2008, OPT EXPRESS, V16, P5757, DOI 10.1364/OE.16.005757; Kasparian J, 2008, OPT EXPRESS, V16, P466, DOI 10.1364/OE.16.000466; Martinez-Herrero R, 2008, OPT COMMUN, V281, P3046, DOI 10.1016/j.optcom.2008.02.005; Polesana P, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.043814; Polynkin P, 2009, SCIENCE, V324, P229, DOI 10.1126/science.1169544; *SWISS NSF, 2000211161981 SWISS	16	22	22	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					194	195		10.1126/science.1172244	http://dx.doi.org/10.1126/science.1172244			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359574				2022-12-28	WOS:000265024400030
J	Miller, SJ				Miller, Scott J.			Total Chemical Synthesis Peers into the Biosynthetic Black Box	SCIENCE			English	Editorial Material							EPIDITHIODIOXOPIPERAZINES		Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University	Miller, SJ (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.	scott.miller@yale.edu	Miller, Scott/N-7761-2017	Miller, Scott/0000-0001-7817-1318				Chen Y, 2005, BIOCHEM BIOPH RES CO, V329, P1334, DOI 10.1016/j.bbrc.2005.02.115; Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; CRISPINO GA, 1993, SCIENCE, V259, P64, DOI 10.1126/science.8418495; Fox EM, 2008, MYCOL RES, V112, P162, DOI 10.1016/j.mycres.2007.08.017; FUKUYAMA T, 1981, TETRAHEDRON, V37, P2045, DOI 10.1016/S0040-4020(01)97960-8; Gardiner DM, 2005, MICROBIOL-SGM, V151, P1021, DOI 10.1099/mic.0.27847-0; Kim J, 2009, SCIENCE, V324, P238, DOI 10.1126/science.1170777; KIRBY GW, 1980, BIOSYNTH MYCOTOX, P301; KISHI Y, 1973, J AM CHEM SOC, V95, P6490, DOI 10.1021/ja00800a077; Movassaghi M, 2007, ANGEW CHEM INT EDIT, V46, P3725, DOI 10.1002/anie.200700705; Nicolaou KC, 2000, ANGEW CHEM INT EDIT, V39, P44; Overman LE, 2007, ORG LETT, V9, P5267, DOI 10.1021/ol702518t; Son BW, 1999, NAT PROD LETT, V13, P213, DOI 10.1080/10575639908048788; WILLIAMS RM, 1980, J ORG CHEM, V45, P2625, DOI 10.1021/jo01301a017	14	5	5	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					186	187		10.1126/science.1172081	http://dx.doi.org/10.1126/science.1172081			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359569				2022-12-28	WOS:000265024400025
J	Cyr-Choiniere, O; Daou, R; Laliberte, F; LeBoeuf, D; Doiron-Leyraud, N; Chang, J; Yan, JQ; Cheng, JG; Zhou, JS; Goodenough, JB; Pyon, S; Takayama, T; Takagi, H; Tanaka, Y; Taillefer, L				Cyr-Choiniere, Olivier; Daou, R.; Laliberte, Francis; LeBoeuf, David; Doiron-Leyraud, Nicolas; Chang, J.; Yan, J. -Q.; Cheng, J. -G.; Zhou, J. -S.; Goodenough, J. B.; Pyon, S.; Takayama, T.; Takagi, H.; Tanaka, Y.; Taillefer, Louis			Enhancement of the Nernst effect by stripe order in a high-T-c superconductor	NATURE			English	Article							FERMI-SURFACE	The Nernst effect in metals is highly sensitive to two kinds of phase transition: superconductivity and density-wave order(1). The large, positive Nernst signal observed in hole-doped high-T-c superconductors(2) above their transition temperature (T-c) has so far been attributed to fluctuating superconductivity(3). Here we report that in some of these materials the large Nernst signal is in fact the result of stripe order, a form of spin/charge modulation(4) that causes a reconstruction of the Fermi surface(5). In La2-xSrxCuO4 (LSCO) doped with Nd or Eu, the onset of stripe order causes the Nernst signal to change from being small and negative to being large and positive, as revealed either by lowering the hole concentration across the quantum critical point in Nd-doped LSCO (refs 6-8) or by lowering the temperature across the ordering temperature in Eu-doped LSCO (refs 9, 10). In the second case, two separate peaks are resolved, respectively associated with the onset of stripe order at high temperature and superconductivity near T-c.	[Cyr-Choiniere, Olivier; Daou, R.; Laliberte, Francis; LeBoeuf, David; Doiron-Leyraud, Nicolas; Chang, J.; Taillefer, Louis] Univ Sherbrooke, Dept Phys, Sherbrooke, PQ J1K 2R1, Canada; [Cyr-Choiniere, Olivier; Daou, R.; Laliberte, Francis; LeBoeuf, David; Doiron-Leyraud, Nicolas; Chang, J.; Taillefer, Louis] Univ Sherbrooke, RQMP, Sherbrooke, PQ J1K 2R1, Canada; [Yan, J. -Q.; Cheng, J. -G.; Zhou, J. -S.; Goodenough, J. B.] Univ Texas Austin, Texas Mat Inst, Austin, TX 78712 USA; [Pyon, S.; Takayama, T.; Takagi, H.; Tanaka, Y.] Univ Tokyo, Dept Adv Mat, Kashiwa, Chiba 2778561, Japan; [Takagi, H.] RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan; [Tanaka, Y.] RIKEN, SPring8 Ctr, Mikazuki, Hyogo 6795148, Japan; [Taillefer, Louis] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada	University of Sherbrooke; University of Sherbrooke; University of Texas System; University of Texas Austin; University of Tokyo; RIKEN; RIKEN; Canadian Institute for Advanced Research (CIFAR)	Taillefer, L (corresponding author), Univ Sherbrooke, Dept Phys, Sherbrooke, PQ J1K 2R1, Canada.	louis.taillefer@physique.usherbrooke.ca	PYON, Sunseng/B-2618-2011; Chang, Johan/F-1506-2014; Takagi, Hidenori/B-2935-2010; Cheng, Jinguang/A-8342-2012; TAKAGI, HIDENORI/Q-1041-2019; Biradar, Nirmala/AAY-2295-2020	Chang, Johan/0000-0002-4655-1516; Cheng, Jinguang/0000-0002-4969-1960; TAKAGI, HIDENORI/0000-0001-5700-3761; Yan, Jiaqiang/0000-0001-6625-4706; Goodenough, John Bannister/0000-0001-9350-3034; Pyon, Sunseng/0000-0002-5716-1791	Swiss National Science Foundation; US National Science Foundation; MEXT Japan; National Science and Engineering Research Council of Canada; Fonds Quebecois de la Recherche sur la Nature et les Technologies and a Canada Research Chair	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); US National Science Foundation(National Science Foundation (NSF)); MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Quebecois de la Recherche sur la Nature et les Technologies and a Canada Research Chair(Canada Research Chairs)	We thank K. Behnia, S. Sachdev and A.-M. S. Tremblay for discussions, and J. Corbin for his assistance with the experiments. J. C. is supported by a Fellowship from the Swiss National Science Foundation. J.-S.Z. and J. B. G. were supported by a US National Science Foundation grant. H. T. acknowledges MEXT Japan for a Grant-in-Aid for Scientific Research. L. T. acknowledges support from the Canadian Institute for Advanced Research and funding from the National Science and Engineering Research Council of Canada, the Fonds Quebecois de la Recherche sur la Nature et les Technologies and a Canada Research Chair.	Behnia K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.076603; Behnia K, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/11/113101; Bel R, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.220501; Chakravarty S, 2008, SCIENCE, V319, P735, DOI 10.1126/science.1154320; Daou R, 2009, NAT PHYS, V5, P31, DOI [10.1038/nphys1109, 10.1038/NPHYS1109]; DAOU R, 2008, THREMOPOWER PSEUDOGA; Doiron-Leyraud N, 2007, NATURE, V447, P565, DOI 10.1038/nature05872; FINK J, 2008, CHARGE ORDER LA1 8 X; HACKL A, 2009, NERNST EFFECT ELECT; Hunt AW, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.134525; Ichikawa N, 2000, PHYS REV LETT, V85, P1738, DOI 10.1103/PhysRevLett.85.1738; LeBoeuf D, 2007, NATURE, V450, P533, DOI 10.1038/nature06332; Li PC, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.174512; Lin J, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.115108; Millis AJ, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.220503; TAILLEFER L, 2009, J PHYS COND IN PRESS; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Xu ZA, 2000, NATURE, V406, P486, DOI 10.1038/35020016	19	112	112	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 9	2009	458	7239					743	745		10.1038/nature07931	http://dx.doi.org/10.1038/nature07931			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19360083				2022-12-28	WOS:000265193600036
J	Bland, JM; Altman, DG				Bland, J. Martin; Altman, Douglas G.			Practice Statistics Notes Analysis of continuous data from small samples	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bland, J. Martin] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Wolfson Coll Annexe, Oxford OX2 6UD, England	University of York - UK; University of Oxford	Bland, JM (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	mb55@york.ac.uk						ALTMAN DG, 1991, PRACTICAL STAT MED R, P224; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3167; BAKER CJ, 1980, NEW ENGL J MED, V303, P173, DOI 10.1056/NEJM198007243030401; SIEGEL S, 1956, NONPARAMETRIC STAT B, P32	4	40	40	0	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 6	2009	338								a3166	10.1136/bmj.a3166	http://dx.doi.org/10.1136/bmj.a3166			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431ZF	19349342				2022-12-28	WOS:000265102600001
J	Taggart, DP				Taggart, David P.			PCI or CABG in coronary artery disease?	LANCET			English	Editorial Material							BYPASS GRAFT; SURVIVAL; MULTIVESSEL; REVASCULARIZATION; INTERVENTION; OUTCOMES; TRIALS; STENTS		Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England	University of Oxford	Taggart, DP (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England.	David.Taggart@orh.nhs.uk						Bair TL, 2007, CIRCULATION, V116, pI226, DOI 10.1161/CIRCULATIONAHA.106.681346; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bravata DM, 2007, ANN INTERN MED, V147, P703, DOI 10.7326/0003-4819-147-10-200711200-00185; Brener SJ, 2004, CIRCULATION, V109, P2290, DOI 10.1161/01.CIR.0000126826.58526.14; Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048; Hannan EL, 2008, NEW ENGL J MED, V358, P331, DOI 10.1056/NEJMoa071804; Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; Hoffman SN, 2003, J AM COLL CARDIOL, V41, P1293, DOI 10.1016/S0735-1097(03)00157-8; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101; Lytle BW, 2004, ANN THORAC SURG, V78, P2005, DOI 10.1016/j.athoracsur.2004.05.070; Malenka DJ, 2005, CIRCULATION, V112, pI371, DOI 10.1161/CIRCULATIONAHA.104.526392; Niles NW, 2001, J AM COLL CARDIOL, V37, P1008, DOI 10.1016/S0735-1097(00)01205-5; Pell JP, 2004, DIABETIC MED, V21, P790, DOI 10.1111/j.1464-5491.2004.01171.x; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Smith PK, 2006, ANN THORAC SURG, V82, P1420, DOI 10.1016/j.athoracsur.2006.04.044; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Taggart DP, 2006, ANN THORAC SURG, V82, P1966, DOI 10.1016/j.athoracsur.2006.06.035; Taggart DP, 2001, LANCET, V358, P870, DOI 10.1016/S0140-6736(01)06069-X; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1	21	26	29	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2009	373	9670					1150	1152		10.1016/S0140-6736(09)60574-2	http://dx.doi.org/10.1016/S0140-6736(09)60574-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429SO	19303631				2022-12-28	WOS:000264940600006
J	Bethke, A; Fielenbach, N; Wang, Z; Mangelsdorf, DJ; Antebi, A				Bethke, Axel; Fielenbach, Nicole; Wang, Zhu; Mangelsdorf, David J.; Antebi, Adam			Nuclear Hormone Receptor Regulation of MicroRNAs Controls Developmental Progression	SCIENCE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; DAUER FORMATION; DAF-12; IDENTIFICATION; MUTATIONS; ENCODES; MIR-48; LARVAL; LIN-14	In response to small-molecule signals such as retinoids or steroids, nuclear receptors activate gene expression to regulate development in different tissues. MicroRNAs turn off target gene expression within cells by binding complementary regions in messenger RNA transcripts, and they have been broadly implicated in development and disease. Here we show that the Caenorhabditis elegans nuclear receptor DAF-12 and its steroidal ligand directly activate promoters of let-7 microRNA family members to down-regulate the microRNA target hbl-1, which drives progression of epidermal stem cells from second to third larval stage patterns of cell division. Conversely, the receptor without the ligand represses microRNA expression during developmental arrest. These findings identify microRNAs as components of a hormone-coupled molecular switch that shuts off earlier developmental programs to allow for later ones.	[Bethke, Axel; Fielenbach, Nicole; Antebi, Adam] Baylor Coll Med, Dept Mol & Cellular Biol, Huffington Ctr Aging, Houston, TX 77030 USA; [Bethke, Axel] Univ Osnabruck, Fachbereich Biol Chem, D-49069 Osnabruck, Germany; [Wang, Zhu; Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Wang, Zhu; Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Antebi, Adam] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany	Baylor College of Medicine; University Osnabruck; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Max Planck Society	Antebi, A (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Huffington Ctr Aging, 1 Baylor Plaza, Houston, TX 77030 USA.	aantebi@bcm.edu	Wang, Zhu/H-3844-2013	Mangelsdorf, David/0000-0002-4355-0796	NIH [GM077201]; Ellison Medical Foundation; Howard Hughes Medical Institute; Robert A. Welch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077201] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Our thanks go to G. Hayes, G. Ruvkun, V. Ambros, and A. Rougvie for strains; N. Timchenko for gel shift support; and D. Magner, S. Greene, and F. Schroeder for manuscript comments. This work was supported by NIH grant GM077201 and the Ellison Medical Foundation (A.A.), and the Howard Hughes Medical Institute and the Robert A. Welch Foundation (D.J.M.).	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Antebi A, 2000, GENE DEV, V14, P1512; Antebi A, 1998, DEVELOPMENT, V125, P1191; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; CHALFIE M, 1981, CELL, V24, P59, DOI 10.1016/0092-8674(81)90501-8; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Hayes GD, 2006, DEVELOPMENT, V133, P4631, DOI 10.1242/dev.02655; Jia KL, 2002, DEVELOPMENT, V129, P221; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li M, 2005, DEV CELL, V9, P415, DOI 10.1016/j.devcel.2005.08.002; Ludewig AH, 2004, GENE DEV, V18, P2120, DOI 10.1101/gad.312604; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rougvie AE, 2005, DEVELOPMENT, V132, P3787, DOI 10.1242/dev.01972; Shostak Y, 2004, GENE DEV, V18, P2529, DOI 10.1101/gad.1218504; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	21	122	134	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					95	98		10.1126/science.1164899	http://dx.doi.org/10.1126/science.1164899			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342589	Green Accepted			2022-12-28	WOS:000264802100040
J	Kloxin, AM; Kasko, AM; Salinas, CN; Anseth, KS				Kloxin, April M.; Kasko, Andrea M.; Salinas, Chelsea N.; Anseth, Kristi S.			Photodegradable Hydrogels for Dynamic Tuning of Physical and Chemical Properties	SCIENCE			English	Article							MESENCHYMAL STEM-CELLS; CHONDROGENIC DIFFERENTIATION; BEHAVIOR; TISSUE; DEGRADATION; MIGRATION; GROWTH; BIOMATERIALS; NETWORKS; POLYMERS	We report a strategy to create photodegradable poly(ethylene glycol)-based hydrogels through rapid polymerization of cytocompatible macromers for remote manipulation of gel properties in situ. Postgelation control of the gel properties was demonstrated to introduce temporal changes, creation of arbitrarily shaped features, and on-demand pendant functionality release. Channels photodegraded within a hydrogel containing encapsulated cells allow cell migration. Temporal variation of the biochemical gel composition was used to influence chondrogenic differentiation of encapsulated stem cells. Photodegradable gels that allow real-time manipulation of material properties or chemistry provide dynamic environments with the scope to answer fundamental questions about material regulation of live cell function and may affect an array of applications from design of drug delivery vehicles to tissue engineering systems.	[Kloxin, April M.; Kasko, Andrea M.; Salinas, Chelsea N.; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Kasko, Andrea M.; Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Anseth, KS (corresponding author), Univ Colorado, Dept Chem & Biol Engn, 424 UCB ECCH 111, Boulder, CO 80309 USA.	Kristi.Anseth@colorado.edu			Howard Hughes Medical Institute; NIH [DE12998, DE16523]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012998] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank C. Bowman, T. Scott, and C. Kloxin for comments on early versions of this manuscript and valuable discussions; A. Aimetti for peptide synthesis training; J. McCall and S. Anderson for cell culture assistance; M. Schwartz for cell migration discussions; C. Bowman and his laboratory for use of and assistance with the rheometer and profilometer; C. Kloxin for assistance with image analysis; C. DeForest, Carl Zeiss, Inc., and the Howard Hughes Medical Institute Janelia Farms campus for assistance with and use of the Zeiss 710 two-photon confocal LSM; and the Howard Hughes Medical Institute and the NIH (grants DE12998 and DE16523) for research support. A.K. thanks the NASA Graduate Student Researchers Program fellowship and the Department of Education Graduate Assistance in Areas of National Need fellowship for support. A patent related to this work has been submitted (U.S. Patent Application No. 11/374,471).	Alvarez M, 2008, ADV MATER, V20, P4563, DOI 10.1002/adma.200800746; [Anonymous], 1991, INTRO POLYM; Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004; Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805; BRYANT SJ, 2005, SCAFFOLDING TISSUE E, P69; Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647; Hudalla GA, 2008, BIOMACROMOLECULES, V9, P842, DOI 10.1021/bm701179s; Kenny PA, 2003, INT J CANCER, V107, P688, DOI 10.1002/ijc.11491; Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021; KHAN SA, 1992, RHEOL ACTA, V31, P151, DOI 10.1007/BF00373237; Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202; Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007; Metters A, 2005, BIOMACROMOLECULES, V6, P290, DOI 10.1021/bm049607o; Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004; Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682; Rice MA, 2006, BIOMACROMOLECULES, V7, P1968, DOI 10.1021/bm060086+; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035; Salinas CN, 2007, TISSUE ENG, V13, P1025, DOI 10.1089/ten.2006.0126; Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004; Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Tavella S, 1997, J CELL SCI, V110, P2261; Tayalia P, 2008, ADV MATER, V20, P4494, DOI 10.1002/adma.200801319; Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616; Wosnick JH, 2008, CHEM MATER, V20, P55, DOI 10.1021/cm071158m; Zhao YR, 2004, J AM CHEM SOC, V126, P4653, DOI 10.1021/ja036958m	34	1290	1341	31	1036	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					59	63		10.1126/science.1169494	http://dx.doi.org/10.1126/science.1169494			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	427TN	19342581	Green Accepted			2022-12-28	WOS:000264802100030
J	Bensinger, SJ; Tontonoz, P				Bensinger, Steven J.; Tontonoz, Peter			A Nurr1 Pathway for Neuroprotection	CELL			English	Editorial Material							PPAR-GAMMA; TRANSREPRESSION	Mutations in the gene encoding the orphan nuclear receptor Nurr1 are linked to a rare familial form of Parkinson's disease. By examining the function of its mouse homolog, Saijo et al. (2009) provide evidence that Nurr1 protects dopaminergic neurons by suppressing inflammatory gene expression in astrocytes and microglia.	[Tontonoz, Peter] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Bensinger, Steven J.] Univ Calif Los Angeles, Inst Mol Med, Los Angeles, CA 90095 USA; [Bensinger, Steven J.; Tontonoz, Peter] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Tontonoz, P (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	ptontonoz@mednet.ucla.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Le W, 1999, J NEUROCHEM, V73, P2218; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Sakurada K, 1999, DEVELOPMENT, V126, P4017; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	9	42	45	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					26	28		10.1016/j.cell.2009.03.024	http://dx.doi.org/10.1016/j.cell.2009.03.024			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345183	Bronze			2022-12-28	WOS:000264813300010
J	Huber-Wagner, S; Lefering, R; Qvick, LM; Korner, M; Kay, MV; Pfeifer, KJ; Reiser, M; Mutschler, W; Kanz, KG				Huber-Wagner, Stefan; Lefering, Rolf; Qvick, Lars-Mikael; Koerner, Markus; Kay, Michael V.; Pfeifer, Klaus-Juergen; Reiser, Maximilian; Mutschler, Wolf; Kanz, Karl-Georg		German Trauma Soc	Effect of whole-body CT during trauma resuscitation on survival: a retrospective, multicentre study	LANCET			English	Article							COMPUTED-TOMOGRAPHY; MULTISLICE CT; GERMAN SOCIETY; BLUNT TRAUMA; WORK-UP; DIAGNOSIS; SPINE; SURGERY; INJURY	Background The number of trauma centres using whole-body CT for early assessment of primary trauma is increasing. There is no evidence to suggest that use of whole-body CT has any effect on the outcome of patients with major trauma. We therefore compared the probability of survival in patients with blunt trauma who had whole-body CT during resuscitation with those who had not. Methods In a retrospective, multicentre study, we used the data recorded in the trauma registry of the German Trauma Society to calculate the probability of survival according to the trauma and injury severity score (TRISS), revised injury severity classification (RISC) score, and standardised mortality ratio (SMR, ratio of recorded to expected mortality) for 4621 patients with blunt trauma given whole-body or non-whole-body CT. Findings 1494 (32%) of 4621 patients were given whole-body CT. Mean age was 42.6 years (SD 20.7), 3364 (73%) were men, and mean injury-severity score was 29.7 (13.0). SMR based on TRISS was 0.745 (95% CI 0.633-0.859) for patients given whole-body CT versus 1.023 (0.909-1.137) for those given non-whole-body CT (p<0.001). SMR based on the RISC score was 0.865 (0.774-0.956) for patients given whole-body CT versus 1.034 (0.959-1.109) for those given non-whole-body CT (p=0.017). The relative reduction in mortality based on TRISS was 25% (14-37) versus 13% (4-23) based on RISC score. Multivariate adjustment for hospital level, year of trauma, and potential Centre effects confirmed that whole-body CT is an independent predictor for survival (p <= 0.002). The number needed to scan was 17 based on TRISS and 32 based on RISC calculation. Interpretation Integration of whole-body CT into early trauma care significantly increased the probability of survival in patients with polytrauma. Whole-body CT is recommended as a standard diagnostic method during the early resuscitation phase for patients with polytrauma.	[Huber-Wagner, Stefan; Qvick, Lars-Mikael; Kay, Michael V.; Mutschler, Wolf; Kanz, Karl-Georg] Univ Munich, Munich Univ Hosp, Dept Trauma Surg, D-80336 Munich, Germany; [Lefering, Rolf] Univ Witten Herdecke, Fac Med, Inst Res Operat Med, Cologne, Germany; [Koerner, Markus; Pfeifer, Klaus-Juergen; Reiser, Maximilian] Univ Munich, Munich Univ Hosp, Dept Clin Radiol, D-80336 Munich, Germany	University of Munich; University of Cologne; Witten Herdecke University; University of Munich	Huber-Wagner, S (corresponding author), Univ Munich, Munich Univ Hosp, Dept Trauma Surg, Campus Innenstadt,Nussbaumstr 20, D-80336 Munich, Germany.	stefan.huber@med.uni-muenchen.de	Seekamp, Andreas/E-3252-2010		Deutsche Forschungsgemeinschaft [Ne 385/5]; Novo Nordisk A/S, Bagsvaerd, Denmark	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Novo Nordisk A/S, Bagsvaerd, Denmark(Novo Nordisk)	The trauma registry of the German Trauma Society (Deutsche Gesellschaft fur Unfallchirurgie) was partly funded by the Deutsche Forschungsgemeinschaft Ne 385/5 and by a grant from Novo Nordisk A/S, Bagsvaerd, Denmark. This study is part of LMQ's thesis and is published with permission of the Ludwig-Maximilians-University in Munich.	*ANN REP TRAUM REG, 2003, COL WORK GROUP POL G; Brenner DJ, 2004, RADIOLOGY, V232, P735, DOI 10.1148/radiol.2323031095; Brown CVR, 2005, J TRAUMA, V58, P890, DOI 10.1097/01.TA.0000162149.89139.FF; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; CHAMPION HR, 1983, WORLD J SURG, V7, P4, DOI 10.1007/BF01655906; Deunk J, 2007, J TRAUMA, V63, P757, DOI 10.1097/01.ta.0000235878.42251.8d; Fanucci E, 2007, EMERG RADIOL, V13, P251, DOI 10.1007/s10140-006-0554-0; Fox SH, 1998, NEUROIMAG CLIN N AM, V8, P497; Fuchs T, 2000, EUR J RADIOL, V36, P69, DOI 10.1016/S0720-048X(00)00269-2; Hogan GJ, 2005, RADIOLOGY, V237, P106, DOI 10.1148/radiol.2371040697; Hosmer DW, 1997, STAT MED, V16, P965; KALENDER WA, 1990, RADIOLOGY, V176, P181, DOI 10.1148/radiology.176.1.2353088; Kanz KG, 2004, UNFALLCHIRURG, V107, P937, DOI 10.1007/s00113-004-0845-4; Klingenbeck-Regn K, 1999, EUR J RADIOL, V31, P110, DOI 10.1016/S0720-048X(99)00086-8; LEFERING R, 2007, THESIS U WITTEN HERD, P1; Leidner B, 2001, EMERG RADIOL, V8, P20, DOI DOI 10.1007/PL00011863; Low R, 1997, ROFO-FORTSCHR RONTG, V166, P382, DOI 10.1055/s-2007-1015446; Philipp MO, 2003, EUR J RADIOL, V48, P2, DOI 10.1016/S0720-048X(03)00206-7; Prokop A, 2006, UNFALLCHIRURG, V109, P545, DOI 10.1007/s00113-006-1086-5; Ptak T, 2003, RADIOLOGY, V229, P902, DOI 10.1148/radiol.2293021651; Ptak T, 2001, EMERG RADIOL, V8, P250, DOI DOI 10.1007/PL00011915; Rieger M, 2002, ANAESTHESIST, V51, P835, DOI 10.1007/s00101-002-0369-7; Rivas LA, 2003, RADIOL CLIN N AM, V41, P599, DOI 10.1016/S0033-8389(03)00027-7; Rixen D, 2001, UNFALLCHIRURG, V104, P230, DOI 10.1007/s001130050719; Ruchhjoltz S, 2002, CHIRURG, V73, P1005, DOI 10.1007/s00104-002-0429-1; Ruchholtz S, 2008, DTSCH ARZTEBL INT, V105, P225, DOI 10.3238/arztebl.2008.0225; Ruchholtz S, 2000, UNFALLCHIRURG, V103, P30, DOI 10.1007/s001130050005; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; Sampson MA, 2006, CLIN RADIOL, V61, P365, DOI 10.1016/j.crad.2005.12.009; Tien HC, 2007, J TRAUMA, V62, P151, DOI 10.1097/TA.0b013e31802d9700; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Watura R, 2004, BRIT J RADIOL, V77, pS46, DOI 10.1259/bjr/52620263	33	569	584	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2009	373	9673					1455	1461		10.1016/S0140-6736(09)60232-4	http://dx.doi.org/10.1016/S0140-6736(09)60232-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437QL	19321199				2022-12-28	WOS:000265501900034
J	Larimer, ME; Malone, DK; Garner, MD; Atkins, DC; Burlingham, B; Lonczak, HS; Tanzer, K; Ginzler, J; Clifasefi, SL; Hobson, WG; Marlatt, GA				Larimer, Mary E.; Malone, Daniel K.; Garner, Michelle D.; Atkins, David C.; Burlingham, Bonnie; Lonczak, Heather S.; Tanzer, Kenneth; Ginzler, Joshua; Clifasefi, Seema L.; Hobson, William G.; Marlatt, G. Alan			Health Care and Public Service Use and Costs Before and After Provision of Housing for Chronically Homeless Persons With Severe Alcohol Problems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual Meeting of the Substance-Abuse-Policy-Research-Program	DEC 15-16, 2008	Tucson, AZ	Substance Abuse Policy Res Program			SEVERE MENTAL-ILLNESS; OUTCOMES; PEOPLE; IMPACT; EMERGENCY; PROGRAM; TRIAL	Context Chronically homeless individuals with severe alcohol problems often have multiple medical and psychiatric problems and use costly health and criminal justice services at high rates. Objective To evaluate association of a "Housing First" intervention for chronically homeless individuals with severe alcohol problems with health care use and costs. Design, Setting, and Participants Quasi-experimental design comparing 95 housed participants (with drinking permitted) with 39 wait-list control participants enrolled between November 2005 and March 2007 in Seattle, Washington. Main Outcome Measures Use and cost of services (jail bookings, days incarcerated, shelter and sobering center use, hospital-based medical services, publicly funded alcohol and drug detoxification and treatment, emergency medical services, and Medicaid-funded services) for Housing First participants relative to wait-list controls. Results Housing First participants had total costs of $8 175 922 in the year prior to the study, or median costs of $4066 per person per month (interquartile range [IQR], $2067-$8264). Median monthly costs decreased to $1492 (IQR, $337-$5709) and $958 (IQR, $98-$3200) after 6 and 12 months in housing, respectively. Poisson generalized estimating equation regressions using propensity score adjustments showed total cost rate reduction of 53% for housed participants relative to wait-list controls (rate ratio, 0.47; 95% confidence interval, 0.25-0.88) over the first 6 months. Total cost offsets for Housing First participants relative to controls averaged $2449 per person per month after accounting for housing program costs. Conclusions In this population of chronically homeless individuals with high service use and costs, a Housing First program was associated with a relative decrease in costs after 6 months. These benefits increased to the extent that participants were retained in housing longer.	[Larimer, Mary E.; Atkins, David C.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Burlingham, Bonnie; Clifasefi, Seema L.; Marlatt, G. Alan] Univ Washington, Addict Behav Res Ctr, Seattle, WA 98195 USA; [Lonczak, Heather S.; Ginzler, Joshua] Univ Washington, Alcohol & Drug Abuse Inst, Seattle, WA 98195 USA; [Garner, Michelle D.] Univ Washington, Social Work Program, Tacoma, WA USA; [Malone, Daniel K.; Tanzer, Kenneth; Hobson, William G.] Downtown Emergency Serv Ctr, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Tacoma	Larimer, ME (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, 1100 NE 45th St,Ste 300,Box 354944, Seattle, WA 98195 USA.	larimer@u.washington.edu	Clifasefi, Seema/P-2631-2019	Atkins, David/0000-0002-5781-9880	NIAAA NIH HHS [T32 AA007455-25, 2K05AA00113-17] Funding Source: Medline; NIDA NIH HHS [5K01DA014685-5] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007455, K05AA000113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA014685] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Burt M., 2004, STRATEGIES REDUCING; Cheng AL, 2007, J NERV MENT DIS, V195, P83, DOI 10.1097/01.nmd.0000252313.49043.f2; Cook TD, 2002, EXPT QUASIEXPERIMENT, P1, DOI 10.1198/jasa.2005.s22; Cox GB, 1998, J STUD ALCOHOL, V59, P523, DOI 10.15288/jsa.1998.59.523; *CTR MENT HLTH SER, SMA043870 CTR MENT H; Culhane DP, 2008, J AM PLANN ASSOC, V74, P111, DOI 10.1080/01944360701821618; Culhane Dennis P., 2007, ACCOUNTABILITY COST; Culhane DP, 2002, HOUS POLICY DEBATE, V13, P107, DOI 10.1080/10511482.2002.9521437; Diehr P, 1999, ANNU REV PUBL HEALTH, V20, P125, DOI 10.1146/annurev.publhealth.20.1.125; Dunford JV, 2006, ANN EMERG MED, V47, P328, DOI 10.1016/j.annemergmed.2005.11.017; Gelman A., 2007, DATA ANAL USING REGR; Hwang SW, 2000, JAMA-J AM MED ASSOC, V283, P2152, DOI 10.1001/jama.283.16.2152; Ishorst-Witte Frauke, 2001, Archiv fuer Kriminologie, V208, P129; Kertesz SG, 2007, J BEHAV HEALTH SER R, V34, P17, DOI 10.1007/s11414-006-9041-3; KIVLAHAN DR, 1990, J CONSULT CLIN PSYCH, V58, P805, DOI 10.1037/0022-006X.58.6.805; Kushel MB, 2001, JAMA-J AM MED ASSOC, V285, P200, DOI 10.1001/jama.285.2.200; Kushel MB, 2002, AM J PUBLIC HEALTH, V92, P778, DOI 10.2105/AJPH.92.5.778; Kyle T, 2008, HEALTH SOC CARE COMM, V16, P1, DOI 10.1111/j.1365-2524.2007.00723.x; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Martinez TE, 2006, PSYCHIAT SERV, V57, P992, DOI 10.1176/appi.ps.57.7.992; McLellan AT, 2006, AM J ADDICTION, V15, P113, DOI 10.1080/10550490500528316; Milby JB, 2005, AM J PUBLIC HEALTH, V95, P1259, DOI 10.2105/AJPH.2004.039743; O'Connell J., 2005, PREMATURE MORTALITY; O'Toole TP, 2004, J URBAN HEALTH, V81, P606, DOI 10.1093/jurban/jth144; PEARSON CL, 2007, APPL HOUSING 1 MODEL; Podymow T, 2006, CAN MED ASSOC J, V174, P45, DOI 10.1503/cmaj.1041350; *PUBL HLTH SEATTL, 2006 ANN REP HOM DEA; Rosenbaum P. R., 2002, OBSERVATIONAL STUDIE; Rosenheck R, 2003, ARCH GEN PSYCHIAT, V60, P940, DOI 10.1001/archpsyc.60.9.940; Siegel CE, 2006, PSYCHIAT SERV, V57, P982, DOI 10.1176/appi.ps.57.7.982; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; SVOBODA T, 2006, THESIS U TORONTO TOR; TROYERMERKEL M, 1986, COMPREHENSIVE REV TR; Tsemberis S, 2004, AM J PUBLIC HEALTH, V94, P651, DOI 10.2105/AJPH.94.4.651; Turnbull J, 2007, CAN MED ASSOC J, V177, P1065, DOI 10.1503/cmaj.071294; Wilcox R. R., 2011, INTRO ROBUST ESTIMAT; Willenbring ML, 1990, ALCOHOLISM TREATMENT, V7, P79; Wright NMJ, 2006, BRIT J GEN PRACT, V56, P286	38	410	411	0	71	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 1	2009	301	13					1349	1357		10.1001/jama.2009.414	http://dx.doi.org/10.1001/jama.2009.414			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	426LM	19336710	Bronze			2022-12-28	WOS:000264709800024
J	Nath, D; Shadan, S				Nath, Deepa; Shadan, Sadaf			THE UBIQUITIN SYSTEM	NATURE			English	Editorial Material																			0	28	30	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 26	2009	458	7237					421	421		10.1038/458421a	http://dx.doi.org/10.1038/458421a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19325620	Bronze			2022-12-28	WOS:000264532400029
J	Hall, MA; Schulman, KA				Hall, Mark A.; Schulman, Kevin A.			Ownership of Medical Information	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH DATA; ASSOCIATION; FRAMEWORK; PROPERTY		[Hall, Mark A.] Wake Forest Univ, Sch Law, Translat Sci Inst, Winston Salem, NC 27109 USA; [Hall, Mark A.] Wake Forest Univ, Sch Med, Dept Social Sci & Hlth Policy, Div Publ Hlth Sci, Winston Salem, NC 27109 USA; [Schulman, Kevin A.] Duke Univ, Fuqua Sch Business, Hlth Sector Management Program, Durham, NC 27706 USA; [Schulman, Kevin A.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Schulman, Kevin A.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27706 USA	Wake Forest University; Wake Forest University; Duke University; Duke University; Duke University	Hall, MA (corresponding author), Wake Forest Univ, Sch Law, Translat Sci Inst, Winston Salem, NC 27109 USA.	mhall@wfubmc.edu		Hall, Mark A./0000-0001-6277-144X				*ALT, 2007, REV PERS HLTH REC PH; Bloomrosen M, 2008, J AM MED INFORM ASSN, V15, P715, DOI 10.1197/jamia.M2905; *C BUDG OFF, 2008, EV COSTS BEN HLTH IN; FRIED BM, GAUGING PROGR NATL H; HAISLMAIER EF, 2006, 1131 HER FDN; HALL MA, OUR FRAGMEN IN PRESS; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; HERSZENHORN DM, 2009, NY TIMES        0707, pA11; Hoffman S., 2007, BC L REV, V48, P331; *PCHRI, 2006, HARV MED SCH M PERS; Safran C, 2007, J AM MED INFORM ASSN, V14, P1, DOI 10.1197/jamia.M2273; Smith HE, 2007, YALE LAW J, V116, P1742, DOI 10.2307/20455776; Stearns PV, 2000, J LEGAL MED, V21, P79, DOI 10.1080/019476400272819; Suter SM, 2004, GEORGE WASH LAW REV, V72, P737; Waller A A, 1998, J AHIMA, V69, P28	15	35	35	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 25	2009	301	12					1282	1284		10.1001/jama.2009.389	http://dx.doi.org/10.1001/jama.2009.389			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	423JO	19318657				2022-12-28	WOS:000264492800030
J	Madden, JDW				Madden, John D. W.			Stiffer Than Steel	SCIENCE			English	Editorial Material									Univ British Columbia, Dept Elect & Comp Engn, Adv Mat & Proc Engn Labs, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Madden, JDW (corresponding author), Univ British Columbia, Dept Elect & Comp Engn, Adv Mat & Proc Engn Labs, Vancouver, BC V6T 1Z4, Canada.	jmadden@ece.ubc.ca	Madden, John DW/B-8948-2009	Madden, John DW/0000-0002-0014-4712				Aliev AE, 2009, SCIENCE, V323, P1575, DOI 10.1126/science.1168312; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406	2	7	7	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 20	2009	323	5921					1571	1572		10.1126/science.1171169	http://dx.doi.org/10.1126/science.1171169			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299609				2022-12-28	WOS:000264342300027
J	McCallum, IJD; Ong, S; Mercer-Jones, M				McCallum, Iain J. D.; Ong, Sarah; Mercer-Jones, Mark			Chronic constipation in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SLOW-TRANSIT CONSTIPATION; IRRITABLE-BOWEL-SYNDROME; BIOFEEDBACK; PREVALENCE; DEFECATION; THERAPY		[McCallum, Iain J. D.; Ong, Sarah; Mercer-Jones, Mark] Gateshead Hlth NHS Fdn Trust, Queen Elizabeth Hosp, Colorectal Unit, Gateshead NE9 6SX, England		Mercer-Jones, M (corresponding author), Gateshead Hlth NHS Fdn Trust, Queen Elizabeth Hosp, Colorectal Unit, Gateshead NE9 6SX, England.	mark.mercer-jones@ghnt.nhs.uk						Acheson AG, 2008, BRIT MED J, V336, P380, DOI 10.1136/bmj.39465.674745.80; AGARWAL A, 2006, BRIT MED J, V332, P280; Agrawal A, 2006, BMJ-BRIT MED J, V332, P280, DOI 10.1136/bmj.332.7536.280; Bassotti G, 2004, BMJ-BRIT MED J, V328, P393, DOI 10.1136/bmj.328.7436.393; Boccasanta P, 2004, INT J COLORECTAL DIS, V19, P359, DOI 10.1007/s00384-003-0572-2; D'Hoore A, 2006, SURG ENDOSC, V20, P1919, DOI 10.1007/s00464-005-0485-y; Garrigues V, 2004, AM J EPIDEMIOL, V159, P520, DOI 10.1093/aje/kwh072; Higgins PDR, 2004, AM J GASTROENTEROL, V99, P750, DOI 10.1111/j.1572-0241.2004.04114.x; JORGE JMN, 1994, DIS COLON RECTUM, V37, P1112, DOI 10.1007/BF02049813; Khaikin M, 2006, WORLD J GASTROENTERO, V12, P3168, DOI 10.3748/wjg.v12.i20.3168; Knowles CH, 2000, NEUROGASTROENT MOTIL, V12, P181; Koh CE, 2008, BRIT J SURG, V95, P1079, DOI 10.1002/bjs.6303; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lubowski DZ, 1996, DIS COLON RECTUM, V39, P23, DOI 10.1007/BF02048263; Nelson R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003431.pub2; *NICE, 2008, 61 NICE; *NICE, 2008, 27 NICE; Park DH, 2005, INT J COLORECTAL DIS, V20, P272, DOI 10.1007/s00384-004-0662-9; Ramkumar D, 2005, AM J GASTROENTEROL, V100, P936, DOI 10.1111/j.1572-0241.2005.40925.x; Rao SSC, 2005, AM J GASTROENTEROL, V100, P1605, DOI 10.1111/j.1572-0241.2005.41845.x; Rao SSC, 2001, GASTROENTEROL CLIN N, V30, P97, DOI 10.1016/S0889-8553(05)70169-2; Ron Y, 2001, DIS COLON RECTUM, V44, P1821, DOI 10.1007/BF02234461; Rongen MJGM, 2001, DIS COLON RECTUM, V44, P1644, DOI 10.1007/BF02234385; Sikirov D, 2003, DIGEST DIS SCI, V48, P1201, DOI 10.1023/A:1024180319005; Spiller R, 2007, GUT, V56, P1770, DOI 10.1136/gut.2007.119446; Thompson WG, 2000, GUT, V46, P78, DOI 10.1136/gut.46.1.78; Zutshi M, 2007, INT J COLORECTAL DIS, V22, P265, DOI 10.1007/s00384-006-0189-3	27	35	35	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2009	338								b831	10.1136/bmj.b831	http://dx.doi.org/10.1136/bmj.b831			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422NX	19304766				2022-12-28	WOS:000264436100002
J	Rhee, HJ; June, YG; Lee, JS; Lee, KK; Ha, JH; Kim, ZH; Jeon, SJ; Cho, MH				Rhee, Hanju; June, Young-Gun; Lee, Jang-Soo; Lee, Kyung-Koo; Ha, Jeong-Hyon; Kim, Zee Hwan; Jeon, Seung-Joon; Cho, Minhaeng			Femtosecond characterization of vibrational optical activity of chiral molecules	NATURE			English	Article							CIRCULAR-DICHROISM; SPECTROSCOPY; POLYPEPTIDES	Optical activity(1-3) is the result of chiral molecules interacting differently with left versus right circularly polarized light. Because of this intrinsic link to molecular structure, the determination of optical activity through circular dichroism (CD) spectroscopy has long served as a routine method for obtaining structural information about chemical and biological systems in condensed phases(4-6). A recent development is time-resolved CD spectroscopy, which can in principle map the structural changes associated with biomolecular function(7) and thus lead to mechanistic insights into fundamental biological processes. But implementing time-resolved CD measurements is experimentally challenging because CD is a notoriously weak effect (a factor of 10(-4)-10(-6) smaller than absorption). In fact, this problem has so far prevented time-resolved vibrational CD experiments. Here we show that vibrational CD spectroscopy with femtosecond time resolution can be realized when using heterodyned spectral interferometry to detect(8-10) the phase and amplitude of the infrared optical activity free-induction-decay field in time (much like in a pulsed NMR experiment). We show that we can detect extremely weak signals in the presence of large achiral background contributions, by simultaneously measuring with a femtosecond laser pulse the vibrational CD and optical rotatory dispersion spectra of dissolved chiral limonene molecules. We have so far only targeted molecules in equilibrium, but it would be straightforward to extend the method for the observation of ultrafast structural changes such as those occurring during protein folding or asymmetric chemical reactions. That is, we should now be in a position to produce 'molecular motion pictures'(11) of fundamental molecular processes from a chiral perspective.	[Rhee, Hanju; June, Young-Gun; Lee, Jang-Soo; Lee, Kyung-Koo; Kim, Zee Hwan; Jeon, Seung-Joon; Cho, Minhaeng] Korea Univ, Dept Chem, Seoul 136701, South Korea; [Rhee, Hanju; Lee, Jang-Soo; Lee, Kyung-Koo; Cho, Minhaeng] Korea Univ, Ctr Multidimens Spect, Seoul 136701, South Korea; [Ha, Jeong-Hyon; Jeon, Seung-Joon; Cho, Minhaeng] Korea Basic Sci Inst, Multidimens Spect Lab, Seoul 136713, South Korea	Korea University; Korea University; Korea Basic Science Institute (KBSI)	Cho, MH (corresponding author), Korea Univ, Dept Chem, Seoul 136701, South Korea.	mcho@korea.ac.kr	Cho, Minhaeng/C-9983-2011; Kim, Zee Hwan/A-9273-2010	Cho, Minhaeng/0000-0003-1618-1056; Lee, Jangsoo/0000-0002-0255-1629	Creative Research Initiatives of MEST/KOSEF; Frontier Research Laboratory Program of KBSI	Creative Research Initiatives of MEST/KOSEF(Korea Science and Engineering Foundation); Frontier Research Laboratory Program of KBSI	This work was supported by Creative Research Initiatives (CMDS) of MEST/KOSEF ( M. C.) and the Frontier Research Laboratory Program of KBSI (S.--J.J)	BRIDGES TJ, 1965, APPL OPTICS, V4, P1121, DOI 10.1364/AO.4.001121; Brixner T, 2005, NATURE, V434, P625, DOI 10.1038/nature03429; Brixner T, 2004, OPT LETT, V29, P884, DOI 10.1364/OL.29.000884; Chin DH, 2002, P NATL ACAD SCI USA, V99, P15416, DOI 10.1073/pnas.232591399; CHIRGADZE YN, 1971, BIOPOLYMERS, V10, P809, DOI 10.1002/bip.360100505; Cho MH, 2008, CHEM REV, V108, P1331, DOI 10.1021/cr078377b; Cho M, 2006, NATURE, V444, P431, DOI 10.1038/444431a; Choi JH, 2004, J CHEM PHYS, V120, P4383, DOI 10.1063/1.1644100; Choi JH, 2008, PHYS CHEM CHEM PHYS, V10, P3839, DOI 10.1039/b719263k; Choi JH, 2006, BIOPOLYMERS, V83, P519, DOI 10.1002/bip.20583; Clarke DT, 1999, P NATL ACAD SCI USA, V96, P7232, DOI 10.1073/pnas.96.13.7232; Cowan ML, 2005, NATURE, V434, P199, DOI 10.1038/nature03383; Gallagher SM, 1998, J OPT SOC AM B, V15, P2338, DOI 10.1364/JOSAB.15.002338; GILLARD RD, 1990, NATURE, V347, P594; Goldbeck RA, 1997, ANNU REV PHYS CHEM, V48, P453, DOI 10.1146/annurev.physchem.48.1.453; Guo CN, 2006, VIB SPECTROSC, V42, P254, DOI 10.1016/j.vibspec.2006.05.013; KEIDERLING TA, 1986, NATURE, V322, P851, DOI 10.1038/322851a0; Lepetit L, 1995, J OPT SOC AM B, V12, P2467, DOI 10.1364/JOSAB.12.002467; LEWIS JW, 1985, J PHYS CHEM-US, V89, P289, DOI 10.1021/j100248a023; Nakanishi K., 2000, CIRCULAR DICHROISM P; Niezborala C, 2006, J OPT SOC AM B, V23, P2418, DOI 10.1364/JOSAB.23.002418; Rhee H, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2968130; Rosenfeld L, 1929, Z PHYS, V52, P161, DOI 10.1007/BF01342393; SCHRADER VB, 1972, ANGEW CHEM, V84, P218; Silva RAGD, 2000, P NATL ACAD SCI USA, V97, P8318, DOI 10.1073/pnas.140161997; TINOCO I, 1987, ANNU REV BIOPHYS BIO, V16, P319, DOI 10.1146/annurev.bb.16.060187.001535; Walecki WJ, 1997, OPT LETT, V22, P81, DOI 10.1364/OL.22.000081; XIE XL, 1990, J AM CHEM SOC, V112, P7802, DOI 10.1021/ja00177a054; Zanni MT, 2001, P NATL ACAD SCI USA, V98, P11265, DOI 10.1073/pnas.201412998	29	139	140	4	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					310	313		10.1038/nature07846	http://dx.doi.org/10.1038/nature07846			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19295604				2022-12-28	WOS:000264285600035
J	Rosenberg, RN				Rosenberg, Roger N.			Consciousness, Coma, and Brain Death-2009	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AWARENESS		[Rosenberg, Roger N.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Rosenberg, Roger N.] Univ Texas SW Med Ctr Dallas, Rush Alzheimers Dis Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rosenberg, RN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	roger.rosenberg@utsouthwestern.edu						[Anonymous], 1968, JAMA, V205, P337; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; BRUST JCM, 2005, MERRITTS NEUROLOGY, P20; Childs NL, 1996, NEW ENGL J MED, V334, P24, DOI 10.1056/NEJM199601043340105; Crick F., 1994, ASTONISHING HYPOTHES; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GLACINO JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI DOI 10.1097/00001199-199708000-00005; JOYNT RJ, 1984, JAMA-J AM MED ASSOC, V252, P680, DOI 10.1001/jama.252.5.680; Owen AM, 2007, ARCH NEUROL-CHICAGO, V64, P1098, DOI 10.1001/archneur.64.8.1098; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Portas CM, 1998, J NEUROSCI, V18, P8979; Rosenberg RN, 2008, ARCH NEUROL-CHICAGO, V65, P307, DOI 10.1001/archneur.65.3.307; Schiff ND, 2008, NATURE, V452, P120, DOI 10.1038/nature06818; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606	16	23	25	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 18	2009	301	11					1172	1174		10.1001/jama.2009.224	http://dx.doi.org/10.1001/jama.2009.224			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419UC	19293420	Bronze			2022-12-28	WOS:000264244200025
J	Andrew, TL; Tsai, HY; Menon, R				Andrew, Trisha L.; Tsai, Hsin-Yu; Menon, Rajesh			Confining Light to Deep Subwavelength Dimensions to Enable Optical Nanopatterning	SCIENCE			English	Article							MICROSCOPY; RESOLUTION; MEMORIES	In the past, the formation of microscale patterns in the far field by light has been diffractively limited in resolution to roughly half the wavelength of the radiation used. Here, we demonstrate lines with an average width of 36 nanometers (nm), about one-tenth the illuminating wavelength lambda(1) = 325 nm, made by applying a film of thermally stable photochromic molecules above the photoresist. Simultaneous irradiation of a second wavelength, lambda(2) = 633 nm, renders the film opaque to the writing beam except at nodal sites, which let through a spatially constrained segment of incident lambda(1) light, allowing subdiffractional patterning. The same experiment also demonstrates a patterning of periodic lines whose widths are about one-tenth their period, which is far smaller than what has been thought to be lithographically possible.	[Tsai, Hsin-Yu; Menon, Rajesh] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Menon, Rajesh] LumArray, Somerville, MA 02143 USA; [Tsai, Hsin-Yu] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Andrew, Trisha L.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Menon, R (corresponding author), MIT, Elect Res Lab, Cambridge, MA 02139 USA.	rmenon@mit.edu			LumArray [6916866]; MIT Deshpande Center for Technological Innovation; Defense Advanced Research Projects Agency Small Business Innovation Research award [W31P4Q-05-C-R156]	LumArray; MIT Deshpande Center for Technological Innovation; Defense Advanced Research Projects Agency Small Business Innovation Research award(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	We thank F. Stellacci and T. Swager for advice on synthesis of the photochromic molecules, H. Koh for the ellipsometric measurements, T. OReilly for assistance with the Lloyds-mirror interferometer, and H. Smith for suggestions on the manuscript. T.L.A. was partially funded by a subcontract (6916866) from LumArray. H.Y.T. was partially funded by an ignition grant from the MIT Deshpande Center for Technological Innovation. R.M. was partially funded by a Defense Advanced Research Projects Agency Small Business Innovation Research award (W31P4Q-05-C-R156). Three patents have been filed through MIT based on the work presented herein.	Abbe E., 1873, ARCH F MIKROSK ANAT, V9, P413, DOI [10.1007/bf02956173, DOI 10.1007/BF02956173, 10.1007/ BF02956173]; ASH EA, 1972, NATURE, V237, P510, DOI 10.1038/237510a0; BETZIG E, 1991, SCIENCE, V251, P1468, DOI 10.1126/science.251.5000.1468; Chovin A, 2004, NANO LETT, V4, P1965, DOI 10.1021/nl048824s; Crano JC, 1999, T APPL CHEM, P1; DARCY PJ, 1981, J CHEM SOC PERK T 1, P202, DOI 10.1039/p19810000202; Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759; Frey HG, 2002, APPL PHYS LETT, V81, P5030, DOI 10.1063/1.1530736; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; Irie M, 2000, CHEM REV, V100, P1685, DOI 10.1021/cr980069d; Ito T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2227633; Jacob Z, 2006, OPT EXPRESS, V14, P8247, DOI 10.1364/OE.14.008247; Menon R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.043905; Menon R, 2006, J OPT SOC AM A, V23, P2290, DOI 10.1364/JOSAA.23.002290; Menon R, 2009, J OPT SOC AM A, V26, P297, DOI 10.1364/JOSAA.26.000297; Murooka K, 2003, J VAC SCI TECHNOL B, V21, P2668, DOI 10.1116/1.1627803; Novotny L, 1998, ULTRAMICROSCOPY, V71, P341, DOI 10.1016/S0304-3991(97)00066-1; Ozbay E, 2006, SCIENCE, V311, P189, DOI 10.1126/science.1114849; Pease RF, 2005, MICROELECTRON ENG, V78-79, P381, DOI 10.1016/j.mee.2005.01.009; TAFLOVE A, 2000, COPUTATION ELECTRODY; Tsai HY, 2008, OPT LETT, V33, P2916, DOI 10.1364/OL.33.002916; Tsai HY, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2775092; Yin XB, 2002, APPL PHYS LETT, V81, P3663, DOI 10.1063/1.1519329; Yokoyama Y, 2000, CHEM REV, V100, P1717, DOI 10.1021/cr980070c	24	191	211	6	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					917	921		10.1126/science.1167704	http://dx.doi.org/10.1126/science.1167704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19359545				2022-12-28	WOS:000266048800032
J	Staedke, SG; Mwebaza, N; Kamya, MR; Clark, TD; Dorsey, G; Rosenthal, PJ; Whitty, CJM				Staedke, Sarah G.; Mwebaza, Norah; Kamya, Moses R.; Clark, Tamara D.; Dorsey, Grant; Rosenthal, Philip J.; Whitty, Christopher J. M.			Home management of malaria with artemether-lumefantrine compared with standard care in urban Ugandan children: a randomised controlled trial	LANCET			English	Article							COMBINATION THERAPY; UNCOMPLICATED MALARIA; FEBRILE ILLNESS; HEALTH-WORKERS; AFRICA; FEVER; ACCEPTABILITY; FEASIBILITY; ARTESUNATE; MORBIDITY	Background Home management of malaria-the presumptive treatment of febrile children with antimalarial drugs-is advocated to ensure prompt effective treatment of the disease. We assessed the effect of home delivery of artemether-lumefantrine on the incidence of antimalarial treatment and on clinical outcomes in children from an urban setting with fairly low malaria transmission. Methods In Kampala, Uganda, 437 children aged between land 6 years from 325 households were randomly assigned by a computer-generated sequence to receive home delivery of prepackaged artemether-lumefantrine for presumptive treatment of febrile illnesses (n=225) or current standard of care (n=212). Randomisation was done by household after a pilot period of 1 month. After randomisation, study participants were followed up for an additional 12 months and information on their health and treatment of illnesses was obtained by use of monthly questionnaires and household diaries, which were completed by the participants' carers. The primary outcome was treatment incidence density per person-year. Analysis of the primary outcome was done on the modified intention-to-treat population, which included all participants apart from those excluded before data collection. This trial is registered with ClinicalTrials.gov, number NCT00115921. Findings Eight participants in the home management group and four in the standard care group were excluded before data collection; therefore, the primary analysis was done in 217 and 208 participants, respectively. The home management group received nearly twice the number of antimalarial treatments as the standard care group (4.66 per person-year vs 2.53 per person-year; incidence rate ratio [IRR] 1.72, 95% Cl 1.43-2.06, p<0.0001), and nearly five times the number given to children with microscopically confirmed malaria in a comparable cohort of children (4.66 per person-year vs 1.03 per person-year, IRR 5.19, 95% CI 4.24-6.35, p<0.0001). Clinical data were available for 189 children in the home management group and 176 in the control group at study end; the main reasons for exclusion were movement out of the study area or loss to follow-up. The proportion of participants with parasitaemia dat final assessment in the intervention group was lower than in the control group (four [2%] vs 17 [10%], p=0.006), but there were no other differences in standard malariometric indices, including anaemia. Serious adverse events were captured retrospectively. One child died in each group (home management-severe pneumonia and possible septicaemia; standard care-presumed respiratory failure). Interpretation Although home management of malaria led to prompt treatment of fever, there was little effect on clinical outcomes. The substantial over-treatment suggests that artemether-lumefantrine provided in the home might not be appropriate for large urban areas or settings with fairly low malaria transmission.	[Staedke, Sarah G.; Whitty, Christopher J. M.] London Sch Hyg & Trop Med, London WC1, England; [Mwebaza, Norah; Kamya, Moses R.] Makerere Univ, Sch Med, Kampala, Uganda; [Clark, Tamara D.; Dorsey, Grant; Rosenthal, Philip J.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA USA	University of London; London School of Hygiene & Tropical Medicine; Makerere University; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Staedke, SG (corresponding author), MU UCSF Res Collaborat, Mulago Hosp Complex,Malaria House,POB 7475, Kampala, Uganda.	sarah.staedke@lshtm.ac.uk	Whitty, Christopher/C-7740-2012	Whitty, Christopher/0000-0002-6076-5027	Gates Malaria Partnership	Gates Malaria Partnership	We thank the clinical study team of Horence Nankya, Talemwa Nalugwa, Rita Kabuleta, Mary Yaledi, Stephen Tumwebaze, Kizito Tema, Levi Mugenyi, and Joseph Kasule. We also thank the laboratory technicians, Regina Nakafeero and Maxwell Kilama; the administrative staff. Catherine Tugaineyo, Kenneth Mwebaze, and Richard Oluga; Marx Dongo for his assistance with recruitment; Brian Greenwood for his input on the study design: Sarah Kemble for her assistance at the onset of the study; Yoel Lubell for assistance with the cost analysis; the Mulago I I I community, local leaders, arid particularly, Fred Ssaka; arid the study participants and their parents/guardians. This investigation received financial support from the Gates Malaria Partnership. Philip Rosenthal is a Doris Duke Charitable Foundation Distinguished Clinical Scientist.	Ajayi IO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-6; [Anonymous], 2004, SCAL HOM BAS MAN MAL; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Chinbuah AM, 2006, TROP MED INT HEALTH, V11, P1003, DOI 10.1111/j.1365-3156.2006.01654.x; Clark TD, 2008, J INFECT DIS, V198, P393, DOI 10.1086/589778; D'Alessandro U, 2005, TROP MED INT HEALTH, V10, P1, DOI 10.1111/j.1365-3156.2004.01375.x; Davis JC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-18; Delacollette C, 1996, B WORLD HEALTH ORGAN, V74, P423; Dorsey G, 2002, LANCET, V360, P2031, DOI 10.1016/S0140-6736(02)12021-6; Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210; Goodman CA, 1999, LANCET, V354, P378, DOI 10.1016/S0140-6736(99)02141-8; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Hopkins H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-134; Kallander Karin, 2006, BMC Int Health Hum Rights, V6, P2, DOI 10.1186/1472-698X-6-2; Keiser J, 2004, AM J TROP MED HYG, V71, P118, DOI 10.4269/ajtmh.2004.71.118; Kemble SK, 2006, AM J TROP MED HYG, V74, P999, DOI 10.4269/ajtmh.2006.74.999; Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0; Kilian AHD, 2003, TROP MED INT HEALTH, V8, P431, DOI 10.1046/j.1365-3156.2003.01044.x; Kouyate B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-50; McCombie SC, 1996, SOC SCI MED, V43, P933, DOI 10.1016/0277-9536(95)00446-7; MENON A, 1990, T ROY SOC TROP MED H, V84, P768, DOI 10.1016/0035-9203(90)90071-L; Nsabagasani X, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-11; Nsungwa-Sabiiti J, 2007, T ROY SOC TROP MED H, V101, P1199, DOI 10.1016/j.trstmh.2007.08.005; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Pagnoni F, 2005, TROP MED INT HEALTH, V10, P621; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; *ROLL BACK MAL PAR, MON EV REF GROUP MER; Snow RW, 2003, TRENDS PARASITOL, V19, P363, DOI 10.1016/S1471-4922(03)00168-5; SPENCER H C, 1987, Annals of Tropical Medicine and Parasitology, V81, P13; Talisuna AO, 2004, CLIN MICROBIOL REV, V17, P235, DOI 10.1128/CMR.17.1.235-254.2004; *UG MIN HLTH, 2004, IMPL GUID HOM BAS MA; *UG MIN HLTH, 2004, MAN UNC MAL PRACT GU; *WHO, 2003, AB DECL PLAN ACT; Wiseman V, 2005, HEALTH POLICY PLANN, V20, P394, DOI 10.1093/heapol/czi042; World Health Organization, 2005, WHOHTMMAL20051101	39	30	31	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 9	2009	373	9675					1623	1631		10.1016/S0140-6736(09)60328-7	http://dx.doi.org/10.1016/S0140-6736(09)60328-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	445QJ	19362361				2022-12-28	WOS:000266066300033
J	Reithinger, R; Tarleton, RL; Urbina, JA; Kitron, U; Gurtler, RE				Reithinger, Richard; Tarleton, Rick L.; Urbina, Julio A.; Kitron, Uriel; Guertler, Ricardo E.			Eliminating Chagas disease: challenges and a roadmap	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRYPANOSOMA-CRUZI; TRANSMISSION		[Reithinger, Richard] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Dis Control & Vector Biol Unit, London WC1E 7HT, England; [Tarleton, Rick L.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Urbina, Julio A.] Inst Venezolano Invest Cient, Caracas, Venezuela; [Kitron, Uriel] Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA; [Guertler, Ricardo E.] Univ Buenos Aires, Dept Ecol Genet & Evolut, Buenos Aires, DF, Argentina	University of London; London School of Hygiene & Tropical Medicine; University System of Georgia; University of Georgia; Venezuelan Institute Science Research; Emory University; University of Buenos Aires	Reithinger, R (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Dis Control & Vector Biol Unit, Keppel St, London WC1E 7HT, England.	rreithinger@yahoo.co.uk	Tarleton, Rick/AES-8572-2022	Kitron, Uriel/0000-0003-0493-2043; Reithinger, Richard/0000-0001-5710-1556; Tarleton, Rick/0000-0002-9589-5243	FOGARTY INTERNATIONAL CENTER [R01TW005836] Funding Source: NIH RePORTER; FIC NIH HHS [R01 TW005836-01, R01 TW005836] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Attaran A, 2006, LANCET, V368, P1768, DOI 10.1016/S0140-6736(06)69730-4; Beard CB, 2003, EMERG INFECT DIS, V9, P103, DOI 10.3201/eid0901.020217; Bowman NM, 2008, CLIN INFECT DIS, V46, P1822, DOI 10.1086/588299; *CAMP ACC ESS MED, 2008, REV SOC BREAS MED TR, V41, P315; *COMM DIS CTR, PAR HLTH TRYP; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Diaz JH, 2008, J TRAVEL MED, V15, P184, DOI 10.1111/j.1708-8305.2008.00205.x; Dorn PL, 2007, EMERG INFECT DIS, V13, P605, DOI 10.3201/eid1304.061002; Hotez P, 2006, ADV EXP MED BIOL, V582, P23; Kroeger A, 2003, AM J TROP MED HYG, V68, P307, DOI 10.4269/ajtmh.2003.68.307; Leiby DA, 2008, J INFECT DIS, V198, P609, DOI 10.1086/590159; Lescure FX, 2008, EMERG INFECT DIS, V14, P644, DOI 10.3201/eid1404.070489; *MIN SAL, 2006, GUIAS AT PAC INF TRY; Pirard M, 2005, TRANSFUSION, V45, P554, DOI 10.1111/j.0041-1132.2005.04214.x; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Reithinger R, 2006, AM J TROP MED HYG, V74, P766, DOI 10.4269/ajtmh.2006.74.766; Roll Back Malaria Monitoring and Evaluation Reference Group, 2005, MAL IND SURV BAS DOC; *SCR SAL, INF EP MOB 2005 VERS; Stramer S. L., 2007, Morbidity and Mortality Weekly Report, V56, P141; Tarleton RL, 2007, PLOS MED, V4, P1852, DOI 10.1371/journal.pmed.0040332; *WHO, NEW GLOB EFF EL CHAN; *WHO, STRAT DIR RES DIS BU; *WHO, 2004, WHO REP 2004 CHANG H; WHO Expert Committee, 2002, CONTR CHAG DIS; World Health Organization, 2007, WHO CONS INT BIOL RE; Yabsley MJ, 2002, J WILDLIFE DIS, V38, P75, DOI 10.7589/0090-3558-38.1.75; YADON ZE, 2006, DECENTRALIZACION GES; [No title captured]; [No title captured]	30	39	39	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2009	338								b1283	10.1136/bmj.b1283	http://dx.doi.org/10.1136/bmj.b1283			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	434TI	19366739	Green Accepted, Green Published			2022-12-28	WOS:000265296600003
J	Elwood, PC; Gallagher, AM; Duthie, GG; Mur, LAJ; Morgan, G				Elwood, Peter C.; Gallagher, Alison M.; Duthie, Garry G.; Mur, Luis A. J.; Morgan, Gareth			Aspirin, salicylates, and cancer	LANCET			English	Review							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LOW-DOSE ASPIRIN; COLORECTAL-CANCER; BREAST-CANCER; INDUCE APOPTOSIS; RANDOMIZED-TRIAL; COLON-CANCER; GENOMIC INSTABILITY; MEDIATED APOPTOSIS; PRIMARY PREVENTION	Evidence from a wide range of sources suggests that individuals taking aspirin and related non-steroidal anti-inflammatory drugs have reduced risk of large bowel cancer. Work in animals supports cancer reduction with aspirin, but no long-term randomised clinical trials exist in human beings, and randomisation would be ethically unacceptable because vascular protection would have to be denied to a proportion of the participants. However, opportunistic trials of aspirin, designed to test vascular protection, provide some evidence of a reduction in cancer, but only after at least 10 years. We summarise evidence for the potential benefit of aspirin and natural salicylates in cancer prevention. Possible mechanisms of action and directions for further work are discussed, and implications for clinical practice are considered.	[Gallagher, Alison M.] Univ Ulster, No Ireland Ctr Food & Hlth, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland; [Elwood, Peter C.] Cardiff Univ, Sch Med, Cardiff, Wales; [Duthie, Garry G.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Mur, Luis A. J.] Univ Wales, Inst Biol Sci, Aberystwyth, Dyfed, Wales; [Morgan, Gareth] Welsh Aspirin Grp, Swansea, W Glam, Wales	Ulster University; Cardiff University; University of Aberdeen; Aberystwyth University	Gallagher, AM (corresponding author), Univ Ulster, No Ireland Ctr Food & Hlth, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland.	am.gallagher@ulster.ac.uk	Mur, Luis a. j./U-1052-2017	Mur, Luis a. j./0000-0002-0961-9817; Gallagher, Alison/0000-0003-2109-3472	Scottish Executive Rural Affairs Department (SEERAD); Scottish Enterprise; Cranberry Research Institute; European Union; UK Food Standard Agency	Scottish Executive Rural Affairs Department (SEERAD); Scottish Enterprise; Cranberry Research Institute; European Union(European Commission); UK Food Standard Agency	PCE reports receiving lecture fees from Bayer, GGD reports receiving research grants from the Scottish Executive Rural Affairs Department (SEERAD), the Scottish Enterprise, the Cranberry Research Institute, the European Union Framework programme, and the UK Food Standard Agency; we declare that we have no conflict of interest.	Agrawal A, 2008, INT J CLIN PRACT, V62, P444, DOI 10.1111/j.1742-1241.2007.01668.x; Asano TK, 2004, DIS COLON RECTUM, V47, P665, DOI 10.1007/s10350-003-0111-9; Barnes CJ, 1998, GASTROENTEROLOGY, V114, P873, DOI 10.1016/S0016-5085(98)70305-1; Baron JA, 2003, PROG EXP TUMOR RES, V37, P1; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Battaglia V, 2005, J BIOL CHEM, V280, P33864, DOI 10.1074/jbc.M502391200; Baxter GJ, 2001, EUR J NUTR, V40, P289, DOI 10.1007/s394-001-8358-x; Bellosillo B, 1998, BLOOD, V92, P1406, DOI 10.1182/blood.V92.4.1406.416k17_1406_1414; BENNETT A, 1975, GUT, V16, P409; Blacklock CJ, 2001, J CLIN PATHOL, V54, P553, DOI 10.1136/jcp.54.7.553; Borthwick GM, 2006, FASEB J, V20, P2009, DOI 10.1096/fj.06-5987com; Bosetti C, 2006, CANCER CAUSE CONTROL, V17, P871, DOI 10.1007/s10552-006-0033-7; Chan AT, 2007, ARCH INTERN MED, V167, P562, DOI 10.1001/archinte.167.6.562; Chan FKL, 2005, NEW ENGL J MED, V352, P238, DOI 10.1056/NEJMoa042087; Chan TA, 1998, P NATL ACAD SCI USA, V95, P681, DOI 10.1073/pnas.95.2.681; Charames GS, 2003, CURR MOL MED, V3, P589, DOI 10.2174/1566524033479456; Chell S, 2006, BBA-REV CANCER, V1766, P104, DOI 10.1016/j.bbcan.2006.05.002; Chung YM, 2003, FREE RADICAL BIO MED, V34, P434, DOI 10.1016/S0891-5849(02)01301-1; Collet JP, 1999, BRIT J CANCER, V81, P62, DOI 10.1038/sj.bjc.6690651; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Curtis MJ, 2004, PLANT J, V38, P244, DOI 10.1111/j.1365-313X.2004.02040.x; Din FVN, 2004, BRIT J CANCER, V91, P381, DOI 10.1038/sj.bjc.6601913; Drew JE, 2005, BIOCHEM PHARMACOL, V70, P888, DOI 10.1016/j.bcp.2005.06.011; Elder DJE, 1996, CANCER RES, V56, P2273; Featherstone C, 1997, LANCET, V350, P418, DOI 10.1016/S0140-6736(05)64147-5; Fiorucci S, 2001, DIGEST LIVER DIS, V33, pS35, DOI 10.1016/S1590-8658(01)80157-2; Flossmann E, 2007, INT J EPIDEMIOL, V36, P962, DOI 10.1093/ije/dym200; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Friis S, 2002, INT J CANCER, V97, P96, DOI 10.1002/ijc.1581; GANN PH, 1993, JNCI-J NATL CANCER I, V85, P1220, DOI 10.1093/jnci/85.15.1220; GASIC GJ, 1968, P NATL ACAD SCI USA, V61, P46, DOI 10.1073/pnas.61.1.46; GASIC GJ, 1972, LANCET, V2, P932; Genkinger JM, 2004, AM J EPIDEMIOL, V160, P1223, DOI 10.1093/aje/kwh339; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; Goel A, 2003, CLIN CANCER RES, V9, P383; Gonzalez ER, 1998, AM J HEALTH-SYST PH, V55, pS4, DOI 10.1093/ajhp/55.suppl_1.S4; Gonzalez-Perez A, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-28; Grady WM, 2004, CANCER METAST REV, V23, P11, DOI 10.1023/A:1025861527711; Harris RE, 2005, ONCOL REP, V13, P559; Harris RE, 2003, CANCER RES, V63, P6096; Hawk ET, 2004, GASTROENTEROLOGY, V126, P1423, DOI 10.1053/j.gastro.2004.03.002; He J, 1998, JAMA-J AM MED ASSOC, V280, P1930, DOI 10.1001/jama.280.22.1930; Hernandez-Diaz S, 2002, J CLIN EPIDEMIOL, V55, P157, DOI 10.1016/S0895-4356(01)00461-9; Herschman HR, 1996, BBA-LIPID LIPID MET, V1299, P125, DOI 10.1016/0005-2760(95)00194-8; Hong WK, 1997, SCIENCE, V278, P1073, DOI 10.1126/science.278.5340.1073; *INT AG RES CANC, 1997, IARC HDB CANC PREV N, V1; IWAMA T, 1994, CANCER, V73, P2065, DOI 10.1002/1097-0142(19940415)73:8<2065::AID-CNCR2820730809>3.0.CO;2-O; Jacobs EJ, 2005, JAMA-J AM MED ASSOC, V294, P105, DOI 10.1001/jama.294.1.105; Jacobs EJ, 2005, JNCI-J NATL CANCER I, V97, P975, DOI 10.1093/jnci/dji173; Jacobs EJ, 2007, JNCI-J NATL CANCER I, V99, P608, DOI 10.1093/jnci/djk132; JAFFE BM, 1974, PROSTAGLANDINS, V6, P453, DOI 10.1016/S0090-6980(74)80055-9; Jankowski J, 2004, JNCI-J NATL CANCER I, V96, P885, DOI 10.1093/jnci/djh171; Janne PA, 2000, NEW ENGL J MED, V342, P1960, DOI 10.1056/NEJM200006293422606; Janssen PLTMK, 1997, CANCER LETT, V114, P163, DOI 10.1016/S0304-3835(97)04650-8; Jolly K, 2002, DRUGS, V62, P945, DOI 10.2165/00003495-200262060-00006; Kashfi K, 2005, BIOCHEM PHARMACOL, V70, P969, DOI 10.1016/j.bcp.2005.05.004; KASSIRER JP, 1994, NEW ENGL J MED, V330, P1895, DOI 10.1056/NEJM199406303302611; Khuder SA, 2001, BRIT J CANCER, V84, P1188, DOI 10.1054/bjoc.2000.1709; KOLENICH JJ, 1972, LANCET, V2, P714; KOLODNER RD, 1995, TRENDS BIOCHEM SCI, V20, P397, DOI 10.1016/S0968-0004(00)89087-8; Kune GA, 2007, INT J EPIDEMIOL, V36, P951, DOI 10.1093/ije/dym193; Lai KC, 2002, NEW ENGL J MED, V346, P2033, DOI 10.1056/NEJMoa012877; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lanas A, 2002, ALIMENT PHARM THER, V16, P779, DOI 10.1046/j.1365-2036.2002.01230.x; Lawrence JR, 2003, J CLIN PATHOL, V56, P651, DOI 10.1136/jcp.56.9.651; Lin HJ, 2002, CANCER EPIDEM BIOMAR, V11, P1305; LIU B, 1995, NAT MED, V1, P348, DOI 10.1038/nm0495-348; Mahdi JG, 2006, CELL PROLIFERAT, V39, P249, DOI 10.1111/j.1365-2184.2006.00390.x; MARCUS AJ, 1995, NEW ENGL J MED, V333, P656, DOI 10.1056/NEJM199509073331011; Mathers JC, 2003, P NUTR SOC, V62, P51, DOI 10.1079/PNS2002236; McQuaid KR, 2006, AM J MED, V119, P624, DOI 10.1016/j.amjmed.2005.10.039; MEHDY MC, 1994, PLANT PHYSIOL, V105, P467, DOI 10.1104/pp.105.2.467; Miliaras S, 2004, Tech Coloproctol, V8 Suppl 1, ps59, DOI 10.1007/s10151-004-0113-1; MODRICH P, 1987, ANNU REV BIOCHEM, V56, P435, DOI 10.1146/annurev.biochem.56.1.435; MORITA I, 1995, J BIOL CHEM, V270, P10902, DOI 10.1074/jbc.270.18.10902; Mur LAJ, 2000, PLANT J, V23, P609, DOI 10.1046/j.1365-313x.2000.00825.x; Neill SJ, 2002, J EXP BOT, V53, P1237, DOI 10.1093/jexbot/53.372.1237; Norman C, 2004, PLANT PHYSIOL, V134, P492, DOI 10.1104/pp.103.031039; Nunez L, 2006, J PHYSIOL-LONDON, V571, P57, DOI 10.1113/jphysiol.2005.100586; *OFF NAT STAT, 2000, OFF NAT STAT DS S13, V2; Paterson JR, 2006, J AGR FOOD CHEM, V54, P2891, DOI 10.1021/jf058158w; Paterson JR, 2001, QJM-MON J ASSOC PHYS, V94, P445, DOI 10.1093/qjmed/94.8.445; Paterson T, 2006, P NUTR SOC, V65, P93, DOI 10.1079/PNS2005477; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Pierpoint WS, 1997, INTERDISCIPL SCI REV, V22, P45; POWLES TJ, 1973, BRIT J CANCER, V28, P316, DOI 10.1038/bjc.1973.154; RAO CV, 1995, CANCER RES, V55, P1464; Reddy BS, 1999, CARCINOGENESIS, V20, P1645, DOI 10.1093/carcin/20.8.1645; Rigas B, 2000, MED HYPOTHESES, V54, P210, DOI 10.1054/mehy.1999.0023; ROBERTSON GL, 1981, J SCI FOOD AGR, V32, P833, DOI 10.1002/jsfa.2740320813; Rodriguez LAG, 2000, EPIDEMIOLOGY, V11, P376, DOI 10.1097/00001648-200007000-00003; Rodriguez LAG, 2001, BRIT J CLIN PHARMACO, V52, P563, DOI 10.1046/j.0306-5251.2001.01476.x; Ruffin MT, 1997, JNCI-J NATL CANCER I, V89, P1152, DOI 10.1093/jnci/89.15.1152; Ruschoff J, 1998, P NATL ACAD SCI USA, V95, P11301, DOI 10.1073/pnas.95.19.11301; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Sanmuganathan PS, 2001, HEART, V85, P265, DOI 10.1136/heart.85.3.265; Schwenger P, 1997, P NATL ACAD SCI USA, V94, P2869, DOI 10.1073/pnas.94.7.2869; Shureiqi I, 2001, CANCER RES, V61, P4879; Smalley W, 1999, ARCH INTERN MED, V159, P161, DOI 10.1001/archinte.159.2.161; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Stark LA, 2001, FASEB J, V15, P1273, DOI 10.1096/fj.00-0529fje; SWAIN AR, 1985, J AM DIET ASSOC, V85, P950; Terry MB, 2004, JAMA-J AM MED ASSOC, V291, P2433, DOI 10.1001/jama.291.20.2433; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Vainio H, 1997, CANCER EPIDEM BIOMAR, V6, P749; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Velayos FS, 2005, AM J GASTROENTEROL, V100, P1345, DOI 10.1111/j.1572-0241.2005.41442.x; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Wu KK, 2000, CIRCULATION, V102, P2022, DOI 10.1161/01.CIR.102.17.2022; Xu XM, 1999, P NATL ACAD SCI USA, V96, P5292, DOI 10.1073/pnas.96.9.5292; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhang SM, 2008, BRIT J CANCER, V98, P989, DOI 10.1038/sj.bjc.6604240; Zhang ZH, 2000, GASTROENTEROLOGY, V118, P1012, DOI 10.1016/S0016-5085(00)70352-0; Zhou XM, 2001, CARCINOGENESIS, V22, P1393, DOI 10.1093/carcin/22.9.1393; Zimmermann KC, 2000, NEOPLASIA, V2, P505, DOI 10.1038/sj.neo.7900120	116	226	243	1	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2009	373	9671					1301	1309		10.1016/S0140-6736(09)60243-9	http://dx.doi.org/10.1016/S0140-6736(09)60243-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432PN	19328542				2022-12-28	WOS:000265146300033
J	Konhauser, KO; Pecoits, E; Lalonde, SV; Papineau, D; Nisbet, EG; Barley, ME; Arndt, NT; Zahnle, K; Kamber, BS				Konhauser, Kurt O.; Pecoits, Ernesto; Lalonde, Stefan V.; Papineau, Dominic; Nisbet, Euan G.; Barley, Mark E.; Arndt, Nicholas T.; Zahnle, Kevin; Kamber, Balz S.			Oceanic nickel depletion and a methanogen famine before the Great Oxidation Event	NATURE			English	Article							RISE; NI; GEOCHEMISTRY; TECTONICS; CHEMISTRY; SULFUR; GROWTH; CRUST; IRON; PB	It has been suggested that a decrease in atmospheric methane levels triggered the progressive rise of atmospheric oxygen, the so-called Great Oxidation Event, about 2.4 Gyr ago(1). Oxidative weathering of terrestrial sulphides, increased oceanic sulphate, and the ecological success of sulphate-reducing microorganisms over methanogens has been proposed as a possible cause for the methane collapse(1), but this explanation is difficult to reconcile with the rock record(2,3). Banded iron formations preserve a history of Precambrian oceanic elemental abundance and can provide insights into our understanding of early microbial life and its influence on the evolution of the Earth system(4,5). Here we report a decline in the molar nickel to iron ratio recorded in banded iron formations about 2.7 Gyr ago, which we attribute to a reduced flux of nickel to the oceans, a consequence of cooling upper-mantle temperatures and decreased eruption of nickel-rich ultramafic rocks at the time. We measured nickel partition coefficients between simulated Precambrian sea water and diverse iron hydroxides, and subsequently determined that dissolved nickel concentrations may have reached similar to 400nM throughout much of the Archaean eon, but dropped below similar to 200nM by 2.5 Gyr ago and to modern day values(6) (similar to 9 nM) by similar to 550 Myr ago. Nickel is a key metal cofactor in several enzymes of methanogens(7) and we propose that its decline would have stifled their activity in the ancient oceans and disrupted the supply of biogenic methane. A decline in biogenic methane production therefore could have occurred before increasing environmental oxygenation and not necessarily be related to it. The enzymatic reliance of methanogens on a diminishing supply of volcanic nickel links mantle evolution to the redox state of the atmosphere.	[Konhauser, Kurt O.; Pecoits, Ernesto; Lalonde, Stefan V.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Papineau, Dominic] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Nisbet, Euan G.] Royal Holloway Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England; [Barley, Mark E.] Univ Western Australia, Sch Earth & Environm, Crawley, WA 6009, Australia; [Arndt, Nicholas T.] Univ Grenoble 1, Lab Geodynam Chaine Alpines Maison Geosci, F-38041 Grenoble, France; [Zahnle, Kevin] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Kamber, Balz S.] Laurentian Univ, Dept Earth Sci, Sudbury, ON P3E 2C6, Canada	University of Alberta; Carnegie Institution for Science; University of London; Royal Holloway University London; University of Western Australia; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Laurentian University	Konhauser, KO (corresponding author), Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada.	kurtk@ualberta.ca	Papineau, Dominic/AAD-6366-2019; Kamber, Balz/A-1823-2008	Konhauser, Kurt/0000-0001-7722-7068; Kamber, Balz/0000-0002-8720-0608; Papineau, Dominic/0000-0003-0063-7514	Natural Science and Engineering Research Council of Canada (NSERC); Australian Research Council (ARC)	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Australian Research Council (ARC)(Australian Research Council)	We thank M. Labbe for sample preparation, G. Chen and A. Simonetti for assistance with LA-ICP-MS analyses in the Radiogenic Isotope Facility at the University of Alberta, and S. Matveev for assistance with electron microprobe analyses. Field assistance by W. Mueller is acknowledged for Hunter Mine Group samples. Samples from the Loch Maree Group were provided by A. Wright. Funding was provided by the Natural Science and Engineering Research Council of Canada (NSERC) to K. O. K., the Canada Research Chairs Program to B. S. K., the Australian Research Council (ARC) to M. E. B., and NASA Exobiology and Evolutionary Biology Program individually to D. P. and K. Z. This manuscript was improved by discussions with R. Buick, J. Kasting and M. Lesher, and reviews by R. Frei and M. Saito.	Arndt N, 2008, KOMATIITE, P1, DOI 10.1017/CBO9780511535550; ARNDT NT, 1991, TECTONOPHYSICS, V187, P411, DOI 10.1016/0040-1951(91)90479-C; Barley ME, 1998, PRECAMBRIAN RES, V91, P65, DOI 10.1016/S0301-9268(98)00039-4; Barley ME, 2005, EARTH PLANET SC LETT, V238, P156, DOI 10.1016/j.epsl.2005.06.062; Basiliko N, 2001, BIOGEOCHEMISTRY, V52, P133, DOI 10.1023/A:1006461803585; Berry AJ, 2008, NATURE, V455, P960, DOI 10.1038/nature07377; Bjerrum CJ, 2002, NATURE, V417, P159, DOI 10.1038/417159a; Catling DC, 2007, PHILOS T R SOC A, V365, P1867, DOI 10.1098/rsta.2007.2047; Chester R., 2000, MARINE GEOCHEMISTRY; CONDIE KC, 1993, CHEM GEOL, V104, P1, DOI 10.1016/0009-2541(93)90140-E; DIEKERT G, 1980, ARCH MICROBIOL, V127, P273, DOI 10.1007/BF00427204; Drever J.I., 1988, GEOCHEMISTRY NATURAL; Frausto da Silva J.J.R., 1991, BIOL CHEM ELEMENTS I; Hannington MD, 2003, MINER DEPOSITA, V38, P393, DOI 10.1007/s00126-002-0298-z; Hausrath EM, 2007, GEOBIOLOGY, V5, P49, DOI 10.1111/j.1472-4669.2007.00095.x; JARRELL KF, 1982, J BACTERIOL, V149, P346, DOI 10.1128/JB.149.1.346-353.1982; JAUN B, 2007, METAL IONS LIFE SCI, V0002, P00323; Kamber BS, 2005, EARTH PLANET SC LETT, V240, P276, DOI 10.1016/j.epsl.2005.09.037; Kamber BS, 2001, GEOCHIM COSMOCHIM AC, V65, P2509, DOI 10.1016/S0016-7037(01)00613-5; KEAYS RR, 1995, LITHOS, V34, P1; Kharecha P, 2005, GEOBIOLOGY, V3, P53, DOI 10.1111/j.1472-4669.2005.00049.x; Kida K, 2001, J BIOSCI BIOENG, V91, P590, DOI 10.1263/jbb.91.590; Konhauser KO, 2007, SCIENCE, V315, P1234, DOI 10.1126/science.1136328; Kruger M, 2003, NATURE, V426, P878, DOI 10.1038/nature02207; Kump LR, 2007, NATURE, V448, P1033, DOI 10.1038/nature06058; Maliva RG, 2005, GEOL SOC AM BULL, V117, P835, DOI 10.1130/B25555.1; MCLENNAN SM, 1989, REV MINERAL, V21, P169; MCLENNAN SM, 1983, GEOCHIM COSMOCHIM AC, V47, P1211, DOI 10.1016/0016-7037(83)90063-7; Nisbet E.G., 1982, KOMATIITES, P501; OZTURK M, 1995, MAR CHEM, V48, P329, DOI 10.1016/0304-4203(95)92785-Q; Papineau D, 2007, EARTH PLANET SC LETT, V255, P188, DOI 10.1016/j.epsl.2006.12.015; Saito MA, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002216; Saito MA, 2003, INORG CHIM ACTA, V356, P308, DOI 10.1016/S0020-1693(03)00442-0; SCHONHEIT P, 1979, ARCH MICROBIOL, V123, P105, DOI 10.1007/BF00403508; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Shima S, 2007, CHEM REC, V7, P37, DOI 10.1002/tcr.20111; Taylor S. R., 1985, CONTINENTAL CRUST IT, DOI DOI 10.1002/GJ.3350210116; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; TRENDALL AF, 2002, SPECIAL PUBLICATION, V33, P33, DOI DOI 10.1016/J.PRECAMRES.2016.04.016; Zahnle K., 2006, GEOBIOLOGY, V4, P271, DOI 10.1111/j.1472-4669.2006.00085.x	40	305	324	8	198	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					750	U85		10.1038/nature07858	http://dx.doi.org/10.1038/nature07858			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19360085				2022-12-28	WOS:000265193600038
J	Hammer, F; Stewart, PM				Hammer, Fabian; Stewart, Paul M.			Practice Rational Testing Investigating hypertension in a young person	BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY ALDOSTERONISM		[Hammer, Fabian; Stewart, Paul M.] Univ Birmingham, Div Med Sci, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Stewart, PM (corresponding author), Univ Birmingham, Div Med Sci, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England.	p.m.stewart@bham.ac.uk			National Institute for Health Research [NF-SI-0508-10356] Funding Source: researchfish; Medical Research Council [G0600432] Funding Source: Medline; MRC [G0600432] Funding Source: UKRI	National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Eisenhofer G, 2005, CLIN CHEM, V51, P735, DOI 10.1373/clinchem.2004.045484; Garovic VD, 2005, CIRCULATION, V112, P1362, DOI 10.1161/CIRCULATIONAHA.104.492348; Mosso L, 2003, HYPERTENSION, V42, P161, DOI 10.1161/01.HYP.0000079505.25750.11; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; YOUNG WF, 1990, MAYO CLIN PROC, V65, P96, DOI 10.1016/S0025-6196(12)62114-4	5	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 6	2009	338								b1043	10.1136/bmj.b1043	http://dx.doi.org/10.1136/bmj.b1043			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431ZF	19349343				2022-12-28	WOS:000265102600002
J	TaufiqUrRahman; Skupin, A; Falcke, M; Taylor, CW				TaufiqUrRahman; Skupin, Alexander; Falcke, Martin; Taylor, Colin W.			Clustering of InsP(3) receptors by InsP(3) retunes their regulation by InsP(3) and Ca2+	NATURE			English	Article							INOSITOL TRISPHOSPHATE RECEPTOR; CHANNELS RYANODINE RECEPTORS; CALCIUM-RELEASE CHANNELS; IP3 RECEPTORS; SPATIAL-DISTRIBUTION; XENOPUS OOCYTES; INACTIVATION; MEMBRANE; PATTERNS; KINETICS	The versatility of Ca2+ signals derives from their spatio-temporal organization(1,2). For Ca2+ signals initiated by inositol-1,4,5-trisphosphate (InsP(3)), this requires local interactions between InsP(3) receptors (InsP(3)Rs)(3,4) mediated by their rapid stimulation and slower inhibition(4) by cytosolic Ca2+. This allows hierarchical recruitment of Ca2+ release events as the InsP(3) concentration increases(5). Single InsP(3)Rs respond first, then clustered InsP(3)Rs open together giving a local 'Ca2+ puff', and as puffs become more frequent they ignite regenerative Ca2+ waves(1,5-9). Using nuclear patch-clamp recording(10), here we demonstrate that InsP(3)Rs are initially randomly distributed with an estimated separation of similar to 1 mu m. Low concentrations of InsP(3) cause InsP(3)Rs to aggregate rapidly and reversibly into small clusters of about four closely associated InsP(3)Rs. At resting cytosolic [Ca2+], clustered InsP(3)Rs open independently, but with lower open probability, shorter open time, and less InsP(3) sensitivity than lone InsP(3)Rs. Increasing cytosolic [Ca2+] reverses the inhibition caused by clustering, InsP(3)R gating becomes coupled, and the duration of multiple openings is prolonged. Clustering both exposes InsP(3)Rs to local Ca2+ rises and increases the effects of Ca2+. Dynamic regulation of clustering by InsP(3) retunes InsP(3)R sensitivity to InsP(3) and Ca2+, facilitating hierarchical recruitment of the elementary events that underlie all InsP(3)-evoked Ca2+ signals(3,5).	[TaufiqUrRahman; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Skupin, Alexander; Falcke, Martin] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Falcke, Martin] Helmholtz Ctr Berlin Mat & Energy, D-14109 Berlin, Germany	University of Cambridge; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB)	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	cwt1000@cam.ac.uk	Falcke, Martin/I-2966-2012	Falcke, Martin/0000-0001-7137-1114; SKUPIN, Alexander/0000-0002-8955-8304	The Wellcome Trust; The Biotechnology and Biological Sciences Research Council; Jameel Family Trust; IRTG 'Genomics and Systems Biology of Molecular Networks' of the Deutsche Forschungsgemeinschaft	The Wellcome Trust(Wellcome TrustEuropean Commission); The Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Jameel Family Trust; IRTG 'Genomics and Systems Biology of Molecular Networks' of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by The Wellcome Trust ( C. W. T.), The Biotechnology and Biological Sciences Research Council ( C. W. T.), a scholarship from the Jameel Family Trust (T.-U.-R.), and the IRTG 'Genomics and Systems Biology of Molecular Networks' of the Deutsche Forschungsgemeinschaft ( A. S.). We thank S. Dedos for help with DT40 cells, D. Prole and B. Billups for advice, and T. Kurosaki for providing DT40-KO cells.	Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Boehning D, 2001, BIOPHYS J, V81, P117, DOI 10.1016/S0006-3495(01)75685-8; Bootman MD, 1997, CELL, V91, P367, DOI 10.1016/S0092-8674(00)80420-1; BOURGUIGNON LYW, 1993, CELL BIOL INT, V17, P751, DOI 10.1006/cbir.1993.1136; Dargan SL, 2003, J PHYSIOL-LONDON, V553, P775, DOI 10.1113/jphysiol.2003.054247; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Falcke M, 2004, ADV PHYS, V53, P255, DOI 10.1080/00018730410001703159; Ferreri-Jacobia M, 2005, J BIOL CHEM, V280, P3824, DOI 10.1074/jbc.M409462200; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Fukatsu K, 2004, J BIOL CHEM, V279, P48976, DOI 10.1074/jbc.M408364200; Horne JH, 1997, SCIENCE, V276, P1690, DOI 10.1126/science.276.5319.1690; Ionescu L, 2006, J PHYSIOL-LONDON, V573, P645, DOI 10.1113/jphysiol.2006.109504; Katayama E, 1996, EMBO J, V15, P4844, DOI 10.1002/j.1460-2075.1996.tb00865.x; Mak DOD, 1998, AM J PHYSIOL-CELL PH, V275, pC179, DOI 10.1152/ajpcell.1998.275.1.C179; Mak DOD, 1997, J GEN PHYSIOL, V109, P571, DOI 10.1085/jgp.109.5.571; Marchant J, 1999, EMBO J, V18, P5285, DOI 10.1093/emboj/18.19.5285; Marchant JS, 2001, EMBO J, V20, P65, DOI 10.1093/emboj/20.1.65; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; Prole DL, 2003, J GEN PHYSIOL, V122, P775, DOI 10.1085/jgp.200308897; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Shuai JW, 2006, BIOPHYS J, V91, P4033, DOI 10.1529/biophysj.106.088880; Sneyd J, 2005, PROG BIOPHYS MOL BIO, V89, P207, DOI 10.1016/j.pbiomolbio.2004.11.001; Sun XP, 1998, J PHYSIOL-LONDON, V509, P67, DOI 10.1111/j.1469-7793.1998.067bo.x; Tateishi Y, 2005, J BIOL CHEM, V280, P6816, DOI 10.1074/jbc.M405469200; Yin CC, 2005, J MOL BIOL, V349, P538, DOI 10.1016/j.jmb.2005.04.002	26	107	108	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					655	659		10.1038/nature07763	http://dx.doi.org/10.1038/nature07763			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19348050	Green Accepted			2022-12-28	WOS:000264796200046
J	Detsky, AS				Detsky, Allan S.			The Art of Pimping	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Ste 427, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						Ausiello DA, 2008, J CLIN INVEST, V118, P3805, DOI 10.1172/JCI37666; BRANCATI FL, 1989, JAMA-J AM MED ASSOC, V262, P89, DOI 10.1001/jama.262.1.89; Ross JS, 2008, JAMA-J AM MED ASSOC, V300, P1934, DOI 10.1001/jama.300.16.1934	3	44	44	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 1	2009	301	13					1379	1381		10.1001/jama.2009.247	http://dx.doi.org/10.1001/jama.2009.247			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426LM	19336716				2022-12-28	WOS:000264709800030
J	Hubner, W; McNerney, GP; Chen, P; Dale, BM; Gordon, RE; Chuang, FYS; Li, XD; Asmuth, DM; Huser, T; Chen, BK				Huebner, Wolfgang; McNerney, Gregory P.; Chen, Ping; Dale, Benjamin M.; Gordon, Ronald E.; Chuang, Frank Y. S.; Li, Xiao-Dong; Asmuth, David M.; Huser, Thomas; Chen, Benjamin K.			Quantitative 3D Video Microscopy of HIV Transfer Across T Cell Virological Synapses	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GP41 CYTOPLASMIC TAIL; LYMPHOCYTES; FUSION; SPREAD; ENTRY; CYTOSKELETON; REPLICATION; ENDOCYTOSIS; INFECTION	The spread of HIV between immune cells is greatly enhanced by cell-cell adhesions called virological synapses, although the underlying mechanisms have been unclear. With use of an infectious, fluorescent clone of HIV, we tracked the movement of Gag in live CD4 T cells and captured the direct translocation of HIV across the virological synapse. Quantitative, high-speed three-dimensional (3D) video microscopy revealed the rapid formation of micrometer-sized "buttons" containing oligomerized viral Gag protein. Electron microscopy showed that these buttons were packed with budding viral crescents. Viral transfer events were observed to form virus-laden internal compartments within target cells. Continuous time-lapse monitoring showed preferential infection through synapses. Thus, HIV dissemination may be enhanced by virological synapse-mediated cell adhesion coupled to viral endocytosis.	[Huebner, Wolfgang; Chen, Ping; Dale, Benjamin M.; Chen, Benjamin K.] Mt Sinai Sch Med, Dept Med, Inst Immunol, Div Infect Dis, New York, NY 10029 USA; [Gordon, Ronald E.] Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA; [McNerney, Gregory P.; Chuang, Frank Y. S.; Huser, Thomas] Univ Calif Davis, NSF Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA; [Li, Xiao-Dong; Asmuth, David M.; Huser, Thomas] Univ Calif Davis, Med Ctr, Dept Internal Med, Sacramento, CA 95817 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Science Foundation (NSF); University of California System; University of California Davis; University of California System; University of California Davis	Chen, BK (corresponding author), Mt Sinai Sch Med, Dept Med, Inst Immunol, Div Infect Dis, New York, NY 10029 USA.	ben.chen@mssm.edu	Huser, Thomas/K-7291-2019; Hubner, Wolfgang/O-7907-2016	Huser, Thomas/0000-0003-2348-7416; Chen, Benjamin K/0000-0002-5404-1997; Asmuth, David/0000-0003-0916-7950; Hubner, Wolfgang/0000-0002-1128-6468	NIH [AI074420-02]; Burroughs Wellcome Fund Investigator Award; Hirschl Weill Caulier Career Scientist Award; Mount Sinai School of Medicine Microscopy Shared Resource Facility [NIH-NCI 5R24 CA095823-04, NSF-DBI-9724504, NIH-S10RR09145-01]; NSF Center for Biophotonics Science and Technology [PHY012099]; UCD Health System Research Award; UCD Clinical and Translational Science Center [NIH-NCRR ULRR024146]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA028866] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigator Award(Burroughs Wellcome Fund); Hirschl Weill Caulier Career Scientist Award; Mount Sinai School of Medicine Microscopy Shared Resource Facility; NSF Center for Biophotonics Science and Technology; UCD Health System Research Award; UCD Clinical and Translational Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. H. Cheng, V. Simon, M. Klotman, R. Iyengar, and A. Del Portillo for critiques and discussions; R. Huq for microscopy support; S. Izadmehr for image analysis; M. Grisotto and V. Sahi for cell sorting; H. Bell for electron microscopy support; and S. Lira for imaging support. Work was supported by NIH grant AI074420-02, Burroughs Wellcome Fund Investigator Award, and Hirschl Weill Caulier Career Scientist Award to B.K.C. Imaging was supported by Mount Sinai School of Medicine Microscopy Shared Resource Facility grants NIH-NCI 5R24 CA095823-04, NSF-DBI-9724504, and NIH-S10RR09145-01; by the NSF Center for Biophotonics Science and Technology (cooperative agreement PHY012099); a UCD Health System Research Award to T.H.; and the UCD Clinical and Translational Science Center grant NIH-NCRR ULRR024146 (T.H. and D.M.A.).	Blanco J, 2004, J BIOL CHEM, V279, P51305, DOI 10.1074/jbc.M408547200; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Derdowski A, 2004, J VIROL, V78, P1230, DOI 10.1128/JVI.78.3.1230-1242.2004; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Fackler OT, 2000, CURR BIOL, V10, P1005, DOI 10.1016/S0960-9822(00)00654-0; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Hubner W, 2007, J VIROL, V81, P12596, DOI 10.1128/JVI.01088-07; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jolly C, 2005, J VIROL, V79, P12088, DOI 10.1128/JVI.79.18.12088-12094.2005; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Jolly C, 2007, J VIROL, V81, P13916, DOI 10.1128/JVI.01585-07; Jolly C, 2007, J VIROL, V81, P5547, DOI 10.1128/JVI.01469-06; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Larson DR, 2003, J CELL BIOL, V162, P1233, DOI 10.1083/jcb.200303200; Marechal V, 2001, J VIROL, V75, P11166, DOI 10.1128/JVI.75.22.11166-11177.2001; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Schaeffer E, 2004, J VIROL, V78, P1375, DOI 10.1128/JVI.78.3.1375-1383.2004; Sol-Foulon N, 2007, EMBO J, V26, P516, DOI 10.1038/sj.emboj.7601509; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004; Wyss S, 2005, J VIROL, V79, P12231, DOI 10.1128/JVI.79.19.12231-12241.2005	26	359	363	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1743	1747		10.1126/science.1167525	http://dx.doi.org/10.1126/science.1167525			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325119	Green Accepted			2022-12-28	WOS:000264559800044
J	Gaisser, S; Hopkins, MM; Liddell, K; Zika, E; Ibarreta, D				Gaisser, Sibylle; Hopkins, Michael M.; Liddell, Kathleen; Zika, Eleni; Ibarreta, Dolores			The phantom menace of gene patents	NATURE			English	Editorial Material									[Gaisser, Sibylle] Fraunhofer Inst Syst & Innovat Res, D-76139 Karlsruhe, Germany; [Hopkins, Michael M.] Univ Sussex, SPRU Sci & Technol Policy Res, Brighton BN1 9QE, E Sussex, England; [Liddell, Kathleen] Univ Cambridge, Ctr Intellectual Property & Informat Law, Cambridge CB3 9DZ, England; [Zika, Eleni; Ibarreta, Dolores] Inst Prospect Technol Studies, European Commiss Joint Res Ctr, E-41092 Seville, Spain	Fraunhofer Gesellschaft; University of Sussex; University of Cambridge; European Commission Joint Research Centre; EC JRC Institute for Prospective Technological Studies (IPTS)	Gaisser, S (corresponding author), Fraunhofer Inst Syst & Innovat Res, 48 Breslauer St, D-76139 Karlsruhe, Germany.	m.m.hopkins@sussex.ac.uk						Ayme S, 2008, EUR J HUM GENET, V16, pS3, DOI 10.1038/sj.ejhg.5201929; Carlson B, 2009, GENET ENG BIOTECHN N, V29, P14; Cho MK, 2003, J MOL DIAGN, V5, P3, DOI 10.1016/S1525-1578(10)60444-8; *COMM COUNC EUR PA, 2005, DEV IMPL PAT LAW FIE; Hopkins M. M., 2006, PATENTING HUMAN DNA; Hopkins MM, 2007, NAT BIOTECHNOL, V25, P185, DOI 10.1038/nbt0207-185; Lacasa I.D., 2004, SCI PUBL POLICY, V31, P385; Matthijs G, 2004, BRIT MED J, V329, P1358, DOI 10.1136/bmj.329.7479.1358; Matthijs G, 2008, CLIN MED, V8, P58, DOI 10.7861/clinmedicine.8-1-58; Zika E, 2006, PHARMACOGENETICS PHA	10	23	23	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 26	2009	458	7237					407	408		10.1038/458407a	http://dx.doi.org/10.1038/458407a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19325609				2022-12-28	WOS:000264532400019
J	Kendrick, T; Dowrick, C; McBride, A; Howe, A; Clarke, P; Maisey, S; Moore, M; Smith, PW				Kendrick, Tony; Dowrick, Christopher; McBride, Anita; Howe, Amanda; Clarke, Pamela; Maisey, Sue; Moore, Michael; Smith, Peter W.			Management of depression in UK general practice in relation to scores on depression severity questionnaires: analysis of medical record data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; HOSPITAL ANXIETY; PROJECT; PHQ-9; METAANALYSIS; DISORDERS; VALIDITY; SCALE	Objective To determine if general practitioner rates of antidepressant drug prescribing and referrals to specialist services for depression vary in line with patients' scores on depression severity questionnaires. Design Analysis of anonymised medical record data. Setting 38 general practices in three sites Southampton, Liverpool, and Norfolk. Data reviewed Records for 2294 patients assessed with severity questionnaires for depression between April 2006 and March 2007 inclusive. Main outcome measures Rates of prescribing of antidepressants and referrals to specialist mental health or social services. Results 1658 patients were assessed with the 9 item patient health questionnaire (PHQ-9), 584 with the depression subscale of the hospital anxiety and depression scale (HADS), and 52 with the Beck depression inventory, 2nd edition (BDI-II). Overall, 79.1% of patients assessed with either PHQ-9 or HADS received a prescription for an antidepressant, and 22.8% were referred to specialist services. Prescriptions and referrals were significantly associated with higher severity scores. However, overall rates of treatment and referral were similar for patients assessed with either measure despite the fact that, with PHQ-9, 83.5% of patients were classified as moderately to severely depressed and in need of treatment, whereas only 55.6% of patients were so classified with HADS. Rates of treatment were lower for older patients and for patients with comorbid physical illness (including coronary heart disease and diabetes) despite the fact that screening for depression among such patients is encouraged in the quality and outcomes framework. Conclusions General practitioners do not decide on drug treatment or referral for depression on the basis of questionnaire scores alone, but also take account of other factors such as age and physical illness. The two most widely used severity questionnaires perform inconsistently in practice, suggesting that changing the recommended threshold scores for intervention might make the measures more valid, more consistent with practitioners' clinical judgment, and more acceptable to practitioners as a way of classifying patients.	[Kendrick, Tony; Moore, Michael] Univ Southampton, Primary Med Care Grp, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England; [Dowrick, Christopher; Clarke, Pamela] Univ Liverpool, Sch Populat Community & Behav Sci, Liverpool L69 3GB, Merseyside, England; [Howe, Amanda; Maisey, Sue] Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; [Smith, Peter W.] Univ Southampton, Southampton Stat Sci Res Inst, Southampton SO17 1BJ, Hants, England	University of Southampton; University of Liverpool; University of East Anglia; University of Southampton	Kendrick, T (corresponding author), Univ Southampton, Primary Med Care Grp, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England.	A.R.Kendrick@Southampton.ac.uk	Kendrick, Tony/H-8558-2014; Moore, Michael/C-3447-2011	Kendrick, Tony/0000-0003-1618-9381; Moore, Michael/0000-0002-5127-4509; Smith, Peter/0000-0003-4423-5410	Lilly; Lundbeck; Servier; Wyeth pharmaceuticals; Southampton City Primary Care Trust and the Mental Health Research Network, West, North West, and East Anglia hubs	Lilly(Eli Lilly); Lundbeck(Lundbeck Corporation); Servier(Servier); Wyeth pharmaceuticals(Wyeth); Southampton City Primary Care Trust and the Mental Health Research Network, West, North West, and East Anglia hubs	Funding: This study was funded by an unrestricted educational grant from Lilly, Lundbeck, Servier, and Wyeth pharmaceuticals. It also received funding from Southampton City Primary Care Trust and the Mental Health Research Network, West, North West, and East Anglia hubs. None of the above bodies had any role in study design; the collection, analysis, and interpretation of data; the writing of the paper; or the decision to submit this paper for publication. The study was sponsored by the University of Liverpool.	Adams G, 2004, J CLIN EPIDEMIOL, V57, P785, DOI 10.1016/j.jclinepi.2003.12.013; *AG CONC, 2008, UND UNTR RISK EXP OL; Anderson IM, 2000, J PSYCHOPHARMACOL, V14, P3, DOI 10.1177/026988110001400101; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Arnau RC, 2001, HEALTH PSYCHOL, V20, P112, DOI 10.1037//0278-6133.20.2.112; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Beck AT, 1996, PSYCHOL ASSESS; *BRIT MED ASS, 2006, NHS EMPL REV GMS CON; Cameron IM, 2008, BRIT J GEN PRACT, V58, P32, DOI 10.3399/bjgp08X263794; DOWRICK C, 1995, BMJ-BRIT MED J, V311, P1274, DOI 10.1136/bmj.311.7015.1274; DOWRICK C, 1995, PRIMARY CARE PSYCHIA, V1, P255; Dowrick C, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b663; Gilbody S, 2007, BRIT J GEN PRACT, V57, P650; Jeffries D, 2006, BRIT J GEN PRACT, V56, P392; Kendrick T, 2005, BRIT J GEN PRACT, V55, P280; Kendrick T, 2001, BRIT J GEN PRACT, V51, P911; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9; *MACARTHUR IN DEPR, 2008, US PHQ 9 TREATM SEL; National Collaborating Centre for Mental Health, 2004, DEPR MAN DEPR PRIM S; *NHS INF CTR, 2008, QUAL OUTC FRAM DAT; Prescription Pricing Authority, 2007, PRESCR AN COST PACT; Thompson C, 2000, LANCET, V355, P185, DOI 10.1016/S0140-6736(99)03171-2; Thompson C, 2001, BRIT J PSYCHIAT, V179, P317, DOI 10.1192/bjp.179.4.317; WILKINSON MJB, 1988, J ROY COLL GEN PRACT, V38, P311; Williams JW, 2004, ANN INTERN MED, V140, P1015, DOI 10.7326/0003-4819-140-12-200406150-00012; Williams JW, 2002, JAMA-J AM MED ASSOC, V287, P1160, DOI 10.1001/jama.287.9.1160; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	28	143	144	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2009	338								b750	10.1136/bmj.b750	http://dx.doi.org/10.1136/bmj.b750			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422NW	19299475	hybrid, Green Accepted			2022-12-28	WOS:000264436000002
J	Phelps, AC; Maciejewski, PK; Nilsson, M; Balboni, TA; Wright, AA; Paulk, ME; Trice, E; Schrag, D; Peteet, JR; Block, SD; Prigerson, HG				Phelps, Andrea C.; Maciejewski, Paul K.; Nilsson, Matthew; Balboni, Tracy A.; Wright, Alexi A.; Paulk, M. Elizabeth; Trice, Elizabeth; Schrag, Deborah; Peteet, John R.; Block, Susan D.; Prigerson, Holly G.			Religious Coping and Use of Intensive Life-Prolonging Care Near Death in Patients With Advanced Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; ILL ELDERLY-PATIENTS; TREATMENT PREFERENCES; DECISION-MAKING; AFRICAN-AMERICANS; MENTAL-HEALTH; END; QUESTIONNAIRE; ACKNOWLEDGMENT; RESUSCITATION	Context Patients frequently rely on religious faith to cope with cancer, but little is known about the associations between religious coping and the use of intensive life-prolonging care at the end of life. Objective To determine the way religious coping relates to the use of intensive life-prolonging end-of-life care among patients with advanced cancer. Design, Setting, and Participants A US multisite, prospective, longitudinal cohort of 345 patients with advanced cancer, who were enrolled between January 1, 2003, and August 31, 2007. The Brief RCOPE assessed positive religious coping. Baseline interviews assessed psychosocial and religious/spiritual measures, advance care planning, and end-of-life treatment preferences. Patients were followed up until death, a median of 122 days after baseline assessment. Main Outcome Measures Intensive life-prolonging care, defined as receipt of mechanical ventilation or resuscitation in the last week of life. Analyses were adjusted for demographic factors significantly associated with positive religious coping and any end-of-life outcome at P < .05 (ie, age and race/ethnicity). The main outcome was further adjusted for potential psychosocial confounders (eg, other coping styles, terminal illness acknowledgment, spiritual support, preference for heroics, and advance care planning). Results A high level of positive religious coping at baseline was significantly associated with receipt of mechanical ventilation compared with patients with a low level (11.3% vs 3.6%; adjusted odds ratio [AOR], 2.81 [95% confidence interval {CI}, 1.03-7.69]; P = .04) and intensive life-prolonging care during the last week of life (13.6% vs 4.2%; AOR, 2.90 [ 95% CI, 1.14-7.35]; P = .03) after adjusting for age and race. In the model that further adjusted for other coping styles, terminal illness acknowledgment, support of spiritual needs, preference for heroics, and advance care planning (do-not-resuscitate order, living will, and health care proxy/durable power of attorney), positive religious coping remained a significant predictor of receiving intensive life-prolonging care near death (AOR, 2.90 [95% CI, 1.07-7.89]; P = .04). Conclusions Positive religious coping in patients with advanced cancer is associated with receipt of intensive life-prolonging medical care near death. Further research is needed to determine the mechanisms for this association.	[Phelps, Andrea C.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Phelps, Andrea C.; Maciejewski, Paul K.; Nilsson, Matthew; Balboni, Tracy A.; Wright, Alexi A.; Trice, Elizabeth; Prigerson, Holly G.] Dana Farber Canc Inst, Ctr Psychooncol & Palliat Care Res, Boston, MA 02115 USA; [Balboni, Tracy A.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Wright, Alexi A.; Trice, Elizabeth; Schrag, Deborah] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Peteet, John R.; Block, Susan D.; Prigerson, Holly G.] Dana Farber Canc Inst, Dept Psychooncol & Palliat Care, Boston, MA 02115 USA; [Paulk, M. Elizabeth] Univ Texas SW Med Ctr Dallas, Parkland Hosp, Dallas, TX 75390 USA; [Paulk, M. Elizabeth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Maciejewski, Paul K.; Peteet, John R.; Block, Susan D.; Prigerson, Holly G.] Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA; [Block, Susan D.; Prigerson, Holly G.] Harvard Univ, Sch Med, Ctr Palliat Care, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Prigerson, HG (corresponding author), Dana Farber Canc Inst, Ctr Psychooncol & Palliat Care Res, 44 Binney St,Room 268, Boston, MA 02115 USA.	Holly_Prigerson@dfci.harvard.edu	Prigerson, Holly/GWV-3283-2022; Wright, Alexi/T-5793-2019; Prigerson, Holly/L-3800-2019; Balboni, Tracy/AAH-4490-2020	Prigerson, Holly/0000-0002-7075-4268; 	National Cancer Institute [CA 106370]; National Institute of Mental Health [MH63892]; Fetzer Institute; NATIONAL CANCER INSTITUTE [T32CA009172, R01CA106370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063892] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fetzer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by grant CA 106370 from the National Cancer Institute, grant MH63892 from the National Institute of Mental Health, and a Fetzer Institute grant on spirituality at the end of life.	Ano GG, 2005, J CLIN PSYCHOL, V61, P461, DOI 10.1002/jclp.20049; Balboni TA, 2007, J CLIN ONCOL, V25, P555, DOI 10.1200/JCO.2006.07.9046; Braun UK, 2008, J GEN INTERN MED, V23, P267, DOI 10.1007/s11606-007-0487-7; Bullock K, 2006, J PALLIAT MED, V9, P183, DOI 10.1089/jpm.2006.9.183; Canada AL, 2006, GYNECOL ONCOL, V101, P102, DOI 10.1016/j.ygyno.2005.09.045; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chatters LM, 2000, ANNU REV PUBL HEALTH, V21, P335, DOI 10.1146/annurev.publhealth.21.1.335; Cohen SR, 1996, CANCER-AM CANCER SOC, V77, P576, DOI 10.1002/(SICI)1097-0142(19960201)77:3<576::AID-CNCR22>3.0.CO;2-0; Cohen SR, 1997, PALLIATIVE MED, V11, P3; Crawley L, 2000, JAMA-J AM MED ASSOC, V284, P2518, DOI 10.1001/jama.284.19.2518; Curlin FA, 2007, AM J PSYCHIAT, V164, P1825, DOI 10.1176/appi.ajp.2007.06122088; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Fitchett G, 2004, INT J PSYCHIAT MED, V34, P179, DOI 10.2190/UCJ9-DP4M-9C0X-835M; Goodlin SJ, 1999, JAMA-J AM MED ASSOC, V282, P2333, DOI 10.1001/jama.282.24.2333; Jacobs LM, 2008, ARCH SURG-CHICAGO, V143, P730, DOI 10.1001/archsurg.143.8.730; Johnson KS, 2005, J AM GERIATR SOC, V53, P711, DOI 10.1111/j.1532-5415.2005.53224.x; KARNOFSKY DA, 1948, CANCER-AM CANCER SOC, V1, P634, DOI 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L; Kershaw TS, 2008, ANN BEHAV MED, V36, P117, DOI 10.1007/s12160-008-9058-3; Koenig H, 2001, HDB RELIG HLTH; Lutgendorf SK, 2002, CANCER, V94, P131, DOI 10.1002/cncr.10155; McKinley ED, 1996, J GEN INTERN MED, V11, P651, DOI 10.1007/BF02600155; Pargament KI, 2000, J CLIN PSYCHOL, V56, P519, DOI 10.1002/(SICI)1097-4679(200004)56:4<519::AID-JCLP6>3.0.CO;2-1; Pargament KI, 1998, J CLIN PSYCHOL, V54, P77; Pargament KI, 2004, J HEALTH PSYCHOL, V9, P713, DOI 10.1177/1359105304045366; Pargament KI, 2001, ARCH INTERN MED, V161, P1881, DOI 10.1001/archinte.161.15.1881; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; PRIGERSON HG, 1992, J HEALTH SOC BEHAV, V33, P378, DOI 10.2307/2137315; Ray A, 2006, J PALLIAT MED, V9, P1359, DOI 10.1089/jpm.2006.9.1359; Sears SR, 2007, J BEHAV MED, V30, P533, DOI 10.1007/s10865-007-9128-1; Silvestri GA, 2003, J CLIN ONCOL, V21, P1379, DOI 10.1200/JCO.2003.08.036; Smith AK, 2008, J CLIN ONCOL, V26, P4131, DOI 10.1200/JCO.2007.14.8452; Sullivan MA, 2004, PSYCHOSOMATICS, V45, P119, DOI 10.1176/appi.psy.45.2.119; Sulmasy DP, 2006, JAMA-J AM MED ASSOC, V296, P1385, DOI 10.1001/jama.296.11.1385; Tarakeshwar N, 2006, J PALLIAT MED, V9, P646, DOI 10.1089/jpm.2006.9.646; True G, 2005, ANN BEHAV MED, V30, P174, DOI 10.1207/s15324796abm3002_10; Van Ness PH, 2008, J AGING HEALTH, V20, P545, DOI 10.1177/0898264308317538; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	39	285	288	1	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 18	2009	301	11					1140	1147		10.1001/jama.2009.341	http://dx.doi.org/10.1001/jama.2009.341			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	419UC	19293414	Green Accepted, Bronze			2022-12-28	WOS:000264244200019
J	Rees, PJ				Rees, P. John			Review: Inhaled corticosteroids do not reduce mortality but increase pneumonia in chronic obstructive pulmonary disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							METAANALYSIS		Kings Coll London, Sch Med, London WC2R 2LS, England	University of London; King's College London	Rees, PJ (corresponding author), Kings Coll London, Sch Med, London WC2R 2LS, England.							Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; Drummond MB, 2008, JAMA-J AM MED ASSOC, V300, P2407, DOI 10.1001/jama.2008.717; Patel BD, 2008, AM J RESP CRIT CARE, V178, P500, DOI 10.1164/rccm.200801-059OC; Sobieraj DM, 2008, CLIN THER, V30, P1416, DOI 10.1016/j.clinthera.2008.08.004	4	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6							JC3-6	10.7326/0003-4819-150-6-200903170-02006	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423AJ	19306488				2022-12-28	WOS:000264468500029
J	Cooper, LT				Cooper, Leslie T., Jr.			Medical Progress: Myocarditis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GIANT-CELL MYOCARDITIS; COXSACKIEVIRUS B3-INDUCED MYOCARDITIS; CARDIOVASCULAR MAGNETIC-RESONANCE; BIOPSY-PROVEN MYOCARDITIS; LEFT-VENTRICULAR FUNCTION; DILATED CARDIOMYOPATHY; ENDOMYOCARDIAL BIOPSY; FULMINANT MYOCARDITIS; EUROPEAN-SOCIETY; TASK-FORCE		Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic	Cooper, LT (corresponding author), Mayo Clin, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.	cooper.leslie@mayo.edu		Cooper, Leslie/0000-0003-1002-3313	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056267, R56HL056267] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL056267, R56 HL056267] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abdel-Aty H, 2005, J AM COLL CARDIOL, V45, P1815, DOI 10.1016/j.jacc.2004.11.069; Adams KF, 2006, J CARD FAIL, V12, P10, DOI 10.1016/j.cardfail.2005.12.001; Amabile N, 2006, HEART, V92, P1269, DOI 10.1136/hrt.2005.078402; Andreoletti L, 2007, J AM COLL CARDIOL, V50, P2207, DOI 10.1016/j.jacc.2007.07.080; Angelini A, 2000, HEART, V84, P245, DOI 10.1136/heart.84.3.245; Antone SM, 1997, J IMMUNOL, V159, P5422; Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3; Arness MK, 2004, AM J EPIDEMIOL, V160, P642, DOI 10.1093/aje/kwh269; Badorff C, 2004, MED MICROBIOL IMMUN, V193, P121, DOI 10.1007/s00430-003-0189-7; Badorff C, 1999, NAT MED, V5, P320, DOI 10.1038/6543; Barton M, 2008, PEDIATR INFECT DIS J, V27, P831, DOI 10.1097/INF.0b013e31816ff7b2; Basso C, 2008, EUR HEART J, V29, P2760, DOI 10.1093/eurheartj/ehn415; Baughman KL, 2006, CIRCULATION, V113, P593, DOI 10.1161/CIRCULATIONAHA.105.589663; BECK MA, 1995, NAT MED, V1, P433, DOI 10.1038/nm0595-433; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bowles NE, 2002, J AM COLL CARDIOL, V39, P892, DOI 10.1016/S0735-1097(02)01688-1; CABINIAN AE, 1990, J LAB CLIN MED, V115, P454; Caforio ALP, 2007, EUR HEART J, V28, P1326, DOI 10.1093/eurheartj/ehm076; Caforio ALP, 2002, EUR J HEART FAIL, V4, P411, DOI 10.1016/S1388-9842(02)00010-7; Chen FH, 2002, AIDS RES HUM RETROV, V18, P777, DOI 10.1089/08892220260139512; Chen YS, 2005, EUR J CARDIO-THORAC, V27, P931, DOI 10.1016/j.ejcts.2005.01.042; Chimenti C, 2004, J AM COLL CARDIOL, V43, P2305, DOI 10.1016/j.jacc.2003.12.056; CHOW LH, 1989, J AM COLL CARDIOL, V14, P915, DOI 10.1016/0735-1097(89)90465-8; Cooper Leslie T, 2007, Congest Heart Fail, V13, P193, DOI 10.1111/j.1527-5299.2007.06410.x; Cooper LT, 2007, CIRCULATION, V116, P2216, DOI 10.1161/CIRCULATIONAHA.107.186093; Cooper LT, 2005, NAT CLIN PRACT CARD, V2, P544, DOI 10.1038/ncpcardio0322; Cooper LT, 1997, NEW ENGL J MED, V336, P1860, DOI 10.1056/NEJM199706263362603; Corradi D, 2004, HUM PATHOL, V35, P1160, DOI 10.1016/j.humpath.2004.05.008; Corssmit EPM, 1999, CARDIOLOGY, V91, P272, DOI 10.1159/000006923; COSTANZONORDIN MR, 1985, J AM COLL CARDIOL, V6, P1078, DOI 10.1016/S0735-1097(85)80312-0; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Daniels PR, 2000, CARDIOVASC PATHOL, V9, P287, DOI 10.1016/S1054-8807(00)00049-1; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; DRUCKER NA, 1994, CIRCULATION, V89, P252, DOI 10.1161/01.CIR.89.1.252; Eriksson U, 2004, NAT MED, V10, P105, DOI 10.1038/nm0104-105a; Eriksson U, 2003, NAT MED, V9, P1484, DOI 10.1038/nm960; Fairweather D, 2005, REV MED VIROL, V15, P17, DOI 10.1002/rmv.445; Fairweather D, 2004, AUTOIMMUNITY, V37, P131, DOI 10.1080/0891693042000196200; Farrar DJ, 2002, J HEART LUNG TRANSPL, V21, P516, DOI 10.1016/S1053-2498(01)00408-9; Felker GM, 2000, J AM COLL CARDIOL, V36, P227, DOI 10.1016/S0735-1097(00)00690-2; Friedrich MG, 1998, CIRCULATION, V97, P1802, DOI 10.1161/01.CIR.97.18.1802; Frisancho-Kiss S, 2007, J IMMUNOL, V178, P6710, DOI 10.4049/jimmunol.178.11.6710; Frustaci A, 2007, EUR HEART J, V28, P733, DOI 10.1093/eurheartj/ehl525; Fuse K, 2005, CIRCULATION, V112, P2276, DOI 10.1161/CIRCULATIONAHA.105.536433; Galvin JE, 2000, J CLIN INVEST, V106, P217, DOI 10.1172/JCI7132; Gauntt CJ, 1996, VIRUS RES, V41, P89, DOI 10.1016/0168-1702(95)01250-8; Gauntt CJ, 1996, VIRUS RES, V45, P69, DOI 10.1016/0168-1702(96)01384-6; GIFFORD R, 1951, AM J PATHOL, V27, P1047; Gutberlet M, 2008, RADIOLOGY, V246, P401, DOI 10.1148/radiol.2461062179; Hare JM, 2001, EUR HEART J, V22, P269, DOI 10.1053/euhj.2000.2272; HERSKOWITZ A, 1990, J AM COLL CARDIOL, V15, P624, DOI 10.1016/0735-1097(90)90637-5; HUBER SA, 1994, J VIROL, V68, P5126, DOI 10.1128/JVI.68.8.5126-5132.1994; Huber SA, 1999, ANN NY ACAD SCI, V887, P181, DOI 10.1111/j.1749-6632.1999.tb07932.x; Huber SA, 2006, CIRC RES, V99, P1109, DOI 10.1161/01.RES.0000249405.13536.49; Hufnagel G, 2000, HERZ, V25, P279, DOI 10.1007/s000590050021; Hunt, 2006, J AM COLL CARDIOL, V47, P1503, DOI 10.1016/j.jacc.2006.02.030; Hunt Sharon Ann, 2005, J Am Coll Cardiol, V46, pe1, DOI 10.1016/j.jacc.2005.08.022; Ilback NG, 1996, TOXICOL LETT, V89, P19, DOI 10.1016/S0378-4274(96)03777-0; Jahangir A, 1998, CLIN INFECT DIS, V27, P1424, DOI 10.1086/515014; KHATIB R, 1990, J LAB CLIN MED, V116, P116; Kilgallen CM, 1998, CLIN CARDIOL, V21, P48, DOI 10.1002/clc.4960210109; Kim KS, 2005, J VIROL, V79, P7024, DOI 10.1128/JVI.79.11.7024-7041.2005; Kindermann I, 2008, CIRCULATION, V118, P639, DOI 10.1161/CIRCULATIONAHA.108.769489; KODAMA M, 1994, CIRC RES, V75, P278, DOI 10.1161/01.RES.75.2.278; Kuhl U, 2005, CIRCULATION, V112, P1965, DOI 10.1161/CIRCULATIONAHA.105.548156; Kuhl U, 2005, CIRCULATION, V111, P887, DOI 10.1161/01.CIR.0000155616.07901.35; Kuhl U, 2003, CIRCULATION, V107, P2793, DOI 10.1161/01.CIR.0000072766.67150.51; Laissy JP, 2002, CHEST, V122, P1638, DOI 10.1378/chest.122.5.1638; Lauer B, 1997, J AM COLL CARDIOL, V30, P1354, DOI 10.1016/S0735-1097(97)00317-3; Li Y, 2006, J IMMUNOL, V177, P8234, DOI 10.4049/jimmunol.177.11.8234; Li YW, 2000, CIRCULATION, V101, P231, DOI 10.1161/01.CIR.101.3.231; LIEBERMAN EB, 1991, J AM COLL CARDIOL, V18, P1617, DOI 10.1016/0735-1097(91)90493-S; Magnani JW, 2006, AM HEART J, V151, P463, DOI 10.1016/j.ahj.2005.03.037; Magnani JW, 2006, CIRCULATION, V113, P876, DOI 10.1161/CIRCULATIONAHA.105.584532; Mahrholdt H, 2004, CIRCULATION, V109, P1250, DOI 10.1161/01.CIR.0000118493.13323.81; Mahrholdt H, 2006, CIRCULATION, V114, P1581, DOI 10.1161/CIRCULATIONAHA.105.606509; Maisch B, 2000, HERZ, V25, P200, DOI 10.1007/s000590050007; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Maron BJ, 2005, J AM COLL CARDIOL, V45, P1340, DOI 10.1016/j.jacc.2005.02.011; Martino TA, 1998, VIROLOGY, V244, P302, DOI 10.1006/viro.1998.9122; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; Matsumori A, 2006, J CARD FAIL, V12, P293, DOI 10.1016/j.cardfail.2005.11.004; Matsumori A, 2005, CIRC RES, V96, P144, DOI 10.1161/01.RES.0000156077.54903.67; MATSUMORI A, 1987, J AM COLL CARDIOL, V9, P1320, DOI 10.1016/S0735-1097(87)80472-2; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; MCALISTER HF, 1989, ANN INTERN MED, V110, P339, DOI 10.7326/0003-4819-110-5-339; McCarthy RE, 2000, NEW ENGL J MED, V342, P690, DOI 10.1056/NEJM200003093421003; McCully R B, 2005, Heart, V91, P202, DOI 10.1136/hrt.2004.035675; McNamara DM, 2001, CIRCULATION, V103, P2254; MENDES LA, 1994, AM HEART J, V128, P301, DOI 10.1016/0002-8703(94)90483-9; Mendes LA, 1999, AM HEART J, V138, P303, DOI 10.1016/S0002-8703(99)70116-X; Moloney ED, 2005, J HEART LUNG TRANSPL, V24, P1103, DOI 10.1016/j.healun.2004.06.015; MORGERA T, 1992, AM HEART J, V124, P455, DOI 10.1016/0002-8703(92)90613-Z; Nakashima H, 1998, JPN HEART J, V39, P763; Nishii M, 2004, J AM COLL CARDIOL, V44, P1292, DOI 10.1016/j.jacc.2004.01.055; Nugent AW, 2003, NEW ENGL J MED, V348, P1639, DOI 10.1056/NEJMoa021737; Oberg AL, 2008, J PROTEOME RES, V7, P225, DOI 10.1021/pr700734f; OKADA I, 1992, J LAB CLIN MED, V120, P569; Ono M, 2006, J IMMUNOL, V176, P4748, DOI 10.4049/jimmunol.176.8.4748; Opavsky MA, 1999, CIRC RES, V85, P551, DOI 10.1161/01.RES.85.6.551; Pallansch MA, 1997, CURR TOP MICROBIOL, V223, P13; PARRILLO JE, 1989, NEW ENGL J MED, V321, P1061, DOI 10.1056/NEJM198910193211601; Perens G, 2007, PEDIATR CARDIOL, V28, P21, DOI 10.1007/s00246-006-1322-3; Rahman JE, 2004, J AM COLL CARDIOL, V43, P410, DOI 10.1016/j.jacc.2003.08.043; Rangachari M, 2006, J EXP MED, V203, P2009, DOI 10.1084/jem.20052222; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; RAY CG, 1989, J INFECT DIS, V159, P829, DOI 10.1093/infdis/159.5.829; RAY CG, 1989, J INFECT DIS, V160, P564; REZKALLA S, 1988, J LAB CLIN MED, V112, P118; Saegusa S, 2007, CARDIOVASC DRUG THER, V21, P155, DOI 10.1007/s10557-007-6024-4; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; SCHULZE K, 1990, CIRCULATION, V81, P959, DOI 10.1161/01.CIR.81.3.959; Schwartz J, 2004, VIROLOGY, V330, P16, DOI 10.1016/j.virol.2004.06.051; Sheppard R, 2005, J AM COLL CARDIOL, V46, P1036, DOI 10.1016/j.jacc.2005.05.067; Smith SC, 1997, CIRCULATION, V95, P163, DOI 10.1161/01.CIR.95.1.163; Spodick DH, 1997, MAYO CLIN PROC, V72, P996; Stanton C, 2008, INT J CARDIOL, V128, P38, DOI 10.1016/j.ijcard.2007.05.016; Staudt A, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.027; TALIERCIO CP, 1985, MAYO CLIN PROC, V60, P463, DOI 10.1016/S0025-6196(12)60870-2; Tam PE, 2006, VIRAL IMMUNOL, V19, P133, DOI 10.1089/vim.2006.19.133; TOMINAGA M, 1991, CIRCULATION, V83, P2021, DOI 10.1161/01.CIR.83.6.2021; Topkara VK, 2006, J THORAC CARDIOV SUR, V131, P1190, DOI 10.1016/j.jtcvs.2005.08.073; Torre-Amione G, 2008, LANCET, V371, P228, DOI 10.1016/S0140-6736(08)60134-8; Towbin JA, 2006, JAMA-J AM MED ASSOC, V296, P1867, DOI 10.1001/jama.296.15.1867; Tracy S, 2000, J MED VIROL, V62, P70, DOI 10.1002/1096-9071(200009)62:1<70::AID-JMV11>3.0.CO;2-R; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wojnicz R, 2001, CIRCULATION, V104, P39, DOI 10.1161/01.CIR.104.1.39; Yazaki Y, 1998, AM J CARDIOL, V82, P537, DOI 10.1016/S0002-9149(98)00377-4; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233	130	823	852	3	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 9	2009	360	15					1526	1538		10.1056/NEJMra0800028	http://dx.doi.org/10.1056/NEJMra0800028			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430GL	19357408	Green Accepted			2022-12-28	WOS:000264976800009
J	Bergmann, O; Bhardwaj, RD; Bernard, S; Zdunek, S; Barnabe-Heider, F; Walsh, S; Zupicich, J; Alkass, K; Buchholz, BA; Druid, H; Jovinge, S; Frisen, J				Bergmann, Olaf; Bhardwaj, Ratan D.; Bernard, Samuel; Zdunek, Sofia; Barnabe-Heider, Fanie; Walsh, Stuart; Zupicich, Joel; Alkass, Kanar; Buchholz, Bruce A.; Druid, Henrik; Jovinge, Stefan; Frisen, Jonas			Evidence for Cardiomyocyte Renewal in Humans	SCIENCE			English	Article							CARDIAC MYOCYTES; NUCLEAR TESTS; HUMAN HEARTS; CELLS; HYPERTROPHY; PROGENITORS; ORIGINS; C-14	It has been difficult to establish whether we are limited to the heart muscle cells we are born with or if cardiomyocytes are generated also later in life. We have taken advantage of the integration of carbon-14, generated by nuclear bomb tests during the Cold War, into DNA to establish the age of cardiomyocytes in humans. We report that cardiomyocytes renew, with a gradual decrease from 1% turning over annually at the age of 25 to 0.45% at the age of 75. Fewer than 50% of cardiomyocytes are exchanged during a normal life span. The capacity to generate cardiomyocytes in the adult human heart suggests that it may be rational to work toward the development of therapeutic strategies aimed at stimulating this process in cardiac pathologies.	[Bergmann, Olaf; Bhardwaj, Ratan D.; Zdunek, Sofia; Barnabe-Heider, Fanie; Zupicich, Joel; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Bernard, Samuel] Univ Lyon 1, Inst Camille Jordan, CNRS, UMR5208, F-69622 Villeurbanne, France; [Walsh, Stuart; Jovinge, Stefan] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, SE-22184 Lund, Sweden; [Alkass, Kanar; Druid, Henrik] Karolinska Inst, Dept Forens Med, SE-17177 Stockholm, Sweden; [Buchholz, Bruce A.] Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94551 USA; [Jovinge, Stefan] Univ Lund Hosp, Dept Cardiol, SE-22185 Lund, Sweden	Karolinska Institutet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Lund University; Karolinska Institutet; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Lund University; Skane University Hospital	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se	Bernard, Samuel/A-5623-2009; Buchholz, Bruce A/G-1356-2011; Schick, Joel/ABA-3728-2021; Bergmann, Olaf/A-5706-2009	Bernard, Samuel/0000-0002-8442-9968; Buchholz, Bruce A/0000-0002-9531-551X; Schick, Joel/0000-0002-8623-4910; Bergmann, Olaf/0000-0003-1065-4107; Druid, Henrik/0000-0002-9198-023X; alkass, kanar/0000-0002-9154-5393	Swedish Heart-Lung Foundation; Swedish Research Council; Knut och Alice Wallenbergs Stiftelse; Human Frontiers Science Program; Swedish Cancer Society; Foundation for Strategic Research; Karolinska Institutet; Juvenile Diabetes Research Foundation; NIH/NCRR [RR13461]; European Commission; Tobias Foundation; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Canadian Institutes of Health Research fellowships; Christopher and Dana Reeve Foundation fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103483] Funding Source: NIH RePORTER	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Human Frontiers Science Program(Human Frontier Science Program); Swedish Cancer Society(Swedish Cancer Society); Foundation for Strategic Research; Karolinska Institutet(Karolinska Institutet); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Tobias Foundation; Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Canadian Institutes of Health Research fellowships(Canadian Institutes of Health Research (CIHR)); Christopher and Dana Reeve Foundation fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Lee, K. Spalding, and members of the Frisen lab for valuable discussions; M. Toro and K. Hamrin for help with flow cytometry; P. Reimer for assistance with radiocarbon interpretation; R. Cassidy, M. Muller, and E. Klaile for technical advice; M. Stahlberg and T. Bergman for help with high-performance liquid chromatography; and D. Kurdyla and P. Zermeno for producing graphite. This study was supported by grants from the Swedish Heart-Lung Foundation, the Swedish Research Council, Knut och Alice Wallenbergs Stiftelse, Human Frontiers Science Program, the Swedish Cancer Society, the Foundation for Strategic Research, the Karolinska Institutet, the Juvenile Diabetes Research Foundation, NIH/NCRR (RR13461), European Commission FP7 CardioCell, and the Tobias Foundation. This work was performed in part under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. R.D.B. and F.B.-H. were supported by fellowships from the Canadian Institutes of Health Research, and F.B.-H. was also supported by a fellowship from the Christopher and Dana Reeve Foundation.	Adler C, 1991, DEV REGENERATIVE POT, P227; Anversa P, 2002, NATURE, V415, P240, DOI 10.1038/415240a; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; BRODSKY VY, 1994, VIRCHOWS ARCH, V424, P429; Butany J, 2005, LANCET ONCOL, V6, P219, DOI 10.1016/S1470-2045(05)70093-0; DEVRIES H, 1958, SCIENCE, V128, P1550, DOI 10.1126/science.128.3338.1550; HARKNESS DD, 1972, NATURE, V240, P302, DOI 10.1038/240302a0; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2002, CIRC RES, V90, P634, DOI 10.1161/01.RES.0000014822.62629.EB; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; LIBBY WF, 1964, SCIENCE, V146, P1171; Martin-Puig S, 2008, CELL STEM CELL, V2, P320, DOI 10.1016/j.stem.2008.03.010; Nouspikel T, 2002, DNA REPAIR, V1, P59, DOI 10.1016/S1568-7864(01)00005-2; NYDAL R, 1965, NATURE, V206, P1029, DOI 10.1038/2061029a0; Olivetti G, 1996, J MOL CELL CARDIOL, V28, P1463, DOI 10.1006/jmcc.1996.0137; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; Parmacek MS, 2004, PROG CARDIOVASC DIS, V47, P159, DOI 10.1016/j.pcad.2004.07.003; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; PFITZER P, 1971, CURR TOP PATHOL, V54, P125; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spalding KL, 2005, NATURE, V437, P333, DOI 10.1038/437333a; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Wild EM, 2000, NUCL INSTRUM METH B, V172, P944, DOI 10.1016/S0168-583X(00)00227-5; Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002	28	2044	2148	9	250	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					98	102		10.1126/science.1164680	http://dx.doi.org/10.1126/science.1164680			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342590	Green Submitted, Green Accepted			2022-12-28	WOS:000264802100041
J	Victora, CG; Peters, DH				Victora, Cesar G.; Peters, David H.			Seguro Popular in Mexico: is premature evaluation healthy?	LANCET			English	Editorial Material									[Victora, Cesar G.] Univ Fed Pelotas, BR-96020220 Pelotas, Brazil; [Victora, Cesar G.; Peters, David H.] Johns Hopkins Univ, Baltimore, MD USA	Universidade Federal de Pelotas; Johns Hopkins University	Victora, CG (corresponding author), Univ Fed Pelotas, BR-96020220 Pelotas, Brazil.	cvictora@terra.com.br	Victora, Cesar Gomes/Y-2455-2019; Victora, Cesar G/D-4476-2013	Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180; Peters, David/0000-0001-8377-3444				Bryce J, 2005, HEALTH POLICY PLANN, V20, pI94, DOI 10.1093/heapol/czi056; Haines A, 2004, LANCET, V364, P1204, DOI 10.1016/S0140-6736(04)17160-2; IMAI K, 2008, STAT SCI; King G, 2009, LANCET, V373, P1447, DOI 10.1016/S0140-6736(09)60239-7; Little RJ, 2000, ANNU REV PUBL HEALTH, V21, P121, DOI 10.1146/annurev.publhealth.21.1.121; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; Rivera JA, 2004, JAMA-J AM MED ASSOC, V291, P2563, DOI 10.1001/jama.291.21.2563	7	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2009	373	9673					1404	1405		10.1016/S0140-6736(09)60564-X	http://dx.doi.org/10.1016/S0140-6736(09)60564-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	437QL	19359035				2022-12-28	WOS:000265501900006
J	Adams, RW; Aguilar, JA; Atkinson, KD; Cowley, MJ; Elliott, PIP; Duckett, SB; Green, GGR; Khazal, IG; Lopez-Serrano, J; Williamson, DC				Adams, Ralph W.; Aguilar, Juan A.; Atkinson, Kevin D.; Cowley, Michael J.; Elliott, Paul I. P.; Duckett, Simon B.; Green, Gary G. R.; Khazal, Iman G.; Lopez-Serrano, Joaqun; Williamson, David C.			Reversible Interactions with para-Hydrogen Enhance NMR Sensitivity by Polarization Transfer	SCIENCE			English	Article							NOBEL LECTURE; SPECTROSCOPY; CHEMISTRY	The sensitivity of both nuclear magnetic resonance spectroscopy and magnetic resonance imaging is very low because the detected signal strength depends on the small population difference between spin states even in high magnetic fields. Hyperpolarization methods can be used to increase this difference and thereby enhance signal strength. This has been achieved previously by incorporating the molecular spin singlet para-hydrogen into hydrogenation reaction products. We show here that a metal complex can facilitate the reversible interaction of para-hydrogen with a suitable organic substrate such that up to an 800-fold increase in proton, carbon, and nitrogen signal strengths are seen for the substrate without its hydrogenation. These polarized signals can be selectively detected when combined with methods that suppress background signals.	[Adams, Ralph W.; Aguilar, Juan A.; Atkinson, Kevin D.; Cowley, Michael J.; Elliott, Paul I. P.; Duckett, Simon B.; Khazal, Iman G.; Lopez-Serrano, Joaqun; Williamson, David C.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Green, Gary G. R.] Univ York, York Neuroimaging Ctr, Bioctr York Sci Pk, York YO10 5DG, N Yorkshire, England	University of York - UK; University of York - UK	Duckett, SB (corresponding author), Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England.	sbd3@york.ac.uk	Adams, Ralph/H-9205-2012; Lopez-Serrano, Joaquin/A-2267-2011; Cowley, Michael/AAQ-5067-2020; Green, Gary GR/D-3543-2009; Cowley, Michael J/C-5169-2014; Cowley, Michael J/H-8512-2012; Aguilar, Juan A./B-5315-2015; Duckett, Simon/M-1790-2016	Adams, Ralph/0000-0001-8009-5334; Lopez-Serrano, Joaquin/0000-0003-3999-0155; Cowley, Michael/0000-0003-0664-2891; Green, Gary GR/0000-0003-1977-7509; Cowley, Michael J/0000-0003-0664-2891; Aguilar, Juan A./0000-0001-9181-8892; Duckett, Simon/0000-0002-9788-6615; Elliott, Paul/0000-0003-1570-3289	University of York; White-Rose Health Innovation Partnership; Engineering and Physical Sciences Research Council; Medical Research Council; Biotechnology and Biological Sciences Research Council; Spanish Ministry of Education and Science [CSD 2007-00006]; EPSRC [EP/F022530/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F022530/1] Funding Source: researchfish	University of York(European Commission); White-Rose Health Innovation Partnership; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Spanish Ministry of Education and Science(Spanish Government); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the University of York, the White-Rose Health Innovation Partnership, the Engineering and Physical Sciences Research Council, the Medical Research Council, Biotechnology and Biological Sciences Research Council, the Spanish Ministry of Education and Science [Project Consolider ORFEO (CSD 2007-00006)], and Bruker Bio-Spin. We thank Bruker Bio-Spin, R. Perutz, P. Walton, M. Hymers, S. Johnson, M. Mortimer, and K. Armour for advice and helpful discussions. We have filed a patent application, P115707GB, based on this work	Aguilar JA, 2007, CHEM COMMUN, P1183, DOI 10.1039/b616307f; Anwar MS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.040501; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Blazina D, 2004, DALTON T, P2601, DOI 10.1039/b409606a; Bouchard LS, 2008, SCIENCE, V319, P442, DOI 10.1126/science.1151787; BOWERS CR, 1987, J AM CHEM SOC, V109, P5541, DOI 10.1021/ja00252a049; Carravetta M, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1893983; CRABTREE RH, 1986, J AM CHEM SOC, V108, P4032, DOI 10.1021/ja00274a030; Driehuys B, 2006, SCIENCE, V314, P432, DOI 10.1126/science.1134532; ERNST RR, 1992, ANGEW CHEM INT EDIT, V31, P805, DOI 10.1002/anie.199208053; Frydman L, 2007, NAT PHYS, V3, P415, DOI 10.1038/nphys597; Golman K, 2003, P NATL ACAD SCI USA, V100, P10435, DOI 10.1073/pnas.1733836100; Kemsley J, 2008, CHEM ENG NEWS, V86, P12, DOI 10.1021/cen-v086n043.p012; Kuhn LT, 2007, TOP CURR CHEM, V276, P25, DOI 10.1007/128_064; Merritt ME, 2007, P NATL ACAD SCI USA, V104, P19773, DOI 10.1073/pnas.0706235104; Morris P.G., 1986, NUCL MAGNETIC RESONA; OPPELT A, 1986, Electromedica (English Edition), V54, P15; Schroder L, 2006, SCIENCE, V314, P446, DOI 10.1126/science.1131847; Wood NJ, 2007, J AM CHEM SOC, V129, P11012, DOI 10.1021/ja074286k; Wuthrich K, 2003, ANGEW CHEM INT EDIT, V42, P3340, DOI 10.1002/anie.200300595; Zeeman P, 1908, NATURE, V78, P369, DOI 10.1038/078369a0	21	615	622	9	259	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1708	1711		10.1126/science.1168877	http://dx.doi.org/10.1126/science.1168877			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325111	Green Accepted			2022-12-28	WOS:000264559800034
J	Hoeller, D; Dikic, I				Hoeller, Daniela; Dikic, Ivan			Targeting the ubiquitin system in cancer therapy	NATURE			English	Review							ACTIVE PROTEASOME INHIBITOR; TUMOR-SUPPRESSOR PROTEIN; KAPPA-B ACTIVATION; P53 NUCLEAR EXPORT; DEUBIQUITINATING ENZYMES; DEPENDENT APOPTOSIS; MULTIPLE-MYELOMA; BINDING DOMAINS; DNA-DAMAGE; LIGASE	The ubiquitin system is a network of proteins dedicated to the ubiquitylation of cellular targets and the subsequent control of numerous cellular functions. The deregulation of components of this elaborate network leads to human pathogenesis, including the development of many types of tumour. Alterations in the ubiquitin system that occur during the initiation and progression of cancer are now being uncovered, and this knowledge is starting to be exploited for both molecular diagnostics and the development of novel strategies to combat cancer.	[Dikic, Ivan] Univ Frankfurt, Inst Biochem & Cluster Excellence Macromol Comple, D-60590 Frankfurt, Germany; [Hoeller, Daniela] Innsbruck Med Univ, Div Med Biochem, A-6020 Innsbruck, Austria; [Dikic, Ivan] Mediterranean Inst Life Sci, Tumor Biol Program, Split 21000, Croatia; [Dikic, Ivan] Univ Split, Sch Med, Dept Immunol, Split 21000, Croatia	Goethe University Frankfurt; Medical University of Innsbruck; University of Split	Dikic, I (corresponding author), Univ Frankfurt, Inst Biochem & Cluster Excellence Macromol Comple, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	dikic@biochem2.uni-frankfurt.de	Hoeller, Daniela/GVT-8953-2022; Dikic, Ivan/O-4650-2015	Dikic, Ivan/0000-0001-8156-9511	European Molecular Biology Organization (EMBO); German Research Foundation (DFG); Cluster of Excellence `Macromolecular Complexes' (Goethe University Frankfurt)	European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); German Research Foundation (DFG)(German Research Foundation (DFG)); Cluster of Excellence `Macromolecular Complexes' (Goethe University Frankfurt)	We thank A. Ciechanover, R. Deshaies, M. Pagano, K. Rajalingam, D. Vucic and members of the Dikic laboratory for critical reading of the manuscript. We apologize to those investigators whose contributions are not described here because of space limitations. D. H. is supported by a European Molecular Biology Organization (EMBO) long-term fellowship. I. D. acknowledges support from the German Research Foundation (DFG) and the Cluster of Excellence `Macromolecular Complexes' (Goethe University Frankfurt).	Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Bennett EJ, 2008, NAT STRUCT MOL BIOL, V15, P20, DOI 10.1038/nsmb0108-20; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Brooks CL, 2004, CELL CYCLE, V3, P436; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Cardozo T, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S9; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chauhan D, 2008, BLOOD, V111, P1654, DOI 10.1182/blood-2006-10-050476; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Cummings J, 2006, BRIT J CANCER, V95, P42, DOI 10.1038/sj.bjc.6603220; Dahlmann B, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S3; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; Dorsey BD, 2008, J MED CHEM, V51, P1068, DOI 10.1021/jm7010589; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gimm O, 2000, AM J PATHOL, V156, P1693, DOI 10.1016/S0002-9440(10)65040-7; Gu HT, 2008, MOL CANCER THER, V7, P2298, DOI 10.1158/1535-7163.MCT-08-0186; Guedat P, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S14; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hjerpe R, 2008, INT J BIOCHEM CELL B, V40, P1126, DOI 10.1016/j.biocel.2007.11.021; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Kaelin WG, 2007, CLIN CANCER RES, V13, p680S, DOI 10.1158/1078-0432.CCR-06-1865; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Ling YH, 2003, CLIN CANCER RES, V9, P1145; Liu YC, 2003, CHEM BIOL, V10, P837, DOI 10.1016/j.chembiol.2003.08.010; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Meister S, 2007, CANCER RES, V67, P1783, DOI 10.1158/0008-5472.CAN-06-2258; Miller CP, 2007, BLOOD, V110, P267, DOI 10.1182/blood-2006-03-013128; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Nickeleit I, 2008, CANCER CELL, V14, P23, DOI 10.1016/j.ccr.2008.05.016; Nie LH, 2007, J BIOL CHEM, V282, P14616, DOI 10.1074/jbc.M610515200; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Noels H, 2007, J BIOL CHEM, V282, P10180, DOI 10.1074/jbc.M611038200; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Piva R, 2008, BLOOD, V111, P2765, DOI 10.1182/blood-2007-07-100651; Popov N, 2007, CELL CYCLE, V6, P2327, DOI 10.4161/cc.6.19.4804; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Richardson PG, 2008, EXPERT REV ANTICANC, V8, P1053, DOI 10.1586/14737140.8.7.1053; RUBIN DM, 1995, CURR BIOL, V5, P854, DOI 10.1016/S0960-9822(95)00172-2; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tobinai K, 2007, INT J CLIN ONCOL, V12, P318, DOI 10.1007/s10147-007-0695-5; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; VanderBorght A, 2006, ONCOGENE, V25, P6672, DOI 10.1038/sj.onc.1209667; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Verma R, 2004, SCIENCE, V306, P117, DOI 10.1126/science.1100946; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wright CW, 2005, J CLIN INVEST, V115, P2673, DOI 10.1172/JCI26251; Yang YL, 2005, CANCER CELL, V7, P547, DOI 10.1016/j.ccr.2005.04.029	75	447	489	0	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					438	444		10.1038/nature07960	http://dx.doi.org/10.1038/nature07960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19325623				2022-12-28	WOS:000264532400032
J	Mandl, KD; Kohane, IS				Mandl, Kenneth D.; Kohane, Isaac S.			No Small Change for the Health Information Economy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mandl, Kenneth D.] Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Mandl, KD (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.		Kohane, Isaac Kohane/K-3716-2012	Kohane, Isaac Kohane/0000-0003-2192-5160				Diamond CC, 2008, HEALTH AFFAIR, V27, pW383, DOI 10.1377/hlthaff.27.5.w383; Goedert Joseph, 2008, Health Data Manag, V16, P47; Kibbe DC, 2004, AM FAM PHYSICIAN, V70, P1220; Mandl KD, 2008, NEW ENGL J MED, V358, P1732, DOI 10.1056/NEJMsb0800220; Stead WW, 2009, COMPUTATIONAL TECHNO	5	80	81	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2009	360	13					1278	1281		10.1056/NEJMp0900411	http://dx.doi.org/10.1056/NEJMp0900411			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	423VP	19321867				2022-12-28	WOS:000264524100003
J	Raiborg, C; Stenmark, H				Raiborg, Camilla; Stenmark, Harald			The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins	NATURE			English	Review							DOA4 DEUBIQUITINATING ENZYME; UBIQUITIN-BINDING; STRUCTURAL BASIS; AUTOPHAGIC CLEARANCE; CRYSTAL-STRUCTURE; CLATHRIN COATS; EGF RECEPTOR; II COMPLEX; HRS; COMPONENT	Selective trafficking of membrane proteins to lysosomes for destruction is required for proper cell signalling and metabolism. Ubiquitylation aids this process by specifying which proteins should be transported to the lysosome lumen by the multivesicular endosome pathway. The endosomal sorting complex required for transport (ESCRT) machinery sorts cargo labelled with ubiquitin into invaginations of endosome membranes. Then, through a highly conserved mechanism also used in cytokinesis and viral budding, it mediates the breaking off of the cargo-containing intraluminal vesicles from the perimeter membrane. The involvement of the ESCRT machinery in suppressing diseases such as cancer, neurodegeneration and infections underscores its importance to the cell.	[Raiborg, Camilla; Stenmark, Harald] Univ Oslo, Norwegian Radium Hosp, Ctr Canc Biomed, Oslo, Norway; [Raiborg, Camilla; Stenmark, Harald] Rikshosp Univ Hosp, Inst Canc Res, Dept Biochem, N-0310 Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway	Stenmark, H (corresponding author), Univ Oslo, Norwegian Radium Hosp, Ctr Canc Biomed, Oslo, Norway.	stenmark@ulrik.uio.no	Stenmark, Harald/B-8868-2008		Norwegian Cancer Society; Research Council of Norway; Novo-Nordisk Foundation; Hartmann Family Foundation	Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); Novo-Nordisk Foundation(Novo Nordisk Foundation); Hartmann Family Foundation	C.R. is a postdoctoral fellow of the Norwegian Cancer Society. We also thank the Research Council of Norway, the Novo-Nordisk Foundation and the Hartmann Family Foundation for supporting our research.	Alam SL, 2006, NAT STRUCT MOL BIOL, V13, P1029, DOI 10.1038/nsmb1160; Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chu T, 2006, J CELL BIOL, V175, P815, DOI 10.1083/jcb.200608053; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; Doyotte A, 2005, J CELL SCI, V118, P3003, DOI 10.1242/jcs.02421; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Ghazi-Tabatabai S, 2008, STRUCTURE, V16, P1345, DOI 10.1016/j.str.2008.06.010; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P1031, DOI 10.1038/nsmb1163; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Im YJ, 2008, DEV CELL, V14, P902, DOI 10.1016/j.devcel.2008.04.004; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim BY, 2007, MOL BIOL CELL, V18, P1129, DOI 10.1091/mbc.E06-09-0787; KIM BY, 2007, BIOCHEM BIOPH RES CO, DOI DOI 10.1016/J.BBRC.2007.08.046; KOMADA M, 1995, MOL CELL BIOL, V15, P6213; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kostelansky MS, 2007, CELL, V129, P485, DOI 10.1016/j.cell.2007.03.016; Krempler A, 2002, J BIOL CHEM, V277, P43216, DOI 10.1074/jbc.M207662200; Langelier C, 2006, J VIROL, V80, P9465, DOI 10.1128/JVI.01049-06; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Leung KF, 2008, TRAFFIC, V9, P1698, DOI 10.1111/j.1600-0854.2008.00797.x; Li J, 2008, CELL CYCLE, V7, P2886, DOI 10.4161/cc.7.18.6677; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Martin-Serrano J, 2007, TRAFFIC, V8, P1297, DOI 10.1111/j.1600-0854.2007.00609.x; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; McCullough J, 2008, P NATL ACAD SCI USA, V105, P7687, DOI 10.1073/pnas.0801567105; Mizuno E, 2006, TRAFFIC, V7, P1017, DOI 10.1111/j.1600-0854.2006.00452.x; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Morita E, 2007, CELL HOST MICROBE, V2, P41, DOI 10.1016/j.chom.2007.06.003; Nikko E, 2007, TRAFFIC, V8, P566, DOI 10.1111/j.1600-0854.2007.00553.x; Nixon RA, 2006, J ALZHEIMERS DIS, V9, P277; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Parkinson N, 2006, NEUROLOGY, V67, P1074, DOI 10.1212/01.wnl.0000231510.89311.8b; Philips JA, 2008, P NATL ACAD SCI USA, V105, P3070, DOI 10.1073/pnas.0707206105; Pineda-Molina E, 2006, TRAFFIC, V7, P1007, DOI 10.1111/j.1600-0854.2006.00440.x; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Pons V, 2008, PLOS BIOL, V6, P1942, DOI 10.1371/journal.pbio.0060214; Prag G, 2007, DEV CELL, V12, P973, DOI 10.1016/j.devcel.2007.04.013; Puertollano R, 2005, J BIOL CHEM, V280, P9258, DOI 10.1074/jbc.M412481200; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Raiborg C, 2001, J CELL SCI, V114, P2255; Raiborg C, 2006, J CELL SCI, V119, P2414, DOI 10.1242/jcs.02978; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Roxrud I, 2008, J CELL BIOL, V180, P1205, DOI 10.1083/jcb.200708115; Rue SM, 2008, MOL BIOL CELL, V19, P475, DOI 10.1091/mbc.E07-07-0694; Rusten TE, 2008, AUTOPHAGY, V4, P233, DOI 10.4161/auto.5396; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Seet LF, 2004, J BIOL CHEM, V279, P4670, DOI 10.1074/jbc.M311228200; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Slagsvold T, 2005, J BIOL CHEM, V280, P19600, DOI 10.1074/jbc.M501510200; Spitzer C, 2006, DEVELOPMENT, V133, P4679, DOI 10.1242/dev.02654; Stuchell MD, 2004, J BIOL CHEM, V279, P36059, DOI 10.1074/jbc.M405226200; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Takeshita T, 1996, BIOCHEM BIOPH RES CO, V225, P1035, DOI 10.1006/bbrc.1996.1290; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Umebayashi K, 2008, MOL BIOL CELL, V19, P3454, DOI 10.1091/mbc.E07-10-0988; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vieira OV, 2004, MOL CELL BIOL, V24, P4593, DOI 10.1128/MCB.24.10.4593-4604.2004; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Xu ZH, 2003, BIOCHEM BIOPH RES CO, V311, P1057, DOI 10.1016/j.bbrc.2003.10.109	100	950	980	7	195	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					445	452		10.1038/nature07961	http://dx.doi.org/10.1038/nature07961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19325624				2022-12-28	WOS:000264532400033
J	Timsit, JF; Schwebel, C; Bouadma, L; Geffroy, A; Garrouste-Orgeas, M; Pease, S; Herault, MC; Haouache, H; Calvino-Gunther, S; Gestin, B; Armand-Lefevre, L; Leflon, V; Chaplain, C; Benali, A; Francais, A; Adrie, C; Zahar, JR; Thuong, M; Arrault, X; Croize, J; Lucet, JC				Timsit, Jean-Francois; Schwebel, Carole; Bouadma, Lila; Geffroy, Arnaud; Garrouste-Orgeas, Maite; Pease, Sebastian; Herault, Marie-Christine; Haouache, Hakim; Calvino-Gunther, Silvia; Gestin, Brieuc; Armand-Lefevre, Laurence; Leflon, Veronique; Chaplain, Chantal; Benali, Adel; Francais, Adrien; Adrie, Christophe; Zahar, Jean-Ralph; Thuong, Marie; Arrault, Xavier; Croize, Jacques; Lucet, Jean-Christophe		Dressing Study Grp	Chlorhexidine-Impregnated Sponges and Less Frequent Dressing Changes for Prevention of Catheter-Related Infections in Critically Ill Adults A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLOOD-STREAM INFECTIONS; CENTRAL VENOUS CATHETERS; INTENSIVE-CARE-UNIT; POVIDONE-IODINE; COLONIZATION; SURVEILLANCE; DIAGNOSIS; METAANALYSIS; ANTISEPTICS; BACTEREMIA	Context Use of a chlorhexidine gluconate-impregnated sponge (CHGIS) in intravascular catheter dressings may reduce catheter-related infections (CRIs). Changing catheter dressings every 3 days may be more frequent than necessary. Objective To assess superiority of CHGIS dressings regarding the rate of major CRIs (clinical sepsis with or without bloodstream infection) and noninferiority (less than 3% colonization-rate increase) of 7-day vs 3-day dressing changes. Design, Setting, and Patients Assessor-blind, 2 x 2 factorial, randomized controlled trial conducted from December 2006 through June 2008 and recruiting patients from 7 intensive care units in 3 university and 2 general hospitals in France. Patients were adults (>18 years) expected to require an arterial catheter, central-vein catheter, or both inserted for 48 hours or longer. Interventions Use of CHGIS vs standard dressings (controls). Scheduled change of unsoiled adherent dressings every 3 vs every 7 days, with immediate change of any soiled or leaking dressings. Main Outcome Measures Major CRIs for comparison of CHGIS vs control dressings; colonization rate for comparison of 3-vs 7-day dressing changes. Results Of 2095 eligible patients, 1636 (3778 catheters, 28 931 catheter-days) could be evaluated. The median duration of catheter insertion was 6 (interquartile range [IQR], 4-10) days. There was no interaction between the interventions. Use of CHGIS dressings decreased the rates of major CRIs (10/1953 [0.5%], 0.6 per 1000 catheter-days vs 19/1825 [1.1%], 1.4 per 1000 catheter-days; hazard ratio [HR], 0.39 [95% confidence interval {CI}, 0.17-0.93]; P=.03) and catheter-related bloodstream infections (6/1953 catheters, 0.40 per 1000 catheter-days vs 17/1825 catheters, 1.3 per 1000 catheter-days; HR, 0.24 [95% CI, 0.09-0.65]). Use of CHGIS dressings was not associated with greater resistance of bacteria in skin samples at catheter removal. Severe CHGIS-associated contact dermatitis occurred in 8 patients (5.3 per 1000 catheters). Use of CHGIS dressings prevented 1 major CRI per 117 catheters. Catheter colonization rates were 142 of 1657 catheters (7.8%) in the 3-day group (10.4 per 1000 catheter-days) and 168 of 1828 catheters (8.6%) in the 7-day group (11.0 per 1000 catheter-days), a mean absolute difference of 0.8%(95% CI,-1.78% to 2.15%) (HR, 0.99; 95% CI, 0.77-1.28), indicating noninferiority of 7-day changes. The median number of dressing changes per catheter was 4(IQR, 3-6) in the 3-day group and 3 (IQR, 2-5) in the 7-day group (P<.001). Conclusions Use of CHGIS dressings with intravascular catheters in the intensive care unit reduced risk of infection even when background infection rates were low. Reducing the frequency of changing unsoiled adherent dressings from every 3 days to every 7 days modestly reduces the total number of dressing changes and appears safe. Trial Registration clinicaltrials.gov Identifier: NCT00417235	[Timsit, Jean-Francois; Calvino-Gunther, Silvia; Francais, Adrien] Univ Grenoble 1, Albert Boniot Inst, INSERM, U823, F-38076 Grenoble, France; [Timsit, Jean-Francois; Schwebel, Carole; Calvino-Gunther, Silvia] Albert Michallon Univ Hosp, Med Intens Care Unit, Grenoble, France; [Geffroy, Arnaud] Bichat Claude Bernard Univ Hosp, Surg Intens Care Unit, Paris, France; [Armand-Lefevre, Laurence] Bichat Claude Bernard Univ Hosp, Dept Bacteriol, Paris, France; [Arrault, Xavier] Bichat Claude Bernard Univ Hosp, Drug Delivery Dept, Paris, France; [Lucet, Jean-Christophe] Bichat Claude Bernard Univ Hosp, Infect Control Unit, Paris, France; [Garrouste-Orgeas, Maite] St Joseph Hosp Network, Med Surg Intens Care Unit, Paris, France; [Benali, Adel] St Joseph Hosp Network, Dept Microbiol, Paris, France; [Pease, Sebastian] Beaujon Univ Hosp, Surg Intens Care Unit, Clichy, France; [Leflon, Veronique] Beaujon Univ Hosp, Dept Microbiol, Clichy, France; [Herault, Marie-Christine] Grenoble Univ Hosp, Surg Intens Care Unit, Grenoble, France; [Gestin, Brieuc; Croize, Jacques] Grenoble Univ Hosp, Dept Microbiol, Grenoble, France; [Chaplain, Chantal] Delafontaine Hosp, Dept Microbiol, St Denis, France; [Adrie, Christophe] Cochin Hosp, Dept Physiol, Paris, France; [Zahar, Jean-Ralph] Hop Necker Enfants Malad, Paris, France; [Thuong, Marie] Natl Biomed Agcy, La Plaine St Denis, France; [Lucet, Jean-Christophe] AP HP, Paris, France; [Lucet, Jean-Christophe] Univ Paris 07, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite	Timsit, JF (corresponding author), Univ Grenoble 1, Albert Boniot Inst, INSERM, U823, F-38076 Grenoble, France.	jftimsit@chu-grenoble.fr	ARMAND-LEFEVRE, Laurence/A-4751-2018	ARMAND-LEFEVRE, Laurence/0000-0002-2013-3252; Paugam-Burtz, Catherine/0000-0002-8168-7152; MOURVILLIER, BRUNO/0000-0001-5227-1468	French Ministry of Health [2005-PHN01]	French Ministry of Health	Funding/Support: This study was supported by a public grant from the French Ministry of Health (Projet Hospitalier de Recherche Clinique 2005-PHN01). Ethicon Inc donated the Biopatch dressings used in the study.	Benhamou E, 2002, BONE MARROW TRANSPL, V29, P653, DOI 10.1038/sj.bmt.1703511; Bhende S, 2004, INFECT CONT HOSP EP, V25, P664, DOI 10.1086/502458; Blot F, 1999, LANCET, V354, P1071, DOI 10.1016/S0140-6736(98)11134-0; BRUNBUISSON C, 1987, ARCH INTERN MED, V147, P873, DOI 10.1001/archinte.147.5.873; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Chaiyakunapruk N, 2002, ANN INTERN MED, V136, P792, DOI 10.7326/0003-4819-136-11-200206040-00007; Chambers ST, 2005, J HOSP INFECT, V61, P53, DOI 10.1016/j.jhin.2005.01.023; Coopersmith CM, 2002, CRIT CARE MED, V30, P59, DOI 10.1097/00003246-200201000-00009; Crawford AG, 2004, INFECT CONT HOSP EP, V25, P668, DOI 10.1086/502459; Darouiche RO, 1999, NEW ENGL J MED, V340, P1, DOI 10.1056/NEJM199901073400101; Eggimann P, 2000, LANCET, V355, P1864, DOI 10.1016/S0140-6736(00)02291-1; FRENEY J, 1988, ANTIMICROB AGENTS CH, V32, P873, DOI 10.1128/AAC.32.6.873; GAIL M, 1985, BIOMETRICS, V41, P361, DOI 10.2307/2530862; Garland JS, 2001, PEDIATRICS, V107, P1431, DOI 10.1542/peds.107.6.1431; Ho KM, 2006, J ANTIMICROB CHEMOTH, V58, P281, DOI 10.1093/jac/dkl234; *I VEILL SAN, 2006, DONN NAT RES AL INV; Laura R, 2000, Haematologica, V85, P275; Lee E, 1992, NATO ASI SER, P237; Lemaire F, 2005, INTENS CARE MED, V31, P476, DOI 10.1007/s00134-005-2574-8; Levy I, 2005, PEDIATR INFECT DIS J, V24, P676, DOI 10.1097/01.inf.0000172934.98865.14; McAlister FA, 2003, JAMA-J AM MED ASSOC, V289, P2545, DOI 10.1001/jama.289.19.2545; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009; Mermel LA, 2001, CLIN INFECT DIS, V32, P1249, DOI 10.1086/320001; Merrer J, 2001, JAMA-J AM MED ASSOC, V286, P700, DOI 10.1001/jama.286.6.700; Milstone AM, 2008, CLIN INFECT DIS, V46, P274, DOI 10.1086/524736; O'Grady NP, 2002, INFECT CONT HOSP EP, V23, P759, DOI 10.1086/502007; Parienti JJ, 2004, CRIT CARE MED, V32, P708, DOI 10.1097/01.CCM.0000115265.05604.7B; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Renaud B, 2001, AM J RESP CRIT CARE, V163, P1584, DOI 10.1164/ajrccm.163.7.9912080; Ruschulte H, 2009, ANN HEMATOL, V88, P267, DOI 10.1007/s00277-008-0568-7; Soufir L, 1999, INFECT CONT HOSP EP, V20, P396, DOI 10.1086/501639; Suetens C, 2007, J HOSP INFECT, V65, P171, DOI 10.1016/S0195-6701(07)60038-3; Timsit J-F, 2005, Ann Fr Anesth Reanim, V24, P315, DOI 10.1016/j.annfar.2004.12.022; Timsit JF, 2007, CURR OPIN CRIT CARE, V13, P563, DOI 10.1097/MCC.0b013e3282efa03f; Timsit JF, 2002, INTENS CARE MED, V28, P1006, DOI 10.1007/s00134-002-1371-x; Veenstra DL, 1999, JAMA-J AM MED ASSOC, V282, P554, DOI 10.1001/jama.282.6.554; WILKINSON DS, 1970, ACTA DERM-VENEREOL, V50, P287; Zuschneid I, 2003, INFECT CONT HOSP EP, V24, P501, DOI 10.1086/502236	40	287	300	1	32	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 25	2009	301	12					1231	1241		10.1001/jama.2009.376	http://dx.doi.org/10.1001/jama.2009.376			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423JO	19318651	Bronze			2022-12-28	WOS:000264492800023
J	Carpenter, LM; Linsell, L; Brooks, C; Keegan, TJ; Langdon, T; Doyle, P; Maconochie, NES; Fletcher, T; Nieuwenhuijsen, MJ; Beral, V; Venables, KM				Carpenter, L. M.; Linsell, L.; Brooks, C.; Keegan, T. J.; Langdon, T.; Doyle, P.; Maconochie, N. E. S.; Fletcher, T.; Nieuwenhuijsen, M. J.; Beral, V.; Venables, K. M.			Cancer morbidity in British military veterans included in chemical warfare agent experiments at Porton Down: cohort study	BRITISH MEDICAL JOURNAL			English	Article							MUSTARD GAS; EXPOSURES	Objective To determine cancer morbidity in members of the armed forces who took part in tests of chemical warfare agents from 1941 to 1989. Design Historical cohort study, with cohort members followed up to December 2004. Data source Archive of UK government research facility at Porton Down, UK military personnel records, and national death and cancer records. Participants All veterans included in the cohort study of mortality, excluding those known to have died or been lost to follow-up before 1 January 1971 when the UK cancer registration system commenced. 17 013 male members of the UK armed forces who took part in tests (Porton Down veterans) and a similar group of 16 520 who did not (non-Porton Down veterans). Main outcome measures Cancer morbidity in each group of veterans; rate ratios, with 95% confidence intervals, adjusted for age group and calendar period. Results 3457 cancers were reported in the Porton Down veterans compared with 3380 cancers in the non-Porton Down veterans. While overall cancer morbidity was the same in both groups (rate ratio 1.00, 95% confidence interval 0.95 to 1.05), Porton Down veterans had higher rates of ill defined malignant neoplasms (1.12, 1.02 to 1.22), in situ neoplasms (1.45, 1.06 to 2.00), and those of uncertain or unknown behaviour (1.32, 1.01 to 1.73). Conclusion Overall cancer morbidity in Porton Down veterans was no different from that in non-Porton Down veterans.	[Carpenter, L. M.; Linsell, L.; Brooks, C.; Keegan, T. J.; Langdon, T.; Venables, K. M.] Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England; [Doyle, P.; Maconochie, N. E. S.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Fletcher, T.] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England; [Nieuwenhuijsen, M. J.] IMIM, Ctr Res Environm Epidemiol, Barcelona 08003, Spain; [Nieuwenhuijsen, M. J.] CIBERESP, Barcelona 08003, Spain; [Nieuwenhuijsen, M. J.] Univ London Imperial Coll Sci Technol & Med, Div Epidemiol Publ Hlth & Primary Care, London SW7 2AZ, England; [Beral, V.] Univ Oxford, Canc Epidemiol Unit, Oxford OX3 7LF, England	University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Imperial College London; University of Oxford	Carpenter, LM (corresponding author), Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England.	lucy.carpenter@dphpc.ox.ac.uk; kate.venables@dphpc.ox.ac.uk	Nieuwenhuijsen, Mark J/C-3914-2017; Fletcher, Tony/D-2394-2011	Nieuwenhuijsen, Mark J/0000-0001-9461-7981; Fletcher, Tony/0000-0003-3385-200X; Keegan, Thomas/0000-0003-3691-953X; Brooks, Claire/0000-0002-3410-8971	MRC; Department of Public Health; Nuffield College, University of Oxford; Medical Research Council [G0200288] Funding Source: researchfish; MRC [G0200288] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Public Health; Nuffield College, University of Oxford; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: This study was funded by the MRC with funds provided to it by the MoD. Additional funds were provided by the Department of Public Health and Nuffield College, University of Oxford. The MRC set up a liaison group to oversee the progress of the study. The MoD had no role in study design, analysis, and interpretation of data. The MoD facilitated access to its archives but had no role in deciding which data were abstracted. The MoD was sent a copy of the paper for factual comment but had no role in writing the paper or in the decision to submit for publication. The Universities of Oxford and London are independent of both the MRC and the MoD.	EASTON DF, 1988, BRIT J IND MED, V45, P652; EVANS R, 2000, GASSED; Hills, 1993, STAT MODELS EPIDEMIO; International Agency for Research Cancer, IARC MON EV CARC RIS; Keegan TJ, 2007, ANN OCCUP HYG, V51, P441, DOI 10.1093/annhyg/mem017; Keegan TJ, 2009, ANN OCCUP HYG, V53, P83, DOI 10.1093/annhyg/men040; MANTEL N, 1959, J NATL CANCER I, V22, P719; Ministry of Defence, 2006, HIST SURV PORT SERV; Pechura C., 1993, VETERANS RISK HLTH E; VENABLES KM, 2009, BRIT MED J, pB613; WADA S, 1968, LANCET, V1, P1161	11	5	5	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 24	2009	338								b655	10.1136/bmj.b655	http://dx.doi.org/10.1136/bmj.b655			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LP	19318700	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000264639500010
J	Goessling, W; North, TE; Loewer, S; Lord, AM; Lee, S; Stoick-Cooper, CL; Weidinger, G; Puder, M; Daley, GQ; Moon, RT; Zon, LI				Goessling, Wolfram; North, Trista E.; Loewer, Sabine; Lord, Allegra M.; Lee, Sang; Stoick-Cooper, Cristi L.; Weidinger, Gilbert; Puder, Mark; Daley, George Q.; Moon, Randall T.; Zon, Leonard I.			Genetic Interaction of PGE2 and Wnt Signaling Regulates Developmental Specification of Stem Cells and Regeneration	CELL			English	Article							FAMILIAL ADENOMATOUS POLYPOSIS; GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; WNT/BETA-CATENIN; COLON-CANCER; LONG-TERM; PROSTAGLANDIN E-2; GAMMA-CATENIN; ZEBRAFISH; PHOSPHORYLATION	Interactions between developmental signaling pathways govern the formation and function of stem cells. Prostaglandin (PG) E2 regulates vertebrate hematopoietic stem cells (HSC). Similarly, the Wnt signaling pathway controls HSC self-renewal and bone marrow repopulation. Here, we show that wnt reporter activity in zebrafish HSCs is responsive to PGE2 modulation, demonstrating a direct interaction in vivo. Inhibition of PGE2 synthesis blocked wnt-induced alterations in HSC formation. PGE2 modified the wnt signaling cascade at the level of beta-catenin degradation through cAMP/PKA-mediated stabilizing phosphorylation events. The PGE2/Wnt interaction regulated murine stem and progenitor populations in vitro in hematopoietic ES cell assays and in vivo following transplantation. The relationship between PGE2 and Wnt was also conserved during regeneration of other organ systems. Our work provides in vivo evidence that Wnt activation in stem cells requires PGE2, and suggests the PGE2/Wnt interaction is a master regulator of vertebrate regeneration and recovery.	[Goessling, Wolfram; North, Trista E.; Daley, George Q.; Zon, Leonard I.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Goessling, Wolfram; North, Trista E.; Loewer, Sabine; Lord, Allegra M.; Lee, Sang; Puder, Mark; Daley, George Q.; Zon, Leonard I.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Goessling, Wolfram; North, Trista E.; Loewer, Sabine; Lord, Allegra M.; Daley, George Q.; Zon, Leonard I.] Childrens Hosp, Howard Hughes Med Inst, Stem Cell Program, Boston, MA 02115 USA; [Lee, Sang; Puder, Mark] Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Stoick-Cooper, Cristi L.; Weidinger, Gilbert; Moon, Randall T.] Univ Washington, Howard Hughes Med Inst, Inst Stem Cell & Regenerat Med, Sch Med, Seattle, WA 98195 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zon, LI (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	zon@enders.tch.harvard.edu	Moon, Randall/M-5605-2019; Weidinger, Gilbert/A-8342-2010; North, Trista/ABG-4789-2020; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Weidinger, Gilbert/0000-0003-3599-6760; North, Trista/0000-0003-1249-563X; Moon, Randall T/0000-0002-9352-1408; Goessling, Wolfram/0000-0001-9972-1569	National Institutes of Health; American Gastroenterological Association; American Cancer Society; Human Frontier Science Program; NATIONAL CANCER INSTITUTE [R01CA103846] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Gastroenterological Association; American Cancer Society(American Cancer Society); Human Frontier Science Program(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank: D. Langenau and C. Ceol for critical reading of the manuscript; C. R. Walkley and L. Purton for advice on HSC transplants; and J. Harris and C. C. Cutting for technical assistance. This work was supported by the National Institutes of Health (W. G., G. Q. D., R. T. M., and L. I. Z.), the American Gastroenterological Association (W. G.), the American Cancer Society (T. E. N.), and the Human Frontier Science Program (S. L.). G. Q. D., R. T. M., L. I. Z. are Howard Hughes Medical Institute investigators.	Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Boolbol SK, 1996, CANCER RES, V56, P2556; Buchanan FG, 2006, CANCER CELL, V9, P6, DOI 10.1016/j.ccr.2005.12.029; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Clevers H, 2006, NEW ENGL J MED, V354, P761, DOI 10.1056/NEJMcibr055457; Congdon KL, 2008, STEM CELLS, V26, P1202, DOI 10.1634/stemcells.2007-0768; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; FISHER JW, 1984, BLOOD CELLS, V10, P241; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; GIARDIELLO FM, 1993, NEW ENGL J MED, V328, P1313, DOI 10.1056/NEJM199305063281805; Giardiello FM, 2002, NEW ENGL J MED, V346, P1054, DOI 10.1056/NEJMoa012015; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; GOLDSTEIN IM, 1997, INFLAMMATION, V2, P309; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lewis JL, 2004, DEVELOPMENT, V131, P1299, DOI 10.1242/dev.01007; Lorenz M, 1999, EXP HEMATOL, V27, P1494, DOI 10.1016/S0301-472X(99)00087-9; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Nakanishi M, 2008, CANCER RES, V68, P3251, DOI 10.1158/0008-5472.CAN-07-6100; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; NOCKA KH, 1989, LEUKEMIA RES, V13, P527, DOI 10.1016/0145-2126(89)90119-7; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Shao JY, 2005, J BIOL CHEM, V280, P26565, DOI 10.1074/jbc.M413056200; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; WILLIAMS N, 1980, J CELL PHYSIOL, V103, P239, DOI 10.1002/jcp.1041030208; Zhu H, 2005, DEV BIOL, V281, P256, DOI 10.1016/j.ydbio.2005.01.034	44	533	579	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1136	1147		10.1016/j.cell.2009.01.015	http://dx.doi.org/10.1016/j.cell.2009.01.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303855	Green Accepted, Bronze			2022-12-28	WOS:000264403900018
J	Garber, AM				Garber, Alan M.			An Uncertain Future for Cardiovascular Drug Development?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Garber, Alan M.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Garber, Alan M.] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Garber, Alan M.] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Garber, Alan M.] Natl Bur Econ Res, Hlth Care Program, Cambridge, MA 02138 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; National Bureau of Economic Research	Garber, AM (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA.		Garber, Alan M/F-1476-2010					Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; *PHARM RES MAN AM, 2009 REP MED DEV HEA; *US DRUG SAF SYST, 2007, FUT DRUG SAF PROM PR; Wald NJ, 2003, BRIT MED J, V327, P586; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; WALD NJ, 2006, BMJ-BRIT MED J, V60, P823; Wang S.S., 2008, WALL STREET J   0930	7	18	19	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2009	360	12					1169	1171		10.1056/NEJMp0808414	http://dx.doi.org/10.1056/NEJMp0808414			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420IU	19297568	Green Published, Green Submitted			2022-12-28	WOS:000264283400001
J	Reisenauer, C; Solomayer, E				Reisenauer, Christl; Solomayer, Erich			Pelvic-Organ Prolapse and Uterine Inversion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Reisenauer, Christl; Solomayer, Erich] Univ Tubingen Hosp, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Reisenauer, C (corresponding author), Univ Tubingen Hosp, D-72076 Tubingen, Germany.	christl.reisenauer@med.uni-tuebingen.de							0	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2009	360	12					1238	1238		10.1056/NEJMicm0800355	http://dx.doi.org/10.1056/NEJMicm0800355			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420IU	19297576				2022-12-28	WOS:000264283400010
J	Yates, R				Yates, Rob			Universal health care and the removal of user fees	LANCET			English	Editorial Material							AFRICA		UK Dept Int Dev, London SW1E 5HE, England		Yates, R (corresponding author), UK Dept Int Dev, 1 Palace St, London SW1E 5HE, England.	rob-yates@dfid.gov.uk		Yates, Robert/0000-0002-6149-7335				Akin J.S., 1987, FINANCING HLTH SERVI; BATUNGWANAYO C, 2006, IMPACT PRESIDENTIAL; Bitran R, 2003, WAIVERS EXEMPTIONS H; Cohen J., 2007, FREE DISTRIBUTION CO; DEININGER MP, 2004, 3276 WORLD BANK; Gilson L, 1997, HEALTH POLICY PLANN, V12, P273, DOI 10.1093/oxfordjournals.heapol.a018882; Gilson L, 2005, BMJ-BRIT MED J, V331, P762, DOI 10.1136/bmj.331.7519.762; James C, 2005, BMJ-BRIT MED J, V331, P747, DOI 10.1136/bmj.331.7519.747; James CD, 2006, APPL HEALTH ECON HEA, V5, P137, DOI 10.2165/00148365-200605030-00001; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; KREMER M, 2004, 35 CTR GLOB DEV; Masiye F., 2005, HLTH CARE FINANCING; Ministry of Planning, 2006, DOC STRAT CROISS RED; Nabyonga J, 2005, HEALTH POLICY PLANN, V20, P100, DOI 10.1093/heapol/czi012; O'Donnell O, 2007, WORLD BANK ECON REV, V21, P93, DOI 10.1093/wber/lhl009; Pearson Mark, 2004, ISSUES PAPER CASE AB; SHIEBER G, 2006, FINANC DEV, V43, P4; Witter S, 2005, ABILITY PAY HLTH CAR; World Bank, 2004, WORLD DEV REP 2004 M	19	153	152	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 13	2009	373	9680					2078	2081		10.1016/S0140-6736(09)60258-0	http://dx.doi.org/10.1016/S0140-6736(09)60258-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459DJ	19362359	Green Submitted			2022-12-28	WOS:000267080100035
J	Giugliano, RP; White, JA; Bode, C; Armstrong, PW; Montalescot, G; Lewis, BS; van't Hof, A; Berdan, LG; Lee, KL; Strony, JT; Hildemann, S; Veltri, E; Van De Werf, F; Braunwald, E; Harrington, RA; Califf, RM; Newby, LK				Giugliano, Robert P.; White, Jennifer A.; Bode, Christoph; Armstrong, Paul W.; Montalescot, Gilles; Lewis, Basil S.; van't Hof, Arnoud; Berdan, Lisa G.; Lee, Kerry L.; Strony, John T.; Hildemann, Steven; Veltri, Enrico; Van de Werf, Frans; Braunwald, Eugene; Harrington, Robert A.; Califf, Robert M.; Newby, L. Kristin		EARLY ACS Investigators	Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLYCOPROTEIN IIB/IIIA INHIBITORS; PLACEBO-CONTROLLED TRIAL; CLINICAL-OUTCOMES; MEDICAL THERAPY; TASK-FORCE; INTERVENTION; ABCIXIMAB; REVASCULARIZATION; PRETREATMENT; CLOPIDOGREL	BACKGROUND Glycoprotein IIb/IIIa inhibitors are indicated in patients with acute coronary syndromes who are undergoing an invasive procedure. The optimal timing of the initiation of such therapy is unknown. METHODS We compared a strategy of early, routine administration of eptifibatide with delayed, provisional administration in 9492 patients who had acute coronary syndromes without ST-segment elevation and who were assigned to an invasive strategy. Patients were randomly assigned to receive either early eptifibatide (two boluses, each containing 180 mu g per kilogram of body weight, administered 10 minutes apart, and a standard infusion >= 12 hours before angiography) or a matching placebo infusion with provisional use of eptifibatide after angiography (delayed eptifibatide). The primary efficacy end point was a composite of death, myocardial infarction, recurrent ischemia requiring urgent revascularization, or the occurrence of a thrombotic complication during percutaneous coronary intervention that required bolus therapy opposite to the initial study-group assignment ("thrombotic bailout") at 96 hours. The key secondary end point was a composite of death or myocardial infarction within the first 30 days. Key safety end points were bleeding and the need for transfusion within the first 120 hours after randomization. RESULTS The primary end point occurred in 9.3% of patients in the early-eptifibatide group and in 10.0% in the delayed-eptifibatide group (odds ratio, 0.92; 95% confidence interval [CI], 0.80 to 1.06; P = 0.23). At 30 days, the rate of death or myocardial infarction was 11.2% in the early-eptifibatide group, as compared with 12.3% in the delayed-eptifibatide group (odds ratio, 0.89; 95% CI, 0.79 to 1.01; P = 0.08). Patients in the early-eptifibatide group had significantly higher rates of bleeding and red-cell transfusion. There was no significant difference between the two groups in rates of severe bleeding or nonhemorrhagic serious adverse events. CONCLUSIONS In patients who had acute coronary syndromes without ST-segment elevation, the use of eptifibatide 12 hours or more before angiography was not superior to the provisional use of eptifibatide after angiography. The early use of eptifibatide was associated with an increased risk of non-life-threatening bleeding and need for transfusion. (ClinicalTrials.gov number, NCT00089895.)	[Giugliano, Robert P.; Braunwald, Eugene] Brigham & Womens Hosp, TIMI Study Grp, Boston, MA 02115 USA; [White, Jennifer A.; Berdan, Lisa G.; Lee, Kerry L.; Harrington, Robert A.; Califf, Robert M.; Newby, L. Kristin] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Bode, Christoph] Univ Freiburg Klinikum, Freiburg, Germany; [Armstrong, Paul W.] Univ Alberta, Edmonton, AB, Canada; [Montalescot, Gilles] CHU Pitie Salpetriere, Paris, France; [Lewis, Basil S.] Lady Davis Carmel Med Ctr, Haifa, Israel; [van't Hof, Arnoud] Isala Klin, Zwolle, Netherlands; [Strony, John T.; Veltri, Enrico] Schering Plough Corp, Kenilworth, NJ USA; [Hildemann, Steven] Essex Pharma, Munich, Germany; [Van de Werf, Frans] Univ Ziekenhuis Gasthuisberg, Leuven, Belgium	Harvard University; Brigham & Women's Hospital; Duke University; University of Freiburg; University of Alberta; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Clalit Health Services; Carmel Medical Center; Isala Clinics; Merck & Company; Schering Plough Corporation; KU Leuven; University Hospital Leuven	Giugliano, RP (corresponding author), Brigham & Womens Hosp, TIMI Study Grp, 350 Longwood Ave,1st Fl, Boston, MA 02115 USA.	rgiugliano@partners.org	FERNANDEZ-VAZQUEZ, FELIPE FFV/R-8969-2018; Linhart, Ales/O-2375-2017; Svistov, Aleksandr S/G-8291-2018; Zorkun, Cafer/S-7132-2016; Zorkun, Cafer/Q-1247-2019; Ponikowski, Piotr/O-6454-2015; Prabhakaran, Dorairaj/B-4147-2011; Widimsky, Petr/P-8088-2016; Boldueva, Svetlana/AAH-3862-2019; Pershukov, Igor/D-2135-2016; Giugliano, Robert/N-7233-2017	FERNANDEZ-VAZQUEZ, FELIPE FFV/0000-0001-7187-1290; Linhart, Ales/0000-0002-3372-7850; Svistov, Aleksandr S/0000-0003-0246-5680; Zorkun, Cafer/0000-0002-6726-0478; Zorkun, Cafer/0000-0002-6726-0478; Ponikowski, Piotr/0000-0002-3391-7064; Prabhakaran, Dorairaj/0000-0002-3172-834X; Widimsky, Petr/0000-0001-5686-7752; Boldueva, Svetlana/0000-0002-1898-084X; Pershukov, Igor/0000-0002-5356-1886; Giugliano, Robert/0000-0003-4110-7675; Armstrong, Paul/0000-0002-0460-3445; ELBAZ, Meyer/0000-0002-3520-7883; A. Samad, Bassem/0000-0001-9440-5073; moreu, jose/0000-0003-4020-0325; Van de Werf, Frans/0000-0001-9479-7767; Brilakis, Emmanouil/0000-0001-9416-9701	Schering-Plough and Millennium Pharmaceuticals	Schering-Plough and Millennium Pharmaceuticals	Supported by Schering-Plough and Millennium Pharmaceuticals.	Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; ANDERSON JL, 2008, J AM COLL CARDIOL, V51, P974; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Bazzino O, 1998, NEW ENGL J MED, V338, P1498; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; Bertrand ME, 2002, EUR HEART J, V23, P1809, DOI 10.1053/euhj.2002.3385; Bertrand ME, 2003, EUR HEART J, V24, P1174, DOI 10.1016/S0195-668X(03)00231-8; Bertrand ME, 2003, EUR HEART J, V24, P485, DOI 10.1016/S0195-668X(03)00080-0; Boersma E, 1999, CIRCULATION, V100, P2045, DOI 10.1161/01.CIR.100.20.2045; Boersma E, 2002, LANCET, V359, P2120; Boersma E, 2002, LANCET, V359, P189, DOI 10.1016/S0140-6736(02)07442-1; Bolognese L, 2006, J AM COLL CARDIOL, V47, P522, DOI 10.1016/j.jacc.2005.11.012; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Cohen M, 2006, J AM COLL CARDIOL, V48, P1346, DOI 10.1016/j.jacc.2006.05.058; Freemantle N, 2001, BRIT MED J, V322, P989, DOI 10.1136/bmj.322.7292.989; Giugliano RP, 2005, AM HEART J, V149, P994, DOI 10.1016/j.ahj.2005.03.029; Kastrati A, 2006, JAMA-J AM MED ASSOC, V295, P1531, DOI 10.1001/jama.295.13.joc60034; Kleiman NS, 2000, CIRCULATION, V101, P751, DOI 10.1161/01.CIR.101.7.751; Ndrepepa G, 2008, EUR HEART J, V29, P455, DOI 10.1093/eurheartj/ehm562; Pieper KS, 2004, CIRCULATION, V109, P641, DOI 10.1161/01.CIR.0000112570.97220.89; Roe MT, 2003, AM HEART J, V146, P993, DOI 10.1016/S0002-8703(03)00517-9; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Simoons ML, 1997, LANCET, V349, P1429; Simoons ML, 2001, LANCET, V357, P1915; Stone GW, 2007, JAMA-J AM MED ASSOC, V297, P591, DOI 10.1001/jama.297.6.591; Tcheng JE, 2000, LANCET, V356, P2037; The ESPRIT Investigators, 2001, LANCET, V357, P1370; The PRISM-PLUS Investigators, 1998, NEW ENGL J MED, V339, P415; Topol E, 1998, NEW ENGL J MED, V339, P436; 1997, LANCET, V350, P744	30	340	355	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2009	360	21					2176	2190		10.1056/NEJMoa0901316	http://dx.doi.org/10.1056/NEJMoa0901316			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447QI	19332455				2022-12-28	WOS:000266206000005
J	Yang, L; Garbe, DS; Bashaw, GJ				Yang, Long; Garbe, David S.; Bashaw, Greg J.			A Frazzled/DCC-Dependent Transcriptional Switch Regulates Midline Axon Guidance	SCIENCE			English	Article							CNS MIDLINE; GROWTH CONE; DROSOPHILA-MIDLINE; COMMISSURAL AXONS; RECEPTOR; ATTRACTION; ROUNDABOUT; OUTGROWTH; SLIT; ROBO	Precise wiring of the nervous system depends on coordinating the action of conserved families of proteins that direct axons to their appropriate targets. Slit-roundabout repulsion and netrin-deleted in colorectal cancer (DCC) (frazzled) attraction must be tightly regulated to control midline axon guidance in vertebrates and invertebrates, but the mechanism mediating this regulation is poorly defined. Here, we show that the Fra receptor has two genetically separable functions in regulating midline guidance in Drosophila. First, Fra mediates canonical chemoattraction in response to netrin, and, second, it functions independently of netrin to activate commissureless transcription, allowing attraction to be coupled to the down-regulation of repulsion in precrossing commissural axons.	[Yang, Long; Garbe, David S.; Bashaw, Greg J.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Bashaw, GJ (corresponding author), Univ Penn, Sch Med, Dept Neurosci, 1113 BRB2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	gbashaw@mail.med.upenn.edu			NIH [NS054739, NS046333]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS046333, R01NS054739, R01NS046333] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS054739 and NS046333 to G.J.B.	Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Garbe DS, 2007, DEVELOPMENT, V134, P4325, DOI 10.1242/dev.012872; Garbe DS, 2007, J NEUROSCI, V27, P3584, DOI 10.1523/JNEUROSCI.0301-07.2007; Garbe DS, 2004, CRIT REV BIOCHEM MOL, V39, P319, DOI 10.1080/10409230490906797; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Gong QZ, 1999, DEVELOPMENT, V126, P1451; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Keleman K, 2005, NAT NEUROSCI, V8, P156, DOI 10.1038/nn1388; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Murray MJ, 1999, J NEUROSCI, V19, P7901; *NIH, NS054739 NIH; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445	25	62	62	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					944	947		10.1126/science.1171320	http://dx.doi.org/10.1126/science.1171320			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19325078	Green Accepted			2022-12-28	WOS:000266048800041
J	Chandramohanadas, R; Davis, PH; Beiting, DP; Harbut, MB; Darling, C; Velmourougane, G; Lee, MY; Greer, PA; Roos, DS; Greenbaum, DC				Chandramohanadas, Rajesh; Davis, Paul H.; Beiting, Daniel P.; Harbut, Michael B.; Darling, Claire; Velmourougane, Geetha; Lee, Ming Yeh; Greer, Peter A.; Roos, David S.; Greenbaum, Doron C.			Apicomplexan Parasites Co-Opt Host Calpains to Facilitate Their Escape from Infected Cells	SCIENCE			English	Article							RED-BLOOD-CELLS; MALARIA PARASITE; TOXOPLASMA-GONDII; PLASMODIUM-FALCIPARUM; EMBRYONIC-DEVELOPMENT; PROTEASE INHIBITORS; ERYTHROCYTE; CALPASTATIN; DISRUPTION; MEMBRANE	Apicomplexan parasites, including Plasmodium falciparum and Toxoplasma gondii (the causative agents of malaria and toxoplasmosis, respectively), are responsible for considerable morbidity and mortality worldwide. These pathogenic protozoa replicate within an intracellular vacuole inside of infected host cells, from which they must escape to initiate a new lytic cycle. By integrating cell biological, pharmacological, and genetic approaches, we provide evidence that both Plasmodium and Toxoplasma hijack host cell calpain proteases to facilitate parasite egress. Immunodepletion or inhibition of calpain-1 in hypotonically lysed and resealed erythrocytes prevented the escape of P. falciparum parasites, which was restored by adding purified calpain-1. Similarly, efficient egress of T. gondii from mammalian fibroblasts was blocked by either small interfering RNA-mediated suppression or genetic deletion of calpain activity and could be restored by genetic complementation.	[Chandramohanadas, Rajesh; Harbut, Michael B.; Darling, Claire; Velmourougane, Geetha; Greenbaum, Doron C.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Davis, Paul H.; Beiting, Daniel P.; Lee, Ming Yeh; Roos, David S.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Davis, Paul H.; Beiting, Daniel P.; Lee, Ming Yeh; Roos, David S.] Univ Penn, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA; [Greer, Peter A.] Queens Univ, Dept Pathol & Mol Med, Queens Canc Res Inst, Kingston, ON K7L 3N6, Canada	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; McMaster University; Queens University - Canada	Greenbaum, DC (corresponding author), Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA.	dorong@upenn.edu	Chandramohanadas, Rajesh/GLT-0218-2022; Davis, Paul H/J-6141-2012; Beiting, Daniel/AAG-6275-2019	Davis, Paul H/0000-0002-0526-3841; Chandramohanadas, Rajesh/0000-0002-8760-0396; Roos, David Siker/0000-0001-6725-4089	National Research Service Awards; Ellison Medical Foundation; NIH; Ritter Foundation; Penn Genome Frontiers Institute; Penn Institute for Translational Medicine and Therapeutics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI077268, R37AI028724, F32AI075846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008076] Funding Source: NIH RePORTER	National Research Service Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ritter Foundation; Penn Genome Frontiers Institute; Penn Institute for Translational Medicine and Therapeutics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. W. Doms, M. Marti, and M. Klemba for critical discussions; the Penn Proteomics Core for mass spectrometry; and M. A. Lampson for help with imaging. P. falciparum expressing GFP were provided by O. S. Harb. P.H.D. and D.P.B. are funded by National Research Service Awards, and D.S.R. is an Ellison Medical Foundation Senior Scholar in Global Infectious Disease, supported by grants from NIH. D.C.G. was supported by the Ritter Foundation, the Penn Genome Frontiers Institute, and the Penn Institute for Translational Medicine and Therapeutics.	Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; BIANCO AE, 1986, EXP PARASITOL, V62, P275, DOI 10.1016/0014-4894(86)90032-9; Black MW, 2000, MOL CELL BIOL, V20, P9399, DOI 10.1128/MCB.20.24.9399-9408.2000; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Dutt P, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-3; Gil-Parrado S, 2003, BIOL CHEM, V384, P395, DOI 10.1515/BC.2003.045; Glushakova S, 2005, CURR BIOL, V15, P1645, DOI 10.1016/j.cub.2005.07.067; Glushakova S, 2009, CELL MICROBIOL, V11, P95, DOI 10.1111/j.1462-5822.2008.01242.x; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Greenbaum DC, 2002, SCIENCE, V298, P2002, DOI 10.1126/science.1077426; HADLEY T, 1983, EXP PARASITOL, V55, P306, DOI 10.1016/0014-4894(83)90027-9; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Hanspal M, 2002, MOL BIOCHEM PARASIT, V122, P227, DOI 10.1016/S0166-6851(02)00104-4; Hu K, 2002, MOL BIOL CELL, V13, P593, DOI 10.1091/mbc.01-06-0309; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Moldoveanu T, 2008, NATURE, V456, P404, DOI 10.1038/nature07353; Murphy SC, 2006, PLOS MED, V3, P2403, DOI 10.1371/journal.pmed.0030528; Nishi M, 2008, J CELL SCI, V121, P1559, DOI 10.1242/jcs.021089; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; Russo I, 2009, P NATL ACAD SCI USA, V106, P1554, DOI 10.1073/pnas.0806926106; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; WEISS L, 1989, AM J TROP MED HYG, V41, P135, DOI 10.4269/ajtmh.1989.41.135; Wickham ME, 2003, J BIOL CHEM, V278, P37658, DOI 10.1074/jbc.M305252200; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	29	118	125	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					794	797		10.1126/science.1171085	http://dx.doi.org/10.1126/science.1171085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19342550	Green Accepted			2022-12-28	WOS:000265832400049
J	Hwang, PH				Hwang, Peter H.			A 51-Year-Old Woman With Acute Onset of Facial Pressure, Rhinorrhea, and Tooth Pain Review of Acute Rhinosinusitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MAXILLARY SINUSITIS; ACUTE BACTERIAL RHINOSINUSITIS; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; COMMUNITY-ACQUIRED SINUSITIS; HAEMOPHILUS-INFLUENZAE; DOUBLE-BLIND; ANTIMICROBIAL THERAPY; AMOXICILLIN-CLAVULANATE; STAPHYLOCOCCUS-AUREUS	Acute rhinosinusitis is a common ailment accounting for millions of office visits annually, including that of Mrs D, a 51-year-old woman presenting with 5 days of upper respiratory illness and facial pain. Her case is used to review the diagnosis and treatment of acute rhinosinusitis. Acute viral rhinosinusitis can be difficult to distinguish from acute bacterial rhinosinusitis, especially during the first 10 days of symptoms. Evidence-based clinical practice guidelines developed to guide diagnosis and treatment of acute viral and bacterial rhinosinusitis recommend that the diagnosis of acute rhinosinusitis be based on the presence of "cardinal symptoms" of purulent rhinorrhea and either facial pressure or nasal obstruction of less than 4 weeks' duration. Antibiotic treatment generally can be withheld during the first 10 days of symptoms for mild to moderate cases, given the likelihood of acute viral rhinosinusitis or of spontaneously resolving acute bacterial rhinosinusitis. After 10 days, the likelihood of acute bacterial rhinosinusitis increases, and initiation of antibiotic therapy is supported by practice guidelines. Complications of sinusitis, though rare, can be serious and require early recognition and treatment.	[Hwang, Peter H.] Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA; [Hwang, Peter H.] Stanford Sinus Ctr, Stanford, CA USA; [Hwang, Peter H.] Stanford Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Hwang, PH (corresponding author), Dept Otolaryngol, 801 Welch Rd, Stanford, CA 94305 USA.	phwang@ohns.stanford.edu		Hwang, Peter/0000-0002-0786-4675				Anand VK, 2004, ANN OTO RHINOL LARYN, V113, P3, DOI 10.1177/00034894041130S502; Anon JB, 2004, OTOLARYNG HEAD NECK, V130, P1, DOI 10.1016/j.otohns.2003.12.003; AXELSSON A, 1973, LARYNGOSCOPE, V83, P2003, DOI 10.1288/00005537-197312000-00011; Benninger MS, 2006, OTOLARYNG HEAD NECK, V134, P3, DOI 10.1016/j.otohns.2005.10.010; Benninger MS, 2002, OTOLARYNG HEAD NECK, V127, P7, DOI 10.1067/mhn.2002.124847; BERG O, 1988, ACTA OTO-LARYNGOL, V105, P343, DOI 10.3109/00016488809097017; Bhattacharyya N, 2001, AM J RHINOL, V15, P169, DOI 10.2500/105065801779954184; BOLGER WE, 1991, LARYNGOSCOPE, V101, P56; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Braun JJ, 1997, ALLERGY, V52, P650, DOI 10.1111/j.1398-9995.1997.tb01044.x; Brook I, 1999, ANN OTO RHINOL LARYN, V108, P645, DOI 10.1177/000348949910800704; Brook I, 2008, J MED MICROBIOL, V57, P1015, DOI 10.1099/jmm.0.2008/000851-0; Brook I, 2006, OTOLARYNG HEAD NECK, V135, P349, DOI 10.1016/j.otohns.2005.10.059; Brook I, 2006, J MED MICROBIOL, V55, P943, DOI 10.1099/jmm.0.46346-0; Bucher HC, 2003, ARCH INTERN MED, V163, P1793, DOI 10.1001/archinte.163.15.1793; Caenen M, 2005, RHINOLOGY, V43, P205; de Ferranti SD, 1998, BMJ-BRIT MED J, V317, P632, DOI 10.1136/bmj.317.7159.632; De Sutter AI, 2002, J FAM PRACTICE, V51, P317; deBock GH, 1997, J CLIN EPIDEMIOL, V50, P881, DOI 10.1016/S0895-4356(97)00117-0; Engels EA, 2000, J CLIN EPIDEMIOL, V53, P852, DOI 10.1016/S0895-4356(00)00209-2; EVANS FO, 1975, NEW ENGL J MED, V293, P735, DOI 10.1056/NEJM197510092931502; Falagas ME, 2008, LANCET INFECT DIS, V8, P543, DOI 10.1016/S1473-3099(08)70202-0; Fokkens W, 2005, ALLERGY, V60, P583, DOI 10.1111/j.1398-9995.2005.00830.x; Garavello W, 2005, INT ARCH ALLERGY IMM, V137, P310, DOI 10.1159/000086462; Garcia-Cobos S, 2007, ANTIMICROB AGENTS CH, V51, P2564, DOI 10.1128/AAC.00354-07; Gold SM, 1997, LARYNGOSCOPE, V107, P1586, DOI 10.1097/00005537-199712000-00002; Graf Peter M, 2007, Clin Allergy Immunol, V19, P295; GWALTNEY JM, 1992, J ALLERGY CLIN IMMUN, V90, P457, DOI 10.1016/0091-6749(92)90169-3; Gwaltney JM, 1996, CLIN INFECT DIS, V23, P1209, DOI 10.1093/clinids/23.6.1209; GWALTNEY JM, 1994, NEW ENGL J MED, V330, P25, DOI 10.1056/NEJM199401063300105; Gwaltney JM, 1997, ANTIMICROB AGENTS CH, V41, P1517, DOI 10.1128/AAC.41.7.1517; Gwaltney JM, 1996, CLIN INFECT DIS, V23, P1224; HAMORY BH, 1979, J INFECT DIS, V139, P197, DOI 10.1093/infdis/139.2.197; Hansen JG, 2000, SCAND J PRIM HEALTH, V18, P44; Harris R, 2006, AM J RHINOL, V20, P101, DOI 10.1177/194589240602000119; HAVAS TE, 1988, ARCH OTOLARYNGOL, V114, P856; Haye R, 1998, EUR J CLIN MICROBIOL, V17, P309, DOI 10.1007/BF01709452; Henry DC, 2004, CLIN THER, V26, P2026, DOI 10.1016/j.clinthera.2004.12.004; Hickner JM, 2001, ANN EMERG MED, V37, P703; Hotomi M, 2006, ACTA OTO-LARYNGOL, V126, P240, DOI 10.1080/00016480500314287; Howe L, 2004, CLIN OTOLARYNGOL, V29, P725, DOI 10.1111/j.1365-2273.2004.00889.x; Inanli S, 2002, LARYNGOSCOPE, V112, P320; Jacobs MR, 2003, J ANTIMICROB CHEMOTH, V52, P229, DOI 10.1093/jac/dkg321; Jacobs MR, 1999, ANTIMICROB AGENTS CH, V43, P1901, DOI 10.1128/AAC.43.8.1901; Kalcioglu MT, 2003, AM J RHINOL, V17, P143, DOI 10.1177/194589240301700306; Kombogiorgas D, 2007, BRIT J NEUROSURG, V21, P603, DOI 10.1080/02688690701552856; Lindbaek M, 1996, Fam Med, V28, P183; Lindbaek M, 1996, BMJ-BRIT MED J, V313, P325, DOI 10.1136/bmj.313.7053.325; Mafee MF, 2006, CLIN REV ALLERG IMMU, V30, P165, DOI 10.1385/CRIAI:30:3:165; Meltzer EO, 2004, OTOLARYNG HEAD NECK, V131, pS1, DOI 10.1016/j.otohns.2004.09.067; Payne SC, 2007, CLIN INFECT DIS, V45, pE121, DOI 10.1086/522763; Poole MD, 2004, OTOLARYNG HEAD NECK, V130, P46, DOI 10.1016/j.otohns.2003.12.002; Puhakka T, 1998, J ALLERGY CLIN IMMUN, V102, P403, DOI 10.1016/S0091-6749(98)70127-7; Pynnonen MA, 2007, ARCH OTOLARYNGOL, V133, P1115, DOI 10.1001/archotol.133.11.1115; Rabago D, 2002, J FAM PRACTICE, V51, P1049; Rosenfeld RM, 2007, OTOLARYNG HEAD NECK, V137, pS1, DOI 10.1016/j.otohns.2007.06.726; Rosenfeld RM, 2007, OTOLARYNG HEAD NECK, V137, pS32, DOI 10.1016/j.otohns.2007.06.724; SAVOLAINEN S, 1989, EUR J CLIN MICROBIOL, V8, P131, DOI 10.1007/BF01963896; Seiden AM, 2004, OTOLARYNG CLIN N AM, V37, P1159, DOI 10.1016/j.otc.2004.06.007; Seki H, 1999, CHEMOTHERAPY, V45, P15, DOI 10.1159/000007160; Slavin Raymond G, 2005, J Allergy Clin Immunol, V116, pS13, DOI 10.1016/j.jaci.2005.09.048; Talbot GH, 2001, CLIN INFECT DIS, V33, P1668, DOI 10.1086/323813; vanBuchem FL, 1997, LANCET, V349, P683, DOI 10.1016/S0140-6736(96)07585-X; Vogan JC, 2000, OTOLARYNG HEAD NECK, V122, P370, DOI 10.1016/S0194-5998(00)70051-9; WILLIAMS JW, 1992, ANN INTERN MED, V117, P705, DOI 10.7326/0003-4819-117-9-705; Williamson IG, 2007, JAMA-J AM MED ASSOC, V298, P2487, DOI 10.1001/jama.298.21.2487; Younis RT, 2002, LARYNGOSCOPE, V112, P224, DOI 10.1097/00005537-200202000-00005; Zalmanovici A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005149.pub2	68	6	6	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	2009	301	17					1798	1807		10.1001/jama.2009.481	http://dx.doi.org/10.1001/jama.2009.481			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441AU	19336696				2022-12-28	WOS:000265742500029
J	Jones, RH; Velazquez, EJ; Michler, RE; Sopko, G; Oh, JK; O'Connor, CM; Hill, JA; Menicanti, L; Sadowski, Z; Desvigne-Nickens, P; Rouleau, JL; Lee, KL				Jones, Robert H.; Velazquez, Eric J.; Michler, Robert E.; Sopko, George; Oh, Jae K.; O'Connor, Christopher M.; Hill, James A.; Menicanti, Lorenzo; Sadowski, Zygmunt; Desvigne-Nickens, Patrice; Rouleau, Jean-Lucien; Lee, Kerry L.		STICH Hypothesis 2 Investigators	Coronary Bypass Surgery with or without Surgical Ventricular Reconstruction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGESTIVE-HEART-FAILURE; ANTERIOR MYOCARDIAL-INFARCTION; CLINICAL-TRIALS; RESTORATION; THERAPY; CARVEDILOL; DISEASE	Background Surgical ventricular reconstruction is a specific procedure designed to reduce left ventricular volume in patients with heart failure caused by coronary artery disease. We conducted a trial to address the question of whether surgical ventricular reconstruction added to coronary-artery bypass grafting (CABG) would decrease the rate of death or hospitalization for cardiac causes, as compared with CABG alone. Methods Between September 2002 and January 2006, a total of 1000 patients with an ejection fraction of 35% or less, coronary artery disease that was amenable to CABG, and dominant anterior left ventricular dysfunction that was amenable to surgical ventricular reconstruction were randomly assigned to undergo either CABG alone (499 patients) or CABG with surgical ventricular reconstruction (501 patients). The primary outcome was a composite of death from any cause and hospitalization for cardiac causes. The median follow-up was 48 months. Results Surgical ventricular reconstruction reduced the end-systolic volume index by 19%, as compared with a reduction of 6% with CABG alone. Cardiac symptoms and exercise tolerance improved from baseline to a similar degree in the two study groups. However, no significant difference was observed in the primary outcome, which occurred in 292 patients (59%) who were assigned to undergo CABG alone and in 289 patients (58%) who were assigned to undergo CABG with surgical ventricular reconstruction ( hazard ratio for the combined approach, 0.99; 95% confidence interval, 0.84 to 1.17; P = 0.90). Conclusions Adding surgical ventricular reconstruction to CABG reduced the left ventricular volume, as compared with CABG alone. However, this anatomical change was not associated with a greater improvement in symptoms or exercise tolerance or with a reduction in the rate of death or hospitalization for cardiac causes. (ClinicalTrials.gov number, NCT00023595.)	[Jones, Robert H.; Velazquez, Eric J.; O'Connor, Christopher M.; Lee, Kerry L.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27710 USA; [Michler, Robert E.] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA; [Sopko, George; Desvigne-Nickens, Patrice] NHLBI, NIH, Bethesda, MD 20892 USA; [Oh, Jae K.] Mayo Clin, Rochester, MN USA; [Hill, James A.] Univ Florida, Coll Med, Gainesville, FL USA; [Menicanti, Lorenzo] San Donato Hosp, Milan, Italy; [Sadowski, Zygmunt] Natl Inst Cardiol, Warsaw, Poland; [Rouleau, Jean-Lucien] Univ Montreal, Inst Cardiol Montreal, Montreal, PQ, Canada	Duke University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Mayo Clinic; State University System of Florida; University of Florida; IRCCS Policlinico San Donato; Institute of Cardiology - Poland; Universite de Montreal; Institut de Cardiologie de Montreal	Jones, RH (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, POB 2986, Durham, NC 27710 USA.	jones060@mc.duke.edu	Siepe, Matthias/AAF-9846-2019; Beyersdorf, Friedhelm/AAK-3718-2020; Adlbrecht, Christopher/D-3971-2009; menicanti, lorenzo/K-5649-2018; Senni, Michele/J-9380-2018; Crestanello, Juan/E-2930-2011	Siepe, Matthias/0000-0003-3305-9343; Beyersdorf, Friedhelm/0000-0003-2975-2751; Adlbrecht, Christopher/0000-0003-3743-3881; menicanti, lorenzo/0000-0001-8530-6284; Senni, Michele/0000-0001-5502-7882; Maurer, Gerald/0000-0002-9043-7657; Jansz, Paul/0000-0002-4721-5549; Bochenek, Andrzej/0000-0002-3046-3001; Cirillo, Marco/0000-0001-8595-8223; Golba, Krzysztof/0000-0001-5722-7976; Kukulski, Tomasz/0000-0003-1911-8159	National Heart, Lung, and Blood Institute [5U01-HL-69015, 5U01-HL-69013, 5U01-HL-69010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069013, U01HL069015, R01HL105853, U01HL069010] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants (5U01-HL-69015, 5U01-HL-69013, and 5U01-HL-69010) from the National Heart, Lung, and Blood Institute.	Alfieri O, 2003, AM J CARDIOL, V91, p81F, DOI 10.1016/S0002-9149(02)03342-8; Athanasuleas CL, 2004, J AM COLL CARDIOL, V44, P1439, DOI 10.1016/j.jacc.2004.07.017; Athanasuleas CL, 1998, J CARDIAC SURG, V13, P418, DOI 10.1111/j.1540-8191.1998.tb01077.x; Athanasuleas CL, 2001, J AM COLL CARDIOL, V37, P1199, DOI 10.1016/S0735-1097(01)01119-6; BAX JJ, 2004, HEART, V90, P26; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; COX DR, 1972, J R STAT SOC B, V187, P220; Doughty RN, 1997, J AM COLL CARDIOL, V29, P1060, DOI 10.1016/S0735-1097(97)00012-0; Doughty RN, 2004, CIRCULATION, V109, P201, DOI 10.1161/01.CIR.0000108928.25690.94; EAGLE KA, 2005, CIRCULATION, V111, P2014; Eagle Kim A, 2004, Circulation, V110, pe340; GREENBERG B, 1995, CIRCULATION, V91, P2573, DOI 10.1161/01.CIR.91.10.2573; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Jones RH, 2001, J AM COLL CARDIOL, V37, P1210, DOI 10.1016/S0735-1097(01)01123-8; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; LEE KL, 1990, CIRCULATION, V82, P1705, DOI 10.1161/01.CIR.82.5.1705; Menicanti L, 2007, J THORAC CARDIOV SUR, V134, P433, DOI 10.1016/j.jtcvs.2006.12.027; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; PFEFFER MA, 1988, NEW ENGL J MED, V319, P80, DOI 10.1056/NEJM198807143190204; Prucz RB, 2008, ANN THORAC SURG, V86, P806, DOI 10.1016/j.athoracsur.2008.05.009; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Velazquez EJ, 2007, J THORAC CARDIOV SUR, V134, P1540, DOI 10.1016/j.jtcvs.2007.05.069	24	481	527	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1705	1717		10.1056/NEJMoa0900559	http://dx.doi.org/10.1056/NEJMoa0900559			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435XY	19329820	Green Accepted			2022-12-28	WOS:000265377800005
J	Wood, R; Lawn, SD				Wood, Robin; Lawn, Stephen D.			Should the CD4 threshold for starting ART be raised?	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; HIV-INFECTION; PENDULUM; AFRICA; ADULTS		[Wood, Robin; Lawn, Stephen D.] Univ Cape Town, Fac Hlth Sci, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Lawn, Stephen D.] London Sch Hyg & Trop Med, Dept Infect & Trop Med, Clin Res Unit, London WC1, England	University of Cape Town; University of London; London School of Hygiene & Tropical Medicine	Lawn, SD (corresponding author), Univ Cape Town, Fac Hlth Sci, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	stevelawn@yahoo.co.uk	Wood, Robin/G-8509-2011					Badri M, 2006, LANCET, V368, P1254, DOI 10.1016/S0140-6736(06)69117-4; *DEP HLTH HUM SERV, 2008, GUID US ANT AG HIV 1; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; HO DD, 1995, NEW ENGL J MED, V333, P450, DOI 10.1056/NEJM199508173330710; Holmberg SD, 2004, CLIN INFECT DIS, V39, P1699, DOI 10.1086/425743; Lane HC, 2003, ANN INTERN MED, V138, P680, DOI 10.7326/0003-4819-138-8-200304150-00018; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; *NAT I ALL INF DIS, 2009, EFF IMM DEF ANT TREA; Schechter M, 2004, J INFECT DIS, V190, P1043, DOI 10.1086/422852; World Health Organization, 2006, ANT THER HIV INF AD; 2009, LANCET, V373, P1352, DOI DOI 10.1016/S0140-6736(09)60612-7	12	6	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2009	373	9672					1314	1316		10.1016/S0140-6736(09)60654-1	http://dx.doi.org/10.1016/S0140-6736(09)60654-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434UR	19361856				2022-12-28	WOS:000265300100005
J	Ashall, L; Horton, CA; Nelson, DE; Paszek, P; Harper, CV; Sillitoe, K; Ryan, S; Spiller, DG; Unitt, JF; Broomhead, DS; Kell, DB; Rand, DA; See, V; White, MRH				Ashall, Louise; Horton, Caroline A.; Nelson, David E.; Paszek, Pawel; Harper, Claire V.; Sillitoe, Kate; Ryan, Sheila; Spiller, David G.; Unitt, John F.; Broomhead, David S.; Kell, Douglas B.; Rand, David A.; See, Violaine; White, Michael R. H.			Pulsatile Stimulation Determines Timing and Specificity of NF-kappa B-Dependent Transcription	SCIENCE			English	Article							DEUBIQUITINATING ENZYME; TEMPORAL CONTROL; FEEDBACK LOOP; OSCILLATIONS; DYNAMICS	The nuclear factor kappa B (NF-kappa B) transcription factor regulates cellular stress responses and the immune response to infection. NF-kappa B activation results in oscillations in nuclear NF-kappa B abundance. To define the function of these oscillations, we treated cells with repeated short pulses of tumor necrosis factor-alpha at various intervals to mimic pulsatile inflammatory signals. At all pulse intervals that were analyzed, we observed synchronous cycles of NF-kappa B nuclear translocation. Lower frequency stimulations gave repeated full-amplitude translocations, whereas higher frequency pulses gave reduced translocation, indicating a failure to reset. Deterministic and stochastic mathematical models predicted how negative feedback loops regulate both the resetting of the system and cellular heterogeneity. Altering the stimulation intervals gave different patterns of NF-kappa B-dependent gene expression, which supports the idea that oscillation frequency has a functional role.	[Ashall, Louise; Horton, Caroline A.; Nelson, David E.; Paszek, Pawel; Harper, Claire V.; Sillitoe, Kate; Ryan, Sheila; Spiller, David G.; See, Violaine; White, Michael R. H.] Sch Biol Sci, Ctr Cell Imaging, Liverpool L69 7ZB, Merseyside, England; [Unitt, John F.] AstraZeneca R&D Charnwood, Dept Mol Biol, Loughborough LE11 5RH, Leics, England; [Broomhead, David S.] Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England; [Kell, Douglas B.] Univ Manchester, Sch Chem, Manchester Ctr Integrat Syst Biol, Manchester M1 7DN, Lancs, England; [Kell, Douglas B.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Rand, David A.] Univ Warwick, Coventry CV4 7AL, W Midlands, England	University of Liverpool; AstraZeneca; University of Manchester; University of Manchester; University of Manchester; University of Warwick	White, MRH (corresponding author), Sch Biol Sci, Ctr Cell Imaging, Biosci Res Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.	mwhite@liv.ac.uk	Broomhead, David S/C-6836-2009; Nelson, David/AAX-5648-2021; Rand, David A/J-9085-2012; Paszek, Pawel/J-2840-2012; Kell, Douglas/E-8318-2011; Spiller, David G/I-3645-2012	Nelson, David/0000-0002-5034-0885; Rand, David A/0000-0002-2217-3274; Paszek, Pawel/0000-0002-0363-0716; Kell, Douglas/0000-0001-5838-7963; Spiller, David Geoffrey/0000-0003-2502-6787; harper, claire/0000-0001-6228-4078; White, Michael/0000-0002-3617-3232	Biotechnology and Biological Sciences Research Council (BBSRC) [BBD0107481, BBF0059381, BBC0082191, BBC0071581]; Medical Research Council [G0500346]; Professor John Glover Memorial Research Fellowship; Engineering and Physical Sciences Research Council Senior Fellowship [EP/C544587/1, GR/S29256/01]; European Union [005137]; Royal Society/Wolfson Merit Award; BBSRC David Phillips Research Fellowship [BBC5204711]; BBSRC [BB/F005938/1, BB/D010748/1, BB/E012965/1, BB/E004210/1] Funding Source: UKRI; EPSRC [EP/C544587/1] Funding Source: UKRI; MRC [G0500346] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E012965/1, BB/C008219/1, BB/F005938/1, BB/E004210/1, BB/C007158/1, BB/C520471/1, BB/D010748/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [GR/S29256/01, EP/C544587/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Professor John Glover Memorial Research Fellowship; Engineering and Physical Sciences Research Council Senior Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Union(European Commission); Royal Society/Wolfson Merit Award(Royal Society of London); BBSRC David Phillips Research Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank N. Perkins for reading the manuscript and D. Jackson, M. Kimmel, and T. Lipniacki for discussion. The work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) grants BBD0107481, BBF0059381, BBC0082191, and BBC0071581; BBSRC studentships to L.A. and K.S. (AstraZeneca Collaborative Awards in Science and Engineering); and Medical Research Council grant G0500346. C.V.H. holds a Professor John Glover Memorial Research Fellowship; D.A.R. held an Engineering and Physical Sciences Research Council Senior Fellowship [EP/C544587/1, GR/S29256/01 and European Union (BioSim Network contract 005137)]; D.B.K. holds a Royal Society/Wolfson Merit Award; and V.S. holds a BBSRC David Phillips Research Fellowship (BBC5204711). Hamamatsu Photonics and Carl Zeiss Limited provided training and technical support.	Barken D, 2005, SCIENCE, V308, DOI 10.1126/science.1107904; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200; Friedrichsen S, 2006, ENDOCRINOLOGY, V147, P773, DOI 10.1210/en.2005-0967; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayot F, 2006, J THEOR BIOL, V240, P583, DOI 10.1016/j.jtbi.2005.10.018; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Ihekwaba AEC, 2005, IEE P SYST BIOL, V152, P153, DOI 10.1049/ip-syb:20050050; KEAMS JD, 2006, J CELL BIOL, V173, P659; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lipniacki T, 2006, BIOPHYS J, V90, P725, DOI 10.1529/biophysj.104.056754; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Nelson DE, 2005, SCIENCE, V308, DOI 10.1126/science.1108198; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319	24	408	416	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					242	246		10.1126/science.1164860	http://dx.doi.org/10.1126/science.1164860			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359585	Green Accepted, Green Submitted			2022-12-28	WOS:000265024400044
J	Hedrick, TL; Cheng, B; Deng, XY				Hedrick, Tyson L.; Cheng, Bo; Deng, Xinyan			Wingbeat Time and the Scaling of Passive Rotational Damping in Flapping Flight	SCIENCE			English	Article							MANEUVERING FLIGHT; INSECT FLIGHT; AERODYNAMICS; BEHAVIOR; STABILITY	Flying animals exhibit remarkable capabilities for both generating maneuvers and stabilizing their course and orientation after perturbation. Here we show that flapping fliers ranging in size from fruit flies to large birds benefit from substantial damping of angular velocity through a passive mechanism termed flapping counter-torque (FCT). Our FCT model predicts that isometrically scaled animals experience similar damping on a per-wingbeat time scale, resulting in similar turning dynamics in wingbeat time regardless of body size. The model also shows how animals may simultaneously specialize in both maneuverability and stability (at the cost of efficiency) and provides a framework for linking morphology, wing kinematics, maneuverability, and flight dynamics across a wide range of flying animals spanning insects, bats, and birds.	[Hedrick, Tyson L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Cheng, Bo; Deng, Xinyan] Univ Delaware, Dept Mech Engn, Newark, DE 19716 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Delaware	Hedrick, TL (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	thedrick@bio.unc.edu; deng@udel.edu	Deng, Xinyan/C-4511-2011; Deng, Xinyan/C-6393-2011; Cheng, Bo/K-8817-2012; Hedrick, Tyson/GZH-3140-2022; Sikandar, Usama/F-6586-2016	Hedrick, Tyson/0000-0002-6573-9602; Cheng, Bo/0000-0002-6982-0811	NSF, Division of Integrative Organismal Systems [0732267]; NSF, Division of Information and Intelligent Systems [0545931]	NSF, Division of Integrative Organismal Systems(National Science Foundation (NSF)); NSF, Division of Information and Intelligent Systems(National Science Foundation (NSF))	We thank A. Biewener of Harvard University and S. Swartz and K. Breuer of Brown University for providing the hummingbird and fruit bat data. This work was funded in part by NSF grant 0732267 (Division of Integrative Organismal Systems) to T.L.H. and NSF grant 0545931 (Division of Information and Intelligent Systems) to X.D.	Boeddeker N, 2005, J EXP BIOL, V208, P1563, DOI 10.1242/jeb.01558; BUELTHOFF H, 1980, Z NATURFORSCH C, V35, P811; Deng XY, 2006, IEEE T ROBOT, V22, P789, DOI 10.1109/TRO.2006.875483; Dudley R., 2000, BIOMECHANICS INSECT; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P41, DOI 10.1098/rstb.1984.0051; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Greenewalt C.H., 1962, SMITHSON MISC COLLNS, V144, P1, DOI DOI 10.1007/S00360-016-1016-Y; Hedrick TL, 2007, J EXP BIOL, V210, P1897, DOI 10.1242/jeb.002055; Hesselberg T, 2007, J EXP BIOL, V210, P4319, DOI 10.1242/jeb.010389; Hunter TA, 2005, CONDOR, V107, P570, DOI 10.1650/0010-5422(2005)107[0570:COTWSO]2.0.CO;2; LAND MF, 1974, J COMP PHYSIOL, V89, P331, DOI 10.1007/BF00695351; MAYER M, 1988, J COMP PHYSIOL A, V163, P389, DOI 10.1007/BF00604014; PRINGLE JWS, 1957, INSECT FLIGHT, P86; Ribak G, 2007, J COMP PHYSIOL A, V193, P1065, DOI 10.1007/s00359-007-0259-1; Sane SP, 2003, J EXP BIOL, V206, P4191, DOI 10.1242/jeb.00663; Stiles FG, 2005, AUK, V122, P872, DOI 10.1642/0004-8038(2005)122[0872:WMAFBO]2.0.CO;2; Sun M, 2007, J EXP BIOL, V210, P2714, DOI 10.1242/jeb.004507; Taylor GK, 2003, J EXP BIOL, V206, P2803, DOI 10.1242/jeb.00501; Taylor GK, 2002, J THEOR BIOL, V214, P351, DOI 10.1006/jtbi.2001.2470; Taylor GK, 2001, BIOL REV, V76, P449, DOI 10.1017/S1464793101005759; Taylor GK, 2008, J EXP BIOL, V211, P258, DOI 10.1242/jeb.012625; Taylor GK, 2007, ADV INSECT PHYSIOL, V34, P231, DOI 10.1016/S0065-2806(07)34005-8; Usherwood JR, 2002, J EXP BIOL, V205, P1565; WAGNER H, 1986, PHILOS T ROY SOC B, V312, P527, DOI 10.1098/rstb.1986.0017; Warrick DR, 1998, J EXP BIOL, V201, P655	25	194	196	4	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					252	255		10.1126/science.1168431	http://dx.doi.org/10.1126/science.1168431			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359586				2022-12-28	WOS:000265024400046
J	Yusuf, S; Lonn, E; Bosch, J				Yusuf, Salim; Lonn, Eva; Bosch, Jackie			Lipid lowering for primary prevention	LANCET			English	Editorial Material							C-REACTIVE PROTEIN; HEART-FAILURE; CARDIOVASCULAR-DISEASE; ROSUVASTATIN; MORTALITY; EVENTS; TRIAL		[Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; Hamilton Hlth Sci, Hamilton, ON L8L 2X2, Canada	McMaster University; Population Health Research Institute; McMaster University	Yusuf, S (corresponding author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca	Bosch, Jacqueline/AAP-6910-2021	Bosch, Jacqueline/0000-0001-6292-4207; Yusuf, Salim/0000-0003-4776-5601				Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Freeman DJ, 2001, CIRCULATION, V103, P357; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Lloyd-Jones DM, 2006, ANN INTERN MED, V145, P35, DOI 10.7326/0003-4819-145-1-200607040-00129; McKie PM, 2006, HYPERTENSION, V47, P874, DOI 10.1161/01.HYP.0000216794.24161.8c; McMurray J, 2008, CIRCULATION, V118, pS711; Mills EJ, 2008, J AM COLL CARDIOL, V52, P1769, DOI 10.1016/j.jacc.2008.08.039; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Xavier D, 2009, NAT CLIN PRACT CARD, V6, P96, DOI 10.1038/ncpcardio1438	12	37	41	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 4	2009	373	9670					1152	1155		10.1016/S0140-6736(09)60357-3	http://dx.doi.org/10.1016/S0140-6736(09)60357-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429SO	19345816				2022-12-28	WOS:000264940600007
J	Regnard, C; Randall, F				Regnard, Claud; Randall, Fiona			Should hospices be exempt from following national cardiopulmonary resuscitation guidelines? No	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Regnard, Claud] St Oswalds Hosp, Newcastle Hosp NHS Trust, Newcastle Upon Tyne NE3 1EE, Tyne & Wear, England; [Regnard, Claud] Northumberland Tyne & Wear NHS Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Randall, Fiona] Royal Bournemouth & Christchurch NHS Fdn Trust, Christchurch, Dorset, England	Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Regnard, C (corresponding author), St Oswalds Hosp, Newcastle Hosp NHS Trust, Newcastle Upon Tyne NE3 1EE, Tyne & Wear, England.	claudregnard@stoswaldsuk.org						Adults with Incapacity (Scotland) Act 2000, 2000, ADULTS INCAPACITY SC; *PUBL GUARD OFF, 2007, MENT CAP ACT 2005 CO; *ROYAL COLL NURS B, 2007, DEC REL CARD RES JOI; UK Government, 2005, MENT CAP ACT 2005	4	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 26	2009	338								b986	10.1136/bmj.b986	http://dx.doi.org/10.1136/bmj.b986			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LR	19325182				2022-12-28	WOS:000264639700007
J	Zhu, M; Zhao, WJ; Jia, LT; Lu, J; Qiao, T; Qu, QM				Zhu, Min; Zhao, Wenjin; Jia, Liantao; Lu, Jing; Qiao, Tuo; Qu, Qingming			The oldest articulated osteichthyan reveals mosaic gnathostome characters	NATURE			English	Article							BONY FISHES; INTERRELATIONSHIPS	The evolutionary history of osteichthyans (bony fishes plus tetrapods) extends back to the Ludlow epoch of the Silurian period. However, these Silurian forms have been documented exclusively by fragmentary fossils. Here we report the discovery of an exceptionally preserved primitive fish from the Ludlow of Yunnan, China, that represents the oldest near-complete gnathostome (jawed vertebrate). The postcranial skeleton of this fish includes a primitive pectoral girdle and median fin spine as in non-osteichthyan gnathostomes, but a derived macromeric squamation as in crown osteichthyans, and substantiates the unexpected mix of postcranial features in basal sarcopterygians, previously restored from the disarticulated remains of Psarolepis. As the oldest articulated sarcopterygian, the new taxon offers insights into the origin and early divergence of osteichthyans, and indicates that the minimum date for the actinopterygian-sarcopterygian split was no later than 419 million years ago.	[Zhu, Min; Zhao, Wenjin; Jia, Liantao; Lu, Jing; Qiao, Tuo; Qu, Qingming] Chinese Acad Sci, IVPP, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China; [Lu, Jing; Qiao, Tuo; Qu, Qingming] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhu, M (corresponding author), Chinese Acad Sci, IVPP, Key Lab Evolutionary Systemat Vertebrates, POB 643, Beijing 100044, Peoples R China.	zhumin@ivpp.ac.cn	Zhu, Min/E-8728-2012; Qu, Qingming/R-7194-2016; Qiao, Tuo/AAJ-6317-2021; min, zhu/AAL-6712-2021	Zhu, Min/0000-0002-4786-0898; Qu, Qingming/0000-0002-8291-8493; Qiao, Tuo/0000-0002-0488-7265; Zhao, Wenjin/0000-0002-9649-2171	MST of China [2006CB806400]; Chinese Academy of Sciences; National Natural Science Foundation of China; CAS/SAFEA International Partnership Program for Creative Research Teams; Australian Research Council Discovery [DP0772138]	MST of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); Australian Research Council Discovery(Australian Research Council)	We thank M.-M. Chang, P. Janvier, J. Long, P. Ahlberg, X.-B. Yu and B. Choo for discussions, X.-B. Yu and B. Choo for improving the manuscript, J. Zhang and C.-H. Xiong for field work, X.-F. Lu and C.-H. Xiong for specimen preparation, W.-D. Zhang and W. Wang for making thin sections, B. Choo for life restoration, J.-L. Huang for illustrations, and J. Zhang for photography. This work was supported by the Major State Basic Research Projects (2006CB806400) of MST of China, the Chinese Academy of Sciences, the National Natural Science Foundation of China, and the CAS/SAFEA International Partnership Program for Creative Research Teams. M. Z., J. L. and T. Q. thank G. Young and J. Long for the examination of Australian specimens with the support of an Australian Research Council Discovery Grant (DP0772138).	Andrews S. M., 2006, T ROY SOC EDINBURGH, V96, P197, DOI DOI 10.1017/S0263593300001309; Basden AM, 2000, NATURE, V403, P185, DOI 10.1038/35003183; Basden AM, 2001, J VERTEBR PALEONTOL, V21, P754, DOI 10.1671/0272-4634(2001)021[0754:APANFT]2.0.CO;2; Bemis WE, 1997, ENVIRON BIOL FISH, V48, P25, DOI 10.1023/A:1007370213924; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Botella H, 2007, NATURE, V448, P583, DOI 10.1038/nature05989; Burrow Carole J., 1999, Records of the Western Australian Museum Supplement, V57, P1; Cumbaa SL, 2002, CAN J EARTH SCI, V39, P1457, DOI 10.1139/E02-047; Denison R., 1978, Handbook of Paleoichthyology, V2, P1; DENISON R H, 1968, Fieldiana Geology, V17, P353; Fang R.S., 1985, MIDDLE SILURIAN EARL; Friedman M, 2007, J SYST PALAEONTOL, V5, P289, DOI 10.1017/S1477201907002052; Friedman M, 2006, J PALEONTOL, V80, P1186, DOI 10.1666/0022-3360(2006)80[1186:ANAFTF]2.0.CO;2; Gagnier P.-Y., 1989, Courier Forschungsinstitut Senckenberg, V110, P123; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Grande L., 1991, J VERTEBRATE PA S001, V1, P1, DOI DOI 10.1080/02724634.1991.10011424; GROSS W, 1969, LETHAIA, V2, P15, DOI 10.1111/j.1502-3931.1969.tb01249.x; GROSS W, 1968, LETHAIA, V1, P184, DOI 10.1111/j.1502-3931.1968.tb01736.x; Janvier P., 1978, Eesti NSV Teaduste Akadeemia Toimetised Geoloogia, V27, P88; Janvier P., 1996, EARLY VERTEBRATES; Janvier Philippe, 1999, Geodiversitas, V21, P33; JARVIK E, 1972, Meddelelser om Gronland, V187, P1; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; Long M., 1988, U HAWAII WORKING PAP, V7, P1; Miller RF, 2003, NATURE, V425, P501, DOI 10.1038/nature02001; Min Z, 1997, LETHAIA, V30, P293; Muller J, 2005, BIOESSAYS, V27, P1069, DOI 10.1002/bies.20286; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; PAN J, 1986, B CHINESE ACAD GEOLO, V15, P227; PEARSON D M, 1979, Transactions of the Royal Society of Edinburgh, V70, P337; RICHTER M, 1995, ZOOL J LINN SOC-LOND, V114, P173, DOI 10.1006/zjls.1995.0023; Rong J.-y., 1990, Journal of Stratigraphy, V14, P161; Sansom IJ, 2001, SYST ASSOC SPEC VOL, V61, P156; Schultze H. P., 1968, Bulletin of the British Museum (Natural History) Geology, V16, P341; Schultze HP, 2001, SYST ASSOC SPEC VOL, V61, P315; SCHULTZE HP, 1992, FOSSIL FISHES LIVING, P233; Swofford D.L., 2003, PAUP VERSION 40 B10; Ting V. K., 1937, Bulletin of the Geological Society of China, V16, P1; Walliser O.H., 1989, Courier Forschungsinstitut Senckenberg, V110, P111; Wang Cheng-yuan, 2001, Journal of Stratigraphy, V25, P125; Wang N.-z., 1989, Acta Palaeontologica Sinica, V28, P192; Yu XB, 1998, J VERTEBR PALEONTOL, V18, P261, DOI 10.1080/02724634.1998.10011055; Zhang YT, 2001, INT J ENG SCI, V39, P1, DOI 10.1016/S0020-7225(00)00013-6; Zhu M, 2001, SYST ASSOC SPEC VOL, V61, P289; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu M, 2006, NATURE, V441, P77, DOI 10.1038/nature04563; Zhu M, 2002, NATURE, V418, P767, DOI 10.1038/nature00871; Zhu M, 2001, NATURE, V410, P81, DOI 10.1038/35065078; Zhu M., 2004, RECENT ADV ORIGIN EA, P271	50	163	181	8	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					469	474		10.1038/nature07855	http://dx.doi.org/10.1038/nature07855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19325627				2022-12-28	WOS:000264532400036
J	Good, M; Tang, G; Singleton, J; Remenyi, A; Lim, WA				Good, Matthew; Tang, Grace; Singleton, Julie; Remenyi, Attila; Lim, Wendell A.			The Ste5 Scaffold Directs Mating Signaling by Catalytically Unlocking the Fus3 MAP Kinase for Activation	CELL			English	Article							PHEROMONE RESPONSE; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; DOCKING INTERACTIONS; MUTATIONAL ANALYSIS; BINDING DOMAIN; YEAST; SPECIFICITY; PATHWAY; MECHANISMS	The scaffold protein Ste5 is required to properly direct signaling through the yeast mating pathway to the mitogen-activated protein kinase (MAPK), Fus3. Scaffolds are thought to function by tethering kinase and substrate in proximity. We find, however, that the previously identified Fus3-binding site on Ste5 is not required for signaling, suggesting an alternative mechanism controls Fus3's activation by the MAPKK Ste7. Reconstituting MAPK signaling in vitro, we find that Fus3 is an intrinsically poor substrate for Ste7, although the related filamentation MAPK, Kss1, is an excellent substrate. We identify and structurally characterize a domain in Ste5 that catalytically unlocks Fus3 for phosphorylation by Ste7. This domain selectively increases the k(cat) of Ste7 -> Fus3 phosphorylation but has no effect on Ste7 -> Kss1 phosphorylation. The dual requirement for both Ste7 and this Ste5 domain in Fus3 activation explains why Fus3 is selectively activated by the mating pathway and not by other pathways that also utilize Ste7.	[Good, Matthew; Tang, Grace; Singleton, Julie; Remenyi, Attila; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Remenyi, Attila] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Good, Matthew] Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Eotvos Lorand University; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 600 16th St, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu	Remenyi, Attila/N-1345-2016; Good, Matthew C/GLS-0964-2022	Good, Matthew/0000-0002-6367-1034; Remenyi, Attila/0000-0002-8345-1311	Genentech; Achievement Rewards for College Scientists; Leukemia and Lymphoma Society; National Institutes of Health; Packard Foundation; Wellcome Trust; Marie Curie Reintegration Grant; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055040] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); Achievement Rewards for College Scientists; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Foundation(The David & Lucile Packard Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Marie Curie Reintegration Grant(European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by fellowships from Genentech (M. C. G.) and Achievement Rewards for College Scientists (M. C. G.), and the Leukemia and Lymphoma Society (A. R.). It was also supported by the National Institutes of Health (W. A. L.) and the Packard Foundation (W. A. L.), The Wellcome Trust (A. R.) a Marie Curie Reintegration Grant (A. R.) and the Howard Hughes Medical Institute. Thanks to P. Egea for help with structure determination, and to G. Narlikar, A. Chau, N. Helman, and J. Zalatan for assistance and advice. Also thanks to J. Weissman, D. Morgan, E. McCullagh, and H. Ramage, and members of the Lim Lab for thoughtful discussions. W. A. L. would like to dedicate this paper to the memory of Jeremy R. Knowles and Frederic M. Richards, two of his teachers.	Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Bardwell L, 1996, MOL CELL BIOL, V16, P3637; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; BRILL JA, 1994, MOL BIOL CELL, V5, P297, DOI 10.1091/mbc.5.3.297; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Burack WR, 2002, CURR OPIN IMMUNOL, V14, P312, DOI 10.1016/S0952-7915(02)00347-3; CHOI KY, 1994, CELL, V78, P499; Chou S, 2004, CELL, V119, P981, DOI 10.1016/j.cell.2004.11.053; DeLano W.L, PYMOL MOL GRAPHICS S; Flatauer LJ, 2005, MOL CELL BIOL, V25, P1793, DOI 10.1128/MCB.25.5.1793-1803.2005; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Inouye C, 1997, GENETICS, V147, P479; Inouye C, 1997, SCIENCE, V278, P103, DOI 10.1126/science.278.5335.103; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Maleri S, 2004, MOL CELL BIOL, V24, P9221, DOI 10.1128/MCB.24.20.9221-9238.2004; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Schwartz MA, 2006, CURR GENET, V49, P351, DOI 10.1007/s00294-006-0061-6; Sette C, 2000, MOL BIOL CELL, V11, P4033, DOI 10.1091/mbc.11.11.4033; van Drogen F, 2002, CURR BIOL, V12, pR53, DOI 10.1016/S0960-9822(01)00672-8; van Drogen F, 2001, NAT CELL BIOL, V3, P1051, DOI 10.1038/ncb1201-1051; WHITEWAY MS, 1995, SCIENCE, V269, P1572, DOI 10.1126/science.7667635; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020	31	139	143	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1085	1097		10.1016/j.cell.2009.01.049	http://dx.doi.org/10.1016/j.cell.2009.01.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303851	Bronze, Green Accepted			2022-12-28	WOS:000264403900014
J	Heintzman, ND; Hon, GC; Hawkins, RD; Kheradpour, P; Stark, A; Harp, LF; Ye, Z; Lee, LK; Stuart, RK; Ching, CW; Ching, KA; Antosiewicz-Bourget, JE; Liu, H; Zhang, XM; Green, RD; Lobanenkov, VV; Stewart, R; Thomson, JA; Crawford, GE; Kellis, M; Ren, B				Heintzman, Nathaniel D.; Hon, Gary C.; Hawkins, R. David; Kheradpour, Pouya; Stark, Alexander; Harp, Lindsey F.; Ye, Zhen; Lee, Leonard K.; Stuart, Rhona K.; Ching, Christina W.; Ching, Keith A.; Antosiewicz-Bourget, Jessica E.; Liu, Hui; Zhang, Xinmin; Green, Roland D.; Lobanenkov, Victor V.; Stewart, Ron; Thomson, James A.; Crawford, Gregory E.; Kellis, Manolis; Ren, Bing			Histone modifications at human enhancers reflect global cell-type-specific gene expression	NATURE			English	Article							HUMAN GENOME; BINDING-SITES; TRANSCRIPTION; PROMOTERS; ELEMENTS; SEQUENCE; RECEPTOR; MAP	The human body is composed of diverse cell types with distinct functions. Although it is known that lineage specification depends on cell-specific gene expression, which in turn is driven by promoters, enhancers, insulators and other cis-regulatory DNA sequences for each gene(1-3), the relative roles of these regulatory elements in this process are not clear. We have previously developed a chromatin-immunoprecipitation-based microarray method (ChIP-chip) to locate promoters, enhancers and insulators in the human genome(4-6). Here we use the same approach to identify these elements in multiple cell types and investigate their roles in cell-type-specific gene expression. We observed that the chromatin state at promoters and CTCF-binding at insulators is largely invariant across diverse cell types. In contrast, enhancers are marked with highly cell-type-specific histone modification patterns, strongly correlate to cell-type-specific gene expression programs on a global scale, and are functionally active in a cell-type-specific manner. Our results define over 55,000 potential transcriptional enhancers in the human genome, significantly expanding the current catalogue of human enhancers and highlighting the role of these elements in cell-type-specific gene expression.	[Heintzman, Nathaniel D.; Hon, Gary C.; Hawkins, R. David; Harp, Lindsey F.; Ye, Zhen; Lee, Leonard K.; Stuart, Rhona K.; Ching, Christina W.; Ching, Keith A.; Ren, Bing] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Heintzman, Nathaniel D.] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Hon, Gary C.] Univ Calif San Diego, Sch Med, Bioinformat Program, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Kheradpour, Pouya; Stark, Alexander; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Stark, Alexander; Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Antosiewicz-Bourget, Jessica E.; Stewart, Ron; Thomson, James A.] Morgridge Inst Res, Madison, WI 53707 USA; [Liu, Hui; Zhang, Xinmin; Green, Roland D.] Roche NimbleGen Inc, Madison, WI 53719 USA; [Lobanenkov, Victor V.] NIAID, Rockville, MD 20852 USA; [Thomson, James A.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Crawford, Gregory E.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Crawford, Gregory E.] Duke Univ, Dept Pediat, Durham, NC 27708 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; Roche Holding; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Wisconsin System; University of Wisconsin Madison; Duke University; Duke University	Ren, B (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	biren@ucsd.edu	Lobanenkov, Victor/ABD-5710-2021; Stark, Alexander/D-1473-2012; Kellis, Manolis/ABE-7385-2020; Lobanenkov, Victor V./AGQ-8903-2022	Stark, Alexander/0000-0003-2611-0841; Kellis, Manolis/0000-0001-7113-9630; Lobanenkov, Victor/0000-0001-6665-3635; Stuart, Rhona/0000-0001-5916-9693	American Cancer Society; NIAID; LICR; NHGRI; NCI; CIRM; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037, U01HG003151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000860] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); LICR; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CIRM(California Institute for Regenerative Medicine); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Ren laboratory for comments. This work was supported by funding from American Cancer Society (R. D. H.), NIAID Intramural Research Program (V. V. L.), LICR (B. R.), NHGRI (B. R.), NCI (B. R.) and CIRM (B. R.).	Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Heintzman ND, 2007, CELL MOL LIFE SCI, V64, P386, DOI 10.1007/s00018-006-6295-0; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kheradpour P, 2007, GENOME RES, V17, P1919, DOI 10.1101/gr.7090407; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Kleinjan DA, 2001, HUM MOL GENET, V10, P2049, DOI 10.1093/hmg/10.19.2049; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wolf AT, 2005, BLOOD, V105, P1060, DOI 10.1182/blood-2003-12-4383; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018	25	1711	1752	2	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					108	112		10.1038/nature07829	http://dx.doi.org/10.1038/nature07829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19295514	Green Accepted, Green Submitted			2022-12-28	WOS:000265801300039
J	Garcia-Moreno, C				Garcia-Moreno, Claudia			Gender inequality and fire-related deaths in India	LANCET			English	Editorial Material							INTIMATE PARTNER VIOLENCE; HEALTH CONSEQUENCES; WOMENS HEALTH		WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland	World Health Organization	Garcia-Moreno, C (corresponding author), WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland.	garciamorenoc@who.int						Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Hassan Fatma, 2004, Inj Control Saf Promot, V11, P111, DOI 10.1080/15660970412331292333; Heise L., 2002, WORLD REPORT VIOLENC, P88; Mohanty Manoj Kumar, 2004, Leg Med (Tokyo), V6, P151, DOI 10.1016/j.legalmed.2004.05.001; Plichta SB, 2004, J INTERPERS VIOLENCE, V19, P1296, DOI 10.1177/0886260504269685; Ribeiro PS, 2008, INT J GYNECOL OBSTET, V102, P82, DOI 10.1016/j.ijgo.2008.01.025; Sanghavi P, 2009, LANCET, V373, P1282, DOI 10.1016/S0140-6736(09)60235-X	8	13	13	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 11	2009	373	9671					1230	1231		10.1016/S0140-6736(09)60706-6	http://dx.doi.org/10.1016/S0140-6736(09)60706-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	432PN	19362659				2022-12-28	WOS:000265146300007
J	Marquardt, H; Speziale, S; Reichmann, HJ; Frost, DJ; Schilling, FR; Garnero, EJ				Marquardt, Hauke; Speziale, Sergio; Reichmann, Hans J.; Frost, Daniel J.; Schilling, Frank R.; Garnero, Edward J.			Elastic Shear Anisotropy of Ferropericlase in Earth's Lower Mantle	SCIENCE			English	Article							POST-PEROVSKITE PHASE; SPIN TRANSITION; SEISMIC ANISOTROPY; GPA; IRON; MGO; (MG,FE)O; DEFORMATION; SYSTEMATICS; OXIDES	Seismic shear anisotropy in the lowermost mantle most likely results from elastic shear anisotropy and lattice preferred orientation of its constituent minerals, including perovskite, post-perovskite, and ferropericlase. Measurements of the elastic shear anisotropy of single-crystal (Mg0.9Fe0.1)O up to 69 gigapascals (GPa) show that it increased considerably across the pressure-induced spin transition of iron between 40 and 60 GPa. Increasing iron content further enhances the anisotropy. This leads to at least 50% stronger elastic shear anisotropy of (Mg, Fe) O in the lowermost mantle compared to MgO, which is typically used in geodynamic modeling. Our results imply that ferropericlase is the dominant cause of seismic shear anisotropy in the lower mantle.	[Marquardt, Hauke; Speziale, Sergio; Reichmann, Hans J.; Schilling, Frank R.] GFZ German Res Ctr Geosci, D-14473 Potsdam, Germany; [Frost, Daniel J.] Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany; [Garnero, Edward J.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA	Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Bayreuth; Arizona State University; Arizona State University-Tempe	Marquardt, H (corresponding author), GFZ German Res Ctr Geosci, D-14473 Potsdam, Germany.	hama@gfz-potsdam.de	Frost, Daniel J/B-7526-2016; Schilling, Frank/K-2904-2013	Frost, Daniel J/0000-0002-4443-8149; Schilling, Frank/0000-0002-0538-3931	NSF [EAR-0711401]	NSF(National Science Foundation (NSF))	We thank J.-F. Lin, S. Jahn, T. Duffy, M. Koch-Muller, R. Jeanloz, K. Hartmann, and two anonymous reviewers for helpful comments and ideas on the project and the manuscript; A. Kurnosov for gas-loading at Bayerisches Geoinstitut, H. Wilhelm for assistance at the Diamond Light Source; and M. Gottschalk and T. Boffa Ballaran for single-crystal x-ray diffraction. E.J.G. acknowledges support from NSF grant EAR-0711401.	Badro J, 2003, SCIENCE, V300, P789, DOI 10.1126/science.1081311; Crowhurst JC, 2008, SCIENCE, V319, P451, DOI 10.1126/science.1149606; Garnero EJ, 2004, SCIENCE, V306, P259, DOI 10.1126/science.1103411; Jackson JM, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004052; Jacobsen SD, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000490; KARATO S, 1989, PHYS EARTH PLANET IN, V55, P234, DOI 10.1016/0031-9201(89)90071-X; Karki BB, 1999, SCIENCE, V286, P1705, DOI 10.1126/science.286.5445.1705; Kendall JM, 1996, NATURE, V381, P409, DOI 10.1038/381409a0; Keppler H, 2007, AM MINERAL, V92, P433, DOI 10.2138/am.2007.2454; Kobayashi Y, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023257; Lay T, 1998, NATURE, V392, P461, DOI 10.1038/33083; Lin JF, 2005, NATURE, V436, P377, DOI 10.1038/nature03825; Lin JF, 2007, SCIENCE, V317, P1740, DOI 10.1126/science.1144997; Lin JF, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028099; Madi K, 2005, EARTH PLANET SC LETT, V237, P223, DOI 10.1016/j.epsl.2005.06.027; McNamara AK, 2002, NATURE, V416, P310, DOI 10.1038/416310a; Merkel S, 2007, SCIENCE, V316, P1729, DOI 10.1126/science.1140609; Murakami M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021956; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Murakami M, 2009, EARTH PLANET SC LETT, V277, P123, DOI 10.1016/j.epsl.2008.10.010; Panning M, 2004, SCIENCE, V303, P351, DOI 10.1126/science.1091524; Reichmann HJ, 2008, AM MINERAL, V93, P1306, DOI 10.2138/am.2008.2717; Sinogeikin SV, 2000, PHYS EARTH PLANET IN, V120, P43, DOI 10.1016/S0031-9201(00)00143-6; Speziale S, 2005, P NATL ACAD SCI USA, V102, P17918, DOI 10.1073/pnas.0508919102; Tsuchiya T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.198501; Tsuchiya T, 2001, J CHEM PHYS, V114, P10086, DOI 10.1063/1.1371498; Wenk HR, 2006, EARTH PLANET SC LETT, V245, P302, DOI 10.1016/j.epsl.2006.02.028; Wentzcovitch RM, 2006, P NATL ACAD SCI USA, V103, P543, DOI 10.1073/pnas.0506879103; Wookey J, 2005, NATURE, V438, P1004, DOI 10.1038/nature04345; Yamazaki D, 2002, PHYS EARTH PLANET IN, V131, P251, DOI 10.1016/S0031-9201(02)00037-7; Zha CS, 2000, P NATL ACAD SCI USA, V97, P13494, DOI 10.1073/pnas.240466697	31	111	117	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					224	226		10.1126/science.1169365	http://dx.doi.org/10.1126/science.1169365			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359580				2022-12-28	WOS:000265024400038
J	Tersoff, J; Jesson, DE; Tang, WX				Tersoff, J.; Jesson, D. E.; Tang, W. X.			Running Droplets of Gallium from Evaporation of Gallium Arsenide	SCIENCE			English	Article							CONGRUENT VAPORIZATION; GA-AS; SURFACES; RECONSTRUCTIONS; GROWTH; MOTION; SYSTEM	High-temperature annealing of gallium arsenide in vacuum causes excess evaporation of arsenic, with accumulation of gallium as liquid droplets on the surface. Using real-time in situ surface electron microscopy, we found that these droplets spontaneously run across the crystal surface. Running droplets have been seen in many systems, but they typically require special surface preparation or gradient forces. In contrast, we show that noncongruent evaporation automatically provides a driving force for running droplets. The motion is predicted and observed to slow and stop near a characteristic temperature, with the speed increasing both below and above this temperature. The same behavior is expected to occur during the evaporation of similar III-V semiconductors such as indium arsenide.	[Tersoff, J.] IBM Corp, Div Res, TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA; [Jesson, D. E.; Tang, W. X.] Monash Univ, Sch Phys, Clayton, Vic 3800, Australia	International Business Machines (IBM); Monash University	Tersoff, J (corresponding author), IBM Corp, Div Res, TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA.	tersoff@us.ibm.com; david.jesson@sci.monash.edu.au	Tang, Wen Xin/F-9929-2010	Jesson, David/0000-0003-0897-1445	Australian Research Council [DP0556492, DP0985290]	Australian Research Council(Australian Research Council)	We thank R. Mackie for technical support. Supported by Australian Research Council grants DP0556492 and DP0985290 (D.E.J., W.X.T.).	ARTHUR JR, 1967, J PHYS CHEM SOLIDS, V28, P2257, DOI 10.1016/0022-3697(67)90251-X; BAIN CD, 1994, NATURE, V372, P414, DOI 10.1038/372414a0; CHATILLON C, 1995, J CRYST GROWTH, V151, P91, DOI 10.1016/0022-0248(95)00044-5; CHAUDHURY MK, 1992, SCIENCE, V256, P1539, DOI 10.1126/science.256.5063.1539; DOSSANTOS DF, 1995, PHYS REV LETT, V75, P2972, DOI 10.1103/PhysRevLett.75.2972; FOXTON CT, 1973, J PHYS CHEM SOLIDS, V34, P1693; Heyn C, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.075317; Huang SS, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2234564; Ichimura K, 2000, SCIENCE, V288, P1624, DOI 10.1126/science.288.5471.1624; IIZUKA K, 1995, J CRYST GROWTH, V150, P13, DOI 10.1016/0022-0248(94)00722-5; Isomura N, 2007, J CRYST GROWTH, V301, P26, DOI 10.1016/j.jcrysgro.2006.11.185; KAXIRAS E, 1987, PHYS REV B, V35, P9625, DOI 10.1103/PhysRevB.35.9625; LOWES TD, 1993, J APPL PHYS, V73, P4937, DOI 10.1063/1.353812; MACKIE R, DP0556492 AUSTR RES; Mano T, 2005, NANO LETT, V5, P425, DOI 10.1021/nl048192+; Nepijko SA, 2001, J MICROSC-OXFORD, V203, P269, DOI 10.1046/j.1365-2818.2001.00895.x; QIAN GX, 1988, PHYS REV B, V38, P7649, DOI 10.1103/PhysRevB.38.7649; Schmid AK, 2000, SCIENCE, V290, P1561, DOI 10.1126/science.290.5496.1561; SHEN JY, 1990, J CRYST GROWTH, V106, P543, DOI 10.1016/0022-0248(90)90028-J; Sumino Y, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.068301; Tsao J. Y., 1993, MAT FUNDAMENTALS MOL; Yamagiwa M, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2354007; ZINKEALLMANG M, 1992, PHYS REV LETT, V68, P2358, DOI 10.1103/PhysRevLett.68.2358	23	125	127	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					236	238		10.1126/science.1169546	http://dx.doi.org/10.1126/science.1169546			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359583				2022-12-28	WOS:000265024400042
J	Laurance, J				Laurance, Jeremy			On reflection The costs of care	LANCET			English	Editorial Material												J.Laurance@independent.co.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 4	2009	373	9670					1165	1165		10.1016/S0140-6736(09)60670-X	http://dx.doi.org/10.1016/S0140-6736(09)60670-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429SO	19345817				2022-12-28	WOS:000264940600013
J	Gasteiger, HA; Markovic, NM				Gasteiger, Hubert A.; Markovic, Nenad M.			Just a Dream-or Future Reality?	SCIENCE			English	Editorial Material							OXYGEN REDUCTION; FUEL-CELLS; CATALYSTS; ELECTROCATALYSTS; STABILITY		[Gasteiger, Hubert A.] MIT, Dept Mech Engn, Electrochem Energy Lab, Cambridge, MA 02139 USA; [Markovic, Nenad M.] Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA	Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Argonne National Laboratory	Gasteiger, HA (corresponding author), MIT, Dept Mech Engn, Electrochem Energy Lab, Cambridge, MA 02139 USA.	hubert.gasteiger@gmail.com; markovic@anl.gov	T, Maiyalagan/C-5716-2011; Gasteiger, Hubert/Y-8338-2019	T, Maiyalagan/0000-0003-3528-3824; Gasteiger, Hubert/0000-0001-8199-8703				Adzic RR, 2007, TOP CATAL, V46, P249, DOI 10.1007/s11244-007-9003-x; Bashyam R, 2006, NATURE, V443, P63, DOI 10.1038/nature05118; Bouwkamp-Wijnoltz AL, 2002, J PHYS CHEM B, V106, P12993, DOI 10.1021/jp0266087; COLLMAN JP, 1980, J AM CHEM SOC, V102, P6027, DOI 10.1021/ja00539a009; Debe MK, 2006, J POWER SOURCES, V161, P1002, DOI 10.1016/j.jpowsour.2006.05.033; Garsuch A., 2009, HDB FUEL CELLS FUNDA, V5, P71; Gasteiger HA, 2005, APPL CATAL B-ENVIRON, V56, P9, DOI 10.1016/j.apcatb.2004.06.021; GUPTA S, 1989, J APPL ELECTROCHEM, V19, P19, DOI 10.1007/BF01039385; Jaouen F, 2007, ELECTROCHIM ACTA, V52, P5975, DOI 10.1016/j.electacta.2007.03.045; Koh S, 2007, J AM CHEM SOC, V129, P12624, DOI 10.1021/ja0742784; Koslowski UI, 2008, J PHYS CHEM C, V112, P15356, DOI 10.1021/jp802456e; Lefevre M, 2005, J PHYS CHEM B, V109, P16718, DOI 10.1021/jp0529265; Lefevre M, 2009, SCIENCE, V324, P71, DOI 10.1126/science.1170051; Neyerlin KC, 2009, J POWER SOURCES, V186, P261, DOI 10.1016/j.jpowsour.2008.10.062; Qiu JM, 2007, ADV MATER, V19, P1703, DOI 10.1002/adma.200602374; Shao-Horn Y, 2007, TOP CATAL, V46, P285, DOI 10.1007/s11244-007-9000-0; Stamenkovic VR, 2007, SCIENCE, V315, P493, DOI 10.1126/science.1135941; WIPKE K, 2009, HDB FUEL CELLS FUNDA, V6, P893	18	1157	1172	13	632	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 3	2009	324	5923					48	49		10.1126/science.1172083	http://dx.doi.org/10.1126/science.1172083			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342578				2022-12-28	WOS:000264802100026
J	Hansen, DM; Galetti, M				Hansen, Dennis M.; Galetti, Mauro			The Forgotten Megafauna	SCIENCE			English	Editorial Material							SEED DISPERSAL; ANACHRONISMS; EXTINCTIONS; FRUITS		[Hansen, Dennis M.; Galetti, Mauro] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Galetti, Mauro] UNESP Sao Paulo State Univ, Dept Ecol, BR-13506900 Sao Paulo, Brazil	Stanford University; Universidade Estadual Paulista	Hansen, DM (corresponding author), Stanford Univ, Dept Biol, 371 Serra Mall, Stanford, CA 94305 USA.	dmhansen@stanford.edu	Galetti, Mauro/M-8751-2013; Galetti, Mauro/C-5275-2008; Hansen, Dennis M/A-3307-2008	Galetti, Mauro/0000-0002-8187-8696; Galetti, Mauro/0000-0002-8187-8696; Hansen, Dennis M/0000-0002-9584-2766				Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Collevatti RG, 2003, MOL ECOL, V12, P105, DOI 10.1046/j.1365-294X.2003.01701.x; Dirzo R., 1991, PLANT ANIMAL INTERAC, P273; Guimaraes Paulo R. Jr, 2008, PLoS ONE, V3, pUnpaginated, DOI 10.1371/journal.pone.0001745; HALLWACHS W, 1986, FRUGIVORES SEED DISP, P285, DOI DOI 10.1007/978-94-009-4812-9_25; Hansen DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002111; JANZEN DH, 1982, SCIENCE, V215, P19, DOI 10.1126/science.215.4528.19; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Martin P. S., 1995, QUATERNARY EXTINCTIO; Meehan HJ, 2002, J BIOGEOGR, V29, P695, DOI 10.1046/j.1365-2699.2002.00718.x; Owen-Smith R.N., 1988, MEGAHERBIVORES INFLU, DOI [10.1017/CBO9780511565441, DOI 10.1017/CBO9780511565441]; Wallace, 1876, GEOGRAPHICAL DISTRIB; Wright SJ, 2007, BIOTROPICA, V39, P289, DOI 10.1111/j.1744-7429.2007.00293.x	13	145	148	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					42	43		10.1126/science.1172393	http://dx.doi.org/10.1126/science.1172393			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342573				2022-12-28	WOS:000264802100021
J	Song, FJ; Loke, YK; Walsh, T; Glenny, AM; Eastwood, AJ; Altman, DG				Song, Fujian; Loke, Yoon K.; Walsh, Tanya; Glenny, Anne-Marie; Eastwood, Alison J.; Altman, Douglas G.			Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MIXED TREATMENT COMPARISONS; ACTIVE-CONTROL TRIALS; COMPETING INTERVENTIONS; CLINICAL-TRIALS; METAANALYSIS; EFFICACY; PLACEBO	Objective To investigate basic assumptions and other methodological problems in the application of indirect comparison in systematic reviews of competing healthcare interventions. Design Survey of published systematic reviews. Inclusion criteria Systematic reviews published between 2000 and 2007 in which an indirect approach had been explicitly used. Data extraction Identified reviews were assessed for comprehensiveness of the literature search, method for indirect comparison, and whether assumptions about similarity and consistency were explicitly mentioned. Results The survey included 88 review reports. In 13 reviews, indirect comparison was informal. Results from different trials were naively compared without using a common control in six reviews. Adjusted indirect comparison was usually done using classic frequentist methods (n=49) or more complex methods (n=18). The key assumption of trial similarity was explicitly mentioned in only 40 of the 88 reviews. The consistency assumption was not explicit in most cases where direct and indirect evidence were compared or combined (18/30). Evidence from head to head comparison trials was not systematically searched for or not included in nine cases. Conclusions Identified methodological problems were an unclear understanding of underlying assumptions, inappropriate search and selection of relevant trials, use of inappropriate or flawed methods, lack of objective and validated methods to assess or improve trial similarity, and inadequate comparison or inappropriate combination of direct and indirect evidence. Adequate understanding of basic assumptions underlying indirect and mixed treatment comparison is crucial to resolve these methodological problems. Appendix 1 PubMed search strategy Appendix 2 Characteristics of identified reports Appendix 3 Identified studies References of included studies	[Song, Fujian; Loke, Yoon K.] Univ E Anglia, Fac Hlth, Norwich NR4 7TJ, Norfolk, England; [Walsh, Tanya; Glenny, Anne-Marie] Univ Manchester, Sch Dent, Manchester M13 9PL, Lancs, England; [Altman, Douglas G.] Ctr Stat Med, Oxford, England	University of East Anglia; University of Manchester; University of Oxford	Song, FJ (corresponding author), Univ E Anglia, Fac Hlth, Norwich NR4 7TJ, Norfolk, England.	fujian.song@uea.ac.uk	Song, Fujian/B-3516-2013	Walsh, Tanya/0000-0001-7003-8854; Glenny, Anne-Marie/0000-0003-4037-2899				Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Chou R, 2006, LANCET, V368, P1503, DOI 10.1016/S0140-6736(06)69638-4; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Fisher LD, 2001, AM HEART J, V141, P26, DOI 10.1067/mhj.2001.111262; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Hasselblad V, 2001, DRUG INF J, V35, P435, DOI 10.1177/009286150103500212; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; Ioannidis JPA, 2006, LANCET, V368, P1470, DOI 10.1016/S0140-6736(06)69615-3; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lu GB, 2006, J AM STAT ASSOC, V101, P447, DOI 10.1198/016214505000001302; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; POCOK SJ, 1996, CLIN TRIALS PRACTICA; Song F, 2008, J CLIN EPIDEMIOL, V61, P455, DOI 10.1016/j.jclinepi.2007.06.006; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; Song FJ, 2000, CONTROL CLIN TRIALS, V21, P488, DOI 10.1016/S0197-2456(00)00055-6	19	275	291	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2009	338								b1147	10.1136/bmj.b1147	http://dx.doi.org/10.1136/bmj.b1147			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429AP	19346285	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000264893500002
J	Adriani, O; Barbarino, GC; Bazilevskaya, GA; Bellotti, R; Boezio, M; Bogomolov, EA; Bonechi, L; Bongi, M; Bonvicini, V; Bottai, S; Bruno, A; Cafagna, F; Campana, D; Carlson, P; Casolino, M; Castellini, G; De Pascale, MP; De Rosa, G; De Simone, N; Di Felice, V; Galper, AM; Grishantseva, L; Hofverberg, P; Koldashov, SV; Krutkov, SY; Kvashnin, AN; Leonov, A; Malvezzi, V; Marcelli, L; Menn, W; Mikhailov, VV; Mocchiutti, E; Orsi, S; Osteria, G; Papini, P; Pearce, M; Picozza, P; Ricci, M; Ricciarini, SB; Simon, M; Sparvoli, R; Spillantini, P; Stozhkov, YI; Vacchi, A; Vannuccini, E; Vasilyev, G; Voronov, SA; Yurkin, YT; Zampa, G; Zampa, N; Zverev, VG				Adriani, O.; Barbarino, G. C.; Bazilevskaya, G. A.; Bellotti, R.; Boezio, M.; Bogomolov, E. A.; Bonechi, L.; Bongi, M.; Bonvicini, V.; Bottai, S.; Bruno, A.; Cafagna, F.; Campana, D.; Carlson, P.; Casolino, M.; Castellini, G.; De Pascale, M. P.; De Rosa, G.; De Simone, N.; Di Felice, V.; Galper, A. M.; Grishantseva, L.; Hofverberg, P.; Koldashov, S. V.; Krutkov, S. Y.; Kvashnin, A. N.; Leonov, A.; Malvezzi, V.; Marcelli, L.; Menn, W.; Mikhailov, V. V.; Mocchiutti, E.; Orsi, S.; Osteria, G.; Papini, P.; Pearce, M.; Picozza, P.; Ricci, M.; Ricciarini, S. B.; Simon, M.; Sparvoli, R.; Spillantini, P.; Stozhkov, Y. I.; Vacchi, A.; Vannuccini, E.; Vasilyev, G.; Voronov, S. A.; Yurkin, Y. T.; Zampa, G.; Zampa, N.; Zverev, V. G.			An anomalous positron abundance in cosmic rays with energies 1.5-100 GeV	NATURE			English	Article							DARK-MATTER; ELECTRON; FRACTION; PARTICLE	Antiparticles account for a small fraction of cosmic rays and are known to be produced in interactions between cosmic-ray nuclei and atoms in the interstellar medium(1), which is referred to as a 'secondary source'. Positrons might also originate in objects such as pulsars(2) and microquasars(3) or through dark matter annihilation(4), which would be 'primary sources'. Previous statistically limited measurements(5-7) of the ratio of positron and electron fluxes have been interpreted as evidence for a primary source for the positrons, as has an increase in the total electron+positron flux at energies between 300 and 600 GeV (ref. 8). Here we report a measurement of the positron fraction in the energy range 1.5-100 GeV. We find that the positron fraction increases sharply overmuch of that range, in a way that appears to be completely inconsistent with secondary sources. We therefore conclude that a primary source, be it an astrophysical object or dark matter annihilation, is necessary.	[Casolino, M.; De Pascale, M. P.; De Simone, N.; Di Felice, V.; Malvezzi, V.; Marcelli, L.; Orsi, S.; Picozza, P.; Sparvoli, R.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Adriani, O.; Bonechi, L.; Spillantini, P.] Univ Florence, Dept Phys, I-50019 Florence, Italy; [Adriani, O.; Bonechi, L.; Bongi, M.; Bottai, S.; Papini, P.; Ricciarini, S. B.; Spillantini, P.; Vannuccini, E.] Ist Nazl Fis Nucl, Sez Florene, I-50019 Florence, Italy; [Barbarino, G. C.] Univ Naples Federico II, Dept Phys, I-80126 Naples, Italy; [Barbarino, G. C.; Campana, D.; De Rosa, G.; Osteria, G.] Univ Naples Federico II, Sez Naples, I-80126 Naples, Italy; [Bazilevskaya, G. A.; Kvashnin, A. N.; Stozhkov, Y. I.] PN Lebedev Phys Inst, RU-119991 Moscow, Russia; [Bellotti, R.; Bruno, A.] Univ Bari, Dept Phys, I-70126 Bari, Italy; [Bellotti, R.; Bruno, A.; Cafagna, F.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Boezio, M.; Bonvicini, V.; Mocchiutti, E.; Vacchi, A.; Zampa, G.; Zampa, N.] Ist Nazl Fis Nucl, Sez Trieste, I-34012 Trieste, Italy; [Bogomolov, E. A.; Krutkov, S. Y.; Vasilyev, G.] AF Ioffe Phys Tech Inst, RU-194021 St Petersburg, Russia; [Carlson, P.; Hofverberg, P.; Orsi, S.; Pearce, M.] AlbaNova Univ Ctr, Dept Phys, KTH, SE-10691 Stockholm, Sweden; [Castellini, G.] IFAC, I-50019 Florence, Italy; [De Pascale, M. P.; De Simone, N.; Di Felice, V.; Picozza, P.; Sparvoli, R.] Univ Roma Tor Vergata, Dept Phys, I-00133 Rome, Italy; [Galper, A. M.; Grishantseva, L.; Koldashov, S. V.; Leonov, A.; Mikhailov, V. V.; Voronov, S. A.; Yurkin, Y. T.; Zverev, V. G.] Moscow Engn & Phys Inst, RU-11540 Moscow, Russia; [Menn, W.; Simon, M.] Univ Siegen, D-57068 Siegen, Germany; [Pearce, M.] AlbaNova Univ Ctr, Oskar Klein Ctr Cosmoparticle Phys, SE-10691 Stockholm, Sweden; [Ricci, M.] Ist Nazl Fis Nucl, Lab Nazl Frascati, I-00044 Frascati, Italy	Istituto Nazionale di Fisica Nucleare (INFN); University of Florence; Istituto Nazionale di Fisica Nucleare (INFN); University of Naples Federico II; University of Naples Federico II; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute; Universita degli Studi di Bari Aldo Moro; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Ioffe Physical Technical Institute; Royal Institute of Technology; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisica Applicata "Nello Carrara" (IFAC-CNR); University of Rome Tor Vergata; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute); Universitat Siegen; Oskar Klein Centre; Istituto Nazionale di Fisica Nucleare (INFN)	Picozza, P (corresponding author), Ist Nazl Fis Nucl, Sez Roma Tor Vergata, Via Ricerca Sci 1, I-00133 Rome, Italy.	Piergiorgio.Picozza@roma2.infn.it	Vannuccini, Elena/ABH-4180-2020; Yuri, Stozhkov/ABG-7096-2021; Mikhailov, Vladimir V/B-5368-2014; S., Krutkov/E-7561-2014; Galper, Arkady M/M-9610-2015; Bazilevskaya, Galina/M-6175-2015; Sparvoli, Roberta/H-8024-2018; Ricciarini, Sergio Bruno/AAW-1098-2020; Bongi, Massimo/L-9417-2015; Kvashnin, Aleksandr N/M-8673-2015; Boezio, Mirko/ABC-4188-2020; Barbarino, Giancarlo/L-2559-2015; marcelli, laura/K-8860-2016; De Rosa, Gianfranca/E-8737-2012; Casolino, Marco/ABI-1081-2020; Bongi, Massimo/AAA-9384-2022; Vacchi, Andrea G/C-1291-2010; Mocchiutti, Emiliano/I-8049-2013; Voronov, Sergey A/P-9654-2016; Cafagna, Francesco/A-9299-2010; Vasilyev, Gennady/E-4843-2014; Leonov, Alexey/E-4698-2016; Osteria, Giuseppe/ABH-3196-2020; Stozhkov, Yuri/M-7433-2015; Osteria, Giuseppe/AAS-2038-2020; Di Felice, Valeria/L-2989-2016; Castellini, Guido/C-6716-2018	Mikhailov, Vladimir V/0000-0003-3851-2901; Bazilevskaya, Galina/0000-0003-3319-684X; Sparvoli, Roberta/0000-0002-6314-6117; Ricciarini, Sergio Bruno/0000-0001-6176-3368; Bongi, Massimo/0000-0002-6050-1937; Kvashnin, Aleksandr N/0000-0001-7218-6738; Boezio, Mirko/0000-0002-8015-2981; Barbarino, Giancarlo/0000-0001-9253-3397; marcelli, laura/0000-0002-3180-1228; De Rosa, Gianfranca/0000-0002-2197-511X; Bongi, Massimo/0000-0002-6050-1937; Vacchi, Andrea G/0000-0003-3855-5856; Mocchiutti, Emiliano/0000-0001-7856-551X; Voronov, Sergey A/0000-0002-9209-0618; Cafagna, Francesco/0000-0002-7450-4784; Osteria, Giuseppe/0000-0002-9871-8103; Stozhkov, Yuri/0000-0003-1917-0328; Osteria, Giuseppe/0000-0002-9871-8103; Bellotti, Roberto/0000-0003-3198-2708; Picozza, Piergiorgio/0000-0002-7986-3321; Campana, Donatella/0000-0003-1504-9707; casolino, marco/0000-0001-6067-5104; Bonvicini, Valter/0000-0003-1826-5843; Papini, Paolo/0000-0003-4718-2895; Castellini, Guido/0000-0002-0177-0643	The Italian Space Agency (ASI); Deutsches Zentrumfur Luftund Raumfahrt (DLR); The Swedish National Space Board; The Swedish Research Council; The Russian Space Agency (Roscosmos); The Russian Foundation for Basic Research	The Italian Space Agency (ASI)(Agenzia Spaziale Italiana (ASI)); Deutsches Zentrumfur Luftund Raumfahrt (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); The Swedish National Space Board; The Swedish Research Council(Swedish Research Council); The Russian Space Agency (Roscosmos); The Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	We thank D. Marinucci for discussions concerning statistical methods, D. Muller, S. Swordy and their group at University of Chicago, G. Bellettini and G. Chiarelli for discussions about the data analysis and L. Bergstro m for comments on the interpretation of our results. We acknowledge support from The Italian Space Agency (ASI), Deutsches Zentrumfur Luftund Raumfahrt (DLR), The Swedish National Space Board, The Swedish Research Council, The Russian Space Agency (Roscosmos) and The Russian Foundation for Basic Research.	Adriani O, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.051101; Aguilar M, 2007, PHYS LETT B, V646, P145, DOI 10.1016/j.physletb.2007.01.024; Aharonian F, 2006, ASTRON ASTROPHYS, V448, pL43, DOI 10.1051/0004-6361:200600014; Alcaraz J, 2000, PHYS LETT B, V484, P10, DOI 10.1016/S0370-2693(00)00588-8; ATOYAN AM, 1995, PHYS REV D, V52, P3265, DOI 10.1103/PhysRevD.52.3265; Barwick SW, 1997, ASTROPHYS J, V482, pL191, DOI 10.1086/310706; Beatty JJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.241102; Berezhko EG, 2002, ASTRON ASTROPHYS, V395, P943, DOI 10.1051/0004-6361:20021219; Bergstrom L, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.103520; Bertone G, 2005, PHYS REP, V405, P279, DOI 10.1016/j.physrep.2004.08.031; Boezio M, 2000, ASTROPHYS J, V532, P653, DOI 10.1086/308545; Busching I, 2008, ASTROPHYS J LETT, V678, pL39, DOI 10.1086/588465; Chang J, 2008, NATURE, V456, P362, DOI 10.1038/nature07477; Cheng HC, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.211301; CHOLIS I, 2008, CASE 700 GEV WIMP CO; Clem J., 2008, P 30 INT COSM RAY C, V1, P477; DELAHAYE T, 2008, GALACTIC SECONDARY P; Donato F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.071301; Golden RL, 1996, ASTROPHYS J, V457, pL103, DOI 10.1086/309896; GRAJEK P, 2008, IS PAMELA POSITRON E; Grimani C, 2004, ASTRON ASTROPHYS, V418, P649, DOI 10.1051/0004-6361:20040044; Heinz S, 2002, ASTRON ASTROPHYS, V390, P751, DOI 10.1051/0004-6361:20020615; Hooper D, 2009, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2009/01/025; Jungman G, 1996, PHYS REP, V267, P195, DOI 10.1016/0370-1573(95)00058-5; Komatsu E, 2009, ASTROPHYS J SUPPL S, V180, P330, DOI 10.1088/0067-0049/180/2/330; Moskalenko IV, 1998, ASTROPHYS J, V493, P694, DOI 10.1086/305152; Picozza P, 2007, ASTROPART PHYS, V27, P296, DOI 10.1016/j.astropartphys.2006.12.002; Serpico PD, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.021302; Servant G, 2003, NUCL PHYS B, V650, P391, DOI 10.1016/S0550-3213(02)01012-X; YUKSEL H, 2008, TEV GAMMA RAYS GEMIN	30	1667	1692	3	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					607	609		10.1038/nature07942	http://dx.doi.org/10.1038/nature07942			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19340076	Green Submitted			2022-12-28	WOS:000264796200035
J	Gilfillan, SMV; Lollar, BS; Holland, G; Blagburn, D; Stevens, S; Schoell, M; Cassidy, M; Ding, ZJ; Zhou, Z; Lacrampe-Couloume, G; Ballentine, CJ				Gilfillan, Stuart M. V.; Lollar, Barbara Sherwood; Holland, Greg; Blagburn, Dave; Stevens, Scott; Schoell, Martin; Cassidy, Martin; Ding, Zhenju; Zhou, Zheng; Lacrampe-Couloume, Georges; Ballentine, Chris J.			Solubility trapping in formation water as dominant CO2 sink in natural gas fields	NATURE			English	Article							ROCK INTERACTIONS; NOBLE-GASES; CARBON; BASIN; GROUNDWATER; RESERVOIRS	Injecting CO2 into deep geological strata is proposed as a safe and economically favourable means of storing CO2 captured from industrial point sources(1-3). It is difficult, however, to assess the long-term consequences of CO2 flooding in the subsurface from decadal observations of existing disposal sites(1,2). Both the site design and long-term safety modelling critically depend on how and where CO2 will be stored in the site over its lifetime(2-4). Within a geological storage site, the injected CO2 can dissolve in solution or precipitate as carbonate minerals. Here we identify and quantify the principal mechanism of CO2 fluid phase removal in nine natural gas fields in North America, China and Europe, using noble gas and carbon isotope tracers. The natural gas fields investigated in our study are dominated by a CO2 phase and provide a natural analogue for assessing the geological storage of anthropogenic CO2 over millennial timescales(1,2,5,6). We find that in seven gas fields with siliciclastic or carbonate-dominated reservoir lithologies, dissolution in formation water at a pH of 5-5.8 is the sole major sink for CO2. In two fields with siliciclastic reservoir lithologies, some CO2 loss through precipitation as carbonate minerals cannot be ruled out, but can account for a maximum of 18 per cent of the loss of emplaced CO2. In view of our findings that geological mineral fixation is a minor CO2 trapping mechanism in natural gas fields, we suggest that long-term anthropogenic CO2 storage models in similar geological systems should focus on the potential mobility of CO2 dissolved in water.	[Gilfillan, Stuart M. V.; Holland, Greg; Blagburn, Dave; Ding, Zhenju; Zhou, Zheng; Ballentine, Chris J.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England; [Gilfillan, Stuart M. V.] Univ Edinburgh, Grant Inst, Sch Geosci, Scottish Ctr Carbon Storage, Edinburgh EH9 3JW, Midlothian, Scotland; [Lollar, Barbara Sherwood; Lacrampe-Couloume, Georges] Univ Toronto, Dept Geol, Toronto, ON M5S 3B1, Canada; [Stevens, Scott] Adv Resources Int, Arlington, VA 22203 USA; [Schoell, Martin] GasConsult Int, Berkeley, CA 94703 USA; [Cassidy, Martin] Univ Houston, Dept Earth & Atmospher Sci, Houston, TX 77204 USA; [Ding, Zhenju] China Univ Geosci, Wuhan 430074, Peoples R China	University of Manchester; University of Edinburgh; University of Toronto; University of Houston System; University of Houston; China University of Geosciences	Gilfillan, SMV (corresponding author), Univ Manchester, Sch Earth Atmospher & Environm Sci, Oxford Rd, Manchester M13 9PL, Lancs, England.	stuart.gilfillan@ed.ac.uk	Zhou, Zheng/D-8800-2014; Gifillan, Stuart M. V./W-2631-2019; Lacrampe-Couloume, Georges/P-6093-2019; Lacrampe-Couloume, Georges/AAW-9291-2020	Zhou, Zheng/0000-0002-2490-8801; Gifillan, Stuart M. V./0000-0003-1929-2843; Ballentine, Chris/0000-0001-9382-070X	Natural Environmental Research Council (NERC); NERC [NE/C516479/1, NE/D004292, NE/F002823]; UK Energy Research Centre [NE/C513169/1]; Natural Sciences and Engineering Research Council of Canada Discovery grant; Engineering and Physical Sciences Research Council [EP/H022961/1, DT/F007744/1] Funding Source: researchfish; Natural Environment Research Council [NE/F004699/1, NE/C516401/1, NE/C513169/1, NE/G015163/1] Funding Source: researchfish; EPSRC [DT/F007744/1, EP/H022961/1] Funding Source: UKRI; NERC [NE/G015163/1, NE/F004699/1] Funding Source: UKRI	Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK Energy Research Centre; Natural Sciences and Engineering Research Council of Canada Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	S. M. V. G. was supported by a Natural Environmental Research Council (NERC)-funded PhD studentship in Manchester and a NERC- funded postdoctoral position, grant NE/C516479/1 in Edinburgh and Glasgow, and UK Energy Research Centre grant NE/C513169/1. Manchester work was further partly funded by NERC grants NE/D004292 and NE/F002823. Toronto work was further partly funded by an Natural Sciences and Engineering Research Council of Canada Discovery grant to B. S. L. We thank the field operators for permission to sample the US gas reservoirs and support in the field, particularly L. Nugent ( Sheep Mountain), T. Muhic and D. Miller and G. Grove ( McCallum dome) and T. White (St Johns dome). S. M. V. G. would like to thank R. S. Haszeldine and Z. Shipton for supporting this work. Review by R. H. Worden is appreciated.	Baines S.J., 2004, GEOLOGICAL STORAGE C, V233, P1; BAINES SJ, 2004, SPECIAL PUBLICATION, V233, P59, DOI DOI 10.1144/GSL.SP.2004.233.01.06; Ballentine CJ, 2002, REV MINERAL GEOCHEM, V47, P539, DOI 10.2138/rmg.2002.47.13; Ballentine CJ, 2002, REV MINERAL GEOCHEM, V47, P481, DOI 10.2138/rmg.2002.47.12; Ballentine CJ, 2002, GEOCHIM COSMOCHIM AC, V66, P2483, DOI 10.1016/S0016-7037(02)00850-5; Ballentine CJ, 2001, NATURE, V409, P327, DOI 10.1038/35053046; BRADSHAW J, 2004, P 7 INT C GREENH GAS, P541; Broadhead R. F., 1998, LITE GEOL, V20, P2; Cathles LM, 2007, GEOFLUIDS, V7, P441, DOI 10.1111/j.1468-8123.2007.00198.x; Clark I.D., 1997, ENV ISOTOPES HYDROLO, P55; Crovetto R., 1982, Journal of Chemical Physics, V76, P1077, DOI 10.1063/1.443074; DEINES P, 1974, GEOCHIM COSMOCHIM AC, V38, P1147, DOI 10.1016/0016-7037(74)90010-6; Fritz P., 1980, HDB ENV ISOTOPE GEOC, V1, P1; GALE J, 2004, GEOLOGICAL STORAGE C, P7; Gilfillan SM, 2008, GEOCHIM COSMOCHIM AC, V72, P1174, DOI 10.1016/j.gca.2007.10.009; Kharaka YK, 2006, GEOLOGY, V34, P577, DOI 10.1130/G22357.1; Kintisch E, 2008, SCIENCE, V320, P306, DOI 10.1126/science.320.5874.306; Knauss KG, 2005, CHEM GEOL, V217, P339, DOI 10.1016/j.chemgeo.2004.12.017; LOLLAR BS, 1994, GEOCHIM COSMOCHIM AC, V58, P5279, DOI 10.1016/0016-7037(94)90311-5; Lollar BS, 1997, GEOCHIM COSMOCHIM AC, V61, P2295; Pearce JM, 1996, ENERG CONVERS MANAGE, V37, P1123, DOI 10.1016/0196-8904(95)00309-6; Scharlin P., 1996, SOLUBILITY DATA SERI, V62; Schrag DP, 2007, SCIENCE, V315, P812, DOI 10.1126/science.1137632; SMITH SP, 1985, EOS, V66, P397; TORGERSEN T, 1985, GEOCHIM COSMOCHIM AC, V49, P1211, DOI 10.1016/0016-7037(85)90011-0; WORDEN RH, 2004, GEOLOGICAL STORAGE C, P211; Xu S, 1995, APPL GEOCHEM, V10, P643, DOI 10.1016/0883-2927(95)00033-X; Xu S, 1997, J ASIAN EARTH SCI, V15, P89, DOI 10.1016/S1367-9120(97)90108-5; XU S, 1995, GEOCHIM COSMOCHIM AC, V59, P4675, DOI 10.1016/0016-7037(95)00301-0	29	329	339	19	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					614	618		10.1038/nature07852	http://dx.doi.org/10.1038/nature07852			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19340078	Green Accepted			2022-12-28	WOS:000264796200037
J	Xu, P; Duong, DM; Seyfried, NT; Cheng, DM; Xie, Y; Robert, J; Rush, J; Hochstrasser, M; Finley, D; Peng, J				Xu, Ping; Duong, Duc M.; Seyfried, Nicholas T.; Cheng, Dongmei; Xie, Yang; Robert, Jessica; Rush, John; Hochstrasser, Mark; Finley, Daniel; Peng, Junmin			Quantitative Proteomics Reveals the Function of Unconventional Ubiquitin Chains in Proteasomal Degradation	CELL			English	Article							DOA4 DEUBIQUITINATING ENZYME; MASS-SPECTROMETRY; POLYUBIQUITIN CHAINS; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PROTEIN LIGASES; 26S PROTEASOME; IN-VITRO; YEAST; COMPLEX	All seven lysine residues in ubiquitin contribute to the synthesis of polyubiquitin chains on protein substrates. Whereas K48-linked chains are well established as mediators of proteasomal degradation, and K63-linked chains act in nonproteolytic events, the roles of unconventional polyubiquitin chains linked through K6, K11, K27, K29, or K33 are not well understood. Here, we report that the unconventional linkages are abundant in vivo and that all non-K63 linkages may target proteins for degradation. Ubiquitin with K48 as the single lysine cannot support yeast viability, and different linkages have partially redundant functions. By profiling both the entire yeast proteome and ubiquitinated proteins in wild-type and ubiquitin K11R mutant strains using mass spectrometry, we identified K11 linkage-specific substrates, including Ubc6, a ubiquitin-conjugating enzyme involved in endoplasmic reticulum-associated degradation (ERAD). Ubc6 primarily synthesizes K11-linked chains, and K11 linkages function in the ERAD pathway. Thus, unconventional polyubiquitin chains are critical for ubiquitin-proteasome system function.	[Xu, Ping; Duong, Duc M.; Seyfried, Nicholas T.; Cheng, Dongmei; Peng, Junmin] Emory Univ, Dept Human Genet, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Xie, Yang; Hochstrasser, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Robert, Jessica; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Rush, John] Cell Signaling Technol, Beverly, MA 01915 USA	Emory University; Yale University; Harvard University; Harvard Medical School	Peng, J (corresponding author), Emory Univ, Dept Human Genet, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA.	jpeng@emory.edu	Peng, Junmin/N-2614-2018	Peng, Junmin/0000-0003-0472-7648; Hochstrasser, Mark/0000-0002-1131-5484; Duong, Duc/0000-0001-5880-1888	National Institutes of Health [GM046904, GM043601, DK069580, CA126222, AG025688]; NATIONAL CANCER INSTITUTE [R21CA126222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK069580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043601, R01GM046904, R37GM046904, R01GM043601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. Coffino, A. Corbett, G. Crouse, R. Cohen, E. Dammer, J. Fridovich-Keil, M. Hoyt, M. Jonikas, C. Kahana, C.-W. Liu, J. Mullally, P. Philippsen, D. Reines, J. Roelofs, R. Rothstein, T. Sommer, Y. Tone, P. Walter, J. Weissman, K. Wilkinson, Q. Xia, and T. Yao for reagents and discussion. We also thank D. Kirkpatrick and K. Wilkinson for critical reading and H. Boldt and C. Strauss for editing. This work was funded by National Institutes of Health grants (GM046904 to M.H.; GM043601 to D.F.; and DK069580, CA126222, and AG025688 to J.P.).	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Bazirgan OA, 2008, J BIOL CHEM, V283, P12797, DOI 10.1074/jbc.M801122200; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kee Y, 2006, J BIOL CHEM, V281, P36724, DOI 10.1074/jbc.M608756200; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Lopez-Fanarraga M, 2001, J STRUCT BIOL, V135, P219, DOI 10.1006/jsbi.2001.4386; Meierhofer D, 2008, J PROTEOME RES, V7, P4566, DOI 10.1021/pr800468j; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Seyfried NT, 2008, ANAL CHEM, V80, P4161, DOI 10.1021/ac702516a; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; Xu P, 2006, ISRAEL J CHEM, V46, P171, DOI 10.1560/1JVL-J4EE-FVW4-MXRE	43	796	831	4	106	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					133	145		10.1016/j.cell.2009.01.041	http://dx.doi.org/10.1016/j.cell.2009.01.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345192	Green Accepted, Bronze			2022-12-28	WOS:000264813300020
J	Hildebrandt, D; Glasser, D; Hausberger, B; Patel, B; Glasser, BJ				Hildebrandt, Diane; Glasser, David; Hausberger, Brendon; Patel, Bilal; Glasser, Benjamin J.			Producing Transportation Fuels with Less Work	SCIENCE			English	Editorial Material							ENERGY; INTEGRATION		[Hildebrandt, Diane; Glasser, David; Hausberger, Brendon; Patel, Bilal] Univ Witwatersrand, Dept Chem & Met Engn, Ctr Mat & Proc Synth, ZA-2050 Wits, South Africa; [Glasser, Benjamin J.] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA	University of Witwatersrand; Rutgers State University New Brunswick	Hildebrandt, D (corresponding author), Univ Witwatersrand, Dept Chem & Met Engn, Ctr Mat & Proc Synth, ZA-2050 Wits, South Africa.	diane.hildebrandt@wits.ac.za	Patel, Bilal/K-3845-2012; Glasser, David/A-7215-2015; Hildebrandt, Diane/AAU-4664-2020; Hildebrandt, Diane/G-3611-2013	Patel, Bilal/0000-0002-1681-0249; Glasser, David/0000-0001-9510-722X; Hildebrandt, Diane/0000-0001-7873-8855; Hildebrandt, Diane/0000-0001-7873-8855				Agrawal R, 2005, AICHE J, V51, P1582, DOI 10.1002/aic.10561; Agrawal R, 2007, P NATL ACAD SCI USA, V104, P4828, DOI 10.1073/pnas.0609921104; HILDEBRANDT D, 2008, 1 WORLD CTL C PAR 3; Hildebrant D., 2007, [No title captured], Patent No. [WO/2007/122498, 2007122498]; Lee S, 2007, HDB ALTERNATIVE FUEL; Leites IL, 2003, ENERGY, V28, P55, DOI 10.1016/S0360-5442(02)00107-X; Levenspiel O, 2005, IND ENG CHEM RES, V44, P5073, DOI 10.1021/ie040169b; Mukoma P, 2006, IND ENG CHEM RES, V45, P5928, DOI 10.1021/ie0505256; OAKI H, 1982, J CHEM ENG JPN, V15, P52; Patel B, 2005, IND ENG CHEM RES, V44, P3529, DOI 10.1021/ie048787f; Patel B, 2007, IND ENG CHEM RES, V46, P8756, DOI 10.1021/ie061554z; Sheppard MC, 2007, AICHE J, V53, P3022, DOI 10.1002/aic.11356; Shinnar R, 2007, CHEM ENG PROG, V103, P10; Shinnar R, 2006, SCIENCE, V313, P1243, DOI 10.1126/science.1130338; Yamamoto M, 2002, ENERG CONVERS MANAGE, V43, P1271, DOI 10.1016/S0196-8904(02)00013-4	15	30	42	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 27	2009	323	5922					1680	1681		10.1126/science.1168455	http://dx.doi.org/10.1126/science.1168455			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325103				2022-12-28	WOS:000264559800025
J	Jonikas, MC; Collins, SR; Denic, V; Oh, E; Quan, EM; Schmid, V; Weibezahn, J; Schwappach, B; Walter, P; Weissman, JS; Schuldiner, M				Jonikas, Martin C.; Collins, Sean R.; Denic, Vladimir; Oh, Eugene; Quan, Erin M.; Schmid, Volker; Weibezahn, Jimena; Schwappach, Blanche; Walter, Peter; Weissman, Jonathan S.; Schuldiner, Maya			Comprehensive Characterization of Genes Required for Protein Folding in the Endoplasmic Reticulum	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; TAIL-ANCHORED PROTEINS; QUALITY-CONTROL; MISFOLDED PROTEINS; SECRETORY PATHWAY; YEAST; ER; DEGRADATION; INSERTION; MEMBRANE	Protein folding in the endoplasmic reticulum is a complex process whose malfunction is implicated in disease and aging. By using the cell's endogenous sensor (the unfolded protein response), we identified several hundred yeast genes with roles in endoplasmic reticulum folding and systematically characterized their functional interdependencies by measuring unfolded protein response levels in double mutants. This strategy revealed multiple conserved factors critical for endoplasmic reticulum folding, including an intimate dependence on the later secretory pathway, a previously uncharacterized six-protein transmembrane complex, and a co-chaperone complex that delivers tail-anchored proteins to their membrane insertion machinery. The use of a quantitative reporter in a comprehensive screen followed by systematic analysis of genetic dependencies should be broadly applicable to functional dissection of complex cellular processes from yeast to human.	[Jonikas, Martin C.; Collins, Sean R.; Denic, Vladimir; Oh, Eugene; Quan, Erin M.; Weibezahn, Jimena; Weissman, Jonathan S.; Schuldiner, Maya] Univ Calif San Francisco, Dept Cellular & Mol Physiol, San Francisco, CA 94143 USA; [Jonikas, Martin C.; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Jonikas, Martin C.; Collins, Sean R.; Denic, Vladimir; Oh, Eugene; Quan, Erin M.; Weibezahn, Jimena; Walter, Peter; Weissman, Jonathan S.; Schuldiner, Maya] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Jonikas, Martin C.; Collins, Sean R.; Denic, Vladimir; Oh, Eugene; Quan, Erin M.; Weibezahn, Jimena; Weissman, Jonathan S.; Schuldiner, Maya] Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA; [Schmid, Volker; Schwappach, Blanche] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Manchester	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Physiol, San Francisco, CA 94143 USA.	weissman@cmp.ucsf.edu	Schuldiner, Maya/C-9488-2009	Oh, Eugene/0000-0003-1970-8423; Collins, Sean/0000-0002-4276-5840; Weissman, Jonathan/0000-0003-2445-670X; Schwappach, Blanche/0000-0003-0225-6432; Schuldiner, Maya/0000-0001-9947-115X	Howard Hughes Medical Institute; NSF; International Human Frontier Science Program; NIH [K99/R00]; European Molecular Biology Organization long-term fellowship; Deutsche Forschungsgemeinschaft; Wellcome Trust	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF(National Science Foundation (NSF)); International Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank C.-S. Chin for flow cytometry software development; C. Boone, D. Breslow, N. Krogan, D. Ng, and C. Wang for reagents; K. Thorn for microscopy assistance; S. Zhou, D. King, G. Cagney, and N. Krogan for mass spectrometry analyses; J. Metz, P. Nittler, A. Carroll, J. Hill, J. Ihmels, S. Wang, and C. Chu for technical help; R. Andino, T. Aragon, A. Battle, N. Bradshaw, J. DeRisi, N. Friedman, J. Hollien, J. Newman, D. Koller, R. Kupferman, H. Madhani, L. Osherovich, F. Papa, and members of the Weissman, Walter, and Schwappach labs for stimulating discussion; B. Toyama for graphics; and M. Bassik, D. Breslow, O. Brandman, S. Churchman, and S. Neher for comments on the manuscript. This work was supported by the Howard Hughes Medical Institute (J.S.W. and P.W.), the NSF (M.C.J. and E.M.Q.), the International Human Frontier Science Program (M.S. and J.W.), an NIH K99/R00 award (M.S.), a European Molecular Biology Organization long-term fellowship (J.W.), the Deutsche Forschungsgemeinschaft (V.S.), and the Wellcome Trust (B.S.).	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Borgese N, 2003, BIOCHEM SOC T, V31, P1238; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Burri L, 2004, TRAFFIC, V5, P45, DOI 10.1046/j.1600-0854.2003.00151.x; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	33	503	521	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1693	1697		10.1126/science.1167983	http://dx.doi.org/10.1126/science.1167983			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325107	Green Accepted			2022-12-28	WOS:000264559800030
J	Adhiyaman, V; Adhiyaman, S				Adhiyaman, Vedamurthy; Adhiyaman, Sonja			10-Minute Consultation Transient ischaemic attack	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Adhiyaman, Vedamurthy] Glan Clwyd Gen Hosp, Rhyl LL18 5UJ, Denbigh, Wales; [Adhiyaman, Sonja] Laurels Surg, Flint CH6 5AF, England		Adhiyaman, V (corresponding author), Glan Clwyd Gen Hosp, Rhyl LL18 5UJ, Denbigh, Wales.	adhiyamanv@yahoo.co.uk							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 23	2009	338								a2343	10.1136/bmj.a2343	http://dx.doi.org/10.1136/bmj.a2343			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LO	19307272				2022-12-28	WOS:000264639400001
J	Weed, HG				Weed, Harrison G.			Review: Enhanced oral hygiene prevents respiratory infection in older persons in hospitals and nursing homes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Ohio State Univ, Coll Med, Columbus, OH 43210 USA	Ohio State University	Weed, HG (corresponding author), Ohio State Univ, Coll Med, Columbus, OH 43210 USA.							Azarpazhooh A, 2006, J PERIODONTOL, V77, P1465, DOI 10.1902/jop.2006.060010	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6							JC3-7	10.7326/0003-4819-150-6-200903170-02007	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423AJ	19306489				2022-12-28	WOS:000264468500030
J	Gore, J; Youk, H; van Oudenaarden, A				Gore, Jeff; Youk, Hyun; van Oudenaarden, Alexander			Snowdrift game dynamics and facultative cheating in yeast	NATURE			English	Article							COOPERATION; EVOLUTION; CONFLICT; POPULATIONS; COMPETITION; GENE	The origin of cooperation is a central challenge to our understanding of evolution(1-3). The fact that microbial interactions can be manipulated in ways that animal interactions cannot has led to a growing interest in microbial models of cooperation(4-10) and competition(11,12). For the budding yeast Saccharomyces cerevisiae to grow on sucrose, the disaccharide must first be hydrolysed by the enzyme invertase(13,14). This hydrolysis reaction is performed outside the cytoplasm in the periplasmic space between the plasma membrane and the cell wall. Here we demonstrate that the vast majority ( 99 per cent) of the monosaccharides created by sucrose hydrolysis diffuse away before they can be imported into the cell, serving to make invertase production and secretion a cooperative behaviour(15,16). A mutant cheater strain that does not produce invertase is able to take advantage of and invade a population of wild-type cooperator cells. However, over a wide range of conditions, the wild-type cooperator can also invade a population of cheater cells. Therefore, we observe steady-state coexistence between the two strains in well-mixed culture resulting from the fact that rare strategies outperform common strategies-the defining features of what game theorists call the snowdrift game(17). A model of the cooperative interaction incorporating nonlinear benefits explains the origin of this coexistence. We are able to alter the outcome of the competition by varying either the cost of cooperation or the glucose concentration in the media. Finally, we note that glucose repression of invertase expression in wild-type cells produces a strategy that is optimal for the snowdrift game-wild-type cells cooperate only when competing against cheater cells.	[Gore, Jeff; Youk, Hyun; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019; Youk, Hyun/E-2661-2016	Youk, Hyun/0000-0003-1687-5760	Pappalardo Postdoctoral Fellowship; NIH K99 Pathways to Independence; Lester Wolfe Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068957, K99GM085279] Funding Source: NIH RePORTER	Pappalardo Postdoctoral Fellowship; NIH K99 Pathways to Independence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lester Wolfe Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank D. Kim, A. Raj, K. Gora, D. Muzzey and B. Pando for discussions and/or experimental help. This work was supported by grants from the US National Institutes of Health (NIH) and National Science Foundation to A. v. O. J. G. is supported through a Pappalardo Postdoctoral Fellowship and an NIH K99 Pathways to Independence Award. H. Y. was supported by a Lester Wolfe Fellowship.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; CHAO L, 1981, P NATL ACAD SCI-BIOL, V78, P6324, DOI 10.1073/pnas.78.10.6324; DICKINSON JR, 2004, METABOLISM MOL PHYSL, P54; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Fiegna F, 2003, P ROY SOC B-BIOL SCI, V270, P1527, DOI 10.1098/rspb.2003.2387; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Greig D, 2004, P ROYAL SOC B S, V271, P25, DOI [DOI 10.1098/RSBL.2003.0083), 10.1098/rsbl.2003.0083]; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P17290, DOI 10.1073/pnas.0607971103; Maclean RC, 2008, J EVOLUTION BIOL, V21, P1836, DOI 10.1111/j.1420-9101.2008.01579.x; MacLean RC, 2006, NATURE, V441, P498, DOI 10.1038/nature04624; Maynard Smith J., 1982, pi; MOTRO U, 1991, J THEOR BIOL, V151, P145, DOI 10.1016/S0022-5193(05)80358-3; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Naumov GI, 1996, FEMS MICROBIOL LETT, V135, P31, DOI 10.1016/0378-1097(95)00424-6; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ozcan S, 1997, YEAST, V13, P127; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Santorelli LA, 2008, NATURE, V451, P1107, DOI 10.1038/nature06558; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Skyrms B., 2004, STAG HUNT EVOLUTION, DOI DOI 10.1017/CBO9781139165228; Smukalla S, 2008, CELL, V135, P726, DOI 10.1016/j.cell.2008.09.037; Velicer GJ, 2003, TRENDS MICROBIOL, V11, P330, DOI 10.1016/S0966-842X(03)00152-5; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461	29	436	443	3	106	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					253	256		10.1038/nature07921	http://dx.doi.org/10.1038/nature07921			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19349960	Green Accepted			2022-12-28	WOS:000266036100041
J	Kim, KJ; Lee, JC; Ahn, SM; Lee, KS; Lee, CW; Cho, YJ; Seo, S; Shin, KH; Choe, SB; Lee, HW				Kim, Kab-Jin; Lee, Jae-Chul; Ahn, Sung-Min; Lee, Kang-Soo; Lee, Chang-Won; Cho, Young Jin; Seo, Sunae; Shin, Kyung-Ho; Choe, Sug-Bong; Lee, Hyun-Woo			Interdimensional universality of dynamic interfaces	NATURE			English	Article							MAGNETIZATION REVERSAL; DOMAIN-WALL; CRITICALITY; CREEP; AVALANCHES; BEHAVIOR; FILMS	Despite the complexity and diversity of nature, there exists universality in the form of critical scaling laws among various dissimilar systems and processes such as stock markets(1), earthquakes(2), crackling noise(3), lung inflation(4) and vortices in superconductors(5). This universality is mainly independent of the microscopic details, depending only on the symmetry and dimension of the system. Exploring how universality is affected by the system dimensions is an important unresolved problem. Here we demonstrate experimentally that universality persists even at a dimensionality crossover in ferromagnetic nanowires. As the wire width decreases, the magnetic domain wall dynamics changes from elastic creep(6-9) in two dimensions to a particle-like stochastic behaviour(10) in one dimension. Applying finite-size scaling, we find that all our experimental data in one and two dimensions (including the crossover regime) collapse onto a single curve, signalling universality at the criticality transition. The crossover to the one-dimensional regime occurs at a few hundred nanometres, corresponding to the integration scale for modern nanodevices.	[Kim, Kab-Jin; Lee, Jae-Chul; Ahn, Sung-Min; Lee, Kang-Soo; Choe, Sug-Bong] Seoul Natl Univ, Ctr Subwavelength Opt, Seoul 151742, South Korea; [Kim, Kab-Jin; Lee, Jae-Chul; Ahn, Sung-Min; Lee, Kang-Soo; Choe, Sug-Bong] Seoul Natl Univ, Sch Phys & Astron, Seoul 151742, South Korea; [Lee, Jae-Chul; Shin, Kyung-Ho] Korea Adv Inst Sci & Technol, Ctr Spintron Res, Seoul 136791, South Korea; [Lee, Chang-Won; Cho, Young Jin; Seo, Sunae] Samsung Adv Inst Technol, Yongin 449712, South Korea; [Lee, Hyun-Woo] Pohang Univ Sci & Technol, PCTP, Pohang 790784, Kyungbuk, South Korea; [Lee, Hyun-Woo] Pohang Univ Sci & Technol, Dept Phys, Pohang 790784, Kyungbuk, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Samsung; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Choe, SB (corresponding author), Seoul Natl Univ, Ctr Subwavelength Opt, Seoul 151742, South Korea.	sugbong@snu.ac.kr; hwl@postech.ac.kr	Kim, Kab Jin/GXW-0144-2022; Lee, Chang-Won/C-2709-2009; Choe, Sug-Bong/AAO-4427-2020; Kim, Kab-Jin/Q-2017-2016; Lee, Hyun-Woo/B-8995-2008	Lee, Chang-Won/0000-0003-0546-0439; Kim, Kab-Jin/0000-0002-8378-3746; Lee, Hyun-Woo/0000-0002-1648-8093	KOSEF [R0A-2007-000-20032-0, R01-2007-000-20281-0, R11-2000-071, R11-2008-095-01000-0]; Seoul Science Fellowship; KIST; MEST	KOSEF(Korea Science and Engineering Foundation); Seoul Science Fellowship; KIST(Korea Institute of Science & Technology Information (KISTI)); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by KOSEF through the NRL programme (R0A-2007-000-20032-0). H.-W. L. was supported by KOSEF (R01-2007-000-20281-0, R11-2000-071). K.-J. K. was supported by the Seoul Science Fellowship and the Seoul R&BD programme. J.-C. L. was supported by KOSEF (R11-2008-095-01000-0). K.-H. S. was supported by the KIST Institutional Program and by the TND Frontier Project funded by MEST.	BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; BLATTER G, 1994, REV MOD PHYS, V66, P1125, DOI 10.1103/RevModPhys.66.1125; CARLSON JM, 1994, REV MOD PHYS, V66, P657, DOI 10.1103/RevModPhys.66.657; Cayssol F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.107202; Chauve P, 2000, PHYS REV B, V62, P6241, DOI 10.1103/PhysRevB.62.6241; Choe SB, 2002, APPL PHYS LETT, V80, P1791, DOI 10.1063/1.1457527; Cizeau P, 1997, PHYS REV LETT, V79, P4669, DOI 10.1103/PhysRevLett.79.4669; DERRIDA B, 1983, J STAT PHYS, V31, P433, DOI 10.1007/BF01019492; FISHER DS, 1986, PHYS REV LETT, V56, P1964, DOI 10.1103/PhysRevLett.56.1964; Kim DH, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.087203; KIRBY RD, 1994, PHYS REV B, V49, P10810, DOI 10.1103/PhysRevB.49.10810; LEDOUSSAL P, 1995, PHYSICA C, V254, P63, DOI 10.1016/0921-4534(95)00545-5; Lemerle S, 1998, PHYS REV LETT, V80, P849, DOI 10.1103/PhysRevLett.80.849; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; Metaxas PJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.217208; PERKOVIC O, 1995, PHYS REV LETT, V75, P4528, DOI 10.1103/PhysRevLett.75.4528; POMMIER J, 1990, PHYS REV LETT, V65, P2054, DOI 10.1103/PhysRevLett.65.2054; Ryu KS, 2007, NAT PHYS, V3, P547, DOI 10.1038/nphys659; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675; Skomski R, 2000, PHYS REV B, V62, P3900, DOI 10.1103/PhysRevB.62.3900; SUKI B, 1994, NATURE, V368, P615, DOI 10.1038/368615a0	21	119	119	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					740	742		10.1038/nature07874	http://dx.doi.org/10.1038/nature07874			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19360082				2022-12-28	WOS:000265193600035
J	Amer, A; Fischer, H				Amer, Ahdi; Fischer, Howard			Neonatal Breast Enlargement	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Amer, Ahdi; Fischer, Howard] Wayne State Univ, Sch Med, Detroit, MI 48201 USA	Wayne State University	Amer, A (corresponding author), Wayne State Univ, Sch Med, Detroit, MI 48201 USA.	aamer@med.wayne.edu							0	8	8	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 2	2009	360	14					1445	1445		10.1056/NEJMicm0707832	http://dx.doi.org/10.1056/NEJMicm0707832			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427AL	19339724				2022-12-28	WOS:000264751800010
J	Camacho, DM; Collins, JJ				Camacho, Diogo M.; Collins, James J.			Systems Biology Strikes Gold	CELL			English	Editorial Material							NETWORKS	Integrating synthetic biology and systems biology efforts can advance our understanding of biomolecular systems. This is illustrated in this issue by Cantone et al. (2009), who construct a synthetic gene network in yeast and use it to assess and benchmark systems biology approaches for reverse engineering endogenous gene networks.	[Camacho, Diogo M.; Collins, James J.] Boston Univ, Ctr BioDynam, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA; [Camacho, Diogo M.; Collins, James J.] Boston Univ, Ctr Appl Biotechnol, Boston, MA 02215 USA	Boston University; Howard Hughes Medical Institute; Boston University	Collins, JJ (corresponding author), Boston Univ, Ctr BioDynam, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA.	jcollins@bu.edu	Camacho, Diogo/A-5623-2010	Camacho, Diogo/0000-0002-1971-3524	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bonneau R, 2008, NAT CHEM BIOL, V4, P658, DOI 10.1038/nchembio.122; Camacho D, 2007, ANN NY ACAD SCI, V1115, P73, DOI 10.1196/annals.1407.006; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Lorenz DR, 2009, P NATL ACAD SCI USA, V106, P1145, DOI 10.1073/pnas.0812551106; Margolin LG, 2006, J TURBUL, V7, P1, DOI 10.1080/14685240500331595; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448	9	18	18	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					24	26		10.1016/j.cell.2009.03.032	http://dx.doi.org/10.1016/j.cell.2009.03.032			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345182	Bronze			2022-12-28	WOS:000264813300009
J	Hayashi, MK; Tang, CY; Verpelli, C; Narayanan, R; Stearns, MH; Xu, RM; Li, HL; Sala, C; Hayashi, Y				Hayashi, Mariko Kato; Tang, Chunyan; Verpelli, Chiara; Narayanan, Radhakrishnan; Stearns, Marissa H.; Xu, Rui-Ming; Li, Huilin; Sala, Carlo; Hayashi, Yasunori			The Postsynaptic Density Proteins Homer and Shank Form a Polymeric Network Structure	CELL			English	Article							CRYSTAL-STRUCTURE; COMPLEX REVEALS; RAT FOREBRAIN; EVH1 DOMAIN; KINASE-II; FAMILY; RECEPTOR; SYNAPSES; BINDS; RECOGNITION	The postsynaptic density (PSD) is crucial for synaptic functions, but the molecular architecture retaining its structure and components remains elusive. Homer and Shank are among the most abundant scaffolding proteins in the PSD, working synergistically for maturation of dendritic spines. Here, we demonstrate that Homer and Shank, together, form a mesh-like matrix structure. Crystallographic analysis of this region revealed a pair of parallel dimeric coiled coils intercalated in a tail-to-tail fashion to form a tetramer, giving rise to the unique configuration of a pair of N-terminal EVH1 domains at each end of the coiled coil. In neurons, the tetramerization is required for structural integrity of the dendritic spines and recruitment of proteins to synapses. We propose that the Homer-Shank complex serves as a structural framework and as an assembly platform for other PSD proteins.	[Hayashi, Mariko Kato; Narayanan, Radhakrishnan; Stearns, Marissa H.; Hayashi, Yasunori] MIT, Dept Brain & Cognit Sci, RIKEN MIT Neurosci Res Ctr, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Hayashi, Mariko Kato; Hayashi, Yasunori] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Tang, Chunyan; Li, Huilin] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Verpelli, Chiara; Sala, Carlo] Univ Milan, Consiglio Nazl Ric, Inst Neurosci, I-20129 Milan, Italy; [Verpelli, Chiara; Sala, Carlo] Univ Milan, Dept Pharmacol, I-20129 Milan, Italy; [Xu, Rui-Ming] New York Univ, Structural Biol Program, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med,Sch Med, New York, NY 10016 USA; [Xu, Rui-Ming] New York Univ, Sch Med, Dept Pharmacol, New York, NY 10016 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; RIKEN; United States Department of Energy (DOE); Brookhaven National Laboratory; Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Milan; New York University; New York University	Hayashi, MK (corresponding author), MIT, Dept Brain & Cognit Sci, RIKEN MIT Neurosci Res Ctr, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	hayashim@mit.edu	Hayashi, Yasunori/AAF-1408-2019; Hayashi, Mariko K/L-1187-2013; Hayashi, Mariko/HHY-7722-2022; Verpelli, Chiara/K-6673-2016; xu, rui/GRX-5734-2022; Verpelli, Chiara/AAH-1140-2020; Hayashi, Yasunori/C-2249-2008; Tang, Chunyan/E-8352-2010; Sala, Carlo/A-2493-2009	Hayashi, Yasunori/0000-0002-7560-3004; Hayashi, Mariko K/0000-0001-8296-4599; Hayashi, Mariko/0000-0001-8296-4599; Verpelli, Chiara/0000-0003-2949-9725; Verpelli, Chiara/0000-0003-2949-9725; Hayashi, Yasunori/0000-0002-7560-3004; Sala, Carlo/0000-0003-0662-9523; Li, Huilin/0000-0001-8085-8928	NIH [GM68762, R01DA17310]; RIKEN; Ministry of Education, Science, and Culture of Japan; Telethon Italy [GGP06208]; Fondazione Cariplo [2006-0779/109251]; Compagnia di San Paolo [2005-1964];  [NSF-0070319]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074985, P50GM068762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017310] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RIKEN; Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Telethon Italy(Fondazione Telethon); Fondazione Cariplo(Fondazione Cariplo); Compagnia di San Paolo(Compagnia di San Paolo); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The crystallographic data were deposited in PDB with accession number 3CVE (Homer1b) and 3CVF (Homer3a). We thank Doctors Amy E. Keating, Robert T. Sauer, Myung Jong Kim, Amanda Mower, Teiichi Furuichi, and Morgan Sheng for helpful discussion and sharing of resources, as well as Ms. Cristina Zucchi and Ms. Valentina Giannini for technical help. The Biophysical Instrumentation Facility for the Study of Complex Macromolecular Systems (supported by NSF-0070319 and NIH GM68762) at Massachusetts Institute of Technology is gratefully acknowledged. This work was supported by RIKEN; NIH grant R01DA17310; Grant-in-Aid from the Ministry of Education, Science, and Culture of Japan (Y.H.); Telethon Italy (grant number GGP06208); Fondazione Cariplo (project number 2006-0779/109251); and Compagnia di San Paolo (project number 2005-1964) (C.S.).	Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Boeckers TM, 2005, J NEUROCHEM, V92, P519, DOI 10.1111/j.1471-4159.2004.02910.x; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Hayashi MK, 2006, J NEUROSCI, V26, P8492, DOI 10.1523/JNEUROSCI.2731-06.2006; Hayashi Y, 2005, NEURON, V46, P529, DOI 10.1016/j.neuron.2005.05.006; Im YJ, 2003, J BIOL CHEM, V278, P48099, DOI 10.1074/jbc.M306919200; Irie K, 2002, J MOL BIOL, V318, P1117, DOI 10.1016/S0022-2836(02)00170-5; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Minakami R, 2000, BIOCHEM BIOPH RES CO, V272, P466, DOI 10.1006/bbrc.2000.2777; Mio K, 2007, J MOL BIOL, V367, P373, DOI 10.1016/j.jmb.2006.12.043; Mizutani A, 2008, J NEUROSCI, V28, P5369, DOI 10.1523/JNEUROSCI.4738-07.2008; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Petersen JD, 2003, J NEUROSCI, V23, P11270; Romorini S, 2004, J NEUROSCI, V24, P9391, DOI 10.1523/JNEUROSCI.3314-04.2004; Sala C, 2003, J NEUROSCI, V23, P6327; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sato C, 2004, J MOL BIOL, V336, P155, DOI 10.1016/j.jmb.2003.11.024; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shiraishi-Yamaguchi Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-206; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Sugiyama Y, 2005, NAT METHODS, V2, P677, DOI 10.1038/NMETH783; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Worley PF, 2007, CELL CALCIUM, V42, P363, DOI 10.1016/j.ceca.2007.05.007; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5	35	246	249	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 2	2009	137	1					159	171		10.1016/j.cell.2009.01.050	http://dx.doi.org/10.1016/j.cell.2009.01.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345194	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000264813300022
J	Garattini, S; Chalmers, I				Garattini, Silvio; Chalmers, Iain			Patients and the public deserve big changes in evaluation of drugs	BRITISH MEDICAL JOURNAL			English	Article							PHARMACEUTICAL-INDUSTRY; RANDOMIZED-TRIALS; HEALTH; INFORMATION; DISCLOSURE; LAW		[Garattini, Silvio] Mario Negri Inst Pharmacol Res, I-20156 Milan, Italy; [Chalmers, Iain] Summertown Pavil, Oxford OX2 7LG, England	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Garattini, S (corresponding author), Mario Negri Inst Pharmacol Res, Via Giuseppe La Masa 19, I-20156 Milan, Italy.	garattini@marionegri.it	Garattini, Silvio/AAA-6390-2020	Garattini, Silvio/0000-0003-0647-9297				*ASS BRIT PHARM IN, 2008, ABPI BEST PRACT MOD; Burton B, 2008, BRIT MED J, V336, P1268, DOI 10.1136/bmj.39598.476250.DB; CAPO IV, 2003, GAZZETTA UFFICIA 1 S, V274, P95; Chalmers I, 2005, CLIN TRIALS, V2, P229; Chalmers I., 2006, SIGNIFICANCE, V3, P172; Chalmers I, 2006, J ROY SOC MED, V99, P337, DOI 10.1258/jrsm.99.7.337; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; *CMR INT, 2006, 2006 GLOB R D PERF M, P7; Coombes R, 2008, BRIT MED J, V336, P576, DOI 10.1136/bmj.39517.500961.DB; *DEP TRAD IND, R D SCOR 2006 TOP 80; Dyer O, 2008, BRIT MED J, V336, P850, DOI 10.1136/bmj.39553.506597.DB; Garattini S, 2001, LANCET, V358, P64, DOI 10.1016/S0140-6736(00)05258-2; Garattini S, 2007, BMJ-BRIT MED J, V335, P803, DOI 10.1136/bmj.39281.615706.94; Grimes DA, 2005, OBSTET GYNECOL, V105, P1114, DOI 10.1097/01.AOG.0000157445.67309.19; Groves T, 2008, BRIT MED J, V336, P170, DOI 10.1136/bmj.39469.465139.80; Herxheimer A, 2003, BRIT MED J, V326, P1208, DOI 10.1136/bmj.326.7400.1208; Hirst J, 2003, BRIT MED J, V326, P1211, DOI 10.1136/bmj.326.7400.1211-a; JACK A, 2008, FINANCIAL TIMES 0513; Jack A, 2008, BRIT MED J, V336, P418, DOI 10.1136/bmj.39491.469005.94; Light D. W., 2006, MONITORING FINANCIAL, P29; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; Pandolfini C, 2005, EUR J PEDIATR, V164, P552, DOI 10.1007/s00431-005-1698-8; RIDDELL RW, 1958, S CLIN TRIALS HELD R; Roberts I, 1998, LANCET, V352, P726, DOI 10.1016/S0140-6736(98)07600-4; Roehr B, 2008, BRIT MED J, V336, P737, DOI 10.1136/bmj.39539.578507.DB; Tallon D, 2000, LANCET, V355, P2037, DOI 10.1016/S0140-6736(00)02351-5; Trotta F, 2008, ANN ONCOL, V19, P1347, DOI 10.1093/annonc/mdn042; VANDENBROUCKE JP, 2005, BMJ; Vitry A, 2008, INTERN MED J, V38, P559, DOI 10.1111/j.1445-5994.2007.01588.x	30	57	57	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 31	2009	338								b1025	10.1136/bmj.b1025	http://dx.doi.org/10.1136/bmj.b1025			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429AL	19336489				2022-12-28	WOS:000264893100001
J	Takeuchi, K; Nakano, Y; Kato, U; Kaneda, M; Aizu, M; Awano, W; Yonemura, S; Kiyonaka, S; Mori, Y; Yamamoto, D; Umeda, M				Takeuchi, Ken-ichi; Nakano, Yoshiro; Kato, Utako; Kaneda, Mizuho; Aizu, Masako; Awano, Wakae; Yonemura, Shigenobu; Kiyonaka, Shigeki; Mori, Yasuo; Yamamoto, Daisuke; Umeda, Masato			Changes in Temperature Preferences and Energy Homeostasis in Dystroglycan Mutants	SCIENCE			English	Article							DEHYDROGENASE COMPLEX; DROSOPHILA; CELLS; EXTINCTION; METABOLISM	Temperature affects the physiology, behavior, and evolution of organisms. We conducted mutagenesis and screens for mutants with altered temperature preference in Drosophila melanogaster and identified a cryophilic (cold-seeking) mutant, named atsugari (atu). Reduced expression of the Drosophila ortholog of dystroglycan (DmDG) induced tolerance to cold as well as preference for the low temperature. A sustained increase in mitochondrial oxidative metabolism caused by the reduced expression of DmDG accounted for the cryophilic phenotype of the atu mutant. Although most ectothermic animals do not use metabolically produced heat to regulate body temperature, our results indicate that their thermoregulatory behavior is closely linked to rates of mitochondrial oxidative metabolism and that a mutation in a single gene can induce a sustained change in energy homeostasis and the thermal responses.	[Takeuchi, Ken-ichi; Kato, Utako; Umeda, Masato] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Takeuchi, Ken-ichi; Kaneda, Mizuho; Aizu, Masako; Umeda, Masato] Tokyo Metropolitan Inst Med Sci, Bunkyo Ku, Tokyo 1138613, Japan; [Nakano, Yoshiro] Hyogo Coll Med, Dept Genet, Nishinomiya, Hyogo 6638501, Japan; [Awano, Wakae] Mitsubishi Kasei Inst Life Sci, Tokyo 1948511, Japan; [Yonemura, Shigenobu] RIKEN Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kiyonaka, Shigeki; Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6068501, Japan; [Yamamoto, Daisuke] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808578, Japan	Kyoto University; Tokyo Metropolitan Institute of Medical Science; Hyogo College of Medicine; RIKEN; Kyoto University; Tohoku University	Umeda, M (corresponding author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.	umeda@scl.kyoto-u.ac.jp	Kiyonaka, Shigeki/AAM-7303-2021	, Daisuke/0000-0002-4623-0106	MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan [1802012]; The Novartis Foundation (Japan); The Tohoku Neuroscience Global Centers of Excellence program; Grants-in-Aid for Scientific Research [20249015] Funding Source: KAKEN	MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Novartis Foundation (Japan); The Tohoku Neuroscience Global Centers of Excellence program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Nakano for statistical analysis; H. Suzuki and J. Ikenouchi for assistance with electron microscopy; R. Niwa, M. O'Connor, A. P. Gould, and M. Kamakura for providing GAL4 flies; N. Juni for helpful discussions; A. Yamaguchi, Y. Yamaguchi, and M. Nishikawa for technical assistance; and R. Matsuda, H. Takeshima, Y. Nagai, and M. Ui for valuable advice and encouragement. This work was supported in part by Special Coordination Funds for Promoting Science and Technology from MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan, and by a research grant from The Novartis Foundation (Japan) for the Promotion of Science. D.Y. was supported by Specially Promoted Research grant 1802012 from MEXT and The Tohoku Neuroscience Global Centers of Excellence program.	Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bennett A.F., 1996, ANIMALS TEMPERATURE; BULLOCK TH, 1955, BIOL REV, V30, P311, DOI 10.1111/j.1469-185X.1955.tb01211.x; CROWLEY TJ, 1988, SCIENCE, V240, P996, DOI 10.1126/science.240.4855.996; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; Gailly P, 2002, BBA-PROTEINS PROTEOM, V1600, P38, DOI 10.1016/S1570-9639(02)00442-9; Gisolfi C., 2000, HOT BRAIN SURVIVAL T; Greener MJ, 2000, FEBS LETT, V482, P13, DOI 10.1016/S0014-5793(00)02018-4; Heinrich B., 1993, HOT BLOODED INSECTS; Kammenga JE, 2007, PLOS GENET, V3, P358, DOI 10.1371/journal.pgen.0030034; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mayhew PJ, 2008, P ROY SOC B-BIOL SCI, V275, P47, DOI 10.1098/rspb.2007.1302; MCCORMACK JG, 1981, BIOCHEM J, V196, P619, DOI 10.1042/bj1960619; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Steiner AA, 2002, ANNU REV PHYSIOL, V64, P263, DOI 10.1146/annurev.physiol.64.081501.155856	19	44	46	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1740	1743		10.1126/science.1165712	http://dx.doi.org/10.1126/science.1165712			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325118				2022-12-28	WOS:000264559800043
J	Tan, T; Brett, SJ; Stokes, T				Tan, Toni; Brett, Stephen J.; Stokes, Tim		Guideline Dev Grp	Guidelines Rehabilitation after critical illness: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Brett, Stephen J.] Hammersmith Hosp, Imperial Coll Healthcare NHS Trust, London W12 0HS, England; [Tan, Toni; Stokes, Tim] Natl Inst Hlth & Clin Excellence, Ctr Clin Practice, Manchester M1 4BD, Lancs, England	Imperial College London; National Institute for Health & Care Excellence	Brett, SJ (corresponding author), Hammersmith Hosp, Imperial Coll Healthcare NHS Trust, London W12 0HS, England.	stephen.brett@imperial.ac.uk	Stokes, Tim/M-9420-2018; McWilliams, David/AAI-2463-2019	Stokes, Tim/0000-0002-1127-1952; McWilliams, David/0000-0002-9086-2557				Broomhead LR, 2002, CRIT CARE, V6, P411, DOI 10.1186/cc1532; *ICNARC, CAS MIX PROGR; Jones C, 2003, CRIT CARE MED, V31, P2456, DOI 10.1097/01.CCM.0000089938.56725.33; *NAT I HLTH CLIN E, 2007, CLIN GUID NAT I HLTH, V50; *NAT I HLTH CLIN E, 2009, CLIN GUID NAT I HLTH, V83; *NAT I HLTH CLIN E, 2005, CLIN GUID NAT I HLTH, V26; *NAT I HLTH CLIN E, 2007, CLIN GUID NAT I HLTH, V23; *NAT I HLTH CLIN E, 2007, CLIN GUID NAT I HLTH, V22; National Institute for Health and Clinical Excellence, 2006, CLIN GUID NAT I HLTH; National Institute for Health and Clinical Excellence, GUID MAN 2009	10	46	47	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 25	2009	338								b822	10.1136/bmj.b822	http://dx.doi.org/10.1136/bmj.b822			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LQ	19321554				2022-12-28	WOS:000264639600017
J	Venables, KM; Brooks, C; Linsell, L; Keegan, TJ; Langdon, T; Fletcher, T; Nieuwenhuijsen, MJ; Maconochie, NES; Doyle, P; Beral, V; Carpenter, LM				Venables, K. M.; Brooks, C.; Linsell, L.; Keegan, T. J.; Langdon, T.; Fletcher, T.; Nieuwenhuijsen, M. J.; Maconochie, N. E. S.; Doyle, P.; Beral, V.; Carpenter, L. M.			Mortality in British military participants in human experimental research into chemical warfare agents at Porton Down: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MUSTARD-GAS INJURY; LUNG-CANCER; WORLD-WAR-1 VETERANS; EXPOSURES; NEOPLASIA	Objective To investigate any long term effects on mortality in participants in experimental research related to chemical warfare agents from 1941 to 1989. Design Historical cohort study. Data sources Archive of UK government research facility at Porton Down, UK military personnel records, and national death and cancer records. Participants 18 276 male members of the UK armed forces who had spent one or more short periods (median 4 days between first and last test) at Porton Down and a comparison group of 17 600 non-Porton Down veterans followed to 31 December 2004. Main outcome measures Mortality rate ratio of Porton Down compared with non-Porton Down veterans and standardised mortality ratio of each veteran group compared with the general population. Both ratios adjusted for age group and calendar period. Results Porton Down veterans were similar to non-Porton Down veterans in year of enlistment (median 1951) but had longer military service (median 6.2 v 5.0 years). After a median follow-up of 43 years, 40% (7306) of Porton Down and 39% (6900) of non-Porton Down veterans had died. All cause mortality was slightly greater in Porton Down veterans (rate ratio 1.06, 95% confidence interval 1.03 to 1.10, P<0.001), more so for deaths outside the UK (1.26, 1.09 to 1.46). Of 12 cause specific groups examined, rate ratios in Porton Down veterans were increased for deaths attributed to infectious and parasitic (1.57, 1.07 to 2.29), genitourinary (1.46, 1.04 to 2.04), circulatory (1.07, 1.01 to 1.12), and external (non-medical) (1.17, 1.00 to 1.37) causes and decreased for deaths attributed to in situ, benign, and unspecified neoplasms (0.60, 0.37 to 0.99). There was no clear relation between type of chemical exposure and cause specific mortality. The mortality in both groups of veterans was lower than that in the general population (standardised mortality ratio 0.88, 0.85 to 0.90; 0.82, 0.80 to 0.84). Conclusions Mortality was slightly higher in Porton Down than non-Porton Down veterans. With lack of information on other important factors, such as smoking or service overseas, it is not possible to attribute the small excess mortality to chemical exposures at Porton Down.	[Venables, K. M.; Brooks, C.; Linsell, L.; Keegan, T. J.; Langdon, T.; Carpenter, L. M.] Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England; [Fletcher, T.] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England; [Nieuwenhuijsen, M. J.] IMIM, Ctr Res Environm Epidemiol, Barcelona 08003, Spain; [Nieuwenhuijsen, M. J.] CIBERESP, Barcelona 08003, Spain; [Nieuwenhuijsen, M. J.] Univ London Imperial Coll Sci Technol & Med, Div Epidemiol Publ Hlth & Primary Care, London SW7 2AZ, England; [Maconochie, N. E. S.; Doyle, P.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Beral, V.] Univ Oxford, Canc Epidemiol Unit, Oxford OX3 7LF, England	University of Oxford; University of London; London School of Hygiene & Tropical Medicine; Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Venables, KM (corresponding author), Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England.	kate.venables@dphpc.ox.ac.uk; lucy.carpenter@dphpc.ox.ac.uk	Nieuwenhuijsen, Mark J/C-3914-2017; Fletcher, Tony/D-2394-2011	Nieuwenhuijsen, Mark J/0000-0001-9461-7981; Fletcher, Tony/0000-0003-3385-200X; Keegan, Thomas/0000-0003-3691-953X; Brooks, Claire/0000-0002-3410-8971	MRC; Department of Public Health; Nuffield College, University of Oxford; MRC [G0200288] Funding Source: UKRI; Medical Research Council [G0200288] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Public Health; Nuffield College, University of Oxford; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: This study was funded by the MRC with funds provided to it by the MoD. Additional funds were provided by the Department of Public Health and Nuffield College, University of Oxford. The MRC set up a liaison group to oversee the progress of the study. The MoD had no role in study design, analysis, and interpretation of data. The MoD facilitated access to its archives but had no role in deciding which data were abstracted. The MoD was sent a copy of the paper for factual comment but had no role in writing the paper or in the decision to submit for publication. The universities of Oxford and London are independent of both the MRC and the MoD.	Allender S, 2006, OCCUP MED-OXFORD, V56, P329, DOI 10.1093/occmed/kql059; Balali-Mood M, 2005, FUND CLIN PHARMACOL, V19, P713, DOI 10.1111/j.1472-8206.2005.00364.x; BEEBE GW, 1960, J NATL CANCER I, V25, P1231; Bullman T, 2000, ANN EPIDEMIOL, V10, P333, DOI 10.1016/S1047-2797(00)00060-0; CARPENTER LM, 2009, BMJ-BRIT MED J, pB655; Carter G. B., 2000, CHEM BIOL DEFENCE PO; Case RAM, 1955, BRIT J PREV SOC MED, V9, P62; Coleman K, 2005, HISTORY OF CHEMICAL WARFARE, P1, DOI 10.1057/9780230501836; Council N. R, 1985, POSSIBLE LONG TERM H, V3; DARBY SC, 1990, BRIT J IND MED, V47, P793; EASTON DF, 1988, BRIT J IND MED, V45, P652; EVANS R, 2000, GASSED; HARRIS R, 1982, HIGHER FORM KILLING; Hills, 1993, STAT MODELS EPIDEMIO; Inskip H, 1997, OCCUP ENVIRON MED, V54, P209, DOI 10.1136/oem.54.3.209; International Agency for Research Cancer, IARC MON EV CARC RIS; Keegan TJ, 2007, ANN OCCUP HYG, V51, P441, DOI 10.1093/annhyg/mem017; Keegan TJ, 2009, ANN OCCUP HYG, V53, P83, DOI 10.1093/annhyg/men040; MANTEL N, 1959, J NATL CANCER I, V22, P719; Ministry of Defence, 2006, HIST SURV PORT SERV; *NAT RES COUNC, 1982, POSS LONG TERM EFF S, V1; *NAT RES COUNC, 1982, POSS LONG TERM EFF S, V2; NORMAN JE, 1975, JNCI-J NATL CANCER I, V54, P311, DOI 10.1093/jnci/54.2.311; Pechura C., 1993, VETERANS RISK HLTH E; WADA S, 1968, LANCET, V1, P1161	25	4	4	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2009	338								b613	10.1136/bmj.b613	http://dx.doi.org/10.1136/bmj.b613			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LP	19318699	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000264639500009
J	Hutchinson, MD; Callans, DJ				Hutchinson, Mathew D.; Callans, David J.			Should doctors recommend automated external defibrillators for use at home after myocardial infarction? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIAC-ARREST		[Hutchinson, Mathew D.; Callans, David J.] Univ Penn Hlth Syst, Philadelphia, PA 19104 USA	University of Pennsylvania	Callans, DJ (corresponding author), Univ Penn Hlth Syst, Philadelphia, PA 19104 USA.	david.callans@uphs.upenn.edu	Callans, David/ABH-2176-2021	Hutchinson, Mathew/0000-0002-8286-0113				Bardy GH, 2008, NEW ENGL J MED, V358, P1793, DOI 10.1056/NEJMoa0801651; Becker L, 1998, CIRCULATION, V97, P2106, DOI 10.1161/01.CIR.97.21.2106; Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; Cobb LA, 2002, JAMA-J AM MED ASSOC, V288, P3008, DOI 10.1001/jama.288.23.3008; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2009	338								b876	10.1136/bmj.b876	http://dx.doi.org/10.1136/bmj.b876			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LO	19307278				2022-12-28	WOS:000264639400019
J	Parren, PWHI; Burton, DR				Parren, Paul W. H. I.; Burton, Dennis R.			Two-in-One Designer Antibodies	SCIENCE			English	Editorial Material							METASTATIC COLORECTAL-CANCER; CHEMOTHERAPY; COMBINATIONS; PROMISCUITY; BEVACIZUMAB		[Parren, Paul W. H. I.] Genmab, NL-3584 CM Utrecht, Netherlands; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbiol Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA	Genmab; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute	Parren, PWHI (corresponding author), Genmab, Yalelaan 60, NL-3584 CM Utrecht, Netherlands.	p.parren@genmab.com; burton@scripps.edu		Parren, Paul/0000-0002-4365-3859				Ben-Kasus T, 2009, P NATL ACAD SCI USA, V106, P3294, DOI 10.1073/pnas.0812059106; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Carter P, 2001, NAT REV CANCER, V1, P118, DOI 10.1038/35101072; Dechant M, 2008, CANCER RES, V68, P4998, DOI 10.1158/0008-5472.CAN-07-6226; Guo F, 2006, P NATL ACAD SCI USA, V103, P11009, DOI 10.1073/pnas.0603822103; Hecht JR, 2009, J CLIN ONCOL, V27, P672, DOI 10.1200/JCO.2008.19.8135; Hudson PJ, 2003, NAT MED, V9, P129, DOI 10.1038/nm0103-129; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Mariuzza RA, 2006, IMMUNITY, V24, P359, DOI 10.1016/j.immuni.2006.03.009; NERI D, 1995, J MOL BIOL, V246, P367, DOI 10.1006/jmbi.1994.0091; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Sethi DK, 2006, IMMUNITY, V24, P429, DOI 10.1016/j.immuni.2006.02.010; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345	16	9	13	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 20	2009	323	5921					1567	1568		10.1126/science.1172253	http://dx.doi.org/10.1126/science.1172253			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299606				2022-12-28	WOS:000264342300024
J	Okuda, S; Tsutsui, H; Shiina, K; Sprunck, S; Takeuchi, H; Yui, R; Kasahara, RD; Hamamura, Y; Mizukami, A; Susaki, D; Kawano, N; Sakakibara, T; Namiki, S; Itoh, K; Otsuka, K; Matsuzaki, M; Nozaki, H; Kuroiwa, T; Nakano, A; Kanaoka, MM; Dresselhaus, T; Sasaki, N; Higashiyama, T				Okuda, Satohiro; Tsutsui, Hiroki; Shiina, Keiko; Sprunck, Stefanie; Takeuchi, Hidenori; Yui, Ryoko; Kasahara, Ryushiro D.; Hamamura, Yuki; Mizukami, Akane; Susaki, Daichi; Kawano, Nao; Sakakibara, Takashi; Namiki, Shoko; Itoh, Kie; Otsuka, Kurataka; Matsuzaki, Motomichi; Nozaki, Hisayoshi; Kuroiwa, Tsuneyoshi; Nakano, Akihiko; Kanaoka, Masahiro M.; Dresselhaus, Thomas; Sasaki, Narie; Higashiyama, Tetsuya			Defensin-like polypeptide LUREs are pollen tube attractants secreted from synergid cells	NATURE			English	Article							TORENIA-FOURNIERI; FEMALE GAMETOPHYTE; ANTIMICROBIAL PEPTIDES; DOUBLE FERTILIZATION; EMBRYO SAC; IN-VITRO; GUIDANCE; ARABIDOPSIS; GENES; PROTEIN	For more than 140 years, pollen tube guidance in flowering plants has been thought to be mediated by chemoattractants derived from target ovules(1). However, there has been no convincing evidence of any particular molecule being the true attractant that actually controls the navigation of pollen tubes towards ovules. Emerging data indicate that two synergid cells on the side of the egg cell emit a diffusible, species-specific signal to attract the pollen tube at the last step of pollen tube guidance(1-3). Here we report that secreted, cysteine-rich polypeptides (CRPs) in a subgroup of defensin-like proteins are attractants derived from the synergid cells. We isolated synergid cells of Torenia fournieri, a unique plant with a protruding embryo sac, to identify transcripts encoding secreted proteins as candidate molecules for the chemoattractant(s). We found two CRPs, abundantly and predominantly expressed in the synergid cell, which are secreted to the surface of the egg apparatus. Moreover, they showed activity in vitro to attract competent pollen tubes of their own species and were named as LUREs. Injection of morpholino antisense oligomers against the LUREs impaired pollen tube attraction, supporting the finding that LUREs are the attractants derived from the synergid cells of T. fournieri.	[Okuda, Satohiro; Tsutsui, Hiroki; Shiina, Keiko; Takeuchi, Hidenori; Yui, Ryoko; Kasahara, Ryushiro D.; Hamamura, Yuki; Mizukami, Akane; Susaki, Daichi; Kawano, Nao; Sakakibara, Takashi; Namiki, Shoko; Kanaoka, Masahiro M.; Sasaki, Narie; Higashiyama, Tetsuya] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Aichi 4648602, Japan; [Sprunck, Stefanie; Dresselhaus, Thomas] Univ Regensburg, D-93053 Regensburg, Germany; [Itoh, Kie] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; [Otsuka, Kurataka; Matsuzaki, Motomichi; Nozaki, Hisayoshi; Nakano, Akihiko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kuroiwa, Tsuneyoshi] Rikkyo St Pauls Univ, Grad Sch Sci, Res Informat Ctr Extremophile, Tokyo 1718501, Japan; [Nakano, Akihiko] RIKEN, Adv Sci Inst, Mol Membrane Biol Lab, Wako, Saitama 3510198, Japan	Nagoya University; University of Regensburg; University of Tokyo; University of Tokyo; Rikkyo University; RIKEN	Higashiyama, T (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Furo Cho, Aichi 4648602, Japan.	higashi@bio.nagoya-u.ac.jp	NOZAKI, HISAYOSHI/G-4926-2014; Matsuzaki, Motomichi/D-4043-2016; Higashiyama, Tetsuya/C-2882-2012; Tsutsui, Hiroki/ABC-1564-2021; Nakano, Akihiko/G-4942-2014; Nakano, Akihiko/C-6185-2009; Takeuchi, Hidenori/AFG-8500-2022; Nakano, Akihiko/A-6420-2016; KANAOKA, Masahiro/I-7192-2014	Matsuzaki, Motomichi/0000-0001-5811-798X; Higashiyama, Tetsuya/0000-0002-7346-360X; Tsutsui, Hiroki/0000-0001-5710-3367; Nakano, Akihiko/0000-0003-3635-548X; Takeuchi, Hidenori/0000-0002-0719-3736; Nakano, Akihiko/0000-0003-3635-548X; KANAOKA, Masahiro/0000-0003-4913-6278; Nozaki, Hisayoshi/0000-0002-9308-4498; Susaki, Daichi/0000-0002-9465-9222	Grant-in-Aid for Young Scientists (Start-up); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [20870020]; Creative Scientific Research, MEXT, Japan [18GS0314-01]; Yamada Science Foundation, Japan; Grant-in-Aid for Scientific Research (B), MEXT, Japan [19370017]; Grant-in-Aid for Scientific Research on Priority Areas [18075004]; PRESTO project; Japan Science and Technology Agency, Japan	Grant-in-Aid for Young Scientists (Start-up)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Creative Scientific Research, MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Yamada Science Foundation, Japan; Grant-in-Aid for Scientific Research (B), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grant-in-Aid for Scientific Research on Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); PRESTO project; Japan Science and Technology Agency, Japan(Japan Science & Technology Agency (JST))	We thank T. Suzuki for help with the analysis of the EST sequences, S. Takayama for providing chemically synthesized and refolded SP11 peptides, W. Uchida for checking the diameter of the glass needles for microinjection by scanning electron microscopy and N. Iwata for assistance in preparing plant materials. This work was supported in part by a Grant-in-Aid for Young Scientists (Start-up), Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (20870020 to M. M. K.); a Grant-in-Aid for Creative Scientific Research, MEXT, Japan (18GS0314-01 to N. S.); a grant from Yamada Science Foundation, Japan (to T. H.); a Grant-in-Aid for Scientific Research (B), MEXT, Japan (19370017 to T. H.); a Grant-in-Aid for Scientific Research on Priority Areas (18075004 to T. H.), and PRESTO project, Japan Science and Technology Agency, Japan (to T. H.).	Berger F, 2008, TRENDS PLANT SCI, V13, P437, DOI 10.1016/j.tplants.2008.05.011; Cheung AY, 2001, SCIENCE, V293, P1441, DOI 10.1126/science.1065051; Cordts S, 2001, PLANT J, V25, P103, DOI 10.1046/j.0960-7412.2000.00944.x; CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0; Doughty J, 1998, PLANT CELL, V10, P1333, DOI 10.1105/tpc.10.8.1333; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Han YZ, 2000, PLANTA, V211, P158, DOI 10.1007/s004250000289; Higashiyama T, 2001, SCIENCE, V293, P1480, DOI 10.1126/science.1062429; Higashiyama T, 1998, PLANT CELL, V10, P2019, DOI 10.1105/tpc.10.12.2019; Higashiyama T, 2002, J PLANT RES, V115, P149, DOI 10.1007/s102650200020; Higashiyama T, 2008, SEX PLANT REPROD, V21, P17, DOI 10.1007/s00497-007-0064-6; Higashiyama T, 2006, PLANT CELL MONOGR, V3, P265, DOI 10.1007/7089_053; Higashiyama T, 2006, PLANT PHYSIOL, V142, P481, DOI 10.1104/pp.106.083832; Imre K, 1999, SEX PLANT REPROD, V12, P152, DOI 10.1007/s004970050186; Ingouff M, 2007, CURR BIOL, V17, P1032, DOI 10.1016/j.cub.2007.05.019; Jones-Rhoades MW, 2007, PLOS GENET, V3, P1848, DOI 10.1371/journal.pgen.0030171; Karkare S, 2006, APPL MICROBIOL BIOT, V71, P575, DOI 10.1007/s00253-006-0434-2; Kasahara RD, 2005, PLANT CELL, V17, P2981, DOI 10.1105/tpc.105.034603; Kim S, 2003, P NATL ACAD SCI USA, V100, P16125, DOI 10.1073/pnas.2533800100; Marton ML, 2008, SEX PLANT REPROD, V21, P37, DOI 10.1007/s00497-007-0062-8; Marton ML, 2005, SCIENCE, V307, P573, DOI 10.1126/science.1104954; Palanivelu R, 2003, CELL, V114, P47, DOI 10.1016/S0092-8674(03)00479-3; Park SY, 2000, PLANT CELL, V12, P151, DOI 10.1105/tpc.12.1.151; Punwani JA, 2008, SEX PLANT REPROD, V21, P7, DOI 10.1007/s00497-007-0059-3; Punwani JA, 2007, PLANT CELL, V19, P2557, DOI 10.1105/tpc.107.052076; Silverstein KAT, 2005, PLANT PHYSIOL, V138, P600, DOI 10.1104/pp.105.060079; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Sprunck S, 2005, PLANT J, V41, P660, DOI 10.1111/j.1365-313X.2005.02332.x; Takayama S, 2001, NATURE, V413, P534, DOI 10.1038/35097104; Wolters-Arts M, 1998, NATURE, V392, P818, DOI 10.1038/33929; Yang HP, 2006, PLANTA, V224, P1004, DOI 10.1007/s00425-006-0283-3; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101	32	429	456	4	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					357	U122		10.1038/nature07882	http://dx.doi.org/10.1038/nature07882			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19295610				2022-12-28	WOS:000264285600045
J	Weaver, LK				Weaver, Lindell K.			Carbon Monoxide Poisoning	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WHITE-MATTER HYPERINTENSITIES; HYPERBARIC-OXYGEN; CARBOXYHEMOGLOBIN LEVELS; RAT-BRAIN; INTOXICATION; SEQUELAE; PHOSPHORYLATION; SPECTROSCOPY; IMPAIRMENT; PREDICTION	A 39-year-old female executive has a several-month history of fatigue, headache, and memory lapse. Multiple specialists have performed evaluations, but no diagnosis has been established. During a period of feeling worse than usual, she called a friend, who arrived at the residence to find the woman semicomatose and called 911. The patient was given supplemental oxygen and transported to the emergency department, where she is alert and has nonfocal findings on examination. Her carboxyhemoglobin level is 18%. How should she be treated? What is the expected outcome?	[Weaver, Lindell K.] Latter Day St Hosp, Dept Hyperbar Med, Salt Lake City, UT 84143 USA; [Weaver, Lindell K.] Intermt Med Ctr, Dept Hyperbar Med, Murray, UT USA	Intermountain Healthcare; Intermountain Medical Center	Weaver, LK (corresponding author), Latter Day St Hosp, Dept Hyperbar Med, 8th Ave & C St, Salt Lake City, UT 84143 USA.	lindell.weaver@imail.org						Alonso JR, 2003, PHARMACOL TOXICOL, V93, P142, DOI 10.1034/j.1600-0773.2003.930306.x; Amitai Y, 1998, ARCH NEUROL-CHICAGO, V55, P845, DOI 10.1001/archneur.55.6.845; Annane D, 2001, INTENS CARE MED, V27, P1776, DOI 10.1007/s00134-001-1127-z; BALZAN MV, 1994, POSTGRAD MED J, V70, P699, DOI 10.1136/pgmj.70.828.699; Boehning D, 2003, NEURON, V40, P129, DOI 10.1016/S0896-6273(03)00596-8; BROWN SD, 1992, J CLIN INVEST, V89, P666, DOI 10.1172/JCI115633; Chin BY, 2007, P NATL ACAD SCI USA, V104, P5109, DOI 10.1073/pnas.0609611104; CHOI IS, 1983, ARCH NEUROL-CHICAGO, V40, P433, DOI 10.1001/archneur.1983.04050070063016; Cronje FJ, 2004, FREE RADICAL BIO MED, V37, P1802, DOI 10.1016/j.freeradbiomed.2004.08.022; den Heijer T, 2006, NEUROLOGY, V66, P540, DOI 10.1212/01.wnl.0000198256.54809.0e; DUCASSE JL, 1995, UNDERSEA HYPERBAR M, V22, P9; Durak AC, 2005, ACTA RADIOL, V46, P322, DOI 10.1080/02841850510021085; Ernst A, 1998, NEW ENGL J MED, V339, P1603, DOI 10.1056/NEJM199811263392206; Gale SD, 1999, BRAIN INJURY, V13, P229, DOI 10.1080/026990599121601; Gesell L, 2008, HYPERBARIC OXYGEN TH; Hampson NB, 2007, UNDERSEA HYPERBAR M, V34, P163; Hampson NB, 2008, AM J EMERG MED, V26, P665, DOI 10.1016/j.ajem.2007.10.005; Hampson Neil B., 1995, Journal of Emergency Medicine, V13, P227, DOI 10.1016/0736-4679(94)00144-8; Hopkins RO, 2007, AM J RESP CRIT CARE, V176, P1001, DOI 10.1164/rccm.200702-290OC; Hopkins RO, 2008, UNDERSEA HYPERBAR M, V35, P258; Jasper BW, 2005, COGN BEHAV NEUROL, V18, P127, DOI 10.1097/01.wnn.0000160820.07836.cf; JUURLINK DN, 2005, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.PUB2; Kalay N, 2007, AM J CARDIOL, V99, P322, DOI 10.1016/j.amjcard.2006.08.030; KIM J K, 1987, Yonsei Medical Journal, V28, P266; KLEES M, 1985, SCI TOTAL ENVIRON, V44, P165, DOI 10.1016/0048-9697(85)90120-2; KOREN G, 1991, REPROD TOXICOL, V5, P397, DOI 10.1016/0890-6238(91)90002-W; Mannaioni PF, 2006, INFLAMM RES, V55, P261, DOI 10.1007/s00011-006-0084-y; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; MYERS RAM, 1985, ANN EMERG MED, V14, P1163, DOI 10.1016/S0196-0644(85)81022-2; *NAT CTR ENV ASS O, 2000, EPA PUBL; Parkinson RB, 2002, NEUROLOGY, V58, P1525, DOI 10.1212/WNL.58.10.1525; Penney D, 2008, CARBON MONOXIDE POIS, P551; PETERSON JE, 1970, ARCH ENVIRON HEALTH, V21, P165, DOI 10.1080/00039896.1970.10667215; Piantadosi C.A., 1996, CARBON MONOXIDE, P163; Piantadosi CA, 1997, EXP NEUROL, V147, P103, DOI 10.1006/exnr.1997.6584; Pulsipher DT, 2006, UNDERSEA HYPERBAR M, V33, P245; RAPHAEL JC, 1989, LANCET, V2, P414; Satran D, 2005, J AM COLL CARDIOL, V45, P1513, DOI 10.1016/j.jacc.2005.01.044; Scheinkestel CD, 1999, MED J AUSTRALIA, V170, P203, DOI 10.5694/j.1326-5377.1999.tb140318.x; Smith EE, 2008, ARCH NEUROL-CHICAGO, V65, P94, DOI 10.1001/archneurol.2007.23; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Taille C, 2003, J BIOL CHEM, V278, P27160, DOI 10.1074/jbc.M300364200; Terajima K, 2008, EUR NEUROL, V59, P55, DOI 10.1159/000109262; Thom SR, 2008, PHYSL MED HYPERBARIC, V321, P347; Thom SR, 2006, AM J RESP CRIT CARE, V174, P1239, DOI 10.1164/rccm.200604-557OC; THORN SR, 1995, ANN EMERG MED, V25, P474, DOI 10.1016/S0196-0644(95)70261-X; TOUGER M, 1995, ANN EMERG MED, V25, P481, DOI 10.1016/S0196-0644(95)70262-8; *UL, 1996, 2034 UL; VANHOESEN KB, 1989, JAMA-J AM MED ASSOC, V261, P1039, DOI 10.1001/jama.261.7.1039; VANHOESEN KB, 1990, JAMA-J AM MED ASSOC, V273, P2750; Weaver LK, 2007, AM J RESP CRIT CARE, V176, P491, DOI 10.1164/rccm.200701-026OC; Weaver LK, 2000, CHEST, V117, P801, DOI 10.1378/chest.117.3.801; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Weaver LK, 2008, UNDERSEA HYPERBAR M, P258; Wolf SJ, 2008, ANN EMERG MED, V51, P138, DOI 10.1016/j.annemergmed.2007.10.012; Zhang XC, 2003, J BIOL CHEM, V278, P1248, DOI 10.1074/jbc.M208419200	56	464	493	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2009	360	12					1217	1225		10.1056/NEJMcp0808891	http://dx.doi.org/10.1056/NEJMcp0808891			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420IU	19297574				2022-12-28	WOS:000264283400008
J	Hohenberger, P				Hohenberger, Peter			Adjuvant imatinib in GIST: a self-fulfilling prophecy, or more?	LANCET			English	Editorial Material							GASTROINTESTINAL STROMAL TUMORS; MUTATIONS; DIAGNOSIS		Univ Heidelberg, Fac Med, Dept Surg, Div Surg Oncol & Thorac Surg, D-68135 Mannheim, Germany	Ruprecht Karls University Heidelberg	Hohenberger, P (corresponding author), Univ Heidelberg, Fac Med, Dept Surg, Div Surg Oncol & Thorac Surg, D-68135 Mannheim, Germany.	peter.hohenberger@chr.ma.uni-heidelberg.de						Casali PG, 2008, ANN ONCOL, V19, P35, DOI 10.1093/annonc/mdn080; Corless CL, 2005, J CLIN ONCOL, V23, P5357, DOI 10.1200/JCO.2005.14.068; Debiec-Rychter M, 2006, EUR J CANCER, V42, P1093, DOI 10.1016/j.ejca.2006.01.030; DeMatteo RP, 2009, LANCET, V373, P1097, DOI 10.1016/S0140-6736(09)60500-6; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; Gronchi A, 2009, EUR J CANCER, V45, P1103, DOI 10.1016/j.ejca.2009.02.009; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; Mussi C, 2008, CLIN CANCER RES, V14, P4550, DOI 10.1158/1078-0432.CCR-08-0086; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0	9	4	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2009	373	9669					1058	1060		10.1016/S0140-6736(09)60562-6	http://dx.doi.org/10.1016/S0140-6736(09)60562-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427IS	19303138				2022-12-28	WOS:000264773600006
J	Smith, S				Smith, Stephen			The value of Academic Health Science Centres for UK medicine	LANCET			English	Editorial Material							NATIONS		Univ London Imperial Coll Sci Technol & Med, Fac Med, Imperial Coll Healthcare NHS Trust, London SW7 2AZ, England	Imperial College London	Smith, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Imperial Coll Healthcare NHS Trust, London SW7 2AZ, England.	s.k.smith@imperial.ac.uk		Smith, Stephen/0000-0003-1912-3935				Cooksey D., 2006, REV UK HLTH RES FUND; Darzi A., 2008, HIGH QUALITY CARE AL; HIER JS, 2008, STRATEGIC PLANNING H; Hussey PS, 2004, HEALTH AFFAIR, V23, P89, DOI 10.1377/hlthaff.23.3.89; Kastor JA, 2003, AM J MED, V114, P774, DOI 10.1016/S0002-9343(03)00266-3; King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a; Nolte E, 2008, HEALTH AFFAIR, V27, P58, DOI 10.1377/hlthaff.27.1.58; Organization for Economic Co-Operation and Development (OECD), 2007, HLTH GLANC 2007 OECD; Weiner BJ, 2001, ACAD MED, V76, P113, DOI 10.1097/00001888-200102000-00007	9	10	10	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2009	373	9669					1056	1058		10.1016/S0140-6736(09)60629-2	http://dx.doi.org/10.1016/S0140-6736(09)60629-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	427IS	19328987				2022-12-28	WOS:000264773600005
J	Makarov, V; Manina, G; Mikusova, K; Mollmann, U; Ryabova, O; Saint-Joanis, B; Dhar, N; Pasca, MR; Buroni, S; Lucarelli, AP; Milano, A; De Rossi, E; Belanova, M; Bobovska, A; Dianiskova, P; Kordulakova, J; Sala, C; Fullam, E; Schneider, P; McKinney, JD; Brodin, P; Christophe, T; Waddell, S; Butcher, P; Albrethsen, J; Rosenkrands, I; Brosch, R; Nandi, V; Bharath, S; Gaonkar, S; Shandil, RK; Balasubramanian, V; Balganesh, T; Tyagi, S; Grosset, J; Riccardi, G; Cole, ST				Makarov, Vadim; Manina, Giulia; Mikusova, Katarina; Moellmann, Ute; Ryabova, Olga; Saint-Joanis, Brigitte; Dhar, Neeraj; Pasca, Maria Rosalia; Buroni, Silvia; Lucarelli, Anna Paola; Milano, Anna; De Rossi, Edda; Belanova, Martina; Bobovska, Adela; Dianiskova, Petronela; Kordulakova, Jana; Sala, Claudia; Fullam, Elizabeth; Schneider, Patricia; McKinney, John D.; Brodin, Priscille; Christophe, Thierry; Waddell, Simon; Butcher, Philip; Albrethsen, Jakob; Rosenkrands, Ida; Brosch, Roland; Nandi, Vrinda; Bharath, Sowmya; Gaonkar, Sheshagiri; Shandil, Radha K.; Balasubramanian, Venkataraman; Balganesh, Tanjore; Tyagi, Sandeep; Grosset, Jacques; Riccardi, Giovanna; Cole, Stewart T.			Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis	SCIENCE			English	Article							CELL-WALL; IDENTIFICATION	New drugs are required to counter the tuberculosis (TB) pandemic. Here, we describe the synthesis and characterization of 1,3-benzothiazin-4-ones (BTZs), a new class of antimycobacterial agents that kill Mycobacterium tuberculosis in vitro, ex vivo, and in mouse models of TB. Using genetics and biochemistry, we identified the enzyme decaprenylphosphoryl-beta-D-ribose 2'-epimerase as a major BTZ target. Inhibition of this enzymatic activity abolishes the formation of decaprenylphosphoryl arabinose, a key precursor that is required for the synthesis of the cell-wall arabinans, thus provoking cell lysis and bacterial death. The most advanced compound, BTZ043, is a candidate for inclusion in combination therapies for both drug-sensitive and extensively drug-resistant TB.	[Makarov, Vadim; Ryabova, Olga] Russian Acad Sci, AN Bakh Biochem Inst, Moscow 119071, Russia; [Manina, Giulia; Pasca, Maria Rosalia; Buroni, Silvia; Lucarelli, Anna Paola; Milano, Anna; De Rossi, Edda; Riccardi, Giovanna] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Mikusova, Katarina; Belanova, Martina; Bobovska, Adela; Dianiskova, Petronela; Kordulakova, Jana] Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava 84215, Slovakia; [Moellmann, Ute] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Mol & Appl Microbiol, D-07745 Jena, Germany; [Saint-Joanis, Brigitte; Brosch, Roland] Inst Pasteur, F-75724 Paris 15, France; [Dhar, Neeraj; Sala, Claudia; Fullam, Elizabeth; Schneider, Patricia; McKinney, John D.; Cole, Stewart T.] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland; [Brodin, Priscille; Christophe, Thierry] Inst Pasteur Korea, Inserm Avenir Grp, Seoul 136791, South Korea; [Waddell, Simon; Butcher, Philip] Univ London St Georges Hosp, Div Cellular & Mol Med, London SE17 ORE, England; [Albrethsen, Jakob; Rosenkrands, Ida] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen S, Denmark; [Nandi, Vrinda; Bharath, Sowmya; Gaonkar, Sheshagiri; Shandil, Radha K.; Balasubramanian, Venkataraman; Balganesh, Tanjore] AstraZeneca India, Bangalore, Karnataka, India; [Tyagi, Sandeep; Grosset, Jacques] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21231 USA	Research Center of Biotechnology RAS; Russian Academy of Sciences; University of Pavia; Comenius University Bratislava; Hans Knoll Institute (HKI); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Institut Pasteur Korea; St Georges University London; Statens Serum Institut; AstraZeneca; Johns Hopkins University		stewart.cole@epfl.ch	Makarov, Vadim/AAE-5483-2021; riccardi, gabriele/A-9269-2012; Buroni, Silvia/AAX-5454-2020; Brodin, Priscille/E-5802-2014; Brosch, Roland/AAZ-3850-2021; Manina, Giulia/AAI-5496-2020; Sala, Claudia/AAM-8395-2020; Brosch, Roland/ABB-4108-2021; Waddell, Simon J/A-9170-2013; Mikusova, Katarina/I-3622-2014; Pasca, Maria Rosalia/J-8752-2016; Kordulakova, Jana/I-3887-2014; Sala, Claudia/R-6037-2017; Brodin, Priscille/N-6979-2019; Riabova, Olga/K-6030-2015; Dhar, Neeraj/K-8171-2013; Makarov, Vadim/HGB-7756-2022	Makarov, Vadim/0000-0001-8746-2694; Brodin, Priscille/0000-0003-0991-7344; Brosch, Roland/0000-0003-2587-3863; Sala, Claudia/0000-0003-4031-4648; Waddell, Simon J/0000-0002-3684-9116; Pasca, Maria Rosalia/0000-0002-8906-4937; Kordulakova, Jana/0000-0003-2834-0165; Sala, Claudia/0000-0003-4031-4648; Brodin, Priscille/0000-0003-0991-7344; Riabova, Olga/0000-0002-3794-6495; Dhar, Neeraj/0000-0002-5887-8137; Makarov, Vadim/0000-0001-8746-2694; Mikusova, Katarina/0000-0002-0100-4877; Buroni, Silvia/0000-0002-6979-2275; deboosere, Nathalie/0000-0002-2873-5485; Butcher, Philip/0000-0003-1223-9097; Albrethsen, Jakob/0000-0002-2842-1128; RICCARDI, Giovanna/0000-0003-3295-0070; MANINA, GIULIA/0000-0001-9905-6095	European Commission [LHSP-CT-2005-018923]; Wellcome Trust [062511]	European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank A. Deshpande, I. Heinemann, P. Hojrup, K. Johnsson, M. K. N. Kumar, N. Kumar, L. Pagani, P. Marone, M. R. McNeil, I. Old, J. Reddy, S. Schmitt, P. Vachaspati, and C. Weigel for their help and support. Patents related to this work have been filed (WO/2007/134625, WO/2009/010163, and PCT/EP2008/001088). The NM4TB Consortium is funded by the European Commission (LHSP-CT-2005-018923), and microarray work at St Georges Hospital, University of London, is supported by the Wellcome Trust (grant 062511). Microarray data are Minimum Information About a Microarray Experiment (MIAME) compliant and deposited under accession number E-BUGS-80 at http://bugs.sgul.ac.uk/E-BUGS-80.	Abraham VC, 2004, TRENDS BIOTECHNOL, V22, P15, DOI 10.1016/j.tibtech.2003.10.012; Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Balganesh TS, 2008, TRENDS PHARMACOL SCI, V29, P576, DOI 10.1016/j.tips.2008.08.001; Barry C, 2001, TUBERCULOSIS, V81, P1, DOI 10.1054/tube.2001.0288; Barry Clifton E., 2007, Infectious Disorders - Drug Targets, V7, P182; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Fenistein D, 2008, CYTOM PART A, V73A, P958, DOI 10.1002/cyto.a.20627; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Makarov V., 2007, [No title captured], Patent No. [2029583, EP 2029583]; Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103; MARKAROV V, 2006, J ANTIMICROB CHEMOTH, V57, P1134; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Mikusova K, 2005, J BACTERIOL, V187, P8020, DOI 10.1128/JB.187.23.8020-8025.2005; MIKUSOVA K, 1995, ANTIMICROB AGENTS CH, V39, P2484, DOI 10.1128/AAC.39.11.2484; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Waddell SJ, 2007, CURR MOL MED, V7, P287, DOI 10.2174/156652407780598548; Wolucka BA, 2008, FEBS J, V275, P2691, DOI 10.1111/j.1742-4658.2008.06395.x; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; Zhang Y, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P115; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	24	523	558	2	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					801	804		10.1126/science.1171583	http://dx.doi.org/10.1126/science.1171583			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19299584	Green Accepted			2022-12-28	WOS:000265832400051
J	Serneels, L; Van Biervliet, J; Craessaerts, K; Dejaegere, T; Horre, K; Van Houtvin, T; Esselmann, H; Paul, S; Schafer, MK; Berezovska, O; Hyman, BT; Sprangers, B; Sciot, R; Moons, L; Jucker, M; Yang, ZX; May, PC; Karran, E; Wiltfang, J; D'Hooge, R; De Strooper, B				Serneels, Lutgarde; Van Biervliet, Jerome; Craessaerts, Katleen; Dejaegere, Tim; Horre, Katrien; Van Houtvin, Tine; Esselmann, Hermann; Paul, Sabine; Schaefer, Martin K.; Berezovska, Oksana; Hyman, Bradley T.; Sprangers, Ben; Sciot, Raf; Moons, Lieve; Jucker, Mathias; Yang, Zhixiang; May, Patrick C.; Karran, Eric; Wiltfang, Jens; D'Hooge, Rudi; De Strooper, Bart			gamma-Secretase Heterogeneity in the Aph1 Subunit: Relevance for Alzheimer's Disease	SCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; MODERATE REDUCTION; TRANSGENIC MODEL; IN-VIVO; MICE; PRESENILIN-1; COMPLEXES; DEFICIENCY; EXPRESSION; CLEAVAGE	The gamma-secretase complex plays a role in Alzheimer's disease and cancer progression. The development of clinically useful inhibitors, however, is complicated by the role of the gamma-secretase complex in regulated intramembrane proteolysis of Notch and other essential proteins. Different gamma-secretase complexes containing different Presenilin or Aph1 protein subunits are present in various tissues. Here we show that these complexes have heterogeneous biochemical and physiological properties. Specific inactivation of the Aph1B gamma-secretase in a mouse Alzheimer's disease model led to improvements of Alzheimer's disease-relevant phenotypic features without any Notch-related side effects. The Aph1B complex contributes to total gamma-secretase activity in the human brain, and thus specific targeting of Aph1B-containing gamma-secretase complexes may help generate less toxic therapies for Alzheimer's disease.	[Serneels, Lutgarde; Van Biervliet, Jerome; Craessaerts, Katleen; Dejaegere, Tim; Horre, Katrien; Van Houtvin, Tine; De Strooper, Bart] Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Serneels, Lutgarde; Van Biervliet, Jerome; Craessaerts, Katleen; Dejaegere, Tim; Horre, Katrien; Van Houtvin, Tine; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Esselmann, Hermann; Paul, Sabine; Wiltfang, Jens] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany; [Esselmann, Hermann; Paul, Sabine; Wiltfang, Jens] Univ Duisburg Essen, Rhine State Hosp Essen, Dept Psychiat & Psychotherapy, D-45147 Essen, Germany; [Schaefer, Martin K.] Univ Marburg, Inst Anat & Cell Biol, Dept Mol Neurosci, D-35032 Marburg, Germany; [Berezovska, Oksana; Hyman, Bradley T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Disorders, Charlestown, MA 02129 USA; [Sprangers, Ben] Katholieke Univ Leuven, Lab Expt Transplantat, B-3000 Louvain, Belgium; [Sciot, Raf] Katholieke Univ Leuven, Lab Morphol & Mol Pathol, B-3000 Louvain, Belgium; [Moons, Lieve] Katholieke Univ Leuven, Lab Neural Circuit Dev & Regenerat, Dept Biol, B-3000 Louvain, Belgium; [Jucker, Mathias] Univ Tubingen, Dept Cellular Neurol, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; [Yang, Zhixiang; May, Patrick C.] Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery Res, Indianapolis, IN 46285 USA; [Karran, Eric] Lilly Res Ctr Ltd, Windlesham GU20 6PH, Surrey, England; [D'Hooge, Rudi] Katholieke Univ Leuven, Dept Psychol, Lab Biol Psychol, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University of Erlangen Nuremberg; University of Duisburg Essen; Philipps University Marburg; Harvard University; Massachusetts General Hospital; KU Leuven; KU Leuven; KU Leuven; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eli Lilly; Eli Lilly; KU Leuven	De Strooper, B (corresponding author), Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, Herestr 49, B-3000 Louvain, Belgium.	bart.destrooper@med.kuleuven.be	Cruz e Silva, Odete/AAH-5595-2020; De Strooper, Bart/F-6507-2012; de+Strooper, Bart/Z-1638-2019; Sprangers, Ben/T-6559-2017	De Strooper, Bart/0000-0001-5455-5819; Sprangers, Ben/0000-0003-1314-9675; Moons, Lieve (Godelieve)/0000-0003-0186-1411; Serneels, Lutgarde/0000-0002-5463-4231; Wiltfang, Jens/0000-0003-1492-5330; sciot, raf/0000-0003-2244-5839; Horre, Katrien/0000-0002-6801-3137	Alzheimers Association; Fund for Scientific Research Flanders; KULeuven (Geconcerteerde onderzoeksacties); Federal Office for Scientific Affairs, Belgium; Flemish Government [Methusalem]; MEMOSAD of the European Union [F2-2007-200611]; NIH [P01AG015379, R01AG026593, AG026593, AG 13579]; NATIONAL INSTITUTE ON AGING [P01AG015379, R01AG026593] Funding Source: NIH RePORTER	Alzheimers Association(Alzheimer's Association); Fund for Scientific Research Flanders(FWO); KULeuven (Geconcerteerde onderzoeksacties)(KU Leuven); Federal Office for Scientific Affairs, Belgium; Flemish Government(European Commission); MEMOSAD of the European Union; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Peeters for assistance in pathological evaluations, C. Mathieu for FACS analysis, L. Van Aerschot for assistance with behavioral testing, S. Terclavers and H. Schieb for technical assistance, and A. Thathiah for proofreading the manuscript. This work was supported by a Pioneer award from the Alzheimers Association; the Fund for Scientific Research Flanders (to R.D. and B.D.S.); KULeuven (Geconcerteerde onderzoeksacties); Federal Office for Scientific Affairs, Belgium; a Methusalem grant of the Flemish Government; MEMOSAD (F2-2007-200611) of the European Union; and NIH grants P01AG015379, R01AG026593, and AG026593 (to B.T.H.) and NIH AG 13579 (to B.T.H. and O.B.). B.D.S. is a paid consultant for Eli Lilly and Envivo Pharmaceuticals; B.T.H. is a paid consultant for Elan, Genentech, Pfizer, Takeda, Link, and Neurophage.	Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Choi SH, 2007, J NEUROSCI, V27, P13579, DOI 10.1523/JNEUROSCI.4821-07.2007; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dejaegere T, 2008, P NATL ACAD SCI USA, V105, P9775, DOI 10.1073/pnas.0800507105; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hebert SS, 2004, NEUROBIOL DIS, V17, P260, DOI 10.1016/j.nbd.2004.08.002; Hollingworth P, 2006, J AM GERIATR SOC, V54, P1348, DOI 10.1111/j.1532-5415.2006.00854.x; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Kawai T, 2005, NEUROSCI LETT, V380, P17, DOI 10.1016/j.neulet.2005.01.005; King DL, 2002, PHYSIOL BEHAV, V75, P627, DOI 10.1016/S0031-9384(02)00639-X; Li T, 2007, J NEUROSCI, V27, P10849, DOI 10.1523/JNEUROSCI.2152-07.2007; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005; Pugh PL, 2007, BEHAV BRAIN RES, V178, P18, DOI 10.1016/j.bbr.2006.11.044; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Sivere JT, 2008, GASTROENTEROLOGY, V134, P544, DOI 10.1053/j.gastro.2007.11.003; Tournoy J, 2004, HUM MOL GENET, V13, P1321, DOI 10.1093/hmg/ddh151; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200	24	195	210	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					639	642		10.1126/science.1171176	http://dx.doi.org/10.1126/science.1171176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19299585	Green Accepted			2022-12-28	WOS:000265608800043
J	Kitahata, MM; Gange, SJ; Abraham, AG; Merriman, B; Saag, MS; Justice, AC; Hogg, RS; Deeks, SG; Eron, JJ; Brooks, JT; Rourke, SB; Gill, MJ; Bosch, RJ; Martin, JN; Klein, MB; Jacobson, LP; Rodriguez, B; Sterling, TR; Kirk, GD; Napravnik, S; Rachlis, AR; Calzavara, LM; Horberg, MA; Silverberg, MJ; Gebo, KA; Goedert, JJ; Benson, CA; Collier, AC; Van Rompaey, SE; Crane, HM; McKaig, RG; Lau, B; Freeman, AM; Moore, RD				Kitahata, Mari M.; Gange, Stephen J.; Abraham, Alison G.; Merriman, Barry; Saag, Michael S.; Justice, Amy C.; Hogg, Robert S.; Deeks, Steven G.; Eron, Joseph J.; Brooks, John T.; Rourke, Sean B.; Gill, M. John; Bosch, Ronald J.; Martin, Jeffrey N.; Klein, Marina B.; Jacobson, Lisa P.; Rodriguez, Benigno; Sterling, Timothy R.; Kirk, Gregory D.; Napravnik, Sonia; Rachlis, Anita R.; Calzavara, Liviana M.; Horberg, Michael A.; Silverberg, Michael J.; Gebo, Kelly A.; Goedert, James J.; Benson, Constance A.; Collier, Ann C.; Van Rompaey, Stephen E.; Crane, Heidi M.; McKaig, Rosemary G.; Lau, Bryan; Freeman, Aimee M.; Moore, Richard D.		NA-ACCORD Investigators	Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4 CELL COUNT; DISEASE PROGRESSION; INFECTED PATIENTS; BASE-LINE; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; LYMPHOCYTE COUNTS; VIRAL LOAD; AIDS	BACKGROUND The optimal time for the initiation of antiretroviral therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection is uncertain. METHODS We conducted two parallel analyses involving a total of 17,517 asymptomatic patients with HIV infection in the United States and Canada who received medical care during the period from 1996 through 2005. None of the patients had undergone previous antiretroviral therapy. In each group, we stratified the patients according to the CD4+ count (351 to 500 cells per cubic millimeter or >500 cells per cubic millimeter) at the initiation of antiretroviral therapy. In each group, we compared the relative risk of death for patients who initiated therapy when the CD4+ count was above each of the two thresholds of interest (early-therapy group) with that of patients who deferred therapy until the CD4+ count fell below these thresholds (deferred-therapy group). RESULTS In the first analysis, which involved 8362 patients, 2084 (25%) initiated therapy at a CD4+ count of 351 to 500 cells per cubic millimeter, and 6278 (75%) deferred therapy. After adjustment for calendar year, cohort of patients, and demographic and clinical characteristics, among patients in the deferred-therapy group there was an increase in the risk of death of 69%, as compared with that in the early-therapy group (relative risk in the deferred-therapy group, 1.69; 95% confidence interval [CI], 1.26 to 2.26; P<0.001). In the second analysis involving 9155 patients, 2220 (24%) initiated therapy at a CD4+ count of more than 500 cells per cubic millimeter and 6935 (76%) deferred therapy. Among patients in the deferred-therapy group, there was an increase in the risk of death of 94% (relative risk, 1.94; 95% CI, 1.37 to 2.79; P<0.001). CONCLUSIONS The early initiation of antiretroviral therapy before the CD4+ count fell below two prespecified thresholds significantly improved survival, as compared with deferred therapy.	[Kitahata, Mari M.] Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA; [Gange, Stephen J.; Abraham, Alison G.; Merriman, Barry; Jacobson, Lisa P.; Kirk, Gregory D.; Gebo, Kelly A.; Lau, Bryan; Freeman, Aimee M.; Moore, Richard D.] Johns Hopkins Univ, Baltimore, MD USA; [Saag, Michael S.] Univ Alabama Birmingham, Birmingham, AL USA; [Justice, Amy C.] Yale Univ, New Haven, CT USA; [Justice, Amy C.] Vet Affairs Connecticut Healthcare Syst, New Haven, CT USA; [Hogg, Robert S.] British Columbia Ctr Excellence & HIV AIDS, Vancouver, BC, Canada; [Hogg, Robert S.] Simon Fraser Univ, Vancouver, BC, Canada; [Deeks, Steven G.; Martin, Jeffrey N.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Eron, Joseph J.; Napravnik, Sonia] Univ N Carolina, Chapel Hill, NC USA; [Brooks, John T.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Rourke, Sean B.; Rachlis, Anita R.; Calzavara, Liviana M.] Univ Toronto, Toronto, ON, Canada; [Gill, M. John] Univ Calgary, Calgary, AB, Canada; [Bosch, Ronald J.] Harvard Univ, Sch Med, Boston, MA USA; [Klein, Marina B.] McGill Univ, Montreal, PQ, Canada; [Rodriguez, Benigno] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Sterling, Timothy R.] Vanderbilt Univ, Nashville, TN USA; [Horberg, Michael A.; Silverberg, Michael J.] Kaiser Permanente No Calif, Oakland, CA USA; [Goedert, James J.; McKaig, Rosemary G.] NIH, Bethesda, MD 20892 USA; [Benson, Constance A.] Univ Calif San Diego, San Diego, CA 92103 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; Centers for Disease Control & Prevention - USA; University of Toronto; University of Calgary; Harvard University; Harvard Medical School; McGill University; Case Western Reserve University; Vanderbilt University; Kaiser Permanente; National Institutes of Health (NIH) - USA; University of California System; University of California San Diego	Kitahata, MM (corresponding author), Univ Washington, Harborview Med Ctr, 325 9th Ave,Box 359931, Seattle, WA 98104 USA.	kitahata@u.washington.edu	Rodriguez, Benigno/C-3365-2009; Gange, Stephen/AGY-5004-2022; Montaner, Julio/K-7621-2012; Hogg, Robert S/B-2783-2012; Gebo, Kelly/AHA-7533-2022; Dodsley, Maria/G-7083-2016; Gill, Michael John/G-7083-2016	Rodriguez, Benigno/0000-0001-9736-7957; Gange, Stephen/0000-0001-7842-512X; Hogg, Robert S/0000-0003-3463-5488; Gebo, Kelly/0000-0003-4010-398X; Dodsley, Maria/0000-0001-7587-558X; Gill, Michael John/0000-0002-8546-8790; Jacobson, Lisa P./0000-0003-1722-6826; Klein, Marina/0000-0002-3063-8430; Freeman, Aimee/0000-0003-1346-3365	National Institutes of Health; Agency for Healthcare Research and Quality; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIACP010176] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052, UL1RR025747, UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI042590, P30AI027767, P30AI027757, U01AI069434, U01AI068634, U01AI068636, U01AI034994, U01AI035039, P30AI054999, U01AI035043, U01AI034993, U01AI069432, K01AI071754, U01AI069918, K01AI071725, U01AI035042, K23AI060464, U01AI035041, P30AI050410, U01AI038855, U01AI034989, U01AI038858, U01AI035004, U01AI035040, R24AI067039, U01AI031834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA013566, R01AA016893, R21AA015032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004334, R01DA011602, R01DA012568, R56DA004334, K24DA000432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by grants from the National Institutes of Health and from the Agency for Healthcare Research and Quality.	Ahdieh-Grant L, 2003, AM J EPIDEMIOL, V157, P738, DOI 10.1093/aje/kwg036; *AIDSINFO, 2008, GUID US ANT AG HIV 1; Anastos K, 2002, ARCH INTERN MED, V162, P1973, DOI 10.1001/archinte.162.17.1973; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; Bozzette SA, 2003, NEW ENGL J MED, V348, P702, DOI 10.1056/NEJMoa022048; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Carpenter CCJ, 1996, JAMA-J AM MED ASSOC, V276, P146, DOI 10.1001/jama.276.2.146; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Cole SR, 2004, STAT MED, V23, P3351, DOI 10.1002/sim.1579; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Egger M, 2006, J INFECT DIS, V194, P612, DOI 10.1086/506362; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Florence E, 2003, HIV Med, V4, P255, DOI 10.1046/j.1468-1293.2003.00156.x; Frisch M, 2001, JAMA-J AM MED ASSOC, V285, P1736, DOI 10.1001/jama.285.13.1736; Gange SJ, 2007, INT J EPIDEMIOL, V36, P294, DOI 10.1093/ije/dyl286; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gras L, 2007, JAIDS-J ACQ IMM DEF, V45, P183, DOI 10.1097/QAI.0b013e31804d685b; Greub G, 2001, LANCET, V357, P1536; Gulick RM, 2006, CLIN INFECT DIS, V43, P942, DOI 10.1086/507549; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hernan MA, 2006, BASIC CLIN PHARMACOL, V98, P237, DOI 10.1111/j.1742-7843.2006.pto_329.x; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Hughes MD, 2008, J INFECT DIS, V197, P1084, DOI 10.1086/586712; Jaen A, 2008, JAIDS-J ACQ IMM DEF, V47, P212, DOI 10.1097/QAI.0b013e31815ee282; Kaplan JE, 2003, CLIN INFECT DIS, V37, P951, DOI 10.1086/377606; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; King MS, 2004, J INFECT DIS, V190, P280, DOI 10.1086/422037; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lane HC, 2003, ANN INTERN MED, V138, P680, DOI 10.7326/0003-4819-138-8-200304150-00018; Lange CG, 2003, AIDS, V17, P2015, DOI 10.1097/00002030-200309260-00002; Lau B, 2007, JAIDS-J ACQ IMM DEF, V44, P179, DOI 10.1097/01.qai.0000247229.68246.c5; Lepri AC, 2001, AIDS, V15, P983, DOI 10.1097/00002030-200105250-00006; Lichtenstein KA, 2008, JAIDS-J ACQ IMM DEF, V47, P27, DOI 10.1097/QAI.0b013e31815acacc; May M, 2005, J CLIN EPIDEMIOL, V58, P1033, DOI 10.1016/j.jclinepi.2005.02.015; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; May MT, 2006, LANCET, V368, P451, DOI 10.1016/S0140-6736(06)69152-6; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Opravil M, 2002, AIDS, V16, P1371, DOI 10.1097/00002030-200207050-00009; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Paterson DL, 2002, ANN INTERN MED, V136, P253, DOI 10.7326/0003-4819-136-3-200202050-00020; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Phillips AN, 2003, AIDS, V17, P1863, DOI 10.1097/00002030-200309050-00004; Phillips AN, 2007, AIDS, V21, P1717; Richman DD, 2004, AIDS, V18, P1393, DOI 10.1097/01.aids.0000131310.52526.c7; Robins J, 2008, STAT MED, V27, P4678, DOI 10.1002/sim.3301; Rosenbaum P. R., 2002, OBSERVATIONAL STUDIE; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Smit C, 2006, AIDS, V20, P741, DOI 10.1097/01.aids.0000216375.99560.a2; Sterling TR, 2003, CLIN INFECT DIS, V36, P812, DOI 10.1086/367934; Sterling TR, 2001, AIDS, V15, P2251, DOI 10.1097/00002030-200111230-00006; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; van Sighem AI, 2003, AIDS, V17, P2227, DOI 10.1097/00002030-200310170-00011; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Weis N, 2006, CLIN INFECT DIS, V42, P1481, DOI 10.1086/503569	62	828	879	0	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2009	360	18					1815	1826		10.1056/NEJMoa0807252	http://dx.doi.org/10.1056/NEJMoa0807252			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	438MU	19339714	Green Accepted, Green Submitted			2022-12-28	WOS:000265560300004
J	Tobalske, BW				Tobalske, Bret W.			Symmetry in Turns	SCIENCE			English	Editorial Material							MANEUVERING FLIGHT; KINEMATICS; MANEUVERABILITY; DROSOPHILA		Univ Montana, Field Res Stn Ft Missoula, Div Biol Sci, Missoula, MT 59812 USA	University of Montana System; University of Montana	Tobalske, BW (corresponding author), Univ Montana, Field Res Stn Ft Missoula, Div Biol Sci, Missoula, MT 59812 USA.	bret.tobalske@mso.umt.edu						Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Full RJ, 2002, INTEGR COMP BIOL, V42, P149, DOI 10.1093/icb/42.1.149; Hedrick TL, 2007, J EXP BIOL, V210, P1897, DOI 10.1242/jeb.002055; Hedrick TL, 2009, SCIENCE, V324, P252, DOI 10.1126/science.1168431; Iriarte-Diaz J, 2008, J EXP BIOL, V211, P3478, DOI 10.1242/jeb.017590; Lehmann FO, 2001, J EXP BIOL, V204, P627; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; Riskin DK, 2008, J THEOR BIOL, V254, P604, DOI 10.1016/j.jtbi.2008.06.011; Tobalske BW, 2007, J EXP BIOL, V210, P2368, DOI 10.1242/jeb.005686; Vogel S., 1994, LIFE MOVING FLUIDS P; Warrick DR, 2002, INTEGR COMP BIOL, V42, P141, DOI 10.1093/icb/42.1.141; Zufferey J.-C., 2008, BIOINSPIRED FLYING R	12	1	1	2	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					190	191		10.1126/science.1172839	http://dx.doi.org/10.1126/science.1172839			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359571				2022-12-28	WOS:000265024400027
J	Ip, S; Lichtenstein, AH; Chung, M; Lau, J; Balk, EM				Ip, Stanley; Lichtenstein, Alice H.; Chung, Mei; Lau, Joseph; Balk, Ethan M.			Systematic Review: Association of Low-Density Lipoprotein Subfractions With Cardiovascular Outcomes	ANNALS OF INTERNAL MEDICINE			English	Review							CORONARY-ARTERY-DISEASE; MAGNETIC-RESONANCE-SPECTROSCOPY; HEART-DISEASE; PARTICLE-SIZE; ATHEROSCLEROSIS INTERVENTION; RISK-FACTORS; LDL; MEN; PROGRESSION; SUPPLEMENTATION	Background: Measures of low-density lipoprotein (LDL) subfractions have been proposed as an independent risk factor for cardiovascular disease. Purpose: To review published studies that reported relationships between LDL subfractions and cardiovascular outcomes. Data Sources: MEDLINE (1950 to 5 January 2009), CAB Abstracts (1973 to 30 June 2008), and Cochrane Central Register of Controlled Trials (2nd quarter of 2008), limited to English-language studies. Study Selection: 3 reviewers selected longitudinal studies with 10 or more participants that reported an association between LDL subfractions and incidence or severity of cardiovascular disease and in which plasma samples were collected before outcome determination. Data Extraction: Data were extracted from 24 studies. The 10 studies that used analytical methods available for clinical use (all of which used nuclear magnetic resonance) had full data extraction, including quality assessment (good, fair, or poor). All studies were extracted by 1 researcher and verified by another. Data Synthesis: All 24 studies, and the subset of 10 nuclear magnetic resonance studies, were heterogeneous in terms of the specific tests analyzed, analytical methods used, participants investigated, and outcomes measured. Higher LDL particle number was consistently associated with increased risk for cardiovascular disease, independent of other lipid measurements. Other LDL subfractions were generally not associated with cardiovascular disease after adjustment for cholesterol concentrations. No study evaluated the incremental value of LDL subfractions beyond traditional cardiovascular risk factors or their test performance. Limitation: Publication bias was a possibility. Conclusion: Higher LDL particle number has been associated with cardiovascular disease incidence, but studies have not determined whether any measures of LDL subfractions add incremental benefit to traditional risk factor assessment. Routine use of clinically available LDL subfraction tests to estimate cardiovascular disease risk is premature.	[Balk, Ethan M.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Tufts Evidence Based Practice Ctr, Boston, MA 02111 USA; Tufts Univ, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Balk, EM (corresponding author), Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Tufts Evidence Based Practice Ctr, Box 63,800 Washington St, Boston, MA 02111 USA.	ebalk@tuftsmedicalcenter.org	Balk, Ethan/AAJ-2547-2020		Agency for Healthcare Research and Quality; U.S. Department of Health and Human Services [290-02-0022]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054727] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); U.S. Department of Health and Human Services; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant Support: By the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, under contract 290-02-0022.	Agency for Healthcare Research and Quality, 2007, METH REF GUID EFF CO; Arsenault BJ, 2007, EUR HEART J, V28, P2770, DOI 10.1093/eurheartj/ehm390; Austin MA, 2000, AM J CARDIOL, V86, P412, DOI 10.1016/S0002-9149(00)00956-5; BALK E, 2008, LOW DENSITY LIPOPROT; Bazzano LA, 2006, JAMA-J AM MED ASSOC, V296, P2720, DOI 10.1001/jama.296.22.2720; Berneis KK, 2002, J LIPID RES, V43, P1363, DOI 10.1194/jlr.R200004-JLR200; Blake GJ, 2002, CIRCULATION, V106, P1930, DOI 10.1161/01.CIR.0000033222.75187.B9; Bleys J, 2006, AM J CLIN NUTR, V84, P880, DOI 10.1093/ajcn/84.4.880; Blumenthal RS, 2007, JAMA-J AM MED ASSOC, V297, P641, DOI 10.1001/jama.297.6.641; Brunzell JD, 2008, DIABETES CARE, V31, P811, DOI 10.2337/dc08-9018; Campbell DJ, 2007, EUR J CARDIOV PREV R, V14, P413, DOI 10.1097/HJR.0b013e328010f275; Campos H, 2001, JAMA-J AM MED ASSOC, V286, P1468, DOI 10.1001/jama.286.12.1468; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Chapman MJ, 1998, EUR HEART J, V19, pA24; CHUNG M, 2009, COMP METHODS LDL SUB; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cromwell WC, 2007, J CLIN LIPIDOL, V1, P583, DOI 10.1016/j.jacl.2007.10.001; De Bree A, 2002, PHARMACOL REV, V54, P599, DOI 10.1124/pr.54.4.599; El Harchaoui K, 2007, J AM COLL CARDIOL, V49, P547, DOI 10.1016/j.jacc.2006.09.043; Ensign W, 2006, CLIN CHEM, V52, P1722, DOI 10.1373/clinchem.2005.059949; Gardner CD, 1996, JAMA-J AM MED ASSOC, V276, P875, DOI 10.1001/jama.276.11.875; Howard BV, 2000, ARTERIOSCL THROM VAS, V20, P830, DOI 10.1161/01.ATV.20.3.830; Hsia J, 2008, ARTERIOSCL THROM VAS, V28, P1666, DOI 10.1161/ATVBAHA.108.170431; KRAUSS RM, 1995, AM J CARDIOL, V75, pB53, DOI 10.1016/0002-9149(95)80012-H; Krauss RM, 2001, ANNU REV NUTR, V21, P283, DOI 10.1146/annurev.nutr.21.1.283; Kuller L, 2002, ARTERIOSCL THROM VAS, V22, P1175, DOI 10.1161/01.ATV.0000022015.97341.3A; Kuller LH, 2007, ATHEROSCLEROSIS, V195, P122, DOI 10.1016/j.atherosclerosis.2006.09.001; Mack WJ, 1996, ARTERIOSCL THROM VAS, V16, P697, DOI 10.1161/01.ATV.16.5.697; Miller BD, 1996, CIRCULATION, V94, P2146, DOI 10.1161/01.CIR.94.9.2146; Mykkanen L, 1999, ARTERIOSCL THROM VAS, V19, P2742, DOI 10.1161/01.ATV.19.11.2742; Otvos JD, 2006, CIRCULATION, V113, P1556, DOI 10.1161/CIRCULATIONAHA.105.565135; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Rosenson RS, 2002, AM J CARDIOL, V90, P89, DOI 10.1016/S0002-9149(02)02427-X; Ruotolo G, 1998, J AM COLL CARDIOL, V32, P1648, DOI 10.1016/S0735-1097(98)00442-2; Smith GD, 2005, LANCET, V366, P1679, DOI 10.1016/S0140-6736(05)67676-3; Soedamah-Muthu SS, 2003, DIABETOLOGIA, V46, P674, DOI 10.1007/s00125-003-1094-8; St-Pierre AC, 2005, ARTERIOSCL THROM VAS, V25, P553, DOI 10.1161/01.ATV.0000154144.73236.f4; Stampfer MJ, 1996, JAMA-J AM MED ASSOC, V276, P882, DOI 10.1001/jama.276.11.882; Vakkilainen J, 2003, CIRCULATION, V107, P1733, DOI 10.1161/01.CIR.0000057982.50167.6E; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; WATTS GF, 1993, METABOLISM, V42, P1461, DOI 10.1016/0026-0495(93)90199-X; Zhao Xue-Qiao, 2003, Med Sci Monit, V9, pCR48	43	108	111	1	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2009	150	7					474	+		10.7326/0003-4819-150-7-200904070-00007	http://dx.doi.org/10.7326/0003-4819-150-7-200904070-00007			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432EZ	19349632	Green Accepted			2022-12-28	WOS:000265117600005
J	Dallek, R				Dallek, Robert			All the President's scholarly men	NATURE			English	Editorial Material									Univ Calif Los Angeles, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Dallek, R (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.	rdallek@aol.com						Bird Kai., 2005, AM PROMETHEUS TRIUMP; Burns James MacGregor, 1956, ROOSEVELT LION FOX; Dallek Robert, 1998, FLAWED GIANT L JOHNS; Dallek Robert, 2007, NIXON KISSINGER PART; Dallek Robert, 2003, JF KENNEDY UNFINISHE; Goldstein Gordon M., 2008, LESSONS DISASTER M B; McNamara Robert, 1995, RETROSPECT TRAGEDY L	7	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 2	2009	458	7238					572	573		10.1038/458572a	http://dx.doi.org/10.1038/458572a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427RK	19340062	Bronze			2022-12-28	WOS:000264796200020
J	Ermers, MJJ; Rovers, MM; van Woensel, JB; Kimpen, JLL; Bont, LJ				Ermers, Marieke J. J.; Rovers, Maroeska M.; van Woensel, Job B.; Kimpen, Jan L. L.; Bont, Louis J.		RSV Corticosteroid Study Grp	The effect of high dose inhaled corticosteroids on wheeze in infants after respiratory syncytial virus infection: randomised double blind placebo controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE BRONCHIOLITIS; PRESCHOOL-CHILDREN; TRACT INFECTION; ASTHMA; DEXAMETHASONE; BUDESONIDE; MANAGEMENT; MONTELUKAST; PREVENTION; THERAPY	Objective To determine whether early initiated anti-inflammatory therapy with prolonged high dose inhaled glucocorticoids influences the occurrence and severity of recurrent wheeze after respiratory syncytial virus related lower respiratory tract infections. Design Randomised double blind placebo controlled trial. Setting Paediatric departments of 19 Dutch clinical centres. Participants 243 previously healthy infants (126 boys, 117 girls) aged less than 13 months and admitted to hospital with respiratory syncytial virus infection. Interventions 200 mu g extra fine hydrofluoroalkane (HFA) beclometasone dipropionate twice daily or matched placebo administered by a pressurised metered dose inhaler and a spacer during the first three months after hospital admission. Main outcome measure The primary outcome was the number of days with wheeze in the year after the three month intervention period. Results Of the 243 eligible infants, 119 were randomised to receive beclometasone and 124 to receive placebo. No significant difference was found in the number of days with wheeze between the two groups (total days, 1761/33 568 in the beclometasone group v 2301/36 556 in the placebo group, P=0.31) and the proportion of infants with wheeze did not differ between the groups (61% in the beclometasone group v 62% in the placebo group, P=0.90). In the predefined subgroup of infants who did not need mechanical ventilation (n=221), beclometasone reduced the number of days with wheeze by 32% (relative reduction in total days, 1315/30 405 in the beclometasone group v 2120/33 149 in the placebo group, P=0.046). This reduction was most pronounced during the first six months of the follow-up year after intervention. The proportion of infants with wheeze did not differ between the groups (59% in the beclometasone group v 60% in the placebo group, P=0.89). Conclusions Early initiated high dose extra fine HFA beclometasone to infants during the first three months after hospital admission for respiratory syncytial virus infection has no major effect on recurrent wheeze. The general use of such treatment during lower respiratory tract infection with respiratory syncytial virus should not be advocated. Trial registration Current Controlled Trials ISRCTN12352714.	[Kimpen, Jan L. L.; Bont, Louis J.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat Infect Dis, NL-3508 AB Utrecht, Netherlands; [Rovers, Maroeska M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 AB Utrecht, Netherlands; [van Woensel, Job B.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Paediat Intens Care, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Bont, LJ (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat Infect Dis, POB 85090, NL-3508 AB Utrecht, Netherlands.	l.bont@umcutrecht.nl	Rovers, Maroeska/F-2969-2014	Rovers, Maroeska/0000-0002-3095-170X	Dutch Asthma Foundation [3.2.03.22]	Dutch Asthma Foundation	This study was supported by a grant from the Dutch Asthma Foundation (No 3.2.03.22). No financial support was obtained from pharmaceutical companies. The study drugs and inhalers were provided unconditionally by the manufacturers.	Agertoft L, 2000, NEW ENGL J MED, V343, P1064, DOI 10.1056/NEJM200010123431502; Arets HGM, 2003, RESP MED, V97, P366, DOI 10.1053/rmed.2002.1452; Barben J, 2003, SWISS MED WKLY, V133, P9; Behrendt CE, 1998, EUR J PEDIATR, V157, P215, DOI 10.1007/s004310050798; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Bisgaard H, 2003, AM J RESP CRIT CARE, V167, P379, DOI 10.1164/rccm.200207-747OC; Bisgaard H, 2008, AM J RESP CRIT CARE, V178, P854, DOI 10.1164/rccm.200706-910OC; Blom D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004881.pub2; Bont L, 2000, AM J RESP CRIT CARE, V161, P1518, DOI 10.1164/ajrccm.161.5.9904078; Bont L, 2004, THORAX, V59, P512, DOI 10.1136/thx.2003.013391; Bont L, 2004, PEDIATR INFECT DIS J, V23, P414, DOI 10.1097/01.inf.0000122604.32137.29; Bont L, 2001, PEDIATR INFECT DIS J, V20, P277, DOI 10.1097/00006454-200103000-00012; Bont L, 2006, NEW ENGL J MED, V355, P624; Bulow SM, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e77; Bunge EM, 2005, ARCH DIS CHILD, V90, P351, DOI 10.1136/adc.2003.048645; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Cahill P, 2002, Ir Med J, V95, P167; CARLSEN K, 1988, ARCH DIS CHILD, V63, P1428, DOI 10.1136/adc.63.12.1428; Chauliac ES, 2006, PEDIATR PULM, V41, P829, DOI 10.1002/ppul.20450; Christakis DA, 2005, PEDIATRICS, V115, P878, DOI 10.1542/peds.2004-1299; Corneli HM, 2007, NEW ENGL J MED, V357, P331, DOI 10.1056/NEJMoa071255; De Boeck K, 1997, J PEDIATR-US, V131, P919, DOI 10.1016/S0022-3476(97)70044-1; Ermers MJJ, 2007, J ALLERGY CLIN IMMUN, V119, P1086, DOI 10.1016/j.jaci.2006.12.655; Fox GF, 1999, ARCH DIS CHILD, V80, P343, DOI 10.1136/adc.80.4.343; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Janssens HM, 2003, CHEST, V123, P2083, DOI 10.1378/chest.123.6.2083; Kajosaari M, 2000, PEDIATR ALLERGY IMMU, V11, P198, DOI 10.1034/j.1399-3038.2000.00068.x; Kamps AWA, 2000, PEDIATR PULM, V29, P39, DOI 10.1002/(SICI)1099-0496(200001)29:1<39::AID-PPUL7>3.0.CO;2-G; Kimpen JLL, 1997, PEDIATR INFECT DIS J, V16, P479, DOI 10.1097/00006454-199705000-00004; Kuehni CE, 2001, LANCET, V357, P1821, DOI 10.1016/S0140-6736(00)04958-8; Lehtinen P, 2007, J ALLERGY CLIN IMMUN, V119, P570, DOI 10.1016/j.jaci.2006.11.003; McKean M, 2000, Cochrane Database Syst Rev, pCD001107, DOI 10.1002/14651858.CD001107; Perez-Yarza EG, 2007, PEDIATR INFECT DIS J, V26, P733, DOI 10.1097/INF.0b013e3180618c42; Plint AC, 2004, ACAD EMERG MED, V11, P353, DOI 10.1197/j.aem.2003.12.003; Reijonen T, 1996, ARCH PEDIAT ADOL MED, V150, P512, DOI 10.1001/archpedi.1996.02170300066013; Richter H, 1998, J PEDIATR-US, V132, P849, DOI 10.1016/S0022-3476(98)70316-6; RIJCKEN B, 1992, TIJDSCHR SOC GEZONDH, V70, P259; Roosevelt G, 1996, LANCET, V348, P292, DOI 10.1016/S0140-6736(96)02285-4; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Stevens CA, 2003, EUR RESPIR J, V21, P1000, DOI 10.1183/09031936.03.00057002	42	47	48	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2009	338								b897	10.1136/bmj.b897	http://dx.doi.org/10.1136/bmj.b897			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429AL	19336497	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000264893100020
J	Kiatpongsan, S; Sipp, D				Kiatpongsan, Sorapop; Sipp, Douglas			Monitoring and Regulating Offshore Stem Cell Clinics	SCIENCE			English	Editorial Material									[Sipp, Douglas] RIKEN, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; [Kiatpongsan, Sorapop] Chulalongkorn Univ, Fac Med, Dept Obstet & Gynecol, Bangkok 10330, Thailand; [Kiatpongsan, Sorapop] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Vincent Obstet & Gynecol Serv,Vincent Ctr Reprod, Boston, MA 02114 USA; [Kiatpongsan, Sorapop] Harvard Univ, John F Kennedy Sch Govt, Sci Technol & Publ Policy Program, Sci Technol & Globalizat Project,Belfer Ctr Sci &, Cambridge, MA 02138 USA; [Sipp, Douglas] Kyoto Univ, Ctr iPS Res & Applicat, Inst Integrated Cell Mat Sci, Kyoto 6068501, Japan	RIKEN; Chulalongkorn University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Kyoto University	Sipp, D (corresponding author), RIKEN, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan.	sipp@cdb.riken.jp	Sipp, Doug/C-9218-2017; Kiatpongsan, Sorapop/ABG-7845-2021	Sipp, Doug/0000-0002-5979-0938; 				Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Arom Kitipan V, 2008, Asian Cardiovasc Thorac Ann, V16, P143; BOSELEY S, 2006, GUARDIAN        0501; DU J, 2005, STEM CELL MISSION CH; EBBIN M, 2007, BERMUDA SUN     0914; EINHORN B, 2005, BUSINESS WEEK   0110, P34; Enserink M, 2006, SCIENCE, V313, P160, DOI 10.1126/science.313.5784.160; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; *INT SOC STEM CELL, 2008, GUID CLIN TRANSL STE; *JUV DIAB RES FDN, PART CLIN TRIAL; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; ONO D, 2007, KABC TV NEWS; Porat Y, 2006, BRIT J HAEMATOL, V135, P703, DOI 10.1111/j.1365-2141.2006.06344.x; PRENTICE D, 2004, MONITORING STEM CELL; PRICE S, 2007, NATION NEWS BAR 1126; SIPP D, 2007, STEM CELL REPORT, V2, P62; STEELE J, 2007, VESCELL ADULT S 1219; *US FTC, FREQ ASK ADV QUEST G; Zarembo A., 2005, LOS ANGELES TIM 0220; 2008, ROYAL GAZETTE   0818; 2008, BANGKOK POST    0622	21	76	77	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 20	2009	323	5921					1564	1565		10.1126/science.1168451	http://dx.doi.org/10.1126/science.1168451			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299604				2022-12-28	WOS:000264342300022
J	Lee, KK; Hlatky, MA				Lee, Keane K.; Hlatky, Mark A.			Reynolds Risk Score for men predicted cardiovascular events more accurately than traditional risk factors only	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lee, Keane K.; Hlatky, Mark A.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Lee, KK (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.							Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251	1	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6							JC3-14	10.7326/0003-4819-150-6-200903170-02014	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-02014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423AJ	19306496				2022-12-28	WOS:000264468500036
J	Kirby, T				Kirby, Tony			Nicola Roxon: Australia's Minister for Health and Ageing	LANCET			English	Biographical-Item												tony.kirby@lancet.com							0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2009	373	9669					1073	1073		10.1016/S0140-6736(09)60637-1	http://dx.doi.org/10.1016/S0140-6736(09)60637-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427IS	19328990				2022-12-28	WOS:000264773600014
J	Spencer, SL; Gaudet, S; Albeck, JG; Burke, JM; Sorger, PK				Spencer, Sabrina L.; Gaudet, Suzanne; Albeck, John G.; Burke, John M.; Sorger, Peter K.			Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis	NATURE			English	Article							TUMOR-CELL; PROTEIN; ACTIVATION; NOISE; ROBUSTNESS; EXPRESSION; FAMILY; KILL	In microorganisms, noise in gene expression gives rise to cell-to-cell variability in protein concentrations(1-7). In mammalian cells, protein levels also vary(8-10) and individual cells differ widely in their responsiveness to uniform physiological stimuli(11-15). In the case of apoptosis mediated by TRAIL (tumour necrosis factor (TNF)related apoptosis-inducing ligand) it is common for some cells in a clonal population to die while others survive-a striking divergence in cell fate. Among cells that die, the time between TRAIL exposure and caspase activation is highly variable. Here we image sister cells expressing reporters of caspase activation and mitochondrial outer membrane permeabilization after exposure to TRAIL. We show that naturally occurring differences in the levels or states of proteins regulating receptor-mediated apoptosis are the primary causes of cell-to-cell variability in the timing and probability of death in human cell lines. Protein state is transmitted from mother to daughter, giving rise to transient heritability in fate, but protein synthesis promotes rapid divergence so that sister cells soon become no more similar to each other than pairs of cells chosen at random. Our results have implications for understanding 'fractional killing' of tumour cells after exposure to chemotherapy, and for variability in mammalian signal transduction in general.	[Spencer, Sabrina L.; Gaudet, Suzanne; Albeck, John G.; Burke, John M.; Sorger, Peter K.] Harvard Univ, Sch Med, Dept Syst Biol, Ctr Cell Decis Proc, Boston, MA 02115 USA; [Spencer, Sabrina L.] MIT, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Sorger, PK (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Ctr Cell Decis Proc, Boston, MA 02115 USA.	peter_sorger@hms.harvard.edu		Altan-Bonnet, Gregoire/0000-0002-7283-3162; SPENCER, SABRINA/0000-0002-5798-3007; Gaudet, Suzanne/0000-0002-5701-2825; Sorger, Peter/0000-0002-3364-1838	National Institute of Health [GM68762, CA112967]; NATIONAL CANCER INSTITUTE [U54CA112967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Flusberg, S. Govind, L. Kleiman, A. Letai, B. Millard, R. Milo, T. Norman, J. Paulsson and R. Ward for their help. This work was supported by National Institute of Health (NIH grants) GM68762 and CA112967.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BERENBAUM MC, 1972, CANCER CHEMOTH REP 1, V56, P563; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Goldstein JC, 2000, ANN NY ACAD SCI, V926, P132; Kaufmann BB, 2007, PLOS BIOL, V5, P1973, DOI 10.1371/journal.pbio.0050239; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	29	697	713	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					428	U144		10.1038/nature08012	http://dx.doi.org/10.1038/nature08012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19363473	Green Accepted			2022-12-28	WOS:000266243700046
J	Nurden, AT; Viallard, JF; Nurden, P				Nurden, Alan T.; Viallard, Jean-Francois; Nurden, Paquita			New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura	LANCET			English	Article							RECOMBINANT HUMAN THROMBOPOIETIN; CELL-DEPLETING THERAPY; BONE-MARROW; T-CELLS; MONOCLONAL-ANTIBODY; RECEPTOR; AMG-531; EFFICACY; AGONIST; SPLEEN	Idiopathic thrombocytopenic purpura is an acquired disease characterised by a low platelet count. Development of autoantibodies is a main cause of the disease. Although many patients have few symptoms, life-threatening bleeding can arise and hence, when platelet counts fall to unacceptable values treatment should be initiated. However, conventional immunosuppressive approaches can fail, perhaps because of the heterogeneous nature of the disease. Newly developed agents that increase platelet production by stimulating megakaryocytes-such as drugs that bind to the thrombopoietin receptor c-MPL-offer an alternative treatment strategy. Although initial thrombopoietin analogues caused adverse immune reactions, second-generation thrombopoietin-receptor agonists that are in late-stage clinical development seem promising. In particular, eltrombopag and romiplostim safely increase and maintain platelet production in patients with refractory disease. However, long-term side-effects are being assessed and the exact role of these agents in the overall treatment strategy of chronic idiopathic thrombocytopenic purpura remains to be established.	[Nurden, Alan T.; Nurden, Paquita] Hop Xavier Arnozan, French Natl Reference Ctr Platelet Disorders, F-33600 Pessac, France; [Viallard, Jean-Francois] Hop Haut Leveque, Serv Med Interne, Pessac, France	CHU Bordeaux; CHU Bordeaux	Nurden, AT (corresponding author), Hop Xavier Arnozan, French Natl Reference Ctr Platelet Disorders, F-33600 Pessac, France.	alan.nurden@cnrshl.u-bordeaux2.fr						Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Bahjat FR, 2008, ARTHRITIS RHEUM-US, V58, P1433, DOI 10.1002/art.23428; Baker JE, 2008, CARDIOVASC RES, V77, P44, DOI 10.1093/cvr/cvm026; BALLEM PJ, 1987, J CLIN INVEST, V80, P33, DOI 10.1172/JCI113060; Boruchov DM, 2007, BLOOD, V110, P3526, DOI 10.1182/blood-2007-01-065763; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; Broudy VC, 2004, CYTOKINE, V25, P52, DOI 10.1016/j.cyto.2003.05.001; Bussel JB, 2008, HAEMATOL-HEMATOL J, V93, P379; Bussel JB, 2008, HAEMATOL-HEMATOL J, V93, P125; Bussel JB, 2007, NEW ENGL J MED, V357, P2237, DOI 10.1056/NEJMoa073275; Bussel JB, 2006, NEW ENGL J MED, V355, P1672, DOI 10.1056/NEJMoa054626; Bussel JB, 2009, BLOOD, V113, P2161, DOI 10.1182/blood-2008-04-150078; Bussel JB, 2002, BLOOD REV, V16, P31, DOI 10.1054/blre.2001.0178; Chang M, 2003, BLOOD, V102, P887, DOI 10.1182/blood-2002-05-1475; Cines DB, 2007, CURR OPIN HEMATOL, V14, P511, DOI 10.1097/MOH.0b013e3282ba5552; Cooper N, 2004, BRIT J HAEMATOL, V125, P232, DOI 10.1111/j.1365-2141.2004.04889.x; Cooper N, 2004, BRIT J HAEMATOL, V124, P511, DOI 10.1111/j.1365-2141.2004.04804.x; Cwirla SE, 1997, SCIENCE, V276, P1696, DOI 10.1126/science.276.5319.1696; Deng BJ, 1998, BLOOD, V92, P1981, DOI 10.1182/blood.V92.6.1981.418k15_1981_1988; Desjardins RE, 2007, J SUPPORT ONCOL S2, V5, P68; Despujol CPD, 2008, BRIT J HAEMATOL, V142, P638, DOI 10.1111/j.1365-2141.2008.07228.x; Deutsch VR, 2006, BRIT J HAEMATOL, V134, P453, DOI 10.1111/j.1365-2141.2006.06215.x; Emilia G, 2002, BLOOD, V99, P1482, DOI 10.1182/blood.V99.4.1482; Erickson-Miller CL, 2005, EXP HEMATOL, V33, P85, DOI 10.1016/j.exphem.2004.09.006; Fogarty PF, 2007, CURR OPIN HEMATOL, V14, P515, DOI 10.1097/MOH.0b013e3282ab98c7; Frederickson S, 2006, P NATL ACAD SCI USA, V103, P14307, DOI 10.1073/pnas.0602658103; Fukushima-Shintani M, 2008, EXP HEMATOL, V36, P1337, DOI 10.1016/j.exphem.2008.04.020; George JN, 2006, J THROMB HAEMOST, V4, P1664, DOI 10.1111/j.1538-7836.2006.02013.x; George JN, 2009, BRIT J HAEMATOL, V144, P409, DOI 10.1111/j.1365-2141.2008.07464.x; George JN, 1996, BLOOD, V88, P3, DOI 10.1182/blood.V88.1.3.3; Godeau B, 2008, BLOOD, V112, P999, DOI 10.1182/blood-2008-01-131029; Godeau B, 2007, CURR OPIN HEMATOL, V14, P535, DOI 10.1097/MOH.0b013e3282b9748f; Harker LA, 2000, BLOOD, V95, P2514; Houwerzijl EJ, 2004, BLOOD, V103, P500, DOI 10.1182/blood-2003-01-0275; Inagaki K, 2004, BLOOD, V104, P58, DOI 10.1182/blood-2003-10-3623; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jenkins JM, 2007, BLOOD, V109, P4739, DOI 10.1182/blood-2006-11-057968; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kaushansky K, 2002, ONCOGENE, V21, P3359, DOI 10.1038/sj.onc.1205323; Kimura T, 1998, FEBS LETT, V428, P250, DOI 10.1016/S0014-5793(98)00536-5; Kobos R, 2008, CLIN LYMPHOMA MYELOM, V8, P33, DOI 10.3816/CLM.2008.n.002; Kojouri K, 2004, BLOOD, V104, P2623, DOI 10.1182/blood-2004-03-1168; Kumagai Y, 2007, J CLIN PHARMACOL, V47, P1489, DOI 10.1177/0091270007306563; Kuter DJ, 2008, LANCET, V371, P395, DOI 10.1016/S0140-6736(08)60203-2; Kuter DJ, 2007, BLOOD, V109, P4607, DOI 10.1182/blood-2006-10-019315; Kuter DJ, 2002, BLOOD, V100, P3457, DOI 10.1182/blood.V100.10.3457; Kuwana M, 2003, BLOOD, V101, P621, DOI 10.1182/blood-2002-07-2157; Kuwana M, 2002, J IMMUNOL, V168, P3675, DOI 10.4049/jimmunol.168.7.3675; Li JZ, 2001, BLOOD, V98, P3241, DOI 10.1182/blood.V98.12.3241; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; McHutchison JG, 2007, NEW ENGL J MED, V357, P2227, DOI 10.1056/NEJMoa073255; McIntosh B, 2008, EXP HEMATOL, V36, P799, DOI 10.1016/j.exphem.2008.02.012; Mueller BU, 2009, PEDIATR BLOOD CANCER, V52, P259, DOI 10.1002/pbc.21757; Nakamura T, 2006, BLOOD, V107, P4300, DOI 10.1182/blood-2005-11-4433; Newland A, 2006, BRIT J HAEMATOL, V135, P547, DOI 10.1111/j.1365-2141.2006.06339.x; Nogami W, 2008, HAEMATOL-HEMATOL J, V93, P1495, DOI 10.3324/haematol.12752; Nurden P, 2008, THROMB HAEMOSTASIS, V99, P253, DOI 10.1160/TH07-09-0568; Olsson B, 2003, NAT MED, V9, P1123, DOI 10.1038/nm921; Olsson B, 2008, BLOOD, V112, P1078, DOI 10.1182/blood-2008-02-139402; Orita T, 2005, BLOOD, V105, P562, DOI 10.1182/blood-2004-04-1482; Patel VL, 2008, BRIT J HAEMATOL, V141, P545, DOI 10.1111/j.1365-2141.2008.07039.x; Podolanczuk A, 2009, BLOOD, V113, P3154, DOI 10.1182/blood-2008-07-166439; Porcelijn L, 1998, THROMB HAEMOSTASIS, V79, P1101, DOI 10.1055/s-0037-1615023; Provan D, 2003, BRIT J HAEMATOL, V120, P574; Rioux JD, 2005, NATURE, V435, P584, DOI 10.1038/nature03723; Sarnoylenko A, 2008, CELL SIGNAL, V20, P154, DOI 10.1016/j.cellsig.2007.10.006; SEMPLE JW, 1991, BLOOD, V78, P2619; Siragam V, 2006, NAT MED, V12, P688, DOI 10.1038/nm1416; Solanilla A, 2005, BLOOD, V105, P215, DOI 10.1182/blood-2003-07-2367; Stasi R, 2008, BLOOD, V112, P1147, DOI 10.1182/blood-2007-12-129262; Stasi R, 2008, THROMB HAEMOSTASIS, V99, P4, DOI 10.1160/TH07-08-0513; Stasi R, 2007, BLOOD, V110, P2924, DOI 10.1182/blood-2007-02-068999; Stasi R, 2009, BLOOD, V113, P1231, DOI 10.1182/blood-2008-07-167155; Sungaran R, 1997, BLOOD, V89, P101, DOI 10.1182/blood.V89.1.101; Tarantino MD, 2007, CURR OPIN HEMATOL, V14, P526, DOI 10.1097/MOH.0b013e3282ab98df; Tiu RV, 2008, EXPERT OPIN BIOL TH, V8, P1021, DOI [10.1517/14712598.8.7.1021, 10.1517/14712598.8.7.1021 ]; Vadhan-Raj S, 2000, ANN INTERN MED, V132, P364, DOI 10.7326/0003-4819-132-5-200003070-00005; Wang B, 2004, CLIN PHARMACOL THER, V76, P628, DOI 10.1016/j.clpt.2004.08.010; Yamane A, 2008, BLOOD, V112, P542, DOI 10.1182/blood-2007-12-125906; Yu J, 2008, BLOOD, V112, P1325, DOI 10.1182/blood-2008-01-135335	80	45	53	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2009	373	9674					1562	1569		10.1016/S0140-6736(09)60255-5	http://dx.doi.org/10.1016/S0140-6736(09)60255-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440OT	19324405				2022-12-28	WOS:000265710300035
J	Heiman, MG; Shaham, S				Heiman, Maxwell G.; Shaham, Shai			DEX-1 and DYF-7 Establish Sensory Dendrite Length by Anchoring Dendritic Tips during Cell Migration	CELL			English	Article							NERVOUS-SYSTEM; C-ELEGANS; BASEMENT-MEMBRANE; ZONA-PELLUCIDA; EXPRESSION; PROTEIN; MECHANISMS; DOMAIN; MOUSE; GENE	Cells are devices whose structures delimit function. For example, in the nervous system, neuronal and glial shapes dictate paths of information flow. To understand how cells acquire their shapes, we examined the formation of a sense organ in C. elegans. Using time-lapse imaging, we found that sensory dendrites form by stationary anchoring of dendritic tips during cell-body migration. Agenetic screen identified DEX-1 and DYF-7, extracellular proteins required for dendritic tip anchoring, which act cooperatively at the time and place of anchoring. DEX-1 and DYF-7 contain, respectively, zonadhesin and zona pellucida domains, and DYF-7 self-associates into multimers important for anchoring. Thus, unlike other dendrites, amphid dendritic tips are positioned by DEX-1 and DYF-7 without the need for long-range guidance cues. In sequence and function, DEX-1 and DYF-7 resemble tectorins, which anchor stereocilia in the inner ear, suggesting that a sensory dendrite anchor may have evolved into part of a mechanosensor.	[Heiman, Maxwell G.; Shaham, Shai] Rockefeller Univ, New York, NY 10065 USA	Rockefeller University	Shaham, S (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	shaham@rockefeller.edu		Heiman, Maxwell/0000-0002-2557-6490	NIH [1R01NS064273]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064273] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Yun Lu for preparing the electron micrograph in Figure S1B; Valeri Thomson, the Rockefeller University Bio- Imaging Resource Center, and members of Ulrike Gaul's laboratory for technical help; Cori Bargmann, Alison North, and members of the Shaham laboratory for comments on the manuscript; and Myriam Heiman. M. G. H. was a fellow of the Jane Coffin Childs Memorial Fund for Medical Research. S. S. is a Klingenstein Fellow in the Neurosciences and a Monique Weill-Caulier Scholar. This work was supported in part by a grant from the Patterson Trust and by NIH grant 1R01NS064273 to S. S.	ALTMAN J, 1990, EXP NEUROL, V107, P23, DOI 10.1016/0014-4886(90)90060-6; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Benard CY, 2006, DEVELOPMENT, V133, P3329, DOI 10.1242/dev.02507; Bi M, 2003, BIOCHEM J, V375, P477, DOI 10.1042/BJ20030753; BRENNER S, 1974, GENETICS, V77, P71; Chen H, 1996, J STRUCT BIOL, V116, P56, DOI 10.1006/jsbi.1996.0010; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Di Schiavi E, 2005, EUR J NEUROSCI, V21, P3291, DOI 10.1111/j.1460-9568.2005.04164.x; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gao FB, 2007, CURR OPIN NEUROBIOL, V17, P525, DOI 10.1016/j.conb.2007.08.004; Gilmour D, 2004, NAT NEUROSCI, V7, P491, DOI 10.1038/nn1235; Halfter W, 2002, J NEUROSCI, V22, P6029; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; HARDY DM, 1995, J BIOL CHEM, V270, P26025, DOI 10.1074/jbc.270.44.26025; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Jovine Luca, 2006, BMC Biochem, V7, P11, DOI 10.1186/1471-2091-7-11; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; Kim S, 2000, SCIENCE, V288, P150, DOI 10.1126/science.288.5463.150; Landmann F, 2004, DEV BIOL, V265, P478, DOI 10.1016/j.ydbio.2003.09.009; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; LI XJ, 1995, J BIOL CHEM, V270, P17674, DOI 10.1074/jbc.270.30.17674; MANGO SE, 1994, DEVELOPMENT, V120, P3019; Matsushita F, 2000, BIOCHEM BIOPH RES CO, V268, P275, DOI 10.1006/bbrc.2000.2104; Monne M, 2008, NATURE, V456, P653, DOI 10.1038/nature07599; Nguyen CQ, 1999, DEV BIOL, V207, P86, DOI 10.1006/dbio.1998.9173; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Paley W., 1803, NATURAL THEOLOGY EVI; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Russell IJ, 2007, NAT NEUROSCI, V10, P215, DOI 10.1038/nn1828; Shaham S, 2006, CURR OPIN NEUROBIOL, V16, P522, DOI 10.1016/j.conb.2006.08.001; Solecki DJ, 2006, GENE DEV, V20, P2639, DOI 10.1101/gad.1462506; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; STARICH TA, 1995, GENETICS, V139, P171; Stiernagle Theresa, 2006, WormBook, P1; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Williams DW, 2004, J NEUROSCI, V24, P1541, DOI 10.1523/JNEUROSCI.4521-03.2004; Wu GY, 2003, J COMP NEUROL, V459, P392, DOI 10.1002/cne.10618; Yaron A, 2007, DEV NEUROBIOL, V67, P1216, DOI 10.1002/dneu.20512; Yu RYL, 2000, EMBO J, V19, P3542, DOI 10.1093/emboj/19.14.3542; Zallen JA, 1999, DEVELOPMENT, V126, P3679	51	113	118	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					344	355		10.1016/j.cell.2009.01.057	http://dx.doi.org/10.1016/j.cell.2009.01.057			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19344940	Green Accepted, Bronze			2022-12-28	WOS:000265456800026
J	Krum, H; Schlaich, M; Whitbourn, R; Sobotka, PA; Sadowski, J; Bartus, K; Kapelak, B; Walton, A; Sievert, H; Thambar, S; Abraham, WT; Esler, M				Krum, Henry; Schlaich, Markus; Whitbourn, Rob; Sobotka, Paul A.; Sadowski, Jerzy; Bartus, Krzysztof; Kapelak, Boguslaw; Walton, Anthony; Sievert, Horst; Thambar, Suku; Abraham, William T.; Esler, Murray			Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study	LANCET			English	Article							NERVOUS-SYSTEM; NEURAL-CONTROL; PREVENTS; AFFERENT; KIDNEY	Background Renal sympathetic hyperactivity is associated with hypertension and its progression, chronic kidney disease, and heart failure. We did a proof-of-principle trial of therapeutic renal sympathetic denervation in patients with resistant hypertension (ie, systolic blood pressure >= 160 mm Hg on three or more antihypertensive medications, including a diuretic) to assess safety and blood-pressure reduction effectiveness. Methods We enrolled 50 patients at five Australian and European centres; 5 patients were excluded for anatomical reasons (mainly on the basis of dual renal artery systems). Patients received percutaneous radiofrequency catheter-based treatment between June, 2007, and November, 2008, with subsequent follow-up to 1 year. We assessed the effectiveness of renal sympathetic denervation with renal noradrenaline spillover in a subgroup of patients. Primary endpoints were office blood pressure and safety data before and at 1, 3, 6, 9, and 12 months after procedure. Renal angiography was done before, immediately after, and 14-30 days after procedure, and magnetic resonance angiogram 6 months after procedure. We assessed blood-pressure lowering effectiveness by repeated measures ANOVA. This study is registered in Australia and Europe with ClinicalTrials.gov, numbers NCT 00483808 and NCT 00664638. Findings In treated patients, baseline mean office blood pressure was 177/101 mm Hg (SD 20/15), (mean 4.7 antihypertensive medications); estimated glomerular filtration rate was 81 mL/min/1.73m(2) (S D 23); and mean reduction in renal noradrenaline spillover was 47% (95% CI 28-65%). Office blood pressures after procedure were reduced by -14/-10, -21/-10, -22/-11, -24/-11, and -27/-17 mm Hg at 1, 3, 6, 9, and 12 months, respectively. In the five non-treated patients, mean rise in office blood pressure was +3/-2, +2/+3, +14/+9, and +26/+17 mm Hg at 1, 3, 6, and 9 months, respectively. One intraprocedural renal artery dissection occurred before radiofrequency energy delivery, without further sequelae. There were no other renovascular complications. Interpretation Catheter-based renal denervation causes substantial and sustained blood-pressure reduction, without serious adverse events, in patients with resistant hypertension. Prospective randomised clinical trials are needed to investigate the usefulness of this procedure in the management of this condition.	[Krum, Henry] Monash Univ, Ctr Cardiovasc Res & Educ Therapeut, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Schlaich, Markus; Esler, Murray] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Whitbourn, Rob] St Vincents Hosp, Melbourne, Vic, Australia; [Sobotka, Paul A.] Ardian Inc, Palo Alto, CA USA; [Sobotka, Paul A.; Abraham, William T.] Ohio State Univ, Columbus, OH 43210 USA; [Sadowski, Jerzy; Bartus, Krzysztof; Kapelak, Boguslaw] Jagiellonian Univ, Krakow, Poland; [Krum, Henry; Walton, Anthony] Alfred Hosp, Melbourne, Vic, Australia; [Sievert, Horst] Cardiovasc Ctr Frankfurt, Frankfurt, Germany; [Thambar, Suku] John Hunter Hosp, Newcastle, NSW, Australia	Monash University; Baker Heart and Diabetes Institute; St Vincent's Hospital Melbourne; University System of Ohio; Ohio State University; Jagiellonian University; Florey Institute of Neuroscience & Mental Health; Cardiovascular Center (CVC) Frankfurt; John Hunter Hospital	Krum, H (corresponding author), Monash Univ, Alfred Hosp, Ctr Cardiovasc Res & Educ Therapeut, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.	henry.krum@med.monash.edu.au	Schlaich, Markus P/E-7468-2010; Bartus, Krzysztof/AAR-3822-2021	Bartus, Krzysztof/0000-0002-3457-6978; Schlaich, Markus/0000-0002-1765-0195; Thambar, Suku/0000-0002-0801-7021				Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; CAMPESE VM, 1995, AM J KIDNEY DIS, V26, P861, DOI 10.1016/0272-6386(95)90456-5; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; DiBona GF, 2003, HYPERTENSION, V41, P621, DOI 10.1161/01.HYP.0000047205.52509.8A; DiBona GF, 2002, CURR OPIN NEPHROL HY, V11, P197, DOI 10.1097/00041552-200203000-00011; DIBONA GF, 1987, ARTIF ORGANS, V11, P457, DOI 10.1111/j.1525-1594.1987.tb02710.x; DiBona GF, 1997, PHYSIOL REV, V77, P75, DOI 10.1152/physrev.1997.77.1.75; ESLER M, 1988, HYPERTENSION, V11, P3, DOI 10.1161/01.HYP.11.1.3; EVELYN KA, 1960, AM J MED, V28, P188, DOI 10.1016/0002-9343(60)90184-4; Fagius J, 2003, ACTA PHYSIOL SCAND, V177, P337, DOI 10.1046/j.1365-201X.2003.01086.x; Grassi G, 2008, HYPERTENSION, V52, P925, DOI 10.1161/HYPERTENSIONAHA.108.116368; Hausberg M, 2002, CIRCULATION, V106, P1974, DOI 10.1161/01.CIR.0000034043.16664.96; Joles JA, 2004, HYPERTENSION, V43, P699, DOI 10.1161/01.HYP.0000121881.77212.b1; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LJOYDJONES D, 2009, CIRCULATION, V119, P480; Luippold G, 2004, NEPHROL DIAL TRANSPL, V19, P342, DOI 10.1093/ndt/gfg584; MORRISSEY DM, 1953, LANCET, V264, P403; OBRIEN E, 1988, LANCET, V2, P397; Sarafidis PA, 2008, J AM COLL CARDIOL, V52, P1749, DOI 10.1016/j.jacc.2008.08.036; Schlaich MP, 2004, HYPERTENSION, V43, P169, DOI 10.1161/01.HYP.0000103160.35395.9E; SCHLAICH MP, 2009, J AM SOC NE IN PRESS; SMITHWICK RH, 1953, JAMA-J AM MED ASSOC, V152, P1501, DOI 10.1001/jama.1953.03690160001001; Ye SH, 2002, AM J HYPERTENS, V15, P717, DOI 10.1016/S0895-7061(02)02959-X	25	1546	1879	4	144	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2009	373	9671					1275	1281		10.1016/S0140-6736(09)60566-3	http://dx.doi.org/10.1016/S0140-6736(09)60566-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432PN	19332353				2022-12-28	WOS:000265146300030
J	Lichtenbelt, WDV; Vanhommerig, JW; Smulders, NM; Drossaerts, JMAFL; Kemerink, GJ; Bouvy, ND; Schrauwen, P; Teule, GJJ				Lichtenbelt, Wouter D. van Marken; Vanhommerig, Joost W.; Smulders, Nanda M.; Drossaerts, Jamie M. A. F. L.; Kemerink, Gerrit J.; Bouvy, Nicole D.; Schrauwen, Patrick; Teule, G. J. Jaap			Cold-Activated Brown Adipose Tissue in Healthy Men.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UPPER CHEST REGION; F-18-FDG PET/CT; ADAPTIVE THERMOGENESIS; ENERGY-EXPENDITURE; SKELETAL-MUSCLE; USA-FAT; TEMPERATURE; HUMANS; RESPONSES; PRDM16	Background: Studies in animals indicate that brown adipose tissue is important in the regulation of body weight, and it is possible that individual variation in adaptive thermogenesis can be attributed to variations in the amount or activity of brown adipose tissue. Until recently, the presence of brown adipose tissue was thought to be relevant only in small mammals and infants, with negligible physiologic relevance in adult humans. We performed a systematic examination of the presence, distribution, and activity of brown adipose tissue in lean and obese men during exposure to cold temperature. Brown-adipose-tissue activity was studied in relation to body composition and energy metabolism. Methods: We studied 24 healthy men -- 10 who were lean (body-mass index [BMI] [the weight in kilograms divided by the square of the height in meters], <25) and 14 who were overweight or obese (BMI, greater/equal 25) -- under thermoneutral conditions (22 degreesC) and during mild cold exposure (16 degreesC). Putative brown-adipose-tissue activity was determined with the use of integrated (sup 18)F-fluorodeoxyglucose positron-emission tomography and computed tomography. Body composition and energy expenditure were measured with the use of dual-energy x-ray absorptiometry and indirect calorimetry. Results: Brown-adipose-tissue activity was observed in 23 of the 24 subjects (96%) during cold exposure but not under thermoneutral conditions. The activity was significantly lower in the overweight or obese subjects than in the lean subjects (P=0.007). BMI and percentage of body fat both had significant negative correlations with brown adipose tissue, whereas resting metabolic rate had a significant positive correlation. Conclusions: The percentage of young men with brown adipose tissue is high, but its activity is reduced in men who are overweight or obese. Brown adipose tissue may be metabolically important in men, and the fact that it is reduced yet present in most overweight or obese subjects may make it a target for the treatment of obesity. N Engl J Med 2009;360:1500-8.	[Lichtenbelt, Wouter D. van Marken; Vanhommerig, Joost W.; Drossaerts, Jamie M. A. F. L.; Schrauwen, Patrick] Maastricht Univ, Dept Human Biol, Med Ctr, Nutr & Toxicol Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Smulders, Nanda M.; Kemerink, Gerrit J.; Teule, G. J. Jaap] Maastricht Univ, Dept Nucl Med, Med Ctr, NL-6200 MD Maastricht, Netherlands; [Bouvy, Nicole D.] Maastricht Univ, Dept Gen Surg, Med Ctr, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University	Lichtenbelt, WDV (corresponding author), Maastricht Univ, Dept Human Biol, Med Ctr, Nutr & Toxicol Res Inst Maastricht, POB 616, NL-6200 MD Maastricht, Netherlands.	markenlichtenbelt@hb.unimaas.nl	Bouvy, Nicole/AAD-2844-2021; Vanhommerig, Joost W/E-5753-2016	schrauwen, patrick/0000-0002-0973-847X				Adachi I, 2006, OBES REV S2, V7, P87; [Anonymous], 2004, 9886 NENENISO; ASTRUP A, 1985, AM J PHYSIOL, V248, pE507, DOI 10.1152/ajpendo.1985.248.5.E507; Cannon B, 2008, NATURE, V454, P947, DOI 10.1038/454947a; Christiansen E, 2002, EUR J CLIN INVEST, V32, P826, DOI 10.1046/j.1365-2362.2002.01036.x; Claessens-van Ooijen AMJ, 2006, OBESITY, V14, P1914, DOI 10.1038/oby.2006.223; Cohade C, 2003, J NUCL MED, V44, P1267; Cohade C, 2003, J NUCL MED, V44, P170; GRIFFITHS M, 1990, LANCET, V336, P76, DOI 10.1016/0140-6736(90)91592-X; Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6; HEATON JM, 1972, J ANAT, V112, P35; Himms-Hagen J, 2001, Rev Endocr Metab Disord, V2, P395, DOI 10.1023/A:1011856617047; HUTTUNEN P, 1981, EUR J APPL PHYSIOL O, V46, P339, DOI 10.1007/BF00422121; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; Rousseau C, 2006, EUR J NUCL MED MOL I, V33, P785, DOI 10.1007/s00259-006-0066-x; RUBINSTEIN EH, 1990, ANESTHESIOLOGY, V73, P541, DOI 10.1097/00000542-199009000-00027; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Sturkenboom MGG, 2004, NUCL MED COMMUN, V25, P1109, DOI 10.1097/00006231-200411000-00007; Lichtenbelt WDV, 2006, PHYSIOL BEHAV, V88, P489, DOI 10.1016/j.physbeh.2006.04.026; van Ooijen AMJ, 2004, PHYSIOL BEHAV, V82, P545, DOI 10.1016/j.physbeh.2004.05.001; Wijers SLJ, 2007, J CLIN ENDOCR METAB, V92, P4299, DOI 10.1210/jc.2007-1065; Wijers SLJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001777; Yeung HWD, 2003, J NUCL MED, V44, P1789	28	2422	2490	3	190	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 9	2009	360	15					1500	1508						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430GL	19357405	Bronze, Green Published			2022-12-28	WOS:000264976800006
J	Psaty, BM				Psaty, Bruce M.			Conflict of Interest, Disclosure, and Trial Reports	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORONARY HEART-DISEASE; HIGH BLOOD-PRESSURE; BETA-BLOCKERS; PRIMARY PREVENTION; INDUSTRY; GIFTS		[Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative	Psaty, BM (corresponding author), Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu			NHLBI NIH HHS [HL080295, HL087652, HL74745, HL085251] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085251, U01HL080295, R01HL080295, R01HL087652, R01HL074745] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARIELY D, 2008, SCI BASIS INFLUENCE, P13; Chaudhry S, 2002, BRIT MED J, V325, P1391, DOI 10.1136/bmj.325.7377.1391; Dana J, 2003, JAMA-J AM MED ASSOC, V290, P252, DOI 10.1001/jama.290.2.252; Fleming TR, 2008, NEW ENGL J MED, V359, P1400, DOI 10.1056/NEJMe0807372; Katz D, 2003, AM J BIOETHICS, V3, P39, DOI 10.1162/15265160360706552; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Peto R, 2008, NEW ENGL J MED, V359, P1357, DOI 10.1056/NEJMsa0806603; PSATY BM, 1990, JAMA-J AM MED ASSOC, V263, P1653, DOI 10.1001/jama.263.12.1653; PSATY BM, 1990, AM J CARDIOL, V66, pG12, DOI 10.1016/0002-9149(90)90386-F; Psaty BM, 1999, BRIT MED J, V319, P589, DOI 10.1136/bmj.319.7210.589; PSATY BM, 1989, JAMA-J AM MED ASSOC, V261, P2087, DOI 10.1001/jama.261.14.2087; Steinman MA, 2001, AM J MED, V110, P551, DOI 10.1016/S0002-9343(01)00660-X; *TASK FORC, 2008, REP AAMC TASK FORC I, P1; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779	14	15	15	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 8	2009	301	14					1477	1479		10.1001/jama.2009.466	http://dx.doi.org/10.1001/jama.2009.466			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429MN	19351946				2022-12-28	WOS:000264924900029
J	Van Cutsem, E; Kohne, CH; Hitre, E; Zaluski, J; Chien, CRC; Makhson, A; D'Haens, G; Pinter, T; Lim, R; Bodoky, G; Roh, JK; Folprecht, G; Ruff, P; Stroh, C; Tejpar, S; Schlichting, M; Nippgen, J; Rougier, P				Van Cutsem, Eric; Koehne, Claus-Henning; Hitre, Erika; Zaluski, Jerzy; Chien, Chung-Rong Chang; Makhson, Anatoly; D'Haens, Geert; Pinter, Tamas; Lim, Robert; Bodoky, Gyoergy; Roh, Jae Kyung; Folprecht, Gunnar; Ruff, Paul; Stroh, Christopher; Tejpar, Sabine; Schlichting, Michael; Nippgen, Johannes; Rougier, Philippe			Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							K-RAS MUTATIONS; 1ST-LINE TREATMENT; PLUS IRINOTECAN; PHASE-III; FLUOROURACIL; OXALIPLATIN; LEUCOVORIN; KRAS; COMBINATION; TRIAL	Background We investigated the efficacy of cetuximab plus irinotecan, fluorouracil, and leucovorin (FOLFIRI) as first-line treatment for metastatic colorectal cancer and sought associations between the mutation status of the KRAS gene in tumors and clinical response to cetuximab. Methods We randomly assigned patients with epidermal growth factor receptor-positive colorectal cancer with unresectable metastases to receive FOLFIRI either alone or in combination with cetuximab. The primary end point was progression-free survival. Results A total of 599 patients received cetuximab plus FOLFIRI, and 599 received FOLFIRI alone. The hazard ratio for progression-free survival in the cetuximab-FOLFIRI group as compared with the FOLFIRI group was 0.85 (95% confidence interval [CI], 0.72 to 0.99; P = 0.048). There was no significant difference in the overall survival between the two treatment groups (hazard ratio, 0.93; 95% CI, 0.81 to 1.07; P = 0.31). There was a significant interaction between treatment group and KRAS mutation status for tumor response (P = 0.03) but not for progression-free survival (P = 0.07) or overall survival (P = 0.44). The hazard ratio for progression-free survival among patients with wild-type-KRAS tumors was 0.68 (95% CI, 0.50 to 0.94), in favor of the cetuximab-FOLFIRI group. The following grade 3 or 4 adverse events were more frequent with cetuximab plus FOLFIRI than with FOLFIRI alone: skin reactions (which were grade 3 only) (in 19.7% vs. 0.2% of patients, P<0.001), infusion-related reactions (in 2.5% vs. 0%, P<0.001), and diarrhea (in 15.7% vs. 10.5%, P = 0.008). Conclusions First-line treatment with cetuximab plus FOLFIRI, as compared with FOLFIRI alone, reduced the risk of progression of metastatic colorectal cancer. The benefit of cetuximab was limited to patients with KRAS wild-type tumors. (ClinicalTrials.gov number, NCT00154102.)	[Van Cutsem, Eric] Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, Belgium; [D'Haens, Geert] Imelda Ziekenhuis, Bonheiden, Belgium; [Koehne, Claus-Henning] Klinikum Oldenburg, Oldenburg, Germany; [Folprecht, Gunnar] Univ Klinikum Carl Gustav Carus, Dresden, Germany; [Stroh, Christopher; Schlichting, Michael; Nippgen, Johannes] E Merck AG, D-6100 Darmstadt, Germany; [Hitre, Erika] Orszagos Onkol Intezet, Budapest, Hungary; [Pinter, Tamas] Petz Aladar Cty Teaching Hosp, Gyor, Hungary; [Bodoky, Gyoergy] St Laszlo Hosp, Budapest, Hungary; [Zaluski, Jerzy] Wielkopolskie Ctr Onkol, Poznan, Poland; [Chien, Chung-Rong Chang] Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Makhson, Anatoly] Moscow City Oncol Clin Hosp 62, Moscow, Russia; [Lim, Robert] Natl Univ Singapore Hosp, Singapore 119074, Singapore; [Roh, Jae Kyung] Yonsei Univ, Coll Med, Seoul, South Korea; [Ruff, Paul] Univ Witwatersrand, Johannesburg, South Africa; [Rougier, Philippe] Hop Ambroise Pare, Boulogne, France	KU Leuven; University Hospital Leuven; Imeldaziekenhuis; Klinikum Oldenburg; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Merck KGaA; Szent Laszlo Hospital; Wielkopolskie Centrum Onkologii; Chang Gung Memorial Hospital; National University of Singapore; Yonsei University; Yonsei University Health System; University of Witwatersrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Van Cutsem, E (corresponding author), Univ Hosp Gasthuisberg, Digest Oncol Unit, Herestr 49, B-3000 Louvain, Belgium.	eric.vancutsem@uz.kuleuven.ac.be	Folprecht, Gunnar/F-8638-2011; Van+Cutsem, Eric/ABE-1762-2021	Folprecht, Gunnar/0000-0002-9321-9911; Bodoky, Gyorgy/0000-0002-5659-2020	Merck (Darmstadt); Roche; Sanofi- Aventis	Merck (Darmstadt)(Merck & Company); Roche(Roche Holding); Sanofi- Aventis(Sanofi-Aventis)	Supported by Merck (Darmstadt).; Dr. Van Cutsem reports receiving consulting or advisory fees from Amgen, Merck (Darmstadt), Pfizer, Roche, and Sanofi-Aventis; lecture fees from Amgen, Merck (Darmstadt), Roche, and Sanofi- Aventis; and grant support from Merck (Darmstadt) and Roche; Dr. Kohne, consulting or advisory fees and lecture fees from Amgen, Merck (Darmstadt), Pfizer, Roche, and Sanofi- Aventis; Dr. Lim, lecture fees from Roche; Dr. Folprecht, advisory fees from Roche, lecture fees from Merck (Darmstadt), Pfizer, and Sanofi- Aventis, and grant support from Merck (Darmstadt) and Sanofi- Aventis; Dr. Tejpar, grant support from Merck (Darmstadt); and Dr. Rougier, consulting or advisory fees from Merck (Darmstadt), Pfizer, Roche, and Sanofi- Aventis and lecture fees from Merck (Darmstadt), Pfizer, and Sanofi- Aventis. Drs. Stroh, Schlichting, and Nippgen report being employees of Merck (Darmstadt). No other potential conflict of interest relevant to this article was reported.; We thank our patients and nursing staff, contributors from other centers, and Merck (Darmstadt) personnel.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Arber N, 2000, GASTROENTEROLOGY, V118, P1045, DOI 10.1016/S0016-5085(00)70357-X; Arnold D, 2008, ANN ONCOL, V19, P1442, DOI 10.1093/annonc/mdn150; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Bokernever C, 2007, EJC SUPPL, V5, P236, DOI 10.1016/S1359-6349(07)70932-1; CERVANTEE A, 2008, J CLIN ONCOL S, V26, pS210; Chen CY, 2004, CLIN CHEM, V50, P481, DOI 10.1373/clinchem.2003.024505; Collett, 2003, MODELLING SURVIVAL D; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; Douillard JY, 2000, LANCET, V355, P1372; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Folprecht G, 2006, ANN ONCOL, V17, P450, DOI 10.1093/annonc/mdj084; Food and Drug Administration, CLIN TRIAL ENDP APPR; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Lenz HJ, 2006, J CLIN ONCOL, V24, P4914, DOI 10.1200/JCO.2006.06.7595; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; MCLELLAN EA, 1993, GUT, V34, P392, DOI 10.1136/gut.34.3.392; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rougier P, 2004, J CLIN ONCOL, V22, p248S; Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Schilsky RL, 2002, CLIN CANCER RES, V8, P935; Simeonov A, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf090; Tabernero J, 2007, J CLIN ONCOL, V25, P5225, DOI 10.1200/JCO.2007.13.2183; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Van Cutsem E, 2007, BEST PRACT RES CL GA, V21, P1089, DOI 10.1016/j.bpg.2007.10.020; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620	35	2952	3011	2	215	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 2	2009	360	14					1408	1417		10.1056/NEJMoa0805019	http://dx.doi.org/10.1056/NEJMoa0805019			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427AL	19339720				2022-12-28	WOS:000264751800006
J	Ellins, J; Ham, C; Parker, H				Ellins, Jo; Ham, Chris; Parker, Helen			Feature Primary care Opening up the primary medical care market	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ham, Chris; Parker, Helen] Hlth Serv Management Ctr, Birmingham B15 2RT, W Midlands, England	University of Birmingham		J.L.Ellins@bham.ac.uk		Ellins, Jo/0000-0001-8138-9385				Baker R, 2007, BRIT J GEN PRACT, V57, P283; *C BRIT IND, 2007, JUST WHAT PAT ORD BE; Cole A, 2008, BRIT MED J, V336, P1406, DOI 10.1136/bmj.a330; Corrigan P., 2005, REGISTERING CHOICE P; *DEP HLTH, 2003, BUILD BEST CHOIC RES; Department of Health, 2008, NHS NEXT STAG REV OU; Department of Health, 2008, FRAM MAN CHOIC COOP; ELLINS J, 2008, CHOICE COMPETITION P; *HC HLTH COMM, 2009, 1 HC HLTH COMM; *HC HLTH COMM, 2006, 4 HC HLTH COMM; National Audit Office, 2006, PROV OUT OF HOURS CA; Pollock A, 2006, BRIT J GEN PRACT, V56, P565; St John of God Health Care, 2019, OUR VIS; WEST D, 2008, HLTH SERVICE J  0925	14	9	9	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 31	2009	338								b1127	10.1136/bmj.b1127	http://dx.doi.org/10.1136/bmj.b1127			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429AL	19336479				2022-12-28	WOS:000264893100003
J	Casaburi, R; ZuWallack, R				Casaburi, Richard; ZuWallack, Richard			Pulmonary Rehabilitation for Management of Chronic Obstructive Pulmonary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AIRWAY-OBSTRUCTION; EXERCISE; PREDICTORS; BENEFITS; VENTILATION; MORTALITY; ADHERENCE; SURVIVAL; MUSCLE; COPD	A 61-year-old woman is referred for pulmonary consultation. She smoked one pack of cigarettes a day for 45 years but quit a year ago. For 2 years she has noted progressive exertional dyspnea, with breathlessness occurring when she is walking up one flight of stairs or hurrying on level ground. A diagnosis of chronic obstructive pulmonary disease (COPD) was made a year ago, and she was treated with inhaled medications. She is sedentary and recently gained 15 lb (6.8 kg); her only frequent social activity is playing cards. Her physical examination is normal except for a weight of 195 lb (88.5 kg) (body-mass index [the weight in kilograms divided by the square of the height in meters], 32) and for decreased breath sounds and prolonged expiration on chest auscultation. Spirometry reveals moderate airway obstruction; an echocardiogram is normal. The pulmonary consultant recommends enrollment in a pulmonary rehabilitation program.	[Casaburi, Richard] Harbor UCLA Med Ctr, Lo Angeles Biomed Res Inst, Rehabil Clin Trials Ctr, Torrance, CA 90502 USA; [ZuWallack, Richard] St Francis Hosp & Med Ctr, Hartford, CT USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Saint Francis Hospital & Medical Center	Casaburi, R (corresponding author), Harbor UCLA Med Ctr, Lo Angeles Biomed Res Inst, Rehabil Clin Trials Ctr, 1124 W Carson St,Bldg J4, Torrance, CA 90502 USA.	casaburi@ucla.edu						Agusti AGN, 2002, AM J RESP CRIT CARE, V166, P485, DOI 10.1164/rccm.2108013; [Anonymous], 1999, AM J RESP CRIT CARE, V159, pS1; BABB TG, 1991, J APPL PHYSIOL, V70, P223, DOI 10.1152/jappl.1991.70.1.223; Bourbeau J, 2003, ARCH INTERN MED, V163, P585, DOI 10.1001/archinte.163.5.585; Bourbeau J, 2006, CHEST, V130, P1704, DOI 10.1378/chest.130.6.1704; *CAL PULM REH COLL, 2004, CARDIOPULM REHABIL, V24, P52; Casaburi R, 2005, CHEST, V127, P809, DOI 10.1378/chest.127.3.809; Casaburi R, 1997, AM J RESP CRIT CARE, V155, P1541, DOI 10.1164/ajrccm.155.5.9154855; Casaburi R, 2004, AM J RESP CRIT CARE, V170, P870, DOI 10.1164/rccm.200305-617OC; CASABURI R, 1991, AM REV RESPIR DIS, V143, P9, DOI 10.1164/ajrccm/143.1.9; Casaburi R, 1993, PRINCIPLES PRACTICE, P204; Casaburi R, 2008, AM J RESP CRIT CARE, V177, P805, DOI 10.1164/rccm.200801-181ED; Celli BR, 2006, EUR RESPIR J, V27, P242, DOI 10.1183/09031936.06.00129305; CELLI BR, 1986, NEW ENGL J MED, V314, P1485, DOI 10.1056/NEJM198606053142305; Decramer M, 2005, RESP MED, V99, pS3, DOI 10.1016/j.rmed.2005.09.010; Emtner M, 2003, AM J RESP CRIT CARE, V168, P1034, DOI 10.1164/rccm.200212-1525OC; Fan VS, 2008, COPD, V5, P105, DOI 10.1080/15412550801941190; FERREIRA IM, 2008, COCHRANE DB SYST REV, V2; Garcia-Aymerich J, 2006, THORAX, V61, P772, DOI 10.1136/thx.2006.060145; Garrod R, 2006, EUR RESPIR J, V27, P788, DOI 10.1183/09031936.06.00130605; Griffiths TL, 2001, THORAX, V56, P779, DOI 10.1136/thorax.56.10.779; Griffiths TL, 2000, LANCET, V355, P1280; Griffiths TL, 2000, LANCET, V355, P362, DOI 10.1016/S0140-6736(99)07042-7; GUYATT GH, 1987, THORAX, V42, P773, DOI 10.1136/thx.42.10.773; Haas F, 1993, PRINCIPLES PRACTICE, P241; Huiart L, 2005, CHEST, V128, P2640, DOI 10.1378/chest.128.4.2640; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Lacasse Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub2; Lacasse Yves, 2002, J Cardiopulm Rehabil, V22, P148, DOI 10.1097/00008483-200205000-00004; Maltais F, 2000, THORAX, V55, P848, DOI 10.1136/thorax.55.10.848; McGhan R, 2007, CHEST, V132, P1748, DOI 10.1378/chest.06-3018; Morgan MDL, 2001, THORAX, V56, P827; Nici L, 2006, AM J RESP CRIT CARE, V173, P1390, DOI 10.1164/rccm.200508-1211ST; Nishimura K, 2002, CHEST, V121, P1434, DOI 10.1378/chest.121.5.1434; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pepin Veronique, 2007, COPD, V4, P195, DOI 10.1080/15412550701480489; PETTY TL, 1969, ANN INTERN MED, V70, P1109, DOI 10.7326/0003-4819-70-6-1109; Pinto-Plata VM, 2004, EUR RESPIR J, V23, P28, DOI 10.1183/09031936.03.00034603; Pitta F, 2008, CHEST, V134, P273, DOI 10.1378/chest.07-2655; Porszasz J, 2005, CHEST, V128, P2025, DOI 10.1378/chest.128.4.2025; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; RIES AL, 1995, ANN INTERN MED, V122, P823, DOI 10.7326/0003-4819-122-11-199506010-00003; Ries AL, 2003, AM J RESP CRIT CARE, V167, P880, DOI 10.1164/rccm.200204-318OC; Ries AL, 2007, CHEST, V131, p4S, DOI 10.1378/chest.06-2418; Saey D, 2003, AM J RESP CRIT CARE, V168, P425, DOI 10.1164/rccm.200208-856OC; Sewell L, 2005, CHEST, V128, P1194, DOI 10.1378/chest.128.3.1194; Steele BG, 2008, ARCH PHYS MED REHAB, V89, P404, DOI 10.1016/j.apmr.2007.11.003; Troosters T, 2005, AM J RESP CRIT CARE, V172, P19, DOI 10.1164/rccm.200408-1109SO; Troosters T, 2001, J Cardiopulm Rehabil, V21, P10, DOI 10.1097/00008483-200101000-00004; van Eeden SF, 2008, RESPIRATION, V75, P224, DOI 10.1159/000111820; Wagner PD, 2006, RESPIROLOGY, V11, P681, DOI 10.1111/j.1440-1843.2006.00939.x; Wasserman K, 2004, PRINCIPLES EXERCISE, V4th; Weisberg J, 2002, CHEST, V121, P1070, DOI 10.1378/chest.121.4.1070	53	170	181	2	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2009	360	13					1329	1335		10.1056/NEJMct0804632	http://dx.doi.org/10.1056/NEJMct0804632			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423VP	19321869				2022-12-28	WOS:000264524100008
J	Pantilat, SZ				Pantilat, Steven Z.			Communicating With Seriously Ill Patients Better Words to Say	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE; END; SKILLS		Univ Calif San Francisco, Dept Med, Div Hosp Med, Palliat Care Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Pantilat, SZ (corresponding author), Univ Calif San Francisco, Dept Med, Div Hosp Med, Palliat Care Program, Box 0903,521 Parnassus Ave,Ste C-126, San Francisco, CA 94143 USA.	stevep@medicine.ucsf.edu						Apa Pesidential Task Force, 2006, AM PSYCHOL, V61, P271, DOI 10.1037/0003-066X.61.4.271; Block S D, 1998, J Palliat Med, V1, P347, DOI 10.1089/jpm.1998.1.347; Jackson VA, 2008, J PALLIAT MED, V11, P893, DOI 10.1089/jpm.2007.2480; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Lienard A, 2006, ANN ONCOL, V17, P1450, DOI 10.1093/annonc/mdl142; Lo B, 2005, JAMA-J AM MED ASSOC, V294, P1810, DOI 10.1001/jama.294.14.1810; Meisel A, 2000, JAMA-J AM MED ASSOC, V284, P2495, DOI 10.1001/jama.284.19.2495; QUILL TE, 1995, ANN INTERN MED, V122, P368, DOI 10.7326/0003-4819-122-5-199503010-00008; Quill TE, 2001, ANN INTERN MED, V135, P551, DOI 10.7326/0003-4819-135-7-200110020-00022; Saba GW, 2006, ANN FAM MED, V4, P54, DOI 10.1370/afm.393; Schofield PE, 2003, ANN ONCOL, V14, P48, DOI 10.1093/annonc/mdg010; Selph RB, 2008, J GEN INTERN MED, V23, P1311, DOI 10.1007/s11606-008-0643-8; Stapleton RD, 2006, CRIT CARE MED, V34, P1679, DOI 10.1097/01.CCM.0000218409.58256.AA; Tulsky JA, 2005, JAMA-J AM MED ASSOC, V294, P359, DOI 10.1001/jama.294.3.359	14	33	33	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 25	2009	301	12					1279	1281		10.1001/jama.2009.396	http://dx.doi.org/10.1001/jama.2009.396			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423JO	19318656				2022-12-28	WOS:000264492800029
J	Rizzetti, MC; Liberini, P; Zarattini, G; Catalani, S; Pazzaglia, U; Apostoli, P; Padovani, A				Rizzetti, Maria Cristina; Liberini, Paolo; Zarattini, Guido; Catalani, Simona; Pazzaglia, Ugo; Apostoli, Pietro; Padovani, Alessandro			Loss of sight and sound. Could it be the hip?	LANCET			English	Editorial Material									[Rizzetti, Maria Cristina; Liberini, Paolo; Padovani, Alessandro] Univ Brescia, Spedali Civili, Dept Med & Surg Sci, Neurol Unit, I-25123 Brescia, Italy; [Catalani, Simona; Apostoli, Pietro] Univ Brescia, Spedali Civili, Dept Expt & Appl Med, Sect Occupat Hlth & Ind Hyg, I-25123 Brescia, Italy; [Zarattini, Guido; Pazzaglia, Ugo] Univ Brescia, Spedali Civili, Dept Surg Radiol & Forens Sci, Unit Orthopaed & Traumatol, I-25123 Brescia, Italy	Hospital Spedali Civili Brescia; University of Brescia; Hospital Spedali Civili Brescia; University of Brescia; Hospital Spedali Civili Brescia; University of Brescia	Rizzetti, MC (corresponding author), Univ Brescia, Spedali Civili, Dept Med & Surg Sci, Neurol Unit, Piazzale Spedali Civili 1, I-25123 Brescia, Italy.	rizzetti@hotmail.it	Apostoli, Pietro pa/E-7609-2010; Padovani, Alessandro/ABI-7312-2020	Padovani, Alessandro/0000-0002-0119-3639				Busse B, 2008, J BIOMED MATER RES A, V87A, P536, DOI 10.1002/jbm.a.31794; Lison D, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P511, DOI 10.1016/B978-012369413-3/50080-X; MEECHAM HM, 1991, J NEUROL NEUROSUR PS, V54, P374, DOI 10.1136/jnnp.54.4.374; SCHIRRMA.UO, 1967, BRIT MED J, V1, P544, DOI 10.1136/bmj.1.5539.544; Steens W, 2006, ACTA ORTHOP, V77, P830, DOI 10.1080/17453670610013079	5	109	111	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					1052	1052		10.1016/S0140-6736(09)60490-6	http://dx.doi.org/10.1016/S0140-6736(09)60490-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422AA	19304018				2022-12-28	WOS:000264398200034
J	Singh, S				Singh, Seema			Building Public-Private Research Partnerships in Troubled Times	CELL			English	Editorial Material								The Indian government is launching a series of new initiatives to boost public-private research partnerships and to jumpstart science-driven economic growth. But will the current global economic downturn hamper these efforts?											0	0	0	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 20	2009	136	6					987	989		10.1016/j.cell.2009.03.011	http://dx.doi.org/10.1016/j.cell.2009.03.011			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303838	Bronze			2022-12-28	WOS:000264403900001
J	Dumville, JC; Worthy, G; Bland, JM; Cullum, N; Dowson, C; Iglesias, C; Mitchell, JL; Nelson, EA; Soares, MO; Torgerson, DJ				Dumville, Jo C.; Worthy, Gill; Bland, J. Martin; Cullum, Nicky; Dowson, Christopher; Iglesias, Cynthia; Mitchell, Joanne L.; Nelson, E. Andrea; Soares, Marta O.; Torgerson, David J.		VenUS II Team	Larval therapy for leg ulcers (VenUS II): randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; EXTRACELLULAR-MATRIX COMPONENTS; HUMAN DERMAL FIBROBLASTS; LUCILIA-SERICATA-LARVAE; MAGGOT THERAPY; DIABETIC FOOT; EXCRETIONS/SECRETIONS; SECRETIONS; DEBRIDEMENT; MIGRATION	Objective To compare the clinical effectiveness of larval therapy with a standard debridement technique (hydrogel) for sloughy or necrotic leg ulcers. Design Pragmatic, three armed randomised controlled trial. Setting Community nurse led services, hospital wards, and hospital outpatient leg ulcer clinics in urban and rural settings, United Kingdom. Participants 267 patients with at least one venous or mixed venous and arterial ulcer with at least 25% coverage of slough or necrotic tissue, and an ankle brachial pressure index of 0.6 or more. Interventions Loose larvae, bagged larvae, and hydrogel. Main outcome measures The primary outcome was time to healing of the largest eligible ulcer. Secondary outcomes were time to debridement, health related quality of life (SF-12), bacterial load, presence of meticillin resistant Staphylococcus aureus, adverse events, and ulcer related pain (visual analogue scale, from 0 mm for no pain to 150 mm for worst pain imaginable). Results Time to healing was not significantly different between the loose or bagged larvae group and the hydrogel group (hazard ratio for healing using larvae v hydrogel 1.13, 95% confidence interval 0.76 to 1.68; P=0.54). Larval therapy significantly reduced the time to debridement (2.31, 1.65 to 3.2; P<0.001). Health related quality of life and change in bacterial load over time were not significantly different between the groups. 6.7% of participants had MRSA at baseline. No difference was found between larval therapy and hydrogel in their ability to eradicate MRSA by the end of the debridement phase (75% (9/12) v 50% (3/6); P=0.34), although this comparison was underpowered. Mean ulcer related pain scores were higher in either larvae group compared with hydrogel (mean difference in pain score: loose larvae v hydrogel 46.74 (95% confidence interval 32.44 to 61.04), P<0.001; bagged larvae v hydrogel 38.58 (23.46 to 53.70), P<0.001). Conclusions Larval therapy did not improve the rate of healing of sloughy or necrotic leg ulcers or reduce bacterial load compared with hydrogel but did significantly reduce the time to debridement and increase ulcer pain. Trial registration Current Controlled Trials ISRCTN55114812 and National Research Register N0484123692.	[Worthy, Gill; Bland, J. Martin; Cullum, Nicky; Torgerson, David J.] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Dowson, Christopher] Univ Warwick, Coventry CV4 7AL, W Midlands, England; [Mitchell, Joanne L.] Micropathology Ltd, Coventry, W Midlands, England; [Nelson, E. Andrea] Univ Leeds, Sch Healthcare, Leeds LS2 9JT, W Yorkshire, England	University of York - UK; University of Warwick; University of Leeds		jd34@york.ac.uk	Dowson, Christopher/ABG-5083-2021; Cullum, Nicky A/F-2438-2011; Torgerson, David/L-4566-2019; Dowson, Chris/N-6195-2014; Nelson, Andrea/K-2733-2012; Dumville, Jo C/O-7867-2014; Cullum, Nicky/AAT-5888-2020	Dowson, Christopher/0000-0002-8294-8836; Cullum, Nicky A/0000-0003-2631-123X; Torgerson, David/0000-0002-1667-4275; Dowson, Chris/0000-0002-8294-8836; Nelson, Andrea/0000-0001-6741-3078; Dumville, Jo C/0000-0002-6546-3685; Cullum, Nicky/0000-0003-2631-123X; McGinnis, Elizabeth/0000-0002-2848-9149; Adderley, Una/0000-0003-1894-3755; Soares, Marta Ferreira Oliveira/0000-0003-1579-8513	UK National Institute for Health Research Health Technology Assessment Programme [01/41/04]; National Institute for Health Research [01/41/04] Funding Source: researchfish	UK National Institute for Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding: This project was funded by the UK National Institute for Health Research Health Technology Assessment Programme (project No 01/41/04). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Department of Health. Zoobiotic supplied and distributed the loose larvae at no cost and Biomonde supplied the bagged larvae at no cost. These manufacturers had no role in the design of the trial or in the collection, analysis, and interpretation of the data.	Armstrong DG, 2002, J AM PODIAT MED ASSN, V92, P398, DOI 10.7547/87507315-92-7-398; Bexfield A, 2004, MICROBES INFECT, V6, P1297, DOI 10.1016/j.micinf.2004.08.011; Chambers L, 2003, BRIT J DERMATOL, V148, P14, DOI 10.1046/j.1365-2133.2003.04935.x; Cullum N, 2001, Health Technol Assess, V5, P1; Cullum N, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000265; Cullum N, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; HORN KL, 1976, ARCH OTOLARYNGOL, V102, P377; Horobin AJ, 2006, J INVEST DERMATOL, V126, P1410, DOI 10.1038/sj.jid.5700256; Horobin AJ, 2005, WOUND REPAIR REGEN, V13, P422, DOI 10.1111/j.1067-1927.2005.130410.x; Horobin AJ, 2003, BRIT J DERMATOL, V148, P923, DOI 10.1046/j.1365-2133.2003.05314.x; Huberman L, 2007, J Wound Care, V16, P123; Huberman L, 2007, MED VET ENTOMOL, V21, P127, DOI 10.1111/j.1365-2915.2007.00668.x; Iglesias C, 2004, HEALTH TECHNOL ASSES, V8, P1; Iglesias CP, 2005, QUAL LIFE RES, V14, P1705, DOI 10.1007/s11136-005-2751-9; Lecornet E, 2007, DIABETES CARE, V30, P2341, DOI 10.2337/dc07-0743; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Mumcuoglu KY, 2001, J MED ENTOMOL, V38, P161, DOI 10.1603/0022-2585-38.2.161; NELZEN O, 1994, BRIT J SURG, V81, P182, DOI 10.1002/bjs.1800810206; O'Brien Mark, 2002, Br J Community Nurs, P10; Prete PE, 1997, LIFE SCI, V60, P505, DOI 10.1016/S0024-3205(96)00688-1; Richardson Moira, 2004, Nurs Stand, V19, ppassim; SHERMAN RA, 1988, MED VET ENTOMOL, V2, P225, DOI 10.1111/j.1365-2915.1988.tb00188.x; Sherman RA, 2000, ANNU REV ENTOMOL, V45, P55, DOI 10.1146/annurev.ento.45.1.55; Sherman Ronald, 2005, Adv Skin Wound Care, V18, P12; Soares MO, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b825; Tentolouris N, 2006, CLIN MICROBIOL INFEC, V12, P186, DOI 10.1111/j.1469-0691.2005.01279.x; Thomas S, 1999, J Tissue Viability, V9, P127; Thomas S, 1996, J Wound Care, V5, P60; van der Plas MJA, 2008, J ANTIMICROB CHEMOTH, V61, P117, DOI 10.1093/jac/dkm407; van der Plas MJA, 2007, MICROBES INFECT, V9, P507, DOI 10.1016/j.micinf.2007.01.008; Wareing PW, 2001, INT J FOOD SCI TECH, V36, P1, DOI 10.1046/j.1365-2621.2001.00419.x; Wayman J, 2000, J Tissue Viability, V10, P91	32	139	143	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2009	338								b773	10.1136/bmj.b773	http://dx.doi.org/10.1136/bmj.b773			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422NW	19304577	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000264436000003
J	Diehl, AK				Diehl, Andrew K.			Combined therapy with folic acid and vitamins B-6 and B-12 did not affect cancer risk in women at high risk for CV disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Diehl, AK (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.							Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Giovannucci E, 2002, J NUTR, V132, p2350S, DOI 10.1093/jn/132.8.2350S; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Zhang SMM, 2008, JAMA-J AM MED ASSOC, V300, P2012, DOI 10.1001/jama.2008.555	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6							JC3-9	10.7326/0003-4819-150-6-200903170-02009	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423AJ	19306491				2022-12-28	WOS:000264468500032
J	Benitez, MA				Benitez, Mary Ann			Climate change could affect mosquito-borne diseases in Asia	LANCET			English	Editorial Material																			0	24	27	1	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2009	373	9669					1070	1070		10.1016/S0140-6736(09)60634-6	http://dx.doi.org/10.1016/S0140-6736(09)60634-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427IS	19338070				2022-12-28	WOS:000264773600013
J	Jha, AK; DesRoches, CM; Campbell, EG; Donelan, K; Rao, SR; Ferris, TG; Shields, A; Rosenbaum, S; Blumenthal, D				Jha, Ashish K.; DesRoches, Catherine M.; Campbell, Eric G.; Donelan, Karen; Rao, Sowmya R.; Ferris, Timothy G.; Shields, Alexandra; Rosenbaum, Sara; Blumenthal, David			Use of Electronic Health Records in U. S. Hospitals	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHYSICIAN ORDER ENTRY; INFORMATION-TECHNOLOGY; UNITED-STATES; CARE; QUALITY; ADOPTION; ORGANIZATIONS; SYSTEMS	BACKGROUND Despite a consensus that the use of health information technology should lead to more efficient, safer, and higher-quality care, there are no reliable estimates of the prevalence of adoption of electronic health records in U. S. hospitals. METHODS We surveyed all acute care hospitals that are members of the American Hospital Association for the presence of specific electronic-record functionalities. Using a definition of electronic health records based on expert consensus, we determined the proportion of hospitals that had such systems in their clinical areas. We also examined the relationship of adoption of electronic health records to specific hospital characteristics and factors that were reported to be barriers to or facilitators of adoption. RESULTS On the basis of responses from 63.1% of hospitals surveyed, only 1.5% of U. S. hospitals have a comprehensive electronic-records system (i.e., present in all clinical units), and an additional 7.6% have a basic system (i.e., present in at least one clinical unit). Computerized provider-order entry for medications has been implemented in only 17% of hospitals. Larger hospitals, those located in urban areas, and teaching hospitals were more likely to have electronic-records systems. Respondents cited capital requirements and high maintenance costs as the primary barriers to implementation, although hospitals with electronic-records systems were less likely to cite these barriers than hospitals without such systems. CONCLUSIONS The very low levels of adoption of electronic health records in U. S. hospitals suggest that policymakers face substantial obstacles to the achievement of health care performance goals that depend on health information technology. A policy strategy focused on financial support, interoperability, and training of technical support staff may be necessary to spur adoption of electronic-records systems in U. S. hospitals.	[Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; [Jha, Ashish K.] Vet Affairs Boston Healthcare Syst, Boston, MA USA; [DesRoches, Catherine M.; Campbell, Eric G.; Donelan, Karen; Rao, Sowmya R.; Ferris, Timothy G.; Shields, Alexandra; Blumenthal, David] Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02114 USA; [Rao, Sowmya R.] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [Rosenbaum, Sara] George Washington Univ, Dept Hlth Policy, Washington, DC USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; George Washington University	Jha, AK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	ajha@hsph.harvard.edu	Donelan, Karen/R-6162-2019; DesRoches, Catherine/ABC-9869-2020; Tao, Youyou/D-2367-2014	DesRoches, Catherine/0000-0001-5373-855X; 	Office of the National Coordinator for Health Information Technology in the Department of Health and Human Services; Robert Wood Johnson Foundation	Office of the National Coordinator for Health Information Technology in the Department of Health and Human Services; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	Supported by grants from the Office of the National Coordinator for Health Information Technology in the Department of Health and Human Services and the Robert Wood Johnson Foundation.	Adler-Milstein J, 2008, HEALTH AFFAIR, V27, pW60, DOI 10.1377/hlthaff.27.1.w60; Adler-Milstein J, 2009, HEALTH AFFAIR, V28, P483, DOI 10.1377/hlthaff.28.2.483; American Hospital Association, 2005, FORW MOM HOSP US INF; Ash JS, 2004, J AM MED INFORM ASSN, V11, P95, DOI 10.1197/jamia.M1427; Blumenthal D., 2006, HLTH INFORM TECHNOLO; Blumenthal D, 2007, NEW ENGL J MED, V356, P2527, DOI 10.1056/NEJMhpr066212; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Cutler DM, 2005, HEALTH AFFAIR, V24, P1654, DOI 10.1377/hlthaff.24.6.1654; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; Furukawa MF, 2008, HEALTH AFFAIR, V27, P865, DOI 10.1377/hlthaff.27.3.865; *HIMSS, 2002, 2002 HOT TOP SURV; Institute of Medicine, 2003, KEY CAP EL HLTH REC; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Jha AK, 2006, HEALTH AFFAIR, V25, pW496, DOI 10.1377/hlthaff.25.w496; Jha AK, 2008, INT J MED INFORM, V77, P848, DOI 10.1016/j.ijmedinf.2008.06.007; LASCHOBER M, 2005, HOSP RESPONSES PUBLI; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Perlin JB, 2006, HEALTH ECON POLICY L, V1, P99, DOI 10.1017/S1744133105001222; Schoen C, 2006, HEALTH AFFAIR, V25, pW555, DOI 10.1377/hlthaff.25.w555; Scott JT, 2005, BRIT MED J, V331, P1313, DOI 10.1136/bmj.38638.497477.68; Sequist TD, 2007, J AM MED INFORM ASSN, V14, P191, DOI 10.1197/jamia.M2234; Simon SR, 2007, J AM MED INFORM ASSN, V14, P110, DOI 10.1197/jamia.M2187; Smith C, 2006, HEALTH AFFAIR, V25, P186, DOI 10.1377/hlthaff.25.1.186	24	871	879	1	129	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 16	2009	360	16					1628	1638		10.1056/NEJMsa0900592	http://dx.doi.org/10.1056/NEJMsa0900592			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	433BH	19321858				2022-12-28	WOS:000265178000007
J	Koga, T; Fujimoto, K				Koga, Takeharu; Fujimoto, Kiminori			Kerley's A, B, and C Lines.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Koga, Takeharu] Asakura Med Assoc Hosp, Asakura 8380069, Japan; [Fujimoto, Kiminori] Kurume Univ, Sch Med, Kurume, Fukuoka 8300011, Japan	Kurume University	Koga, T (corresponding author), Asakura Med Assoc Hosp, Asakura 8380069, Japan.								0	4	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 9	2009	360	15					1539	1539		10.1056/NEJMicm0708489	http://dx.doi.org/10.1056/NEJMicm0708489			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430GL	19357409				2022-12-28	WOS:000264976800010
J	Marteau, TM; Ashcroft, RE; Oliver, A				Marteau, Theresa M.; Ashcroft, Richard E.; Oliver, Adam			Using financial incentives to achieve healthy behaviour	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICATION; PAY		[Marteau, Theresa M.] Kings Coll London, London SE1 9RT, England; [Ashcroft, Richard E.] Queen Mary Univ London, Sch Law, London E1 4NS, England; [Oliver, Adam] Univ London London Sch Econ & Polit Sci, LSE Hlth, London WC2A 2AE, England	University of London; King's College London; University of London; Queen Mary University London; University of London; London School Economics & Political Science	Marteau, TM (corresponding author), Kings Coll London, Guys Campus, London SE1 9RT, England.	theresa.marteau@kcl.ac.uk	Oliver, Adam/CAG-2031-2022		Wellcome Trust [086031] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		*APM HLTH EUR, 2007, IT HLTH MIN BACKS PL; APPLEBY J, 2009, USA TODAY       0120; Berns GS, 2007, TRENDS COGN SCI, V11, P482, DOI 10.1016/j.tics.2007.08.011; Cahill K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004986.pub3; Claassen D, 2007, PSYCHIATR BULL, V31, P4, DOI 10.1192/pb.31.1.4; Claassen D, 2007, J MED ETHICS, V33, P189, DOI 10.1136/jme.2006.016188; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Domjan M., 2015, PRINCIPLES LEARNING; *E AYRSH COUNC, PUP EARN JUST REW HL; *E KENT COAST NHS, POUNDS POUNDS; Frankfurt, 1971, J PHILOS, DOI [10.2307/2024717, DOI 10.2307/2024717]; Frey BS, 2001, J ECON SURV, V15, P589, DOI 10.1111/1467-6419.00150; Giuffrida A, 1997, BRIT MED J, V315, P703, DOI 10.1136/bmj.315.7110.703; Heyman J, 2004, PSYCHOL SCI, V15, P787, DOI 10.1111/j.0956-7976.2004.00757.x; Kane RL, 2004, AM J PREV MED, V27, P327, DOI 10.1016/j.amepre.2004.07.002; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Le Grand J, 2008, J R STAT SOC A STAT, V171, P843; Long JA, 2008, J GEN INTERN MED, V23, P1647, DOI 10.1007/s11606-008-0739-1; Lussier JP, 2006, ADDICTION, V101, P192, DOI 10.1111/j.1360-0443.2006.01311.x; Neal DT, 2006, CURR DIR PSYCHOL SCI, V15, P198, DOI 10.1111/j.1467-8721.2006.00435.x; Ory MG, 2002, HEALTH EDUC RES, V17, P500, DOI 10.1093/her/17.5.500; Paul-Ebhohimhen V, 2008, OBES REV, V9, P355, DOI 10.1111/j.1467-789X.2007.00409.x; Prendergast M, 2006, ADDICTION, V101, P1546, DOI 10.1111/j.1360-0443.2006.01581.x; *PROGRESA, ED HLTH NUTR PROGR M; Ross L., 1991, PERSON SITUATION; Shibuya K, 2008, LANCET, V371, P789, DOI 10.1016/S0140-6736(08)60356-6; Sutherland K, 2008, MED CARE RES REV, V65, p36S, DOI 10.1177/1077558708324235; Thaler RH., 2021, NUDGE FINAL EDITION; Volpp KG, 2009, NEW ENGL J MED, V360, P699, DOI 10.1056/NEJMsa0806819	29	177	178	0	38	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2009	338								b1415	10.1136/bmj.b1415	http://dx.doi.org/10.1136/bmj.b1415			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	431ZK	19359291				2022-12-28	WOS:000265103100005
J	Flynn, KE; Pina, IL; Whellan, DJ; Lin, L; Blumenthal, JA; Ellis, SJ; Fine, LJ; Howlett, JG; Keteyian, SJ; Kitzman, DW; Kraus, WE; Miller, NH; Schulman, KA; Spertus, JA; O'Connor, CM; Weinfurt, KP				Flynn, Kathryn E.; Pina, Ileana L.; Whellan, David J.; Lin, Li; Blumenthal, James A.; Ellis, Stephen J.; Fine, Lawrence J.; Howlett, Jonathan G.; Keteyian, Steven J.; Kitzman, Dalane W.; Kraus, William E.; Miller, Nancy Houston; Schulman, Kevin A.; Spertus, John A.; O'Connor, Christopher M.; Weinfurt, Kevin P.			Effects of Exercise Training on Health Status in Patients With Chronic Heart Failure HF-ACTION Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	81st Annual Scientific Session of the American-Heart-Association	NOV 08-12, 2008	New Orleans, LA	Amer Heart Assoc			QUALITY-OF-LIFE; CARDIAC RESYNCHRONIZATION; ELDERLY-PATIENTS; PREDICTORS; CAPACITY; OUTCOMES; MIRACLE; SAFETY	Context Findings from previous studies of the effects of exercise training on patient-reported health status have been inconsistent. Objective To test the effects of exercise training on health status among patients with heart failure. Design, Setting, and Patients Multicenter, randomized controlled trial among 2331 medically stable outpatients with heart failure with left ventricular ejection fraction of 35% or less. Patients were randomized from April 2003 through February 2007. Interventions Usual care plus aerobic exercise training (n = 1172), consisting of 36 supervised sessions followed by home-based training, vs usual care alone (n = 1159). Randomization was stratified by heart failure etiology, which was a covariate in all models. Main Outcome Measures Kansas City Cardiomyopathy Questionnaire (KCCQ) overall summary scale and key subscales at baseline, every 3 months for 12 months, and annually thereafter for up to 4 years. The KCCQ is scored from 0 to 100 with higher scores corresponding to better health status. Treatment group effects were estimated using linear mixed models according to the intention-to-treat principle. Results Median follow-up was 2.5 years. At 3 months, usual care plus exercise training led to greater improvement in the KCCQ overall summary score (mean, 5.21; 95% confidence interval, 4.42 to 6.00) compared with usual care alone (3.28; 95% confidence interval, 2.48 to 4.09). The additional 1.93-point increase (95% confidence interval, 0.84 to 3.01) in the exercise training group was statistically significant (P < .001). After 3 months, there were no further significant changes in KCCQ score for either group (P = .85 for the difference between slopes), resulting in a sustained, greater improvement overall for the exercise group (P < .001). Results were similar on the KCCQ subscales, and no subgroup interactions were detected. Conclusions Exercise training conferred modest but statistically significant improvements in self-reported health status compared with usual care without training. Improvements occurred early and persisted over time. Trial Registration clinicaltrials.gov Identifier: NCT00047437.	[Flynn, Kathryn E.] Duke Univ, Sch Med, Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC 27715 USA; [Flynn, Kathryn E.; Blumenthal, James A.; Weinfurt, Kevin P.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27715 USA; [Kraus, William E.; Schulman, Kevin A.; O'Connor, Christopher M.] Duke Univ, Sch Med, Dept Med, Durham, NC 27715 USA; [Pina, Ileana L.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Whellan, David J.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA; [Fine, Lawrence J.] NHLBI, Div Prevent & Populat Sci, Bethesda, MD 20892 USA; [Miller, Nancy Houston] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Howlett, Jonathan G.] Dalhousie Univ, Queen Elizabeth Hlth Sci Ctr 2, Halifax, NS, Canada; [Keteyian, Steven J.] Henry Ford Hosp, Div Cardiovasc Med, Detroit, MI 48202 USA; [Kitzman, Dalane W.] Wake Forest Univ, Sch Med, Dept Internal Med, Winston Salem, NC 27109 USA; [Spertus, John A.] St Lukes Hlth Syst, Mid Amer Heart Inst, Kansas City, MO USA; [Spertus, John A.] Univ Missouri Kansas City, Kansas City, MO USA	Duke University; Duke University; Duke University; Case Western Reserve University; Jefferson University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Stanford University; Dalhousie University; Queen Elizabeth II Health Sciences Centre; Henry Ford Health System; Henry Ford Hospital; Wake Forest University; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City	Flynn, KE (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, Ctr Clin & Genet Econ, POB 17969, Durham, NC 27715 USA.	kathryn.flynn@duke.edu	Flynn, Kathryn E/M-5346-2013; Howlett, Jonathan/T-2589-2019; Spertus, John/ABD-3075-2021	Flynn, Kathryn E/0000-0002-4427-3583; Kraus, William E/0000-0003-1930-9684; Hittinger, Luc/0000-0003-1933-5815; Handberg, Eileen/0000-0002-7805-9577; Howlett, Jonathan/0000-0002-0535-9771; Hershberger, Ray/0000-0001-5683-6526; Zile, Michael/0000-0001-7076-221X	NHLBI NIH HHS [5U01HL064257, U01 HL066494-04, U01 HL064257-01A2, 5U01HL066501, U01 HL064250-06, U01 HL068980, U01 HL066497-04, U01 HL068980-05, 5U01HL066482, U01 HL066501, U01 HL064264-05, 5U01HL066494, 5U01HL068973, U01 HL068973-06, U01 HL066461, U01 HL068973, U01 HL063747, U01 HL066491-06, U01 HL066491, 5U01HL064265, 5U01HL064250, U01 HL064264, 5U01HL066497, U01 HL064265, U01 HL066482-04, U01 HL066497, 5U01HL068980, U01 HL064250, U01 HL064265-04, 5U01HL064264, 5U01HL066461, U01 HL066461-06S1, U01 HL064257, 5U01HL066491, U01 HL066494, U01 HL063747-06S1, 5U01HL063747, U01 HL066482, U01 HL066501-06] Funding Source: Medline; NIA NIH HHS [R37 AG018915] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Belardinelli R, 1999, CIRCULATION, V99, P1173, DOI 10.1161/01.CIR.99.9.1173; Brunner EJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002128.pub2; Bryk A. S., 1992, HIERARCHICAL LINEAR; Chien CL, 2008, AUST J PHYSIOTHER, V54, P87, DOI 10.1016/S0004-9514(08)70041-2; COATS AJS, 1990, LANCET, V335, P63, DOI 10.1016/0140-6736(90)90536-E; DRACUP K, 1992, J HEART LUNG TRANSPL, V11, P273; Gary RA, 2004, HEART LUNG, V33, P210, DOI 10.1016/j.hrtlng.2004.01.004; GIBBONS RD, 1993, ARCH GEN PSYCHIAT, V50, P739; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Havranek EP, 2004, J AM COLL CARDIOL, V44, P2333, DOI 10.1016/j.jacc.2004.09.034; Keteyian SJ, 1996, ANN INTERN MED, V124, P1051, DOI 10.7326/0003-4819-124-12-199606150-00004; Keteyian SJ, 1999, AM HEART J, V138, P233, DOI 10.1016/S0002-8703(99)70106-7; KRAEMER HC, 1989, J CONSULT CLIN PSYCH, V57, P148, DOI 10.1037/0022-006X.57.1.148; Krumholz HM, 1998, CIRCULATION, V97, P958; McKelvie RS, 2008, HEART FAIL REV, V13, P3, DOI 10.1007/s10741-007-9052-z; McKelvie RS, 2002, AM HEART J, V144, P23, DOI 10.1067/mhj.2002.123310; Metra M, 2000, CIRCULATION, V102, P546; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; Pires LA, 2006, AM HEART J, V151, P837, DOI 10.1016/j.ahj.2005.06.024; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Shah MR, 2001, AM J CARDIOL, V88, P987, DOI 10.1016/S0002-9149(01)01975-0; Spertus J, 2005, AM HEART J, V150, P707, DOI 10.1016/j.ahj.2004.12.010; Whellan DJ, 2007, AM HEART J, V153, P201, DOI 10.1016/j.ahj.2006.11.007; Wielenga RP, 1998, CORONARY ARTERY DIS, V9, P765, DOI 10.1097/00019501-199809110-00010; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685	25	493	514	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 8	2009	301	14					1451	1459		10.1001/jama.2009.457	http://dx.doi.org/10.1001/jama.2009.457			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	429MN	19351942	Bronze, Green Accepted			2022-12-28	WOS:000264924900025
J	Halford, J; Hunt, L; Millington, G				Halford, Julie; Hunt, Laura; Millington, George			A Patient's Journey Hyperhidrosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Halford, Julie] Hampshire Clin, Old Basing RG24 7AL, England; [Millington, George] Norfolk & Norwich Univ Hosp, Norwich NR4 7UY, Norfolk, England	Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital	Halford, J (corresponding author), Hampshire Clin, Old Basing RG24 7AL, England.	info@hyperhidrosisuk.org							0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2009	338								b1166	10.1136/bmj.b1166	http://dx.doi.org/10.1136/bmj.b1166			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431ZH	19351672				2022-12-28	WOS:000265102800002
J	Murry, CE; Lee, RT				Murry, Charles E.; Lee, Richard T.			Turnover After the Fallout	SCIENCE			English	Editorial Material							HEARTS		[Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Dept Pathol, Seattle, WA 98109 USA; [Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Dept Bioengn, Seattle, WA 98109 USA; [Lee, Richard T.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div,Dept Med, Cambridge, MA 02139 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital	Murry, CE (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Dept Pathol, Seattle, WA 98109 USA.	murry@u.washington.edu; rlee@partners.org		Lee, Richard/0000-0003-4687-1381				ADLER CP, 1986, J MOL CELL CARDIOL, V18, P39, DOI 10.1016/S0022-2828(86)80981-6; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; GRUENWALD P, 1960, AM J CLIN PATHOL, V34, P247; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Nakajima H, 2004, CIRC RES, V94, P1606, DOI 10.1161/01.RES.0000132279.99249.f4; Olivetti G, 1996, J MOL CELL CARDIOL, V28, P1463, DOI 10.1006/jmcc.1996.0137; Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220	9	11	11	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 3	2009	324	5923					47	48		10.1126/science.1172255	http://dx.doi.org/10.1126/science.1172255			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342577				2022-12-28	WOS:000264802100025
J	Wallberg-Henriksson, H; Zierath, JR				Wallberg-Henriksson, Harriet; Zierath, Juleen R.			A New Twist on Brown Fat Metabolism	CELL			English	Editorial Material							DELTA	The transcriptional coactivator PGC-1 alpha promotes mitochondrial biogenesis and thermogenic programs in brown adipose tissue. Pan et al. (2009) identify the transcription factor twist-1 as a negative feedback regulator of PGC-1 alpha.	[Wallberg-Henriksson, Harriet; Zierath, Juleen R.] Karolinska Inst, Sect Integrat Physiol, Dept Mol Med & Surg, S-17177 Stockholm, Sweden; [Wallberg-Henriksson, Harriet; Zierath, Juleen R.] Karolinska Inst, Sect Integrat Physiol, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Zierath, JR (corresponding author), Karolinska Inst, Sect Integrat Physiol, Dept Mol Med & Surg, S-17177 Stockholm, Sweden.	juleen.zierath@ki.se		Zierath, Juleen/0000-0001-6891-7497				Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Dahlman I, 2007, INT J OBESITY, V31, P1629, DOI 10.1038/sj.ijo.0803657; Kramer DK, 2007, J BIOL CHEM, V282, P19313, DOI 10.1074/jbc.M702329200; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Pantke O A, 1975, Birth Defects Orig Artic Ser, V11, P190; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Sosic D, 2003, CELL CYCLE, V2, P76, DOI 10.4161/cc.2.2.338; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1	9	6	6	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					22	24		10.1016/j.cell.2009.03.029	http://dx.doi.org/10.1016/j.cell.2009.03.029			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345181	Bronze			2022-12-28	WOS:000264813300008
J	Gostin, LO; Nass, S				Gostin, Lawrence O.; Nass, Sharyl			Reforming the HIPAA Privacy Rule Safeguarding Privacy and Promoting Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Nass, Sharyl] Natl Acad Sci, Inst Med, Washington, DC 20418 USA	Georgetown University; National Academies of Sciences, Engineering & Medicine	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Nass, Sharyl/0000-0001-5874-5337; Gostin, Lawrence/0000-0001-5286-4044				*AM SOC CLIN ONC, 2008, IMP PRIV RUL CANC RE; [Anonymous], FEDERAL POLICY PROTE; Armstrong D, 2005, ARCH INTERN MED, V165, P1125, DOI 10.1001/archinte.165.10.1125; *ASS AC HLTH CTR, 2009, HIPAA PRIV RUL LACKS; Breese P, 2004, ANN INTERN MED, V141, P897, DOI 10.7326/0003-4819-141-11-200412070-00034; BUSH GW, 13335 OFF NAT COORD; Greene S. M., 2008, IMPACT HIPAA PRIVACY; Lydon-Rochelle M, 2004, MATERN CHILD HLTH J, V8, P35, DOI 10.1023/B:MACI.0000020054.40836.7e; [National Academy of Sciences Institute of Medicine], 2009, HIPAA PRIV RUL ENH P; Ness RB, 2007, JAMA-J AM MED ASSOC, V298, P2164, DOI 10.1001/jama.298.18.2164; ROTENBERG M, 2004, STANFORD TECHNOL LAW, V1, P1; Rothstein MA, 2005, J LAW MED ETHICS, V33, P154, DOI 10.1111/j.1748-720X.2005.tb00217.x; Thomas R, DATA SHARING REV REP; STANDARDS PRIVACY IN	14	33	33	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 1	2009	301	13					1373	1375		10.1001/jama.2009.424	http://dx.doi.org/10.1001/jama.2009.424			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426LM	19336713				2022-12-28	WOS:000264709800027
J	Bianchi, ME; Manfredi, AA				Bianchi, Marco E.; Manfredi, Angelo A.			Dangers In and Out	SCIENCE			English	Editorial Material							NF-KAPPA-B; IMMUNE-RESPONSES; NECROTIC CELLS; TISSUE-DAMAGE; HMGB1; ACTIVATION; PROTEIN; COMPLEXES; CD24; DNA		[Bianchi, Marco E.] San Raffaele Univ, Fac Med, I-20132 Milan, Italy; Ist Sci San Raffaele, I-20132 Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Bianchi, ME (corresponding author), San Raffaele Univ, Fac Med, Via Olgettina 58, I-20132 Milan, Italy.	bianchi.marco@hsr.it	Bianchi, Marco Emilio/K-3417-2018; Manfredi, Angelo A./C-7018-2014	Bianchi, Marco Emilio/0000-0002-5329-6445; Manfredi, Angelo A./0000-0001-8370-6970				Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Liu Y, 2007, TRENDS IMMUNOL, V28, P315, DOI 10.1016/j.it.2007.05.001; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Palumbo R, 2007, J CELL BIOL, V179, P33, DOI 10.1083/jcb.200704015; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165	13	102	115	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 27	2009	323	5922					1683	1684		10.1126/science.1172794	http://dx.doi.org/10.1126/science.1172794			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325105				2022-12-28	WOS:000264559800027
J	Mercante, G; Barbieri, V				Mercante, Giuseppe; Barbieri, Verter			Mediastinal Extension of a Goiter	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mercante, Giuseppe; Barbieri, Verter] Arcispedale Santa Maria Nuova, I-42100 Reggio Emilia, Italy	IRCCS Arcispedale S. Maria Nuova	Mercante, G (corresponding author), Arcispedale Santa Maria Nuova, I-42100 Reggio Emilia, Italy.	giuseppe.mercante@asmn.re.it	Mercante, Giuseppe/G-2542-2018	Mercante, Giuseppe/0000-0002-1009-7892					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2009	360	13					E19	E19		10.1056/NEJMicm0708070	http://dx.doi.org/10.1056/NEJMicm0708070			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423VP	19321864				2022-12-28	WOS:000264524100010
J	Dobscha, SK; Corson, K; Perrin, NA; Hanson, GC; Leibowitz, RQ; Doak, MN; Dickinson, KC; Sullivan, MD; Gerrity, MS				Dobscha, Steven K.; Corson, Kathryn; Perrin, Nancy A.; Hanson, Ginger C.; Leibowitz, Ruth Q.; Doak, Melanie N.; Dickinson, Kathryn C.; Sullivan, Mark D.; Gerrity, Martha S.			Collaborative Care for Chronic Pain in Primary Care A Cluster Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC NONCANCER PAIN; CLINICALLY IMPORTANT DIFFERENCE; IMPROVING PRIMARY-CARE; BACK-PAIN; DEPRESSION CARE; CHRONIC ILLNESS; SCREENING-TEST; HEALTH-STATUS; DISABILITY; MANAGEMENT	Context Chronic pain is common in primary care patients and is associated with distress, disability, and increased health care use. Objective To assess whether a collaborative intervention can improve chronic pain related outcomes, including comorbid depression severity, in a Department of Veterans Affairs primary care setting. Design, Setting, and Participants Cluster randomized controlled trial of a collaborative care assistance with pain treatment intervention vs treatment as usual at 5 primary care clinics of 1 Department of Veterans Affairs Medical Center. Forty-two primary care clinicians were randomized to the assistance with pain treatment intervention group or the treatment as usual group. The 401 patients had musculoskeletal pain diagnoses, moderate or greater pain intensity, and disability lasting 12 weeks or longer and were assigned to the same treatment groups as their clinicians. Recruitment occurred from January 2006 to January 2007 and follow-up concluded in January 2008. Intervention Assistance with pain treatment included a 2-session clinician education program, patient assessment, education and activation, symptom monitoring, feedback and recommendations to clinicians, and facilitation of specialty care. Main Outcome Measures Changes over 12 months in pain-related disability (Roland-Morris Disability Questionnaire, range of 0-24), pain intensity (Chronic Pain Grade [CPG] Pain Intensity subscale, range of 0-100), and depression (Patient Health Questionnaire 9 [PHQ-9], range of 0-27), measured as beta coefficients (difference in slopes in points per month). Results Intervention patients had a mean (SD) of 10.6 (4.5) contacts with the assistance with pain treatment team. Compared with the patients receiving treatment as usual, intervention patients showed greater improvements in pain-related disability (Roland-Morris Disability Questionnaire beta, -0.101 [95% confidence interval {CI}, -0.163 to -0.040]; P=.004 and CPG Pain Intensity subscale beta, -0.270 [95% CI, -0.480 to -0.061]; P=.01). Among patients with baseline depression (PHQ-9 score >= 10), there was greater improvement in depression severity in patients receiving the intervention compared with patients receiving treatment as usual (PHQ-9 beta, -0.177 [95% CI, -0.295 to -0.060]; P=.003). The differences in scores between baseline and 12 months for the assistance with pain treatment intervention group and the treatment as usual group, respectively, were -1.4 vs -0.2 for the Roland-Morris Disability Questionnaire, -4.7 vs -0.6 for the CPG Pain Intensity subscale, and -3.7 vs -1.2 for PHQ-9. Conclusion The assistance with pain treatment collaborative intervention resulted in modest but statistically significant improvement in a variety of outcome measures. Trial Registration clinicaltrials.gov Identifier: NCT00129480	[Dobscha, Steven K.; Corson, Kathryn; Leibowitz, Ruth Q.; Dickinson, Kathryn C.; Gerrity, Martha S.] Portland VA Med Ctr, Portland Ctr Study Chron Comorbid Mental & Phys D, Portland, OR 97239 USA; [Doak, Melanie N.] Portland VA Med Ctr, Div Primary Care, Portland, OR 97239 USA; [Gerrity, Martha S.] Portland VA Med Ctr, Div Hosp & Specialty Med, Portland, OR 97239 USA; [Dobscha, Steven K.; Corson, Kathryn] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Doak, Melanie N.; Gerrity, Martha S.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Perrin, Nancy A.; Hanson, Ginger C.] Oregon Hlth & Sci Univ, Sch Nursing, Portland, OR 97201 USA; [Sullivan, Mark D.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Washington; University of Washington Seattle	Dobscha, SK (corresponding author), Portland VA Med Ctr, Portland Ctr Study Chron Comorbid Mental & Phys D, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	steven.dobscha@va.gov		Gerrity, Martha/0000-0002-8772-4591; Hanson, Ginger/0000-0003-3306-752X	Department of Veterans Affairs, Veterans Health Administration, and Health Services Research and Development Service [PMI 03-195, REA 06-174]; Greenwall Foundation	Department of Veterans Affairs, Veterans Health Administration, and Health Services Research and Development Service(US Department of Veterans Affairs); Greenwall Foundation	Funding/Support: This research was supported by the Department of Veterans Affairs, Veterans Health Administration, and Health Services Research and Development Service Projects PMI 03-195 and REA 06-174. Some research team members received training on chronic pain communication skills developed with a grant from the Greenwall Foundation.	Ahles TA, 2006, ANN FAM MED, V4, P341, DOI 10.1370/afm.527; *AM CHRON PAIN ASS, 2005, PATHW PAIN; [Anonymous], 1998, J Am Geriatr Soc, V46, P635; Bair MJ, 2005, J GEN INTERN MED, V20, P62; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; BALDERSON B, 2004, UNDERSTANDING TREATI; Becker N, 2000, PAIN, V84, P203, DOI 10.1016/S0304-3959(99)00209-2; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Chelminski PR, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-3; Cherkin DC, 1996, SPINE, V21, P345, DOI 10.1097/00007632-199602010-00019; Clark JD, 2002, J PAIN SYMPTOM MANAG, V23, P131, DOI 10.1016/S0885-3924(01)00396-7; Cocco KM, 1998, PSYCHOL ASSESSMENT, V10, P408, DOI 10.1037/1040-3590.10.4.408; Crosby FE, 2006, PAIN MANAG NURS, V7, P12, DOI 10.1016/j.pmn.2005.12.001; Dobscha SK, 2008, PAIN MED, V9, P1050, DOI 10.1111/j.1526-4637.2008.00457.x; Dobscha SK, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-16; Elliott AM, 2000, PAIN, V88, P303, DOI 10.1016/S0304-3959(00)00337-7; Eriksen J, 2006, PAIN, V125, P172, DOI 10.1016/j.pain.2006.06.009; Farrar JT, 2000, PAIN, V88, P287, DOI 10.1016/S0304-3959(00)00339-0; Ferrell B, 2002, J AM GERIATR SOC, V50, pS205, DOI 10.1046/j.1532-5415.50.6s.1.x; Grotle M, 2005, SPINE, V30, P130, DOI 10.1097/01.brs.0000149184.16509.73; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; Harper R, 1997, THORAX, V52, P879, DOI 10.1136/thx.52.10.879; Jenkinson C, 1997, MED CARE, V35, P1109, DOI 10.1097/00005650-199711000-00003; Katon W, 1999, ARCH GEN PSYCHIAT, V56, P1109, DOI 10.1001/archpsyc.56.12.1109; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; KERNS RD, 1988, J CONSULT CLIN PSYCH, V56, P870, DOI 10.1037/0022-006X.56.6.870; Kirsch B, 2000, VHSJ, P49; KIRSCH B, 2000, VET HLTH SYSTEM J, V5, P53; KIRSCH B, 2000, VHSJ, V5, P47; KIRSCH B, 2000, VET HLTH SYSTEM J, V5, P59; Koike AK, 2002, AM J PSYCHIAT, V159, P1738, DOI 10.1176/appi.ajp.159.10.1738; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lauridsen HH, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-82; Lin EHB, 1997, MED CARE, V35, P831, DOI 10.1097/00005650-199708000-00008; Lin EHB, 2003, JAMA-J AM MED ASSOC, V290, P2428, DOI 10.1001/jama.290.18.2428; Litz B.T, 1993, PTSD CHECKL PCL REL; Liu CF, 2007, AM J MANAG CARE, V13, P652; Luo N, 2005, MED CARE, V43, P1078, DOI 10.1097/01.mlr.0000182493.57090.c1; PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011; Raudenbush Stephen, 2004, HLM 6; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Reid MC, 2002, J GEN INTERN MED, V17, P173, DOI 10.1046/j.1525-1497.2002.10435.x; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; Saha S, 2008, J GEN INTERN MED, V23, P654, DOI 10.1007/s11606-008-0521-4; Sloan KL, 2003, MED CARE, V41, P761, DOI 10.1097/00005650-200306000-00009; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stratford PW, 1998, PHYS THER, V78, P1186, DOI 10.1093/ptj/78.11.1186; Sullivan MD, 2006, J GEN INTERN MED, V21, P360, DOI 10.1111/j.1525-1497.2006.00352.x; Turk DC, 2002, CLIN J PAIN, V18, P355, DOI 10.1097/00002508-200211000-00003; Turk DC, 2003, PAIN, V106, P337, DOI 10.1016/j.pain.2003.08.001; Unutzer J, 2001, MED CARE, V39, P785, DOI 10.1097/00005650-200108000-00005; *US BUR CENS, VET 2000 CENS 2000; *US DEP VET AFF, VETOPO2007 VERS 1 0; *VA DEP DEF, MAN OP THER CHRON PA; *VA OFF QUAL PERF, VET SAT PERC PAT REP; Verhaak PFM, 1998, PAIN, V77, P231, DOI 10.1016/S0304-3959(98)00117-1; Von Korff M, 2005, PAIN, V113, P323, DOI 10.1016/j.pain.2004.11.007; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Weathers FW, 1996, MEASUREMENT STRESS T; Weingarten SR, 2002, BRIT MED J, V325, P925, DOI 10.1136/bmj.325.7370.925; Weinger K, 2003, DIABETES SPECTRUM, V16, P104, DOI DOI 10.2337/; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Williams JW, 2007, GEN HOSP PSYCHIAT, V29, P91, DOI 10.1016/j.genhosppsych.2006.12.003	67	226	226	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 25	2009	301	12					1242	1252		10.1001/jama.2009.377	http://dx.doi.org/10.1001/jama.2009.377			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423JO	19318652				2022-12-28	WOS:000264492800024
J	Zheng, XT; You, HL; Xu, X; Dong, ZM				Zheng, Xiao-Ting; You, Hai-Lu; Xu, Xing; Dong, Zhi-Ming			An Early Cretaceous heterodontosaurid dinosaur with filamentous integumentary structures	NATURE			English	Article							ORNITHISCHIAN DINOSAURS; FEATHERS; CHINA; ORIGIN; BIRD; SINOSAUROPTERYX	Ornithischia is one of the two major groups of dinosaurs, with heterodontosauridae as one of its major clades. Heterodontosauridae is characterized by small, gracile bodies and a problematic phylogenetic position(1,2). Recent phylogenetic work indicates that it represents the most basal group of all well-known ornithischians(3). Previous heterodontosaurid records are mainly from the Early Jurassic period (205-190 million years ago) of Africa(1,3). Here we report a new heterodontosaurid, Tianyulong confuciusi gen. et sp. nov., from the Early Cretaceous period (144-99 million years ago) of western Liaoning Province, China. Tianyulong extends the geographical distribution of heterodontosaurids to Asia and confirms the clade's previously questionable temporal range extension into the Early Cretaceous period. More surprisingly, Tianyulong bears long, singular and unbranched filamentous integumentary (outer skin) structures. This represents the first confirmed report, to our knowledge, of filamentous integumentary structures in an ornithischian dinosaur.	[You, Hai-Lu] Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; [Zheng, Xiao-Ting] Shandong Tianyu Museum Nat, Pingyi 273300, Shandong, Peoples R China; [Xu, Xing; Dong, Zhi-Ming] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China	Chinese Academy of Geological Sciences; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	You, HL (corresponding author), Chinese Acad Geol Sci, Inst Geol, 26 Baiwanzhuang Rd, Beijing 100037, Peoples R China.	youhailu@gmail.com		You, Hai-Lu/0000-0003-2203-6461	National Natural Science Foundation of China [40672007]; Ministry of Science and Technology; Hundred Talents Project of the Ministry of Land and Resources of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Hundred Talents Project of the Ministry of Land and Resources of China	We thank P.-J. Chen for arranging the study, Y.-Q. Zhang for preparing the specimen, J. D. Harris for improving the manuscript, and L.-D. Xing for drawing Fig. 1d. H.-L. Y. was supported by grants from the National Natural Science Foundation of China (40672007), the 973 Project and the Basic Outlay of Scientific Research Work from the Ministry of Science and Technology, and the Hundred Talents Project of the Ministry of Land and Resources of China.	Butler RJ, 2008, J VERTEBR PALEONTOL, V28, P702, DOI 10.1671/0272-4634(2008)28[702:AJSOTP]2.0.CO;2; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Currie PJ, 2001, CAN J EARTH SCI, V38, P1705, DOI 10.1139/e01-050; Feduccia A, 2005, J MORPHOL, V266, P125, DOI 10.1002/jmor.10382; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Ji Q., 2004, MESOZOIC JEHOL BIOTA; [季强 Ji Qiang], 2002, [地质论评, Geological Review], V48, P221; Jones TD, 2000, SCIENCE, V288, P2202, DOI 10.1126/science.288.5474.2202; Lingham-Soliar T, 2007, P ROY SOC B-BIOL SCI, V274, P1823, DOI 10.1098/rspb.2007.0352; Mayr G, 2002, NATURWISSENSCHAFTEN, V89, P361, DOI 10.1007/s00114-002-0339-6; Naish D, 2008, J GEOL SOC LONDON, V165, P613, DOI 10.1144/0016-76492007-154; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P393; Norman DB, 2002, SPEC PAP PALAEONTOL, P161; Prum RO, 2002, Q REV BIOL, V77, P261, DOI 10.1086/341993; Reisz RR, 2000, NATURE, V408, P428, DOI 10.1038/35044204; Sanchez-Hernandez B, 2007, PALAEOGEOGR PALAEOCL, V249, P180, DOI 10.1016/j.palaeo.2007.01.009; SHAROV AG, 1970, PALEONTOL J, P112; Voigt S, 2009, NATURWISSENSCHAFTEN, V96, P81, DOI 10.1007/s00114-008-0453-1; Wang XL, 2002, CHINESE SCI BULL, V47, P226, DOI 10.1360/02tb9054; Weiss K M, 1990, Epidemiology, V1, P486, DOI 10.1097/00001648-199011000-00012; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589; Xu X, 2006, INTEGR ZOOL, V1, P4, DOI 10.1111/j.1749-4877.2006.00004.x; Xu X, 2006, P ROY SOC B-BIOL SCI, V273, P2135, DOI 10.1098/rspb.2006.3566; Yu MK, 2002, NATURE, V420, P308, DOI 10.1038/nature01196; Zhang FC, 2000, SCIENCE, V290, P1955, DOI 10.1126/science.290.5498.1955; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zhang FC, 2008, SCI CHINA SER D, V51, P625, DOI 10.1007/s11430-008-0050-3; Zhang FC, 2006, GEOL J, V41, P395, DOI 10.1002/gj.1057; Zheng XT, 2007, ACTA GEOL SIN-ENGL, V81, P703; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	30	121	130	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 19	2009	458	7236					333	336		10.1038/nature07856	http://dx.doi.org/10.1038/nature07856			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19295609				2022-12-28	WOS:000264285600040
J	Ali, O; Srikantha, M; Bhat, W; Uzoigwe, CE				Ali, Omer; Srikantha, Maithili; Bhat, Waseem; Uzoigwe, Chika Edward			Picture Quiz Postural headache	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SPONTANEOUS INTRACRANIAL HYPOTENSION; MARFAN-SYNDROME		[Ali, Omer; Srikantha, Maithili; Uzoigwe, Chika Edward] Milton Keynes Dist Gen Hosp, Milton Keynes MK6 5LD, Bucks, England; [Bhat, Waseem] Hull Royal Infirm, Kingston Upon Hull HU3 2JZ, N Humberside, England	University of Hull	Ali, O (corresponding author), Milton Keynes Dist Gen Hosp, Milton Keynes MK6 5LD, Bucks, England.	omerali@doctors.org.uk						Berroir S, 2004, NEUROLOGY, V63, P1950, DOI 10.1212/01.WNL.0000144339.34733.E9; Cheuret E, 2008, CHILD NERV SYST, V24, P509, DOI 10.1007/s00381-007-0506-3; Couch JR, 2008, CURR TREAT OPTION NE, V10, P3, DOI 10.1007/s11940-008-0001-5; DAVENPORT RJ, 1995, J NEUROL NEUROSUR PS, V59, P516, DOI 10.1136/jnnp.59.5.516; Fattori R, 1999, LANCET, V354, P910, DOI 10.1016/S0140-6736(98)12448-0; Roos KL, 2003, SEMIN NEUROL, V23, P105; Schievink WI, 2006, JAMA-J AM MED ASSOC, V295, P2286, DOI 10.1001/jama.295.19.2286; Schievink WI, 2005, J NEUROSURG, V103, P608, DOI 10.3171/jns.2005.103.4.0608; Schievink WI, 2004, J NEUROSURG, V100, P1098, DOI 10.3171/jns.2004.100.6.1098; Schievink WI, 2003, ARCH NEUROL-CHICAGO, V60, P1713, DOI 10.1001/archneur.60.12.1713; Schievink WI, 1998, J NEUROSURG, V88, P243, DOI 10.3171/jns.1998.88.2.0243; Schrijver I, 2002, J NEUROSURG, V96, P483, DOI 10.3171/jns.2002.96.3.0483; Vishteh AG, 1998, J NEUROSURG, V89, P483, DOI 10.3171/jns.1998.89.3.0483; Wijdicks EFM, 1998, NEUROSURGERY, V42, P769, DOI 10.1097/00006123-199804000-00053; Winter SCA, 2002, J NEUROSURG, V96, P343, DOI 10.3171/spi.2002.96.3.0343	15	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2009	338								b911	10.1136/bmj.b911	http://dx.doi.org/10.1136/bmj.b911			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422NV	19299414				2022-12-28	WOS:000264435900011
J	Lopez-Jimenez, F				Lopez-Jimenez, Francisco			Speakable and unspeakable facts about BMI and mortality	LANCET			English	Editorial Material							BODY-COMPOSITION; ADIPOSITY; OBESITY; WEIGHT; RISK		Mayo Clin, Coll Med, Mayo Fdn, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic	Lopez-Jimenez, F (corresponding author), Mayo Clin, Coll Med, Mayo Fdn, Div Cardiovasc Dis, Rochester, MN 55905 USA.	lopez@mayo.edu						Akinnusi ME, 2008, CRIT CARE MED, V36, P151, DOI 10.1097/01.CCM.0000297885.60037.6E; Jankowski CM, 2008, OBESITY, V16, P1039, DOI 10.1038/oby.2007.84; Kassirer JP, 1998, NEW ENGL J MED, V338, P52, DOI 10.1056/NEJM199801013380109; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Oliveros H, 2008, OBESITY, V16, P515, DOI 10.1038/oby.2007.102; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Romero-Corral A, 2008, J AM COLL CARDIOL, V51, pA350; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Snijder MB, 2004, J HYPERTENS, V22, P2339, DOI 10.1097/00004872-200412000-00016; Van Pelt RE, 2005, J CLIN ENDOCR METAB, V90, P4573, DOI 10.1210/jc.2004-1764; Wannamethee SG, 2005, AM J CLIN NUTR, V82, P996, DOI 10.1093/ajcn/82.5.996; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	13	32	32	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2009	373	9669					1055	1056		10.1016/S0140-6736(09)60628-0	http://dx.doi.org/10.1016/S0140-6736(09)60628-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427IS	19328986				2022-12-28	WOS:000264773600004
J	Glynn, RJ; Danielson, E; Fonseca, FAH; Genest, J; Gotto, AM; Kastelein, JJP; Koenig, W; Libby, P; Lorenzatti, AJ; MacFadyen, JG; Nordestgaard, BG; Shepherd, J; Willerson, JT; Ridker, PM				Glynn, Robert J.; Danielson, Eleanor; Fonseca, Francisco A. H.; Genest, Jacques; Gotto, Antonio M., Jr.; Kastelein, John J. P.; Koenig, Wolfgang; Libby, Peter; Lorenzatti, Alberto J.; MacFadyen, Jean G.; Nordestgaard, Borge G.; Shepherd, James; Willerson, James T.; Ridker, Paul M.			A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; ARTERIAL CARDIOVASCULAR EVENTS; COA REDUCTASE INHIBITORS; DEEP-VEIN THROMBOSIS; LOW-DOSE ASPIRIN; RISK-FACTORS; PULMONARY-EMBOLISM; STATIN THERAPY; DISEASE; HEART	BACKGROUND Controversy persists regarding the extent of shared pathways between arterial and venous thrombosis and whether treatments of known efficacy for one disease process have consistent benefits for the other. Observational studies have yielded variable estimates of the effect of statin therapy on the risk of venous thromboembolism, and evidence from randomized trials is lacking. METHODS We randomly assigned 17,802 apparently healthy men and women with both low-density lipoprotein (LDL) cholesterol levels of less than 130 mg per deciliter (3.4 mmol per liter) and high-sensitivity C-reactive protein levels of 2.0 mg per liter or higher to receive rosuvastatin, 20 mg per day, or placebo. We followed participants for the first occurrence of pulmonary embolism or deep-vein thrombosis and performed analyses of the data on an intention-to-treat basis. RESULTS During a median follow-up period of 1.9 years (maximum, 5.0), symptomatic venous thromboembolism occurred in 94 participants: 34 in the rosuvastatin group and 60 in the placebo group. The rates of venous thromboembolism were 0.18 and 0.32 event per 100 person-years of follow-up in the rosuvastatin and placebo groups, respectively (hazard ratio with rosuvastatin, 0.57; 95% confidence interval [CI], 0.37 to 0.86; P = 0.007); the corresponding rates for unprovoked venous thromboembolism (i.e., occurring in the absence of a known malignant condition, trauma, hospitalization, or surgery) were 0.10 and 0.17 (hazard ratio, 0.61; 95% CI, 0.35 to 1.09; P = 0.09) and for provoked venous thromboembolism (i.e., occurring in patients with cancer or during or shortly after trauma, hospitalization, or surgery), 0.08 and 0.16 (hazard ratio, 0.52; 95% CI, 0.28 to 0.96; P = 0.03). The rates of pulmonary embolism were 0.09 in the rosuvastatin group and 0.12 in the placebo group (hazard ratio, 0.77; 95% CI, 0.41 to 1.45; P = 0.42), whereas the rates of deep-vein thrombosis only were 0.09 and 0.20, respectively (hazard ratio, 0.45; 95% CI, 0.25 to 0.79; P = 0.004). Consistent effects were observed in all the subgroups examined. No significant differences were seen between treatment groups in the rates of bleeding episodes. CONCLUSIONS In this trial of apparently healthy persons, rosuvastatin significantly reduced the occurrence of symptomatic venous thromboembolism. (ClinicalTrials.gov number, NCT00239681.)	[Glynn, Robert J.; Danielson, Eleanor; MacFadyen, Jean G.; Ridker, Paul M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; [Libby, Peter; Ridker, Paul M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02215 USA; [Fonseca, Francisco A. H.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Genest, Jacques] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Gotto, Antonio M., Jr.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Koenig, Wolfgang] Univ Ulm, Ulm, Germany; [Lorenzatti, Alberto J.] Hosp Cordoba, Cordoba, Argentina; [Nordestgaard, Borge G.] Univ Copenhagen, Herlev Hosp, Copenhagen Univ Hosp, DK-2730 Herlev, Denmark; [Shepherd, James] Univ Glasgow, Glasgow, Lanark, Scotland; [Willerson, James T.] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Universidade Federal de Sao Paulo (UNIFESP); McGill University; Cornell University; University of Amsterdam; Academic Medical Center Amsterdam; Ulm University; University of Copenhagen; Herlev & Gentofte Hospital; University of Glasgow; Saint Lukes Episcopal Hospital; Texas Heart Institute	Glynn, RJ (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, 900 Commonwealth Ave, Boston, MA 02215 USA.	rglynn@rics.bwh.harvard.edu	Kastelein, John/AAF-7950-2020; Complexos, INCT Fluidos/H-9172-2013; Fonseca, Francisco Antonio Helfenstein/A-6480-2010; Libby, Peter/AAY-6404-2021; Nordestgaard, Borge Gronne/ABF-1310-2020	Fonseca, Francisco Antonio Helfenstein/0000-0002-9911-4598; Libby, Peter/0000-0002-1502-502X; Koenig, Wolfgang/0000-0002-2064-9603; Venkatasubramanian, Siddharth/0000-0002-5860-0768	AstraZeneca; National Institute on Aging [AG031061]; NATIONAL INSTITUTE ON AGING [R01AG031061] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported primarily by AstraZeneca and also by a grant from the National Institute on Aging (AG031061).	Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204; Agnelli G, 2006, J THROMB HAEMOST, V4, P1886, DOI 10.1111/j.1538-7836.2006.02138.x; Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Chamberlain AM, 2008, BLOOD, V112, P2675, DOI 10.1182/blood-2008-05-157412; Doggen CJM, 2004, J THROMB HAEMOST, V2, P700, DOI 10.1111/j.1538-7836.2004.00696.x; Eichinger S, 2007, CIRCULATION, V115, P1609, DOI 10.1161/CIRCULATIONAHA.106.649954; EVERETT BM, 2009, J THROMB HAEMOS 0124; Glynn RJ, 2005, AM J EPIDEMIOL, V162, P975, DOI 10.1093/aje/kwi309; Glynn RJ, 2007, ANN INTERN MED, V147, P525, DOI 10.7326/0003-4819-147-8-200710160-00004; Glynn RJ, 2006, J CLIN EPIDEMIOL, V59, P819, DOI 10.1016/j.jclinepi.2005.12.012; Goldhaber SZ, 1997, JAMA-J AM MED ASSOC, V277, P642, DOI 10.1001/jama.277.8.642; Grady D, 2000, ANN INTERN MED, V132, P689, DOI 10.7326/0003-4819-132-9-200005020-00002; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hansson PO, 1999, ARCH INTERN MED, V159, P1886, DOI 10.1001/archinte.159.16.1886; Kaba NK, 2004, J THROMB HAEMOST, V2, P718, DOI 10.1111/j.1538-7836.2004.00658.x; Lacut K, 2004, FUND CLIN PHARMACOL, V18, P477, DOI 10.1111/j.1472-8206.2004.00252.x; Lowe GDO, 2006, J THROMB HAEMOST, V4, P1882, DOI 10.1111/j.1538-7836.2006.02130.x; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157; Ramcharan AS, 2009, J THROMB HAEMOST, V7, P514, DOI 10.1111/j.1538-7836.2008.03235.x; Ray JG, 2004, J THROMB HAEMOST, V2, P695, DOI 10.1111/j.1538-7836.2004.00705.x; Ray JG, 2001, ARCH INTERN MED, V161, P1405, DOI 10.1001/archinte.161.11.1405; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2007, AM J CARDIOL, V100, P1659, DOI 10.1016/j.amjcard.2007.09.072; Ridker PM, 1997, NEW ENGL J MED, V337, P356; Sen-Banerjee S, 2005, CIRCULATION, V112, P720, DOI 10.1161/CIRCULATIONAHA.104.525774; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Smeeth L, 2009, BRIT J CLIN PHARMACO, V67, P99, DOI 10.1111/j.1365-2125.2008.03308.x; Sorensen HT, 2009, J THROMB HAEMOST, V7, P521, DOI 10.1111/j.1538-7836.2009.03279.x; Sorensen HT, 2007, LANCET, V370, P1773, DOI 10.1016/S0140-6736(07)61745-0; Tsai AW, 2002, AM J MED, V113, P636, DOI 10.1016/S0002-9343(02)01345-1; Tsai AW, 2002, ARCH INTERN MED, V162, P1182, DOI 10.1001/archinte.162.10.1182; Undas A, 2005, ARTERIOSCL THROM VAS, V25, P287, DOI 10.1161/01.ATV.0000151647.14923.ec; Vaitkus PT, 2005, THROMB HAEMOSTASIS, V93, P76, DOI 10.1160/TH04-05-0323; Yang CC, 2002, BRIT J CLIN PHARMACO, V53, P101, DOI 10.1046/j.0306-5251.2001.01523.x	36	542	557	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2009	360	18					1851	1861		10.1056/NEJMoa0900241	http://dx.doi.org/10.1056/NEJMoa0900241			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	438MU	19329822	Green Accepted			2022-12-28	WOS:000265560300007
J	Yusuf, S; Haridas, KK; Iyengar, SS; Jaison, TM; Joshi, P; Kerkar, P; Naik, S; Prabhakaran, D; Thanikachalam, S; Thomas, N; Parwani, J; Maseeh, A; Srinivasulu, B; Srinivas, J; Rangadham, K; Rayadurgee, NM; Balaji, Y; Bhavishya, Y; Parikh, K; Chag, M; Shah, U; Joseph, JJJ; Nesaraj, KJ; Malarvizhi, V; Patil, CB; Bantwal, G; Nagesh, H; Santosh, MI; Dwivedi, S; Ramesh, SS; Suresh, S; Ayyar, V; Rana, P; Tumari, DP; Agarwal, NB; Deshpande, N; Bhagchandani, R; Bhagchandani, S; Gupta, BK; Agarwal, DK; Panwar, RB; Bindu, AV; Alexander, KG; Pradeep, R; Nambiar, A; Das, CK; Ramu, M; Nayar, P; Poongothai, S; Mohan, V; Chidambaram, N; Diwan, R; Umarani, R; Bhuvaneswaran, JS; Mehta, A; Mittal, A; Sahwnay, JPS; Sidhu, G; Mehta, R; Singh, R; Bhambari, S; Rain, AR; Sastry, BKS; Rao, D; Karmalkar, M; Shah, PK; Govindaiah, P; Dharmi, S; Joshi, S; Naik, S; Gulla, SP; Rao, SP; Bharani, A; Patel, A; Mishra, BS; Chandwani, P; Gupta, R; Sreenivas, N; Reddy, SVR; Reddy, TVK; Kumar, V; Roy, DG; Paul, SK; Puri, A; Fisher, L; Sinha, N; Saxena, P; Kumar, S; Puri, VK; Modi, A; Thacker, HP; Mehta, K; Mehta, P; Srinivas, A; Guruprasad, HP; Bawangade, A; Khan, A; Jain, AS; Sane, D; Deshpande, M; Singh, H; Singh, M; Varma, S; Hiremath, J; Mehta, M; Bendarkar, S; Jain, RK; Rao, SP; Leela, AC; Devendrappa, HR; Narendra, J; Manoi, EB; Mohanan, PP; Vijayraghavan, G; Padmaja, NP; Thomas, N; Subitha, S; Rao, B; Rao, KD; Ganvir, B; Joshi, R; Kalantri, SP; Grish, P; Pais, P; Sigamani, A; Thomas, T; Xavier, D; Xavier, F; Afzal, R; Collingwood, B; Copland, I; Cunningham, J; Eikelboom, J; Johnston, M; Teo, K; Pais, P; Afazal, R; Mohan, V; Gupta, R; Thomas, N				Yusuf, S.; Haridas, K. K.; Iyengar, S. S.; Jaison, T. M.; Joshi, P.; Kerkar, P.; Naik, S.; Prabhakaran, D.; Thanikachalam, S.; Thomas, N.; Parwani, J.; Maseeh, A.; Srinivasulu, B.; Srinivas, J.; Rangadham, K.; Rayadurgee, N. M.; Balaji, Y.; Bhavishya, Y.; Parikh, K.; Chag, M.; Shah, U.; Joseph, J. J. J.; Nesaraj, K. J.; Malarvizhi, V.; Patil, C. B.; Bantwal, G.; Nagesh, H.; Santosh, M. I.; Dwivedi, S.; Ramesh, S. S.; Suresh, S.; Ayyar, V.; Rana, P.; Tumari, D. P.; Agarwal, N. B.; Deshpande, N.; Bhagchandani, R.; Bhagchandani, S.; Gupta, B. K.; Agarwal, D. K.; Panwar, R. B.; Bindu, A. V.; Alexander, K. G.; Pradeep, R.; Nambiar, A.; Das, C. K.; Ramu, M.; Nayar, P.; Poongothai, S.; Mohan, V.; Chidambaram, N.; Diwan, R.; Umarani, R.; Bhuvaneswaran, J. S.; Mehta, A.; Mittal, A.; Sahwnay, J. P. S.; Sidhu, G.; Mehta, R.; Singh, R.; Bhambari, S.; Rain, A. R.; Sastry, B. K. S.; Rao, D.; Karmalkar, M.; Shah, P. K.; Govindaiah, P.; Dharmi, S.; Joshi, S.; Naik, S.; Gulla, S. P.; Rao, S. P.; Bharani, A.; Patel, A.; Mishra, B. S.; Chandwani, P.; Gupta, R.; Sreenivas, N.; Reddy, S. V. R.; Reddy, T. V. K.; Kumar, V.; Roy, D. G.; Paul, S. K.; Puri, A.; Fisher, L.; Sinha, N.; Saxena, P.; Kumar, S.; Puri, V. K.; Modi, A.; Thacker, H. P.; Mehta, K.; Mehta, P.; Srinivas, A.; Guruprasad, H. P.; Bawangade, A.; Khan, A.; Jain, A. S.; Sane, D.; Deshpande, M.; Singh, H.; Singh, M.; Varma, S.; Hiremath, J.; Mehta, M.; Bendarkar, S.; Jain, R. K.; Rao, S. P.; Leela, A. C.; Devendrappa, H. R.; Narendra, J.; Manoi, E. B.; Mohanan, P. P.; Vijayraghavan, G.; Padmaja, N. P.; Thomas, N.; Subitha, S.; Rao, B.; Rao, K. D.; Ganvir, B.; Joshi, R.; Kalantri, S. P.; Grish, P.; Pais, P.; Sigamani, A.; Thomas, T.; Xavier, D.; Xavier, F.; Afzal, R.; Collingwood, B.; Copland, I.; Cunningham, J.; Eikelboom, J.; Johnston, M.; Teo, K.; Pais, P.; Afazal, R.; Mohan, V.; Gupta, R.; Thomas, N.			Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial	LANCET			English	Article							MYOCARDIAL-INFARCTION; VASCULAR-DISEASE; METAANALYSIS; CHOLESTEROL; STATINS; STROKE	Background The combination of three blood-pressure-lowering drugs at low doses, with a statin, aspirin, and folic acid (the polypill), could reduce cardiovascular events by more than 80% in healthy individuals. We examined the effect of the Polycap on blood pressure, lipids, heart rate, and urinary thromboxane 132, and assessed its tolerability. Methods In a double-blind trial in 50 centres in India, 2053 individuals without cardiovascular disease, aged 45-80 years, and with one risk factor were randomly assigned, by a central secure website, to the Polycap (n=412) consisting of low doses of thiazide (12.5 mg), atenolol (50 mg), ramipril (5 mg), simvastatin (20 mg), and aspirin (100 mg) per day; or to eight other groups, each with about 200 individuals, of aspirin alone, simvastatin alone, hydrochlorthiazide alone, three combinations of the two blood-pressure-lowering drugs, three blood-pressure-lowering drugs alone, or three blood-pressure-lowering drugs plus aspirin. The primary outcomes were LDL for the effect of lipids, blood pressure for antihypertensive drugs, heart rate for the effects of atenolol, urinary 11-dehydrothromboxane B2 for the antiplatelet effects of aspirin, and rates of discontinuation of drugs for safety. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00443794. Findings Compared with groups not receiving blood-pressure-lowering drugs, the Polycap reduced systolic blood pressure by 7.4 mm Hg (95% CI 6.1-8.1) and diastolic blood pressure by 5.6 mm Hg (4.7-6.4), which was similar when three blood-pressure-lowering drugs were used, with or without aspirin. Reductions in blood pressure increased with the number of drugs used (2.2/1.3 mm Hg with one drug, 4.7/3.6 mm Hg with two drugs, and 6.3/4.5 mm Hg with three drugs). Polycap reduced LDL cholesterol by 0.70 mmol/L (95% CI 0.62-0.78),which was less than that with simvastatin alone (0.83 mmol/L, 0.72-0.93; p=0.04); both reductions were greater than for groups without simvastatin (p<0.0001). The reductions in heart rate with Polycap and other groups using atenolol were similar (7.0 beats per min), and both were significantly greater than that in groups without atenolol (p<0.0001). The reductions in 11-dehydrothromboxane B2 were similar with the Polycap (283.1 ng/mmol creatinine, 95% CI 229.1-337.0) compared with the three blood. p res sure-lowering drugs plus aspirin (350.0 ng/mmol creatinine, 294.6-404.0), and aspirin alone (348.8 ng/mmol creatinine, 277.6-419.9) compared with groups without aspirin. Tolerability of the Polycap was similar to that of other treatments, with no evidence of increasing intolerability with increasing number of active components in one pill. Interpretation This Polycap formulation could be conveniently used to reduce multiple risk factors and cardiovascular risk. Funding Cadila Pharmaceuticals, Ahmedabad, India.	[Yusuf, S.] Hamilton Hlth Sci & McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada	McMaster University; Population Health Research Institute	Yusuf, S (corresponding author), Hamilton Hlth Sci & McMaster Univ, Populat Hlth Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca	Nambiar, Arjun/T-6204-2019; Patakamuri, Govindaiah/E-1692-2011; Srinivas, ANS/W-5377-2019; Kalantri, Shriprakash/ABG-9318-2021; Prabhakaran, Dorairaj/B-4147-2011; Eikelboom, John/AAG-6117-2019	Kalantri, Shriprakash/0000-0002-1633-1029; Prabhakaran, Dorairaj/0000-0002-3172-834X; Eikelboom, John/0000-0003-4126-1285; Yusuf, Salim/0000-0003-4776-5601	Cadila Pharmaceuticals, Ahmedabad, India	Cadila Pharmaceuticals, Ahmedabad, India	This study was sponsored by Cadila Pharmaceuticals, Ahmedabad, India. We thank Judy Lindeman for secretarial assistance, and Corgenix (Broomfield, CO, USA) for providing Aspirinworks kits and supporting the costs of performing thromboxane assays.	Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Xavier D, 2009, NAT CLIN PRACT CARD, V6, P96, DOI 10.1038/ncpcardio1438; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Yusuf S, 2002, LANCET, V360, P2, DOI 10.1016/S0140-6736(02)09358-3; Yusuf S, 2000, NEW ENGL J MED, V342, P145	10	354	368	0	41	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 18	2009	373	9672					1341	1351		10.1016/S0140-6736(09)60611-5	http://dx.doi.org/10.1016/S0140-6736(09)60611-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434UR	19339045				2022-12-28	WOS:000265300100032
J	Doumas, M; Douma, S				Doumas, Michael; Douma, Stella			Interventional management of resistant hypertension	LANCET			English	Editorial Material									[Doumas, Michael] George Washington Univ, Vet Affairs Med Ctr, Hypertens & Cardiovasc Res Clin, Washington, DC 20005 USA; [Douma, Stella] Aristotle Univ Thessaloniki, Hippokrat Hosp, Dept Internal Med 2, GR-54006 Thessaloniki, Greece	George Washington University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Aristotle University of Thessaloniki	Doumas, M (corresponding author), George Washington Univ, Vet Affairs Med Ctr, Hypertens & Cardiovasc Res Clin, Washington, DC 20005 USA.	michalisdoumas@yahoo.co.uk		Doumas, Michael/0000-0002-7269-8044				Burke SL, 2008, HYPERTENSION, V51, P278, DOI 10.1161/HYPERTENSIONAHA.107.100800; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; DiBona GF, 2005, AM J PHYSIOL-REG I, V289, pR633, DOI 10.1152/ajpregu.00258.2005; Douma S, 2008, LANCET, V371, P1921, DOI 10.1016/S0140-6736(08)60834-X; Doumas M, 2009, EXPERT OPIN THER TAR, V13, P413, DOI [10.1517/14728220902780185 , 10.1517/14728220902780185]; Kaplan NM, 2008, LANCET, V371, P1890, DOI 10.1016/S0140-6736(08)60809-0; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; MacMahon S, 2008, LANCET, V371, P1480, DOI 10.1016/S0140-6736(08)60632-7; Nishizaka MK, 2003, AM J HYPERTENS, V16, P925, DOI 10.1016/S0895-7061(03)01032-X; PEET MM, 1947, NEW ENGL J MED, V236, P270, DOI 10.1056/NEJM194702202360802; Sarafidis PA, 2008, J AM COLL CARDIOL, V52, P1749, DOI 10.1016/j.jacc.2008.08.036; Wojciechowski D, 2008, J CLIN HYPERTENS, V10, P837, DOI 10.1111/j.1751-7176.2008.00037.x	12	24	53	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2009	373	9671					1228	1230		10.1016/S0140-6736(09)60624-3	http://dx.doi.org/10.1016/S0140-6736(09)60624-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	432PN	19332354				2022-12-28	WOS:000265146300006
J	Gennari, L; Bilezikian, JP				Gennari, Luigi; Bilezikian, John P.			Glucocorticoid-induced osteoporosis: hope on the HORIZON	LANCET			English	Editorial Material							ALENDRONATE; APOPTOSIS; THERAPY; BISPHOSPHONATES; PREVENTION; MECHANISMS; OSTEOCYTE; WOMEN; BONE		[Gennari, Luigi] Univ Siena, Dept Internal Med Endocrine Metab Sci & Biochem, I-53100 Siena, Italy; [Bilezikian, John P.] Columbia Univ, Coll Phys & Surg, Dept Med, Metab Bone Dis Unit,Div Endocrinol, New York, NY USA	University of Siena; Columbia University	Gennari, L (corresponding author), Univ Siena, Dept Internal Med Endocrine Metab Sci & Biochem, I-53100 Siena, Italy.	gennari@unisi.it	Gennari, Luigi/J-7013-2016	Gennari, Luigi/0000-0001-6833-4232				Adler RA, 2003, ARCH INTERN MED, V163, P2619, DOI 10.1001/archinte.163.21.2619; Armamento-Villareal R, 2006, NEW ENGL J MED, V355, P2048, DOI 10.1056/NEJMc062268; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Canalis E, 2007, OSTEOPOROSIS INT, V18, P1319, DOI 10.1007/s00198-007-0394-0; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Plotkin LI, 2005, J BIOL CHEM, V280, P7317, DOI 10.1074/jbc.M412817200; Reid DM, 2009, LANCET, V373, P1253, DOI 10.1016/S0140-6736(09)60250-6; Reid DM, 2000, J BONE MINER RES, V15, P1006, DOI 10.1359/jbmr.2000.15.6.1006; Saag KG, 2007, NEW ENGL J MED, V357, P2028, DOI 10.1056/NEJMoa071408; Saag KG, 1998, NEW ENGL J MED, V339, P292, DOI 10.1056/NEJM199807303390502; Siris ES, 2006, MAYO CLIN PROC, V81, P1013, DOI 10.4065/81.8.1013; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799	12	15	19	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 11	2009	373	9671					1225	1226		10.1016/S0140-6736(09)60704-2	http://dx.doi.org/10.1016/S0140-6736(09)60704-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	432PN	19362657				2022-12-28	WOS:000265146300004
J	Tredget, EE; Ding, J				Tredget, Edward E.; Ding, Jie			Wound healing: from embryos to adults and back again	LANCET			English	Editorial Material									[Tredget, Edward E.] Univ Alberta, Dept Crit Care Med, Div Plast Surg, Edmonton, AB T6G 2B7, Canada; [Ding, Jie] Univ Alberta, Div Plast Surg, Dept Surg, Edmonton, AB T6G 2B7, Canada	University of Alberta; University of Alberta	Tredget, EE (corresponding author), Univ Alberta, Dept Crit Care Med, Div Plast Surg, Edmonton, AB T6G 2B7, Canada.	etredget@ualberta.ca						ARMOUR A, 2007, WOUND REPAIR REGE S1, V15, P56; Cutroneo KR, 2007, WOUND REPAIR REGEN, V15, pS54, DOI 10.1111/j.1524-475X.2007.00226.x; De Crescenzo G, 2006, J MOL BIOL, V355, P47, DOI 10.1016/j.jmb.2005.10.022; Duncan JAL, 2006, PLAST RECONSTR SURG, V118, P909, DOI 10.1097/01.prs.0000232378.88776.b0; Dunkin CSJ, 2007, PLAST RECONSTR SURG, V119, P1722, DOI 10.1097/01.prs.0000258829.07399.f0; Ferguson MWJ, 2009, LANCET, V373, P1264, DOI 10.1016/S0140-6736(09)60322-6; Hansen Wiebke, 2008, Inflammation & Allergy Drug Targets, V7, P217, DOI 10.2174/187152808786848360; Kohama K, 2002, J DENT RES, V81, P688, DOI 10.1177/154405910208101007; LADAK A, CLIN PLASTI IN PRESS; Lakatos HF, 2007, PPAR RES, V2007, DOI 10.1155/2007/71323; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P421; Scheid A, 2002, FASEB J, V16, P411, DOI 10.1096/fj.01-0496fje; SCOTT PG, 1994, ADV STR BIO, V3, P157; SHAH M, 1995, J CELL SCI, V108, P985; Tredget EE, 2006, J INTERF CYTOK RES, V26, P179, DOI 10.1089/jir.2006.26.179	16	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2009	373	9671					1226	1228		10.1016/S0140-6736(09)60705-4	http://dx.doi.org/10.1016/S0140-6736(09)60705-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	432PN	19362658				2022-12-28	WOS:000265146300005
J	Archibald, JM				Archibald, John M.			Green Evolution, Green Revolution	SCIENCE			English	Editorial Material							MARINE ECOSYSTEMS; GENOMIC INSIGHTS; LAND PLANTS; DIVERSITY; SEQUENCE; NUCLEAR; ALGAE		Dalhousie Univ, Canadian Inst Adv Res, Program Integrated Microbial Biodivers, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada	Canadian Institute for Advanced Research (CIFAR); Dalhousie University	Archibald, JM (corresponding author), Dalhousie Univ, Canadian Inst Adv Res, Program Integrated Microbial Biodivers, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada.	john.archibald@dal.ca						COURTIES C, 1994, NATURE, V370, P255, DOI 10.1038/370255a0; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Guillou L, 2004, PROTIST, V155, P193, DOI 10.1078/143446104774199592; Karol KG, 2001, SCIENCE, V294, P2351, DOI 10.1126/science.1065156; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keeling Patrick J, 2007, Trends Genet, V23, P151, DOI 10.1016/j.tig.2007.02.008; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Marin B, 1999, PROTIST, V150, P399, DOI 10.1016/S1434-4610(99)70041-6; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Parker MS, 2008, ANNU REV GENET, V42, P619, DOI 10.1146/annurev.genet.42.110807.091417; Rodriguez-Ezpeleta N, 2007, MOL BIOL EVOL, V24, P723, DOI 10.1093/molbev/msl200; Vaulot D, 2008, FEMS MICROBIOL REV, V32, P795, DOI 10.1111/j.1574-6976.2008.00121.x; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222	15	10	10	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					191	192		10.1126/science.1172972	http://dx.doi.org/10.1126/science.1172972			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	430WX	19359572				2022-12-28	WOS:000265024400028
J	Gerdes, JM; Davis, EE; Katsanis, N				Gerdes, Jantje M.; Davis, Erica E.; Katsanis, Nicholas			The Vertebrate Primary Cilium in Development, Homeostasis, and Disease	CELL			English	Review							BARDET-BIEDL-SYNDROME; POLYCYSTIC KIDNEY-DISEASE; PLANAR CELL POLARITY; LEFT-RIGHT ASYMMETRY; SMOOTH-MUSCLE-CELLS; INTRAFLAGELLAR TRANSPORT PROTEINS; BASAL BODY PROTEIN; JOUBERT-SYNDROME; MECKEL-SYNDROME; KINESIN-II	Cilia are complex structures that have garnered interest because of their roles in vertebrate development and their involvement in human genetic disorders. In contrast to multicellular invertebrates in which cilia are restricted to specific cell types, these organelles are found almost ubiquitously in vertebrate cells, where they serve a diverse set of signaling functions. Here, we highlight properties of vertebrate cilia, with particular emphasis on their relationship with other subcellular structures, and explore the physiological consequences of ciliary dysfunction.	[Gerdes, Jantje M.; Davis, Erica E.; Katsanis, Nicholas] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	Johns Hopkins University	Katsanis, N (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	katsanis@jhmi.edu	Katsanis, Nicholas/E-1837-2012; Gerdes, Jantje Mareike/M-9868-2014	Gerdes, Jantje Mareike/0000-0001-6885-5441; Davis, Erica/0000-0002-2412-8397; Katsanis, Nicholas/0000-0002-2480-0171	National Institute of Child Health and Development [R01HD04260, R01DK072301, R01DK075972]; National Institute of Diabetes, Digestive and Kidney Disorders [F32 DK079541]; Macular Vision Research Foundation; Foundation for Fighting Blindness; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK079541, R01DK072301, R01DK075972] Funding Source: NIH RePORTER	National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Diabetes, Digestive and Kidney Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Macular Vision Research Foundation; Foundation for Fighting Blindness; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are indebted to J. Badano, E. Oh, J. Robinson, and N. Zaghloul for their critical review of the manuscript and A. Gherman for technical assistance. This work was supported by grant R01HD04260 from the National Institute of Child Health and Development (N.K.), R01DK072301, and R01DK075972 (N.K.) and NRSA fellowship F32 DK079541 (E.E.D.) from the National Institute of Diabetes, Digestive and Kidney Disorders, the Macular Vision Research Foundation (N.K.), and the Foundation for Fighting Blindness (N.K.).	Abdelkhalek Hanaa Ben, 2004, Genes Dev, V18, P1725; Adler PN, 2004, CURR BIOL, V14, P2046, DOI 10.1016/j.cub.2004.11.007; AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Beckers A, 2007, P NATL ACAD SCI USA, V104, P17554; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Bergmann C, 2008, AM J HUM GENET, V82, P959, DOI 10.1016/j.ajhg.2008.02.017; Bonnafe E, 2004, MOL CELL BIOL, V24, P4417, DOI 10.1128/MCB.24.10.4417-4427.2004; Brailov I, 2000, BRAIN RES, V872, P271, DOI 10.1016/S0006-8993(00)02519-1; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; DUTCHER SK, 1995, TRENDS GENET, V11, P398, DOI 10.1016/S0168-9525(00)89123-4; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Eley L, 2004, CELL BIOL INT, V28, P119, DOI 10.1016/j.cellbi.2003.11.009; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; Feistel K, 2006, DEV DYNAM, V235, P3348, DOI 10.1002/dvdy.20986; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Fromherz S, 2004, J CELL SCI, V117, P303, DOI 10.1242/jcs.00859; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Haraguchi K, 2006, J BIOL CHEM, V281, P4094, DOI 10.1074/jbc.M507028200; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Hill P, 2007, HUM MOL GENET, V16, P2089, DOI 10.1093/hmg/ddm156; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Houde C, 2006, DEV BIOL, V300, P523, DOI 10.1016/j.ydbio.2006.09.001; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Karmous-Benailly H, 2005, AM J HUM GENET, V76, P493, DOI 10.1086/428679; Keller LC, 2009, MOL BIOL CELL, V20, P1150, DOI 10.1091/mbc.E08-06-0619; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Le Bot N, 1998, J CELL BIOL, V143, P1559, DOI 10.1083/jcb.143.6.1559; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Liu SM, 2002, DEVELOPMENT, V129, P5839, DOI 10.1242/dev.00173; Liu Y, 2007, DEVELOPMENT, V134, P1111, DOI 10.1242/dev.02806; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Ma M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030018; Mahjoub MR, 2005, J AM SOC NEPHROL, V16, P3485, DOI 10.1681/ASN.2005080824; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; McEwen DP, 2007, P NATL ACAD SCI USA, V104, P15917, DOI 10.1073/pnas.0704140104; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Nurnberger J, 2002, MOL BIOL CELL, V13, P3096, DOI 10.1091/mbc.E02-04-0195; O'Connell MJ, 2003, TRENDS CELL BIOL, V13, P221, DOI 10.1016/S0962-8924(03)00056-4; Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892; Omori Y, 2008, NAT CELL BIOL, V10, P437, DOI 10.1038/ncb1706; Pan JM, 2004, DEV CELL, V6, P445, DOI 10.1016/S1534-5807(04)00064-4; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Poole CA, 1997, CELL BIOL INT, V21, P483, DOI 10.1006/cbir.1997.0177; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Qian Q, 2003, J AM SOC NEPHROL, V14, P2280, DOI 10.1097/01.ASN.0000080185.38113.A3; REESE TS, 1965, J CELL BIOL, V25, P209, DOI 10.1083/jcb.25.2.209; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Seto ES, 2004, TRENDS CELL BIOL, V14, P45, DOI 10.1016/j.tcb.2003.11.004; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Tabin CJ, 2006, CELL, V127, P27, DOI 10.1016/j.cell.2006.09.018; Tan PL, 2007, P NATL ACAD SCI USA, V104, P17524, DOI 10.1073/pnas.0706618104; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; Torkko JM, 2008, J CELL SCI, V121, P1193, DOI 10.1242/jcs.015495; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Tsang WY, 2008, DEV CELL, V15, P187, DOI 10.1016/j.devcel.2008.07.004; Tsiokas L, 2007, CELL SIGNAL, V19, P444, DOI 10.1016/j.cellsig.2006.09.005; Upadhya P, 2000, P NATL ACAD SCI USA, V97, P217, DOI 10.1073/pnas.97.1.217; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Vieira OV, 2006, P NATL ACAD SCI USA, V103, P18556, DOI 10.1073/pnas.0608291103; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Wang SX, 2004, J AM SOC NEPHROL, V15, P592, DOI 10.1097/01.ASN.0000113793.12558.1D; Wolf MTF, 2007, KIDNEY INT, V72, P1520, DOI 10.1038/sj.ki.5002630; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; Zhang M, 2004, BIOCHEM BIOPH RES CO, V324, P1413, DOI 10.1016/j.bbrc.2004.09.207	118	537	549	1	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					32	45		10.1016/j.cell.2009.03.023	http://dx.doi.org/10.1016/j.cell.2009.03.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345185	Green Accepted, Bronze			2022-12-28	WOS:000264813300012
J	Lavy, C; James, A; Wilson-MacDonald, J; Fairbank, J				Lavy, Chris; James, Andrew; Wilson-MacDonald, James; Fairbank, Jeremy			Cauda equina syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LUMBAR SPINE; SURGERY; METAANALYSIS; HERNIATION		[Lavy, Chris; James, Andrew; Wilson-MacDonald, James; Fairbank, Jeremy] Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Surg, Oxford OX3 7LD, England	Nuffield Orthopaedic Centre	Lavy, C (corresponding author), Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Surg, Oxford OX3 7LD, England.	christopher.lavy@ndos.ox.ac.uk	Fairbank, Jeremy/AAA-3411-2019					Adilay U, 2007, MINIM INVAS NEUROSUR, V50, P292, DOI 10.1055/s-2007-973822; Ahn H, 2005, SPINE, V30, pE662, DOI 10.1097/01.brs.0000184560.78192.f6; Ahn UM, 2000, SPINE, V25, P1515, DOI 10.1097/00007632-200006150-00010; AKBAR A, 2002, J PAK MED ASS, V96, P52; Bell DA, 2007, BRIT J NEUROSURG, V21, P201, DOI 10.1080/02688690701317144; Cohen David B, 2004, Neurosurg Focus, V16, pe2; Delong WB, 2008, J NEUROSURG-SPINE, V8, P305, DOI 10.3171/SPI/2008/8/4/305; Gleave J, 2005, BRIT J NEUROSURG, V19, P307, DOI 10.1080/02688690500305357; GLEAVE J R W, 1990, British Journal of Neurosurgery, V4, P205, DOI 10.3109/02688699008992725; Gleave JRW, 2002, BRIT J NEUROSURG, V16, P325, DOI 10.1080/0268869021000032887; HALDEMAN S, 1992, SPINE, V17, P1469, DOI 10.1097/00007632-199212000-00005; Haswell K, 2008, SPINE, V33, P68, DOI 10.1097/BRS.0b013e31815e3949; Jensen Randy L, 2004, Neurosurg Focus, V16, pe7; Jerwood D, 2006, BRIT J NEUROSURG, V20, P178, DOI 10.1080/02688690600802691; Kostuik John P, 2004, Neurosurg Focus, V16, pe8; KOSTUIK JP, 1986, J BONE JOINT SURG AM, V68A, P386, DOI 10.2106/00004623-198668030-00011; Loo CC, 1999, ACTA ANAESTH SCAND, V43, P371, DOI 10.1034/j.1399-6576.1999.430402.x; McCarthy MJH, 2007, SPINE, V32, P207, DOI 10.1097/01.brs.0000251750.20508.84; Moonis G, 2003, SPINE, V28, pE430, DOI 10.1097/01.BRS.0000085359.59829.44; Nigam V, 2007, EUR SPINE J, V16, pS322, DOI 10.1007/s00586-006-0272-z; PARKE WW, 1981, J BONE JOINT SURG AM, V63, P53, DOI 10.2106/00004623-198163010-00007; Podnar S, 2007, MUSCLE NERVE, V35, P529, DOI 10.1002/mus.20696; Qureshi A, 2007, EUR SPINE J, V16, P2143, DOI 10.1007/s00586-007-0491-y; Shaw M, 2004, J SPINAL DISORD TECH, V17, P442, DOI 10.1097/01.bsd.0000112086.85112.cf; Todd NV, 2005, BRIT J NEUROSURG, V19, P301, DOI 10.1080/02688690500305324	25	67	67	4	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2009	338								b936	10.1136/bmj.b936	http://dx.doi.org/10.1136/bmj.b936			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429AL	19336488				2022-12-28	WOS:000264893100021
J	Tremblay, M				Tremblay, Michael			Commentary: Risks of doing as the Romans do	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Tremblay Consulting, Ashford TN25 6RJ, Kent, England		Tremblay, M (corresponding author), Tremblay Consulting, Ashford TN25 6RJ, Kent, England.	mike@tremblay-consulting.biz	Tremblay, Michael/L-5325-2019					Ackerly DC, 2009, HEALTH AFFAIR, V28, pW68, DOI 10.1377/hlthaff.28.1.w68; *AG IT FARM, RES PRIOR; COSTAFONT J, 2008, EUROHEALTH, V12, P14; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; PERMANAND G, 2004, REGULATING PHARM EUR, P43	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2009	338								b1107	10.1136/bmj.b1107	http://dx.doi.org/10.1136/bmj.b1107			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429AL	19336490				2022-12-28	WOS:000264893100002
J	Koten, JW; Wood, G; Hagoort, P; Goebel, R; Propping, P; Willmes, K; Boomsma, DI				Koten, Jan Willem, Jr.; Wood, Guilherme; Hagoort, Peter; Goebel, Rainer; Propping, Peter; Willmes, Klaus; Boomsma, Dorret I.			Genetic Contribution to Variation in Cognitive Function: An fMRI Study in Twins	SCIENCE			English	Article							WORKING-MEMORY; BRAIN; HERITABILITY; INFORMATION; LANGUAGE; CORTEX	Little is known about the genetic contribution to individual differences in neural networks subserving cognition function. In this functional magnetic resonance imaging (fMRI) twin study, we found a significant genetic influence on brain activation in neural networks supporting digit working memory tasks. Participants activating frontal-parietal networks responded faster than individuals relying more on language-related brain networks. There were genetic influences on brain activation in language-relevant brain circuits that were atypical for numerical working memory tasks as such. This suggests that differences in cognition might be related to brain activation patterns that differ qualitatively among individuals.	[Koten, Jan Willem, Jr.; Willmes, Klaus] Rhein Westfal TH Aachen, Sect Neuropsychol, Aachen, Germany; [Koten, Jan Willem, Jr.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Wood, Guilherme] Paris Lodron Univ Salzburg, Inst Psychol, Salzburg, Austria; [Hagoort, Peter] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Goebel, Rainer] Maastricht Univ, Fac Psychol, Dept Cognit Neurosci, Maastricht, Netherlands; [Propping, Peter] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Hagoort, Peter] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Goebel, Rainer] Inst Royal Netherlands Acad Arts & Sci KNAW, Netherlands Inst Neurosci, Amsterdam, Netherlands	RWTH Aachen University; Vrije Universiteit Amsterdam; Salzburg University; Radboud University Nijmegen; Maastricht University; University of Bonn; Max Planck Society; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Koten, JW (corresponding author), Rhein Westfal TH Aachen, Sect Neuropsychol, Aachen, Germany.	jan.koten@gmx.de	Willmes, Klaus F/A-1268-2014; Hagoort, Peter/B-7417-2012; Boomsma, Dorret I/AAX-4470-2020	Willmes, Klaus F/0000-0002-9012-0553; Maia de Oliveira Wood, Guilherme/0000-0001-5055-5336; Goebel, Rainer/0000-0003-1780-2467	Netherlands Organisation for Scientific Research (NWO) [DN-58-103]; German Research Foundation (DFG) [WI 1804/3-1&2, PR131/20-1&2]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); German Research Foundation (DFG)(German Research Foundation (DFG))	We thank C. van Baal, K. Amunts, and J. Weber. Grants from the Netherlands Organisation for Scientific Research (NWO) (DN-58-103) and the German Research Foundation (DFG) (WI 1804/3-1 & 2; PR131/20-1&2) are gratefully acknowledged.	Baddeley A.D., 1974, PSYCHOL LEARNING MOT; Bartley AJ, 1997, BRAIN, V120, P257, DOI 10.1093/brain/120.2.257; Boomsma D, 2002, NAT REV GENET, V3, P872, DOI 10.1038/nrg932; Butterworth B., 1999, WHAT COUNTS EVERY BR; Cote C, 2007, HUM BRAIN MAPP, V28, P482, DOI 10.1002/hbm.20400; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Feredoes E, 2007, J NEUROSCI, V27, P11003, DOI 10.1523/JNEUROSCI.1573-07.2007; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Green AE, 2008, NAT REV NEUROSCI, V9, P710, DOI 10.1038/nrn2461; Gruber O, 2004, ACTA PSYCHOL, V115, P105, DOI 10.1016/j.actpsy.2003.12.003; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; HITCH GJ, 1978, COGNITIVE PSYCHOL, V10, P302, DOI 10.1016/0010-0285(78)90002-6; Matthews SC, 2007, NEUROIMAGE, V38, P223, DOI 10.1016/j.neuroimage.2007.07.015; NEALE MC, 2004, MX MANUAL; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; Polk TA, 2007, J NEUROSCI, V27, P13921, DOI 10.1523/JNEUROSCI.4001-07.2007; Posthuma D, 2000, BEHAV GENET, V30, P147, DOI 10.1023/A:1001959306025; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Sakai KL, 2004, CEREB CORTEX, V14, P1233, DOI 10.1093/cercor/bhh084; Schmitt JE, 2008, CEREB CORTEX, V18, P1737, DOI 10.1093/cercor/bhm211; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Sommer IEC, 2002, BRAIN, V125, P2710, DOI 10.1093/brain/awf284; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; van Beijsterveldt CEM, 2002, BIOL PSYCHOL, V61, P111, DOI 10.1016/S0301-0511(02)00055-8; VERNON PA, 1989, PERS INDIV DIFFER, V10, P573, DOI 10.1016/0191-8869(89)90040-8; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255	26	70	71	3	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 27	2009	323	5922					1737	1740		10.1126/science.1167371	http://dx.doi.org/10.1126/science.1167371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325117	Green Published			2022-12-28	WOS:000264559800042
J	McCowan, LME; Dekker, GA; Chan, E; Stewart, A; Chappell, LC; Hunter, M; Moss-Morris, R; North, RA				McCowan, Lesley M. E.; Dekker, Gustaaf A.; Chan, Eliza; Stewart, Alistair; Chappell, Lucy C.; Hunter, Misty; Moss-Morris, Rona; North, Robyn A.		SCOPE Consortium	Spontaneous preterm birth and small for gestational age infants in women who stop smoking early in pregnancy: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							CIGARETTE-SMOKING; PERINATAL-MORTALITY; PERCEIVED STRESS; MAJOR DEPRESSION; WEIGHT STANDARDS; REDUCTION; CESSATION; NICOTINE; COTININE; SMOKERS	Objectives To compare pregnancy outcomes between women who stopped smoking in early pregnancy and those who either did not smoke in pregnancy or continued to smoke. Design Prospective cohort study. Setting Auckland, New Zealand and Adelaide, Australia. Participants 2504 nulliparous women participating in the Screening for Pregnancy Endpoints (SCOPE) study grouped by maternal smoking status at 15 (+/- 1) week's gestation. Main outcome measures Spontaneous preterm birth and small for gestational age infants (birth weight < 10th customised centile). We compared odds of these outcomes between stopped smokers and non-smokers, and between current smokers and stopped smokers, using logistic regression, adjusting for demographic and clinical risk factors. Results 80% (n=1992) of women were non-smokers, 10% (n=261) had stopped smoking, and 10% (n=251) were current smokers. We noted no differences in rates of spontaneous preterm birth (4%, n=88 v 4%, n=10; adjusted odds ratio 1.03, 95% confidence interval 10.49 to 2.18; P=0.66) or small for gestational age infants (10%, n=195 v 10%, n=27; 1.06, 0.67 to 1.68; P=0.8) between non-smokers and stopped smokers. Current smokers had higher rates of spontaneous preterm birth (10%, n=25 v 4%, n=10; 3.21, 1.42 to 7.23; P=0.006) and small for gestational age infants (17%, n=42 v 10%, n=27; 1.76, 1.03 to 3.02; P=0.03) than stopped smokers. Conclusion In women who stopped smoking before 15 weeks' gestation, rates of spontaneous preterm birth and small for gestational age infants did not differ from those in non-smokers, indicating that these severe adverse effects of smoking may be reversible if smoking is stopped early in pregnancy.	[McCowan, Lesley M. E.; Chan, Eliza; Hunter, Misty] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Dept Obstet & Gynaecol, Auckland 1, New Zealand; [Stewart, Alistair] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Dept Epidemiol & Biostat, Auckland 1, New Zealand; [North, Robyn A.] Univ Adelaide, Sch Paediat & Reprod Hlth, Discipline Obstet & Gynaecol, Adelaide, SA 5005, Australia; [Chappell, Lucy C.] Kings Coll London, Div Reprod & Endocrinol, London, England; [Moss-Morris, Rona] Univ Southampton, Sch Psychol, Southampton SO9 5NH, Hants, England; [Dekker, Gustaaf A.] Univ Adelaide, Lyell McEwin Hosp, Women & Childrens Div, Adelaide, SA, Australia	University of Auckland; University of Auckland; University of Adelaide; University of London; King's College London; University of Southampton; Lyell McEwin Hospital; University of Adelaide	McCowan, LME (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Dept Obstet & Gynaecol, Auckland 1, New Zealand.	l.mccowan@auckland.ac.nz	McCowan, Lesley/C-2215-2009	McCowan, Lesley/0000-0001-9915-7873; Moss-Morris, Rona/0000-0002-2927-3446	New Zealand SCOPE Study; New Enterprise Research Fund; Foundation for Research Science and Technology; Health Research Council; Evelyn Bond Fund; Auckland District Health Board Charitable Trust; Australian SCOPE Study; Premier's Science and Research Fund, South Australian Government	New Zealand SCOPE Study; New Enterprise Research Fund; Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology); Health Research Council; Evelyn Bond Fund; Auckland District Health Board Charitable Trust; Australian SCOPE Study; Premier's Science and Research Fund, South Australian Government	New Zealand SCOPE Study - New Enterprise Research Fund, Foundation for Research Science and Technology; Health Research Council; Evelyn Bond Fund, Auckland District Health Board Charitable Trust. Australian SCOPE Study - Premier's Science and Research Fund, South Australian Government. The study sponsors had no role in study design, data analysis, or writing this report.	Andres R L, 2000, Semin Neonatol, V5, P231, DOI 10.1053/siny.2000.0025; BENOWITZ NL, 1983, NEW ENGL J MED, V309, P139, DOI 10.1056/NEJM198307213090303; BIBER A, 1987, TOXICOL LETT, V35, P45, DOI 10.1016/0378-4274(87)90084-1; Blalock JA, 2006, AM J ADDICTION, V15, P268, DOI 10.1080/10550490600754309; Brown MA, 2000, AUST NZ J OBSTET GYN, V40, P133, DOI 10.1111/j.1479-828X.2000.tb01136.x; BUTLER NR, 1972, BMJ-BRIT MED J, V2, P127, DOI 10.1136/bmj.2.5806.127; Castles A, 1999, AM J PREV MED, V16, P208, DOI 10.1016/S0749-3797(98)00089-0; *CDC, 1997, MMWR-MORBID MORTAL W, V46, P1048; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; Cnattingius S, 1999, NEW ENGL J MED, V341, P943, DOI 10.1056/NEJM199909233411303; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COHEN S, 1990, HEALTH PSYCHOL, V9, P466, DOI 10.1037/0278-6133.9.4.466; Ego A, 2006, AM J OBSTET GYNECOL, V194, P1042, DOI 10.1016/j.ajog.2005.10.816; Fergusson DM, 2003, PSYCHOL MED, V33, P1357, DOI 10.1017/S0033291703008596; GARDOSI JFA, 2007, CUSTOMISED CENTILE C; Gilman SE, 2008, AM J PUBLIC HEALTH, V98, P448, DOI 10.2105/AJPH.2006.102772; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P36; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; LI CQ, 1993, JAMA-J AM MED ASSOC, V269, P1519, DOI 10.1001/jama.269.12.1519; Ludman EJ, 2000, HEALTH PSYCHOL, V19, P21, DOI 10.1037/0278-6133.19.1.21; LUMLEY J, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001055.PUB2; MACARTHUR C, 1988, BRIT J OBSTET GYNAEC, V95, P551, DOI 10.1111/j.1471-0528.1988.tb09481.x; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; McCowan L, 2007, ACTRN12607000551493; Miller D P, 2001, Nicotine Tob Res, V3, P25, DOI 10.1080/14622200020032079; Peindl KS, 2004, J AFFECT DISORDERS, V80, P37, DOI 10.1016/S0165-0327(03)00052-1; Secker-Walker RH, 2003, ADDICT BEHAV, V28, P55, DOI 10.1016/S0306-4603(01)00216-7; Zhang X, 2007, BJOG-INT J OBSTET GY, V114, P474, DOI 10.1111/j.1471-0528.2007.01273.x	28	150	156	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 26	2009	338								b1081	10.1136/bmj.b1081	http://dx.doi.org/10.1136/bmj.b1081			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	425LR	19325177	Green Published, hybrid			2022-12-28	WOS:000264639700001
J	Maron, BJ; Roberts, WC; Arad, M; Haas, TS; Spirito, P; Wright, GB; Almquist, AK; Baffa, JM; Saul, JP; Ho, CY; Seidman, J; Seidman, CE				Maron, Barry J.; Roberts, William C.; Arad, Michael; Haas, Tammy S.; Spirito, Paolo; Wright, Gregory B.; Almquist, Adrian K.; Baffa, Jeanne M.; Saul, J. Philip; Ho, Carolyn Y.; Seidman, Jonathan; Seidman, Christine E.			Clinical Outcome and Phenotypic Expression in LAMP2 Cardiomyopathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYOSIN HEAVY-CHAIN; HYPERTROPHIC CARDIOMYOPATHY; DANON DISEASE; TROPONIN-T; PREVALENCE; MUTATIONS; GENE	Context Mutations in X-linked lysosome-associated membrane protein gene (LAMP2; Danon disease) produce a cardiomyopathy in young patients that clinically mimics severe hypertrophic cardiomyopathy (HCM) due to sarcomere protein mutations. However, the natural history and phenotypic expression of this newly recognized disease is incompletely resolved and its identification may have important clinical implications. Objectives To determine the clinical consequences, outcome, and phenotypic expression of LAMP2 cardiomyopathy associated with diagnostic and management strategies. Design, Setting, and Patients Clinical course and outcome were assessed prospectively in 7 young patients (6 boys) with defined LAMP2 mutations from the time of diagnosis (age 7-17 years; median, 14 years) to October 2008. Phenotypic expression of this disease was assessed both clinically and at autopsy. Main Outcome Measures Progressive heart failure, cardiac death, and transplant. Results Over a mean (SD) follow-up of 8.6 (2.6) years, and by age 14 to 24 years, the study patients developed left ventricular systolic dysfunction (mean [SD] ejection fraction, 25% [7%]) and cavity enlargement, as well as particularly adverse clinical consequences, including progressive refractory heart failure and death (n= 4), sudden death (n= 1), aborted cardiac arrest (n= 1), or heart transplantation (n= 1). Left ventricular hypertrophy was particularly marked (maximum thickness, 29-65 mm; mean [SD], 44 [15] mm), including 2 patients with massive ventricular septal thickness of 60 mm and 65 mm at ages 23 and 14 years, respectively. In 6 patients, a ventricular pre-excitation pattern at study entry was associated with markedly increased voltages of R-wave or S-wave (15-145 mm; mean [SD], 69 [39] mm), and deeply inverted T-waves. Autopsy findings included a combination of histopathologic features that were consistent with a lysosomal storage disease (ie, clusters of vacuolated myocytes) but also typical of HCM due to sarcomere protein mutations (ie, myocyte disarray, small vessel disease, myocardial scarring). Conclusions LAMP2 cardiomyopathy is a profound disease process characterized by progressive clinical deterioration leading rapidly to cardiac death in young patients (<25 years). These observations underscore the importance of timely molecular diagnosis for predicting prognosis and early consideration of heart transplantation.	[Maron, Barry J.; Haas, Tammy S.; Almquist, Adrian K.] Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN 55407 USA; [Roberts, William C.] Baylor Cardiovasc Res Inst, Dallas, TX USA; [Arad, Michael] Chaim Sheba Med Ctr, Inst Heart, Tal Hashomer, Israel; [Arad, Michael] Chaim Sheba Med Ctr, Heart Failure Serv, Tal Hashomer, Israel; [Spirito, Paolo] Osped Osped Galliera, Div Cardiol, Genoa, Italy; [Wright, Gregory B.] Childrens Heart Clin, Minneapolis, MN USA; [Baffa, Jeanne M.] Alfred I Dupont Hosp Children, Nemours Cardiac Ctr, Wilmington, DE USA; [Saul, J. Philip] Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; [Ho, Carolyn Y.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Seidman, Jonathan; Seidman, Christine E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Minneapolis Heart Institute Foundation; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Ente Ospedaliero Ospedali Galliera; Nemours Alfred I. duPont Hospital for Children; Medical University of South Carolina; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Maron, BJ (corresponding author), Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, 920 E 28th St,Ste 620, Minneapolis, MN 55407 USA.	hcm.maron@mhif.org		Ho, Carolyn/0000-0002-7334-7924	Howard Hughes Medical Institute; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084553] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding/Support: This study was supported in part by grants from the Howard Hughes Medical Institute and National Institutes of Health.	Ackerman MJ, 2002, J AM COLL CARDIOL, V39, P2042, DOI 10.1016/S0735-1097(02)01900-9; Arad M, 2005, NEW ENGL J MED, V352, P362, DOI 10.1056/NEJMoa033349; Bertini E, 2005, NEUROPEDIATRICS, V36, P309, DOI 10.1055/s-2005-872844; Charron P, 2004, HEART, V90, P842, DOI 10.1136/hrt.2003.029504; Echaniz-Laguna A, 2006, MUSCLE NERVE, V33, P393, DOI 10.1002/mus.20471; Fanin M, 2006, AM J PATHOL, V168, P1309, DOI 10.2353/ajpath.2006.050646; Harris KM, 2006, CIRCULATION, V114, P216, DOI 10.1161/CIRCULATIONAHA.105.583500; Maron BJ, 2007, JAMA-J AM MED ASSOC, V298, P405, DOI 10.1001/jama.298.4.405; Maron BJ, 2003, J AM COLL CARDIOL, V42, P882, DOI 10.1016/S0735-1097(03)00855-6; MARON BJ, 1995, CIRCULATION, V92, P2748, DOI 10.1161/01.CIR.92.9.2748; MARON BJ, 1979, CIRCULATION, V59, P689, DOI 10.1161/01.CIR.59.4.689; MARON BJ, 1986, J AM COLL CARDIOL, V8, P545, DOI 10.1016/S0735-1097(86)80181-4; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; ROBERTS CS, 1989, PROGR CARDIOLOGY, V2, P3; ROBERTS WC, 1985, AM J CARDIOL, V55, P485, DOI 10.1016/0002-9149(85)90399-6; Sugie K, 2002, NEUROLOGY, V58, P1773, DOI 10.1212/WNL.58.12.1773; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Taylor MRG, 2007, J HUM GENET, V52, P830, DOI 10.1007/s10038-007-0184-8; Van Driest SL, 2002, CIRCULATION, V106, P3085, DOI 10.1161/01.CIR.0000042675.59901.14; Varnava AM, 2001, AM J CARDIOL, V88, P275, DOI 10.1016/S0002-9149(01)01640-X; Yang Z, 2005, CIRCULATION, V112, P1612, DOI 10.1161/CIRCULATIONAHA.105.546481	22	223	240	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 25	2009	301	12					1253	1259		10.1001/jama.2009.371	http://dx.doi.org/10.1001/jama.2009.371			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423JO	19318653	Green Accepted, Bronze			2022-12-28	WOS:000264492800025
J	Summerskill, W; Collingridge, D; Frankish, H				Summerskill, William; Collingridge, David; Frankish, Helen			Protocols, probity, and publication	LANCET			English	Editorial Material							TRIALS		[Summerskill, William] The Lancet, London NW1 7BY, England; [Collingridge, David] Lancet Oncol, London NW1 7BY, England; [Frankish, Helen] Lancet Neurol, London NW1 7BY, England		Summerskill, W (corresponding author), The Lancet, London NW1 7BY, England.							Al-Marzouki S, 2008, LANCET, V372, P201, DOI 10.1016/S0140-6736(08)61060-0; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Cohen EEW, 2009, LANCET ONCOL, V10, P247, DOI 10.1016/S1470-2045(09)70002-6; Coultas David, 2007, Proc Am Thorac Soc, V4, P194, DOI 10.1513/pats.200701-007GC; De Angelis C, 2005, LANCET, V365, P1827, DOI 10.1016/S0140-6736(05)66588-9; *INT COMM MED J ED, 2008, BIOM J WRIT ED UNPUB; Lassere M, 2002, LANCET, V360, P1620, DOI 10.1016/S0140-6736(02)11652-7; McNamee D, 1997, LANCET, V350, P6, DOI 10.1016/S0140-6736(05)66237-X; McNamee D, 2008, LANCET, V372, P189, DOI 10.1016/S0140-6736(08)61053-3; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779	11	24	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					992	992		10.1016/S0140-6736(09)60590-0	http://dx.doi.org/10.1016/S0140-6736(09)60590-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	422AA	19304003				2022-12-28	WOS:000264398200011
J	Ezhkova, E; Pasolli, HA; Parker, JS; Stokes, N; Su, IH; Hannon, G; Tarakhovsky, A; Fuchs, E				Ezhkova, Elena; Pasolli, H. Amalia; Parker, Joel S.; Stokes, Nicole; Su, I-hsin; Hannon, Gregory; Tarakhovsky, Alexander; Fuchs, Elaine			Ezh2 Orchestrates Gene Expression for the Stepwise Differentiation of Tissue-Specific Stem Cells	CELL			English	Article							POLYCOMB GROUP PROTEINS; SELF-RENEWAL; DEVELOPMENTAL REGULATORS; CORNIFIED ENVELOPE; PROXIMAL PROMOTER; BMI-1; SKIN; METHYLATION; CHROMATIN; BARRIER	Although in vitro studies of embryonic stem cells have identified polycomb repressor complexes (PRCs) as key regulators of differentiation, it remains unclear as to how PRC-mediated mechanisms control fates of multipotent progenitors in developing tissues. Here, we show that an essential PRC component, Ezh2, is expressed in epidermal progenitors but diminishes concomitant with embryonic differentiation and with postnatal decline in proliferative activity. We show that Ezh2 controls proliferative potential of basal progenitors by repressing the Ink4A-Ink4B locus and tempers the developmental rate of differentiation by preventing premature recruitment of AP1 transcriptional activator to the structural genes that are required for epidermal differentiation. Together, our studies reveal that PRCs control epigenetic modifications temporally and spatially in tissue-restricted stem cells. They maintain their proliferative potential and globally repressing undesirable differentiation programs while selectively establishing a specific terminal differentiation program in a stepwise fashion.	[Ezhkova, Elena; Pasolli, H. Amalia; Stokes, Nicole; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Su, I-hsin; Tarakhovsky, Alexander] Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10065 USA; [Parker, Joel S.] Express Anal Inc, Durham, NC 27502 USA; [Su, I-hsin] Nanyang Technol Univ, Div Genom & Genet, Sch Biol Sci, Singapore 637551, Singapore; [Hannon, Gregory] Cold Spring Harbor Lab, Watson Sch Biol Sci, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Hannon, Gregory/AAB-3568-2019; Parker, Joel/AAG-1108-2019; Fuchs, Elaine/G-1565-2016; Su, I-hsin/A-2207-2011	Su, I-hsin/0000-0002-5894-9580; Pasolli, Hilda Amalia/0000-0003-3899-3530; Ezhkova, Elena/0000-0003-4154-1615	Life Sciences Research Foundation; NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452] Funding Source: NIH RePORTER	Life Sciences Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Markus Schober, Scott Williams, Greg Wang (Allis's lab), Maria Nikolova, June Racelis, Svetlana Mazel, Christopher Bare, Xiaoxuan Fan, and Agnes Viale for technical assistance and our colleagues in the Fuchs laboratory, especially Jonathan Nowak, Rui Yi, and Valerie Horsley, for constructive discussion and criticisms. E. E. is a NY Stem Cell Foundation postdoctoral fellow of the Life Sciences Research Foundation. E. F. is an HHMI Investigator. This work was supported by a grant (E. F.) from the NIH.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; DILLON N, 1993, TRENDS GENET, V9, P134, DOI 10.1016/0168-9525(93)90208-Y; DISEPIO D, 1995, J BIOL CHEM, V270, P10792, DOI 10.1074/jbc.270.18.10792; Eckert RL, 1997, J INVEST DERMATOL, V109, P501, DOI 10.1111/1523-1747.ep12336477; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Frye M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000763; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Jackson B, 2005, J INVEST DERMATOL, V124, P1062, DOI 10.1111/j.0022-202X.2005.23699.x; Jang SI, 1996, J BIOL CHEM, V271, P24105, DOI 10.1074/jbc.271.39.24105; Jaubert J, 2003, DEVELOPMENT, V130, P2767, DOI 10.1242/dev.00477; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Marshall D, 2001, P NATL ACAD SCI USA, V98, P13031, DOI 10.1073/pnas.231489198; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Patel S, 2006, P NATL ACAD SCI USA, V103, P18668, DOI 10.1073/pnas.0608658103; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; RASTELLI L, 1993, EMBO J, V12, P1513, DOI 10.1002/j.1460-2075.1993.tb05795.x; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Sauvageau M, 2008, PLOS BIOL, V6, P678, DOI 10.1371/journal.pbio.0060113; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; STEVEN AC, 1990, J STRUCT BIOL, V104, P150, DOI 10.1016/1047-8477(90)90071-J; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006	49	447	455	2	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1122	1135		10.1016/j.cell.2008.12.043	http://dx.doi.org/10.1016/j.cell.2008.12.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303854	Green Accepted, Bronze			2022-12-28	WOS:000264403900017
J	Law, JA; Jacobsen, SE				Law, Julie A.; Jacobsen, Steven E.			Dynamic DNA Methylation	SCIENCE			English	Editorial Material							EPIGENETIC INHERITANCE; ARABIDOPSIS-THALIANA; GENOME; PLANTS		[Law, Julie A.; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Law, JA (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu	Law, Julie A/A-9566-2011	Law, Julie A/0000-0001-7472-7753	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060398] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM060398-09] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Mochizuki K, 2004, CURR OPIN GENET DEV, V14, P181, DOI 10.1016/j.gde.2004.01.004; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Woo HR, 2007, GENE DEV, V21, P267, DOI 10.1101/gad.1512007	13	42	46	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 20	2009	323	5921					1568	1569		10.1126/science.1172782	http://dx.doi.org/10.1126/science.1172782			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299607				2022-12-28	WOS:000264342300025
J	Sommer, DD; Banglawala, S				Sommer, Doron D.; Banglawala, Sarfaraz			Prednisolone, but not valacyclovir, reduced time to complete recovery of facial-nerve function in Bell palsy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Sommer, Doron D.; Banglawala, Sarfaraz] McMaster Univ, Med Ctr, Hamilton, ON, Canada	McMaster University	Sommer, DD (corresponding author), McMaster Univ, Med Ctr, Hamilton, ON, Canada.		Sommer, Doron/AAQ-1761-2021	Sommer, Doron/0000-0001-9692-7414				Allen C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004753.pub2; Engstrom M, 2008, LANCET NEUROL, V7, P993, DOI 10.1016/S1474-4422(08)70221-7; Peitersen E, 2002, ACTA OTO-LARYNGOL, V122, P4, DOI 10.1080/000164802320401694; Salinas RA, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001942.PUB2; Sullivan FM, 2007, NEW ENGL J MED, V357, P1598, DOI 10.1056/NEJMoa072006	5	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6							JC3-12	10.7326/0003-4819-150-6-200903170-02012	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423AJ	19306494				2022-12-28	WOS:000264468500034
J	Sankaranarayanan, R; Nene, BM; Shastri, SS; Jayant, K; Muwonge, R; Budukh, AM; Hingmire, S; Malvi, SG; Thorat, R; Kothari, A; Chinoy, R; Kelkar, R; Kane, S; Desai, S; Keskar, VR; Rajeshwarkar, R; Panse, N; Dinshaw, KA				Sankaranarayanan, Rengaswamy; Nene, Bhagwan M.; Shastri, Surendra S.; Jayant, Kasturi; Muwonge, Richard; Budukh, Atul M.; Hingmire, Sanjay; Malvi, Sylla G.; Thorat, Ranjit; Kothari, Ashok; Chinoy, Roshan; Kelkar, Rohini; Kane, Shubhada; Desai, Sangeetha; Keskar, Vijay R.; Rajeshwarkar, Raghevendra; Panse, Nandkumar; Dinshaw, Ketayun A.			HPV Screening for Cervical Cancer in Rural India	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL	Background In October 1999, we began to measure the effect of a single round of screening by testing for human papillomavirus (HPV), cytologic testing, or visual inspection of the cervix with acetic acid (VIA) on the incidence of cervical cancer and the associated rates of death in the Osmanabad district in India. Methods In this cluster-randomized trial, 52 clusters of villages, with a total of 131,746 healthy women between the ages of 30 and 59 years, were randomly assigned to four groups of 13 clusters each. The groups were randomly assigned to undergo screening by HPV testing (34,126 women), cytologic testing (32,058), or VIA (34,074) or to receive standard care (31,488, control group). Women who had positive results on screening underwent colposcopy and directed biopsies, and those with cervical precancerous lesions or cancer received appropriate treatment. Results In the HPV-testing group, cervical cancer was diagnosed in 127 subjects (of whom 39 had stage II or higher), as compared with 118 subjects (of whom 82 had advanced disease) in the control group (hazard ratio for the detection of advanced cancer in the HPV-testing group, 0.47; 95% confidence interval [CI], 0.32 to 0.69). There were 34 deaths from cancer in the HPV-testing group, as compared with 64 in the control group (hazard ratio, 0.52; 95% CI, 0.33 to 0.83). No significant reductions in the numbers of advanced cancers or deaths were observed in the cytologic-testing group or in the VIA group, as compared with the control group. Mild adverse events were reported in 0.1% of screened women. Conclusions In a low-resource setting, a single round of HPV testing was associated with a significant reduction in the numbers of advanced cervical cancers and deaths from cervical cancer.	[Sankaranarayanan, Rengaswamy; Muwonge, Richard] Int Agcy Res Canc, F-69008 Lyon, France; [Nene, Bhagwan M.; Jayant, Kasturi; Budukh, Atul M.; Hingmire, Sanjay; Malvi, Sylla G.; Thorat, Ranjit; Kothari, Ashok; Keskar, Vijay R.; Rajeshwarkar, Raghevendra; Panse, Nandkumar] Nargis Dutt Mem Canc Hosp, Tata Mem Ctr, Rural Canc Project, Barshi, India; [Shastri, Surendra S.; Chinoy, Roshan; Kelkar, Rohini; Kane, Shubhada; Desai, Sangeetha; Dinshaw, Ketayun A.] Tata Mem Hosp, Bombay, Maharashtra, India	World Health Organization; International Agency for Research on Cancer (IARC); Tata Memorial Centre (TMC); Tata Memorial Centre (TMC); Tata Memorial Hospital	Sankaranarayanan, R (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69008 Lyon, France.	sankar@iarc.fr	Muwonge, Richard/P-6375-2015; Budukh, Atul/AAC-5675-2022	Weinberg, Clarice/0000-0002-7713-8556	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Supported by the Bill and Melinda Gates Foundation, through the Alliance for Cervical Cancer Prevention.	[Anonymous], 2021, CANC INCIDENCE 5 CON; [Anonymous], 2005, IARC HDB CANC PREVEN, V10; Denny L, 2005, JAMA-J AM MED ASSOC, V294, P2173, DOI 10.1001/jama.294.17.2173; FERLAY J, 2004, IARC CANCERBASE 5 VE; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Hermanek P., 1987, TNM CLASSIFICATION M, V4, P13; Jensen OM, 1991, IARC SCI PUBLICATION, V95; KURMAN RJ, 1991, OBSTET GYNECOL, V77, P779; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; SANKARANARAYANA.R, 2003, IARC TECHNICAL PUBLI, V41; Sankaranarayanan R, 2005, INT J CANCER, V116, P617, DOI 10.1002/ijc.21050; Sankaranarayanan R, 2001, B WORLD HEALTH ORGAN, V79, P954; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Sellors J. W., 2003, COLPOSCOPY TREATMENT; Tavassoli F A, 2003, WHO CLASSIFICATION T, V5	15	837	867	1	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2009	360	14					1385	1394		10.1056/NEJMoa0808516	http://dx.doi.org/10.1056/NEJMoa0808516			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427AL	19339719	Green Submitted, Bronze			2022-12-28	WOS:000264751800004
